[ {
  "name" : "lk_adverse_event_severity",
  "rows" : [ {
    "name" : "severity_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "Grade 1 Mild Adverse Event",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C41338",
    "description" : "A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.",
    "id" : null
  }, {
    "name" : "Grade 2 Moderate Adverse Event",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C41339",
    "description" : "A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.",
    "id" : null
  }, {
    "name" : "Grade 3 Severe Adverse Event",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C41340",
    "description" : "A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.",
    "id" : null
  }, {
    "name" : "Grade 4 Life Threatening or Disabling Adverse Event",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C41337",
    "description" : "An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.)",
    "id" : null
  }, {
    "name" : "Grade 5 Death Related to Adverse Event",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48275",
    "description" : "The termination of life as a result of an adverse event.",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "",
    "description" : "Adverse Event is not specified or not received. If no Adverse Event value is received, then this is the system default value.",
    "id" : null
  } ]
}, {
  "name" : "lk_age_event",
  "rows" : [ {
    "name" : "Age at enrollment",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000011",
    "description" : "Age Event is the Age at enrollment. In the case of a subject enrolled in multiple studies, this value is the minimum age for all the studies.",
    "id" : ""
  }, {
    "name" : "Age at infection",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000011",
    "description" : "Age Event is the Age at infection.",
    "id" : ""
  }, {
    "name" : "Age at initial treatment",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000011",
    "description" : "Age Event is the Age at initial treatment.",
    "id" : ""
  }, {
    "name" : "Age at initial vaccine administration",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000011",
    "description" : "Age Event is the Age at initial vaccine administration.",
    "id" : ""
  }, {
    "name" : "Age at Study Day 0",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000011",
    "description" : "Age Event is the Age at Study Day 0.",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000011",
    "description" : "Age Event is not specified or not received. If no Age Event value is received, then this is the system default value.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000011",
    "description" : "Age Event is some Other value not in CV Terms.",
    "id" : ""
  }, {
    "name" : "Postmenstrual age",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C114090",
    "description" : "Best estimate of the first day of last menstrual period to birth plus time elapsed from day of birth. [def-source: NCI][attr: NICHD]",
    "id" : ""
  } ]
}, {
  "name" : "lk_amount_unit",
  "rows" : [ {
    "name" : "AFU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C77534",
    "description" : "Arbitrary Fluorescence Units",
    "id" : ""
  }, {
    "name" : "AI",
    "link" : "https://www.aacc.org/publications/cln/articles/2014/june/ana-testing",
    "description" : "Antibody Index",
    "id" : ""
  }, {
    "name" : "AU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C70504",
    "description" : "Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.",
    "id" : ""
  }, {
    "name" : "cells/kg body weight",
    "link" : "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138781/",
    "description" : "Cells per kg body weight",
    "id" : ""
  }, {
    "name" : "CFU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C68902",
    "description" : "A derived unit of viable cell concentration defined as the number of colony forming units in one milliliter of substance",
    "id" : ""
  }, {
    "name" : "DK units/ml",
    "link" : "https://repository.niddk.nih.gov/studies/aab-calibrators/",
    "description" : "The NIDDK calibrators were tested together with dilutions of the WHO reference serum using harmonized assays on five occasions in the BDC, Bristol, and Munich laboratories and reported as WHO units/ml by calibration as previously described. For each of the NIDDK calibrators, the median value of the WHO units/ml obtained for the 15 measurements was assigned as its calibrator unit. The assigned units were termed digestive and kidney units (DK units)/ml.",
    "id" : ""
  }, {
    "name" : "g/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64783",
    "description" : "A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.",
    "id" : ""
  }, {
    "name" : "g/l",
    "link" : "http://purl.obolibrary.org/obo/UO_0000175",
    "description" : "grams per liter",
    "id" : ""
  }, {
    "name" : "gm",
    "link" : "http://purl.obolibrary.org/obo/UO_0000021",
    "description" : "gram",
    "id" : ""
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : ""
  }, {
    "name" : "HAU",
    "link" : "http://en.wikipedia.org/wiki/Virus_quantification",
    "description" : "hemagglutination units",
    "id" : ""
  }, {
    "name" : "IU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48579",
    "description" : "The unitage assigned by the WHO to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization (e.g. hormones, enzymes, and vaccines), to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.",
    "id" : ""
  }, {
    "name" : "iu/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67376",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.",
    "id" : ""
  }, {
    "name" : "IU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67377",
    "description" : "A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.",
    "id" : ""
  }, {
    "name" : "Kallikrein Inactivator Unit per Milliliter",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C73531",
    "description" : "An arbitrary unit of a kallikrein inactivator concentration equal to the concentration at which one milliliter of the mixture contains one unit of the kallikrein inactivator.",
    "id" : ""
  }, {
    "name" : "kg",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C28252",
    "description" : "A basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds.",
    "id" : ""
  }, {
    "name" : "l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48505",
    "description" : "The non-SI unit of volume accepted for use with the SI. One liter is equal to cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.",
    "id" : ""
  }, {
    "name" : "M",
    "link" : "http://purl.obolibrary.org/obo/UO_0000062",
    "description" : "molar",
    "id" : ""
  }, {
    "name" : "mg",
    "link" : "http://purl.obolibrary.org/obo/UO_0000022",
    "description" : "milligram",
    "id" : ""
  }, {
    "name" : "mg/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67015",
    "description" : "A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.",
    "id" : ""
  }, {
    "name" : "mg/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64572",
    "description" : "A metric unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one cubic meter. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of a substance which mass equal to one gram occupies the volume of one cubic meter.",
    "id" : ""
  }, {
    "name" : "mg/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258798001",
    "description" : "microgram per milliliter",
    "id" : ""
  }, {
    "name" : "miu/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67376",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.",
    "id" : ""
  }, {
    "name" : "ml",
    "link" : "http://purl.obolibrary.org/obo/UO_0000098",
    "description" : "milliliter",
    "id" : ""
  }, {
    "name" : "mM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000063",
    "description" : "millimolar",
    "id" : ""
  }, {
    "name" : "MOI",
    "link" : "http://en.wikipedia.org/wiki/Multiplicity_of_infection",
    "description" : "multiplicity of infection",
    "id" : ""
  }, {
    "name" : "ng",
    "link" : "http://purl.obolibrary.org/obo/UO_0000024",
    "description" : "nanogram",
    "id" : ""
  }, {
    "name" : "ng/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67326",
    "description" : "A unit of mass concentration defined as the concentration of one nanogram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume of one deciliter.",
    "id" : ""
  }, {
    "name" : "ng/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258806002",
    "description" : "nanogram per milliliter",
    "id" : ""
  }, {
    "name" : "ng/nl",
    "link" : "",
    "description" : "nanogram per nanoliter",
    "id" : ""
  }, {
    "name" : "ng/ul",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/272082007",
    "description" : "nanogram per microliter",
    "id" : ""
  }, {
    "name" : "nl",
    "link" : "http://purl.obolibrary.org/obo/UO_0000102",
    "description" : "nanoliter",
    "id" : ""
  }, {
    "name" : "nM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000065",
    "description" : "nanomolar",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : ""
  }, {
    "name" : "NPX",
    "link" : "https://www.olink.com/question/what-is-npx/",
    "description" : "NPX, Normalized Protein eXpression, is Olink's arbitrary unit which is in Log2 scale.  It is calculated from Ct values and data pre-processing (normalization) is performed to minimize both intra- and inter-assay variation. NPX data allows users to identify changes for individual protein levels across their sample set, and then use this data to establish protein signatures. The NPX scale is inverted compared to that of Ct. This means that a high NPX value equals a high protein concentration. Because NPX is in a log2 scale, a 1 NPX difference means a doubling of protein concentration. If needed NPX values can be converted into linear scale: 2^NPX= linear NPX.",
    "id" : ""
  }, {
    "name" : "optical density",
    "link" : "http://purl.obolibrary.org/obo/CHMO_0002039",
    "description" : "The measurement of the light transmitted through a sample for a given wavelength. [database_cross_reference: ISBN:038733341X]",
    "id" : ""
  }, {
    "name" : "PFU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67264",
    "description" : "Plaque-forming unit. A measure of viable infectious entities (e.g. viral particles or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope and/or to the naked eye as a plaque. A number of plaque forming units (PFU) per unit volume is a conventional way to refer the titer of an infective entity in a specimen or preparation.",
    "id" : ""
  }, {
    "name" : "PFUe",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67264",
    "description" : "Plaque-forming unit equivalents",
    "id" : ""
  }, {
    "name" : "pg",
    "link" : "http://purl.obolibrary.org/obo/UO_0000025",
    "description" : "picogram",
    "id" : ""
  }, {
    "name" : "pg/mg creatinine",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C85780",
    "description" : "Protein/Creatinine [Ratio] in Urine",
    "id" : ""
  }, {
    "name" : "pg/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67327",
    "description" : "picogram per milliliter",
    "id" : ""
  }, {
    "name" : "pg/nl",
    "link" : "",
    "description" : "picogram per nanoliter",
    "id" : ""
  }, {
    "name" : "pg/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67306",
    "description" : "picogram per microliter",
    "id" : ""
  }, {
    "name" : "pl",
    "link" : "http://purl.obolibrary.org/obo/UO_0000103",
    "description" : "picoliter",
    "id" : ""
  }, {
    "name" : "pM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000066",
    "description" : "picomolar",
    "id" : ""
  }, {
    "name" : "Pound",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48531",
    "description" : "The traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds.",
    "id" : ""
  }, {
    "name" : "TCID50",
    "link" : "http://en.wikipedia.org/wiki/Virus_quantification",
    "description" : "mean tissue culture infective dose",
    "id" : ""
  }, {
    "name" : "Thousand Cells per Microliter",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C1883312",
    "description" : "A unit of cell concentration expressed as a number of cells in thousands per unit volume equal to one microliter. Synonyms: 10E3 Cells/uL, Kcells/ul.",
    "id" : ""
  }, {
    "name" : "ug",
    "link" : "http://purl.obolibrary.org/obo/UO_0000023",
    "description" : "microgram",
    "id" : ""
  }, {
    "name" : "ug/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67305",
    "description" : "A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter.",
    "id" : ""
  }, {
    "name" : "ug/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67306",
    "description" : "A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumetric mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter.",
    "id" : ""
  }, {
    "name" : "ug/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258801007",
    "description" : "microgram per milliliter",
    "id" : ""
  }, {
    "name" : "ug/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C42576",
    "description" : "microgram per microliter",
    "id" : ""
  }, {
    "name" : "uiu/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67405",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one millionth of international unit per one milliliter of system volume.",
    "id" : ""
  }, {
    "name" : "ul",
    "link" : "http://purl.obolibrary.org/obo/UO_0000101",
    "description" : "microliter",
    "id" : ""
  }, {
    "name" : "uM",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258814008",
    "description" : "micromolar",
    "id" : ""
  }, {
    "name" : "umol/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48508",
    "description" : "A unit of concentration (molarity unit) equal to one one-millionth of a mole (10E-6 mole) of solute per one liter of solution.",
    "id" : ""
  }, {
    "name" : "units/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/259002007",
    "description" : "Enzyme Unit per Milliliter. Unit of catalytic activity concentration defined as activity equal to one enzyme unit per one milliliter of system volume.",
    "id" : ""
  } ]
}, {
  "name" : "lk_analyte",
  "rows" : [ {
    "name" : "immunology_symbol ;\nshort_label ;\nanalyte_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "- ; hHLA-A*2 ; ANA975",
    "link" : "http://purl.obolibrary.org/obo/PR_P01892",
    "description" : "HLA class I histocompatibility antigen, A-2 alpha chain (human)",
    "id" : "-"
  }, {
    "name" : "AA4 ; hCD93 ; ANA918",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NPY3",
    "description" : "complement component C1q receptor (human)",
    "id" : "-"
  }, {
    "name" : "ACKR3 ; hACKR3 ; ANA1",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/57007",
    "description" : "atypical chemokine receptor 3 (human)",
    "id" : "57007"
  }, {
    "name" : "Ackr3 ; mACKR3 ; ANA475",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12778",
    "description" : "atypical chemokine receptor 3 (mouse)",
    "id" : "12778"
  }, {
    "name" : "AFP ; AFP ; ANA704",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/174",
    "description" : "AFP (human)",
    "id" : "174"
  }, {
    "name" : "Annexin ; hANXA5 ; ANA909",
    "link" : "http://purl.obolibrary.org/obo/PR_P08758",
    "description" : "annexin A5 (human)",
    "id" : "-"
  }, {
    "name" : "B7 ; hCD80 ; ANA866",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/941",
    "description" : "T-lymphocyte activation antigen CD80 (human)",
    "id" : "941"
  }, {
    "name" : "B7-2 ; hCD86 ; ANA868",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/942",
    "description" : "T-lymphocyte activation antigen CD86 (human)",
    "id" : "942"
  }, {
    "name" : "BAFF ; hTNFSF13B ; ANA241",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/10673",
    "description" : "tumor necrosis factor ligand superfamily member 13B (human)",
    "id" : "10673"
  }, {
    "name" : "BCL2 ; hBCL2 ; ANA904",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/596",
    "description" : "apoptosis regulator Bcl-2 (human)",
    "id" : "596"
  }, {
    "name" : "Bcl2 ; mBCL2 ; ANA1005",
    "link" : "http://purl.obolibrary.org/obo/PR_P10417",
    "description" : "apoptosis regulator Bcl-2 (mouse)",
    "id" : "12043"
  }, {
    "name" : "BCL6 ; hBCL6 ; ANA910",
    "link" : "http://purl.obolibrary.org/obo/PR_P41182",
    "description" : "B-cell lymphoma 6 protein (human)",
    "id" : "-"
  }, {
    "name" : "Bcl6 ; mBCL6 ; ANA1110",
    "link" : "http://purl.obolibrary.org/obo/PR_P41183",
    "description" : "B-cell lymphoma 6 protein homolog (mouse)",
    "id" : "12053"
  }, {
    "name" : "BDCA1 ; hCD1C ; ANA895",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/911",
    "description" : "T-cell surface glycoprotein CD1c (human)",
    "id" : "911"
  }, {
    "name" : "BDCA2, CD303 ; hCLEC4C ; ANA870",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/170482",
    "description" : "C-type lectin domain family 4 member C (human)",
    "id" : "170482"
  }, {
    "name" : "BDCA3 ; hTHBD ; ANA894",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/7056",
    "description" : "thrombomodulin (human)",
    "id" : "7056"
  }, {
    "name" : "BDNF ; BDNF ; ANA701",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/627",
    "description" : "BDNF (human)",
    "id" : "627"
  }, {
    "name" : "BOB ; hGPR15 ; ANA896",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/2838",
    "description" : "G-protein coupled receptor 15 (human)",
    "id" : "2838"
  }, {
    "name" : "Caspase-3 ; hCASP3 ; ANA911",
    "link" : "http://purl.obolibrary.org/obo/PR_P42574",
    "description" : "caspase-3 (human)",
    "id" : "-"
  }, {
    "name" : "CCL1 ; hCCL1 ; ANA2",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6346",
    "description" : "C-C motif chemokine 1 (human)",
    "id" : "6346"
  }, {
    "name" : "Ccl1 ; mCCL1 ; ANA476",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20290",
    "description" : "C-C motif chemokine 1 (mouse)",
    "id" : "20290"
  }, {
    "name" : "CCL14 ; hCCL14 ; ANA5",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6358",
    "description" : "C-C motif chemokine 14 (human)",
    "id" : "6358"
  }, {
    "name" : "CCL15 ; hCCL15 ; ANA6",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6359",
    "description" : "C-C motif chemokine 15 (human)",
    "id" : "6359"
  }, {
    "name" : "CCL16 ; hCCL16 ; ANA7",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6360",
    "description" : "C-C motif chemokine 16 (human)",
    "id" : "6360"
  }, {
    "name" : "Ccl17 ; CCL17 ; ANA478",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20295",
    "description" : "C-C motif chemokine 17",
    "id" : "20295"
  }, {
    "name" : "CCL18 ; hCCL18 ; ANA9",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6362",
    "description" : "C-C motif chemokine 18 (human)",
    "id" : "6362"
  }, {
    "name" : "CCL19 ; hCCL19 ; ANA10",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6363",
    "description" : "C-C motif chemokine 19 (human)",
    "id" : "6363"
  }, {
    "name" : "Ccl19 ; mCcl19 ; ANA479",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/24047",
    "description" : "C-C motif chemokine 19 (mouse)",
    "id" : "24047"
  }, {
    "name" : "Ccl2 ; mCCL2 ; ANA480",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20296",
    "description" : "C-C motif chemokine 2 (mouse)",
    "id" : "20296"
  }, {
    "name" : "CCL20 ; hCCL20 ; ANA12",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6364",
    "description" : "C-C motif chemokine 20 (human)",
    "id" : "6364"
  }, {
    "name" : "Ccl20 ; mCCL20 ; ANA481",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20297",
    "description" : "C-C motif chemokine 20 (mouse)",
    "id" : "20297"
  }, {
    "name" : "CCL21 ; hCCL21 ; ANA13",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6366",
    "description" : "C-C motif chemokine 21 (human)",
    "id" : "6366"
  }, {
    "name" : "Ccl21a ; mCcl21a ; ANA482",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18829",
    "description" : "C-C motif chemokine 21a (mouse)",
    "id" : "18829"
  }, {
    "name" : "CCL22 ; hCCL22 ; ANA14",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6367",
    "description" : "C-C motif chemokine 22 (human)",
    "id" : "6367"
  }, {
    "name" : "Ccl22 ; mCCL22 ; ANA483",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20299",
    "description" : "C-C motif chemokine 22 (mouse)",
    "id" : "20299"
  }, {
    "name" : "CCL23 ; hCCL23 ; ANA15",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6368",
    "description" : "C-C motif chemokine 23 (human)",
    "id" : "6368"
  }, {
    "name" : "CCL24 ; hCCL24 ; ANA16",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6369",
    "description" : "C-C motif chemokine 24 (human)",
    "id" : "6369"
  }, {
    "name" : "Ccl24 ; mCCL24 ; ANA484",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56221",
    "description" : "C-C motif chemokine 24 (mouse)",
    "id" : "56221"
  }, {
    "name" : "CCL25 ; hCCL25 ; ANA17",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6370",
    "description" : "C-C motif chemokine 25 (human)",
    "id" : "6370"
  }, {
    "name" : "Ccl25 ; mCcl25 ; ANA485",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20300",
    "description" : "C-C motif chemokine 25 (mouse)",
    "id" : "20300"
  }, {
    "name" : "Ccl26 ; CCL26 ; ANA486",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/541307",
    "description" : "C-C motif chemokine 26",
    "id" : "541307"
  }, {
    "name" : "CCL26 ; hCCL26 ; ANA18",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/10344",
    "description" : "C-C motif chemokine 26 (human)",
    "id" : "10344"
  }, {
    "name" : "Ccl27a ; mCCL27 ; ANA487",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20301",
    "description" : "C-C motif chemokine 27 (mouse)",
    "id" : "20301"
  }, {
    "name" : "Ccl3 ; mCCL3 ; ANA488",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20302",
    "description" : "C-C motif chemokine 3 (mouse)",
    "id" : "20302"
  }, {
    "name" : "CCL3L1 ; CCL3L1 ; ANA21",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6349",
    "description" : "CCL3L1 (human)",
    "id" : "6349"
  }, {
    "name" : "CCL3L3 ; hCCL3L ; ANA22",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/414062",
    "description" : "C-C motif chemokine 3-like 1 (human)",
    "id" : "414062"
  }, {
    "name" : "CCL3P1 ; CCL3 ; ANA23",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/390788",
    "description" : "C-C motif chemokine 3",
    "id" : "390788"
  }, {
    "name" : "CCL4L1 ; CCL4L1 ; ANA25",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/388372",
    "description" : "CCL4L1 (human)",
    "id" : "388372"
  }, {
    "name" : "CCL4L2 ; hCCL4L ; ANA26",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/9560",
    "description" : "C-C motif chemokine 4-like (human)",
    "id" : "9560"
  }, {
    "name" : "Ccl5 ; mCCL5 ; ANA490",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20304",
    "description" : "C-C motif chemokine 5 (mouse)",
    "id" : "20304"
  }, {
    "name" : "Ccl7 ; mCCL7 ; ANA491",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20306",
    "description" : "C-C motif chemokine 7 (mouse)",
    "id" : "20306"
  }, {
    "name" : "CCL8 ; hCCL8 ; ANA29",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6355",
    "description" : "C-C motif chemokine 8 (human)",
    "id" : "6355"
  }, {
    "name" : "Ccl8 ; mCcl8 ; ANA492",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20307",
    "description" : "C-C motif chemokine 8 (mouse)",
    "id" : "20307"
  }, {
    "name" : "CCR1 ; hCCR1 ; ANA30",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1230",
    "description" : "C-C chemokine receptor type 1 (human)",
    "id" : "1230"
  }, {
    "name" : "Ccr1 ; mCCR1 ; ANA493",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12768",
    "description" : "C-C chemokine receptor type 1 (mouse)",
    "id" : "12768"
  }, {
    "name" : "CCR10 ; hCCR10 ; ANA31",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2826",
    "description" : "C-C chemokine receptor type 10 (human)",
    "id" : "2826"
  }, {
    "name" : "Ccr10 ; mCCR10 ; ANA494",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12777",
    "description" : "C-C chemokine receptor type 10 (mouse)",
    "id" : "12777"
  }, {
    "name" : "CCR2 ; hCCR2 ; ANA32",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/729230",
    "description" : "C-C chemokine receptor type 2 (human)",
    "id" : "729230"
  }, {
    "name" : "Ccr2 ; mCCR2 ; ANA495",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12772",
    "description" : "C-C chemokine receptor type 2 (mouse)",
    "id" : "12772"
  }, {
    "name" : "CCR3 ; hCCR3 ; ANA33",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1232",
    "description" : "C-C chemokine receptor type 3 (human)",
    "id" : "1232"
  }, {
    "name" : "Ccr3 ; mCCR3 ; ANA496",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12771",
    "description" : "C-C chemokine receptor type 3 (mouse)",
    "id" : "12771"
  }, {
    "name" : "CCR4 ; hCCR4 ; ANA34",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1233",
    "description" : "C-C chemokine receptor type 4 (human)",
    "id" : "1233"
  }, {
    "name" : "Ccr4 ; mCCR4 ; ANA497",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12773",
    "description" : "C-C chemokine receptor type 4 (mouse)",
    "id" : "12773"
  }, {
    "name" : "CCR5 ; hCCR5 ; ANA35",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1234",
    "description" : "C-C chemokine receptor type 5 (human)",
    "id" : "1234"
  }, {
    "name" : "Ccr5 ; mCCR5 ; ANA498",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12774",
    "description" : "C-C chemokine receptor type 5 (mouse)",
    "id" : "12774"
  }, {
    "name" : "CCR6 ; hCCR6 ; ANA36",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1235",
    "description" : "C-C chemokine receptor type 6 (human)",
    "id" : "1235"
  }, {
    "name" : "Ccr6 ; mCCR6 ; ANA499",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12458",
    "description" : "C-C chemokine receptor type 6 (mouse)",
    "id" : "12458"
  }, {
    "name" : "CCR7 ; hCCR7 ; ANA37",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1236",
    "description" : "C-C chemokine receptor type 7 (human)",
    "id" : "1236"
  }, {
    "name" : "Ccr7 ; mCCR7 ; ANA500",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12775",
    "description" : "C-C chemokine receptor type 7 (mouse)",
    "id" : "12775"
  }, {
    "name" : "CCR8 ; hCCR8 ; ANA38",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1237",
    "description" : "C-C chemokine receptor type 8 (human)",
    "id" : "1237"
  }, {
    "name" : "Ccr8 ; mCCR8 ; ANA501",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12776",
    "description" : "C-C chemokine receptor type 8 (mouse)",
    "id" : "12776"
  }, {
    "name" : "CCR9 ; hCCR9 ; ANA824",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/10803",
    "description" : "C-C chemokine receptor type 9 (human)",
    "id" : "10803"
  }, {
    "name" : "Ccr9 ; mCCR9 ; ANA502",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12769",
    "description" : "C-C chemokine receptor type 9 (mouse)",
    "id" : "12769"
  }, {
    "name" : "CCRL1 ; hCX3CR1 ; ANA59",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1524",
    "description" : "CX3C chemokine receptor 1 (human)",
    "id" : "1524"
  }, {
    "name" : "CD10 ; hMME ; ANA930",
    "link" : "http://purl.obolibrary.org/obo/PR_P08473",
    "description" : "neprilysin (human)",
    "id" : "-"
  }, {
    "name" : "CD100 ; hSEMA4D ; ANA1218",
    "link" : "http://purl.obolibrary.org/obo/PR_Q92854",
    "description" : "semaphorin-4D (human)",
    "id" : "10507"
  }, {
    "name" : "CD101 ; hCD101 ; ANA1219",
    "link" : "http://purl.obolibrary.org/obo/PR_Q93033",
    "description" : "immunoglobulin superfamily member 2 (human)",
    "id" : "9398"
  }, {
    "name" : "Cd101 ; mCD101 ; ANA942",
    "link" : "http://purl.obolibrary.org/obo/PR_A8E0Y8",
    "description" : "immunoglobulin superfamily member 2 (mouse)",
    "id" : "630146"
  }, {
    "name" : "CD102 ; hICAM2 ; ANA1025",
    "link" : "http://purl.obolibrary.org/obo/PR_P13598",
    "description" : "intercellular adhesion molecule 2 (human)",
    "id" : "3384"
  }, {
    "name" : "CD103 ; hITGAE ; ANA877",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3682",
    "description" : "integrin alpha-E (human)",
    "id" : "3682"
  }, {
    "name" : "CD104 ; hITGB4 ; ANA1043",
    "link" : "http://purl.obolibrary.org/obo/PR_P16144",
    "description" : "integrin beta-4 (human)",
    "id" : "3691"
  }, {
    "name" : "CD105 ; hENG ; ANA1050",
    "link" : "http://purl.obolibrary.org/obo/PR_P17813",
    "description" : "endoglin (human)",
    "id" : "2022"
  }, {
    "name" : "CD107a ; hLAMP1 ; ANA887",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3916",
    "description" : "lysosome-associated membrane glycoprotein 1 (human)",
    "id" : "3916"
  }, {
    "name" : "CD107b ; hLAMP2 ; ANA1024",
    "link" : "http://purl.obolibrary.org/obo/PR_P13473",
    "description" : "lysosome-associated membrane glycoprotein 2 (human)",
    "id" : "3920"
  }, {
    "name" : "CD108 ; hSEMA7A ; ANA965",
    "link" : "http://purl.obolibrary.org/obo/PR_O75326",
    "description" : "semaphorin-7A (human)",
    "id" : "8482"
  }, {
    "name" : "CD109 ; hCD109 ; ANA1188",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6YHK3",
    "description" : "CD109 antigen (human)",
    "id" : "135228"
  }, {
    "name" : "Cd109 ; mCD109 ; ANA1207",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8R422",
    "description" : "CD109 antigen (mouse)",
    "id" : "235505"
  }, {
    "name" : "CD111 ; hNECTIN1 ; ANA1158",
    "link" : "http://purl.obolibrary.org/obo/PR_Q15223",
    "description" : "nectin-1 (human)",
    "id" : "5818"
  }, {
    "name" : "CD112 ; hNECTIN2 ; ANA1217",
    "link" : "http://purl.obolibrary.org/obo/PR_Q92692",
    "description" : "nectin-2 (human)",
    "id" : "5819"
  }, {
    "name" : "CD11a ; hITGAL ; ANA1059",
    "link" : "http://purl.obolibrary.org/obo/PR_P20701",
    "description" : "integrin alpha-L (human)",
    "id" : "3683"
  }, {
    "name" : "CD11b ; hITGAM ; ANA878",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3684",
    "description" : "integrin alpha-M (human)",
    "id" : "3684"
  }, {
    "name" : "CD11c ; hITGAX ; ANA814",
    "link" : "http://purl.obolibrary.org/obo/PR_P20702",
    "description" : "integrin alpha-X (human)",
    "id" : "3687"
  }, {
    "name" : "CD11d ; hITGAD ; ANA1153",
    "link" : "http://purl.obolibrary.org/obo/PR_Q13349",
    "description" : "integrin alpha-D (human)",
    "id" : "3681"
  }, {
    "name" : "CD123 ; hIL3RA ; ANA173",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3563",
    "description" : "interleukin-3 receptor subunit alpha (human)",
    "id" : "3563"
  }, {
    "name" : "CD127 ; hIL7R ; ANA182",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3575",
    "description" : "interleukin-7 receptor subunit alpha (human)",
    "id" : "3575"
  }, {
    "name" : "CD13 ; hANPEP ; ANA1033",
    "link" : "http://purl.obolibrary.org/obo/PR_P15144",
    "description" : "aminopeptidase N (human)",
    "id" : "290"
  }, {
    "name" : "CD133 ; hPROM1 ; ANA954",
    "link" : "http://purl.obolibrary.org/obo/PR_O43490",
    "description" : "prominin-1 (human)",
    "id" : "8842"
  }, {
    "name" : "CD138 ; hSDC1 ; ANA891",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/6382",
    "description" : "syndecan-1 (human)",
    "id" : "6382"
  }, {
    "name" : "CD14 ; hCD14 ; ANA804",
    "link" : "http://purl.obolibrary.org/obo/PR_P08571",
    "description" : "monocyte differentiation antigen CD14 (human)",
    "id" : "929"
  }, {
    "name" : "Cd14 ; mCD14 ; ANA1006",
    "link" : "http://purl.obolibrary.org/obo/PR_P10810",
    "description" : "monocyte differentiation antigen CD14 (mouse)",
    "id" : "12475"
  }, {
    "name" : "CD142 ; hF3 ; ANA1028",
    "link" : "http://purl.obolibrary.org/obo/PR_P13726",
    "description" : "tissue factor (human)",
    "id" : "2152"
  }, {
    "name" : "CD143 ; hACE ; ANA1019",
    "link" : "http://purl.obolibrary.org/obo/PR_P12821",
    "description" : "angiotensin-converting enzyme (human)",
    "id" : "1636"
  }, {
    "name" : "CD144 ; hCDH5 ; ANA1095",
    "link" : "http://purl.obolibrary.org/obo/PR_P33151",
    "description" : "cadherin-5 (human)",
    "id" : "1003"
  }, {
    "name" : "CD146 ; hMCAM ; ANA1115",
    "link" : "http://purl.obolibrary.org/obo/PR_P43121",
    "description" : "cell surface glycoprotein MUC18 (human)",
    "id" : "4162"
  }, {
    "name" : "CD147 ; hBSG ; ANA1098",
    "link" : "http://purl.obolibrary.org/obo/PR_P35613",
    "description" : "basigin (human)",
    "id" : "682"
  }, {
    "name" : "CD148 ; hPTPRJ ; ANA1151",
    "link" : "http://purl.obolibrary.org/obo/PR_Q12913",
    "description" : "receptor-type tyrosine-protein phosphatase eta (human)",
    "id" : "5795"
  }, {
    "name" : "CD15 ; hFUT4 ; ANA875",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/2526",
    "description" : "alpha-(1,3)-fucosyltransferase 4 (human)",
    "id" : "2526"
  }, {
    "name" : "CD150 ; hSLAMF1 ; ANA1152",
    "link" : "http://purl.obolibrary.org/obo/PR_Q13291",
    "description" : "signaling lymphocytic activation molecule (human)",
    "id" : "6504"
  }, {
    "name" : "CD151 ; hCD151 ; ANA1119",
    "link" : "http://purl.obolibrary.org/obo/PR_P48509",
    "description" : "CD151 antigen (human)",
    "id" : "977"
  }, {
    "name" : "Cd151 ; mCD151 ; ANA953",
    "link" : "http://purl.obolibrary.org/obo/PR_O35566",
    "description" : "CD151 antigen (mouse)",
    "id" : "12476"
  }, {
    "name" : "CD152 ; hCTLA4 ; ANA871",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/1493",
    "description" : "cytotoxic T-lymphocyte protein 4 (human)",
    "id" : "1493"
  }, {
    "name" : "CD154 ; hCD40LG ; ANA43",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/959",
    "description" : "CD40 ligand (human)",
    "id" : "959"
  }, {
    "name" : "CD155 ; hPVR ; ANA1034",
    "link" : "http://purl.obolibrary.org/obo/PR_P15151",
    "description" : "poliovirus receptor (human)",
    "id" : "5817"
  }, {
    "name" : "CD156A ; hADAM8 ; ANA1131",
    "link" : "http://purl.obolibrary.org/obo/PR_P78325",
    "description" : "disintegrin and metalloproteinase domain-containing protein 8 (human)",
    "id" : "101"
  }, {
    "name" : "CD156B ; hADAM17 ; ANA1133",
    "link" : "http://purl.obolibrary.org/obo/PR_P78536",
    "description" : "disintegrin and metalloproteinase domain-containing protein 17 (human)",
    "id" : "6868"
  }, {
    "name" : "CD156c ; hADAM10 ; ANA948",
    "link" : "http://purl.obolibrary.org/obo/PR_O14672",
    "description" : "disintegrin and metalloproteinase domain-containing protein 10 (human)",
    "id" : "102"
  }, {
    "name" : "CD157 ; hBST1 ; ANA1149",
    "link" : "http://purl.obolibrary.org/obo/PR_Q10588",
    "description" : "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (human)",
    "id" : "683"
  }, {
    "name" : "CD158A ; hKIR2DL1 ; ANA879",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3802",
    "description" : "killer cell immunoglobulin-like receptor 2DL1 (human)",
    "id" : "3802"
  }, {
    "name" : "CD158B1 ; hKIR2DL2 ; ANA880",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3803",
    "description" : "killer cell immunoglobulin-like receptor 2DL2 (human)",
    "id" : "3803"
  }, {
    "name" : "CD158B2 ; hKIR2DL3 ; ANA881",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3804",
    "description" : "killer cell immunoglobulin-like receptor 2DL3 (human)",
    "id" : "3804"
  }, {
    "name" : "CD158D ; hKIR2DL4 ; ANA1224",
    "link" : "http://purl.obolibrary.org/obo/PR_Q99706",
    "description" : "killer cell immunoglobulin-like receptor 2DL4 (human)",
    "id" : "3805"
  }, {
    "name" : "CD158E1 ; hKIR3DL1 ; ANA882",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3811",
    "description" : "killer cell immunoglobulin-like receptor 3DL1 (human)",
    "id" : "3811"
  }, {
    "name" : "CD158F ; hKIR2DL5A ; ANA1199",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8N109",
    "description" : "killer cell immunoglobulin-like receptor 2DL5A (human)",
    "id" : "57292"
  }, {
    "name" : "CD158G ; hKIR2DS5 ; ANA1156",
    "link" : "http://purl.obolibrary.org/obo/PR_Q14953",
    "description" : "killer cell immunoglobulin-like receptor 2DS5 (human)",
    "id" : "3810"
  }, {
    "name" : "CD158H ; hKIR2DS1 ; ANA1157",
    "link" : "http://purl.obolibrary.org/obo/PR_Q14954",
    "description" : "killer cell immunoglobulin-like receptor 2DS1 (human)",
    "id" : "3806"
  }, {
    "name" : "CD158i ; hKIR2DS4 ; ANA1118",
    "link" : "http://purl.obolibrary.org/obo/PR_P43632",
    "description" : "killer cell immunoglobulin-like receptor 2DS4 (human)",
    "id" : "3809"
  }, {
    "name" : "CD158J ; hKIR2DS2 ; ANA1117",
    "link" : "http://purl.obolibrary.org/obo/PR_P43631",
    "description" : "killer cell immunoglobulin-like receptor 2DS2 (human)",
    "id" : "100132285"
  }, {
    "name" : "CD158k ; hKIR3DL2 ; ANA1116",
    "link" : "http://purl.obolibrary.org/obo/PR_P43630",
    "description" : "killer cell immunoglobulin-like receptor 3DL2 (human)",
    "id" : "3812"
  }, {
    "name" : "CD158z ; hKIR3DL3 ; ANA1204",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8N743",
    "description" : "killer cell immunoglobulin-like receptor 3DL3 (human)",
    "id" : "-"
  }, {
    "name" : "CD159c ; hKLRC2 ; ANA1080",
    "link" : "http://purl.obolibrary.org/obo/PR_P26717",
    "description" : "NKG2-C type II integral membrane protein (human)",
    "id" : "3822"
  }, {
    "name" : "CD16 ; hFCGR3A ; ANA811",
    "link" : "http://purl.obolibrary.org/obo/PR_P08637",
    "description" : "low affinity immunoglobulin gamma Fc region receptor III-A (human)",
    "id" : "2214"
  }, {
    "name" : "CD160 ; hCD160 ; ANA973",
    "link" : "http://purl.obolibrary.org/obo/PR_O95971",
    "description" : "CD160 antigen (human)",
    "id" : "11126"
  }, {
    "name" : "Cd160 ; mCD160 ; ANA970",
    "link" : "http://purl.obolibrary.org/obo/PR_O88875",
    "description" : "CD160 antigen (mouse)",
    "id" : "54215"
  }, {
    "name" : "CD161 ; hKLRB1 ; ANA883",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3820",
    "description" : "killer cell lectin-like receptor subfamily B member 1 (human)",
    "id" : "3820"
  }, {
    "name" : "CD163 ; hCD163 ; ANA1192",
    "link" : "http://purl.obolibrary.org/obo/PR_Q86VB7",
    "description" : "scavenger receptor cysteine-rich type 1 protein M130 (human)",
    "id" : "9332"
  }, {
    "name" : "Cd163 ; mCD163 ; ANA1164",
    "link" : "http://purl.obolibrary.org/obo/PR_Q2VLH6",
    "description" : "scavenger receptor cysteine-rich type 1 protein M130 (mouse)",
    "id" : "93671"
  }, {
    "name" : "CD164 ; hCD164 ; ANA1141",
    "link" : "http://purl.obolibrary.org/obo/PR_Q04900",
    "description" : "sialomucin core protein 24 (human)",
    "id" : "8763"
  }, {
    "name" : "Cd164 ; mCD164 ; ANA1250",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9R0L9",
    "description" : "sialomucin core protein 24 (mouse)",
    "id" : "53599"
  }, {
    "name" : "Cd164l2 ; mCD164L2 ; ANA1229",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9D6W7",
    "description" : "CD164 sialomucin-like 2 protein (mouse)",
    "id" : "69655"
  }, {
    "name" : "CD166 ; hALCAM ; ANA1154",
    "link" : "http://purl.obolibrary.org/obo/PR_Q13740",
    "description" : "CD166 antigen (human)",
    "id" : "214"
  }, {
    "name" : "CD167 ; hDDR1 ; ANA1145",
    "link" : "http://purl.obolibrary.org/obo/PR_Q08345",
    "description" : "epithelial discoidin domain-containing receptor 1 (human)",
    "id" : "780"
  }, {
    "name" : "CD168 ; hHMMR ; ANA966",
    "link" : "http://purl.obolibrary.org/obo/PR_O75330",
    "description" : "hyaluronan mediated motility receptor (human)",
    "id" : "3161"
  }, {
    "name" : "CD169 ; hSIGLEC1 ; ANA1227",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9BZZ2",
    "description" : "sialoadhesin (human)",
    "id" : "6614"
  }, {
    "name" : "CD16b ; hFCGR3B ; ANA960",
    "link" : "http://purl.obolibrary.org/obo/PR_O75015",
    "description" : "low affinity immunoglobulin gamma Fc region receptor III-B (human)",
    "id" : "2215"
  }, {
    "name" : "CD170 ; hSIGLEC5 ; ANA951",
    "link" : "http://purl.obolibrary.org/obo/PR_O15389",
    "description" : "sialic acid-binding Ig-like lectin 5 (human)",
    "id" : "8778"
  }, {
    "name" : "CD171 ; hL1CAM ; ANA1092",
    "link" : "http://purl.obolibrary.org/obo/PR_P32004",
    "description" : "neural cell adhesion molecule L1 (human)",
    "id" : "3897"
  }, {
    "name" : "CD172a ; hSIRPA ; ANA1130",
    "link" : "http://purl.obolibrary.org/obo/PR_P78324",
    "description" : "tyrosine-protein phosphatase non-receptor type substrate 1 (human)",
    "id" : "140885"
  }, {
    "name" : "CD172b ; hSIRPB1 ; ANA935",
    "link" : "http://purl.obolibrary.org/obo/PR_000026875",
    "description" : "signal-regulatory protein beta-1 (human)",
    "id" : "10326"
  }, {
    "name" : "CD172g ; hSIRPG ; ANA1247",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9P1W8",
    "description" : "signal-regulatory protein gamma (human)",
    "id" : "55423"
  }, {
    "name" : "CD174 ; hFUT3 ; ANA1061",
    "link" : "http://purl.obolibrary.org/obo/PR_P21217",
    "description" : "galactoside 3(4)-L-fucosyltransferase (human)",
    "id" : "2525"
  }, {
    "name" : "CD177 ; hCD177 ; ANA1203",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8N6Q3",
    "description" : "CD177 antigen (human)",
    "id" : "57126"
  }, {
    "name" : "Cd177 ; mCd177 ; ANA1206",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8R2S8",
    "description" : "CD177 antigen (mouse)",
    "id" : "68891"
  }, {
    "name" : "CD179a ; hVPREB1 ; ANA1017",
    "link" : "http://purl.obolibrary.org/obo/PR_P12018",
    "description" : "immunoglobulin iota chain (human)",
    "id" : "7441"
  }, {
    "name" : "CD179B ; hIGLL1 ; ANA1040",
    "link" : "http://purl.obolibrary.org/obo/PR_P15814",
    "description" : "immunoglobulin lambda-like polypeptide 1 (human)",
    "id" : "3543"
  }, {
    "name" : "CD18 ; hITGB2 ; ANA985",
    "link" : "http://purl.obolibrary.org/obo/PR_P05107",
    "description" : "integrin beta-2 (human)",
    "id" : "3689"
  }, {
    "name" : "CD180 ; hCD180 ; ANA1223",
    "link" : "http://purl.obolibrary.org/obo/PR_Q99467",
    "description" : "CD180 antigen (human)",
    "id" : "4064"
  }, {
    "name" : "Cd180 ; mCD180 ; ANA1176",
    "link" : "http://purl.obolibrary.org/obo/PR_Q62192",
    "description" : "CD180 antigen (mouse)",
    "id" : "17079"
  }, {
    "name" : "CD19 ; hCD19 ; ANA805",
    "link" : "http://purl.obolibrary.org/obo/PR_P15391",
    "description" : "B-lymphocyte antigen CD19 (human)",
    "id" : "930"
  }, {
    "name" : "Cd19 ; mCD19 ; ANA1078",
    "link" : "http://purl.obolibrary.org/obo/PR_P25918",
    "description" : "B-lymphocyte antigen CD19 (mouse)",
    "id" : "12478"
  }, {
    "name" : "CD1a ; hCD1A ; ANA988",
    "link" : "http://purl.obolibrary.org/obo/PR_P06126",
    "description" : "T-cell surface glycoprotein CD1a (human)",
    "id" : "909"
  }, {
    "name" : "CD1b ; hCD1B ; ANA1084",
    "link" : "http://purl.obolibrary.org/obo/PR_P29016",
    "description" : "T-cell surface glycoprotein CD1b (human)",
    "id" : "910"
  }, {
    "name" : "CD1d ; hCD1D ; ANA1039",
    "link" : "http://purl.obolibrary.org/obo/PR_P15813",
    "description" : "antigen-presenting glycoprotein CD1d (human)",
    "id" : "912"
  }, {
    "name" : "Cd1d1 ; mCD1D ; ANA1011",
    "link" : "http://purl.obolibrary.org/obo/PR_P11609",
    "description" : "antigen-presenting glycoprotein CD1d1 (mouse)",
    "id" : "12479"
  }, {
    "name" : "Cd1d2 ; mCd1d2 ; ANA1012",
    "link" : "http://purl.obolibrary.org/obo/PR_P11610",
    "description" : "antigen-presenting glycoprotein CD1d2 (mouse)",
    "id" : "12480"
  }, {
    "name" : "CD1e ; hCD1E ; ANA1038",
    "link" : "http://purl.obolibrary.org/obo/PR_P15812",
    "description" : "T-cell surface glycoprotein CD1e, membrane-associated (human)",
    "id" : "913"
  }, {
    "name" : "CD2 ; hCD2 ; ANA860",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/914",
    "description" : "T-cell surface antigen CD2 (human)",
    "id" : "914"
  }, {
    "name" : "Cd2 ; mCD2 ; ANA1000",
    "link" : "http://purl.obolibrary.org/obo/PR_P08920",
    "description" : "T-cell surface antigen CD2 (mouse)",
    "id" : "12481"
  }, {
    "name" : "CD20 ; hMS4A1 ; ANA806",
    "link" : "http://purl.obolibrary.org/obo/PR_P11836",
    "description" : "B-lymphocyte antigen CD20 (human)",
    "id" : "931"
  }, {
    "name" : "CD200 ; hCD200 ; ANA1111",
    "link" : "http://purl.obolibrary.org/obo/PR_P41217",
    "description" : "OX-2 membrane glycoprotein (human)",
    "id" : "4345"
  }, {
    "name" : "Cd200 ; mCD200 ; ANA956",
    "link" : "http://purl.obolibrary.org/obo/PR_O54901",
    "description" : "OX-2 membrane glycoprotein (mouse)",
    "id" : "-"
  }, {
    "name" : "Cd200r1 ; mCd200r1 ; ANA1232",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9ES57",
    "description" : "cell surface glycoprotein CD200 receptor 1 (mouse)",
    "id" : "57781"
  }, {
    "name" : "Cd200r2 ; mCD200R1L ; ANA1187",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6XJV6",
    "description" : "cell surface glycoprotein CD200 receptor 2 (mouse)",
    "id" : "271375"
  }, {
    "name" : "Cd200r3 ; mCd200r3 ; ANA1168",
    "link" : "http://purl.obolibrary.org/obo/PR_Q5UKY4",
    "description" : "cell surface glycoprotein CD200 receptor 3 (mouse)",
    "id" : "74603"
  }, {
    "name" : "Cd200r4 ; mCd200r4 ; ANA1186",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6XJV4",
    "description" : "cell surface glycoprotein CD200 receptor 4 (mouse)",
    "id" : "239849"
  }, {
    "name" : "CD201 ; hPROCR ; ANA1259",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UNN8",
    "description" : "endothelial protein C receptor (human)",
    "id" : "10544"
  }, {
    "name" : "CD202b ; hTEK ; ANA1139",
    "link" : "http://purl.obolibrary.org/obo/PR_Q02763",
    "description" : "angiopoietin-1 receptor (human)",
    "id" : "7010"
  }, {
    "name" : "CD203c ; hENPP3 ; ANA947",
    "link" : "http://purl.obolibrary.org/obo/PR_O14638",
    "description" : "ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (human)",
    "id" : "5169"
  }, {
    "name" : "CD204 ; hMSR1 ; ANA1064",
    "link" : "http://purl.obolibrary.org/obo/PR_P21757",
    "description" : "macrophage scavenger receptor types I and II (human)",
    "id" : "4481"
  }, {
    "name" : "CD205 ; hLY75 ; ANA937",
    "link" : "http://purl.obolibrary.org/obo/PR_000034294",
    "description" : "lymphocyte antigen 75 (human)",
    "id" : "4065"
  }, {
    "name" : "CD206 ; hMRC1 ; ANA1072",
    "link" : "http://purl.obolibrary.org/obo/PR_P22897",
    "description" : "macrophage mannose receptor 1 (human)",
    "id" : "4360"
  }, {
    "name" : "CD207 ; hCD207 ; ANA1255",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UJ71",
    "description" : "C-type lectin domain family 4 member K (human)",
    "id" : "50489"
  }, {
    "name" : "Cd207 ; mCD207 ; ANA1208",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8VBX4",
    "description" : "C-type lectin domain family 4 member K (mouse)",
    "id" : "246278"
  }, {
    "name" : "CD208 ; hLAMP3 ; ANA1261",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UQV4",
    "description" : "lysosome-associated membrane glycoprotein 3 (human)",
    "id" : "27074"
  }, {
    "name" : "Cd209a ; mCd209a ; ANA1216",
    "link" : "http://purl.obolibrary.org/obo/PR_Q91ZX1",
    "description" : "CD209 antigen-like protein A (mouse)",
    "id" : "170786"
  }, {
    "name" : "Cd209b ; mCd209b ; ANA1194",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8CJ91",
    "description" : "CD209 antigen-like protein B (mouse)",
    "id" : "69165"
  }, {
    "name" : "Cd209c ; mCd209c ; ANA1215",
    "link" : "http://purl.obolibrary.org/obo/PR_Q91ZW9",
    "description" : "CD209 antigen-like protein C (mouse)",
    "id" : "170776"
  }, {
    "name" : "Cd209d ; mCd209d ; ANA1214",
    "link" : "http://purl.obolibrary.org/obo/PR_Q91ZW8",
    "description" : "CD209 antigen-like protein D (mouse)",
    "id" : "170779"
  }, {
    "name" : "Cd209e ; mCd209e ; ANA1213",
    "link" : "http://purl.obolibrary.org/obo/PR_Q91ZW7",
    "description" : "CD209 antigen-like protein E (mouse)",
    "id" : "170780"
  }, {
    "name" : "CD21 ; hCR2 ; ANA919",
    "link" : "http://purl.obolibrary.org/obo/PR_P20023",
    "description" : "complement receptor type 2 (human)",
    "id" : "-"
  }, {
    "name" : "CD213A1 ; hIL13RA1 ; ANA128",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3597",
    "description" : "interleukin-13 receptor subunit alpha-1 (human)",
    "id" : "3597"
  }, {
    "name" : "CD213A2 ; hIL13RA2 ; ANA129",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3598",
    "description" : "interleukin-13 receptor subunit alpha-2 (human)",
    "id" : "3598"
  }, {
    "name" : "Cd22 ; mCD22 ; ANA1097",
    "link" : "http://purl.obolibrary.org/obo/PR_P35329",
    "description" : "B-cell receptor CD22 (mouse)",
    "id" : "12483"
  }, {
    "name" : "CD220 ; hINSR ; ANA989",
    "link" : "http://purl.obolibrary.org/obo/PR_P06213",
    "description" : "insulin receptor (human)",
    "id" : "3643"
  }, {
    "name" : "CD221 ; hIGF1R ; ANA993",
    "link" : "http://purl.obolibrary.org/obo/PR_P08069",
    "description" : "insulin-like growth factor 1 receptor (human)",
    "id" : "3480"
  }, {
    "name" : "CD222 ; hIGF2R ; ANA1013",
    "link" : "http://purl.obolibrary.org/obo/PR_P11717",
    "description" : "cation-independent mannose-6-phosphate receptor (human)",
    "id" : "3482"
  }, {
    "name" : "CD223 ; hLAG3 ; ANA1054",
    "link" : "http://purl.obolibrary.org/obo/PR_P18627",
    "description" : "lymphocyte activation gene 3 protein (human)",
    "id" : "3902"
  }, {
    "name" : "CD224 ; hGGT1 ; ANA1058",
    "link" : "http://purl.obolibrary.org/obo/PR_P19440",
    "description" : "glutathione hydrolase 1 proenzyme (human)",
    "id" : "2678"
  }, {
    "name" : "CD225 ; hIFITM1 ; ANA1021",
    "link" : "http://purl.obolibrary.org/obo/PR_P13164",
    "description" : "interferon-induced transmembrane protein 1 (human)",
    "id" : "8519"
  }, {
    "name" : "CD226 ; hCD226 ; ANA1160",
    "link" : "http://purl.obolibrary.org/obo/PR_Q15762",
    "description" : "CD226 antigen (human)",
    "id" : "10666"
  }, {
    "name" : "Cd226 ; mCD226 ; ANA1198",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8K4F0",
    "description" : "CD226 antigen (mouse)",
    "id" : "225825"
  }, {
    "name" : "CD227 ; hMUC1 ; ANA1041",
    "link" : "http://purl.obolibrary.org/obo/PR_P15941",
    "description" : "mucin-1 (human)",
    "id" : "4582"
  }, {
    "name" : "CD228 ; hMELTF ; ANA998",
    "link" : "http://purl.obolibrary.org/obo/PR_P08582",
    "description" : "melanotransferrin (human)",
    "id" : "4241"
  }, {
    "name" : "CD229 ; hLY9 ; ANA1235",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9HBG7",
    "description" : "T-lymphocyte surface antigen Ly-9 (human)",
    "id" : "4063"
  }, {
    "name" : "CD23 ; hFCER2 ; ANA922",
    "link" : "http://purl.obolibrary.org/obo/PR_P06734",
    "description" : "low affinity immunoglobulin epsilon Fc receptor (human)",
    "id" : "-"
  }, {
    "name" : "CD230 ; hPRNP ; ANA936",
    "link" : "http://purl.obolibrary.org/obo/PR_000030020",
    "description" : "major prion protein (human)",
    "id" : "5621"
  }, {
    "name" : "CD231 ; hTSPAN7 ; ANA1113",
    "link" : "http://purl.obolibrary.org/obo/PR_P41732",
    "description" : "tetraspanin-7 (human)",
    "id" : "7102"
  }, {
    "name" : "CD232 ; hPLXNC1 ; ANA958",
    "link" : "http://purl.obolibrary.org/obo/PR_O60486",
    "description" : "plexin-C1 (human)",
    "id" : "10154"
  }, {
    "name" : "CD233 ; hSLC4A1 ; ANA977",
    "link" : "http://purl.obolibrary.org/obo/PR_P02730",
    "description" : "band 3 anion transport protein (human)",
    "id" : "6521"
  }, {
    "name" : "CD234 ; hACKR1 ; ANA1161",
    "link" : "http://purl.obolibrary.org/obo/PR_Q16570",
    "description" : "atypical chemokine receptor 1 (human)",
    "id" : "2532"
  }, {
    "name" : "CD235a ; hGYPA ; ANA976",
    "link" : "http://purl.obolibrary.org/obo/PR_P02724",
    "description" : "glycophorin-A (human)",
    "id" : "2993"
  }, {
    "name" : "CD235b ; hGYPB ; ANA987",
    "link" : "http://purl.obolibrary.org/obo/PR_P06028",
    "description" : "glycophorin-B (human)",
    "id" : "2994"
  }, {
    "name" : "CD236R ; hGYPC ; ANA983",
    "link" : "http://purl.obolibrary.org/obo/PR_P04921",
    "description" : "glycophorin-C (human)",
    "id" : "2995"
  }, {
    "name" : "CD238 ; hKEL ; ANA1073",
    "link" : "http://purl.obolibrary.org/obo/PR_P23276",
    "description" : "kell blood group glycoprotein (human)",
    "id" : "3792"
  }, {
    "name" : "CD239 ; hBCAM ; ANA1122",
    "link" : "http://purl.obolibrary.org/obo/PR_P50895",
    "description" : "basal cell adhesion molecule (human)",
    "id" : "4059"
  }, {
    "name" : "CD24 ; hCD24 ; ANA807",
    "link" : "http://purl.obolibrary.org/obo/PR_P25063",
    "description" : "signal transducer CD24 (human)",
    "id" : "100133941"
  }, {
    "name" : "CD240CE ; hRHCE ; ANA1053",
    "link" : "http://purl.obolibrary.org/obo/PR_P18577",
    "description" : "blood group Rh(CE) polypeptide (human)",
    "id" : "6006"
  }, {
    "name" : "CD240D ; hRHD ; ANA1138",
    "link" : "http://purl.obolibrary.org/obo/PR_Q02161",
    "description" : "blood group Rh(D) polypeptide (human)",
    "id" : "6007"
  }, {
    "name" : "CD241 ; hRHAG ; ANA1137",
    "link" : "http://purl.obolibrary.org/obo/PR_Q02094",
    "description" : "ammonium transporter Rh type A (human)",
    "id" : "6005"
  }, {
    "name" : "CD242 ; hICAM4 ; ANA1155",
    "link" : "http://purl.obolibrary.org/obo/PR_Q14773",
    "description" : "intercellular adhesion molecule 4 (human)",
    "id" : "3386"
  }, {
    "name" : "CD243 ; hABCB1 ; ANA996",
    "link" : "http://purl.obolibrary.org/obo/PR_P08183",
    "description" : "multidrug resistance protein 1 (human)",
    "id" : "5243"
  }, {
    "name" : "CD244 ; hCD244 ; ANA1226",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9BZW8",
    "description" : "natural killer cell receptor 2B4 (human)",
    "id" : "51744"
  }, {
    "name" : "Cd244a ; mCD244 ; ANA1143",
    "link" : "http://purl.obolibrary.org/obo/PR_Q07763",
    "description" : "natural killer cell receptor 2B4 (mouse)",
    "id" : "18106"
  }, {
    "name" : "CD246 ; hALK ; ANA1258",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UM73",
    "description" : "ALK tyrosine kinase receptor (human)",
    "id" : "238"
  }, {
    "name" : "CD247 ; hCD247 ; ANA1060",
    "link" : "http://purl.obolibrary.org/obo/PR_P20963",
    "description" : "T-cell surface glycoprotein CD3 (human)",
    "id" : "919"
  }, {
    "name" : "Cd247 ; mCD247 ; ANA1076",
    "link" : "http://purl.obolibrary.org/obo/PR_P24161",
    "description" : "T-cell surface glycoprotein CD3 isoforms eta/zeta (mouse)",
    "id" : "12503"
  }, {
    "name" : "CD248 ; hCD248 ; ANA1236",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9HCU0",
    "description" : "endosialin (human)",
    "id" : "57124"
  }, {
    "name" : "Cd248 ; mCD248 ; ANA1212",
    "link" : "http://purl.obolibrary.org/obo/PR_Q91V98",
    "description" : "endosialin (mouse)",
    "id" : "70445"
  }, {
    "name" : "CD249 ; hENPEP ; ANA1142",
    "link" : "http://purl.obolibrary.org/obo/PR_Q07075",
    "description" : "glutamyl aminopeptidase (human)",
    "id" : "2028"
  }, {
    "name" : "Cd24a ; mCD24 ; ANA1077",
    "link" : "http://purl.obolibrary.org/obo/PR_P24807",
    "description" : "signal transducer CD24 (mouse)",
    "id" : "12484"
  }, {
    "name" : "CD26 ; hDPP4 ; ANA1081",
    "link" : "http://purl.obolibrary.org/obo/PR_P27487",
    "description" : "dipeptidyl peptidase 4 (human)",
    "id" : "1803"
  }, {
    "name" : "CD266 ; hTNFRSF12A ; ANA1240",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NP84",
    "description" : "tumor necrosis factor receptor superfamily member 12A (human)",
    "id" : "51330"
  }, {
    "name" : "CD268 ; hTNFRSF13C ; ANA1222",
    "link" : "http://purl.obolibrary.org/obo/PR_Q96RJ3",
    "description" : "tumor necrosis factor receptor superfamily member 13C (human)",
    "id" : "115650"
  }, {
    "name" : "CD27 ; hCD27 ; ANA40",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/939",
    "description" : "CD27 antigen (human)",
    "id" : "939"
  }, {
    "name" : "Cd27 ; mCD27 ; ANA503",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21940",
    "description" : "CD27 antigen (mouse)",
    "id" : "21940"
  }, {
    "name" : "CD271 ; hNGFR ; ANA994",
    "link" : "http://purl.obolibrary.org/obo/PR_P08138",
    "description" : "tumor necrosis factor receptor superfamily member 16 (human)",
    "id" : "4804"
  }, {
    "name" : "CD272 ; hBTLA ; ANA1191",
    "link" : "http://purl.obolibrary.org/obo/PR_Q7Z6A9",
    "description" : "B- and T-lymphocyte attenuator (human)",
    "id" : "151888"
  }, {
    "name" : "CD274 ; hCD274 ; ANA1246",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NZQ7",
    "description" : "programmed cell death 1 ligand 1 (human)",
    "id" : "29126"
  }, {
    "name" : "Cd274 ; mCD274 ; ANA1231",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9EP73",
    "description" : "programmed cell death 1 ligand 1 (mouse)",
    "id" : "60533"
  }, {
    "name" : "CD275 ; hICOSLG ; ANA964",
    "link" : "http://purl.obolibrary.org/obo/PR_O75144",
    "description" : "ICOS ligand (human)",
    "id" : "23308"
  }, {
    "name" : "CD276 ; hCD276 ; ANA1169",
    "link" : "http://purl.obolibrary.org/obo/PR_Q5ZPR3",
    "description" : "CD276 antigen (human)",
    "id" : "80381"
  }, {
    "name" : "Cd276 ; mCD276 ; ANA1210",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8VE98",
    "description" : "CD276 antigen (mouse)",
    "id" : "102657"
  }, {
    "name" : "CD277 ; hBTN3A1 ; ANA946",
    "link" : "http://purl.obolibrary.org/obo/PR_O00481",
    "description" : "butyrophilin subfamily 3 member A1 (human)",
    "id" : "11119"
  }, {
    "name" : "CD278 ; hICOS ; ANA898",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/29851",
    "description" : "inducible T-cell costimulator (human)",
    "id" : "29851"
  }, {
    "name" : "CD28 ; hCD28 ; ANA863",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/940",
    "description" : "T-cell-specific surface glycoprotein CD28 (human)",
    "id" : "940"
  }, {
    "name" : "Cd28 ; mCD28 ; ANA1086",
    "link" : "http://purl.obolibrary.org/obo/PR_P31041",
    "description" : "T-cell-specific surface glycoprotein CD28 (mouse)",
    "id" : "12487"
  }, {
    "name" : "CD280 ; hMRC2 ; ANA1251",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UBG0",
    "description" : "C-type mannose receptor 2 (human)",
    "id" : "9902"
  }, {
    "name" : "CD281 ; hTLR1 ; ANA1159",
    "link" : "http://purl.obolibrary.org/obo/PR_Q15399",
    "description" : "Toll-like receptor 1 (human)",
    "id" : "7096"
  }, {
    "name" : "CD282 ; hTLR2 ; ANA959",
    "link" : "http://purl.obolibrary.org/obo/PR_O60603",
    "description" : "Toll-like receptor 2 (human)",
    "id" : "7097"
  }, {
    "name" : "CD283 ; hTLR3 ; ANA952",
    "link" : "http://purl.obolibrary.org/obo/PR_O15455",
    "description" : "Toll-like receptor 3 (human)",
    "id" : "7098"
  }, {
    "name" : "CD284 ; hTLR4 ; ANA944",
    "link" : "http://purl.obolibrary.org/obo/PR_O00206",
    "description" : "Toll-like receptor 4 (human)",
    "id" : "7099"
  }, {
    "name" : "CD288 ; hTLR8 ; ANA1245",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NR97",
    "description" : "Toll-like receptor 8 (human)",
    "id" : "51311"
  }, {
    "name" : "CD289 ; hTLR9 ; ANA1244",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NR96",
    "description" : "Toll-like receptor 9 (human)",
    "id" : "54106"
  }, {
    "name" : "CD29 ; hITGB1 ; ANA986",
    "link" : "http://purl.obolibrary.org/obo/PR_P05556",
    "description" : "integrin beta-1 (human)",
    "id" : "3688"
  }, {
    "name" : "CD290 ; hTLR10 ; ANA1225",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9BXR5",
    "description" : "Toll-like receptor 10 (human)",
    "id" : "81793"
  }, {
    "name" : "CD292 ; hBMPR1A ; ANA1101",
    "link" : "http://purl.obolibrary.org/obo/PR_P36894",
    "description" : "bone morphogenetic protein receptor type-1A (human)",
    "id" : "657"
  }, {
    "name" : "CD294 ; hPTGDR2 ; ANA1264",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9Y5Y4",
    "description" : "prostaglandin D2 receptor 2 (human)",
    "id" : "11251"
  }, {
    "name" : "CD295 ; hLEPR ; ANA899",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3953",
    "description" : "leptin receptor (human)",
    "id" : "3953"
  }, {
    "name" : "CD296 ; hART1 ; ANA1123",
    "link" : "http://purl.obolibrary.org/obo/PR_P52961",
    "description" : "GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 (human)",
    "id" : "417"
  }, {
    "name" : "CD297 ; hART4 ; ANA1220",
    "link" : "http://purl.obolibrary.org/obo/PR_Q93070",
    "description" : "ecto-ADP-ribosyltransferase 4 (human)",
    "id" : "420"
  }, {
    "name" : "CD298 ; hATP1B3 ; ANA1124",
    "link" : "http://purl.obolibrary.org/obo/PR_P54709",
    "description" : "sodium/potassium-transporting ATPase subunit beta-3 (human)",
    "id" : "483"
  }, {
    "name" : "CD299 ; hCLEC4M ; ANA1233",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9H2X3",
    "description" : "C-type lectin domain family 4 member M (human)",
    "id" : "10332"
  }, {
    "name" : "Cd2ap ; mCD2AP ; ANA1239",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9JLQ0",
    "description" : "CD2-associated protein (mouse)",
    "id" : "12488"
  }, {
    "name" : "Cd2bp2 ; mCD2BP2 ; ANA1228",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9CWK3",
    "description" : "CD2 antigen cytoplasmic tail-binding protein 2 (mouse)",
    "id" : "70233"
  }, {
    "name" : "CD3 ; hCD3E ; ANA809",
    "link" : "http://purl.obolibrary.org/obo/PR_P07766",
    "description" : "T-cell surface glycoprotein CD3 epsilon chain (human)",
    "id" : "916"
  }, {
    "name" : "CD300a ; hCD300A ; ANA1252",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UGN4",
    "description" : "CMRF35-like molecule 8 (human)",
    "id" : "11314"
  }, {
    "name" : "Cd300a ; mCD300A ; ANA1183",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6SJQ0",
    "description" : "CMRF35-like molecule 8 (mouse)",
    "id" : "217303"
  }, {
    "name" : "CD300c ; hCD300C ; ANA1146",
    "link" : "http://purl.obolibrary.org/obo/PR_Q08708",
    "description" : "CMRF35-like molecule 6 (human)",
    "id" : "10871"
  }, {
    "name" : "Cd300c ; mCD300C ; ANA940",
    "link" : "http://purl.obolibrary.org/obo/PR_A2A7V7",
    "description" : "CMRF35-like molecule 6 (mouse)",
    "id" : "387565"
  }, {
    "name" : "Cd300c2 ; mClm ; ANA1190",
    "link" : "http://purl.obolibrary.org/obo/PR_Q7TSN2",
    "description" : "CMRF35-like molecule (mouse)",
    "id" : "140497"
  }, {
    "name" : "CD300e ; hCD300E ; ANA1167",
    "link" : "http://purl.obolibrary.org/obo/PR_Q496F6",
    "description" : "CMRF35-like molecule 2 (human)",
    "id" : "342510"
  }, {
    "name" : "Cd300e ; mCD300E ; ANA1197",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8K249",
    "description" : "CMRF35-like molecule 2 (mouse)",
    "id" : "217306"
  }, {
    "name" : "Cd300lb ; mCD300LB ; ANA1166",
    "link" : "http://purl.obolibrary.org/obo/PR_Q3U497",
    "description" : "CMRF35-like molecule 7 (mouse)",
    "id" : "217304"
  }, {
    "name" : "Cd300ld ; mClm5 ; ANA1209",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8VCH2",
    "description" : "CMRF35-like molecule 5 (mouse)",
    "id" : "217305"
  }, {
    "name" : "Cd300ld3 ; mClm3 ; ANA1184",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6SJQ5",
    "description" : "CMRF35-like molecule 3 (mouse)",
    "id" : "382551"
  }, {
    "name" : "Cd300lf ; mCD300LF ; ANA1185",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6SJQ7",
    "description" : "CMRF35-like molecule 1 (mouse)",
    "id" : "246746"
  }, {
    "name" : "Cd300lg ; mCd300lg ; ANA1163",
    "link" : "http://purl.obolibrary.org/obo/PR_Q1ERP8",
    "description" : "CMRF35-like molecule 9 (mouse)",
    "id" : "52685"
  }, {
    "name" : "CD301 ; hCLEC10A ; ANA1195",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8IUN9",
    "description" : "C-type lectin domain family 10 member A (human)",
    "id" : "10462"
  }, {
    "name" : "CD302 ; hCD302 ; ANA1196",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8IX05",
    "description" : "CD302 antigen (human)",
    "id" : "9936"
  }, {
    "name" : "Cd302 ; mCD302 ; ANA1230",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9DCG2",
    "description" : "CD302 antigen (mouse)",
    "id" : "66205"
  }, {
    "name" : "CD304 ; hNRP1 ; ANA949",
    "link" : "http://purl.obolibrary.org/obo/PR_O14786",
    "description" : "neuropilin-1 (human)",
    "id" : "8829"
  }, {
    "name" : "CD305 ; hLAIR1 ; ANA1180",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6GTX8",
    "description" : "leukocyte-associated immunoglobulin-like receptor 1 (human)",
    "id" : "3903"
  }, {
    "name" : "CD306 ; hLAIR2 ; ANA1181",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6ISS4",
    "description" : "leukocyte-associated immunoglobulin-like receptor 2 (human)",
    "id" : "3904"
  }, {
    "name" : "CD309 ; hKDR ; ANA1100",
    "link" : "http://purl.obolibrary.org/obo/PR_P35968",
    "description" : "vascular endothelial growth factor receptor 2 (human)",
    "id" : "3791"
  }, {
    "name" : "CD31 ; hPECAM1 ; ANA1044",
    "link" : "http://purl.obolibrary.org/obo/PR_P16284",
    "description" : "platelet endothelial cell adhesion molecule (human)",
    "id" : "5175"
  }, {
    "name" : "CD312 ; hADGRE2 ; ANA1253",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UHX3",
    "description" : "adhesion G protein-coupled receptor E2 (human)",
    "id" : "30817"
  }, {
    "name" : "CD314 ; hKLRK1 ; ANA886",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/22914",
    "description" : "NKG2-D type II integral membrane protein (human)",
    "id" : "22914"
  }, {
    "name" : "CD315 ; hPTGFRN ; ANA1248",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9P2B2",
    "description" : "prostaglandin F2 receptor negative regulator (human)",
    "id" : "5738"
  }, {
    "name" : "CD316 ; hIGSF8 ; ANA1221",
    "link" : "http://purl.obolibrary.org/obo/PR_Q969P0",
    "description" : "immunoglobulin superfamily member 8 (human)",
    "id" : "93185"
  }, {
    "name" : "CD317 ; hBST2 ; ANA1150",
    "link" : "http://purl.obolibrary.org/obo/PR_Q10589",
    "description" : "bone marrow stromal antigen 2 (human)",
    "id" : "684"
  }, {
    "name" : "CD318 ; hCDCP1 ; ANA1234",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9H5V8",
    "description" : "CUB domain-containing protein 1 (human)",
    "id" : "64866"
  }, {
    "name" : "CD319 ; hSLAMF7 ; ANA1242",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NQ25",
    "description" : "SLAM family member 7 (human)",
    "id" : "57823"
  }, {
    "name" : "CD320 ; hCD320 ; ANA1241",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NPF0",
    "description" : "CD320 antigen (human)",
    "id" : "51293"
  }, {
    "name" : "Cd320 ; mCD320 ; ANA1266",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9Z1P5",
    "description" : "CD320 antigen (mouse)",
    "id" : "54219"
  }, {
    "name" : "CD321 ; hF11R ; ANA1265",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9Y624",
    "description" : "junctional adhesion molecule A (human)",
    "id" : "50848"
  }, {
    "name" : "CD322 ; hJAM2 ; ANA1126",
    "link" : "http://purl.obolibrary.org/obo/PR_P57087",
    "description" : "junctional adhesion molecule B (human)",
    "id" : "58494"
  }, {
    "name" : "CD324 ; hCDH1 ; ANA1020",
    "link" : "http://purl.obolibrary.org/obo/PR_P12830",
    "description" : "cadherin-1 (human)",
    "id" : "999"
  }, {
    "name" : "CD326 ; hEPCAM ; ANA1045",
    "link" : "http://purl.obolibrary.org/obo/PR_P16422",
    "description" : "epithelial cell adhesion molecule (human)",
    "id" : "4072"
  }, {
    "name" : "CD32A ; hFCGR2A ; ANA1018",
    "link" : "http://purl.obolibrary.org/obo/PR_P12318",
    "description" : "low affinity immunoglobulin gamma Fc region receptor II-a (human)",
    "id" : "2212"
  }, {
    "name" : "CD32B ; hFCGR2B ; ANA1088",
    "link" : "http://purl.obolibrary.org/obo/PR_P31994",
    "description" : "low affinity immunoglobulin gamma Fc region receptor II-b (human)",
    "id" : "2213"
  }, {
    "name" : "CD32C ; hFCGR2C ; ANA1089",
    "link" : "http://purl.obolibrary.org/obo/PR_P31995",
    "description" : "low affinity immunoglobulin gamma Fc region receptor II-c (human)",
    "id" : "9103"
  }, {
    "name" : "Cd33 ; mCD33 ; ANA1177",
    "link" : "http://purl.obolibrary.org/obo/PR_Q63994",
    "description" : "myeloid cell surface antigen CD33 (mouse)",
    "id" : "12489"
  }, {
    "name" : "CD331 ; hFGFR1 ; ANA1009",
    "link" : "http://purl.obolibrary.org/obo/PR_P11362",
    "description" : "fibroblast growth factor receptor 1 (human)",
    "id" : "2260"
  }, {
    "name" : "CD332 ; hFGFR2 ; ANA1065",
    "link" : "http://purl.obolibrary.org/obo/PR_P21802",
    "description" : "fibroblast growth factor receptor 2 (human)",
    "id" : "2263"
  }, {
    "name" : "CD333 ; hFGFR3 ; ANA1070",
    "link" : "http://purl.obolibrary.org/obo/PR_P22607",
    "description" : "fibroblast growth factor receptor 3 (human)",
    "id" : "2261"
  }, {
    "name" : "CD334 ; hFGFR4 ; ANA1069",
    "link" : "http://purl.obolibrary.org/obo/PR_P22455",
    "description" : "fibroblast growth factor receptor 4 (human)",
    "id" : "2264"
  }, {
    "name" : "CD335 ; hNCR1 ; ANA967",
    "link" : "http://purl.obolibrary.org/obo/PR_O76036",
    "description" : "natural cytotoxicity triggering receptor 1 (human)",
    "id" : "9437"
  }, {
    "name" : "CD337 ; hNCR3 ; ANA950",
    "link" : "http://purl.obolibrary.org/obo/PR_O14931",
    "description" : "natural cytotoxicity triggering receptor 3 (human)",
    "id" : "259197"
  }, {
    "name" : "CD339 ; hJAG1 ; ANA1132",
    "link" : "http://purl.obolibrary.org/obo/PR_P78504",
    "description" : "protein jagged-1 (human)",
    "id" : "182"
  }, {
    "name" : "CD34 ; hCD34 ; ANA1083",
    "link" : "http://purl.obolibrary.org/obo/PR_P28906",
    "description" : "hematopoietic progenitor cell antigen CD34 (human)",
    "id" : "947"
  }, {
    "name" : "Cd34 ; mCD34 ; ANA1178",
    "link" : "http://purl.obolibrary.org/obo/PR_Q64314",
    "description" : "hematopoietic progenitor cell antigen CD34 (mouse)",
    "id" : "12490"
  }, {
    "name" : "CD340 ; hERBB2 ; ANA982",
    "link" : "http://purl.obolibrary.org/obo/PR_P04626",
    "description" : "receptor tyrosine-protein kinase erbB-2 (human)",
    "id" : "2064"
  }, {
    "name" : "CD344 ; hFZD4 ; ANA1256",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9ULV1",
    "description" : "frizzled-4 (human)",
    "id" : "8322"
  }, {
    "name" : "CD349 ; hFZD9 ; ANA943",
    "link" : "http://purl.obolibrary.org/obo/PR_O00144",
    "description" : "frizzled-9 (human)",
    "id" : "8326"
  }, {
    "name" : "CD35 ; hCR1 ; ANA1051",
    "link" : "http://purl.obolibrary.org/obo/PR_P17927",
    "description" : "complement receptor type 1 (human)",
    "id" : "1378"
  }, {
    "name" : "CD350 ; hFZD10 ; ANA1257",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9ULW2",
    "description" : "frizzled-10 (human)",
    "id" : "11211"
  }, {
    "name" : "CD36 ; hCD36 ; ANA1047",
    "link" : "http://purl.obolibrary.org/obo/PR_P16671",
    "description" : "platelet glycoprotein 4 (human)",
    "id" : "948"
  }, {
    "name" : "Cd36 ; mCD36 ; ANA1148",
    "link" : "http://purl.obolibrary.org/obo/PR_Q08857",
    "description" : "platelet glycoprotein 4 (mouse)",
    "id" : "12491"
  }, {
    "name" : "CD37 ; hCD37 ; ANA1008",
    "link" : "http://purl.obolibrary.org/obo/PR_P11049",
    "description" : "leukocyte antigen CD37 (human)",
    "id" : "951"
  }, {
    "name" : "Cd37 ; mCD37 ; ANA1172",
    "link" : "http://purl.obolibrary.org/obo/PR_Q61470",
    "description" : "leukocyte antigen CD37 (mouse)",
    "id" : "12493"
  }, {
    "name" : "CD38 ; hCD38 ; ANA808",
    "link" : "http://purl.obolibrary.org/obo/PR_P28907",
    "description" : "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (human)",
    "id" : "952"
  }, {
    "name" : "Cd38 ; mCD38 ; ANA1125",
    "link" : "http://purl.obolibrary.org/obo/PR_P56528",
    "description" : "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (mouse)",
    "id" : "12494"
  }, {
    "name" : "CD39 ; hENTPD1 ; ANA921",
    "link" : "http://purl.obolibrary.org/obo/PR_P49961",
    "description" : "ectonucleoside triphosphate diphosphohydrolase 1 (human)",
    "id" : "-"
  }, {
    "name" : "CD3d ; hCD3D ; ANA979",
    "link" : "http://purl.obolibrary.org/obo/PR_P04234",
    "description" : "T-cell surface glycoprotein CD3 delta chain (human)",
    "id" : "915"
  }, {
    "name" : "Cd3d ; mCD3D ; ANA980",
    "link" : "http://purl.obolibrary.org/obo/PR_P04235",
    "description" : "T-cell surface glycoprotein CD3 delta chain (mouse)",
    "id" : "12500"
  }, {
    "name" : "Cd3e ; mCD3E ; ANA1071",
    "link" : "http://purl.obolibrary.org/obo/PR_P22646",
    "description" : "T-cell surface glycoprotein CD3 epsilon chain (mouse)",
    "id" : "12501"
  }, {
    "name" : "Cd3eap ; mCD3EAP ; ANA1189",
    "link" : "http://purl.obolibrary.org/obo/PR_Q76KJ5",
    "description" : "DNA-directed RNA polymerase I subunit RPA34 (mouse)",
    "id" : "70333"
  }, {
    "name" : "CD3g ; hCD3G ; ANA1003",
    "link" : "http://purl.obolibrary.org/obo/PR_P09693",
    "description" : "T-cell surface glycoprotein CD3 gamma chain (human)",
    "id" : "917"
  }, {
    "name" : "Cd3g ; mCD3G ; ANA1016",
    "link" : "http://purl.obolibrary.org/obo/PR_P11942",
    "description" : "T-cell surface glycoprotein CD3 gamma chain (mouse)",
    "id" : "12502"
  }, {
    "name" : "CD4 ; hCD4 ; ANA41",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/920",
    "description" : "T-cell surface glycoprotein CD4 (human)",
    "id" : "920"
  }, {
    "name" : "Cd4 ; mCD4 ; ANA504",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12504",
    "description" : "T-cell surface glycoprotein CD4 (mouse)",
    "id" : "12504"
  }, {
    "name" : "CD40 ; hCD40 ; ANA42",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/958",
    "description" : "tumor necrosis factor receptor superfamily member 5 (human)",
    "id" : "958"
  }, {
    "name" : "Cd40 ; mCD40 ; ANA505",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21939",
    "description" : "tumor necrosis factor receptor superfamily member 5 (mouse)",
    "id" : "21939"
  }, {
    "name" : "Cd40lg ; mCD40LG ; ANA506",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21947",
    "description" : "CD40 ligand (mouse)",
    "id" : "21947"
  }, {
    "name" : "CD41 ; hITGA2B ; ANA997",
    "link" : "http://purl.obolibrary.org/obo/PR_P08514",
    "description" : "integrin alpha-IIb (human)",
    "id" : "3674"
  }, {
    "name" : "CD42a ; hGP9 ; ANA1032",
    "link" : "http://purl.obolibrary.org/obo/PR_P14770",
    "description" : "platelet glycoprotein IX (human)",
    "id" : "2815"
  }, {
    "name" : "CD42b ; hGP1BA ; ANA992",
    "link" : "http://purl.obolibrary.org/obo/PR_P07359",
    "description" : "platelet glycoprotein Ib alpha chain (human)",
    "id" : "2811"
  }, {
    "name" : "CD42c ; hGP1BB ; ANA1022",
    "link" : "http://purl.obolibrary.org/obo/PR_P13224",
    "description" : "platelet glycoprotein Ib beta chain (human)",
    "id" : "2812"
  }, {
    "name" : "CD42d ; hGP5 ; ANA1103",
    "link" : "http://purl.obolibrary.org/obo/PR_P40197",
    "description" : "platelet glycoprotein V (human)",
    "id" : "2814"
  }, {
    "name" : "CD43 ; hSPN ; ANA893",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/6693",
    "description" : "leukosialin (human)",
    "id" : "6693"
  }, {
    "name" : "CD44 ; hCD44 ; ANA914",
    "link" : "http://purl.obolibrary.org/obo/PR_P16070",
    "description" : "CD44 antigen (human)",
    "id" : "-"
  }, {
    "name" : "Cd44 ; mCD44 ; ANA1035",
    "link" : "http://purl.obolibrary.org/obo/PR_P15379",
    "description" : "CD44 antigen (mouse)",
    "id" : "12505"
  }, {
    "name" : "CD45RA ; hPTPRC/iso:h6 ; ANA816",
    "link" : "http://purl.obolibrary.org/obo/PR_P08575-8",
    "description" : "receptor-type tyrosine-protein phosphatase C isoform h6 (human)",
    "id" : "5788"
  }, {
    "name" : "CD45RO ; PTPRC/iso:CD45RO ; ANA822",
    "link" : "http://purl.obolibrary.org/obo/PR_000001017",
    "description" : "receptor-type tyrosine-protein phosphatase C isoform CD45RO",
    "id" : "5788"
  }, {
    "name" : "CD46 ; hCD46 ; ANA1036",
    "link" : "http://purl.obolibrary.org/obo/PR_P15529",
    "description" : "membrane cofactor protein (human)",
    "id" : "4179"
  }, {
    "name" : "Cd46 ; mCD46 ; ANA968",
    "link" : "http://purl.obolibrary.org/obo/PR_O88174",
    "description" : "membrane cofactor protein (mouse)",
    "id" : "17221"
  }, {
    "name" : "CD47 ; hCD47 ; ANA1147",
    "link" : "http://purl.obolibrary.org/obo/PR_Q08722",
    "description" : "leukocyte surface antigen CD47 (human)",
    "id" : "961"
  }, {
    "name" : "Cd47 ; mCD47 ; ANA1175",
    "link" : "http://purl.obolibrary.org/obo/PR_Q61735",
    "description" : "leukocyte surface antigen CD47 (mouse)",
    "id" : "16423"
  }, {
    "name" : "CD48 ; hCD48 ; ANA1001",
    "link" : "http://purl.obolibrary.org/obo/PR_P09326",
    "description" : "CD48 antigen (human)",
    "id" : "962"
  }, {
    "name" : "Cd48 ; mCD48 ; ANA1052",
    "link" : "http://purl.obolibrary.org/obo/PR_P18181",
    "description" : "CD48 antigen (mouse)",
    "id" : "12506"
  }, {
    "name" : "CD49 ; hITGA6 ; ANA876",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3655",
    "description" : "integrin alpha-6 (human)",
    "id" : "3655"
  }, {
    "name" : "CD49a ; hITGA1 ; ANA927",
    "link" : "http://purl.obolibrary.org/obo/PR_P56199",
    "description" : "integrin alpha-1 (human)",
    "id" : "-"
  }, {
    "name" : "CD49b ; hITGA2 ; ANA1048",
    "link" : "http://purl.obolibrary.org/obo/PR_P17301",
    "description" : "integrin alpha-2 (human)",
    "id" : "3673"
  }, {
    "name" : "CD49c ; hITGA3 ; ANA1079",
    "link" : "http://purl.obolibrary.org/obo/PR_P26006",
    "description" : "integrin alpha-3 (human)",
    "id" : "3675"
  }, {
    "name" : "CD49d ; hITGA4 ; ANA1026",
    "link" : "http://purl.obolibrary.org/obo/PR_P13612",
    "description" : "integrin alpha-4 (human)",
    "id" : "3676"
  }, {
    "name" : "CD49e ; hITGA5 ; ANA999",
    "link" : "http://purl.obolibrary.org/obo/PR_P08648",
    "description" : "integrin alpha-5 (human)",
    "id" : "3678"
  }, {
    "name" : "CD5 ; hCD5 ; ANA915",
    "link" : "http://purl.obolibrary.org/obo/PR_P06127",
    "description" : "T-cell surface glycoprotein CD5 (human)",
    "id" : "-"
  }, {
    "name" : "Cd5 ; mCD5 ; ANA1023",
    "link" : "http://purl.obolibrary.org/obo/PR_P13379",
    "description" : "T-cell surface glycoprotein CD5 (mouse)",
    "id" : "12507"
  }, {
    "name" : "CD50 ; hICAM3 ; ANA1094",
    "link" : "http://purl.obolibrary.org/obo/PR_P32942",
    "description" : "intercellular adhesion molecule 3 (human)",
    "id" : "3385"
  }, {
    "name" : "CD51 ; hITGAV ; ANA991",
    "link" : "http://purl.obolibrary.org/obo/PR_P06756",
    "description" : "integrin alpha-V (human)",
    "id" : "3685"
  }, {
    "name" : "CD52 ; hCD52 ; ANA1087",
    "link" : "http://purl.obolibrary.org/obo/PR_P31358",
    "description" : "CAMPATH-1 antigen (human)",
    "id" : "1043"
  }, {
    "name" : "Cd52 ; mCD52 ; ANA1179",
    "link" : "http://purl.obolibrary.org/obo/PR_Q64389",
    "description" : "CAMPATH-1 antigen (mouse)",
    "id" : "23833"
  }, {
    "name" : "CD53 ; hCD53 ; ANA1057",
    "link" : "http://purl.obolibrary.org/obo/PR_P19397",
    "description" : "leukocyte surface antigen CD53 (human)",
    "id" : "963"
  }, {
    "name" : "Cd53 ; mCD53 ; ANA1171",
    "link" : "http://purl.obolibrary.org/obo/PR_Q61451",
    "description" : "leukocyte surface antigen CD53 (mouse)",
    "id" : "12508"
  }, {
    "name" : "CD55 ; hCD55 ; ANA995",
    "link" : "http://purl.obolibrary.org/obo/PR_P08174",
    "description" : "complement decay-accelerating factor (human)",
    "id" : "1604"
  }, {
    "name" : "Cd55 ; mCd55 ; ANA1173",
    "link" : "http://purl.obolibrary.org/obo/PR_Q61475",
    "description" : "complement decay-accelerating factor, GPI-anchored (mouse)",
    "id" : "13136"
  }, {
    "name" : "Cd55b ; mCd55b ; ANA1174",
    "link" : "http://purl.obolibrary.org/obo/PR_Q61476",
    "description" : "complement decay-accelerating factor transmembrane isoform (mouse)",
    "id" : "13137"
  }, {
    "name" : "CD56 ; hNCAM1 ; ANA815",
    "link" : "http://purl.obolibrary.org/obo/PR_P13591",
    "description" : "neural cell adhesion molecule 1 (human)",
    "id" : "4684"
  }, {
    "name" : "CD57 ; hB3GAT1 ; ANA823",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/27087",
    "description" : "galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (human)",
    "id" : "27087"
  }, {
    "name" : "CD58 ; hCD58 ; ANA1056",
    "link" : "http://purl.obolibrary.org/obo/PR_P19256",
    "description" : "lymphocyte function-associated antigen 3 (human)",
    "id" : "965"
  }, {
    "name" : "CD59 ; hCD59 ; ANA1030",
    "link" : "http://purl.obolibrary.org/obo/PR_P13987",
    "description" : "CD59 glycoprotein (human)",
    "id" : "966"
  }, {
    "name" : "Cd59a ; mCd59a ; ANA957",
    "link" : "http://purl.obolibrary.org/obo/PR_O55186",
    "description" : "CD59A glycoprotein (mouse)",
    "id" : "12509"
  }, {
    "name" : "Cd59b ; mCd59b ; ANA1127",
    "link" : "http://purl.obolibrary.org/obo/PR_P58019",
    "description" : "CD59B glycoprotein (mouse)",
    "id" : "333883"
  }, {
    "name" : "Cd5l ; mCD5L ; ANA1249",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9QWK4",
    "description" : "CD5 antigen-like (mouse)",
    "id" : "11801"
  }, {
    "name" : "CD6 ; hCD6 ; ANA1085",
    "link" : "http://purl.obolibrary.org/obo/PR_P30203",
    "description" : "T-cell differentiation antigen CD6 (human)",
    "id" : "923"
  }, {
    "name" : "Cd6 ; mCD6 ; ANA1170",
    "link" : "http://purl.obolibrary.org/obo/PR_Q61003",
    "description" : "T-cell differentiation antigen CD6 (mouse)",
    "id" : "12511"
  }, {
    "name" : "CD61 ; hITGB3 ; ANA984",
    "link" : "http://purl.obolibrary.org/obo/PR_P05106",
    "description" : "integrin beta-3 (human)",
    "id" : "3690"
  }, {
    "name" : "CD62E ; hSELE ; ANA1046",
    "link" : "http://purl.obolibrary.org/obo/PR_P16581",
    "description" : "E-selectin (human)",
    "id" : "6401"
  }, {
    "name" : "CD62L ; hSELL ; ANA712",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6401",
    "description" : "L-selectin (human)",
    "id" : "6401"
  }, {
    "name" : "CD62P ; hSELP ; ANA1042",
    "link" : "http://purl.obolibrary.org/obo/PR_P16109",
    "description" : "P-selectin (human)",
    "id" : "6403"
  }, {
    "name" : "CD63 ; hCD63 ; ANA902",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/967",
    "description" : "CD63 antigen (human)",
    "id" : "967"
  }, {
    "name" : "Cd63 ; mCD63 ; ANA1112",
    "link" : "http://purl.obolibrary.org/obo/PR_P41731",
    "description" : "CD63 antigen (mouse)",
    "id" : "12512"
  }, {
    "name" : "CD64 ; hFCGR1A ; ANA873",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/2209",
    "description" : "high affinity immunoglobulin gamma Fc receptor I (human)",
    "id" : "2209"
  }, {
    "name" : "CD66a ; hCEACAM1 ; ANA1027",
    "link" : "http://purl.obolibrary.org/obo/PR_P13688",
    "description" : "carcinoembryonic antigen-related cell adhesion molecule 1 (human)",
    "id" : "634"
  }, {
    "name" : "CD66b ; hCEACAM8 ; ANA1091",
    "link" : "http://purl.obolibrary.org/obo/PR_P31997",
    "description" : "carcinoembryonic antigen-related cell adhesion molecule 8 (human)",
    "id" : "1088"
  }, {
    "name" : "CD66c ; hCEACAM6 ; ANA1105",
    "link" : "http://purl.obolibrary.org/obo/PR_P40199",
    "description" : "carcinoembryonic antigen-related cell adhesion molecule 6 (human)",
    "id" : "4680"
  }, {
    "name" : "CD66d ; hCEACAM3 ; ANA1104",
    "link" : "http://purl.obolibrary.org/obo/PR_P40198",
    "description" : "carcinoembryonic antigen-related cell adhesion molecule 3 (human)",
    "id" : "1084"
  }, {
    "name" : "CD66e ; hCEACAM5 ; ANA990",
    "link" : "http://purl.obolibrary.org/obo/PR_P06731",
    "description" : "carcinoembryonic antigen-related cell adhesion molecule 5 (human)",
    "id" : "1048"
  }, {
    "name" : "CD66f ; hPSG1 ; ANA1010",
    "link" : "http://purl.obolibrary.org/obo/PR_P11464",
    "description" : "pregnancy-specific beta-1-glycoprotein 1 (human)",
    "id" : "5669"
  }, {
    "name" : "CD68 ; hCD68 ; ANA1096",
    "link" : "http://purl.obolibrary.org/obo/PR_P34810",
    "description" : "macrosialin (human)",
    "id" : "968"
  }, {
    "name" : "Cd68 ; mCD68 ; ANA1090",
    "link" : "http://purl.obolibrary.org/obo/PR_P31996",
    "description" : "macrosialin (mouse)",
    "id" : "12514"
  }, {
    "name" : "CD69 ; hCD69 ; ANA865",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/969",
    "description" : "early activation antigen CD69 (human)",
    "id" : "969"
  }, {
    "name" : "Cd69 ; mCD69 ; ANA1102",
    "link" : "http://purl.obolibrary.org/obo/PR_P37217",
    "description" : "early activation antigen CD69 (mouse)",
    "id" : "12515"
  }, {
    "name" : "CD7 ; hCD7 ; ANA1002",
    "link" : "http://purl.obolibrary.org/obo/PR_P09564",
    "description" : "T-cell antigen CD7 (human)",
    "id" : "924"
  }, {
    "name" : "Cd7 ; mCD7 ; ANA1121",
    "link" : "http://purl.obolibrary.org/obo/PR_P50283",
    "description" : "T-cell antigen CD7 (mouse)",
    "id" : "12516"
  }, {
    "name" : "CD70 ; hCD70 ; ANA44",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/970",
    "description" : "CD70 antigen (human)",
    "id" : "970"
  }, {
    "name" : "Cd70 ; mCD70 ; ANA507",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21948",
    "description" : "CD70 antigen (mouse)",
    "id" : "21948"
  }, {
    "name" : "CD71a ; hTFRC ; ANA932",
    "link" : "http://purl.obolibrary.org/obo/PR_P02786",
    "description" : "transferrin receptor protein 1 (human)",
    "id" : "-"
  }, {
    "name" : "CD72 ; hCD72 ; ANA1066",
    "link" : "http://purl.obolibrary.org/obo/PR_P21854",
    "description" : "B-cell differentiation antigen CD72 (human)",
    "id" : "971"
  }, {
    "name" : "Cd72 ; mCD72 ; ANA1067",
    "link" : "http://purl.obolibrary.org/obo/PR_P21855",
    "description" : "B-cell differentiation antigen CD72 (mouse)",
    "id" : "12517"
  }, {
    "name" : "CD73 ; hNT5E ; ANA1062",
    "link" : "http://purl.obolibrary.org/obo/PR_P21589",
    "description" : "5'-nucleotidase (human)",
    "id" : "4907"
  }, {
    "name" : "CD74 ; hCD74 ; ANA978",
    "link" : "http://purl.obolibrary.org/obo/PR_P04233",
    "description" : "HLA class II histocompatibility antigen gamma chain (human)",
    "id" : "972"
  }, {
    "name" : "Cd74 ; mCD74 ; ANA981",
    "link" : "http://purl.obolibrary.org/obo/PR_P04441",
    "description" : "H-2 class II histocompatibility antigen gamma chain (mouse)",
    "id" : "16149"
  }, {
    "name" : "CD79a ; hCD79A ; ANA1015",
    "link" : "http://purl.obolibrary.org/obo/PR_P11912",
    "description" : "B-cell antigen receptor complex-associated protein alpha chain (human)",
    "id" : "973"
  }, {
    "name" : "Cd79a ; mCD79A ; ANA1014",
    "link" : "http://purl.obolibrary.org/obo/PR_P11911",
    "description" : "B-cell antigen receptor complex-associated protein alpha chain (mouse)",
    "id" : "12518"
  }, {
    "name" : "CD79b ; hCD79B ; ANA1109",
    "link" : "http://purl.obolibrary.org/obo/PR_P40259",
    "description" : "B-cell antigen receptor complex-associated protein beta chain (human)",
    "id" : "974"
  }, {
    "name" : "Cd79b ; mCD79B ; ANA1037",
    "link" : "http://purl.obolibrary.org/obo/PR_P15530",
    "description" : "B-cell antigen receptor complex-associated protein beta chain (mouse)",
    "id" : "15985"
  }, {
    "name" : "CD8 ; hCD8A ; ANA810",
    "link" : "http://purl.obolibrary.org/obo/PR_P01732",
    "description" : "T-cell surface glycoprotein CD8 alpha chain (human)",
    "id" : "925"
  }, {
    "name" : "Cd80 ; mCD80 ; ANA1135",
    "link" : "http://purl.obolibrary.org/obo/PR_Q00609",
    "description" : "T-lymphocyte activation antigen CD80 (mouse)",
    "id" : "12519"
  }, {
    "name" : "CD81 ; hCD81 ; ANA1129",
    "link" : "http://purl.obolibrary.org/obo/PR_P60033",
    "description" : "CD81 antigen (human)",
    "id" : "975"
  }, {
    "name" : "Cd81 ; mCD81 ; ANA1099",
    "link" : "http://purl.obolibrary.org/obo/PR_P35762",
    "description" : "CD81 antigen (mouse)",
    "id" : "12520"
  }, {
    "name" : "CD82 ; hCD82 ; ANA1082",
    "link" : "http://purl.obolibrary.org/obo/PR_P27701",
    "description" : "CD82 antigen (human)",
    "id" : "3732"
  }, {
    "name" : "Cd82 ; mCD82 ; ANA1107",
    "link" : "http://purl.obolibrary.org/obo/PR_P40237",
    "description" : "CD82 antigen (mouse)",
    "id" : "12521"
  }, {
    "name" : "CD83 ; hCD83 ; ANA916",
    "link" : "http://purl.obolibrary.org/obo/PR_Q01151",
    "description" : "CD83 antigen (human)",
    "id" : "-"
  }, {
    "name" : "Cd83 ; mCD83 ; ANA969",
    "link" : "http://purl.obolibrary.org/obo/PR_O88324",
    "description" : "CD83 antigen (mouse)",
    "id" : "12522"
  }, {
    "name" : "CD84 ; hCD84 ; ANA1254",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UIB8",
    "description" : "SLAM family member 5 (human)",
    "id" : "8832"
  }, {
    "name" : "Cd84 ; mCD84 ; ANA1162",
    "link" : "http://purl.obolibrary.org/obo/PR_Q18PI6",
    "description" : "SLAM family member 5 (mouse)",
    "id" : "12523"
  }, {
    "name" : "CD85a ; hLILRB3 ; ANA962",
    "link" : "http://purl.obolibrary.org/obo/PR_O75022",
    "description" : "leukocyte immunoglobulin-like receptor subfamily B member 3 (human)",
    "id" : "107987462"
  }, {
    "name" : "CD85b ; hLILRA6 ; ANA1182",
    "link" : "http://purl.obolibrary.org/obo/PR_Q6PI73",
    "description" : "leukocyte immunoglobulin-like receptor subfamily A member 6 (human)",
    "id" : "-"
  }, {
    "name" : "CD85c ; hLILRB5 ; ANA963",
    "link" : "http://purl.obolibrary.org/obo/PR_O75023",
    "description" : "leukocyte immunoglobulin-like receptor subfamily B member 5 (human)",
    "id" : "10990"
  }, {
    "name" : "CD85d ; hLILRB2 ; ANA1201",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8N423",
    "description" : "leukocyte immunoglobulin-like receptor subfamily B member 2 (human)",
    "id" : "-"
  }, {
    "name" : "CD85e ; hLILRA3 ; ANA1202",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8N6C8",
    "description" : "leukocyte immunoglobulin-like receptor subfamily A member 3 (human)",
    "id" : "11026"
  }, {
    "name" : "CD85f ; hLILRA5 ; ANA941",
    "link" : "http://purl.obolibrary.org/obo/PR_A6NI73",
    "description" : "leukocyte immunoglobulin-like receptor subfamily A member 5 (human)",
    "id" : "353514"
  }, {
    "name" : "CD85g ; hLILRA4 ; ANA1128",
    "link" : "http://purl.obolibrary.org/obo/PR_P59901",
    "description" : "leukocyte immunoglobulin-like receptor subfamily A member 4 (human)",
    "id" : "23547"
  }, {
    "name" : "CD85h ; hLILRA2 ; ANA1200",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8N149",
    "description" : "leukocyte immunoglobulin-like receptor subfamily A member 2 (human)",
    "id" : "11027"
  }, {
    "name" : "CD85i ; hLILRA1 ; ANA961",
    "link" : "http://purl.obolibrary.org/obo/PR_O75019",
    "description" : "leukocyte immunoglobulin-like receptor subfamily A member 1 (human)",
    "id" : "11024"
  }, {
    "name" : "CD85J ; hLILRB1 ; ANA888",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/10859",
    "description" : "leukocyte immunoglobulin-like receptor subfamily B member 1 (human)",
    "id" : "10859"
  }, {
    "name" : "CD85k ; hLILRB4 ; ANA1205",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8NHJ6",
    "description" : "leukocyte immunoglobulin-like receptor subfamily B member 4 (human)",
    "id" : "11006"
  }, {
    "name" : "Cd86 ; mCD86 ; ANA1114",
    "link" : "http://purl.obolibrary.org/obo/PR_P42082",
    "description" : "T-lymphocyte activation antigen CD86 (mouse)",
    "id" : "12524"
  }, {
    "name" : "CD87 ; hPLAUR ; ANA1140",
    "link" : "http://purl.obolibrary.org/obo/PR_Q03405",
    "description" : "urokinase plasminogen activator surface receptor (human)",
    "id" : "5329"
  }, {
    "name" : "CD88 ; hC5AR1 ; ANA1063",
    "link" : "http://purl.obolibrary.org/obo/PR_P21730",
    "description" : "C5a anaphylatoxin chemotactic receptor 1 (human)",
    "id" : "728"
  }, {
    "name" : "CD89 ; hFCAR ; ANA1075",
    "link" : "http://purl.obolibrary.org/obo/PR_P24071",
    "description" : "immunoglobulin alpha Fc receptor (human)",
    "id" : "2204"
  }, {
    "name" : "Cd8a ; mCD8A ; ANA974",
    "link" : "http://purl.obolibrary.org/obo/PR_P01731",
    "description" : "T-cell surface glycoprotein CD8 alpha chain (mouse)",
    "id" : "12525"
  }, {
    "name" : "CD8b ; hCD8B ; ANA1007",
    "link" : "http://purl.obolibrary.org/obo/PR_P10966",
    "description" : "T-cell surface glycoprotein CD8 beta chain (human)",
    "id" : "926"
  }, {
    "name" : "Cd8b1 ; mCD8B ; ANA1004",
    "link" : "http://purl.obolibrary.org/obo/PR_P10300",
    "description" : "T-cell surface glycoprotein CD8 beta chain (mouse)",
    "id" : "12526"
  }, {
    "name" : "CD9 ; hCD9 ; ANA1068",
    "link" : "http://purl.obolibrary.org/obo/PR_P21926",
    "description" : "CD9 antigen (human)",
    "id" : "928"
  }, {
    "name" : "Cd9 ; mCD9 ; ANA1108",
    "link" : "http://purl.obolibrary.org/obo/PR_P40240",
    "description" : "CD9 antigen (mouse)",
    "id" : "12527"
  }, {
    "name" : "CD90 ; hTHY1 ; ANA934",
    "link" : "http://purl.obolibrary.org/obo/PR_P04216",
    "description" : "Thy-1 membrane glycoprotein (human)",
    "id" : "-"
  }, {
    "name" : "CD91 ; hLRP1 ; ANA1144",
    "link" : "http://purl.obolibrary.org/obo/PR_Q07954",
    "description" : "prolow-density lipoprotein receptor-related protein 1 (human)",
    "id" : "4035"
  }, {
    "name" : "Cd93 ; mCD93 ; ANA971",
    "link" : "http://purl.obolibrary.org/obo/PR_O89103",
    "description" : "complement component C1q receptor (mouse)",
    "id" : "17064"
  }, {
    "name" : "CD94 ; hKLRD1 ; ANA884",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3824",
    "description" : "natural killer cells antigen CD94 (human)",
    "id" : "3824"
  }, {
    "name" : "CD95 ; hFAS ; ANA85",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/355",
    "description" : "tumor necrosis factor receptor superfamily member 6 (human)",
    "id" : "355"
  }, {
    "name" : "CD96 ; hCD96 ; ANA1106",
    "link" : "http://purl.obolibrary.org/obo/PR_P40200",
    "description" : "T-cell surface protein tactile (human)",
    "id" : "10225"
  }, {
    "name" : "Cd96 ; mCD96 ; ANA1165",
    "link" : "http://purl.obolibrary.org/obo/PR_Q3U0X8",
    "description" : "T-cell surface protein tactile (mouse)",
    "id" : "84544"
  }, {
    "name" : "CD97 ; hADGRE5 ; ANA1120",
    "link" : "http://purl.obolibrary.org/obo/PR_P48960",
    "description" : "CD97 antigen (human)",
    "id" : "976"
  }, {
    "name" : "CD98 ; hSLC7A5 ; ANA1136",
    "link" : "http://purl.obolibrary.org/obo/PR_Q01650",
    "description" : "large neutral amino acids transporter small subunit 1 (human)",
    "id" : "8140"
  }, {
    "name" : "CD99 ; hCD99 ; ANA1031",
    "link" : "http://purl.obolibrary.org/obo/PR_P14209",
    "description" : "CD99 antigen (human)",
    "id" : "4267"
  }, {
    "name" : "Cd99l2 ; mCD99L2 ; ANA1193",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8BIF0",
    "description" : "CD99 antigen-like protein 2 (mouse)",
    "id" : "171486"
  }, {
    "name" : "CDw113 ; hNECTIN3 ; ANA1243",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9NQS3",
    "description" : "nectin-3 (human)",
    "id" : "25945"
  }, {
    "name" : "CDw218b ; hIL18RAP ; ANA972",
    "link" : "http://purl.obolibrary.org/obo/PR_O95256",
    "description" : "interleukin-18 receptor accessory protein (human)",
    "id" : "8807"
  }, {
    "name" : "CDw293 ; hBMPR1B ; ANA945",
    "link" : "http://purl.obolibrary.org/obo/PR_O00238",
    "description" : "bone morphogenetic protein receptor type-1B (human)",
    "id" : "658"
  }, {
    "name" : "CDw325 ; hCDH2 ; ANA1055",
    "link" : "http://purl.obolibrary.org/obo/PR_P19022",
    "description" : "cadherin-2 (human)",
    "id" : "1000"
  }, {
    "name" : "CDw327 ; hSIGLEC6 ; ANA955",
    "link" : "http://purl.obolibrary.org/obo/PR_O43699",
    "description" : "sialic acid-binding Ig-like lectin 6 (human)",
    "id" : "946"
  }, {
    "name" : "CDw328 ; hSIGLEC7 ; ANA1262",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9Y286",
    "description" : "sialic acid-binding Ig-like lectin 7 (human)",
    "id" : "27036"
  }, {
    "name" : "CDw329 ; hSIGLEC9 ; ANA1263",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9Y336",
    "description" : "sialic acid-binding Ig-like lectin 9 (human)",
    "id" : "27180"
  }, {
    "name" : "CDw338 ; hABCG2 ; ANA1260",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9UNQ0",
    "description" : "ATP-binding cassette sub-family G member 2 (human)",
    "id" : "9429"
  }, {
    "name" : "CDW92 ; hSLC44A1 ; ANA1211",
    "link" : "http://purl.obolibrary.org/obo/PR_Q8WWI5",
    "description" : "choline transporter-like protein 1 (human)",
    "id" : "23446"
  }, {
    "name" : "CENPB ; hCENPB ; ANA821",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1059",
    "description" : "major centromere autoantigen B (human)",
    "id" : "1059"
  }, {
    "name" : "CKLF ; hCKLF ; ANA45",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/51192",
    "description" : "chemokine-like factor (human)",
    "id" : "51192"
  }, {
    "name" : "Cklf ; mCKLF ; ANA508",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/75458",
    "description" : "chemokine-like factor (mouse)",
    "id" : "75458"
  }, {
    "name" : "CLA, CD162 ; hSELPLG ; ANA903",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/6404",
    "description" : "P-selectin glycoprotein ligand 1 (human)",
    "id" : "6404"
  }, {
    "name" : "CLCF1 ; hCLCF1 ; ANA46",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/23529",
    "description" : "cardiotrophin-like cytokine factor 1 (human)",
    "id" : "23529"
  }, {
    "name" : "Clcf1 ; mCLCF1 ; ANA509",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56708",
    "description" : "cardiotrophin-like cytokine factor 1 (mouse)",
    "id" : "56708"
  }, {
    "name" : "Cmtm1 ; CMTM1 ; ANA510",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/100504164",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 1",
    "id" : "100504164"
  }, {
    "name" : "CMTM1 ; hCMTM1 ; ANA47",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/113540",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 1 (human)",
    "id" : "113540"
  }, {
    "name" : "CMTM6 ; hCMTM6 ; ANA48",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/54918",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 6 (human)",
    "id" : "54918"
  }, {
    "name" : "Cmtm6 ; mCMTM6 ; ANA511",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/67213",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 6 (mouse)",
    "id" : "67213"
  }, {
    "name" : "CMTM7 ; hCMTM7 ; ANA49",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/112616",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 7 (human)",
    "id" : "112616"
  }, {
    "name" : "Cmtm7 ; mCMTM7 ; ANA512",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/102545",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 7 (mouse)",
    "id" : "102545"
  }, {
    "name" : "CNTFR ; hCNTFR ; ANA50",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1271",
    "description" : "ciliary neurotrophic factor receptor subunit alpha (human)",
    "id" : "1271"
  }, {
    "name" : "Cntfr ; mCNTFR ; ANA513",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12804",
    "description" : "ciliary neurotrophic factor receptor subunit alpha (mouse)",
    "id" : "12804"
  }, {
    "name" : "Csf1 ; mCSF1 ; ANA514",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12977",
    "description" : "macrophage colony-stimulating factor 1 (mouse)",
    "id" : "12977"
  }, {
    "name" : "CSF1R ; hCSF1R ; ANA52",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1436",
    "description" : "macrophage colony-stimulating factor 1 receptor (human)",
    "id" : "1436"
  }, {
    "name" : "Csf1r ; mCSF1R ; ANA515",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12978",
    "description" : "macrophage colony-stimulating factor 1 receptor (mouse)",
    "id" : "12978"
  }, {
    "name" : "Csf2 ; mCSF2 ; ANA516",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12981",
    "description" : "granulocyte-macrophage colony-stimulating factor (mouse)",
    "id" : "12981"
  }, {
    "name" : "CSF2RA ; hCSF2RA ; ANA54",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1438",
    "description" : "granulocyte-macrophage colony-stimulating factor receptor subunit alpha (human)",
    "id" : "1438"
  }, {
    "name" : "Csf2ra ; mCSF2RA ; ANA517",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12982",
    "description" : "granulocyte-macrophage colony-stimulating factor receptor subunit alpha (mouse)",
    "id" : "12982"
  }, {
    "name" : "CSF2RB ; hCSF2RB ; ANA55",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1439",
    "description" : "cytokine receptor common subunit beta (human)",
    "id" : "1439"
  }, {
    "name" : "Csf2rb ; mCsf2rb ; ANA518",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12983",
    "description" : "cytokine receptor common subunit beta (mouse)",
    "id" : "12983"
  }, {
    "name" : "CSF3 ; hCSF3 ; ANA56",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1440",
    "description" : "granulocyte colony-stimulating factor (human)",
    "id" : "1440"
  }, {
    "name" : "Csf3 ; mCSF3 ; ANA519",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12985",
    "description" : "granulocyte colony-stimulating factor (mouse)",
    "id" : "12985"
  }, {
    "name" : "CSF3R ; hCSF3R ; ANA57",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1441",
    "description" : "granulocyte colony-stimulating factor receptor (human)",
    "id" : "1441"
  }, {
    "name" : "Csf3r ; mCSF3R ; ANA520",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12986",
    "description" : "granulocyte colony-stimulating factor receptor (mouse)",
    "id" : "12986"
  }, {
    "name" : "CTACK ; hCCL27 ; ANA19",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/10850",
    "description" : "C-C motif chemokine 27 (human)",
    "id" : "10850"
  }, {
    "name" : "Cx3cr1 ; mCX3CR1 ; ANA522",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/13051",
    "description" : "CX3C chemokine receptor 1 (mouse)",
    "id" : "13051"
  }, {
    "name" : "Cxcl1 ; mCXCL1 ; ANA523",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/14825",
    "description" : "growth-regulated alpha protein (mouse)",
    "id" : "14825"
  }, {
    "name" : "CXCL11 ; hCXCL11 ; ANA62",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6373",
    "description" : "C-X-C motif chemokine 11 (human)",
    "id" : "6373"
  }, {
    "name" : "Cxcl11 ; mCxcl11 ; ANA525",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56066",
    "description" : "C-X-C motif chemokine 11 (mouse)",
    "id" : "56066"
  }, {
    "name" : "CXCL12 ; hCXCL12 ; ANA63",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6387",
    "description" : "stromal cell-derived factor 1 (human)",
    "id" : "6387"
  }, {
    "name" : "Cxcl12 ; mCXCL12 ; ANA526",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20315",
    "description" : "stromal cell-derived factor 1 (mouse)",
    "id" : "20315"
  }, {
    "name" : "CXCL13 ; hCXCL13 ; ANA64",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/10563",
    "description" : "C-X-C motif chemokine 13 (human)",
    "id" : "10563"
  }, {
    "name" : "Cxcl13 ; mCXCL13 ; ANA527",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/55985",
    "description" : "C-X-C motif chemokine 13 (mouse)",
    "id" : "55985"
  }, {
    "name" : "CXCL14 ; hCXCL14 ; ANA65",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/9547",
    "description" : "C-X-C motif chemokine 14 (human)",
    "id" : "9547"
  }, {
    "name" : "Cxcl14 ; mCXCL14 ; ANA528",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/57266",
    "description" : "C-X-C motif chemokine 14 (mouse)",
    "id" : "57266"
  }, {
    "name" : "CXCL16 ; hCXCL16 ; ANA66",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/58191",
    "description" : "C-X-C motif chemokine 16 (human)",
    "id" : "58191"
  }, {
    "name" : "Cxcl16 ; mCXCL16 ; ANA529",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/66102",
    "description" : "C-X-C motif chemokine 16 (mouse)",
    "id" : "66102"
  }, {
    "name" : "CXCL17 ; hCXCL17 ; ANA67",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/284340",
    "description" : "C-X-C motif chemokine 17 (human)",
    "id" : "284340"
  }, {
    "name" : "Cxcl17 ; mCXCL17 ; ANA530",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/232983",
    "description" : "C-X-C motif chemokine 17 (mouse)",
    "id" : "232983"
  }, {
    "name" : "Cxcl2 ; mCxcl2 ; ANA531",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20310",
    "description" : "C-X-C motif chemokine 2 (mouse)",
    "id" : "20310"
  }, {
    "name" : "CXCL3 ; hCXCL3 ; ANA69",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2921",
    "description" : "C-X-C motif chemokine 3 (human)",
    "id" : "2921"
  }, {
    "name" : "Cxcl3 ; mCxcl3 ; ANA532",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/330122",
    "description" : "C-X-C motif chemokine 3 (mouse)",
    "id" : "330122"
  }, {
    "name" : "CXCL5 ; hCXCL5 ; ANA70",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6374",
    "description" : "C-X-C motif chemokine 5 (human)",
    "id" : "6374"
  }, {
    "name" : "Cxcl5 ; mCXCL5 ; ANA533",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20311",
    "description" : "C-X-C motif chemokine 5 (mouse)",
    "id" : "20311"
  }, {
    "name" : "CXCL6 ; hCXCL6 ; ANA71",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6372",
    "description" : "C-X-C motif chemokine 6 (human)",
    "id" : "6372"
  }, {
    "name" : "CXCL9 ; hCXCL9 ; ANA73",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4283",
    "description" : "C-X-C motif chemokine 9 (human)",
    "id" : "4283"
  }, {
    "name" : "Cxcl9 ; mCXCL9 ; ANA534",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/17329",
    "description" : "C-X-C motif chemokine 9 (mouse)",
    "id" : "17329"
  }, {
    "name" : "CXCR1 ; hCXCR1 ; ANA74",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3577",
    "description" : "C-X-C chemokine receptor type 1 (human)",
    "id" : "3577"
  }, {
    "name" : "Cxcr1 ; mCxcr1 ; ANA535",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/227288",
    "description" : "C-X-C chemokine receptor type 1 (mouse)",
    "id" : "227288"
  }, {
    "name" : "CXCR2 ; hCXCR2 ; ANA75",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3579",
    "description" : "C-X-C chemokine receptor type 2 (human)",
    "id" : "3579"
  }, {
    "name" : "Cxcr2 ; mCXCR2 ; ANA536",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12765",
    "description" : "C-X-C chemokine receptor type 2 (mouse)",
    "id" : "12765"
  }, {
    "name" : "CXCR3 ; hCXCR3 ; ANA76",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2833",
    "description" : "C-X-C chemokine receptor type 3 (human)",
    "id" : "2833"
  }, {
    "name" : "Cxcr3 ; mCXCR3 ; ANA537",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12766",
    "description" : "C-X-C chemokine receptor type 3 (mouse)",
    "id" : "12766"
  }, {
    "name" : "CXCR4 ; hCXCR4 ; ANA77",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7852",
    "description" : "C-X-C chemokine receptor type 4 (human)",
    "id" : "7852"
  }, {
    "name" : "Cxcr4 ; mCXCR4 ; ANA538",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12767",
    "description" : "C-X-C chemokine receptor type 4 (mouse)",
    "id" : "12767"
  }, {
    "name" : "CXCR5 ; hCXCR5 ; ANA78",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/643",
    "description" : "C-X-C chemokine receptor type 5 (human)",
    "id" : "643"
  }, {
    "name" : "Cxcr5 ; mCXCR5 ; ANA539",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/12145",
    "description" : "C-X-C chemokine receptor type 5 (mouse)",
    "id" : "12145"
  }, {
    "name" : "CXCR6 ; hCXCR6 ; ANA79",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/10663",
    "description" : "C-X-C chemokine receptor type 6 (human)",
    "id" : "10663"
  }, {
    "name" : "Cxcr6 ; mCXCR6 ; ANA540",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/80901",
    "description" : "C-X-C chemokine receptor type 6 (mouse)",
    "id" : "80901"
  }, {
    "name" : "DC-SIGN1 ; hCD209 ; ANA869",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/30835",
    "description" : "CD209 antigen (human)",
    "id" : "30835"
  }, {
    "name" : "EBI3 ; hEBI3 ; ANA80",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/10148",
    "description" : "interleukin-27 subunit beta (human)",
    "id" : "10148"
  }, {
    "name" : "Ebi3 ; mEBI3 ; ANA541",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/50498",
    "description" : "interleukin-27 subunit beta (mouse)",
    "id" : "50498"
  }, {
    "name" : "EGF ; hEGF ; ANA81",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1950",
    "description" : "pro-epidermal growth factor (human)",
    "id" : "1950"
  }, {
    "name" : "Egf ; mEGF ; ANA542",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/13645",
    "description" : "pro-epidermal growth factor (mouse)",
    "id" : "13645"
  }, {
    "name" : "EGFR ; hEGFR ; ANA82",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1956",
    "description" : "epidermal growth factor receptor (human)",
    "id" : "1956"
  }, {
    "name" : "Egfr ; mEGFR ; ANA543",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/13649",
    "description" : "epidermal growth factor receptor (mouse)",
    "id" : "13649"
  }, {
    "name" : "Eotaxin ; hCCL11 ; ANA3",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6356",
    "description" : "eotaxin (human)",
    "id" : "6356"
  }, {
    "name" : "Eotaxin ; mCCL11 ; ANA477",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20292",
    "description" : "eotaxin (mouse)",
    "id" : "20292"
  }, {
    "name" : "EPO ; hEPO ; ANA83",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2056",
    "description" : "erythropoietin (human)",
    "id" : "2056"
  }, {
    "name" : "Epo ; mEPO ; ANA544",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/13856",
    "description" : "erythropoietin (mouse)",
    "id" : "13856"
  }, {
    "name" : "EPOR ; hEPOR ; ANA84",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2057",
    "description" : "erythropoietin receptor (human)",
    "id" : "2057"
  }, {
    "name" : "Epor ; mEPOR ; ANA545",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/13857",
    "description" : "erythropoietin receptor (mouse)",
    "id" : "13857"
  }, {
    "name" : "Fas ; mFAS ; ANA546",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/14102",
    "description" : "tumor necrosis factor receptor superfamily member 6 (mouse)",
    "id" : "14102"
  }, {
    "name" : "Fasl ; mFASLG ; ANA547",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/14103",
    "description" : "tumor necrosis factor ligand superfamily member 6 (mouse)",
    "id" : "14103"
  }, {
    "name" : "FASLG ; hFASLG ; ANA86",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/356",
    "description" : "tumor necrosis factor ligand superfamily member 6 (human)",
    "id" : "356"
  }, {
    "name" : "FGF1 ; hFGF1 ; ANA87",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2246",
    "description" : "fibroblast growth factor 1 (human)",
    "id" : "2246"
  }, {
    "name" : "Fgf1 ; mFGF1 ; ANA548",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/14164",
    "description" : "fibroblast growth factor 1 (mouse)",
    "id" : "14164"
  }, {
    "name" : "FGFB ; hFGF2 ; ANA88",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2247",
    "description" : "fibroblast growth factor 2 (human)",
    "id" : "2247"
  }, {
    "name" : "Fgfb ; mFGF2 ; ANA549",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/14173",
    "description" : "fibroblast growth factor 2 (mouse)",
    "id" : "14173"
  }, {
    "name" : "FIGF ; hVEGFD ; ANA710",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2277",
    "description" : "vascular endothelial growth factor D (human)",
    "id" : "2277"
  }, {
    "name" : "FLT3 ; hFLT3 ; ANA89",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2322",
    "description" : "receptor-type tyrosine-protein kinase FLT3 (human)",
    "id" : "2322"
  }, {
    "name" : "Flt3 ; mFLT3 ; ANA550",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/14255",
    "description" : "receptor-type tyrosine-protein kinase FLT3 (mouse)",
    "id" : "14255"
  }, {
    "name" : "Flt3l ; mFLT3LG ; ANA551",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/14256",
    "description" : "fms-related tyrosine kinase 3 ligand (mouse)",
    "id" : "14256"
  }, {
    "name" : "FLT3LG ; hFLT3LG ; ANA90",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2323",
    "description" : "fms-related tyrosine kinase 3 ligand (human)",
    "id" : "2323"
  }, {
    "name" : "FOXP3 ; hFOXP3 ; ANA874",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/50943",
    "description" : "forkhead box protein P3 (human)",
    "id" : "50943"
  }, {
    "name" : "FRACTALKINE ; hCX3CL1 ; ANA58",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6376",
    "description" : "fractalkine (human)",
    "id" : "6376"
  }, {
    "name" : "Fractalkine ; mCX3CL1 ; ANA521",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20312",
    "description" : "fractalkine (mouse)",
    "id" : "20312"
  }, {
    "name" : "GDF15 ; hGDF15 ; ANA91",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/9518",
    "description" : "growth/differentiation factor 15 (human)",
    "id" : "9518"
  }, {
    "name" : "Gdf15 ; mGDF15 ; ANA552",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/23886",
    "description" : "growth/differentiation factor 15 (mouse)",
    "id" : "23886"
  }, {
    "name" : "GMCSF ; hCSF2 ; ANA53",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1437",
    "description" : "granulocyte-macrophage colony-stimulating factor (human)",
    "id" : "1437"
  }, {
    "name" : "GranB ; hGZMB ; ANA897",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3002",
    "description" : "granzyme B (human)",
    "id" : "3002"
  }, {
    "name" : "GRO ; hCXCL1 ; ANA60",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2919",
    "description" : "growth-regulated alpha protein (human)",
    "id" : "2919"
  }, {
    "name" : "HGF ; hHGF ; ANA92",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3082",
    "description" : "hepatocyte growth factor (human)",
    "id" : "3082"
  }, {
    "name" : "Hgf ; mHGF ; ANA553",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15234",
    "description" : "hepatocyte growth factor (mouse)",
    "id" : "15234"
  }, {
    "name" : "hIKZF2 ;  ; ANA1274",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/22807",
    "description" : "zinc finger protein Helios",
    "id" : "22807"
  }, {
    "name" : "HLA-A ; hHLA-A ; ANA938",
    "link" : "http://purl.obolibrary.org/obo/PR_000036948",
    "description" : "HLA class I histocompatibility antigen A alpha chain (human)",
    "id" : "-"
  }, {
    "name" : "HLA-C ; hHLA-C ; ANA939",
    "link" : "http://purl.obolibrary.org/obo/PR_000036950",
    "description" : "HLA class I histocompatibility antigen C alpha chain (human)",
    "id" : "-"
  }, {
    "name" : "HLA-E ; hHLA-E ; ANA1029",
    "link" : "http://purl.obolibrary.org/obo/PR_P13747",
    "description" : "HLA class I histocompatibility antigen, alpha chain E (human)",
    "id" : "3133"
  }, {
    "name" : "HLA-G ; hHLA-G ; ANA1049",
    "link" : "http://purl.obolibrary.org/obo/PR_P17693",
    "description" : "HLA class I histocompatibility antigen, alpha chain G (human)",
    "id" : "3135"
  }, {
    "name" : "HLADR ; hHLA-DRA ; ANA812",
    "link" : "http://purl.obolibrary.org/obo/PR_P01903",
    "description" : "HLA class II histocompatibility antigen, DR alpha chain (human)",
    "id" : "3122"
  }, {
    "name" : "hMR1 ;  ; ANA1279",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3140",
    "description" : "MHC class I-related gene protein",
    "id" : "3140"
  }, {
    "name" : "hTIGIT ;  ; ANA1272",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/201633",
    "description" : "T-cell immunoreceptor with Ig and ITIM domains",
    "id" : "201633"
  }, {
    "name" : "hTRAV1-2 ;  ; ANA1277",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/28692",
    "description" : "T cell receptor alpha variable 1-2",
    "id" : "28692"
  }, {
    "name" : "hTRD ;  ; ANA1278",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/6964",
    "description" : "T cell receptor delta constant",
    "id" : "6964"
  }, {
    "name" : "hTRDV2 ;  ; ANA1276",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/28517",
    "description" : "T cell receptor delta variable 2",
    "id" : "28517"
  }, {
    "name" : "ICAM1 ; ICAM1 ; ANA705",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3383",
    "description" : "ICAM1 (human)",
    "id" : "3383"
  }, {
    "name" : "IFNA ; fam:hIFNA ; ANA717",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3438",
    "description" : "interferon alpha (human)",
    "id" : "3438"
  }, {
    "name" : "IFNA1 ; Ifna1 ; ANA93",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3439",
    "description" : "interferon alpha-1",
    "id" : "3439"
  }, {
    "name" : "Ifna1 ; mIfna1 ; ANA554",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15962",
    "description" : "interferon alpha-1 (mouse)",
    "id" : "15962"
  }, {
    "name" : "IFNA10 ; hIFNA10 ; ANA94",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3446",
    "description" : "interferon alpha-10 (human)",
    "id" : "3446"
  }, {
    "name" : "Ifna10 ; IFNA10 ; ANA555",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/110296",
    "description" : "interferon alpha-10",
    "id" : "110296"
  }, {
    "name" : "IFNA13 ; Ifna13 ; ANA95",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3447",
    "description" : "interferon alpha-13",
    "id" : "3447"
  }, {
    "name" : "Ifna13 ; mIfna13 ; ANA556",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/230396",
    "description" : "interferon alpha-13 (mouse)",
    "id" : "230396"
  }, {
    "name" : "IFNA14 ; hIFNA14 ; ANA96",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3448",
    "description" : "interferon alpha-14 (human)",
    "id" : "3448"
  }, {
    "name" : "Ifna14 ; IFNA14 ; ANA557",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/404549",
    "description" : "interferon alpha-14",
    "id" : "404549"
  }, {
    "name" : "IFNA16 ; hIFNA16 ; ANA97",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3449",
    "description" : "interferon alpha-16 (human)",
    "id" : "3449"
  }, {
    "name" : "Ifna16 ; IFNA16 ; ANA558",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/230398",
    "description" : "interferon alpha-16",
    "id" : "230398"
  }, {
    "name" : "IFNA17 ; hIFNA17 ; ANA98",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3451",
    "description" : "interferon alpha-17 (human)",
    "id" : "3451"
  }, {
    "name" : "IFNA2 ; hIFNA2 ; ANA99",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3440",
    "description" : "interferon alpha-2 (human)",
    "id" : "3440"
  }, {
    "name" : "Ifna2 ; mIfna2 ; ANA559",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15965",
    "description" : "interferon alpha-2 (mouse)",
    "id" : "15965"
  }, {
    "name" : "IFNA21 ; hIFNA21 ; ANA100",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3452",
    "description" : "interferon alpha-21 (human)",
    "id" : "3452"
  }, {
    "name" : "IFNA4 ; hIFNA4 ; ANA101",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3441",
    "description" : "interferon alpha-4 (human)",
    "id" : "3441"
  }, {
    "name" : "Ifna4 ; mIfna4 ; ANA560",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15967",
    "description" : "interferon alpha-4 (mouse)",
    "id" : "15967"
  }, {
    "name" : "IFNA5 ; hIFNA5 ; ANA102",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3442",
    "description" : "interferon alpha-5 (human)",
    "id" : "3442"
  }, {
    "name" : "Ifna5 ; mIfna5 ; ANA561",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15968",
    "description" : "interferon alpha-5 (mouse)",
    "id" : "15968"
  }, {
    "name" : "IFNA6 ; hIFNA6 ; ANA103",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3443",
    "description" : "interferon alpha-6 (human)",
    "id" : "3443"
  }, {
    "name" : "Ifna6 ; mIfna6 ; ANA562",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15969",
    "description" : "interferon alpha-6 (mouse)",
    "id" : "15969"
  }, {
    "name" : "IFNA7 ; hIFNA7 ; ANA104",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3444",
    "description" : "interferon alpha-7 (human)",
    "id" : "3444"
  }, {
    "name" : "Ifna7 ; mIfna7 ; ANA563",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15970",
    "description" : "interferon alpha-7 (mouse)",
    "id" : "15970"
  }, {
    "name" : "IFNA8 ; hIFNA8 ; ANA105",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3445",
    "description" : "interferon alpha-8 (human)",
    "id" : "3445"
  }, {
    "name" : "IFNAR1 ; hIFNAR1 ; ANA106",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3454",
    "description" : "interferon alpha/beta receptor 1 (human)",
    "id" : "3454"
  }, {
    "name" : "Ifnar1 ; mIFNAR1 ; ANA565",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15975",
    "description" : "interferon alpha/beta receptor 1 (mouse)",
    "id" : "15975"
  }, {
    "name" : "IFNAR2 ; hIFNAR2 ; ANA107",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3455",
    "description" : "interferon alpha/beta receptor 2 (human)",
    "id" : "3455"
  }, {
    "name" : "Ifnar2 ; mIFNAR2 ; ANA566",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15976",
    "description" : "interferon alpha/beta receptor 2 (mouse)",
    "id" : "15976"
  }, {
    "name" : "IFNB1 ; hIFNB1 ; ANA108",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3456",
    "description" : "interferon beta (human)",
    "id" : "3456"
  }, {
    "name" : "Ifnb1 ; mIFNB1 ; ANA567",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15977",
    "description" : "interferon beta (mouse)",
    "id" : "15977"
  }, {
    "name" : "IFNE ; hIFNE ; ANA109",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/338376",
    "description" : "interferon epsilon (human)",
    "id" : "338376"
  }, {
    "name" : "Ifne ; mIFNE ; ANA568",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/230405",
    "description" : "interferon epsilon (mouse)",
    "id" : "230405"
  }, {
    "name" : "IFNG ; hIFNG ; ANA110",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3458",
    "description" : "interferon gamma (human)",
    "id" : "3458"
  }, {
    "name" : "Ifng ; mIFNG ; ANA569",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15978",
    "description" : "interferon gamma (mouse)",
    "id" : "15978"
  }, {
    "name" : "IFNGR1 ; hIFNGR1 ; ANA111",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3459",
    "description" : "interferon gamma receptor 1 (human)",
    "id" : "3459"
  }, {
    "name" : "Ifngr1 ; mIFNGR1 ; ANA570",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15979",
    "description" : "interferon gamma receptor 1 (mouse)",
    "id" : "15979"
  }, {
    "name" : "IFNGR2 ; hIFNGR2 ; ANA112",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3460",
    "description" : "interferon gamma receptor 2 (human)",
    "id" : "3460"
  }, {
    "name" : "Ifngr2 ; IFNGR2 ; ANA571",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15980",
    "description" : "interferon-gamma receptor beta chain",
    "id" : "15980"
  }, {
    "name" : "IFNK ; hIFNK ; ANA113",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56832",
    "description" : "interferon kappa (human)",
    "id" : "56832"
  }, {
    "name" : "Ifnk ; mIFNK ; ANA572",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/387510",
    "description" : "interferon kappa (mouse)",
    "id" : "387510"
  }, {
    "name" : "IFNL1 ; hIFNL1 ; ANA114",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/282618",
    "description" : "interferon lambda-1 (human)",
    "id" : "282618"
  }, {
    "name" : "Ifnl2 ; mIfnl2 ; ANA573",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/330496",
    "description" : "interferon lambda-2 (mouse)",
    "id" : "330496"
  }, {
    "name" : "IFNL3 ; hIFNL3 ; ANA116",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/282617",
    "description" : "interferon lambda-3 (human)",
    "id" : "282617"
  }, {
    "name" : "Ifnl3 ; mIfnl3 ; ANA574",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/338374",
    "description" : "interferon lambda-3 (mouse)",
    "id" : "338374"
  }, {
    "name" : "IFNLR1 ; hIFNLR1 ; ANA117",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/163702",
    "description" : "interferon lambda receptor 1 (human)",
    "id" : "163702"
  }, {
    "name" : "Ifnlr1 ; mIFNLR1 ; ANA575",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/242700",
    "description" : "interferon lambda receptor 1 (mouse)",
    "id" : "242700"
  }, {
    "name" : "IgA1 ; hIGHA1 ; ANA820",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3493",
    "description" : "immunoglobulin heavy constant alpha 1 (human)",
    "id" : "3493"
  }, {
    "name" : "IgA2 ; hIGHA2 ; ANA819",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3494",
    "description" : "immunoglobulin heavy constant alpha 2 (human)",
    "id" : "3494"
  }, {
    "name" : "IgD ; hIGHD ; ANA813",
    "link" : "http://purl.obolibrary.org/obo/PR_P01880",
    "description" : "immunoglobulin heavy constant delta (human)",
    "id" : "3495"
  }, {
    "name" : "IGF1 ; IGF1 ; ANA713",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3479",
    "description" : "IGF1 (human)",
    "id" : "3479"
  }, {
    "name" : "IGFBP3 ; IGFBP3 ; ANA706",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3486",
    "description" : "IGFBP3 (human)",
    "id" : "3486"
  }, {
    "name" : "IgG ;  ; ANA1281",
    "link" : "https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGHG1&keywords=IgG1",
    "description" : "immunoglobulin heavy constant gamma 1",
    "id" : "3500"
  }, {
    "name" : "IgM ; hIGHM ; ANA817",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3507",
    "description" : "immunoglobulin heavy constant mu (human)",
    "id" : "3507"
  }, {
    "name" : "IL10 ; hIL10 ; ANA118",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3586",
    "description" : "interleukin-10 (human)",
    "id" : "3586"
  }, {
    "name" : "Il10 ; mIL10 ; ANA576",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16153",
    "description" : "interleukin-10 (mouse)",
    "id" : "16153"
  }, {
    "name" : "IL10RA ; hIL10RA ; ANA119",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3587",
    "description" : "interleukin-10 receptor subunit alpha (human)",
    "id" : "3587"
  }, {
    "name" : "Il10ra ; mIL10RA ; ANA577",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16154",
    "description" : "interleukin-10 receptor subunit alpha (mouse)",
    "id" : "16154"
  }, {
    "name" : "IL10RB ; hIL10RB ; ANA120",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3588",
    "description" : "interleukin-10 receptor subunit beta (human)",
    "id" : "3588"
  }, {
    "name" : "Il10rb ; mIL10RB ; ANA578",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16155",
    "description" : "interleukin-10 receptor subunit beta (mouse)",
    "id" : "16155"
  }, {
    "name" : "IL11 ; hIL11 ; ANA121",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3589",
    "description" : "interleukin-11 (human)",
    "id" : "3589"
  }, {
    "name" : "Il11 ; mIL11 ; ANA579",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16156",
    "description" : "interleukin-11 (mouse)",
    "id" : "16156"
  }, {
    "name" : "IL11RA ; hIL11RA ; ANA122",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3590",
    "description" : "interleukin-11 receptor subunit alpha (human)",
    "id" : "3590"
  }, {
    "name" : "Il11ra1 ; mIl11ra1 ; ANA580",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16157",
    "description" : "interleukin-11 receptor subunit alpha-1 (mouse)",
    "id" : "16157"
  }, {
    "name" : "IL12p35 ; hIL12A ; ANA123",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3592",
    "description" : "interleukin-12 subunit alpha (human)",
    "id" : "3592"
  }, {
    "name" : "Il12p35 ; mIL12A ; ANA581",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16159",
    "description" : "interleukin-12 subunit alpha (mouse)",
    "id" : "16159"
  }, {
    "name" : "IL12p40 ; hIL12B ; ANA124",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3593",
    "description" : "interleukin-12 subunit beta (human)",
    "id" : "3593"
  }, {
    "name" : "IL12p40 ; mIL12B ; ANA582",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16160",
    "description" : "interleukin-12 subunit beta (mouse)",
    "id" : "16160"
  }, {
    "name" : "IL12p70 ; hIL12 ; ANA800",
    "link" : "http://purl.obolibrary.org/obo/PR_000044524",
    "description" : "interleukin-12 complex (human)",
    "id" : ""
  }, {
    "name" : "IL12RB1 ; hIL12RB1 ; ANA125",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3594",
    "description" : "interleukin-12 receptor subunit beta-1 (human)",
    "id" : "3594"
  }, {
    "name" : "Il12rb1 ; mIL12RB1 ; ANA583",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16161",
    "description" : "interleukin-12 receptor subunit beta-1 (mouse)",
    "id" : "16161"
  }, {
    "name" : "IL12RB2 ; hIL12RB2 ; ANA126",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3595",
    "description" : "interleukin-12 receptor subunit beta-2 (human)",
    "id" : "3595"
  }, {
    "name" : "Il12rb2 ; mIL12RB2 ; ANA584",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16162",
    "description" : "interleukin-12 receptor subunit beta-2 (mouse)",
    "id" : "16162"
  }, {
    "name" : "IL13 ; hIL13 ; ANA127",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3596",
    "description" : "interleukin-13 (human)",
    "id" : "3596"
  }, {
    "name" : "Il13 ; mIL13 ; ANA585",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16163",
    "description" : "interleukin-13 (mouse)",
    "id" : "16163"
  }, {
    "name" : "Il13ra1 ; mIL13RA1 ; ANA586",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16164",
    "description" : "interleukin-13 receptor subunit alpha-1 (mouse)",
    "id" : "16164"
  }, {
    "name" : "Il13ra2 ; mIL13RA2 ; ANA587",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16165",
    "description" : "interleukin-13 receptor subunit alpha-2 (mouse)",
    "id" : "16165"
  }, {
    "name" : "IL15 ; hIL15 ; ANA130",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3600",
    "description" : "interleukin-15 (human)",
    "id" : "3600"
  }, {
    "name" : "Il15 ; mIL15 ; ANA588",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16168",
    "description" : "interleukin-15 (mouse)",
    "id" : "16168"
  }, {
    "name" : "IL15RA ; hIL15RA ; ANA131",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3601",
    "description" : "interleukin-15 receptor subunit alpha (human)",
    "id" : "3601"
  }, {
    "name" : "Il15ra ; mIL15RA ; ANA589",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16169",
    "description" : "interleukin-15 receptor subunit alpha (mouse)",
    "id" : "16169"
  }, {
    "name" : "IL16 ; hIL16 ; ANA132",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3603",
    "description" : "pro-interleukin-16 (human)",
    "id" : "3603"
  }, {
    "name" : "Il16 ; mIL16 ; ANA590",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16170",
    "description" : "pro-interleukin-16 (mouse)",
    "id" : "16170"
  }, {
    "name" : "IL17 ; hIL17F-17A ; ANA801",
    "link" : "http://purl.obolibrary.org/obo/PR_000044528",
    "description" : "interleukin 17F/17A heterodimer (human)",
    "id" : ""
  }, {
    "name" : "IL17A ; hIL17A ; ANA133",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3605",
    "description" : "interleukin-17A (human)",
    "id" : "3605"
  }, {
    "name" : "Il17a ; mIL17A ; ANA591",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16171",
    "description" : "interleukin-17A (mouse)",
    "id" : "16171"
  }, {
    "name" : "IL17B ; hIL17B ; ANA134",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/27190",
    "description" : "interleukin-17B (human)",
    "id" : "27190"
  }, {
    "name" : "Il17b ; mIL17B ; ANA592",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56069",
    "description" : "interleukin-17B (mouse)",
    "id" : "56069"
  }, {
    "name" : "IL17C ; hIL17C ; ANA135",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/27189",
    "description" : "interleukin-17C (human)",
    "id" : "27189"
  }, {
    "name" : "Il17c ; mIL17C ; ANA593",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/234836",
    "description" : "interleukin-17C (mouse)",
    "id" : "234836"
  }, {
    "name" : "IL17D ; hIL17D ; ANA136",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/53342",
    "description" : "interleukin-17D (human)",
    "id" : "53342"
  }, {
    "name" : "Il17d ; IL17D ; ANA594",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/239114",
    "description" : "interleukin-17D",
    "id" : "239114"
  }, {
    "name" : "IL17F ; hIL17F ; ANA137",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/112744",
    "description" : "interleukin-17F (human)",
    "id" : "112744"
  }, {
    "name" : "Il17f ; mIL17F ; ANA595",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/257630",
    "description" : "interleukin-17F (mouse)",
    "id" : "257630"
  }, {
    "name" : "IL17RA ; hIL17RA ; ANA138",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/23765",
    "description" : "interleukin-17 receptor A (human)",
    "id" : "23765"
  }, {
    "name" : "Il17ra ; mIL17RA ; ANA596",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16172",
    "description" : "interleukin-17 receptor A (mouse)",
    "id" : "16172"
  }, {
    "name" : "IL18 ; hIL18 ; ANA139",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3606",
    "description" : "interleukin-18 (human)",
    "id" : "3606"
  }, {
    "name" : "Il18 ; mIL18 ; ANA597",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16173",
    "description" : "interleukin-18 (mouse)",
    "id" : "16173"
  }, {
    "name" : "IL18R1 ; hIL18R1 ; ANA140",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8809",
    "description" : "interleukin-18 receptor 1 (human)",
    "id" : "8809"
  }, {
    "name" : "il18r1 ; mIL18R1 ; ANA698",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16182",
    "description" : "interleukin-18 receptor 1 (mouse)",
    "id" : "16182"
  }, {
    "name" : "IL19 ; hIL19 ; ANA141",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/29949",
    "description" : "interleukin-19 (human)",
    "id" : "29949"
  }, {
    "name" : "Il19 ; mIL19 ; ANA598",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/329244",
    "description" : "interleukin-19 (mouse)",
    "id" : "329244"
  }, {
    "name" : "IL1A ; hIL1A ; ANA142",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3552",
    "description" : "interleukin-1 alpha (human)",
    "id" : "3552"
  }, {
    "name" : "Il1a ; mIL1A ; ANA599",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16175",
    "description" : "interleukin-1 alpha (mouse)",
    "id" : "16175"
  }, {
    "name" : "IL1B ; hIL1B ; ANA143",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3553",
    "description" : "interleukin-1 beta (human)",
    "id" : "3553"
  }, {
    "name" : "Il1b ; mIL1B ; ANA600",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16176",
    "description" : "interleukin-1 beta (mouse)",
    "id" : "16176"
  }, {
    "name" : "IL1F10 ; hIL1F10 ; ANA144",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/84639",
    "description" : "interleukin-1 family member 10 (human)",
    "id" : "84639"
  }, {
    "name" : "Il1f10 ; mIL1F10 ; ANA601",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/215274",
    "description" : "interleukin-1 family member 10 (mouse)",
    "id" : "215274"
  }, {
    "name" : "Il1f5 ; mIL36RN ; ANA602",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/54450",
    "description" : "interleukin-36 receptor antagonist protein (mouse)",
    "id" : "54450"
  }, {
    "name" : "IL1R1 ; hIL1R1 ; ANA145",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3554",
    "description" : "interleukin-1 receptor type 1 (human)",
    "id" : "3554"
  }, {
    "name" : "Il1r1 ; mIL1R1 ; ANA603",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16177",
    "description" : "interleukin-1 receptor type 1 (mouse)",
    "id" : "16177"
  }, {
    "name" : "IL1R2 ; hIL1R2 ; ANA146",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7850",
    "description" : "interleukin-1 receptor type 2 (human)",
    "id" : "7850"
  }, {
    "name" : "Il1r2 ; mIL1R2 ; ANA604",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16178",
    "description" : "interleukin-1 receptor type 2 (mouse)",
    "id" : "16178"
  }, {
    "name" : "IL1RN ; hIL1RN ; ANA147",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3557",
    "description" : "interleukin-1 receptor antagonist protein (human)",
    "id" : "3557"
  }, {
    "name" : "Il1rn ; mIL1RN ; ANA605",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16181",
    "description" : "interleukin-1 receptor antagonist protein (mouse)",
    "id" : "16181"
  }, {
    "name" : "IL2 ; hIL2 ; ANA148",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3558",
    "description" : "interleukin-2 (human)",
    "id" : "3558"
  }, {
    "name" : "Il2 ; mIL2 ; ANA606",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16183",
    "description" : "interleukin-2 (mouse)",
    "id" : "16183"
  }, {
    "name" : "IL20 ; hIL20 ; ANA149",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/50604",
    "description" : "interleukin-20 (human)",
    "id" : "50604"
  }, {
    "name" : "Il20 ; mIL20 ; ANA607",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/58181",
    "description" : "interleukin-20 (mouse)",
    "id" : "58181"
  }, {
    "name" : "IL20RA ; hIL20RA ; ANA150",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/53832",
    "description" : "interleukin-20 receptor subunit alpha (human)",
    "id" : "53832"
  }, {
    "name" : "Il20ra ; mIL20RA ; ANA608",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/237313",
    "description" : "interleukin-20 receptor subunit alpha (mouse)",
    "id" : "237313"
  }, {
    "name" : "IL20RB ; hIL20RB ; ANA151",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/53833",
    "description" : "interleukin-20 receptor subunit beta (human)",
    "id" : "53833"
  }, {
    "name" : "Il20rb ; IL20RB ; ANA609",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/213208",
    "description" : "interleukin-20 receptor subunit beta",
    "id" : "213208"
  }, {
    "name" : "IL21 ; hIL21 ; ANA152",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/59067",
    "description" : "interleukin-21 (human)",
    "id" : "59067"
  }, {
    "name" : "Il21 ; mIL21 ; ANA610",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/60505",
    "description" : "interleukin-21 (mouse)",
    "id" : "60505"
  }, {
    "name" : "IL21R ; hIL21R ; ANA153",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/50615",
    "description" : "interleukin-21 receptor (human)",
    "id" : "50615"
  }, {
    "name" : "Il21r ; mIL21R ; ANA611",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/60504",
    "description" : "interleukin-21 receptor (mouse)",
    "id" : "60504"
  }, {
    "name" : "IL22 ; hIL22 ; ANA154",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/50616",
    "description" : "interleukin-22 (human)",
    "id" : "50616"
  }, {
    "name" : "Il22 ; mIl22 ; ANA612",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/50929",
    "description" : "interleukin-22 (mouse)",
    "id" : "50929"
  }, {
    "name" : "IL22RA1 ; hIL22RA1 ; ANA155",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/58985",
    "description" : "interleukin-22 receptor subunit alpha-1 (human)",
    "id" : "58985"
  }, {
    "name" : "Il22ra1 ; mIL22RA1 ; ANA613",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/230828",
    "description" : "interleukin-22 receptor subunit alpha-1 (mouse)",
    "id" : "230828"
  }, {
    "name" : "IL22RA2 ; hIL22RA2 ; ANA156",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/116379",
    "description" : "interleukin-22 receptor subunit alpha-2 (human)",
    "id" : "116379"
  }, {
    "name" : "Il22ra2 ; mIL22RA2 ; ANA614",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/237310",
    "description" : "interleukin-22 receptor subunit alpha-2 (mouse)",
    "id" : "237310"
  }, {
    "name" : "IL23 ; hIL23 ; ANA802",
    "link" : "http://purl.obolibrary.org/obo/PR_000044525",
    "description" : "interleukin-23 complex (human)",
    "id" : ""
  }, {
    "name" : "IL23A ; hIL23A ; ANA157",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/51561",
    "description" : "interleukin-23 subunit alpha (human)",
    "id" : "51561"
  }, {
    "name" : "Il23a ; mIL23A ; ANA615",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/83430",
    "description" : "interleukin-23 subunit alpha (mouse)",
    "id" : "83430"
  }, {
    "name" : "IL23R ; hIL23R ; ANA158",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/149233",
    "description" : "interleukin-23 receptor (human)",
    "id" : "149233"
  }, {
    "name" : "Il23r ; mIL23R ; ANA616",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/209590",
    "description" : "interleukin-23 receptor (mouse)",
    "id" : "209590"
  }, {
    "name" : "IL24 ; hIL24 ; ANA159",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/11009",
    "description" : "interleukin-24 (human)",
    "id" : "11009"
  }, {
    "name" : "Il24 ; mIL24 ; ANA617",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/93672",
    "description" : "interleukin-24 (mouse)",
    "id" : "93672"
  }, {
    "name" : "IL25 ; hIL25 ; ANA160",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/64806",
    "description" : "interleukin-25 (human)",
    "id" : "64806"
  }, {
    "name" : "Il25 ; mMYDGF ; ANA618",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/140806",
    "description" : "myeloid-derived growth factor (mouse)",
    "id" : "140806"
  }, {
    "name" : "IL26 ; hIL26 ; ANA161",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/55801",
    "description" : "interleukin-26 (human)",
    "id" : "55801"
  }, {
    "name" : "IL27 ; hIL27 ; ANA162",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/246778",
    "description" : "interleukin-27 subunit alpha (human)",
    "id" : "246778"
  }, {
    "name" : "Il27 ; mIL27 ; ANA619",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/246779",
    "description" : "interleukin-27 subunit alpha (mouse)",
    "id" : "246779"
  }, {
    "name" : "IL28A ; hIFNL2 ; ANA115",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/282616",
    "description" : "interferon lambda-2 (human)",
    "id" : "282616"
  }, {
    "name" : "IL2RA ; hIL2RA ; ANA163",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3559",
    "description" : "interleukin-2 receptor subunit alpha (human)",
    "id" : "3559"
  }, {
    "name" : "Il2ra ; mIL2RA ; ANA620",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16184",
    "description" : "interleukin-2 receptor subunit alpha (mouse)",
    "id" : "16184"
  }, {
    "name" : "IL2RB ; hIL2RB ; ANA164",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3560",
    "description" : "interleukin-2 receptor subunit beta (human)",
    "id" : "3560"
  }, {
    "name" : "Il2rb ; mIL2RB ; ANA621",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16185",
    "description" : "interleukin-2 receptor subunit beta (mouse)",
    "id" : "16185"
  }, {
    "name" : "IL2RG ; hIL2RG ; ANA165",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3561",
    "description" : "cytokine receptor common subunit gamma (human)",
    "id" : "3561"
  }, {
    "name" : "Il2rg ; mIL2RG ; ANA622",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16186",
    "description" : "cytokine receptor common subunit gamma (mouse)",
    "id" : "16186"
  }, {
    "name" : "IL3 ; hIL3 ; ANA166",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3562",
    "description" : "interleukin-3 (human)",
    "id" : "3562"
  }, {
    "name" : "Il3 ; mIL3 ; ANA623",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16187",
    "description" : "interleukin-3 (mouse)",
    "id" : "16187"
  }, {
    "name" : "IL31 ; hIL31 ; ANA167",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/386653",
    "description" : "interleukin-31 (human)",
    "id" : "386653"
  }, {
    "name" : "Il31 ; mIL31 ; ANA624",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/76399",
    "description" : "interleukin-31 (mouse)",
    "id" : "76399"
  }, {
    "name" : "IL32 ; hIL32 ; ANA168",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/9235",
    "description" : "interleukin-32 (human)",
    "id" : "9235"
  }, {
    "name" : "IL33 ; hIL33 ; ANA169",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/90865",
    "description" : "interleukin-33 (human)",
    "id" : "90865"
  }, {
    "name" : "Il33 ; mIL33 ; ANA625",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/77125",
    "description" : "interleukin-33 (mouse)",
    "id" : "77125"
  }, {
    "name" : "IL34 ; hIL34 ; ANA170",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/146433",
    "description" : "interleukin-34 (human)",
    "id" : "146433"
  }, {
    "name" : "Il34 ; mIL34 ; ANA626",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/76527",
    "description" : "interleukin-34 (mouse)",
    "id" : "76527"
  }, {
    "name" : "IL36G ; hIL36G ; ANA171",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56300",
    "description" : "interleukin-36 gamma (human)",
    "id" : "56300"
  }, {
    "name" : "IL36RN ; hIL36RN ; ANA172",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/26525",
    "description" : "interleukin-36 receptor antagonist protein (human)",
    "id" : "26525"
  }, {
    "name" : "Il3ra ; mIL3RA ; ANA627",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16188",
    "description" : "interleukin-3 receptor subunit alpha (mouse)",
    "id" : "16188"
  }, {
    "name" : "IL4 ; hIL4 ; ANA174",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3565",
    "description" : "interleukin-4 (human)",
    "id" : "3565"
  }, {
    "name" : "Il4 ; mIL4 ; ANA628",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16189",
    "description" : "interleukin-4 (mouse)",
    "id" : "16189"
  }, {
    "name" : "IL4R ; hIL4R ; ANA175",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3566",
    "description" : "interleukin-4 receptor subunit alpha (human)",
    "id" : "3566"
  }, {
    "name" : "Il4ra ; mIL4R ; ANA629",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16190",
    "description" : "interleukin-4 receptor subunit alpha (mouse)",
    "id" : "16190"
  }, {
    "name" : "IL5 ; hIL5 ; ANA176",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3567",
    "description" : "interleukin-5 (human)",
    "id" : "3567"
  }, {
    "name" : "Il5 ; mIL5 ; ANA630",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16191",
    "description" : "interleukin-5 (mouse)",
    "id" : "16191"
  }, {
    "name" : "IL5RA ; hIL5RA ; ANA177",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3568",
    "description" : "interleukin-5 receptor subunit alpha (human)",
    "id" : "3568"
  }, {
    "name" : "Il5ra ; mIL5RA ; ANA631",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16192",
    "description" : "interleukin-5 receptor subunit alpha (mouse)",
    "id" : "16192"
  }, {
    "name" : "IL6 ; hIL6 ; ANA178",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3569",
    "description" : "interleukin-6 (human)",
    "id" : "3569"
  }, {
    "name" : "Il6 ; mIL6 ; ANA632",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16193",
    "description" : "interleukin-6 (mouse)",
    "id" : "16193"
  }, {
    "name" : "IL6R ; hIL6R ; ANA179",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3570",
    "description" : "interleukin-6 receptor subunit alpha (human)",
    "id" : "3570"
  }, {
    "name" : "Il6ra ; mIL6R ; ANA633",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16194",
    "description" : "interleukin-6 receptor subunit alpha (mouse)",
    "id" : "16194"
  }, {
    "name" : "IL6ST ; hIL6ST ; ANA180",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3572",
    "description" : "interleukin-6 receptor subunit beta (human)",
    "id" : "3572"
  }, {
    "name" : "Il6st ; mIL6ST ; ANA634",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16195",
    "description" : "interleukin-6 receptor subunit beta (mouse)",
    "id" : "16195"
  }, {
    "name" : "IL7 ; hIL7 ; ANA181",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3574",
    "description" : "interleukin-7 (human)",
    "id" : "3574"
  }, {
    "name" : "Il7 ; mIL7 ; ANA635",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16196",
    "description" : "interleukin-7 (mouse)",
    "id" : "16196"
  }, {
    "name" : "Il7r ; mIL7R ; ANA636",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16197",
    "description" : "interleukin-7 receptor subunit alpha (mouse)",
    "id" : "16197"
  }, {
    "name" : "IL8 ; hCXCL8 ; ANA72",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3576",
    "description" : "interleukin-8 (human)",
    "id" : "3576"
  }, {
    "name" : "IL9 ; hIL9 ; ANA183",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3578",
    "description" : "interleukin-9 (human)",
    "id" : "3578"
  }, {
    "name" : "Il9 ; mIL9 ; ANA637",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16198",
    "description" : "interleukin-9 (mouse)",
    "id" : "16198"
  }, {
    "name" : "IL9R ; hIL9R ; ANA184",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3581",
    "description" : "interleukin-9 receptor (human)",
    "id" : "3581"
  }, {
    "name" : "Il9r ; mIL9R ; ANA638",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16199",
    "description" : "interleukin-9 receptor (mouse)",
    "id" : "16199"
  }, {
    "name" : "IP-10 ; hCXCL10 ; ANA61",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3627",
    "description" : "C-X-C motif chemokine 10 (human)",
    "id" : "3627"
  }, {
    "name" : "IP-10 ; mCXCL10 ; ANA524",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15945",
    "description" : "C-X-C motif chemokine 10 (mouse)",
    "id" : "15945"
  }, {
    "name" : "Itgal ; mITGAL ; ANA1074",
    "link" : "http://purl.obolibrary.org/obo/PR_P24063",
    "description" : "integrin alpha-L (mouse)",
    "id" : "-"
  }, {
    "name" : "Ki67 ; hMKI67 ; ANA889",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/4288",
    "description" : "proliferation marker protein Ki-67 (human)",
    "id" : "4288"
  }, {
    "name" : "Kir3dl1 ; mKir3dl1 ; ANA1134",
    "link" : "http://purl.obolibrary.org/obo/PR_P83555",
    "description" : "killer cell immunoglobulin-like receptor 3DL1 (mouse)",
    "id" : "-"
  }, {
    "name" : "KIT ; hKIT ; ANA185",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3815",
    "description" : "mast/stem cell growth factor receptor Kit (human)",
    "id" : "3815"
  }, {
    "name" : "Kit ; mKIT ; ANA639",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16590",
    "description" : "mast/stem cell growth factor receptor Kit (mouse)",
    "id" : "16590"
  }, {
    "name" : "Kitl ; mKITLG ; ANA640",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/17311",
    "description" : "kit ligand (mouse)",
    "id" : "17311"
  }, {
    "name" : "KITLG ; hKITLG ; ANA186",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4254",
    "description" : "kit ligand (human)",
    "id" : "4254"
  }, {
    "name" : "LBT ; hLTB ; ANA187",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4050",
    "description" : "lymphotoxin-beta (human)",
    "id" : "4050"
  }, {
    "name" : "LECT1 ; hCNMD ; ANA188",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/11061",
    "description" : "leukocyte cell-derived chemotaxin 1 (human)",
    "id" : "11061"
  }, {
    "name" : "Lect1 ; mCNMD ; ANA641",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16840",
    "description" : "leukocyte cell-derived chemotaxin 1 (mouse)",
    "id" : "16840"
  }, {
    "name" : "LECT2 ; hLECT2 ; ANA189",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3950",
    "description" : "leukocyte cell-derived chemotaxin-2 (human)",
    "id" : "3950"
  }, {
    "name" : "Lect2 ; mLECT2 ; ANA642",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16841",
    "description" : "leukocyte cell-derived chemotaxin-2 (mouse)",
    "id" : "16841"
  }, {
    "name" : "LEP ; LEP ; ANA714",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3952",
    "description" : "LEP (human)",
    "id" : "3952"
  }, {
    "name" : "LIF ; hLIF ; ANA190",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3976",
    "description" : "leukemia inhibitory factor (human)",
    "id" : "3976"
  }, {
    "name" : "Lif ; mLIF ; ANA643",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16878",
    "description" : "leukemia inhibitory factor (mouse)",
    "id" : "16878"
  }, {
    "name" : "LIFR ; hLIFR ; ANA191",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3977",
    "description" : "leukemia inhibitory factor receptor (human)",
    "id" : "3977"
  }, {
    "name" : "Lifr ; mLIFR ; ANA644",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16880",
    "description" : "leukemia inhibitory factor receptor (mouse)",
    "id" : "16880"
  }, {
    "name" : "Ltb ; mLTB ; ANA646",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16994",
    "description" : "lymphotoxin-beta (mouse)",
    "id" : "16994"
  }, {
    "name" : "LTBR ; hLTBR ; ANA193",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4055",
    "description" : "tumor necrosis factor receptor superfamily member 3 (human)",
    "id" : "4055"
  }, {
    "name" : "Ltbr ; mLTBR ; ANA647",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/17000",
    "description" : "tumor necrosis factor receptor superfamily member 3 (mouse)",
    "id" : "17000"
  }, {
    "name" : "MCP1 ; hCCL2 ; ANA11",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6347",
    "description" : "C-C motif chemokine 2 (human)",
    "id" : "6347"
  }, {
    "name" : "MCP3 ; hCCL7 ; ANA28",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6354",
    "description" : "C-C motif chemokine 7 (human)",
    "id" : "6354"
  }, {
    "name" : "MCP4 ; hCCL13 ; ANA4",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6357",
    "description" : "C-C motif chemokine 13 (human)",
    "id" : "6357"
  }, {
    "name" : "MCSF ; hCSF1 ; ANA51",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/1435",
    "description" : "macrophage colony-stimulating factor 1 (human)",
    "id" : "1435"
  }, {
    "name" : "MET ; hMET ; ANA194",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4233",
    "description" : "hepatocyte growth factor receptor (human)",
    "id" : "4233"
  }, {
    "name" : "Met ; mMET ; ANA648",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/17295",
    "description" : "hepatocyte growth factor receptor (mouse)",
    "id" : "17295"
  }, {
    "name" : "MIF ; hMIF ; ANA195",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4282",
    "description" : "macrophage migration inhibitory factor (human)",
    "id" : "4282"
  }, {
    "name" : "Mif ; mMIF ; ANA649",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/17319",
    "description" : "macrophage migration inhibitory factor (mouse)",
    "id" : "17319"
  }, {
    "name" : "mIKZF2 ;  ; ANA1275",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/22779",
    "description" : "zinc finger protein Helios",
    "id" : "22779"
  }, {
    "name" : "MIP1A ; hCCL3 ; ANA20",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6348",
    "description" : "C-C motif chemokine 3 (human)",
    "id" : "6348"
  }, {
    "name" : "MIP1B ; hCCL4 ; ANA24",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6351",
    "description" : "C-C motif chemokine 4 (human)",
    "id" : "6351"
  }, {
    "name" : "Mip1b ; mCCL4 ; ANA489",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20303",
    "description" : "C-C motif chemokine 4 (mouse)",
    "id" : "20303"
  }, {
    "name" : "MIP2 ; hCXCL2 ; ANA68",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2920",
    "description" : "C-X-C motif chemokine 2 (human)",
    "id" : "2920"
  }, {
    "name" : "MPL ; hMPL ; ANA196",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4352",
    "description" : "thrombopoietin receptor (human)",
    "id" : "4352"
  }, {
    "name" : "Mpl ; mMPL ; ANA650",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/17480",
    "description" : "thrombopoietin receptor (mouse)",
    "id" : "17480"
  }, {
    "name" : "MPO ; MPO ; ANA707",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4353",
    "description" : "MPO (human)",
    "id" : "4353"
  }, {
    "name" : "MST1 ; hMST1 ; ANA197",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4485",
    "description" : "hepatocyte growth factor-like protein (human)",
    "id" : "4485"
  }, {
    "name" : "Mst1 ; mMST1 ; ANA651",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/15235",
    "description" : "hepatocyte growth factor-like protein (mouse)",
    "id" : "15235"
  }, {
    "name" : "MST1R ; hMST1R ; ANA198",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4486",
    "description" : "macrophage-stimulating protein receptor (human)",
    "id" : "4486"
  }, {
    "name" : "Mst1r ; mMST1R ; ANA652",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/19882",
    "description" : "macrophage-stimulating protein receptor (mouse)",
    "id" : "19882"
  }, {
    "name" : "mTIGIT ;  ; ANA1273",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/100043314",
    "description" : "T-cell immunoreceptor with Ig and ITIM domains",
    "id" : "100043314"
  }, {
    "name" : "Nectin1 ; mNECTIN1 ; ANA1237",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9JKF6",
    "description" : "nectin-1 (mouse)",
    "id" : "58235"
  }, {
    "name" : "Nectin2 ; mNECTIN2 ; ANA1093",
    "link" : "http://purl.obolibrary.org/obo/PR_P32507",
    "description" : "nectin-2 (mouse)",
    "id" : "19294"
  }, {
    "name" : "Nectin3 ; mNECTIN3 ; ANA1238",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9JLB9",
    "description" : "nectin-3 (mouse)",
    "id" : "58998"
  }, {
    "name" : "NGF ; NGF ; ANA699",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4803",
    "description" : "NGF (human)",
    "id" : "4803"
  }, {
    "name" : "NKG2A ; hKLRC1 ; ANA861",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/3821",
    "description" : "NKG2-A/NKG2-B type II integral membrane protein (human)",
    "id" : "3821"
  }, {
    "name" : "NKP44 ; hNCR2 ; ANA885",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/9436",
    "description" : "natural cytotoxicity triggering receptor 2 (human)",
    "id" : "9436"
  }, {
    "name" : "OPG ; hTNFRSF11B ; ANA226",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4982",
    "description" : "tumor necrosis factor receptor superfamily member 11B (human)",
    "id" : "4982"
  }, {
    "name" : "OSM ; hOSM ; ANA199",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5008",
    "description" : "oncostatin-M (human)",
    "id" : "5008"
  }, {
    "name" : "Osm ; mOSM ; ANA653",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18413",
    "description" : "oncostatin-M (mouse)",
    "id" : "18413"
  }, {
    "name" : "OSMR ; hOSMR ; ANA200",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/9180",
    "description" : "oncostatin-M-specific receptor subunit beta (human)",
    "id" : "9180"
  }, {
    "name" : "Osmr ; mOSMR ; ANA654",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18414",
    "description" : "oncostatin-M-specific receptor subunit beta (mouse)",
    "id" : "18414"
  }, {
    "name" : "PAI1 ; SERPINE1 ; ANA708",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5054",
    "description" : "SERPINE1 (human)",
    "id" : "5054"
  }, {
    "name" : "PAPPA ; PAPPA ; ANA700",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5069",
    "description" : "PAPPA (human)",
    "id" : "5069"
  }, {
    "name" : "PD1 ; hPDCD1 ; ANA818",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5133",
    "description" : "programmed cell death protein 1 (human)",
    "id" : "5133"
  }, {
    "name" : "PDGF ; hPDGF-AB ; ANA803",
    "link" : "http://purl.obolibrary.org/obo/PR_000044755",
    "description" : "platelet-derived growth factor complex AB dimer (human)",
    "id" : ""
  }, {
    "name" : "PDGFA ; hPDGFA ; ANA201",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5154",
    "description" : "platelet-derived growth factor subunit A (human)",
    "id" : "5154"
  }, {
    "name" : "Pdgfa ; mPDGFA ; ANA655",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18590",
    "description" : "platelet-derived growth factor subunit A (mouse)",
    "id" : "18590"
  }, {
    "name" : "PDGFB ; hPDGFB ; ANA202",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5155",
    "description" : "platelet-derived growth factor subunit B (human)",
    "id" : "5155"
  }, {
    "name" : "Pdgfb ; mPDGFB ; ANA656",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18591",
    "description" : "platelet-derived growth factor subunit B (mouse)",
    "id" : "18591"
  }, {
    "name" : "PDGFRA ; hPDGFRA ; ANA203",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5156",
    "description" : "platelet-derived growth factor receptor alpha (human)",
    "id" : "5156"
  }, {
    "name" : "Pdgfra ; mPDGFRA ; ANA657",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18595",
    "description" : "platelet-derived growth factor receptor alpha (mouse)",
    "id" : "18595"
  }, {
    "name" : "PDGFRB ; hPDGFRB ; ANA204",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5159",
    "description" : "platelet-derived growth factor receptor beta (human)",
    "id" : "5159"
  }, {
    "name" : "Pdgfrb ; mPDGFRB ; ANA658",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18596",
    "description" : "platelet-derived growth factor receptor beta (mouse)",
    "id" : "18596"
  }, {
    "name" : "PDL2 ; hPDCD1LG2 ; ANA931",
    "link" : "http://purl.obolibrary.org/obo/PR_Q9BQ51",
    "description" : "programmed cell death 1 ligand 2 (human)",
    "id" : "-"
  }, {
    "name" : "Perforin ; hPRF1 ; ANA890",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/5551",
    "description" : "perforin-1 (human)",
    "id" : "5551"
  }, {
    "name" : "PF4 ; hPF4 ; ANA205",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5196",
    "description" : "platelet factor 4 (human)",
    "id" : "5196"
  }, {
    "name" : "Pf4 ; mPF4 ; ANA659",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56744",
    "description" : "platelet factor 4 (mouse)",
    "id" : "56744"
  }, {
    "name" : "PF4V1 ; hPF4V1 ; ANA206",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5197",
    "description" : "platelet factor 4 variant (human)",
    "id" : "5197"
  }, {
    "name" : "PIGF ; PIGF ; ANA715",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5281",
    "description" : "PIGF (human)",
    "id" : "5281"
  }, {
    "name" : "PPBP ; hPPBP ; ANA207",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5473",
    "description" : "platelet basic protein (human)",
    "id" : "5473"
  }, {
    "name" : "Ppbp ; PPBP ; ANA660",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/57349",
    "description" : "platelet basic protein",
    "id" : "57349"
  }, {
    "name" : "PRTN3 ; PRTN3 ; ANA703",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/5657",
    "description" : "PRTN3 (human)",
    "id" : "5657"
  }, {
    "name" : "pSTAT1 ; hSTAT1/iso:1/Phos:1 ; ANA907",
    "link" : "http://purl.obolibrary.org/obo/PR_000026858",
    "description" : "signal transducer and activator of transcription 1 isoform 1 phosphorylated 1 (human)",
    "id" : "-"
  }, {
    "name" : "pSTAT3 ; hSTAT3/Phos:1 ; ANA908",
    "link" : "http://purl.obolibrary.org/obo/PR_000045774",
    "description" : "signal transducer and activator of transcription 3 phosphorylated 1 (human)",
    "id" : "-"
  }, {
    "name" : "PTPRC ;  ; ANA1285",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/5788",
    "description" : "receptor-type tyrosine-protein phosphatase C�",
    "id" : "5788"
  }, {
    "name" : "RANKL ; hTNFSF11 ; ANA238",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8600",
    "description" : "tumor necrosis factor ligand superfamily member 11 (human)",
    "id" : "8600"
  }, {
    "name" : "RANTES ; hCCL5 ; ANA27",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6352",
    "description" : "C-C motif chemokine 5 (human)",
    "id" : "6352"
  }, {
    "name" : "RETN ; hRETN ; ANA208",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/56729",
    "description" : "resistin (human)",
    "id" : "56729"
  }, {
    "name" : "Retn ; mRETN ; ANA661",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/57264",
    "description" : "resistin (mouse)",
    "id" : "57264"
  }, {
    "name" : "SIGLEC-2 ; hCD22 ; ANA862",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/933",
    "description" : "B-cell receptor CD22 (human)",
    "id" : "933"
  }, {
    "name" : "SIGLEC-3 ; hCD33 ; ANA864",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/945",
    "description" : "myeloid cell surface antigen CD33 (human)",
    "id" : "945"
  }, {
    "name" : "SLAN ; hSECISBP2L ; ANA906",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/9728",
    "description" : "selenocysteine insertion sequence-binding protein 2-like (human)",
    "id" : "9728"
  }, {
    "name" : "SPP1 ; hSPP1 ; ANA209",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6696",
    "description" : "osteopontin (human)",
    "id" : "6696"
  }, {
    "name" : "Spp1 ; mSPP1 ; ANA662",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/20750",
    "description" : "osteopontin (mouse)",
    "id" : "20750"
  }, {
    "name" : "STAT1 ; hSTAT1 ; ANA892",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/6772",
    "description" : "signal transducer and activator of transcription 1-alpha/beta (human)",
    "id" : "6772"
  }, {
    "name" : "STAT3 ; hSTAT3 ; ANA900",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/6774",
    "description" : "signal transducer and activator of transcription 3 (human)",
    "id" : "6774"
  }, {
    "name" : "STAT5 ; hSTAT5A ; ANA901",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/6776",
    "description" : "signal transducer and activator of transcription 5A (human)",
    "id" : "6776"
  }, {
    "name" : "TARC ; hCCL17 ; ANA8",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6361",
    "description" : "C-C motif chemokine 17 (human)",
    "id" : "6361"
  }, {
    "name" : "TDGF1P2 ; hTDGF1P3 ; ANA210",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/22816",
    "description" : "teratocarcinoma-derived growth factor 3 (human)",
    "id" : "22816"
  }, {
    "name" : "TDGF1P3 ; TDGF1P3 ; ANA211",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6998",
    "description" : "TDGF1P3 (human)",
    "id" : "6998"
  }, {
    "name" : "TGFA ; TGFA ; ANA212",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7039",
    "description" : "TGFA (human)",
    "id" : "7039"
  }, {
    "name" : "Tgfa ; Tgfa ; ANA663",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21802",
    "description" : "Tgfa (mouse)",
    "id" : "21802"
  }, {
    "name" : "TGFB1 ; hTGFB1 ; ANA213",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7040",
    "description" : "transforming growth factor beta-1 (human)",
    "id" : "7040"
  }, {
    "name" : "Tgfb1 ; mTGFB1 ; ANA664",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21803",
    "description" : "transforming growth factor beta-1 proprotein (mouse)",
    "id" : "21803"
  }, {
    "name" : "TGFB2 ; hTGFB2 ; ANA214",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7042",
    "description" : "transforming growth factor beta-2 (human)",
    "id" : "7042"
  }, {
    "name" : "Tgfb2 ; mTGFB2 ; ANA665",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21808",
    "description" : "transforming growth factor beta-2 proprotein (mouse)",
    "id" : "21808"
  }, {
    "name" : "TGFB3 ; hTGFB3 ; ANA215",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7043",
    "description" : "transforming growth factor beta-3 (human)",
    "id" : "7043"
  }, {
    "name" : "Tgfb3 ; mTGFB3 ; ANA666",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21809",
    "description" : "transforming growth factor beta-3 (mouse)",
    "id" : "21809"
  }, {
    "name" : "TGFBR1 ; hTGFBR1 ; ANA216",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7046",
    "description" : "TGF-beta receptor type-1 (human)",
    "id" : "7046"
  }, {
    "name" : "Tgfbr1 ; mTGFBR1 ; ANA667",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21812",
    "description" : "TGF-beta receptor type-1 (mouse)",
    "id" : "21812"
  }, {
    "name" : "TGFBR2 ; hTGFBR2 ; ANA217",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7048",
    "description" : "TGF-beta receptor type-2 (human)",
    "id" : "7048"
  }, {
    "name" : "Tgfbr2 ; mTGFBR2 ; ANA668",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21813",
    "description" : "TGF-beta receptor type-2 (mouse)",
    "id" : "21813"
  }, {
    "name" : "TGFBR3 ; hTGFBR3 ; ANA218",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7049",
    "description" : "transforming growth factor beta receptor type 3 (human)",
    "id" : "7049"
  }, {
    "name" : "Tgfbr3 ; mTGFBR3 ; ANA669",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21814",
    "description" : "transforming growth factor beta receptor type 3 (mouse)",
    "id" : "21814"
  }, {
    "name" : "THPO ; hTHPO ; ANA219",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7066",
    "description" : "thrombopoietin (human)",
    "id" : "7066"
  }, {
    "name" : "Thpo ; mTHPO ; ANA670",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21832",
    "description" : "thrombopoietin (mouse)",
    "id" : "21832"
  }, {
    "name" : "TLR5 ; hTLR5 ; ANA872",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/7100",
    "description" : "Toll-like receptor 5 (human)",
    "id" : "7100"
  }, {
    "name" : "TLR6 ; hTLR6 ; ANA867",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/10333",
    "description" : "Toll-like receptor 6 (human)",
    "id" : "10333"
  }, {
    "name" : "TLR7 ; hTLR7 ; ANA39",
    "link" : "https://www.ncbi.nlm.nih.gov/gene/51284",
    "description" : "Toll-like receptor 7 (human)",
    "id" : "51284"
  }, {
    "name" : "TNFA ; hTNF ; ANA220",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7124",
    "description" : "tumor necrosis factor (human)",
    "id" : "7124"
  }, {
    "name" : "Tnfa ; mTNF ; ANA671",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21926",
    "description" : "tumor necrosis factor (mouse)",
    "id" : "21926"
  }, {
    "name" : "TNFB ; hLTA ; ANA192",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/4049",
    "description" : "lymphotoxin-alpha (human)",
    "id" : "4049"
  }, {
    "name" : "Tnfb ; mLTA ; ANA645",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16992",
    "description" : "lymphotoxin-alpha (mouse)",
    "id" : "16992"
  }, {
    "name" : "TNFRSF10A ; hTNFRSF10A ; ANA221",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8797",
    "description" : "tumor necrosis factor receptor superfamily member 10A (human)",
    "id" : "8797"
  }, {
    "name" : "TNFRSF10B ; hTNFRSF10B ; ANA222",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8795",
    "description" : "tumor necrosis factor receptor superfamily member 10B (human)",
    "id" : "8795"
  }, {
    "name" : "Tnfrsf10b ; mTnfrsf10b ; ANA672",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21933",
    "description" : "tumor necrosis factor receptor superfamily member 10B (mouse)",
    "id" : "21933"
  }, {
    "name" : "TNFRSF10C ; hTNFRSF10C ; ANA223",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8794",
    "description" : "tumor necrosis factor receptor superfamily member 10C (human)",
    "id" : "8794"
  }, {
    "name" : "TNFRSF10D ; hTNFRSF10D ; ANA224",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8793",
    "description" : "tumor necrosis factor receptor superfamily member 10D (human)",
    "id" : "8793"
  }, {
    "name" : "TNFRSF11A ; hTNFRSF11A ; ANA225",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8792",
    "description" : "tumor necrosis factor receptor superfamily member 11A (human)",
    "id" : "8792"
  }, {
    "name" : "Tnfrsf11a ; mTNFRSF11A ; ANA673",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21934",
    "description" : "tumor necrosis factor receptor superfamily member 11A (mouse)",
    "id" : "21934"
  }, {
    "name" : "Tnfrsf11b ; mTNFRSF11B ; ANA674",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/18383",
    "description" : "tumor necrosis factor receptor superfamily member 11B (mouse)",
    "id" : "18383"
  }, {
    "name" : "TNFRSF13B ; hTNFRSF13B ; ANA227",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/23495",
    "description" : "tumor necrosis factor receptor superfamily member 13B (human)",
    "id" : "23495"
  }, {
    "name" : "Tnfrsf13b ; mTNFRSF13B ; ANA675",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/57916",
    "description" : "tumor necrosis factor receptor superfamily member 13B (mouse)",
    "id" : "57916"
  }, {
    "name" : "TNFRSF14 ; hTNFRSF14 ; ANA228",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8764",
    "description" : "tumor necrosis factor receptor superfamily member 14 (human)",
    "id" : "8764"
  }, {
    "name" : "Tnfrsf14 ; mTNFRSF14 ; ANA676",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/230979",
    "description" : "tumor necrosis factor receptor superfamily member 14 (mouse)",
    "id" : "230979"
  }, {
    "name" : "TNFRSF17 ; hTNFRSF17 ; ANA229",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/608",
    "description" : "tumor necrosis factor receptor superfamily member 17 (human)",
    "id" : "608"
  }, {
    "name" : "Tnfrsf17 ; mTNFRSF17 ; ANA677",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21935",
    "description" : "tumor necrosis factor receptor superfamily member 17 (mouse)",
    "id" : "21935"
  }, {
    "name" : "TNFRSF18 ; hTNFRSF18 ; ANA230",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8784",
    "description" : "tumor necrosis factor receptor superfamily member 18 (human)",
    "id" : "8784"
  }, {
    "name" : "Tnfrsf18 ; mTnfrsf18 ; ANA678",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21936",
    "description" : "tumor necrosis factor receptor superfamily member 18 (mouse)",
    "id" : "21936"
  }, {
    "name" : "TNFRSF1A ; hTNFRSF1A ; ANA231",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7132",
    "description" : "tumor necrosis factor receptor superfamily member 1A (human)",
    "id" : "7132"
  }, {
    "name" : "Tnfrsf1a ; mTNFRSF1A ; ANA679",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21937",
    "description" : "tumor necrosis factor receptor superfamily member 1A (mouse)",
    "id" : "21937"
  }, {
    "name" : "TNFRSF1B ; hTNFRSF1B ; ANA232",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7133",
    "description" : "tumor necrosis factor receptor superfamily member 1B (human)",
    "id" : "7133"
  }, {
    "name" : "Tnfrsf1b ; mTNFRSF1B ; ANA680",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21938",
    "description" : "tumor necrosis factor receptor superfamily member 1B (mouse)",
    "id" : "21938"
  }, {
    "name" : "TNFRSF25 ; hTNFRSF25 ; ANA233",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8718",
    "description" : "tumor necrosis factor receptor superfamily member 25 (human)",
    "id" : "8718"
  }, {
    "name" : "Tnfrsf25 ; TNFRSF25 ; ANA681",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/85030",
    "description" : "tumor necrosis factor receptor superfamily member 25",
    "id" : "85030"
  }, {
    "name" : "TNFRSF4 ; hTNFRSF4 ; ANA234",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7293",
    "description" : "tumor necrosis factor receptor superfamily member 4 (human)",
    "id" : "7293"
  }, {
    "name" : "Tnfrsf4 ; mTNFRSF4 ; ANA682",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/22163",
    "description" : "tumor necrosis factor receptor superfamily member 4 (mouse)",
    "id" : "22163"
  }, {
    "name" : "TNFRSF8 ; hTNFRSF8 ; ANA235",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/943",
    "description" : "tumor necrosis factor receptor superfamily member 8 (human)",
    "id" : "943"
  }, {
    "name" : "Tnfrsf8 ; mTNFRSF8 ; ANA683",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21941",
    "description" : "tumor necrosis factor receptor superfamily member 8 (mouse)",
    "id" : "21941"
  }, {
    "name" : "TNFRSF9 ; hTNFRSF9 ; ANA236",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/3604",
    "description" : "tumor necrosis factor receptor superfamily member 9 (human)",
    "id" : "3604"
  }, {
    "name" : "Tnfrsf9 ; mTNFRSF9 ; ANA684",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21942",
    "description" : "tumor necrosis factor receptor superfamily member 9 (mouse)",
    "id" : "21942"
  }, {
    "name" : "Tnfsf10 ; mTNFSF10 ; ANA685",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/22035",
    "description" : "tumor necrosis factor ligand superfamily member 10 (mouse)",
    "id" : "22035"
  }, {
    "name" : "Tnfsf11 ; mTNFSF11 ; ANA686",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21943",
    "description" : "tumor necrosis factor ligand superfamily member 11 (mouse)",
    "id" : "21943"
  }, {
    "name" : "TNFSF12 ; hTNFSF12 ; ANA239",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8742",
    "description" : "tumor necrosis factor ligand superfamily member 12 (human)",
    "id" : "8742"
  }, {
    "name" : "Tnfsf12 ; mTNFSF12 ; ANA687",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21944",
    "description" : "tumor necrosis factor ligand superfamily member 12 (mouse)",
    "id" : "21944"
  }, {
    "name" : "TNFSF13 ; hTNFSF13 ; ANA240",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8741",
    "description" : "tumor necrosis factor ligand superfamily member 13 (human)",
    "id" : "8741"
  }, {
    "name" : "Tnfsf13 ; mTNFSF13 ; ANA688",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/69583",
    "description" : "tumor necrosis factor ligand superfamily member 13 (mouse)",
    "id" : "69583"
  }, {
    "name" : "Tnfsf13b ; mTNFSF13B ; ANA689",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/24099",
    "description" : "tumor necrosis factor ligand superfamily member 13B (mouse)",
    "id" : "24099"
  }, {
    "name" : "TNFSF14 ; hTNFSF14 ; ANA242",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8740",
    "description" : "tumor necrosis factor ligand superfamily member 14 (human)",
    "id" : "8740"
  }, {
    "name" : "Tnfsf14 ; mTNFSF14 ; ANA690",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/50930",
    "description" : "tumor necrosis factor ligand superfamily member 14 (mouse)",
    "id" : "50930"
  }, {
    "name" : "TNFSF15 ; hTNFSF15 ; ANA243",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/9966",
    "description" : "tumor necrosis factor ligand superfamily member 15 (human)",
    "id" : "9966"
  }, {
    "name" : "Tnfsf15 ; mTNFSF15 ; ANA691",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/326623",
    "description" : "tumor necrosis factor ligand superfamily member 15 (mouse)",
    "id" : "326623"
  }, {
    "name" : "TNFSF18 ; hTNFSF18 ; ANA244",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8995",
    "description" : "tumor necrosis factor ligand superfamily member 18 (human)",
    "id" : "8995"
  }, {
    "name" : "Tnfsf18 ; mTNFSF18 ; ANA692",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/240873",
    "description" : "tumor necrosis factor ligand superfamily member 18 (mouse)",
    "id" : "240873"
  }, {
    "name" : "TNFSF4 ; hTNFSF4 ; ANA245",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7292",
    "description" : "tumor necrosis factor ligand superfamily member 4 (human)",
    "id" : "7292"
  }, {
    "name" : "Tnfsf4 ; mTNFSF4 ; ANA693",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/22164",
    "description" : "tumor necrosis factor ligand superfamily member 4 (mouse)",
    "id" : "22164"
  }, {
    "name" : "TNFSF8 ; hTNFSF8 ; ANA246",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/944",
    "description" : "tumor necrosis factor ligand superfamily member 8 (human)",
    "id" : "944"
  }, {
    "name" : "Tnfsf8 ; mTNFSF8 ; ANA694",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21949",
    "description" : "tumor necrosis factor ligand superfamily member 8 (mouse)",
    "id" : "21949"
  }, {
    "name" : "TNFSF9 ; hTNFSF9 ; ANA247",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8744",
    "description" : "tumor necrosis factor ligand superfamily member 9 (human)",
    "id" : "8744"
  }, {
    "name" : "Tnfsf9 ; mTNFSF9 ; ANA695",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/21950",
    "description" : "tumor necrosis factor ligand superfamily member 9 (mouse)",
    "id" : "21950"
  }, {
    "name" : "TRAIL ; hTNFSF10 ; ANA237",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/8743",
    "description" : "tumor necrosis factor ligand superfamily member 10 (human)",
    "id" : "8743"
  }, {
    "name" : "TSLP ; TSLP ; ANA716",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/85480",
    "description" : "TSLP (human)",
    "id" : "85480"
  }, {
    "name" : "VCAM1 ; VCAM1 ; ANA702",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7412",
    "description" : "VCAM1 (human)",
    "id" : "7412"
  }, {
    "name" : "VEGFA ; VEGFA ; ANA709",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/7422",
    "description" : "VEGFA (human)",
    "id" : "7422"
  }, {
    "name" : "XCL1 ; hXCL1 ; ANA248",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6375",
    "description" : "lymphotactin (human)",
    "id" : "6375"
  }, {
    "name" : "Xcl1 ; mXCL1 ; ANA696",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/16963",
    "description" : "lymphotactin (mouse)",
    "id" : "16963"
  }, {
    "name" : "XCL2 ; hXCL2 ; ANA249",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/6846",
    "description" : "cytokine SCM-1 beta (human)",
    "id" : "6846"
  }, {
    "name" : "XCR1 ; hXCR1 ; ANA250",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/2829",
    "description" : "chemokine XC receptor 1 (human)",
    "id" : "2829"
  }, {
    "name" : "Xcr1 ; mXCR1 ; ANA697",
    "link" : "http://www.ncbi.nlm.nih.gov/gene/23832",
    "description" : "chemokine XC receptor 1 (mouse)",
    "id" : "23832"
  } ]
}, {
  "name" : "lk_ancestral_population",
  "rows" : [ {
    "name" : "Australia",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "Australia and all of its islands (for example, Groote Eylandt, Tasmania, etc).",
    "id" : ""
  }, {
    "name" : "Central Asia",
    "link" : "https://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan and Afghanistan",
    "id" : ""
  }, {
    "name" : "Europe",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "An area bounded by Franz Joseph Land, Svalbard, Iceland, the northern coast of the Mediterranean and Black Seas, and those areas of Russia west of the Caspian Sea and Kazakhstan. Includes Mediterranean islands that are part of European nations, with the exception of Cyprus and islands that are part of Turkey.",
    "id" : ""
  }, {
    "name" : "None of the Above",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "The population area is unknown.",
    "id" : ""
  }, {
    "name" : "North Africa",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "Nations on the African continent north of a line drawn between Nouadhibou in Mauritania and Djiubouti. Includes all of Western Sahara, Morocco, Algeria, Lyibia, Egypt, Eritrea, and Djibouti and northern areas of Mauritania, Mali, Niger, Chad, Sudan, and Ethiopia.",
    "id" : ""
  }, {
    "name" : "North America",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "Canada, the United States, Mexico, the Aleutian islands and Greenland.",
    "id" : ""
  }, {
    "name" : "North-East Asia",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "Russia north (and associated islands), Mongolia, China east and east of the Gulf of Chihli, the Korean peninsula, and the islands of Japan.",
    "id" : ""
  }, {
    "name" : "Oceania",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "An area of the Pacific bounded by the Hawaiian Islands, Easter Island, the islands of New Zealand, the Sunda Islands, Madagascar, those areas of Borneo not part of Malaysia, and the Phillipines.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "This category is for populations derived from more than one of the other regions defined here.",
    "id" : ""
  }, {
    "name" : "South America",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "All of the South American and the Central American nations and associated islands, and the Caribbean.",
    "id" : ""
  }, {
    "name" : "South Asia",
    "link" : "https://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "Pakistan, India, Sri Lanka and Bangladesh.",
    "id" : ""
  }, {
    "name" : "South-East Asia",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "China West, Taiwan, Nepal, Bhutan, Vietnam, Myanmar (Burma), Laos, Cambodia, Thailand, Malaysia (including the Malaysian area of Borneo) and Singapore.",
    "id" : ""
  }, {
    "name" : "Sub-Saharan Africa",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "The area on the African continent south of the Sahara, defined by a line drawn between Nouadhibou in Mauritania and Djiubouti, and the islands associated with the nations of that area. Includes the southern areas of Mauritania, Mali, Niger, Chad, Sudan, and Ethiopia. Madagascar is not included in this region.",
    "id" : ""
  }, {
    "name" : "Unknown",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0439673",
    "description" : "A proper value is applicable, but not known.((HL7V3.0)",
    "id" : ""
  }, {
    "name" : "Western Asia",
    "link" : "http://www.allelefrequencies.net/datasets.asp#tag_4",
    "description" : "Cyprus, Turkey (and associated islands), Georgia, Armenia, Azerbaijan, Syria, Lebanon, Israel, the Palestinian Territories, Jordan, the Saudi peninsula, Iraq, Kuwait and Iran.",
    "id" : ""
  } ]
}, {
  "name" : "lk_animal_sex",
  "rows" : [ {
    "name" : "Female",
    "link" : "",
    "description" : "Gender is Female.",
    "id" : ""
  }, {
    "name" : "Male",
    "link" : "",
    "description" : "Gender is Male.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "Gender is Other. Value may be used to differeniate as neither Male or Female.",
    "id" : ""
  }, {
    "name" : "Unknown",
    "link" : "",
    "description" : "Gender is Unknown. Value may be used to signify that gender is unknown at the time.",
    "id" : ""
  } ]
}, {
  "name" : "lk_arm_type",
  "rows" : [ {
    "name" : "type_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "Active Comparator Arm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C174267",
    "description" : "An arm describing the active comparator.",
    "id" : null
  }, {
    "name" : "Experimental Arm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C174266",
    "description" : "An arm describing the intervention or treatment plan for a group of participants in the study receiving test product(s).",
    "id" : null
  }, {
    "name" : "Healthy Control",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C94342",
    "description" : "A healthy subject that is matched with an affected individual in a trial.",
    "id" : null
  }, {
    "name" : "Intervention",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25218",
    "description" : "An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.",
    "id" : null
  }, {
    "name" : "Negative Control",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64357",
    "description" : "A control sample where a negative result is expected, to help correlate a positive result with the variable being tested.",
    "id" : null
  }, {
    "name" : "No Intervention Arm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C174270",
    "description" : "A study arm without an intervention or treatment.",
    "id" : null
  }, {
    "name" : "Observational",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C16084",
    "description" : "Studies among cancer patients and healthy populations that involve no intervention or alteration in the status of the participants.",
    "id" : null
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "Other or unknown type of study arm",
    "id" : null
  }, {
    "name" : "Placebo Comparator Arm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C174268",
    "description" : "An arm describing the placebo comparator.",
    "id" : null
  }, {
    "name" : "Positive Control",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64356",
    "description" : "A control sample that is known to produce a positive result if the test is working as expected.",
    "id" : null
  }, {
    "name" : "Sham Comparator Arm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C174269",
    "description" : "An arm describing the sham comparator.",
    "id" : null
  }, {
    "name" : "Treatment Arm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15538",
    "description" : "A specific treatment plan within a clinical trial that describes the activities a subject will be involved in as he or she progresses through the study.",
    "id" : null
  }, {
    "name" : "Vaccination",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15346",
    "description" : "Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis or treatment.",
    "id" : null
  } ]
}, {
  "name" : "lk_arm_type_pref_mapping",
  "rows" : [ {
    "name" : "name_reported",
    "link" : null,
    "description" : "name_preferred",
    "id" : null
  }, {
    "name" : "Active Comparator",
    "link" : null,
    "description" : "Active Comparator Arm",
    "id" : null
  }, {
    "name" : "Arm",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "arm (protocol)",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "Experimental",
    "link" : null,
    "description" : "Experimental Arm",
    "id" : null
  }, {
    "name" : "Intervention or Procedure",
    "link" : null,
    "description" : "Intervention",
    "id" : null
  }, {
    "name" : "Intervention Strategies",
    "link" : null,
    "description" : "Intervention",
    "id" : null
  }, {
    "name" : "Interventional",
    "link" : null,
    "description" : "Intervention",
    "id" : null
  }, {
    "name" : "interventionDescription",
    "link" : null,
    "description" : "Intervention",
    "id" : null
  }, {
    "name" : "Investigational Arm",
    "link" : null,
    "description" : "Experimental Arm",
    "id" : null
  }, {
    "name" : "Negative_Control",
    "link" : null,
    "description" : "Negative Control",
    "id" : null
  }, {
    "name" : "No Intervention",
    "link" : null,
    "description" : "No Intervention Arm",
    "id" : null
  }, {
    "name" : "Observational Study",
    "link" : null,
    "description" : "Observational",
    "id" : null
  }, {
    "name" : "Observational Trial",
    "link" : null,
    "description" : "Observational",
    "id" : null
  }, {
    "name" : "Placebo Comparator",
    "link" : null,
    "description" : "Placebo Comparator Arm",
    "id" : null
  }, {
    "name" : "Placebo Control Arm",
    "link" : null,
    "description" : "Placebo Comparator Arm",
    "id" : null
  }, {
    "name" : "Planned Arm",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "Postive_Control",
    "link" : null,
    "description" : "Positive Control",
    "id" : null
  }, {
    "name" : "Procedure",
    "link" : null,
    "description" : "Intervention",
    "id" : null
  }, {
    "name" : "Protocol Arm",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "Protocol Treatment Arm",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "Sham Comparator",
    "link" : null,
    "description" : "Sham Comparator Arm",
    "id" : null
  }, {
    "name" : "Sham Intervention Arm",
    "link" : null,
    "description" : "Sham Comparator Arm",
    "id" : null
  }, {
    "name" : "study arm",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "study_arm",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "Treatment",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "treatment type",
    "link" : null,
    "description" : "Intervention",
    "id" : null
  }, {
    "name" : "TREATMENT_ARM",
    "link" : null,
    "description" : "Treatment Arm",
    "id" : null
  }, {
    "name" : "treatment_type",
    "link" : null,
    "description" : "Intervention",
    "id" : null
  } ]
}, {
  "name" : "lk_cell_pop_statistic_unit",
  "rows" : [ {
    "name" : "statistic_unit_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48938",
    "description" : "cell count",
    "id" : null
  }, {
    "name" : "cells/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74919",
    "description" : "A unit of cell concentration expressed in cells per unit of volume equal to one milliliter.",
    "id" : null
  }, {
    "name" : "cells/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67242",
    "description" : "A unit of cell concentration expressed as a number of cells per unit volume equal to one microliter.",
    "id" : null
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : null
  }, {
    "name" : "MFI at 90th percentile",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C96687",
    "description" : "Mean Fluorescence Intensity at 90th Percentile.  MFI : A unit of measure equal to the geometric mean fluorescence intensity of a log-normal distribution of fluorescence signals.",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : null
  }, {
    "name" : "percentage",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25613",
    "description" : "A fraction or ratio with 100 understood as the denominator. e.g. percentage of a cell population of interest within a parent population",
    "id" : null
  }, {
    "name" : "stim/unstim fold change",
    "link" : "https://en.wikipedia.org/wiki/Fold_change",
    "description" : "Fold change comparing stimulated vs unstimulated sample",
    "id" : null
  } ]
}, {
  "name" : "lk_cell_population",
  "rows" : [ {
    "name" : "population_prefix_preferred ;\npopulation_name_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "- ; basophil",
    "link" : "http://purl.obolibrary.org/obo/CL_0000767",
    "description" : "Any of the immature or mature forms of a granular leukocyte that in its mature form has an irregularly shaped, pale-staining nucleus that is partially constricted into two lobes, and with cytoplasm that contains coarse, bluish-black granules of variable size. Basophils contain vasoactive amines such as histamine and serotonin, which are released on appropriate stimulation. A basophil is CD123-positive, CD193-positive, CD203c-positive, and FceRIa-positive.;Matures in the bone marrow and account for <1% of leukocytes in the peripheral blood, spleen, and bone marrow. Basophils are described as being CD11a-positive, CD11b-positive, CD13-positive, CD15-positive, CD18-positive, CD21-positive, CD25-positive, CD29-positive, CD35-positive, CD40-positive, CD40L-positive, CD44-positive, CD45R-negative, CD46-positive, CD49a-positive, CD49b-positive, CD49d-positive, CD55-positive, CD59-positive, CD62L-positive, CD63-positive, CD69-positive, CD90-negative, CD116-positive, CD117-negative, CD124-positive, CD125-positive, CD131-positive, CD161-positive, CD184-positive, CD191-positive, CD192-positive, CD197-positive, CD200R3-positive, CD218-positive, CD282-positive, CD284-positive, CD289-positive, CD290-positive, CD294-positive, natural killer cell receptor 2B4-positive, smad1-positive, CD3-negative, CD4-negative, CD7-negative, CD8-negative, CD14-negative, CD15-negative, CD16-negative, CD19-negative, CD20-negative, CD34-negative, CD36-negative, CD45R-negative, CD56-negative, CD57-negative, CD235a-negative, and GR1-negative. Transcription factors- GATA1-positive, PU.1-positive.",
    "id" : null
  }, {
    "name" : "- ; cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000000",
    "description" : "A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.;The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one).",
    "id" : null
  }, {
    "name" : "- ; eosinophil",
    "link" : "http://purl.obolibrary.org/obo/CL_0000771",
    "description" : "Any of the immature or mature forms of a granular leukocyte with a nucleus that usually has two lobes connected by one or more slender threads of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and which can be stained by the dye eosin. Eosinophils are CD9-positive, CD191-positive, and CD193-positive.;Eosinophils are also CD14-negative, CD32-positive, CD44-positive, CD48-positive, CD69-positive, CD192-negative, MBP1-positive, MBP2-positive, TLR2-negative, TLR4-negative, and lineage-negative (B220, CD2, CD14, CD19, CD56, CD71, CD117, CD123, CD235a (glycophorin A), and TER119). The cytokines IL-3, IL-5, and GM-CSF are involved in their development and differentiation. Usually considered CD16-negative, CD16 is observed on eosinophilic metamyelocyte.",
    "id" : null
  }, {
    "name" : "- ; erythrocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000232",
    "description" : "A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen.",
    "id" : null
  }, {
    "name" : "- ; granulocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000094",
    "description" : "A leukocyte with abundant granules in the cytoplasm.",
    "id" : null
  }, {
    "name" : "- ; hematopoietic stem cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000037",
    "description" : "A stem cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system. Hematopoietic stem cells lack cell markers of effector cells (lin-). Lin- is defined by lacking one or more of the following cell surface markers: CD2, CD3 epsilon, CD4, CD5 ,CD8 alpha chain, CD11b, CD14, CD19, CD20, CD56, ly6G, ter119.",
    "id" : null
  }, {
    "name" : "- ; innate lymphoid cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001065",
    "description" : "A lymphocyte that lacks characteristic T cell, B cell, myeloid cell, and dendritic cell markers, that functions as part of the innate immune response to produce cytokines and other effector responses.",
    "id" : null
  }, {
    "name" : "- ; leukocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000738",
    "description" : "An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.",
    "id" : null
  }, {
    "name" : "- ; leukocyte, platelet",
    "link" : "http://purl.obolibrary.org/obo/CL_0000738;http://purl.obolibrary.org/obo/CL_0000233",
    "description" : "An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.;A non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation.;Platelets are reportedly CCR1-positive, CCR2-negative, CCR3-positive, CCR4-positive, CCR5-negative, CCR6-negative, CCR7-negative, CCR8-negative, CCR9-negative, CCR10-negative, CD16-positive, CD23-positive, CD32-positive, CD40-positive, CD41-positive CD42-positive, CD61-positive, CD62P-positive, CD64-positive, CD89-positive, CD102-positive, CD147-positive (activated platelets), CD154-positive (activated platelets), CD162-positive, CD209, CD282-positive, CD284-positive, CD289-positive, CD181-negative, CD182-negative, CD183-negative, CD184-positive, CLEC2-positive, GPVI-positive, JAMC-positive, PAR1-positive, PAR2-negative, PAR3-positive, PAR4-positive, TSP1-positive, and TXA2R-positive. Platelets can reportedly produce CCL2, CCL3, CCL5, CCL7, CCL17, CD40L, CXCL1, CXCL4, CXCL4L1, CXCL5, CXCL7, CXCL8, CXCL12, EGF, factor V, factor VII, factor XI, factor XIII, bFGF, histamine, IGF-1, IL-1beta, PAI-1, PDGF, plasminogen, protein S, serotonin, TGF-beta, TFPI, VEGF, and vWF.",
    "id" : null
  }, {
    "name" : "- ; Live/Dead",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000169",
    "description" : "Viable cells",
    "id" : null
  }, {
    "name" : "- ; lymphocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000542",
    "description" : "A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.;Editors note: consider adding taxon constraint to vertebrata (PMID:18025161)",
    "id" : null
  }, {
    "name" : "- ; mature neutrophil",
    "link" : "http://purl.obolibrary.org/obo/CL_0000096",
    "description" : "A fully differentiated neutrophil, a granular leukocyte having a nucleus with three to five lobes connected by slender threads, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. They are produced in bone marrow at a rate of 5e10-10e10/day and have a half-life of 6-8 hours. Neutrophils are CD15-positive, CD16-positive, CD32-positive, CD43-positive, CD181-positive, and CD182-positive.;Neutrophils are also capable of secreting GRO-alpha, IL-1beta, IL-1ra, IL-3, IL-12, IP-10, MIG, MIP-1alpha, MIP-1beta, TGF-beta, TNF-alpha, VEGF, and anti-microbial peptides. They can positively influence the chemotaxis of basophils, T-cells, monocytes, macrophages, dendritic cells, and other neutrophils. Neutrophils are also CD35-positive, CD64-positive, CD89-positive, CD184-positive, and fMLP receptor-positive Ly-6G-positive (mouse), TLR2-low, TLR4-low, and lineage-negative (CD2, CD3, CD5, CD9, CD19, CD36, CD49d, CD56, CD61, CD235a (glycophorin-A)).",
    "id" : null
  }, {
    "name" : "- ; neutrophil",
    "link" : "http://purl.obolibrary.org/obo/CL_0000775",
    "description" : "Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.",
    "id" : null
  }, {
    "name" : "- ; PBMC",
    "link" : "http://purl.obolibrary.org/obo/CL_2000001",
    "description" : "A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.",
    "id" : null
  }, {
    "name" : "- ; platelet",
    "link" : "http://purl.obolibrary.org/obo/CL_0000233",
    "description" : "A non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation.;Platelets are reportedly CCR1-positive, CCR2-negative, CCR3-positive, CCR4-positive, CCR5-negative, CCR6-negative, CCR7-negative, CCR8-negative, CCR9-negative, CCR10-negative, CD16-positive, CD23-positive, CD32-positive, CD40-positive, CD41-positive CD42-positive, CD61-positive, CD62P-positive, CD64-positive, CD89-positive, CD102-positive, CD147-positive (activated platelets), CD154-positive (activated platelets), CD162-positive, CD209, CD282-positive, CD284-positive, CD289-positive, CD181-negative, CD182-negative, CD183-negative, CD184-positive, CLEC2-positive, GPVI-positive, JAMC-positive, PAR1-positive, PAR2-negative, PAR3-positive, PAR4-positive, TSP1-positive, and TXA2R-positive. Platelets can reportedly produce CCL2, CCL3, CCL5, CCL7, CCL17, CD40L, CXCL1, CXCL4, CXCL4L1, CXCL5, CXCL7, CXCL8, CXCL12, EGF, factor V, factor VII, factor XI, factor XIII, bFGF, histamine, IGF-1, IL-1beta, PAI-1, PDGF, plasminogen, protein S, serotonin, TGF-beta, TFPI, VEGF, and vWF.",
    "id" : null
  }, {
    "name" : "- ; reticulocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000558",
    "description" : "An immature erythrocyte that changes the protein composition of its plasma membrane by exosome formation and extrusion. The types of protein removed differ between species though removal of the transferrin receptor is apparent in mammals and birds.",
    "id" : null
  }, {
    "name" : "- ; Total Cells",
    "link" : "NA",
    "description" : "NA",
    "id" : null
  }, {
    "name" : "B ; B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000236",
    "description" : "A lymphocyte of B lineage with the phenotype CD19-positive, CD20-positive, and capable of B cell mediated immunity.",
    "id" : null
  }, {
    "name" : "B ; class switched memory B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000972",
    "description" : "A class switched memory B cell is a memory B cell that has undergone Ig class switching and therefore is IgM-negative on the cell surface. These cells are CD27-positive and have either IgG, IgE, or IgA on the cell surface.;Per DSD: Class switched memory B cells are also reportedly CD48-positive, CD229-positive, and CD352-positive.",
    "id" : null
  }, {
    "name" : "B ; IgD+ memory B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000970",
    "description" : "An unswitched memory B cell is a memory B cell that has the phenotype IgM-positive, IgD-positive, CD27-positive, CD138-negative, IgG-negative, IgE-negative, and IgA-negative.",
    "id" : null
  }, {
    "name" : "B ; IgD- memory B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001053",
    "description" : "A memory B cell that lacks expression of surface IgD.",
    "id" : null
  }, {
    "name" : "B ; IgG memory B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000979",
    "description" : "An IgG memory B cell is a class switched memory B cell that is class switched and expresses IgG on the cell surface.",
    "id" : null
  }, {
    "name" : "B ; immature B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000816",
    "description" : "An immature B cell is a B cell that has the phenotype surface IgM-positive and surface IgD-negative, and have not undergone class immunoglobulin class switching or peripheral encounter with antigen and activation.;Immature B cells are also reportedly CD5-positive, CD10-positive, CD19-positive, CD20-positive, CD21-positive, CD22-positive, CD24-positive, CD25-negative, CD27-negative, CD34-negative, CD38-positive, CD40-positive, CD43-negative, CD45-positive, CD48-positive, CD53-positive, CD79a-positive, CD80-negative, CD81-positive, CD86-negative, CD95-negative, CD127-negative, CD138-negative, CD185-positive, CD196-positive, MHCII/HLA-DR-positive, RAG-positive, TdT-negative, Vpre-B-negative, and preBCR-negative. Transcription factors expressed: Pax5-positive.",
    "id" : null
  }, {
    "name" : "B ; marginal zone B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000845",
    "description" : "A mature B cell that is located in the marginal zone of the spleen with the phenotype CD23-negative and CD21-positive and expressing a B cell receptor usually reactive to bacterial cell wall components or senescent self components such as oxidized-LDL. This cell type is also described as being CD19-positive, B220-positive, IgM-high, AA4-negative, CD35-high.;MZ B cells are reportedly CD1-positive (mice), CD20-positive, CD48-positive, CD84-positive, CD150-positive, CD229-positive, and CD352-positive.",
    "id" : null
  }, {
    "name" : "B ; mature B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000785",
    "description" : "A B cell that is mature, having left the bone marrow. Initially, these cells are IgM-positive and IgD-positive, and they can be activated by antigen.;Mature B cells are also reportedly CD10-negative, CD19-positive, CD22-positive, CD34-negative, CD48-positive, CD79a-positive, CD84-positive, CD127-negative, CD352-positive, RAG-negative, TdT-negative, Vpre-B-negative, and pre-BCR-negative. Transcription factors expressed: Pax5-positive.",
    "id" : null
  }, {
    "name" : "B ; memory B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000787",
    "description" : "A memory B cell is a mature B cell that is long-lived, readily activated upon re-encounter of its antigenic determinant, and has been selected for expression of higher affinity immunoglobulin. This cell type has the phenotype CD19-positive, CD20-positive, MHC Class II-positive, and CD138-negative.",
    "id" : null
  }, {
    "name" : "B ; naive B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000788",
    "description" : "A naive B cell is a mature B cell that has the phenotype surface IgD-positive, surface IgM-positive, CD20-positive, CD27-negative and that has not yet been activated by antigen in the periphery.",
    "id" : null
  }, {
    "name" : "B ; plasma cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000786",
    "description" : "A terminally differentiated, post-mitotic, antibody secreting cell of the B cell lineage with the phenotype CD138-positive, surface immunonoglobulin-negative, and MHC Class II-negative. Plasma cells are oval or round with extensive rough endoplasmic reticulum, a well-developed Golgi apparatus, and a round nucleus having a characteristic cartwheel heterochromatin pattern and are devoted to producing large amounts of immunoglobulin.;Plasma cells develop in the spleen and migrate to the bone marrow. Plasma cells are also reportedly CD5-negative, CD10-negative, CD19-positive, CD20-negative, CD21-negative, CD22-negative, CD23-negative, CD24-negative, CD25-negative, CD27-positive, CD34-negative, CD38-positive, CD40-positive, CD43-positive, CD45-positive, CD48-positive, CD53-low, CD80-negative, CD81-positive, CD86-positive, CD95-positive, CD196-negative, CD229-positive, CD270-positive, CD352-positive, CD361-positive, and IgD-negative. Transcription factors: BLIMP1-positive, IRF4-positive, PAX5-negative, SpiB-negative, Ets1-negative, and XBP1-positive.",
    "id" : null
  }, {
    "name" : "B ; plasmablast",
    "link" : "http://purl.obolibrary.org/obo/CL_0000980",
    "description" : "An activated mature (naive or memory) B cell that is secreting immunoglobulin, typified by being CD27-positive, CD38-positive, CD138-negative.",
    "id" : null
  }, {
    "name" : "B ; T1 B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000958",
    "description" : "A transitional stage B cell that migrates from the bone marrow into the peripheral circulation, and finally to the spleen. This cell type has the phenotype surface IgM-positive, surface IgD-negative, CD21-negative, CD23-negative, and CD62L-negative, and CD93-positive. This cell type has also been described as IgM-high, CD19-positive, B220-positive, AA4-positive, and CD23-negative.;T1 B cells are also reportedly CD10-negative/positive??, CD20-positive, CD24-positive, CD38-positive, CD48-positive, CD84-positive, CD150-positive, CD244-negative, and CD352-positive.",
    "id" : null
  }, {
    "name" : "B ; T2 B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000959",
    "description" : "A transitional stage B cell that has the phenotype surface IgM-positive, surface IgD-postive, CD21-positive, CD23-positive, CD62L-negative, CD93-positive and is located in the splenic B follicles. This cell type has also been described as IgM-high, CD19-positive, B220-positive, AA4-positive, and CD23-positive.;T2 B cells are also reportedly CD20-positive, CD24-positive, CD38-positive, CD48-positive, CD84-positive, CD150-positive, CD244-negative, and CD352-positive.",
    "id" : null
  }, {
    "name" : "B ; transitional B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000818",
    "description" : "An immature B cell of an intermediate stage between the pre-B cell stage and the mature naive stage with the phenotype surface IgM-positive and CD19-positive, and are subject to the process of B cell selection. A transitional B cell migrates from the bone marrow into the peripheral circulation, and then to the spleen.",
    "id" : null
  }, {
    "name" : "B ; unswitched memory B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000970",
    "description" : "An unswitched memory B cell is a memory B cell that has the phenotype IgM+, IgD+, CD27+, CD138-, IgG-, IgE-, and IgA-.",
    "id" : null
  }, {
    "name" : "DC ; CD1c-positive myeloid dendritic cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0002399",
    "description" : "A myeloid dendritic cell found in the blood that is CD1c-positive.;Normally represent 10-20% of peripheral blood mDCs (human). They are also CD281-positive (TLR1), CD282-positive (TLR2), CD283-positive (TLR3), CD284-positive (TLR4), CD285-positive (TLR5), CD286-positive (TLR6), CD288-positive (TLR8), and CD290-positive (TLR10) [PMID:20204387]. Upon TLR stimulation, these cells were potent producers of CXCL8 (IL-8), while producing little TNF-alpha.",
    "id" : null
  }, {
    "name" : "DC ; conventional dendritic cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000990",
    "description" : "Conventional dendritic cell is a dendritic cell that is CD11c-high.",
    "id" : null
  }, {
    "name" : "DC ; dendritic cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000451",
    "description" : "A cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. These cells are lineage negative (CD3-negative, CD19-negative, CD34-negative, and CD56-negative).",
    "id" : null
  }, {
    "name" : "DC ; myeloid dendritic cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000782",
    "description" : "A dendritic cell of the myeloid lineage.",
    "id" : null
  }, {
    "name" : "DC ; plasmacytoid dendritic cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000784",
    "description" : "A dendritic cell type of distinct morphology, localization, and surface marker expression (CD123-positive) from other dendritic cell types and associated with early stage immune responses, particularly the release of physiologically abundant amounts of type I interferons in response to infection.",
    "id" : null
  }, {
    "name" : "M ; CD14-positive monocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0001054",
    "description" : "A monocyte that expresses CD14 and is negative for the lineage markers CD3, CD19, and CD20.;This cell type is compatible with the HIPC Lyoplate markers for 'monocyte'. Note that while CD14 is considered a reliable marker for human monocytes, it is only expressed on approximately 85% of mouse monocytes.",
    "id" : null
  }, {
    "name" : "M ; CD16+ monocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0002397",
    "description" : "A CD14-positive monocyte that is also CD16-positive and CCR2-negative.",
    "id" : null
  }, {
    "name" : "M ; CD16- monocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0002057",
    "description" : "A classical monocyte that is CD14-positive, CD16-negative, CD64-positive, CD163-positive.",
    "id" : null
  }, {
    "name" : "M ; monocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000576",
    "description" : "Myeloid mononuclear recirculating leukocyte that can act as a precursor of tissue macrophages, osteoclasts and some populations of tissue dendritic cells.",
    "id" : null
  }, {
    "name" : "NK ; CD16+ CD56+  NK cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000939",
    "description" : "A mature natural killer cell that has the phenotype CD56-low, CD16-positive and which is capable of cytotoxicity and cytokine production.",
    "id" : null
  }, {
    "name" : "NK ; CD16- CD56bright NK cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000938",
    "description" : "NK cell that has the phenotype CD56-bright, CD16-negative, and CD84-positive with the function to secrete interferon-gamma but is not cytotoxic.",
    "id" : null
  }, {
    "name" : "NK ; NK cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000623",
    "description" : "A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.",
    "id" : null
  }, {
    "name" : "T ; activated CCR4+ Treg",
    "link" : "http://purl.obolibrary.org/obo/CL_0001048",
    "description" : "A CD4-positive, CD25-positive, CCR4-positive, alpha-beta T regulatory cell with the phenotype HLA-DRA-positive, indicating recent activation.",
    "id" : null
  }, {
    "name" : "T ; activated CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001043",
    "description" : "A recently activated CD4-positive, alpha-beta T cell with the phenotype HLA-DRA-positive, CD38-positive, CD69-positive, CD62L-negative, CD127-negative, and CD25-positive.",
    "id" : null
  }, {
    "name" : "T ; activated CD4-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000896",
    "description" : "A recently activated CD4-positive, alpha-beta T cell with the phenotype CD69-positive, CD62L-negative, CD127-negative, and CD25-positive.",
    "id" : null
  }, {
    "name" : "T ; activated CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001049",
    "description" : "A recently activated CD8-positive, alpha-beta T cell with the phenotype HLA-DRA-positive, CD38-positive, CD69-positive, CD62L-negative, CD127-negative, CCR7-negative, and CD25-positive.",
    "id" : null
  }, {
    "name" : "T ; activated CD8-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000906",
    "description" : "A CD8+, alpha-beta T cell with the phenotype CD69+, CD62L-, CD127-, CD25+, and CCR7-.",
    "id" : null
  }, {
    "name" : "T ; CCR4+ Treg",
    "link" : "http://purl.obolibrary.org/obo/CL_0001045",
    "description" : "A naive regulatory T cell with the phenotype CD4-positive, CD25-positive, CD127lo, CCR4-positive, and CD45RO-negative.",
    "id" : null
  }, {
    "name" : "T ; CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000624",
    "description" : "A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.",
    "id" : null
  }, {
    "name" : "T ; CD4-positive helper T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000492",
    "description" : "A CD4-positive, alpha-beta T cell that cooperates with other lymphocytes via direct contact or cytokine release to initiate a variety of immune functions.",
    "id" : null
  }, {
    "name" : "T ; CD4-positive type I NK T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000923",
    "description" : "A type I NK T cell that has the phenotype CD4+.",
    "id" : null
  }, {
    "name" : "T ; CD4-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000624",
    "description" : "A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.",
    "id" : null
  }, {
    "name" : "T ; CD4-positive, CD25-positive, alpha-beta regulatory T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000792",
    "description" : "A CD4+, CD25+, alpha-beta T cell that regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.",
    "id" : null
  }, {
    "name" : "T ; CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000625",
    "description" : "A T cell expressing an alpha-beta T cell receptor and the CD8 coreceptor.",
    "id" : null
  }, {
    "name" : "T ; central memory CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000904",
    "description" : "CD4-positive, alpha-beta memory T cell with the phenotype CCR7-positive, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "T ; central memory CD4-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000904",
    "description" : "CD4+, alpha-beta memory T cell with the phenotype CCR7+, CD127+, CD45RA-, CD45RO+, and CD25-.",
    "id" : null
  }, {
    "name" : "T ; central memory CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000907",
    "description" : "CD8-positive, alpha-beta memory T cell with the phenotype CCR7-positive, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "T ; central memory CD8-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000907",
    "description" : "CD8+, alpha-beta memory T cell with the phenotype CCR7+, CD127+, CD45RA-, CD45RO+, and CD25-.",
    "id" : null
  }, {
    "name" : "T ; effector CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001044",
    "description" : "A CD4-positive, alpha-beta T cell with the phenotype CCR7-negative, CD45RA-positive.",
    "id" : null
  }, {
    "name" : "T ; effector CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001050",
    "description" : "A CD8-positive, alpha-beta T cell with the phenotype CCR7-negative, CD45RA-positive.",
    "id" : null
  }, {
    "name" : "T ; effector CD8-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001050",
    "description" : "A CD8+, alpha-beta T cell with the phenotype CCR7-, CD45RA+.",
    "id" : null
  }, {
    "name" : "T ; effector memory CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000905",
    "description" : "CD4-positive, alpha-beta memory T cell with the phenotype CCR7-negative, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "T ; effector memory CD4-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000905",
    "description" : "CD4+, alpha-beta memory T cell with the phenotype CCR7-, CD127+, CD45RA-, CD45RO+, and CD25-.",
    "id" : null
  }, {
    "name" : "T ; effector memory CD4-positive, alpha-beta T cell, terminally differentiated",
    "link" : "http://purl.obolibrary.org/obo/CL_0001087",
    "description" : "A CD4+, alpha beta memory T cell with the phenotype CD45RA+, CD45RO-, and CCR7-.",
    "id" : null
  }, {
    "name" : "T ; effector memory CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000913",
    "description" : "CD8-positive, alpha-beta memory T cell with the phenotype CCR7-negative, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "T ; effector memory CD8-positive, alpha-beta T cell, terminally differentiated",
    "link" : "http://purl.obolibrary.org/obo/CL_0001062",
    "description" : "A CD8+, alpha beta memory T cell with the phenotype CD45RA+, CD45RO-, and CCR7-.",
    "id" : null
  }, {
    "name" : "T ; gamma-delta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000798",
    "description" : "A T cell that expresses a gamma-delta T cell receptor complex.;Note that gamma-delta T cells have both thymic and extrathymic differentiation pathways.",
    "id" : null
  }, {
    "name" : "T ; helper T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000912",
    "description" : "A effector T cell that provides help in the form of secreted cytokines to other immune cells.",
    "id" : null
  }, {
    "name" : "T ; memory CCR4+ Treg",
    "link" : "http://purl.obolibrary.org/obo/CL_0001046",
    "description" : "A memory regulatory T cell with phenotype CD4-positive, CD25-positive, CD127lo, CCR4-positive, and CD45RO-positive.",
    "id" : null
  }, {
    "name" : "T ; mucosal invariant T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000940",
    "description" : "An alpha-beta T cell that is found in the lamina propria of mucosal tissues and is restricted by the MR-1 molecule.",
    "id" : null
  }, {
    "name" : "T ; naive CCR4+ Treg",
    "link" : "http://purl.obolibrary.org/obo/CL_0001045",
    "description" : "A naive regulatory T cell with the phenotype CD4-positive, CD25-positive, CD127lo, CCR4-positive, and CD45RO-negative.",
    "id" : null
  }, {
    "name" : "T ; naive CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000895",
    "description" : "An antigen inexperienced CD4-positive, alpha-beta T cell with the phenotype CCR7-positive, CD127-positive and CD62L-positive. This cell type develops in the thymus. This cell type is also described as being CD25-negative, CD62L-high, and CD44-low.",
    "id" : null
  }, {
    "name" : "T ; naive CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000900",
    "description" : "A CD8-positive, alpha-beta T cell that has not experienced activation via antigen contact and has the phenotype CD45RA-positive, CCR7-positive and CD127-positive. This cell type is also described as being CD25-negative, CD62L-high and CD44-low.",
    "id" : null
  }, {
    "name" : "T ; naive regulatory T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0002677",
    "description" : "A regulatory T cell that has not encountered antigen.",
    "id" : null
  }, {
    "name" : "T ; naive T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000898",
    "description" : "Mature T cell not yet exposed to antigen with the phenotype CCR7-positive, CD45RA-positive, and CD127-positive. This cell type is also described as being CD25-negative, CD62L-high and CD44-low.",
    "id" : null
  }, {
    "name" : "T ; naive thymus-derived CD4-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000895",
    "description" : "An antigen inexperienced CD4+, alpha-beta T cell with the phenotype CCR7+, CD127+ and CD62L+. This cell type develops in the thymus. This cell type is also described as being CD25-, CD62L-high, and CD44-low.",
    "id" : null
  }, {
    "name" : "T ; naive thymus-derived CD8-positive, alpha-beta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000900",
    "description" : "A CD8+, alpha-beta T cell that has not experienced activation via antigen contact and has the phenotype CD45RA+, CCR7+ and CD127+. This cell type is also described as being CD25-, CD62L-high and CD44-low.",
    "id" : null
  }, {
    "name" : "T ; NK T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000814",
    "description" : "A mature alpha-beta T cell of a distinct lineage that bears natural killer markers and a T cell receptor specific for a limited set of ligands. NK T cells have activation and regulatory roles particularly early in an immune response.",
    "id" : null
  }, {
    "name" : "T ; non-Tc1/Tc17 CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0001052;http://purl.obolibrary.org/obo/CL_0000918",
    "description" : "A CD8-positive, alpha-beta T cell that has the phenotype CXCR3-negative, CCR6-negative.;A CD8-positive, alpha-beta positive T cell expressing GATA-3 and secreting IL-4.",
    "id" : null
  }, {
    "name" : "T ; non-Th1/Th17  CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000546",
    "description" : "A CD4-positive, alpha-beta T cell that has the phenotype GATA-3-positive, CXCR3-negative, CCR6-negative, and is capable of producing interleukin-4.",
    "id" : null
  }, {
    "name" : "T ; regulatory T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000815",
    "description" : "A T cell which regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.;This cell type may express FoxP3 and CD25 and secretes IL-10 and TGF-beta.",
    "id" : null
  }, {
    "name" : "T ; T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000084",
    "description" : "A type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.",
    "id" : null
  }, {
    "name" : "T ; T follicular helper cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0002038",
    "description" : "A CD4-positive, CXCR5-positive, CCR7-negative alpha-beta T cell located in follicles of secondary lymph nodes that expresses is BCL6-high, ICOS-high and PD1-high, and stimulates follicular B cells to undergo class-switching and antibody production.",
    "id" : null
  }, {
    "name" : "T ; Tc1 CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000917",
    "description" : "A CD8-positive, alpha-beta positive T cell that has the phenotype T-bet-positive, eomesodermin-positive, CXCR3-positive, CCR6-negative, and is capable of producing interferon-gamma.",
    "id" : null
  }, {
    "name" : "T ; Tc17 CD8+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0002128",
    "description" : "A CD8-positive, alpha-beta T cell that has the phenotype CXCR3-negative, CCR6-positive, CCR5-high, CD45RA-negative, and capable of producing IL-17 and some IFNg.",
    "id" : null
  }, {
    "name" : "T ; Th1 CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000545",
    "description" : "A CD4-positive, alpha-beta T cell that has the phenotype T-bet-positive, CXCR3-positive, CCR6-negative, and is capable of producing interferon-gamma.",
    "id" : null
  }, {
    "name" : "T ; Th17 CD4+ T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000899",
    "description" : "CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive, CXCR3-negative, CCR6-positive, and capable of producing IL-17.",
    "id" : null
  }, {
    "name" : "T ; Treg",
    "link" : "http://purl.obolibrary.org/obo/CL_0000792",
    "description" : "A CD4-positive, CD25-positive, alpha-beta T cell that regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.",
    "id" : null
  } ]
}, {
  "name" : "lk_cell_population_definition",
  "rows" : [ {
    "name" : "population_defnition_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.",
    "link" : "http://purl.obolibrary.org/obo/CL_2000001",
    "description" : "A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.",
    "id" : null
  }, {
    "name" : "A lymphocyte that lacks characteristic T cell, B cell, myeloid cell, and dendritic cell markers, that functions as part of the innate immune response to produce cytokines and other effector responses.",
    "link" : "http://purl.obolibrary.org/obo/CL_0001065",
    "description" : "A lymphocyte that lacks characteristic T cell, B cell, myeloid cell, and dendritic cell markers, that functions as part of the innate immune response to produce cytokines and other effector responses.",
    "id" : null
  }, {
    "name" : "A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.",
    "link" : "http://purl.obolibrary.org/obo/CL_0000624",
    "description" : "A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.",
    "id" : null
  }, {
    "name" : "A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen.",
    "link" : "http://purl.obolibrary.org/obo/CL_0000232",
    "description" : "A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen.",
    "id" : null
  }, {
    "name" : "A regulatory T cell that has not encountered antigen.",
    "link" : "http://purl.obolibrary.org/obo/CL_0002677",
    "description" : "A regulatory T cell that has not encountered antigen.",
    "id" : null
  }, {
    "name" : "A stem cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system. Hematopoietic stem cells lack cell markers of effector cells (lin-). Lin- is defined by lacking one or more of the following cell surface markers: CD2, CD3 epsilon, CD4, CD5 ,CD8 alpha chain, CD11b, CD14, CD19, CD20, CD56, ly6G, ter119.",
    "link" : "http://purl.obolibrary.org/obo/CL_0000037",
    "description" : "A stem cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system. Hematopoietic stem cells lack cell markers of effector cells (lin-). Lin- is defined by lacking one or more of the following cell surface markers: CD2, CD3 epsilon, CD4, CD5 ,CD8 alpha chain, CD11b, CD14, CD19, CD20, CD56, ly6G, ter119.",
    "id" : null
  }, {
    "name" : "A type I NK T cell that has the phenotype CD4+.",
    "link" : "http://purl.obolibrary.org/obo/CL_0000923",
    "description" : "A type I NK T cell that has the phenotype CD4+.",
    "id" : null
  }, {
    "name" : "All cells in a sample",
    "link" : "NA",
    "description" : "NA",
    "id" : null
  }, {
    "name" : "An alpha-beta T cell that is found in the lamina propria of mucosal tissues and is restricted by the MR-1 molecule.",
    "link" : "http://purl.obolibrary.org/obo/CL_0000940",
    "description" : "An alpha-beta T cell that is found in the lamina propria of mucosal tissues and is restricted by the MR-1 molecule.",
    "id" : null
  }, {
    "name" : "An unswitched memory B cell is a memory B cell that has the phenotype IgM+, IgD+, CD27+, CD138-, IgG-, IgE-, and IgA-.",
    "link" : "http://purl.obolibrary.org/obo/CL_0000970",
    "description" : "An unswitched memory B cell is a memory B cell that has the phenotype IgM+, IgD+, CD27+, CD138-, IgG-, IgE-, and IgA-.",
    "id" : null
  }, {
    "name" : "CCR1+, CCR2-, CCR3+, CCR4+, CCR5-, CCR6-, CCR7-, CCR8-, CCR9-, CCR10-, CD16+, CD23+, CD32+, CD40+, CD41+ CD42+, CD61+, CD62P+, CD64+, CD89+, CD102+, CD147+, CD154+, CD162+, CD209, CD282+, CD284+, CD289+, CD181-, CD182-, CD183-, CD184+, CLEC2+, GPVI+, JAMC+, PAR1+, PAR2-, PAR3+, PAR4+, TSP1+, and TXA2R+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000738;http://purl.obolibrary.org/obo/CL_0000233",
    "description" : "An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.;A non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation.;Platelets are reportedly CCR1-positive, CCR2-negative, CCR3-positive, CCR4-positive, CCR5-negative, CCR6-negative, CCR7-negative, CCR8-negative, CCR9-negative, CCR10-negative, CD16-positive, CD23-positive, CD32-positive, CD40-positive, CD41-positive CD42-positive, CD61-positive, CD62P-positive, CD64-positive, CD89-positive, CD102-positive, CD147-positive (activated platelets), CD154-positive (activated platelets), CD162-positive, CD209, CD282-positive, CD284-positive, CD289-positive, CD181-negative, CD182-negative, CD183-negative, CD184-positive, CLEC2-positive, GPVI-positive, JAMC-positive, PAR1-positive, PAR2-negative, PAR3-positive, PAR4-positive, TSP1-positive, and TXA2R-positive. Platelets can reportedly produce CCL2, CCL3, CCL5, CCL7, CCL17, CD40L, CXCL1, CXCL4, CXCL4L1, CXCL5, CXCL7, CXCL8, CXCL12, EGF, factor V, factor VII, factor XI, factor XIII, bFGF, histamine, IGF-1, IL-1beta, PAI-1, PDGF, plasminogen, protein S, serotonin, TGF-beta, TFPI, VEGF, and vWF.",
    "id" : null
  }, {
    "name" : "CCR1+, CCR2-, CCR3+, CCR4+, CCR5-, CCR6-, CCR7-, CCR8-, CCR9-, CCR10-, CD16+, CD23+, CD32+, CD40+, CD41+ CD42+, CD61+, CD62P+, CD64+, CD89+, CD102+, CD147+, CD154+, CD162+, CD209, CD282+, CD284+, CD289+, CD181-, CD182-, CD183-, CD184+, CLEC2+, GPVI+, JAMC+, PAR1+, PAR2-, PAR3+, PAR4+, TSP1+, TXA2R+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000233",
    "description" : "A non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation.;Platelets are reportedly CCR1-positive, CCR2-negative, CCR3-positive, CCR4-positive, CCR5-negative, CCR6-negative, CCR7-negative, CCR8-negative, CCR9-negative, CCR10-negative, CD16-positive, CD23-positive, CD32-positive, CD40-positive, CD41-positive CD42-positive, CD61-positive, CD62P-positive, CD64-positive, CD89-positive, CD102-positive, CD147-positive (activated platelets), CD154-positive (activated platelets), CD162-positive, CD209, CD282-positive, CD284-positive, CD289-positive, CD181-negative, CD182-negative, CD183-negative, CD184-positive, CLEC2-positive, GPVI-positive, JAMC-positive, PAR1-positive, PAR2-negative, PAR3-positive, PAR4-positive, TSP1-positive, and TXA2R-positive. Platelets can reportedly produce CCL2, CCL3, CCL5, CCL7, CCL17, CD40L, CXCL1, CXCL4, CXCL4L1, CXCL5, CXCL7, CXCL8, CXCL12, EGF, factor V, factor VII, factor XI, factor XIII, bFGF, histamine, IGF-1, IL-1beta, PAI-1, PDGF, plasminogen, protein S, serotonin, TGF-beta, TFPI, VEGF, and vWF.",
    "id" : null
  }, {
    "name" : "CCR7+, CD45RA+, CD127+, CD25-, CD62Lhi, and CD44lo",
    "link" : "http://purl.obolibrary.org/obo/CL_0000898",
    "description" : "Mature T cell not yet exposed to antigen with the phenotype CCR7-positive, CD45RA-positive, and CD127-positive. This cell type is also described as being CD25-negative, CD62L-high and CD44-low.",
    "id" : null
  }, {
    "name" : "CD10-, CD19+, CD22+, CD34-, CD48+, CD79a+, CD84+, CD127-, CD352+, RAG-, TdT-, Vpre-B-, pre-BCR-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000785",
    "description" : "A B cell that is mature, having left the bone marrow. Initially, these cells are IgM-positive and IgD-positive, and they can be activated by antigen.;Mature B cells are also reportedly CD10-negative, CD19-positive, CD22-positive, CD34-negative, CD48-positive, CD79a-positive, CD84-positive, CD127-negative, CD352-positive, RAG-negative, TdT-negative, Vpre-B-negative, and pre-BCR-negative. Transcription factors expressed: Pax5-positive.",
    "id" : null
  }, {
    "name" : "CD11chi",
    "link" : "http://purl.obolibrary.org/obo/CL_0000990",
    "description" : "Conventional dendritic cell is a dendritic cell that is CD11c-high.",
    "id" : null
  }, {
    "name" : "CD123+, CD193+, CD203c+, FceRIa+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000767",
    "description" : "Any of the immature or mature forms of a granular leukocyte that in its mature form has an irregularly shaped, pale-staining nucleus that is partially constricted into two lobes, and with cytoplasm that contains coarse, bluish-black granules of variable size. Basophils contain vasoactive amines such as histamine and serotonin, which are released on appropriate stimulation. A basophil is CD123-positive, CD193-positive, CD203c-positive, and FceRIa-positive.;Matures in the bone marrow and account for <1% of leukocytes in the peripheral blood, spleen, and bone marrow. Basophils are described as being CD11a-positive, CD11b-positive, CD13-positive, CD15-positive, CD18-positive, CD21-positive, CD25-positive, CD29-positive, CD35-positive, CD40-positive, CD40L-positive, CD44-positive, CD45R-negative, CD46-positive, CD49a-positive, CD49b-positive, CD49d-positive, CD55-positive, CD59-positive, CD62L-positive, CD63-positive, CD69-positive, CD90-negative, CD116-positive, CD117-negative, CD124-positive, CD125-positive, CD131-positive, CD161-positive, CD184-positive, CD191-positive, CD192-positive, CD197-positive, CD200R3-positive, CD218-positive, CD282-positive, CD284-positive, CD289-positive, CD290-positive, CD294-positive, natural killer cell receptor 2B4-positive, smad1-positive, CD3-negative, CD4-negative, CD7-negative, CD8-negative, CD14-negative, CD15-negative, CD16-negative, CD19-negative, CD20-negative, CD34-negative, CD36-negative, CD45R-negative, CD56-negative, CD57-negative, CD235a-negative, and GR1-negative. Transcription factors- GATA1-positive, PU.1-positive.",
    "id" : null
  }, {
    "name" : "CD138+, CD5-, CD10-, CD19+, CD20-, CD21-, CD22-, CD23-, CD24-, CD25-, CD27+, CD34-, CD38+, CD40+, CD43+, CD45+, CD48+, CD53lo, CD80-, CD81+, CD86+, CD95+, CD196-, CD229+, CD270+, CD352+, CD361+, and IgD-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000786",
    "description" : "A terminally differentiated, post-mitotic, antibody secreting cell of the B cell lineage with the phenotype CD138-positive, surface immunonoglobulin-negative, and MHC Class II-negative. Plasma cells are oval or round with extensive rough endoplasmic reticulum, a well-developed Golgi apparatus, and a round nucleus having a characteristic cartwheel heterochromatin pattern and are devoted to producing large amounts of immunoglobulin.;Plasma cells develop in the spleen and migrate to the bone marrow. Plasma cells are also reportedly CD5-negative, CD10-negative, CD19-positive, CD20-negative, CD21-negative, CD22-negative, CD23-negative, CD24-negative, CD25-negative, CD27-positive, CD34-negative, CD38-positive, CD40-positive, CD43-positive, CD45-positive, CD48-positive, CD53-low, CD80-negative, CD81-positive, CD86-positive, CD95-positive, CD196-negative, CD229-positive, CD270-positive, CD352-positive, CD361-positive, and IgD-negative. Transcription factors: BLIMP1-positive, IRF4-positive, PAX5-negative, SpiB-negative, Ets1-negative, and XBP1-positive.",
    "id" : null
  }, {
    "name" : "CD14+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001054",
    "description" : "A monocyte that expresses CD14 and is negative for the lineage markers CD3, CD19, and CD20.;This cell type is compatible with the HIPC Lyoplate markers for 'monocyte'. Note that while CD14 is considered a reliable marker for human monocytes, it is only expressed on approximately 85% of mouse monocytes.",
    "id" : null
  }, {
    "name" : "CD15+, CD16+, CD32+, CD43+, CD181+, CD182+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000096",
    "description" : "A fully differentiated neutrophil, a granular leukocyte having a nucleus with three to five lobes connected by slender threads, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. They are produced in bone marrow at a rate of 5e10-10e10/day and have a half-life of 6-8 hours. Neutrophils are CD15-positive, CD16-positive, CD32-positive, CD43-positive, CD181-positive, and CD182-positive.;Neutrophils are also capable of secreting GRO-alpha, IL-1beta, IL-1ra, IL-3, IL-12, IP-10, MIG, MIP-1alpha, MIP-1beta, TGF-beta, TNF-alpha, VEGF, and anti-microbial peptides. They can positively influence the chemotaxis of basophils, T-cells, monocytes, macrophages, dendritic cells, and other neutrophils. Neutrophils are also CD35-positive, CD64-positive, CD89-positive, CD184-positive, and fMLP receptor-positive Ly-6G-positive (mouse), TLR2-low, TLR4-low, and lineage-negative (CD2, CD3, CD5, CD9, CD19, CD36, CD49d, CD56, CD61, CD235a (glycophorin-A)).",
    "id" : null
  }, {
    "name" : "CD1c+, CD281+, CD282+, CD283+, CD284+, CD285+, CD286+, CD288+, CD290+",
    "link" : "http://purl.obolibrary.org/obo/CL_0002399",
    "description" : "A myeloid dendritic cell found in the blood that is CD1c-positive.;Normally represent 10-20% of peripheral blood mDCs (human). They are also CD281-positive (TLR1), CD282-positive (TLR2), CD283-positive (TLR3), CD284-positive (TLR4), CD285-positive (TLR5), CD286-positive (TLR6), CD288-positive (TLR8), and CD290-positive (TLR10) [PMID:20204387]. Upon TLR stimulation, these cells were potent producers of CXCL8 (IL-8), while producing little TNF-alpha.",
    "id" : null
  }, {
    "name" : "CD23-, CD21+, CD19+, B220+, IgM-hi, AA4-, CD35-hi",
    "link" : "http://purl.obolibrary.org/obo/CL_0000845",
    "description" : "A mature B cell that is located in the marginal zone of the spleen with the phenotype CD23-negative and CD21-positive and expressing a B cell receptor usually reactive to bacterial cell wall components or senescent self components such as oxidized-LDL. This cell type is also described as being CD19-positive, B220-positive, IgM-high, AA4-negative, CD35-high.;MZ B cells are reportedly CD1-positive (mice), CD20-positive, CD48-positive, CD84-positive, CD150-positive, CD229-positive, and CD352-positive.",
    "id" : null
  }, {
    "name" : "CD27+, CD48+, CD229+, CD352+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000972",
    "description" : "A class switched memory B cell is a memory B cell that has undergone Ig class switching and therefore is IgM-negative on the cell surface. These cells are CD27-positive and have either IgG, IgE, or IgA on the cell surface.;Per DSD: Class switched memory B cells are also reportedly CD48-positive, CD229-positive, and CD352-positive.",
    "id" : null
  }, {
    "name" : "CD3+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000084",
    "description" : "A type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000624",
    "description" : "A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD127lo, CD25+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000792",
    "description" : "A CD4-positive, CD25-positive, alpha-beta T cell that regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD127lo, CD25+, CCR4+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001045",
    "description" : "A naive regulatory T cell with the phenotype CD4-positive, CD25-positive, CD127lo, CCR4-positive, and CD45RO-negative.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD127lo, CD25+, CCR4+, CD45RO+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001046",
    "description" : "A memory regulatory T cell with phenotype CD4-positive, CD25-positive, CD127lo, CCR4-positive, and CD45RO-positive.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD127lo, CD25+, CCR4+, CD45RO-",
    "link" : "http://purl.obolibrary.org/obo/CL_0001045",
    "description" : "A naive regulatory T cell with the phenotype CD4-positive, CD25-positive, CD127lo, CCR4-positive, and CD45RO-negative.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD127lo, CD25+, CCR4+, HLA-DR+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001048",
    "description" : "A CD4-positive, CD25-positive, CCR4-positive, alpha-beta T regulatory cell with the phenotype HLA-DRA-positive, indicating recent activation.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CCR7+, CD45RA+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000895",
    "description" : "An antigen inexperienced CD4-positive, alpha-beta T cell with the phenotype CCR7-positive, CD127-positive and CD62L-positive. This cell type develops in the thymus. This cell type is also described as being CD25-negative, CD62L-high, and CD44-low.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CCR7+, CD45RA-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000904",
    "description" : "CD4-positive, alpha-beta memory T cell with the phenotype CCR7-positive, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CCR7-, CD45RA+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001044",
    "description" : "A CD4-positive, alpha-beta T cell with the phenotype CCR7-negative, CD45RA-positive.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CCR7-, CD45RA-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000905",
    "description" : "CD4-positive, alpha-beta memory T cell with the phenotype CCR7-negative, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CD38+, HLA-DR+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001043",
    "description" : "A recently activated CD4-positive, alpha-beta T cell with the phenotype HLA-DRA-positive, CD38-positive, CD69-positive, CD62L-negative, CD127-negative, and CD25-positive.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CXCR3+, CCR6-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000545",
    "description" : "A CD4-positive, alpha-beta T cell that has the phenotype T-bet-positive, CXCR3-positive, CCR6-negative, and is capable of producing interferon-gamma.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CXCR3-, CCR6+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000899",
    "description" : "CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive, CXCR3-negative, CCR6-positive, and capable of producing IL-17.",
    "id" : null
  }, {
    "name" : "CD3+, CD4+, CD8-, CXCR3-, CCR6-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000546",
    "description" : "A CD4-positive, alpha-beta T cell that has the phenotype GATA-3-positive, CXCR3-negative, CCR6-negative, and is capable of producing interleukin-4.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CCR7+, CD45RA+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000900",
    "description" : "A CD8-positive, alpha-beta T cell that has not experienced activation via antigen contact and has the phenotype CD45RA-positive, CCR7-positive and CD127-positive. This cell type is also described as being CD25-negative, CD62L-high and CD44-low.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CCR7+, CD45RA-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000907",
    "description" : "CD8-positive, alpha-beta memory T cell with the phenotype CCR7-positive, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CCR7-, CD45RA+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001050",
    "description" : "A CD8-positive, alpha-beta T cell with the phenotype CCR7-negative, CD45RA-positive.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CCR7-, CD45RA-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000913",
    "description" : "CD8-positive, alpha-beta memory T cell with the phenotype CCR7-negative, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CD38+, HLA-DR+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001049",
    "description" : "A recently activated CD8-positive, alpha-beta T cell with the phenotype HLA-DRA-positive, CD38-positive, CD69-positive, CD62L-negative, CD127-negative, CCR7-negative, and CD25-positive.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CXCR3+, CCR6-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000917",
    "description" : "A CD8-positive, alpha-beta positive T cell that has the phenotype T-bet-positive, eomesodermin-positive, CXCR3-positive, CCR6-negative, and is capable of producing interferon-gamma.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CXCR3-, CCR6+",
    "link" : "http://purl.obolibrary.org/obo/CL_0002128",
    "description" : "A CD8-positive, alpha-beta T cell that has the phenotype CXCR3-negative, CCR6-positive, CCR5-high, CD45RA-negative, and capable of producing IL-17 and some IFNg.",
    "id" : null
  }, {
    "name" : "CD3+, CD4-, CD8+, CXCR3-, CCR6-",
    "link" : "http://purl.obolibrary.org/obo/CL_0001052;http://purl.obolibrary.org/obo/CL_0000918",
    "description" : "A CD8-positive, alpha-beta T cell that has the phenotype CXCR3-negative, CCR6-negative.;A CD8-positive, alpha-beta positive T cell expressing GATA-3 and secreting IL-4.",
    "id" : null
  }, {
    "name" : "CD3+, CD56+, CD14-, CD33-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000814",
    "description" : "A mature alpha-beta T cell of a distinct lineage that bears natural killer markers and a T cell receptor specific for a limited set of ligands. NK T cells have activation and regulatory roles particularly early in an immune response.",
    "id" : null
  }, {
    "name" : "CD3+, CD8+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000625",
    "description" : "A T cell expressing an alpha-beta T cell receptor and the CD8 coreceptor.",
    "id" : null
  }, {
    "name" : "CD3-, CD19+ , CD20+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000236",
    "description" : "A lymphocyte of B lineage with the phenotype CD19-positive, CD20-positive, and capable of B cell mediated immunity.",
    "id" : null
  }, {
    "name" : "CD3-, CD19+, CD20+, CD24hi, CD38hi",
    "link" : "http://purl.obolibrary.org/obo/CL_0000818",
    "description" : "An immature B cell of an intermediate stage between the pre-B cell stage and the mature naive stage with the phenotype surface IgM-positive and CD19-positive, and are subject to the process of B cell selection. A transitional B cell migrates from the bone marrow into the peripheral circulation, and then to the spleen.",
    "id" : null
  }, {
    "name" : "CD3-, CD19+, CD20+, CD27+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000787",
    "description" : "A memory B cell is a mature B cell that is long-lived, readily activated upon re-encounter of its antigenic determinant, and has been selected for expression of higher affinity immunoglobulin. This cell type has the phenotype CD19-positive, CD20-positive, MHC Class II-positive, and CD138-negative.",
    "id" : null
  }, {
    "name" : "CD3-, CD19+, CD20+, CD27+, IgD+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000970",
    "description" : "An unswitched memory B cell is a memory B cell that has the phenotype IgM-positive, IgD-positive, CD27-positive, CD138-negative, IgG-negative, IgE-negative, and IgA-negative.",
    "id" : null
  }, {
    "name" : "CD3-, CD19+, CD20+, CD27+, IgD-",
    "link" : "http://purl.obolibrary.org/obo/CL_0001053",
    "description" : "A memory B cell that lacks expression of surface IgD.",
    "id" : null
  }, {
    "name" : "CD3-, CD19+, CD20+, CD27-, IgD+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000788",
    "description" : "A naive B cell is a mature B cell that has the phenotype surface IgD-positive, surface IgM-positive, CD20-positive, CD27-negative and that has not yet been activated by antigen in the periphery.",
    "id" : null
  }, {
    "name" : "CD3-, CD19+, CD20-, CD27hi, CD38hi",
    "link" : "http://purl.obolibrary.org/obo/CL_0000980",
    "description" : "An activated mature (naive or memory) B cell that is secreting immunoglobulin, typified by being CD27-positive, CD38-positive, CD138-negative.",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000576",
    "description" : "Myeloid mononuclear recirculating leukocyte that can act as a precursor of tissue macrophages, osteoclasts and some populations of tissue dendritic cells.",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14+, CD16+",
    "link" : "http://purl.obolibrary.org/obo/CL_0002397",
    "description" : "A CD14-positive monocyte that is also CD16-positive and CCR2-negative.",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14+, CD16-",
    "link" : "http://purl.obolibrary.org/obo/CL_0002057",
    "description" : "A classical monocyte that is CD14-positive, CD16-negative, CD64-positive, CD163-positive.",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14-, CD16-, CD56-, HLA-DR+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000451",
    "description" : "A cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. These cells are lineage negative (CD3-negative, CD19-negative, CD34-negative, and CD56-negative).",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14-, CD16-, CD56-, HLA-DR+, CD11c+, CD123-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000782",
    "description" : "A dendritic cell of the myeloid lineage.",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14-, CD16-, CD56-, HLA-DR+, CD11c-, CD123+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000784",
    "description" : "A dendritic cell type of distinct morphology, localization, and surface marker expression (CD123-positive) from other dendritic cell types and associated with early stage immune responses, particularly the release of physiologically abundant amounts of type I interferons in response to infection.",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14-, HLA-DR-, CD16+, CD56+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000939",
    "description" : "A mature natural killer cell that has the phenotype CD56-low, CD16-positive and which is capable of cytotoxicity and cytokine production.",
    "id" : null
  }, {
    "name" : "CD3-, CD19-, CD20-, CD14-, HLA-DR-, CD16-, CD56++",
    "link" : "http://purl.obolibrary.org/obo/CL_0000938",
    "description" : "NK cell that has the phenotype CD56-bright, CD16-negative, and CD84-positive with the function to secrete interferon-gamma but is not cytotoxic.",
    "id" : null
  }, {
    "name" : "CD3-, CD56+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000623",
    "description" : "A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.",
    "id" : null
  }, {
    "name" : "CD4+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000492",
    "description" : "A CD4-positive, alpha-beta T cell that cooperates with other lymphocytes via direct contact or cytokine release to initiate a variety of immune functions.",
    "id" : null
  }, {
    "name" : "CD4+, CCR7+, CD127+, CD25-, CD62Lhi, CD44lo",
    "link" : "http://purl.obolibrary.org/obo/CL_0000895",
    "description" : "An antigen inexperienced CD4+, alpha-beta T cell with the phenotype CCR7+, CD127+ and CD62L+. This cell type develops in the thymus. This cell type is also described as being CD25-, CD62L-high, and CD44-low.",
    "id" : null
  }, {
    "name" : "CD4+, CCR7+, CD127+, CD45RA-, CD45RO+, CD25-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000904",
    "description" : "CD4+, alpha-beta memory T cell with the phenotype CCR7+, CD127+, CD45RA-, CD45RO+, and CD25-.",
    "id" : null
  }, {
    "name" : "CD4+, CCR7-, CD127+, CD45RA-, CD45RO+, CD25-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000905",
    "description" : "CD4+, alpha-beta memory T cell with the phenotype CCR7-, CD127+, CD45RA-, CD45RO+, and CD25-.",
    "id" : null
  }, {
    "name" : "CD4+, CD25+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000792",
    "description" : "A CD4+, CD25+, alpha-beta T cell that regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.",
    "id" : null
  }, {
    "name" : "CD4+, CD45RA+, CD45RO-, CCR7-",
    "link" : "http://purl.obolibrary.org/obo/CL_0001087",
    "description" : "A CD4+, alpha beta memory T cell with the phenotype CD45RA+, CD45RO-, and CCR7-.",
    "id" : null
  }, {
    "name" : "CD4+, CD69+, CD62L-, CD127-, and CD25+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000896",
    "description" : "A recently activated CD4-positive, alpha-beta T cell with the phenotype CD69-positive, CD62L-negative, CD127-negative, and CD25-positive.",
    "id" : null
  }, {
    "name" : "CD4+, CXCR5+, CCR7-",
    "link" : "http://purl.obolibrary.org/obo/CL_0002038",
    "description" : "A CD4-positive, CXCR5-positive, CCR7-negative alpha-beta T cell located in follicles of secondary lymph nodes that expresses is BCL6-high, ICOS-high and PD1-high, and stimulates follicular B cells to undergo class-switching and antibody production.",
    "id" : null
  }, {
    "name" : "CD5+, CD10+, CD19+, CD20+, CD21+, CD22+, CD24+, CD25-, CD27-, CD34-, CD38+, CD40+, CD43-, CD45+, CD48+, CD53+, CD79a+, CD80-, CD81+, CD86-, CD95-, CD127-, CD138-, CD185+, CD196+, MHCII/HLA-DR+, RAG+, TdT-, Vpre-B-, preBCR-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000816",
    "description" : "An immature B cell is a B cell that has the phenotype surface IgM-positive and surface IgD-negative, and have not undergone class immunoglobulin class switching or peripheral encounter with antigen and activation.;Immature B cells are also reportedly CD5-positive, CD10-positive, CD19-positive, CD20-positive, CD21-positive, CD22-positive, CD24-positive, CD25-negative, CD27-negative, CD34-negative, CD38-positive, CD40-positive, CD43-negative, CD45-positive, CD48-positive, CD53-positive, CD79a-positive, CD80-negative, CD81-positive, CD86-negative, CD95-negative, CD127-negative, CD138-negative, CD185-positive, CD196-positive, MHCII/HLA-DR-positive, RAG-positive, TdT-negative, Vpre-B-negative, and preBCR-negative. Transcription factors expressed: Pax5-positive.",
    "id" : null
  }, {
    "name" : "CD8+, CCR7+, CD127+, CD45RA-, CD45RO+, CD25-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000907",
    "description" : "CD8+, alpha-beta memory T cell with the phenotype CCR7+, CD127+, CD45RA-, CD45RO+, and CD25-.",
    "id" : null
  }, {
    "name" : "CD8+, CCR7-, CD45RA+",
    "link" : "http://purl.obolibrary.org/obo/CL_0001050",
    "description" : "A CD8+, alpha-beta T cell with the phenotype CCR7-, CD45RA+.",
    "id" : null
  }, {
    "name" : "CD8+, CD45RA+, CCR7+, CD127+, CD25-, CD62Lhi, CD44lo",
    "link" : "http://purl.obolibrary.org/obo/CL_0000900",
    "description" : "A CD8+, alpha-beta T cell that has not experienced activation via antigen contact and has the phenotype CD45RA+, CCR7+ and CD127+. This cell type is also described as being CD25-, CD62L-high and CD44-low.",
    "id" : null
  }, {
    "name" : "CD8+, CD45RA+, CD45RO-, CCR7-",
    "link" : "http://purl.obolibrary.org/obo/CL_0001062",
    "description" : "A CD8+, alpha beta memory T cell with the phenotype CD45RA+, CD45RO-, and CCR7-.",
    "id" : null
  }, {
    "name" : "CD8+, CD69+, CD62L-, CD127-, CD25+, and CCR7-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000906",
    "description" : "A CD8+, alpha-beta T cell with the phenotype CD69+, CD62L-, CD127-, CD25+, and CCR7-.",
    "id" : null
  }, {
    "name" : "CD9+, CD191+, CD193+, CD14-, CD32+, CD44+, CD48+, CD69+, CD192-, MBP1+, MBP2+, TLR2-, TLR4-",
    "link" : "http://purl.obolibrary.org/obo/CL_0000771",
    "description" : "Any of the immature or mature forms of a granular leukocyte with a nucleus that usually has two lobes connected by one or more slender threads of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and which can be stained by the dye eosin. Eosinophils are CD9-positive, CD191-positive, and CD193-positive.;Eosinophils are also CD14-negative, CD32-positive, CD44-positive, CD48-positive, CD69-positive, CD192-negative, MBP1-positive, MBP2-positive, TLR2-negative, TLR4-negative, and lineage-negative (B220, CD2, CD14, CD19, CD56, CD71, CD117, CD123, CD235a (glycophorin A), and TER119). The cytokines IL-3, IL-5, and GM-CSF are involved in their development and differentiation. Usually considered CD16-negative, CD16 is observed on eosinophilic metamyelocyte.",
    "id" : null
  }, {
    "name" : "Cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000000",
    "description" : "A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.;The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one).",
    "id" : null
  }, {
    "name" : "FoxP3, CD25, IL-10, TGF-beta",
    "link" : "http://purl.obolibrary.org/obo/CL_0000815",
    "description" : "A T cell which regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.;This cell type may express FoxP3 and CD25 and secretes IL-10 and TGF-beta.",
    "id" : null
  }, {
    "name" : "gamma-delta T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000798",
    "description" : "A T cell that expresses a gamma-delta T cell receptor complex.;Note that gamma-delta T cells have both thymic and extrathymic differentiation pathways.",
    "id" : null
  }, {
    "name" : "Granulocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000094",
    "description" : "A leukocyte with abundant granules in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Helper T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000912",
    "description" : "A effector T cell that provides help in the form of secreted cytokines to other immune cells.",
    "id" : null
  }, {
    "name" : "IgD+, CD21+, CD23+, CD62L-, CD93+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000959",
    "description" : "A transitional stage B cell that has the phenotype surface IgM-positive, surface IgD-postive, CD21-positive, CD23-positive, CD62L-negative, CD93-positive and is located in the splenic B follicles. This cell type has also been described as IgM-high, CD19-positive, B220-positive, AA4-positive, and CD23-positive.;T2 B cells are also reportedly CD20-positive, CD24-positive, CD38-positive, CD48-positive, CD84-positive, CD150-positive, CD244-negative, and CD352-positive.",
    "id" : null
  }, {
    "name" : "IgD-, CD21-, CD23-, and CD62L-, CD93+",
    "link" : "http://purl.obolibrary.org/obo/CL_0000958",
    "description" : "A transitional stage B cell that migrates from the bone marrow into the peripheral circulation, and finally to the spleen. This cell type has the phenotype surface IgM-positive, surface IgD-negative, CD21-negative, CD23-negative, and CD62L-negative, and CD93-positive. This cell type has also been described as IgM-high, CD19-positive, B220-positive, AA4-positive, and CD23-negative.;T1 B cells are also reportedly CD10-negative/positive??, CD20-positive, CD24-positive, CD38-positive, CD48-positive, CD84-positive, CD150-positive, CD244-negative, and CD352-positive.",
    "id" : null
  }, {
    "name" : "IgG memory B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000979",
    "description" : "An IgG memory B cell is a class switched memory B cell that is class switched and expresses IgG on the cell surface.",
    "id" : null
  }, {
    "name" : "Immature Erythrocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000558",
    "description" : "An immature erythrocyte that changes the protein composition of its plasma membrane by exosome formation and extrusion. The types of protein removed differ between species though removal of the transferrin receptor is apparent in mammals and birds.",
    "id" : null
  }, {
    "name" : "Leukocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000738",
    "description" : "An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.",
    "id" : null
  }, {
    "name" : "Living cells gated from dead cells",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000169",
    "description" : "Viable cells",
    "id" : null
  }, {
    "name" : "Lymphocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000542",
    "description" : "A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.;Editors note: consider adding taxon constraint to vertebrata (PMID:18025161)",
    "id" : null
  }, {
    "name" : "Neutrophil",
    "link" : "http://purl.obolibrary.org/obo/CL_0000775",
    "description" : "Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.",
    "id" : null
  } ]
}, {
  "name" : "lk_cell_population_pref_map",
  "rows" : [ {
    "name" : "name_reported",
    "link" : null,
    "description" : "name_preferred",
    "id" : null
  }, {
    "name" : "0min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "100min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "10min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "120min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "15min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "20min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "30min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "40min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "50min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "5min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "60min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "80min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "90min",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "AA4 lo mature and marginal zonal B cells",
    "link" : null,
    "description" : "marginal zone B cell",
    "id" : null
  }, {
    "name" : "AA4hi Immature B cells",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "Activated CD4 T cell",
    "link" : null,
    "description" : "activated CD4-positive, alpha-beta T cell",
    "id" : null
  }, {
    "name" : "activated memory B cell",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "All Events",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Annexin negative",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Antibody Secreting Cells (ASCs)",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B cell: pSTAT1",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B cell: pSTAT3",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B cell: pSTAT5",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature anti-IgM treated replicate 1",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature anti-IgM treated replicate 2",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature BAFF + anti-IgM treated replicate 1",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature BAFF + anti-IgM treated replicate 2",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature BAFF treated replicate 1",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature BAFF treated replicate 2",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature untreated replicate 1",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Immature untreated replicate 2",
    "link" : null,
    "description" : "immature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature anti-IgM treated replicate 1",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature anti-IgM treated replicate 2",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature anti-IgM treated replicate 3",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature BAFF + anti-IgM treated replicate 1",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature BAFF + anti-IgM treated replicate 2",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature BAFF + anti-IgM treated replicate 3",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature BAFF treated replicate 1",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature BAFF treated replicate 2",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature BAFF treated replicate 3",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature untreated replicate 1",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature untreated replicate 2",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B cells in Mature untreated replicate 3",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "B lym CD19+,Freq. of,WBC CD45+",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B lym CD27+,Freq. of,Q3: CD19+, CD20-",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B-cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "B-cells out of leukocytes",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "basophils",
    "link" : null,
    "description" : "basophil",
    "id" : null
  }, {
    "name" : "Bcells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Bcl2_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Bcl2_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "BCL6+ CD4+CD44low",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BCL6+ Non-Tfh",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BCL6+ Tfh",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "BDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "BDCA3_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD2n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD2n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD2p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD2p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD40n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD40p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD86n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD86n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD86p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "BDCA3_pmDC",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "Bulk CD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Bulk CD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ CD4+ T cell",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ central memory CD4+ T cell",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ central memory CD8+ T cell",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ effector memory CD4+ T cell",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ effector memory CD8+ T cell",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ naive CD4+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "Caspase-3+ naive CD8+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "CCR6+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CCR6pCXCR3p_nonTFH",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CCR6pCXCR3p_TFH",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "CCR7+ CD4+CD44low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CCR7+ Non-Tfh",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CCR7+ Tfh",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "CD107a+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD107a+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD107a+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD107a+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD107a+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "CD107a+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD11b+ CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD11b+ CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD11b- CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD11b- CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD11bn_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD11bp_CD14dimCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD11bp_CD14pCD16n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD11bp_CD14pCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD11bp_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD11c_pWBC",
    "link" : null,
    "description" : "leukocyte",
    "id" : null
  }, {
    "name" : "CD123_pWBC",
    "link" : null,
    "description" : "leukocyte",
    "id" : null
  }, {
    "name" : "CD127loCD25p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD138",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD138+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD138_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD138_CD86",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD138_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14+ monocytes",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14+CD16+ monocyte",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14+CD16+ monocytes out of leukocytes",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14+CD16- monocyte",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14+CD16- monocytes out of leukocytes",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14-CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD14-CD16+ monocytes out of leukocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD14-CD16- monocytes out of leukocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD14-positive, CD16-negative classical monocyte",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14dimCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14lo CD16+ monocyte",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14lo CD16- monocyte",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD14n_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14nCD16n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14nCD16n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14nCD16n_CD86",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14nCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14nCD16p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14nCD16p_CD86",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14p_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14pCD16n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14pCD16n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14pCD16n_CD86",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14pCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14pCD16p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD14pCD16p_CD86",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD154+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD154+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD154+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD154+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD154+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "CD154+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD16+ monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD16+CD14+ monocytes",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD16+CD14- monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD16- monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD16-CD56bright NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD161+ NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD161+ NKT cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD161+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD161+CD45RA+ Tregs",
    "link" : null,
    "description" : "regulatory T cell",
    "id" : null
  }, {
    "name" : "CD161+CD45RA- Tregs",
    "link" : null,
    "description" : "regulatory T cell",
    "id" : null
  }, {
    "name" : "CD161+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD161- NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD161- NKT cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD161-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD161-CD45RA+ Tregs",
    "link" : null,
    "description" : "regulatory T cell",
    "id" : null
  }, {
    "name" : "CD161-CD45RA- Tregs",
    "link" : null,
    "description" : "regulatory T cell",
    "id" : null
  }, {
    "name" : "CD161-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD16hi CD11b+ neutrophil",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "CD16hi CD11b- neutrophil",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "CD16lo CD11b+ neutrophil",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "CD16lo CD11b- neutrophil",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "CD16n_CD11bn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_CD11bp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_CD86n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_CX3CR1n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_CX3CR1p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_HLADRn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_HLADRp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_NK",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD16n_SLANn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16n_SLANp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16nCD11bn_immature2Neu",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16nCD11bp_immature1Neu",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_CD11bn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_CD11bp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_CD86n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_CX3CR1n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_CX3CR1p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_HLADRn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_HLADRp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_NK",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD16p_SLANn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16p_SLANp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16pCD11bn_Xartefact",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD16pCD11bp_matureNeu",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ among lymphocytes",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27-/MTG+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27-/MTG+/T1",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27-/MTG+/T2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27-/MTG+/T3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27-/MTG+/TN",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD+CD27-/MTG-/TN",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD-CD27+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+ IgD-CD27-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+/IgD+CD27+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+/IgD+CD27-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+/IgD-CD27+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+/IgD-CD27-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19+IgD-CD27+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19_CD27p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19_CD27p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19hi",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20n_CD86p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20n_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20p_CD86p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD19pCD20p_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c+ myeloid dendritic cell",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD1c_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD2n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD2n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD2p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD2p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD40n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD40p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD86n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD86n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD86p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD1c_pmDC",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2+ BDCA3+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2+ CD1c+ myeloid dendritic cell",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2+ plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2- BDCA3+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2- CD1c+ myeloid dendritic cell",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2- myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD2- plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD20+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD20- B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD20- CD3- cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD20- CD3- lymphocytes",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "CD20nCD19p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD20pCD19p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD25p_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD25p_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD27+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD27+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD27-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD27nIgDn_B",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD27pCD19",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD28+CD27+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD28+CD27- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD28+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD28+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD28-CD27+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD28-CD27- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD28-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD2n_BDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2n_BDCA3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2n_CD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2n_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2nCD86n_BDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2nCD86n_BDCA3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2nCD86n_CD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2nCD86p_BDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2nCD86p_BDCA3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2nCD86p_CD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2p_BDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2p_BDCA3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2p_CD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2p_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2pCD86n_BDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2pCD86n_BDCA3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2pCD86n_CD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2pCD86p_BDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2pCD86p_BDCA3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD2pCD86p_CD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD3 Viability",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3+ lymphocytes",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "CD3+ NKT cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD3+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD3+/CD4+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD3+/CD8+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD3- lymphocytes",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "CD314+CD94+ NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD314+CD94+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD314+CD94+CD8- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD314+CD94- NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD314+CD94-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD314+CD94-CD8- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD314-CD94+ NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD314-CD94+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD314-CD94+CD8- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD314-CD94- NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD314-CD94-CD8+T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD314-CD94-CD8- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD33+ monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD38bri_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD38bri_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD3_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3_DR",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3_ICOS",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3_ICOSp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3hi NKT cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD3p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3p_CD27",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3p_CD38",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3p_CD56",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3p_CD56_CD27",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD3p_CD56_CD38",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4 positive CD8 negative",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4 T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+: pSTAT1",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+: pSTAT3",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+: pSTAT5",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD27+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD27- T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD28+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD28- T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD44+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD45RA+: pSTAT1",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD45RA+: pSTAT3",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD45RA+: pSTAT5",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD45RA-: pSTAT1",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD45RA-: pSTAT3",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD45RA-: pSTAT5",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CD69+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+CXCR5+BCL6+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4+Foxp3GFP+ events",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD40+ BDCA3+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40+ CD1c+ myeloid dendritic cell",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD40+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40+ plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40- BDCA3+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40- CD1c+ myeloid dendritic cell",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40- myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40- plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD40p_CD14dimCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD40p_CD14pCD16n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD40p_CD14pCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45+ cells/uL",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RA negative",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RAnCD4n_BDCA2_pBDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RAnCD4n_CD1c_pCD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RAnCD4p_BDCA2_pBDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RAnCD4p_CD1c_pCD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RApCD4n_BDCA2_pBDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RApCD4n_CD1c_pCD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RApCD4p_BDCA2_pBDCA2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD45RApCD4p_CD1c_pCD1c",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD4_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4_DR",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4_ICOS",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD4_ICOSp_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD56br_pLY",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD56diCD16n_pLY",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD56diCD16p_pLY",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD56nCD16p_pLY",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD57+ NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD57+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD57+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD57- NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD57-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD57-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD62L+ CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD62L+ CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD62L+ CD4+CD44low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD62L+ Non-Tfh",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD62L+ Tfh",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "CD62L- CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD62L- CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD62L- neutrophil",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "CD62Ln_pmatureNeu",
    "link" : null,
    "description" : "mature neutrophil",
    "id" : null
  }, {
    "name" : "CD62Lp_CD14dimCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD62Lp_CD14pCD16n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD62Lp_CD14pCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD62Lp_pmatureNeu",
    "link" : null,
    "description" : "mature neutrophil",
    "id" : null
  }, {
    "name" : "CD69+ CD4+CD44low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD69+ Non-Tfh",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD69+ Tfh",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "CD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8 T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg+ cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg+IL2+TNFa+ cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg+IL2+TNFa- cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg+IL2-TNFa+ cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg+IL2-TNFa- cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg-IL2+TNFa+ cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg-IL2+TNFa- cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IFNg-IL2-TNFa+ cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ IL2+ cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ Tet+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+ TNFa+ cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+: pSTAT1",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+: pSTAT3",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+: pSTAT5",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+CD45RA+: pSTAT1",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+CD45RA+: pSTAT3",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+CD45RA+: pSTAT5",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+CD45RA-: pSTAT1",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+CD45RA-: pSTAT3",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+CD45RA-: pSTAT5",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8+CD69+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "CD80+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD80+ plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD80+CD14+CD16+ monocyte",
    "link" : null,
    "description" : "CD16+ monocyte",
    "id" : null
  }, {
    "name" : "CD80+CD14+CD16- monocyte",
    "link" : null,
    "description" : "CD16+ monocyte",
    "id" : null
  }, {
    "name" : "CD80+CD14-CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD83+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD83+ plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD83+CD14+CD16+ monocyte",
    "link" : null,
    "description" : "CD16+ monocyte",
    "id" : null
  }, {
    "name" : "CD83+CD14+CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD83+CD14-CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD85j+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD85j+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD85j-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD85j-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD86",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD86+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD86+ BDCA3+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86+ CD138+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD86+ CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD86+ CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD86+ CD1c+ myeloid dendritic cell",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86+ CD20+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD86+ CD20- B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD86+ IgD+ memory B cell",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "CD86+ IgD- CD27- B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CD86+ IgD- memory B cell",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "CD86+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86+ naive B cell",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "CD86+ plasmablast",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "CD86+ plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86+ transitional B cell",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "CD86+CD14+CD16+ monocyte",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD86+CD14+CD16- monocyte",
    "link" : null,
    "description" : "CD14-positive monocyte",
    "id" : null
  }, {
    "name" : "CD86+CD14-CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD86- BDCA3+ myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86- CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD86- CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CD86- CD1c+ myeloid dendritic cell",
    "link" : null,
    "description" : "CD1c-positive myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86- myeloid dendritic cell",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86- plasmacytoid dendritic cell",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "CD86n_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD86p_CD14dimCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD86p_CD14pCD16n",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD86p_CD14pCD16p",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD86p_Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CD8_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_CCR6",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_CCR6_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_CXCR3",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_CXCR3_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_CXCR5",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_CXCR5_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_DR",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_ICOS",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD8_ICOSp_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD94+ NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD94+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD94+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CD94- NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CD94-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CD94-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "central memory CD4+ T cells",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "central memory CD8+ T cells",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "CFSE+ cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "CM_CD4",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "CM_CD8",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "CTLA4p_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CTLA4p_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CX3CR1+ CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CX3CR1+ CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CX3CR1- CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CX3CR1- CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CX3CR1hi HLA-DR+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CX3CR1lo HLA-DR+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CXCR3+ B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CXCR3+ CD33+ monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CXCR3+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CXCR3+ NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CXCR3+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CXCR3+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CXCR3-FMO B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "CXCR3-FMO CD33+ monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "CXCR3-FMO CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "CXCR3-FMO CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "CXCR3-FMO NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "CXCR5+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "DC",
    "link" : null,
    "description" : "dendritic cell",
    "id" : null
  }, {
    "name" : "dn",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "DR_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "DR_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "DRnCD38n_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "DRnCD38n_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "DRnCD38p_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "DRnCD38p_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "DRpCD38n_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "DRpCD38n_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "DRpCD38p_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "DRpCD38p_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "effector CD4+ T cells",
    "link" : null,
    "description" : "effector CD4+ T cell",
    "id" : null
  }, {
    "name" : "effector CD8+ T cells",
    "link" : null,
    "description" : "effector CD8+ T cell",
    "id" : null
  }, {
    "name" : "effector memory CD4+ T cells",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "effector memory CD8+ T cells",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "EM_CD4",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "EM_CD8",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "eos_abs",
    "link" : null,
    "description" : "eosinophil",
    "id" : null
  }, {
    "name" : "FCOM R10:- + - - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R10:- - + - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R10:- - + - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R11:+ + - - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R11:+ - + - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R11:+ - + - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R12:- + + - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R12:- + + - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R12:- - + - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R13:+ + + - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R13:+ + + - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R13:+ - + - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R14:- + + - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R14:- - - + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R14:- - - + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R15:+ + + - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R15:+ - - + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R15:+ - - + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R16:- + - + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R16:- + - + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R16:- - - + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R17:+ + - + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R17:+ + - + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R17:+ - - + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R18:- + - + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R18:- - + + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R18:- - + + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R19:+ + - + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R19:+ - + + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R19:+ - + + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R20:- + + + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R20:- + + + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R20:- - + + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R21:+ + + + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R21:+ + + + after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R21:+ - + + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R22:- + + + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R23:+ + + + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R23:+ + + + after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R23:- + - - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R24:- + - + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R25:- - - - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R26:- - - + after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R6:- - - - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R6:- - - - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R7:+ - - - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R7:+ - - - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R8 :- + - - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R8 :- + - - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R8 :- - - - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R9 :+ + - - after Lymph",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R9 :+ + - - after MNC",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FCOM R9 :+ - - - after Lymph CD25 Bright",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "FoxP3p_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "FoxP3p_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "gamma-delta T cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "GranB_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "GranB_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Granulo: pSTAT1",
    "link" : null,
    "description" : "granulocyte",
    "id" : null
  }, {
    "name" : "Granulo: pSTAT3",
    "link" : null,
    "description" : "granulocyte",
    "id" : null
  }, {
    "name" : "Granulo: pSTAT5",
    "link" : null,
    "description" : "granulocyte",
    "id" : null
  }, {
    "name" : "granulocytes out of leukocytes",
    "link" : null,
    "description" : "granulocyte",
    "id" : null
  }, {
    "name" : "GzB+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "GzB+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "GzB+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "GzB+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "GzB+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "GzB+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ CD4+ T cell",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "HLA-DR+ T cell",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ T follicular helper cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ T helper cell",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Tfh1 CD4+ T cell",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Tfh1/17 CD4+ T cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Tfh17 CD4+ T cell",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Tfh2 CD4+ T cell",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Th1 CD4+ T cell",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Th1/17 CD4+ T cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Th17 CD4+ T cell",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DR+ Th2 CD4+ T cell",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLA-DRhi CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "HLA-DRhi CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "HLA-DRlo CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "HLA-DRlo CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "HLADR+ CD138+ B Cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "HLADR+ CD20+ B Cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "HLADR+ CD20- B Cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "HLADR+ CD27+ B Cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "HLADR+ IgD+ Memory B Cell",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "HLADR+ IgD- CD27- B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "HLADR+ IgD- Memory B Cell",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "HLADR+ Naive B Cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "HLADR+ NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "HLADR+ plasmablast",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "HLADR+ transitional B Cell",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "HLADR+CD38+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLADR+CD38+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "HLADR+CD38-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLADR+CD38-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "HLADR- NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "HLADR-CD38+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLADR-CD38+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "HLADR-CD38-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "HLADR-CD38-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ CD4+ T cell",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ CD4+CD44low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ Non-Tfh",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "ICOS+ T cell",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "ICOS+ T follicular helper cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "ICOS+ T follicular helper cell type 1",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ T follicular helper cell type 17",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ T follicular helper cell type 2",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ T helper cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "ICOS+ Tfh",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "ICOS+ Tfh1 CD4+ T cell",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ Tfh1/17 CD4+ T cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "ICOS+ Tfh17 CD4+ T cell",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ Tfh2 CD4+ T cell",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ Th1 CD4+ T cell",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ Th1/17 CD4+ T cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "ICOS+ Th17 CD4+ T cell",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+ Th2 CD4+ T cell",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+CD4+ T cell",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS+CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ICOS-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_CCR6pCXCR3p_nonTFH",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "ICOS_CCR6pCXCR3p_TFH",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "ICOS_CD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_CD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_TFH",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "ICOS_TFH1",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_TFH17",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_TFH2",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_TH1",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_TH17",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "ICOS_TH2",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID1, CD3+ of viable CD45+ cells (Total T cells)",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "ID10, HLA-DR+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID100, IgG+ of IgD-CD27+ memory B cells",
    "link" : null,
    "description" : "IgG memory B cell",
    "id" : null
  }, {
    "name" : "ID101, IgD+CD27+ of CD20+ B cells* (IgD+CD27+ memory B)",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "ID102, CD23+ of IgD+CD27+ memory B cells",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "ID103, CD38+ of IgD+CD27+ memory B cells*",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "ID104, CD80+ of IgD+CD27+ memory B cells",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "ID105, CD86+ of IgD+CD27+ memory B cells",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "ID106, IgD+CD27- of CD20+ B cells* (Naive B)",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "ID107, CD21+ of Naive B cells",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "ID108, CD38+ of Naive B cells",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "ID109, CD80+ of Naive B cells",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "ID11, CD40+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID110, CD86+ of Naive B cells",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "ID111, IgA+ of Naive B cells",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "ID112, IgG+ of Naive B cells",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "ID113, IgD-CD27- of CD20+ B cells* (IgD-CD27- memory B)",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID114, CD21+ of IgD-CD27- memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID116, CD80+ of IgD-CD27- memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID117, CD86+ of IgD-CD27- memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID118, CD23+ of IgD-CD27- memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID119, IgA+ of IgD-CD27- memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID12, CD161+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID120, IgG+ of IgD-CD27- memory B cells",
    "link" : null,
    "description" : "IgG memory B cell",
    "id" : null
  }, {
    "name" : "ID13, CD196+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID14, IL17+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID15, IL21+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID16, IL22+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID17, IL23+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID19, IL17+ of CD161+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID2, CD4+ of total T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID20, IL21+ of CD161+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID21, IL22+ of CD161+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID22, CD161- of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID23, IL17+ of CD161-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID24, IL21+ of CD161-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID25, IL22+ of CD161-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID26, IL2+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID28, IL4+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID29.T2, TNFa+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID29.T3, TNFa+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID3, CD4+CD8+ of total T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "ID30, CD39+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID31, CD103+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID32, CD127(IL7R)+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID33.T1, CD27+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID33.T2, CD27+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID33.T3, CD27+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID34, CD45RA+ of CD4+ T cells (Naive T)",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID35, CD45RA- of CD4+ T cells (Total memory CD4+ T)",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID36, CD27+CCR7- of memory CD4+ T cells (Effector memory CD4+ T)",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID37, CD27+CCR7+ of memory CD4+ T cells (Central memory CD4+ T)",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID39, CD69+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID4, CD8+ of total T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID40, CD25+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID41, CD38+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID42, HLA-DR+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID43, CD39+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID44, CD103+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID45, TNFa+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID46, IL17A+ of CD8+ T cells (Tc17)",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID47, IL23R+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID48, IL2+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID49, INFg+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID5, CD4-CD8- of total T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "ID50, Perforin+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID51.T2, TNFa+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID51.T3, TNFa+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID52.T1, CD27+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID53, CD45RA+ of CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID54, CD27+ of CD45RA+CD8+ T cells (Naive CD8+ T)",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID55, CD27- of CD45RA+CD8+ T cells (EMRA CD8+ T)",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID56, CD45RA- of CD8+ T cells (CD45RA- memory CD8+ T)",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID57, CD27+CCR7+ of CD45RA- memory CD8+ T cells (Central memory CD8+ T)",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID58, CD27-CCR7- of CD45RA- memory CD8+ T cells (Effector memory CD8+ T)",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "ID59, CD25hi FoxP3+ of CD4+ T cells (Treg)",
    "link" : null,
    "description" : "regulatory T cell",
    "id" : null
  }, {
    "name" : "ID64, CD14+ of viable CD45+ cells (Total Monocytes)",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "ID65, CD40+ of total monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "ID66, CD83+ of total monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "ID67, CD86+ of total monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "ID68, HLA-DR+ of total monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "ID69, TNFa+ of total monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "ID7, CD69+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID70, HLA-DR+ of Lin-CD45+ (Total Dendritic cells)",
    "link" : null,
    "description" : "dendritic cell",
    "id" : null
  }, {
    "name" : "ID71, TNFa+ of total DCs",
    "link" : null,
    "description" : "dendritic cell",
    "id" : null
  }, {
    "name" : "ID72, INFa+ of total DCs",
    "link" : null,
    "description" : "dendritic cell",
    "id" : null
  }, {
    "name" : "ID73, CD11c+CD123- of total DCs (Myeloid DCs)",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "ID74, TNFa+ of mDCs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "ID75, IFNa+ of mDCs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "ID76, CD11c-CD123+ of total DCs (Plasmacytoid DCs)",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "ID77, TNFa+ of pDCs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "ID78, INFa+ of pDCs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "ID79, CD11c+CD123+ of total DCs",
    "link" : null,
    "description" : "dendritic cell",
    "id" : null
  }, {
    "name" : "ID8, CD25+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID80, CD19+ of viable CD45+ (Total B cells)",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "ID81, CD80+ of CD20+ B cells (CD80+ activated mature B)",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "ID82, CD86+ of CD20+ B cells (CD86+ activated mature B)",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "ID83, IgA+ of CD20+ B cells (IgA+ mature B)",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "ID84, IgG+ of CD20+ B cells (IgG+ mature B)",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "ID85, IgM+IgD+ of CD20+ B cells (IgM+IgD+ mature B)",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "ID86, IgM-IgD- of CD20+ B cells (IgM-IgD- mature B)",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "ID87, CD27hi CD38hi of CD20- B cells (Plasmablasts)",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "ID89, CD21+ of plasmablasts",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "ID9, CD38+ of CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "ID90, CD10+CD27- of CD20+ B cells (Transitional B)",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "ID91, CD38+ of transitional B cells",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "ID93, CD21+ of transitional B cells",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "ID94, IgD-CD27+ of CD20+ B cells* (IgD-CD27+ memory B)",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID95, CD23+ of IgD-CD27+ memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID96, CD38+ of IgD-CD27+ memory B cells*",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID97, CD80+ of IgD-CD27+ memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID98, CD86+ of IgD-CD27+ memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "ID99, IgA+ of IgD-CD27+ memory B cells",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "IFN-g",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "IFN-g Ki-67 negative",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "IFN-g Ki-67 positive",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "IFNg or IL2 + CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "IFNg or IL2 + CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IFNg or IL2 + CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IFNg or IL2 + CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "IFNg or IL2 + gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "IFNg or IL2 + NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IFNg+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "IFNg+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IFNg+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IFNg+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "IFNg+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "IFNg+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IgD+ memory B cell",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "IgD+CD27+ B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgD+CD27- B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgD- CD27- B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgD-CD27+ B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgD-CD27- B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgDn_memory_B",
    "link" : null,
    "description" : "IgD- memory B cell",
    "id" : null
  }, {
    "name" : "IgDnCD27n_abs",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgDnCD27n_CD86p_abs",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgDnCD27p_abs",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgDnCD27p_CD86p_abs",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgDp_memory_B",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "IgDpCD27p_abs",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IgDpCD27p_CD86p_abs",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "IL-2",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "IL-2 Ki-67 negative",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "IL-2 Ki-67 positive",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "IL10+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "IL10+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL10+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL10+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "IL10+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "IL10+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL13+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "IL13+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL13+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL13+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "IL13+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "IL13+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL17+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "IL17+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL17+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL17+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "IL17+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "IL17+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL2+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "IL2+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL2+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL2+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "IL2+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "IL2+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL2+Interferon gamma+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL2+Interferon gamma- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL2+Perforin+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL2+Perforin- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL2-Interferon gamma+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL2-Interferon gamma- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL2-Perforin+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL2-Perforin- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "IL4+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "IL4+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL4+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "IL4+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "IL4+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "IL4+ NK T-cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "Intact cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Intact singlets",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Interferon gamma+Perforin+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Interferon gamma+Perforin- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Interferon gamma-Perforin+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Interferon gamma-Perforin- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Ki-67",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "KI67+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "KI67+ CD4+ T cell",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "KI67+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "KI67+ central memory CD4+ T cell",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "KI67+ central memory CD8+ T cell",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "KI67+ effector memory CD4+ T cell",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "KI67+ effector memory CD8+ T cell",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "KI67+ naive CD4+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "KI67+ naive CD8+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "Ki67_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Ki67_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Ki67nBcl2bri_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Ki67nBcl2bri_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Ki67nBcl2dim_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Ki67nBcl2dim_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Ki67pBcl2bri_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Ki67pBcl2bri_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Ki67pBcl2dim_pCD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Ki67pBcl2dim_pCD8",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "leukocyte-platelet aggregates",
    "link" : null,
    "description" : "leukocyte, platelet",
    "id" : null
  }, {
    "name" : "leukocytes out of live cells",
    "link" : null,
    "description" : "leukocyte",
    "id" : null
  }, {
    "name" : "live",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA+/Infected",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA+/Infected/SSC high",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA+/Infected/SSC low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA+/Uninfected",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA+/Uninfected/SSC high",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA+/Uninfected/SSC low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA-",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA-/Infected",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA-/Infected/SSC high",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA-/Infected/SSC low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA-/Uninfected",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA-/Uninfected/SSC high",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD4 T cells/CD4+ CD45RA-/Uninfected/SSC low",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD8 T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD8 T cells/CD8+ CD45RA+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD8 T cells/CD8+ CD45RA+/Infected",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD8 T cells/CD8+ CD45RA+/Uninfected",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD8 T cells/CD8+ CD45RA-",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD8 T cells/CD8+ CD45RA-/Infected",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/CD8 T cells/CD8+ CD45RA-/Uninfected",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/B cells/Infected",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/B cells/Uninfected",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Monocytes/Infected",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Monocytes/Uninfected",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Other cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Other cells/Infected",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Other cells/Infected/SSC high",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Other cells/Infected/SSC low",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Other cells/Uninfected",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Other cells/Uninfected/SSC high",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Non T cells/Other cells/Uninfected/SSC low",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live cells/Total infected cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Live Lymphocytes",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "live platelets out of total platelets",
    "link" : null,
    "description" : "platelet",
    "id" : null
  }, {
    "name" : "live-cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "lymphocytes",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "Lymphocytes by FSC SSC",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "lymphocytes out of leukocytes",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "lymphocytes/live",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "lymphocytes/live/CD3+CD4+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "lymphocytes/liveCD3+CD4+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Marginal zonal B cells",
    "link" : null,
    "description" : "marginal zone B cell",
    "id" : null
  }, {
    "name" : "Mature B cells",
    "link" : null,
    "description" : "mature B cell",
    "id" : null
  }, {
    "name" : "mDC",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_abs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD2n",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD2n_abs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD2p",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD2p_abs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD40n",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD40p",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD86n",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD86n_abs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD86p",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDC_CD86p_abs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDCs",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "mDCs among CD19+/CD14+",
    "link" : null,
    "description" : "myeloid dendritic cell",
    "id" : null
  }, {
    "name" : "Memory B cell,Freq. of,Q2: CD19+, CD20+",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "memory B cells",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "mo",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Mo_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Mo_CD40p_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Mo_SLAN_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Mono: pSTAT1",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Mono: pSTAT3",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Mono: pSTAT5",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "monocytes out of leukocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Naive B cell,Freq. of,Q2: CD19+, CD20+",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "naive B cells",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "Naive CD4 T cells",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "naive CD4+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "naive CD4+ T cells",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "Naive CD8 T cells",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "naive CD8+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "naive CD8+ T cells",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "naive thymus-derived CD8-positive, alpha-beta T cell",
    "link" : null,
    "description" : "naive CD8+ T cell",
    "id" : null
  }, {
    "name" : "naive_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "naive_B",
    "link" : null,
    "description" : "naive B cell",
    "id" : null
  }, {
    "name" : "Naive_CD4",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "Naive_CD8",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "naive_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "neu_abs",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "Neutros",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "NK",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "NK T-cells",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "NK_CD27",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "NK_CD38",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "NKT cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "Non BT: pSTAT1",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Non BT: pSTAT3",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Non BT: pSTAT5",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "non-leukocytes out of live cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "non-naive CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "non-naive CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "non-T lymphocytes",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Non-Tfh",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "non-TFH CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "non-TFH CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "nonB-nonT-nonmonocyte-nonbasophils",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "nonbasophils",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "nonmonocyte-nonbasophils",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "nonNK-nonB-nonT-nonmonocyte-nonbasophils",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "nonTFH_CD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "not the preferred cell pop name",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "not the preferred cell pop name natural killer cell",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "NP CD49a+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "NP tetramer",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "PA CD49a+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "PA tetramer",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "PB",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "PB_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "PB_CD86",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "PB_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "PD-1+ CD4+ T cell",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "PD-1+ CD8+ T cell",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "PD-1+ central memory CD4+ T cell",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "PD-1+ central memory CD8+ T cell",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "PD-1+ effector memory CD4+ T cell",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "PD-1+ effector memory CD8+ T cell",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "PD-1+ naive CD4+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "PD-1+ naive CD8+ T cell",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "PD1+ B cell",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "PD1+CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "PD1+CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "PD1-CD4+ T cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "PD1-CD8+ T cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "pDC",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_abs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD2n",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD2n_abs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD2p",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD2p_abs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD40n",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD40p",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD86n",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD86n_abs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD86p",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDC_CD86p_abs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "pDCs",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "Plasma cells,Freq. of,B lym CD27+",
    "link" : null,
    "description" : "plasma cell",
    "id" : null
  }, {
    "name" : "Plasmablast + Plasma Cells Abs#",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "Plasmablast,Freq. of,Q3: CD19+, CD20-",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "Plasmablast_PC",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "plasmablasts",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "Plasmacell",
    "link" : null,
    "description" : "plasmablast",
    "id" : null
  }, {
    "name" : "platelet-aggregated monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "platelet-aggregated neutrophils",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "pMDs among CD19+/CD14+",
    "link" : null,
    "description" : "plasmacytoid dendritic cell",
    "id" : null
  }, {
    "name" : "possible reticulocyte progenitors out of live cells",
    "link" : null,
    "description" : "reticulocyte",
    "id" : null
  }, {
    "name" : "Pre CD4",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Pre CD8",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Q2: CD19+,, CD20+,Freq. of,B lym CD19+",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Q3: CD19+,, CD20-,Freq. of,B lym CD19+",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "QC10_CM_pCD8",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "QC11_Naive_pCD8",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "QC12_EM_pCD8",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "QC14_TEFF_pCD8",
    "link" : null,
    "description" : "effector CD8+ T cell",
    "id" : null
  }, {
    "name" : "QC2_CD4_pLY",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "QC3_CD8_pLY",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "QC4_CD4_pLY",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "QC5_CM_pCD4",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "QC6_Naive_pCD4",
    "link" : null,
    "description" : "naive T cell",
    "id" : null
  }, {
    "name" : "QC7_EM_pCD4",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "QC8_TEFF_pCD4",
    "link" : null,
    "description" : "effector CD4+ T cell",
    "id" : null
  }, {
    "name" : "QC9_CD8_pLY",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "QC_CD4",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "QCGran",
    "link" : null,
    "description" : "granulocyte",
    "id" : null
  }, {
    "name" : "QCGran_abs",
    "link" : null,
    "description" : "granulocyte",
    "id" : null
  }, {
    "name" : "R10:Auto-/Auto+/Auto-/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:CD11C-/CD80+/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:CD11C-/CD86+/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:CD1c-/IgD+/CD27-/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:CD45RA-/CD45RO+/CD8-/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:CD57-/CD56+/CD8-/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:CD8-/CD25+/CD4-/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:CD8-/CD69+/CD4-/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:EMA-/EMA+/EMA-/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:HLADR-/CD80+/CD27-/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R10:IgG1-/IgG1+/IgG1-/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:Auto+/Auto+/Auto-/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:CD11C+/CD80+/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:CD11C+/CD86+/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:CD1c+/IgD+/CD27-/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:CD45RA+/CD45RO+/CD8-/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:CD57+/CD56+/CD8-/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:CD8+/CD25+/CD4-/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:CD8+/CD69+/CD4-/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:EMA+/EMA+/EMA-/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:HLADR+/CD80+/CD27-/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R11:IgG1+/IgG1+/IgG1-/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:Auto-/Auto-/Auto+/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:CD11C-/CD80-/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:CD11C-/CD86-/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:CD1c-/IgD-/CD27+/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:CD45RA-/CD45RO-/CD8+/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:CD57-/CD56-/CD8+/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:CD8-/CD25-/CD4+/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:CD8-/CD69-/CD4+/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:EMA-/EMA-/EMA+/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:HLADR-/CD80-/CD27+/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R12:IgG1-/IgG1-/IgG1+/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:Auto+/Auto-/Auto+/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:CD11C+/CD80-/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:CD11C+/CD86-/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:CD1c+/IgD-/CD27+/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:CD45RA+/CD45RO-/CD8+/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:CD57+/CD56-/CD8+/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:CD8+/CD25-/CD4+/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:CD8+/CD69-/CD4+/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:EMA+/EMA-/EMA+/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:HLADR+/CD80-/CD27+/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R13:IgG1+/IgG1-/IgG1+/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:Auto-/Auto+/Auto+/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:CD11C-/CD80+/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:CD11C-/CD86+/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:CD1c-/IgD+/CD27+/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:CD45RA-/CD45RO+/CD8+/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:CD57-/CD56+/CD8+/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:CD8-/CD25+/CD4+/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:CD8-/CD69+/CD4+/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:EMA-/EMA+/EMA+/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:HLADR-/CD80+/CD27+/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R14:IgG1-/IgG1+/IgG1+/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:Auto+/Auto+/Auto+/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:CD11C+/CD80+/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:CD11C+/CD86+/CD3,56,19,14+/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:CD1c+/IgD+/CD27+/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:CD45RA+/CD45RO+/CD8+/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:CD57+/CD56+/CD8+/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:CD8+/CD25+/CD4+/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:CD8+/CD69+/CD4+/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:EMA+/EMA+/EMA+/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:HLADR+/CD80+/CD27+/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R15:IgG1+/IgG1+/IgG1+/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:Auto-/Auto-/Auto-/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:CD11C-/CD80-/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:CD11C-/CD86-/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:CD1c-/IgD-/CD27-/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:CD45RA-/CD45RO-/CD8-/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:CD57-/CD56-/CD8-/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:CD8-/CD25-/CD4-/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:CD8-/CD69-/CD4-/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:EMA-/EMA-/EMA-/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:HLADR-/CD80-/CD27-/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R16:IgG1-/IgG1-/IgG1-/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:Auto+/Auto-/Auto-/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:CD11C+/CD80-/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:CD11C+/CD86-/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:CD1c+/IgD-/CD27-/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:CD45RA+/CD45RO-/CD8-/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:CD57+/CD56-/CD8-/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:CD8+/CD25-/CD4-/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:CD8+/CD69-/CD4-/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:EMA+/EMA-/EMA-/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:HLADR+/CD80-/CD27-/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R17:IgG1+/IgG1-/IgG1-/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:Auto-/Auto+/Auto-/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:CD11C-/CD80+/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:CD11C-/CD86+/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:CD1c-/IgD+/CD27-/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:CD45RA-/CD45RO+/CD8-/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:CD57-/CD56+/CD8-/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:CD8-/CD25+/CD4-/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:CD8-/CD69+/CD4-/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:EMA-/EMA+/EMA-/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:HLADR-/CD80+/CD27-/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R18:IgG1-/IgG1+/IgG1-/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:Auto+/Auto+/Auto-/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:CD11C+/CD80+/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:CD11C+/CD86+/CD3,56,19,14-/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:CD1c+/IgD+/CD27-/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:CD45RA+/CD45RO+/CD8-/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:CD57+/CD56+/CD8-/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:CD8+/CD25+/CD4-/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:CD8+/CD69+/CD4-/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:EMA+/EMA+/EMA-/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:HLADR+/CD80+/CD27-/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R19:IgG1+/IgG1+/IgG1-/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:Auto-/Auto-/Auto+/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:CD11C-/CD80-/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:CD11C-/CD86-/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:CD1c-/IgD-/CD27+/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:CD45RA-/CD45RO-/CD8+/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:CD57-/CD56-/CD8+/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:CD8-/CD25-/CD4+/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:CD8-/CD69-/CD4+/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:EMA-/EMA-/EMA+/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:HLADR-/CD80-/CD27+/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R20:IgG1-/IgG1-/IgG1+/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:Auto+/Auto-/Auto+/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:CD11C+/CD80-/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:CD11C+/CD86-/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:CD1c+/IgD-/CD27+/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:CD45RA+/CD45RO-/CD8+/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:CD57+/CD56-/CD8+/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:CD8+/CD25-/CD4+/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:CD8+/CD69-/CD4+/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:EMA+/EMA-/EMA+/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:HLADR+/CD80-/CD27+/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R21:IgG1+/IgG1-/IgG1+/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:Auto-/Auto+/Auto+/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:CD11C-/CD80+/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:CD11C-/CD86+/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:CD1c-/IgD+/CD27+/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:CD45RA-/CD45RO+/CD8+/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:CD57-/CD56+/CD8+/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:CD8-/CD25+/CD4+/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:CD8-/CD69+/CD4+/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:EMA-/EMA+/EMA+/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:HLADR-/CD80+/CD27+/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R22:IgG1-/IgG1+/IgG1+/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:Auto+/Auto+/Auto+/Auto+/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:CD11C+/CD80+/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:CD11C+/CD86+/CD3,56,19,14+/HLADR+/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:CD1c+/IgD+/CD27+/CD19+/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:CD45RA+/CD45RO+/CD8+/CD4+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:CD57+/CD56+/CD8+/CD3+/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:CD8+/CD25+/CD4+/CD3+/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:CD8+/CD69+/CD4+/CD3+/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:EMA+/EMA+/EMA+/EMA+/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:HLADR+/CD80+/CD27+/CD19+/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R23:IgG1+/IgG1+/IgG1+/IgG1+/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:Auto-/Auto-/Auto-/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:CD11C-/CD80-/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:CD11C-/CD86-/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:CD1c-/IgD-/CD27-/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:CD45RA-/CD45RO-/CD8-/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:CD57-/CD56-/CD8-/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:CD8-/CD25-/CD4-/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:CD8-/CD69-/CD4-/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:EMA-/EMA-/EMA-/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:HLADR-/CD80-/CD27-/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R24:IgG1-/IgG1-/IgG1-/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:Auto+/Auto-/Auto-/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:CD11C+/CD80-/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:CD11C+/CD86-/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:CD1c+/IgD-/CD27-/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:CD45RA+/CD45RO-/CD8-/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:CD57+/CD56-/CD8-/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:CD8+/CD25-/CD4-/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:CD8+/CD69-/CD4-/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:EMA+/EMA-/EMA-/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:HLADR+/CD80-/CD27-/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R25:IgG1+/IgG1-/IgG1-/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:Auto-/Auto+/Auto-/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:CD11C-/CD80+/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:CD11C-/CD86+/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:CD1c-/IgD+/CD27-/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:CD45RA-/CD45RO+/CD8-/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:CD57-/CD56+/CD8-/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:CD8-/CD25+/CD4-/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:CD8-/CD69+/CD4-/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:EMA-/EMA+/EMA-/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:HLADR-/CD80+/CD27-/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R26:IgG1-/IgG1+/IgG1-/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:Auto+/Auto+/Auto-/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:CD11C+/CD80+/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:CD11C+/CD86+/CD3,56,19,14-/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:CD1c+/IgD+/CD27-/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:CD45RA+/CD45RO+/CD8-/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:CD57+/CD56+/CD8-/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:CD8+/CD25+/CD4-/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:CD8+/CD69+/CD4-/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:EMA+/EMA+/EMA-/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:HLADR+/CD80+/CD27-/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R27:IgG1+/IgG1+/IgG1-/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:Auto-/Auto-/Auto+/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:CD11C-/CD80-/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:CD11C-/CD86-/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:CD1c-/IgD-/CD27+/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:CD45RA-/CD45RO-/CD8+/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:CD57-/CD56-/CD8+/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:CD8-/CD25-/CD4+/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:CD8-/CD69-/CD4+/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:EMA-/EMA-/EMA+/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:HLADR-/CD80-/CD27+/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R28:IgG1-/IgG1-/IgG1+/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:Auto+/Auto-/Auto+/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:CD11C+/CD80-/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:CD11C+/CD86-/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:CD1c+/IgD-/CD27+/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:CD45RA+/CD45RO-/CD8+/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:CD57+/CD56-/CD8+/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:CD8+/CD25-/CD4+/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:CD8+/CD69-/CD4+/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:EMA+/EMA-/EMA+/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:HLADR+/CD80-/CD27+/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R29:IgG1+/IgG1-/IgG1+/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:Auto-/Auto+/Auto+/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:CD11C-/CD80+/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:CD11C-/CD86+/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:CD1c-/IgD+/CD27+/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:CD45RA-/CD45RO+/CD8+/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:CD57-/CD56+/CD8+/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:CD8-/CD25+/CD4+/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:CD8-/CD69+/CD4+/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:EMA-/EMA+/EMA+/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:HLADR-/CD80+/CD27+/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R30:IgG1-/IgG1+/IgG1+/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:Auto+/Auto+/Auto+/Auto-/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:CD11C+/CD80+/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:CD11C+/CD86+/CD3,56,19,14+/HLADR-/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:CD1c+/IgD+/CD27+/CD19-/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:CD45RA+/CD45RO+/CD8+/CD4-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:CD57+/CD56+/CD8+/CD3-/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:CD8+/CD25+/CD4+/CD3-/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:CD8+/CD69+/CD4+/CD3-/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:EMA+/EMA+/EMA+/EMA-/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:HLADR+/CD80+/CD27+/CD19-/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R31:IgG1+/IgG1+/IgG1+/IgG1-/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:Auto-/Auto-/Auto-/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:CD11C-/CD80-/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:CD11C-/CD86-/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:CD1c-/IgD-/CD27-/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:CD45RA-/CD45RO-/CD8-/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:CD57-/CD56-/CD8-/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:CD8-/CD25-/CD4-/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:CD8-/CD69-/CD4-/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:EMA-/EMA-/EMA-/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:HLADR-/CD80-/CD27-/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R32:IgG1-/IgG1-/IgG1-/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:Auto+/Auto-/Auto-/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:CD11C+/CD80-/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:CD11C+/CD86-/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:CD1c+/IgD-/CD27-/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:CD45RA+/CD45RO-/CD8-/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:CD57+/CD56-/CD8-/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:CD8+/CD25-/CD4-/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:CD8+/CD69-/CD4-/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:EMA+/EMA-/EMA-/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:HLADR+/CD80-/CD27-/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R33:IgG1+/IgG1-/IgG1-/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:Auto-/Auto+/Auto-/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:CD11C-/CD80+/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:CD11C-/CD86+/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:CD1c-/IgD+/CD27-/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:CD45RA-/CD45RO+/CD8-/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:CD57-/CD56+/CD8-/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:CD8-/CD25+/CD4-/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:CD8-/CD69+/CD4-/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:EMA-/EMA+/EMA-/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:HLADR-/CD80+/CD27-/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R34:IgG1-/IgG1+/IgG1-/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:Auto+/Auto+/Auto-/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:CD11C+/CD80+/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:CD11C+/CD86+/CD3,56,19,14-/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:CD1c+/IgD+/CD27-/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:CD45RA+/CD45RO+/CD8-/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:CD57+/CD56+/CD8-/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:CD8+/CD25+/CD4-/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:CD8+/CD69+/CD4-/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:EMA+/EMA+/EMA-/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:HLADR+/CD80+/CD27-/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R35:IgG1+/IgG1+/IgG1-/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:Auto-/Auto-/Auto+/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:CD11C-/CD80-/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:CD11C-/CD86-/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:CD1c-/IgD-/CD27+/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:CD45RA-/CD45RO-/CD8+/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:CD57-/CD56-/CD8+/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:CD8-/CD25-/CD4+/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:CD8-/CD69-/CD4+/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:EMA-/EMA-/EMA+/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:HLADR-/CD80-/CD27+/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R36:IgG1-/IgG1-/IgG1+/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:Auto+/Auto-/Auto+/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:CD11C+/CD80-/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:CD11C+/CD86-/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:CD1c+/IgD-/CD27+/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:CD45RA+/CD45RO-/CD8+/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:CD57+/CD56-/CD8+/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:CD8+/CD25-/CD4+/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:CD8+/CD69-/CD4+/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:EMA+/EMA-/EMA+/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:HLADR+/CD80-/CD27+/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R37:IgG1+/IgG1-/IgG1+/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:Auto-/Auto+/Auto+/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:CD11C-/CD80+/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:CD11C-/CD86+/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:CD1c-/IgD+/CD27+/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:CD45RA-/CD45RO+/CD8+/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:CD57-/CD56+/CD8+/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:CD8-/CD25+/CD4+/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:CD8-/CD69+/CD4+/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:EMA-/EMA+/EMA+/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:HLADR-/CD80+/CD27+/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R38:IgG1-/IgG1+/IgG1+/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:Auto+/Auto+/Auto+/Auto+/Auto+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:CD11C+/CD80+/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:CD11C+/CD86+/CD3,56,19,14+/HLADR+/CD123+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:CD1c+/IgD+/CD27+/CD19+/IgM+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:CD45RA+/CD45RO+/CD8+/CD4+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:CD57+/CD56+/CD8+/CD3+/CD14+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:CD8+/CD25+/CD4+/CD3+/CD62L+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:CD8+/CD69+/CD4+/CD3+/HLADR+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:EMA+/EMA+/EMA+/EMA+/EMA+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:HLADR+/CD80+/CD27+/CD19+/CD86+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R39:IgG1+/IgG1+/IgG1+/IgG1+/IgG1+",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :Auto-/Auto-/Auto-/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :CD11C-/CD80-/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :CD11C-/CD86-/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :CD1c-/IgD-/CD27-/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :CD45RA-/CD45RO-/CD8-/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :CD57-/CD56-/CD8-/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :CD8-/CD25-/CD4-/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :CD8-/CD69-/CD4-/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :EMA-/EMA-/EMA-/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :HLADR-/CD80-/CD27-/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R8 :IgG1-/IgG1-/IgG1-/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :Auto+/Auto-/Auto-/Auto-/Auto-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :CD11C+/CD80-/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :CD11C+/CD86-/CD3,56,19,14-/HLADR-/CD123-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :CD1c+/IgD-/CD27-/CD19-/IgM-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :CD45RA+/CD45RO-/CD8-/CD4-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :CD57+/CD56-/CD8-/CD3-/CD14-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :CD8+/CD25-/CD4-/CD3-/CD62L-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :CD8+/CD69-/CD4-/CD3-/HLADR-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :EMA+/EMA-/EMA-/EMA-/EMA-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :HLADR+/CD80-/CD27-/CD19-/CD86-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "R9 :IgG1+/IgG1-/IgG1-/IgG1-/IgG1-",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "reticulocytes out of live cells",
    "link" : null,
    "description" : "reticulocyte",
    "id" : null
  }, {
    "name" : "single cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "single leukocytes",
    "link" : null,
    "description" : "leukocyte",
    "id" : null
  }, {
    "name" : "single monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "single neutrophils",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "single non-leukocytes out of live cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Singlets",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Slan",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "SLAN+ CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "SLAN+ CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "SLAN+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "SLAN- CD16+ monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "SLAN- CD16- monocyte",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "switched memory B cell",
    "link" : null,
    "description" : "class switched memory B cell",
    "id" : null
  }, {
    "name" : "T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T follicular helper cell type 1",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T follicular helper cell type 17",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T follicular helper cell type 2",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T helper cell",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "T-cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T-cells out of leukocytes",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T2_CD19_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD19_CD27_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD19_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD19p_CD20n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD19p_CD20n_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD19p_CD20p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD19p_CD20p_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27n_IgDn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27n_IgDn_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27n_IgDp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27n_IgDp_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27p_IgDn_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27p_IgDn_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27p_IgDp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_CD27p_IgDp_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_PB_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_PB_CD138_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_PB_CD138_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_PB_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_trans_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T2_trans_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T3_Eos_abs",
    "link" : null,
    "description" : "eosinophil",
    "id" : null
  }, {
    "name" : "T3_Mono_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD11b_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16n_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16p_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16p_CD11b_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16p_CD2_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16p_CD40_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16p_CD86_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16p_CX3CR1_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14nCD16p_DR_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16n_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16n_CD11b_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16n_CD2_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16n_CD40_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16n_CD86_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16n_CX3CR1_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16n_DR_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16p_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16p_CD11b_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16p_CD2_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16p_CD40_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16p_CD86_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16p_CX3CR1_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD14pCD16p_DR_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD2_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD40_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CD86_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_CX3CR1_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Mono_DR_abs",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "T3_Neu_abs",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "T3_Neu_CD16nCD11bn_abs",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "T3_Neu_CD16nCD11bp_abs",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "T3_Neu_CD16pCD11bn_abs",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "T3_Neu_CD16pCD11bp_abs",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "T3_Slan_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T3_Slan_CD11b_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T3_Slan_CD2_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T3_Slan_CD40_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T3_Slan_CD86_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T3_Slan_CX3CR1_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T3_Slan_DR_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_BDCA2_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_BDCA2p_CD2p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_BDCA2p_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_BDCA3_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_CD11c_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_CD11cp_CD2p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_CD11cp_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_CD1c_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_CD1cp_CD2p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T4_CD1cp_CD86p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T5_CD3_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T5_CD4_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_CD4_ICOSp_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_CD8_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "T5_CD8_ICOSp_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "T5_TFH17_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TFH17_ICOSp_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TFH1_17_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T5_TFH1_17_ICOSp_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T5_TFH1_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TFH1_ICOSp_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TFH2_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TFH2_ICOSp_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TFH_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T5_TFH_ICOSp_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T5_TH17_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TH17_ICOSp_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TH1_17_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T5_TH1_17_ICOSp_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T5_TH1_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TH1_ICOSp_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TH2_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TH2_ICOSp_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T5_TH_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T5_TH_ICOSp_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T6B_CD127loCD25hi_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD127loCD25hi_CLAnCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD127loCD25hi_CLAnCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD127loCD25hi_CLApCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD127loCD25hi_CLApCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD127loCD25hi_DR_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CD127nCD25n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CD127nCD25p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CD127pCD25n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CD127pCD25p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CLAnCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CLAnCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CLApCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_CLApCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56_DR_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CD127nCD25n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CD127nCD25p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CD127pCD25n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CD127pCD25p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CLAnCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CLAnCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CLApCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_CLApCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56bri_DR_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CD127nCD25n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CD127nCD25p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CD127pCD25n_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CD127pCD25p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CLAnCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CLAnCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CLApCD62Ln_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_CLApCD62Lp_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3nCD56dim_DR_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T6B_CD3p_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T6B_CD4_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T6B_CD4_CLAnCD62Ln_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T6B_CD4_CLAnCD62Lp_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T6B_CD4_CLApCD62Ln_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T6B_CD4_CLApCD62Lp_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T6B_CD4_DR_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CD127nCD25n_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CD127nCD25p_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CD127pCD25n_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CD127pCD25p_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CLAnCD62Ln_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CLAnCD62Lp_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CLApCD62Ln_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_CLApCD62Lp_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T6B_NKT_DR_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_CCR4_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_CCR6nCD161n_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_CCR6nCD161p_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_CCR6pCD161n_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_CCR6pCD161p_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_CD161_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_CD4_CLA_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH17_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH17_CCR4_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH17_CD161_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH17_CLA_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_17_CCR4_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_17_CD161_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_17_CLA_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_7_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_CCR4_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_CD161_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH1_CLA_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH2_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH2_CCR4_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH2_CD161_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH2_CLA_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TFH_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CCR4_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CCR6nCD161n_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CCR6nCD161p_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CCR6pCD161n_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CCR6pCD161p_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CD161_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CD161_CCR4_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CD161_CD161_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CD161_CLA_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TFH_CLA_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T7_TH17_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH17_CCR4_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH17_CD161_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH17_CLA_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_17_CCR4_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_17_CD161_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_17_CLA_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_7_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_CCR4_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_CD161_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH1_CLA_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH2_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH2_CCR4_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH2_CD161_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH2_CLA_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "T7_TH_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH_CCR4_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH_CCR6nCD161n_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH_CCR6nCD161p_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH_CCR6pCD161n_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH_CCR6pCD161p_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH_CD161_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T7_TH_CLA_abs",
    "link" : null,
    "description" : "CD4-positive helper T cell",
    "id" : null
  }, {
    "name" : "T9_CD19_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T9_CD19_CCR9p_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T9_CD19_CLA_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T9_CD19_DR_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T9_CD19_Ki67_abs",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "T9_CD3_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3_CCR9p_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3_CLA_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3_DR_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3_Ki67_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3dp_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3dp_CLA_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3dp_DR_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3dp_Ki67_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3pDN_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3pDN_CCR9p_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3pDN_CLA_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3pDN_DR_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD3pDN_Ki67_abs",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "T9_CD4_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD4_CCR9p_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD4_CLA_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD4_DR_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD4_Ki67_abs",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD8_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD8_CCR9p_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD8_CLA_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD8_DR_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "T9_CD8_Ki67_abs",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "T9_NK_abs",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "T9_NK_CCR9p_abs",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "T9_NK_CLA_abs",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "T9_NK_DR_abs",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "T9_NK_Ki67_abs",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "T9_NKT_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T9_NKT_CCR9p_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T9_NKT_CLA_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T9_NKT_DR_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T9_NKT_Ki67_abs",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "T9_TFH_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T9_TFH_CCR9p_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T9_TFH_CLA_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T9_TFH_DR_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "T9_TFH_Ki67_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "Tcm CD4 T cells",
    "link" : null,
    "description" : "central memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "Tcm CD8 T cells",
    "link" : null,
    "description" : "central memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "TEFF_CD4",
    "link" : null,
    "description" : "effector CD4+ T cell",
    "id" : null
  }, {
    "name" : "TEFF_CD8",
    "link" : null,
    "description" : "effector CD8+ T cell",
    "id" : null
  }, {
    "name" : "Tem CD4 T cells",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "Tem CD8 T cells",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "Temra CD4 T cells",
    "link" : null,
    "description" : "effector memory CD4+ T cell",
    "id" : null
  }, {
    "name" : "Temra CD8 T cells",
    "link" : null,
    "description" : "effector memory CD8+ T cell",
    "id" : null
  }, {
    "name" : "Tet+ CD8+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Tfh",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH CD4+ T cells",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH CD8+ T cells",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "Tfh cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH1",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Tfh1 CD4+ T cell",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Tfh1/17 CD4+ T cell",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH17",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Tfh17 CD4+ T cell",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH17_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH17_DR",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH17_ICOS",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH17_ICOSp",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH17_ICOSp_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH1_17",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH1_17_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH1_17_DR",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH1_17_ICOS",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH1_17_ICOSp_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH1_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH1_DR",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH1_ICOS",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH1_ICOSp_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH2",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "Tfh2 CD4+ T cell",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH2_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH2_DR",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH2_ICOS",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH2_ICOSp_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TFH_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH_DR",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH_ICOS",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TFH_ICOSp_abs",
    "link" : null,
    "description" : "T follicular helper cell",
    "id" : null
  }, {
    "name" : "TH",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH1",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th1 non-TFH CD4+ T cells",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th1 non-TFH CD8+ T cells",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th1 TFH CD4+ T cells",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th1 TFH CD8+ T cells",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th1/17 CD4+ T cell",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH17",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th17 non-TFH CD4+ T cells",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th17 non-TFH CD8+ T cells",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th17 TFH CD4+ T cells",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th17 TFH CD8+ T cells",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH17_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH17_DR",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH17_ICOS",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH17_ICOSp_abs",
    "link" : null,
    "description" : "Th17 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH1_17",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH1_17_abs",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH1_17_DR",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH1_17_ICOS",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH1_17_ICOSp_abs",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH1_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH1_DR",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH1_ICOS",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH1_ICOSp_abs",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH1_nonTFH",
    "link" : null,
    "description" : "Th1 CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH2",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th2 CD4+ T cell",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th2 non-TFH CD4+ T cells",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th2 non-TFH CD8+ T cells",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th2 TFH CD4+ T cells",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "Th2 TFH CD8+ T cells",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH2_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH2_DR",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH2_ICOS",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH2_ICOSp_abs",
    "link" : null,
    "description" : "non-Th1/Th17  CD4+ T cell",
    "id" : null
  }, {
    "name" : "TH_abs",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH_DR",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH_ICOS",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "TH_ICOSp_abs",
    "link" : null,
    "description" : "helper T cell",
    "id" : null
  }, {
    "name" : "Time exclusion",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "tissue-like memory B cell",
    "link" : null,
    "description" : "memory B cell",
    "id" : null
  }, {
    "name" : "TNF-a",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "TNF-a Ki-67 negative",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "TNF-a Ki-67 positive",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "TNFa+ CD4 T-cells",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "TNFa+ CD56dim NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "TNFa+ CD56hi NK cells",
    "link" : null,
    "description" : "NK cell",
    "id" : null
  }, {
    "name" : "TNFa+ CD8 T-cells",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "TNFa+ gd T-cells",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "TNFa+ NK T-cells",
    "link" : null,
    "description" : "NK T cell",
    "id" : null
  }, {
    "name" : "Total B cells (CD19)",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Total Cells",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "total monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "total neutrophils",
    "link" : null,
    "description" : "neutrophil",
    "id" : null
  }, {
    "name" : "traditional T cell",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "trans_abs",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "trans_CD86p_abs",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "Transition B cell,Freq. of,Q2: CD19+, CD20+",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "transitional B cells",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "Transitional type 1 or T1 immature B cells",
    "link" : null,
    "description" : "T1 B cell",
    "id" : null
  }, {
    "name" : "Transitional type 2 or T2 immature B cells",
    "link" : null,
    "description" : "T2 B cell",
    "id" : null
  }, {
    "name" : "transitionalb_",
    "link" : null,
    "description" : "transitional B cell",
    "id" : null
  }, {
    "name" : "Tregs",
    "link" : null,
    "description" : "regulatory T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha+Interferon gamma+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha+Interferon gamma- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha+Perforin+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha+Perforin- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha-Interferon gamma+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha-Interferon gamma- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha-Perforin+ T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Tumor necrosis factor alpha-Perforin- T cells",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "viable",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "viable/singlets",
    "link" : null,
    "description" : "cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymph",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymph/CD3+",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymph/CD3+/CD4+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymph/CD3+/CD8+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD3+ CD56+",
    "link" : null,
    "description" : "T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD4+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD4+/CD27+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD4+/CD28+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD4+/Q1: CD45RAD, CD27+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD4+/Q2: CD45RA+, CD27+",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD4+/Q3: CD45RA+, CD27D",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD4+/Q4: CD45RAD, CD27D",
    "link" : null,
    "description" : "CD4+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD8+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD8+/CD27+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD8+/CD28+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD8+/Q1: CD45RAD, CD27+",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD8+/Q3: CD45RA+, CD27D",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/CD8+/Q4: CD45RAD, CD27D",
    "link" : null,
    "description" : "CD8+ T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3+/TCRgd",
    "link" : null,
    "description" : "gamma-delta T cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3-",
    "link" : null,
    "description" : "lymphocyte",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Lymphs/CD3-/B cells",
    "link" : null,
    "description" : "B cell",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Monocytes",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  }, {
    "name" : "Viable/Singlets/Monocytes/CD33+",
    "link" : null,
    "description" : "monocyte",
    "id" : null
  } ]
}, {
  "name" : "lk_compound_role",
  "rows" : [ {
    "name" : "Concomitant Medication",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49568",
    "description" : "Compound Role is Concomitant Medication.",
    "id" : ""
  }, {
    "name" : "Intervention",
    "link" : "http://www.ebi.ac.uk/efo/EFO_0002571",
    "description" : "Compound Role is Intervention.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "Compound Role is Other.",
    "id" : ""
  }, {
    "name" : "Substance Use",
    "link" : "http://purl.bioontology.org/ontology/MEDDRA/10070964",
    "description" : "Compound Role is Substance Use.",
    "id" : ""
  } ]
}, {
  "name" : "lk_concentration_unit",
  "rows" : [ {
    "name" : "concentration_unit_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "AFU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C77534",
    "description" : "Arbitrary Fluorescence Units",
    "id" : null
  }, {
    "name" : "AI",
    "link" : "https://www.aacc.org/publications/cln/articles/2014/june/ana-testing",
    "description" : "Antibody Index",
    "id" : null
  }, {
    "name" : "AU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C70504",
    "description" : "Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.",
    "id" : null
  }, {
    "name" : "cells/kg body weight",
    "link" : "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138781/",
    "description" : "Cells per kg body weight",
    "id" : null
  }, {
    "name" : "CFU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C68902",
    "description" : "A derived unit of viable cell concentration defined as the number of colony forming units in one milliliter of substance",
    "id" : null
  }, {
    "name" : "DK units/ml",
    "link" : "https://repository.niddk.nih.gov/studies/aab-calibrators/",
    "description" : "The NIDDK calibrators were tested together with dilutions of the WHO reference serum using harmonized assays on five occasions in the BDC, Bristol, and Munich laboratories and reported as WHO units/ml by calibration as previously described. For each of the NIDDK calibrators, the median value of the WHO units/ml obtained for the 15 measurements was assigned as its calibrator unit. The assigned units were termed digestive and kidney units (DK units)/ml.",
    "id" : null
  }, {
    "name" : "g/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64783",
    "description" : "A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.",
    "id" : null
  }, {
    "name" : "g/l",
    "link" : "http://purl.obolibrary.org/obo/UO_0000175",
    "description" : "grams per liter",
    "id" : null
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : null
  }, {
    "name" : "HAU",
    "link" : "http://en.wikipedia.org/wiki/Virus_quantification",
    "description" : "hemagglutination units",
    "id" : null
  }, {
    "name" : "iu/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67376",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.",
    "id" : null
  }, {
    "name" : "IU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67377",
    "description" : "A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.",
    "id" : null
  }, {
    "name" : "Kallikrein Inactivator Unit per Milliliter",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C73531",
    "description" : "An arbitrary unit of a kallikrein inactivator concentration equal to the concentration at which one milliliter of the mixture contains one unit of the kallikrein inactivator.",
    "id" : null
  }, {
    "name" : "M",
    "link" : "http://purl.obolibrary.org/obo/UO_0000062",
    "description" : "molar",
    "id" : null
  }, {
    "name" : "mg/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67015",
    "description" : "A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.",
    "id" : null
  }, {
    "name" : "mg/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64572",
    "description" : "A metric unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one cubic meter. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of a substance which mass equal to one gram occupies the volume of one cubic meter.",
    "id" : null
  }, {
    "name" : "mg/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258798001",
    "description" : "microgram per milliliter",
    "id" : null
  }, {
    "name" : "miu/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67376",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.",
    "id" : null
  }, {
    "name" : "mM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000063",
    "description" : "millimolar",
    "id" : null
  }, {
    "name" : "MOI",
    "link" : "http://en.wikipedia.org/wiki/Multiplicity_of_infection",
    "description" : "multiplicity of infection",
    "id" : null
  }, {
    "name" : "ng/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67326",
    "description" : "A unit of mass concentration defined as the concentration of one nanogram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume of one deciliter.",
    "id" : null
  }, {
    "name" : "ng/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258806002",
    "description" : "nanogram per milliliter",
    "id" : null
  }, {
    "name" : "ng/nl",
    "link" : "",
    "description" : "nanogram per nanoliter",
    "id" : null
  }, {
    "name" : "ng/ul",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/272082007",
    "description" : "nanogram per microliter",
    "id" : null
  }, {
    "name" : "nM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000065",
    "description" : "nanomolar",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : null
  }, {
    "name" : "NPX",
    "link" : "https://www.olink.com/question/what-is-npx/",
    "description" : "NPX, Normalized Protein eXpression, is Olink's arbitrary unit which is in Log2 scale.  It is calculated from Ct values and data pre-processing (normalization) is performed to minimize both intra- and inter-assay variation. NPX data allows users to identify changes for individual protein levels across their sample set, and then use this data to establish protein signatures. The NPX scale is inverted compared to that of Ct. This means that a high NPX value equals a high protein concentration. Because NPX is in a log2 scale, a 1 NPX difference means a doubling of protein concentration. If needed NPX values can be converted into linear scale: 2^NPX= linear NPX.",
    "id" : null
  }, {
    "name" : "optical density",
    "link" : "http://purl.obolibrary.org/obo/CHMO_0002039",
    "description" : "The measurement of the light transmitted through a sample for a given wavelength. [database_cross_reference: ISBN:038733341X]",
    "id" : null
  }, {
    "name" : "PFU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67264",
    "description" : "Plaque-forming unit. A measure of viable infectious entities (e.g. viral particles or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope and/or to the naked eye as a plaque. A number of plaque forming units (PFU) per unit volume is a conventional way to refer the titer of an infective entity in a specimen or preparation.",
    "id" : null
  }, {
    "name" : "PFUe",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67264",
    "description" : "Plaque-forming unit equivalents",
    "id" : null
  }, {
    "name" : "pg/mg creatinine",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C85780",
    "description" : "Protein/Creatinine [Ratio] in Urine",
    "id" : null
  }, {
    "name" : "pg/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67327",
    "description" : "picogram per milliliter",
    "id" : null
  }, {
    "name" : "pg/nl",
    "link" : "",
    "description" : "picogram per nanoliter",
    "id" : null
  }, {
    "name" : "pg/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67306",
    "description" : "picogram per microliter",
    "id" : null
  }, {
    "name" : "pM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000066",
    "description" : "picomolar",
    "id" : null
  }, {
    "name" : "TCID50",
    "link" : "http://en.wikipedia.org/wiki/Virus_quantification",
    "description" : "mean tissue culture infective dose",
    "id" : null
  }, {
    "name" : "Thousand Cells per Microliter",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C1883312",
    "description" : "A unit of cell concentration expressed as a number of cells in thousands per unit volume equal to one microliter. Synonyms: 10E3 Cells/uL, Kcells/ul.",
    "id" : null
  }, {
    "name" : "ug/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67305",
    "description" : "A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter.",
    "id" : null
  }, {
    "name" : "ug/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67306",
    "description" : "A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumetric mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter.",
    "id" : null
  }, {
    "name" : "ug/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258801007",
    "description" : "microgram per milliliter",
    "id" : null
  }, {
    "name" : "ug/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C42576",
    "description" : "microgram per microliter",
    "id" : null
  }, {
    "name" : "uiu/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67405",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one millionth of international unit per one milliliter of system volume.",
    "id" : null
  }, {
    "name" : "uM",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258814008",
    "description" : "micromolar",
    "id" : null
  }, {
    "name" : "umol/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48508",
    "description" : "A unit of concentration (molarity unit) equal to one one-millionth of a mole (10E-6 mole) of solute per one liter of solution.",
    "id" : null
  }, {
    "name" : "units/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/259002007",
    "description" : "Enzyme Unit per Milliliter. Unit of catalytic activity concentration defined as activity equal to one enzyme unit per one milliliter of system volume.",
    "id" : null
  } ]
}, {
  "name" : "lk_contract_category",
  "rows" : [ {
    "name" : "NIH",
    "link" : "",
    "description" : "NIAID Contract-Grant that will share data: ***makes Contract metadata viewable on Home page",
    "id" : ""
  }, {
    "name" : "OTHER",
    "link" : "",
    "description" : "Other or Miscellaneous Contract or Grant",
    "id" : ""
  } ]
}, {
  "name" : "lk_criterion_category",
  "rows" : [ {
    "name" : "Exclusion",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25370",
    "description" : "Exclusion Criterion used to evaluate whether a subject is a candidate for exclusion in a study.",
    "id" : ""
  }, {
    "name" : "Inclusion",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25532",
    "description" : "Inclusion Criterion used to evaluate whether a subject is a candidate for inclusion in a study.",
    "id" : ""
  } ]
}, {
  "name" : "lk_disease",
  "rows" : [ {
    "name" : "disease_preferred ;\ndisease_ontology_id",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "acquired immunodeficiency syndrome ; DOID:635",
    "link" : "http://purl.obolibrary.org/obo/DOID_635",
    "description" : "A Human immunodeficiency virus infectious disease that results_in reduction in the numbers of CD4-bearing helper T cells below 200 per microliter of blood or 14% of all lymphocytes thereby rendering the subject highly vulnerable to life-threatening infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted_by sexual contact, transmitted_by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted_by congenital method, and transmitted_by contaminated needles. Opportunistic infections are common in people with AIDS.",
    "id" : ""
  }, {
    "name" : "acute disseminated encephalomyelitis ; DOID:639",
    "link" : "http://purl.obolibrary.org/obo/DOID_639",
    "description" : "An encephalomyelitis characterized by inflammation located in brain and located in spinal cord that damages myelin. It usually occurs after viral infection, but also following vaccination, bacterial or parasitic infection.",
    "id" : ""
  }, {
    "name" : "Acute Respiratory Distress Syndrome ; C3353",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3353",
    "description" : "Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.",
    "id" : ""
  }, {
    "name" : "Addison's disease ; DOID:13774",
    "link" : "http://purl.obolibrary.org/obo/DOID_13774",
    "description" : "An adrenal cortical hypofunction that is characterized by insufficient steroid hormone production by the adrenal glands.",
    "id" : "HP:0008207"
  }, {
    "name" : "Aging ; NCIT:C16269",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C16269",
    "description" : "The process of change in the structure and function of an organism that occurs with the passage of time.",
    "id" : ""
  }, {
    "name" : "alcohol dependence ; DOID:0050741",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050741",
    "description" : "A substance dependence that is characterized by tolerance, withdrawal symptoms, increasing use, persistent desire to decrease consumption, time spent obtaining or recovering from alcohol caused by a physical and psychological dependence on alcohol. (UMLS CUI:C0001973)",
    "id" : ""
  }, {
    "name" : "alcohol use disorder ; DOID:1574",
    "link" : "http://purl.obolibrary.org/obo/DOID_1574",
    "description" : "A substance abuse that involves the recurring use of alcoholic beverages despite negative consequences.",
    "id" : ""
  }, {
    "name" : "allergic hypersensitivity disease ; DOID:1205",
    "link" : "http://purl.obolibrary.org/obo/DOID_1205",
    "description" : "An immune system disease that is an exaggerated immune response to allergens, such as insect venom, dust mites, pollen, pet dander, drugs or some foods.",
    "id" : "HP:0012393"
  }, {
    "name" : "allergic rhinitis ; DOID:4481",
    "link" : "http://purl.obolibrary.org/obo/DOID_4481",
    "description" : "A rhinitis that is an allergic inflammation and irritation of the nasal airways involving sneezing, runny nose, nasal congestion, itching and tearing of the eyes caused by exposure to an allergen such as pollen, dust, mold, animal dander and droppings of cockroaches or house dust mites.",
    "id" : "HP:0003193"
  }, {
    "name" : "alopecia areata ; DOID:986",
    "link" : "http://purl.obolibrary.org/obo/DOID_986",
    "description" : "An autoimmune disease resulting in the loss of hair on the scalp and elsewhere on the body initially causing bald spots.",
    "id" : "HP:0002232"
  }, {
    "name" : "Alzheimer's disease ; DOID:10652",
    "link" : "http://purl.obolibrary.org/obo/DOID_10652",
    "description" : "A tauopathy that is characterized by memory lapses, confusion, emotional instability and progressive loss of mental ability and results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood starting and leads in advanced cases to a profound decline in cognitive and physical functioning and is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid.",
    "id" : "HP:0002511"
  }, {
    "name" : "anemia ; DOID:2355",
    "link" : "http://purl.obolibrary.org/obo/DOID_2355",
    "description" : "A hematopoietic system disease that is characterized by a decrease in the normal number of red blood cells.",
    "id" : "HP:0001903"
  }, {
    "name" : "Angina ; NCIT:C51221",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C51221",
    "description" : "Paroxysms of chest pain due to reduced oxygen to the heart. (UMLS CUI:C0002962)",
    "id" : ""
  }, {
    "name" : "anthrax disease ; DOID:7427",
    "link" : "http://purl.obolibrary.org/obo/DOID_7427",
    "description" : "A primary bacterial infectious disease that results_in infection located_in skin, located_in lung lymph nodes or located_in gastrointestinal tract, has_material_basis_in Bacillus anthracis, transmitted_by contact with infected animals or animal products, transmitted_by airborne spores or transmitted_by ingestion of undercooked meat from infected animals and has_symptom skin ulcer, has_symptom nausea, has_symptom poor appetite, has_symptom bloody diarrhea, has_symptom fever or has_symptom shortness of breath.",
    "id" : ""
  }, {
    "name" : "antiphospholipid syndrome ; DOID:2988",
    "link" : "http://purl.obolibrary.org/obo/DOID_2988",
    "description" : "An autoimmune disease that is characterized by recurrent venous or arterial thrombosis and/or fetal losses associated with characteristic elevated levels of antibodies directed against membrane anionic phospholipids (anticardiolipin).",
    "id" : ""
  }, {
    "name" : "antisynthetase syndrome ; DOID:0080744",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080744",
    "description" : "An autoimmune disease that is characterized by myositis, arthralgia, Raynaud phenomenon, mechanic hands, interstitial lung disease, and serum autoantibodies to aminoacyl transfer RNA synthetases.",
    "id" : ""
  }, {
    "name" : "anxiety disorder ; DOID:2030",
    "link" : "http://purl.obolibrary.org/obo/DOID_2030",
    "description" : "A cognitive disorder that involves an excessive, irrational dread of everyday situations.",
    "id" : ""
  }, {
    "name" : "arrhythmia ; SYMP:0000287",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000287",
    "description" : "Arrhythmia is a cardiovascular system symptom consisting of an alteration in rhythm of the heartbeat either in time or force.",
    "id" : ""
  }, {
    "name" : "aspiration pneumonia ; DOID:0050152",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050152",
    "description" : "A bacterial pneumonia which is an acute pulmonary inflammatory response that develops after the inhalation of colonized oropharyngeal material containing bacteria. It is seen in individuals with dysphagia and gastric dysmotility. The disease has_symptom tachypnea and has_symptom cough. (UMLS CUI:C0032290)",
    "id" : ""
  }, {
    "name" : "asthma ; DOID:2841",
    "link" : "http://purl.obolibrary.org/obo/DOID_2841",
    "description" : "A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors. The disease has_symptom recurring periods of wheezing (a whistling sound while breathing), has_symptom chest tightness, has_symptom shortness of breath, has_symptom mucus production and has_symptom coughing.",
    "id" : "HP:0002099"
  }, {
    "name" : "atopic dermatitis ; DOID:3310",
    "link" : "http://purl.obolibrary.org/obo/DOID_3310",
    "description" : "An allergic contact dermatitis that is a chronically relapsing inflammatory allergic response located_in the skin that causes itching and flaking.",
    "id" : "HP:0001047"
  }, {
    "name" : "atrial fibrillation ; DOID:0060224",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060224",
    "description" : "A heart conduction disease that is characterized by uncoordinated electrical activity in the heart's upper chambers (the atria), which causes the heartbeat to become fast and irregular and has symptoms palpitations, weakness, fatigue, lightheadedness, dizziness, confusion, shortness of breath and chest pain. (UMLS CUI:C0004238)",
    "id" : ""
  }, {
    "name" : "autoimmune cardiomyopathy ; DOID:0040095",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040095",
    "description" : "An autoimmune disease of cardiovascular system that is characterized by deterioration of the function of the heart muscle.",
    "id" : ""
  }, {
    "name" : "autoimmune cholangitis ; DOID:0080742",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080742",
    "description" : "An autoimmune hepatitis that is characterized by primary biliary cirrhosis clinical, biochemical, and histologic characteristics with antinuclear antibody positive sera.",
    "id" : ""
  }, {
    "name" : "autoimmune disease ; DOID:417",
    "link" : "http://purl.obolibrary.org/obo/DOID_417",
    "description" : "An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.",
    "id" : ""
  }, {
    "name" : "autoimmune disease of endocrine system ; DOID:0060005",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060005",
    "description" : "An autoimmune disease that is the abnormal functioning of the immune system resulting in production of antibodies or T cells against cells and/or tissues in the endocrine system.",
    "id" : ""
  }, {
    "name" : "autoimmune disease of musculoskeletal system ; DOID:0060032",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060032",
    "description" : "An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the musculoskeletal system.",
    "id" : ""
  }, {
    "name" : "autoimmune glomerulonephritis ; DOID:0040094",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040094",
    "description" : "An autoimmune disease of urogenital tract that is located_in the renal glomerulus.",
    "id" : ""
  }, {
    "name" : "autoimmune hemolytic anemia ; DOID:718",
    "link" : "http://purl.obolibrary.org/obo/DOID_718",
    "description" : "An autoimmune disease of blood that is characterized by deficient red blood cells caused by auto-antibodies.",
    "id" : "HP:0001890"
  }, {
    "name" : "autoimmune hepatitis ; DOID:2048",
    "link" : "http://purl.obolibrary.org/obo/DOID_2048",
    "description" : "An autoimmune disease of gastrointestinal tract that results_in inflammation located_in liver caused by the body's immune system attacking the liver cells.",
    "id" : ""
  }, {
    "name" : "autoimmune peripheral neuropathy ; DOID:0040087",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040087",
    "description" : "An autoimmune disease of peripheral nervous system that results in peripheral neuropathy.",
    "id" : ""
  }, {
    "name" : "autoimmune thrombocytopenic purpura ; DOID:8924",
    "link" : "http://purl.obolibrary.org/obo/DOID_8924",
    "description" : "A primary thrombocytopenia that involves relatively few platelets in blood as a result of autoantibodies.",
    "id" : "HP:0001973"
  }, {
    "name" : "avian influenza ; DOID:4492",
    "link" : "http://purl.obolibrary.org/obo/DOID_4492",
    "description" : "An influenza that results in infection located in respiratory tract of humans, domestic and wild birds, has_material_basis_in Influenza A virus, which is transmitted by contact with infected poultry. Five strains of avian influenza A viruses (H5N1, H7N3, H7N2, H7N7 and H9N2) are known to cause human infections. The infection has_symptom fever, has_symptom cough, has_symptom sore throat, has_symptom muscle aches, has_symptom nausea, has_symptom diarrhea, has_symptom vomiting, has_symptom neurologic changes, has_symptom pneumonia, and has_symptom acute respiratory distress.",
    "id" : ""
  }, {
    "name" : "Bariatric Surgery ; NCIT:C84399",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84399",
    "description" : "Surgery performed in morbidly obese patients to help promote weight loss. The procedure aims at the reduction of the stomach size and it is usually achieved either with the implantation of a medical device or the removal of part of the stomach.",
    "id" : ""
  }, {
    "name" : "Bilateral pleural effusion (disorder) ; SNOMEDCT:425802001",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/425802001",
    "description" : "Bilateral pleural effusion (disorder) (UMLS CUI:C0747635)",
    "id" : ""
  }, {
    "name" : "biliary atresia ; DOID:13608",
    "link" : "http://purl.obolibrary.org/obo/DOID_13608",
    "description" : "A cholestasis characterized by blockage of the ducts that carry bile from the liver to the gallbladder.",
    "id" : "HP:0005912"
  }, {
    "name" : "blood coagulation disease ; DOID:1247",
    "link" : "http://purl.obolibrary.org/obo/DOID_1247",
    "description" : "A hematopoietic system disease that is characterized by abnormal blood clotting or bleeding.",
    "id" : "HP:0001928"
  }, {
    "name" : "Blood Transfusion ; NCIT:C15192",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15192",
    "description" : "The injection of whole blood or a blood component directly into the bloodstream.",
    "id" : ""
  }, {
    "name" : "bone development disease ; DOID:0080006",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080006",
    "description" : "A bone disease that results_in abnormal growth and development located_in bone or located_in cartilage.",
    "id" : ""
  }, {
    "name" : "bone disease ; DOID:0080001",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080001",
    "description" : "A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function.",
    "id" : ""
  }, {
    "name" : "brain glioblastoma multiforme ; DOID:3073",
    "link" : "http://purl.obolibrary.org/obo/DOID_3073",
    "description" : "A brain glioma that has_material_basis_in abnormally proliferating cells derives_from glial cells, has_symptom seizure, headaches, nausea and vomiting, memory loss, changes to personality, mood or concentration; and localized neurological problems.",
    "id" : ""
  }, {
    "name" : "brain glioma ; DOID:0060108",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060108",
    "description" : "A brain cancer that has_material_basis_in glial cells.",
    "id" : ""
  }, {
    "name" : "breast cancer ; DOID:1612",
    "link" : "http://purl.obolibrary.org/obo/DOID_1612",
    "description" : "A thoracic cancer that originates in the mammary gland.",
    "id" : "HP:0003002"
  }, {
    "name" : "bronchiectasis ; DOID:9563",
    "link" : "http://purl.obolibrary.org/obo/DOID_9563",
    "description" : "A bronchial disease that is a chronic inflammatory condition of one or more bronchi or bronchioles marked by dilatation and loss of elasticity of the walls resulting from damage to the airway wall leading to the formation of small sacs on the bronchial wall and impairment of cilia mobility in the lung. Inflammation of the bronchial wall increases mucus secretion which serves as a breeding ground for bacteria. Bronchiectasis is caused by repeated respiratory infections, immune deficiency disorders, hereditary disorders (cystic fibrosis or primary ciliary dyskinesia), mechanical factors (inhaled object or a lung tumor) or inhaling toxic substances. (UMLS CUI:C0006267)",
    "id" : ""
  }, {
    "name" : "bronchiolitis ; DOID:2942",
    "link" : "http://purl.obolibrary.org/obo/DOID_2942",
    "description" : "A lung disease that is an inflammation of the bronchioles, the smallest air passages of the lungs. It is caused by viruses and bacteria. The disease has_symptom cough, has_symptom wheezing, has_symptom shortness of breath, has_symptom fever, has_symptom nasal flaring in infants and has_symptom bluish skin due to lack of oxygen.",
    "id" : "HP:0011950"
  }, {
    "name" : "bronchitis ; DOID:6132",
    "link" : "http://purl.obolibrary.org/obo/DOID_6132",
    "description" : "A bronchial disease that is an inflammation of the bronchial tubes. It is caused by bacteria and viruses. The disease has_symptom cough with mucus, has_symptom shortness of breath, has_symptom low fever and has_symptom chest tightness.",
    "id" : "HP:0012387"
  }, {
    "name" : "Bronchopulmonary Dysplasia ; NCIT:C90599",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C90599",
    "description" : "Chronic lung disease requiring treatment with oxygen for at least 28 days and with a spectrum of severity from mild to severe, that predominantly affects premature infants. While the radiologic pattern is typical in the closer to term patient, the pattern in the small preterm infant is very non-discrete and variable.",
    "id" : ""
  }, {
    "name" : "bullous skin disease ; DOID:8502",
    "link" : "http://purl.obolibrary.org/obo/DOID_8502",
    "description" : "A dermatitis that is characterized by blisters filled with a watery fluid, located_in skin. The disease is associated with the amount of gluten ingested.",
    "id" : ""
  }, {
    "name" : "cancer ; DOID:162",
    "link" : "http://purl.obolibrary.org/obo/DOID_162",
    "description" : "A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis.",
    "id" : "HP:0002664"
  }, {
    "name" : "cardiac arrest ; DOID:0060319",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060319",
    "description" : "A congestive heart failure characterized by a sudden stop in effective blood circulation due to the failure of the heart to contract effectively or at all.",
    "id" : "HP:0001695"
  }, {
    "name" : "cardiomyopathy ; DOID:0050700",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050700",
    "description" : "A heart disease and a myopathy that is characterized by deterioration of the function of the heart muscle.",
    "id" : "HP:0001638"
  }, {
    "name" : "cardiovascular system disease ; DOID:1287",
    "link" : "http://purl.obolibrary.org/obo/DOID_1287",
    "description" : "A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.",
    "id" : "HP:0001626"
  }, {
    "name" : "celiac disease ; DOID:10608",
    "link" : "http://purl.obolibrary.org/obo/DOID_10608",
    "description" : "An autoimmune disease of gastrointestinal tract that is caused by a reaction located_in small intestine to gliadin, a prolamin (gluten protein) found in wheat, and similar proteins found in the crops of the tribe Triticeae. The disease is associated with HLA-DQ gene. It has_symptom abdominal pain, has_symptom constipation, has_symptom diarrhea, has_symptom nausea and vomiting, and has_symptom loss of appetite.",
    "id" : "HP:0002608"
  }, {
    "name" : "Cephalohematoma ; NCIT:C50484",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C50484",
    "description" : "A subperiosteal hemorrhage limited to the surface of one cranial bone, a usually benign condition seen in the newborn as a result of bone trauma.",
    "id" : ""
  }, {
    "name" : "cerebral palsy ; DOID:1969",
    "link" : "http://purl.obolibrary.org/obo/DOID_1969",
    "description" : "A brain disease that is caused by damage to the motor control centers of the developing brain during pregnancy, during childbirth or after birth, which affects muscle movement and balance.",
    "id" : "HP:0100021"
  }, {
    "name" : "cerebrovascular disease ; DOID:6713",
    "link" : "http://purl.obolibrary.org/obo/DOID_6713",
    "description" : "An vascular disease that is characterized by dysfunction of the blood vessels supplying the brain.",
    "id" : ""
  }, {
    "name" : "chickenpox ; DOID:8659",
    "link" : "http://purl.obolibrary.org/obo/DOID_8659",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Human herpesvirus 3, which is transmitted_by direct contact with secretions from the rash, or transmitted_by droplet spread of respiratory secretions. The infection has_symptom anorexia, has_symptom myalgia, has_symptom nausea, has_symptom fever, has_symptom headache, has_symptom sore throat, and has_symptom blisters.",
    "id" : ""
  }, {
    "name" : "chikungunya ; DOID:0050012",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050012",
    "description" : "A viral infectious disease that results_in infection located_in joint, has_material_basis_in Chikungunya virus, which is transmitted_by Aedes mosquito bite. The infection has_symptom fever, has_symptom arthralgia, and has_symptom maculopapular rash.",
    "id" : ""
  }, {
    "name" : "childhood type dermatomyositis ; DOID:14203",
    "link" : "http://purl.obolibrary.org/obo/DOID_14203",
    "description" : "childhood type dermatomyositis",
    "id" : ""
  }, {
    "name" : "chlamydia ; DOID:11263",
    "link" : "https://disease-ontology.org/?id=DOID:11263",
    "description" : "A commensal bacterial infectious disease that is caused by Chlamydia trachomatis.",
    "id" : ""
  }, {
    "name" : "choledochal cyst ; DOID:899",
    "link" : "http://purl.obolibrary.org/obo/DOID_899",
    "description" : "choledochal cyst",
    "id" : "HP:0100890"
  }, {
    "name" : "cholera ; DOID:1498",
    "link" : "http://purl.obolibrary.org/obo/DOID_1498",
    "description" : "A primary bacterial infectious disease that is described as an acute, diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae, which is characterized by profuse watery diarrhea, vomiting, leg cramps, circulatory collapse and shock.",
    "id" : ""
  }, {
    "name" : "chorioamnionitis ; DOID:0050697",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050697",
    "description" : "A placenta disease that is an inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection.",
    "id" : ""
  }, {
    "name" : "chromosomal disease ; DOID:0080014",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080014",
    "description" : "A genetic disease that has_material_basis_in extra, missing, or re-arranged chromosomes.",
    "id" : ""
  }, {
    "name" : "chronic disease course ; OGMS:0000064",
    "link" : "http://purl.obolibrary.org/obo/OGMS_0000064",
    "description" : "A disease course that (a) does not terminate in a return to normal homeostasis and (b) would, absent intervention, fall within abnormal homeostatic range.",
    "id" : ""
  }, {
    "name" : "Chronic Fatigue Syndrome ; NCIT_C3037",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3037",
    "description" : "A syndrome of unknown etiology. Chronic fatigue syndrome (CFS) is a clinical diagnosis characterized by an unexplained persistent or relapsing chronic fatigue that is of at least six months' duration, is not the result of ongoing exertion, is not substantially alleviated by rest, and results in substantial reduction of previous levels of occupational, educational, social, or personal activities. Common concurrent symptoms of at least six months duration include impairment of memory or concentration, diffuse pain, sore throat, tender lymph nodes, headaches of a new type, pattern, or severity, and nonrestorative sleep. The etiology of CFS may be viral or immunologic. Neurasthenia and fibromyalgia may represent related disorders. Also known as myalgic encephalomyelitis.",
    "id" : ""
  }, {
    "name" : "chronic kidney disease ; DOID:784",
    "link" : "http://purl.obolibrary.org/obo/DOID_784",
    "description" : "A kidney failure that is characterized by the gradual loss of kidney function. (UMLS CUI:C1561643)",
    "id" : ""
  }, {
    "name" : "Chronic Liver Disease ; NCIT:C113609",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C113609",
    "description" : "Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests. (UMLS CUI:C0341439)",
    "id" : ""
  }, {
    "name" : "chronic obstructive pulmonary disease ; DOID:3083",
    "link" : "http://purl.obolibrary.org/obo/DOID_3083",
    "description" : "An obstructive lung disease that is characterized by irreversible airflow obstruction due to chronic bronchitis, emphysema, and/or small airways disease.",
    "id" : "HP:0006510"
  }, {
    "name" : "chronic plaque psoriasis ; N/A",
    "link" : "https://dermnetnz.org/topics/chronic-plaque-psoriasis/",
    "description" : "Chronic plaque psoriasis is the most common presentation of psoriasis. It presents as small to large, well-demarcated, red, scaly and thickened areas of skin. It most likely to affect elbows, knees, and lower back but may arise on any part of the body.",
    "id" : "HP:0003765"
  }, {
    "name" : "Chronic Sinusitis ; NCIT:C35151",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C35151",
    "description" : "Inflammation of the paranasal sinuses that typically lasts beyond eight weeks. It is caused by infections, allergies, and the presence of sinus polyps or deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizziness, and breathing difficulties. (UMLS CUI:C0149516)",
    "id" : ""
  }, {
    "name" : "chronic spontaneous urticaria ; DOID:0080749",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080749",
    "description" : "A chronic urticaria that is characterized by urticaria independent of any exogenous stimulus.",
    "id" : ""
  }, {
    "name" : "cirrhosis ; DOID:5082",
    "link" : "http://purl.obolibrary.org/obo/DOID_5082",
    "description" : "liver cirrhosis",
    "id" : ""
  }, {
    "name" : "clinically isolated syndrome ; N/A",
    "link" : "https://www.nationalmssociety.org/Symptoms-Diagnosis/Clinically-Isolated-Syndrome-(CIS)",
    "description" : "Clinically isolated syndrome (CIS) is one of the MS disease courses. CIS refers to a first episode of neurologic symptoms that lasts at least 24 hours and is caused by inflammation or demyelination (loss of the myelin that covers the nerve cells) in the central nervous system (CNS).",
    "id" : ""
  }, {
    "name" : "Clostridium difficile colitis ; DOID:0060185",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060185",
    "description" : "A colitis characterized by an overgrowth of Clostridium difficile bacteria.",
    "id" : ""
  }, {
    "name" : "colitis ; DOID:0060180",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060180",
    "description" : "An inflammatory bowel disease that involves inflammation located_in colon.",
    "id" : "HP:0002583"
  }, {
    "name" : "colorectal cancer ; DOID:9256",
    "link" : "http://purl.obolibrary.org/obo/DOID_9256",
    "description" : "A large intestine cancer that is located_in the colon and/or located_in the rectum.",
    "id" : "HP:0100834"
  }, {
    "name" : "common variable immunodeficiency ; DOID:12177",
    "link" : "http://purl.obolibrary.org/obo/DOID_12177",
    "description" : "An agammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells.",
    "id" : ""
  }, {
    "name" : "congenital adrenal insufficiency ; DOID:0050546",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050546",
    "description" : "An adrenal gland disease that is characterized by cortisol deficiency, hypoaldosteronism and excessive or insufficient sex hormones, has_material_basis_in the mutation in the gene for 21-hydroxylase, 11beta-hydroxylase, 3beta-hydroxysteroid, 17alpha-hydroxylase or 20,22-desmolase.",
    "id" : ""
  }, {
    "name" : "congenital heart disease ; DOID:1682",
    "link" : "http://purl.obolibrary.org/obo/DOID_1682",
    "description" : "congenital heart disease",
    "id" : "HP:0001627"
  }, {
    "name" : "congenital syphilis ; DOID:9856",
    "link" : "http://purl.obolibrary.org/obo/DOID_9856",
    "description" : "A syphilis that results_in a multisystem infection in the fetus via the placenta.",
    "id" : ""
  }, {
    "name" : "congestive heart failure ; DOID:6000",
    "link" : "http://purl.obolibrary.org/obo/DOID_6000",
    "description" : "A heart disease that is characterized by any structural or functional cardiac disorder that impairs the ability of the heart to fill with or pump a sufficient amount of blood throughout the body.",
    "id" : "HP:0001635"
  }, {
    "name" : "conjunctivitis ; DOID:6195",
    "link" : "http://purl.obolibrary.org/obo/DOID_6195",
    "description" : "A conjunctival disease characterized by an inflammation of the conjunctiva, the outermost layer of the eye and the inner surface of the eyelids.",
    "id" : "HP:0000509"
  }, {
    "name" : "connective tissue disease ; DOID:65",
    "link" : "http://purl.obolibrary.org/obo/DOID_65",
    "description" : "A musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage.",
    "id" : ""
  }, {
    "name" : "coronary artery disease ; DOID:3393",
    "link" : "http://purl.obolibrary.org/obo/DOID_3393",
    "description" : "An artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles.",
    "id" : "HP:0001677"
  }, {
    "name" : "COVID-19 ; DOID:0080600",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080600",
    "description" : "A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.",
    "id" : ""
  }, {
    "name" : "COVID-19-Associated Acute Respiratory Distress Syndrome ; C171551",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C171551",
    "description" : "Acute respiratory distress syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
    "id" : ""
  }, {
    "name" : "cranial nerve disease ; DOID:5656",
    "link" : "http://purl.obolibrary.org/obo/DOID_5656",
    "description" : "A neuropathy that is located_in one of the twelve cranial nerves.",
    "id" : "HP:0006824"
  }, {
    "name" : "critical COVID-19 ; DOID:0081012",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/DOID_0081012;https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "id" : ""
  }, {
    "name" : "Crohn's disease ; DOID:8778",
    "link" : "http://purl.obolibrary.org/obo/DOID_8778",
    "description" : "An intestinal disease that involves inflammation located_in intestine.",
    "id" : "HP:0100280"
  }, {
    "name" : "cutaneous lupus erythematosus ; DOID:0050169",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050169",
    "description" : "A lupus erythematosus that causes skin lesions on parts of the body that are exposed to sunlight.",
    "id" : ""
  }, {
    "name" : "cystic fibrosis ; DOID:1485",
    "link" : "http://purl.obolibrary.org/obo/DOID_1485",
    "description" : "A syndrome that is characterized by the buildup of thick, sticky mucus that can damage many organs.",
    "id" : ""
  }, {
    "name" : "cystic kidney disease ; DOID:2975",
    "link" : "http://purl.obolibrary.org/obo/DOID_2975",
    "description" : "Polycystic kidney disease (PKD) is an inherited disorder in which clusters of cysts develop primarily within your kidneys, causing your kidneys to enlarge and lose function over time. Cysts are noncancerous round sacs containing fluid. The cysts vary in size, and they can grow very large.",
    "id" : "HP:0000107"
  }, {
    "name" : "cystinosis ; DOID:1064",
    "link" : "http://purl.obolibrary.org/obo/DOID_1064",
    "description" : "A lysosomal storage disease characterized by the abnormal accumulation of cystine in the lysosomes. It follows an autosomal recessive inheritance pattern and that has_material_basis_in mutations in the CTNS gene, located on chromosome 17.",
    "id" : ""
  }, {
    "name" : "Cytogenetically Normal Acute Myeloid Leukemia ; NCIT:C122687",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122687",
    "description" : "Acute myeloid leukemia not associated with cytogenetic abnormalities.",
    "id" : "HP:0004808"
  }, {
    "name" : "Cytomegaloviral Infection ; NCIT:C53649",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C53649",
    "description" : "A herpesvirus infection caused by Cytomegalovirus. Healthy individuals generally do not produce symptoms. However, the infection may be life-threatening in affected immunocompromised patients. The virus may cause retinitis, esophagitis, gastritis, and colitis. Morphologically, it is characterized by the presence of intranuclear inclusion bodies.",
    "id" : ""
  }, {
    "name" : "dementia ; DOID:1307",
    "link" : "http://purl.obolibrary.org/obo/DOID_1307",
    "description" : "A cognitive disorder resulting from a loss of brain function affecting memory, thinking, language, judgement and behavior.",
    "id" : ""
  }, {
    "name" : "Dementia with psychosis ; UMLS CUI:C0543884",
    "link" : "",
    "description" : "Dementia with psychosis (UMLS CUI:C0543884)",
    "id" : ""
  }, {
    "name" : "dengue disease ; DOID:12205",
    "link" : "http://purl.obolibrary.org/obo/DOID_12205",
    "description" : "A viral infectious disease that results in infection, has_material_basis_in Dengue virus [NCBITaxon:12637] with four serotypes (Dengue virus 1, 2, 3 and 4), which are transmitted by Aedes mosquito bite. The infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding.",
    "id" : ""
  }, {
    "name" : "dengue hemorrhagic fever ; DOID:12206",
    "link" : "http://purl.obolibrary.org/obo/DOID_12206",
    "description" : "A dengue disease that occurs when a person experiences a second infection with a heterologous Dengue virus serotype, which is transmitted_by Aedes mosquito bite. The infection has_symptom hemorrhagic lesions of the skin, has_symptom thrombocytopenia, has_symptom reduction in the fluid part of the blood, and has_symptom high fever.",
    "id" : ""
  }, {
    "name" : "Dependence on peritoneal dialysis due to end stage renal disease ; SNOMEDCT:428937001",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/428937001",
    "description" : "Dependence on peritoneal dialysis due to end stage renal disease (UMLS CUI:C1997877)",
    "id" : ""
  }, {
    "name" : "dermatomyositis ; DOID:10223",
    "link" : "http://purl.obolibrary.org/obo/DOID_10223",
    "description" : "A myositis that results_in inflammation located_in muscle or located_in skin where a skin rash is often seen prior to the onset of muscle weakness. The disease may result from either a viral infection or an autoimmune reaction.",
    "id" : ""
  }, {
    "name" : "dermatophytosis ; DOID:8913",
    "link" : "http://purl.obolibrary.org/obo/DOID_8913",
    "description" : "A cutaneous mycosis that results_in fungal infection located_in scalp, located_in glabrous skin, or located_in nail, has_material_basis_in Ascomycota fungi that belong to a group called dermatophytes, which have the ability to utilize keratin as a nutrient source.",
    "id" : ""
  }, {
    "name" : "developmental disorder of mental health ; DOID:0060037",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060037",
    "description" : "A disease of mental health that occur during a child's developmental period between birth and age 18 resulting in retarding of the child's psychological or physical development.",
    "id" : ""
  }, {
    "name" : "diabetes mellitus ; DOID:9351",
    "link" : "http://purl.obolibrary.org/obo/DOID_9351",
    "description" : "A glucose metabolism disease characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both.",
    "id" : "HP:0000819"
  }, {
    "name" : "diphtheria ; DOID:11405",
    "link" : "http://purl.obolibrary.org/obo/DOID_11405",
    "description" : "A primary bacterial infectious disease that is characterized by sore throat, low fever, and an adherent membrane (a pseudomembrane) on the tonsils, pharynx, and/or nasal cavity. A milder form of diphtheria can be restricted to the skin. It is caused by Corynebacterium diphtheriae, an aerobic Gram-positive bacterium. Diphtheria toxin spreads through the bloodstream and can lead to potentially life-threatening complications that affect other organs of the body, such as the heart and kidneys.",
    "id" : ""
  }, {
    "name" : "disease ; DOID:4",
    "link" : "http://purl.obolibrary.org/obo/DOID_4",
    "description" : "A disease is a disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.",
    "id" : ""
  }, {
    "name" : "disease by infectious agent ; DOID:0050117",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050117",
    "description" : "A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions.",
    "id" : ""
  }, {
    "name" : "disease of metabolism ; DOID:0014667",
    "link" : "http://purl.obolibrary.org/obo/DOID_0014667",
    "description" : "A disease that involving errors in metabolic processes of building or degradation of molecules.",
    "id" : ""
  }, {
    "name" : "diverticulitis ; DOID:7475",
    "link" : "http://purl.obolibrary.org/obo/DOID_7475",
    "description" : "An intestinal disease characterized by the formation and inflammation of diverticula within the bowel wall. (UMLS CUI:C0012813)",
    "id" : ""
  }, {
    "name" : "Dyspnea with Mild Physical Activity ; NCIT_C191546",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C191546",
    "description" : "Dyspnea experienced during minimal exertion.",
    "id" : ""
  }, {
    "name" : "Dyspnea with Moderate Physical Activity ; NCIT_C191547",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C191547",
    "description" : "Dyspnea experienced during moderate exertion.",
    "id" : ""
  }, {
    "name" : "Ebola hemorrhagic fever ; DOID:4325",
    "link" : "http://purl.obolibrary.org/obo/DOID_4325",
    "description" : "A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Zaire ebolavirus, has_material_basis_in Sudan ebolavirus, has_material_basis_in Cote d'Ivoire ebolavirus, or has_material_basis_in Bundibugyo ebolavirus, which are transmitted_by contact with the body fluids of an infected animal or person, transmitted by contaminated fomites, or transmitted by infected medical equipment. The infection has_symptom fever, has_symptom headache, has_symptom joint pain, has_symptom muscle aches, has_symptom sore throat, has_symptom weakness, has_symptom diarrhea, has_symptom vomiting, has_symptom stomach pain, has_symptom rash, has_symptom red eyes, has_symptom hiccups, and has_symptom internal and external bleeding.",
    "id" : ""
  }, {
    "name" : "EBV Infection ; NCIT:C38759",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38759",
    "description" : "An infection that is caused by Epstein-Barr virus.",
    "id" : ""
  }, {
    "name" : "EBV-Related Post-Transplant Lymphoproliferative Disorder ; NCIT:C27696",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C27696",
    "description" : "A lymphoproliferative disorder that develops following organ transplantation and is associated with Epstein-Barr virus infection.",
    "id" : ""
  }, {
    "name" : "eczema herpeticum ; DOID:9123",
    "link" : "http://purl.obolibrary.org/obo/DOID_9123",
    "description" : "A herpes simplex that results_in infection located_in skin, effected by preexisting dermatosis, has_material_basis_in Human herpesvirus 1 or Human herpesvirus 2. The infection has_symptom watery blisters, has_symptom fever, and has_symptom swelling of the lymph nodes.",
    "id" : ""
  }, {
    "name" : "eczema vaccinatum ; N/A",
    "link" : "https://www.medicinenet.com/script/main/art.asp?articlekey=21872",
    "description" : "Eczema vaccinatum: A common concern with smallpox vaccination involving the implantation of the vaccinia virus from the vaccination into the skin of a person with eczema (atopic dermatitis), sometimes with a fatal outcome. Disrupted skin permits viral implantation. Once the virus is implanted, it spreads from cell to cell producing extensive lesions. The skin lesions appear identical to a primary smallpox vaccination. Confluent lesions often cover the entire face, the crook of the elbow in the antecubital fossa, and behind the knee in the popliteal fossa. Viremia (viral spread through the bloodstream) may also occur allowing for the spread of virus to other parts of the body, including skin that is not affected by eczema. Bacterial and fungal invas",
    "id" : ""
  }, {
    "name" : "egg allergy ; DOID:4377",
    "link" : "http://purl.obolibrary.org/obo/DOID_4377",
    "description" : "A food allergy that is an allergy or hypersensitivity to dietary substances from the yolk or whites of eggs, causing an overreaction of the immune system which may lead to severe physical symptoms.",
    "id" : ""
  }, {
    "name" : "encephalitis ; DOID:9588",
    "link" : "http://purl.obolibrary.org/obo/DOID_9588",
    "description" : "A brain disease that is characterized as an acute inflammation of the brain with flu-like symptoms.",
    "id" : "HP:0002383"
  }, {
    "name" : "end stage renal disease ; DOID:783",
    "link" : "http://purl.obolibrary.org/obo/DOID_783",
    "description" : "A chronic kidney disease is characterized by non-functioning kidneys, as the final stage in chronic kidney disease.",
    "id" : ""
  }, {
    "name" : "endocarditis ; DOID:10314",
    "link" : "http://purl.obolibrary.org/obo/DOID_10314",
    "description" : "A endocardium disease characterized by inflammation of the endocardium of the heart chambers and valves.",
    "id" : "HP:0100584"
  }, {
    "name" : "eosinophilic esophagitis ; DOID:13922",
    "link" : "http://purl.obolibrary.org/obo/DOID_13922",
    "description" : "An esophagitis characterized by inflammation involving eosinophils located_in esophagus.",
    "id" : ""
  }, {
    "name" : "epidermolysis bullosa ; DOID:2730",
    "link" : "http://purl.obolibrary.org/obo/DOID_2730",
    "description" : "A vesiculobullous skin disease that is characterized by formation of blisters with only minor skin trauma, which can cause widespread wounds, dehydration, electrolyte abnormalities, and severe infection, frequently develops_from mutations in connective tissue elements, including genes encoding keratin, collagen, and laminin.",
    "id" : ""
  }, {
    "name" : "epilepsy ; DOID:1826",
    "link" : "http://purl.obolibrary.org/obo/DOID_1826",
    "description" : "A brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions.",
    "id" : "HP:0001250"
  }, {
    "name" : "Escherichia Coli Infection ; NCIT:C34594",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C34594",
    "description" : "Infection with the organism Escherichia Coli.",
    "id" : "HP:0002740"
  }, {
    "name" : "esophageal atresia ; DOID:10485",
    "link" : "http://purl.obolibrary.org/obo/DOID_10485",
    "description" : "esophageal atresia",
    "id" : "HP:0002032"
  }, {
    "name" : "esophageal atresia/tracheoesophageal fistula ; DOID:0080171",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080171",
    "description" : "A gastrointestinal system disease that is characterized by abnormal development of the esophagus and trachea where the upper esophagus does not connect (atresia) to the lower esophagus and stomach and may also include tracheoesophageal fistula where the esophagus and the trachea are abnormally connected which allows fluids from the esophagus to get into the airways and interfere with breathing.",
    "id" : ""
  }, {
    "name" : "Failure to Thrive ; NCIT:C107587",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C107587",
    "description" : "A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult. (UMLS CUI:C0015544)",
    "id" : ""
  }, {
    "name" : "Family Medical History ; NCIT:C17726",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17726",
    "description" : "A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.",
    "id" : ""
  }, {
    "name" : "fibromyalgia ; DOID:631",
    "link" : "http://purl.obolibrary.org/obo/DOID_631",
    "description" : "fibromyalgia",
    "id" : ""
  }, {
    "name" : "focal segmental glomerulosclerosis ; DOID:1312",
    "link" : "http://purl.obolibrary.org/obo/DOID_1312",
    "description" : "Focal segmental glomerulosclerosis (FSGS) is a disease in which scar tissue develops on the parts of the kidneys that filter waste from the blood (glomeruli). FSGS can be caused by a variety of conditions.",
    "id" : "HP:0000097"
  }, {
    "name" : "food allergy ; DOID:3044",
    "link" : "http://purl.obolibrary.org/obo/DOID_3044",
    "description" : "A hypersensitivity reaction type I disease that is an abnormal response to a food, triggered by the body's immune system.",
    "id" : ""
  }, {
    "name" : "gastroesophageal reflux disease ; DOID:8534",
    "link" : "http://purl.obolibrary.org/obo/DOID_8534",
    "description" : "gastroesophageal reflux disease",
    "id" : "HP:0002020"
  }, {
    "name" : "glioblastoma ; DOID:3068",
    "link" : "http://purl.obolibrary.org/obo/DOID_3068",
    "description" : "A malignant astrocytoma characterized by the presence of small areas of necrotizing tissue that is surrounded by anaplastic cells as well as the presence of hyperplastic blood vessels, and that has_material_basis_in abnormally proliferating cells derives_from multiple cell types including astrocytes and oligondroctyes.",
    "id" : "HP:0012174"
  }, {
    "name" : "Goodpasture syndrome ; DOID:9808",
    "link" : "http://purl.obolibrary.org/obo/DOID_9808",
    "description" : "An autoimmune disease that is characterized by antibody attack of the basement membrane in lungs and kidneys, leading to bleeding from the lungs and kidney failure.",
    "id" : ""
  }, {
    "name" : "granulomatosis with polyangiitis ; DOID:12132",
    "link" : "http://purl.obolibrary.org/obo/DOID_12132",
    "description" : "An autoimmune disease that is characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract, glomerulonephritis, vasculitis, and the presence of antineutrophil cytoplasmatic autoantibodies (ANCAs) in patient sera, and is located_in lung, located_in kidney, located_in skin resulting from an autoimmune attack by antineutrophil cytoplasmic antibodies against small and medium-size blood vessels.",
    "id" : ""
  }, {
    "name" : "Graves' disease ; DOID:12361",
    "link" : "http://purl.obolibrary.org/obo/DOID_12361",
    "description" : "An autoimmune disease of endocrine system that involves production of excessive amount of thyroid hormones, located_in thyroid gland.",
    "id" : "HP:0100647"
  }, {
    "name" : "Guillain-Barre syndrome ; DOID:12842",
    "link" : "http://purl.obolibrary.org/obo/DOID_12842",
    "description" : "An autoimmune disease of peripheral nervous system that causes body's immune system to attack part of the peripheral nervous system.",
    "id" : ""
  }, {
    "name" : "haemophilus meningitis ; DOID:0080179",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080179",
    "description" : "A bacterial meningitis that has_material_basis_in Haemophilus influenzae infection.",
    "id" : ""
  }, {
    "name" : "healthy ; NCIT:C115935",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115935",
    "description" : "Having no significant health-related issues.",
    "id" : ""
  }, {
    "name" : "Heart Failure ; NCIT:C50577",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C50577",
    "description" : "Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction. (UMLS CUI:C0018801)",
    "id" : ""
  }, {
    "name" : "Heart Transplantation ; NCIT:C15246",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15246",
    "description" : "A surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor.",
    "id" : ""
  }, {
    "name" : "Helicobacter Pylori Infection ; NCIT:C39293",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C39293",
    "description" : "A bacterial infection of the stomach, caused by Helicobacter pylori.  It is associated with the development of peptic ulcer and mucosa-associated lymphoid tissue lymphoma.",
    "id" : "HP:0005202"
  }, {
    "name" : "hematologic cancer ; DOID:2531",
    "link" : "http://purl.obolibrary.org/obo/DOID_2531",
    "description" : "An organ system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes.",
    "id" : "HP:0004377"
  }, {
    "name" : "hematopoietic system disease ; DOID:74",
    "link" : "http://purl.obolibrary.org/obo/DOID_74",
    "description" : "A disease of anatomical entity that has_material_basis_in hematopoietic cells.",
    "id" : "HP:0001871"
  }, {
    "name" : "hemiplegia ; DOID:10969",
    "link" : "http://purl.obolibrary.org/obo/DOID_10969",
    "description" : "A central nervous system disease that is characterized by the complete paralysis of half of the body.",
    "id" : "HP:0002301"
  }, {
    "name" : "hemoglobinopathy ; DOID:2860",
    "link" : "http://purl.obolibrary.org/obo/DOID_2860",
    "description" : "hemoglobinopathy",
    "id" : ""
  }, {
    "name" : "hemolytic-uremic syndrome ; DOID:12554",
    "link" : "http://purl.obolibrary.org/obo/DOID_12554",
    "description" : "A kidney disease that is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs.",
    "id" : "HP:0005575"
  }, {
    "name" : "hepatitis ; DOID:2237",
    "link" : "http://purl.obolibrary.org/obo/DOID_2237",
    "description" : "(UMLS CUI:C0267797)",
    "id" : ""
  }, {
    "name" : "hepatitis A ; DOID:12549",
    "link" : "http://purl.obolibrary.org/obo/DOID_12549",
    "description" : "A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis A virus, which is transmitted_by ingestion of contaminated food or water, or transmitted_by direct contact with an infected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",
    "id" : ""
  }, {
    "name" : "hepatitis B ; DOID:2043",
    "link" : "http://purl.obolibrary.org/obo/DOID_2043",
    "description" : "A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis B virus, which is transmitted_by sexual contact, transmitted_by blood transfusions, and transmitted_by fomites like needles or syringes. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",
    "id" : ""
  }, {
    "name" : "hepatitis C ; DOID:1883",
    "link" : "http://purl.obolibrary.org/obo/DOID_1883",
    "description" : "A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis C virus, which is transmitted_by blood from an infected person enters the body of an uninfected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",
    "id" : ""
  }, {
    "name" : "herpes zoster ; DOID:8536",
    "link" : "http://purl.obolibrary.org/obo/DOID_8536",
    "description" : "A viral infectious disease that results_in infection located_in nerve fiber, has_material_basis_in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted_by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has_symptom rash which is followed by blisters, has_symptom headache, has_symptom fever, has_symptom malaise, has_symptom itching, has_symptom burning pain, and has_symptom paresthesia.",
    "id" : ""
  }, {
    "name" : "human cytomegalovirus infection ; DOID:0080827",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080827",
    "description" : "A viral infectious disease that has_material_basis_in Human betaherpesvirus 5.",
    "id" : ""
  }, {
    "name" : "human immunodeficiency virus infectious disease ; DOID:526",
    "link" : "http://purl.obolibrary.org/obo/DOID_526",
    "description" : "A viral infectious disease that results in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted by sexual contact, transmitted by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted by congenital method, and transmitted by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has symptom diarrhea, has symptom fatigue, has symptom fever, has symptom vaginal yeast infection, has symptom headache, has symptom mouth sores, has symptom muscle aches, has symptom sore throat, and has symptom swollen lymph glands.",
    "id" : ""
  }, {
    "name" : "hydronephrosis ; DOID:11111",
    "link" : "http://purl.obolibrary.org/obo/DOID_11111",
    "description" : "hydronephrosis",
    "id" : "HP:0000126"
  }, {
    "name" : "hypertension ; DOID:10763",
    "link" : "http://purl.obolibrary.org/obo/DOID_10763",
    "description" : "An artery disease characterized by chronic elevated blood pressure in the arteries.",
    "id" : "HP:0000822"
  }, {
    "name" : "Hypertension not adequately controlled ; UMLS CUI:C0857354",
    "link" : "",
    "description" : "Hypertension not adequately controlled (UMLS CUI:C0857354)",
    "id" : ""
  }, {
    "name" : "hypoglycemia ; DOID:9993",
    "link" : "http://purl.obolibrary.org/obo/DOID_9993",
    "description" : "A glucose metabolism disease that is characterized by abnormally low levels of blood glucose.",
    "id" : "HP:0001943"
  }, {
    "name" : "Hyponatremia ; NCIT:C37976",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C37976",
    "description" : "Lower than normal levels of sodium in the circulating blood. (UMLS CUI:C0020625)",
    "id" : ""
  }, {
    "name" : "hypothyroidism ; DOID:1459",
    "link" : "http://purl.obolibrary.org/obo/DOID_1459",
    "description" : "A thyroid gland disease which involves an underproduction of thyroid hormone.",
    "id" : "HP:0000821"
  }, {
    "name" : "hysterectomy history ; OBI:0002398",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002398",
    "description" : "A gynecologic surgery history in which a woman has had a hysterectomy.",
    "id" : ""
  }, {
    "name" : "ichthyosis ; DOID:1697",
    "link" : "http://purl.obolibrary.org/obo/DOID_1697",
    "description" : "A skin disease characterized by drying and scaling of skin with the accumulation of thick scales and cracks that may be painful or bleed.",
    "id" : "HP:0008064"
  }, {
    "name" : "idiopathic pulmonary fibrosis ; DOID:0050156",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050156",
    "description" : "A pulmonary fibrosis that is characterized by scarring of the lung.",
    "id" : ""
  }, {
    "name" : "Immunocompromised ; NCIT:C14139",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C14139",
    "description" : "A loss of any arm of immune functions, resulting in potential or actual increase in infections. This state may be reached secondary to specific genetic lesions, syndromes with unidentified or polygenic causes, acquired deficits from other disease states, or as result of therapy for other diseases or conditions. (UMLS CUI:C2186379)",
    "id" : ""
  }, {
    "name" : "Immunologic Tolerance ; NCIT:C17712",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17712",
    "description" : "An innate tolerance that prevents the body from attacking native proteins and tissue.",
    "id" : ""
  }, {
    "name" : "Immunosuppressive Disorder ; C178942",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C178942",
    "description" : "Immunosuppressive Disorder A disorder in which immune function is suppressed.",
    "id" : ""
  }, {
    "name" : "inflammatory bowel disease ; DOID:0050589",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050589",
    "description" : "An intestinal disease characterized by inflammation located in all parts of digestive tract.",
    "id" : ""
  }, {
    "name" : "Inflammatory Disorder ; C93210",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C93210",
    "description" : "An infectious or non infectious disorder characterized by signs and symptoms derived from focal or extensive tissue infiltration by acute (e.g., polymorphonuclear) or chronic (e.g., lymphocytic-plasmacytic) inflammatory cells. Representative examples of infectious disorders include viral infections, bacterial infections, and parasitic infections. Representative examples of non-infectious inflammatory disorders include inflammatory bowel disease and inflammatory polyps",
    "id" : ""
  }, {
    "name" : "influenza ; DOID:8469",
    "link" : "http://purl.obolibrary.org/obo/DOID_8469",
    "description" : "A viral infectious disease that results in infection, located in respiratory tract, has_material_basis_in Influenzavirus A, has_material_basis_in Influenzavirus B, or has_material_basis_in Influenzavirus C, which are transmitted_by droplet spread of oronasal secretions during coughing, sneezing, or talking from an infected person. It is a highly contagious disease that affects birds and mammals and has_symptom chills, has_symptom fever, has_symptom sore throat, has_symptom runny nose, has_symptom muscle pains, has_symptom severe headache, has_symptom cough, and has_symptom weakness.",
    "id" : ""
  }, {
    "name" : "interstitial lung disease ; DOID:3082",
    "link" : "http://purl.obolibrary.org/obo/DOID_3082",
    "description" : "A lung disease that is characterized by inflammation and altered lung interstitium compromising pulmonary function and often has_symptom shortness of breath, dyspnea, and/or cough.",
    "id" : "HP:0006530"
  }, {
    "name" : "interstitial nephritis ; DOID:1063",
    "link" : "http://purl.obolibrary.org/obo/DOID_1063",
    "description" : "Interstitial nephritis is a kidney disorder. The kidneys filter waste and extra fluid from the body. When you have interstitial nephritis, the spaces between tubules (small tubes) inside the kidney become inflamed. This reduces the kidneys' ability to filter properly.",
    "id" : "HP:0001970"
  }, {
    "name" : "intestinal infectious disease ; DOID:100",
    "link" : "http://purl.obolibrary.org/obo/DOID_100",
    "description" : "An intestinal disease that involves intestinal infection that has_material_basis_in viruses, bacteria, fungi and parasites.",
    "id" : ""
  }, {
    "name" : "Irritable bowel syndrome with diarrhea ; SNOMEDCT:197125005",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/197125005",
    "description" : "Irritable bowel syndrome with diarrhea (UMLS CUI:C0348898)",
    "id" : ""
  }, {
    "name" : "juvenile rheumatoid arthritis ; DOID:676",
    "link" : "http://purl.obolibrary.org/obo/DOID_676",
    "description" : "A rheumatoid arthritis that involves an autoimmune disease onset in children under 16 which attacks the healthy cells and tissue of located_in joint.",
    "id" : ""
  }, {
    "name" : "keratoconjunctivitis sicca ; DOID:12895",
    "link" : "http://purl.obolibrary.org/obo/DOID_12895",
    "description" : "Dryness of the eye related to deficiency of the tear film components (aqueous, mucin, or lipid), lid surface abnormalities, or epithelial abnormalities. Keratoconjunctivitis sicca often results in a scratchy or sandy sensation (foreign body sensation) in the eyes, and may also be associated with itching, inability to produce tears, photosensitivity, redness, pain, and difficulty in moving the eyelids.",
    "id" : "HP:0001097"
  }, {
    "name" : "kidney cortex necrosis ; DOID:2973",
    "link" : "http://purl.obolibrary.org/obo/DOID_2973",
    "description" : "A kidney cortex disease that is characterized by death of the tissue in the outer part of the kidney that results from blockage of the small arteries that supply blood to the cortex and that causes acute kidney injury.",
    "id" : ""
  }, {
    "name" : "kidney disease ; DOID:557",
    "link" : "http://purl.obolibrary.org/obo/DOID_557",
    "description" : "A urinary system disease that is located in the kidney.",
    "id" : ""
  }, {
    "name" : "kidney failure ; DOID:1074",
    "link" : "http://purl.obolibrary.org/obo/DOID_1074",
    "description" : "A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood.",
    "id" : "HP:0000083"
  }, {
    "name" : "Kidney Transplantation ; NCIT:C15265",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15265",
    "description" : "The transfer of a healthy kidney from a donor to a patient for the purpose of replacing one of the failing kidneys of the patient.",
    "id" : ""
  }, {
    "name" : "Lambert-Eaton myasthenic syndrome ; DOID:0050214",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050214",
    "description" : "A neuromuscular junction disease that is characterized by an abnormality of acetylcholine (ACh) release at the neuromuscular junction which results from an autoimmune attack against voltage-gated calcium channels (VGCC) on the presynaptic motor nerve terminal.",
    "id" : ""
  }, {
    "name" : "laryngomalacia ; DOID:0080833",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080833",
    "description" : "A laryngeal disease that is characterized by inward collapse of flaccid supraglottic structures during inspiration. The most common symptom is noisy breathing (stridor) that is often worse when the infant is on his/her back or crying.",
    "id" : ""
  }, {
    "name" : "leukemia ; DOID:1240",
    "link" : "http://purl.obolibrary.org/obo/DOID_1240",
    "description" : "A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells.",
    "id" : "HP:0001909"
  }, {
    "name" : "lichen planus ; DOID:9201",
    "link" : "http://purl.obolibrary.org/obo/DOID_9201",
    "description" : "A lichen disease that is located_in skin, located_in tongue or located_in oral mucosa, which presents itself in the form of papules, lesions or rashes.",
    "id" : ""
  }, {
    "name" : "Listeria meningitis ; DOID:11572",
    "link" : "http://purl.obolibrary.org/obo/DOID_11572",
    "description" : "A bacterial meningitis that has_material_basis_in Listeria monocytogenes infection.",
    "id" : ""
  }, {
    "name" : "liver cancer ; DOID:3571",
    "link" : "http://purl.obolibrary.org/obo/DOID_3571",
    "description" : "A hepatobiliary system cancer that is located_in the liver.",
    "id" : "HP:0002896"
  }, {
    "name" : "liver disease ; DOID:409",
    "link" : "http://purl.obolibrary.org/obo/DOID_409",
    "description" : "liver disease",
    "id" : "HP:0001392"
  }, {
    "name" : "Liver Transplantation ; NCIT:C15271",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15271",
    "description" : "The transfer of a healthy liver allograft from a donor to a patient.",
    "id" : ""
  }, {
    "name" : "localized scleroderma ; DOID:8472",
    "link" : "http://purl.obolibrary.org/obo/DOID_8472",
    "description" : "localized scleroderma",
    "id" : "HP:0100324"
  }, {
    "name" : "lung adenocarcinoma ; DOID:3910",
    "link" : "http://purl.obolibrary.org/obo/DOID_3910",
    "description" : "A lung non-small cell carcinoma that derives_from epithelial cells of glandular origin.",
    "id" : "HP:0030078"
  }, {
    "name" : "lung cancer ; DOID:1324",
    "link" : "http://purl.obolibrary.org/obo/DOID_1324",
    "description" : "A respiratory system cancer that is located_in the lung.",
    "id" : ""
  }, {
    "name" : "lung disease ; DOID:850",
    "link" : "http://purl.obolibrary.org/obo/DOID_850",
    "description" : "A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide.",
    "id" : "HP:0002088"
  }, {
    "name" : "Lung Transplantation ; NCIT:C15274",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15274",
    "description" : "The surgical transfer of one or both lungs from one individual to another.",
    "id" : ""
  }, {
    "name" : "lupus erythematosus ; DOID:8857",
    "link" : "http://purl.obolibrary.org/obo/DOID_8857",
    "description" : "An autoimmune disease that is characterized by a constellation of findings that include elevated antibodies to nuclear antigens, antiphospholipids, low complement levels, ulcers, non-scarring alopecia, renal or neurologic damage, and low white blood cell and platelet counts, has_symptom rashes, fatigue, arthritis, hair loss, seizures, and symptoms related to affected organs. (UMLS CUI:C0409974)",
    "id" : ""
  }, {
    "name" : "lupus nephritis ; DOID:0080162",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080162",
    "description" : "A glomerulonephritis that is characterized by inflammation of the kidneys resulting from systemic lupus erythematosus.",
    "id" : ""
  }, {
    "name" : "Lyme disease ; DOID:11729",
    "link" : "http://purl.obolibrary.org/obo/DOID_11729",
    "description" : "A primary bacterial infectious disease that results_in infection, has_material_basis_in Borrelia burgdorferi, which is transmitted_by blacklegged tick (Ixodes scapularis) or transmitted_by western blacklegged tick (Ixodes pacificus). The infection has_symptom fever, has_symptom headache, has_symptom fatigue, and has_symptom skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system.",
    "id" : ""
  }, {
    "name" : "lymphocytic choriomeningitis ; DOID:12155",
    "link" : "http://purl.obolibrary.org/obo/DOID_12155",
    "description" : "A viral infectious disease that results in infection located in brain, or located in meninges, or located in brain and meninges, has_material_basis_in Lymphocytic choriomeningitis virus, which is transmitted by common house mouse, Mus musculus. The infection has symptom fever, has symptom lack of appetite, has symptom headache, has symptom muscle aches, has symptom malaise, has symptom nausea, and has symptom vomiting.",
    "id" : ""
  }, {
    "name" : "lymphoma ; DOID:0060058",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060058",
    "description" : "A hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs.",
    "id" : "HP:0002665"
  }, {
    "name" : "malaria ; DOID:12365",
    "link" : "http://purl.obolibrary.org/obo/DOID_12365",
    "description" : "A parasitic protozoa infectious disease characterized as a vector-borne infectious disease caused by the presence of protozoan parasites of the genus Plasmodium in the red blood cells, transmitted from an infected to an uninfected individual by the bite of anopheline mosquitoes, and characterized by periodic attacks of chills and fever that coincide with mass destruction of blood cells and the release of toxic substances by the parasite at the end of each reproductive cycle.",
    "id" : ""
  }, {
    "name" : "Malignant Gastric Neoplasm ; NCIT:C9331",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C9331",
    "description" : "A primary or metastatic malignant neoplasm involving the stomach. (UMLS CUI:C0024623)",
    "id" : ""
  }, {
    "name" : "Malignant Lung Neoplasm ; NCIT:C7377",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C7377",
    "description" : "A primary or metastatic malignant neoplasm involving the lung. (UMLS CUI:C0242379)",
    "id" : ""
  }, {
    "name" : "measles ; DOID:8622",
    "link" : "http://purl.obolibrary.org/obo/DOID_8622",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Measles virus, which is transmitted_by contact with oronasal secretions, or semen of an infected person. The infection has_symptom fever, has_symptom cough, has_symptom coryza, has_symptom conjunctivitis, and has_symptom maculopapular, erythematous rash.",
    "id" : ""
  }, {
    "name" : "meningitis ; DOID:9471",
    "link" : "http://purl.obolibrary.org/obo/DOID_9471",
    "description" : "A central nervous system disease that is characterized by an inflammation of the pia-arachnoid meninges. It can be caused by growth of bacteria, fungi, or parasites within the subarachnoid space or by the growth of bacteria or viruses within the meningeal or ependymal cells.",
    "id" : "HP:0001287"
  }, {
    "name" : "meningococcal meningitis ; DOID:0080176",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080176",
    "description" : "A bacterial meningitis that has_material_basis_in Neisseria meningitidis infection.",
    "id" : ""
  }, {
    "name" : "meningoencephalitis ; DOID:10554",
    "link" : "http://purl.obolibrary.org/obo/DOID_10554",
    "description" : "A central nervous system disease that involves encephalitis which occurs along with meningitis.",
    "id" : ""
  }, {
    "name" : "mental depression ; DOID:1596",
    "link" : "http://purl.obolibrary.org/obo/DOID_1596",
    "description" : "mental depression",
    "id" : ""
  }, {
    "name" : "MERS-CoV ; SNOMEDCT:697932005",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/697932005",
    "description" : "Middle East respiratory syndrome coronavirus",
    "id" : ""
  }, {
    "name" : "Metabolic Syndrome ; NCIT:C84442",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84442",
    "description" : "A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance.",
    "id" : ""
  }, {
    "name" : "milk allergy ; DOID:4376",
    "link" : "http://purl.obolibrary.org/obo/DOID_4376",
    "description" : "A food allergy that results in adverse immune reaction to one or more of the proteins in cow's milk and/or the milk of other animals, which are normally harmless to the non-allergic individual.",
    "id" : ""
  }, {
    "name" : "miscarriage ; SYMP:0000198",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000198",
    "description" : "Miscarriage is a reproductive system symptom characterized by the spontaneous expulsion of a human fetus before it is viable and especially between the 12th and 28th weeks of gestation.",
    "id" : ""
  }, {
    "name" : "mitral valve insufficiency ; DOID:11502",
    "link" : "http://purl.obolibrary.org/obo/DOID_11502",
    "description" : "(UMLS CUI:C0026266)",
    "id" : ""
  }, {
    "name" : "mixed connective tissue disease ; DOID:3492",
    "link" : "http://purl.obolibrary.org/obo/DOID_3492",
    "description" : "A collagen disease that is considered an overlap of three diseases, systemic lupus erythematosus, scleroderma, and polymyositis with very high titers of circulating antinuclear antibody to a ribonucleoprotein antigen.",
    "id" : ""
  }, {
    "name" : "molluscum contagiosum ; DOID:8867",
    "link" : "http://purl.obolibrary.org/obo/DOID_8867",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Molluscum contagiosum virus, which is transmitted_by contact with the skin, and transmitted_by fomites. The infection has_symptom lesions which are flesh-colored with a pit in the center.",
    "id" : ""
  }, {
    "name" : "multiple myeloma ; DOID:9538",
    "link" : "http://purl.obolibrary.org/obo/DOID_9538",
    "description" : "A myeloid neoplasm that is located_in the plasma cells in bone marrow. (UMLS CUI:C0026764)",
    "id" : ""
  }, {
    "name" : "Multiple Pulmonary Nodules ; NCIT:C122408",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122408",
    "description" : "Multiple, small, round or oval, benign or malignant growths in the lung(s), which can be due to infectious, inflammatory, or neoplastic processes. (UMLS CUI:C0748164)",
    "id" : ""
  }, {
    "name" : "multiple sclerosis ; DOID:2377",
    "link" : "http://purl.obolibrary.org/obo/DOID_2377",
    "description" : "A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring.",
    "id" : ""
  }, {
    "name" : "mumps ; DOID:10264",
    "link" : "http://purl.obolibrary.org/obo/DOID_10264",
    "description" : "A viral infectious disease that results in inflammation located in salivary gland, has_material_basis_in Mumps rubulavirus, which is transmitted by droplet spread of saliva or mucus from the mouth, nose, or throat of an infected person, or transmitted by contaminated fomites. The infection has symptom fever, has symptom headache, has symptom muscle aches, has symptom tiredness, has symptom loss of appetite, has symptom swollen and tender salivary glands under the ears or jaw on one or both sides of the face.",
    "id" : ""
  }, {
    "name" : "muscle invasive bladder cancer ; N/A",
    "link" : "https://www.urologyhealth.org/urologic-conditions/muscle-invasive-bladder-cancer",
    "description" : "Muscle invasive bladder cancer (MIBC) is a cancer that spreads into the detrusor muscle of the bladder. The detrusor muscle is the thick muscle deep in the bladder wall. This cancer is more likely to spread to other parts of the body. About 1 out of 4 people who get bladder cancer in the United States have the muscle invasive kind.",
    "id" : "HP:0009725"
  }, {
    "name" : "muscular dystrophy ; DOID:9884",
    "link" : "http://purl.obolibrary.org/obo/DOID_9884",
    "description" : "A myopathy is characterized by progressive skeletal muscle weakness degeneration.",
    "id" : "HP:0003560"
  }, {
    "name" : "musculoskeletal system disease ; DOID:17",
    "link" : "http://purl.obolibrary.org/obo/DOID_17",
    "description" : "A disease of anatomical entity that occurs in the muscular and/or skeletal system.",
    "id" : ""
  }, {
    "name" : "myasthenia gravis ; DOID:437",
    "link" : "http://purl.obolibrary.org/obo/DOID_437",
    "description" : "An autoimmune disease of the nervous system that has_material_basis_in antibodies to acetylcholine receptors at the neuromuscular junction, has_symptom ptosis, has_symptom diplopia, has_symptom dysphagia, has_symptom dysarthria, has_symptom muscle weakness and has_symptom shortness of breath.",
    "id" : ""
  }, {
    "name" : "myocardial infarction ; DOID:5844",
    "link" : "http://purl.obolibrary.org/obo/DOID_5844",
    "description" : "A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.",
    "id" : "HP:0001658"
  }, {
    "name" : "myocarditis ; DOID:820",
    "link" : "http://purl.obolibrary.org/obo/DOID_820",
    "description" : "An extrinsic cardiomyopathy that is characterized as an inflammation of the heart muscle.",
    "id" : "HP:0012819"
  }, {
    "name" : "narcolepsy ; DOID:8986",
    "link" : "http://purl.obolibrary.org/obo/DOID_8986",
    "description" : "A sleep disorder that involves an excessive urge to sleep at inappropriate times, such as while at work.",
    "id" : "HP:0030050"
  }, {
    "name" : "neonatal candidiasis ; DOID:9577",
    "link" : "http://purl.obolibrary.org/obo/DOID_9577",
    "description" : "A candidiasis that involves fungal infection in neonates caused by Candida species. Low birthweight and age, prolonged intravascular catheterization and the use of antibiotic drugs are the principle predisposing conditions for systemic candidiasis in neonates.",
    "id" : ""
  }, {
    "name" : "Neonatal Hypoxic Ischemic Encephalopathy ; NCIT:C119751",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C119751",
    "description" : "Injury to the central nervous system in the newborn period that occurs when there is insufficient delivery of oxygen to all or part of the brain.",
    "id" : ""
  }, {
    "name" : "neoplastic, metastatic ; PATO:0002098",
    "link" : "http://purl.obolibrary.org/obo/PATO_0002098",
    "description" : "A disposition inhering in a tumour by virtue of the bearer's disposition to spread and invade distant tissues.",
    "id" : ""
  }, {
    "name" : "nephrolithiasis ; DOID:585",
    "link" : "http://purl.obolibrary.org/obo/DOID_585",
    "description" : "A kidney disease characterized by the formation of stoney concentrations in the kidneys.",
    "id" : ""
  }, {
    "name" : "Nephrostomy tube (physical object) ; SNOMEDCT:286628000",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/286628000",
    "description" : "Nephrostomy tube (physical object) (UMLS CUI:C0184149)",
    "id" : ""
  }, {
    "name" : "nephrotic syndrome ; DOID:1184",
    "link" : "http://purl.obolibrary.org/obo/DOID_1184",
    "description" : "A nephrosis characterized by marked increase in glomerular protein permeability resulting in marked elevation of urine protein levels, hypoalbuminemia, hyperlipidemia, and hypercoagulability.",
    "id" : "HP:0000100"
  }, {
    "name" : "nervous system disease ; DOID:863",
    "link" : "http://purl.obolibrary.org/obo/DOID_863",
    "description" : "A disease of anatomical entity that is located_in the central nervous system or located_in the peripheral nervous system.",
    "id" : ""
  }, {
    "name" : "neurofibromatosis 1 ; DOID:0111253",
    "link" : "http://purl.obolibrary.org/obo/DOID_0111253",
    "description" : "A neurofibromatosis classically characterized by cafe-au-lait spots, Lisch nodules in the eye, and fibromatous tumors of the skin or in some cases by a high load of spinal tumors that has_material_basis_in heterozygous mutation in NF1 on 17q11.2.",
    "id" : ""
  }, {
    "name" : "neuromuscular disease ; DOID:440",
    "link" : "http://purl.obolibrary.org/obo/DOID_440",
    "description" : "A neuropathy that affect the nerves that control the voluntary muscles. (UMLS CUI:C0027868)",
    "id" : ""
  }, {
    "name" : "neuromyelitis optica ; DOID:8869",
    "link" : "http://purl.obolibrary.org/obo/DOID_8869",
    "description" : "A central nervous system disease characterized by inflammation of the optic nerve (optic neuritis) and inflammation of the spinal cord (myelitis).",
    "id" : ""
  }, {
    "name" : "Newcastle disease ; DOID:2929",
    "link" : "http://purl.obolibrary.org/obo/DOID_2929",
    "description" : "A viral infectious disease that results_in infection in birds and humans, has_material_basis_in Newcastle disease virus, which is transmitted_by contact with feces and urine of an infected bird, or transmitted_by fomites. The infection has_symptom conjunctivitis, has_symptom headache, and has_symptom lacrimation in humans, and has_symptom gasping, has_symptom coughing, has_symptom twisting of head and neck, has_symptom circling, has_symptom complete paralysis, has_symptom watery diarrhea, and has_symptom reduced egg production in birds.",
    "id" : ""
  }, {
    "name" : "non-severe COVID-19 ; DOID:0081014",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/DOID_0081014;https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "id" : ""
  }, {
    "name" : "Not Applicable ; NCIT_C48660",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48660",
    "description" : "Determination of a value is not relevant in the current context",
    "id" : ""
  }, {
    "name" : "Not Specified ; NCIT_C38046",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "Not stated explicitly or in detail",
    "id" : ""
  }, {
    "name" : "nutritional deficiency disease ; DOID:5113",
    "link" : "http://purl.obolibrary.org/obo/DOID_5113",
    "description" : "A nutrition disease that is characterized by deficiency of a nutritional element, such as a vitamin, mineral, carbohydrate, protein, fat, or general energy content.",
    "id" : ""
  }, {
    "name" : "obesity ; DOID:9970",
    "link" : "http://purl.obolibrary.org/obo/DOID_9970",
    "description" : "An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has_material_basis_in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness.",
    "id" : "HP:0001513"
  }, {
    "name" : "optic nerve glioma ; DOID:4992",
    "link" : "http://purl.obolibrary.org/obo/DOID_4992",
    "description" : "optic nerve glioma",
    "id" : "HP:0009734"
  }, {
    "name" : "optic neuritis ; DOID:1210",
    "link" : "http://purl.obolibrary.org/obo/DOID_1210",
    "description" : "An optic nerve disease that results_in inflammation located_in optic nerve which may cause a complete or partial loss of vision.",
    "id" : "HP:0100653"
  }, {
    "name" : "osteoarthritis ; DOID:8398",
    "link" : "http://purl.obolibrary.org/obo/DOID_8398",
    "description" : "An arthritis that has_material_basis_in worn out cartilage located_in joint.",
    "id" : "HP:0002758"
  }, {
    "name" : "Pancreas Transplantation ; NCIT:C15293",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15293",
    "description" : "The surgical transfer of a pancreas from one individual to another.",
    "id" : ""
  }, {
    "name" : "pancreatic cancer ; DOID:1793",
    "link" : "http://purl.obolibrary.org/obo/DOID_1793",
    "description" : "An endocrine gland cancer located_in the pancreas. (UMLS CUI:C0235974)",
    "id" : ""
  }, {
    "name" : "Pancreatic Islet Transplantation ; NCIT:C15352",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15352",
    "description" : "The surgical transfer of pancreatic islet cells from one individual to another.",
    "id" : ""
  }, {
    "name" : "panniculitis ; DOID:1526",
    "link" : "http://purl.obolibrary.org/obo/DOID_1526",
    "description" : "A skin disease that is characterized by inflammation of subcutaneous adipose tissue.",
    "id" : "HP:0012490"
  }, {
    "name" : "paraplegia ; DOID:607",
    "link" : "http://purl.obolibrary.org/obo/DOID_607",
    "description" : "paraplegia",
    "id" : "HP:0010550"
  }, {
    "name" : "Parkinson's disease ; DOID:14330",
    "link" : "http://purl.obolibrary.org/obo/DOID_14330",
    "description" : "A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.",
    "id" : ""
  }, {
    "name" : "Partial Small Intestine Resection ; NCIT:C51512",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C51512",
    "description" : "Surgical removal of part of the small intestine. (UMLS CUI:C0192616)",
    "id" : ""
  }, {
    "name" : "peanut allergy ; DOID:4378",
    "link" : "http://purl.obolibrary.org/obo/DOID_4378",
    "description" : "A legume allergy that is an allergy or hypersensitivity to dietary substances from peanuts causing an overreaction of the immune system which in a small percentage of people may lead to severe physical symptoms.",
    "id" : ""
  }, {
    "name" : "Pediatric acute-onset neuropsychiatric syndrome ; C000631768",
    "link" : "http://purl.bioontology.org/ontology/MESH/C000631768",
    "description" : "PANS pediatric acute-onset neuropsychiatric syndrome",
    "id" : "C000631768"
  }, {
    "name" : "pemphigus vulgaris ; DOID:0060851",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060851",
    "description" : "A pemphigus characterized by autosomal dominant blisters and erosions on the skin and mucous membranes erosions cause by autoantibodies to intercellular cement substance.",
    "id" : ""
  }, {
    "name" : "peptic ulcer disease ; DOID:750",
    "link" : "http://purl.obolibrary.org/obo/DOID_750",
    "description" : "peptic ulcer disease",
    "id" : "HP:0004398"
  }, {
    "name" : "Perennial Allergic Rhinitis ; NCIT:C92189",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92189",
    "description" : "Allergic rhinitis caused by indoor allergens and lasting year round.",
    "id" : "HP:0003193"
  }, {
    "name" : "perinatal necrotizing enterocolitis ; DOID:8677",
    "link" : "http://purl.obolibrary.org/obo/DOID_8677",
    "description" : "perinatal necrotizing enterocolitis",
    "id" : ""
  }, {
    "name" : "peripheral vascular disease ; DOID:341",
    "link" : "http://purl.obolibrary.org/obo/DOID_341",
    "description" : "A vascular disease that is characterized by obstruction of larger arteries not within the coronary, aortic arch vasculature, or brain.",
    "id" : ""
  }, {
    "name" : "Peritoneal Dialysis ; NCIT:C15297",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15297",
    "description" : "A form of dialysis that uses the peritoneum as a membrane across which the infused diasylate exchanges nutrients for waste products that are removed when the fluid is exchanged. (UMLS CUI:C0031139)",
    "id" : ""
  }, {
    "name" : "pernicious anemia ; DOID:13381",
    "link" : "http://purl.obolibrary.org/obo/DOID_13381",
    "description" : "A nutritional deficiency disease that is characterized by a decrease in red blood cells due to malabsorption of vitamin B12, has_symptom fatigue, pallor, shortness of breath, glossitis, ataxia, and/or paresthesia, has_material_basis_in atrophic gastritis, autoimmune disorder affecting the production or function of intrinsic factor, and/or genetic factors.",
    "id" : ""
  }, {
    "name" : "pertussis ; DOID:1116",
    "link" : "http://purl.obolibrary.org/obo/DOID_1116",
    "description" : "A commensal bacterial infectious disease that results_in inflammation located_in respiratory tract, has_material_basis_in Bordetella pertussis, or has_material_basis_in Bordetella parapertussis, which produce toxins that paralyze the cilia of the respiratory epithelial cells. The infection is characterized by a prolonged, high-pitched, deeply indrawn breath (whoop).",
    "id" : ""
  }, {
    "name" : "pervasive developmental disorder ; DOID:0060040",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060040",
    "description" : "A developmental disorder of mental health that refers to a group of five disorders characterized by impairments in socialization and communication, as well as restricted interests and repetitive behaviors.",
    "id" : ""
  }, {
    "name" : "pharyngitis ; DOID:2275",
    "link" : "http://purl.obolibrary.org/obo/DOID_2275",
    "description" : "An upper respiratory tract disease involving inflammation of the throat or pharynx resulting from bacterial, viral, fungal infections or irritants like pollutants or chemical substances and smoking. The infection is often referred to as sore throat. The symptoms include pain during swallowing, enlarged tonsils coated with a white discharge, runny nose, cough and slight fever.",
    "id" : ""
  }, {
    "name" : "physical disorder ; DOID:0080015",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080015",
    "description" : "A disease that has_material_basis_in a genetic abnormality, error with embryonic development, infection or compromised intrauterine environment.",
    "id" : ""
  }, {
    "name" : "pituitary gland disease ; DOID:53",
    "link" : "http://purl.obolibrary.org/obo/DOID_53",
    "description" : "An endocrine system disease that is located_in the pituitary gland.",
    "id" : ""
  }, {
    "name" : "placenta disease ; DOID:780",
    "link" : "http://purl.obolibrary.org/obo/DOID_780",
    "description" : "A uterine disease that is located_in the placenta.",
    "id" : ""
  }, {
    "name" : "plague ; DOID:3482",
    "link" : "http://purl.obolibrary.org/obo/DOID_3482",
    "description" : "A primary bacterial infectious disease that results_in infection, located_in lymph node, located_in vasculature or located_in lungs, has_material_basis_in Yersinia pestis, which is transmitted_by oriental rat flea (Xenopsylla cheopis) infected by feeding on rodents and other mammals, transmitted_by air, transmitted_by direct contact or transmitted_by ingestion of contaminated undercooked food.",
    "id" : ""
  }, {
    "name" : "Plasmodium falciparum malaria ; DOID:14067",
    "link" : "http://purl.obolibrary.org/obo/DOID_14067",
    "description" : "A malaria described as a severe form of the disease caused by a parasite Plasmodium falciparum, which is marked by irrregular recurrence of paroxysms and prolonged or continuous fever.",
    "id" : ""
  }, {
    "name" : "Plasmodium vivax malaria ; DOID:12978",
    "link" : "http://purl.obolibrary.org/obo/DOID_12978",
    "description" : "A malaria that is caused by the protozoan parasite Plasmodium vivax, which induces paroxysms at 48-hour intervals.",
    "id" : ""
  }, {
    "name" : "Pleural effusions, chronic ; UMLS CUI:C0747636",
    "link" : "",
    "description" : "Pleural effusions, chronic (UMLS CUI:C0747636)",
    "id" : ""
  }, {
    "name" : "pneumonia ; DOID:552",
    "link" : "http://purl.obolibrary.org/obo/DOID_552",
    "description" : "A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation).",
    "id" : ""
  }, {
    "name" : "polymyalgia rheumatica ; DOID:853",
    "link" : "http://purl.obolibrary.org/obo/DOID_853",
    "description" : "A collagen disease that is characterized by pain, stiffness, and tenderness of the proximal muscle groups including the shoulder, pelvic girdle and the neck.",
    "id" : ""
  }, {
    "name" : "polymyositis ; DOID:0080745",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080745",
    "description" : "A myositis that is characterized by muscle weakness affecting both sides of your body.",
    "id" : ""
  }, {
    "name" : "portal vein thrombosis ; DOID:11695",
    "link" : "http://purl.obolibrary.org/obo/DOID_11695",
    "description" : "A hepatic vascular disease that is characterized by a blood clot that forms within the hepatic portal vein. (UMLS CUI:C0155773)",
    "id" : ""
  }, {
    "name" : "Post-Acute Sequelae of COVID-19 ; NCIT_C179263",
    "link" : "https://uts.nlm.nih.gov/uts/umls/vocabulary/NCI/C179263",
    "description" : "A constellation of signs and symptoms that can persist for weeks or months after acute infection with SARS-CoV-2, or appear weeks after infection. This condition may be characterized by fatigue, shortness of breath, difficulty focusing or concentrating (\"brain fog\"), sleep disorders, fevers, gastrointestinal symptoms, anxiety, and depression. aka Long-COVID-19. ACC/AHA Definition:  Symptoms that significantly impair quality of life, which started during or after probable or confirmed acute COVID-19 and have persisted 4 wk to 3 mo after the initial diagnosis of COVID-19",
    "id" : ""
  }, {
    "name" : "Post-Transplant Lymphoproliferative Disorder ; NCIT:C4727",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C4727",
    "description" : "Post-transplant lymphoproliferative disorder (PTLD) is a polyclonal (benign) or clonal (malignant) proliferation of lymphoid cells that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft. PTLDs comprise a spectrum ranging from early, Epstein-Barr virus (EBV)-driven polyclonal lymphoid proliferations to EBV-positive or EBV- negative lymphomas of predominantly B-cell or less often T-cell type.",
    "id" : ""
  }, {
    "name" : "post-traumatic stress disorder ; DOID:2055",
    "link" : "http://purl.obolibrary.org/obo/DOID_2055",
    "description" : "An anxiety disorder which results from a traumatic experience that results in psychological trauma.",
    "id" : ""
  }, {
    "name" : "postinfectious encephalitis ; DOID:10993",
    "link" : "http://purl.obolibrary.org/obo/DOID_10993",
    "description" : "An encephalitis that is characterized by the immune system mistakenly attacking healthy cells in the brain instead of attacking only the cells causing the infection, often occuring two to three weeks after the initial infection.",
    "id" : ""
  }, {
    "name" : "pre-eclampsia ; DOID:10591",
    "link" : "http://purl.obolibrary.org/obo/DOID_10591",
    "description" : "A hypertension occurring during pregnancy characterized by large amounts of protein in the urine (proteinuria) and edema, usually by the last trimester of pregnancy.",
    "id" : "HP:0100602"
  }, {
    "name" : "Pregnancy ; NCIT:C25742",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25742",
    "description" : "The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.",
    "id" : ""
  }, {
    "name" : "Prenatal maternal abnormality ; HP:0002686",
    "link" : "http://purl.obolibrary.org/obo/HP_0002686",
    "description" : "Prenatal maternal abnormality",
    "id" : "HP:0002686"
  }, {
    "name" : "Preterm Birth ; NCIT:C92861",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92861",
    "description" : "Birth when a fetus is less than 37 weeks and 0 days gestational age.",
    "id" : ""
  }, {
    "name" : "Previous ; NCIT:C25627",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25627",
    "description" : "Occurring prior to something else.",
    "id" : ""
  }, {
    "name" : "primary biliary cholangitis ; DOID:12236",
    "link" : "http://purl.obolibrary.org/obo/DOID_12236",
    "description" : "A liver cirrhosis characterized by chronic and slow progressive destruction of intrahepatic bile ducts.",
    "id" : "HP:0002613"
  }, {
    "name" : "primary immunodeficiency disease ; DOID:612",
    "link" : "http://purl.obolibrary.org/obo/DOID_612",
    "description" : "An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation.",
    "id" : "HP:0002721"
  }, {
    "name" : "primary sclerosing cholangitis ; DOID:0060643",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060643",
    "description" : "A sclerosing cholangitis characterized by fibroobliterative inflammation of the biliary tract, leading to cirrhosis and portal hypertension.",
    "id" : ""
  }, {
    "name" : "Primary Sjogren Syndrome ; NCIT:C116985",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C116985",
    "description" : "Sjogren syndrome without a concomitant systemic autoimmune disorder.",
    "id" : ""
  }, {
    "name" : "proctitis ; DOID:3127",
    "link" : "http://purl.obolibrary.org/obo/DOID_3127",
    "description" : "A rectal disease that involves inflammation of the rectal mucosa, which results from infection, inflammatory bowel disease, or radiation. Sexually transmitted pathogens (Neisseria gonorrhoeae, Chlamydia trachomatis, herpes simplex virus 1 and 2, Treponema pallidum) and enteric pathogens (Campylobacter, Shigella, Salmonella) are involved in the disease. Symptoms are rectal discomfort and bleeding.",
    "id" : ""
  }, {
    "name" : "psoriasis ; DOID:8893",
    "link" : "http://purl.obolibrary.org/obo/DOID_8893",
    "description" : "A skin disease that is characterized by patches of thick red skin and silvery scales.",
    "id" : "HP:0003765"
  }, {
    "name" : "psoriatic arthritis ; DOID:9008",
    "link" : "http://purl.obolibrary.org/obo/DOID_9008",
    "description" : "An arthritis that is characterized by joint inflammation that usually occurs in combination with psoriasis.",
    "id" : ""
  }, {
    "name" : "Psychiatric Disorder ; NCIT:C2893",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C2893",
    "description" : "A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia. (UMLS CUI:C1658764)",
    "id" : ""
  }, {
    "name" : "psychotic disorder ; DOID:2468",
    "link" : "http://purl.obolibrary.org/obo/DOID_2468",
    "description" : "A cognitive disorder that involves abnormal thinking and perceptions resulting in a disconnection with reality.",
    "id" : ""
  }, {
    "name" : "pulmonary hypertension ; DOID:6432",
    "link" : "http://purl.obolibrary.org/obo/DOID_6432",
    "description" : "A hypertension characterized by an increase of blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries.",
    "id" : "HP:0002092"
  }, {
    "name" : "pustulosis of palm and sole ; DOID:4398",
    "link" : "http://purl.obolibrary.org/obo/DOID_4398",
    "description" : "pustulosis of palm and sole",
    "id" : "HP:0100847"
  }, {
    "name" : "Radiation Exposure ; NCIT:C61398",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/NCIT_C61398",
    "id" : ""
  }, {
    "name" : "Radiation Sickness Syndrome ; NCIT:C50723",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C50723",
    "description" : "The complex of symptoms characterizing the disease known as radiation injury, resulting from excessive exposure (greater than 200 rads or 2 gray) of the whole body (or large part) to ionizing radiation. The earliest of these symptoms are nausea, fatigue, vomiting, and diarrhea, which may be followed by epilation, hemorrhage, inflammation of the mouth and throat, and general loss of energy. In severe cases, where the radiation exposure has been approximately 1000 Rad (10 gray) or more, death may occur within two to four weeks. Those who survive six weeks after the receipt of a single large dose of radiation to the whole body may generally be expected to recover. (U.S. Nuclear Regulatory Commission).",
    "id" : ""
  }, {
    "name" : "Raynaud disease ; DOID:10300",
    "link" : "http://purl.obolibrary.org/obo/DOID_10300",
    "description" : "Raynaud disease",
    "id" : "HP:0030880"
  }, {
    "name" : "recent ; PATO:0001484",
    "link" : "http://purl.obolibrary.org/obo/PATO_0001484",
    "description" : "A quality of a process which occurs near to or not long before the present.",
    "id" : ""
  }, {
    "name" : "Recurrent pregnancy loss ; C2921106",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C2921106",
    "description" : "A medical condition characterized by the loss of two or more pregnancies before the fetus reaches viability. The exact timing for what constitutes \"viability\" may vary, but losses are often counted before 20 weeks of gestation. Recurrent pregnancy loss is a subset of miscarriage, which is more broadly defined as the loss of a pregnancy before viability.",
    "id" : ""
  }, {
    "name" : "Recurrent urinary tract infections ; HP:0000010",
    "link" : "http://purl.obolibrary.org/obo/HP_0000010",
    "description" : "Repeated infections of the urinary tract. (UMLS CUI:C0262655)",
    "id" : "HP:0000010"
  }, {
    "name" : "relapse ; OGMS:0000105",
    "link" : "http://purl.obolibrary.org/obo/OGMS_0000105",
    "description" : "A disease stage which is preceded by a remission and characterized by the return of a manifestation of a disease.",
    "id" : ""
  }, {
    "name" : "relapsing polychondritis ; DOID:2556",
    "link" : "http://purl.obolibrary.org/obo/DOID_2556",
    "description" : "A chondromalacia that is characterized by recurrent inflammation of cartilage and other tissues throughout the body.",
    "id" : ""
  }, {
    "name" : "renal artery obstruction ; DOID:2972",
    "link" : "http://purl.obolibrary.org/obo/DOID_2972",
    "description" : "renal artery obstruction",
    "id" : "HP:0001920"
  }, {
    "name" : "Reproductive Surgery ; NCIT:C157970",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C157970",
    "description" : "A surgical procedure in the field of reproductive medicine.",
    "id" : ""
  }, {
    "name" : "respiratory syncytial virus infectious disease ; DOID:1273",
    "link" : "http://purl.obolibrary.org/obo/DOID_1273",
    "description" : "A viral infectious disease that results_in infection located_in upper respiratory tract or located_in lower respiratory tract, has_material_basis_in Human respiratory syncytial virus, which is transmitted_by droplet spread of nasal secretions from an infected person while coughing or sneezing, or transmitted_by contaminated fomites. The infection has_symptom runny nose, has_symptom fever, has_symptom cough, has_symptom wheezing, and has_symptom respiratory distress.",
    "id" : ""
  }, {
    "name" : "Rheumatic Disease ; DOID_1575",
    "link" : "http://purl.obolibrary.org/obo/DOID_1575",
    "description" : "A musculoskeletal system disease that involves inflammation or pain in the muscles, joints, or fibrous tissue.",
    "id" : ""
  }, {
    "name" : "rheumatic heart disease ; DOID:0050827",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050827",
    "description" : "A heart valve disease that is characterized by repeated inflammation with fibrinous repair caused by an autoimmune reaction to Group A beta-hemolytic streptococci (GAS) that results in valvular damage. The cardinal anatomic changes of the valve include leaflet thickening, commissural fusion, and shortening and thickening of the tendinous cords.",
    "id" : ""
  }, {
    "name" : "rheumatoid arthritis ; DOID:7148",
    "link" : "http://purl.obolibrary.org/obo/DOID_7148",
    "description" : "An arthritis that is an autoimmune disease which attacks healthy cells and tissue located_in joint.",
    "id" : "HP:0001370"
  }, {
    "name" : "rhinitis ; DOID:4483",
    "link" : "http://purl.obolibrary.org/obo/DOID_4483",
    "description" : "A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip.",
    "id" : "HP:0012384"
  }, {
    "name" : "Rhinovirus Infection ; NCIT:C122572",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122572",
    "description" : "An infectious process caused by rhinovirus. The virus usually causes upper respiratory infections, but can infect the lower tract as well.",
    "id" : ""
  }, {
    "name" : "rubella ; DOID:8781",
    "link" : "http://purl.obolibrary.org/obo/DOID_8781",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Rubella virus, which is transmitted_by droplet spread of oronasal secretions from the infected person through coughing and sneezing, and transmitted_by congenital method. The infection has_symptom rash on the face which spreads to the trunk and limbs, has_symptom fever, has_symptom lymphadenopathy, has_symptom joint pains, has_symptom headache, and has_symptom conjunctivitis.",
    "id" : ""
  }, {
    "name" : "salmonellosis ; DOID:0060859",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060859",
    "description" : "A primary bacterial infectious disease caused by the bacteria of the genus Salmonella. It has sypmtoms diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cases, the illness lasts four to seven days, and most people recover without treatment.",
    "id" : ""
  }, {
    "name" : "sarcoidosis ; DOID:11335",
    "link" : "http://purl.obolibrary.org/obo/DOID_11335",
    "description" : "A hypersensitivity reaction type IV disease characterized by the growth of collections of inflammatory cells (granulomas) in multiple organs.",
    "id" : ""
  }, {
    "name" : "sarcoma ; DOID:1115",
    "link" : "http://purl.obolibrary.org/obo/DOID_1115",
    "description" : "A cell type cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm.",
    "id" : ""
  }, {
    "name" : "schistosomiasis ; DOID:1395",
    "link" : "http://purl.obolibrary.org/obo/DOID_1395",
    "description" : "A parasitic helminthiasis infectious disease that involves infection of the intestine, urinary tract, skin, liver and spleen caused by multiple species of the trematode fluke of the genus Schistosoma. The symptoms include fever, chills, nausea, abdominal pain, diarrhea, malaise, myalgia, liver and spleen enlargement, rash and hematuria.",
    "id" : ""
  }, {
    "name" : "scleroderma ; DOID:419",
    "link" : "http://purl.obolibrary.org/obo/DOID_419",
    "description" : "A rheumatic disease that involves the abnormal growth of connective tissue, which supports the skin and internal organs.",
    "id" : "HP:0100324"
  }, {
    "name" : "Seasonal Allergic Rhinitis ; NCIT:C92188",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92188",
    "description" : "Allergic rhinitis caused by outdoor allergens.",
    "id" : "HP:0003193"
  }, {
    "name" : "Severe Acute Respiratory Syndrome (SARS) ; DOID:2945",
    "link" : "http://purl.obolibrary.org/obo/DOID_2945",
    "description" : "A Coronavirus infectious disease that results_in infection located_in respiratory tract, has_material_basis_in SARS coronavirus (SARS-CoV), which is transmitted_by droplet spread of respiratory secretions, transmitted_by ingestion of contaminated food, or transmitted_by fomites. The infection has_symptom fever, has_symptom headache, has_symptom body aches, has_symptom dry cough, and has_symptom hypoxia",
    "id" : ""
  }, {
    "name" : "severe COVID-19 ; DOID:0081013",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/DOID_0081013;https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "id" : ""
  }, {
    "name" : "Sexually Transmitted Disorder ; NCIT:C3365",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3365",
    "description" : "A disorder acquired through sexual contact.",
    "id" : ""
  }, {
    "name" : "Shigellosis ; C157978",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C157978",
    "description" : "An intestinal disease cause by Shigella bacteria.",
    "id" : ""
  }, {
    "name" : "Shoulder Dislocation ; NCIT:C35020",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C35020",
    "description" : "A dislocation of the shoulder joint. (UMLS CUI:C0037005)",
    "id" : ""
  }, {
    "name" : "sickle cell anemia ; DOID:10923",
    "link" : "https://www.disease-ontology.org/?id=DOID:10923",
    "description" : "A blood protein disease that is characterized by low number of red blood cells, repeated infections, and periodic episodes of pain, resulting from atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape. https://en.wikipedia.org/wiki/Sickle_cell_disease, https://ghr.nlm.nih.gov/condition/sickle-cell-disease, https://www.nhlbi.nih.gov/health-topics/sickle-cell-disease",
    "id" : ""
  }, {
    "name" : "sinusitis ; DOID:0050127",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050127",
    "description" : "A paranasal sinus disease involving inflammation of the paranasal sinuses resulting from bacterial, fungal, viral infection, allergic or autoimmune issues. Symptoms can include fever, weakness, fatigue, cough and congestion. There may also be mucus drainage in the back of the throat, called postnasal drip.",
    "id" : "HP:0000255"
  }, {
    "name" : "Sjogren's syndrome ; DOID:12894",
    "link" : "http://purl.obolibrary.org/obo/DOID_12894",
    "description" : "An autoimmune disease that involves attack of immune cells which destroy the exocrine glands that produce tears and saliva.",
    "id" : ""
  }, {
    "name" : "Small Bowel Transplantation ; NCIT:C157985",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C157985",
    "description" : "Replacing diseased bowel with healthy bowel tissue.",
    "id" : ""
  }, {
    "name" : "Small for Gestational Age ; NCIT:C114934",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C114934",
    "description" : "Smaller than normal size according to sex and gestational age related norms, defined as a weight below the 10th percentile for the gestational age (UMLS CUI: C0235991).",
    "id" : "HP:0001518"
  }, {
    "name" : "smallpox ; DOID:8736",
    "link" : "http://purl.obolibrary.org/obo/DOID_8736",
    "description" : "A viral infectious disease that results in infection located in skin, has_material_basis_in Variola virus, which is transmitted by droplets from oral, nasal or pharyngeal mucosa, transmitted by contact with the body fluids, or transmitted by fomites. The infection results in formation of lesions, first on the face, hands and forearms and later on the trunk.",
    "id" : ""
  }, {
    "name" : "Solid Neoplasm ; NCIT:C9292",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C9292",
    "description" : "A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.",
    "id" : ""
  }, {
    "name" : "Solid Organ Transplant Recipient ; NCIT:C130200",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C130200",
    "description" : "An individual who is receiving a transplant of a solid organ.",
    "id" : ""
  }, {
    "name" : "specific developmental disorder ; DOID:0060038",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060038",
    "description" : "A developmental disorder of mental health that categorizes specific learning disabilities and developmental disorders affecting coordination.",
    "id" : ""
  }, {
    "name" : "spinal muscular atrophy ; DOID:12377",
    "link" : "http://purl.obolibrary.org/obo/DOID_12377",
    "description" : "A motor neuron disease that is a degenerative neuromuscular disease characterized by lower motor neuron degeneration associated with progressive muscle weakness and atrophy.",
    "id" : "HP:0007269"
  }, {
    "name" : "spontaneous abortion ; SYMP:0000199",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000199",
    "description" : "Spontaneous abortion is a abortion characterized by the naturally occurring expulsion of a nonviable fetus.",
    "id" : ""
  }, {
    "name" : "Spontaneous Preterm Birth ; NCIT:C112864",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C112864",
    "description" : "Preterm birth from 20 weeks to 36 weeks, 6 days of gestation associated with one of the following: classic preterm labor or preterm premature rupture of membranes.",
    "id" : ""
  }, {
    "name" : "Staphylococcus Aureus Infection ; NCIT:C122576",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122576",
    "description" : "An infectious process in which the bacteria Staphylococcus aureus is present.",
    "id" : "HP:0020072"
  }, {
    "name" : "Stevens-Johnson syndrome ; DOID:0050426",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050426",
    "description" : "A skin disease that is characterized by ulceration of less than 10 percent of the surface area of the body. The disease is often precipitated by the use of medications, such as antibiotics or antiepileptics, or onset of infection.",
    "id" : ""
  }, {
    "name" : "stillbirth ; SYMP:0000849",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000849",
    "description" : "Stillbirth is a reproductive system symptom characterized by the birth of a dead fetus, occurs when a fetus which has died in the uterus or during labor or delivery exits a woman's body.",
    "id" : ""
  }, {
    "name" : "Streptococcal Pharyngitis ; NCIT:C116003",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C116003",
    "description" : "Inflammation of the throat due to Streptococcus pyogenes.",
    "id" : "HP:0020096"
  }, {
    "name" : "Streptococcus pneumonia ; DOID:0040084",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040084",
    "description" : "A bacterial pneumonia has_material_basis_in Streptococcus pneumoniae.",
    "id" : ""
  }, {
    "name" : "substance abuse ; DOID:302",
    "link" : "http://purl.obolibrary.org/obo/DOID_302",
    "description" : "A substance-related disorder that involves a maladaptive pattern of substance use leading to significant impairment in functioning.",
    "id" : ""
  }, {
    "name" : "substance-related disorder ; DOID:303",
    "link" : "http://purl.obolibrary.org/obo/DOID_303",
    "description" : "A disease of mental health involving the abuse or dependence on a substance that is ingested in order to produce a high, alter one's senses, or otherwise affect functioning. (UMLS CUI:C0038586)",
    "id" : ""
  }, {
    "name" : "Sweet syndrome ; DOID:0080746",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080746",
    "description" : "A skin disease that is characterized by sudden onset of well defined tender plaques or nodules accompanied by fever, arthralgias, ocular inflammation, headaches and, rarely, oral or genital lesions.",
    "id" : ""
  }, {
    "name" : "swine influenza ; DOID:0050211",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050211",
    "description" : "An influenza that results_in infection located_in respiratory tract of pigs and humans, has_material_basis_in Influenza C virus, or has_material_basis_in Influenza A virus subtypes (H1N1, H1N2, H3N1, H3N2, and H2N3), which are transmitted_by direct contact with infected pigs. The infection in humans has_symptom fever, has_symptom lethargy, has_symptom lack of appetite, has_symptom coughing, has_symptom runny nose, has_symptom sore throat, has_symptom nausea, has_symptom vomiting, and has_symptom diarrhea.",
    "id" : ""
  }, {
    "name" : "systemic lupus erythematosus ; DOID:9074",
    "link" : "http://purl.obolibrary.org/obo/DOID_9074",
    "description" : "A lupus erythematosus that is an inflammation of connective tissue marked by skin rashes, joint pain and swelling, inflammation of the kidneys and inflammation of the tissue surrounding the heart.",
    "id" : "HP:0002725"
  }, {
    "name" : "systemic scleroderma ; DOID:418",
    "link" : "http://purl.obolibrary.org/obo/DOID_418",
    "description" : "A scleroderma that is characterized by fibrosis (or hardening) of the skin and major organs, as well as vascular alterations, and autoantibodies.",
    "id" : "HP:0100324"
  }, {
    "name" : "tetanus ; DOID:11338",
    "link" : "http://purl.obolibrary.org/obo/DOID_11338",
    "description" : "A primary bacterial infectious disease that results in prolonged contraction of skeletal muscle fibers, has_material_basis_in Clostridium tetani, which produces tetanospasmin, a neurotoxin, which is carried to the brain and spinal cord, where it binds irreversibly to receptors inhibiting neurotransmission. Damaged upper motor neurons cannot control reflex responses to afferent sensory stimuli.",
    "id" : ""
  }, {
    "name" : "tonsillitis ; DOID:10456",
    "link" : "http://purl.obolibrary.org/obo/DOID_10456",
    "description" : "An upper respiratory tract disease which is characterized by inflammation of the tonsils resulting from bacterial (Group A streptococcus) and viral (Epstein-Barr virus, adenovirus) infections. Symptoms include a severe sore throat, painful or difficult swallowing, coughing, headache, myalgia, fever and chills.",
    "id" : "HP:0011110"
  }, {
    "name" : "TORCH syndrome ; DOID:0080835",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080835",
    "description" : "A syndrome that is characterized by congenital infection with toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and other organisms.",
    "id" : ""
  }, {
    "name" : "transverse myelitis ; DOID:0080743",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080743",
    "description" : "A myelitis that is characterized by a band-like sensation across the trunk of the body, with sensory changes below.",
    "id" : ""
  }, {
    "name" : "tuberculosis ; DOID:399",
    "link" : "http://purl.obolibrary.org/obo/DOID_399",
    "description" : "A primary bacterial infectious disease that is located_in lungs, located_in lymph nodes, located_in pericardium, located_in brain, located_in pleura or located_in gastrointestinal tract, has_material_basis_in Mycobacterium tuberculosis, which is transmitted_by droplets released into the air when an infected person coughs or sneezes.",
    "id" : ""
  }, {
    "name" : "tularemia ; DOID:2123",
    "link" : "http://purl.obolibrary.org/obo/DOID_2123",
    "description" : "A primary bacterial infectious disease that has_material_basis_in Francisella tularensis, which is transmitted by dog tick bite (Dermacentor variabilis), transmitted by deer flies (Chrysops sp) or transmitted by contact with infected animal tissues.",
    "id" : ""
  }, {
    "name" : "type 1 diabetes mellitus ; DOID:9744",
    "link" : "http://purl.obolibrary.org/obo/DOID_9744",
    "description" : "A diabetes mellitus that is characterized by destruction of pancreatic beta cells resulting in absent or extremely low insulin production.",
    "id" : "HP:0100651"
  }, {
    "name" : "type 2 diabetes mellitus ; DOID:9352",
    "link" : "http://purl.obolibrary.org/obo/DOID_9352",
    "description" : "A diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin.",
    "id" : "HP:0005978"
  }, {
    "name" : "typhoid fever ; DOID:13258",
    "link" : "http://purl.obolibrary.org/obo/DOID_13258",
    "description" : "A primary bacterial infectious disease that is a communicable systemic illness, has_material_basis_in Salmonella enterica subsp enterica serovar Typhi, which is transmitted_by ingestion of food or water contaminated with the feces of an infected person. The infection has_symptom fever, has_symptom diarrhea, has_symptom prostration, has_symptom headache, has_symptom splenomegaly, has_symptom liver enlargement, has_symptom eruption of rose-colored spots, and has_symptom leukopenia.",
    "id" : ""
  }, {
    "name" : "ulcerative colitis ; DOID:8577",
    "link" : "http://purl.obolibrary.org/obo/DOID_8577",
    "description" : "A colitis that is predominantly confined to the mucosa located_in colon and includes characteristic ulcers, or open sores.",
    "id" : "HP:0100279"
  }, {
    "name" : "upper respiratory tract disease ; DOID:974",
    "link" : "http://purl.obolibrary.org/obo/DOID_974",
    "description" : "A respiratory system disease which involves the upper respiratory tract.",
    "id" : ""
  }, {
    "name" : "urinary tract obstruction ; DOID:5200",
    "link" : "http://purl.obolibrary.org/obo/DOID_5200",
    "description" : "Urinary tract obstruction is a blockage that inhibits the flow of urine through its normal path (the urinary tract), including the kidneys, ureters, bladder, and urethra. Blockage can be complete or partial. Blockage can lead to kidney damage, kidney stones, and infection.",
    "id" : ""
  }, {
    "name" : "uveitis ; DOID:13141",
    "link" : "http://purl.obolibrary.org/obo/DOID_13141",
    "description" : "An uveal disease is characterized by inflammation of any of the layers of the uvea of the eye, which includes the iris, ciliary body, and choroid.",
    "id" : "HP:0000554"
  }, {
    "name" : "vasculitis ; DOID:865",
    "link" : "http://purl.obolibrary.org/obo/DOID_865",
    "description" : "A vascular disease that is characterized by inflammation of the blood vessels.",
    "id" : "HP:0002633"
  }, {
    "name" : "Viral Respiratory Tract Infection ; NCIT:C27219",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C27219",
    "description" : "A respiratory tract infection caused by a virus.  Viruses represent the most common causes of upper and lower respiratory tract infections and include rhinoviruses, influenza viruses, parainfluenza viruses, and respiratory syncytial virus.",
    "id" : ""
  }, {
    "name" : "viral tropism ; NA",
    "link" : "https://www.dictionary.com/browse/viral-tropism",
    "description" : "The specificity of a virus for a particular host tissue, determined in part by the interaction of viral surface structures with receptors present on the surface of the host cell.",
    "id" : ""
  }, {
    "name" : "vitiligo ; DOID:12306",
    "link" : "http://purl.obolibrary.org/obo/DOID_12306",
    "description" : "An autoimmune disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes.",
    "id" : "HP:0001045"
  }, {
    "name" : "Water-Electrolyte Imbalance ; OMIT:0015710",
    "link" : "http://purl.obolibrary.org/obo/OMIT_0015710",
    "description" : "Water-Electrolyte Imbalance",
    "id" : ""
  }, {
    "name" : "weight loss ; SYMP:0000178",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000178",
    "description" : "weight loss",
    "id" : ""
  }, {
    "name" : "West Nile encephalitis ; DOID:2365",
    "link" : "http://purl.obolibrary.org/obo/DOID_2365",
    "description" : "A viral infectious disease that results in inflammation located in brain, has_material_basis_in West Nile virus, which is transmitted_by Culex, transmitted by Aedes, and transmitted_by Anopheles species of mosquitoes. The infection has_symptom high fever, has_symptom headache, has_symptom neck stiffness, has_symptom stupor, has_symptom disorientation, has_symptom coma, has_symptom tremors, has_symptom convulsions, has_symptom muscle weakness, has_symptom vision loss, has_symptom numbness, and has_symptom paralysis.",
    "id" : ""
  }, {
    "name" : "West Nile fever ; DOID:2366",
    "link" : "http://purl.obolibrary.org/obo/DOID_2366",
    "description" : "A viral infectious disease that results_in infection, has_material_basis_in West Nile virus, which is transmitted_by Culex and transmitted_by Aedes mosquitoes. The infection has_symptom fever, has_symptom sore throat, has_symptom headache, has_symptom body ache, has_symptom nausea, has_symptom maculopapular rash and has_symptom vomiting.",
    "id" : ""
  }, {
    "name" : "X-linked agammaglobulinemia ; NCIT_C3822",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3822",
    "description" : "An immunodeficiency state characterized (usually) by profoundly low concentrations of serum immunoglobulins of all classes, although occasionally significant amounts of one or more isotypes can be found. The fundamental defect in XLA affects early lineage B cells",
    "id" : ""
  }, {
    "name" : "yellow fever ; DOID:9682",
    "link" : "http://purl.obolibrary.org/obo/DOID_9682",
    "description" : "A viral infectious disease that results in infection, has_material_basis_in Yellow fever virus, which is transmitted by Aedes, transmitted by Haemagogus, or transmitted by Sabethes species of mosquitoes. The infection has symptom fever, has symptom muscle pain, has symptom backache, has symptom headache, has symptom shivers, has symptom loss of appetite, has symptom jaundice, and has symptom bleeding from the mouth, nose, eyes or stomach leading to vomitus containing blood.",
    "id" : ""
  }, {
    "name" : "Zika fever ; DOID:0060478",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060478",
    "description" : "A viral infectious disease that has_material_basis in Zika virus, which is transmitted_by Aedes aegypti mosquitoes and targets neural progenitor cells and  neuronal cells in all stages of maturity and has_symptom fever, has_symptom rash, has_symptom headaches and has_symptom joint pain.",
    "id" : ""
  } ]
}, {
  "name" : "lk_disease_condition",
  "rows" : [ {
    "name" : "condition_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "acquired immunodeficiency syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_635",
    "description" : "A Human immunodeficiency virus infectious disease that results_in reduction in the numbers of CD4-bearing helper T cells below 200 per microliter of blood or 14% of all lymphocytes thereby rendering the subject highly vulnerable to life-threatening infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted_by sexual contact, transmitted_by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted_by congenital method, and transmitted_by contaminated needles. Opportunistic infections are common in people with AIDS.",
    "id" : ""
  }, {
    "name" : "acute disseminated encephalomyelitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_639",
    "description" : "An encephalomyelitis characterized by inflammation located in brain and located in spinal cord that damages myelin. It usually occurs after viral infection, but also following vaccination, bacterial or parasitic infection.",
    "id" : ""
  }, {
    "name" : "Acute Respiratory Distress Syndrome",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3353",
    "description" : "Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.",
    "id" : ""
  }, {
    "name" : "Addison's disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_13774",
    "description" : "An adrenal cortical hypofunction that is characterized by insufficient steroid hormone production by the adrenal glands.",
    "id" : "HP:0008207"
  }, {
    "name" : "Aging",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C16269",
    "description" : "The process of change in the structure and function of an organism that occurs with the passage of time.",
    "id" : ""
  }, {
    "name" : "alcohol dependence",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050741",
    "description" : "A substance dependence that is characterized by tolerance, withdrawal symptoms, increasing use, persistent desire to decrease consumption, time spent obtaining or recovering from alcohol caused by a physical and psychological dependence on alcohol. (UMLS CUI:C0001973)",
    "id" : ""
  }, {
    "name" : "alcohol use disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_1574",
    "description" : "A substance abuse that involves the recurring use of alcoholic beverages despite negative consequences.",
    "id" : ""
  }, {
    "name" : "allergic hypersensitivity disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_1205",
    "description" : "An immune system disease that is an exaggerated immune response to allergens, such as insect venom, dust mites, pollen, pet dander, drugs or some foods.",
    "id" : "HP:0012393"
  }, {
    "name" : "allergic rhinitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_4481",
    "description" : "A rhinitis that is an allergic inflammation and irritation of the nasal airways involving sneezing, runny nose, nasal congestion, itching and tearing of the eyes caused by exposure to an allergen such as pollen, dust, mold, animal dander and droppings of cockroaches or house dust mites.",
    "id" : "HP:0003193"
  }, {
    "name" : "alopecia areata",
    "link" : "http://purl.obolibrary.org/obo/DOID_986",
    "description" : "An autoimmune disease resulting in the loss of hair on the scalp and elsewhere on the body initially causing bald spots.",
    "id" : "HP:0002232"
  }, {
    "name" : "Alzheimer's disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_10652",
    "description" : "A tauopathy that is characterized by memory lapses, confusion, emotional instability and progressive loss of mental ability and results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood starting and leads in advanced cases to a profound decline in cognitive and physical functioning and is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid.",
    "id" : "HP:0002511"
  }, {
    "name" : "anemia",
    "link" : "http://purl.obolibrary.org/obo/DOID_2355",
    "description" : "A hematopoietic system disease that is characterized by a decrease in the normal number of red blood cells.",
    "id" : "HP:0001903"
  }, {
    "name" : "Angina",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C51221",
    "description" : "Paroxysms of chest pain due to reduced oxygen to the heart. (UMLS CUI:C0002962)",
    "id" : ""
  }, {
    "name" : "anthrax disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_7427",
    "description" : "A primary bacterial infectious disease that results_in infection located_in skin, located_in lung lymph nodes or located_in gastrointestinal tract, has_material_basis_in Bacillus anthracis, transmitted_by contact with infected animals or animal products, transmitted_by airborne spores or transmitted_by ingestion of undercooked meat from infected animals and has_symptom skin ulcer, has_symptom nausea, has_symptom poor appetite, has_symptom bloody diarrhea, has_symptom fever or has_symptom shortness of breath.",
    "id" : ""
  }, {
    "name" : "antiphospholipid syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_2988",
    "description" : "An autoimmune disease that is characterized by recurrent venous or arterial thrombosis and/or fetal losses associated with characteristic elevated levels of antibodies directed against membrane anionic phospholipids (anticardiolipin).",
    "id" : ""
  }, {
    "name" : "antisynthetase syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080744",
    "description" : "An autoimmune disease that is characterized by myositis, arthralgia, Raynaud phenomenon, mechanic hands, interstitial lung disease, and serum autoantibodies to aminoacyl transfer RNA synthetases.",
    "id" : ""
  }, {
    "name" : "anxiety disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_2030",
    "description" : "A cognitive disorder that involves an excessive, irrational dread of everyday situations.",
    "id" : ""
  }, {
    "name" : "arrhythmia",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000287",
    "description" : "Arrhythmia is a cardiovascular system symptom consisting of an alteration in rhythm of the heartbeat either in time or force.",
    "id" : ""
  }, {
    "name" : "aspiration pneumonia",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050152",
    "description" : "A bacterial pneumonia which is an acute pulmonary inflammatory response that develops after the inhalation of colonized oropharyngeal material containing bacteria. It is seen in individuals with dysphagia and gastric dysmotility. The disease has_symptom tachypnea and has_symptom cough. (UMLS CUI:C0032290)",
    "id" : ""
  }, {
    "name" : "asthma",
    "link" : "http://purl.obolibrary.org/obo/DOID_2841",
    "description" : "A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors. The disease has_symptom recurring periods of wheezing (a whistling sound while breathing), has_symptom chest tightness, has_symptom shortness of breath, has_symptom mucus production and has_symptom coughing.",
    "id" : "HP:0002099"
  }, {
    "name" : "atopic dermatitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_3310",
    "description" : "An allergic contact dermatitis that is a chronically relapsing inflammatory allergic response located_in the skin that causes itching and flaking.",
    "id" : "HP:0001047"
  }, {
    "name" : "atrial fibrillation",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060224",
    "description" : "A heart conduction disease that is characterized by uncoordinated electrical activity in the heart's upper chambers (the atria), which causes the heartbeat to become fast and irregular and has symptoms palpitations, weakness, fatigue, lightheadedness, dizziness, confusion, shortness of breath and chest pain. (UMLS CUI:C0004238)",
    "id" : ""
  }, {
    "name" : "autoimmune cardiomyopathy",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040095",
    "description" : "An autoimmune disease of cardiovascular system that is characterized by deterioration of the function of the heart muscle.",
    "id" : ""
  }, {
    "name" : "autoimmune cholangitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080742",
    "description" : "An autoimmune hepatitis that is characterized by primary biliary cirrhosis clinical, biochemical, and histologic characteristics with antinuclear antibody positive sera.",
    "id" : ""
  }, {
    "name" : "autoimmune disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_417",
    "description" : "An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.",
    "id" : ""
  }, {
    "name" : "autoimmune disease of endocrine system",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060005",
    "description" : "An autoimmune disease that is the abnormal functioning of the immune system resulting in production of antibodies or T cells against cells and/or tissues in the endocrine system.",
    "id" : ""
  }, {
    "name" : "autoimmune disease of musculoskeletal system",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060032",
    "description" : "An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the musculoskeletal system.",
    "id" : ""
  }, {
    "name" : "autoimmune glomerulonephritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040094",
    "description" : "An autoimmune disease of urogenital tract that is located_in the renal glomerulus.",
    "id" : ""
  }, {
    "name" : "autoimmune hemolytic anemia",
    "link" : "http://purl.obolibrary.org/obo/DOID_718",
    "description" : "An autoimmune disease of blood that is characterized by deficient red blood cells caused by auto-antibodies.",
    "id" : "HP:0001890"
  }, {
    "name" : "autoimmune hepatitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2048",
    "description" : "An autoimmune disease of gastrointestinal tract that results_in inflammation located_in liver caused by the body's immune system attacking the liver cells.",
    "id" : ""
  }, {
    "name" : "autoimmune peripheral neuropathy",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040087",
    "description" : "An autoimmune disease of peripheral nervous system that results in peripheral neuropathy.",
    "id" : ""
  }, {
    "name" : "autoimmune thrombocytopenic purpura",
    "link" : "http://purl.obolibrary.org/obo/DOID_8924",
    "description" : "A primary thrombocytopenia that involves relatively few platelets in blood as a result of autoantibodies.",
    "id" : "HP:0001973"
  }, {
    "name" : "avian influenza",
    "link" : "http://purl.obolibrary.org/obo/DOID_4492",
    "description" : "An influenza that results in infection located in respiratory tract of humans, domestic and wild birds, has_material_basis_in Influenza A virus, which is transmitted by contact with infected poultry. Five strains of avian influenza A viruses (H5N1, H7N3, H7N2, H7N7 and H9N2) are known to cause human infections. The infection has_symptom fever, has_symptom cough, has_symptom sore throat, has_symptom muscle aches, has_symptom nausea, has_symptom diarrhea, has_symptom vomiting, has_symptom neurologic changes, has_symptom pneumonia, and has_symptom acute respiratory distress.",
    "id" : ""
  }, {
    "name" : "Bariatric Surgery",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84399",
    "description" : "Surgery performed in morbidly obese patients to help promote weight loss. The procedure aims at the reduction of the stomach size and it is usually achieved either with the implantation of a medical device or the removal of part of the stomach.",
    "id" : ""
  }, {
    "name" : "Bilateral pleural effusion (disorder)",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/425802001",
    "description" : "Bilateral pleural effusion (disorder) (UMLS CUI:C0747635)",
    "id" : ""
  }, {
    "name" : "biliary atresia",
    "link" : "http://purl.obolibrary.org/obo/DOID_13608",
    "description" : "A cholestasis characterized by blockage of the ducts that carry bile from the liver to the gallbladder.",
    "id" : "HP:0005912"
  }, {
    "name" : "blood coagulation disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_1247",
    "description" : "A hematopoietic system disease that is characterized by abnormal blood clotting or bleeding.",
    "id" : "HP:0001928"
  }, {
    "name" : "Blood Transfusion",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15192",
    "description" : "The injection of whole blood or a blood component directly into the bloodstream.",
    "id" : ""
  }, {
    "name" : "bone development disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080006",
    "description" : "A bone disease that results_in abnormal growth and development located_in bone or located_in cartilage.",
    "id" : ""
  }, {
    "name" : "bone disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080001",
    "description" : "A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function.",
    "id" : ""
  }, {
    "name" : "brain glioblastoma multiforme",
    "link" : "http://purl.obolibrary.org/obo/DOID_3073",
    "description" : "A brain glioma that has_material_basis_in abnormally proliferating cells derives_from glial cells, has_symptom seizure, headaches, nausea and vomiting, memory loss, changes to personality, mood or concentration; and localized neurological problems.",
    "id" : ""
  }, {
    "name" : "brain glioma",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060108",
    "description" : "A brain cancer that has_material_basis_in glial cells.",
    "id" : ""
  }, {
    "name" : "breast cancer",
    "link" : "http://purl.obolibrary.org/obo/DOID_1612",
    "description" : "A thoracic cancer that originates in the mammary gland.",
    "id" : "HP:0003002"
  }, {
    "name" : "bronchiectasis",
    "link" : "http://purl.obolibrary.org/obo/DOID_9563",
    "description" : "A bronchial disease that is a chronic inflammatory condition of one or more bronchi or bronchioles marked by dilatation and loss of elasticity of the walls resulting from damage to the airway wall leading to the formation of small sacs on the bronchial wall and impairment of cilia mobility in the lung. Inflammation of the bronchial wall increases mucus secretion which serves as a breeding ground for bacteria. Bronchiectasis is caused by repeated respiratory infections, immune deficiency disorders, hereditary disorders (cystic fibrosis or primary ciliary dyskinesia), mechanical factors (inhaled object or a lung tumor) or inhaling toxic substances. (UMLS CUI:C0006267)",
    "id" : ""
  }, {
    "name" : "bronchiolitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2942",
    "description" : "A lung disease that is an inflammation of the bronchioles, the smallest air passages of the lungs. It is caused by viruses and bacteria. The disease has_symptom cough, has_symptom wheezing, has_symptom shortness of breath, has_symptom fever, has_symptom nasal flaring in infants and has_symptom bluish skin due to lack of oxygen.",
    "id" : "HP:0011950"
  }, {
    "name" : "bronchitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_6132",
    "description" : "A bronchial disease that is an inflammation of the bronchial tubes. It is caused by bacteria and viruses. The disease has_symptom cough with mucus, has_symptom shortness of breath, has_symptom low fever and has_symptom chest tightness.",
    "id" : "HP:0012387"
  }, {
    "name" : "Bronchopulmonary Dysplasia",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C90599",
    "description" : "Chronic lung disease requiring treatment with oxygen for at least 28 days and with a spectrum of severity from mild to severe, that predominantly affects premature infants. While the radiologic pattern is typical in the closer to term patient, the pattern in the small preterm infant is very non-discrete and variable.",
    "id" : ""
  }, {
    "name" : "bullous skin disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_8502",
    "description" : "A dermatitis that is characterized by blisters filled with a watery fluid, located_in skin. The disease is associated with the amount of gluten ingested.",
    "id" : ""
  }, {
    "name" : "cancer",
    "link" : "http://purl.obolibrary.org/obo/DOID_162",
    "description" : "A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis.",
    "id" : "HP:0002664"
  }, {
    "name" : "cardiac arrest",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060319",
    "description" : "A congestive heart failure characterized by a sudden stop in effective blood circulation due to the failure of the heart to contract effectively or at all.",
    "id" : "HP:0001695"
  }, {
    "name" : "cardiomyopathy",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050700",
    "description" : "A heart disease and a myopathy that is characterized by deterioration of the function of the heart muscle.",
    "id" : "HP:0001638"
  }, {
    "name" : "cardiovascular system disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_1287",
    "description" : "A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.",
    "id" : "HP:0001626"
  }, {
    "name" : "celiac disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_10608",
    "description" : "An autoimmune disease of gastrointestinal tract that is caused by a reaction located_in small intestine to gliadin, a prolamin (gluten protein) found in wheat, and similar proteins found in the crops of the tribe Triticeae. The disease is associated with HLA-DQ gene. It has_symptom abdominal pain, has_symptom constipation, has_symptom diarrhea, has_symptom nausea and vomiting, and has_symptom loss of appetite.",
    "id" : "HP:0002608"
  }, {
    "name" : "Cephalohematoma",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C50484",
    "description" : "A subperiosteal hemorrhage limited to the surface of one cranial bone, a usually benign condition seen in the newborn as a result of bone trauma.",
    "id" : ""
  }, {
    "name" : "cerebral palsy",
    "link" : "http://purl.obolibrary.org/obo/DOID_1969",
    "description" : "A brain disease that is caused by damage to the motor control centers of the developing brain during pregnancy, during childbirth or after birth, which affects muscle movement and balance.",
    "id" : "HP:0100021"
  }, {
    "name" : "cerebrovascular disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_6713",
    "description" : "An vascular disease that is characterized by dysfunction of the blood vessels supplying the brain.",
    "id" : ""
  }, {
    "name" : "chickenpox",
    "link" : "http://purl.obolibrary.org/obo/DOID_8659",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Human herpesvirus 3, which is transmitted_by direct contact with secretions from the rash, or transmitted_by droplet spread of respiratory secretions. The infection has_symptom anorexia, has_symptom myalgia, has_symptom nausea, has_symptom fever, has_symptom headache, has_symptom sore throat, and has_symptom blisters.",
    "id" : ""
  }, {
    "name" : "chikungunya",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050012",
    "description" : "A viral infectious disease that results_in infection located_in joint, has_material_basis_in Chikungunya virus, which is transmitted_by Aedes mosquito bite. The infection has_symptom fever, has_symptom arthralgia, and has_symptom maculopapular rash.",
    "id" : ""
  }, {
    "name" : "childhood type dermatomyositis",
    "link" : "http://purl.obolibrary.org/obo/DOID_14203",
    "description" : "childhood type dermatomyositis",
    "id" : ""
  }, {
    "name" : "chlamydia",
    "link" : "https://disease-ontology.org/?id=DOID:11263",
    "description" : "A commensal bacterial infectious disease that is caused by Chlamydia trachomatis.",
    "id" : ""
  }, {
    "name" : "choledochal cyst",
    "link" : "http://purl.obolibrary.org/obo/DOID_899",
    "description" : "choledochal cyst",
    "id" : "HP:0100890"
  }, {
    "name" : "cholera",
    "link" : "http://purl.obolibrary.org/obo/DOID_1498",
    "description" : "A primary bacterial infectious disease that is described as an acute, diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae, which is characterized by profuse watery diarrhea, vomiting, leg cramps, circulatory collapse and shock.",
    "id" : ""
  }, {
    "name" : "chorioamnionitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050697",
    "description" : "A placenta disease that is an inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection.",
    "id" : ""
  }, {
    "name" : "chromosomal disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080014",
    "description" : "A genetic disease that has_material_basis_in extra, missing, or re-arranged chromosomes.",
    "id" : ""
  }, {
    "name" : "chronic disease course",
    "link" : "http://purl.obolibrary.org/obo/OGMS_0000064",
    "description" : "A disease course that (a) does not terminate in a return to normal homeostasis and (b) would, absent intervention, fall within abnormal homeostatic range.",
    "id" : ""
  }, {
    "name" : "Chronic Fatigue Syndrome",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3037",
    "description" : "A syndrome of unknown etiology. Chronic fatigue syndrome (CFS) is a clinical diagnosis characterized by an unexplained persistent or relapsing chronic fatigue that is of at least six months' duration, is not the result of ongoing exertion, is not substantially alleviated by rest, and results in substantial reduction of previous levels of occupational, educational, social, or personal activities. Common concurrent symptoms of at least six months duration include impairment of memory or concentration, diffuse pain, sore throat, tender lymph nodes, headaches of a new type, pattern, or severity, and nonrestorative sleep. The etiology of CFS may be viral or immunologic. Neurasthenia and fibromyalgia may represent related disorders. Also known as myalgic encephalomyelitis.",
    "id" : ""
  }, {
    "name" : "chronic kidney disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_784",
    "description" : "A kidney failure that is characterized by the gradual loss of kidney function. (UMLS CUI:C1561643)",
    "id" : ""
  }, {
    "name" : "Chronic Liver Disease",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C113609",
    "description" : "Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests. (UMLS CUI:C0341439)",
    "id" : ""
  }, {
    "name" : "chronic obstructive pulmonary disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_3083",
    "description" : "An obstructive lung disease that is characterized by irreversible airflow obstruction due to chronic bronchitis, emphysema, and/or small airways disease.",
    "id" : "HP:0006510"
  }, {
    "name" : "chronic plaque psoriasis",
    "link" : "https://dermnetnz.org/topics/chronic-plaque-psoriasis/",
    "description" : "Chronic plaque psoriasis is the most common presentation of psoriasis. It presents as small to large, well-demarcated, red, scaly and thickened areas of skin. It most likely to affect elbows, knees, and lower back but may arise on any part of the body.",
    "id" : "HP:0003765"
  }, {
    "name" : "Chronic Sinusitis",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C35151",
    "description" : "Inflammation of the paranasal sinuses that typically lasts beyond eight weeks. It is caused by infections, allergies, and the presence of sinus polyps or deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizziness, and breathing difficulties. (UMLS CUI:C0149516)",
    "id" : ""
  }, {
    "name" : "chronic spontaneous urticaria",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080749",
    "description" : "A chronic urticaria that is characterized by urticaria independent of any exogenous stimulus.",
    "id" : ""
  }, {
    "name" : "cirrhosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_5082",
    "description" : "liver cirrhosis",
    "id" : ""
  }, {
    "name" : "clinically isolated syndrome",
    "link" : "https://www.nationalmssociety.org/Symptoms-Diagnosis/Clinically-Isolated-Syndrome-(CIS)",
    "description" : "Clinically isolated syndrome (CIS) is one of the MS disease courses. CIS refers to a first episode of neurologic symptoms that lasts at least 24 hours and is caused by inflammation or demyelination (loss of the myelin that covers the nerve cells) in the central nervous system (CNS).",
    "id" : ""
  }, {
    "name" : "Clostridium difficile colitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060185",
    "description" : "A colitis characterized by an overgrowth of Clostridium difficile bacteria.",
    "id" : ""
  }, {
    "name" : "colitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060180",
    "description" : "An inflammatory bowel disease that involves inflammation located_in colon.",
    "id" : "HP:0002583"
  }, {
    "name" : "colorectal cancer",
    "link" : "http://purl.obolibrary.org/obo/DOID_9256",
    "description" : "A large intestine cancer that is located_in the colon and/or located_in the rectum.",
    "id" : "HP:0100834"
  }, {
    "name" : "common variable immunodeficiency",
    "link" : "http://purl.obolibrary.org/obo/DOID_12177",
    "description" : "An agammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells.",
    "id" : ""
  }, {
    "name" : "congenital adrenal insufficiency",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050546",
    "description" : "An adrenal gland disease that is characterized by cortisol deficiency, hypoaldosteronism and excessive or insufficient sex hormones, has_material_basis_in the mutation in the gene for 21-hydroxylase, 11beta-hydroxylase, 3beta-hydroxysteroid, 17alpha-hydroxylase or 20,22-desmolase.",
    "id" : ""
  }, {
    "name" : "congenital heart disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_1682",
    "description" : "congenital heart disease",
    "id" : "HP:0001627"
  }, {
    "name" : "congenital syphilis",
    "link" : "http://purl.obolibrary.org/obo/DOID_9856",
    "description" : "A syphilis that results_in a multisystem infection in the fetus via the placenta.",
    "id" : ""
  }, {
    "name" : "congestive heart failure",
    "link" : "http://purl.obolibrary.org/obo/DOID_6000",
    "description" : "A heart disease that is characterized by any structural or functional cardiac disorder that impairs the ability of the heart to fill with or pump a sufficient amount of blood throughout the body.",
    "id" : "HP:0001635"
  }, {
    "name" : "conjunctivitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_6195",
    "description" : "A conjunctival disease characterized by an inflammation of the conjunctiva, the outermost layer of the eye and the inner surface of the eyelids.",
    "id" : "HP:0000509"
  }, {
    "name" : "connective tissue disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_65",
    "description" : "A musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage.",
    "id" : ""
  }, {
    "name" : "coronary artery disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_3393",
    "description" : "An artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles.",
    "id" : "HP:0001677"
  }, {
    "name" : "COVID-19",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080600",
    "description" : "A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.",
    "id" : ""
  }, {
    "name" : "COVID-19-Associated Acute Respiratory Distress Syndrome",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C171551",
    "description" : "Acute respiratory distress syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
    "id" : ""
  }, {
    "name" : "cranial nerve disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_5656",
    "description" : "A neuropathy that is located_in one of the twelve cranial nerves.",
    "id" : "HP:0006824"
  }, {
    "name" : "critical COVID-19",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/DOID_0081012;https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "id" : ""
  }, {
    "name" : "Crohn's disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_8778",
    "description" : "An intestinal disease that involves inflammation located_in intestine.",
    "id" : "HP:0100280"
  }, {
    "name" : "cutaneous lupus erythematosus",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050169",
    "description" : "A lupus erythematosus that causes skin lesions on parts of the body that are exposed to sunlight.",
    "id" : ""
  }, {
    "name" : "cystic fibrosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1485",
    "description" : "A syndrome that is characterized by the buildup of thick, sticky mucus that can damage many organs.",
    "id" : ""
  }, {
    "name" : "cystic kidney disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_2975",
    "description" : "Polycystic kidney disease (PKD) is an inherited disorder in which clusters of cysts develop primarily within your kidneys, causing your kidneys to enlarge and lose function over time. Cysts are noncancerous round sacs containing fluid. The cysts vary in size, and they can grow very large.",
    "id" : "HP:0000107"
  }, {
    "name" : "cystinosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1064",
    "description" : "A lysosomal storage disease characterized by the abnormal accumulation of cystine in the lysosomes. It follows an autosomal recessive inheritance pattern and that has_material_basis_in mutations in the CTNS gene, located on chromosome 17.",
    "id" : ""
  }, {
    "name" : "Cytogenetically Normal Acute Myeloid Leukemia",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122687",
    "description" : "Acute myeloid leukemia not associated with cytogenetic abnormalities.",
    "id" : "HP:0004808"
  }, {
    "name" : "Cytomegaloviral Infection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C53649",
    "description" : "A herpesvirus infection caused by Cytomegalovirus. Healthy individuals generally do not produce symptoms. However, the infection may be life-threatening in affected immunocompromised patients. The virus may cause retinitis, esophagitis, gastritis, and colitis. Morphologically, it is characterized by the presence of intranuclear inclusion bodies.",
    "id" : ""
  }, {
    "name" : "dementia",
    "link" : "http://purl.obolibrary.org/obo/DOID_1307",
    "description" : "A cognitive disorder resulting from a loss of brain function affecting memory, thinking, language, judgement and behavior.",
    "id" : ""
  }, {
    "name" : "Dementia with psychosis",
    "link" : "",
    "description" : "Dementia with psychosis (UMLS CUI:C0543884)",
    "id" : ""
  }, {
    "name" : "dengue disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_12205",
    "description" : "A viral infectious disease that results in infection, has_material_basis_in Dengue virus [NCBITaxon:12637] with four serotypes (Dengue virus 1, 2, 3 and 4), which are transmitted by Aedes mosquito bite. The infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding.",
    "id" : ""
  }, {
    "name" : "dengue hemorrhagic fever",
    "link" : "http://purl.obolibrary.org/obo/DOID_12206",
    "description" : "A dengue disease that occurs when a person experiences a second infection with a heterologous Dengue virus serotype, which is transmitted_by Aedes mosquito bite. The infection has_symptom hemorrhagic lesions of the skin, has_symptom thrombocytopenia, has_symptom reduction in the fluid part of the blood, and has_symptom high fever.",
    "id" : ""
  }, {
    "name" : "Dependence on peritoneal dialysis due to end stage renal disease",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/428937001",
    "description" : "Dependence on peritoneal dialysis due to end stage renal disease (UMLS CUI:C1997877)",
    "id" : ""
  }, {
    "name" : "dermatomyositis",
    "link" : "http://purl.obolibrary.org/obo/DOID_10223",
    "description" : "A myositis that results_in inflammation located_in muscle or located_in skin where a skin rash is often seen prior to the onset of muscle weakness. The disease may result from either a viral infection or an autoimmune reaction.",
    "id" : ""
  }, {
    "name" : "dermatophytosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_8913",
    "description" : "A cutaneous mycosis that results_in fungal infection located_in scalp, located_in glabrous skin, or located_in nail, has_material_basis_in Ascomycota fungi that belong to a group called dermatophytes, which have the ability to utilize keratin as a nutrient source.",
    "id" : ""
  }, {
    "name" : "developmental disorder of mental health",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060037",
    "description" : "A disease of mental health that occur during a child's developmental period between birth and age 18 resulting in retarding of the child's psychological or physical development.",
    "id" : ""
  }, {
    "name" : "diabetes mellitus",
    "link" : "http://purl.obolibrary.org/obo/DOID_9351",
    "description" : "A glucose metabolism disease characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both.",
    "id" : "HP:0000819"
  }, {
    "name" : "diphtheria",
    "link" : "http://purl.obolibrary.org/obo/DOID_11405",
    "description" : "A primary bacterial infectious disease that is characterized by sore throat, low fever, and an adherent membrane (a pseudomembrane) on the tonsils, pharynx, and/or nasal cavity. A milder form of diphtheria can be restricted to the skin. It is caused by Corynebacterium diphtheriae, an aerobic Gram-positive bacterium. Diphtheria toxin spreads through the bloodstream and can lead to potentially life-threatening complications that affect other organs of the body, such as the heart and kidneys.",
    "id" : ""
  }, {
    "name" : "disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_4",
    "description" : "A disease is a disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.",
    "id" : ""
  }, {
    "name" : "disease by infectious agent",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050117",
    "description" : "A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions.",
    "id" : ""
  }, {
    "name" : "disease of metabolism",
    "link" : "http://purl.obolibrary.org/obo/DOID_0014667",
    "description" : "A disease that involving errors in metabolic processes of building or degradation of molecules.",
    "id" : ""
  }, {
    "name" : "diverticulitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_7475",
    "description" : "An intestinal disease characterized by the formation and inflammation of diverticula within the bowel wall. (UMLS CUI:C0012813)",
    "id" : ""
  }, {
    "name" : "Dyspnea with Mild Physical Activity",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C191546",
    "description" : "Dyspnea experienced during minimal exertion.",
    "id" : ""
  }, {
    "name" : "Dyspnea with Moderate Physical Activity",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C191547",
    "description" : "Dyspnea experienced during moderate exertion.",
    "id" : ""
  }, {
    "name" : "Ebola hemorrhagic fever",
    "link" : "http://purl.obolibrary.org/obo/DOID_4325",
    "description" : "A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Zaire ebolavirus, has_material_basis_in Sudan ebolavirus, has_material_basis_in Cote d'Ivoire ebolavirus, or has_material_basis_in Bundibugyo ebolavirus, which are transmitted_by contact with the body fluids of an infected animal or person, transmitted by contaminated fomites, or transmitted by infected medical equipment. The infection has_symptom fever, has_symptom headache, has_symptom joint pain, has_symptom muscle aches, has_symptom sore throat, has_symptom weakness, has_symptom diarrhea, has_symptom vomiting, has_symptom stomach pain, has_symptom rash, has_symptom red eyes, has_symptom hiccups, and has_symptom internal and external bleeding.",
    "id" : ""
  }, {
    "name" : "EBV Infection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38759",
    "description" : "An infection that is caused by Epstein-Barr virus.",
    "id" : ""
  }, {
    "name" : "EBV-Related Post-Transplant Lymphoproliferative Disorder",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C27696",
    "description" : "A lymphoproliferative disorder that develops following organ transplantation and is associated with Epstein-Barr virus infection.",
    "id" : ""
  }, {
    "name" : "eczema herpeticum",
    "link" : "http://purl.obolibrary.org/obo/DOID_9123",
    "description" : "A herpes simplex that results_in infection located_in skin, effected by preexisting dermatosis, has_material_basis_in Human herpesvirus 1 or Human herpesvirus 2. The infection has_symptom watery blisters, has_symptom fever, and has_symptom swelling of the lymph nodes.",
    "id" : ""
  }, {
    "name" : "eczema vaccinatum",
    "link" : "https://www.medicinenet.com/script/main/art.asp?articlekey=21872",
    "description" : "Eczema vaccinatum: A common concern with smallpox vaccination involving the implantation of the vaccinia virus from the vaccination into the skin of a person with eczema (atopic dermatitis), sometimes with a fatal outcome. Disrupted skin permits viral implantation. Once the virus is implanted, it spreads from cell to cell producing extensive lesions. The skin lesions appear identical to a primary smallpox vaccination. Confluent lesions often cover the entire face, the crook of the elbow in the antecubital fossa, and behind the knee in the popliteal fossa. Viremia (viral spread through the bloodstream) may also occur allowing for the spread of virus to other parts of the body, including skin that is not affected by eczema. Bacterial and fungal invas",
    "id" : ""
  }, {
    "name" : "egg allergy",
    "link" : "http://purl.obolibrary.org/obo/DOID_4377",
    "description" : "A food allergy that is an allergy or hypersensitivity to dietary substances from the yolk or whites of eggs, causing an overreaction of the immune system which may lead to severe physical symptoms.",
    "id" : ""
  }, {
    "name" : "encephalitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_9588",
    "description" : "A brain disease that is characterized as an acute inflammation of the brain with flu-like symptoms.",
    "id" : "HP:0002383"
  }, {
    "name" : "end stage renal disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_783",
    "description" : "A chronic kidney disease is characterized by non-functioning kidneys, as the final stage in chronic kidney disease.",
    "id" : ""
  }, {
    "name" : "endocarditis",
    "link" : "http://purl.obolibrary.org/obo/DOID_10314",
    "description" : "A endocardium disease characterized by inflammation of the endocardium of the heart chambers and valves.",
    "id" : "HP:0100584"
  }, {
    "name" : "eosinophilic esophagitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_13922",
    "description" : "An esophagitis characterized by inflammation involving eosinophils located_in esophagus.",
    "id" : ""
  }, {
    "name" : "epidermolysis bullosa",
    "link" : "http://purl.obolibrary.org/obo/DOID_2730",
    "description" : "A vesiculobullous skin disease that is characterized by formation of blisters with only minor skin trauma, which can cause widespread wounds, dehydration, electrolyte abnormalities, and severe infection, frequently develops_from mutations in connective tissue elements, including genes encoding keratin, collagen, and laminin.",
    "id" : ""
  }, {
    "name" : "epilepsy",
    "link" : "http://purl.obolibrary.org/obo/DOID_1826",
    "description" : "A brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions.",
    "id" : "HP:0001250"
  }, {
    "name" : "Escherichia Coli Infection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C34594",
    "description" : "Infection with the organism Escherichia Coli.",
    "id" : "HP:0002740"
  }, {
    "name" : "esophageal atresia",
    "link" : "http://purl.obolibrary.org/obo/DOID_10485",
    "description" : "esophageal atresia",
    "id" : "HP:0002032"
  }, {
    "name" : "esophageal atresia/tracheoesophageal fistula",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080171",
    "description" : "A gastrointestinal system disease that is characterized by abnormal development of the esophagus and trachea where the upper esophagus does not connect (atresia) to the lower esophagus and stomach and may also include tracheoesophageal fistula where the esophagus and the trachea are abnormally connected which allows fluids from the esophagus to get into the airways and interfere with breathing.",
    "id" : ""
  }, {
    "name" : "Failure to Thrive",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C107587",
    "description" : "A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult. (UMLS CUI:C0015544)",
    "id" : ""
  }, {
    "name" : "Family Medical History",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17726",
    "description" : "A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.",
    "id" : ""
  }, {
    "name" : "fibromyalgia",
    "link" : "http://purl.obolibrary.org/obo/DOID_631",
    "description" : "fibromyalgia",
    "id" : ""
  }, {
    "name" : "focal segmental glomerulosclerosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1312",
    "description" : "Focal segmental glomerulosclerosis (FSGS) is a disease in which scar tissue develops on the parts of the kidneys that filter waste from the blood (glomeruli). FSGS can be caused by a variety of conditions.",
    "id" : "HP:0000097"
  }, {
    "name" : "food allergy",
    "link" : "http://purl.obolibrary.org/obo/DOID_3044",
    "description" : "A hypersensitivity reaction type I disease that is an abnormal response to a food, triggered by the body's immune system.",
    "id" : ""
  }, {
    "name" : "gastroesophageal reflux disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_8534",
    "description" : "gastroesophageal reflux disease",
    "id" : "HP:0002020"
  }, {
    "name" : "glioblastoma",
    "link" : "http://purl.obolibrary.org/obo/DOID_3068",
    "description" : "A malignant astrocytoma characterized by the presence of small areas of necrotizing tissue that is surrounded by anaplastic cells as well as the presence of hyperplastic blood vessels, and that has_material_basis_in abnormally proliferating cells derives_from multiple cell types including astrocytes and oligondroctyes.",
    "id" : "HP:0012174"
  }, {
    "name" : "Goodpasture syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_9808",
    "description" : "An autoimmune disease that is characterized by antibody attack of the basement membrane in lungs and kidneys, leading to bleeding from the lungs and kidney failure.",
    "id" : ""
  }, {
    "name" : "granulomatosis with polyangiitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_12132",
    "description" : "An autoimmune disease that is characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract, glomerulonephritis, vasculitis, and the presence of antineutrophil cytoplasmatic autoantibodies (ANCAs) in patient sera, and is located_in lung, located_in kidney, located_in skin resulting from an autoimmune attack by antineutrophil cytoplasmic antibodies against small and medium-size blood vessels.",
    "id" : ""
  }, {
    "name" : "Graves' disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_12361",
    "description" : "An autoimmune disease of endocrine system that involves production of excessive amount of thyroid hormones, located_in thyroid gland.",
    "id" : "HP:0100647"
  }, {
    "name" : "Guillain-Barre syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_12842",
    "description" : "An autoimmune disease of peripheral nervous system that causes body's immune system to attack part of the peripheral nervous system.",
    "id" : ""
  }, {
    "name" : "haemophilus meningitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080179",
    "description" : "A bacterial meningitis that has_material_basis_in Haemophilus influenzae infection.",
    "id" : ""
  }, {
    "name" : "healthy",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115935",
    "description" : "Having no significant health-related issues.",
    "id" : ""
  }, {
    "name" : "Heart Failure",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C50577",
    "description" : "Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction. (UMLS CUI:C0018801)",
    "id" : ""
  }, {
    "name" : "Heart Transplantation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15246",
    "description" : "A surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor.",
    "id" : ""
  }, {
    "name" : "Helicobacter Pylori Infection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C39293",
    "description" : "A bacterial infection of the stomach, caused by Helicobacter pylori.  It is associated with the development of peptic ulcer and mucosa-associated lymphoid tissue lymphoma.",
    "id" : "HP:0005202"
  }, {
    "name" : "hematologic cancer",
    "link" : "http://purl.obolibrary.org/obo/DOID_2531",
    "description" : "An organ system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes.",
    "id" : "HP:0004377"
  }, {
    "name" : "hematopoietic system disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_74",
    "description" : "A disease of anatomical entity that has_material_basis_in hematopoietic cells.",
    "id" : "HP:0001871"
  }, {
    "name" : "hemiplegia",
    "link" : "http://purl.obolibrary.org/obo/DOID_10969",
    "description" : "A central nervous system disease that is characterized by the complete paralysis of half of the body.",
    "id" : "HP:0002301"
  }, {
    "name" : "hemoglobinopathy",
    "link" : "http://purl.obolibrary.org/obo/DOID_2860",
    "description" : "hemoglobinopathy",
    "id" : ""
  }, {
    "name" : "hemolytic-uremic syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_12554",
    "description" : "A kidney disease that is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs.",
    "id" : "HP:0005575"
  }, {
    "name" : "hepatitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2237",
    "description" : "(UMLS CUI:C0267797)",
    "id" : ""
  }, {
    "name" : "hepatitis A",
    "link" : "http://purl.obolibrary.org/obo/DOID_12549",
    "description" : "A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis A virus, which is transmitted_by ingestion of contaminated food or water, or transmitted_by direct contact with an infected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",
    "id" : ""
  }, {
    "name" : "hepatitis B",
    "link" : "http://purl.obolibrary.org/obo/DOID_2043",
    "description" : "A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis B virus, which is transmitted_by sexual contact, transmitted_by blood transfusions, and transmitted_by fomites like needles or syringes. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",
    "id" : ""
  }, {
    "name" : "hepatitis C",
    "link" : "http://purl.obolibrary.org/obo/DOID_1883",
    "description" : "A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis C virus, which is transmitted_by blood from an infected person enters the body of an uninfected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",
    "id" : ""
  }, {
    "name" : "herpes zoster",
    "link" : "http://purl.obolibrary.org/obo/DOID_8536",
    "description" : "A viral infectious disease that results_in infection located_in nerve fiber, has_material_basis_in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted_by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has_symptom rash which is followed by blisters, has_symptom headache, has_symptom fever, has_symptom malaise, has_symptom itching, has_symptom burning pain, and has_symptom paresthesia.",
    "id" : ""
  }, {
    "name" : "human cytomegalovirus infection",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080827",
    "description" : "A viral infectious disease that has_material_basis_in Human betaherpesvirus 5.",
    "id" : ""
  }, {
    "name" : "human immunodeficiency virus infectious disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_526",
    "description" : "A viral infectious disease that results in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted by sexual contact, transmitted by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted by congenital method, and transmitted by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has symptom diarrhea, has symptom fatigue, has symptom fever, has symptom vaginal yeast infection, has symptom headache, has symptom mouth sores, has symptom muscle aches, has symptom sore throat, and has symptom swollen lymph glands.",
    "id" : ""
  }, {
    "name" : "hydronephrosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_11111",
    "description" : "hydronephrosis",
    "id" : "HP:0000126"
  }, {
    "name" : "hypertension",
    "link" : "http://purl.obolibrary.org/obo/DOID_10763",
    "description" : "An artery disease characterized by chronic elevated blood pressure in the arteries.",
    "id" : "HP:0000822"
  }, {
    "name" : "Hypertension not adequately controlled",
    "link" : "",
    "description" : "Hypertension not adequately controlled (UMLS CUI:C0857354)",
    "id" : ""
  }, {
    "name" : "hypoglycemia",
    "link" : "http://purl.obolibrary.org/obo/DOID_9993",
    "description" : "A glucose metabolism disease that is characterized by abnormally low levels of blood glucose.",
    "id" : "HP:0001943"
  }, {
    "name" : "Hyponatremia",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C37976",
    "description" : "Lower than normal levels of sodium in the circulating blood. (UMLS CUI:C0020625)",
    "id" : ""
  }, {
    "name" : "hypothyroidism",
    "link" : "http://purl.obolibrary.org/obo/DOID_1459",
    "description" : "A thyroid gland disease which involves an underproduction of thyroid hormone.",
    "id" : "HP:0000821"
  }, {
    "name" : "hysterectomy history",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002398",
    "description" : "A gynecologic surgery history in which a woman has had a hysterectomy.",
    "id" : ""
  }, {
    "name" : "ichthyosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1697",
    "description" : "A skin disease characterized by drying and scaling of skin with the accumulation of thick scales and cracks that may be painful or bleed.",
    "id" : "HP:0008064"
  }, {
    "name" : "idiopathic pulmonary fibrosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050156",
    "description" : "A pulmonary fibrosis that is characterized by scarring of the lung.",
    "id" : ""
  }, {
    "name" : "Immunocompromised",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C14139",
    "description" : "A loss of any arm of immune functions, resulting in potential or actual increase in infections. This state may be reached secondary to specific genetic lesions, syndromes with unidentified or polygenic causes, acquired deficits from other disease states, or as result of therapy for other diseases or conditions. (UMLS CUI:C2186379)",
    "id" : ""
  }, {
    "name" : "Immunologic Tolerance",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17712",
    "description" : "An innate tolerance that prevents the body from attacking native proteins and tissue.",
    "id" : ""
  }, {
    "name" : "Immunosuppressive Disorder",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C178942",
    "description" : "Immunosuppressive Disorder A disorder in which immune function is suppressed.",
    "id" : ""
  }, {
    "name" : "inflammatory bowel disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050589",
    "description" : "An intestinal disease characterized by inflammation located in all parts of digestive tract.",
    "id" : ""
  }, {
    "name" : "Inflammatory Disorder",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C93210",
    "description" : "An infectious or non infectious disorder characterized by signs and symptoms derived from focal or extensive tissue infiltration by acute (e.g., polymorphonuclear) or chronic (e.g., lymphocytic-plasmacytic) inflammatory cells. Representative examples of infectious disorders include viral infections, bacterial infections, and parasitic infections. Representative examples of non-infectious inflammatory disorders include inflammatory bowel disease and inflammatory polyps",
    "id" : ""
  }, {
    "name" : "influenza",
    "link" : "http://purl.obolibrary.org/obo/DOID_8469",
    "description" : "A viral infectious disease that results in infection, located in respiratory tract, has_material_basis_in Influenzavirus A, has_material_basis_in Influenzavirus B, or has_material_basis_in Influenzavirus C, which are transmitted_by droplet spread of oronasal secretions during coughing, sneezing, or talking from an infected person. It is a highly contagious disease that affects birds and mammals and has_symptom chills, has_symptom fever, has_symptom sore throat, has_symptom runny nose, has_symptom muscle pains, has_symptom severe headache, has_symptom cough, and has_symptom weakness.",
    "id" : ""
  }, {
    "name" : "interstitial lung disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_3082",
    "description" : "A lung disease that is characterized by inflammation and altered lung interstitium compromising pulmonary function and often has_symptom shortness of breath, dyspnea, and/or cough.",
    "id" : "HP:0006530"
  }, {
    "name" : "interstitial nephritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1063",
    "description" : "Interstitial nephritis is a kidney disorder. The kidneys filter waste and extra fluid from the body. When you have interstitial nephritis, the spaces between tubules (small tubes) inside the kidney become inflamed. This reduces the kidneys' ability to filter properly.",
    "id" : "HP:0001970"
  }, {
    "name" : "intestinal infectious disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_100",
    "description" : "An intestinal disease that involves intestinal infection that has_material_basis_in viruses, bacteria, fungi and parasites.",
    "id" : ""
  }, {
    "name" : "Irritable bowel syndrome with diarrhea",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/197125005",
    "description" : "Irritable bowel syndrome with diarrhea (UMLS CUI:C0348898)",
    "id" : ""
  }, {
    "name" : "juvenile rheumatoid arthritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_676",
    "description" : "A rheumatoid arthritis that involves an autoimmune disease onset in children under 16 which attacks the healthy cells and tissue of located_in joint.",
    "id" : ""
  }, {
    "name" : "keratoconjunctivitis sicca",
    "link" : "http://purl.obolibrary.org/obo/DOID_12895",
    "description" : "Dryness of the eye related to deficiency of the tear film components (aqueous, mucin, or lipid), lid surface abnormalities, or epithelial abnormalities. Keratoconjunctivitis sicca often results in a scratchy or sandy sensation (foreign body sensation) in the eyes, and may also be associated with itching, inability to produce tears, photosensitivity, redness, pain, and difficulty in moving the eyelids.",
    "id" : "HP:0001097"
  }, {
    "name" : "kidney cortex necrosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2973",
    "description" : "A kidney cortex disease that is characterized by death of the tissue in the outer part of the kidney that results from blockage of the small arteries that supply blood to the cortex and that causes acute kidney injury.",
    "id" : ""
  }, {
    "name" : "kidney disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_557",
    "description" : "A urinary system disease that is located in the kidney.",
    "id" : ""
  }, {
    "name" : "kidney failure",
    "link" : "http://purl.obolibrary.org/obo/DOID_1074",
    "description" : "A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood.",
    "id" : "HP:0000083"
  }, {
    "name" : "Kidney Transplantation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15265",
    "description" : "The transfer of a healthy kidney from a donor to a patient for the purpose of replacing one of the failing kidneys of the patient.",
    "id" : ""
  }, {
    "name" : "Lambert-Eaton myasthenic syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050214",
    "description" : "A neuromuscular junction disease that is characterized by an abnormality of acetylcholine (ACh) release at the neuromuscular junction which results from an autoimmune attack against voltage-gated calcium channels (VGCC) on the presynaptic motor nerve terminal.",
    "id" : ""
  }, {
    "name" : "laryngomalacia",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080833",
    "description" : "A laryngeal disease that is characterized by inward collapse of flaccid supraglottic structures during inspiration. The most common symptom is noisy breathing (stridor) that is often worse when the infant is on his/her back or crying.",
    "id" : ""
  }, {
    "name" : "leukemia",
    "link" : "http://purl.obolibrary.org/obo/DOID_1240",
    "description" : "A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells.",
    "id" : "HP:0001909"
  }, {
    "name" : "lichen planus",
    "link" : "http://purl.obolibrary.org/obo/DOID_9201",
    "description" : "A lichen disease that is located_in skin, located_in tongue or located_in oral mucosa, which presents itself in the form of papules, lesions or rashes.",
    "id" : ""
  }, {
    "name" : "Listeria meningitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_11572",
    "description" : "A bacterial meningitis that has_material_basis_in Listeria monocytogenes infection.",
    "id" : ""
  }, {
    "name" : "liver cancer",
    "link" : "http://purl.obolibrary.org/obo/DOID_3571",
    "description" : "A hepatobiliary system cancer that is located_in the liver.",
    "id" : "HP:0002896"
  }, {
    "name" : "liver disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_409",
    "description" : "liver disease",
    "id" : "HP:0001392"
  }, {
    "name" : "Liver Transplantation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15271",
    "description" : "The transfer of a healthy liver allograft from a donor to a patient.",
    "id" : ""
  }, {
    "name" : "localized scleroderma",
    "link" : "http://purl.obolibrary.org/obo/DOID_8472",
    "description" : "localized scleroderma",
    "id" : "HP:0100324"
  }, {
    "name" : "lung adenocarcinoma",
    "link" : "http://purl.obolibrary.org/obo/DOID_3910",
    "description" : "A lung non-small cell carcinoma that derives_from epithelial cells of glandular origin.",
    "id" : "HP:0030078"
  }, {
    "name" : "lung cancer",
    "link" : "http://purl.obolibrary.org/obo/DOID_1324",
    "description" : "A respiratory system cancer that is located_in the lung.",
    "id" : ""
  }, {
    "name" : "lung disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_850",
    "description" : "A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide.",
    "id" : "HP:0002088"
  }, {
    "name" : "Lung Transplantation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15274",
    "description" : "The surgical transfer of one or both lungs from one individual to another.",
    "id" : ""
  }, {
    "name" : "lupus erythematosus",
    "link" : "http://purl.obolibrary.org/obo/DOID_8857",
    "description" : "An autoimmune disease that is characterized by a constellation of findings that include elevated antibodies to nuclear antigens, antiphospholipids, low complement levels, ulcers, non-scarring alopecia, renal or neurologic damage, and low white blood cell and platelet counts, has_symptom rashes, fatigue, arthritis, hair loss, seizures, and symptoms related to affected organs. (UMLS CUI:C0409974)",
    "id" : ""
  }, {
    "name" : "lupus nephritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080162",
    "description" : "A glomerulonephritis that is characterized by inflammation of the kidneys resulting from systemic lupus erythematosus.",
    "id" : ""
  }, {
    "name" : "Lyme disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_11729",
    "description" : "A primary bacterial infectious disease that results_in infection, has_material_basis_in Borrelia burgdorferi, which is transmitted_by blacklegged tick (Ixodes scapularis) or transmitted_by western blacklegged tick (Ixodes pacificus). The infection has_symptom fever, has_symptom headache, has_symptom fatigue, and has_symptom skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system.",
    "id" : ""
  }, {
    "name" : "lymphocytic choriomeningitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_12155",
    "description" : "A viral infectious disease that results in infection located in brain, or located in meninges, or located in brain and meninges, has_material_basis_in Lymphocytic choriomeningitis virus, which is transmitted by common house mouse, Mus musculus. The infection has symptom fever, has symptom lack of appetite, has symptom headache, has symptom muscle aches, has symptom malaise, has symptom nausea, and has symptom vomiting.",
    "id" : ""
  }, {
    "name" : "lymphoma",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060058",
    "description" : "A hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs.",
    "id" : "HP:0002665"
  }, {
    "name" : "malaria",
    "link" : "http://purl.obolibrary.org/obo/DOID_12365",
    "description" : "A parasitic protozoa infectious disease characterized as a vector-borne infectious disease caused by the presence of protozoan parasites of the genus Plasmodium in the red blood cells, transmitted from an infected to an uninfected individual by the bite of anopheline mosquitoes, and characterized by periodic attacks of chills and fever that coincide with mass destruction of blood cells and the release of toxic substances by the parasite at the end of each reproductive cycle.",
    "id" : ""
  }, {
    "name" : "Malignant Gastric Neoplasm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C9331",
    "description" : "A primary or metastatic malignant neoplasm involving the stomach. (UMLS CUI:C0024623)",
    "id" : ""
  }, {
    "name" : "Malignant Lung Neoplasm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C7377",
    "description" : "A primary or metastatic malignant neoplasm involving the lung. (UMLS CUI:C0242379)",
    "id" : ""
  }, {
    "name" : "measles",
    "link" : "http://purl.obolibrary.org/obo/DOID_8622",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Measles virus, which is transmitted_by contact with oronasal secretions, or semen of an infected person. The infection has_symptom fever, has_symptom cough, has_symptom coryza, has_symptom conjunctivitis, and has_symptom maculopapular, erythematous rash.",
    "id" : ""
  }, {
    "name" : "meningitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_9471",
    "description" : "A central nervous system disease that is characterized by an inflammation of the pia-arachnoid meninges. It can be caused by growth of bacteria, fungi, or parasites within the subarachnoid space or by the growth of bacteria or viruses within the meningeal or ependymal cells.",
    "id" : "HP:0001287"
  }, {
    "name" : "meningococcal meningitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080176",
    "description" : "A bacterial meningitis that has_material_basis_in Neisseria meningitidis infection.",
    "id" : ""
  }, {
    "name" : "meningoencephalitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_10554",
    "description" : "A central nervous system disease that involves encephalitis which occurs along with meningitis.",
    "id" : ""
  }, {
    "name" : "mental depression",
    "link" : "http://purl.obolibrary.org/obo/DOID_1596",
    "description" : "mental depression",
    "id" : ""
  }, {
    "name" : "MERS-CoV",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/697932005",
    "description" : "Middle East respiratory syndrome coronavirus",
    "id" : ""
  }, {
    "name" : "Metabolic Syndrome",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84442",
    "description" : "A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance.",
    "id" : ""
  }, {
    "name" : "milk allergy",
    "link" : "http://purl.obolibrary.org/obo/DOID_4376",
    "description" : "A food allergy that results in adverse immune reaction to one or more of the proteins in cow's milk and/or the milk of other animals, which are normally harmless to the non-allergic individual.",
    "id" : ""
  }, {
    "name" : "miscarriage",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000198",
    "description" : "Miscarriage is a reproductive system symptom characterized by the spontaneous expulsion of a human fetus before it is viable and especially between the 12th and 28th weeks of gestation.",
    "id" : ""
  }, {
    "name" : "mitral valve insufficiency",
    "link" : "http://purl.obolibrary.org/obo/DOID_11502",
    "description" : "(UMLS CUI:C0026266)",
    "id" : ""
  }, {
    "name" : "mixed connective tissue disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_3492",
    "description" : "A collagen disease that is considered an overlap of three diseases, systemic lupus erythematosus, scleroderma, and polymyositis with very high titers of circulating antinuclear antibody to a ribonucleoprotein antigen.",
    "id" : ""
  }, {
    "name" : "molluscum contagiosum",
    "link" : "http://purl.obolibrary.org/obo/DOID_8867",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Molluscum contagiosum virus, which is transmitted_by contact with the skin, and transmitted_by fomites. The infection has_symptom lesions which are flesh-colored with a pit in the center.",
    "id" : ""
  }, {
    "name" : "multiple myeloma",
    "link" : "http://purl.obolibrary.org/obo/DOID_9538",
    "description" : "A myeloid neoplasm that is located_in the plasma cells in bone marrow. (UMLS CUI:C0026764)",
    "id" : ""
  }, {
    "name" : "Multiple Pulmonary Nodules",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122408",
    "description" : "Multiple, small, round or oval, benign or malignant growths in the lung(s), which can be due to infectious, inflammatory, or neoplastic processes. (UMLS CUI:C0748164)",
    "id" : ""
  }, {
    "name" : "multiple sclerosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2377",
    "description" : "A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring.",
    "id" : ""
  }, {
    "name" : "mumps",
    "link" : "http://purl.obolibrary.org/obo/DOID_10264",
    "description" : "A viral infectious disease that results in inflammation located in salivary gland, has_material_basis_in Mumps rubulavirus, which is transmitted by droplet spread of saliva or mucus from the mouth, nose, or throat of an infected person, or transmitted by contaminated fomites. The infection has symptom fever, has symptom headache, has symptom muscle aches, has symptom tiredness, has symptom loss of appetite, has symptom swollen and tender salivary glands under the ears or jaw on one or both sides of the face.",
    "id" : ""
  }, {
    "name" : "muscle invasive bladder cancer",
    "link" : "https://www.urologyhealth.org/urologic-conditions/muscle-invasive-bladder-cancer",
    "description" : "Muscle invasive bladder cancer (MIBC) is a cancer that spreads into the detrusor muscle of the bladder. The detrusor muscle is the thick muscle deep in the bladder wall. This cancer is more likely to spread to other parts of the body. About 1 out of 4 people who get bladder cancer in the United States have the muscle invasive kind.",
    "id" : "HP:0009725"
  }, {
    "name" : "muscular dystrophy",
    "link" : "http://purl.obolibrary.org/obo/DOID_9884",
    "description" : "A myopathy is characterized by progressive skeletal muscle weakness degeneration.",
    "id" : "HP:0003560"
  }, {
    "name" : "musculoskeletal system disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_17",
    "description" : "A disease of anatomical entity that occurs in the muscular and/or skeletal system.",
    "id" : ""
  }, {
    "name" : "myasthenia gravis",
    "link" : "http://purl.obolibrary.org/obo/DOID_437",
    "description" : "An autoimmune disease of the nervous system that has_material_basis_in antibodies to acetylcholine receptors at the neuromuscular junction, has_symptom ptosis, has_symptom diplopia, has_symptom dysphagia, has_symptom dysarthria, has_symptom muscle weakness and has_symptom shortness of breath.",
    "id" : ""
  }, {
    "name" : "myocardial infarction",
    "link" : "http://purl.obolibrary.org/obo/DOID_5844",
    "description" : "A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.",
    "id" : "HP:0001658"
  }, {
    "name" : "myocarditis",
    "link" : "http://purl.obolibrary.org/obo/DOID_820",
    "description" : "An extrinsic cardiomyopathy that is characterized as an inflammation of the heart muscle.",
    "id" : "HP:0012819"
  }, {
    "name" : "narcolepsy",
    "link" : "http://purl.obolibrary.org/obo/DOID_8986",
    "description" : "A sleep disorder that involves an excessive urge to sleep at inappropriate times, such as while at work.",
    "id" : "HP:0030050"
  }, {
    "name" : "neonatal candidiasis",
    "link" : "http://purl.obolibrary.org/obo/DOID_9577",
    "description" : "A candidiasis that involves fungal infection in neonates caused by Candida species. Low birthweight and age, prolonged intravascular catheterization and the use of antibiotic drugs are the principle predisposing conditions for systemic candidiasis in neonates.",
    "id" : ""
  }, {
    "name" : "Neonatal Hypoxic Ischemic Encephalopathy",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C119751",
    "description" : "Injury to the central nervous system in the newborn period that occurs when there is insufficient delivery of oxygen to all or part of the brain.",
    "id" : ""
  }, {
    "name" : "neoplastic, metastatic",
    "link" : "http://purl.obolibrary.org/obo/PATO_0002098",
    "description" : "A disposition inhering in a tumour by virtue of the bearer's disposition to spread and invade distant tissues.",
    "id" : ""
  }, {
    "name" : "nephrolithiasis",
    "link" : "http://purl.obolibrary.org/obo/DOID_585",
    "description" : "A kidney disease characterized by the formation of stoney concentrations in the kidneys.",
    "id" : ""
  }, {
    "name" : "Nephrostomy tube (physical object)",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/286628000",
    "description" : "Nephrostomy tube (physical object) (UMLS CUI:C0184149)",
    "id" : ""
  }, {
    "name" : "nephrotic syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_1184",
    "description" : "A nephrosis characterized by marked increase in glomerular protein permeability resulting in marked elevation of urine protein levels, hypoalbuminemia, hyperlipidemia, and hypercoagulability.",
    "id" : "HP:0000100"
  }, {
    "name" : "nervous system disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_863",
    "description" : "A disease of anatomical entity that is located_in the central nervous system or located_in the peripheral nervous system.",
    "id" : ""
  }, {
    "name" : "neurofibromatosis 1",
    "link" : "http://purl.obolibrary.org/obo/DOID_0111253",
    "description" : "A neurofibromatosis classically characterized by cafe-au-lait spots, Lisch nodules in the eye, and fibromatous tumors of the skin or in some cases by a high load of spinal tumors that has_material_basis_in heterozygous mutation in NF1 on 17q11.2.",
    "id" : ""
  }, {
    "name" : "neuromuscular disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_440",
    "description" : "A neuropathy that affect the nerves that control the voluntary muscles. (UMLS CUI:C0027868)",
    "id" : ""
  }, {
    "name" : "neuromyelitis optica",
    "link" : "http://purl.obolibrary.org/obo/DOID_8869",
    "description" : "A central nervous system disease characterized by inflammation of the optic nerve (optic neuritis) and inflammation of the spinal cord (myelitis).",
    "id" : ""
  }, {
    "name" : "Newcastle disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_2929",
    "description" : "A viral infectious disease that results_in infection in birds and humans, has_material_basis_in Newcastle disease virus, which is transmitted_by contact with feces and urine of an infected bird, or transmitted_by fomites. The infection has_symptom conjunctivitis, has_symptom headache, and has_symptom lacrimation in humans, and has_symptom gasping, has_symptom coughing, has_symptom twisting of head and neck, has_symptom circling, has_symptom complete paralysis, has_symptom watery diarrhea, and has_symptom reduced egg production in birds.",
    "id" : ""
  }, {
    "name" : "non-severe COVID-19",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/DOID_0081014;https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "id" : ""
  }, {
    "name" : "Not Applicable",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48660",
    "description" : "Determination of a value is not relevant in the current context",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "Not stated explicitly or in detail",
    "id" : ""
  }, {
    "name" : "nutritional deficiency disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_5113",
    "description" : "A nutrition disease that is characterized by deficiency of a nutritional element, such as a vitamin, mineral, carbohydrate, protein, fat, or general energy content.",
    "id" : ""
  }, {
    "name" : "obesity",
    "link" : "http://purl.obolibrary.org/obo/DOID_9970",
    "description" : "An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has_material_basis_in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness.",
    "id" : "HP:0001513"
  }, {
    "name" : "optic nerve glioma",
    "link" : "http://purl.obolibrary.org/obo/DOID_4992",
    "description" : "optic nerve glioma",
    "id" : "HP:0009734"
  }, {
    "name" : "optic neuritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1210",
    "description" : "An optic nerve disease that results_in inflammation located_in optic nerve which may cause a complete or partial loss of vision.",
    "id" : "HP:0100653"
  }, {
    "name" : "osteoarthritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_8398",
    "description" : "An arthritis that has_material_basis_in worn out cartilage located_in joint.",
    "id" : "HP:0002758"
  }, {
    "name" : "Pancreas Transplantation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15293",
    "description" : "The surgical transfer of a pancreas from one individual to another.",
    "id" : ""
  }, {
    "name" : "pancreatic cancer",
    "link" : "http://purl.obolibrary.org/obo/DOID_1793",
    "description" : "An endocrine gland cancer located_in the pancreas. (UMLS CUI:C0235974)",
    "id" : ""
  }, {
    "name" : "Pancreatic Islet Transplantation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15352",
    "description" : "The surgical transfer of pancreatic islet cells from one individual to another.",
    "id" : ""
  }, {
    "name" : "panniculitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1526",
    "description" : "A skin disease that is characterized by inflammation of subcutaneous adipose tissue.",
    "id" : "HP:0012490"
  }, {
    "name" : "paraplegia",
    "link" : "http://purl.obolibrary.org/obo/DOID_607",
    "description" : "paraplegia",
    "id" : "HP:0010550"
  }, {
    "name" : "Parkinson's disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_14330",
    "description" : "A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.",
    "id" : ""
  }, {
    "name" : "Partial Small Intestine Resection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C51512",
    "description" : "Surgical removal of part of the small intestine. (UMLS CUI:C0192616)",
    "id" : ""
  }, {
    "name" : "peanut allergy",
    "link" : "http://purl.obolibrary.org/obo/DOID_4378",
    "description" : "A legume allergy that is an allergy or hypersensitivity to dietary substances from peanuts causing an overreaction of the immune system which in a small percentage of people may lead to severe physical symptoms.",
    "id" : ""
  }, {
    "name" : "Pediatric acute-onset neuropsychiatric syndrome",
    "link" : "http://purl.bioontology.org/ontology/MESH/C000631768",
    "description" : "PANS pediatric acute-onset neuropsychiatric syndrome",
    "id" : "C000631768"
  }, {
    "name" : "pemphigus vulgaris",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060851",
    "description" : "A pemphigus characterized by autosomal dominant blisters and erosions on the skin and mucous membranes erosions cause by autoantibodies to intercellular cement substance.",
    "id" : ""
  }, {
    "name" : "peptic ulcer disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_750",
    "description" : "peptic ulcer disease",
    "id" : "HP:0004398"
  }, {
    "name" : "Perennial Allergic Rhinitis",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92189",
    "description" : "Allergic rhinitis caused by indoor allergens and lasting year round.",
    "id" : "HP:0003193"
  }, {
    "name" : "perinatal necrotizing enterocolitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_8677",
    "description" : "perinatal necrotizing enterocolitis",
    "id" : ""
  }, {
    "name" : "peripheral vascular disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_341",
    "description" : "A vascular disease that is characterized by obstruction of larger arteries not within the coronary, aortic arch vasculature, or brain.",
    "id" : ""
  }, {
    "name" : "Peritoneal Dialysis",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15297",
    "description" : "A form of dialysis that uses the peritoneum as a membrane across which the infused diasylate exchanges nutrients for waste products that are removed when the fluid is exchanged. (UMLS CUI:C0031139)",
    "id" : ""
  }, {
    "name" : "pernicious anemia",
    "link" : "http://purl.obolibrary.org/obo/DOID_13381",
    "description" : "A nutritional deficiency disease that is characterized by a decrease in red blood cells due to malabsorption of vitamin B12, has_symptom fatigue, pallor, shortness of breath, glossitis, ataxia, and/or paresthesia, has_material_basis_in atrophic gastritis, autoimmune disorder affecting the production or function of intrinsic factor, and/or genetic factors.",
    "id" : ""
  }, {
    "name" : "pertussis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1116",
    "description" : "A commensal bacterial infectious disease that results_in inflammation located_in respiratory tract, has_material_basis_in Bordetella pertussis, or has_material_basis_in Bordetella parapertussis, which produce toxins that paralyze the cilia of the respiratory epithelial cells. The infection is characterized by a prolonged, high-pitched, deeply indrawn breath (whoop).",
    "id" : ""
  }, {
    "name" : "pervasive developmental disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060040",
    "description" : "A developmental disorder of mental health that refers to a group of five disorders characterized by impairments in socialization and communication, as well as restricted interests and repetitive behaviors.",
    "id" : ""
  }, {
    "name" : "pharyngitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2275",
    "description" : "An upper respiratory tract disease involving inflammation of the throat or pharynx resulting from bacterial, viral, fungal infections or irritants like pollutants or chemical substances and smoking. The infection is often referred to as sore throat. The symptoms include pain during swallowing, enlarged tonsils coated with a white discharge, runny nose, cough and slight fever.",
    "id" : ""
  }, {
    "name" : "physical disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080015",
    "description" : "A disease that has_material_basis_in a genetic abnormality, error with embryonic development, infection or compromised intrauterine environment.",
    "id" : ""
  }, {
    "name" : "pituitary gland disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_53",
    "description" : "An endocrine system disease that is located_in the pituitary gland.",
    "id" : ""
  }, {
    "name" : "placenta disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_780",
    "description" : "A uterine disease that is located_in the placenta.",
    "id" : ""
  }, {
    "name" : "plague",
    "link" : "http://purl.obolibrary.org/obo/DOID_3482",
    "description" : "A primary bacterial infectious disease that results_in infection, located_in lymph node, located_in vasculature or located_in lungs, has_material_basis_in Yersinia pestis, which is transmitted_by oriental rat flea (Xenopsylla cheopis) infected by feeding on rodents and other mammals, transmitted_by air, transmitted_by direct contact or transmitted_by ingestion of contaminated undercooked food.",
    "id" : ""
  }, {
    "name" : "Plasmodium falciparum malaria",
    "link" : "http://purl.obolibrary.org/obo/DOID_14067",
    "description" : "A malaria described as a severe form of the disease caused by a parasite Plasmodium falciparum, which is marked by irrregular recurrence of paroxysms and prolonged or continuous fever.",
    "id" : ""
  }, {
    "name" : "Plasmodium vivax malaria",
    "link" : "http://purl.obolibrary.org/obo/DOID_12978",
    "description" : "A malaria that is caused by the protozoan parasite Plasmodium vivax, which induces paroxysms at 48-hour intervals.",
    "id" : ""
  }, {
    "name" : "Pleural effusions, chronic",
    "link" : "",
    "description" : "Pleural effusions, chronic (UMLS CUI:C0747636)",
    "id" : ""
  }, {
    "name" : "pneumonia",
    "link" : "http://purl.obolibrary.org/obo/DOID_552",
    "description" : "A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation).",
    "id" : ""
  }, {
    "name" : "polymyalgia rheumatica",
    "link" : "http://purl.obolibrary.org/obo/DOID_853",
    "description" : "A collagen disease that is characterized by pain, stiffness, and tenderness of the proximal muscle groups including the shoulder, pelvic girdle and the neck.",
    "id" : ""
  }, {
    "name" : "polymyositis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080745",
    "description" : "A myositis that is characterized by muscle weakness affecting both sides of your body.",
    "id" : ""
  }, {
    "name" : "portal vein thrombosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_11695",
    "description" : "A hepatic vascular disease that is characterized by a blood clot that forms within the hepatic portal vein. (UMLS CUI:C0155773)",
    "id" : ""
  }, {
    "name" : "Post-Acute Sequelae of COVID-19",
    "link" : "https://uts.nlm.nih.gov/uts/umls/vocabulary/NCI/C179263",
    "description" : "A constellation of signs and symptoms that can persist for weeks or months after acute infection with SARS-CoV-2, or appear weeks after infection. This condition may be characterized by fatigue, shortness of breath, difficulty focusing or concentrating (\"brain fog\"), sleep disorders, fevers, gastrointestinal symptoms, anxiety, and depression. aka Long-COVID-19. ACC/AHA Definition:  Symptoms that significantly impair quality of life, which started during or after probable or confirmed acute COVID-19 and have persisted 4 wk to 3 mo after the initial diagnosis of COVID-19",
    "id" : ""
  }, {
    "name" : "Post-Transplant Lymphoproliferative Disorder",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C4727",
    "description" : "Post-transplant lymphoproliferative disorder (PTLD) is a polyclonal (benign) or clonal (malignant) proliferation of lymphoid cells that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft. PTLDs comprise a spectrum ranging from early, Epstein-Barr virus (EBV)-driven polyclonal lymphoid proliferations to EBV-positive or EBV- negative lymphomas of predominantly B-cell or less often T-cell type.",
    "id" : ""
  }, {
    "name" : "post-traumatic stress disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_2055",
    "description" : "An anxiety disorder which results from a traumatic experience that results in psychological trauma.",
    "id" : ""
  }, {
    "name" : "postinfectious encephalitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_10993",
    "description" : "An encephalitis that is characterized by the immune system mistakenly attacking healthy cells in the brain instead of attacking only the cells causing the infection, often occuring two to three weeks after the initial infection.",
    "id" : ""
  }, {
    "name" : "pre-eclampsia",
    "link" : "http://purl.obolibrary.org/obo/DOID_10591",
    "description" : "A hypertension occurring during pregnancy characterized by large amounts of protein in the urine (proteinuria) and edema, usually by the last trimester of pregnancy.",
    "id" : "HP:0100602"
  }, {
    "name" : "Pregnancy",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25742",
    "description" : "The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.",
    "id" : ""
  }, {
    "name" : "Prenatal maternal abnormality",
    "link" : "http://purl.obolibrary.org/obo/HP_0002686",
    "description" : "Prenatal maternal abnormality",
    "id" : "HP:0002686"
  }, {
    "name" : "Preterm Birth",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92861",
    "description" : "Birth when a fetus is less than 37 weeks and 0 days gestational age.",
    "id" : ""
  }, {
    "name" : "Previous",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25627",
    "description" : "Occurring prior to something else.",
    "id" : ""
  }, {
    "name" : "primary biliary cholangitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_12236",
    "description" : "A liver cirrhosis characterized by chronic and slow progressive destruction of intrahepatic bile ducts.",
    "id" : "HP:0002613"
  }, {
    "name" : "primary immunodeficiency disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_612",
    "description" : "An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation.",
    "id" : "HP:0002721"
  }, {
    "name" : "primary sclerosing cholangitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060643",
    "description" : "A sclerosing cholangitis characterized by fibroobliterative inflammation of the biliary tract, leading to cirrhosis and portal hypertension.",
    "id" : ""
  }, {
    "name" : "Primary Sjogren Syndrome",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C116985",
    "description" : "Sjogren syndrome without a concomitant systemic autoimmune disorder.",
    "id" : ""
  }, {
    "name" : "proctitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_3127",
    "description" : "A rectal disease that involves inflammation of the rectal mucosa, which results from infection, inflammatory bowel disease, or radiation. Sexually transmitted pathogens (Neisseria gonorrhoeae, Chlamydia trachomatis, herpes simplex virus 1 and 2, Treponema pallidum) and enteric pathogens (Campylobacter, Shigella, Salmonella) are involved in the disease. Symptoms are rectal discomfort and bleeding.",
    "id" : ""
  }, {
    "name" : "psoriasis",
    "link" : "http://purl.obolibrary.org/obo/DOID_8893",
    "description" : "A skin disease that is characterized by patches of thick red skin and silvery scales.",
    "id" : "HP:0003765"
  }, {
    "name" : "psoriatic arthritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_9008",
    "description" : "An arthritis that is characterized by joint inflammation that usually occurs in combination with psoriasis.",
    "id" : ""
  }, {
    "name" : "Psychiatric Disorder",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C2893",
    "description" : "A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia. (UMLS CUI:C1658764)",
    "id" : ""
  }, {
    "name" : "psychotic disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_2468",
    "description" : "A cognitive disorder that involves abnormal thinking and perceptions resulting in a disconnection with reality.",
    "id" : ""
  }, {
    "name" : "pulmonary hypertension",
    "link" : "http://purl.obolibrary.org/obo/DOID_6432",
    "description" : "A hypertension characterized by an increase of blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries.",
    "id" : "HP:0002092"
  }, {
    "name" : "pustulosis of palm and sole",
    "link" : "http://purl.obolibrary.org/obo/DOID_4398",
    "description" : "pustulosis of palm and sole",
    "id" : "HP:0100847"
  }, {
    "name" : "Radiation Exposure",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/NCIT_C61398",
    "id" : ""
  }, {
    "name" : "Radiation Sickness Syndrome",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C50723",
    "description" : "The complex of symptoms characterizing the disease known as radiation injury, resulting from excessive exposure (greater than 200 rads or 2 gray) of the whole body (or large part) to ionizing radiation. The earliest of these symptoms are nausea, fatigue, vomiting, and diarrhea, which may be followed by epilation, hemorrhage, inflammation of the mouth and throat, and general loss of energy. In severe cases, where the radiation exposure has been approximately 1000 Rad (10 gray) or more, death may occur within two to four weeks. Those who survive six weeks after the receipt of a single large dose of radiation to the whole body may generally be expected to recover. (U.S. Nuclear Regulatory Commission).",
    "id" : ""
  }, {
    "name" : "Raynaud disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_10300",
    "description" : "Raynaud disease",
    "id" : "HP:0030880"
  }, {
    "name" : "recent",
    "link" : "http://purl.obolibrary.org/obo/PATO_0001484",
    "description" : "A quality of a process which occurs near to or not long before the present.",
    "id" : ""
  }, {
    "name" : "Recurrent pregnancy loss",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C2921106",
    "description" : "A medical condition characterized by the loss of two or more pregnancies before the fetus reaches viability. The exact timing for what constitutes \"viability\" may vary, but losses are often counted before 20 weeks of gestation. Recurrent pregnancy loss is a subset of miscarriage, which is more broadly defined as the loss of a pregnancy before viability.",
    "id" : ""
  }, {
    "name" : "Recurrent urinary tract infections",
    "link" : "http://purl.obolibrary.org/obo/HP_0000010",
    "description" : "Repeated infections of the urinary tract. (UMLS CUI:C0262655)",
    "id" : "HP:0000010"
  }, {
    "name" : "relapse",
    "link" : "http://purl.obolibrary.org/obo/OGMS_0000105",
    "description" : "A disease stage which is preceded by a remission and characterized by the return of a manifestation of a disease.",
    "id" : ""
  }, {
    "name" : "relapsing polychondritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2556",
    "description" : "A chondromalacia that is characterized by recurrent inflammation of cartilage and other tissues throughout the body.",
    "id" : ""
  }, {
    "name" : "renal artery obstruction",
    "link" : "http://purl.obolibrary.org/obo/DOID_2972",
    "description" : "renal artery obstruction",
    "id" : "HP:0001920"
  }, {
    "name" : "Reproductive Surgery",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C157970",
    "description" : "A surgical procedure in the field of reproductive medicine.",
    "id" : ""
  }, {
    "name" : "respiratory syncytial virus infectious disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_1273",
    "description" : "A viral infectious disease that results_in infection located_in upper respiratory tract or located_in lower respiratory tract, has_material_basis_in Human respiratory syncytial virus, which is transmitted_by droplet spread of nasal secretions from an infected person while coughing or sneezing, or transmitted_by contaminated fomites. The infection has_symptom runny nose, has_symptom fever, has_symptom cough, has_symptom wheezing, and has_symptom respiratory distress.",
    "id" : ""
  }, {
    "name" : "Rheumatic Disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_1575",
    "description" : "A musculoskeletal system disease that involves inflammation or pain in the muscles, joints, or fibrous tissue.",
    "id" : ""
  }, {
    "name" : "rheumatic heart disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050827",
    "description" : "A heart valve disease that is characterized by repeated inflammation with fibrinous repair caused by an autoimmune reaction to Group A beta-hemolytic streptococci (GAS) that results in valvular damage. The cardinal anatomic changes of the valve include leaflet thickening, commissural fusion, and shortening and thickening of the tendinous cords.",
    "id" : ""
  }, {
    "name" : "rheumatoid arthritis",
    "link" : "http://purl.obolibrary.org/obo/DOID_7148",
    "description" : "An arthritis that is an autoimmune disease which attacks healthy cells and tissue located_in joint.",
    "id" : "HP:0001370"
  }, {
    "name" : "rhinitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_4483",
    "description" : "A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip.",
    "id" : "HP:0012384"
  }, {
    "name" : "Rhinovirus Infection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122572",
    "description" : "An infectious process caused by rhinovirus. The virus usually causes upper respiratory infections, but can infect the lower tract as well.",
    "id" : ""
  }, {
    "name" : "rubella",
    "link" : "http://purl.obolibrary.org/obo/DOID_8781",
    "description" : "A viral infectious disease that results_in infection located_in skin, has_material_basis_in Rubella virus, which is transmitted_by droplet spread of oronasal secretions from the infected person through coughing and sneezing, and transmitted_by congenital method. The infection has_symptom rash on the face which spreads to the trunk and limbs, has_symptom fever, has_symptom lymphadenopathy, has_symptom joint pains, has_symptom headache, and has_symptom conjunctivitis.",
    "id" : ""
  }, {
    "name" : "salmonellosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060859",
    "description" : "A primary bacterial infectious disease caused by the bacteria of the genus Salmonella. It has sypmtoms diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cases, the illness lasts four to seven days, and most people recover without treatment.",
    "id" : ""
  }, {
    "name" : "sarcoidosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_11335",
    "description" : "A hypersensitivity reaction type IV disease characterized by the growth of collections of inflammatory cells (granulomas) in multiple organs.",
    "id" : ""
  }, {
    "name" : "sarcoma",
    "link" : "http://purl.obolibrary.org/obo/DOID_1115",
    "description" : "A cell type cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm.",
    "id" : ""
  }, {
    "name" : "schistosomiasis",
    "link" : "http://purl.obolibrary.org/obo/DOID_1395",
    "description" : "A parasitic helminthiasis infectious disease that involves infection of the intestine, urinary tract, skin, liver and spleen caused by multiple species of the trematode fluke of the genus Schistosoma. The symptoms include fever, chills, nausea, abdominal pain, diarrhea, malaise, myalgia, liver and spleen enlargement, rash and hematuria.",
    "id" : ""
  }, {
    "name" : "scleroderma",
    "link" : "http://purl.obolibrary.org/obo/DOID_419",
    "description" : "A rheumatic disease that involves the abnormal growth of connective tissue, which supports the skin and internal organs.",
    "id" : "HP:0100324"
  }, {
    "name" : "Seasonal Allergic Rhinitis",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92188",
    "description" : "Allergic rhinitis caused by outdoor allergens.",
    "id" : "HP:0003193"
  }, {
    "name" : "Severe Acute Respiratory Syndrome (SARS)",
    "link" : "http://purl.obolibrary.org/obo/DOID_2945",
    "description" : "A Coronavirus infectious disease that results_in infection located_in respiratory tract, has_material_basis_in SARS coronavirus (SARS-CoV), which is transmitted_by droplet spread of respiratory secretions, transmitted_by ingestion of contaminated food, or transmitted_by fomites. The infection has_symptom fever, has_symptom headache, has_symptom body aches, has_symptom dry cough, and has_symptom hypoxia",
    "id" : ""
  }, {
    "name" : "severe COVID-19",
    "link" : "",
    "description" : "http://purl.obolibrary.org/obo/DOID_0081013;https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "id" : ""
  }, {
    "name" : "Sexually Transmitted Disorder",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3365",
    "description" : "A disorder acquired through sexual contact.",
    "id" : ""
  }, {
    "name" : "Shigellosis",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C157978",
    "description" : "An intestinal disease cause by Shigella bacteria.",
    "id" : ""
  }, {
    "name" : "Shoulder Dislocation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C35020",
    "description" : "A dislocation of the shoulder joint. (UMLS CUI:C0037005)",
    "id" : ""
  }, {
    "name" : "sickle cell anemia",
    "link" : "https://www.disease-ontology.org/?id=DOID:10923",
    "description" : "A blood protein disease that is characterized by low number of red blood cells, repeated infections, and periodic episodes of pain, resulting from atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape. https://en.wikipedia.org/wiki/Sickle_cell_disease, https://ghr.nlm.nih.gov/condition/sickle-cell-disease, https://www.nhlbi.nih.gov/health-topics/sickle-cell-disease",
    "id" : ""
  }, {
    "name" : "sinusitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050127",
    "description" : "A paranasal sinus disease involving inflammation of the paranasal sinuses resulting from bacterial, fungal, viral infection, allergic or autoimmune issues. Symptoms can include fever, weakness, fatigue, cough and congestion. There may also be mucus drainage in the back of the throat, called postnasal drip.",
    "id" : "HP:0000255"
  }, {
    "name" : "Sjogren's syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_12894",
    "description" : "An autoimmune disease that involves attack of immune cells which destroy the exocrine glands that produce tears and saliva.",
    "id" : ""
  }, {
    "name" : "Small Bowel Transplantation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C157985",
    "description" : "Replacing diseased bowel with healthy bowel tissue.",
    "id" : ""
  }, {
    "name" : "Small for Gestational Age",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C114934",
    "description" : "Smaller than normal size according to sex and gestational age related norms, defined as a weight below the 10th percentile for the gestational age (UMLS CUI: C0235991).",
    "id" : "HP:0001518"
  }, {
    "name" : "smallpox",
    "link" : "http://purl.obolibrary.org/obo/DOID_8736",
    "description" : "A viral infectious disease that results in infection located in skin, has_material_basis_in Variola virus, which is transmitted by droplets from oral, nasal or pharyngeal mucosa, transmitted by contact with the body fluids, or transmitted by fomites. The infection results in formation of lesions, first on the face, hands and forearms and later on the trunk.",
    "id" : ""
  }, {
    "name" : "Solid Neoplasm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C9292",
    "description" : "A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.",
    "id" : ""
  }, {
    "name" : "Solid Organ Transplant Recipient",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C130200",
    "description" : "An individual who is receiving a transplant of a solid organ.",
    "id" : ""
  }, {
    "name" : "specific developmental disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060038",
    "description" : "A developmental disorder of mental health that categorizes specific learning disabilities and developmental disorders affecting coordination.",
    "id" : ""
  }, {
    "name" : "spinal muscular atrophy",
    "link" : "http://purl.obolibrary.org/obo/DOID_12377",
    "description" : "A motor neuron disease that is a degenerative neuromuscular disease characterized by lower motor neuron degeneration associated with progressive muscle weakness and atrophy.",
    "id" : "HP:0007269"
  }, {
    "name" : "spontaneous abortion",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000199",
    "description" : "Spontaneous abortion is a abortion characterized by the naturally occurring expulsion of a nonviable fetus.",
    "id" : ""
  }, {
    "name" : "Spontaneous Preterm Birth",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C112864",
    "description" : "Preterm birth from 20 weeks to 36 weeks, 6 days of gestation associated with one of the following: classic preterm labor or preterm premature rupture of membranes.",
    "id" : ""
  }, {
    "name" : "Staphylococcus Aureus Infection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C122576",
    "description" : "An infectious process in which the bacteria Staphylococcus aureus is present.",
    "id" : "HP:0020072"
  }, {
    "name" : "Stevens-Johnson syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050426",
    "description" : "A skin disease that is characterized by ulceration of less than 10 percent of the surface area of the body. The disease is often precipitated by the use of medications, such as antibiotics or antiepileptics, or onset of infection.",
    "id" : ""
  }, {
    "name" : "stillbirth",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000849",
    "description" : "Stillbirth is a reproductive system symptom characterized by the birth of a dead fetus, occurs when a fetus which has died in the uterus or during labor or delivery exits a woman's body.",
    "id" : ""
  }, {
    "name" : "Streptococcal Pharyngitis",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C116003",
    "description" : "Inflammation of the throat due to Streptococcus pyogenes.",
    "id" : "HP:0020096"
  }, {
    "name" : "Streptococcus pneumonia",
    "link" : "http://purl.obolibrary.org/obo/DOID_0040084",
    "description" : "A bacterial pneumonia has_material_basis_in Streptococcus pneumoniae.",
    "id" : ""
  }, {
    "name" : "substance abuse",
    "link" : "http://purl.obolibrary.org/obo/DOID_302",
    "description" : "A substance-related disorder that involves a maladaptive pattern of substance use leading to significant impairment in functioning.",
    "id" : ""
  }, {
    "name" : "substance-related disorder",
    "link" : "http://purl.obolibrary.org/obo/DOID_303",
    "description" : "A disease of mental health involving the abuse or dependence on a substance that is ingested in order to produce a high, alter one's senses, or otherwise affect functioning. (UMLS CUI:C0038586)",
    "id" : ""
  }, {
    "name" : "Sweet syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080746",
    "description" : "A skin disease that is characterized by sudden onset of well defined tender plaques or nodules accompanied by fever, arthralgias, ocular inflammation, headaches and, rarely, oral or genital lesions.",
    "id" : ""
  }, {
    "name" : "swine influenza",
    "link" : "http://purl.obolibrary.org/obo/DOID_0050211",
    "description" : "An influenza that results_in infection located_in respiratory tract of pigs and humans, has_material_basis_in Influenza C virus, or has_material_basis_in Influenza A virus subtypes (H1N1, H1N2, H3N1, H3N2, and H2N3), which are transmitted_by direct contact with infected pigs. The infection in humans has_symptom fever, has_symptom lethargy, has_symptom lack of appetite, has_symptom coughing, has_symptom runny nose, has_symptom sore throat, has_symptom nausea, has_symptom vomiting, and has_symptom diarrhea.",
    "id" : ""
  }, {
    "name" : "systemic lupus erythematosus",
    "link" : "http://purl.obolibrary.org/obo/DOID_9074",
    "description" : "A lupus erythematosus that is an inflammation of connective tissue marked by skin rashes, joint pain and swelling, inflammation of the kidneys and inflammation of the tissue surrounding the heart.",
    "id" : "HP:0002725"
  }, {
    "name" : "systemic scleroderma",
    "link" : "http://purl.obolibrary.org/obo/DOID_418",
    "description" : "A scleroderma that is characterized by fibrosis (or hardening) of the skin and major organs, as well as vascular alterations, and autoantibodies.",
    "id" : "HP:0100324"
  }, {
    "name" : "tetanus",
    "link" : "http://purl.obolibrary.org/obo/DOID_11338",
    "description" : "A primary bacterial infectious disease that results in prolonged contraction of skeletal muscle fibers, has_material_basis_in Clostridium tetani, which produces tetanospasmin, a neurotoxin, which is carried to the brain and spinal cord, where it binds irreversibly to receptors inhibiting neurotransmission. Damaged upper motor neurons cannot control reflex responses to afferent sensory stimuli.",
    "id" : ""
  }, {
    "name" : "tonsillitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_10456",
    "description" : "An upper respiratory tract disease which is characterized by inflammation of the tonsils resulting from bacterial (Group A streptococcus) and viral (Epstein-Barr virus, adenovirus) infections. Symptoms include a severe sore throat, painful or difficult swallowing, coughing, headache, myalgia, fever and chills.",
    "id" : "HP:0011110"
  }, {
    "name" : "TORCH syndrome",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080835",
    "description" : "A syndrome that is characterized by congenital infection with toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and other organisms.",
    "id" : ""
  }, {
    "name" : "transverse myelitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_0080743",
    "description" : "A myelitis that is characterized by a band-like sensation across the trunk of the body, with sensory changes below.",
    "id" : ""
  }, {
    "name" : "tuberculosis",
    "link" : "http://purl.obolibrary.org/obo/DOID_399",
    "description" : "A primary bacterial infectious disease that is located_in lungs, located_in lymph nodes, located_in pericardium, located_in brain, located_in pleura or located_in gastrointestinal tract, has_material_basis_in Mycobacterium tuberculosis, which is transmitted_by droplets released into the air when an infected person coughs or sneezes.",
    "id" : ""
  }, {
    "name" : "tularemia",
    "link" : "http://purl.obolibrary.org/obo/DOID_2123",
    "description" : "A primary bacterial infectious disease that has_material_basis_in Francisella tularensis, which is transmitted by dog tick bite (Dermacentor variabilis), transmitted by deer flies (Chrysops sp) or transmitted by contact with infected animal tissues.",
    "id" : ""
  }, {
    "name" : "type 1 diabetes mellitus",
    "link" : "http://purl.obolibrary.org/obo/DOID_9744",
    "description" : "A diabetes mellitus that is characterized by destruction of pancreatic beta cells resulting in absent or extremely low insulin production.",
    "id" : "HP:0100651"
  }, {
    "name" : "type 2 diabetes mellitus",
    "link" : "http://purl.obolibrary.org/obo/DOID_9352",
    "description" : "A diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin.",
    "id" : "HP:0005978"
  }, {
    "name" : "typhoid fever",
    "link" : "http://purl.obolibrary.org/obo/DOID_13258",
    "description" : "A primary bacterial infectious disease that is a communicable systemic illness, has_material_basis_in Salmonella enterica subsp enterica serovar Typhi, which is transmitted_by ingestion of food or water contaminated with the feces of an infected person. The infection has_symptom fever, has_symptom diarrhea, has_symptom prostration, has_symptom headache, has_symptom splenomegaly, has_symptom liver enlargement, has_symptom eruption of rose-colored spots, and has_symptom leukopenia.",
    "id" : ""
  }, {
    "name" : "ulcerative colitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_8577",
    "description" : "A colitis that is predominantly confined to the mucosa located_in colon and includes characteristic ulcers, or open sores.",
    "id" : "HP:0100279"
  }, {
    "name" : "upper respiratory tract disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_974",
    "description" : "A respiratory system disease which involves the upper respiratory tract.",
    "id" : ""
  }, {
    "name" : "urinary tract obstruction",
    "link" : "http://purl.obolibrary.org/obo/DOID_5200",
    "description" : "Urinary tract obstruction is a blockage that inhibits the flow of urine through its normal path (the urinary tract), including the kidneys, ureters, bladder, and urethra. Blockage can be complete or partial. Blockage can lead to kidney damage, kidney stones, and infection.",
    "id" : ""
  }, {
    "name" : "uveitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_13141",
    "description" : "An uveal disease is characterized by inflammation of any of the layers of the uvea of the eye, which includes the iris, ciliary body, and choroid.",
    "id" : "HP:0000554"
  }, {
    "name" : "vasculitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_865",
    "description" : "A vascular disease that is characterized by inflammation of the blood vessels.",
    "id" : "HP:0002633"
  }, {
    "name" : "Viral Respiratory Tract Infection",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C27219",
    "description" : "A respiratory tract infection caused by a virus.  Viruses represent the most common causes of upper and lower respiratory tract infections and include rhinoviruses, influenza viruses, parainfluenza viruses, and respiratory syncytial virus.",
    "id" : ""
  }, {
    "name" : "viral tropism",
    "link" : "https://www.dictionary.com/browse/viral-tropism",
    "description" : "The specificity of a virus for a particular host tissue, determined in part by the interaction of viral surface structures with receptors present on the surface of the host cell.",
    "id" : ""
  }, {
    "name" : "vitiligo",
    "link" : "http://purl.obolibrary.org/obo/DOID_12306",
    "description" : "An autoimmune disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes.",
    "id" : "HP:0001045"
  }, {
    "name" : "Water-Electrolyte Imbalance",
    "link" : "http://purl.obolibrary.org/obo/OMIT_0015710",
    "description" : "Water-Electrolyte Imbalance",
    "id" : ""
  }, {
    "name" : "weight loss",
    "link" : "http://purl.obolibrary.org/obo/SYMP_0000178",
    "description" : "weight loss",
    "id" : ""
  }, {
    "name" : "West Nile encephalitis",
    "link" : "http://purl.obolibrary.org/obo/DOID_2365",
    "description" : "A viral infectious disease that results in inflammation located in brain, has_material_basis_in West Nile virus, which is transmitted_by Culex, transmitted by Aedes, and transmitted_by Anopheles species of mosquitoes. The infection has_symptom high fever, has_symptom headache, has_symptom neck stiffness, has_symptom stupor, has_symptom disorientation, has_symptom coma, has_symptom tremors, has_symptom convulsions, has_symptom muscle weakness, has_symptom vision loss, has_symptom numbness, and has_symptom paralysis.",
    "id" : ""
  }, {
    "name" : "West Nile fever",
    "link" : "http://purl.obolibrary.org/obo/DOID_2366",
    "description" : "A viral infectious disease that results_in infection, has_material_basis_in West Nile virus, which is transmitted_by Culex and transmitted_by Aedes mosquitoes. The infection has_symptom fever, has_symptom sore throat, has_symptom headache, has_symptom body ache, has_symptom nausea, has_symptom maculopapular rash and has_symptom vomiting.",
    "id" : ""
  }, {
    "name" : "X-linked agammaglobulinemia",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C3822",
    "description" : "An immunodeficiency state characterized (usually) by profoundly low concentrations of serum immunoglobulins of all classes, although occasionally significant amounts of one or more isotypes can be found. The fundamental defect in XLA affects early lineage B cells",
    "id" : ""
  }, {
    "name" : "yellow fever",
    "link" : "http://purl.obolibrary.org/obo/DOID_9682",
    "description" : "A viral infectious disease that results in infection, has_material_basis_in Yellow fever virus, which is transmitted by Aedes, transmitted by Haemagogus, or transmitted by Sabethes species of mosquitoes. The infection has symptom fever, has symptom muscle pain, has symptom backache, has symptom headache, has symptom shivers, has symptom loss of appetite, has symptom jaundice, and has symptom bleeding from the mouth, nose, eyes or stomach leading to vomitus containing blood.",
    "id" : ""
  }, {
    "name" : "Zika fever",
    "link" : "http://purl.obolibrary.org/obo/DOID_0060478",
    "description" : "A viral infectious disease that has_material_basis in Zika virus, which is transmitted_by Aedes aegypti mosquitoes and targets neural progenitor cells and  neuronal cells in all stages of maturity and has_symptom fever, has_symptom rash, has_symptom headaches and has_symptom joint pain.",
    "id" : ""
  } ]
}, {
  "name" : "lk_disease_stage",
  "rows" : [ {
    "name" : "disease_stage_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "Acute/Recent onset",
    "link" : "https://dst.liai.org/BcellDisc.html",
    "description" : "A short-term infection or disease characterized by a dramatic onset and rapid recovery. Primary infections fall under this category.",
    "id" : null
  }, {
    "name" : "Asymptomatic or Presymptomatic Infection",
    "link" : "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3833;https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37998;https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C180882;https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128320",
    "description" : "Without clinical signs or indications that raise the possibility of a particular disorder or dysfunction.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Occurring during, or related to, the time before symptoms appear.:The invasion of an organisms body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce. C3833:C37998:C180882:C128320",
    "id" : null
  }, {
    "name" : "Chronic",
    "link" : "https://dst.liai.org/BcellDisc.html",
    "description" : "A long-term infection or illness and partial remission.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 0",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179010",
    "description" : "Patient is uninfected. There are no clinical or virological evidence of infection.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 1",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179011",
    "description" : "Patient is ambulatory without limitation of activities.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 2",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179012",
    "description" : "Patient is ambulatory but there is limitation of activities.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 3",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179013",
    "description" : "Patient is hospitalized with mild disease but does not require oxygen therapy.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 4",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179014",
    "description" : "Patient is hospitalized with mild disease but requires oxygen by mask or nasal prongs.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 5",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179015",
    "description" : "Patient is hospitalized with severe disease and requires non-invasive ventilation or high-flow oxygen.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 6",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179016",
    "description" : "Patient is hospitalized with severe disease and requires intubation and mechanical ventilation.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 7",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179017",
    "description" : "Patient is hospitalized with severe disease and requires ventilation plus additional organ support via vasopressor therapy, renal replacement therapy, or extracorporeal membrane oxygenation.",
    "id" : null
  }, {
    "name" : "COVID-19 Disease Severity 8",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179018",
    "description" : "Patient is dead.",
    "id" : null
  }, {
    "name" : "Critical COVID-19",
    "link" : "https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "description" : "Defined by the criteria for acute respiratory distress syndrome (ARDS), sepsis, septic shock, or other conditions that would normally require the provision of life-sustaining therapies such as mechanical ventilation (invasive or non-invasive) or vasopressor therapy.",
    "id" : null
  }, {
    "name" : "Critical Illness",
    "link" : "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25467;https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C107499",
    "description" : "Being in or verging on a state of crisis or emergency; urgently needed; absolutely necessary.:A state of ill health, bodily malfunction, or discomfort. C25467:C107499",
    "id" : null
  }, {
    "name" : "Dead",
    "link" : "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28554",
    "description" : "The cessation of life. C28554",
    "id" : null
  }, {
    "name" : "Mild Illness",
    "link" : "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70666 ; https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C107499",
    "description" : "Gentle or temperate in nature or degree.:A state of ill health, bodily malfunction, or discomfort. C70666:C107499",
    "id" : null
  }, {
    "name" : "Moderate Illness",
    "link" : "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376 ; https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C107499",
    "description" : "The quality of being within reasonable or average limits; not excessive or extreme.:A state of ill health, bodily malfunction, or discomfort. C61376:C107499",
    "id" : null
  }, {
    "name" : "Non-severe COVID-19",
    "link" : "https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "description" : "Defined as absence of any criteria for severe or critical COVID-19.",
    "id" : null
  }, {
    "name" : "Not Applicable Or Not Reported",
    "link" : "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48660;https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37998;https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C43234",
    "description" : "Determination of a value is not relevant in the current context.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Not provided or available. C48660:C37998:C43234",
    "id" : null
  }, {
    "name" : "Other",
    "link" : "https://dst.liai.org/BcellDisc.html",
    "description" : "Any disease stage that cannot be classified under the selections above will be classified under \"other.\" Household contacts will be recorded as \"other\".",
    "id" : null
  }, {
    "name" : "Post",
    "link" : "https://dst.liai.org/BcellDisc.html",
    "description" : "Recovery from an illness, including latent (potentially existing but not presently evident or realized) and remission (a period during which symptoms of disease disappear [complete remission]). Note that partial remission will be recorded as \"chronic\".",
    "id" : null
  }, {
    "name" : "SeroNet Covid-19 Disease Severity Death",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/",
    "description" : "Corresponds to WHO Severity Scale 8. Dead.",
    "id" : null
  }, {
    "name" : "SeroNet Covid-19 Disease Severity Mild",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179011, https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179012",
    "description" : "Corresponds to WHO severity scale: (1) Ambulatory, asymptomatic or no limitation of activities or (2) ambulatory, limitation of activities.",
    "id" : null
  }, {
    "name" : "SeroNet Covid-19 Disease Severity Moderate",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179013, https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179014",
    "description" : "Corresponds to WHO severity scale: (3) Hospitalized, no oxygen therapy or (4) hospitalized, oxygen by mask or nasal prongs.",
    "id" : null
  }, {
    "name" : "SeroNet Covid-19 Disease Severity Severe",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179015, https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179016, https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=21.10d&ns=ncit&code=C179017",
    "description" : "Corresponds to WHO severity scale: (5) Hospitalized with severe disease and non-invasive ventilation or high-flow oxygen,  or (6) hospitalized with severe disease with intubation and mechanical ventilation, or  (7) hospitalized with severe disease ventilation + additional organ support - pressors, RRT, ECMO",
    "id" : null
  }, {
    "name" : "SeroNet Covid-19 Disease Severity Unknown",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/",
    "description" : "Covid-19 disease severity is not known.",
    "id" : null
  }, {
    "name" : "Severe COVID-19",
    "link" : "https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1",
    "description" : "Defined by any of: Oxygen saturation < 90% on room air. Respiratory rate > 30 breaths/min in adults and children > 5 years old; >= 60 breaths/min in children < 2 months old; >= 50 in children 2–11 months old; and >= 40 in children 1–5 years old. Signs of severe respiratory distress (accessory muscle use, inability to complete full sentences, and, in children, very severe chest wall indrawing, grunting, central cyanosis, or presence of any other general danger signs).",
    "id" : null
  }, {
    "name" : "Severe Illness",
    "link" : "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70667 ; https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C107499",
    "description" : "Intensely bad or unpleasant in degree, quality or extent.:A state of ill health, bodily malfunction, or discomfort. C70667:C107499",
    "id" : null
  }, {
    "name" : "Unknown",
    "link" : "https://dst.liai.org/BcellDisc.html",
    "description" : "Used when the disease stage is not clearly specified or known.",
    "id" : null
  } ]
}, {
  "name" : "lk_ethnicity",
  "rows" : [ {
    "name" : "Hispanic or Latino",
    "link" : "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/collection-race-and-ethnicity-data-clinical-trials",
    "description" : "A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, \"Spanish origin,\" can be used in addition to \"Hispanic or Latino.\"",
    "id" : ""
  }, {
    "name" : "Not Hispanic or Latino",
    "link" : "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/collection-race-and-ethnicity-data-clinical-trials",
    "description" : "A person not of Hispanic or Latino origin.",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/collection-race-and-ethnicity-data-clinical-trials",
    "description" : "Ethnicity is not specified or not received. If no Ethnicity value is received, then this is the system default value.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/collection-race-and-ethnicity-data-clinical-trials",
    "description" : "A person having an Ethnicity that is some Other value not in CV Terms.",
    "id" : ""
  } ]
}, {
  "name" : "lk_exp_measurement_tech",
  "rows" : [ {
    "name" : "10x feature barcode (CRISPR screening)",
    "link" : "http://www.ebi.ac.uk/efo/EFO_0030013",
    "description" : "The use of 10x Genomics feature barcode technology with the purpose of performing a CRISPR screening.",
    "id" : ""
  }, {
    "name" : "16S rRNA gene sequencing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001960",
    "description" : "An assay that determines taxonomic and community diversity information by sequencing specific genomic regions used as marker of identity or diversity.",
    "id" : ""
  }, {
    "name" : "1D Gel",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001121",
    "description" : "One dimensional gels are used to separate an analyte using one physical feature of the analyte.",
    "id" : ""
  }, {
    "name" : "2D Gel",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001121",
    "description" : "Two dimensional gels are used to separate an analyte using two physical features of the analyte.",
    "id" : ""
  }, {
    "name" : "Array",
    "link" : "http://purl.obolibrary.org/obo/OBI_0400147 ; http://purl.obolibrary.org/obo/OBI_0001204 ; http://purl.obolibrary.org/obo/OBI_0001307 ;  http://purl.obolibrary.org/obo/OBI_0400149",
    "description" : "Arrays (including microarrays) are a set of probes immobilized on a surface. The probes can be oligonucleotides, cDNAs, antibodies and other molecules that recognize a target. Microarrays can be constructed by several methods including (but not limited to in situ oligo synthesis (e.g. Affymetrix), cDNA spotting, bead arrays (e.g. Illumina) and antibody spotting. The position and identity of probes are provided by the manufacturer. The probe identifiers and their target are referred to as annotation or translation of probe identifiers to bioinformatic identifiers. Microarrays can be used for gene expression (mRNA transcript quantification), genotyping, cytokine quantification, etc. Microarrays for gene expression fall into two general classes- single channel and dual channel. The channel refers to the wavelength scanned for fluorescent signals. Affymetrix microarrays are obligatory single channel. There are a host of commercial and non-commercial microarray meanufacturers that use two c",
    "id" : ""
  }, {
    "name" : "B cell receptor repertoire sequencing assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002991",
    "description" : "B cell receptor repertoire sequencing assay",
    "id" : ""
  }, {
    "name" : "Bio-layer Interferometry Assay",
    "link" : "BLI experiments are used to determine the kinetics and affinity of molecular interactions.",
    "description" : "A binding assay that detects a shift in the interference pattern reflected from a layer of immobilized material on the biosensor tip to measure binding to- or dissociating from the material on the biosensor.",
    "id" : ""
  }, {
    "name" : "Bulk RNA-seq assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0003090",
    "description" : "An RNA-seq assay in which the sample that is sequenced is derived from a collection of cells, such as a tissue sample or entire cell culture, and therefore provides results representative of the aggregate of sample cells.",
    "id" : ""
  }, {
    "name" : "Cell Culture",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001876",
    "description" : "A cell culture includes the cells in culture, as well as the media and all additives in which the cells are being grown or in which they are stored.",
    "id" : ""
  }, {
    "name" : "Cell Mediated Immunoassay",
    "link" : "Cell Mediated Immunoassay",
    "description" : "Cell Mediated Immunoassay",
    "id" : ""
  }, {
    "name" : "Chemiluminescent Assay",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0201709",
    "description" : "A type of immunoassay in which the antigen-antibody complex is quantified using light emission, which is generated from a chemical reaction.",
    "id" : ""
  }, {
    "name" : "Circular Dichroism",
    "link" : "http://en.wikipedia.org/wiki/Circular_Dichroism",
    "description" : "Circular Dichroism is a form of spectroscopy used to determine the optical isomerism and secondary structure of molecules.",
    "id" : ""
  }, {
    "name" : "CITE-Seq",
    "link" : "http://www.ebi.ac.uk/efo/EFO_0009294",
    "description" : "CITE-seq is a method in which oligonucleotide-labeled antibodies are used to integrate cellular protein and transcriptome measurements into an efficient, single-cell readout.",
    "id" : ""
  }, {
    "name" : "Colorimetric Cell Viability Assay",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C95027",
    "description" : "A colorimetric assay that can assess the viability of cells by quantitation of the reduction of a yellow tetrazolium salt substrate to a product that has a purple color. This assay can measure the cytotoxicity of a chemical or drug by determining the affect of treatment on cell viability. Has exact synonym: MTT Assay, MTS Assay.",
    "id" : ""
  }, {
    "name" : "CRISPR Screening",
    "link" : "http://www.bioassayontology.org/bao#BAO_0010249",
    "description" : "Genome-wide Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a genome editing tool also known as CRISPR-Cas9, -Cas13, CPF1, etc. It is used to study the relationship between genotype and phenotype by editing, ablating, or knocking out gene expression on a genome-wide scale and studying the resulting phenotypic alterations. CRISPR edits genes in living cells to evaluate the subsequent down-stream effects and also has therapeutic potential.",
    "id" : ""
  }, {
    "name" : "Cryo-Electron Microscopy",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C18113",
    "description" : "Electron microscopy involving an aqueous suspension of a sample which is applied in an extremely thin film to a grid, frozen in liquid nitrogen and maintained in this state by means of a special mount. The imaging of frozen-hydrated molecules and organelles permits the best possible resolution closest to the living state, free of chemical fixatives or stains",
    "id" : ""
  }, {
    "name" : "CyTOF",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002115",
    "description" : "Cytometry Time Of Flight CyTOF (DVS Sciences) or Mass cytometry, or , is a variation of flow cytometry in which antibodies are labeled with heavy metal ion tags rather than fluorochromes. Readout is by time-of-flight mass spectrometry.",
    "id" : ""
  }, {
    "name" : "Cytokine Assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002766",
    "description" : "An analyte assay to study presence, concentration, or amount of cytokines.",
    "id" : ""
  }, {
    "name" : "Cytometric Bead Array Assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000920",
    "description" : "An analyte assay in which a series of beads coated with antibodies specific for different analytes and marked with discrete fluorescent labels are used to simultaneously capture and quantitate soluble analytes.",
    "id" : ""
  }, {
    "name" : "DNA methylation profiling assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000634",
    "description" : "An assay which aims to provide information about state of methylation of DNA molecules using genomic DNA collected from a material entity using a range of techniques and instrument such as DNA sequencers and often relying on treatment with bisulfites to ensure cytosine conversion.",
    "id" : ""
  }, {
    "name" : "DNA microarray",
    "link" : "http://purl.obolibrary.org/obo/OBI_0400148",
    "description" : "Microarray that is used as a physical 2D immobilisation matrix.",
    "id" : ""
  }, {
    "name" : "ELISA",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000661",
    "description" : "Enzyme-Linked ImmunoSorbant Assay. Quantification of a molecule (e.g cytokine) by an antibody immobilization strategy.",
    "id" : ""
  }, {
    "name" : "ELISPOT",
    "link" : "http://purl.obolibrary.org/obo/OBI_0600031",
    "description" : "Enzyme-linked ImmunoSPOT. A variant of ELISA with increased resolution that allows quantifying the number of cells in a population that release a molecule (e.g. cytokine).",
    "id" : ""
  }, {
    "name" : "EMSA",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001671",
    "description" : "Electrophoretic mobility shift assay  is an assay which aims to provide information about Protein-DNA or Protein-RNA interaction and which used gel electrophoresis and relies on the fact the molecular interactions will cause the heterodimer to be retarded on the gel when compared to controls corresponding to protein extract alone and protein extract + neutral nucleic acid.",
    "id" : ""
  }, {
    "name" : "Exome Sequencing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002118",
    "description" : "Technique for sequencing all the protein-coding genes in a genome (known as the exome). Sequencing process which uses deoxyribonucleic acid as input and results in a the creation of DNA sequence information artifact.",
    "id" : ""
  }, {
    "name" : "Flow Cytometry",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000916",
    "description" : "Fluorescence Activated Cell Sorting",
    "id" : ""
  }, {
    "name" : "Fluorescence Resonance Energy Transfer",
    "link" : "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C202404",
    "description" : "A process to measure the proximity of two fluorochromes whereby the excitation energy of one fluorochrome is released and absorbed by the second fluorochrome. It is used to study interactions and structure of macromolecules.",
    "id" : ""
  }, {
    "name" : "Fluorescent Antibody Procedure",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17370",
    "description" : "An immunological procedure in which the antibodies are coupled with molecules which fluoresce under ultra violet (UV) light. This makes them particularly suitable for detection of specific antigens in tissues or on cells.",
    "id" : ""
  }, {
    "name" : "GC_MS",
    "link" : "UMLS Metathesaurus Browser",
    "description" : "Gas Chromatography-Mass Spectrometry. A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.(MSH)",
    "id" : ""
  }, {
    "name" : "Genotyping Assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000435",
    "description" : "An assay which generates data about a genotype from a specimen of genomic DNA. A variety of techniques and instruments can be used to produce information about sequence variation at particular genomic positions. alternative term: SNP analysis; genotype profiling",
    "id" : ""
  }, {
    "name" : "Glycan profiling",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C93248",
    "description" : "The analytical process of characterizing and studying glycans, which are complex carbohydrates or sugars attached to proteins and lipids in biological systems. Glycans play crucial roles in various biological processes, including cell signaling, immune response, and protein folding",
    "id" : ""
  }, {
    "name" : "Hemagglutination Inhibition",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000875",
    "description" : "Quantitate serum antibody to a specific antigen by blocking agglutination of cells.",
    "id" : ""
  }, {
    "name" : "Histological Assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0600020",
    "description" : "An assay that uses visual examination of cells or tissue (or images of them) to make an assessment regarding a quality of the cells or tissue. This assay can include steps of staining, imaging, and judgement.",
    "id" : ""
  }, {
    "name" : "Histopathology",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C18190",
    "description" : "The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.",
    "id" : ""
  }, {
    "name" : "HLA Typing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002122",
    "description" : "Human Leukocyte Antigen typing.",
    "id" : ""
  }, {
    "name" : "HPLC",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002116",
    "description" : "High Performace Liquid Chromotography is used to separate components of a mixture by using a variety of chemical interactions between the substance being analyzed (analyte) and the chromatography column.",
    "id" : ""
  }, {
    "name" : "IgH Sequencing",
    "link" : "IgH Sequencing",
    "description" : "IgH Sequencing",
    "id" : ""
  }, {
    "name" : "Immune Repertoire Deep Sequencing",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C158249",
    "description" : "DNA sequencing of the full complement of genes associated with T and B cell antigen-specific receptors in an individual, performed with a high number of replications.",
    "id" : ""
  }, {
    "name" : "Immunoblot",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000854",
    "description" : "a western blot analysis is an assay which allows detection of protein present in a extract resolved on polyacrylamide gel by electrophoresis, transfered to a membrane made of nitrocellulose or polyvinylidene difluoride and immobilized using formaldehyde based cross linking.",
    "id" : ""
  }, {
    "name" : "Immunohistochemistry",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=ncit&ns=ncit&code=C23020",
    "description" : "Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate.",
    "id" : ""
  }, {
    "name" : "Immunoprecipitation",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001700",
    "description" : "An assay with the objective to determine presence of an analyte by mixing a solution of antigen and antibody and separating out bound antigen:antibody complexes using immunoprecipitation.",
    "id" : ""
  }, {
    "name" : "in situ Hybridization",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17562",
    "description" : "Uses a labelled complementary DNA or RNA strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or the entire tissue (whole mount ISH), in cells and in circulating tumor cells (CTCs).",
    "id" : ""
  }, {
    "name" : "Intracellular Cytokine Stain Flow Cytometric Assay",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C178026",
    "description" : "A technique that is used with flow cytometry to measure cytokine production in isolated cells. Cells are stimulated with an antigen or mitogen, and cytokine secretion is blocked using protein transport inhibitors. The cells are then stained with fluorochrome labeled monoclonal antibodies that target surface markers, fixed and permeabilized, and stained with fluorochrome labeled anti-cytokine monoclonal antibodies prior to analysis by flow cytometry. (NCI)",
    "id" : ""
  }, {
    "name" : "Iontrap_MS",
    "link" : "UMLS Metathesaurus Browser",
    "description" : "Sequential Mass Spectrometry. A mass spectrometry technique that uses an ion trap and Fourier-transform ion-cyclotron resonance (FT-ICR) type instrument to re-fragment the product ions from a mass spec pass. The process can be repeated n times where 'n' represents the number of times the isolation-fragmentation-measurement cycle has been carried out. (NCI)",
    "id" : ""
  }, {
    "name" : "KIR Typing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002121",
    "description" : "Killer cell immunoglobulin-like receptors.",
    "id" : ""
  }, {
    "name" : "Lateral Flow Assay",
    "link" : "http://purl.obolibrary.org/obo/MAXO_0000612",
    "description" : "A procedure using a paper-based platform for the detection and quantification of analytes in complex mixtures, where the sample is placed on a test device for clinical use.",
    "id" : ""
  }, {
    "name" : "LC_MS",
    "link" : "UMLS Metathesaurus Browser",
    "description" : "Liquid Chromatography Mass Spectrometry. An analytical technique wherein liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. (NCI)",
    "id" : ""
  }, {
    "name" : "Line Probe Assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000892",
    "description" : "PCR amplification of a genomic region is performed using biotinylated primers. Following amplification, labelled PCR products are hybridized with specific oligonucleotide probes immobilized on a strip.",
    "id" : ""
  }, {
    "name" : "Liquid Chromatography",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001057",
    "description" : "Chromatography is the collective term for a family of laboratory techniques for the separation of mixtures. It involves passing a mixture which contains the analyte through a stationary phase, which separates it from other molecules in the mixture and allows it to be isolated.",
    "id" : ""
  }, {
    "name" : "Luminex xMAP",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000920",
    "description" : "Microsphere based multiplexing system. Microspheres are color coded and linked to a detector or capture reagent (e.g. antibody, oligonucleotides, peptides, or receptors).",
    "id" : ""
  }, {
    "name" : "Mass Spectrometry",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000470",
    "description" : "Mass spectrometry is an analytical technique used to measure the mass-to-charge ratio of ions.",
    "id" : ""
  }, {
    "name" : "Meso Scale Discovery ECL",
    "link" : "http://en.wikipedia.org/wiki/Electrochemiluminescence",
    "description" : "MSD Electrochemiluminescence (ECL) detection uses labels that emit light when electrochemically stimulated.",
    "id" : ""
  }, {
    "name" : "Methylation Sequencing",
    "link" : "http://www.ebi.ac.uk/efo/EFO_0002761",
    "description" : "An assay in which the methylation state of DNA is determined and is compared between samples using sequencing based technology.",
    "id" : ""
  }, {
    "name" : "Microneutralization Assay",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C120695",
    "description" : "An in vitro assay that is used to determine whether antibodies that can block viral infection are present in a biological specimen. Virus is mixed with serum taken from the subject and is incubated in culture with laboratory cells, which are monitored over time for cytotoxicity.",
    "id" : ""
  }, {
    "name" : "microRNA profiling assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001926",
    "description" : "A transcription profiling assay in which aims to quantify the microRNA species within a biological sample.",
    "id" : ""
  }, {
    "name" : "Microscopy",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002119",
    "description" : "Visualization of very small entities from cellular to sub-cellular and molecular resolution depending on technique.",
    "id" : ""
  }, {
    "name" : "Mixed Lymphocyte Reaction",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002120",
    "description" : "Mixed lymphocyte reaction test is a measure of histocompatibility at the HLA locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days; lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (e.g. measured by tritiated thymidine uptake) whereas those from compatible individuals will not; in the one\\-way MLC test, the lymphocytes from one of the individuals are inactivated thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.",
    "id" : ""
  }, {
    "name" : "Molecular Cloning",
    "link" : "http://purl.obolibrary.org/obo/OBI_0600064",
    "description" : "Molecular cloning refers to the procedure isolating a DNA sequence of interest and obtaining multiple copies of it in an organism.",
    "id" : ""
  }, {
    "name" : "MS_MS",
    "link" : "UMLS Metathesaurus Browser",
    "description" : "Tandem Mass Spectrometry. An analytical technique where mass spectrometry is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. (NCI)",
    "id" : ""
  }, {
    "name" : "Multiplex Bead Array Assay",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=22.04d&ns=ncit&code=C135455",
    "description" : "A type of solid-phase immunoassay that uses distinctly colored microbeads coated with one or more reagents, which may be antigens, antibodies, oligonucleotides, enzyme substrates, or receptors, for the simultaneous detection and measurement of one or many analytes within a single sample.",
    "id" : ""
  }, {
    "name" : "Multiplex Immunoassay",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=22.04d&ns=ncit&code=C179019",
    "description" : "An assay that allows for the simultaneous measurement of multiple analytes in a single sample.",
    "id" : ""
  }, {
    "name" : "Nanostring",
    "link" : "http://www.bioassayontology.org/bao#BAO_0010047",
    "description" : "An assay that uses barcoded hybridization probes to quantify the expression of RNA transcripts by Nanostring technology which uses molecular \"barcodes\" and single molecule imaging to detect and count hundreds of unique transcripts in a single reaction.",
    "id" : ""
  }, {
    "name" : "Nanostring nCounter miRNA expression assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002142",
    "description" : "A microRNA profiling assay using digital molecular barcoding technology to quantify target microRNA molecules without the need for amplification",
    "id" : ""
  }, {
    "name" : "Neuraminidase Inhibition Assay",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C120696",
    "description" : "A type of enzyme-based assay that assesses neuraminidase activity in the presence of an enzyme inhibitor.",
    "id" : ""
  }, {
    "name" : "Neutralizing Antibody Titer Assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000872",
    "description" : "A quantitative assay where different dilutions of serum are mixed with virus and used to infect cells. At the lower dilutions, antibodies will block infection, but at higher dilutions, there will be too few antibodies to have an effect. The simple process of dilution provides a way to compare the virus- neutralizing abilities of different sera. The neutralization titer is expressed as the reciprocal of the highest dilution at which virus infection is blocked.",
    "id" : ""
  }, {
    "name" : "NMR",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000623",
    "description" : "Nuclear Magnetic Resonance spectroscopy is a technique for determining the structure of organic compounds.",
    "id" : ""
  }, {
    "name" : "Northern Blot",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000860",
    "description" : "Northern blots are a derivative of Southern blots where RNA that has been size fractionated (often by 1-D gel electrophoresis) is immobilized on a substrate (e.g. a charged nylon membrane). The blot is(are) hybridized with a labeled probe(s). The position on the blot and the intensity of the label's signal can be used to estimate RNA size and concentration, respectively.",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "Not Specified",
    "description" : "Not Specified",
    "id" : ""
  }, {
    "name" : "Olink assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0003112",
    "description" : "A proximity extension assay that uses quantitative polymerase chain reaction (qPCR) technology to determine the concentration/presence of proteins using a high-multiplex, high-throughput protein biomarker platform. The assay utilizes two distinct oligonucleotide-labeled antibodies ( probes ) that bind at different sites for each detected protein. When the two probes are in close proximity, a new PCR target sequence is formed by a proximity-dependent DNA polymerization event. The resulting sequence is subsequently detected and quantified using standard real-time PCR.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "Other Experiment Measurement Technique not listed.",
    "id" : ""
  }, {
    "name" : "PCR",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000415",
    "description" : "Polymerase Chain Reaction is a technique to amplify a DNA template.",
    "id" : ""
  }, {
    "name" : "phage display binding assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001476",
    "description" : "A binding assay in which a collection of phages expressing a library of different peptides or protein fragnments is used to infect cells, followed by screening for cells that bind a protein of interest, and identifiying the sequence of infecting phages to determine a suitable binding partner.",
    "id" : ""
  }, {
    "name" : "Plaque Reduction Neutralization Assay",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=22.04d&ns=ncit&code=C172555",
    "description" : "A serological test that measures the ability of antibodies in specific concentrations of serum to prevent the formation of plaques in a cell monolayer when combined with a viral suspension.",
    "id" : ""
  }, {
    "name" : "Protein microarray",
    "link" : "http://purl.obolibrary.org/obo/OBI_0400149",
    "description" : "Microarray, usually a piece of glass, on which different molecules of protein have been affixed at separate locations in an ordered manner. These are used to identify protein-protein or protein-small molecule interactions.",
    "id" : ""
  }, {
    "name" : "Pseudovirus Neutralization Assay",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C172552",
    "description" : "An immunoassay that is used to determine whether antibodies that can block pseudovirus replication are present in a biological specimen.",
    "id" : ""
  }, {
    "name" : "Q-PCR",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000893",
    "description" : "Quantitative Polymerase Chain Reaction is used to measure the gene expression of transcripts by comparing the number of cycles in a sample needed to reach a certain threshold value with the known quantities of a transcript needed to reach the same threshold. It is an alternative term of Quantitative Real Time Polymerase Chain Reaction",
    "id" : ""
  }, {
    "name" : "Real time polymerase chain reaction assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000893",
    "description" : "A laboratory technique based on the PCR, which is used to amplify and simultaneously quantify a specific DNA molecule based on the use of complementary probes/primers. It enables both detection and quantification (as absolute number of copies or relative amount when normalized to DNA input or additional normalizing genes) of one or more specific sequences in a DNA sample.",
    "id" : ""
  }, {
    "name" : "Respiratory Pathogen Panel",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C132852",
    "description" : "A diagnostic test for respiratory pathogens that uses PCR for differential diagnosis during upper or lower respiratory tract infection.",
    "id" : ""
  }, {
    "name" : "RNA sequencing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001177;http://purl.obolibrary.org/obo/OBI_0001271",
    "description" : "Sequencing process which uses ribonucleic acid as input and results in a the creation of RNA sequence information artifact.",
    "id" : ""
  }, {
    "name" : "Rnase Protection Assay",
    "link" : "http://en.wikipedia.org/wiki/RNase_protection_assay",
    "description" : "A laboratory technique to identify individual RNA molecules in a heterogeneous RNA sample extracted from cells.",
    "id" : ""
  }, {
    "name" : "SARS-CoV-2 Virus Sequencing",
    "link" : "SARS-CoV-2 Virus Sequencing",
    "description" : "SARS-CoV-2 Virus Sequencing",
    "id" : ""
  }, {
    "name" : "scRNA-seq",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002631",
    "description" : "single-cell RNA sequencing assay. An RNA sequencing assay that uses RNA extracts as input that can be traced to a single cell of origin.",
    "id" : ""
  }, {
    "name" : "Sequencing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0600047",
    "description" : "Sequencing is used to discover new sequence variants and to genotype a sample for known variants.",
    "id" : ""
  }, {
    "name" : "Single-Molecule Array (SIMOA)",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5205784",
    "description" : "A type of enzyme-linked immunoassay in which single molecules can be detected through the use of femtomolar-sized reaction chambers and an excess of fluorescently labeled antibody-bound beads. (NCI)",
    "id" : ""
  }, {
    "name" : "SNP microarray",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001204",
    "description" : "DNA microarray used to detect polymorphisms in DNA samples.",
    "id" : ""
  }, {
    "name" : "SOMAscan assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0003111",
    "description" : "An analyte assay that uses aptamers to detect protein analytes in serum.",
    "id" : ""
  }, {
    "name" : "Southern Blot",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000892",
    "description" : "A Southern blot is a method of capturing DNA molecules that have been seperated by agarose gel electrophoresis for subsequent analysis.",
    "id" : ""
  }, {
    "name" : "Spectral Flow Cytometry",
    "link" : "https://www.thermofisher.com/us/en/home/life-science/cell-analysis/flow-cytometry/flow-cytometry-learning-center/flow-cytometry-resource-library/flow-cytometry-methods/spectral-flow-cytometry-fundamentals.html",
    "description" : "Spectral flow cytometry is based on many of the fundamental aspects of conventional flow cytometry but has unique optical collection and analytical capabilities. With spectral flow cytometry, the emission spectrum of every fluorescence molecule is captured by a set of detectors across a defined wavelength range. Every molecule's fluorescent spectrum can be recognized, recorded as a spectral signature, and used as reference in multicolor applications.",
    "id" : ""
  }, {
    "name" : "Surface Plasmon Resonance",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000923",
    "description" : "An assay that uses the detection of electromagnetic waves in a surface to detect material entities adsorbed to the surface, which changes the local index of refraction.",
    "id" : ""
  }, {
    "name" : "T cell receptor repertoire sequencing assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002990",
    "description" : "T cell receptor repertoire sequencing assay",
    "id" : ""
  }, {
    "name" : "TCID50",
    "link" : "http://en.wikipedia.org/wiki/Virus_Quantification",
    "description" : "50 percent Tissue Culture Infective Dose, (TCID50) is the measure of infectious virus titer. This endpoint dilution assay quantifies the amount of virus required to kill 50% of infected hosts or to produce a cytopathic effect in 50% of inoculated tissue culture cells.",
    "id" : ""
  }, {
    "name" : "Transcription profiling assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000424",
    "description" : "An assay which aims to provide information about gene expression and transcription activity using ribonucleic acids collected from a material entity using a range of techniques and instrument such as DNA sequencers, DNA microarrays, Northern Blot",
    "id" : ""
  }, {
    "name" : "Transcription profiling by array",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001463",
    "description" : "An assay in which the transcriptome of a biological sample is analyzed using array technology.",
    "id" : ""
  }, {
    "name" : "Transcription Profiling by NanoString",
    "link" : "http://www.ebi.ac.uk/efo/EFO_0030058",
    "description" : "The NanoString nCounter gene expression system uses multiplexed probe hybridization to capture and count individual mRNA transcripts. Transcripts for each gene are targeted by a pair of gene-specific probes - a biotinylated capture probe to capture the transcript on a streptavidin-coated slide, and a reporter probe containing a color-coded pattern of fluorescent segments. Imaging of the slide can then identify each captured transcript. PMID:18278033]",
    "id" : ""
  }, {
    "name" : "Virus Neutralization",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000872",
    "description" : "Block a viral function.",
    "id" : ""
  }, {
    "name" : "Virus Plaque Assay",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C174336",
    "description" : "An assay that is used to determine viral quantity by infecting monolayers of host cells with serially diluted virus, covering the monolayers with an immobilizing overlay after a period of incubation to restrict the spread of the virus to neighboring cells, and counting the resulting visible plaques of infected cells.",
    "id" : ""
  }, {
    "name" : "Western Blot",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000854",
    "description" : "Western blot is a method in molecular biology/biochemistry/immunogenetics to detect protein in a given sample of tissue homogenate or extract. It uses gel electrophoresis to separate denatured proteins by mass. The proteins are then transferred out of the gel and onto a membrane (typically nitrocellulose), where they are probed using antibodies specific to the protein. As a result, researchers can examine the amount of protein in a given sample and compare levels between several groups. Other techniques also using antibodies allow detection of proteins in tissues (immunohistochemistry) and cells (immunocytochemistry). The confirmatory HIV test employs a western blot to detect anti-HIV antibody in a human serum sample. A Western blot is also used as the definitive test for Bovine spongiform encephalopathy (BSE, commonly referred to as 'mad cow disease'). Some forms of Lyme disease testing employ Western blotting.",
    "id" : ""
  }, {
    "name" : "Whole Genome Sequencing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002117",
    "description" : "Laboratory process that determines the complete DNA sequence of an organism's genome at a single time. Sequencing process which uses deoxyribonucleic acid as input and results in a the creation of DNA sequence information artifact",
    "id" : ""
  }, {
    "name" : "Whole Virome Sequencing Assay",
    "link" : "http://purl.obolibrary.org/obo/OBI_0002768",
    "description" : "A whole metagenome sequencing assay that intends to provide information on multiple genome sequences from different viruses present in the same input sample.",
    "id" : ""
  }, {
    "name" : "X-Ray Crystallography",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17672",
    "description" : "A technique in crystallography in which the pattern produced by the diffraction of x-rays through the closely spaced lattice of atoms in a crystal is recorded and then analyzed to reveal the nature of that lattice.",
    "id" : ""
  }, {
    "name" : "Yeast Two Hybrid",
    "link" : "http://purl.obolibrary.org/obo/OBI_0001679",
    "description" : "Two-hybrid screening is a molecular biology technique used to discover protein-protein interactions by testing for physical interactions (such as binding) between two proteins.",
    "id" : ""
  } ]
}, {
  "name" : "lk_exposure_material",
  "rows" : [ {
    "name" : "exposure_material_preferred ;\nexposure_material_id",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "2008-2009 trivalent influenza vaccine ; VO:0004809",
    "link" : "http://purl.obolibrary.org/obo/VO_0004809",
    "description" : "2008-2009 trivalent influenza vaccine",
    "id" : null
  }, {
    "name" : "2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008) ; VO:0004810",
    "link" : "http://purl.obolibrary.org/obo/VO_0004810",
    "description" : "2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008)",
    "id" : null
  }, {
    "name" : "ACWY Vax ; VO:0003138",
    "link" : "http://purl.obolibrary.org/obo/VO_0003138",
    "description" : "ACWY Vax",
    "id" : null
  }, {
    "name" : "Ad35.CS.01 malaria vaccine ; VO:0004993",
    "link" : "http://purl.obolibrary.org/obo/VO_0004993",
    "description" : "A P. falciparum malaria vaccine that is formed by tull length CS-expressing replication-deficient recombinant human adenovirus 35.",
    "id" : null
  }, {
    "name" : "AdCOVID ; VO_0005153",
    "link" : "http://purl.obolibrary.org/obo/VO_0005153",
    "description" : "AdCOVID",
    "id" : null
  }, {
    "name" : "Alternaria alternata ; NCBITaxon:5599",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_5599",
    "description" : "species, ascomycetes",
    "id" : null
  }, {
    "name" : "BCG Vaccine ; VO:0000771",
    "link" : "http://purl.obolibrary.org/obo/VO_0000771",
    "description" : "BCG Vaccine is a Mycobacterium tuberculosis vaccine that is a live attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin; BCG).",
    "id" : null
  }, {
    "name" : "Borreliella burgdorferi ; NCBITaxon:139",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_139",
    "description" : "Borreliella burgdorferi",
    "id" : null
  }, {
    "name" : "Chikungunya virus ; NCBITaxon:37124",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_37124",
    "description" : "Found from reported data using NCBI Taxomony Dump: 37124",
    "id" : null
  }, {
    "name" : "Chlamydia trachomatis ; NCBITaxon:813",
    "link" : "https://ontobee.org/ontology/NCBITaxon?iri=http://purl.obolibrary.org/obo/NCBITaxon_813",
    "description" : "Chlamydia trachomatis",
    "id" : null
  }, {
    "name" : "CureVac AG ; VO:0005208",
    "link" : "http://purl.obolibrary.org/obo/VO_0005208",
    "description" : "CureVac AG",
    "id" : null
  }, {
    "name" : "Cytomegalovirus ; NCBITaxon:10358",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10358",
    "description" : "Cytomegalovirus",
    "id" : null
  }, {
    "name" : "Dengue virus 1 ; NCBITaxon:11053",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_11053",
    "description" : "Dengue virus 1",
    "id" : null
  }, {
    "name" : "Dengue virus 2 ; NCBITaxon:11060",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_11060",
    "description" : "Dengue virus 2",
    "id" : null
  }, {
    "name" : "Dengue virus 3 ; NCBITaxon:11069",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_11069",
    "description" : "Found from reported data using NCBI Taxomony Dump: 11069",
    "id" : null
  }, {
    "name" : "Dengue virus ; NCBITaxon:12637",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_12637",
    "description" : "Dengue virus",
    "id" : null
  }, {
    "name" : "diphtheria, tetanus and whole cell pertussis vaccine ; VO:0003106",
    "link" : "http://purl.obolibrary.org/obo/VO_0003106",
    "description" : "diphtheria, tetanus and whole cell pertussis vaccine",
    "id" : null
  }, {
    "name" : "Diphtheria-Tetanus-Pertussis vaccine ; VO:0000738",
    "link" : "http://purl.obolibrary.org/obo/VO_0000738",
    "description" : "Diphtheria-Tetanus-Pertussis vaccine",
    "id" : null
  }, {
    "name" : "Dryvax ; VO:0000035",
    "link" : "http://purl.obolibrary.org/obo/VO_0000035",
    "description" : "a vaccinia virus vaccine that is a freeze-dried calf lymph smallpox vaccine, specifically, Dryvax is a live-virus preparation of vaccinia prepared from calf lymph.",
    "id" : null
  }, {
    "name" : "Engerix-B ; VO:0010711",
    "link" : "http://purl.obolibrary.org/obo/VO_0010711",
    "description" : "Engerix-B",
    "id" : null
  }, {
    "name" : "Fluarix ; VO:0000045",
    "link" : "http://purl.obolibrary.org/obo/VO_0000045",
    "description" : "Fluarix",
    "id" : null
  }, {
    "name" : "FluMist ; VO:0000044",
    "link" : "http://purl.obolibrary.org/obo/VO_0000044",
    "description" : "FluMist",
    "id" : null
  }, {
    "name" : "Fluvirin ; VO:0000046",
    "link" : "http://purl.obolibrary.org/obo/VO_0000046",
    "description" : "Fluvirin",
    "id" : null
  }, {
    "name" : "Fluzone ; VO:0000047",
    "link" : "http://purl.obolibrary.org/obo/VO_0000047",
    "description" : "Fluzone",
    "id" : null
  }, {
    "name" : "Hepacivirus C ; NCBITaxon:11103",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_11103",
    "description" : "Found from reported data using NCBI Taxomony Dump: 11103",
    "id" : null
  }, {
    "name" : "Hepatitis B surface antigen vaccine ; VO_0003150",
    "link" : "http://purl.obolibrary.org/obo/VO_0003150",
    "description" : "A Hepatitis B virus vaccine that uses recombinant Hepatitis B surface antigen as the antigen",
    "id" : null
  }, {
    "name" : "Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B] ; VO_0003270",
    "link" : "http://purl.obolibrary.org/obo/VO_0003270",
    "description" : "Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B]",
    "id" : null
  }, {
    "name" : "Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B] ; VO_0003258",
    "link" : "http://purl.obolibrary.org/obo/VO_0003258",
    "description" : "Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B]",
    "id" : null
  }, {
    "name" : "Hepatitis B virus ; NCBITaxon:10407",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10407",
    "description" : "Hepatitis B virus",
    "id" : null
  }, {
    "name" : "Hepatitis B virus vaccine ; VO_0000644",
    "link" : "http://purl.obolibrary.org/obo/VO_0000644",
    "description" : "A viral vaccine that protects against infection with Hepatitis B virus.",
    "id" : null
  }, {
    "name" : "HEPLISAV-B ; VO:0003152",
    "link" : "http://purl.obolibrary.org/obo/VO_0003152",
    "description" : "A Hepatitis B surface antigen viral vaccine that utilizes a cytidine-phosphate-guanosine oligodeoxynucleotide (CpGODN) 1018, as an adjuvant.",
    "id" : null
  }, {
    "name" : "Human alphaherpesvirus 3 ; NCBITaxon:10335",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10335",
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "Human gammaherpesvirus 4 (Epstein-Barr virus) ; NCBITaxon:10376",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10376",
    "description" : "Human gammaherpesvirus 4 (Epstein-Barr virus)",
    "id" : null
  }, {
    "name" : "human immunodeficiency virus infectious disease ; DOID:526",
    "link" : "http://purl.obolibrary.org/obo/DOID_526",
    "description" : "A viral infectious disease that results in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted by sexual contact, transmitted by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted by congenital method, and transmitted by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has symptom diarrhea, has symptom fatigue, has symptom fever, has symptom vaginal yeast infection, has symptom headache, has symptom mouth sores, has symptom muscle aches, has symptom sore throat, and has symptom swollen lymph glands.",
    "id" : null
  }, {
    "name" : "human immunodeficiency virus vaccine ; VO_0000295",
    "link" : "http://purl.obolibrary.org/obo/VO_0000295",
    "description" : "A viral vaccine that protects against infection with human immunodeficiency virus that causes AIDS.",
    "id" : null
  }, {
    "name" : "Human rhinovirus A16 ; NCBITaxon:31708",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_31708",
    "description" : "Found from reported data using NCBI Taxomony Dump: 31708",
    "id" : null
  }, {
    "name" : "inactivated influenza vaccine ; VO_0001176",
    "link" : "http://purl.obolibrary.org/obo/VO_0001176",
    "description" : "inactivated influenza vaccine is an inactivated viral vaccine that targets at influenza viral infections.",
    "id" : null
  }, {
    "name" : "Influenza A H1N1 2009 Monovalent Vaccine Novartis ; VO:0000081",
    "link" : "http://purl.obolibrary.org/obo/VO_0000081",
    "description" : "Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis)",
    "id" : null
  }, {
    "name" : "Influenza A virus (A/California/7/2009(H1N1)) ; NCBITaxon:1316510",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_1316510",
    "description" : "Found from reported data using NCBI Taxomony Dump: 1316510",
    "id" : null
  }, {
    "name" : "Influenza A virus (A/reassortant/FluMist(California/07/2009 x Ann Arbor/6/1960)(H1N1)) ; NCBITaxon:1701435",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_1701435",
    "description" : "Found from reported data using NCBI Taxomony Dump: 1701435",
    "id" : null
  }, {
    "name" : "Influenza A virus ; NCBITaxon:11320",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_11320",
    "description" : "Influenza A virus",
    "id" : null
  }, {
    "name" : "Influenza virus vaccine ; VO:0000642",
    "link" : "http://purl.obolibrary.org/obo/VO_0000642",
    "description" : "A viral vaccine that protects against infection with influenza virus.",
    "id" : null
  }, {
    "name" : "Influvac ; VO_0000867",
    "link" : "http://purl.obolibrary.org/obo/VO_0000867",
    "description" : "Influvac is an Influenza virus vaccine that is manufactured by Solvay Pharma.",
    "id" : null
  }, {
    "name" : "Ionizing Radiation ; NCIT:C17052",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17052",
    "description" : "High-energy radiation capable of producing ionization in substances through which it passes.",
    "id" : null
  }, {
    "name" : "Johnson & Johnson COVID-19 vaccine ; VO:0005159",
    "link" : "http://purl.obolibrary.org/obo/VO_0005159",
    "description" : "A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 vector expressing S protein, Ad26COVS1; JNJ-78436735",
    "id" : null
  }, {
    "name" : "LC16m8 ; VO:0004091",
    "link" : "http://purl.obolibrary.org/obo/VO_0004091",
    "description" : "LC16m8",
    "id" : null
  }, {
    "name" : "live attenuated influenza vaccine ; VO_0001178",
    "link" : "http://purl.obolibrary.org/obo/VO_0001178",
    "description" : "live attenuated influenza vaccine is a live attenuated vaccine that protects against influenza viral infection.",
    "id" : null
  }, {
    "name" : "Menactra ; VO:0000071",
    "link" : "http://purl.obolibrary.org/obo/VO_0000071",
    "description" : "Menactra",
    "id" : null
  }, {
    "name" : "Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C ; VO:0010725",
    "link" : "http://purl.obolibrary.org/obo/VO_0010725",
    "description" : "Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C",
    "id" : null
  }, {
    "name" : "Menveo ; VO:0001246",
    "link" : "http://purl.obolibrary.org/obo/VO_0001246",
    "description" : "Menveo",
    "id" : null
  }, {
    "name" : "Moderna COVID-19 vaccine ; VO:0005157",
    "link" : "http://purl.obolibrary.org/obo/VO_0005157",
    "description" : "A SARS-CoV2 RNA vaccine made of lipid nanoparticle with mRNA which encodes the S-2P antigen, made of the SARS-CoV-2 glycoprotein with a transmembrane anchor and intact S1-S2 cleavage site",
    "id" : null
  }, {
    "name" : "MRKAd5 HIV-1 gag/pol/nef ; VO:0003133",
    "link" : "http://purl.obolibrary.org/obo/VO_0003133",
    "description" : "The MRK adenovirus type 5 human immunodeficiency virus type 1 clade B gag/pol/nef vaccine is a replication-incompetent adenovirus type 5-vectored vaccine that elicits cell-mediated immunity against conserved human immunodeficiency virus proteins.",
    "id" : null
  }, {
    "name" : "MVA85A ; VO:0003120",
    "link" : "http://purl.obolibrary.org/obo/VO_0003120",
    "description" : "MVA85A",
    "id" : null
  }, {
    "name" : "Mycobacterium tuberculosis ; NCBITaxon:1773",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_1773",
    "description" : "Mycobacterium tuberculosis",
    "id" : null
  }, {
    "name" : "NVX-CoV2373 ; VO:0005155",
    "link" : "http://purl.obolibrary.org/obo/VO_0005155",
    "description" : "A SARS-CoV 2 (rSARS-CoV-2) subunit vaccine made of nanoparticles composed of a trimeric full-length SARS-CoV-2 spike glycoprotein and Matrix-M1 adjuvant",
    "id" : null
  }, {
    "name" : "Other ; Other",
    "link" : "Other",
    "description" : "Other",
    "id" : null
  }, {
    "name" : "Oxford AstraZeneca COVID-19 vaccine ; VO:0005158",
    "link" : "http://purl.obolibrary.org/obo/VO_0005158",
    "description" : "A SARS-CoV2 recombinat vector vaccine made of a chimpanzee adenovirus-vectored vaccine expressing the SARS-CoV-2 spike protein",
    "id" : null
  }, {
    "name" : "P. falciparum RTS,S/AS01 ; VO:0003093",
    "link" : "http://purl.obolibrary.org/obo/VO_0003093",
    "description" : "A malaria vaccine that consists of hepatitis B surface antigen virus-like particles, incorporating a portion of the Plasmodium falciparum-derived circumsporozoite protein and a liposome-based adjuvant.",
    "id" : null
  }, {
    "name" : "Pfizer BioNTech COVID-19 vaccine ; VO:0004987",
    "link" : "http://purl.obolibrary.org/obo/VO_0004987",
    "description" : "A SARS-CoV-2 RNA vaccine formed from a lipid nanoparticle-formulated trimerized SARS-CoV-2 receptor-binding domain",
    "id" : null
  }, {
    "name" : "PfSPZ Vaccine ; VO:0004910",
    "link" : "http://purl.obolibrary.org/obo/VO_0004910",
    "description" : "a malaria vaccine that protects against malaria caused by Plasmodium falciparum",
    "id" : null
  }, {
    "name" : "PfSPZ-CVac ; VO:0004911",
    "link" : "http://purl.obolibrary.org/obo/VO_0004911",
    "description" : "a malaria vaccine that protects against malaria caused by Plasmodium falciparum",
    "id" : null
  }, {
    "name" : "PfSPZ-GA1 ; VO:0004912",
    "link" : "http://purl.obolibrary.org/obo/VO_0004912",
    "description" : "a malaria vaccine that protects against malaria caused by Plasmodium falciparum",
    "id" : null
  }, {
    "name" : "Plasmodium coatneyi ; NCBITaxon:208452",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_208452",
    "description" : "Found from reported data using NCBI Taxomony Dump: 208452",
    "id" : null
  }, {
    "name" : "Plasmodium cynomolgi strain B ; NCBITaxon:1120755",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_1120755",
    "description" : "Found from reported data using NCBI Taxomony Dump: 1120755",
    "id" : null
  }, {
    "name" : "Plasmodium cynomolgi strain Ceylon ; NCBITaxon:5829",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_5829",
    "description" : "Found from reported data using NCBI Taxomony Dump: 5829",
    "id" : null
  }, {
    "name" : "Plasmodium falciparum ; NCBITaxon:5833",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_5833",
    "description" : "malaria parasite P. falciparum",
    "id" : null
  }, {
    "name" : "Plasmodium falciparum vaccine ; VO:0000087",
    "link" : "http://purl.obolibrary.org/obo/VO_0000087",
    "description" : "a malaria vaccine that protects against malaria caused by Plasmodium falciparum.",
    "id" : null
  }, {
    "name" : "Plasmodium vivax ; NCBITaxon:5855",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_5855",
    "description" : "Found from reported data using NCBI Taxomony Dump: 5855",
    "id" : null
  }, {
    "name" : "Pneumovax 23 ; VO:0000088",
    "link" : "http://purl.obolibrary.org/obo/VO_0000088",
    "description" : "Pneumovax 23",
    "id" : null
  }, {
    "name" : "quadrivalent inactivated influenza vaccine ; VO_0010196",
    "link" : "https://www.ebi.ac.uk/ols4/ontologies/vo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FVO_0010196",
    "description" : "quadrivalent inactivated influenza vaccine",
    "id" : null
  }, {
    "name" : "Respiratory syncytial virus ; NCBITaxon:12814",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_12814",
    "description" : "Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults.",
    "id" : null
  }, {
    "name" : "rVSV-EBOV ; VO:0004660",
    "link" : "http://purl.obolibrary.org/obo/VO_0004660",
    "description" : "An Ebola virus vaccine that uses a recombinant vesicular stomatitis virus (rVSV) vector expressing an Ebola filovirus glycoprotein",
    "id" : null
  }, {
    "name" : "SARS Coronavirus 2 B.1.1.529 ; UMLS_CUI:C5564753",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5564753",
    "description" : "WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, T95I, G142D, N211I, G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, D796Y, N856K, Q954H, N969K and L981F. (NCI)",
    "id" : null
  }, {
    "name" : "SARS Coronavirus 2 BA.1 ; UMLS_CUI:C5706968",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5706968",
    "description" : "WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, T95I, G142D, N211I, G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K and L981F. (NCI).",
    "id" : null
  }, {
    "name" : "SARS Coronavirus 2 BA.2 ; UMLS_CUI:C5670041",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5670041",
    "description" : "WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI)",
    "id" : null
  }, {
    "name" : "SARS Coronavirus 2 BA.3 ; UMLS_CUI:C5706967",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5706967",
    "description" : "WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, G142D, N211I, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI)",
    "id" : null
  }, {
    "name" : "SARS Coronavirus 2 BA.4 ; UMLS_CUI:C5706966",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5706966",
    "description" : "WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and 69/70 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. This variant has two novel amino acid variations, a D61L substitution in the ORF6 protein and a L11F in the ORF7b protein. (NCI)",
    "id" : null
  }, {
    "name" : "SARS Coronavirus 2 BA.5 ; UMLS_CUI:C5706965",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5706965",
    "description" : "WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and 69/70 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI)",
    "id" : null
  }, {
    "name" : "SARS Coronavirus 2 C.37 ; UMLS_CUI:C5556619",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5556619",
    "description" : "WHO Name: Lambda. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 247-253 and amino acid substitutions G75V, T76I, L452Q, F490S, D614G and T859N. (NCI)",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 ; NCBITaxon:2697049",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_2697049",
    "description" : "Severe acute respiratory syndrome coronavirus 2, equivalent: 2019-nCoV",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 B.1.1.7 variant ; UMLS_CUI:C5433393",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5433393",
    "description" : "A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69, 70 and 144 and amino acid substitutions N501Y, A570D, D614G, P681H, T716I, S982A and D1118H. The substitutions E484K, S494P and K1191N have also been detected in some but not all sequences for this lineage. (NCI). Also known as B.1.1.7, 20I/501Y.V1, VOC - 202012/01, and UK variant (LNC)",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 B.1.351 variant ; UMLS_CUI:C5433395",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5433395",
    "description" : "A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 241-242 and amino acid substitutions D80A, D215G, K417N, E484K, N501Y, D614G and A701V. (NCI). Also known as B.1.351, 501Y.V2, and South Africa variant (LNC)",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 B.1.617.2 lineage ; UMLS_CUI:C5548982",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5548982",
    "description" : "Also known as WHO Delta variant (LNC)",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 D614G variant ; UMLS_CUI:C5433391",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5433391",
    "description" : "Known as SARS-CoV-2 USA-WA1/2020. https://www.ncbi.nlm.nih.gov/biosample/SAMN18527778",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 Mu variants ; UMLS_CUI:C5564751",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5564751",
    "description" : "A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: an amino acid insertion 146N and amino acid substitutions T95I, Y144T, Y145S, R346K, E484K, N501Y, D614G, P681H and D950N. (NCI). Also known as SARS-CoV-2 B.1.621.",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 P.1 variant ; UMLS_CUI:C5433398",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5433398",
    "description" : "A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I and V1176F. (NCI). Also known as SARS-CoV-2 Gamma; P.1",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 P.2 variant ; UMLS_CUI:C5433392",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5433392",
    "description" : "WHO Name: Zeta. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions E484K, D614G and V1176F. The substitution F565L has also been detected in some but not all sequences for this lineage. (NCI).",
    "id" : null
  }, {
    "name" : "Schistosoma mansoni ; NCBITaxon:6183",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_6183",
    "description" : "Found from reported data using NCBI Taxomony Dump: 6183",
    "id" : null
  }, {
    "name" : "Shigella flexneri 2a ; NCBITaxon:42897",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_42897",
    "description" : "Shigella flexneri, serovar 2a. Extended spectrum beta-lactamase producing Shigella flexneri serovar 2a (133131000112102) SNOMEDCT_US",
    "id" : null
  }, {
    "name" : "Shigella sonnei ; NCBITaxon:624",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_624",
    "description" : "A lactose-fermenting bacterium causing dysentery",
    "id" : null
  }, {
    "name" : "Sinopharm (BBIBP-CorV) ; VO:0005166",
    "link" : "http://purl.obolibrary.org/obo/VO_0005166",
    "description" : "A SARS-CoV-2 inactivated whole virus vaccine that produced in Vero cells that is developed by the Beijing Institute of Biological Products.",
    "id" : null
  }, {
    "name" : "Sputnik V ; VO:0005163",
    "link" : "http://purl.obolibrary.org/obo/VO_0005163",
    "description" : "A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 and Ad5 vectors expressing S protein that lyophilised.",
    "id" : null
  }, {
    "name" : "Stamaril ; VO:0003139",
    "link" : "http://purl.obolibrary.org/obo/VO_0003139",
    "description" : "It is live attenuated YFV vaccine strain 17D manufactured in China, France, Senegal, and the USA. In powder and solvent for suspension for injection in pre-filled syringe.",
    "id" : null
  }, {
    "name" : "Staphylococcus aureus ; NCBITaxon:1280",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_1280",
    "description" : "Staphylococcus aureus is a Gram-positive, round-shaped bacterium that is a member of the Firmicutes, and it is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin.",
    "id" : null
  }, {
    "name" : "unidentified ; NCBITaxon:32644",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_32644",
    "description" : "Found from reported data using NCBI Taxomony Dump: 32644",
    "id" : null
  }, {
    "name" : "Vaccinia virus LC16M8 ; NCBITaxon:10248",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10248",
    "description" : "Found from reported data using NCBI Taxomony Dump: 10248",
    "id" : null
  }, {
    "name" : "Varicella-zoster virus vaccine ; VO:0000669",
    "link" : "http://purl.obolibrary.org/obo/VO_0000669",
    "description" : "a Herpesvirus vaccine that is used against Varicella-zoster virus infection.",
    "id" : null
  }, {
    "name" : "West Nile virus ; NCBITaxon:11082",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_11082",
    "description" : "West Nile virus",
    "id" : null
  }, {
    "name" : "Yellow fever 17D vaccine vector ; VO:0000122",
    "link" : "http://purl.obolibrary.org/obo/VO_0000122",
    "description" : "a viral vaccine vector that uses Yellow fever vaccine strain 17D as the vector.",
    "id" : null
  }, {
    "name" : "YF-Vax ; VO:0000121",
    "link" : "http://purl.obolibrary.org/obo/VO_0000121",
    "description" : "YF-Vax",
    "id" : null
  }, {
    "name" : "Zika virus ; NCBITaxon:64320",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_64320",
    "description" : "Found from reported data using NCBI Taxomony Dump: 64320",
    "id" : null
  }, {
    "name" : "Zostavax ; VO:0000124",
    "link" : "http://purl.obolibrary.org/obo/VO_0000124",
    "description" : "Zostavax",
    "id" : null
  } ]
}, {
  "name" : "lk_exposure_material_pref_map",
  "rows" : [ {
    "name" : "exposure_material_reported",
    "link" : null,
    "description" : "exposure_material_preferred",
    "id" : null
  }, {
    "name" : "0.5 ml hepatitis b surface antigen vaccine 0.04 mg/ml injection [heplisav-b]",
    "link" : null,
    "description" : "Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B]",
    "id" : null
  }, {
    "name" : "1 ml hepatitis b surface antigen vaccine 0.02 mg/ml injection [engerix-b]",
    "link" : null,
    "description" : "Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B]",
    "id" : null
  }, {
    "name" : "17D-204",
    "link" : null,
    "description" : "Stamaril",
    "id" : null
  }, {
    "name" : "2011-2012 trivalent inactivated vaccine",
    "link" : null,
    "description" : "2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008)",
    "id" : null
  }, {
    "name" : "ACWYVax",
    "link" : null,
    "description" : "ACWY Vax",
    "id" : null
  }, {
    "name" : "Bacillus Calmette Guerin",
    "link" : null,
    "description" : "BCG Vaccine",
    "id" : null
  }, {
    "name" : "Bacillus tuberculosis",
    "link" : null,
    "description" : "Mycobacterium tuberculosis",
    "id" : null
  }, {
    "name" : "Bacterium tuberculosis",
    "link" : null,
    "description" : "Mycobacterium tuberculosis",
    "id" : null
  }, {
    "name" : "Borrelia burdorferi",
    "link" : null,
    "description" : "Borreliella burgdorferi",
    "id" : null
  }, {
    "name" : "Borrelia burgdorferi",
    "link" : null,
    "description" : "Borreliella burgdorferi",
    "id" : null
  }, {
    "name" : "Borrelia burgdorferi sensu stricto",
    "link" : null,
    "description" : "Borreliella burgdorferi",
    "id" : null
  }, {
    "name" : "Borrelia burgdorffragment",
    "link" : null,
    "description" : "Borreliella burgdorferi",
    "id" : null
  }, {
    "name" : "chickenpox and shingles virus vaccine",
    "link" : null,
    "description" : "Varicella-zoster virus vaccine",
    "id" : null
  }, {
    "name" : "dengue 2 virus DEN-2",
    "link" : null,
    "description" : "Dengue virus 2",
    "id" : null
  }, {
    "name" : "dengue 3 virus",
    "link" : null,
    "description" : "Dengue virus 3",
    "id" : null
  }, {
    "name" : "dengue type 1 D1 virus",
    "link" : null,
    "description" : "Dengue virus 1",
    "id" : null
  }, {
    "name" : "Dengue virus type 1",
    "link" : null,
    "description" : "Dengue virus 1",
    "id" : null
  }, {
    "name" : "dengue virus type 1 DEN1",
    "link" : null,
    "description" : "Dengue virus 1",
    "id" : null
  }, {
    "name" : "Dengue virus type 2",
    "link" : null,
    "description" : "Dengue virus 2",
    "id" : null
  }, {
    "name" : "Dengue virus type 3",
    "link" : null,
    "description" : "Dengue virus 3",
    "id" : null
  }, {
    "name" : "dengue virus type I",
    "link" : null,
    "description" : "Dengue virus 1",
    "id" : null
  }, {
    "name" : "Dengue virus type II",
    "link" : null,
    "description" : "Dengue virus 2",
    "id" : null
  }, {
    "name" : "dengue virus-1 DEN-1",
    "link" : null,
    "description" : "Dengue virus 1",
    "id" : null
  }, {
    "name" : "dengue-2 virus",
    "link" : null,
    "description" : "Dengue virus 2",
    "id" : null
  }, {
    "name" : "DTaP",
    "link" : null,
    "description" : "Diphtheria-Tetanus-Pertussis vaccine",
    "id" : null
  }, {
    "name" : "DTaP vaccine",
    "link" : null,
    "description" : "Diphtheria-Tetanus-Pertussis vaccine",
    "id" : null
  }, {
    "name" : "DTP",
    "link" : null,
    "description" : "Diphtheria-Tetanus-Pertussis vaccine",
    "id" : null
  }, {
    "name" : "DTP vaccine",
    "link" : null,
    "description" : "Diphtheria-Tetanus-Pertussis vaccine",
    "id" : null
  }, {
    "name" : "DTwP",
    "link" : null,
    "description" : "diphtheria, tetanus and whole cell pertussis vaccine",
    "id" : null
  }, {
    "name" : "DTwP vaccine",
    "link" : null,
    "description" : "diphtheria, tetanus and whole cell pertussis vaccine",
    "id" : null
  }, {
    "name" : "FLUAV",
    "link" : null,
    "description" : "Influenza A virus",
    "id" : null
  }, {
    "name" : "fluzone high-dose seasonal influenza vaccine",
    "link" : null,
    "description" : "Fluzone",
    "id" : null
  }, {
    "name" : "fluzone intradermal trivalent",
    "link" : null,
    "description" : "Fluzone",
    "id" : null
  }, {
    "name" : "Haemamoeba vivax",
    "link" : null,
    "description" : "Plasmodium vivax",
    "id" : null
  }, {
    "name" : "HBsAg-1018",
    "link" : null,
    "description" : "HEPLISAV-B",
    "id" : null
  }, {
    "name" : "hbv vaccine",
    "link" : null,
    "description" : "Hepatitis B virus vaccine",
    "id" : null
  }, {
    "name" : "HCV",
    "link" : null,
    "description" : "Hepacivirus C",
    "id" : null
  }, {
    "name" : "Hepatitis C virus",
    "link" : null,
    "description" : "Hepacivirus C",
    "id" : null
  }, {
    "name" : "hepatitis C virus HCV",
    "link" : null,
    "description" : "Hepacivirus C",
    "id" : null
  }, {
    "name" : "HHV-3",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "hiv vaccine",
    "link" : null,
    "description" : "human immunodeficiency virus vaccine",
    "id" : null
  }, {
    "name" : "human hepatitis C virus",
    "link" : null,
    "description" : "Hepacivirus C",
    "id" : null
  }, {
    "name" : "human hepatitis C virus HCV",
    "link" : null,
    "description" : "Hepacivirus C",
    "id" : null
  }, {
    "name" : "human hepatitis virus C HCV",
    "link" : null,
    "description" : "Hepacivirus C",
    "id" : null
  }, {
    "name" : "Human herpes virus 3",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "Human herpesvirus 3",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "human immunodeficiency virus",
    "link" : null,
    "description" : "human immunodeficiency virus infectious disease",
    "id" : null
  }, {
    "name" : "human immunodeficiency virus 1",
    "link" : null,
    "description" : "human immunodeficiency virus infectious disease",
    "id" : null
  }, {
    "name" : "Human Influenza A Virus",
    "link" : null,
    "description" : "Influenza A virus",
    "id" : null
  }, {
    "name" : "Human rhinovirus 16",
    "link" : null,
    "description" : "Human rhinovirus A16",
    "id" : null
  }, {
    "name" : "Human rhinovirus type 16",
    "link" : null,
    "description" : "Human rhinovirus A16",
    "id" : null
  }, {
    "name" : "Influenza A virus (A/FluMist-CA07/2009(H1N1))",
    "link" : null,
    "description" : "Influenza A virus (A/reassortant/FluMist(California/07/2009 x Ann Arbor/6/1960)(H1N1))",
    "id" : null
  }, {
    "name" : "Influenza vaccine",
    "link" : null,
    "description" : "Influenza virus vaccine",
    "id" : null
  }, {
    "name" : "Influenza virus type A",
    "link" : null,
    "description" : "Influenza A virus",
    "id" : null
  }, {
    "name" : "Lyme disease spirochete",
    "link" : null,
    "description" : "Borreliella burgdorferi",
    "id" : null
  }, {
    "name" : "malaria parasite P. falciparum",
    "link" : null,
    "description" : "Plasmodium falciparum",
    "id" : null
  }, {
    "name" : "malaria parasite P. vivax",
    "link" : null,
    "description" : "Plasmodium vivax",
    "id" : null
  }, {
    "name" : "Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine",
    "link" : null,
    "description" : "Menactra",
    "id" : null
  }, {
    "name" : "miscellaneous nucleic acid",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "modified vaccinia virus Ankara expressing antigen 85A",
    "link" : null,
    "description" : "MVA85A",
    "id" : null
  }, {
    "name" : "MVA expressing antigen 85A",
    "link" : null,
    "description" : "MVA85A",
    "id" : null
  }, {
    "name" : "Mycobacterium tuberculosis typus humanus",
    "link" : null,
    "description" : "Mycobacterium tuberculosis",
    "id" : null
  }, {
    "name" : "Mycobacterium tuberculosis var. hominis",
    "link" : null,
    "description" : "Mycobacterium tuberculosis",
    "id" : null
  }, {
    "name" : "Mycobacterium tuberculosis variant tuberculosis",
    "link" : null,
    "description" : "Mycobacterium tuberculosis",
    "id" : null
  }, {
    "name" : "none",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "not shown",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "not specified",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "other",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "pfspz",
    "link" : null,
    "description" : "PfSPZ Vaccine",
    "id" : null
  }, {
    "name" : "Plasmodium (Laverania) falciparum",
    "link" : null,
    "description" : "Plasmodium falciparum",
    "id" : null
  }, {
    "name" : "Plasmodium cynomolgi (strain Ceylon)",
    "link" : null,
    "description" : "Plasmodium cynomolgi strain Ceylon",
    "id" : null
  }, {
    "name" : "Plasmodium cynomolgi B",
    "link" : null,
    "description" : "Plasmodium cynomolgi strain B",
    "id" : null
  }, {
    "name" : "Pneumovax 23 (USA)",
    "link" : null,
    "description" : "Pneumovax 23",
    "id" : null
  }, {
    "name" : "Pneumovax 23 injectable product",
    "link" : null,
    "description" : "Pneumovax 23",
    "id" : null
  }, {
    "name" : "post-transfusion hepatitis non A non B virus",
    "link" : null,
    "description" : "Hepacivirus C",
    "id" : null
  }, {
    "name" : "RSV",
    "link" : null,
    "description" : "Respiratory syncytial virus",
    "id" : null
  }, {
    "name" : "S. aureus",
    "link" : null,
    "description" : "Staphylococcus aureus",
    "id" : null
  }, {
    "name" : "sanaria pfspz challenge",
    "link" : null,
    "description" : "PfSPZ Vaccine",
    "id" : null
  }, {
    "name" : "SARS-CoV2",
    "link" : null,
    "description" : "SARS-CoV-2",
    "id" : null
  }, {
    "name" : "sonstige nucleic acid",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "Trivalent inactivated influenza",
    "link" : null,
    "description" : "Influenza virus vaccine",
    "id" : null
  }, {
    "name" : "type 1 dengue virus DEN-1",
    "link" : null,
    "description" : "Dengue virus 1",
    "id" : null
  }, {
    "name" : "unclassified sequence",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "unidentified organism",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "unidentified root endophyte",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "unknown",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "unknown organism",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "unspecified",
    "link" : null,
    "description" : "unidentified",
    "id" : null
  }, {
    "name" : "Vaccinia virus (strain LC16M8)",
    "link" : null,
    "description" : "Vaccinia virus LC16M8",
    "id" : null
  }, {
    "name" : "Varicella vaccine",
    "link" : null,
    "description" : "Varicella-zoster virus vaccine",
    "id" : null
  }, {
    "name" : "Varicella Zoster Virus",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "varicella zoster virus VZV",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "Varicella-zoster virus",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "varicella-zoster virus VZV",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "VZV",
    "link" : null,
    "description" : "Human alphaherpesvirus 3",
    "id" : null
  }, {
    "name" : "WNV",
    "link" : null,
    "description" : "West Nile virus",
    "id" : null
  }, {
    "name" : "ZIKV",
    "link" : null,
    "description" : "Zika virus",
    "id" : null
  } ]
}, {
  "name" : "lk_exposure_process",
  "rows" : [ {
    "name" : "exposure_process_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "administering substance in vivo",
    "link" : "http://purl.obolibrary.org/obo/OBI_0600007",
    "description" : "A planned process by which a material is intentionally given to an organism resulting in exposure of the organism to that substance.",
    "id" : null
  }, {
    "name" : "documented exposure without evidence for disease",
    "link" : "",
    "description" : "A process in which an organism is exposed to a substance which is evident from that process having been observed or documented.",
    "id" : null
  }, {
    "name" : "environmental exposure to endemic/ubiquitous agent without evidence for disease",
    "link" : "",
    "description" : "A process in which an organism's  exposure to a material entity is assumed from that material being commonly present in the environment of the organism.",
    "id" : null
  }, {
    "name" : "exposure to substance without evidence for disease",
    "link" : "",
    "description" : "An unplanned process in which an organism comes into contact with a substance without evidence for a disease caused by that exposure.",
    "id" : null
  }, {
    "name" : "exposure with existing immune reactivity without evidence for disease",
    "link" : "http://purl.obolibrary.org/obo/OBI_1110061",
    "description" : "A process in which an organism is exposed to a material entity which is evident by a detectable immune reactivity against it.",
    "id" : null
  }, {
    "name" : "infectious challenge",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000712",
    "description" : "Administering an infectious agent to an organism in order to test if and how an infection will occur.",
    "id" : null
  }, {
    "name" : "no exposure",
    "link" : "",
    "description" : "An organism's lifspan which does not include exposure to a substance of interest.",
    "id" : null
  }, {
    "name" : "occurrence of allergic disease",
    "link" : "http://purl.obolibrary.org/obo/OBI_1110012",
    "description" : "The process in which an allergic disease unfolds.",
    "id" : null
  }, {
    "name" : "occurrence of asymptomatic infection",
    "link" : "",
    "description" : "A process in which an infectious agent is in or on the body of an organism without causing detectable disease .",
    "id" : null
  }, {
    "name" : "occurrence of autoimmune disease",
    "link" : "http://purl.obolibrary.org/obo/OBI_1110054",
    "description" : "The process in which an autoimmune disease unfolds.",
    "id" : null
  }, {
    "name" : "occurrence of cancer",
    "link" : "http://purl.obolibrary.org/obo/OBI_1110053",
    "description" : "The process in which cancer unfolds",
    "id" : null
  }, {
    "name" : "occurrence of cancer associated with virus",
    "link" : "https://ontology.iedb.org/ontology/ONTIE_0003313",
    "description" : "An occurence of cancer where there is evidence for the presence of a cancer causing oncovirus in the tumor.",
    "id" : null
  }, {
    "name" : "occurrence of disease",
    "link" : "http://purl.obolibrary.org/obo/OGMS_0000063",
    "description" : "The process in which a disease unfolds.",
    "id" : null
  }, {
    "name" : "occurrence of infectious disease",
    "link" : "http://purl.obolibrary.org/obo/OBI_1110008",
    "description" : "The process in which an infectious disease unfolds.",
    "id" : null
  }, {
    "name" : "solid tissue transplantation",
    "link" : "https://ontology.iedb.org/ontology/ONTIE_0003311",
    "description" : "A planned process in which solid tissue is transferred to an organism",
    "id" : null
  }, {
    "name" : "transfusion",
    "link" : "https://ontology.iedb.org/ontology/ONTIE_0003312",
    "description" : "A planned process in which a bodily fluid is transferred into an organism",
    "id" : null
  }, {
    "name" : "transplantation or transfusion",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000105",
    "description" : "Transfering a solid tissue (transplant) or bodily fluid (transfusion) to an organism.",
    "id" : null
  }, {
    "name" : "unknown",
    "link" : "",
    "description" : "An organism's lifespan for which there is no available information on an exposure to a material entity of interest.",
    "id" : null
  }, {
    "name" : "vaccination",
    "link" : "",
    "description" : "Adminstering a vaccine to an organism with the intention of inducing immunity against antigen components of the vaccine.",
    "id" : null
  } ]
}, {
  "name" : "lk_exposure_process_pref_map",
  "rows" : [ {
    "name" : "exposure_process_reported",
    "link" : null,
    "description" : "exposure_process_preferred",
    "id" : null
  }, {
    "name" : "occurrence of allergy",
    "link" : null,
    "description" : "occurrence of allergic disease",
    "id" : null
  }, {
    "name" : "vaccine",
    "link" : null,
    "description" : "vaccination",
    "id" : null
  } ]
}, {
  "name" : "lk_hmdb",
  "rows" : [ {
    "name" : "metabolite_name ;\nhmdb_id",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "(S)-3-Hydroxyisobutyric acid ; HMDB0000023",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000023",
    "description" : "(S)-3-Hydroxyisobutyric acid, also known as (S)-3-hydroxy-2-methylpropanoate or 3-hydroxy-isobutyrate, belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom (S)-3-Hydroxyisobutyric acid is soluble (in water) and a weakly acidic compound (based on its pKa) (S)-3-Hydroxyisobutyric acid has been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, (S)-3-hydroxyisobutyric acid is primarily located in the cytoplasm and mitochondria (S)-3-Hydroxyisobutyric acid exists in all eukaryotes, ranging from yeast to humans (S)-3-Hydroxyisobutyric acid can be converted into (S)-methylmalonic acid semialdehyde through the action of the enzymes 3-hydroxyisobutyrate dehydrogenase, mitochondrial and enoyl-CoA hydratase, mitochondrial. In humans, (S)-3-hydroxyisobutyric acid is involved in the valine, leucine and isoleucine degradation pathway (S)-3-Hydroxyisobutyric acid is also involved in several metabolic disorders, some of which include isobutyryl-CoA dehydrogenase deficiency, the maple syrup urine disease pathway, the propionic acidemia pathway, and methylmalonate semialdehyde dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "(S)C(S)S-S-Methylcysteine sulfoxide ; HMDB0029432",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029432",
    "description" : "(S)c(S)S-S-Methylcysteine sulfoxide, also known as kale anemia factor or S-methyl-L-cysteinesulfoxide, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon) (S)c(S)S-S-Methylcysteine sulfoxide exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Within the cell, (S)c(S)S-S-methylcysteine sulfoxide is primarily located in the cytoplasm. Outside of the human body, (S)c(S)S-S-methylcysteine sulfoxide can be found in brassicas, garden onion, and onion-family vegetables. This makes (S)c(S)S-S-methylcysteine sulfoxide a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "1,1-Dimethylbiguanide ; HMDB0001921",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001921",
    "description" : "1,1-Dimethylbiguanide, also known as la-6023metformin or glucophage, belongs to the class of organic compounds known as biguanides. These are organic compounds containing two N-linked guanidines. 1,1-Dimethylbiguanide is a drug which is used for use as an adjunct to diet and exercise in adult patients (18 years and older) with niddm. may also be used for the management of metabolic and reproductive abnormalities associated with polycystic ovary syndrome (pcos). jentadueto is for the treatment of patients when both linagliptin and metformin is appropriate. 1,1-Dimethylbiguanide exists as a solid, slightly soluble (in water), and a very strong basic compound (based on its pKa). 1,1-Dimethylbiguanide has been found in human liver, skeletal muscle and muscle tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, 1,1-dimethylbiguanide is primarily located in the cytoplasm. 1,1-Dimethylbiguanide can be biosynthesized from biguanide. 1,1-Dimethylbiguanide has a bitter taste. 1,1-Dimethylbiguanide is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "1,1-Dimethylbiguanide ; HMDB01921",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001921",
    "description" : "1,1-Dimethylbiguanide, also known as la-6023metformin or glucophage, belongs to the class of organic compounds known as biguanides. These are organic compounds containing two N-linked guanidines. 1,1-Dimethylbiguanide is a drug which is used for use as an adjunct to diet and exercise in adult patients (18 years and older) with niddm. may also be used for the management of metabolic and reproductive abnormalities associated with polycystic ovary syndrome (pcos). jentadueto is for the treatment of patients when both linagliptin and metformin is appropriate. 1,1-Dimethylbiguanide exists as a solid, slightly soluble (in water), and a very strong basic compound (based on its pKa). 1,1-Dimethylbiguanide has been found in human liver, skeletal muscle and muscle tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, 1,1-dimethylbiguanide is primarily located in the cytoplasm. 1,1-Dimethylbiguanide can be biosynthesized from biguanide. 1,1-Dimethylbiguanide has a bitter taste. 1,1-Dimethylbiguanide is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "1,11-Undecanedicarboxylic acid ; HMDB0002327",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002327",
    "description" : "Brassylic acid, also known as brassilate or tridecanedioate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Brassylic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Brassylic acid has been primarily detected in urine. Within the cell, brassylic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "1,2,4-Trimethylbenzene ; HMDB0013733",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013733",
    "description" : "Pseudocumene, also known as pseudocumol or psi-cumene, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Pseudocumene exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Pseudocumene has been primarily detected in urine. Within the cell, pseudocumene is primarily located in the membrane (predicted from logP). Pseudocumene exists in all eukaryotes, ranging from yeast to humans. Pseudocumene can be converted into 2,3,5-trimethylphenol. Pseudocumene is a plastic tasting compound that can be found in black walnut and corn. This makes pseudocumene a potential biomarker for the consumption of these food products. Pseudocumene is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "1,2,4-Trimethylbenzene ; HMDB13733",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013733",
    "description" : "Pseudocumene, also known as pseudocumol or psi-cumene, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Pseudocumene exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Pseudocumene has been primarily detected in urine. Within the cell, pseudocumene is primarily located in the membrane (predicted from logP). Pseudocumene exists in all eukaryotes, ranging from yeast to humans. Pseudocumene can be converted into 2,3,5-trimethylphenol. Pseudocumene is a plastic tasting compound that can be found in black walnut and corn. This makes pseudocumene a potential biomarker for the consumption of these food products. Pseudocumene is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "1,3,7-Trimethyluric acid ; HMDB0002123",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002123",
    "description" : "1,3,7-Trimethyluric acid, also known as 8-oxy-caffeine or 1,3,7-trimethylate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1,3,7-Trimethyluric acid is soluble (in water) and a very weakly acidic compound (based on its pKa). 1,3,7-Trimethyluric acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1,3,7-trimethyluric acid is primarily located in the cytoplasm. 1,3,7-Trimethyluric acid can be biosynthesized from caffeine through the action of the enzymes cytochrome P450 1A2, cytochrome P450 3A4, cytochrome P450 2C8, cytochrome P450 2C9, and cytochrome P450 2E1. In humans, 1,3,7-trimethyluric acid is involved in the caffeine metabolism pathway. Outside of the human body, 1,3,7-trimethyluric acid can be found in a number of food items such as burbot, adzuki bean, colorado pinyon, and corn salad. This makes 1,3,7-trimethyluric acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "1,3-Dimethyluric acid ; HMDB0001857",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001857",
    "description" : "1,3-Dimethyluric acid, also known as 1,3-dimethylate or oxytheophylline, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1,3-Dimethyluric acid exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). 1,3-Dimethyluric acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1,3-dimethyluric acid is primarily located in the cytoplasm. 1,3-Dimethyluric acid can be biosynthesized from 7,9-dihydro-1H-purine-2,6,8(3H)-trione.",
    "id" : null
  }, {
    "name" : "1,3-Dimethyluric acid ; HMDB01857",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001857",
    "description" : "1,3-Dimethyluric acid, also known as 1,3-dimethylate or oxytheophylline, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1,3-Dimethyluric acid exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). 1,3-Dimethyluric acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1,3-dimethyluric acid is primarily located in the cytoplasm. 1,3-Dimethyluric acid can be biosynthesized from 7,9-dihydro-1H-purine-2,6,8(3H)-trione.",
    "id" : null
  }, {
    "name" : "1,7-Dimethyluric acid ; HMDB0011103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011103",
    "description" : "1,7-Dimethyluric acid, also known as 17-dimethylate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1,7-Dimethyluric acid is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 1,7-Dimethyluric acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1,7-dimethyluric acid is primarily located in the cytoplasm. 1,7-Dimethyluric acid can be biosynthesized from paraxanthine; which is mediated by the enzymes cytochrome P450 1A2 and cytochrome P450 2A6. In humans, 1,7-dimethyluric acid is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "1,7-Dimethyluric acid ; HMDB11103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011103",
    "description" : "1,7-Dimethyluric acid, also known as 17-dimethylate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1,7-Dimethyluric acid is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 1,7-Dimethyluric acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1,7-dimethyluric acid is primarily located in the cytoplasm. 1,7-Dimethyluric acid can be biosynthesized from paraxanthine; which is mediated by the enzymes cytochrome P450 1A2 and cytochrome P450 2A6. In humans, 1,7-dimethyluric acid is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "1-Methyladenosine ; HMDB0003331",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003331",
    "description" : "1-Methyladenosine, also known as M1A, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. 1-Methyladenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methyladenosine has been found in human prostate tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 1-methyladenosine is primarily located in the cytoplasm. 1-Methyladenosine can be biosynthesized from adenosine.",
    "id" : null
  }, {
    "name" : "1-Methyladenosine ; HMDB03331",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003331",
    "description" : "1-Methyladenosine, also known as M1A, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. 1-Methyladenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methyladenosine has been found in human prostate tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 1-methyladenosine is primarily located in the cytoplasm. 1-Methyladenosine can be biosynthesized from adenosine.",
    "id" : null
  }, {
    "name" : "1-Methylguanine ; HMDB0003282",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003282",
    "description" : "1-Methylguanine belongs to the class of organic compounds known as 6-oxopurines. These are purines that carry a C=O group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. 1-Methylguanine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, 1-methylguanine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "1-Methylguanine ; HMDB03282",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003282",
    "description" : "1-Methylguanine belongs to the class of organic compounds known as 6-oxopurines. These are purines that carry a C=O group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. 1-Methylguanine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, 1-methylguanine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "1-Methylguanosine ; HMDB0001563",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001563",
    "description" : "1-Methylguanosine, also known as M1G or TRMD protein, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. 1-Methylguanosine is soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methylguanosine has been detected in multiple biofluids, such as urine and blood.",
    "id" : null
  }, {
    "name" : "1-Methylguanosine ; HMDB01563",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001563",
    "description" : "1-Methylguanosine, also known as M1G or TRMD protein, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. 1-Methylguanosine is soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methylguanosine has been detected in multiple biofluids, such as urine and blood.",
    "id" : null
  }, {
    "name" : "1-Methylhistamine ; HMDB0000898",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000898",
    "description" : "1-Methylhistamine, also known as H137, belongs to the class of organic compounds known as 2-arylethylamines. These are primary amines that have the general formula RCCNH2, where R is an organic group. 1-Methylhistamine is slightly soluble (in water) and a very strong basic compound (based on its pKa). 1-Methylhistamine has been found in human bone marrow and brain tissues, and has also been detected in most biofluids, including urine, blood, feces, and cerebrospinal fluid. Within the cell, 1-methylhistamine is primarily located in the cytoplasm. 1-Methylhistamine participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and 1-methylhistamine can be biosynthesized from S-adenosylmethionine and histamine through the action of the enzyme histamine N-methyltransferase. In addition, 1-Methylhistamine can be converted into methylimidazole acetaldehyde; which is catalyzed by the enzyme amine oxidase [flavin-containing] a. In humans, 1-methylhistamine is involved in the histidine metabolism pathway. 1-Methylhistamine is also involved in the metabolic disorder called the histidinemia pathway.",
    "id" : null
  }, {
    "name" : "1-Methylhistamine ; HMDB00898",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000898",
    "description" : "1-Methylhistamine, also known as H137, belongs to the class of organic compounds known as 2-arylethylamines. These are primary amines that have the general formula RCCNH2, where R is an organic group. 1-Methylhistamine is slightly soluble (in water) and a very strong basic compound (based on its pKa). 1-Methylhistamine has been found in human bone marrow and brain tissues, and has also been detected in most biofluids, including urine, blood, feces, and cerebrospinal fluid. Within the cell, 1-methylhistamine is primarily located in the cytoplasm. 1-Methylhistamine participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and 1-methylhistamine can be biosynthesized from S-adenosylmethionine and histamine through the action of the enzyme histamine N-methyltransferase. In addition, 1-Methylhistamine can be converted into methylimidazole acetaldehyde; which is catalyzed by the enzyme amine oxidase [flavin-containing] a. In humans, 1-methylhistamine is involved in the histidine metabolism pathway. 1-Methylhistamine is also involved in the metabolic disorder called the histidinemia pathway.",
    "id" : null
  }, {
    "name" : "1-Methylhistidine ; HMDB0000001",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000001",
    "description" : "1-Methylhistidine, also known as 1-mhis, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 1-Methylhistidine has been found in human muscle and skeletal muscle tissues, and has also been detected in most biofluids, including cerebrospinal fluid, saliva, blood, and feces. Within the cell, 1-methylhistidine is primarily located in the cytoplasm. 1-Methylhistidine participates in a number of enzymatic reactions. In particular, 1-Methylhistidine and Beta-alanine can be converted into anserine; which is catalyzed by the enzyme carnosine synthase 1. In addition, Beta-Alanine and 1-methylhistidine can be biosynthesized from anserine; which is mediated by the enzyme cytosolic non-specific dipeptidase. In humans, 1-methylhistidine is involved in the histidine metabolism pathway. 1-Methylhistidine is also involved in the metabolic disorder called the histidinemia pathway.",
    "id" : null
  }, {
    "name" : "1-Methylhistidine ; HMDB00001",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000001",
    "description" : "1-Methylhistidine, also known as 1-mhis, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 1-Methylhistidine has been found in human muscle and skeletal muscle tissues, and has also been detected in most biofluids, including cerebrospinal fluid, saliva, blood, and feces. Within the cell, 1-methylhistidine is primarily located in the cytoplasm. 1-Methylhistidine participates in a number of enzymatic reactions. In particular, 1-Methylhistidine and Beta-alanine can be converted into anserine; which is catalyzed by the enzyme carnosine synthase 1. In addition, Beta-Alanine and 1-methylhistidine can be biosynthesized from anserine; which is mediated by the enzyme cytosolic non-specific dipeptidase. In humans, 1-methylhistidine is involved in the histidine metabolism pathway. 1-Methylhistidine is also involved in the metabolic disorder called the histidinemia pathway.",
    "id" : null
  }, {
    "name" : "1-Methylinosine ; HMDB0002721",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002721",
    "description" : "1-Methylinosine, also known as m(1)I, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. 1-Methylinosine is soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methylinosine has been detected in multiple biofluids, such as urine and blood. Within the cell, 1-methylinosine is primarily located in the cytoplasm. 1-Methylinosine can be biosynthesized from inosine.",
    "id" : null
  }, {
    "name" : "1-Methylnicotinamide ; HMDB0000699",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000699",
    "description" : "1-Methylnicotinamide, also known as trigonellinamide or trigonellamide chloride, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. 1-Methylnicotinamide is considered to be a practically insoluble (in water) and relatively neutral molecule. 1-Methylnicotinamide has been detected in multiple biofluids, such as urine and blood. Within the cell, 1-methylnicotinamide is primarily located in the cytoplasm. 1-Methylnicotinamide exists in all eukaryotes, ranging from yeast to humans. 1-Methylnicotinamide participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and 1-methylnicotinamide can be biosynthesized from S-adenosylmethionine and niacinamide through its interaction with the enzyme nicotinamide N-methyltransferase. In addition, 1-Methylnicotinamide can be converted into N1-methyl-2-pyridone-5-carboxamide through the action of the enzyme aldehyde oxidase. In humans, 1-methylnicotinamide is involved in the nicotinate and nicotinamide metabolism pathway.",
    "id" : null
  }, {
    "name" : "1-Methylnicotinamide ; HMDB00699",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000699",
    "description" : "1-Methylnicotinamide, also known as trigonellinamide or trigonellamide chloride, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. 1-Methylnicotinamide is considered to be a practically insoluble (in water) and relatively neutral molecule. 1-Methylnicotinamide has been detected in multiple biofluids, such as urine and blood. Within the cell, 1-methylnicotinamide is primarily located in the cytoplasm. 1-Methylnicotinamide exists in all eukaryotes, ranging from yeast to humans. 1-Methylnicotinamide participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and 1-methylnicotinamide can be biosynthesized from S-adenosylmethionine and niacinamide through its interaction with the enzyme nicotinamide N-methyltransferase. In addition, 1-Methylnicotinamide can be converted into N1-methyl-2-pyridone-5-carboxamide through the action of the enzyme aldehyde oxidase. In humans, 1-methylnicotinamide is involved in the nicotinate and nicotinamide metabolism pathway.",
    "id" : null
  }, {
    "name" : "1-Methyluric acid ; HMDB0003099",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003099",
    "description" : "1-Methyluric acid, also known as 1-methylurate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1-Methyluric acid is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methyluric acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1-methyluric acid is primarily located in the cytoplasm. 1-Methyluric acid can be biosynthesized from 1-methylxanthine; which is catalyzed by the enzyme xanthine dehydrogenase/oxidase. In humans, 1-methyluric acid is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "1-Methyluric acid ; HMDB03099",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003099",
    "description" : "1-Methyluric acid, also known as 1-methylurate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1-Methyluric acid is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methyluric acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1-methyluric acid is primarily located in the cytoplasm. 1-Methyluric acid can be biosynthesized from 1-methylxanthine; which is catalyzed by the enzyme xanthine dehydrogenase/oxidase. In humans, 1-methyluric acid is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "1-Methylxanthine ; HMDB0010738",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010738",
    "description" : "1-Methylxanthine belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 1-Methylxanthine is soluble (in water) and a very weakly acidic compound (based on its pKa). 1-Methylxanthine has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 1-methylxanthine is primarily located in the cytoplasm. 1-Methylxanthine participates in a number of enzymatic reactions. In particular, 1-Methylxanthine and formaldehyde can be biosynthesized from theophylline through its interaction with the enzyme cytochrome P450 1A2. In addition, 1-Methylxanthine can be converted into 1-methyluric acid through its interaction with the enzyme xanthine dehydrogenase/oxidase. In humans, 1-methylxanthine is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "10-HDoHE ; HMDB0060037",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060037",
    "description" : "10-Hdohe belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. 10-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 10-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 10-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "10-HDoHE ; HMDB60037",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060037",
    "description" : "10-Hdohe belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. 10-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 10-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 10-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "10Z-Heptadecenoic acid ; HMDB0060038",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060038",
    "description" : ", also known as 17:1 N-7 cis or fa(17:1(10Z)), belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as blood, urine, and feces. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "10Z-Heptadecenoic acid ; HMDB60038",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060038",
    "description" : ", also known as 17:1 N-7 cis or fa(17:1(10Z)), belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as blood, urine, and feces. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "10Z-Nonadecenoic acid ; HMDB0013622",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013622",
    "description" : ", also known as fa(19:1(10Z)) or 10-nonadecenoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "10Z-Nonadecenoic acid ; HMDB13622",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013622",
    "description" : ", also known as fa(19:1(10Z)) or 10-nonadecenoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "11(R)-HETE ; HMDB0004682",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004682",
    "description" : ", also known as 11-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, is considered to be an eicosanoid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "11(R)-HETE ; HMDB04682",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004682",
    "description" : ", also known as 11-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, is considered to be an eicosanoid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "11-HDoHE ; HMDB0060040",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060040",
    "description" : "11-Hdohe belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. 11-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 11-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 11-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "11-HDoHE ; HMDB60040",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060040",
    "description" : "11-Hdohe belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. 11-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 11-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 11-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "11Z-Eicosenoic acid ; HMDB0002231",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002231",
    "description" : "cis-Gondoic acid, also known as 11-eicosenoic acid or (11Z)-eicosenoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. cis-Gondoic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. cis-Gondoic acid has been detected in multiple biofluids, such as saliva, blood, and urine. Within the cell, cis-gondoic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. cis-Gondoic acid is also a parent compound for other transformation products, including but not limited to, N-(11Z-icosenoyl)-sphingosine-1-phosphocholine, 1-palmitoyl-2-(11Z-eicosenoyl)-sn-glycero-3-phosphocholine, and N-gondoylethanolamine. Outside of the human body, cis-gondoic acid can be found in a number of food items such as pomegranate, rocket salad (ssp.), fishes, and brassicas. This makes cis-gondoic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "11Z-Eicosenoic acid ; HMDB02231",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002231",
    "description" : "cis-Gondoic acid, also known as 11-eicosenoic acid or (11Z)-eicosenoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. cis-Gondoic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. cis-Gondoic acid has been detected in multiple biofluids, such as saliva, blood, and urine. Within the cell, cis-gondoic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. cis-Gondoic acid is also a parent compound for other transformation products, including but not limited to, N-(11Z-icosenoyl)-sphingosine-1-phosphocholine, 1-palmitoyl-2-(11Z-eicosenoyl)-sn-glycero-3-phosphocholine, and N-gondoylethanolamine. Outside of the human body, cis-gondoic acid can be found in a number of food items such as pomegranate, rocket salad (ssp.), fishes, and brassicas. This makes cis-gondoic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "12,13-DHOME ; HMDB0004705",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004705",
    "description" : "12,13-Dihome, also known as 12,13-dhoa or isoleukotoxin, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, 12,13-dihome is considered to be an octadecanoid lipid molecule. 12,13-Dihome is considered to be a practically insoluble (in water) and relatively neutral molecule. 12,13-Dihome has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 12,13-dihome is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "12,13-DHOME ; HMDB04705",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004705",
    "description" : "12,13-Dihome, also known as 12,13-dhoa or isoleukotoxin, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, 12,13-dihome is considered to be an octadecanoid lipid molecule. 12,13-Dihome is considered to be a practically insoluble (in water) and relatively neutral molecule. 12,13-Dihome has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 12,13-dihome is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "12-HEPE ; HMDB0010202",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010202",
    "description" : "(+/-)-12-hepe belongs to the class of organic compounds known as hydroxyeicosapentaenoic acids. These are eicosanoic acids with an attached hydroxyl group and five CC double bonds. Thus, (+/-)-12-hepe is considered to be an eicosanoid lipid molecule (+/-)-12-hepe is considered to be a practically insoluble (in water) and relatively neutral molecule (+/-)-12-hepe has been detected in multiple biofluids, such as blood and urine. Within the cell, (+/-)-12-hepe is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "12-HEPE ; HMDB10202",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010202",
    "description" : "(+/-)-12-hepe belongs to the class of organic compounds known as hydroxyeicosapentaenoic acids. These are eicosanoic acids with an attached hydroxyl group and five CC double bonds. Thus, (+/-)-12-hepe is considered to be an eicosanoid lipid molecule (+/-)-12-hepe is considered to be a practically insoluble (in water) and relatively neutral molecule (+/-)-12-hepe has been detected in multiple biofluids, such as blood and urine. Within the cell, (+/-)-12-hepe is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "12-HETE ; HMDB0006111",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006111",
    "description" : ", also known as 12-R-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, is considered to be an eicosanoid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been primarily detected in saliva, blood, urine, and cerebrospinal fluid. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm. has been found to be associated with the diseases known as cerebral vasospasm; has also been linked to the inborn metabolic disorders including peroxisomal biogenesis defect.",
    "id" : null
  }, {
    "name" : "12-HETE ; HMDB06111",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006111",
    "description" : ", also known as 12-R-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, is considered to be an eicosanoid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been primarily detected in saliva, blood, urine, and cerebrospinal fluid. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm. has been found to be associated with the diseases known as cerebral vasospasm; has also been linked to the inborn metabolic disorders including peroxisomal biogenesis defect.",
    "id" : null
  }, {
    "name" : "13-Methylmyristic acid ; HMDB0061707",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061707",
    "description" : "Isopentadecylic acid, also known as iso-C15 or 13-MTD, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Isopentadecylic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Isopentadecylic acid has been detected in multiple biofluids, such as feces and urine. Within the cell, isopentadecylic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Isopentadecylic acid can be converted into isopentadecanoyl-CoA.",
    "id" : null
  }, {
    "name" : "13S-hydroxyoctadecadienoic acid ; HMDB0004667",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004667",
    "description" : "13S-Hode, also known as 13-HODD or 13-lox, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, 13S-hode is considered to be an octadecanoid lipid molecule. 13S-Hode is considered to be a practically insoluble (in water) and relatively neutral molecule. 13S-Hode has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, 13S-hode is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "13S-hydroxyoctadecadienoic acid ; HMDB04667",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004667",
    "description" : "13S-Hode, also known as 13-HODD or 13-lox, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, 13S-hode is considered to be an octadecanoid lipid molecule. 13S-Hode is considered to be a practically insoluble (in water) and relatively neutral molecule. 13S-Hode has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, 13S-hode is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "14-HDoHE ; HMDB0060044",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060044",
    "description" : "14-Hdohe belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. 14-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 14-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 14-hdohe is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "14-HDoHE ; HMDB60044",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060044",
    "description" : "14-Hdohe belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. 14-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 14-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 14-hdohe is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "15(S)-HETE ; HMDB0003876",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003876",
    "description" : "15S-Hete, also known as icomucret or 15(S)-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, 15S-hete is considered to be an eicosanoid lipid molecule. 15S-Hete is considered to be a practically insoluble (in water) and relatively neutral molecule. 15S-Hete has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, 15S-hete is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, 15S-hete is involved in the celecoxib action pathway, the antrafenine action pathway, the fenoprofen action pathway, and the nabumetone action pathway. 15S-Hete is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway. 15S-Hete has been linked to the inborn metabolic disorders including peroxisomal biogenesis defect.",
    "id" : null
  }, {
    "name" : "15(S)-HETE ; HMDB03876",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003876",
    "description" : "15S-Hete, also known as icomucret or 15(S)-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, 15S-hete is considered to be an eicosanoid lipid molecule. 15S-Hete is considered to be a practically insoluble (in water) and relatively neutral molecule. 15S-Hete has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, 15S-hete is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, 15S-hete is involved in the celecoxib action pathway, the antrafenine action pathway, the fenoprofen action pathway, and the nabumetone action pathway. 15S-Hete is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway. 15S-Hete has been linked to the inborn metabolic disorders including peroxisomal biogenesis defect.",
    "id" : null
  }, {
    "name" : "15-Methylpalmitate ; HMDB0061709",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061709",
    "description" : "15-Methylpalmitate, also known as 15-methylhexadecanoate, is a fatty acid methyl ester (FAME). It has an exact mass of 269.25 g/mol and the molecular formula is C17H33O2. Methylpalmitate is a biomarker for the consumption of butte",
    "id" : null
  }, {
    "name" : "16-HDoHE ; HMDB0060047",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060047",
    "description" : "16-Hdohe belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. 16-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 16-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 16-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "16-HDoHE ; HMDB60047",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060047",
    "description" : "16-Hdohe belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. 16-Hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule. 16-Hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, 16-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "16-Hydroxy hexadecanoic acid ; HMDB0006294",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006294",
    "description" : "",
    "id" : null
  }, {
    "name" : "16-Hydroxy hexadecanoic acid ; HMDB06294",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006294",
    "description" : "",
    "id" : null
  }, {
    "name" : "16a-hydroxy DHEA 3-sulfate ; HMDB0062544",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0062544",
    "description" : "16a-Hydroxy dhea 3-sulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 16a-Hydroxy dhea 3-sulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. 16a-Hydroxy dhea 3-sulfate has been found in human hepatic tissue, and has also been primarily detected in urine. Within the cell, 16a-hydroxy dhea 3-sulfate is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "17-HDoHE ; HMDB0010213",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010213",
    "description" : "(+/-)-17-hdohe, also known as 17-hydroxy-dha or 17(R)hdohe, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, (+/-)-17-hdohe is considered to be a docosanoid lipid molecule (+/-)-17-hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule (+/-)-17-hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, (+/-)-17-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome (+/-)-17-hdohe can be biosynthesized from all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.",
    "id" : null
  }, {
    "name" : "17-HDoHE ; HMDB10213",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010213",
    "description" : "(+/-)-17-hdohe, also known as 17-hydroxy-dha or 17(R)hdohe, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, (+/-)-17-hdohe is considered to be a docosanoid lipid molecule (+/-)-17-hdohe is considered to be a practically insoluble (in water) and relatively neutral molecule (+/-)-17-hdohe has been detected in multiple biofluids, such as blood and urine. Within the cell, (+/-)-17-hdohe is primarily located in the membrane (predicted from logP), cytoplasm and adiposome (+/-)-17-hdohe can be biosynthesized from all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.",
    "id" : null
  }, {
    "name" : "17-Methylstearate ; HMDB0061710",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061710",
    "description" : "Isononadecanoic acid, also known as 17-methylstearic acid or 17-methyl-octadecanoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Isononadecanoic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Isononadecanoic acid has been primarily detected in urine. Within the cell, isononadecanoic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Isononadecanoic acid can be biosynthesized from octadecanoic acid. Outside of the human body, isononadecanoic acid can be found in fishes. This makes isononadecanoic acid a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "17-Methylstearate ; HMDB61710",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061710",
    "description" : "Isononadecanoic acid, also known as 17-methylstearic acid or 17-methyl-octadecanoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Isononadecanoic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Isononadecanoic acid has been primarily detected in urine. Within the cell, isononadecanoic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Isononadecanoic acid can be biosynthesized from octadecanoic acid. Outside of the human body, isononadecanoic acid can be found in fishes. This makes isononadecanoic acid a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "1H-Indole-3-acetamide ; HMDB0029739",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029739",
    "description" : "1H-Indole-3-acetamide, also known as auxin amide or 2-(3-indolyl)acetamide, belongs to the class of organic compounds known as 3-alkylindoles. 3-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. 1H-Indole-3-acetamide exists as a solid, slightly soluble (in water), and an extremely weak acidic (essentially neutral) compound (based on its pKa). Within the cell, 1H-indole-3-acetamide is primarily located in the cytoplasm. 1H-Indole-3-acetamide can be biosynthesized from acetamide. Outside of the human body, 1H-indole-3-acetamide can be found in a number of food items such as epazote, cowpea, passion fruit, and japanese persimmon. This makes 1H-indole-3-acetamide a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "1H-Indole-3-acetamide ; HMDB29739",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029739",
    "description" : "1H-Indole-3-acetamide, also known as auxin amide or 2-(3-indolyl)acetamide, belongs to the class of organic compounds known as 3-alkylindoles. 3-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. 1H-Indole-3-acetamide exists as a solid, slightly soluble (in water), and an extremely weak acidic (essentially neutral) compound (based on its pKa). Within the cell, 1H-indole-3-acetamide is primarily located in the cytoplasm. 1H-Indole-3-acetamide can be biosynthesized from acetamide. Outside of the human body, 1H-indole-3-acetamide can be found in a number of food items such as epazote, cowpea, passion fruit, and japanese persimmon. This makes 1H-indole-3-acetamide a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "1H-Indole-3-carboxaldehyde ; HMDB0029737",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029737",
    "description" : "1H-Indole-3-carboxaldehyde, also known as indole-3-aldehyde or 3-formylindole, belongs to the class of organic compounds known as indoles. Indoles are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole. 1H-Indole-3-carboxaldehyde exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Within the cell, 1H-indole-3-carboxaldehyde is primarily located in the cytoplasm. Outside of the human body, 1H-indole-3-carboxaldehyde can be found in a number of food items such as garden tomato, cucumber, brussel sprouts, and barley. This makes 1H-indole-3-carboxaldehyde a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "2,4-Dihydroxybutanoic acid ; HMDB0000360",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000360",
    "description" : "2,4-Dihydroxy-butanoic acid, also known as 2,4-dihydroxybutyrate or 3-deoxytetronic acid, belongs to the class of organic compounds known as short-chain hydroxy acids and derivatives. These are hydroxy acids with an alkyl chain the contains less than 6 carbon atoms. 2,4-Dihydroxy-butanoic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2,4-Dihydroxy-butanoic acid has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid.",
    "id" : null
  }, {
    "name" : "2-Aminobenzoic acid ; HMDB0001123",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001123",
    "description" : "2-Aminobenzoic acid, also known as anthranilate or anthranilic acid, belongs to the class of organic compounds known as aminobenzoic acids. These are benzoic acids containing an amine group attached to the benzene moiety. 2-Aminobenzoic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). 2-Aminobenzoic acid has been found in human epidermis tissue, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, 2-aminobenzoic acid is primarily located in the cytoplasm and mitochondria. 2-Aminobenzoic acid exists in all eukaryotes, ranging from yeast to humans. 2-Aminobenzoic acid participates in a number of enzymatic reactions. In particular, 2-Aminobenzoic acid and formic acid can be biosynthesized from formylanthranilic acid through the action of the enzyme kynurenine formamidase. Furthermore, 2-Aminobenzoic acid and L-alanine can be biosynthesized from L-kynurenine; which is catalyzed by the enzyme kynureninase. Furthermore, Pyruvic acid, L-glutamic acid, and 2-aminobenzoic acid can be biosynthesized from chorismate and L-glutamine through its interaction with the enzyme anthranilate synthase component. Finally, 2-Aminobenzoic acid and phosphoribosyl pyrophosphate can be converted into N-(5-phosphoribosyl)-anthranilate through the action of the enzyme anthranilate phosphoribosyltransferase. In humans, 2-aminobenzoic acid is involved in the tryptophan metabolism pathway. Outside of the human body, 2-aminobenzoic acid can be found in a number of food items such as alpine sweetvetch, corn, garden tomato, and conch. This makes 2-aminobenzoic acid a potential biomarker for the consumption of these food products. 2-Aminobenzoic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "2-Aminoheptanoate ; HMDB0094649",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0094649",
    "description" : "2-Aminoheptanoate, also known as a-aminoenanthate or 2-aminoenanthic acid, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). 2-Aminoheptanoate is soluble (in water) and a moderately acidic compound (based on its pKa). 2-Aminoheptanoate has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "2-aminophenol sulphate ; HMDB0061116",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061116",
    "description" : "2-Aminophenol sulphate belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. 2-Aminophenol sulphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). 2-Aminophenol sulphate can be biosynthesized from 2-aminophenol.",
    "id" : null
  }, {
    "name" : "2-Ethylhydracrylic acid ; HMDB0000396",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000396",
    "description" : "2-Ethyl-hydracrylic acid, also known as 2-(hydroxymethyl)-butyrate or 3-hydroxy-2-ethylpropanoate, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 2-Ethyl-hydracrylic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Ethyl-hydracrylic acid has been detected in multiple biofluids, such as urine and blood. Within the cell, 2-ethyl-hydracrylic acid is primarily located in the cytoplasm and adiposome. 2-Ethyl-hydracrylic acid has been found to be associated with several diseases known as 3-methylglutaconic aciduria type V and short/branched chain acyl-CoA dehydrogenase deficiency; 2-ethyl-hydracrylic acid has also been linked to the inborn metabolic disorders including 3-methylglutaconic aciduria type ii, x-linked.",
    "id" : null
  }, {
    "name" : "2-Fucosyllactose ; HMDB0002098",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002098",
    "description" : "2-Fucosyllactose belongs to the class of organic compounds known as oligosaccharides. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds. 2-Fucosyllactose is soluble (in water) and a very weakly acidic compound (based on its pKa). 2-Fucosyllactose has been detected in multiple biofluids, such as feces and breast milk.",
    "id" : null
  }, {
    "name" : "2-Furoylglycine ; HMDB0000439",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000439",
    "description" : "2-Furoylglycine, also known as pyromucurate or pyromucuric acid, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 2-Furoylglycine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). 2-Furoylglycine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 2-furoylglycine is primarily located in the cytoplasm. 2-Furoylglycine can be biosynthesized from 2-furoic acid.",
    "id" : null
  }, {
    "name" : "2-Furoylglycine ; HMDB00439",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000439",
    "description" : "2-Furoylglycine, also known as pyromucurate or pyromucuric acid, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 2-Furoylglycine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). 2-Furoylglycine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 2-furoylglycine is primarily located in the cytoplasm. 2-Furoylglycine can be biosynthesized from 2-furoic acid.",
    "id" : null
  }, {
    "name" : "2-Hydroxy-3-methylbutyric acid ; HMDB0000407",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000407",
    "description" : "2-Hydroxy-3-methylbutyric acid, also known as 2-hydroxyisovaleric acid or 3-methyl-2-hydroxybutyric acid, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 2-Hydroxy-3-methylbutyric acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Hydroxy-3-methylbutyric acid has been detected in most biofluids, including saliva, urine, cerebrospinal fluid, and blood. Within the cell, 2-hydroxy-3-methylbutyric acid is primarily located in the cytoplasm and adiposome. 2-Hydroxy-3-methylbutyric acid exists in all eukaryotes, ranging from yeast to humans. 2-Hydroxy-3-methylbutyric acid participates in a number of enzymatic reactions. In particular, 2-hydroxy-3-methylbutyric acid can be biosynthesized from isovaleric acid. 2-Hydroxy-3-methylbutyric acid can also be converted into 2-hydroxyisovaleryl-CoA. 2-Hydroxy-3-methylbutyric acid has been found to be associated with the diseases known as dihydrolipoamide dehydrogenase deficiency; 2-hydroxy-3-methylbutyric acid has also been linked to the inborn metabolic disorders including maple syrup urine disease.",
    "id" : null
  }, {
    "name" : "2-Hydroxy-3-methylbutyric acid ; HMDB00407",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000407",
    "description" : "2-Hydroxy-3-methylbutyric acid, also known as 2-hydroxyisovaleric acid or 3-methyl-2-hydroxybutyric acid, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 2-Hydroxy-3-methylbutyric acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Hydroxy-3-methylbutyric acid has been detected in most biofluids, including saliva, urine, cerebrospinal fluid, and blood. Within the cell, 2-hydroxy-3-methylbutyric acid is primarily located in the cytoplasm and adiposome. 2-Hydroxy-3-methylbutyric acid exists in all eukaryotes, ranging from yeast to humans. 2-Hydroxy-3-methylbutyric acid participates in a number of enzymatic reactions. In particular, 2-hydroxy-3-methylbutyric acid can be biosynthesized from isovaleric acid. 2-Hydroxy-3-methylbutyric acid can also be converted into 2-hydroxyisovaleryl-CoA. 2-Hydroxy-3-methylbutyric acid has been found to be associated with the diseases known as dihydrolipoamide dehydrogenase deficiency; 2-hydroxy-3-methylbutyric acid has also been linked to the inborn metabolic disorders including maple syrup urine disease.",
    "id" : null
  }, {
    "name" : "2-Hydroxy-3-methylpentanoic acid ; HMDB0000317",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000317",
    "description" : "2-Hydroxy-3-methyl-pentanoic acid, also known as 2-hydroxy-3-methyl-valerate or (2R,3R)-2-hydroxy-3-methylpentanoate, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 2-Hydroxy-3-methyl-pentanoic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Hydroxy-3-methyl-pentanoic acid has been detected in multiple biofluids, such as saliva, feces, and urine. Within the cell, 2-hydroxy-3-methyl-pentanoic acid is primarily located in the cytoplasm and adiposome. 2-Hydroxy-3-methyl-pentanoic acid exists in all eukaryotes, ranging from yeast to humans. 2-Hydroxy-3-methyl-pentanoic acid has been linked to the inborn metabolic disorders including maple syrup urine disease.",
    "id" : null
  }, {
    "name" : "2-Hydroxy-3-methylpentanoic acid ; HMDB00317",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000317",
    "description" : "2-Hydroxy-3-methyl-pentanoic acid, also known as 2-hydroxy-3-methyl-valerate or (2R,3R)-2-hydroxy-3-methylpentanoate, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 2-Hydroxy-3-methyl-pentanoic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Hydroxy-3-methyl-pentanoic acid has been detected in multiple biofluids, such as saliva, feces, and urine. Within the cell, 2-hydroxy-3-methyl-pentanoic acid is primarily located in the cytoplasm and adiposome. 2-Hydroxy-3-methyl-pentanoic acid exists in all eukaryotes, ranging from yeast to humans. 2-Hydroxy-3-methyl-pentanoic acid has been linked to the inborn metabolic disorders including maple syrup urine disease.",
    "id" : null
  }, {
    "name" : "2-Hydroxyadipic acid ; HMDB0000321",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000321",
    "description" : "2-Hydroxyadipic acid, also known as 2-hydroxyadipate or 2,3,4-trideoxyhexarate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 2-Hydroxyadipic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Hydroxyadipic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 2-hydroxyadipic acid is primarily located in the cytoplasm and adiposome. 2-Hydroxyadipic acid can be biosynthesized from adipic acid. 2-Hydroxyadipic acid is a potentially toxic compound. 2-Hydroxyadipic acid has been linked to several inborn metabolic disorders including 2-ketoadipic acidemia and alpha-aminoadipic aciduria.",
    "id" : null
  }, {
    "name" : "2-Hydroxybutyric acid ; HMDB0000008",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000008",
    "description" : "(+/-)alpha-hydoxy butyric acid, also known as 2-hydroxybutanoic acid or alpha-hydroxybutyrate, belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon (+/-)alpha-hydoxy butyric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa) (+/-)alpha-hydoxy butyric acid has been found in human prostate tissue, and has also been detected in most biofluids, including blood, feces, sweat, and saliva. Within the cell, (+/-)alpha-hydoxy butyric acid is primarily located in the cytoplasm (+/-)alpha-hydoxy butyric acid exists in all eukaryotes, ranging from yeast to humans. In humans, (+/-)alpha-hydoxy butyric acid is involved in the propanoate metabolism pathway (+/-)alpha-hydoxy butyric acid is also involved in a few metabolic disorders, which include the methylmalonic aciduria due to cobalamin-related disorders pathway, the malonic aciduria pathway, and malonyl-CoA decarboxylase deficiency (+/-)alpha-hydoxy butyric acid has been found to be associated with several diseases known as dihydrolipoamide dehydrogenase deficiency and schizophrenia; (+/-)alpha-hydoxy butyric acid has also been linked to the inborn metabolic disorders including pyruvate dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "2-Hydroxybutyric acid ; HMDB00008",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000008",
    "description" : "(+/-)alpha-hydoxy butyric acid, also known as 2-hydroxybutanoic acid or alpha-hydroxybutyrate, belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon (+/-)alpha-hydoxy butyric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa) (+/-)alpha-hydoxy butyric acid has been found in human prostate tissue, and has also been detected in most biofluids, including blood, feces, sweat, and saliva. Within the cell, (+/-)alpha-hydoxy butyric acid is primarily located in the cytoplasm (+/-)alpha-hydoxy butyric acid exists in all eukaryotes, ranging from yeast to humans. In humans, (+/-)alpha-hydoxy butyric acid is involved in the propanoate metabolism pathway (+/-)alpha-hydoxy butyric acid is also involved in a few metabolic disorders, which include the methylmalonic aciduria due to cobalamin-related disorders pathway, the malonic aciduria pathway, and malonyl-CoA decarboxylase deficiency (+/-)alpha-hydoxy butyric acid has been found to be associated with several diseases known as dihydrolipoamide dehydrogenase deficiency and schizophrenia; (+/-)alpha-hydoxy butyric acid has also been linked to the inborn metabolic disorders including pyruvate dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "2-Hydroxydecanoate ; HMDB0094656",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0094656",
    "description" : "2-hydroxydecanoate, also known as alpha-Hydroxycaprate or a-Hydroxycapric acid, is classified as a member of the medium-chain fatty acids. Medium-chain fatty acids are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 2-hydroxydecanoate is considered to be a practically insoluble (in water) and a weak acidic compound. 2-hydroxydecanoate can be found in feces.",
    "id" : null
  }, {
    "name" : "2-Hydroxyglutarate ; HMDB0059655",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0059655",
    "description" : "2-Hydroxyglutaric acid, also known as alpha-hydroxyglutarate, belongs to the class of organic compounds known as short-chain hydroxy acids and derivatives. These are hydroxy acids with an alkyl chain the contains less than 6 carbon atoms. 2-Hydroxyglutaric acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Hydroxyglutaric acid has been found in human brain tissue, and has also been detected in most biofluids, including urine, saliva, blood, and feces. Within the cell, 2-hydroxyglutaric acid is primarily located in the cytoplasm and mitochondria. 2-Hydroxyglutaric acid exists in all eukaryotes, ranging from yeast to humans. In humans, 2-hydroxyglutaric acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the oncogenic action OF succinate pathway, and the oncogenic action OF fumarate pathway. 2-Hydroxyglutaric acid is also involved in a couple of metabolic disorders, which include the oncogenic action OF D-2-hydroxyglutarate in hydroxygluaricaciduria pathway and the oncogenic action OF L-2-hydroxyglutarate in hydroxygluaricaciduria pathway. 2-Hydroxyglutaric acid has been found to be associated with several diseases known as eosinophilic esophagitis and deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome; 2-hydroxyglutaric acid has also been linked to several inborn metabolic disorders including l-2-hydroxyglutaric aciduria, d-2-hydroxyglutaric aciduria, and glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "2-Hydroxyglutarate ; HMDB59655",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0059655",
    "description" : "2-Hydroxyglutaric acid, also known as alpha-hydroxyglutarate, belongs to the class of organic compounds known as short-chain hydroxy acids and derivatives. These are hydroxy acids with an alkyl chain the contains less than 6 carbon atoms. 2-Hydroxyglutaric acid is soluble (in water) and a weakly acidic compound (based on its pKa). 2-Hydroxyglutaric acid has been found in human brain tissue, and has also been detected in most biofluids, including urine, saliva, blood, and feces. Within the cell, 2-hydroxyglutaric acid is primarily located in the cytoplasm and mitochondria. 2-Hydroxyglutaric acid exists in all eukaryotes, ranging from yeast to humans. In humans, 2-hydroxyglutaric acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the oncogenic action OF succinate pathway, and the oncogenic action OF fumarate pathway. 2-Hydroxyglutaric acid is also involved in a couple of metabolic disorders, which include the oncogenic action OF D-2-hydroxyglutarate in hydroxygluaricaciduria pathway and the oncogenic action OF L-2-hydroxyglutarate in hydroxygluaricaciduria pathway. 2-Hydroxyglutaric acid has been found to be associated with several diseases known as eosinophilic esophagitis and deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome; 2-hydroxyglutaric acid has also been linked to several inborn metabolic disorders including l-2-hydroxyglutaric aciduria, d-2-hydroxyglutaric aciduria, and glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "2-Hydroxyhexadecanoic acid ; HMDB0031057",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0031057",
    "description" : "2R-Hydroxypalmitic acid, also known as (R)-2-hydroxypalmitate or (2R)-2-hydroxyhexadecanoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. 2R-Hydroxypalmitic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. 2R-Hydroxypalmitic acid has been detected in multiple biofluids, such as feces and urine. Within the cell, 2R-hydroxypalmitic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. 2R-Hydroxypalmitic acid can be converted into (R)-2-hydroxyhexadecanoyl-CoA.",
    "id" : null
  }, {
    "name" : "2-Hydroxyhexadecanoylcarnitine ; HMDB0013337",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013337",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "2-Hydroxyhexadecanoylcarnitine ; HMDB13337",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013337",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "2-Hydroxyibuprofen ; HMDB0060920",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060920",
    "description" : "2-Hydroxyibuprofen is a metabolite of ibuprofen. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for relief of symptoms of arthritis, fever, as an analgesic (pain reliever), especially where there is an inflammatory component, and dysmenorrhea. Ibuprofen is known to have an antiplatelet effect, though it is relatively mild and somewhat short-lived when compared with aspirin or other better-known antiplatelet drugs. (Wikipedia)",
    "id" : null
  }, {
    "name" : "2-Hydroxymyristic acid ; HMDB0002261",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002261",
    "description" : "2-Hydroxymyristic acid, also known as a-hydroxymyristate or a-hydroxy-N-tetradecylate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. 2-Hydroxymyristic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. 2-Hydroxymyristic acid has been primarily detected in urine. Within the cell, 2-hydroxymyristic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "2-Hydroxymyristic acid ; HMDB02261",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002261",
    "description" : "2-Hydroxymyristic acid, also known as a-hydroxymyristate or a-hydroxy-N-tetradecylate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. 2-Hydroxymyristic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. 2-Hydroxymyristic acid has been primarily detected in urine. Within the cell, 2-hydroxymyristic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "2-Hydroxystearic acid ; HMDB0062549",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0062549",
    "description" : "DL-2-Hydroxy stearic acid, also known as a-hydroxyoctadecanoate or a-hydroxystearate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. DL-2-Hydroxy stearic acid is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. DL-2-Hydroxy stearic acid has been detected in multiple biofluids, such as feces and urine. Within the cell, DL-2-hydroxy stearic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. DL-2-Hydroxy stearic acid can be converted into 2-hydroxystearoyl-CoA and N-2-hydroxystearoylsphingosine.",
    "id" : null
  }, {
    "name" : "2-Isopropylmalic acid ; HMDB0000402",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000402",
    "description" : "2-Isopropyl-malic acid, also known as (2s)-2-isopropylmalate, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 2-Isopropyl-malic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 2-Isopropyl-malic acid has been detected in multiple biofluids, such as saliva, feces, and urine. Within the cell, 2-isopropyl-malic acid is primarily located in the cytoplasm and adiposome. 2-Isopropyl-malic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, 2-isopropyl-malic acid can be found in a number of food items such as celery stalks, potato, winter savory, and agar. This makes 2-isopropyl-malic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "2-Ketobutyric acid ; HMDB0000005",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000005",
    "description" : "3-Methyl pyruvic acid, also known as alpha-ketobutyric acid or 2-oxobutyric acid, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 3-Methyl pyruvic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 3-Methyl pyruvic acid has been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, 3-methyl pyruvic acid is primarily located in the cytoplasm. 3-Methyl pyruvic acid exists in all eukaryotes, ranging from yeast to humans. In humans, 3-methyl pyruvic acid is involved in the methionine metabolism pathway, the selenoamino acid metabolism pathway, the glycine and serine metabolism pathway, and the threonine and 2-oxobutanoate degradation pathway. 3-Methyl pyruvic acid is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, homocystinuria, cystathionine beta-synthase deficiency, the NON ketotic hyperglycinemia pathway, and the hypermethioninemia pathway. Outside of the human body, 3-methyl pyruvic acid can be found in a number of food items such as dock, common persimmon, nutmeg, and common pea. This makes 3-methyl pyruvic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "2-Methylguanosine ; HMDB0005862",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005862",
    "description" : "2-Methylguanosine, also known as M2G, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. 2-Methylguanosine is soluble (in water) and a very weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "2-Methylguanosine ; HMDB05862",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005862",
    "description" : "2-Methylguanosine, also known as M2G, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. 2-Methylguanosine is soluble (in water) and a very weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "2-Piperidinone ; HMDB0011749",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011749",
    "description" : "2-Piperidinone, also known as alpha-piperidone or 2-oxo-piperidine, belongs to the class of organic compounds known as piperidinones. Piperidinones are compounds containing a piperidine ring which bears a ketone. 2-Piperidinone exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). 2-Piperidinone has been detected in multiple biofluids, such as feces, saliva, and blood.",
    "id" : null
  }, {
    "name" : "2-trans,4-cis-Decadienoylcarnitine ; HMDB0013325",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013325",
    "description" : "2-trans,4-cis-Decadienoylcarnitine belongs to the class of organic compounds known as fatty acid esters. These are carboxylic ester derivatives of a fatty acid. 2-trans,4-cis-Decadienoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. 2-trans,4-cis-Decadienoylcarnitine has been primarily detected in urine. Within the cell, 2-trans,4-cis-decadienoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "2-trans,4-cis-Decadienoylcarnitine ; HMDB13325",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013325",
    "description" : "2-trans,4-cis-Decadienoylcarnitine belongs to the class of organic compounds known as fatty acid esters. These are carboxylic ester derivatives of a fatty acid. 2-trans,4-cis-Decadienoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. 2-trans,4-cis-Decadienoylcarnitine has been primarily detected in urine. Within the cell, 2-trans,4-cis-decadienoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "21-Deoxycortisol ; HMDB0004030",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004030",
    "description" : "21-Deoxycortisol belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. 21-Deoxycortisol is considered to be a practically insoluble (in water) and relatively neutral molecule. 21-Deoxycortisol has been found in human hepatic tissue, testicle and endocrine gland tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 21-deoxycortisol is primarily located in the membrane (predicted from logP) and cytoplasm. 21-Deoxycortisol participates in a number of enzymatic reactions. In particular, 21-Deoxycortisol can be converted into 11b-hydroxyprogesterone; which is catalyzed by the enzyme steroid 17-alpha-hydroxylase/17,20 lyase. In addition, 21-Deoxycortisol can be converted into cortisol through its interaction with the enzyme steroid 21-hydroxylase. In humans, 21-deoxycortisol is involved in the steroidogenesis pathway. 21-Deoxycortisol is also involved in several metabolic disorders, some of which include the apparent mineralocorticoid excess syndrome pathway, 21-hydroxylase deficiency (cyp21), corticosterone methyl oxidase I deficiency (cmo I), and corticosterone methyl oxidase II deficiency - cmo II.",
    "id" : null
  }, {
    "name" : "21-Deoxycortisol ; HMDB04030",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004030",
    "description" : "21-Deoxycortisol belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. 21-Deoxycortisol is considered to be a practically insoluble (in water) and relatively neutral molecule. 21-Deoxycortisol has been found in human hepatic tissue, testicle and endocrine gland tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 21-deoxycortisol is primarily located in the membrane (predicted from logP) and cytoplasm. 21-Deoxycortisol participates in a number of enzymatic reactions. In particular, 21-Deoxycortisol can be converted into 11b-hydroxyprogesterone; which is catalyzed by the enzyme steroid 17-alpha-hydroxylase/17,20 lyase. In addition, 21-Deoxycortisol can be converted into cortisol through its interaction with the enzyme steroid 21-hydroxylase. In humans, 21-deoxycortisol is involved in the steroidogenesis pathway. 21-Deoxycortisol is also involved in several metabolic disorders, some of which include the apparent mineralocorticoid excess syndrome pathway, 21-hydroxylase deficiency (cyp21), corticosterone methyl oxidase I deficiency (cmo I), and corticosterone methyl oxidase II deficiency - cmo II.",
    "id" : null
  }, {
    "name" : "3 beta-Hydroxy-5-cholestenoate ; HMDB0012453",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012453",
    "description" : "3 beta-Hydroxy-5-cholestenoate, also known as 3-hcoa or 3-hydroxy-5-cholesten-26-Oic acid, belongs to the class of organic compounds known as monohydroxy bile acids, alcohols and derivatives. These are bile acids, alcohols or any of their derivatives bearing a hydroxyl group. 3 beta-Hydroxy-5-cholestenoate is considered to be a practically insoluble (in water) and relatively neutral molecule. 3 beta-Hydroxy-5-cholestenoate has been found in human hepatic tissue tissue, and has also been primarily detected in urine. Within the cell, 3 beta-hydroxy-5-cholestenoate is primarily located in the membrane (predicted from logP) and cytoplasm. 3 beta-Hydroxy-5-cholestenoate participates in a number of enzymatic reactions. In particular, 3 beta-Hydroxy-5-cholestenoate can be biosynthesized from 27-hydroxycholesterol; which is catalyzed by the enzyme sterol 26-hydroxylase, mitochondrial. In addition, 3 beta-Hydroxy-5-cholestenoate can be converted into 3 beta,7 alpha-dihydroxy-5-cholestenoate through its interaction with the enzyme 25-hydroxycholesterol 7-alpha-hydroxylase. In humans, 3 beta-hydroxy-5-cholestenoate is involved in bile acid biosynthesis pathway, congenital bile acid synthesis defect type III pathway, the cerebrotendinous xanthomatosis (CTX) pathway, and congenital bile acid synthesis defect type II pathway. 3 beta-Hydroxy-5-cholestenoate is also involved in a few metabolic disorders, which include 27-hydroxylase deficiency, the zellweger syndrome pathway, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "3, 5-Tetradecadiencarnitine ; HMDB0013331",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013331",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "3, 5-Tetradecadiencarnitine ; HMDB13331",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013331",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "3-(3-Hydroxyphenyl)propanoic acid ; HMDB0000375",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000375",
    "description" : "3-(3-Hydroxyphenyl)propanoic acid, also known as dihydro-3-coumaric acid or b-(m-hydroxyphenyl)propionate, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. 3-(3-Hydroxyphenyl)propanoic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3-(3-Hydroxyphenyl)propanoic acid has been detected in multiple biofluids, such as feces, urine, and blood. 3-(3-Hydroxyphenyl)propanoic acid participates in a number of enzymatic reactions. In particular, 3-(3-hydroxyphenyl)propanoic acid can be biosynthesized from propionic acid. 3-(3-Hydroxyphenyl)propanoic acid can also be converted into 3-(m-hydroxyphenyl)propanoyl-CoA.",
    "id" : null
  }, {
    "name" : "3-(3-Hydroxyphenyl)propanoic acid ; HMDB00375",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000375",
    "description" : "3-(3-Hydroxyphenyl)propanoic acid, also known as dihydro-3-coumaric acid or b-(m-hydroxyphenyl)propionate, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. 3-(3-Hydroxyphenyl)propanoic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3-(3-Hydroxyphenyl)propanoic acid has been detected in multiple biofluids, such as feces, urine, and blood. 3-(3-Hydroxyphenyl)propanoic acid participates in a number of enzymatic reactions. In particular, 3-(3-hydroxyphenyl)propanoic acid can be biosynthesized from propionic acid. 3-(3-Hydroxyphenyl)propanoic acid can also be converted into 3-(m-hydroxyphenyl)propanoyl-CoA.",
    "id" : null
  }, {
    "name" : "3-Amino-2-piperidone ; HMDB0000323",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000323",
    "description" : "3-Amino-2-piperidone, also known as cyclo-ornithine or 3-aminopiperidine-2-one, belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. 3-Amino-2-piperidone is soluble (in water) and a very weakly acidic compound (based on its pKa). 3-Amino-2-piperidone has been primarily detected in sweat.",
    "id" : null
  }, {
    "name" : "3-Aminoisobutanoic acid ; HMDB0003911",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003911",
    "description" : "3-Amino-isobutanoic acid, also known as 3-aminoisobutanoate or beta-aminoisobutyric acid, belongs to the class of organic compounds known as beta amino acids and derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom. 3-Amino-isobutanoic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 3-Amino-isobutanoic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 3-amino-isobutanoic acid is primarily located in the cytoplasm. 3-Amino-isobutanoic acid exists in all eukaryotes, ranging from yeast to humans. In humans, 3-amino-isobutanoic acid is involved in the pyrimidine metabolism pathway. 3-Amino-isobutanoic acid is also involved in several metabolic disorders, some of which include Beta ureidopropionase deficiency, UMP synthase deficiency (orotic aciduria), the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, and dihydropyrimidinase deficiency.",
    "id" : null
  }, {
    "name" : "3-Carboxy-4-methyl-5-propyl-2-furanpropionic acid ; HMDB0061112",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061112",
    "description" : ", also known as CMPF or u(3,3), belongs to the class of organic compounds known as furanoid fatty acids. These are fatty acids containing a 5-alkylfuran-2-alkanoic acid. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "3-Carboxy-4-methyl-5-propyl-2-furanpropionic acid ; HMDB61112",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061112",
    "description" : ", also known as CMPF or u(3,3), belongs to the class of organic compounds known as furanoid fatty acids. These are fatty acids containing a 5-alkylfuran-2-alkanoic acid. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "3-Hydroxy-11Z-octadecenoylcarnitine ; HMDB0013339",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013339",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "3-Hydroxy-11Z-octadecenoylcarnitine ; HMDB13339",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013339",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "3-Hydroxyanthranilic acid ; HMDB0001476",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001476",
    "description" : "3-Hydroxyanthranilic acid, also known as 2-amino-3-hydroxy-benzoate or 3-ohaa, belongs to the class of organic compounds known as hydroxybenzoic acid derivatives. Hydroxybenzoic acid derivatives are compounds containing a hydroxybenzoic acid (or a derivative), which is a benzene ring bearing a carboxyl and a hydroxyl groups. 3-Hydroxyanthranilic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). 3-Hydroxyanthranilic acid has been found in human epidermis and bladder tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 3-hydroxyanthranilic acid is primarily located in the cytoplasm. 3-Hydroxyanthranilic acid exists in all eukaryotes, ranging from yeast to humans. 3-Hydroxyanthranilic acid participates in a number of enzymatic reactions. In particular, 3-Hydroxyanthranilic acid and L-alanine can be biosynthesized from L-3-hydroxykynurenine; which is catalyzed by the enzyme kynureninase. Furthermore, 3-Hydroxyanthranilic acid can be converted into cinnavalininate through its interaction with the enzyme catalase. Furthermore, L-Alanine and 3-hydroxyanthranilic acid can be biosynthesized from 3-hydroxy-L-kynurenine through its interaction with the enzyme kynureninase. Furthermore, 3-Hydroxyanthranilic acid can be converted into 2-amino-3-carboxymuconic acid semialdehyde; which is catalyzed by the enzyme 3-hydroxyanthranilate 3,4-dioxygenase. Furthermore, 3-Hydroxyanthranilic acid can be converted into 2-amino-3-carboxymuconic acid semialdehyde through the action of the enzyme 3-hydroxyanthranilate 3,4-dioxygenase. Finally, L-Alanine and 3-hydroxyanthranilic acid can be biosynthesized from 3-hydroxy-L-kynurenine; which is mediated by the enzyme kynureninase. In humans, 3-hydroxyanthranilic acid is involved in the tryptophan metabolism pathway.",
    "id" : null
  }, {
    "name" : "3-Hydroxyanthranilic acid ; HMDB01476",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001476",
    "description" : "3-Hydroxyanthranilic acid, also known as 2-amino-3-hydroxy-benzoate or 3-ohaa, belongs to the class of organic compounds known as hydroxybenzoic acid derivatives. Hydroxybenzoic acid derivatives are compounds containing a hydroxybenzoic acid (or a derivative), which is a benzene ring bearing a carboxyl and a hydroxyl groups. 3-Hydroxyanthranilic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). 3-Hydroxyanthranilic acid has been found in human epidermis and bladder tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 3-hydroxyanthranilic acid is primarily located in the cytoplasm. 3-Hydroxyanthranilic acid exists in all eukaryotes, ranging from yeast to humans. 3-Hydroxyanthranilic acid participates in a number of enzymatic reactions. In particular, 3-Hydroxyanthranilic acid and L-alanine can be biosynthesized from L-3-hydroxykynurenine; which is catalyzed by the enzyme kynureninase. Furthermore, 3-Hydroxyanthranilic acid can be converted into cinnavalininate through its interaction with the enzyme catalase. Furthermore, L-Alanine and 3-hydroxyanthranilic acid can be biosynthesized from 3-hydroxy-L-kynurenine through its interaction with the enzyme kynureninase. Furthermore, 3-Hydroxyanthranilic acid can be converted into 2-amino-3-carboxymuconic acid semialdehyde; which is catalyzed by the enzyme 3-hydroxyanthranilate 3,4-dioxygenase. Furthermore, 3-Hydroxyanthranilic acid can be converted into 2-amino-3-carboxymuconic acid semialdehyde through the action of the enzyme 3-hydroxyanthranilate 3,4-dioxygenase. Finally, L-Alanine and 3-hydroxyanthranilic acid can be biosynthesized from 3-hydroxy-L-kynurenine; which is mediated by the enzyme kynureninase. In humans, 3-hydroxyanthranilic acid is involved in the tryptophan metabolism pathway.",
    "id" : null
  }, {
    "name" : "3-Hydroxycapric acid ; HMDB0002203",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002203",
    "description" : ", also known as myrmicacin or 3-hydroxycaprate, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. Thus, is considered to be a fatty acid lipid molecule. is slightly soluble (in water) and a weakly acidic compound (based on its pKa). has been detected in multiple biofluids, such as feces and blood. can be biosynthesized from decanoic acid.",
    "id" : null
  }, {
    "name" : "3-Hydroxycapric acid ; HMDB02203",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002203",
    "description" : ", also known as myrmicacin or 3-hydroxycaprate, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. Thus, is considered to be a fatty acid lipid molecule. is slightly soluble (in water) and a weakly acidic compound (based on its pKa). has been detected in multiple biofluids, such as feces and blood. can be biosynthesized from decanoic acid.",
    "id" : null
  }, {
    "name" : "3-Hydroxydodecanoic acid ; HMDB0000387",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000387",
    "description" : "Beta-Hydroxylauric acid, also known as 3-hydroxy-dodecanoate or 3-OH dodecanoic acid, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. Beta-Hydroxylauric acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Beta-Hydroxylauric acid has been detected in multiple biofluids, such as feces and blood. Within the cell, Beta-hydroxylauric acid is primarily located in the membrane (predicted from logP). Beta-Hydroxylauric acid can be biosynthesized from dodecanoic acid.",
    "id" : null
  }, {
    "name" : "3-hydroxyhexanoic acid ; HMDB0061652",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061652",
    "description" : "DL-3-Hydroxy caproic acid, also known as 3-hydroxycaproate, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. DL-3-Hydroxy caproic acid is soluble (in water) and a weakly acidic compound (based on its pKa). DL-3-Hydroxy caproic acid can be converted into ethyl 3-hydroxyhexanoate.",
    "id" : null
  }, {
    "name" : "3-Hydroxyhippuric acid ; HMDB0006116",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006116",
    "description" : "3-Hydroxyhippuric acid, also known as 3-hydroxybenzoylglycine or 3-hydroxyhippate, belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. 3-Hydroxyhippuric acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). 3-Hydroxyhippuric acid has been detected in multiple biofluids, such as urine and blood. Within the cell, 3-hydroxyhippuric acid is primarily located in the cytoplasm. 3-Hydroxyhippuric acid can be biosynthesized from N-benzoylglycine.",
    "id" : null
  }, {
    "name" : "3-Hydroxyisovaleric acid ; HMDB0000754",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000754",
    "description" : "3-Hydroxy-isovaleric acid, also known as HMB-D6 or 3-hydroxy-3-methylbutyrate, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 3-Hydroxy-isovaleric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 3-Hydroxy-isovaleric acid has been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, 3-hydroxy-isovaleric acid is primarily located in the cytoplasm and adiposome. 3-Hydroxy-isovaleric acid participates in a number of enzymatic reactions. In particular, 3-hydroxy-isovaleric acid can be biosynthesized from isovaleric acid and butyric acid. 3-Hydroxy-isovaleric acid can also be converted into 3-hydroxyisovalerylcarnitine and 3-hydroxyisovaleryl-CoA. 3-Hydroxy-isovaleric acid is a potentially toxic compound. 3-Hydroxy-isovaleric acid has been found to be associated with several diseases known as 3-methylglutaconic aciduria type VI and lung cancer; 3-hydroxy-isovaleric acid has also been linked to several inborn metabolic disorders including biotinidase deficiency, 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, and 3-methylglutaconic aciduria type I.",
    "id" : null
  }, {
    "name" : "3-Hydroxymethylglutaric acid ; HMDB0000355",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000355",
    "description" : "3-Hydroxymethylglutaric acid, also known as meglutol or dicrotalic acid, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 3-Hydroxymethylglutaric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 3-Hydroxymethylglutaric acid has been detected in multiple biofluids, such as saliva and urine. Within the cell, 3-hydroxymethylglutaric acid is primarily located in the cytoplasm and adiposome. 3-Hydroxymethylglutaric acid participates in a number of enzymatic reactions. In particular, 3-hydroxymethylglutaric acid can be biosynthesized from glutaric acid. 3-Hydroxymethylglutaric acid is also a parent compound for other transformation products, including but not limited to, viscumneoside vii, viscumneoside iv, and yanuthone D. Outside of the human body, 3-hydroxymethylglutaric acid can be found in flaxseed. This makes 3-hydroxymethylglutaric acid a potential biomarker for the consumption of this food product. 3-Hydroxymethylglutaric acid is a potentially toxic compound. 3-Hydroxymethylglutaric acid has been linked to the inborn metabolic disorders including 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.",
    "id" : null
  }, {
    "name" : "3-Hydroxymyristate ; HMDB0094672",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0094672",
    "description" : ", also known as 14:0(3-oh), belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been primarily detected in urine. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. participates in a number of enzymatic reactions. In particular, can be biosynthesized from tetradecanoic acid. can also be converted into 3-hydroxytetradecanoyl-CoA.",
    "id" : null
  }, {
    "name" : "3-Hydroxyoctanoic acid ; HMDB0001954",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001954",
    "description" : "3-Hydroxy caprylic acid, also known as 3-hydroxy-octanoate or 3-OH octanoic acid, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. 3-Hydroxy caprylic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 3-Hydroxy caprylic acid participates in a number of enzymatic reactions. In particular, 3-hydroxy caprylic acid can be biosynthesized from octanoic acid. 3-Hydroxy caprylic acid can also be converted into 3-hydroxyoctanoyl-CoA.",
    "id" : null
  }, {
    "name" : "3-Hydroxyoctanoic acid ; HMDB01954",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001954",
    "description" : "3-Hydroxy caprylic acid, also known as 3-hydroxy-octanoate or 3-OH octanoic acid, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. 3-Hydroxy caprylic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 3-Hydroxy caprylic acid participates in a number of enzymatic reactions. In particular, 3-hydroxy caprylic acid can be biosynthesized from octanoic acid. 3-Hydroxy caprylic acid can also be converted into 3-hydroxyoctanoyl-CoA.",
    "id" : null
  }, {
    "name" : "3-Hydroxysebacic acid ; HMDB0000350",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000350",
    "description" : "3-Hydroxy-sebacic acid, also known as 3-hydroxy-decanedioate, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. 3-Hydroxy-sebacic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3-Hydroxy-sebacic acid has been detected in multiple biofluids, such as urine and blood. 3-Hydroxy-sebacic acid can be biosynthesized from sebacic acid. 3-Hydroxy-sebacic acid has been linked to the inborn metabolic disorders including medium chain acyl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "3-Indolebutyric acid ; HMDB0002096",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002096",
    "description" : "3-Indolebutyric acid, also known as indolebutyrate or 1H-indole-3-butanoate, belongs to the class of organic compounds known as 3-alkylindoles. 3-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. 3-Indolebutyric acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. 3-Indolebutyric acid has been primarily detected in blood. Within the cell, 3-indolebutyric acid is primarily located in the membrane (predicted from logP). 3-Indolebutyric acid can be biosynthesized from butyric acid.",
    "id" : null
  }, {
    "name" : "3-Methoxytyrosine ; HMDB0001434",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001434",
    "description" : "3-Methoxytyrosine, also known as 3-O-methyldopa or vanilalanine, belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 3-Methoxytyrosine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 3-Methoxytyrosine has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. 3-Methoxytyrosine has been found to be associated with several diseases known as epilepsy, early-onset, vitamin b6-dependent and pyridoxamine 5-prime-phosphate oxidase deficiency; 3-methoxytyrosine has also been linked to the inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "3-Methyl-2-oxovaleric acid ; HMDB0000491",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000491",
    "description" : "3-Methyl-2-oxovaleric acid, also known as 3-methyl-2-oxopentanoate or 2-oxo-3-methylvalerate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 3-Methyl-2-oxovaleric acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3-Methyl-2-oxovaleric acid has been found in human prostate tissue, and has also been detected in most biofluids, including saliva, blood, feces, and cerebrospinal fluid. Within the cell, 3-methyl-2-oxovaleric acid is primarily located in the cytoplasm. 3-Methyl-2-oxovaleric acid participates in a number of enzymatic reactions. In particular, 3-Methyl-2-oxovaleric acid and L-glutamic acid can be biosynthesized from L-isoleucine and oxoglutaric acid; which is catalyzed by the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In addition, 3-Methyl-2-oxovaleric acid and thiamine pyrophosphate can be converted into 2-methyl-1-hydroxypropyl-THPP; which is mediated by the enzyme 2-oxoisovalerate dehydrogenase. In humans, 3-methyl-2-oxovaleric acid is involved in the valine, leucine and isoleucine degradation pathway. 3-Methyl-2-oxovaleric acid is also involved in several metabolic disorders, some of which include Beta-ketothiolase deficiency, the isovaleric acidemia pathway, 3-hydroxyisobutyric acid dehydrogenase deficiency, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. 3-Methyl-2-oxovaleric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "3-Methyl-2-oxovaleric acid ; HMDB00491",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000491",
    "description" : "3-Methyl-2-oxovaleric acid, also known as 3-methyl-2-oxopentanoate or 2-oxo-3-methylvalerate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 3-Methyl-2-oxovaleric acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3-Methyl-2-oxovaleric acid has been found in human prostate tissue, and has also been detected in most biofluids, including saliva, blood, feces, and cerebrospinal fluid. Within the cell, 3-methyl-2-oxovaleric acid is primarily located in the cytoplasm. 3-Methyl-2-oxovaleric acid participates in a number of enzymatic reactions. In particular, 3-Methyl-2-oxovaleric acid and L-glutamic acid can be biosynthesized from L-isoleucine and oxoglutaric acid; which is catalyzed by the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In addition, 3-Methyl-2-oxovaleric acid and thiamine pyrophosphate can be converted into 2-methyl-1-hydroxypropyl-THPP; which is mediated by the enzyme 2-oxoisovalerate dehydrogenase. In humans, 3-methyl-2-oxovaleric acid is involved in the valine, leucine and isoleucine degradation pathway. 3-Methyl-2-oxovaleric acid is also involved in several metabolic disorders, some of which include Beta-ketothiolase deficiency, the isovaleric acidemia pathway, 3-hydroxyisobutyric acid dehydrogenase deficiency, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. 3-Methyl-2-oxovaleric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "3-Methyladipic acid ; HMDB0000555",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000555",
    "description" : "3-Methyladipic acid, also known as 3-methyladipate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 3-Methyladipic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 3-Methyladipic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 3-methyladipic acid is primarily located in the cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "3-Methyladipic acid ; HMDB00555",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000555",
    "description" : "3-Methyladipic acid, also known as 3-methyladipate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 3-Methyladipic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 3-Methyladipic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 3-methyladipic acid is primarily located in the cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "3-Methylglutaconic acid ; HMDB0000522",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000522",
    "description" : "3E-Methylglutaconic acid, also known as 3E-methylglutaconate or 3-methyl-2-pentenedioic acid, belongs to the class of organic compounds known as methyl-branched fatty acids. These are fatty acids with an acyl chain that has a methyl branch. Usually, they are saturated and contain only one or more methyl group. However, branches other than methyl may be present. 3E-Methylglutaconic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3E-Methylglutaconic acid has been primarily detected in urine. Within the cell, 3E-methylglutaconic acid is primarily located in the cytoplasm and adiposome. 3E-Methylglutaconic acid participates in a number of enzymatic reactions. In particular, 3E-methylglutaconic acid can be biosynthesized from (e)-glutaconic acid. 3E-Methylglutaconic acid can also be converted into trans-3-methylglutaconyl-CoA. 3E-Methylglutaconic acid is a potentially toxic compound. 3E-Methylglutaconic acid has been found to be associated with several diseases known as 3-methylglutaconic aciduria type VI and 3-methylglutaconic aciduria type VII; 3e-methylglutaconic acid has also been linked to several inborn metabolic disorders including 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, 3-methylglutaconic aciduria type ii, x-linked, and 3-methylglutaconic aciduria type I.",
    "id" : null
  }, {
    "name" : "3-Methylhistidine ; HMDB0000479",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000479",
    "description" : "N(pros)-Methyl-L-histidine, also known as 3-methylhistidine, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N(pros)-Methyl-L-histidine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). N(pros)-Methyl-L-histidine has been found in human prostate, muscle and skeletal muscle tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, saliva, and urine. Within the cell, N(pros)-methyl-L-histidine is primarily located in the cytoplasm. N(pros)-Methyl-L-histidine exists in all eukaryotes, ranging from yeast to humans. In humans, N(pros)-methyl-L-histidine is involved in the methylhistidine metabolism pathway, the Beta-alanine metabolism pathway, and the histidine metabolism pathway. N(pros)-Methyl-L-histidine is also involved in several metabolic disorders, some of which include gaba-transaminase deficiency, the carnosinuria, carnosinemia pathway, the histidinemia pathway, and ureidopropionase deficiency.",
    "id" : null
  }, {
    "name" : "3-Methylhistidine ; HMDB00479",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000479",
    "description" : "N(pros)-Methyl-L-histidine, also known as 3-methylhistidine, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N(pros)-Methyl-L-histidine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). N(pros)-Methyl-L-histidine has been found in human prostate, muscle and skeletal muscle tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, saliva, and urine. Within the cell, N(pros)-methyl-L-histidine is primarily located in the cytoplasm. N(pros)-Methyl-L-histidine exists in all eukaryotes, ranging from yeast to humans. In humans, N(pros)-methyl-L-histidine is involved in the methylhistidine metabolism pathway, the Beta-alanine metabolism pathway, and the histidine metabolism pathway. N(pros)-Methyl-L-histidine is also involved in several metabolic disorders, some of which include gaba-transaminase deficiency, the carnosinuria, carnosinemia pathway, the histidinemia pathway, and ureidopropionase deficiency.",
    "id" : null
  }, {
    "name" : "3-Methylxanthine ; HMDB0001886",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001886",
    "description" : "3-Methylxanthine, also known as 3 MX or purine analog, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 3-Methylxanthine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). 3-Methylxanthine has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 3-methylxanthine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "3-Methylxanthine ; HMDB01886",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001886",
    "description" : "3-Methylxanthine, also known as 3 MX or purine analog, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 3-Methylxanthine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). 3-Methylxanthine has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 3-methylxanthine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "3-Oxocholic acid ; HMDB0000502",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000502",
    "description" : "3-Oxocholic acid, also known as 3-dehydrocholate or 3-oxocholate, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. 3-Oxocholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. 3-Oxocholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and urine. Within the cell, 3-oxocholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. 3-Oxocholic acid can be converted into 3-oxocholoyl-CoA.",
    "id" : null
  }, {
    "name" : "3-Phosphoglyceric acid ; HMDB0000807",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000807",
    "description" : "3-Phosphoglyceric acid, also known as glycerate 3-phosphate or 3-PG, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. 3-Phosphoglyceric acid is soluble (in water) and a moderately acidic compound (based on its pKa). 3-Phosphoglyceric acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as saliva and blood. Within the cell, 3-phosphoglyceric acid is primarily located in the cytoplasm and mitochondria. 3-Phosphoglyceric acid exists in all eukaryotes, ranging from yeast to humans. 3-Phosphoglyceric acid participates in a number of enzymatic reactions. In particular, 3-Phosphoglyceric acid can be biosynthesized from glyceric acid through the action of the enzyme glycerate kinase. Furthermore, 3-Phosphoglyceric acid can be converted into phosphohydroxypyruvic acid through the action of the enzyme D-3-phosphoglycerate dehydrogenase. Finally, 3-Phosphoglyceric acid can be converted into glyceric acid; which is catalyzed by the enzyme glycerate kinase. In humans, 3-phosphoglyceric acid is involved in the glycine and serine metabolism pathway, the triosephosphate isomerase pathway, the D-glyceric acidura pathway, and the starch and sucrose metabolism pathway. 3-Phosphoglyceric acid is also involved in several metabolic disorders, some of which include sucrase-isomaltase deficiency, the hyperglycinemia, non-ketotic pathway, cancer (via the Warburg effect), and glycerol kinase deficiency.",
    "id" : null
  }, {
    "name" : "3-Phosphoglyceric acid ; HMDB00807",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000807",
    "description" : "3-Phosphoglyceric acid, also known as glycerate 3-phosphate or 3-PG, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. 3-Phosphoglyceric acid is soluble (in water) and a moderately acidic compound (based on its pKa). 3-Phosphoglyceric acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as saliva and blood. Within the cell, 3-phosphoglyceric acid is primarily located in the cytoplasm and mitochondria. 3-Phosphoglyceric acid exists in all eukaryotes, ranging from yeast to humans. 3-Phosphoglyceric acid participates in a number of enzymatic reactions. In particular, 3-Phosphoglyceric acid can be biosynthesized from glyceric acid through the action of the enzyme glycerate kinase. Furthermore, 3-Phosphoglyceric acid can be converted into phosphohydroxypyruvic acid through the action of the enzyme D-3-phosphoglycerate dehydrogenase. Finally, 3-Phosphoglyceric acid can be converted into glyceric acid; which is catalyzed by the enzyme glycerate kinase. In humans, 3-phosphoglyceric acid is involved in the glycine and serine metabolism pathway, the triosephosphate isomerase pathway, the D-glyceric acidura pathway, and the starch and sucrose metabolism pathway. 3-Phosphoglyceric acid is also involved in several metabolic disorders, some of which include sucrase-isomaltase deficiency, the hyperglycinemia, non-ketotic pathway, cancer (via the Warburg effect), and glycerol kinase deficiency.",
    "id" : null
  }, {
    "name" : "3-Sulfinoalanine ; HMDB0000996",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000996",
    "description" : "3-Sulfinoalanine, also known as cysteine-S-dioxide or cysteine sulfinate, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. 3-Sulfinoalanine is soluble (in water) and a moderately acidic compound (based on its pKa). 3-Sulfinoalanine has been detected in multiple biofluids, such as blood and cerebrospinal fluid. Within the cell, 3-sulfinoalanine is primarily located in the mitochondria. 3-Sulfinoalanine exists in all eukaryotes, ranging from yeast to humans. 3-Sulfinoalanine participates in a number of enzymatic reactions. In particular, 3-Sulfinoalanine can be biosynthesized from L-cysteine through its interaction with the enzyme cysteine dioxygenase type 1. Furthermore, 3-Sulfinoalanine and oxoglutaric acid can be converted into 3-sulfinylpyruvic acid and L-glutamic acid; which is catalyzed by the enzyme aspartate aminotransferase, cytoplasmic. Furthermore, 3-Sulfinoalanine can be biosynthesized from L-cysteine through the action of the enzyme cysteine dioxygenase type 1. Finally, 3-Sulfinoalanine can be converted into hypotaurine through its interaction with the enzyme cysteine sulfinic acid decarboxylase. In humans, 3-sulfinoalanine is involved in the cystinosis, ocular nonnephropathic pathway, the taurine and hypotaurine metabolism pathway, and the cysteine metabolism pathway. 3-Sulfinoalanine is also involved in the metabolic disorder called the Beta-mercaptolactate-cysteine disulfiduria pathway.",
    "id" : null
  }, {
    "name" : "4,5-Dihydroorotic acid ; HMDB0000528",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000528",
    "description" : "4,5-Dihydroorotic acid, also known as hydroorotate, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. 4,5-Dihydroorotic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 4,5-Dihydroorotic acid has been found in human prostate tissue. Within the cell, 4,5-dihydroorotic acid is primarily located in the cytoplasm. 4,5-Dihydroorotic acid exists in all eukaryotes, ranging from yeast to humans. 4,5-Dihydroorotic acid participates in a number of enzymatic reactions. In particular, 4,5-Dihydroorotic acid can be biosynthesized from N-carbamoyl-L-aspartate through its interaction with the enzyme dihydroorotase. In addition, 4,5-Dihydroorotic acid and ubiquinone-1 can be converted into ubiquinol-1 and orotic acid; which is mediated by the enzyme dihydroorotate dehydrogenase, type 2.",
    "id" : null
  }, {
    "name" : "4-Acetamidobutanoic acid ; HMDB0003681",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003681",
    "description" : "4-Acetamidobutanoic acid, also known as N4-acetylaminobutanoate or N-acetyl-4-aminobutyric acid, belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. 4-Acetamidobutanoic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 4-Acetamidobutanoic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. 4-Acetamidobutanoic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, 4-acetamidobutanoic acid can be found in a number of food items such as cocoa bean, yellow zucchini, mustard spinach, and ginkgo nuts. This makes 4-acetamidobutanoic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "4-Acetamidobutanoic acid ; HMDB03681",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003681",
    "description" : "4-Acetamidobutanoic acid, also known as N4-acetylaminobutanoate or N-acetyl-4-aminobutyric acid, belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. 4-Acetamidobutanoic acid is soluble (in water) and a weakly acidic compound (based on its pKa). 4-Acetamidobutanoic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. 4-Acetamidobutanoic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, 4-acetamidobutanoic acid can be found in a number of food items such as cocoa bean, yellow zucchini, mustard spinach, and ginkgo nuts. This makes 4-acetamidobutanoic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "4-ethylphenylsulfate ; HMDB0062551",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0062551",
    "description" : "4-Ethylphenylsulfate belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. 4-Ethylphenylsulfate has been primarily detected in blood. 4-Ethylphenylsulfate can be biosynthesized from 4-ethylphenol.",
    "id" : null
  }, {
    "name" : "4-Guanidinobutanoic acid ; HMDB0003464",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003464",
    "description" : "4-Guanidinobutanoic acid, also known as gamma-guanidinobutyrate or 4-(carbamimidamido)butanoate, belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. 4-Guanidinobutanoic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 4-Guanidinobutanoic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, 4-guanidinobutanoic acid is primarily located in the cytoplasm. 4-Guanidinobutanoic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, 4-guanidinobutanoic acid can be found in apple, french plantain, and loquat. This makes 4-guanidinobutanoic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "4-Hydroxy-2-oxoglutaric acid ; HMDB0002070",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002070",
    "description" : "4-Hydroxy-2-oxoglutaric acid, also known as 2-keto-4-hydroxyglutarate or 4-hydroxy-2-ketoglutarate, belongs to the class of organic compounds known as gamma-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the C4 carbon atom. 4-Hydroxy-2-oxoglutaric acid is soluble (in water) and a moderately acidic compound (based on its pKa). Within the cell, 4-hydroxy-2-oxoglutaric acid is primarily located in the mitochondria. 4-Hydroxy-2-oxoglutaric acid exists in all eukaryotes, ranging from yeast to humans. 4-Hydroxy-2-oxoglutaric acid and L-aspartic acid can be biosynthesized from 4-hydroxy-L-glutamic acid and oxalacetic acid; which is catalyzed by the enzyme aspartate aminotransferase, cytoplasmic. In humans, 4-hydroxy-2-oxoglutaric acid is involved in the arginine and proline metabolism pathway. 4-Hydroxy-2-oxoglutaric acid is also involved in several metabolic disorders, some of which include the hyperprolinemia type II pathway, L-arginine:glycine amidinotransferase deficiency, ornithine aminotransferase deficiency (oat deficiency), and creatine deficiency, guanidinoacetate methyltransferase deficiency.",
    "id" : null
  }, {
    "name" : "4-Hydroxyhippuric acid ; HMDB0013678",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013678",
    "description" : "4-Hydroxyhippuric acid, also known as 4-hydroxybenzoylglycine or 4-hydroxyhippate, belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. 4-Hydroxyhippuric acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 4-Hydroxyhippuric acid has been detected in multiple biofluids, such as feces, urine, and blood. 4-Hydroxyhippuric acid can be biosynthesized from N-benzoylglycine.",
    "id" : null
  }, {
    "name" : "4-Hydroxyphenylpyruvic acid ; HMDB0000707",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000707",
    "description" : "(4-Hydroxyphenyl)pyruvic acid, also known as 4-hydroxy a-oxobenzenepropanoate or hppa, belongs to the class of organic compounds known as phenylpyruvic acid derivatives. Phenylpyruvic acid derivatives are compounds containing a phenylpyruvic acid moiety, which consists of a phenyl group substituted at the second position by an pyruvic acid (4-Hydroxyphenyl)pyruvic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa) (4-Hydroxyphenyl)pyruvic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, (4-hydroxyphenyl)pyruvic acid is primarily located in the cytoplasm and mitochondria (4-Hydroxyphenyl)pyruvic acid exists in all eukaryotes, ranging from yeast to humans. In humans, (4-hydroxyphenyl)pyruvic acid is involved in the disulfiram action pathway, the phenylalanine and tyrosine metabolism pathway, and the tyrosine metabolism pathway (4-Hydroxyphenyl)pyruvic acid is also involved in several metabolic disorders, some of which include the tyrosinemia type 3 (tyro3) pathway, the alkaptonuria pathway, the phenylketonuria pathway, and the tyrosinemia type I pathway. Outside of the human body, (4-hydroxyphenyl)pyruvic acid can be found in a number of food items such as red raspberry, pak choy, enokitake, and spinach. This makes (4-hydroxyphenyl)pyruvic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "4-Hydroxyproline ; HMDB0000725",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000725",
    "description" : "trans-4-Hydroxy-L-proline, also known as hydroxyproline or Hyp, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. trans-4-Hydroxy-L-proline is a drug which is used in france as a combination product for the treatment of small, superficial wounds. trans-4-Hydroxy-L-proline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). trans-4-Hydroxy-L-proline has been found throughout most human tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, trans-4-hydroxy-L-proline is primarily located in the mitochondria and endoplasmic reticulum. trans-4-Hydroxy-L-proline exists in all eukaryotes, ranging from yeast to humans. In humans, trans-4-hydroxy-L-proline is involved in the oncogenic action OF fumarate pathway and the oncogenic action OF succinate pathway. trans-4-Hydroxy-L-proline is also involved in several metabolic disorders, some of which include the hyperornithinemia with gyrate atrophy (hoga) pathway, the hyperprolinemia type I pathway, the hyperprolinemia type II pathway, and L-arginine:glycine amidinotransferase deficiency. trans-4-Hydroxy-L-proline is a potentially toxic compound. trans-4-Hydroxy-L-proline has been found to be associated with several diseases known as hemodialysis and alzheimer's disease; trans-4-hydroxy-l-proline has also been linked to several inborn metabolic disorders including hydroxyprolinemia and iminoglycinuria.",
    "id" : null
  }, {
    "name" : "4-Hydroxyproline ; HMDB00725",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000725",
    "description" : "trans-4-Hydroxy-L-proline, also known as hydroxyproline or Hyp, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. trans-4-Hydroxy-L-proline is a drug which is used in france as a combination product for the treatment of small, superficial wounds. trans-4-Hydroxy-L-proline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). trans-4-Hydroxy-L-proline has been found throughout most human tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, trans-4-hydroxy-L-proline is primarily located in the mitochondria and endoplasmic reticulum. trans-4-Hydroxy-L-proline exists in all eukaryotes, ranging from yeast to humans. In humans, trans-4-hydroxy-L-proline is involved in the oncogenic action OF fumarate pathway and the oncogenic action OF succinate pathway. trans-4-Hydroxy-L-proline is also involved in several metabolic disorders, some of which include the hyperornithinemia with gyrate atrophy (hoga) pathway, the hyperprolinemia type I pathway, the hyperprolinemia type II pathway, and L-arginine:glycine amidinotransferase deficiency. trans-4-Hydroxy-L-proline is a potentially toxic compound. trans-4-Hydroxy-L-proline has been found to be associated with several diseases known as hemodialysis and alzheimer's disease; trans-4-hydroxy-l-proline has also been linked to several inborn metabolic disorders including hydroxyprolinemia and iminoglycinuria.",
    "id" : null
  }, {
    "name" : "4-Hydroxystyrene ; HMDB0004072",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004072",
    "description" : "4-Vinylphenol, also known as P-hydroxystyrene, belongs to the class of organic compounds known as styrenes. These are organic compounds containing an ethenylbenzene moiety. 4-Vinylphenol exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). 4-Vinylphenol exists in all eukaryotes, ranging from yeast to humans. 4-Vinylphenol participates in a number of enzymatic reactions. In particular, 4-vinylphenol can be biosynthesized from styrene. 4-Vinylphenol can also be converted into 4-vinylphenol sulfate. 4-Vinylphenol is a sweet, almond shell, and chemical tasting compound that can be found in a number of food items such as corn, beer, highbush blueberry, and tea. This makes 4-vinylphenol a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "4-Hydroxystyrene ; HMDB04072",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004072",
    "description" : "4-Vinylphenol, also known as P-hydroxystyrene, belongs to the class of organic compounds known as styrenes. These are organic compounds containing an ethenylbenzene moiety. 4-Vinylphenol exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). 4-Vinylphenol exists in all eukaryotes, ranging from yeast to humans. 4-Vinylphenol participates in a number of enzymatic reactions. In particular, 4-vinylphenol can be biosynthesized from styrene. 4-Vinylphenol can also be converted into 4-vinylphenol sulfate. 4-Vinylphenol is a sweet, almond shell, and chemical tasting compound that can be found in a number of food items such as corn, beer, highbush blueberry, and tea. This makes 4-vinylphenol a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "4-Pyridoxic acid ; HMDB0000017",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000017",
    "description" : "4-Pyridoxic acid, also known as 4-pyridoxate, belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. 4-Pyridoxic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). 4-Pyridoxic acid has been found in human liver, bladder and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, 4-pyridoxic acid is primarily located in the cytoplasm. 4-Pyridoxic acid can be biosynthesized from pyridoxal; which is mediated by the enzyme aldehyde oxidase. In humans, 4-pyridoxic acid is involved in the vitamin B6 metabolism pathway. 4-Pyridoxic acid is also involved in the metabolic disorder called the hypophosphatasia pathway.",
    "id" : null
  }, {
    "name" : "4-Pyridoxic acid ; HMDB00017",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000017",
    "description" : "4-Pyridoxic acid, also known as 4-pyridoxate, belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. 4-Pyridoxic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). 4-Pyridoxic acid has been found in human liver, bladder and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, 4-pyridoxic acid is primarily located in the cytoplasm. 4-Pyridoxic acid can be biosynthesized from pyridoxal; which is mediated by the enzyme aldehyde oxidase. In humans, 4-pyridoxic acid is involved in the vitamin B6 metabolism pathway. 4-Pyridoxic acid is also involved in the metabolic disorder called the hypophosphatasia pathway.",
    "id" : null
  }, {
    "name" : "4-Trimethylammoniobutanoic acid ; HMDB0001161",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001161",
    "description" : "4-Trimethylammoniobutanoic acid, also known as gamma-butyrobetaine or deoxycarnitine, belongs to the class of organic compounds known as straight chain fatty acids. These are fatty acids with a straight aliphatic chain. 4-Trimethylammoniobutanoic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. 4-Trimethylammoniobutanoic acid has been found in human liver and kidney tissues, and has also been primarily detected in urine, feces, saliva, and blood. Within the cell, 4-trimethylammoniobutanoic acid is primarily located in the cytoplasm, membrane (predicted from logP), adiposome and mitochondria. 4-Trimethylammoniobutanoic acid participates in a number of enzymatic reactions. In particular, 4-Trimethylammoniobutanoic acid can be biosynthesized from 4-trimethylammoniobutanal through its interaction with the enzyme 4-trimethylaminobutyraldehyde dehydrogenase. In addition, 4-Trimethylammoniobutanoic acid and oxoglutaric acid can be converted into L-carnitine and succinic acid; which is mediated by the enzyme Gamma-butyrobetaine dioxygenase. In humans, 4-trimethylammoniobutanoic acid is involved in carnitine synthesis pathway.",
    "id" : null
  }, {
    "name" : "4-Trimethylammoniobutanoic acid ; HMDB01161",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001161",
    "description" : "4-Trimethylammoniobutanoic acid, also known as gamma-butyrobetaine or deoxycarnitine, belongs to the class of organic compounds known as straight chain fatty acids. These are fatty acids with a straight aliphatic chain. 4-Trimethylammoniobutanoic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. 4-Trimethylammoniobutanoic acid has been found in human liver and kidney tissues, and has also been primarily detected in urine, feces, saliva, and blood. Within the cell, 4-trimethylammoniobutanoic acid is primarily located in the cytoplasm, membrane (predicted from logP), adiposome and mitochondria. 4-Trimethylammoniobutanoic acid participates in a number of enzymatic reactions. In particular, 4-Trimethylammoniobutanoic acid can be biosynthesized from 4-trimethylammoniobutanal through its interaction with the enzyme 4-trimethylaminobutyraldehyde dehydrogenase. In addition, 4-Trimethylammoniobutanoic acid and oxoglutaric acid can be converted into L-carnitine and succinic acid; which is mediated by the enzyme Gamma-butyrobetaine dioxygenase. In humans, 4-trimethylammoniobutanoic acid is involved in carnitine synthesis pathway.",
    "id" : null
  }, {
    "name" : "4-Vinylphenol sulfate ; HMDB0062775",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0062775",
    "description" : "4-Vinylphenol sulfate belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. 4-Vinylphenol sulfate has been detected in multiple biofluids, such as urine and blood. 4-Vinylphenol sulfate can be biosynthesized from 4-hydroxystyrene.",
    "id" : null
  }, {
    "name" : "5,6-Dihydrouridine ; HMDB0000497",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000497",
    "description" : "5,6-Dihydrouridine belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). 5,6-Dihydrouridine is soluble (in water) and a very weakly acidic compound (based on its pKa). 5,6-Dihydrouridine has been detected in multiple biofluids, such as urine and blood. Within the cell, 5,6-dihydrouridine is primarily located in the cytoplasm. 5,6-Dihydrouridine can be converted into 3-(3-amino-3-carboxypropyl)-5,6-dihydrouridine.",
    "id" : null
  }, {
    "name" : "5-Acetylamino-6-amino-3-methyluracil ; HMDB0004400",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004400",
    "description" : "5-Acetylamino-6-amino-3-methyluracil, also known as aamu or 5-ammu, belongs to the class of organic compounds known as n-acetylarylamines. These are acetamides where one or more amide hydrogens is substituted by an aryl group. 5-Acetylamino-6-amino-3-methyluracil is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 5-Acetylamino-6-amino-3-methyluracil has been detected in multiple biofluids, such as feces, urine, and blood. In humans, 5-acetylamino-6-amino-3-methyluracil is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "5-Acetylamino-6-amino-3-methyluracil ; HMDB04400",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004400",
    "description" : "5-Acetylamino-6-amino-3-methyluracil, also known as aamu or 5-ammu, belongs to the class of organic compounds known as n-acetylarylamines. These are acetamides where one or more amide hydrogens is substituted by an aryl group. 5-Acetylamino-6-amino-3-methyluracil is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 5-Acetylamino-6-amino-3-methyluracil has been detected in multiple biofluids, such as feces, urine, and blood. In humans, 5-acetylamino-6-amino-3-methyluracil is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "5-Acetylamino-6-formylamino-3-methyluracil ; HMDB0011105",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011105",
    "description" : "5-Acetylamino-6-formylamino-3-methyluracil, also known as afmu, belongs to the class of organic compounds known as hydroxypyrimidines. These are organic compounds containing a hydroxyl group attached to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. 5-Acetylamino-6-formylamino-3-methyluracil is considered to be a practically insoluble (in water) and relatively neutral molecule. 5-Acetylamino-6-formylamino-3-methyluracil has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 5-acetylamino-6-formylamino-3-methyluracil is primarily located in the cytoplasm. 5-Acetylamino-6-formylamino-3-methyluracil can be biosynthesized from paraxanthine and acetyl-CoA; which is mediated by the enzyme arylamine N-acetyltransferase 2. In humans, 5-acetylamino-6-formylamino-3-methyluracil is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "5-Aminolevulinic acid ; HMDB0001149",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001149",
    "description" : "5-Amino-levulinic acid, also known as 5-aminolevulinate or 5-amino-4-oxopentanoate, belongs to the class of organic compounds known as delta amino acids and derivatives. Delta amino acids and derivatives are compounds containing a carboxylic acid group and an amino group at the C5 carbon atom. 5-Amino-levulinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 5-Amino-levulinic acid has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 5-amino-levulinic acid is primarily located in the mitochondria and cytoplasm. 5-Amino-levulinic acid exists in all eukaryotes, ranging from yeast to humans. In humans, 5-amino-levulinic acid is involved in the porphyrin metabolism pathway and the glycine and serine metabolism pathway. 5-Amino-levulinic acid is also involved in several metabolic disorders, some of which include 3-phosphoglycerate dehydrogenase deficiency, the acute intermittent porphyria pathway, the NON ketotic hyperglycinemia pathway, and the hyperglycinemia, non-ketotic pathway. Outside of the human body, 5-amino-levulinic acid can be found in a number of food items such as mamey sapote, sunflower, grapefruit/pummelo hybrid, and burbot. This makes 5-amino-levulinic acid a potential biomarker for the consumption of these food products. 5-Amino-levulinic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "5-Aminolevulinic acid ; HMDB01149",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001149",
    "description" : "5-Amino-levulinic acid, also known as 5-aminolevulinate or 5-amino-4-oxopentanoate, belongs to the class of organic compounds known as delta amino acids and derivatives. Delta amino acids and derivatives are compounds containing a carboxylic acid group and an amino group at the C5 carbon atom. 5-Amino-levulinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 5-Amino-levulinic acid has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 5-amino-levulinic acid is primarily located in the mitochondria and cytoplasm. 5-Amino-levulinic acid exists in all eukaryotes, ranging from yeast to humans. In humans, 5-amino-levulinic acid is involved in the porphyrin metabolism pathway and the glycine and serine metabolism pathway. 5-Amino-levulinic acid is also involved in several metabolic disorders, some of which include 3-phosphoglycerate dehydrogenase deficiency, the acute intermittent porphyria pathway, the NON ketotic hyperglycinemia pathway, and the hyperglycinemia, non-ketotic pathway. Outside of the human body, 5-amino-levulinic acid can be found in a number of food items such as mamey sapote, sunflower, grapefruit/pummelo hybrid, and burbot. This makes 5-amino-levulinic acid a potential biomarker for the consumption of these food products. 5-Amino-levulinic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "5-HEPE ; HMDB0005081",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005081",
    "description" : "(+/-)-5-hepe belongs to the class of organic compounds known as hydroxyeicosapentaenoic acids. These are eicosanoic acids with an attached hydroxyl group and five CC double bonds. Thus, (+/-)-5-hepe is considered to be an eicosanoid lipid molecule (+/-)-5-hepe is considered to be a practically insoluble (in water) and relatively neutral molecule (+/-)-5-hepe has been detected in multiple biofluids, such as blood and urine. Within the cell, (+/-)-5-hepe is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "5-HETE ; HMDB0011134",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011134",
    "description" : "5S-Hete, also known as 5(S)-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, 5S-hete is considered to be an eicosanoid lipid molecule. 5S-Hete is considered to be a practically insoluble (in water) and relatively neutral molecule. 5S-Hete has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 5S-hete is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, 5S-hete is involved in the salicylate-sodium action pathway, the magnesium salicylate action pathway, the valdecoxib action pathway, and the lumiracoxib action pathway. 5S-Hete is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway.",
    "id" : null
  }, {
    "name" : "5-HETE ; HMDB11134",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011134",
    "description" : "5S-Hete, also known as 5(S)-hete, belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, 5S-hete is considered to be an eicosanoid lipid molecule. 5S-Hete is considered to be a practically insoluble (in water) and relatively neutral molecule. 5S-Hete has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 5S-hete is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, 5S-hete is involved in the salicylate-sodium action pathway, the magnesium salicylate action pathway, the valdecoxib action pathway, and the lumiracoxib action pathway. 5S-Hete is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway.",
    "id" : null
  }, {
    "name" : "5-Hydroxy-L-tryptophan ; HMDB0000472",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000472",
    "description" : "5-Hydroxy-L-tryptophan, also known as oxitriptan or levothym, belongs to the class of organic compounds known as serotonins. Serotonins are compounds containing a serotonin moiety, which consists of an indole that bears an aminoethyl a position 2 and a hydroxyl group at position 5. 5-Hydroxy-L-tryptophan is a drug which is used for use as an antidepressant, appetite suppressant, and sleep aid. 5-Hydroxy-L-tryptophan exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). 5-Hydroxy-L-tryptophan has been found in human prostate tissue, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, 5-hydroxy-L-tryptophan is primarily located in the cytoplasm. 5-Hydroxy-L-tryptophan participates in a number of enzymatic reactions. In particular, 5-Hydroxy-L-tryptophan and 4a-hydroxytetrahydrobiopterin can be biosynthesized from L-tryptophan and tetrahydrobiopterin; which is mediated by the enzyme tryptophan 5-hydroxylase 1. In addition, 5-Hydroxy-L-tryptophan can be converted into serotonin through its interaction with the enzyme aromatic-L-amino-acid decarboxylase. In humans, 5-hydroxy-L-tryptophan is involved in the tryptophan metabolism pathway. 5-Hydroxy-L-tryptophan has been linked to the inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "5-Hydroxy-L-tryptophan ; HMDB00472",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000472",
    "description" : "5-Hydroxy-L-tryptophan, also known as oxitriptan or levothym, belongs to the class of organic compounds known as serotonins. Serotonins are compounds containing a serotonin moiety, which consists of an indole that bears an aminoethyl a position 2 and a hydroxyl group at position 5. 5-Hydroxy-L-tryptophan is a drug which is used for use as an antidepressant, appetite suppressant, and sleep aid. 5-Hydroxy-L-tryptophan exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). 5-Hydroxy-L-tryptophan has been found in human prostate tissue, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, 5-hydroxy-L-tryptophan is primarily located in the cytoplasm. 5-Hydroxy-L-tryptophan participates in a number of enzymatic reactions. In particular, 5-Hydroxy-L-tryptophan and 4a-hydroxytetrahydrobiopterin can be biosynthesized from L-tryptophan and tetrahydrobiopterin; which is mediated by the enzyme tryptophan 5-hydroxylase 1. In addition, 5-Hydroxy-L-tryptophan can be converted into serotonin through its interaction with the enzyme aromatic-L-amino-acid decarboxylase. In humans, 5-hydroxy-L-tryptophan is involved in the tryptophan metabolism pathway. 5-Hydroxy-L-tryptophan has been linked to the inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "5-Hydroxyindoleacetic acid ; HMDB0000763",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000763",
    "description" : "5-Hydroxyindoleacetic acid, also known as 5-hiaa or 5-hydroxyindole-3-acetate, belongs to the class of organic compounds known as indole-3-acetic acid derivatives. Indole-3-acetic acid derivatives are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. 5-Hydroxyindoleacetic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). 5-Hydroxyindoleacetic acid has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, 5-hydroxyindoleacetic acid is primarily located in the cytoplasm and mitochondria. 5-Hydroxyindoleacetic acid participates in a number of enzymatic reactions. In particular, 5-Hydroxyindoleacetic acid can be biosynthesized from 5-hydroxyindoleacetaldehyde through the action of the enzyme aldehyde dehydrogenase, mitochondrial. In addition, 5-Hydroxyindoleacetic acid and S-adenosylmethionine can be converted into 5-methoxyindoleacetate and S-adenosylhomocysteine through the action of the enzyme acetylserotonin O-methyltransferase. In humans, 5-hydroxyindoleacetic acid is involved in the tryptophan metabolism pathway. Outside of the human body, 5-hydroxyindoleacetic acid can be found in a number of food items such as lemon thyme, chicory roots, custard apple, and durian. This makes 5-hydroxyindoleacetic acid a potential biomarker for the consumption of these food products. 5-Hydroxyindoleacetic acid has been found to be associated with several diseases known as schizophrenia, hereditary spastic paraplegia, dopamine-serotonin vesicular transport defect, and brunner syndrome; 5-hydroxyindoleacetic acid has also been linked to the inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "5-Hydroxylysine ; HMDB0000450",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000450",
    "description" : "5-Hydroxylysine, also known as lysine, 5 hydroxy, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. 5-Hydroxylysine is soluble (in water) and a moderately acidic compound (based on its pKa). 5-Hydroxylysine has been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, 5-hydroxylysine is primarily located in the cytoplasm. 5-Hydroxylysine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, 5-hydroxylysine can be found in broad bean and pulses. This makes 5-hydroxylysine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "5-Hydroxylysine ; HMDB00450",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000450",
    "description" : "5-Hydroxylysine, also known as lysine, 5 hydroxy, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. 5-Hydroxylysine is soluble (in water) and a moderately acidic compound (based on its pKa). 5-Hydroxylysine has been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, 5-hydroxylysine is primarily located in the cytoplasm. 5-Hydroxylysine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, 5-hydroxylysine can be found in broad bean and pulses. This makes 5-hydroxylysine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "5-Hydroxymethyl-4-methyluracil ; HMDB0000544",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000544",
    "description" : "5-Hydroxymethyl-4-methyluracil, also known as pentoxyl or 4-methyl-5-hydroxymethyluracil, belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. 5-Hydroxymethyl-4-methyluracil is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, 5-hydroxymethyl-4-methyluracil is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "5-Hydroxymethyl-4-methyluracil ; HMDB00544",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000544",
    "description" : "5-Hydroxymethyl-4-methyluracil, also known as pentoxyl or 4-methyl-5-hydroxymethyluracil, belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. 5-Hydroxymethyl-4-methyluracil is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, 5-hydroxymethyl-4-methyluracil is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "5-Hydroxytryptophol ; HMDB0001855",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001855",
    "description" : "5-Hydroxytryptophol, also known as 5-hydroxyindol or 5-htol, belongs to the class of organic compounds known as hydroxyindoles. These are organic compounds containing an indole moiety that carries a hydroxyl group. 5-Hydroxytryptophol is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 5-Hydroxytryptophol has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Outside of the human body, 5-hydroxytryptophol can be found in a number of food items such as yam, cumin, oil-seed camellia, and chia. This makes 5-hydroxytryptophol a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "5-Hydroxytryptophol ; HMDB01855",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001855",
    "description" : "5-Hydroxytryptophol, also known as 5-hydroxyindol or 5-htol, belongs to the class of organic compounds known as hydroxyindoles. These are organic compounds containing an indole moiety that carries a hydroxyl group. 5-Hydroxytryptophol is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 5-Hydroxytryptophol has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Outside of the human body, 5-hydroxytryptophol can be found in a number of food items such as yam, cumin, oil-seed camellia, and chia. This makes 5-hydroxytryptophol a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "5-Methylthioribose ; HMDB0001087",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001087",
    "description" : "5-Methylthioribose belongs to the class of organic compounds known as pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms. 5-Methylthioribose is soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, 5-methylthioribose is primarily located in the cytoplasm. Outside of the human body, 5-methylthioribose can be found in a number of food items such as hedge mustard, atlantic herring, cucurbita (gourd), and burdock. This makes 5-methylthioribose a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "5alpha-Androstan-3alpha,17beta-diol disulfate ; HMDB0094682",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0094682",
    "description" : "5alpha-Androstan-3alpha,17beta-diol disulfate, also known as 5a-androstan-3a,17b-diol disulfuric acid or 5-androstane-3,17s-diol disulphate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Androstan-3alpha,17beta-diol disulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. 5alpha-Androstan-3alpha,17beta-diol disulfate has been found in human hepatic tissue, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, 5alpha-androstan-3alpha,17beta-diol disulfate is primarily located in the membrane (predicted from logP) and cytoplasm. 5alpha-Androstan-3alpha,17beta-diol disulfate can be biosynthesized from 5alpha-androstane-3beta,17beta-diol.",
    "id" : null
  }, {
    "name" : "5alpha-pregnan-3beta,20alpha-diol disulfate ; HMDB0094650",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0094650",
    "description" : "5alpha-Pregnan-3beta,20alpha-diol disulfate, also known as 5a-pregnan-3b,20a-diol disulfuric acid or 5-pregnan-3s,20-diol disulfate, belongs to the class of organic compounds known as 2,4,5-trisubstituted thiazoles. 2,4,5-trisubstituted thiazoles are compounds containing a thiazole ring substituted at positions 2, 4 and 5 only. 5alpha-Pregnan-3beta,20alpha-diol disulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. 5alpha-Pregnan-3beta,20alpha-diol disulfate has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "5Z-Dodecenoic acid ; HMDB0000529",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000529",
    "description" : "Lauroleinic acid, also known as 5-dodecenoate or 5-dodecenoic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Lauroleinic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Lauroleinic acid has been detected in multiple biofluids, such as blood and urine. Within the cell, lauroleinic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome.",
    "id" : null
  }, {
    "name" : "5Z-Dodecenoic acid ; HMDB00529",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000529",
    "description" : "Lauroleinic acid, also known as 5-dodecenoate or 5-dodecenoic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Lauroleinic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Lauroleinic acid has been detected in multiple biofluids, such as blood and urine. Within the cell, lauroleinic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome.",
    "id" : null
  }, {
    "name" : "6,8-Dihydroxypurine ; HMDB0001182",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001182",
    "description" : "6,8-Dihydroxypurine, also known as 6,8-purinediol or 8-oxohypoxanthine, belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. 6,8-Dihydroxypurine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "6,8-Dihydroxypurine ; HMDB01182",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001182",
    "description" : "6,8-Dihydroxypurine, also known as 6,8-purinediol or 8-oxohypoxanthine, belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. 6,8-Dihydroxypurine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "6-Oxopiperidine-2-carboxylic acid ; HMDB0061705",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061705",
    "description" : "6-Oxopiperidine-2-carboxylic acid, also known as adipo-2,6-lactam or cyclic alpha-aminoadipic acid, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. 6-Oxopiperidine-2-carboxylic acid is soluble (in water) and a weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "7-Ketodeoxycholic acid ; HMDB0000391",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000391",
    "description" : ", also known as 7-oxodeoxycholate, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Thus, is considered to be a bile acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and urine. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "7-Ketodeoxycholic acid ; HMDB00391",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000391",
    "description" : ", also known as 7-oxodeoxycholate, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Thus, is considered to be a bile acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and urine. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "7-Methylguanine ; HMDB0000897",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000897",
    "description" : "7-Methylguanine, also known as n7-me-G, belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. 7-Methylguanine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). 7-Methylguanine has been detected in multiple biofluids, such as feces and blood. Within the cell, 7-methylguanine is primarily located in the cytoplasm. 7-Methylguanine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "7-Methylguanine ; HMDB00897",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000897",
    "description" : "7-Methylguanine, also known as n7-me-G, belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. 7-Methylguanine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). 7-Methylguanine has been detected in multiple biofluids, such as feces and blood. Within the cell, 7-methylguanine is primarily located in the cytoplasm. 7-Methylguanine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "7alpha-Hydroxy-3-oxo-4-cholestenoate ; HMDB0012458",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012458",
    "description" : "7alpha-Hydroxy-3-oxo-4-cholestenoate, also known as 7-hoca or (7)-7-hydroxy-3-oxocholest-4-en-26-Oate, belongs to the class of organic compounds known as monohydroxy bile acids, alcohols and derivatives. These are bile acids, alcohols or any of their derivatives bearing a hydroxyl group. 7alpha-Hydroxy-3-oxo-4-cholestenoate is considered to be a practically insoluble (in water) and relatively neutral molecule. 7alpha-Hydroxy-3-oxo-4-cholestenoate has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 7alpha-hydroxy-3-oxo-4-cholestenoate is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, 7alpha-hydroxy-3-oxo-4-cholestenoate is involved in congenital bile acid synthesis defect type II pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type III pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. 7alpha-Hydroxy-3-oxo-4-cholestenoate is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "8,11,14-Eicosatrienoic acid ; HMDB0002925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002925",
    "description" : "Bishomo-gamma-linolenic acid, also known as (Z,Z,Z)-8,11,14-icosatrienoate or 8,11,14-eicosatrienoic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Bishomo-gamma-linolenic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Bishomo-gamma-linolenic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Bishomo-gamma-linolenic acid has been found in human adipose tissue and epidermis tissues, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, bishomo-gamma-linolenic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. In humans, bishomo-gamma-linolenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "8,11,14-Eicosatrienoic acid ; HMDB02925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002925",
    "description" : "Bishomo-gamma-linolenic acid, also known as (Z,Z,Z)-8,11,14-icosatrienoate or 8,11,14-eicosatrienoic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Bishomo-gamma-linolenic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Bishomo-gamma-linolenic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Bishomo-gamma-linolenic acid has been found in human adipose tissue and epidermis tissues, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, bishomo-gamma-linolenic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. In humans, bishomo-gamma-linolenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "8-HETE ; HMDB0004679",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004679",
    "description" : "8S-Hete belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, 8S-hete is considered to be an eicosanoid lipid molecule. 8S-Hete is considered to be a practically insoluble (in water) and relatively neutral molecule. 8S-Hete has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 8S-hete is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, 8S-hete is involved in the trisalicylate-choline action pathway, the bromfenac action pathway, the rofecoxib action pathway, and the acetylsalicylic Acid action pathway. 8S-Hete is also involved in a couple of metabolic disorders, which include the tiaprofenic Acid action pathway and leukotriene C4 synthesis deficiency.",
    "id" : null
  }, {
    "name" : "8-HETE ; HMDB04679",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004679",
    "description" : "8S-Hete belongs to the class of organic compounds known as hydroxyeicosatetraenoic acids. These are eicosanoic acids with an attached hydroxyl group and four CC double bonds. Thus, 8S-hete is considered to be an eicosanoid lipid molecule. 8S-Hete is considered to be a practically insoluble (in water) and relatively neutral molecule. 8S-Hete has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 8S-hete is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, 8S-hete is involved in the trisalicylate-choline action pathway, the bromfenac action pathway, the rofecoxib action pathway, and the acetylsalicylic Acid action pathway. 8S-Hete is also involved in a couple of metabolic disorders, which include the tiaprofenic Acid action pathway and leukotriene C4 synthesis deficiency.",
    "id" : null
  }, {
    "name" : "9,10-DHOME ; HMDB0004704",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004704",
    "description" : "9,10-Dihome, also known as 9,10-dhoa or leukotoxin diol, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, 9,10-dihome is considered to be an octadecanoid lipid molecule. 9,10-Dihome is considered to be a practically insoluble (in water) and relatively neutral molecule. 9,10-Dihome has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 9,10-dihome is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "9,10-DHOME ; HMDB04704",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004704",
    "description" : "9,10-Dihome, also known as 9,10-dhoa or leukotoxin diol, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, 9,10-dihome is considered to be an octadecanoid lipid molecule. 9,10-Dihome is considered to be a practically insoluble (in water) and relatively neutral molecule. 9,10-Dihome has been detected in multiple biofluids, such as blood, cerebrospinal fluid, and urine. Within the cell, 9,10-dihome is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "9-cis-Retinoic acid ; HMDB0002369",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002369",
    "description" : "9-cis-Retinoic acid, also known as alitretinoin or panretin, belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. 9-cis-Retinoic acid is a drug which is used for topical treatment of cutaneous lesions in patients with aids-related kaposi's sarcoma. 9-cis-Retinoic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. 9-cis-Retinoic acid has been primarily detected in blood. Within the cell, 9-cis-retinoic acid is primarily located in the membrane (predicted from logP) and cytoplasm. 9-cis-Retinoic acid participates in a number of enzymatic reactions. In particular, 9-cis-Retinoic acid can be biosynthesized from 9-cis-retinal through the action of the enzyme retinal dehydrogenase 1. In addition, 9-cis-Retinoic acid can be biosynthesized from 9-cis-retinal; which is mediated by the enzyme retinal dehydrogenase 2. In humans, 9-cis-retinoic acid is involved in the retinol metabolism pathway. 9-cis-Retinoic acid is also involved in the metabolic disorder called vitamin a deficiency.",
    "id" : null
  }, {
    "name" : "9-cis-Retinoic acid ; HMDB02369",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002369",
    "description" : "9-cis-Retinoic acid, also known as alitretinoin or panretin, belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. 9-cis-Retinoic acid is a drug which is used for topical treatment of cutaneous lesions in patients with aids-related kaposi's sarcoma. 9-cis-Retinoic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. 9-cis-Retinoic acid has been primarily detected in blood. Within the cell, 9-cis-retinoic acid is primarily located in the membrane (predicted from logP) and cytoplasm. 9-cis-Retinoic acid participates in a number of enzymatic reactions. In particular, 9-cis-Retinoic acid can be biosynthesized from 9-cis-retinal through the action of the enzyme retinal dehydrogenase 1. In addition, 9-cis-Retinoic acid can be biosynthesized from 9-cis-retinal; which is mediated by the enzyme retinal dehydrogenase 2. In humans, 9-cis-retinoic acid is involved in the retinol metabolism pathway. 9-cis-Retinoic acid is also involved in the metabolic disorder called vitamin a deficiency.",
    "id" : null
  }, {
    "name" : "Acesulfame ; HMDB0033585",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0033585",
    "description" : "Acesulfame, also known as acesulphamo or acesulfame sodium, belongs to the class of organic compounds known as organic sulfuric acids and derivatives. These are organic compounds containing the sulfuric acid or a derivative thereof. Acesulfame exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Within the cell, acesulfame is primarily located in the cytoplasm. Acesulfame has a bitter taste.",
    "id" : null
  }, {
    "name" : "Acesulfame ; HMDB33585",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0033585",
    "description" : "Acesulfame, also known as acesulphamo or acesulfame sodium, belongs to the class of organic compounds known as organic sulfuric acids and derivatives. These are organic compounds containing the sulfuric acid or a derivative thereof. Acesulfame exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Within the cell, acesulfame is primarily located in the cytoplasm. Acesulfame has a bitter taste.",
    "id" : null
  }, {
    "name" : "Acetaminophen ; HMDB0001859",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001859",
    "description" : "Acetaminophen, also known as paracetamol or apap, belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that are unsubstituted at the 2-position. Acetaminophen is a drug which is used for temporary relief of fever, minor aches, and pains. Acetaminophen exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Acetaminophen has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, feces, blood, and cerebrospinal fluid. Within the cell, acetaminophen is primarily located in the cytoplasm. Acetaminophen participates in a number of enzymatic reactions. In particular, Acetaminophen can be converted into NAPQI through the action of the enzymes cytochrome P450 2E1, cytochrome P450 1A2, cytochrome P450 2D6, cytochrome P450 3A4, and cytochrome P450 2A6. In addition, Acetaminophen and uridine diphosphate glucuronic acid can be converted into acetaminophen glucuronide and uridine 5'-diphosphate through the action of the enzymes UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 1-1, and UDP-glucuronosyltransferase 1-6. In humans, acetaminophen is involved in the acetaminophen metabolism pathway and the acetaminophen action pathway. Acetaminophen has a bitter taste. Acetaminophen is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Acetaminophen ; HMDB01859",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001859",
    "description" : "Acetaminophen, also known as paracetamol or apap, belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that are unsubstituted at the 2-position. Acetaminophen is a drug which is used for temporary relief of fever, minor aches, and pains. Acetaminophen exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Acetaminophen has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, feces, blood, and cerebrospinal fluid. Within the cell, acetaminophen is primarily located in the cytoplasm. Acetaminophen participates in a number of enzymatic reactions. In particular, Acetaminophen can be converted into NAPQI through the action of the enzymes cytochrome P450 2E1, cytochrome P450 1A2, cytochrome P450 2D6, cytochrome P450 3A4, and cytochrome P450 2A6. In addition, Acetaminophen and uridine diphosphate glucuronic acid can be converted into acetaminophen glucuronide and uridine 5'-diphosphate through the action of the enzymes UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 1-1, and UDP-glucuronosyltransferase 1-6. In humans, acetaminophen is involved in the acetaminophen metabolism pathway and the acetaminophen action pathway. Acetaminophen has a bitter taste. Acetaminophen is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Acetaminophen glucuronide ; HMDB0010316",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010316",
    "description" : "Acetaminophen glucuronide, also known as 4-glucuronosidoacetanilide or deethylphenacetin glucuronide, belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Acetaminophen glucuronide is soluble (in water) and a weakly acidic compound (based on its pKa). Acetaminophen glucuronide has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, acetaminophen glucuronide is primarily located in the cytoplasm. Acetaminophen glucuronide participates in a number of enzymatic reactions. In particular, Acetaminophen glucuronide and uridine 5'-diphosphate can be biosynthesized from acetaminophen and uridine diphosphate glucuronic acid; which is mediated by the enzymes UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 1-1, and UDP-glucuronosyltransferase 1-6. In addition, Acetaminophen glucuronide can be converted into acetaminophen glucuronide; which is catalyzed by the enzyme ATP-binding cassette sub-family g member 2. In humans, acetaminophen glucuronide is involved in the acetaminophen metabolism pathway. Acetaminophen glucuronide has been linked to the inborn metabolic disorders including beta-thalassemia.",
    "id" : null
  }, {
    "name" : "Acetaminophen glucuronide ; HMDB10316",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010316",
    "description" : "Acetaminophen glucuronide, also known as 4-glucuronosidoacetanilide or deethylphenacetin glucuronide, belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Acetaminophen glucuronide is soluble (in water) and a weakly acidic compound (based on its pKa). Acetaminophen glucuronide has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, acetaminophen glucuronide is primarily located in the cytoplasm. Acetaminophen glucuronide participates in a number of enzymatic reactions. In particular, Acetaminophen glucuronide and uridine 5'-diphosphate can be biosynthesized from acetaminophen and uridine diphosphate glucuronic acid; which is mediated by the enzymes UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 1-1, and UDP-glucuronosyltransferase 1-6. In addition, Acetaminophen glucuronide can be converted into acetaminophen glucuronide; which is catalyzed by the enzyme ATP-binding cassette sub-family g member 2. In humans, acetaminophen glucuronide is involved in the acetaminophen metabolism pathway. Acetaminophen glucuronide has been linked to the inborn metabolic disorders including beta-thalassemia.",
    "id" : null
  }, {
    "name" : "Acetoacetic acid ; HMDB0000060",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000060",
    "description" : "Acetoacetic acid, also known as 3-oxobutanoic acid or 3-oxobutyrate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. Acetoacetic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Acetoacetic acid has been found in human liver and spleen tissues, and has also been detected in most biofluids, including blood, urine, cerebrospinal fluid, and feces. Within the cell, acetoacetic acid is primarily located in the cytoplasm, mitochondria and peroxisome. Acetoacetic acid exists in all eukaryotes, ranging from yeast to humans. Acetoacetic acid and succinyl-CoA can be converted into succinic acid through the action of the enzyme succinyl-coa:3-ketoacid coenzyme A transferase 1, mitochondrial. In humans, acetoacetic acid is involved in the butyrate metabolism pathway, the disulfiram action pathway, fatty acid biosynthesis pathway, and the phenylalanine and tyrosine metabolism pathway. Acetoacetic acid is also involved in several metabolic disorders, some of which include the 3-methylglutaconic aciduria type III pathway, dopamine beta-hydroxylase deficiency, the propionic acidemia pathway, and 3-methylcrotonyl CoA carboxylase deficiency type I. Acetoacetic acid has been found to be associated with several diseases known as ketosis, pyruvate dehydrogenase phosphatase deficiency, anoxia, and schizophrenia; acetoacetic acid has also been linked to the inborn metabolic disorders including glucose transporter type 1 deficiency syndrome.",
    "id" : null
  }, {
    "name" : "Acetylcarnosine ; HMDB0012881",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012881",
    "description" : "Acetylcarnosine belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Acetylcarnosine is slightly soluble (in water) and a weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "Acetylcarnosine ; HMDB12881",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012881",
    "description" : "Acetylcarnosine belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Acetylcarnosine is slightly soluble (in water) and a weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "Acetylcholine ; HMDB0000895",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000895",
    "description" : "Acetylcholine , also known as ACh or choline acetate, belongs to the class of organic compounds known as acyl cholines. These are acylated derivatives of choline. Choline or 2-Hydroxy-N,N,N-trimethylethanaminium is a quaternary ammonium salt with the chemical formula (CH3)3N+(CH2)2OH. Acetylcholine is a drug which is used to obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required. Acetylcholine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Acetylcholine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as saliva and cerebrospinal fluid. Within the cell, acetylcholine is primarily located in the cytoplasm, nucleus, myelin sheath and mitochondria. In humans, acetylcholine is involved in phospholipid biosynthesis pathway, the lafutidine H2-antihistamine action pathway, the cimetidine action pathway, and the omeprazole action pathway. Acetylcholine is also involved in the metabolic disorder called the metiamide action pathway. Outside of the human body, acetylcholine can be found in a number of food items such as red bell pepper, potato, carrot, and green bell pepper. This makes acetylcholine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Acetylcholine ; HMDB00895",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000895",
    "description" : "Acetylcholine , also known as ACh or choline acetate, belongs to the class of organic compounds known as acyl cholines. These are acylated derivatives of choline. Choline or 2-Hydroxy-N,N,N-trimethylethanaminium is a quaternary ammonium salt with the chemical formula (CH3)3N+(CH2)2OH. Acetylcholine is a drug which is used to obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required. Acetylcholine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Acetylcholine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as saliva and cerebrospinal fluid. Within the cell, acetylcholine is primarily located in the cytoplasm, nucleus, myelin sheath and mitochondria. In humans, acetylcholine is involved in phospholipid biosynthesis pathway, the lafutidine H2-antihistamine action pathway, the cimetidine action pathway, and the omeprazole action pathway. Acetylcholine is also involved in the metabolic disorder called the metiamide action pathway. Outside of the human body, acetylcholine can be found in a number of food items such as red bell pepper, potato, carrot, and green bell pepper. This makes acetylcholine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Acetylglycine ; HMDB0000532",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000532",
    "description" : "Acetylglycine, also known as acetamidoacetate or aceturic acid, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Acetylglycine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Acetylglycine has been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, acetylglycine is primarily located in the cytoplasm. Acetylglycine has been linked to the inborn metabolic disorders including aminoacylase I deficiency.",
    "id" : null
  }, {
    "name" : "Acetylhomoserine ; HMDB0029423",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029423",
    "description" : "Acetylhomoserine, also known as homoserine acetate, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Acetylhomoserine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Within the cell, acetylhomoserine is primarily located in the cytoplasm. Acetylhomoserine exists in all eukaryotes, ranging from yeast to humans. Acetylhomoserine participates in a number of enzymatic reactions. In particular, Acetylhomoserine can be biosynthesized from L-homoserine and acetyl-CoA through its interaction with the enzyme homoserine O-trans-acetylase. Furthermore, Acetylhomoserine and hydrogen sulfide can be converted into acetic acid and homocysteine through the action of the enzyme O-acetylhomoserine (thiol)-lyase. Furthermore, Acetylhomoserine and hydrogen sulfide can be converted into acetic acid and homocysteine through its interaction with the enzyme O-acetylhomoserine (thiol)-lyase. Furthermore, Acetylhomoserine can be biosynthesized from L-homoserine and acetyl-CoA; which is mediated by the enzyme homoserine O-trans-acetylase. Finally, Selenocysteine and acetylhomoserine can be converted into selenocystathionine and acetic acid; which is catalyzed by the enzyme cystathionine gamma-synthase. Outside of the human body, acetylhomoserine can be found in common pea and pulses. This makes acetylhomoserine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Adenine ; HMDB0000034",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000034",
    "description" : "Adenine, also known as 6-aminopurine or Ade, belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. Adenine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Adenine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Adenine has been found throughout all human tissues, and has also been detected in most biofluids, including blood, cerebrospinal fluid, saliva, and urine. Within the cell, adenine is primarily located in the cytoplasm, nucleus and lysosome. Adenine exists in all eukaryotes, ranging from yeast to humans. Adenine participates in a number of enzymatic reactions. In particular, Adenine and ribose 1-phosphate can be biosynthesized from adenosine through the action of the enzyme purine nucleoside phosphorylase. In addition, Adenine and deoxyribose 1-phosphate can be biosynthesized from deoxyadenosine; which is mediated by the enzyme purine nucleoside phosphorylase. In humans, adenine is involved in the azathioprine action pathway, the purine metabolism pathway, the thioguanine action pathway, and the mercaptopurine action pathway. Adenine is also involved in several metabolic disorders, some of which include adenine phosphoribosyltransferase deficiency (aprt), molybdenum cofactor deficiency, the lesch-nyhan syndrome (LNS) pathway, and xanthine dehydrogenase deficiency (xanthinuria). Adenine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Adenosine ; HMDB0000050",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000050",
    "description" : "Adenosine, also known as adenocard or ade-rib, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Adenosine is a drug which is used as an initial treatment for the termination of paroxysmal supraventricular tachycardia (pvst), including that associated with accessory bypass tracts, and is a drug of choice for terminating stable, narrow-complex supraventricular tachycardias (svt). also used as an adjunct to thallous chloride ti 201 myocardial perfusion scintigraphy (thallium stress test) in patients who are unable to exercise adequately, as well as an adjunct to vagal maneuvers and clinical assessment to establish a specific diagnosis of undefined, stable, narrow-complex svt. Adenosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Adenosine has been found throughout all human tissues, and has also been detected in most biofluids, including urine, feces, cerebrospinal fluid, and saliva. Within the cell, adenosine is primarily located in the mitochondria and lysosome. Adenosine exists in all eukaryotes, ranging from yeast to humans. Adenosine participates in a number of enzymatic reactions. In particular, Adenosine can be converted into inosine through its interaction with the enzyme adenosine deaminase. In addition, Adenosine can be converted into adenine and ribose 1-phosphate through its interaction with the enzyme purine nucleoside phosphorylase. In humans, adenosine is involved in the thioguanine action pathway, the azathioprine action pathway, the methionine metabolism pathway, and the mercaptopurine action pathway. Adenosine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, the hypermethioninemia pathway, adenine phosphoribosyltransferase deficiency (aprt), and adenosine deaminase deficiency. Adenosine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Adenosine ; HMDB00050",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000050",
    "description" : "Adenosine, also known as adenocard or ade-rib, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Adenosine is a drug which is used as an initial treatment for the termination of paroxysmal supraventricular tachycardia (pvst), including that associated with accessory bypass tracts, and is a drug of choice for terminating stable, narrow-complex supraventricular tachycardias (svt). also used as an adjunct to thallous chloride ti 201 myocardial perfusion scintigraphy (thallium stress test) in patients who are unable to exercise adequately, as well as an adjunct to vagal maneuvers and clinical assessment to establish a specific diagnosis of undefined, stable, narrow-complex svt. Adenosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Adenosine has been found throughout all human tissues, and has also been detected in most biofluids, including urine, feces, cerebrospinal fluid, and saliva. Within the cell, adenosine is primarily located in the mitochondria and lysosome. Adenosine exists in all eukaryotes, ranging from yeast to humans. Adenosine participates in a number of enzymatic reactions. In particular, Adenosine can be converted into inosine through its interaction with the enzyme adenosine deaminase. In addition, Adenosine can be converted into adenine and ribose 1-phosphate through its interaction with the enzyme purine nucleoside phosphorylase. In humans, adenosine is involved in the thioguanine action pathway, the azathioprine action pathway, the methionine metabolism pathway, and the mercaptopurine action pathway. Adenosine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, the hypermethioninemia pathway, adenine phosphoribosyltransferase deficiency (aprt), and adenosine deaminase deficiency. Adenosine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Adenosine monophosphate ; HMDB0000045",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000045",
    "description" : "Adenosine monophosphate, also known as adenylic acid or AMP, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenosine monophosphate is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Adenosine monophosphate exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Adenosine monophosphate has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, saliva, and cerebrospinal fluid. Adenosine monophosphate can be found anywhere throughout the human cell, such as in golgi, endoplasmic reticulum, lysosome, and peroxisome. Adenosine monophosphate exists in all eukaryotes, ranging from yeast to humans. Adenosine monophosphate can be biosynthesized from L-serine through its interaction with the enzyme serine--trna ligase, cytoplasmic. In humans, adenosine monophosphate is involved in the delavirdine action pathway, the spectinomycin action pathway, the mercaptopurine action pathway, and the propanoate metabolism pathway. Adenosine monophosphate is also involved in several metabolic disorders, some of which include transaldolase deficiency, 3-phosphoglycerate dehydrogenase deficiency, the hyperprolinemia type II pathway, and creatine deficiency, guanidinoacetate methyltransferase deficiency. Outside of the human body, adenosine monophosphate can be found in a number of food items such as elliott's blueberry, conch, nanking cherry, and jackfruit. This makes adenosine monophosphate a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Adenosine monophosphate ; HMDB00045",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000045",
    "description" : "Adenosine monophosphate, also known as adenylic acid or AMP, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenosine monophosphate is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Adenosine monophosphate exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Adenosine monophosphate has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, saliva, and cerebrospinal fluid. Adenosine monophosphate can be found anywhere throughout the human cell, such as in golgi, endoplasmic reticulum, lysosome, and peroxisome. Adenosine monophosphate exists in all eukaryotes, ranging from yeast to humans. Adenosine monophosphate can be biosynthesized from L-serine through its interaction with the enzyme serine--trna ligase, cytoplasmic. In humans, adenosine monophosphate is involved in the delavirdine action pathway, the spectinomycin action pathway, the mercaptopurine action pathway, and the propanoate metabolism pathway. Adenosine monophosphate is also involved in several metabolic disorders, some of which include transaldolase deficiency, 3-phosphoglycerate dehydrogenase deficiency, the hyperprolinemia type II pathway, and creatine deficiency, guanidinoacetate methyltransferase deficiency. Outside of the human body, adenosine monophosphate can be found in a number of food items such as elliott's blueberry, conch, nanking cherry, and jackfruit. This makes adenosine monophosphate a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Adenosine triphosphate ; HMDB0000538",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000538",
    "description" : "Adenosine triphosphate, also known as ATP or atriphos, belongs to the class of organic compounds known as purine ribonucleoside triphosphates. These are purine ribobucleotides with a triphosphate group linked to the ribose moiety. Adenosine triphosphate is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Adenosine triphosphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Adenosine triphosphate has been found throughout most human tissues, and has also been detected in multiple biofluids, such as saliva, blood, and cerebrospinal fluid. Adenosine triphosphate can be found anywhere throughout the human cell, such as in peroxisome, nucleus, mitochondria, and cytoplasm. Adenosine triphosphate exists in all eukaryotes, ranging from yeast to humans. In humans, adenosine triphosphate is involved in phosphatidylcholine biosynthesis PC(22:0/18:4(6Z,9Z,12Z,15Z)) pathway, phosphatidylcholine biosynthesis PC(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)) pathway, phosphatidylcholine biosynthesis PC(24:1(15Z)/20:2(11Z,14Z)) pathway, and phosphatidylethanolamine biosynthesis pe(9D3/13d5) pathway. Adenosine triphosphate is also involved in several metabolic disorders, some of which include the primary hyperoxaluria II, PH2 pathway, the fanconi-bickel syndrome pathway, the 3-methylglutaconic aciduria type III pathway, and the transfer OF acetyl groups into mitochondria pathway. Outside of the human body, adenosine triphosphate can be found in a number of food items such as watermelon, napa cabbage, broad bean, and flaxseed. This makes adenosine triphosphate a potential biomarker for the consumption of these food products. Adenosine triphosphate is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Adenosine triphosphate ; HMDB00538",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000538",
    "description" : "Adenosine triphosphate, also known as ATP or atriphos, belongs to the class of organic compounds known as purine ribonucleoside triphosphates. These are purine ribobucleotides with a triphosphate group linked to the ribose moiety. Adenosine triphosphate is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Adenosine triphosphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Adenosine triphosphate has been found throughout most human tissues, and has also been detected in multiple biofluids, such as saliva, blood, and cerebrospinal fluid. Adenosine triphosphate can be found anywhere throughout the human cell, such as in peroxisome, nucleus, mitochondria, and cytoplasm. Adenosine triphosphate exists in all eukaryotes, ranging from yeast to humans. In humans, adenosine triphosphate is involved in phosphatidylcholine biosynthesis PC(22:0/18:4(6Z,9Z,12Z,15Z)) pathway, phosphatidylcholine biosynthesis PC(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)) pathway, phosphatidylcholine biosynthesis PC(24:1(15Z)/20:2(11Z,14Z)) pathway, and phosphatidylethanolamine biosynthesis pe(9D3/13d5) pathway. Adenosine triphosphate is also involved in several metabolic disorders, some of which include the primary hyperoxaluria II, PH2 pathway, the fanconi-bickel syndrome pathway, the 3-methylglutaconic aciduria type III pathway, and the transfer OF acetyl groups into mitochondria pathway. Outside of the human body, adenosine triphosphate can be found in a number of food items such as watermelon, napa cabbage, broad bean, and flaxseed. This makes adenosine triphosphate a potential biomarker for the consumption of these food products. Adenosine triphosphate is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Adipic acid ; HMDB0000448",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000448",
    "description" : "Adipic acid, also known as adipate or hexanedioate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Adipic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Adipic acid has been found in human liver and kidney tissues, and has also been detected in most biofluids, including blood, saliva, urine, and feces. Within the cell, adipic acid is primarily located in the cytoplasm and adiposome. Adipic acid is also a parent compound for other transformation products, including but not limited to, 3-methyladipic acid, bis(2-ethylhexyl) adipate, and 3-aminoadipic acid. Adipic acid is an odorless tasting compound that can be found in a number of food items such as root vegetables, fats and oils, common beet, and fruits. This makes adipic acid a potential biomarker for the consumption of these food products. Adipic acid has been found to be associated with several diseases known as 3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxydicarboxylic aciduria, and anorexia nervosa; adipic acid has also been linked to several inborn metabolic disorders including medium chain acyl-CoA dehydrogenase deficiency and malonyl-CoA decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "Adipic acid ; HMDB00448",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000448",
    "description" : "Adipic acid, also known as adipate or hexanedioate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Adipic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Adipic acid has been found in human liver and kidney tissues, and has also been detected in most biofluids, including blood, saliva, urine, and feces. Within the cell, adipic acid is primarily located in the cytoplasm and adiposome. Adipic acid is also a parent compound for other transformation products, including but not limited to, 3-methyladipic acid, bis(2-ethylhexyl) adipate, and 3-aminoadipic acid. Adipic acid is an odorless tasting compound that can be found in a number of food items such as root vegetables, fats and oils, common beet, and fruits. This makes adipic acid a potential biomarker for the consumption of these food products. Adipic acid has been found to be associated with several diseases known as 3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxydicarboxylic aciduria, and anorexia nervosa; adipic acid has also been linked to several inborn metabolic disorders including medium chain acyl-CoA dehydrogenase deficiency and malonyl-CoA decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "ADP ; HMDB0001341",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001341",
    "description" : "Adp, also known as H3ADP or magnesium ADP, belongs to the class of organic compounds known as purine ribonucleoside diphosphates. These are purine ribobucleotides with diphosphate group linked to the ribose moiety. Adp is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adp has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Adp can be found anywhere throughout the human cell, such as in cytoplasm, nucleus, mitochondria, and peroxisome. Adp exists in all eukaryotes, ranging from yeast to humans. In humans, Adp is involved in phosphatidylethanolamine biosynthesis pe(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) pathway, phosphatidylcholine biosynthesis PC(22:0/22:2(13Z,16Z)) pathway, phosphatidylethanolamine biosynthesis pe(18:1(11Z)/18:1(9Z)) pathway, and phosphatidylcholine biosynthesis PC(11D3/11m5) pathway. Adp is also involved in several metabolic disorders, some of which include isobutyryl-CoA dehydrogenase deficiency, pyruvate dehydrogenase deficiency (e2), xanthine dehydrogenase deficiency (xanthinuria), and the congenital disorder OF glycosylation CDG-iid pathway.",
    "id" : null
  }, {
    "name" : "ADP ; HMDB01341",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001341",
    "description" : "Adp, also known as H3ADP or magnesium ADP, belongs to the class of organic compounds known as purine ribonucleoside diphosphates. These are purine ribobucleotides with diphosphate group linked to the ribose moiety. Adp is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adp has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Adp can be found anywhere throughout the human cell, such as in cytoplasm, nucleus, mitochondria, and peroxisome. Adp exists in all eukaryotes, ranging from yeast to humans. In humans, Adp is involved in phosphatidylethanolamine biosynthesis pe(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) pathway, phosphatidylcholine biosynthesis PC(22:0/22:2(13Z,16Z)) pathway, phosphatidylethanolamine biosynthesis pe(18:1(11Z)/18:1(9Z)) pathway, and phosphatidylcholine biosynthesis PC(11D3/11m5) pathway. Adp is also involved in several metabolic disorders, some of which include isobutyryl-CoA dehydrogenase deficiency, pyruvate dehydrogenase deficiency (e2), xanthine dehydrogenase deficiency (xanthinuria), and the congenital disorder OF glycosylation CDG-iid pathway.",
    "id" : null
  }, {
    "name" : "Adrenic acid ; HMDB0002226",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002226",
    "description" : "Adrenic acid, also known as adrenate, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Adrenic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Adrenic acid has been detected in multiple biofluids, such as blood and urine. Adrenic acid can be found anywhere throughout the human cell, such as in cytoplasm, adiposome, peroxisome, and myelin sheath. Adrenic acid participates in a number of enzymatic reactions. In particular, Adrenic acid can be biosynthesized from arachidonic acid through its interaction with the enzyme elongation OF very long chain fatty acids protein 5. In addition, Adrenic acid can be converted into tetracosatetraenoic acid (24:4N-6); which is mediated by the enzyme elongation OF very long chain fatty acids protein 4. In humans, adrenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "Adrenic acid ; HMDB02226",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002226",
    "description" : "Adrenic acid, also known as adrenate, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Adrenic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Adrenic acid has been detected in multiple biofluids, such as blood and urine. Adrenic acid can be found anywhere throughout the human cell, such as in cytoplasm, adiposome, peroxisome, and myelin sheath. Adrenic acid participates in a number of enzymatic reactions. In particular, Adrenic acid can be biosynthesized from arachidonic acid through its interaction with the enzyme elongation OF very long chain fatty acids protein 5. In addition, Adrenic acid can be converted into tetracosatetraenoic acid (24:4N-6); which is mediated by the enzyme elongation OF very long chain fatty acids protein 4. In humans, adrenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "Allantoin ; HMDB0000462",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000462",
    "description" : "Allantoin, also known as glyoxyldiureide or 5-ureidohydantoin, belongs to the class of organic compounds known as imidazoles. Imidazoles are compounds containing an imidazole ring, which is an aromatic five-member ring with two nitrogen atoms at positions 1 and 3, and three carbon atoms. Allantoin exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Allantoin has been detected in most biofluids, including urine, feces, cerebrospinal fluid, and blood. Within the cell, allantoin is primarily located in the cytoplasm. Allantoin exists in all eukaryotes, ranging from yeast to humans. Allantoin can be biosynthesized from hydantoin. Outside of the human body, allantoin can be found in a number of food items such as rowal, lotus, pasta, and date. This makes allantoin a potential biomarker for the consumption of these food products. Allantoin is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Allantoin ; HMDB00462",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000462",
    "description" : "Allantoin, also known as glyoxyldiureide or 5-ureidohydantoin, belongs to the class of organic compounds known as imidazoles. Imidazoles are compounds containing an imidazole ring, which is an aromatic five-member ring with two nitrogen atoms at positions 1 and 3, and three carbon atoms. Allantoin exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Allantoin has been detected in most biofluids, including urine, feces, cerebrospinal fluid, and blood. Within the cell, allantoin is primarily located in the cytoplasm. Allantoin exists in all eukaryotes, ranging from yeast to humans. Allantoin can be biosynthesized from hydantoin. Outside of the human body, allantoin can be found in a number of food items such as rowal, lotus, pasta, and date. This makes allantoin a potential biomarker for the consumption of these food products. Allantoin is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Allocholic acid ; HMDB0000505",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000505",
    "description" : "Cholic acid, also known as cholate or cholsaeure, belongs to the class of organic compounds known as trihydroxy bile acids, alcohols and derivatives. These are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Cholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cholic acid has been found throughout all human tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, cholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Cholic acid participates in a number of enzymatic reactions. In particular, Chenodeoxycholoyl-CoA and cholic acid can be converted into chenodeoxycholic acid; which is catalyzed by the enzyme bile acyl-CoA synthetase. In addition, Cholic acid can be biosynthesized from choloyl-CoA; which is mediated by the enzyme bile acyl-CoA synthetase. In humans, cholic acid is involved in the cerebrotendinous xanthomatosis (CTX) pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, and congenital bile acid synthesis defect type III pathway. Cholic acid is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway. Outside of the human body, cholic acid can be found in a number of food items such as ginkgo nuts, celeriac, lotus, and small-leaf linden. This makes cholic acid a potential biomarker for the consumption of these food products. Cholic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Allopurinol ; HMDB0014581",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0014581",
    "description" : "Allopurinol, also known as zyloprim or milurit, belongs to the class of organic compounds known as pyrazolo[3,4-d]pyrimidines. These are aromatic heterocyclic compounds containing a pyrazolo[3,4-d]pyrimidine ring system, which consists of a pyrazole ring fused to but and not sharing a nitrogen atom with a pyrimidine ring. Allopurinol is a drug which is used for the treatment of hyperuricemia associated with primary or secondary gout. also indicated for the treatment of primary or secondary uric acid nephropathy, with or without the symptoms of gout, as well as chemotherapy-induced hyperuricemia and recurrent renal calculi. Allopurinol exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Allopurinol has been detected in multiple biofluids, such as urine and blood. Within the cell, allopurinol is primarily located in the cytoplasm. Allopurinol participates in a number of enzymatic reactions. In particular, allopurinol can be biosynthesized from 1H-pyrazolo[4,3-D]pyrimidine. Allopurinol can also be converted into allopurinol riboside. Allopurinol is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Allopurinol ; HMDB14581",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0014581",
    "description" : "Allopurinol, also known as zyloprim or milurit, belongs to the class of organic compounds known as pyrazolo[3,4-d]pyrimidines. These are aromatic heterocyclic compounds containing a pyrazolo[3,4-d]pyrimidine ring system, which consists of a pyrazole ring fused to but and not sharing a nitrogen atom with a pyrimidine ring. Allopurinol is a drug which is used for the treatment of hyperuricemia associated with primary or secondary gout. also indicated for the treatment of primary or secondary uric acid nephropathy, with or without the symptoms of gout, as well as chemotherapy-induced hyperuricemia and recurrent renal calculi. Allopurinol exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Allopurinol has been detected in multiple biofluids, such as urine and blood. Within the cell, allopurinol is primarily located in the cytoplasm. Allopurinol participates in a number of enzymatic reactions. In particular, allopurinol can be biosynthesized from 1H-pyrazolo[4,3-D]pyrimidine. Allopurinol can also be converted into allopurinol riboside. Allopurinol is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Allopurinol riboside ; HMDB0000481",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000481",
    "description" : "Allopurinol riboside belongs to the class of organic compounds known as pyrazolo[3,4-d]pyrimidine glycosides. These are nucleosides or derivatives thereof that consist of a pyazolo[3,2-d]pyrimidine ring system that is N-glycosidically linked to a ribose or deoxyribose. They bear the sugar moiety on the pyrimidine part of the molecule. Allopurinol riboside is soluble (in water) and a very weakly acidic compound (based on its pKa). Allopurinol riboside has been primarily detected in blood. Within the cell, allopurinol riboside is primarily located in the cytoplasm. Allopurinol riboside can be converted into allopurinol.",
    "id" : null
  }, {
    "name" : "Allopurinol riboside ; HMDB00481",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000481",
    "description" : "Allopurinol riboside belongs to the class of organic compounds known as pyrazolo[3,4-d]pyrimidine glycosides. These are nucleosides or derivatives thereof that consist of a pyazolo[3,2-d]pyrimidine ring system that is N-glycosidically linked to a ribose or deoxyribose. They bear the sugar moiety on the pyrimidine part of the molecule. Allopurinol riboside is soluble (in water) and a very weakly acidic compound (based on its pKa). Allopurinol riboside has been primarily detected in blood. Within the cell, allopurinol riboside is primarily located in the cytoplasm. Allopurinol riboside can be converted into allopurinol.",
    "id" : null
  }, {
    "name" : "alpha-CEHC ; HMDB0001518",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001518",
    "description" : "Alpha-Cehc, also known as A-cehc, belongs to the class of organic compounds known as 1-benzopyrans. These are organic aromatic compounds that 1-benzopyran, a bicyclic compound made up of a benzene ring fused to a pyran, so that the oxygen atom is at the 1-position. Alpha-Cehc is considered to be a practically insoluble (in water) and relatively neutral molecule. Alpha-Cehc has been primarily detected in blood. Within the cell, Alpha-cehc is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "alpha-CEHC ; HMDB01518",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001518",
    "description" : "Alpha-Cehc, also known as A-cehc, belongs to the class of organic compounds known as 1-benzopyrans. These are organic aromatic compounds that 1-benzopyran, a bicyclic compound made up of a benzene ring fused to a pyran, so that the oxygen atom is at the 1-position. Alpha-Cehc is considered to be a practically insoluble (in water) and relatively neutral molecule. Alpha-Cehc has been primarily detected in blood. Within the cell, Alpha-cehc is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "alpha-Ketoisovaleric acid ; HMDB0000019",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000019",
    "description" : ", also known as alpha-ketovaline or 2-oxoisovalerate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. Thus, is considered to be a fatty acid lipid molecule. exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). has been detected in most biofluids, including feces, saliva, cerebrospinal fluid, and urine. Within the cell, is primarily located in the cytoplasm and mitochondria. exists in all eukaryotes, ranging from yeast to humans. In humans, is involved in the valine, leucine and isoleucine degradation pathway. is also involved in several metabolic disorders, some of which include the 3-methylglutaconic aciduria type I pathway, 3-methylcrotonyl CoA carboxylase deficiency type I, the 3-methylglutaconic aciduria type IV pathway, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Outside of the human body, can be found in a number of food items such as mung bean, poppy, pistachio, and garden onion. This makes a potential biomarker for the consumption of these food products. is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "alpha-Ketoisovaleric acid ; HMDB00019",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000019",
    "description" : ", also known as alpha-ketovaline or 2-oxoisovalerate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. Thus, is considered to be a fatty acid lipid molecule. exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). has been detected in most biofluids, including feces, saliva, cerebrospinal fluid, and urine. Within the cell, is primarily located in the cytoplasm and mitochondria. exists in all eukaryotes, ranging from yeast to humans. In humans, is involved in the valine, leucine and isoleucine degradation pathway. is also involved in several metabolic disorders, some of which include the 3-methylglutaconic aciduria type I pathway, 3-methylcrotonyl CoA carboxylase deficiency type I, the 3-methylglutaconic aciduria type IV pathway, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Outside of the human body, can be found in a number of food items such as mung bean, poppy, pistachio, and garden onion. This makes a potential biomarker for the consumption of these food products. is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Alpha-Lactose ; HMDB0000186",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000186",
    "description" : "Alpha-Lactose, also known as anhydrous lactose or tablettose, belongs to the class of organic compounds known as o-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Alpha-Lactose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Alpha-Lactose has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and breast milk. Within the cell, Alpha-lactose is primarily located in the cytoplasm, lysosome and golgi. Alpha-Lactose participates in a number of enzymatic reactions. In particular, Uridine 5'-diphosphate and Alpha-lactose can be biosynthesized from D-glucose and uridine diphosphategalactose through its interaction with the enzyme lactose synthase. In addition, Alpha-Lactose can be converted into melibiose and D-galactose through its interaction with the enzyme Alpha-galactosidase a. In humans, Alpha-lactose is involved in the lactose degradation pathway, the galactose metabolism pathway, lactose synthesis pathway, and the lactose intolerance pathway. Alpha-Lactose is also involved in a few metabolic disorders, which include glut-1 deficiency syndrome, the congenital disorder OF glycosylation CDG-iid pathway, and the galactosemia pathway. Outside of the human body, Alpha-lactose can be found in cow milk. This makes Alpha-lactose a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Alpha-Linolenic acid ; HMDB0001388",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001388",
    "description" : "Alpha-Linolenic acid, also known as linolenate or ALA, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Alpha-Linolenic acid is a drug which is used for nutritional supplementation and for treating dietary shortage or imbalance. Alpha-Linolenic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Alpha-Linolenic acid has been found throughout most human tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, Alpha-linolenic acid is primarily located in the cytoplasm and membrane (predicted from logP). Alpha-Linolenic acid can be converted into stearidonic acid; which is catalyzed by the enzyme fatty acid desaturase 2. In humans, Alpha-linolenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Outside of the human body, Alpha-linolenic acid can be found in a number of food items such as rubus (blackberry, raspberry), bitter gourd, sparkleberry, and romaine lettuce. This makes Alpha-linolenic acid a potential biomarker for the consumption of these food products. Alpha-Linolenic acid is a potentially toxic compound. Alpha-Linolenic acid has been found to be associated with several diseases known as thyroid cancer, essential hypertension, and hypertension; alpha-linolenic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Alpha-Linolenic acid ; HMDB01388",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001388",
    "description" : "Alpha-Linolenic acid, also known as linolenate or ALA, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Alpha-Linolenic acid is a drug which is used for nutritional supplementation and for treating dietary shortage or imbalance. Alpha-Linolenic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Alpha-Linolenic acid has been found throughout most human tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, Alpha-linolenic acid is primarily located in the cytoplasm and membrane (predicted from logP). Alpha-Linolenic acid can be converted into stearidonic acid; which is catalyzed by the enzyme fatty acid desaturase 2. In humans, Alpha-linolenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Outside of the human body, Alpha-linolenic acid can be found in a number of food items such as rubus (blackberry, raspberry), bitter gourd, sparkleberry, and romaine lettuce. This makes Alpha-linolenic acid a potential biomarker for the consumption of these food products. Alpha-Linolenic acid is a potentially toxic compound. Alpha-Linolenic acid has been found to be associated with several diseases known as thyroid cancer, essential hypertension, and hypertension; alpha-linolenic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Alpha-Muricholic acid ; HMDB0000506",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000506",
    "description" : "Alpha-Muricholic acid, also known as A-muricholate, belongs to the class of organic compounds known as trihydroxy bile acids, alcohols and derivatives. These are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Alpha-Muricholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Alpha-Muricholic acid has been found throughout all human tissues, and has also been primarily detected in urine. Within the cell, Alpha-muricholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Alpha-Muricholic acid ; HMDB00506",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000506",
    "description" : "Alpha-Muricholic acid, also known as A-muricholate, belongs to the class of organic compounds known as trihydroxy bile acids, alcohols and derivatives. These are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Alpha-Muricholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Alpha-Muricholic acid has been found throughout all human tissues, and has also been primarily detected in urine. Within the cell, Alpha-muricholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "alpha-Tocopherol ; HMDB0001893",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001893",
    "description" : "Alpha-Tocopherol, also known as vitamin e or D-tocopherol, belongs to the class of organic compounds known as tocopherols. These are vitamin E derivatives containing a saturated trimethyltridecyl chain attached to the carbon C6 atom of a benzopyran ring system. The differ from tocotrienols that contain an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain. Thus, Alpha-tocopherol is considered to be a quinone lipid molecule. Alpha-Tocopherol exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Alpha-Tocopherol has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, breast milk, blood, and cerebrospinal fluid. Within the cell, Alpha-tocopherol is primarily located in the cytoplasm and membrane (predicted from logP). Alpha-Tocopherol can be converted into 13-hydroxy-alpha-tocopherol. Outside of the human body, Alpha-tocopherol can be found in a number of food items such as red bell pepper, sea-buckthornberry, capers, and carrot. This makes Alpha-tocopherol a potential biomarker for the consumption of these food products. Alpha-Tocopherol is a potentially toxic compound. Alpha-Tocopherol has been found to be associated with several diseases known as thyroid cancer, vitamin e deficiency, parkinson's disease, and cerebrotendinous xanthomatosis; alpha-tocopherol has also been linked to the inborn metabolic disorders including abetalipoproteinemia.",
    "id" : null
  }, {
    "name" : "alpha-Tocopherol ; HMDB01893",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001893",
    "description" : "Alpha-Tocopherol, also known as vitamin e or D-tocopherol, belongs to the class of organic compounds known as tocopherols. These are vitamin E derivatives containing a saturated trimethyltridecyl chain attached to the carbon C6 atom of a benzopyran ring system. The differ from tocotrienols that contain an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain. Thus, Alpha-tocopherol is considered to be a quinone lipid molecule. Alpha-Tocopherol exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Alpha-Tocopherol has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, breast milk, blood, and cerebrospinal fluid. Within the cell, Alpha-tocopherol is primarily located in the cytoplasm and membrane (predicted from logP). Alpha-Tocopherol can be converted into 13-hydroxy-alpha-tocopherol. Outside of the human body, Alpha-tocopherol can be found in a number of food items such as red bell pepper, sea-buckthornberry, capers, and carrot. This makes Alpha-tocopherol a potential biomarker for the consumption of these food products. Alpha-Tocopherol is a potentially toxic compound. Alpha-Tocopherol has been found to be associated with several diseases known as thyroid cancer, vitamin e deficiency, parkinson's disease, and cerebrotendinous xanthomatosis; alpha-tocopherol has also been linked to the inborn metabolic disorders including abetalipoproteinemia.",
    "id" : null
  }, {
    "name" : "Aminoadipic acid ; HMDB0000510",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000510",
    "description" : "Aminoadipic acid, also known as a-aminoadipate or Aad, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Aminoadipic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Aminoadipic acid has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, aminoadipic acid is primarily located in the cytoplasm and mitochondria. Aminoadipic acid participates in a number of enzymatic reactions. In particular, Aminoadipic acid can be biosynthesized from allysine; which is catalyzed by the enzyme Alpha-aminoadipic semialdehyde dehydrogenase. In addition, Aminoadipic acid and oxoglutaric acid can be converted into oxoadipic acid and L-glutamic acid; which is mediated by the enzyme kynurenine/alpha-aminoadipate aminotransferase, mitochondrial. In humans, aminoadipic acid is involved in the pyridoxine dependency with seizures pathway and the lysine degradation pathway. Aminoadipic acid is also involved in several metabolic disorders, some of which include the saccharopinuria/hyperlysinemia II pathway, the 2-aminoadipic 2-oxoadipic aciduria pathway, the glutaric aciduria type I pathway, and the hyperlysinemia II or saccharopinuria pathway. Outside of the human body, aminoadipic acid can be found in common sage and spearmint. This makes aminoadipic acid a potential biomarker for the consumption of these food products. Aminoadipic acid is a potentially toxic compound. Aminoadipic acid has been found to be associated with several diseases known as schizophrenia and alpha-aminoadipic and alpha-ketoadipic aciduria; aminoadipic acid has also been linked to several inborn metabolic disorders including 2-ketoadipic acidemia and alpha-aminoadipic aciduria.",
    "id" : null
  }, {
    "name" : "Aminoadipic acid ; HMDB00510",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000510",
    "description" : "Aminoadipic acid, also known as a-aminoadipate or Aad, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Aminoadipic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Aminoadipic acid has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, aminoadipic acid is primarily located in the cytoplasm and mitochondria. Aminoadipic acid participates in a number of enzymatic reactions. In particular, Aminoadipic acid can be biosynthesized from allysine; which is catalyzed by the enzyme Alpha-aminoadipic semialdehyde dehydrogenase. In addition, Aminoadipic acid and oxoglutaric acid can be converted into oxoadipic acid and L-glutamic acid; which is mediated by the enzyme kynurenine/alpha-aminoadipate aminotransferase, mitochondrial. In humans, aminoadipic acid is involved in the pyridoxine dependency with seizures pathway and the lysine degradation pathway. Aminoadipic acid is also involved in several metabolic disorders, some of which include the saccharopinuria/hyperlysinemia II pathway, the 2-aminoadipic 2-oxoadipic aciduria pathway, the glutaric aciduria type I pathway, and the hyperlysinemia II or saccharopinuria pathway. Outside of the human body, aminoadipic acid can be found in common sage and spearmint. This makes aminoadipic acid a potential biomarker for the consumption of these food products. Aminoadipic acid is a potentially toxic compound. Aminoadipic acid has been found to be associated with several diseases known as schizophrenia and alpha-aminoadipic and alpha-ketoadipic aciduria; aminoadipic acid has also been linked to several inborn metabolic disorders including 2-ketoadipic acidemia and alpha-aminoadipic aciduria.",
    "id" : null
  }, {
    "name" : "Amoxicillin ; HMDB0015193",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0015193",
    "description" : "Amoxicillin, also known as clamoxyl or amopenixin, belongs to the class of organic compounds known as penicillins. These are organic compounds containing the penicillin core structure, which is structurally characterized by a penam ring bearing two methyl groups at position 2, and an amide group at position 6 [starting from the sulfur atom at position 1]. Amoxicillin is a drug which is used for the treatment of infections of the ear, nose, and throat, the genitourinary tract, the skin and skin structure, and the lower respiratory tract due to susceptible (only b-lactamase-negative) strains of &lt;i&gt;streptococcus&lt;/i&gt; spp (a- and b-hemolytic strains only), &lt;i&gt;s. pneumoniae&lt;/i&gt;, &lt;i&gt;staphylococcus&lt;/i&gt; spp., &lt;i&gt;h. influenzae&lt;/i&gt;, &lt;i&gt;e. coli&lt;/i&gt;, &lt;i&gt;p. mirabilis&lt;/i&gt;, or &lt;i&gt;e. faecalis&lt;/i&gt;. also for the treatment of acute, uncomplicated gonorrhea (ano-genital and urethral infections) due to &lt;i&gt;n. gonorrhoeae&lt;/i&gt; (males and females). Amoxicillin exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Amoxicillin has been detected in multiple biofluids, such as urine and blood. Within the cell, amoxicillin is primarily located in the cytoplasm and membrane (predicted from logP). Amoxicillin is also a parent compound for other transformation products, including but not limited to, amoxicillin diketopiperazine, amoxicilloyl polylysine, and amoxicilloyl-butylamine.",
    "id" : null
  }, {
    "name" : "Anandamide ; HMDB0004080",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004080",
    "description" : "Anandamide (20:4, N-6), also known as arachidonylethanolamide or AEA, belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, anandamide (20:4, N-6) is considered to be a fatty amide lipid molecule. Anandamide (20:4, N-6) is considered to be a practically insoluble (in water) and relatively neutral molecule. Anandamide (20:4, N-6) has been detected in multiple biofluids, such as blood and cerebrospinal fluid. Within the cell, anandamide (20:4, N-6) is primarily located in the membrane (predicted from logP). Anandamide (20:4, N-6) participates in a number of enzymatic reactions. In particular, anandamide (20:4, N-6) can be biosynthesized from arachidonic acid. Anandamide (20:4, N-6) is also a parent compound for other transformation products, including but not limited to, N-arachidonoylethanolamine phosphate(2-), N-[(5Z,8Z,14Z)-11,12-epoxyicosatrienoyl]ethanolamine, and O-oleoylanandamide.",
    "id" : null
  }, {
    "name" : "Androsterone sulfate ; HMDB0002759",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002759",
    "description" : "5alpha-Androstane-3alpha-ol-17-one sulfate, also known as 3alpha-hydroxy-5alpha-androstan-17-one 3-sulfate or 5-androstane-3-ol-17-one sulfuric acid, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Androstane-3alpha-ol-17-one sulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. 5alpha-Androstane-3alpha-ol-17-one sulfate has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, 5alpha-androstane-3alpha-ol-17-one sulfate is primarily located in the cytoplasm, membrane (predicted from logP) and endoplasmic reticulum. In humans, 5alpha-androstane-3alpha-ol-17-one sulfate is involved in the androgen and estrogen metabolism pathway.",
    "id" : null
  }, {
    "name" : "Arachidic acid ; HMDB0002212",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002212",
    "description" : "Arachidic acid, also known as eicosanoic acid or eicosanoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Arachidic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Arachidic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, arachidic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Arachidic acid is also a parent compound for other transformation products, including but not limited to, 18-methylicosanoic acid, N-icosanoylsphingosine, and beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(11)-N-eicosanoylsphingosine. Outside of the human body, arachidic acid can be found in a number of food items such as nutmeg, oyster mushroom, yardlong bean, and millet. This makes arachidic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Arachidic acid ; HMDB02212",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002212",
    "description" : "Arachidic acid, also known as eicosanoic acid or eicosanoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Arachidic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Arachidic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, arachidic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Arachidic acid is also a parent compound for other transformation products, including but not limited to, 18-methylicosanoic acid, N-icosanoylsphingosine, and beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(11)-N-eicosanoylsphingosine. Outside of the human body, arachidic acid can be found in a number of food items such as nutmeg, oyster mushroom, yardlong bean, and millet. This makes arachidic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Arachidonic acid ; HMDB0001043",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001043",
    "description" : "Arachidonic acid, also known as arachidonate or AA, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Arachidonic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Arachidonic acid has been found throughout most human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, feces, and blood. Arachidonic acid can be found anywhere throughout the human cell, such as in adiposome, cytoplasm, endoplasmic reticulum, and membrane (predicted from logP). Arachidonic acid participates in a number of enzymatic reactions. In particular, Arachidonic acid can be biosynthesized from 8,11,14-eicosatrienoic acid through its interaction with the enzyme fatty acid desaturase 1. In addition, Arachidonic acid can be converted into adrenic acid through its interaction with the enzyme elongation OF very long chain fatty acids protein 5. In humans, arachidonic acid is involved in the tolmetin action pathway, the indomethacin action pathway, the acetaminophen action pathway, and the nabumetone action pathway. Arachidonic acid is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway. Outside of the human body, arachidonic acid can be found in a number of food items such as yellow zucchini, radish, garfish, and carrot. This makes arachidonic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Arachidonic acid ; HMDB01043",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001043",
    "description" : "Arachidonic acid, also known as arachidonate or AA, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Arachidonic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Arachidonic acid has been found throughout most human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, feces, and blood. Arachidonic acid can be found anywhere throughout the human cell, such as in adiposome, cytoplasm, endoplasmic reticulum, and membrane (predicted from logP). Arachidonic acid participates in a number of enzymatic reactions. In particular, Arachidonic acid can be biosynthesized from 8,11,14-eicosatrienoic acid through its interaction with the enzyme fatty acid desaturase 1. In addition, Arachidonic acid can be converted into adrenic acid through its interaction with the enzyme elongation OF very long chain fatty acids protein 5. In humans, arachidonic acid is involved in the tolmetin action pathway, the indomethacin action pathway, the acetaminophen action pathway, and the nabumetone action pathway. Arachidonic acid is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway. Outside of the human body, arachidonic acid can be found in a number of food items such as yellow zucchini, radish, garfish, and carrot. This makes arachidonic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Arachidonyl carnitine ; HMDB0006455",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006455",
    "description" : "Arachidonyl carnitine, also known as c20:4(n-6) carnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Arachidonyl carnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Arachidonyl carnitine has been detected in multiple biofluids, such as blood and urine. Within the cell, arachidonyl carnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria.",
    "id" : null
  }, {
    "name" : "Arachidonyl carnitine ; HMDB06455",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006455",
    "description" : "Arachidonyl carnitine, also known as c20:4(n-6) carnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Arachidonyl carnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Arachidonyl carnitine has been detected in multiple biofluids, such as blood and urine. Within the cell, arachidonyl carnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria.",
    "id" : null
  }, {
    "name" : "Aspartylglycosamine ; HMDB0000489",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000489",
    "description" : "Aspartylglycosamine, also known as aadg or N-adgp-asn, belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Aspartylglycosamine is soluble (in water) and a moderately acidic compound (based on its pKa). Aspartylglycosamine has been found in human spleen tissue, and has also been primarily detected in urine. Within the cell, aspartylglycosamine is primarily located in the cytoplasm. Aspartylglycosamine has been linked to the inborn metabolic disorders including aspartylglucosaminuria.",
    "id" : null
  }, {
    "name" : "Asymmetric dimethylarginine ; HMDB0001539",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001539",
    "description" : "Dimethyl-L-arginine, also known as adma, belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Dimethyl-L-arginine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Dimethyl-L-arginine has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, dimethyl-L-arginine is primarily located in the cytoplasm and mitochondria. Dimethyl-L-arginine exists in all eukaryotes, ranging from yeast to humans. Dimethyl-L-arginine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Asymmetric dimethylarginine ; HMDB01539",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001539",
    "description" : "Dimethyl-L-arginine, also known as adma, belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Dimethyl-L-arginine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Dimethyl-L-arginine has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, dimethyl-L-arginine is primarily located in the cytoplasm and mitochondria. Dimethyl-L-arginine exists in all eukaryotes, ranging from yeast to humans. Dimethyl-L-arginine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Atenolol ; HMDB0001924",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001924",
    "description" : "Atenolol, also known as tenormin or unibloc, belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids. Atenolol is a drug which is used for the management of hypertention and long-term management of patients with angina pectoris. Atenolol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Atenolol has been primarily detected in blood. In humans, atenolol is involved in the atenolol action pathway. Atenolol is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Atenolol ; HMDB01924",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001924",
    "description" : "Atenolol, also known as tenormin or unibloc, belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids. Atenolol is a drug which is used for the management of hypertention and long-term management of patients with angina pectoris. Atenolol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Atenolol has been primarily detected in blood. In humans, atenolol is involved in the atenolol action pathway. Atenolol is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Azelaic acid ; HMDB0000784",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000784",
    "description" : "Azelaic acid, also known as azelex or finacea, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Azelaic acid is a drug which is used for the topical treatment of mild-to-moderate inflammatory acne vulgaris. Azelaic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Azelaic acid has been found in human prostate and skin tissues, and has also been detected in most biofluids, including blood, breast milk, saliva, and feces. Within the cell, azelaic acid is primarily located in the cytoplasm and adiposome. Azelaic acid is also a parent compound for other transformation products, including but not limited to, 1-O-hexadecyl-2-(8-carboxyoctanoyl)-sn-glycero-3-phosphocholine, 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine, and 1-azelaoyl-sn-glycero-3-phosphocholine. Azelaic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Azelaic acid ; HMDB00784",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000784",
    "description" : "Azelaic acid, also known as azelex or finacea, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Azelaic acid is a drug which is used for the topical treatment of mild-to-moderate inflammatory acne vulgaris. Azelaic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Azelaic acid has been found in human prostate and skin tissues, and has also been detected in most biofluids, including blood, breast milk, saliva, and feces. Within the cell, azelaic acid is primarily located in the cytoplasm and adiposome. Azelaic acid is also a parent compound for other transformation products, including but not limited to, 1-O-hexadecyl-2-(8-carboxyoctanoyl)-sn-glycero-3-phosphocholine, 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine, and 1-azelaoyl-sn-glycero-3-phosphocholine. Azelaic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Benzoic acid ; HMDB0001870",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001870",
    "description" : "Benzoic acid, also known as benzoate or E210, belongs to the class of organic compounds known as benzoic acids. These are organic Compounds containing a benzene ring which bears at least one carboxyl group. Benzoic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Benzoic acid has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, feces, urine, and sweat. Within the cell, benzoic acid is primarily located in the cytoplasm and endoplasmic reticulum. Benzoic acid exists in all eukaryotes, ranging from yeast to humans. Benzoic acid is also a parent compound for other transformation products, including but not limited to, 4-(2-carboxyphenyl)-2-oxobut-3-enoic acid, 4-hydroxy-3-octaprenylbenzoic acid, and hydroxybenzoic acid. Benzoic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "beta-Alanine ; HMDB0000056",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000056",
    "description" : "Beta-Alanine, also known as 3-aminopropanoate or bala, belongs to the class of organic compounds known as beta amino acids and derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom. Beta-Alanine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Beta-Alanine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, blood, saliva, and urine. Within the cell, Beta-alanine is primarily located in the cytoplasm and mitochondria. Beta-Alanine exists in all eukaryotes, ranging from yeast to humans. Beta-Alanine participates in a number of enzymatic reactions. In particular, Beta-Alanine and oxoglutaric acid can be converted into malonic semialdehyde and L-glutamic acid through its interaction with the enzyme 4-aminobutyrate aminotransferase, mitochondrial. Furthermore, Beta-Alanine can be biosynthesized from L-aspartic acid through the action of the enzyme glutamate decarboxylase 1. Furthermore, Beta-Alanine can be biosynthesized from ureidopropionic acid through its interaction with the enzyme Beta-ureidopropionase. Finally, Beta-Alanine and 3-methylhistidine can be biosynthesized from anserine; which is catalyzed by the enzyme Beta-ala-his dipeptidase. In humans, Beta-alanine is involved in the aspartate metabolism pathway, the pyrimidine metabolism pathway, the histidine metabolism pathway, and the Beta-alanine metabolism pathway. Beta-Alanine is also involved in several metabolic disorders, some of which include dihydropyrimidinase deficiency, Beta ureidopropionase deficiency, the histidinemia pathway, and the canavan disease pathway. Outside of the human body, Beta-alanine can be found in a number of food items such as barley, banana, ceylon cinnamon, and green bean. This makes Beta-alanine a potential biomarker for the consumption of these food products. Beta-Alanine is a potentially toxic compound. Beta-Alanine has been found to be associated with the diseases known as methylmalonate semialdehyde dehydrogenase deficiency; beta-alanine has also been linked to the inborn metabolic disorders including hyper beta-alaninemia.",
    "id" : null
  }, {
    "name" : "beta-Cryptoxanthin ; HMDB0033844",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0033844",
    "description" : "Beta-Cryptoxanthin, also known as 3-hydroxy-b-carotene or b,b-caroten-3-ol, belongs to the class of organic compounds known as xanthophylls. These are carotenoids containing an oxygenated carotene backbone. Carotenes are characterized by the presence of two end-groups (mostly cyclohexene rings, but also cyclopentene rings or acyclic groups) linked by a long branched alkyl chain. Carotenes belonging form a subgroup of the carotenoids family. Xanthophylls arise by oxygenation of the carotene backbone. Beta-Cryptoxanthin exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Beta-Cryptoxanthin has been detected in multiple biofluids, such as blood and breast milk. Within the cell, Beta-cryptoxanthin is primarily located in the membrane (predicted from logP) and cytoplasm. Outside of the human body, Beta-cryptoxanthin can be found in a number of food items such as cowpea, garlic, mandarin orange (clementine, tangerine), and sake. This makes Beta-cryptoxanthin a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Betaine ; HMDB0000043",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000043",
    "description" : "Betaine, also known as glycine betaine or acidin pepsin, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Betaine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Betaine has been found throughout most human tissues, and has also been detected in most biofluids, including blood, breast milk, saliva, and urine. Within the cell, betaine is primarily located in the cytoplasm and mitochondria. Betaine exists in all eukaryotes, ranging from yeast to humans. Betaine participates in a number of enzymatic reactions. In particular, Betaine and homocysteine can be converted into dimethylglycine and L-methionine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, Betaine can be biosynthesized from betaine aldehyde through the action of the enzyme Alpha-aminoadipic semialdehyde dehydrogenase. Furthermore, Betaine and homocysteine can be converted into dimethylglycine and L-methionine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. Finally, Betaine can be biosynthesized from choline; which is catalyzed by the enzyme choline dehydrogenase, mitochondrial. In humans, betaine is involved in the sarcosine oncometabolite pathway, the methionine metabolism pathway, the glycine and serine metabolism pathway, and the betaine metabolism pathway. Betaine is also involved in several metabolic disorders, some of which include the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, the sarcosinemia pathway, glycine N-methyltransferase deficiency, and cystathionine Beta-synthase deficiency. Betaine is a bland tasting compound that can be found in a number of food items such as shiitake, garden tomato (var.), wax gourd, and olive. This makes betaine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Betaine ; HMDB00043",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000043",
    "description" : "Betaine, also known as glycine betaine or acidin pepsin, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Betaine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Betaine has been found throughout most human tissues, and has also been detected in most biofluids, including blood, breast milk, saliva, and urine. Within the cell, betaine is primarily located in the cytoplasm and mitochondria. Betaine exists in all eukaryotes, ranging from yeast to humans. Betaine participates in a number of enzymatic reactions. In particular, Betaine and homocysteine can be converted into dimethylglycine and L-methionine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, Betaine can be biosynthesized from betaine aldehyde through the action of the enzyme Alpha-aminoadipic semialdehyde dehydrogenase. Furthermore, Betaine and homocysteine can be converted into dimethylglycine and L-methionine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. Finally, Betaine can be biosynthesized from choline; which is catalyzed by the enzyme choline dehydrogenase, mitochondrial. In humans, betaine is involved in the sarcosine oncometabolite pathway, the methionine metabolism pathway, the glycine and serine metabolism pathway, and the betaine metabolism pathway. Betaine is also involved in several metabolic disorders, some of which include the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, the sarcosinemia pathway, glycine N-methyltransferase deficiency, and cystathionine Beta-synthase deficiency. Betaine is a bland tasting compound that can be found in a number of food items such as shiitake, garden tomato (var.), wax gourd, and olive. This makes betaine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Betonicine ; HMDB0029412",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029412",
    "description" : "Betonicine, also known as achillein, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Betonicine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Betonicine has been primarily detected in urine. Within the cell, betonicine is primarily located in the cytoplasm. Betonicine can be biosynthesized from trans-4-hydroxy-L-proline zwitterion. Outside of the human body, betonicine can be found in herbs and spices and pulses. This makes betonicine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Bilirubin ; HMDB0000054",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000054",
    "description" : "4E,15Z-Bilirubin ixa belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. 4E,15Z-Bilirubin ixa is considered to be a practically insoluble (in water) and relatively neutral molecule. 4E,15Z-Bilirubin ixa has been primarily detected in blood. Within the cell, 4E,15Z-bilirubin ixa is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Bilirubin ; HMDB00054",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000054",
    "description" : "4E,15Z-Bilirubin ixa belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. 4E,15Z-Bilirubin ixa is considered to be a practically insoluble (in water) and relatively neutral molecule. 4E,15Z-Bilirubin ixa has been primarily detected in blood. Within the cell, 4E,15Z-bilirubin ixa is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Biliverdin ; HMDB0001008",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001008",
    "description" : "Biliverdin, also known as biliverdin ix or dehydrobilirubin, belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. Biliverdin is considered to be a practically insoluble (in water) and relatively neutral molecule. Biliverdin has been found in human prostate and placenta tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, biliverdin is primarily located in the cytoplasm, membrane (predicted from logP) and nucleus. In humans, biliverdin is involved in the porphyrin metabolism pathway. Biliverdin is also involved in several metabolic disorders, some of which include the acute intermittent porphyria pathway, congenital erythropoietic porphyria (cep) or gunther disease pathway, the porphyria variegata (PV) pathway, and the hereditary coproporphyria (HCP) pathway.",
    "id" : null
  }, {
    "name" : "Biliverdin ; HMDB01008",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001008",
    "description" : "Biliverdin, also known as biliverdin ix or dehydrobilirubin, belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. Biliverdin is considered to be a practically insoluble (in water) and relatively neutral molecule. Biliverdin has been found in human prostate and placenta tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, biliverdin is primarily located in the cytoplasm, membrane (predicted from logP) and nucleus. In humans, biliverdin is involved in the porphyrin metabolism pathway. Biliverdin is also involved in several metabolic disorders, some of which include the acute intermittent porphyria pathway, congenital erythropoietic porphyria (cep) or gunther disease pathway, the porphyria variegata (PV) pathway, and the hereditary coproporphyria (HCP) pathway.",
    "id" : null
  }, {
    "name" : "Bromine ; HMDB0031434",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0031434",
    "description" : "Bromine, also known as brom or BR2, belongs to the class of inorganic compounds known as homogeneous halogens. These are inorganic non-metallic compounds in which the largest atom is a nobel gas. Outside of the human body, bromine can be found in a number of food items such as orange bell pepper, bilberry, common grape, and white cabbage. This makes bromine a potential biomarker for the consumption of these food products. Bromine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Butyrylcarnitine ; HMDB0002013",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002013",
    "description" : ", also known as butyrylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, is considered to be a fatty ester lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm. has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Butyrylcarnitine ; HMDB02013",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002013",
    "description" : ", also known as butyrylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, is considered to be a fatty ester lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, is primarily located in the membrane (predicted from logP) and cytoplasm. has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Caffeine ; HMDB0001847",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001847",
    "description" : "Caffeine, also known as coffein or theine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Caffeine is a drug which is used for management of fatigue, orthostatic hypotension, and for the short term treatment of apnea of prematurity in infants. Caffeine exists as a solid, soluble (in water), and an extremely weak basic (essentially neutral) compound (based on its pKa). Caffeine has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, feces, cerebrospinal fluid, and urine. Within the cell, caffeine is primarily located in the cytoplasm. Caffeine participates in a number of enzymatic reactions. In particular, Caffeine can be converted into paraxanthine and formaldehyde through its interaction with the enzyme cytochrome P450 1A2. In addition, Caffeine can be converted into theobromine and formaldehyde; which is catalyzed by the enzymes cytochrome P450 1A2 and cytochrome P450 2E1. In humans, caffeine is involved in the caffeine metabolism pathway. Outside of the human body, caffeine can be found in pulses. This makes caffeine a potential biomarker for the consumption of this food product. Caffeine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Caffeine ; HMDB01847",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001847",
    "description" : "Caffeine, also known as coffein or theine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Caffeine is a drug which is used for management of fatigue, orthostatic hypotension, and for the short term treatment of apnea of prematurity in infants. Caffeine exists as a solid, soluble (in water), and an extremely weak basic (essentially neutral) compound (based on its pKa). Caffeine has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, feces, cerebrospinal fluid, and urine. Within the cell, caffeine is primarily located in the cytoplasm. Caffeine participates in a number of enzymatic reactions. In particular, Caffeine can be converted into paraxanthine and formaldehyde through its interaction with the enzyme cytochrome P450 1A2. In addition, Caffeine can be converted into theobromine and formaldehyde; which is catalyzed by the enzymes cytochrome P450 1A2 and cytochrome P450 2E1. In humans, caffeine is involved in the caffeine metabolism pathway. Outside of the human body, caffeine can be found in pulses. This makes caffeine a potential biomarker for the consumption of this food product. Caffeine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Campesterol ; HMDB0002869",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002869",
    "description" : "Campesterol belongs to the class of organic compounds known as ergosterols and derivatives. These are steroids containing ergosta-5,7,22-trien-3beta-ol or a derivative thereof, which is based on the 3beta-hydroxylated ergostane skeleton. Thus, campesterol is considered to be a sterol lipid molecule. Campesterol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Campesterol has been found in human kidney, muscle and hepatic tissue tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, campesterol is primarily located in the membrane (predicted from logP) and cytoplasm. Campesterol can be biosynthesized from campestane.",
    "id" : null
  }, {
    "name" : "Campesterol ; HMDB02869",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002869",
    "description" : "Campesterol belongs to the class of organic compounds known as ergosterols and derivatives. These are steroids containing ergosta-5,7,22-trien-3beta-ol or a derivative thereof, which is based on the 3beta-hydroxylated ergostane skeleton. Thus, campesterol is considered to be a sterol lipid molecule. Campesterol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Campesterol has been found in human kidney, muscle and hepatic tissue tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, campesterol is primarily located in the membrane (predicted from logP) and cytoplasm. Campesterol can be biosynthesized from campestane.",
    "id" : null
  }, {
    "name" : "Capric acid ; HMDB0000511",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000511",
    "description" : "Capric acid, also known as decanoate or decylic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Capric acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Capric acid has been found in human epidermis tissue, and has also been detected in most biofluids, including saliva, sweat, feces, and breast milk. Within the cell, capric acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Capric acid exists in all eukaryotes, ranging from yeast to humans. Capric acid participates in a number of enzymatic reactions. In particular, Capric acid can be biosynthesized from trans-dec-2-enoic acid; which is catalyzed by the enzyme fatty acid synthase. enoyl reductase domain. Furthermore, Capric acid and malonic acid can be converted into 3-oxododecanoic acid; which is mediated by the enzyme fatty acid synthase. Beta ketoacyl synthase domain. Furthermore, Capric acid can be biosynthesized from trans-dec-2-enoic acid through the action of the enzyme fatty acid synthase. enoyl reductase domain. Finally, Capric acid and malonic acid can be converted into 3-oxododecanoic acid; which is catalyzed by the enzyme fatty acid synthase. Beta ketoacyl synthase domain. In humans, capric acid is involved in fatty acid biosynthesis pathway and the Beta oxidation OF very long chain fatty acids pathway. Outside of the human body, capric acid can be found in a number of food items such as daikon radish, thistle, sacred lotus, and garden tomato (var.). This makes capric acid a potential biomarker for the consumption of these food products. Capric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Capric acid ; HMDB00511",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000511",
    "description" : "Capric acid, also known as decanoate or decylic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Capric acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Capric acid has been found in human epidermis tissue, and has also been detected in most biofluids, including saliva, sweat, feces, and breast milk. Within the cell, capric acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Capric acid exists in all eukaryotes, ranging from yeast to humans. Capric acid participates in a number of enzymatic reactions. In particular, Capric acid can be biosynthesized from trans-dec-2-enoic acid; which is catalyzed by the enzyme fatty acid synthase. enoyl reductase domain. Furthermore, Capric acid and malonic acid can be converted into 3-oxododecanoic acid; which is mediated by the enzyme fatty acid synthase. Beta ketoacyl synthase domain. Furthermore, Capric acid can be biosynthesized from trans-dec-2-enoic acid through the action of the enzyme fatty acid synthase. enoyl reductase domain. Finally, Capric acid and malonic acid can be converted into 3-oxododecanoic acid; which is catalyzed by the enzyme fatty acid synthase. Beta ketoacyl synthase domain. In humans, capric acid is involved in fatty acid biosynthesis pathway and the Beta oxidation OF very long chain fatty acids pathway. Outside of the human body, capric acid can be found in a number of food items such as daikon radish, thistle, sacred lotus, and garden tomato (var.). This makes capric acid a potential biomarker for the consumption of these food products. Capric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Caproate (6:0) ; HMDB0061883",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061883",
    "description" : "Caproic acid, also known as hexanoate or caproate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Caproic acid exists as a liquid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Caproic acid has been detected in most biofluids, including cerebrospinal fluid, feces, sweat, and urine. Within the cell, caproic acid is primarily located in the cytoplasm and adiposome. Caproic acid exists in all eukaryotes, ranging from yeast to humans. In humans, caproic acid is involved in fatty acid biosynthesis pathway and the Beta oxidation OF very long chain fatty acids pathway. Caproic acid is also involved in a couple of metabolic disorders, which include the mitochondrial Beta-oxidation OF short chain saturated fatty acids pathway and short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (schad). Outside of the human body, caproic acid can be found in a number of food items such as sweet basil, wild carrot, agar, and wax gourd. This makes caproic acid a potential biomarker for the consumption of these food products. Caproic acid is a potentially toxic compound. Caproic acid has been linked to several inborn metabolic disorders including celiac disease and medium chain acyl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Caprylic acid ; HMDB0000482",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000482",
    "description" : "Caprylic acid, also known as 8:0 or octylic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Caprylic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Caprylic acid has been found in human epidermis tissue, and has also been detected in most biofluids, including breast milk, feces, urine, and sweat. Within the cell, caprylic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Caprylic acid exists in all eukaryotes, ranging from yeast to humans. Caprylic acid participates in a number of enzymatic reactions. In particular, Caprylic acid can be biosynthesized from trans-2-octenoic acid; which is catalyzed by the enzyme fatty acid synthase. enoyl reductase domain. Furthermore, Caprylic acid and malonic acid can be converted into 3-oxodecanoic acid through its interaction with the enzyme fatty acid synthase. Beta ketoacyl synthase domain. Furthermore, Caprylic acid can be biosynthesized from trans-2-octenoic acid; which is mediated by the enzyme fatty acid synthase. enoyl reductase domain. Finally, Caprylic acid and malonic acid can be converted into 3-oxodecanoic acid through the action of the enzyme fatty acid synthase. Beta ketoacyl synthase domain. In humans, caprylic acid is involved in the Beta oxidation OF very long chain fatty acids pathway and fatty acid biosynthesis pathway. Caprylic acid is also involved in the metabolic disorder called the mitochondrial Beta-oxidation OF short chain saturated fatty acids pathway. Outside of the human body, caprylic acid can be found in tea. This makes caprylic acid a potential biomarker for the consumption of this food product. Caprylic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Caprylic acid ; HMDB00482",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000482",
    "description" : "Caprylic acid, also known as 8:0 or octylic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Caprylic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Caprylic acid has been found in human epidermis tissue, and has also been detected in most biofluids, including breast milk, feces, urine, and sweat. Within the cell, caprylic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Caprylic acid exists in all eukaryotes, ranging from yeast to humans. Caprylic acid participates in a number of enzymatic reactions. In particular, Caprylic acid can be biosynthesized from trans-2-octenoic acid; which is catalyzed by the enzyme fatty acid synthase. enoyl reductase domain. Furthermore, Caprylic acid and malonic acid can be converted into 3-oxodecanoic acid through its interaction with the enzyme fatty acid synthase. Beta ketoacyl synthase domain. Furthermore, Caprylic acid can be biosynthesized from trans-2-octenoic acid; which is mediated by the enzyme fatty acid synthase. enoyl reductase domain. Finally, Caprylic acid and malonic acid can be converted into 3-oxodecanoic acid through the action of the enzyme fatty acid synthase. Beta ketoacyl synthase domain. In humans, caprylic acid is involved in the Beta oxidation OF very long chain fatty acids pathway and fatty acid biosynthesis pathway. Caprylic acid is also involved in the metabolic disorder called the mitochondrial Beta-oxidation OF short chain saturated fatty acids pathway. Outside of the human body, caprylic acid can be found in tea. This makes caprylic acid a potential biomarker for the consumption of this food product. Caprylic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Capryloylglycine ; HMDB0000832",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000832",
    "description" : "Capryloylglycine, also known as 2-octanamidoacetate or N-octanoyl-glycine, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Capryloylglycine is considered to be a practically insoluble (in water) and relatively neutral molecule. Capryloylglycine has been primarily detected in urine. Within the cell, capryloylglycine is primarily located in the membrane (predicted from logP). Capryloylglycine can be biosynthesized from octanoic acid and glycine.",
    "id" : null
  }, {
    "name" : "Carboxy-ibuprofen ; HMDB0060564",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060564",
    "description" : "Carboxy-ibuprofen is a metabolite of ibuprofen. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for relief of symptoms of arthritis, fever, as an analgesic (pain reliever), especially where there is an inflammatory component, and dysmenorrhea. Ibuprofen is known to have an antiplatelet effect, though it is relatively mild and somewhat short-lived when compared with aspirin or other better-known antiplatelet drugs. (Wikipedia)",
    "id" : null
  }, {
    "name" : "Carnosine ; HMDB0000033",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000033",
    "description" : "Carnosine, also known as b-alanylhistidine or ignotine, belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Carnosine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Carnosine has been found throughout most human tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, carnosine is primarily located in the cytoplasm. Carnosine exists in all eukaryotes, ranging from yeast to humans. Carnosine participates in a number of enzymatic reactions. In particular, Carnosine can be converted into Beta-alanine and L-histidine; which is catalyzed by the enzyme Beta-ala-his dipeptidase. In addition, Carnosine can be converted into Beta-alanine and L-histidine through the action of the enzyme Beta-ala-his dipeptidase. In humans, carnosine is involved in the histidine metabolism pathway and the Beta-alanine metabolism pathway. Carnosine is also involved in several metabolic disorders, some of which include the carnosinuria, carnosinemia pathway, the histidinemia pathway, gaba-transaminase deficiency, and ureidopropionase deficiency. Carnosine has been found to be associated with the diseases known as alzheimer's disease; carnosine has also been linked to the inborn metabolic disorders including carnosinuria.",
    "id" : null
  }, {
    "name" : "CE(14:0) ; HMDB0006725",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006725",
    "description" : "14:0 Cholesteryl ester, also known as cholesteryl myristate or 1-myristoyl-cholesterol, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Thus, 14:0 cholesteryl ester is considered to be a sterol lipid molecule. 14:0 Cholesteryl ester is considered to be a practically insoluble (in water) and relatively neutral molecule. 14:0 Cholesteryl ester has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 14:0 cholesteryl ester is primarily located in the membrane (predicted from logP) and cytoplasm. 14:0 Cholesteryl ester exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "CE(14:0) ; HMDB06725",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006725",
    "description" : "14:0 Cholesteryl ester, also known as cholesteryl myristate or 1-myristoyl-cholesterol, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Thus, 14:0 cholesteryl ester is considered to be a sterol lipid molecule. 14:0 Cholesteryl ester is considered to be a practically insoluble (in water) and relatively neutral molecule. 14:0 Cholesteryl ester has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 14:0 cholesteryl ester is primarily located in the membrane (predicted from logP) and cytoplasm. 14:0 Cholesteryl ester exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "CE(16:0) ; HMDB0000885",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000885",
    "description" : "16:0 Cholesteryl ester, also known as CE or cholesterol palmitate, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Thus, 16:0 cholesteryl ester is considered to be a sterol lipid molecule. 16:0 Cholesteryl ester exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. 16:0 Cholesteryl ester has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 16:0 cholesteryl ester is primarily located in the membrane (predicted from logP) and cytoplasm. 16:0 Cholesteryl ester exists in all eukaryotes, ranging from yeast to humans. 16:0 Cholesteryl ester has been linked to the inborn metabolic disorders including hypercholesterolemia.",
    "id" : null
  }, {
    "name" : "CE(16:0) ; HMDB00885",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000885",
    "description" : "16:0 Cholesteryl ester, also known as CE or cholesterol palmitate, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Thus, 16:0 cholesteryl ester is considered to be a sterol lipid molecule. 16:0 Cholesteryl ester exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. 16:0 Cholesteryl ester has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 16:0 cholesteryl ester is primarily located in the membrane (predicted from logP) and cytoplasm. 16:0 Cholesteryl ester exists in all eukaryotes, ranging from yeast to humans. 16:0 Cholesteryl ester has been linked to the inborn metabolic disorders including hypercholesterolemia.",
    "id" : null
  }, {
    "name" : "CE(16:1(9Z)) ; HMDB0000658",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000658",
    "description" : "16:1 Cholesteryl ester, also known as cholesteryl 9-palmitoleate or 1-palmitoleoyl-cholesterol, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Thus, 16:1 cholesteryl ester is considered to be a sterol lipid molecule. 16:1 Cholesteryl ester is considered to be a practically insoluble (in water) and relatively neutral molecule. 16:1 Cholesteryl ester has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 16:1 cholesteryl ester is primarily located in the membrane (predicted from logP) and cytoplasm. 16:1 Cholesteryl ester can be biosynthesized from (9Z)-hexadecenoic acid.",
    "id" : null
  }, {
    "name" : "CE(16:1(9Z)) ; HMDB00658",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000658",
    "description" : "16:1 Cholesteryl ester, also known as cholesteryl 9-palmitoleate or 1-palmitoleoyl-cholesterol, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Thus, 16:1 cholesteryl ester is considered to be a sterol lipid molecule. 16:1 Cholesteryl ester is considered to be a practically insoluble (in water) and relatively neutral molecule. 16:1 Cholesteryl ester has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, 16:1 cholesteryl ester is primarily located in the membrane (predicted from logP) and cytoplasm. 16:1 Cholesteryl ester can be biosynthesized from (9Z)-hexadecenoic acid.",
    "id" : null
  }, {
    "name" : "CE(18:0) ; HMDB0010368",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010368",
    "description" : "Ce(18:0), also known as ce(18:0/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(18:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:0) is primarily located in the membrane (predicted from logP) and cytoplasm. Ce(18:0) exists in all eukaryotes, ranging from yeast to humans. In humans, ce(18:0) is involved in the ibandronate action pathway, the zoledronate action pathway, the lovastatin action pathway, and the simvastatin action pathway. Ce(18:0) is also involved in several metabolic disorders, some of which include the cholesteryl ester storage disease pathway, the wolman disease pathway, the mevalonic aciduria pathway, and lysosomal acid lipase deficiency (wolman disease).",
    "id" : null
  }, {
    "name" : "CE(18:0) ; HMDB10368",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010368",
    "description" : "Ce(18:0), also known as ce(18:0/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(18:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:0) is primarily located in the membrane (predicted from logP) and cytoplasm. Ce(18:0) exists in all eukaryotes, ranging from yeast to humans. In humans, ce(18:0) is involved in the ibandronate action pathway, the zoledronate action pathway, the lovastatin action pathway, and the simvastatin action pathway. Ce(18:0) is also involved in several metabolic disorders, some of which include the cholesteryl ester storage disease pathway, the wolman disease pathway, the mevalonic aciduria pathway, and lysosomal acid lipase deficiency (wolman disease).",
    "id" : null
  }, {
    "name" : "CE(18:1(9Z)) ; HMDB0000918",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000918",
    "description" : "Ce(18:1(9Z)), also known as ce(18:1) or ce(18:1n9/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:1(9Z)) exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Ce(18:1(9Z)) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:1(9Z)) is primarily located in the membrane (predicted from logP), myelin sheath and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(18:1(9Z)) ; HMDB00918",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000918",
    "description" : "Ce(18:1(9Z)), also known as ce(18:1) or ce(18:1n9/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:1(9Z)) exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Ce(18:1(9Z)) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:1(9Z)) is primarily located in the membrane (predicted from logP), myelin sheath and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(18:2(9Z,12Z)) ; HMDB0000610",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000610",
    "description" : "Ce(18:2(9Z,12Z)), also known as ce(18:2) or ce(18:2n6/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(18:2(9Z,12Z)) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(18:2(9Z,12Z)) ; HMDB00610",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000610",
    "description" : "Ce(18:2(9Z,12Z)), also known as ce(18:2) or ce(18:2n6/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(18:2(9Z,12Z)) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(18:3(9Z,12Z,15Z)) ; HMDB0010370",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010370",
    "description" : "Ce(18:3(9Z,12Z,15Z)), also known as cholesterol linolenate or ce(18:3), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(18:3(9Z,12Z,15Z)) ; HMDB10370",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010370",
    "description" : "Ce(18:3(9Z,12Z,15Z)), also known as cholesterol linolenate or ce(18:3), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(20:3(8Z,11Z,14Z)) ; HMDB0006736",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006736",
    "description" : "Ce(20:3(8Z,11Z,14Z)), also known as 20:3 cholesterol ester or ce(20:3), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(20:3(8Z,11Z,14Z)) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(20:3(8Z,11Z,14Z)) ; HMDB06736",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006736",
    "description" : "Ce(20:3(8Z,11Z,14Z)), also known as 20:3 cholesterol ester or ce(20:3), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(20:3(8Z,11Z,14Z)) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(20:4(5Z,8Z,11Z,14Z)) ; HMDB0006726",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006726",
    "description" : "Ce(20:4(5Z,8Z,11Z,14Z)), also known as cholesterol arachidonate or 20:4 cholesterol ester, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(20:4(5Z,8Z,11Z,14Z)) has been primarily detected in blood. Within the cell, ce(20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "CE(20:4(5Z,8Z,11Z,14Z)) ; HMDB06726",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006726",
    "description" : "Ce(20:4(5Z,8Z,11Z,14Z)), also known as cholesterol arachidonate or 20:4 cholesterol ester, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(20:4(5Z,8Z,11Z,14Z)) has been primarily detected in blood. Within the cell, ce(20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "CE(20:5(5Z,8Z,11Z,14Z,17Z) ; HMDB0006731",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006731",
    "description" : "Ce(20:5(5Z,8Z,11Z,14Z,17Z), also known as 20:5 cholesterol ester or cholesteryl eicosapentaenoate, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(20:5(5Z,8Z,11Z,14Z,17Z) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(20:5(5Z,8Z,11Z,14Z,17Z) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(20:5(5Z,8Z,11Z,14Z,17Z) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(20:5(5Z,8Z,11Z,14Z,17Z) ; HMDB06731",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006731",
    "description" : "Ce(20:5(5Z,8Z,11Z,14Z,17Z), also known as 20:5 cholesterol ester or cholesteryl eicosapentaenoate, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(20:5(5Z,8Z,11Z,14Z,17Z) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(20:5(5Z,8Z,11Z,14Z,17Z) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(20:5(5Z,8Z,11Z,14Z,17Z) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(22:4(7Z,10Z,13Z,16Z)) ; HMDB0006729",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006729",
    "description" : "Ce(22:4(7Z,10Z,13Z,16Z)), also known as cholesteryl 1-adrenoic acid or 22:4 cholesterol ester, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(22:4(7Z,10Z,13Z,16Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(22:4(7Z,10Z,13Z,16Z)) has been found in human hepatic tissue tissue, and has also been primarily detected in urine. Within the cell, ce(22:4(7Z,10Z,13Z,16Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(22:4(7Z,10Z,13Z,16Z)) ; HMDB06729",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006729",
    "description" : "Ce(22:4(7Z,10Z,13Z,16Z)), also known as cholesteryl 1-adrenoic acid or 22:4 cholesterol ester, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(22:4(7Z,10Z,13Z,16Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(22:4(7Z,10Z,13Z,16Z)) has been found in human hepatic tissue tissue, and has also been primarily detected in urine. Within the cell, ce(22:4(7Z,10Z,13Z,16Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(22:5(7Z,10Z,13Z,16Z,19Z)) ; HMDB0010375",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010375",
    "description" : "Ce(22:5(7Z,10Z,13Z,16Z,19Z)), also known as cholesteryl 1-docosapentaenoate or ce(22:5/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(22:5(7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(22:5(7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(22:5(7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(22:5(7Z,10Z,13Z,16Z,19Z)) ; HMDB10375",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010375",
    "description" : "Ce(22:5(7Z,10Z,13Z,16Z,19Z)), also known as cholesteryl 1-docosapentaenoate or ce(22:5/0:0), belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(22:5(7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(22:5(7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(22:5(7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0006733",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006733",
    "description" : "Ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as cholesteryl docosahexaenoate or 22:6 cholesterol ester, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB06733",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006733",
    "description" : "Ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as cholesteryl docosahexaenoate or 22:6 cholesterol ester, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, ce(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Cer(d18:1/24:1(15Z)) ; HMDB0004953",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004953",
    "description" : "Cer(D18:1/24:1(15Z)), also known as C24:1 cer or N-nervonylsphingosine, belongs to the class of organic compounds known as ceramides. These are lipid molecules containing a sphingosine in which the amine group is linked to a fatty acid. Thus, cer(D18:1/24:1(15Z)) is considered to be a ceramide lipid molecule. Cer(D18:1/24:1(15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/24:1(15Z)) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/24:1(15Z)) can be found anywhere throughout the human cell, such as in endosome, cytoplasm, mitochondria, and membrane (predicted from logP). Cer(D18:1/24:1(15Z)) can be biosynthesized from (15Z)-tetracosenoic acid.",
    "id" : null
  }, {
    "name" : "Cer(d18:1/24:1(15Z)) ; HMDB04953",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004953",
    "description" : "Cer(D18:1/24:1(15Z)), also known as C24:1 cer or N-nervonylsphingosine, belongs to the class of organic compounds known as ceramides. These are lipid molecules containing a sphingosine in which the amine group is linked to a fatty acid. Thus, cer(D18:1/24:1(15Z)) is considered to be a ceramide lipid molecule. Cer(D18:1/24:1(15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/24:1(15Z)) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/24:1(15Z)) can be found anywhere throughout the human cell, such as in endosome, cytoplasm, mitochondria, and membrane (predicted from logP). Cer(D18:1/24:1(15Z)) can be biosynthesized from (15Z)-tetracosenoic acid.",
    "id" : null
  }, {
    "name" : "Ceramide (d18:1/16:0) ; HMDB0004949",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004949",
    "description" : "Cer(D18:1/16:0), also known as C16 cer or nfa(C16)cer, belongs to the class of organic compounds known as long-chain ceramides. These are ceramides bearing a long chain fatty acid. Thus, cer(D18:1/16:0) is considered to be a ceramide lipid molecule. Cer(D18:1/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/16:0) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/16:0) can be found anywhere throughout the human cell, such as in cytoplasm, intracellular membrane, membrane (predicted from logP), and myelin sheath. Cer(D18:1/16:0) can be biosynthesized from hexadecanoic acid.",
    "id" : null
  }, {
    "name" : "Ceramide (d18:1/16:0) ; HMDB04949",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004949",
    "description" : "Cer(D18:1/16:0), also known as C16 cer or nfa(C16)cer, belongs to the class of organic compounds known as long-chain ceramides. These are ceramides bearing a long chain fatty acid. Thus, cer(D18:1/16:0) is considered to be a ceramide lipid molecule. Cer(D18:1/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/16:0) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/16:0) can be found anywhere throughout the human cell, such as in cytoplasm, intracellular membrane, membrane (predicted from logP), and myelin sheath. Cer(D18:1/16:0) can be biosynthesized from hexadecanoic acid.",
    "id" : null
  }, {
    "name" : "Ceramide (d18:1/22:0) ; HMDB0004952",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004952",
    "description" : "Cer(D18:1/22:0), also known as C22 cer or ceramide, belongs to the class of organic compounds known as ceramides. These are lipid molecules containing a sphingosine in which the amine group is linked to a fatty acid. Thus, cer(D18:1/22:0) is considered to be a ceramide lipid molecule. Cer(D18:1/22:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/22:0) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/22:0) can be found anywhere throughout the human cell, such as in myelin sheath, endosome, cytoplasm, and intracellular membrane. Cer(D18:1/22:0) can be biosynthesized from docosanoic acid.",
    "id" : null
  }, {
    "name" : "Ceramide (d18:1/22:0) ; HMDB04952",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004952",
    "description" : "Cer(D18:1/22:0), also known as C22 cer or ceramide, belongs to the class of organic compounds known as ceramides. These are lipid molecules containing a sphingosine in which the amine group is linked to a fatty acid. Thus, cer(D18:1/22:0) is considered to be a ceramide lipid molecule. Cer(D18:1/22:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/22:0) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/22:0) can be found anywhere throughout the human cell, such as in myelin sheath, endosome, cytoplasm, and intracellular membrane. Cer(D18:1/22:0) can be biosynthesized from docosanoic acid.",
    "id" : null
  }, {
    "name" : "Ceramide (d18:1/24:0) ; HMDB0004956",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004956",
    "description" : "Cer(D18:1/24:0), also known as C24 cer or ceramide, belongs to the class of organic compounds known as ceramides. These are lipid molecules containing a sphingosine in which the amine group is linked to a fatty acid. Thus, cer(D18:1/24:0) is considered to be a ceramide lipid molecule. Cer(D18:1/24:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/24:0) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/24:0) can be found anywhere throughout the human cell, such as in intracellular membrane, cytoplasm, mitochondria, and endosome. Cer(D18:1/24:0) can be biosynthesized from tetracosanoic acid.",
    "id" : null
  }, {
    "name" : "Ceramide (d18:1/24:0) ; HMDB04956",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004956",
    "description" : "Cer(D18:1/24:0), also known as C24 cer or ceramide, belongs to the class of organic compounds known as ceramides. These are lipid molecules containing a sphingosine in which the amine group is linked to a fatty acid. Thus, cer(D18:1/24:0) is considered to be a ceramide lipid molecule. Cer(D18:1/24:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. Cer(D18:1/24:0) has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and blood. Cer(D18:1/24:0) can be found anywhere throughout the human cell, such as in intracellular membrane, cytoplasm, mitochondria, and endosome. Cer(D18:1/24:0) can be biosynthesized from tetracosanoic acid.",
    "id" : null
  }, {
    "name" : "Chenodeoxycholic acid ; HMDB0000518",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000518",
    "description" : "Chenodeoxycholic acid, also known as chenodeoxycholate or chenix, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Chenodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Chenodeoxycholic acid has been found in human hepatic tissue and liver tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, chenodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Chenodeoxycholic acid can be biosynthesized from chenodeoxycholoyl-CoA and cholic acid; which is mediated by the enzyme bile acyl-CoA synthetase. In humans, chenodeoxycholic acid is involved in bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, the cerebrotendinous xanthomatosis (CTX) pathway, and congenital bile acid synthesis defect type III pathway. Chenodeoxycholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Chenodeoxycholic acid ; HMDB00518",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000518",
    "description" : "Chenodeoxycholic acid, also known as chenodeoxycholate or chenix, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Chenodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Chenodeoxycholic acid has been found in human hepatic tissue and liver tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, chenodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Chenodeoxycholic acid can be biosynthesized from chenodeoxycholoyl-CoA and cholic acid; which is mediated by the enzyme bile acyl-CoA synthetase. In humans, chenodeoxycholic acid is involved in bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, the cerebrotendinous xanthomatosis (CTX) pathway, and congenital bile acid synthesis defect type III pathway. Chenodeoxycholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Chenodeoxycholic acid glycine conjugate ; HMDB0000637",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000637",
    "description" : "Chenodeoxycholic acid glycine conjugate, also known as (23R)-hydroxychenodeoxycholylglycine or 12-deoxycholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Chenodeoxycholic acid glycine conjugate is considered to be a practically insoluble (in water) and relatively neutral molecule. Chenodeoxycholic acid glycine conjugate has been found in human hepatic tissue and prostate tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, chenodeoxycholic acid glycine conjugate is primarily located in the membrane (predicted from logP) and cytoplasm. Chenodeoxycholic acid glycine conjugate and glycocholic acid can be biosynthesized from chenodeoxycholoyl-CoA and glycine through its interaction with the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, chenodeoxycholic acid glycine conjugate is involved in bile acid biosynthesis pathway, the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, and congenital bile acid synthesis defect type II pathway. Chenodeoxycholic acid glycine conjugate is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, the familial hypercholanemia (fhca) pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Chenodeoxycholic acid glycine conjugate ; HMDB00637",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000637",
    "description" : "Chenodeoxycholic acid glycine conjugate, also known as (23R)-hydroxychenodeoxycholylglycine or 12-deoxycholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Chenodeoxycholic acid glycine conjugate is considered to be a practically insoluble (in water) and relatively neutral molecule. Chenodeoxycholic acid glycine conjugate has been found in human hepatic tissue and prostate tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, chenodeoxycholic acid glycine conjugate is primarily located in the membrane (predicted from logP) and cytoplasm. Chenodeoxycholic acid glycine conjugate and glycocholic acid can be biosynthesized from chenodeoxycholoyl-CoA and glycine through its interaction with the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, chenodeoxycholic acid glycine conjugate is involved in bile acid biosynthesis pathway, the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, and congenital bile acid synthesis defect type II pathway. Chenodeoxycholic acid glycine conjugate is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, the familial hypercholanemia (fhca) pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Cholestenone ; HMDB0000921",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000921",
    "description" : "Cholestenone belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. Thus, cholestenone is considered to be a sterol lipid molecule. Cholestenone exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cholestenone has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, cholestenone is primarily located in the membrane (predicted from logP) and cytoplasm. Cholestenone is also a parent compound for other transformation products, including but not limited to, 3-ketocholest-4-en-26-al, 26-hydroxycholest-4-en-3-one, and 7alpha,25-dihydroxy-4-cholesten-3-one.",
    "id" : null
  }, {
    "name" : "Cholesterol ; HMDB0000067",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000067",
    "description" : "Cholesterol, also known as cholesterin or cordulan, belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. Thus, cholesterol is considered to be a sterol lipid molecule. Cholesterol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cholesterol has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, cerebrospinal fluid, and bile. Cholesterol can be found anywhere throughout the human cell, such as in lysosome, cytoplasm, membrane (predicted from logP), and endoplasmic reticulum. Cholesterol participates in a number of enzymatic reactions. In particular, Cholesterol can be converted into 22b-hydroxycholesterol through its interaction with the enzyme cholesterol side-chain cleavage enzyme, mitochondrial. Furthermore, Cholesterol can be converted into 20alpha-hydroxycholesterol through its interaction with the enzyme cholesterol side-chain cleavage enzyme, mitochondrial. Furthermore, Cholesterol can be converted into 7a-hydroxycholesterol through its interaction with the enzyme cholesterol 7-alpha-monooxygenase. Finally, Cholesterol and palmitic acid can be biosynthesized from ce(22:2(13Z,16Z)) through the action of the enzyme lysosomal acid lipase/cholesteryl ester hydrolase. In humans, cholesterol is involved in bile acid biosynthesis pathway, steroid biosynthesis pathway, the lovastatin action pathway, and the zoledronate action pathway. Cholesterol is also involved in several metabolic disorders, some of which include the child syndrome pathway, adrenal hyperplasia type 5 or congenital adrenal hyperplasia due to 17 Alpha-hydroxylase deficiency, the apparent mineralocorticoid excess syndrome pathway, and the hypercholesterolemia pathway.",
    "id" : null
  }, {
    "name" : "Cholesterol ; HMDB00067",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000067",
    "description" : "Cholesterol, also known as cholesterin or cordulan, belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. Thus, cholesterol is considered to be a sterol lipid molecule. Cholesterol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cholesterol has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, cerebrospinal fluid, and bile. Cholesterol can be found anywhere throughout the human cell, such as in lysosome, cytoplasm, membrane (predicted from logP), and endoplasmic reticulum. Cholesterol participates in a number of enzymatic reactions. In particular, Cholesterol can be converted into 22b-hydroxycholesterol through its interaction with the enzyme cholesterol side-chain cleavage enzyme, mitochondrial. Furthermore, Cholesterol can be converted into 20alpha-hydroxycholesterol through its interaction with the enzyme cholesterol side-chain cleavage enzyme, mitochondrial. Furthermore, Cholesterol can be converted into 7a-hydroxycholesterol through its interaction with the enzyme cholesterol 7-alpha-monooxygenase. Finally, Cholesterol and palmitic acid can be biosynthesized from ce(22:2(13Z,16Z)) through the action of the enzyme lysosomal acid lipase/cholesteryl ester hydrolase. In humans, cholesterol is involved in bile acid biosynthesis pathway, steroid biosynthesis pathway, the lovastatin action pathway, and the zoledronate action pathway. Cholesterol is also involved in several metabolic disorders, some of which include the child syndrome pathway, adrenal hyperplasia type 5 or congenital adrenal hyperplasia due to 17 Alpha-hydroxylase deficiency, the apparent mineralocorticoid excess syndrome pathway, and the hypercholesterolemia pathway.",
    "id" : null
  }, {
    "name" : "Cholic acid ; HMDB0000619",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000619",
    "description" : "Cholic acid, also known as cholate or cholsaeure, belongs to the class of organic compounds known as trihydroxy bile acids, alcohols and derivatives. These are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Cholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cholic acid has been found throughout all human tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, cholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Cholic acid participates in a number of enzymatic reactions. In particular, Chenodeoxycholoyl-CoA and cholic acid can be converted into chenodeoxycholic acid; which is catalyzed by the enzyme bile acyl-CoA synthetase. In addition, Cholic acid can be biosynthesized from choloyl-CoA; which is mediated by the enzyme bile acyl-CoA synthetase. In humans, cholic acid is involved in the cerebrotendinous xanthomatosis (CTX) pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, and congenital bile acid synthesis defect type III pathway. Cholic acid is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway. Outside of the human body, cholic acid can be found in a number of food items such as ginkgo nuts, celeriac, lotus, and small-leaf linden. This makes cholic acid a potential biomarker for the consumption of these food products. Cholic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Cholic acid ; HMDB00619",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000619",
    "description" : "Cholic acid, also known as cholate or cholsaeure, belongs to the class of organic compounds known as trihydroxy bile acids, alcohols and derivatives. These are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Cholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cholic acid has been found throughout all human tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, cholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Cholic acid participates in a number of enzymatic reactions. In particular, Chenodeoxycholoyl-CoA and cholic acid can be converted into chenodeoxycholic acid; which is catalyzed by the enzyme bile acyl-CoA synthetase. In addition, Cholic acid can be biosynthesized from choloyl-CoA; which is mediated by the enzyme bile acyl-CoA synthetase. In humans, cholic acid is involved in the cerebrotendinous xanthomatosis (CTX) pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, and congenital bile acid synthesis defect type III pathway. Cholic acid is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway. Outside of the human body, cholic acid can be found in a number of food items such as ginkgo nuts, celeriac, lotus, and small-leaf linden. This makes cholic acid a potential biomarker for the consumption of these food products. Cholic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Choline ; HMDB0000097",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000097",
    "description" : "Choline, also known as bilineurine or choline ion, belongs to the class of organic compounds known as cholines. These are organic compounds containing a N,N,N-trimethylethanolammonium cation. Choline is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Choline exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Choline has been found throughout most human tissues, and has also been detected in most biofluids, including breast milk, urine, blood, and cerebrospinal fluid. Choline can be found anywhere throughout the human cell, such as in nucleus, myelin sheath, mitochondria, and endoplasmic reticulum. Choline exists in all eukaryotes, ranging from yeast to humans. Choline participates in a number of enzymatic reactions. In particular, Choline can be converted into betaine aldehyde; which is mediated by the enzyme choline dehydrogenase, mitochondrial. In addition, Choline can be converted into betaine; which is mediated by the enzyme choline dehydrogenase, mitochondrial. In humans, choline is involved in phosphatidylcholine biosynthesis PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) pathway, phosphatidylethanolamine biosynthesis pe(18:0/20:2(11Z,14Z)) pathway, phosphatidylethanolamine biosynthesis pe(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) pathway, and phosphatidylcholine biosynthesis PC(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) pathway. Choline is also involved in several metabolic disorders, some of which include glycine N-methyltransferase deficiency, the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, methionine adenosyltransferase deficiency, and S-adenosylhomocysteine (sah) hydrolase deficiency.",
    "id" : null
  }, {
    "name" : "Choline ; HMDB00097",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000097",
    "description" : "Choline, also known as bilineurine or choline ion, belongs to the class of organic compounds known as cholines. These are organic compounds containing a N,N,N-trimethylethanolammonium cation. Choline is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Choline exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Choline has been found throughout most human tissues, and has also been detected in most biofluids, including breast milk, urine, blood, and cerebrospinal fluid. Choline can be found anywhere throughout the human cell, such as in nucleus, myelin sheath, mitochondria, and endoplasmic reticulum. Choline exists in all eukaryotes, ranging from yeast to humans. Choline participates in a number of enzymatic reactions. In particular, Choline can be converted into betaine aldehyde; which is mediated by the enzyme choline dehydrogenase, mitochondrial. In addition, Choline can be converted into betaine; which is mediated by the enzyme choline dehydrogenase, mitochondrial. In humans, choline is involved in phosphatidylcholine biosynthesis PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) pathway, phosphatidylethanolamine biosynthesis pe(18:0/20:2(11Z,14Z)) pathway, phosphatidylethanolamine biosynthesis pe(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) pathway, and phosphatidylcholine biosynthesis PC(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) pathway. Choline is also involved in several metabolic disorders, some of which include glycine N-methyltransferase deficiency, the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, methionine adenosyltransferase deficiency, and S-adenosylhomocysteine (sah) hydrolase deficiency.",
    "id" : null
  }, {
    "name" : "Cinnamoylglycine ; HMDB0011621",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011621",
    "description" : "Cinnamoylglycine belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Cinnamoylglycine is considered to be a practically insoluble (in water) and relatively neutral molecule. Cinnamoylglycine has been primarily detected in blood.",
    "id" : null
  }, {
    "name" : "Cinnamoylglycine ; HMDB11621",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011621",
    "description" : "Cinnamoylglycine belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Cinnamoylglycine is considered to be a practically insoluble (in water) and relatively neutral molecule. Cinnamoylglycine has been primarily detected in blood.",
    "id" : null
  }, {
    "name" : "cis-5-Tetradecenoylcarnitine ; HMDB0002014",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002014",
    "description" : "cis-5-Tetradecenoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, cis-5-tetradecenoylcarnitine is considered to be a fatty ester lipid molecule. cis-5-Tetradecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. cis-5-Tetradecenoylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, cis-5-tetradecenoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "cis-5-Tetradecenoylcarnitine ; HMDB02014",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002014",
    "description" : "cis-5-Tetradecenoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, cis-5-tetradecenoylcarnitine is considered to be a fatty ester lipid molecule. cis-5-Tetradecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. cis-5-Tetradecenoylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, cis-5-tetradecenoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "cis-Aconitic acid ; HMDB0000072",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000072",
    "description" : "cis-Aconitic acid, also known as cis-aconitate or acid, acontic, belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. cis-Aconitic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). cis-Aconitic acid has been found in human prostate tissue, and has also been detected in most biofluids, including cerebrospinal fluid, urine, breast milk, and saliva. Within the cell, cis-aconitic acid is primarily located in the cytoplasm and mitochondria. cis-Aconitic acid exists in all eukaryotes, ranging from yeast to humans. cis-Aconitic acid participates in a number of enzymatic reactions. In particular, cis-Aconitic acid can be biosynthesized from citric acid; which is mediated by the enzyme aconitate hydratase, mitochondrial. In addition, cis-Aconitic acid can be converted into isocitric acid; which is catalyzed by the enzyme aconitate hydratase, mitochondrial. In humans, cis-aconitic acid is involved in the congenital lactic acidosis pathway, the oncogenic action OF fumarate pathway, the oncogenic action OF succinate pathway, and the oncogenic action OF 2-hydroxyglutarate pathway. cis-Aconitic acid is also involved in several metabolic disorders, some of which include the glutaminolysis and cancer pathway, mitochondrial complex II deficiency, fumarase deficiency, and 2-ketoglutarate dehydrogenase complex deficiency. cis-Aconitic acid is a very mild, musty, and nutty tasting compound that can be found in a number of food items such as barley, corn, red beetroot, and potato. This makes cis-aconitic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "cis-Aconitic acid ; HMDB00072",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000072",
    "description" : "cis-Aconitic acid, also known as cis-aconitate or acid, acontic, belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. cis-Aconitic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). cis-Aconitic acid has been found in human prostate tissue, and has also been detected in most biofluids, including cerebrospinal fluid, urine, breast milk, and saliva. Within the cell, cis-aconitic acid is primarily located in the cytoplasm and mitochondria. cis-Aconitic acid exists in all eukaryotes, ranging from yeast to humans. cis-Aconitic acid participates in a number of enzymatic reactions. In particular, cis-Aconitic acid can be biosynthesized from citric acid; which is mediated by the enzyme aconitate hydratase, mitochondrial. In addition, cis-Aconitic acid can be converted into isocitric acid; which is catalyzed by the enzyme aconitate hydratase, mitochondrial. In humans, cis-aconitic acid is involved in the congenital lactic acidosis pathway, the oncogenic action OF fumarate pathway, the oncogenic action OF succinate pathway, and the oncogenic action OF 2-hydroxyglutarate pathway. cis-Aconitic acid is also involved in several metabolic disorders, some of which include the glutaminolysis and cancer pathway, mitochondrial complex II deficiency, fumarase deficiency, and 2-ketoglutarate dehydrogenase complex deficiency. cis-Aconitic acid is a very mild, musty, and nutty tasting compound that can be found in a number of food items such as barley, corn, red beetroot, and potato. This makes cis-aconitic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Citramalic acid ; HMDB0000426",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000426",
    "description" : "2-Hydroxy-2-methylbutanedioic acid, also known as citramalate or alpha-hydroxypyrotartaric acid, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. 2-Hydroxy-2-methylbutanedioic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 2-Hydroxy-2-methylbutanedioic acid has been primarily detected in saliva, feces, urine, and blood. Within the cell, 2-hydroxy-2-methylbutanedioic acid is primarily located in the cytoplasm and adiposome. 2-Hydroxy-2-methylbutanedioic acid exists in all eukaryotes, ranging from yeast to humans. 2-Hydroxy-2-methylbutanedioic acid can be biosynthesized from succinic acid. Outside of the human body, 2-hydroxy-2-methylbutanedioic acid can be found in pomes. This makes 2-hydroxy-2-methylbutanedioic acid a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Citric acid ; HMDB0000094",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000094",
    "description" : "Citric acid, also known as citrate or citronensaeure, belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. Citric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Citric acid has been found throughout all human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, saliva, and breast milk. Within the cell, citric acid is primarily located in the cytoplasm and mitochondria. Citric acid exists in all eukaryotes, ranging from yeast to humans. Citric acid participates in a number of enzymatic reactions. In particular, Citric acid can be biosynthesized from oxalacetic acid through the action of the enzyme citrate synthase, mitochondrial. In addition, Citric acid can be converted into cis-aconitic acid through the action of the enzyme aconitate hydratase, mitochondrial. In humans, citric acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the citric Acid cycle pathway, the oncogenic action OF fumarate pathway, and the congenital lactic acidosis pathway. Citric acid is also involved in several metabolic disorders, some of which include the oncogenic action OF D-2-hydroxyglutarate in hydroxygluaricaciduria pathway, pyruvate dehydrogenase deficiency (e2), the oncogenic action OF L-2-hydroxyglutarate in hydroxygluaricaciduria pathway, and fumarase deficiency. Outside of the human body, citric acid can be found in a number of food items such as opium poppy, red raspberry, devilfish, and bamboo shoots. This makes citric acid a potential biomarker for the consumption of these food products. Citric acid has been found to be associated with several diseases known as rhabdomyolysis and deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome; citric acid has also been linked to several inborn metabolic disorders including maple syrup urine disease, primary hypomagnesemia, and tyrosinemia I.",
    "id" : null
  }, {
    "name" : "Citric acid ; HMDB00094",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000094",
    "description" : "Citric acid, also known as citrate or citronensaeure, belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. Citric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Citric acid has been found throughout all human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, saliva, and breast milk. Within the cell, citric acid is primarily located in the cytoplasm and mitochondria. Citric acid exists in all eukaryotes, ranging from yeast to humans. Citric acid participates in a number of enzymatic reactions. In particular, Citric acid can be biosynthesized from oxalacetic acid through the action of the enzyme citrate synthase, mitochondrial. In addition, Citric acid can be converted into cis-aconitic acid through the action of the enzyme aconitate hydratase, mitochondrial. In humans, citric acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the citric Acid cycle pathway, the oncogenic action OF fumarate pathway, and the congenital lactic acidosis pathway. Citric acid is also involved in several metabolic disorders, some of which include the oncogenic action OF D-2-hydroxyglutarate in hydroxygluaricaciduria pathway, pyruvate dehydrogenase deficiency (e2), the oncogenic action OF L-2-hydroxyglutarate in hydroxygluaricaciduria pathway, and fumarase deficiency. Outside of the human body, citric acid can be found in a number of food items such as opium poppy, red raspberry, devilfish, and bamboo shoots. This makes citric acid a potential biomarker for the consumption of these food products. Citric acid has been found to be associated with several diseases known as rhabdomyolysis and deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome; citric acid has also been linked to several inborn metabolic disorders including maple syrup urine disease, primary hypomagnesemia, and tyrosinemia I.",
    "id" : null
  }, {
    "name" : "Citrulline ; HMDB0000904",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000904",
    "description" : "Citrulline, also known as Cit or -ureidonorvaline, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Citrulline is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Citrulline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Citrulline has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, blood, feces, and urine. Within the cell, citrulline is primarily located in the mitochondria, myelin sheath and cytoplasm. Citrulline exists in all eukaryotes, ranging from yeast to humans. Citrulline participates in a number of enzymatic reactions. In particular, Citrulline and L-aspartic acid can be converted into argininosuccinic acid; which is catalyzed by the enzyme argininosuccinate synthase. Furthermore, Citrulline can be biosynthesized from carbamoyl phosphate and ornithine through the action of the enzyme ornithine carbamoyltransferase, mitochondrial. Furthermore, Citrulline can be biosynthesized from carbamoyl phosphate and ornithine; which is mediated by the enzyme ornithine carbamoyltransferase, mitochondrial. Finally, Citrulline and L-aspartic acid can be converted into argininosuccinic acid; which is catalyzed by the enzyme argininosuccinate synthase. In humans, citrulline is involved in the aspartate metabolism pathway, the urea cycle pathway, and the arginine and proline metabolism pathway. Citrulline is also involved in several metabolic disorders, some of which include the argininosuccinic aciduria pathway, creatine deficiency, guanidinoacetate methyltransferase deficiency, the hypoacetylaspartia pathway, and the hyperprolinemia type II pathway. Citrulline is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Citrulline ; HMDB00904",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000904",
    "description" : "Citrulline, also known as Cit or -ureidonorvaline, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Citrulline is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Citrulline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Citrulline has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, blood, feces, and urine. Within the cell, citrulline is primarily located in the mitochondria, myelin sheath and cytoplasm. Citrulline exists in all eukaryotes, ranging from yeast to humans. Citrulline participates in a number of enzymatic reactions. In particular, Citrulline and L-aspartic acid can be converted into argininosuccinic acid; which is catalyzed by the enzyme argininosuccinate synthase. Furthermore, Citrulline can be biosynthesized from carbamoyl phosphate and ornithine through the action of the enzyme ornithine carbamoyltransferase, mitochondrial. Furthermore, Citrulline can be biosynthesized from carbamoyl phosphate and ornithine; which is mediated by the enzyme ornithine carbamoyltransferase, mitochondrial. Finally, Citrulline and L-aspartic acid can be converted into argininosuccinic acid; which is catalyzed by the enzyme argininosuccinate synthase. In humans, citrulline is involved in the aspartate metabolism pathway, the urea cycle pathway, and the arginine and proline metabolism pathway. Citrulline is also involved in several metabolic disorders, some of which include the argininosuccinic aciduria pathway, creatine deficiency, guanidinoacetate methyltransferase deficiency, the hypoacetylaspartia pathway, and the hyperprolinemia type II pathway. Citrulline is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Corticosterone ; HMDB0001547",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001547",
    "description" : "Corticosterone, also known as 17-deoxycortisol or 11-b, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, corticosterone is considered to be a steroid lipid molecule. Corticosterone exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Corticosterone has been found throughout most human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, corticosterone is primarily located in the cytoplasm, membrane (predicted from logP), mitochondria and endoplasmic reticulum. Corticosterone participates in a number of enzymatic reactions. In particular, Corticosterone can be converted into 18-hydroxycorticosterone through its interaction with the enzyme cytochrome P450 11B1. In addition, Corticosterone can be biosynthesized from 11b-hydroxyprogesterone through its interaction with the enzyme steroid 21-hydroxylase. In humans, corticosterone is involved in the steroidogenesis pathway. Corticosterone is also involved in several metabolic disorders, some of which include 21-hydroxylase deficiency (cyp21), adrenal hyperplasia type 3 or congenital adrenal hyperplasia due to 21-hydroxylase deficiency, the apparent mineralocorticoid excess syndrome pathway, and 3-Beta-hydroxysteroid dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Corticosterone ; HMDB01547",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001547",
    "description" : "Corticosterone, also known as 17-deoxycortisol or 11-b, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, corticosterone is considered to be a steroid lipid molecule. Corticosterone exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Corticosterone has been found throughout most human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, corticosterone is primarily located in the cytoplasm, membrane (predicted from logP), mitochondria and endoplasmic reticulum. Corticosterone participates in a number of enzymatic reactions. In particular, Corticosterone can be converted into 18-hydroxycorticosterone through its interaction with the enzyme cytochrome P450 11B1. In addition, Corticosterone can be biosynthesized from 11b-hydroxyprogesterone through its interaction with the enzyme steroid 21-hydroxylase. In humans, corticosterone is involved in the steroidogenesis pathway. Corticosterone is also involved in several metabolic disorders, some of which include 21-hydroxylase deficiency (cyp21), adrenal hyperplasia type 3 or congenital adrenal hyperplasia due to 21-hydroxylase deficiency, the apparent mineralocorticoid excess syndrome pathway, and 3-Beta-hydroxysteroid dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Cortisol ; HMDB0000063",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000063",
    "description" : "Cortisol, also known as epicort or cortril, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, cortisol is considered to be a steroid lipid molecule. Cortisol is a drug which is used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. also used to treat endocrine (hormonal) disorders (adrenal insufficiency, addisons disease). it is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and crohn's disease. Cortisol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cortisol has been found throughout most human tissues, and has also been primarily detected in urine, saliva, blood, and cerebrospinal fluid. Within the cell, cortisol is primarily located in the cytoplasm, membrane (predicted from logP), mitochondria and endoplasmic reticulum. Cortisol participates in a number of enzymatic reactions. In particular, Cortisol can be biosynthesized from 21-deoxycortisol through the action of the enzyme steroid 21-hydroxylase. In addition, Cortisol can be biosynthesized from cortexolone through its interaction with the enzyme cytochrome P450 11B1. In humans, cortisol is involved in the corticotropin activation OF cortisol production pathway and the steroidogenesis pathway. Cortisol is also involved in several metabolic disorders, some of which include adrenal hyperplasia type 3 or congenital adrenal hyperplasia due to 21-hydroxylase deficiency, the congenital lipoid adrenal hyperplasia (clah) or lipoid cah pathway, 21-hydroxylase deficiency (cyp21), and 3-Beta-hydroxysteroid dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Cortisol ; HMDB00063",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000063",
    "description" : "Cortisol, also known as epicort or cortril, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, cortisol is considered to be a steroid lipid molecule. Cortisol is a drug which is used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. also used to treat endocrine (hormonal) disorders (adrenal insufficiency, addisons disease). it is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and crohn's disease. Cortisol exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cortisol has been found throughout most human tissues, and has also been primarily detected in urine, saliva, blood, and cerebrospinal fluid. Within the cell, cortisol is primarily located in the cytoplasm, membrane (predicted from logP), mitochondria and endoplasmic reticulum. Cortisol participates in a number of enzymatic reactions. In particular, Cortisol can be biosynthesized from 21-deoxycortisol through the action of the enzyme steroid 21-hydroxylase. In addition, Cortisol can be biosynthesized from cortexolone through its interaction with the enzyme cytochrome P450 11B1. In humans, cortisol is involved in the corticotropin activation OF cortisol production pathway and the steroidogenesis pathway. Cortisol is also involved in several metabolic disorders, some of which include adrenal hyperplasia type 3 or congenital adrenal hyperplasia due to 21-hydroxylase deficiency, the congenital lipoid adrenal hyperplasia (clah) or lipoid cah pathway, 21-hydroxylase deficiency (cyp21), and 3-Beta-hydroxysteroid dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Cortisone ; HMDB0002802",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002802",
    "description" : "Cortisone, also known as cortef or locoid, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, cortisone is considered to be a steroid lipid molecule. Cortisone exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cortisone has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, cortisone is primarily located in the membrane (predicted from logP), endoplasmic reticulum, myelin sheath and cytoplasm. Cortisone participates in a number of enzymatic reactions. In particular, Cortisone can be biosynthesized from 17a,21-dihydroxy-5b-pregnane-3,11,20-trione through its interaction with the enzyme 3-oxo-5-beta-steroid 4-dehydrogenase. In addition, Cortisone, nadph, and hydrogen ion can be biosynthesized from cortisol and nadp through the action of the enzyme corticosteroid 11-beta-dehydrogenase isozyme 2. In humans, cortisone is involved in the steroidogenesis pathway. Cortisone is also involved in several metabolic disorders, some of which include 21-hydroxylase deficiency (cyp21), adrenal hyperplasia type 5 or congenital adrenal hyperplasia due to 17 Alpha-hydroxylase deficiency, corticosterone methyl oxidase I deficiency (cmo I), and adrenal hyperplasia type 3 or congenital adrenal hyperplasia due to 21-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Cortisone ; HMDB02802",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002802",
    "description" : "Cortisone, also known as cortef or locoid, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, cortisone is considered to be a steroid lipid molecule. Cortisone exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Cortisone has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, cortisone is primarily located in the membrane (predicted from logP), endoplasmic reticulum, myelin sheath and cytoplasm. Cortisone participates in a number of enzymatic reactions. In particular, Cortisone can be biosynthesized from 17a,21-dihydroxy-5b-pregnane-3,11,20-trione through its interaction with the enzyme 3-oxo-5-beta-steroid 4-dehydrogenase. In addition, Cortisone, nadph, and hydrogen ion can be biosynthesized from cortisol and nadp through the action of the enzyme corticosteroid 11-beta-dehydrogenase isozyme 2. In humans, cortisone is involved in the steroidogenesis pathway. Cortisone is also involved in several metabolic disorders, some of which include 21-hydroxylase deficiency (cyp21), adrenal hyperplasia type 5 or congenital adrenal hyperplasia due to 17 Alpha-hydroxylase deficiency, corticosterone methyl oxidase I deficiency (cmo I), and adrenal hyperplasia type 3 or congenital adrenal hyperplasia due to 21-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Cotinine ; HMDB0001046",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001046",
    "description" : "Cotinine, also known as (S)-cotinine or cotininum, belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. Cotinine exists as a solid, soluble (in water), and a strong basic compound (based on its pKa). Cotinine has been found throughout most human tissues, and has also been primarily detected in urine, saliva, blood, and cerebrospinal fluid. Within the cell, cotinine is primarily located in the cytoplasm. Cotinine participates in a number of enzymatic reactions. In particular, Cotinine can be biosynthesized from nicotine imine; which is mediated by the enzyme aldehyde oxidase. In addition, Cotinine can be converted into hydroxycotinine through the action of the enzyme cytochrome P450 2A6. In humans, cotinine is involved in the nicotine action pathway and the nicotine metabolism pathway. Outside of the human body, cotinine can be found in a number of food items such as onion-family vegetables, rowanberry, ginger, and swamp cabbage. This makes cotinine a potential biomarker for the consumption of these food products. Cotinine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Cotinine ; HMDB01046",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001046",
    "description" : "Cotinine, also known as (S)-cotinine or cotininum, belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. Cotinine exists as a solid, soluble (in water), and a strong basic compound (based on its pKa). Cotinine has been found throughout most human tissues, and has also been primarily detected in urine, saliva, blood, and cerebrospinal fluid. Within the cell, cotinine is primarily located in the cytoplasm. Cotinine participates in a number of enzymatic reactions. In particular, Cotinine can be biosynthesized from nicotine imine; which is mediated by the enzyme aldehyde oxidase. In addition, Cotinine can be converted into hydroxycotinine through the action of the enzyme cytochrome P450 2A6. In humans, cotinine is involved in the nicotine action pathway and the nicotine metabolism pathway. Outside of the human body, cotinine can be found in a number of food items such as onion-family vegetables, rowanberry, ginger, and swamp cabbage. This makes cotinine a potential biomarker for the consumption of these food products. Cotinine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Creatine ; HMDB0000064",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000064",
    "description" : "Creatine, also known as cosmocair C 100 or krebiozon, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Creatine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Creatine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Creatine has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, blood, saliva, and breast milk. Within the cell, creatine is primarily located in the cytoplasm, mitochondria and myelin sheath. Creatine participates in a number of enzymatic reactions. In particular, S-Adenosylmethionine and creatine can be biosynthesized from guanidoacetic acid and S-adenosylhomocysteine; which is catalyzed by the enzyme guanidinoacetate N-methyltransferase. In addition, S-Adenosylhomocysteine and creatine can be biosynthesized from S-adenosylmethionine and guanidoacetic acid through the action of the enzyme guanidinoacetate N-methyltransferase. In humans, creatine is involved in the glycine and serine metabolism pathway and the arginine and proline metabolism pathway. Creatine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, creatine deficiency, guanidinoacetate methyltransferase deficiency, L-arginine:glycine amidinotransferase deficiency, and the hyperprolinemia type I pathway. Creatine is a potentially toxic compound. Creatine has been found to be associated with several diseases known as rhabdomyolysis, cirrhosis, cerebral creatine deficiency syndrome 3, and schizophrenia; creatine has also been linked to the inborn metabolic disorders including hypermethioninemia.",
    "id" : null
  }, {
    "name" : "Creatine ; HMDB00064",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000064",
    "description" : "Creatine, also known as cosmocair C 100 or krebiozon, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Creatine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Creatine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Creatine has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, blood, saliva, and breast milk. Within the cell, creatine is primarily located in the cytoplasm, mitochondria and myelin sheath. Creatine participates in a number of enzymatic reactions. In particular, S-Adenosylmethionine and creatine can be biosynthesized from guanidoacetic acid and S-adenosylhomocysteine; which is catalyzed by the enzyme guanidinoacetate N-methyltransferase. In addition, S-Adenosylhomocysteine and creatine can be biosynthesized from S-adenosylmethionine and guanidoacetic acid through the action of the enzyme guanidinoacetate N-methyltransferase. In humans, creatine is involved in the glycine and serine metabolism pathway and the arginine and proline metabolism pathway. Creatine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, creatine deficiency, guanidinoacetate methyltransferase deficiency, L-arginine:glycine amidinotransferase deficiency, and the hyperprolinemia type I pathway. Creatine is a potentially toxic compound. Creatine has been found to be associated with several diseases known as rhabdomyolysis, cirrhosis, cerebral creatine deficiency syndrome 3, and schizophrenia; creatine has also been linked to the inborn metabolic disorders including hypermethioninemia.",
    "id" : null
  }, {
    "name" : "Creatinine ; HMDB0000562",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000562",
    "description" : "Creatinine, also known as krebiozen, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Creatinine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Creatinine has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, blood, urine, and feces. Within the cell, creatinine is primarily located in the cytoplasm. Creatinine can be biosynthesized from creatine. Outside of the human body, creatinine can be found in a number of food items such as annual wild rice, pepper (c. frutescens), prunus (cherry, plum), and kumquat. This makes creatinine a potential biomarker for the consumption of these food products. Creatinine has been found to be associated with several diseases known as hypoparathyroidism-retardation-dysmorphism syndrome, familial partial lipodystrophy, long-chain fatty acids, defect in transport of, and lipodystrophy, congenital generalized; creatinine has also been linked to the inborn metabolic disorders including phenylketonuria.",
    "id" : null
  }, {
    "name" : "Creatinine ; HMDB00562",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000562",
    "description" : "Creatinine, also known as krebiozen, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Creatinine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Creatinine has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, blood, urine, and feces. Within the cell, creatinine is primarily located in the cytoplasm. Creatinine can be biosynthesized from creatine. Outside of the human body, creatinine can be found in a number of food items such as annual wild rice, pepper (c. frutescens), prunus (cherry, plum), and kumquat. This makes creatinine a potential biomarker for the consumption of these food products. Creatinine has been found to be associated with several diseases known as hypoparathyroidism-retardation-dysmorphism syndrome, familial partial lipodystrophy, long-chain fatty acids, defect in transport of, and lipodystrophy, congenital generalized; creatinine has also been linked to the inborn metabolic disorders including phenylketonuria.",
    "id" : null
  }, {
    "name" : "Cysteineglutathione disulfide ; HMDB0000656",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000656",
    "description" : "Cysteineglutathione disulfide, also known as cyssg or nereithione, belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Cysteineglutathione disulfide exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Cysteineglutathione disulfide has been primarily detected in saliva. Within the cell, cysteineglutathione disulfide is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Cysteinylglycine ; HMDB0000078",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000078",
    "description" : "L-Cysteinylglycine, also known as cys-gly or CG, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. L-Cysteinylglycine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). L-Cysteinylglycine has been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, L-cysteinylglycine is primarily located in the cytoplasm. L-Cysteinylglycine exists in all eukaryotes, ranging from yeast to humans. In humans, L-cysteinylglycine is involved in the glutathione metabolism pathway. L-Cysteinylglycine is also involved in several metabolic disorders, some of which include Gamma-glutamyl-transpeptidase deficiency, glutathione synthetase deficiency, 5-oxoprolinase deficiency, and Gamma-glutamyltransferase deficiency. L-Cysteinylglycine has been linked to the inborn metabolic disorders including phenylketonuria.",
    "id" : null
  }, {
    "name" : "Cytidine ; HMDB0000089",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000089",
    "description" : "Cytarabine, also known as ara-C or cytosar-u, belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. Cytarabine is a drug which is used for the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia. Cytarabine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Cytarabine has been detected in multiple biofluids, such as urine and blood. Within the cell, cytarabine is primarily located in the cytoplasm. Cytarabine can be biosynthesized from cytosine. Outside of the human body, cytarabine can be found in a number of food items such as guava, root vegetables, sweet orange, and herbs and spices. This makes cytarabine a potential biomarker for the consumption of these food products. Cytarabine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Cytosine ; HMDB0000630",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000630",
    "description" : "Cytosine, also known as C, belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Cytosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Cytosine has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and plasma. Cytosine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, cytosine can be found in a number of food items such as new zealand spinach, medlar, french plantain, and hickory nut. This makes cytosine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Cytosine ; HMDB00630",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000630",
    "description" : "Cytosine, also known as C, belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Cytosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Cytosine has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and plasma. Cytosine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, cytosine can be found in a number of food items such as new zealand spinach, medlar, french plantain, and hickory nut. This makes cytosine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "D-alpha-Aminobutyric acid ; HMDB0000650",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000650",
    "description" : ", also known as D-2-aminobutyrate, belongs to the class of organic compounds known as d-alpha-amino acids. These are alpha amino acids which have the D-configuration of the alpha-carbon atom. Thus, is considered to be a fatty acid lipid molecule. is soluble (in water) and a moderately acidic compound (based on its pKa). has been primarily detected in saliva, feces, urine, and blood. Within the cell, is primarily located in the cytoplasm. Outside of the human body, can be found in a number of food items such as common pea, pulses, green bean, and nuts. This makes a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "D-alpha-Aminobutyric acid ; HMDB00650",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000650",
    "description" : ", also known as D-2-aminobutyrate, belongs to the class of organic compounds known as d-alpha-amino acids. These are alpha amino acids which have the D-configuration of the alpha-carbon atom. Thus, is considered to be a fatty acid lipid molecule. is soluble (in water) and a moderately acidic compound (based on its pKa). has been primarily detected in saliva, feces, urine, and blood. Within the cell, is primarily located in the cytoplasm. Outside of the human body, can be found in a number of food items such as common pea, pulses, green bean, and nuts. This makes a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "D-Glucose ; HMDB0000122",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000122",
    "description" : "D-Glucose, also known as dextrose or D-GLC, belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. D-Glucose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). D-Glucose has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, saliva, blood, and urine. Within the cell, D-glucose is primarily located in the lysosome, endoplasmic reticulum, golgi and myelin sheath. D-Glucose exists in all eukaryotes, ranging from yeast to humans. D-Glucose participates in a number of enzymatic reactions. In particular, D-Glucose can be biosynthesized from glucose 1-phosphate through the action of the enzyme glucose-6-phosphatase. Furthermore, D-Glucose and uridine diphosphategalactose can be converted into uridine 5'-diphosphate and Alpha-lactose through the action of the enzyme lactose synthase. Furthermore, Ceramide (D18:1/18:0) and D-glucose can be biosynthesized from glucosylceramide and water; which is catalyzed by the enzyme glucosylceramidase. Finally, D-Glucose can be converted into glucose 6-phosphate; which is mediated by the enzyme hexokinase-2. In humans, D-glucose is involved in the metachromatic leukodystrophy (MLD) pathway, the triosephosphate isomerase pathway, the gliclazide action pathway, and the pancreas function pathway. D-Glucose is also involved in several metabolic disorders, some of which include the congenital disorder OF glycosylation CDG-iid pathway, the transfer OF acetyl groups into mitochondria pathway, the gaucher disease pathway, and the fanconi-bickel syndrome pathway. D-Glucose is a potentially toxic compound. D-Glucose has been found to be associated with several diseases known as hyperinsulinemic hypoglycemia, familial, 1, HHF1 and diabetes mellitus type 2; d-glucose has also been linked to several inborn metabolic disorders including 3-methyl-crotonyl-glycinuria, primary hypomagnesemia, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.",
    "id" : null
  }, {
    "name" : "D-Glucose ; HMDB00122",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000122",
    "description" : "D-Glucose, also known as dextrose or D-GLC, belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. D-Glucose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). D-Glucose has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, saliva, blood, and urine. Within the cell, D-glucose is primarily located in the lysosome, endoplasmic reticulum, golgi and myelin sheath. D-Glucose exists in all eukaryotes, ranging from yeast to humans. D-Glucose participates in a number of enzymatic reactions. In particular, D-Glucose can be biosynthesized from glucose 1-phosphate through the action of the enzyme glucose-6-phosphatase. Furthermore, D-Glucose and uridine diphosphategalactose can be converted into uridine 5'-diphosphate and Alpha-lactose through the action of the enzyme lactose synthase. Furthermore, Ceramide (D18:1/18:0) and D-glucose can be biosynthesized from glucosylceramide and water; which is catalyzed by the enzyme glucosylceramidase. Finally, D-Glucose can be converted into glucose 6-phosphate; which is mediated by the enzyme hexokinase-2. In humans, D-glucose is involved in the metachromatic leukodystrophy (MLD) pathway, the triosephosphate isomerase pathway, the gliclazide action pathway, and the pancreas function pathway. D-Glucose is also involved in several metabolic disorders, some of which include the congenital disorder OF glycosylation CDG-iid pathway, the transfer OF acetyl groups into mitochondria pathway, the gaucher disease pathway, and the fanconi-bickel syndrome pathway. D-Glucose is a potentially toxic compound. D-Glucose has been found to be associated with several diseases known as hyperinsulinemic hypoglycemia, familial, 1, HHF1 and diabetes mellitus type 2; d-glucose has also been linked to several inborn metabolic disorders including 3-methyl-crotonyl-glycinuria, primary hypomagnesemia, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.",
    "id" : null
  }, {
    "name" : "D-Glucuronic acid ; HMDB0000127",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000127",
    "description" : "D-Glucuronic acid, also known as glcaa or D-glucuronate, belongs to the class of organic compounds known as glucuronic acid derivatives. Glucuronic acid derivatives are compounds containing a glucuronic acid moiety (or a derivative), which consists of a glucose moiety with the C6 carbon oxidized to a carboxylic acid. D-Glucuronic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). D-Glucuronic acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, D-glucuronic acid is primarily located in the cytoplasm, lysosome and endoplasmic reticulum. D-Glucuronic acid can be biosynthesized from isovalerylglucuronide through the action of the enzyme Beta-glucuronidase. In humans, D-glucuronic acid is involved in the inositol metabolism pathway and the starch and sucrose metabolism pathway. D-Glucuronic acid is also involved in several metabolic disorders, some of which include the glycogenosis, type iii. cori disease, debrancher glycogenosis pathway, sucrase-isomaltase deficiency, the mucopolysaccharidosis vi. sly syndrome pathway, and the glycogenosis, type vi. hers disease pathway.",
    "id" : null
  }, {
    "name" : "D-Glucuronic acid ; HMDB00127",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000127",
    "description" : "D-Glucuronic acid, also known as glcaa or D-glucuronate, belongs to the class of organic compounds known as glucuronic acid derivatives. Glucuronic acid derivatives are compounds containing a glucuronic acid moiety (or a derivative), which consists of a glucose moiety with the C6 carbon oxidized to a carboxylic acid. D-Glucuronic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). D-Glucuronic acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, D-glucuronic acid is primarily located in the cytoplasm, lysosome and endoplasmic reticulum. D-Glucuronic acid can be biosynthesized from isovalerylglucuronide through the action of the enzyme Beta-glucuronidase. In humans, D-glucuronic acid is involved in the inositol metabolism pathway and the starch and sucrose metabolism pathway. D-Glucuronic acid is also involved in several metabolic disorders, some of which include the glycogenosis, type iii. cori disease, debrancher glycogenosis pathway, sucrase-isomaltase deficiency, the mucopolysaccharidosis vi. sly syndrome pathway, and the glycogenosis, type vi. hers disease pathway.",
    "id" : null
  }, {
    "name" : "D-Leucic acid ; HMDB0000624",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000624",
    "description" : "D-Leucic acid, also known as D-leucate or delta-leucic acid, belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group. D-Leucic acid is soluble (in water) and a weakly acidic compound (based on its pKa). D-Leucic acid has been detected in multiple biofluids, such as blood and urine. Within the cell, D-leucic acid is primarily located in the cytoplasm and adiposome. D-Leucic acid can be converted into (R)-2-hydroxy-4-methylpentanoyl-CoA.",
    "id" : null
  }, {
    "name" : "D-Maltose ; HMDB0000163",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000163",
    "description" : "D-Maltose, also known as alpha-malt sugar or finetose F, belongs to the class of organic compounds known as o-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. D-Maltose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). D-Maltose has been found in human liver and kidney tissues, and has also been primarily detected in feces, urine, blood, and sweat. Within the cell, D-maltose is primarily located in the cytoplasm and lysosome. D-Maltose participates in a number of enzymatic reactions. In particular, D-Maltose can be converted into Alpha-D-glucose; which is mediated by the enzyme maltase-glucoamylase, intestinal. In addition, D-Maltose can be converted into Alpha-D-glucose through its interaction with the enzyme glycogen debranching enzyme. In humans, D-maltose is involved in the starch and sucrose metabolism pathway. D-Maltose is also involved in several metabolic disorders, some of which include the glycogenosis, type iv. amylopectinosis, anderson disease pathway, glycogen synthetase deficiency, sucrase-isomaltase deficiency, and the glycogenosis, type vi. hers disease pathway.",
    "id" : null
  }, {
    "name" : "D-Mannose ; HMDB0000169",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000169",
    "description" : "D-Mannose, also known as mannopyranose or carubinose, belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. D-Mannose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). D-Mannose has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, breast milk, feces, and urine. D-Mannose can be found anywhere throughout the human cell, such as in golgi, endoplasmic reticulum, lysosome, and cytoplasm. D-Mannose exists in all eukaryotes, ranging from yeast to humans. D-Mannose participates in a number of enzymatic reactions. In particular, D-Mannose can be converted into mannose 6-phosphate through the action of the enzyme hexokinase-1. In addition, D-Galactose and D-mannose can be converted into epimelibiose; which is mediated by the enzyme Alpha-galactosidase a. In humans, D-mannose is involved in the fructose and mannose degradation pathway, the galactose metabolism pathway, and the fructose intolerance, hereditary pathway. D-Mannose is also involved in a couple of metabolic disorders, which include the fructosuria pathway and the galactosemia pathway.",
    "id" : null
  }, {
    "name" : "D-Ribose ; HMDB0000283",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000283",
    "description" : "D-Ribose, also known as ribose, belongs to the class of organic compounds known as pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms. D-Ribose exists as a solid, very soluble (in water), and a very weakly acidic compound (based on its pKa). D-Ribose has been found throughout most human tissues, and has also been detected in most biofluids, including blood, urine, saliva, and cerebrospinal fluid. D-Ribose exists in all eukaryotes, ranging from yeast to humans. D-Ribose can be converted into D-ribose 5-phosphate through its interaction with the enzyme ribokinase. In humans, D-ribose is involved in the pentose phosphate pathway. D-Ribose is also involved in a few metabolic disorders, which include glucose-6-phosphate dehydrogenase deficiency, transaldolase deficiency, and ribose-5-phosphate isomerase deficiency. Outside of the human body, D-ribose can be found in a number of food items such as fruits, other soy product, chinese mustard, and cucurbita (gourd). This makes D-ribose a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "D-Threitol ; HMDB0004136",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004136",
    "description" : "D-Threitol, also known as D-threo-tetritol, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. D-Threitol is very soluble (in water) and a very weakly acidic compound (based on its pKa). D-Threitol has been primarily detected in feces, urine, blood, and cerebrospinal fluid. D-Threitol has been linked to the inborn metabolic disorders including ribose-5-phosphate isomerase deficiency.",
    "id" : null
  }, {
    "name" : "D-Threitol ; HMDB04136",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004136",
    "description" : "D-Threitol, also known as D-threo-tetritol, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. D-Threitol is very soluble (in water) and a very weakly acidic compound (based on its pKa). D-Threitol has been primarily detected in feces, urine, blood, and cerebrospinal fluid. D-Threitol has been linked to the inborn metabolic disorders including ribose-5-phosphate isomerase deficiency.",
    "id" : null
  }, {
    "name" : "D-Urobilin ; HMDB0004161",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004161",
    "description" : "D-Urobilin belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. D-Urobilin is considered to be a practically insoluble (in water) and relatively neutral molecule. D-Urobilin has been detected in multiple biofluids, such as feces and urine.",
    "id" : null
  }, {
    "name" : "D-Urobilinogen ; HMDB0004158",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004158",
    "description" : "D-Urobilinogen belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. D-Urobilinogen is considered to be a practically insoluble (in water) and relatively neutral molecule. D-Urobilinogen has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, D-urobilinogen is primarily located in the membrane (predicted from logP). D-Urobilinogen exists in all eukaryotes, ranging from yeast to humans. In humans, D-urobilinogen is involved in the porphyrin metabolism pathway. D-Urobilinogen is also involved in several metabolic disorders, some of which include the acute intermittent porphyria pathway, congenital erythropoietic porphyria (cep) or gunther disease pathway, the hereditary coproporphyria (HCP) pathway, and the porphyria variegata (PV) pathway.",
    "id" : null
  }, {
    "name" : "D-Urobilinogen ; HMDB04158",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004158",
    "description" : "D-Urobilinogen belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. D-Urobilinogen is considered to be a practically insoluble (in water) and relatively neutral molecule. D-Urobilinogen has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, D-urobilinogen is primarily located in the membrane (predicted from logP). D-Urobilinogen exists in all eukaryotes, ranging from yeast to humans. In humans, D-urobilinogen is involved in the porphyrin metabolism pathway. D-Urobilinogen is also involved in several metabolic disorders, some of which include the acute intermittent porphyria pathway, congenital erythropoietic porphyria (cep) or gunther disease pathway, the hereditary coproporphyria (HCP) pathway, and the porphyria variegata (PV) pathway.",
    "id" : null
  }, {
    "name" : "D-Xylose ; HMDB0000098",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000098",
    "description" : "D-Xylose, also known as xylose or xylopyranose, belongs to the class of organic compounds known as pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms. D-Xylose exists as a solid, very soluble (in water), and a very weakly acidic compound (based on its pKa). D-Xylose has been found throughout all human tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, D-xylose is primarily located in the cytoplasm and lysosome. Outside of the human body, D-xylose can be found in flaxseed. This makes D-xylose a potential biomarker for the consumption of this food product. D-Xylose is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Decanoylcarnitine ; HMDB0000651",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000651",
    "description" : "Decanoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, decanoylcarnitine is considered to be a fatty ester lipid molecule. Decanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Decanoylcarnitine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, decanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Decanoylcarnitine has been linked to several inborn metabolic disorders including celiac disease and glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Decanoylcarnitine ; HMDB00651",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000651",
    "description" : "Decanoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, decanoylcarnitine is considered to be a fatty ester lipid molecule. Decanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Decanoylcarnitine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, decanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Decanoylcarnitine has been linked to several inborn metabolic disorders including celiac disease and glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Delta-Hexanolactone ; HMDB0000453",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000453",
    "description" : "Delta-Hexanolactone, also known as -hexanolactone or epsilon-caprolactone, belongs to the class of organic compounds known as delta valerolactones. These are cyclic organic compounds containing an oxan-2- one moiety. Delta-Hexanolactone is soluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). Within the cell, Delta-hexanolactone is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Deoxycholic acid ; HMDB0000626",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000626",
    "description" : "Deoxycholic acid, also known as deoxycholate or acid, deoxycholic, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Deoxycholic acid is a drug which is used for improvement in appearance of moderate to severe fullness associated with submental fat in adults. . Deoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Deoxycholic acid has been found in human hepatic tissue and intestine tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, deoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, deoxycholic acid is involved in the cerebrotendinous xanthomatosis (CTX) pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, and congenital bile acid synthesis defect type III pathway. Deoxycholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, the zellweger syndrome pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Deoxycholic acid ; HMDB00626",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000626",
    "description" : "Deoxycholic acid, also known as deoxycholate or acid, deoxycholic, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Deoxycholic acid is a drug which is used for improvement in appearance of moderate to severe fullness associated with submental fat in adults. . Deoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Deoxycholic acid has been found in human hepatic tissue and intestine tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, deoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, deoxycholic acid is involved in the cerebrotendinous xanthomatosis (CTX) pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, and congenital bile acid synthesis defect type III pathway. Deoxycholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, the zellweger syndrome pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Deoxycholic acid glycine conjugate ; HMDB0000631",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000631",
    "description" : "Deoxycholic acid glycine conjugate, also known as glycodeoxycholate or deoxycholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Deoxycholic acid glycine conjugate is considered to be a practically insoluble (in water) and relatively neutral molecule. Deoxycholic acid glycine conjugate has been found in human hepatic tissue and prostate tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, deoxycholic acid glycine conjugate is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, deoxycholic acid glycine conjugate is involved in the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type II pathway, bile acid biosynthesis pathway, and congenital bile acid synthesis defect type III pathway. Deoxycholic acid glycine conjugate is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Deoxycholic acid glycine conjugate ; HMDB00631",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000631",
    "description" : "Deoxycholic acid glycine conjugate, also known as glycodeoxycholate or deoxycholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Deoxycholic acid glycine conjugate is considered to be a practically insoluble (in water) and relatively neutral molecule. Deoxycholic acid glycine conjugate has been found in human hepatic tissue and prostate tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, deoxycholic acid glycine conjugate is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, deoxycholic acid glycine conjugate is involved in the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type II pathway, bile acid biosynthesis pathway, and congenital bile acid synthesis defect type III pathway. Deoxycholic acid glycine conjugate is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Deoxyuridine ; HMDB0000012",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000012",
    "description" : "Deoxyuridine, also known as dU, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. Deoxyuridine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Deoxyuridine has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, deoxyuridine is primarily located in the mitochondria and nucleus. Deoxyuridine participates in a number of enzymatic reactions. In particular, Deoxyuridine can be biosynthesized from deoxycytidine through the action of the enzyme cytidine deaminase. In addition, Deoxyuridine can be converted into uracil and deoxyribose 1-phosphate through its interaction with the enzyme thymidine phosphorylase. In humans, deoxyuridine is involved in the pyrimidine metabolism pathway. Deoxyuridine is also involved in several metabolic disorders, some of which include the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, UMP synthase deficiency (orotic aciduria), Beta ureidopropionase deficiency, and dihydropyrimidinase deficiency.",
    "id" : null
  }, {
    "name" : "DG(16:0/16:0/0:0) ; HMDB0007098",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007098",
    "description" : "DG(16:0/16:0/0:0), also known as DAG(16:0/16:0) or diacylglycerol(32:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/16:0/0:0) is considered to be a diradylglycerol lipid molecule. DG(16:0/16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/16:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/16:0/0:0) is primarily located in the membrane (predicted from logP). DG(16:0/16:0/0:0) participates in a number of enzymatic reactions. In particular, DG(16:0/16:0/0:0) can be biosynthesized from PA(16:0/16:0) through the action of the enzyme phosphatidate phosphatase. Furthermore, DG(16:0/16:0/0:0) and myristoleoyl-CoA can be converted into TG(16:0/16:0/14:1(9Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(16:0/16:0/0:0) can be biosynthesized from PA(16:0/16:0) through the action of the enzyme phosphatidate phosphatase. Finally, DG(16:0/16:0/0:0) and palmityl-CoA can be converted into TG(16:0/16:0/16:0)[iso]; which is mediated by the enzyme diacylglycerol O-acyltransferase. In humans, DG(16:0/16:0/0:0) is involved in the glycerolipid metabolism pathway, phospholipid biosynthesis pathway, the D-glyceric acidura pathway, and phosphatidylethanolamine biosynthesis pe(16:0/16:0) pathway. DG(16:0/16:0/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z)) pathway, familial lipoprotein lipase deficiency, and de novo triacylglycerol biosynthesis TG(16:0/16:0/14:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/16:0/0:0) ; HMDB07098",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007098",
    "description" : "DG(16:0/16:0/0:0), also known as DAG(16:0/16:0) or diacylglycerol(32:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/16:0/0:0) is considered to be a diradylglycerol lipid molecule. DG(16:0/16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/16:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/16:0/0:0) is primarily located in the membrane (predicted from logP). DG(16:0/16:0/0:0) participates in a number of enzymatic reactions. In particular, DG(16:0/16:0/0:0) can be biosynthesized from PA(16:0/16:0) through the action of the enzyme phosphatidate phosphatase. Furthermore, DG(16:0/16:0/0:0) and myristoleoyl-CoA can be converted into TG(16:0/16:0/14:1(9Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(16:0/16:0/0:0) can be biosynthesized from PA(16:0/16:0) through the action of the enzyme phosphatidate phosphatase. Finally, DG(16:0/16:0/0:0) and palmityl-CoA can be converted into TG(16:0/16:0/16:0)[iso]; which is mediated by the enzyme diacylglycerol O-acyltransferase. In humans, DG(16:0/16:0/0:0) is involved in the glycerolipid metabolism pathway, phospholipid biosynthesis pathway, the D-glyceric acidura pathway, and phosphatidylethanolamine biosynthesis pe(16:0/16:0) pathway. DG(16:0/16:0/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z)) pathway, familial lipoprotein lipase deficiency, and de novo triacylglycerol biosynthesis TG(16:0/16:0/14:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/16:1(9Z)/0:0) ; HMDB0007099",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007099",
    "description" : "DG(16:0/16:1(9Z)/0:0)[iso2], also known as diacylglycerol or DAG(16:0/16:1), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/16:1(9Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:0/16:1(9Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/16:1(9Z)/0:0)[iso2] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/16:1(9Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP). In humans, DG(16:0/16:1(9Z)/0:0)[iso2] is involved in phosphatidylcholine biosynthesis PC(16:0/16:1(9Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/16:1(9Z)) pathway. DG(16:0/16:1(9Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/20:1(11Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/18:3(6Z,9Z,12Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/16:0) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/16:1(9Z)/0:0) ; HMDB07099",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007099",
    "description" : "DG(16:0/16:1(9Z)/0:0)[iso2], also known as diacylglycerol or DAG(16:0/16:1), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/16:1(9Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:0/16:1(9Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/16:1(9Z)/0:0)[iso2] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/16:1(9Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP). In humans, DG(16:0/16:1(9Z)/0:0)[iso2] is involved in phosphatidylcholine biosynthesis PC(16:0/16:1(9Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/16:1(9Z)) pathway. DG(16:0/16:1(9Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/20:1(11Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/18:3(6Z,9Z,12Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/16:0) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/18:0/0:0) ; HMDB0007100",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007100",
    "description" : "DG(16:0/18:0/0:0)[iso2], also known as DAG(16:0/18:0) or diacylglycerol(16:0/18:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/18:0/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:0/18:0/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/18:0/0:0)[iso2] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/18:0/0:0)[iso2] is primarily located in the membrane (predicted from logP). In humans, DG(16:0/18:0/0:0)[iso2] is involved in phosphatidylethanolamine biosynthesis pe(16:0/18:0) pathway and phosphatidylcholine biosynthesis PC(16:0/18:0) pathway. DG(16:0/18:0/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/18:0/22:4(7Z,10Z,13Z,16Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:0/18:1(9Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:0/18:1(11Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/18:0/20:3(5Z,8Z,11Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/18:0/0:0) ; HMDB07100",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007100",
    "description" : "DG(16:0/18:0/0:0)[iso2], also known as DAG(16:0/18:0) or diacylglycerol(16:0/18:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/18:0/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:0/18:0/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/18:0/0:0)[iso2] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/18:0/0:0)[iso2] is primarily located in the membrane (predicted from logP). In humans, DG(16:0/18:0/0:0)[iso2] is involved in phosphatidylethanolamine biosynthesis pe(16:0/18:0) pathway and phosphatidylcholine biosynthesis PC(16:0/18:0) pathway. DG(16:0/18:0/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/18:0/22:4(7Z,10Z,13Z,16Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:0/18:1(9Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:0/18:1(11Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/18:0/20:3(5Z,8Z,11Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/18:1(9Z)/0:0) ; HMDB0007102",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007102",
    "description" : "DG(16:0/18:1(9Z)/0:0), also known as diacylglycerol or DAG(16:0/18:1), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/18:1(9Z)/0:0) is considered to be a diradylglycerol lipid molecule. DG(16:0/18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/18:1(9Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP). DG(16:0/18:1(9Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(16:0/18:1(9Z)/0:0) can be biosynthesized from PA(16:0/18:1(9Z)) through the action of the enzyme phosphatidate phosphatase. Furthermore, DG(16:0/18:1(9Z)/0:0) and myristoleoyl-CoA can be converted into TG(16:0/18:1(9Z)/14:1(9Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(16:0/18:1(9Z)/0:0) can be biosynthesized from PA(16:0/18:1(9Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(16:0/18:1(9Z)/0:0) and palmityl-CoA can be converted into TG(16:0/18:1(9Z)/16:0) through the action of the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(16:0/18:1(9Z)/0:0) can be biosynthesized from PA(16:0/18:1(9Z)); which is catalyzed by the enzyme phosphatidate phosphatase. Finally, DG(16:0/18:1(9Z)/0:0) and palmitoleyl-CoA can be converted into TG(16:0/18:1(9Z)/16:1(9Z)); which is mediated by the enzyme diacylglycerol O-acyltransferase. In humans, DG(16:0/18:1(9Z)/0:0) is involved in phosphatidylcholine biosynthesis PC(16:0/18:1(9Z)) pathway, phosphatidylethanolamine biosynthesis pe(16:0/18:1(9Z)) pathway, and the phosphatidylinositol phosphate metabolism pathway. DG(16:0/18:1(9Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/24:0) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/14:1(9Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/24:1(15Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/20:0) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/18:1(9Z)/0:0) ; HMDB07102",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007102",
    "description" : "DG(16:0/18:1(9Z)/0:0), also known as diacylglycerol or DAG(16:0/18:1), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(16:0/18:1(9Z)/0:0) is considered to be a diradylglycerol lipid molecule. DG(16:0/18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/18:1(9Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(16:0/18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP). DG(16:0/18:1(9Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(16:0/18:1(9Z)/0:0) can be biosynthesized from PA(16:0/18:1(9Z)) through the action of the enzyme phosphatidate phosphatase. Furthermore, DG(16:0/18:1(9Z)/0:0) and myristoleoyl-CoA can be converted into TG(16:0/18:1(9Z)/14:1(9Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(16:0/18:1(9Z)/0:0) can be biosynthesized from PA(16:0/18:1(9Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(16:0/18:1(9Z)/0:0) and palmityl-CoA can be converted into TG(16:0/18:1(9Z)/16:0) through the action of the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(16:0/18:1(9Z)/0:0) can be biosynthesized from PA(16:0/18:1(9Z)); which is catalyzed by the enzyme phosphatidate phosphatase. Finally, DG(16:0/18:1(9Z)/0:0) and palmitoleyl-CoA can be converted into TG(16:0/18:1(9Z)/16:1(9Z)); which is mediated by the enzyme diacylglycerol O-acyltransferase. In humans, DG(16:0/18:1(9Z)/0:0) is involved in phosphatidylcholine biosynthesis PC(16:0/18:1(9Z)) pathway, phosphatidylethanolamine biosynthesis pe(16:0/18:1(9Z)) pathway, and the phosphatidylinositol phosphate metabolism pathway. DG(16:0/18:1(9Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/24:0) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/14:1(9Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/24:1(15Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/20:0) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/18:2(9Z,12Z)/0:0) ; HMDB0007103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007103",
    "description" : "DG(16:0/18:2(9Z,12Z)/0:0)[iso2], also known as diacylglycerol(16:0/18:2) or DAG(16:0/18:2), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/18:2(9Z,12Z)/0:0)[iso2] has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is involved in phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/18:2(9Z,12Z)) pathway. DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/16:0) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/14:1(9Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:0/18:2(9Z,12Z)/0:0) ; HMDB07103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007103",
    "description" : "DG(16:0/18:2(9Z,12Z)/0:0)[iso2], also known as diacylglycerol(16:0/18:2) or DAG(16:0/18:2), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:0/18:2(9Z,12Z)/0:0)[iso2] has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is involved in phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/18:2(9Z,12Z)) pathway. DG(16:0/18:2(9Z,12Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/16:0) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) pathway, de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/14:1(9Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:1(9Z)/18:2(9Z,12Z)/0:0) ; HMDB0007132",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007132",
    "description" : "DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2], also known as DAG(16:1N7/18:2N6) or diacylglycerol(16:1/18:2), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is involved in phosphatidylethanolamine biosynthesis pe(16:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(16:1(9Z)/18:2(9Z,12Z)) pathway. DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/18:1(11Z)) pathway, de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/22:1(13Z)) pathway, de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(16:1(9Z)/18:2(9Z,12Z)/0:0) ; HMDB07132",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007132",
    "description" : "DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2], also known as DAG(16:1N7/18:2N6) or diacylglycerol(16:1/18:2), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is involved in phosphatidylethanolamine biosynthesis pe(16:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(16:1(9Z)/18:2(9Z,12Z)) pathway. DG(16:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/18:1(11Z)) pathway, de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/22:1(13Z)) pathway, de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, and de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:0/18:0/0:0) ; HMDB0007158",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007158",
    "description" : "DG(18:0/18:0/0:0), also known as diacyl glycerol or DAG(18:0/18:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(18:0/18:0/0:0) is considered to be a diradylglycerol lipid molecule. DG(18:0/18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:0/18:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:0/18:0/0:0) is primarily located in the membrane (predicted from logP). DG(18:0/18:0/0:0) participates in a number of enzymatic reactions. In particular, DG(18:0/18:0/0:0) can be biosynthesized from PA(18:0/18:0) through its interaction with the enzyme phosphatidate phosphatase. Furthermore, DG(18:0/18:0/0:0) and myristoleoyl-CoA can be converted into TG(18:0/18:0/14:1(9Z)); which is mediated by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:0/18:0/0:0) can be biosynthesized from PA(18:0/18:0) through the action of the enzyme phosphatidate phosphatase. Furthermore, DG(18:0/18:0/0:0) and palmitoleyl-CoA can be converted into TG(18:0/18:0/16:1(9Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:0/18:0/0:0) can be biosynthesized from PA(18:0/18:0); which is catalyzed by the enzyme phosphatidate phosphatase. Finally, DG(18:0/18:0/0:0) and stearoyl-CoA can be converted into TG(18:0/18:0/18:0); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:0/18:0/0:0) is involved in phosphatidylcholine biosynthesis PC(18:0/18:0) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:0) pathway. DG(18:0/18:0/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:0/18:0/22:1(13Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/18:0/18:1(11Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/18:0/18:0) pathway, and de novo triacylglycerol biosynthesis TG(18:0/18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:0/18:0/0:0) ; HMDB07158",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007158",
    "description" : "DG(18:0/18:0/0:0), also known as diacyl glycerol or DAG(18:0/18:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(18:0/18:0/0:0) is considered to be a diradylglycerol lipid molecule. DG(18:0/18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:0/18:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:0/18:0/0:0) is primarily located in the membrane (predicted from logP). DG(18:0/18:0/0:0) participates in a number of enzymatic reactions. In particular, DG(18:0/18:0/0:0) can be biosynthesized from PA(18:0/18:0) through its interaction with the enzyme phosphatidate phosphatase. Furthermore, DG(18:0/18:0/0:0) and myristoleoyl-CoA can be converted into TG(18:0/18:0/14:1(9Z)); which is mediated by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:0/18:0/0:0) can be biosynthesized from PA(18:0/18:0) through the action of the enzyme phosphatidate phosphatase. Furthermore, DG(18:0/18:0/0:0) and palmitoleyl-CoA can be converted into TG(18:0/18:0/16:1(9Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:0/18:0/0:0) can be biosynthesized from PA(18:0/18:0); which is catalyzed by the enzyme phosphatidate phosphatase. Finally, DG(18:0/18:0/0:0) and stearoyl-CoA can be converted into TG(18:0/18:0/18:0); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:0/18:0/0:0) is involved in phosphatidylcholine biosynthesis PC(18:0/18:0) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:0) pathway. DG(18:0/18:0/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:0/18:0/22:1(13Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/18:0/18:1(11Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/18:0/18:0) pathway, and de novo triacylglycerol biosynthesis TG(18:0/18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0) ; HMDB0007170",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007170",
    "description" : "DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2], also known as diacylglycerol(18:0/20:4) or DAG(18:0/20:4), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP). In humans, DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is involved in phosphatidylcholine biosynthesis PC(18:0/20:4(5Z,8Z,11Z,14Z)) pathway, the activation OF PKC through g protein coupled receptor pathway, and phosphatidylethanolamine biosynthesis pe(18:0/20:4(5Z,8Z,11Z,14Z)) pathway. DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0) ; HMDB07170",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007170",
    "description" : "DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2], also known as diacylglycerol(18:0/20:4) or DAG(18:0/20:4), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP). In humans, DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is involved in phosphatidylcholine biosynthesis PC(18:0/20:4(5Z,8Z,11Z,14Z)) pathway, the activation OF PKC through g protein coupled receptor pathway, and phosphatidylethanolamine biosynthesis pe(18:0/20:4(5Z,8Z,11Z,14Z)) pathway. DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) pathway, de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) ; HMDB0007199",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007199",
    "description" : "DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0), also known as DG(18:1/20:4) or diacylglycerol(38:5), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is primarily located in the membrane (predicted from logP). DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from PA(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and cis-vaccenoyl-CoA can be converted into TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) through the action of the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from PA(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and oleoyl-CoA can be converted into TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from PA(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)); which is mediated by the enzyme phosphatidate phosphatase. Finally, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and linoleoyl-CoA can be converted into TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is involved in phosphatidylethanolamine biosynthesis pe(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway. DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) ; HMDB07199",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007199",
    "description" : "DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0), also known as DG(18:1/20:4) or diacylglycerol(38:5), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is primarily located in the membrane (predicted from logP). DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from PA(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and cis-vaccenoyl-CoA can be converted into TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) through the action of the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from PA(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and oleoyl-CoA can be converted into TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from PA(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)); which is mediated by the enzyme phosphatidate phosphatase. Finally, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and linoleoyl-CoA can be converted into TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is involved in phosphatidylethanolamine biosynthesis pe(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway. DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(9Z)/18:0/0:0) ; HMDB0007216",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007216",
    "description" : "DG(18:1(9Z)/18:0/0:0), also known as diacylglycerol or DAG(18:1/18:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. DG(18:1(9Z)/18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(9Z)/18:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:1(9Z)/18:0/0:0) is primarily located in the membrane (predicted from logP). DG(18:1(9Z)/18:0/0:0) participates in a number of enzymatic reactions. In particular, DG(18:1(9Z)/18:0/0:0) can be biosynthesized from PA(18:1(9Z)/18:0); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:0/0:0) and oleoyl-CoA can be converted into TG(18:1(9Z)/18:0/18:1(9Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:0/0:0) can be biosynthesized from PA(18:1(9Z)/18:0); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:0/0:0) and linoleoyl-CoA can be converted into TG(18:1(9Z)/18:0/18:2(9Z,12Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:0/0:0) can be biosynthesized from PA(18:1(9Z)/18:0) through the action of the enzyme phosphatidate phosphatase. Finally, DG(18:1(9Z)/18:0/0:0) and gamma-linolenoyl-CoA can be converted into TG(18:1(9Z)/18:0/18:3(6Z,9Z,12Z)) through the action of the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:1(9Z)/18:0/0:0) is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:0) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:0) pathway. DG(18:1(9Z)/18:0/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/22:4(7Z,10Z,13Z,16Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/20:3(5Z,8Z,11Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/18:4(6Z,9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(9Z)/18:0/0:0) ; HMDB07216",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007216",
    "description" : "DG(18:1(9Z)/18:0/0:0), also known as diacylglycerol or DAG(18:1/18:0), belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. DG(18:1(9Z)/18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(9Z)/18:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:1(9Z)/18:0/0:0) is primarily located in the membrane (predicted from logP). DG(18:1(9Z)/18:0/0:0) participates in a number of enzymatic reactions. In particular, DG(18:1(9Z)/18:0/0:0) can be biosynthesized from PA(18:1(9Z)/18:0); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:0/0:0) and oleoyl-CoA can be converted into TG(18:1(9Z)/18:0/18:1(9Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:0/0:0) can be biosynthesized from PA(18:1(9Z)/18:0); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:0/0:0) and linoleoyl-CoA can be converted into TG(18:1(9Z)/18:0/18:2(9Z,12Z)) through its interaction with the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:0/0:0) can be biosynthesized from PA(18:1(9Z)/18:0) through the action of the enzyme phosphatidate phosphatase. Finally, DG(18:1(9Z)/18:0/0:0) and gamma-linolenoyl-CoA can be converted into TG(18:1(9Z)/18:0/18:3(6Z,9Z,12Z)) through the action of the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:1(9Z)/18:0/0:0) is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:0) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:0) pathway. DG(18:1(9Z)/18:0/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/22:4(7Z,10Z,13Z,16Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/20:3(5Z,8Z,11Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:0/18:4(6Z,9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(9Z)/18:1(9Z)/0:0) ; HMDB0007218",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007218",
    "description" : "DG(18:1(9Z)/18:1(9Z)/0:0), also known as sn-1,2-dioleoylglycerol or sn-1,2-diolein, belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(18:1(9Z)/18:1(9Z)/0:0) is considered to be a diradylglycerol lipid molecule. DG(18:1(9Z)/18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(9Z)/18:1(9Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:1(9Z)/18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP). DG(18:1(9Z)/18:1(9Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(18:1(9Z)/18:1(9Z)/0:0) can be biosynthesized from PA(18:1(9Z)/18:1(9Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) and oleoyl-CoA can be converted into TG(18:1(9Z)/18:1(9Z)/18:1(9Z))[iso] through the action of the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) can be biosynthesized from PA(18:1(9Z)/18:1(9Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) and linoleoyl-CoA can be converted into TG(18:1(9Z)/18:1(9Z)/18:2(9Z,12Z))[iso3]; which is mediated by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) can be biosynthesized from PA(18:1(9Z)/18:1(9Z)) through the action of the enzyme phosphatidate phosphatase. Finally, DG(18:1(9Z)/18:1(9Z)/0:0) and gamma-linolenoyl-CoA can be converted into TG(18:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z))[iso6] through its interaction with the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:1(9Z)/18:1(9Z)/0:0) is involved in phosphatidylcholine biosynthesis PC(18:1(9Z)/18:1(9Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:1(9Z)) pathway. DG(18:1(9Z)/18:1(9Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/24:1(15Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(9Z)/18:1(9Z)/0:0) ; HMDB07218",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007218",
    "description" : "DG(18:1(9Z)/18:1(9Z)/0:0), also known as sn-1,2-dioleoylglycerol or sn-1,2-diolein, belongs to the class of organic compounds known as 1,2-diacylglycerols. These are diacylglycerols containing a glycerol acylated at positions 1 and 2. Thus, DG(18:1(9Z)/18:1(9Z)/0:0) is considered to be a diradylglycerol lipid molecule. DG(18:1(9Z)/18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(9Z)/18:1(9Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, DG(18:1(9Z)/18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP). DG(18:1(9Z)/18:1(9Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(18:1(9Z)/18:1(9Z)/0:0) can be biosynthesized from PA(18:1(9Z)/18:1(9Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) and oleoyl-CoA can be converted into TG(18:1(9Z)/18:1(9Z)/18:1(9Z))[iso] through the action of the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) can be biosynthesized from PA(18:1(9Z)/18:1(9Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) and linoleoyl-CoA can be converted into TG(18:1(9Z)/18:1(9Z)/18:2(9Z,12Z))[iso3]; which is mediated by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:1(9Z)/18:1(9Z)/0:0) can be biosynthesized from PA(18:1(9Z)/18:1(9Z)) through the action of the enzyme phosphatidate phosphatase. Finally, DG(18:1(9Z)/18:1(9Z)/0:0) and gamma-linolenoyl-CoA can be converted into TG(18:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z))[iso6] through its interaction with the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:1(9Z)/18:1(9Z)/0:0) is involved in phosphatidylcholine biosynthesis PC(18:1(9Z)/18:1(9Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:1(9Z)) pathway. DG(18:1(9Z)/18:1(9Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/24:1(15Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(9Z)/18:2(9Z,12Z)/0:0) ; HMDB0007219",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007219",
    "description" : "DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2], also known as DAG(18:1/18:2) or diacylglycerol(18:1/18:2), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:2(9Z,12Z)) pathway. DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/20:2(11Z,14Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:1(9Z)/18:2(9Z,12Z)/0:0) ; HMDB07219",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007219",
    "description" : "DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2], also known as DAG(18:1/18:2) or diacylglycerol(18:1/18:2), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a diradylglycerol lipid molecule. DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:2(9Z,12Z)) pathway. DG(18:1(9Z)/18:2(9Z,12Z)/0:0)[iso2] is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/20:2(11Z,14Z)) pathway, de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) ; HMDB0007248",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007248",
    "description" : "DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0), also known as DAG(18:2/18:2) or DAG(18:2OMEGA6/18:2OMEGA6), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is considered to be a diradylglycerol lipid molecule. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and cytoplasm. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) can be biosynthesized from PA(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) and linoleoyl-CoA can be converted into TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) can be biosynthesized from PA(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) and gamma-linolenoyl-CoA can be converted into TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))[iso3]; which is mediated by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) can be biosynthesized from PA(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidate phosphatase. Finally, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) and alpha-linolenoyl-CoA can be converted into TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))[iso3] through its interaction with the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is involved in phosphatidylcholine biosynthesis PC(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)) pathway, de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) pathway, de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:2(13Z,16Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) ; HMDB07248",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007248",
    "description" : "DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0), also known as DAG(18:2/18:2) or DAG(18:2OMEGA6/18:2OMEGA6), belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is considered to be a diradylglycerol lipid molecule. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and cytoplasm. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) participates in a number of enzymatic reactions. In particular, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) can be biosynthesized from PA(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) and linoleoyl-CoA can be converted into TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)); which is catalyzed by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) can be biosynthesized from PA(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidate phosphatase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) and gamma-linolenoyl-CoA can be converted into TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))[iso3]; which is mediated by the enzyme diacylglycerol O-acyltransferase. Furthermore, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) can be biosynthesized from PA(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidate phosphatase. Finally, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) and alpha-linolenoyl-CoA can be converted into TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))[iso3] through its interaction with the enzyme diacylglycerol O-acyltransferase. In humans, DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is involved in phosphatidylcholine biosynthesis PC(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway. DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)) pathway, de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) pathway, de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:2(13Z,16Z)) pathway, and de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "Dihomolinoleic acid ; HMDB0061864",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061864",
    "description" : ", also known as 20:2n6 or dihomolinoleate, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Thus, is considered to be a fatty acid lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as saliva, blood, and urine. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. can be converted into 1-octadecanoyl-2-[(10Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine.",
    "id" : null
  }, {
    "name" : "Dihydrothymine ; HMDB0000079",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000079",
    "description" : "Dihydrothymine belongs to the class of organic compounds known as hydropyrimidines. Hydropyrimidines are compounds containing a hydrogenated pyrimidine ring (i.e. containing less than the maximum number of double bonds.). Dihydrothymine is soluble (in water) and a very weakly acidic compound (based on its pKa). Dihydrothymine has been found in human prostate tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, dihydrothymine is primarily located in the cytoplasm. Dihydrothymine participates in a number of enzymatic reactions. In particular, Dihydrothymine can be biosynthesized from thymine through the action of the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. In addition, Dihydrothymine can be converted into ureidoisobutyric acid through the action of the enzyme dihydropyrimidinase. In humans, dihydrothymine is involved in the pyrimidine metabolism pathway. Dihydrothymine is also involved in several metabolic disorders, some of which include UMP synthase deficiency (orotic aciduria), dihydropyrimidinase deficiency, Beta ureidopropionase deficiency, and the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway. Outside of the human body, dihydrothymine can be found in a number of food items such as broad bean, millet, tronchuda cabbage, and alaska wild rhubarb. This makes dihydrothymine a potential biomarker for the consumption of these food products. Dihydrothymine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Dihydrouracil ; HMDB0000076",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000076",
    "description" : "Dihydrouracil belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Dihydrouracil exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Dihydrouracil has been found in human prostate, liver and kidney tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, dihydrouracil is primarily located in the cytoplasm and nucleus. Dihydrouracil participates in a number of enzymatic reactions. In particular, Dihydrouracil can be biosynthesized from uracil; which is mediated by the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. Furthermore, Dihydrouracil can be converted into ureidopropionic acid; which is catalyzed by the enzyme dihydropyrimidinase. Furthermore, Dihydrouracil can be converted into ureidopropionic acid through its interaction with the enzyme dihydropyrimidinase. Finally, Dihydrouracil can be converted into uracil through its interaction with the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. In humans, dihydrouracil is involved in the pyrimidine metabolism pathway and the Beta-alanine metabolism pathway. Dihydrouracil is also involved in several metabolic disorders, some of which include the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, ureidopropionase deficiency, gaba-transaminase deficiency, and Beta ureidopropionase deficiency. Outside of the human body, dihydrouracil can be found in a number of food items such as roman camomile, hyssop, tree fern, and brussel sprouts. This makes dihydrouracil a potential biomarker for the consumption of these food products. Dihydrouracil is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Dimethylglycine ; HMDB0000092",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000092",
    "description" : "Dimethylglycine, also known as N-methylsarcosine, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Dimethylglycine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Dimethylglycine has been found in human liver and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, dimethylglycine is primarily located in the cytoplasm and mitochondria. Dimethylglycine participates in a number of enzymatic reactions. In particular, Dimethylglycine can be converted into formaldehyde and sarcosine; which is mediated by the enzyme dimethylglycine dehydrogenase, mitochondrial. Furthermore, Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine through the action of the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine through its interaction with the enzyme betaine--homocysteine S-methyltransferase 1. Finally, Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. In humans, dimethylglycine is involved in the glycine and serine metabolism pathway, the betaine metabolism pathway, the sarcosine oncometabolite pathway, and the methionine metabolism pathway. Dimethylglycine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, cystathionine Beta-synthase deficiency, the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, and the hypermethioninemia pathway.",
    "id" : null
  }, {
    "name" : "Dimethylglycine ; HMDB00092",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000092",
    "description" : "Dimethylglycine, also known as N-methylsarcosine, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Dimethylglycine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Dimethylglycine has been found in human liver and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, dimethylglycine is primarily located in the cytoplasm and mitochondria. Dimethylglycine participates in a number of enzymatic reactions. In particular, Dimethylglycine can be converted into formaldehyde and sarcosine; which is mediated by the enzyme dimethylglycine dehydrogenase, mitochondrial. Furthermore, Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine through the action of the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine through its interaction with the enzyme betaine--homocysteine S-methyltransferase 1. Finally, Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. In humans, dimethylglycine is involved in the glycine and serine metabolism pathway, the betaine metabolism pathway, the sarcosine oncometabolite pathway, and the methionine metabolism pathway. Dimethylglycine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, cystathionine Beta-synthase deficiency, the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, and the hypermethioninemia pathway.",
    "id" : null
  }, {
    "name" : "Dimethylguanidino valeric acid ; HMDB0240212",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0240212",
    "description" : "Dimethylguanidino valeric acid or DMGV is a product formed from the transamination of asymmetric dimethylarginine (ADMA) via the enzyme alanine-glyoxylate aminotransferase 2 (AGXT2). This pathway is involved in nitric oxide regulation. DMGV has been detected in both blood and urine (PMID:  21945966 ). More recently DMGV has been identified as an independent plasma biomarker of nonalcoholic fatty liver disease (NAFLD). Furthermore, plasma DMGV levels are correlated with biopsy-proven nonalcoholic steatohepatitis (NASH). Plasma DMGV levels have also been found to decline in parallel with improvements in post-procedure cardiometabolic parameters. Plasma DMGV levels have been shown to be able to predict the development of type 2 diabetes up to 12 years before disease onset (PMID: 29083323). Baseline plasma levels of DMGV have been shown to be positively associated with body fat percentage, abdominal visceral fat, very low-density lipoprotein cholesterol (VLDL), and triglycerides. Plasma levels of DMGV are inversely associated with insulin sensitivity, low-density lipoprotein cholesterol, high-density lipoprotein size, and high-density lipoprotein cholesterol (HDL). Overall, DMGV is associated with partial resistance to metabolic health benefits of regular exercise (PMID: 31166569).",
    "id" : null
  }, {
    "name" : "DL-2-Aminooctanoic acid ; HMDB0000991",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000991",
    "description" : "DL-2-Amino-octanoic acid, also known as a-aminocaprylate or alpha-aminocaprylic acid, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). DL-2-Amino-octanoic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). DL-2-Amino-octanoic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, DL-2-amino-octanoic acid is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "DL-2-Aminooctanoic acid ; HMDB00991",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000991",
    "description" : "DL-2-Amino-octanoic acid, also known as a-aminocaprylate or alpha-aminocaprylic acid, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). DL-2-Amino-octanoic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). DL-2-Amino-octanoic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, DL-2-amino-octanoic acid is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Docosadienoate (22:2n6) ; HMDB0061714",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061714",
    "description" : "Docosadienoate (22:2n6), also known as 13,16-docosadienoic acid, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Docosadienoate (22:2n6) is considered to be a practically insoluble (in water) and relatively neutral molecule. Docosadienoate (22:2n6) has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, docosadienoate (22:2n6) is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "Docosahexaenoic acid ; HMDB0002183",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002183",
    "description" : "Dha, also known as doconexent or docosahexaenoate, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, Dha is considered to be a fatty acid lipid molecule. Dha is a drug which is used as a high-docosahexaenoic acid (dha) oral supplement. . Dha is considered to be a practically insoluble (in water) and relatively neutral molecule. Dha has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, Dha is primarily located in the cytoplasm, membrane (predicted from logP), myelin sheath and adiposome. In humans, Dha is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Dha has been found to be associated with several diseases known as hypertension, thyroid cancer, stroke, and essential hypertension; dha has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Docosahexaenoic acid ; HMDB02183",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002183",
    "description" : "Dha, also known as doconexent or docosahexaenoate, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, Dha is considered to be a fatty acid lipid molecule. Dha is a drug which is used as a high-docosahexaenoic acid (dha) oral supplement. . Dha is considered to be a practically insoluble (in water) and relatively neutral molecule. Dha has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, Dha is primarily located in the cytoplasm, membrane (predicted from logP), myelin sheath and adiposome. In humans, Dha is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Dha has been found to be associated with several diseases known as hypertension, thyroid cancer, stroke, and essential hypertension; dha has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Docosapentaenoic acid (22n-6) ; HMDB0001976",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001976",
    "description" : "22:5(4Z,7Z,10Z,13Z,16Z), also known as docosapentaenoate (22N-6) or C22:5N-6,9,12,15,18, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, 22:5(4Z,7Z,10Z,13Z,16Z) is considered to be a docosanoid lipid molecule. 22:5(4Z,7Z,10Z,13Z,16Z) is considered to be a practically insoluble (in water) and relatively neutral molecule. 22:5(4Z,7Z,10Z,13Z,16Z) has been found in human adipose tissue tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 22:5(4Z,7Z,10Z,13Z,16Z) is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. In humans, 22:5(4Z,7Z,10Z,13Z,16Z) is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "Docosapentaenoic acid (22n-6) ; HMDB01976",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001976",
    "description" : "22:5(4Z,7Z,10Z,13Z,16Z), also known as docosapentaenoate (22N-6) or C22:5N-6,9,12,15,18, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, 22:5(4Z,7Z,10Z,13Z,16Z) is considered to be a docosanoid lipid molecule. 22:5(4Z,7Z,10Z,13Z,16Z) is considered to be a practically insoluble (in water) and relatively neutral molecule. 22:5(4Z,7Z,10Z,13Z,16Z) has been found in human adipose tissue tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, 22:5(4Z,7Z,10Z,13Z,16Z) is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. In humans, 22:5(4Z,7Z,10Z,13Z,16Z) is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "Dodecanedioic acid ; HMDB0000623",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000623",
    "description" : "Dodecanedioic acid, also known as 1,12-dodecanedioate or 1,10-dicarboxydecane, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Dodecanedioic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Dodecanedioic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, dodecanedioic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Dodecanedioic acid is also a parent compound for other transformation products, including but not limited to, dodecane, 1,12-di-L-ascorbyl dodecanedioate, and O-dodecanedioylcarnitine.",
    "id" : null
  }, {
    "name" : "Dodecanedioic acid ; HMDB00623",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000623",
    "description" : "Dodecanedioic acid, also known as 1,12-dodecanedioate or 1,10-dicarboxydecane, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Dodecanedioic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Dodecanedioic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, dodecanedioic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Dodecanedioic acid is also a parent compound for other transformation products, including but not limited to, dodecane, 1,12-di-L-ascorbyl dodecanedioate, and O-dodecanedioylcarnitine.",
    "id" : null
  }, {
    "name" : "Dodecanoic acid ; HMDB0000638",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000638",
    "description" : "Lauric acid, also known as dodecanoate or dodecanoic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Lauric acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Lauric acid has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, blood, and sweat. Within the cell, lauric acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Lauric acid exists in all eukaryotes, ranging from yeast to humans. In humans, lauric acid is involved in the Beta oxidation OF very long chain fatty acids pathway, fatty acid biosynthesis pathway, and the adrenoleukodystrophy, X-linked pathway. Lauric acid is also involved in a couple of metabolic disorders, which include the mitochondrial Beta-oxidation OF medium chain saturated fatty acids pathway and carnitine-acylcarnitine translocase deficiency. Outside of the human body, lauric acid can be found in a number of food items such as ginkgo nuts, chinese bayberry, chanterelle, and garden cress. This makes lauric acid a potential biomarker for the consumption of these food products. Lauric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Dodecanoic acid ; HMDB00638",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000638",
    "description" : "Lauric acid, also known as dodecanoate or dodecanoic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Lauric acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Lauric acid has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, blood, and sweat. Within the cell, lauric acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Lauric acid exists in all eukaryotes, ranging from yeast to humans. In humans, lauric acid is involved in the Beta oxidation OF very long chain fatty acids pathway, fatty acid biosynthesis pathway, and the adrenoleukodystrophy, X-linked pathway. Lauric acid is also involved in a couple of metabolic disorders, which include the mitochondrial Beta-oxidation OF medium chain saturated fatty acids pathway and carnitine-acylcarnitine translocase deficiency. Outside of the human body, lauric acid can be found in a number of food items such as ginkgo nuts, chinese bayberry, chanterelle, and garden cress. This makes lauric acid a potential biomarker for the consumption of these food products. Lauric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Dodecanoylcarnitine ; HMDB0002250",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002250",
    "description" : "Dodecanoylcarnitine, also known as lauroylcarnitine or O-C12:0-L-carnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, dodecanoylcarnitine is considered to be a fatty ester lipid molecule. Dodecanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Dodecanoylcarnitine has been found in human liver tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, dodecanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Dodecanoylcarnitine exists in all eukaryotes, ranging from yeast to humans. Dodecanoylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "Dodecanoylcarnitine ; HMDB02250",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002250",
    "description" : "Dodecanoylcarnitine, also known as lauroylcarnitine or O-C12:0-L-carnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, dodecanoylcarnitine is considered to be a fatty ester lipid molecule. Dodecanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Dodecanoylcarnitine has been found in human liver tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, dodecanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Dodecanoylcarnitine exists in all eukaryotes, ranging from yeast to humans. Dodecanoylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "Dopamine 3-O-sulfate ; HMDB0006275",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006275",
    "description" : "Dopamine 3-O-sulfate, also known as dopamine 3-monosulphate, belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. Dopamine 3-O-sulfate exists as a solid, slightly soluble (in water), and an extremely strong acidic compound (based on its pKa). Dopamine 3-O-sulfate has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, dopamine 3-O-sulfate is primarily located in the cytoplasm. Dopamine 3-O-sulfate can be converted into dopamine.",
    "id" : null
  }, {
    "name" : "Dopamine 4-sulfate ; HMDB0004148",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004148",
    "description" : "Dopamine 4-sulfate belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. Dopamine 4-sulfate exists as a solid, slightly soluble (in water), and an extremely strong acidic compound (based on its pKa). Dopamine 4-sulfate has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, dopamine 4-sulfate is primarily located in the cytoplasm. Dopamine 4-sulfate can be converted into dopamine.",
    "id" : null
  }, {
    "name" : "Ectoine ; HMDB0240650",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0240650",
    "description" : "Ectoine belongs to the class of organic compounds known as alpha-amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Ectoine has been identified in urine (PMID: 22409530).",
    "id" : null
  }, {
    "name" : "Eicosadienoic acid ; HMDB0005060",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005060",
    "description" : "Dihomolinoleic acid, also known as 11,14-eicosadienoate or eicosadienoic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Dihomolinoleic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Dihomolinoleic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, dihomolinoleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Dihomolinoleic acid participates in a number of enzymatic reactions. In particular, dihomolinoleic acid can be biosynthesized from arachidic acid. Dihomolinoleic acid is also a parent compound for other transformation products, including but not limited to, 1-octadecyl-2-[(11Z,14Z)-eicosadienoyl]-sn-glycero-3-phosphocholine, (11Z,14Z)-icosadienoyl-containing glycerolipid, and 1-palmitoyl-2-(11Z,14Z-eicosadienoyl)-sn-glycero-3-phosphocholine.",
    "id" : null
  }, {
    "name" : "Eicosadienoic acid ; HMDB05060",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005060",
    "description" : "Dihomolinoleic acid, also known as 11,14-eicosadienoate or eicosadienoic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Dihomolinoleic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Dihomolinoleic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, dihomolinoleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Dihomolinoleic acid participates in a number of enzymatic reactions. In particular, dihomolinoleic acid can be biosynthesized from arachidic acid. Dihomolinoleic acid is also a parent compound for other transformation products, including but not limited to, 1-octadecyl-2-[(11Z,14Z)-eicosadienoyl]-sn-glycero-3-phosphocholine, (11Z,14Z)-icosadienoyl-containing glycerolipid, and 1-palmitoyl-2-(11Z,14Z-eicosadienoyl)-sn-glycero-3-phosphocholine.",
    "id" : null
  }, {
    "name" : "Eicosapentaenoic acid ; HMDB0001999",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001999",
    "description" : "Epa, also known as icosapent or timnodonic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, Epa is considered to be a fatty acid lipid molecule. Epa is considered to be a practically insoluble (in water) and relatively neutral molecule. Epa has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and sweat. Within the cell, Epa is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. In humans, Epa is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Outside of the human body, Epa can be found in a number of food items such as other bread, poppy, pot marjoram, and broad bean. This makes Epa a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Eicosapentaenoic acid ; HMDB01999",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001999",
    "description" : "Epa, also known as icosapent or timnodonic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, Epa is considered to be a fatty acid lipid molecule. Epa is considered to be a practically insoluble (in water) and relatively neutral molecule. Epa has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and sweat. Within the cell, Epa is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. In humans, Epa is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Outside of the human body, Epa can be found in a number of food items such as other bread, poppy, pot marjoram, and broad bean. This makes Epa a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Ergothioneine ; HMDB0003045",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003045",
    "description" : "Ergothioneine, also known as sympectothion, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Ergothioneine is considered to be a practically insoluble (in water) and relatively neutral molecule. Ergothioneine has been primarily detected in blood. Ergothioneine can be converted into 2-sulfenohercynine and S-methyl-L-ergothioneine.",
    "id" : null
  }, {
    "name" : "Erucic acid ; HMDB0002068",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002068",
    "description" : "cis-Erucic acid, also known as cis-eruate or 22:1omega9, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. cis-Erucic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. cis-Erucic acid has been found in human endocrine gland tissue, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, cis-erucic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. cis-Erucic acid is also a parent compound for other transformation products, including but not limited to, ethyl (13Z)-docosenoate, N-[(13Z)-docosenoyl]-tetradecasphing-4-enine-1-phosphoethanolamine, and N-[(13Z)-docosenoyl]sphing-4-enine-1-phosphocholine. cis-Erucic acid has been found to be associated with the diseases known as adrenomyeloneuropathy; cis-erucic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Erucic acid ; HMDB02068",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002068",
    "description" : "cis-Erucic acid, also known as cis-eruate or 22:1omega9, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. cis-Erucic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. cis-Erucic acid has been found in human endocrine gland tissue, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, cis-erucic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. cis-Erucic acid is also a parent compound for other transformation products, including but not limited to, ethyl (13Z)-docosenoate, N-[(13Z)-docosenoyl]-tetradecasphing-4-enine-1-phosphoethanolamine, and N-[(13Z)-docosenoyl]sphing-4-enine-1-phosphocholine. cis-Erucic acid has been found to be associated with the diseases known as adrenomyeloneuropathy; cis-erucic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Erythritol ; HMDB0002994",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002994",
    "description" : "D-Threitol, also known as D-threo-tetritol, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. D-Threitol is very soluble (in water) and a very weakly acidic compound (based on its pKa). D-Threitol has been primarily detected in feces, urine, blood, and cerebrospinal fluid. D-Threitol has been linked to the inborn metabolic disorders including ribose-5-phosphate isomerase deficiency.",
    "id" : null
  }, {
    "name" : "Erythronic acid ; HMDB0000613",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000613",
    "description" : "Erythronic acid, also known as erythronate, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. Erythronic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Erythronic acid has been detected in most biofluids, including urine, saliva, cerebrospinal fluid, and blood. Within the cell, erythronic acid is primarily located in the cytoplasm. Erythronic acid can be converted into 4-phospho-D-erythronic acid and 3-phospho-D-erythronic acid.",
    "id" : null
  }, {
    "name" : "Erythronic acid ; HMDB00613",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000613",
    "description" : "Erythronic acid, also known as erythronate, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. Erythronic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Erythronic acid has been detected in most biofluids, including urine, saliva, cerebrospinal fluid, and blood. Within the cell, erythronic acid is primarily located in the cytoplasm. Erythronic acid can be converted into 4-phospho-D-erythronic acid and 3-phospho-D-erythronic acid.",
    "id" : null
  }, {
    "name" : "Estriol-3-glucuronide ; HMDB0010335",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010335",
    "description" : "Estriol-3-glucuronide, also known as estriol 3-glucosiduronate, belongs to the class of organic compounds known as steroid glucuronide conjugates. These are sterol lipids containing a glucuronide moiety linked to the steroid skeleton. Thus, estriol-3-glucuronide is considered to be a steroid conjugate lipid molecule. Estriol-3-glucuronide is considered to be a practically insoluble (in water) and relatively neutral molecule. Estriol-3-glucuronide has been found in human hepatic tissue, liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, estriol-3-glucuronide is primarily located in the cytoplasm and membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "Ethylmalonic acid ; HMDB0000622",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000622",
    "description" : "Ethylmalonic acid, also known as ethylmalonate or a-carboxybutyrate, belongs to the class of organic compounds known as branched fatty acids. These are fatty acids containing a branched chain. Ethylmalonic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Ethylmalonic acid has been found in human skeletal muscle and prostate tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, ethylmalonic acid is primarily located in the cytoplasm and adiposome. Ethylmalonic acid participates in a number of enzymatic reactions. In particular, ethylmalonic acid can be biosynthesized from malonic acid. Ethylmalonic acid can also be converted into (S)-ethylmalonyl-CoA and (R)-ethylmalonyl-CoA. Ethylmalonic acid is a potentially toxic compound. Ethylmalonic acid has been found to be associated with several diseases known as isobutyryl-CoA dehydrogenase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency, and anorexia nervosa; ethylmalonic acid has also been linked to several inborn metabolic disorders including ethylmalonic encephalopathy and short chain acyl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Etiocholanolone glucuronide ; HMDB0004484",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004484",
    "description" : "Etiocholan-3alpha-ol-17-one 3-glucuronide, also known as 3a-hydroxyetiocholan-17-one 3-glucosiduronate or androsterone glucosiduronate, belongs to the class of organic compounds known as steroid glucuronide conjugates. These are sterol lipids containing a glucuronide moiety linked to the steroid skeleton. Thus, etiocholan-3alpha-ol-17-one 3-glucuronide is considered to be a steroid conjugate lipid molecule. Etiocholan-3alpha-ol-17-one 3-glucuronide is considered to be a practically insoluble (in water) and relatively neutral molecule. Etiocholan-3alpha-ol-17-one 3-glucuronide has been found in human hepatic tissue, liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, etiocholan-3alpha-ol-17-one 3-glucuronide is primarily located in the cytoplasm, membrane (predicted from logP) and endoplasmic reticulum. In humans, etiocholan-3alpha-ol-17-one 3-glucuronide is involved in the androstenedione metabolism pathway.",
    "id" : null
  }, {
    "name" : "Folic acid ; HMDB0000121",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000121",
    "description" : "Folic acid, also known as folate or vitamin m, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Folic acid is a drug which is used for treatment of folic acid deficiency, megaloblastic anemia and in anemias of nutritional supplements, pregnancy, infancy, or childhood. Folic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Folic acid has been found in human brain, kidney and liver tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Folic acid exists in all eukaryotes, ranging from yeast to humans. Folic acid participates in a number of enzymatic reactions. In particular, Folic acid can be biosynthesized from dihydrofolic acid; which is catalyzed by the enzyme dihydrofolate reductase. In addition, Folic acid can be converted into folic acid; which is mediated by the enzyme proton-coupled folate transporter. In humans, folic acid is involved in pterine biosynthesis pathway, the folate malabsorption, hereditary pathway, the folate metabolism pathway, and the methotrexate action pathway. Folic acid is also involved in the metabolic disorder called methylenetetrahydrofolate reductase deficiency (MTHFRD). Folic acid is a potentially toxic compound. Folic acid has been found to be associated with several diseases known as alzheimer's disease, hereditary folate malabsorption, dimethylglycine dehydrogenase deficiency, and rheumatoid arthritis; folic acid has also been linked to the inborn metabolic disorders including folate deficiency.",
    "id" : null
  }, {
    "name" : "Folic acid ; HMDB00121",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000121",
    "description" : "Folic acid, also known as folate or vitamin m, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Folic acid is a drug which is used for treatment of folic acid deficiency, megaloblastic anemia and in anemias of nutritional supplements, pregnancy, infancy, or childhood. Folic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Folic acid has been found in human brain, kidney and liver tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Folic acid exists in all eukaryotes, ranging from yeast to humans. Folic acid participates in a number of enzymatic reactions. In particular, Folic acid can be biosynthesized from dihydrofolic acid; which is catalyzed by the enzyme dihydrofolate reductase. In addition, Folic acid can be converted into folic acid; which is mediated by the enzyme proton-coupled folate transporter. In humans, folic acid is involved in pterine biosynthesis pathway, the folate malabsorption, hereditary pathway, the folate metabolism pathway, and the methotrexate action pathway. Folic acid is also involved in the metabolic disorder called methylenetetrahydrofolate reductase deficiency (MTHFRD). Folic acid is a potentially toxic compound. Folic acid has been found to be associated with several diseases known as alzheimer's disease, hereditary folate malabsorption, dimethylglycine dehydrogenase deficiency, and rheumatoid arthritis; folic acid has also been linked to the inborn metabolic disorders including folate deficiency.",
    "id" : null
  }, {
    "name" : "Formiminoglutamic acid ; HMDB0000854",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000854",
    "description" : "Formiminoglutamic acid, also known as N-formimino-L-glutamate or acid, formiminoglutamic, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Formiminoglutamic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Formiminoglutamic acid has been detected in multiple biofluids, such as feces and urine. Within the cell, formiminoglutamic acid is primarily located in the cytoplasm. Formiminoglutamic acid participates in a number of enzymatic reactions. In particular, Formiminoglutamic acid can be biosynthesized from 4-imidazolone-5-propionic acid through its interaction with the enzyme probable imidazolonepropionase. In addition, Tetrahydrofolic acid and formiminoglutamic acid can be converted into 5-formiminotetrahydrofolic acid and L-glutamic acid through the action of the enzyme formimidoyltransferase-cyclodeaminase. In humans, formiminoglutamic acid is involved in the histidine metabolism pathway. Formiminoglutamic acid is also involved in the metabolic disorder called the histidinemia pathway.",
    "id" : null
  }, {
    "name" : "Fumaric acid ; HMDB0000134",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000134",
    "description" : "Fumaric acid, also known as fumarate or E297, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Fumaric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Fumaric acid has been found in human prostate tissue, and has also been detected in most biofluids, including cerebrospinal fluid, breast milk, urine, and blood. Within the cell, fumaric acid is primarily located in the mitochondria and cytoplasm. Fumaric acid exists in all eukaryotes, ranging from yeast to humans. Fumaric acid participates in a number of enzymatic reactions. In particular, Fumaric acid can be biosynthesized from L-malic acid; which is mediated by the enzyme fumarate hydratase, mitochondrial. Furthermore, Fumaric acid can be biosynthesized from succinic acid through the action of the enzyme succinate dehydrogenase. Furthermore, Fumaric acid and aicar can be biosynthesized from saicar through its interaction with the enzyme adenylosuccinate lyase. Finally, Fumaric acid and adenosine monophosphate can be biosynthesized from adenylsuccinic acid; which is mediated by the enzyme adenylosuccinate lyase. In humans, fumaric acid is involved in the aspartate metabolism pathway, the oncogenic action OF succinate pathway, the citric Acid cycle pathway, and the phenylalanine and tyrosine metabolism pathway. Fumaric acid is also involved in several metabolic disorders, some of which include prolidase deficiency (PD), the alkaptonuria pathway, the tyrosinemia type I pathway, and the hypoacetylaspartia pathway. Outside of the human body, fumaric acid can be found in a number of food items such as common buckwheat, common thyme, garden onion, and jicama. This makes fumaric acid a potential biomarker for the consumption of these food products. Fumaric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Fumaric acid ; HMDB00134",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000134",
    "description" : "Fumaric acid, also known as fumarate or E297, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Fumaric acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Fumaric acid has been found in human prostate tissue, and has also been detected in most biofluids, including cerebrospinal fluid, breast milk, urine, and blood. Within the cell, fumaric acid is primarily located in the mitochondria and cytoplasm. Fumaric acid exists in all eukaryotes, ranging from yeast to humans. Fumaric acid participates in a number of enzymatic reactions. In particular, Fumaric acid can be biosynthesized from L-malic acid; which is mediated by the enzyme fumarate hydratase, mitochondrial. Furthermore, Fumaric acid can be biosynthesized from succinic acid through the action of the enzyme succinate dehydrogenase. Furthermore, Fumaric acid and aicar can be biosynthesized from saicar through its interaction with the enzyme adenylosuccinate lyase. Finally, Fumaric acid and adenosine monophosphate can be biosynthesized from adenylsuccinic acid; which is mediated by the enzyme adenylosuccinate lyase. In humans, fumaric acid is involved in the aspartate metabolism pathway, the oncogenic action OF succinate pathway, the citric Acid cycle pathway, and the phenylalanine and tyrosine metabolism pathway. Fumaric acid is also involved in several metabolic disorders, some of which include prolidase deficiency (PD), the alkaptonuria pathway, the tyrosinemia type I pathway, and the hypoacetylaspartia pathway. Outside of the human body, fumaric acid can be found in a number of food items such as common buckwheat, common thyme, garden onion, and jicama. This makes fumaric acid a potential biomarker for the consumption of these food products. Fumaric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Furosemide ; HMDB0001933",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001933",
    "description" : "Furosemide, also known as frusemide or lasix, belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. Furosemide is a drug which is used for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. also for the treatment of hypertension alone or in combination with other antihypertensive agents. Furosemide exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Furosemide has been found in human kidney tissue. Furosemide can be converted into furosemide through its interaction with the enzyme solute carrier family 22 member 6. In humans, furosemide is involved in the furosemide action pathway.",
    "id" : null
  }, {
    "name" : "Furosemide ; HMDB01933",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001933",
    "description" : "Furosemide, also known as frusemide or lasix, belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. Furosemide is a drug which is used for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. also for the treatment of hypertension alone or in combination with other antihypertensive agents. Furosemide exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Furosemide has been found in human kidney tissue. Furosemide can be converted into furosemide through its interaction with the enzyme solute carrier family 22 member 6. In humans, furosemide is involved in the furosemide action pathway.",
    "id" : null
  }, {
    "name" : "Gabapentin ; HMDB0005015",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005015",
    "description" : "Gabapentin, also known as neurontin or convalis, belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. Gabapentin is a drug which is used for the management of postherpetic neuralgia in adults and as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Gabapentin exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Gabapentin has been found in human brain tissue, and has also been detected in multiple biofluids, such as feces and blood. Gabapentin participates in a number of enzymatic reactions. In particular, gabapentin can be biosynthesized from gamma-aminobutyric acid. Gabapentin can also be converted into gabapentin enacarbil. Gabapentin is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Gabapentin ; HMDB05015",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005015",
    "description" : "Gabapentin, also known as neurontin or convalis, belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. Gabapentin is a drug which is used for the management of postherpetic neuralgia in adults and as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Gabapentin exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Gabapentin has been found in human brain tissue, and has also been detected in multiple biofluids, such as feces and blood. Gabapentin participates in a number of enzymatic reactions. In particular, gabapentin can be biosynthesized from gamma-aminobutyric acid. Gabapentin can also be converted into gabapentin enacarbil. Gabapentin is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Galactonic acid ; HMDB0000565",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000565",
    "description" : "Galactonic acid, also known as D-galactonate, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. Galactonic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Galactonic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, galactonic acid is primarily located in the cytoplasm. Galactonic acid is also a parent compound for other transformation products, including but not limited to, 6-phospho-2-dehydro-3-deoxy-D-galactonic acid, N-acetyl-D-galactosaminic acid, and D-galactono-1,5-lactone.",
    "id" : null
  }, {
    "name" : "gamma-Carboxyglutamic acid ; HMDB0041900",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0041900",
    "description" : "Gamma-Carboxyglutamic acid, also known as G-carboxyglutamate, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Gamma-Carboxyglutamic acid is soluble (in water) and a moderately acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "gamma-CEHC ; HMDB0001931",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001931",
    "description" : "Gamma-Cehc, also known as S-llu-alpha or g-cehc, belongs to the class of organic compounds known as 1-benzopyrans. These are organic aromatic compounds that 1-benzopyran, a bicyclic compound made up of a benzene ring fused to a pyran, so that the oxygen atom is at the 1-position. Gamma-Cehc is considered to be a practically insoluble (in water) and relatively neutral molecule. Gamma-Cehc has been primarily detected in blood. Within the cell, Gamma-cehc is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "gamma-Glutamylalanine ; HMDB0006248",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006248",
    "description" : "L-gamma-Glutamyl-L-alanine, also known as -glutamylalanine or L-gamma-glu-L-ala, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. L-gamma-Glutamyl-L-alanine is soluble (in water) and a moderately acidic compound (based on its pKa). L-gamma-Glutamyl-L-alanine exists in all eukaryotes, ranging from yeast to humans. In humans, L-gamma-glutamyl-L-alanine is involved in the glutathione metabolism pathway. L-gamma-Glutamyl-L-alanine is also involved in several metabolic disorders, some of which include glutathione synthetase deficiency, Gamma-glutamyl-transpeptidase deficiency, 5-oxoprolinase deficiency, and Gamma-glutamyltransferase deficiency.",
    "id" : null
  }, {
    "name" : "gamma-Glutamylglutamic acid ; HMDB0011737",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011737",
    "description" : "Gamma-Glutamylglutamic acid, also known as -glutamylglutamate or gamma-L-glu-L-glu, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Gamma-Glutamylglutamic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gamma-Glutamylglutamic acid has been detected in multiple biofluids, such as feces and blood. Gamma-Glutamylglutamic acid can be biosynthesized from L-glutamic acid.",
    "id" : null
  }, {
    "name" : "gamma-Glutamylglycine ; HMDB0011667",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011667",
    "description" : "Gamma-Glutamylglycine, also known as N-L-glutamylglycine or L-gamma-glu-gly, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Gamma-Glutamylglycine is soluble (in water) and a moderately acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "gamma-Glutamylhistidine ; HMDB0029151",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029151",
    "description" : "Gamma-Glutamylhistidine, also known as L-gamma-glu-L-his or ge-H dipeptide, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Gamma-Glutamylhistidine is slightly soluble (in water) and a moderately acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "gamma-Glutamylleucine ; HMDB0011171",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011171",
    "description" : "Gamma-Glutamylleucine, also known as L-gamma-glu-L-leu or -L-glutamyl-L-leucine, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Gamma-Glutamylleucine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gamma-Glutamylleucine has been detected in multiple biofluids, such as feces and blood. Gamma-Glutamylleucine can be biosynthesized from glutamic acid and leucine. Outside of the human body, Gamma-glutamylleucine can be found in soft-necked garlic. This makes Gamma-glutamylleucine a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "gamma-Glutamylmethionine ; HMDB0034367",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0034367",
    "description" : "H-Glu(met-OH)-OH belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. H-Glu(met-OH)-OH exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). H-Glu(met-OH)-OH can be biosynthesized from L-glutamic acid and L-methionine.",
    "id" : null
  }, {
    "name" : "gamma-Glutamylphenylalanine ; HMDB0000594",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000594",
    "description" : "Gamma-Glutamylphenylalanine, also known as gamma-glu-phe or -glu-phe, belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Gamma-Glutamylphenylalanine is considered to be a practically insoluble (in water) and relatively neutral molecule. Gamma-Glutamylphenylalanine has been found in human kidney tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, Gamma-glutamylphenylalanine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "gamma-Glutamylthreonine ; HMDB0029159",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029159",
    "description" : "Gamma-Glutamylthreonine, also known as L-gamma-glu-L-THR or -L-glutamyl-L-threonine, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Gamma-Glutamylthreonine is soluble (in water) and a moderately acidic compound (based on its pKa). Gamma-Glutamylthreonine has been primarily detected in blood.",
    "id" : null
  }, {
    "name" : "gamma-Glutamyltryptophan ; HMDB0029160",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029160",
    "description" : "Gamma-Glutamyltryptophan, also known as L-gamma-glu-L-TRP or ge-W dipeptide, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Gamma-Glutamyltryptophan is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "gamma-Glutamyltyrosine ; HMDB0011741",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011741",
    "description" : "Gamma-Glutamyltyrosine, also known as glutyrosine or -L-glutamyl-L-tyrosine, belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Gamma-Glutamyltyrosine is considered to be a practically insoluble (in water) and relatively neutral molecule. Gamma-Glutamyltyrosine has been primarily detected in blood. Gamma-Glutamyltyrosine can be biosynthesized from L-glutamic acid and L-tyrosine.",
    "id" : null
  }, {
    "name" : "gamma-Glutamylvaline ; HMDB0011172",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011172",
    "description" : "Gamma-Glutamylvaline, also known as L-gamma-glu-L-val or -L-glutamyl-L-valine, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Gamma-Glutamylvaline is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gamma-Glutamylvaline has been primarily detected in blood.",
    "id" : null
  }, {
    "name" : "Gamma-Linolenic acid ; HMDB0003073",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003073",
    "description" : "Gamma-Linolenic acid, also known as 18:3 (N-6) or GLA, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Gamma-Linolenic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Gamma-Linolenic acid has been found in human adipose tissue and epidermis tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, Gamma-linolenic acid is primarily located in the cytoplasm and membrane (predicted from logP). Gamma-Linolenic acid participates in a number of enzymatic reactions. In particular, Gamma-Linolenic acid can be biosynthesized from linoleic acid through its interaction with the enzyme fatty acid desaturase 2. In addition, Gamma-Linolenic acid can be converted into 8,11,14-eicosatrienoic acid through the action of the enzyme elongation OF very long chain fatty acids protein 5. In humans, Gamma-linolenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "Gamma-Linolenic acid ; HMDB03073",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003073",
    "description" : "Gamma-Linolenic acid, also known as 18:3 (N-6) or GLA, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Gamma-Linolenic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Gamma-Linolenic acid has been found in human adipose tissue and epidermis tissues, and has also been detected in multiple biofluids, such as blood and urine. Within the cell, Gamma-linolenic acid is primarily located in the cytoplasm and membrane (predicted from logP). Gamma-Linolenic acid participates in a number of enzymatic reactions. In particular, Gamma-Linolenic acid can be biosynthesized from linoleic acid through its interaction with the enzyme fatty acid desaturase 2. In addition, Gamma-Linolenic acid can be converted into 8,11,14-eicosatrienoic acid through the action of the enzyme elongation OF very long chain fatty acids protein 5. In humans, Gamma-linolenic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway.",
    "id" : null
  }, {
    "name" : "Gentisic acid ; HMDB0000152",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000152",
    "description" : "Gentisic acid, also known as gentisate or 2,5-dioxybenzoate, belongs to the class of organic compounds known as hydroxybenzoic acid derivatives. Hydroxybenzoic acid derivatives are compounds containing a hydroxybenzoic acid (or a derivative), which is a benzene ring bearing a carboxyl and a hydroxyl groups. Gentisic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Gentisic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, gentisic acid is primarily located in the cytoplasm. Gentisic acid participates in a number of enzymatic reactions. In particular, gentisic acid can be biosynthesized from benzoic acid. Gentisic acid is also a parent compound for other transformation products, including but not limited to, mygalin, 2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside, and 2,5-dihydroxybenzoyl-CoA. Outside of the human body, gentisic acid can be found in a number of food items such as hyssop, common pea, nutmeg, and lemon balm. This makes gentisic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Gentisic acid ; HMDB00152",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000152",
    "description" : "Gentisic acid, also known as gentisate or 2,5-dioxybenzoate, belongs to the class of organic compounds known as hydroxybenzoic acid derivatives. Hydroxybenzoic acid derivatives are compounds containing a hydroxybenzoic acid (or a derivative), which is a benzene ring bearing a carboxyl and a hydroxyl groups. Gentisic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Gentisic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, gentisic acid is primarily located in the cytoplasm. Gentisic acid participates in a number of enzymatic reactions. In particular, gentisic acid can be biosynthesized from benzoic acid. Gentisic acid is also a parent compound for other transformation products, including but not limited to, mygalin, 2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside, and 2,5-dihydroxybenzoyl-CoA. Outside of the human body, gentisic acid can be found in a number of food items such as hyssop, common pea, nutmeg, and lemon balm. This makes gentisic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Gluconic acid ; HMDB0000625",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000625",
    "description" : "Gluconic acid, also known as D-gluconate or dextronic acid, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. Gluconic acid is a drug which is used for use as part of electrolyte supplementation in total parenteral nutrition [fda label]. Gluconic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Gluconic acid has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, gluconic acid is primarily located in the cytoplasm. Gluconic acid exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "Glutamate, gamma-methyl ester ; HMDB0061715",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061715",
    "description" : "Glutamate, gamma-methyl ester, also known as glutamic acid, -methyl ester, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Glutamate, gamma-methyl ester is soluble (in water) and a moderately acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "Glutamyllysine ; HMDB0004207",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004207",
    "description" : "Glutamyllysine, also known as L-glu-L-lys or E-K, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Glutamyllysine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Glutamyllysine has been primarily detected in cerebrospinal fluid. Glutamyllysine can be biosynthesized from L-glutamic acid and L-lysine.",
    "id" : null
  }, {
    "name" : "Glutamyllysine ; HMDB04207",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004207",
    "description" : "Glutamyllysine, also known as L-glu-L-lys or E-K, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Glutamyllysine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Glutamyllysine has been primarily detected in cerebrospinal fluid. Glutamyllysine can be biosynthesized from L-glutamic acid and L-lysine.",
    "id" : null
  }, {
    "name" : "Glutarylcarnitine ; HMDB0013130",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013130",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Glutarylcarnitine ; HMDB13130",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013130",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Glutathione ; HMDB0000125",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000125",
    "description" : "Glutathione, also known as GSH or agifutol S, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Glutathione is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Glutathione exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Glutathione has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, glutathione is primarily located in the cytoplasm, mitochondria and endoplasmic reticulum. Glutathione exists in all eukaryotes, ranging from yeast to humans. Glutathione participates in a number of enzymatic reactions. In particular, Glutathione can be biosynthesized from Gamma-glutamylcysteine and glycine through its interaction with the enzyme glutathione synthetase. Furthermore, Glutathione can be biosynthesized from oxidized glutathione; which is mediated by the enzyme glutathione reductase, mitochondrial. Furthermore, Glutathione can be biosynthesized from Gamma-glutamylcysteine and glycine; which is catalyzed by the enzyme glutathione synthetase. Finally, Glutathione can be converted into oxidized glutathione; which is catalyzed by the enzyme glutathione peroxidase 1. In humans, glutathione is involved in the diflunisal action pathway, the homocarnosinosis pathway, the trisalicylate-choline action pathway, and the cyclophosphamide metabolism pathway. Glutathione is also involved in several metabolic disorders, some of which include the leigh syndrome pathway, Gamma-glutamyltransferase deficiency, the tiaprofenic Acid action pathway, and the 2-hydroxyglutric aciduria (D and L form) pathway. Outside of the human body, glutathione can be found in dill. This makes glutathione a potential biomarker for the consumption of this food product. Glutathione is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Glutathione ; HMDB00125",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000125",
    "description" : "Glutathione, also known as GSH or agifutol S, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Glutathione is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Glutathione exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Glutathione has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, glutathione is primarily located in the cytoplasm, mitochondria and endoplasmic reticulum. Glutathione exists in all eukaryotes, ranging from yeast to humans. Glutathione participates in a number of enzymatic reactions. In particular, Glutathione can be biosynthesized from Gamma-glutamylcysteine and glycine through its interaction with the enzyme glutathione synthetase. Furthermore, Glutathione can be biosynthesized from oxidized glutathione; which is mediated by the enzyme glutathione reductase, mitochondrial. Furthermore, Glutathione can be biosynthesized from Gamma-glutamylcysteine and glycine; which is catalyzed by the enzyme glutathione synthetase. Finally, Glutathione can be converted into oxidized glutathione; which is catalyzed by the enzyme glutathione peroxidase 1. In humans, glutathione is involved in the diflunisal action pathway, the homocarnosinosis pathway, the trisalicylate-choline action pathway, and the cyclophosphamide metabolism pathway. Glutathione is also involved in several metabolic disorders, some of which include the leigh syndrome pathway, Gamma-glutamyltransferase deficiency, the tiaprofenic Acid action pathway, and the 2-hydroxyglutric aciduria (D and L form) pathway. Outside of the human body, glutathione can be found in dill. This makes glutathione a potential biomarker for the consumption of this food product. Glutathione is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Glyceric acid ; HMDB0000139",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000139",
    "description" : "Glyceric acid, also known as glycerate or D-groa, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. Glyceric acid is soluble (in water) and a weakly acidic compound (based on its pKa). Glyceric acid has been found in human prostate tissue, and has also been detected in most biofluids, including cerebrospinal fluid, sweat, blood, and urine. Within the cell, glyceric acid is primarily located in the cytoplasm and mitochondria. Glyceric acid exists in all eukaryotes, ranging from yeast to humans. Glyceric acid participates in a number of enzymatic reactions. In particular, Glyceric acid can be converted into 3-phosphoglyceric acid; which is mediated by the enzyme glycerate kinase. In addition, Glyceric acid can be biosynthesized from 3-phosphoglyceric acid; which is mediated by the enzyme glycerate kinase. In humans, glyceric acid is involved in the glycine and serine metabolism pathway, the glycerolipid metabolism pathway, and the D-glyceric acidura pathway. Glyceric acid is also involved in several metabolic disorders, some of which include dimethylglycine dehydrogenase deficiency, the sarcosinemia pathway, the NON ketotic hyperglycinemia pathway, and glycerol kinase deficiency. Glyceric acid is a potentially toxic compound. Glyceric acid has been found to be associated with the diseases known as schizophrenia; glyceric acid has also been linked to several inborn metabolic disorders including d-glyceric acidemia, primary hyperoxaluria II, and primary hyperoxaluria.",
    "id" : null
  }, {
    "name" : "Glyceric acid ; HMDB00139",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000139",
    "description" : "Glyceric acid, also known as glycerate or D-groa, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. Glyceric acid is soluble (in water) and a weakly acidic compound (based on its pKa). Glyceric acid has been found in human prostate tissue, and has also been detected in most biofluids, including cerebrospinal fluid, sweat, blood, and urine. Within the cell, glyceric acid is primarily located in the cytoplasm and mitochondria. Glyceric acid exists in all eukaryotes, ranging from yeast to humans. Glyceric acid participates in a number of enzymatic reactions. In particular, Glyceric acid can be converted into 3-phosphoglyceric acid; which is mediated by the enzyme glycerate kinase. In addition, Glyceric acid can be biosynthesized from 3-phosphoglyceric acid; which is mediated by the enzyme glycerate kinase. In humans, glyceric acid is involved in the glycine and serine metabolism pathway, the glycerolipid metabolism pathway, and the D-glyceric acidura pathway. Glyceric acid is also involved in several metabolic disorders, some of which include dimethylglycine dehydrogenase deficiency, the sarcosinemia pathway, the NON ketotic hyperglycinemia pathway, and glycerol kinase deficiency. Glyceric acid is a potentially toxic compound. Glyceric acid has been found to be associated with the diseases known as schizophrenia; glyceric acid has also been linked to several inborn metabolic disorders including d-glyceric acidemia, primary hyperoxaluria II, and primary hyperoxaluria.",
    "id" : null
  }, {
    "name" : "Glycerol 3-phosphate ; HMDB0000126",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000126",
    "description" : "Glycerol 3-phosphate, also known as glycerophosphoric acid or sn-gro-1-p, belongs to the class of organic compounds known as glycerophosphates. Glycerophosphates are compounds containing a glycerol linked to a phosphate group. Glycerol 3-phosphate exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Glycerol 3-phosphate has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, glycerol 3-phosphate is primarily located in the cytoplasm and mitochondria. Glycerol 3-phosphate exists in all eukaryotes, ranging from yeast to humans. Glycerol 3-phosphate participates in a number of enzymatic reactions. In particular, Glycerol 3-phosphate can be biosynthesized from dihydroxyacetone phosphate through its interaction with the enzyme glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic. Furthermore, Glycerol 3-phosphate can be converted into cytidine monophosphate; which is catalyzed by the enzyme CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial. Furthermore, Glycerol 3-phosphate can be biosynthesized from dihydroxyacetone phosphate; which is mediated by the enzyme glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic. Furthermore, Palmityl-CoA and glycerol 3-phosphate can be converted into lpa(16:0/0:0) through its interaction with the enzyme glycerol-3-phosphate acyltransferase. Furthermore, Glycerol 3-phosphate can be biosynthesized from dihydroxyacetone phosphate; which is catalyzed by the enzyme glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic. Finally, Palmityl-CoA and glycerol 3-phosphate can be converted into lpa(16:0/0:0) through the action of the enzyme glycerol-3-phosphate acyltransferase. In humans, glycerol 3-phosphate is involved in cardiolipin biosynthesis CL(a-13:0/i-24:0/i-24:0/i-15:0) pathway, cardiolipin biosynthesis CL(i-12:0/i-22:0/i-19:0/i-18:0) pathway, cardiolipin biosynthesis CL(18:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)) pathway, and cardiolipin biosynthesis CL(18:2(9Z,12Z)/18:1(9Z)/18:1(11Z)/16:0) pathway. Glycerol 3-phosphate is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(i-22:0/i-20:0/21:0) pathway, de novo triacylglycerol biosynthesis TG(20:0/19:0/i-20:0) pathway, and de novo triacylglycerol biosynthesis TG(18:1(11Z)/14:0/20:3(8Z,11Z,14Z)) pathway. Outside of the human body, glycerol 3-phosphate can be found in a number of food items such as sweet rowanberry, canada blueberry, spinach, and pepper (c. baccatum). This makes glycerol 3-phosphate a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Glycerol 3-phosphate ; HMDB00126",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000126",
    "description" : "Glycerol 3-phosphate, also known as glycerophosphoric acid or sn-gro-1-p, belongs to the class of organic compounds known as glycerophosphates. Glycerophosphates are compounds containing a glycerol linked to a phosphate group. Glycerol 3-phosphate exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Glycerol 3-phosphate has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, glycerol 3-phosphate is primarily located in the cytoplasm and mitochondria. Glycerol 3-phosphate exists in all eukaryotes, ranging from yeast to humans. Glycerol 3-phosphate participates in a number of enzymatic reactions. In particular, Glycerol 3-phosphate can be biosynthesized from dihydroxyacetone phosphate through its interaction with the enzyme glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic. Furthermore, Glycerol 3-phosphate can be converted into cytidine monophosphate; which is catalyzed by the enzyme CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial. Furthermore, Glycerol 3-phosphate can be biosynthesized from dihydroxyacetone phosphate; which is mediated by the enzyme glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic. Furthermore, Palmityl-CoA and glycerol 3-phosphate can be converted into lpa(16:0/0:0) through its interaction with the enzyme glycerol-3-phosphate acyltransferase. Furthermore, Glycerol 3-phosphate can be biosynthesized from dihydroxyacetone phosphate; which is catalyzed by the enzyme glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic. Finally, Palmityl-CoA and glycerol 3-phosphate can be converted into lpa(16:0/0:0) through the action of the enzyme glycerol-3-phosphate acyltransferase. In humans, glycerol 3-phosphate is involved in cardiolipin biosynthesis CL(a-13:0/i-24:0/i-24:0/i-15:0) pathway, cardiolipin biosynthesis CL(i-12:0/i-22:0/i-19:0/i-18:0) pathway, cardiolipin biosynthesis CL(18:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)) pathway, and cardiolipin biosynthesis CL(18:2(9Z,12Z)/18:1(9Z)/18:1(11Z)/16:0) pathway. Glycerol 3-phosphate is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)) pathway, de novo triacylglycerol biosynthesis TG(i-22:0/i-20:0/21:0) pathway, de novo triacylglycerol biosynthesis TG(20:0/19:0/i-20:0) pathway, and de novo triacylglycerol biosynthesis TG(18:1(11Z)/14:0/20:3(8Z,11Z,14Z)) pathway. Outside of the human body, glycerol 3-phosphate can be found in a number of food items such as sweet rowanberry, canada blueberry, spinach, and pepper (c. baccatum). This makes glycerol 3-phosphate a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Glycerol ; HMDB0000131",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000131",
    "description" : "Glycerol, also known as glycerin or glycyl alcohol, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. Glycerol exists as a liquid, very soluble (in water), and a very weakly acidic compound (based on its pKa). Glycerol has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, sweat, feces, and blood. Within the cell, glycerol is primarily located in the mitochondria, myelin sheath and cytoplasm. Glycerol exists in all eukaryotes, ranging from yeast to humans. Glycerol participates in a number of enzymatic reactions. In particular, Glycerol can be biosynthesized from glyceraldehyde through the action of the enzyme aldose reductase. Furthermore, Glycerol can be converted into glycerol 3-phosphate through the action of the enzyme glycerol kinase. Finally, D-Galactose and glycerol can be converted into galactosylglycerol through the action of the enzyme Alpha-galactosidase a. In humans, glycerol is involved in the D-glyceric acidura pathway, the galactose metabolism pathway, and the glycerolipid metabolism pathway. Glycerol is also involved in a few metabolic disorders, which include glycerol kinase deficiency, the galactosemia pathway, and familial lipoprotein lipase deficiency. Glycerol is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Glycerol triheptadecanoate ; HMDB0031106",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0031106",
    "description" : "TG(17:0/17:0/17:0), also known as triheptadecanoin, 8CI or trimargarin, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(17:0/17:0/17:0) is considered to be a triradylglycerol lipid molecule. TG(17:0/17:0/17:0) exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. TG(17:0/17:0/17:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(17:0/17:0/17:0) is primarily located in the membrane (predicted from logP) and adiposome.",
    "id" : null
  }, {
    "name" : "Glycerol triheptadecanoate ; HMDB31106",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0031106",
    "description" : "TG(17:0/17:0/17:0), also known as triheptadecanoin, 8CI or trimargarin, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(17:0/17:0/17:0) is considered to be a triradylglycerol lipid molecule. TG(17:0/17:0/17:0) exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. TG(17:0/17:0/17:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(17:0/17:0/17:0) is primarily located in the membrane (predicted from logP) and adiposome.",
    "id" : null
  }, {
    "name" : "Glycerophosphocholine ; HMDB0000086",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000086",
    "description" : "Glycerophosphocholine, also known as choline alfoscerate or GPC, belongs to the class of organic compounds known as glycerophosphocholines. These are lipids containing a glycerol moiety carrying a phosphocholine at the 3-position. Glycerophosphocholine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Glycerophosphocholine has been found throughout most human tissues, and has also been detected in most biofluids, including semen, cerebrospinal fluid, saliva, and feces. Within the cell, glycerophosphocholine is primarily located in the cytoplasm. Glycerophosphocholine exists in all eukaryotes, ranging from yeast to humans. Glycerophosphocholine participates in a number of enzymatic reactions. In particular, Glycerophosphocholine can be biosynthesized from 11-cis-retinol and PC(24:1(15Z)/15:0); which is mediated by the enzyme lecithin retinol acyltransferase. In addition, Retinyl ester and glycerophosphocholine can be biosynthesized from vitamin a and PC(24:1(15Z)/15:0); which is mediated by the enzyme lecithin retinol acyltransferase. In humans, glycerophosphocholine is involved in the retinol metabolism pathway. Glycerophosphocholine is also involved in the metabolic disorder called vitamin a deficiency.",
    "id" : null
  }, {
    "name" : "Glycerophosphocholine ; HMDB00086",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000086",
    "description" : "Glycerophosphocholine, also known as choline alfoscerate or GPC, belongs to the class of organic compounds known as glycerophosphocholines. These are lipids containing a glycerol moiety carrying a phosphocholine at the 3-position. Glycerophosphocholine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Glycerophosphocholine has been found throughout most human tissues, and has also been detected in most biofluids, including semen, cerebrospinal fluid, saliva, and feces. Within the cell, glycerophosphocholine is primarily located in the cytoplasm. Glycerophosphocholine exists in all eukaryotes, ranging from yeast to humans. Glycerophosphocholine participates in a number of enzymatic reactions. In particular, Glycerophosphocholine can be biosynthesized from 11-cis-retinol and PC(24:1(15Z)/15:0); which is mediated by the enzyme lecithin retinol acyltransferase. In addition, Retinyl ester and glycerophosphocholine can be biosynthesized from vitamin a and PC(24:1(15Z)/15:0); which is mediated by the enzyme lecithin retinol acyltransferase. In humans, glycerophosphocholine is involved in the retinol metabolism pathway. Glycerophosphocholine is also involved in the metabolic disorder called vitamin a deficiency.",
    "id" : null
  }, {
    "name" : "Glycerylphosphorylethanolamine ; HMDB0000114",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000114",
    "description" : "Glycerylphosphorylethanolamine, also known as gpea, belongs to the class of organic compounds known as organic phosphoramides. These are organic compounds containing the phosphoric acid amide functional group. Glycerylphosphorylethanolamine is soluble (in water) and a moderately acidic compound (based on its pKa). Glycerylphosphorylethanolamine has been found in human brain, prostate and liver tissues. Within the cell, glycerylphosphorylethanolamine is primarily located in the cytoplasm. Glycerylphosphorylethanolamine can be converted into glycerol 3-phosphate and ethanolamine through its interaction with the enzyme glycerophosphodiester phosphodiesterase 1. In humans, glycerylphosphorylethanolamine is involved in phospholipid biosynthesis pathway.",
    "id" : null
  }, {
    "name" : "Glycine ; HMDB0000123",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000123",
    "description" : "Glycine, also known as Gly or aminoacetic acid, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Glycine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Glycine has been found throughout most human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, saliva, and bile. Glycine can be found anywhere throughout the human cell, such as in myelin sheath, cytoplasm, peroxisome, and mitochondria. Glycine exists in all eukaryotes, ranging from yeast to humans. Glycine participates in a number of enzymatic reactions. In particular, Gamma-Glutamylcysteine and glycine can be converted into glutathione through its interaction with the enzyme glutathione synthetase. Furthermore, Chenodeoxycholoyl-CoA and glycine can be converted into chenodeoxycholic acid glycine conjugate and glycocholic acid; which is mediated by the enzyme bile acid-coa:amino acid N-acyltransferase. Furthermore, Acetyl-CoA and glycine can be converted into L-2-amino-3-oxobutanoic acid through the action of the enzyme 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial. Finally, Formaldehyde and glycine can be biosynthesized from sarcosine; which is mediated by the enzyme sarcosine dehydrogenase, mitochondrial. In humans, glycine is involved in the homocarnosinosis pathway, the sarcosine oncometabolite pathway, the glutathione metabolism pathway, and the thioguanine action pathway. Glycine is also involved in several metabolic disorders, some of which include the ammonia recycling pathway, congenital erythropoietic porphyria (cep) or gunther disease pathway, adenylosuccinate lyase deficiency, and succinic semialdehyde dehydrogenase deficiency. Glycine is a potentially toxic compound. Glycine has been found to be associated with several diseases known as phosphoserine phosphatase deficiency, glucoglycinuria, epilepsy, early-onset, vitamin b6-dependent, and hyperglycinemia, lactic acidosis, and seizures; glycine has also been linked to the inborn metabolic disorders including tyrosinemia I.",
    "id" : null
  }, {
    "name" : "Glycine ; HMDB00123",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000123",
    "description" : "Glycine, also known as Gly or aminoacetic acid, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Glycine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Glycine has been found throughout most human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, saliva, and bile. Glycine can be found anywhere throughout the human cell, such as in myelin sheath, cytoplasm, peroxisome, and mitochondria. Glycine exists in all eukaryotes, ranging from yeast to humans. Glycine participates in a number of enzymatic reactions. In particular, Gamma-Glutamylcysteine and glycine can be converted into glutathione through its interaction with the enzyme glutathione synthetase. Furthermore, Chenodeoxycholoyl-CoA and glycine can be converted into chenodeoxycholic acid glycine conjugate and glycocholic acid; which is mediated by the enzyme bile acid-coa:amino acid N-acyltransferase. Furthermore, Acetyl-CoA and glycine can be converted into L-2-amino-3-oxobutanoic acid through the action of the enzyme 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial. Finally, Formaldehyde and glycine can be biosynthesized from sarcosine; which is mediated by the enzyme sarcosine dehydrogenase, mitochondrial. In humans, glycine is involved in the homocarnosinosis pathway, the sarcosine oncometabolite pathway, the glutathione metabolism pathway, and the thioguanine action pathway. Glycine is also involved in several metabolic disorders, some of which include the ammonia recycling pathway, congenital erythropoietic porphyria (cep) or gunther disease pathway, adenylosuccinate lyase deficiency, and succinic semialdehyde dehydrogenase deficiency. Glycine is a potentially toxic compound. Glycine has been found to be associated with several diseases known as phosphoserine phosphatase deficiency, glucoglycinuria, epilepsy, early-onset, vitamin b6-dependent, and hyperglycinemia, lactic acidosis, and seizures; glycine has also been linked to the inborn metabolic disorders including tyrosinemia I.",
    "id" : null
  }, {
    "name" : "Glycocholic acid ; HMDB0000138",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000138",
    "description" : "Glycocholic acid, also known as glycocholate or cholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Glycocholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Glycocholic acid has been found in human hepatic tissue, prostate and liver tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, glycocholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Glycocholic acid participates in a number of enzymatic reactions. In particular, Chenodeoxycholic acid glycine conjugate and glycocholic acid can be biosynthesized from chenodeoxycholoyl-CoA and glycine; which is mediated by the enzyme bile acid-coa:amino acid N-acyltransferase. In addition, Glycocholic acid can be biosynthesized from choloyl-CoA and glycine; which is catalyzed by the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, glycocholic acid is involved in congenital bile acid synthesis defect type II pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type III pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Glycocholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Glycocholic acid ; HMDB00138",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000138",
    "description" : "Glycocholic acid, also known as glycocholate or cholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Glycocholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Glycocholic acid has been found in human hepatic tissue, prostate and liver tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, glycocholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Glycocholic acid participates in a number of enzymatic reactions. In particular, Chenodeoxycholic acid glycine conjugate and glycocholic acid can be biosynthesized from chenodeoxycholoyl-CoA and glycine; which is mediated by the enzyme bile acid-coa:amino acid N-acyltransferase. In addition, Glycocholic acid can be biosynthesized from choloyl-CoA and glycine; which is catalyzed by the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, glycocholic acid is involved in congenital bile acid synthesis defect type II pathway, bile acid biosynthesis pathway, congenital bile acid synthesis defect type III pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Glycocholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Glycoursodeoxycholic acid ; HMDB0000708",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000708",
    "description" : "Glycoursodeoxycholic acid, also known as gudca or ursodeoxycholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Glycoursodeoxycholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Glycoursodeoxycholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, glycoursodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Glycoursodeoxycholic acid can be biosynthesized from ursodeoxycholic acid.",
    "id" : null
  }, {
    "name" : "Glycoursodeoxycholic acid ; HMDB00708",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000708",
    "description" : "Glycoursodeoxycholic acid, also known as gudca or ursodeoxycholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Glycoursodeoxycholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Glycoursodeoxycholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, glycoursodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Glycoursodeoxycholic acid can be biosynthesized from ursodeoxycholic acid.",
    "id" : null
  }, {
    "name" : "Glycylleucine ; HMDB0000759",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000759",
    "description" : "Glycylleucine, also known as GL or gly-DL-leu, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Glycylleucine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Glycylleucine has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, feces, and urine. Within the cell, glycylleucine is primarily located in the mitochondria. Glycylleucine can be biosynthesized from glycine and L-leucine.",
    "id" : null
  }, {
    "name" : "Guanidoacetic acid ; HMDB0000128",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000128",
    "description" : "Guanidoacetic acid, also known as guanidinoacetate or N-amidinoglycine, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Guanidoacetic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Guanidoacetic acid has been found in human brain, liver and kidney tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, guanidoacetic acid is primarily located in the cytoplasm and mitochondria. Guanidoacetic acid participates in a number of enzymatic reactions. In particular, Guanidoacetic acid and orotidylic acid can be biosynthesized from glycine and L-arginine through the action of the enzyme glycine amidinotransferase, mitochondrial. Furthermore, Guanidoacetic acid and S-adenosylhomocysteine can be converted into S-adenosylmethionine and creatine through the action of the enzyme guanidinoacetate N-methyltransferase. Furthermore, Ornithine and guanidoacetic acid can be biosynthesized from L-arginine and glycine through the action of the enzyme glycine amidinotransferase, mitochondrial. Finally, S-Adenosylmethionine and guanidoacetic acid can be converted into S-adenosylhomocysteine and creatine through its interaction with the enzyme guanidinoacetate N-methyltransferase. In humans, guanidoacetic acid is involved in the glycine and serine metabolism pathway and the arginine and proline metabolism pathway. Guanidoacetic acid is also involved in several metabolic disorders, some of which include guanidinoacetate methyltransferase deficiency (gamt deficiency), ornithine aminotransferase deficiency (oat deficiency), the hyperprolinemia type I pathway, and dihydropyrimidine dehydrogenase deficiency (DHPD). Outside of the human body, guanidoacetic acid can be found in apple and loquat. This makes guanidoacetic acid a potential biomarker for the consumption of these food products. Guanidoacetic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Guanidoacetic acid ; HMDB00128",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000128",
    "description" : "Guanidoacetic acid, also known as guanidinoacetate or N-amidinoglycine, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Guanidoacetic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Guanidoacetic acid has been found in human brain, liver and kidney tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, guanidoacetic acid is primarily located in the cytoplasm and mitochondria. Guanidoacetic acid participates in a number of enzymatic reactions. In particular, Guanidoacetic acid and orotidylic acid can be biosynthesized from glycine and L-arginine through the action of the enzyme glycine amidinotransferase, mitochondrial. Furthermore, Guanidoacetic acid and S-adenosylhomocysteine can be converted into S-adenosylmethionine and creatine through the action of the enzyme guanidinoacetate N-methyltransferase. Furthermore, Ornithine and guanidoacetic acid can be biosynthesized from L-arginine and glycine through the action of the enzyme glycine amidinotransferase, mitochondrial. Finally, S-Adenosylmethionine and guanidoacetic acid can be converted into S-adenosylhomocysteine and creatine through its interaction with the enzyme guanidinoacetate N-methyltransferase. In humans, guanidoacetic acid is involved in the glycine and serine metabolism pathway and the arginine and proline metabolism pathway. Guanidoacetic acid is also involved in several metabolic disorders, some of which include guanidinoacetate methyltransferase deficiency (gamt deficiency), ornithine aminotransferase deficiency (oat deficiency), the hyperprolinemia type I pathway, and dihydropyrimidine dehydrogenase deficiency (DHPD). Outside of the human body, guanidoacetic acid can be found in apple and loquat. This makes guanidoacetic acid a potential biomarker for the consumption of these food products. Guanidoacetic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Guanine ; HMDB0000132",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000132",
    "description" : "Guanine, also known as G or mearlmaid aa, belongs to the class of organic compounds known as purines and purine derivatives. These are aromatic heterocyclic compounds containing a purine moiety, which is formed a pyrimidine-ring ring fused to an imidazole ring. Guanine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Guanine has been found throughout most human tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, guanine is primarily located in the myelin sheath. Guanine exists in all eukaryotes, ranging from yeast to humans. Guanine participates in a number of enzymatic reactions. In particular, Guanine and phosphoribosyl pyrophosphate can be biosynthesized from guanosine monophosphate through its interaction with the enzyme adenine phosphoribosyltransferase. In addition, Guanine and ribose 1-phosphate can be biosynthesized from guanosine; which is mediated by the enzyme purine nucleoside phosphorylase. In humans, guanine is involved in the mercaptopurine action pathway, the thioguanine action pathway, the purine metabolism pathway, and the azathioprine action pathway. Guanine is also involved in several metabolic disorders, some of which include purine nucleoside phosphorylase deficiency, the mitochondrial dna depletion syndrome pathway, the xanthinuria type II pathway, and adenosine deaminase deficiency. Outside of the human body, guanine can be found in guava. This makes guanine a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Guanosine ; HMDB0000133",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000133",
    "description" : "Guanosine, also known as G or 2-amino-inosine, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Guanosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Guanosine has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, guanosine is primarily located in the mitochondria, lysosome and cytoplasm. Guanosine exists in all eukaryotes, ranging from yeast to humans. Guanosine participates in a number of enzymatic reactions. In particular, Guanosine can be biosynthesized from guanosine monophosphate; which is mediated by the enzyme cytosolic purine 5'-nucleotidase. In addition, Guanosine can be converted into guanine and ribose 1-phosphate through the action of the enzyme purine nucleoside phosphorylase. In humans, guanosine is involved in the purine metabolism pathway, the azathioprine action pathway, the thioguanine action pathway, and the mercaptopurine action pathway. Guanosine is also involved in several metabolic disorders, some of which include adenylosuccinate lyase deficiency, the gout or kelley-seegmiller syndrome pathway, the AICA-ribosiduria pathway, and the xanthinuria type I pathway.",
    "id" : null
  }, {
    "name" : "Guanosine ; HMDB00133",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000133",
    "description" : "Guanosine, also known as G or 2-amino-inosine, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Guanosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Guanosine has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, guanosine is primarily located in the mitochondria, lysosome and cytoplasm. Guanosine exists in all eukaryotes, ranging from yeast to humans. Guanosine participates in a number of enzymatic reactions. In particular, Guanosine can be biosynthesized from guanosine monophosphate; which is mediated by the enzyme cytosolic purine 5'-nucleotidase. In addition, Guanosine can be converted into guanine and ribose 1-phosphate through the action of the enzyme purine nucleoside phosphorylase. In humans, guanosine is involved in the purine metabolism pathway, the azathioprine action pathway, the thioguanine action pathway, and the mercaptopurine action pathway. Guanosine is also involved in several metabolic disorders, some of which include adenylosuccinate lyase deficiency, the gout or kelley-seegmiller syndrome pathway, the AICA-ribosiduria pathway, and the xanthinuria type I pathway.",
    "id" : null
  }, {
    "name" : "Guanosine diphosphate ; HMDB0001201",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001201",
    "description" : "Guanosine diphosphate, also known as 5'-diphosphate, guanosine or GDP, belongs to the class of organic compounds known as purine ribonucleoside diphosphates. These are purine ribobucleotides with diphosphate group linked to the ribose moiety. Guanosine diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Guanosine diphosphate has been detected in multiple biofluids, such as blood and cerebrospinal fluid. Within the cell, guanosine diphosphate is primarily located in the cytoplasm, mitochondria, nucleus and golgi. Guanosine diphosphate exists in all eukaryotes, ranging from yeast to humans. Guanosine diphosphate participates in a number of enzymatic reactions. In particular, Guanosine diphosphate can be converted into guanosine triphosphate through the action of the enzyme nucleoside diphosphate kinase 6. In addition, Guanosine diphosphate can be converted into guanosine monophosphate; which is catalyzed by the enzyme ectonucleoside triphosphate diphosphohydrolase 5. In humans, guanosine diphosphate is involved in the clocinizine H1-antihistamine action pathway, the alimemazine H1-antihistamine action pathway, the aspartate metabolism pathway, and the intracellular signalling through LHCGR receptor and luteinizing hormone/choriogonadotropin pathway. Guanosine diphosphate is also involved in several metabolic disorders, some of which include the hypoacetylaspartia pathway, the gout or kelley-seegmiller syndrome pathway, adenosine deaminase deficiency, and the leigh syndrome pathway. Outside of the human body, guanosine diphosphate can be found in a number of food items such as garlic, skunk currant, carob, and japanese walnut. This makes guanosine diphosphate a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Guanosine diphosphate ; HMDB01201",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001201",
    "description" : "Guanosine diphosphate, also known as 5'-diphosphate, guanosine or GDP, belongs to the class of organic compounds known as purine ribonucleoside diphosphates. These are purine ribobucleotides with diphosphate group linked to the ribose moiety. Guanosine diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Guanosine diphosphate has been detected in multiple biofluids, such as blood and cerebrospinal fluid. Within the cell, guanosine diphosphate is primarily located in the cytoplasm, mitochondria, nucleus and golgi. Guanosine diphosphate exists in all eukaryotes, ranging from yeast to humans. Guanosine diphosphate participates in a number of enzymatic reactions. In particular, Guanosine diphosphate can be converted into guanosine triphosphate through the action of the enzyme nucleoside diphosphate kinase 6. In addition, Guanosine diphosphate can be converted into guanosine monophosphate; which is catalyzed by the enzyme ectonucleoside triphosphate diphosphohydrolase 5. In humans, guanosine diphosphate is involved in the clocinizine H1-antihistamine action pathway, the alimemazine H1-antihistamine action pathway, the aspartate metabolism pathway, and the intracellular signalling through LHCGR receptor and luteinizing hormone/choriogonadotropin pathway. Guanosine diphosphate is also involved in several metabolic disorders, some of which include the hypoacetylaspartia pathway, the gout or kelley-seegmiller syndrome pathway, adenosine deaminase deficiency, and the leigh syndrome pathway. Outside of the human body, guanosine diphosphate can be found in a number of food items such as garlic, skunk currant, carob, and japanese walnut. This makes guanosine diphosphate a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Heme ; HMDB0003178",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003178",
    "description" : "Heme is the color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. A heme or haem is a prosthetic group that consists of an iron atom contained in the center of a large heterocyclic organic ring called a porphyrin. Not all porphyrins contain iron, but a substantial fraction of porphyrin-containing metalloproteins have heme as their prosthetic subunit; these are known as hemoproteins.",
    "id" : null
  }, {
    "name" : "Heptadecanoic acid ; HMDB0002259",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002259",
    "description" : "Margaric acid, also known as 17:0 or heptadecoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Margaric acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Margaric acid has been found in human skeletal muscle, adipose tissue and prostate tissues, and has also been primarily detected in feces, saliva, blood, and urine. Within the cell, margaric acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Margaric acid exists in all eukaryotes, ranging from yeast to humans. Margaric acid is also a parent compound for other transformation products, including but not limited to, 2-hydroxyheptadecanoic acid, (16R)-16-hydroxymargaric acid, and cholesteryl heptadecanoate.",
    "id" : null
  }, {
    "name" : "Heptadecanoic acid ; HMDB02259",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002259",
    "description" : "Margaric acid, also known as 17:0 or heptadecoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Margaric acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Margaric acid has been found in human skeletal muscle, adipose tissue and prostate tissues, and has also been primarily detected in feces, saliva, blood, and urine. Within the cell, margaric acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Margaric acid exists in all eukaryotes, ranging from yeast to humans. Margaric acid is also a parent compound for other transformation products, including but not limited to, 2-hydroxyheptadecanoic acid, (16R)-16-hydroxymargaric acid, and cholesteryl heptadecanoate.",
    "id" : null
  }, {
    "name" : "Heptanoylcarnitine ; HMDB0013238",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013238",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Heptanoylcarnitine ; HMDB13238",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013238",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Hexacosanoyl carnitine ; HMDB0006347",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006347",
    "description" : "Hexacosanoyl carnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, hexacosanoyl carnitine is considered to be a fatty ester lipid molecule. Hexacosanoyl carnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Hexacosanoyl carnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, hexacosanoyl carnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria.",
    "id" : null
  }, {
    "name" : "Hexacosanoyl carnitine ; HMDB06347",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006347",
    "description" : "Hexacosanoyl carnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, hexacosanoyl carnitine is considered to be a fatty ester lipid molecule. Hexacosanoyl carnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Hexacosanoyl carnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, hexacosanoyl carnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria.",
    "id" : null
  }, {
    "name" : "Hexadecanedioic acid ; HMDB0000672",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000672",
    "description" : "Thapsic acid, also known as thapsate or hexadecanedioate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thapsic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Thapsic acid has been detected in multiple biofluids, such as feces and urine. Within the cell, thapsic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Thapsic acid is also a parent compound for other transformation products, including but not limited to, (3S)-hydroxyhexadecanedioyl-CoA, hexadecanedioyl-CoA, and (3R)-hydroxyhexadecanedioyl-CoA. Outside of the human body, thapsic acid can be found in potato and sweet cherry. This makes thapsic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Hexadecanedioic acid ; HMDB00672",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000672",
    "description" : "Thapsic acid, also known as thapsate or hexadecanedioate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thapsic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Thapsic acid has been detected in multiple biofluids, such as feces and urine. Within the cell, thapsic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Thapsic acid is also a parent compound for other transformation products, including but not limited to, (3S)-hydroxyhexadecanedioyl-CoA, hexadecanedioyl-CoA, and (3R)-hydroxyhexadecanedioyl-CoA. Outside of the human body, thapsic acid can be found in potato and sweet cherry. This makes thapsic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Hexanoylcarnitine ; HMDB0000705",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000705",
    "description" : "Hexanoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, hexanoylcarnitine is considered to be a fatty ester lipid molecule. Hexanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Hexanoylcarnitine has been found in human prostate tissue, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, hexanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Hexanoylcarnitine has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Hexanoylcarnitine ; HMDB0000756",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000756",
    "description" : "Hexanoylcarnitine (CAS: 6418-78-6), also known as caproylcarnitine, is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physicochemical properties as well. High-performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.). Hexanoylcarnitine is a medium-chain acylcarnitine present in the urine of patients with medium-chain acyl-CoA dehydrogenase deficiency (PMID: 1635814). Hexanoylcarnitine is also found to be associated with celiac disease and glutaric aciduria II which are both inborn errors of metabolism.",
    "id" : null
  }, {
    "name" : "Hexanoylcarnitine ; HMDB00705",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000705",
    "description" : "Hexanoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, hexanoylcarnitine is considered to be a fatty ester lipid molecule. Hexanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Hexanoylcarnitine has been found in human prostate tissue, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, hexanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Hexanoylcarnitine has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Hexanoylglycine ; HMDB0000701",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000701",
    "description" : "Hexanoylglycine, also known as N-caproylglycine, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Hexanoylglycine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Hexanoylglycine has been detected in multiple biofluids, such as urine and blood. Hexanoylglycine has been linked to the inborn metabolic disorders including medium chain acyl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Hippuric acid ; HMDB0000714",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000714",
    "description" : "Hippuric acid, also known as N-benzoylglycine or hippurate, belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. Hippuric acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Hippuric acid has been found in human prostate, liver and kidney tissues, and has also been detected in most biofluids, including urine, blood, cerebrospinal fluid, and feces. Within the cell, hippuric acid is primarily located in the cytoplasm. Hippuric acid is also a parent compound for other transformation products, including but not limited to, p-hydroxyhippuric acid, alpha-hydroxyhippuric acid, and m-methylhippuric acid. Outside of the human body, hippuric acid can be found in american cranberry and avocado. This makes hippuric acid a potential biomarker for the consumption of these food products. Hippuric acid is a potentially toxic compound. Hippuric acid has been found to be associated with several diseases known as paraquat poisoning, schizophrenia, and lung cancer; hippuric acid has also been linked to several inborn metabolic disorders including phenylketonuria and propionic acidemia.",
    "id" : null
  }, {
    "name" : "Hippuric acid ; HMDB00714",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000714",
    "description" : "Hippuric acid, also known as N-benzoylglycine or hippurate, belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. Hippuric acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Hippuric acid has been found in human prostate, liver and kidney tissues, and has also been detected in most biofluids, including urine, blood, cerebrospinal fluid, and feces. Within the cell, hippuric acid is primarily located in the cytoplasm. Hippuric acid is also a parent compound for other transformation products, including but not limited to, p-hydroxyhippuric acid, alpha-hydroxyhippuric acid, and m-methylhippuric acid. Outside of the human body, hippuric acid can be found in american cranberry and avocado. This makes hippuric acid a potential biomarker for the consumption of these food products. Hippuric acid is a potentially toxic compound. Hippuric acid has been found to be associated with several diseases known as paraquat poisoning, schizophrenia, and lung cancer; hippuric acid has also been linked to several inborn metabolic disorders including phenylketonuria and propionic acidemia.",
    "id" : null
  }, {
    "name" : "Homo-L-arginine ; HMDB0000670",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000670",
    "description" : "Homo-L-arginine, also known as n6-amidino-lysine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Homo-L-arginine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Homo-L-arginine has been found in human intestine and testicle tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, homo-L-arginine is primarily located in the cytoplasm. Homo-L-arginine has been found to be associated with the diseases known as cirrhosis; homo-l-arginine has also been linked to the inborn metabolic disorders including hyperargininemia.",
    "id" : null
  }, {
    "name" : "Homo-L-arginine ; HMDB00670",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000670",
    "description" : "Homo-L-arginine, also known as n6-amidino-lysine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Homo-L-arginine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Homo-L-arginine has been found in human intestine and testicle tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, homo-L-arginine is primarily located in the cytoplasm. Homo-L-arginine has been found to be associated with the diseases known as cirrhosis; homo-l-arginine has also been linked to the inborn metabolic disorders including hyperargininemia.",
    "id" : null
  }, {
    "name" : "Homocitrulline ; HMDB0000679",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000679",
    "description" : "Homocitrulline belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Homocitrulline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Homocitrulline has been detected in multiple biofluids, such as urine and blood. Within the cell, homocitrulline is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Homocitrulline ; HMDB00679",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000679",
    "description" : "Homocitrulline belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Homocitrulline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Homocitrulline has been detected in multiple biofluids, such as urine and blood. Within the cell, homocitrulline is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Homocysteine ; HMDB0000742",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000742",
    "description" : "Homocysteine, also known as Hcy or homo-cys, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Homocysteine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Homocysteine has been found throughout most human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, homocysteine is primarily located in the cytoplasm. Homocysteine exists in all eukaryotes, ranging from yeast to humans. Homocysteine participates in a number of enzymatic reactions. In particular, Betaine and homocysteine can be converted into dimethylglycine and L-methionine through the action of the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, L-Serine and homocysteine can be converted into L-cystathionine; which is mediated by the enzyme cystathionine beta-synthase. Furthermore, Betaine and homocysteine can be converted into dimethylglycine and L-methionine through its interaction with the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, Homocysteine and 5-methyltetrahydrofolic acid can be converted into L-methionine and tetrahydrofolic acid through its interaction with the enzyme methionine synthase. Furthermore, 5-Methyltetrahydrofolic acid and homocysteine can be converted into tetrahydrofolic acid and L-methionine through the action of the enzyme methionine synthase. Finally, Homocysteine and L-serine can be converted into L-cystathionine through its interaction with the enzyme cystathionine beta-synthase. In humans, homocysteine is involved in the sarcosine oncometabolite pathway, the methionine metabolism pathway, the betaine metabolism pathway, and catecholamine biosynthesis pathway. Homocysteine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, methylenetetrahydrofolate reductase deficiency (MTHFRD), the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, and the hypermethioninemia pathway. Outside of the human body, homocysteine can be found in a number of food items such as acerola, walnut, chinese bayberry, and passion fruit. This makes homocysteine a potential biomarker for the consumption of these food products. Homocysteine is a potentially toxic compound. Homocysteine has been found to be associated with several diseases known as continuous ambulatory peritoneal dialysis, alzheimer's disease, multiple sclerosis, and peripheral neuropathy; homocysteine has also been linked to the inborn metabolic disorders including homocystinuria.",
    "id" : null
  }, {
    "name" : "Homocysteine ; HMDB00742",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000742",
    "description" : "Homocysteine, also known as Hcy or homo-cys, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Homocysteine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Homocysteine has been found throughout most human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, homocysteine is primarily located in the cytoplasm. Homocysteine exists in all eukaryotes, ranging from yeast to humans. Homocysteine participates in a number of enzymatic reactions. In particular, Betaine and homocysteine can be converted into dimethylglycine and L-methionine through the action of the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, L-Serine and homocysteine can be converted into L-cystathionine; which is mediated by the enzyme cystathionine beta-synthase. Furthermore, Betaine and homocysteine can be converted into dimethylglycine and L-methionine through its interaction with the enzyme betaine--homocysteine S-methyltransferase 1. Furthermore, Homocysteine and 5-methyltetrahydrofolic acid can be converted into L-methionine and tetrahydrofolic acid through its interaction with the enzyme methionine synthase. Furthermore, 5-Methyltetrahydrofolic acid and homocysteine can be converted into tetrahydrofolic acid and L-methionine through the action of the enzyme methionine synthase. Finally, Homocysteine and L-serine can be converted into L-cystathionine through its interaction with the enzyme cystathionine beta-synthase. In humans, homocysteine is involved in the sarcosine oncometabolite pathway, the methionine metabolism pathway, the betaine metabolism pathway, and catecholamine biosynthesis pathway. Homocysteine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, methylenetetrahydrofolate reductase deficiency (MTHFRD), the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway, and the hypermethioninemia pathway. Outside of the human body, homocysteine can be found in a number of food items such as acerola, walnut, chinese bayberry, and passion fruit. This makes homocysteine a potential biomarker for the consumption of these food products. Homocysteine is a potentially toxic compound. Homocysteine has been found to be associated with several diseases known as continuous ambulatory peritoneal dialysis, alzheimer's disease, multiple sclerosis, and peripheral neuropathy; homocysteine has also been linked to the inborn metabolic disorders including homocystinuria.",
    "id" : null
  }, {
    "name" : "Homovanillic acid ; HMDB0000118",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000118",
    "description" : "Homovanillic acid, also known as vanillacetate or homovanillate, belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. Homovanillic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Homovanillic acid has been found in human brain, spinal cord and kidney tissues, and has also been detected in most biofluids, including blood, urine, saliva, and feces. Within the cell, homovanillic acid is primarily located in the cytoplasm. Homovanillic acid exists in all eukaryotes, ranging from yeast to humans. Homovanillic acid participates in a number of enzymatic reactions. In particular, Homovanillic acid can be biosynthesized from homovanillin; which is catalyzed by the enzyme aldehyde dehydrogenase, dimeric nadp-preferring. In addition, Homovanillic acid and pyrocatechol can be biosynthesized from 3,4-dihydroxybenzeneacetic acid and guaiacol through its interaction with the enzyme catechol O-methyltransferase. In humans, homovanillic acid is involved in the disulfiram action pathway and the tyrosine metabolism pathway. Homovanillic acid is also involved in several metabolic disorders, some of which include the tyrosinemia type I pathway, tyrosinemia, transient, OF the newborn pathway, dopamine beta-hydroxylase deficiency, and the hawkinsinuria pathway. Outside of the human body, homovanillic acid can be found in avocado, beer, and olive. This makes homovanillic acid a potential biomarker for the consumption of these food products. Homovanillic acid has been found to be associated with several diseases known as narcolepsy, major depressive disorder, and schizophrenia; homovanillic acid has also been linked to several inborn metabolic disorders including celiac disease and growth hormone deficiency.",
    "id" : null
  }, {
    "name" : "Homovanillic acid ; HMDB00118",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000118",
    "description" : "Homovanillic acid, also known as vanillacetate or homovanillate, belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. Homovanillic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Homovanillic acid has been found in human brain, spinal cord and kidney tissues, and has also been detected in most biofluids, including blood, urine, saliva, and feces. Within the cell, homovanillic acid is primarily located in the cytoplasm. Homovanillic acid exists in all eukaryotes, ranging from yeast to humans. Homovanillic acid participates in a number of enzymatic reactions. In particular, Homovanillic acid can be biosynthesized from homovanillin; which is catalyzed by the enzyme aldehyde dehydrogenase, dimeric nadp-preferring. In addition, Homovanillic acid and pyrocatechol can be biosynthesized from 3,4-dihydroxybenzeneacetic acid and guaiacol through its interaction with the enzyme catechol O-methyltransferase. In humans, homovanillic acid is involved in the disulfiram action pathway and the tyrosine metabolism pathway. Homovanillic acid is also involved in several metabolic disorders, some of which include the tyrosinemia type I pathway, tyrosinemia, transient, OF the newborn pathway, dopamine beta-hydroxylase deficiency, and the hawkinsinuria pathway. Outside of the human body, homovanillic acid can be found in avocado, beer, and olive. This makes homovanillic acid a potential biomarker for the consumption of these food products. Homovanillic acid has been found to be associated with several diseases known as narcolepsy, major depressive disorder, and schizophrenia; homovanillic acid has also been linked to several inborn metabolic disorders including celiac disease and growth hormone deficiency.",
    "id" : null
  }, {
    "name" : "Hydantoin-5-propionic acid ; HMDB0001212",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001212",
    "description" : "Hydantoin-5-propionic acid, also known as hydantoin-propionate, belongs to the class of organic compounds known as hydantoins. These are heterocyclic compounds containing an imidazolidine substituted by ketone group at positions 2 and 4. Hydantoin-5-propionic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Within the cell, hydantoin-5-propionic acid is primarily located in the cytoplasm. Hydantoin-5-propionic acid can be converted into hydantoin.",
    "id" : null
  }, {
    "name" : "Hydrochlorothiazide ; HMDB0001928",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001928",
    "description" : "Hydrochlorothiazide, also known as microzide or hydrodiuril, belongs to the class of organic compounds known as 1,2,4-benzothiadiazine-1,1-dioxides. These are aromatic heterocyclic compounds containing a 1,2,4-benzothiadiazine ring system with two S=O bonds at the 1-position. Hydrochlorothiazide is a drug which is used for the treatment of high blood pressure and management of edema. Hydrochlorothiazide exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Hydrochlorothiazide has been found in human adipose tissue and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, hydrochlorothiazide is primarily located in the cytoplasm. Hydrochlorothiazide can be converted into hydrochlorothiazide through the action of the enzyme solute carrier family 22 member 6. In humans, hydrochlorothiazide is involved in the metabolic disorder called the hydrochlorothiazide action pathway. Hydrochlorothiazide is formally rated as a possible carcinogen (by IARC 2B) and is also a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Hydrochlorothiazide ; HMDB01928",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001928",
    "description" : "Hydrochlorothiazide, also known as microzide or hydrodiuril, belongs to the class of organic compounds known as 1,2,4-benzothiadiazine-1,1-dioxides. These are aromatic heterocyclic compounds containing a 1,2,4-benzothiadiazine ring system with two S=O bonds at the 1-position. Hydrochlorothiazide is a drug which is used for the treatment of high blood pressure and management of edema. Hydrochlorothiazide exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Hydrochlorothiazide has been found in human adipose tissue and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, hydrochlorothiazide is primarily located in the cytoplasm. Hydrochlorothiazide can be converted into hydrochlorothiazide through the action of the enzyme solute carrier family 22 member 6. In humans, hydrochlorothiazide is involved in the metabolic disorder called the hydrochlorothiazide action pathway. Hydrochlorothiazide is formally rated as a possible carcinogen (by IARC 2B) and is also a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Hydrocinnamic acid ; HMDB0000764",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000764",
    "description" : "Hydrocinnamic acid, also known as phenylpropanoate or dihydrocinnamate, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. Hydrocinnamic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Hydrocinnamic acid has been found in human liver and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, hydrocinnamic acid is primarily located in the cytoplasm. Hydrocinnamic acid participates in a number of enzymatic reactions. In particular, hydrocinnamic acid can be biosynthesized from propionic acid. Hydrocinnamic acid is also a parent compound for other transformation products, including but not limited to, 3-(3,4-dihydroxyphenyl)propanoic acid, 3-phenylpropionate ester, and 3-hydroxy-3-phenylpropionic acid. Hydrocinnamic acid is a sweet, balsamic, and cinnamon tasting compound that can be found in a number of food items such as sourdock, common wheat, cashew nut, and nuts. This makes hydrocinnamic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Hydrocinnamic acid ; HMDB00764",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000764",
    "description" : "Hydrocinnamic acid, also known as phenylpropanoate or dihydrocinnamate, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. Hydrocinnamic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Hydrocinnamic acid has been found in human liver and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, hydrocinnamic acid is primarily located in the cytoplasm. Hydrocinnamic acid participates in a number of enzymatic reactions. In particular, hydrocinnamic acid can be biosynthesized from propionic acid. Hydrocinnamic acid is also a parent compound for other transformation products, including but not limited to, 3-(3,4-dihydroxyphenyl)propanoic acid, 3-phenylpropionate ester, and 3-hydroxy-3-phenylpropionic acid. Hydrocinnamic acid is a sweet, balsamic, and cinnamon tasting compound that can be found in a number of food items such as sourdock, common wheat, cashew nut, and nuts. This makes hydrocinnamic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Hydroquinone sulfate ; HMDB0240263",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0240263",
    "description" : "Hydroquinone sulfate, also known as quinol monosulfate or quinol sulfuric acid, belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. Hydroquinone sulfate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Hydroquinone sulfate can be biosynthesized from hydroquinone.",
    "id" : null
  }, {
    "name" : "Hydroxybutyrylcarnitine ; HMDB0013127",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013127",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Hydroxybutyrylcarnitine ; HMDB13127",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013127",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Hydroxycotinine ; HMDB0001390",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001390",
    "description" : "Hydroxycotinine belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. Hydroxycotinine is soluble (in water) and a very weakly acidic compound (based on its pKa). Hydroxycotinine has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine, saliva, and blood. Within the cell, hydroxycotinine is primarily located in the cytoplasm. Hydroxycotinine can be biosynthesized from cotinine through its interaction with the enzyme cytochrome P450 2A6. In humans, hydroxycotinine is involved in the nicotine action pathway and the nicotine metabolism pathway.",
    "id" : null
  }, {
    "name" : "Hydroxycotinine ; HMDB01390",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001390",
    "description" : "Hydroxycotinine belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. Hydroxycotinine is soluble (in water) and a very weakly acidic compound (based on its pKa). Hydroxycotinine has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine, saliva, and blood. Within the cell, hydroxycotinine is primarily located in the cytoplasm. Hydroxycotinine can be biosynthesized from cotinine through its interaction with the enzyme cytochrome P450 2A6. In humans, hydroxycotinine is involved in the nicotine action pathway and the nicotine metabolism pathway.",
    "id" : null
  }, {
    "name" : "Hydroxykynurenine ; HMDB0000732",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000732",
    "description" : "Hydroxykynurenine, also known as oh-kynurenine, belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. Hydroxykynurenine exists as a solid, slightly soluble (in water), and an extremely strong acidic compound (based on its pKa). Hydroxykynurenine has been found in human brain tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, hydroxykynurenine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Hydroxyoctanoic acid ; HMDB0000711",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000711",
    "description" : "2-Hydroxy caprylic acid, also known as a-hydroxyoctanoate or alpha-hydroxyoctanoic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 2-Hydroxy caprylic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 2-Hydroxy caprylic acid has been detected in multiple biofluids, such as feces, saliva, and urine. Within the cell, 2-hydroxy caprylic acid is primarily located in the cytoplasm and adiposome. 2-Hydroxy caprylic acid participates in a number of enzymatic reactions. In particular, 2-hydroxy caprylic acid can be biosynthesized from octanoic acid. 2-Hydroxy caprylic acid can also be converted into 2-hydroxyoctanoyl-CoA.",
    "id" : null
  }, {
    "name" : "Hydroxyoctanoic acid ; HMDB00711",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000711",
    "description" : "2-Hydroxy caprylic acid, also known as a-hydroxyoctanoate or alpha-hydroxyoctanoic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 2-Hydroxy caprylic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). 2-Hydroxy caprylic acid has been detected in multiple biofluids, such as feces, saliva, and urine. Within the cell, 2-hydroxy caprylic acid is primarily located in the cytoplasm and adiposome. 2-Hydroxy caprylic acid participates in a number of enzymatic reactions. In particular, 2-hydroxy caprylic acid can be biosynthesized from octanoic acid. 2-Hydroxy caprylic acid can also be converted into 2-hydroxyoctanoyl-CoA.",
    "id" : null
  }, {
    "name" : "Hydroxyphenyllactic acid ; HMDB0000755",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000755",
    "description" : "3-(4-Hydroxyphenyl)lactic acid, also known as 4-hydroxyphenyllactate or hpla, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. 3-(4-Hydroxyphenyl)lactic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3-(4-Hydroxyphenyl)lactic acid has been found in human epidermis and prostate tissues, and has also been detected in most biofluids, including cerebrospinal fluid, urine, feces, and blood. Within the cell, 3-(4-hydroxyphenyl)lactic acid is primarily located in the mitochondria. 3-(4-Hydroxyphenyl)lactic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, 3-(4-hydroxyphenyl)lactic acid can be found in cereals and cereal products. This makes 3-(4-hydroxyphenyl)lactic acid a potential biomarker for the consumption of this food product. 3-(4-Hydroxyphenyl)lactic acid has been found to be associated with the diseases known as supradiaphragmatic malignancy; 3-(4-hydroxyphenyl)lactic acid has also been linked to the inborn metabolic disorders including phenylketonuria.",
    "id" : null
  }, {
    "name" : "Hyodeoxycholic acid ; HMDB0000733",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000733",
    "description" : "Hyodeoxycholic acid, also known as hyodeoxycholate or nahdc compound, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Hyodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Hyodeoxycholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, hyodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Hyodeoxycholic acid ; HMDB00733",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000733",
    "description" : "Hyodeoxycholic acid, also known as hyodeoxycholate or nahdc compound, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Hyodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Hyodeoxycholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, hyodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Hypotaurine ; HMDB0000965",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000965",
    "description" : "Hypotaurine belongs to the class of organic compounds known as sulfinic acids. Sulfinic acids are compounds containing a sulfinic acid functional group, with the general structure RS(=O)OH (R = organyl, not H). Hypotaurine is soluble (in water) and an extremely strong acidic compound (based on its pKa). Hypotaurine has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, hypotaurine is primarily located in the cytoplasm. Hypotaurine exists in all eukaryotes, ranging from yeast to humans. Hypotaurine participates in a number of enzymatic reactions. In particular, Hypotaurine can be biosynthesized from cysteamine; which is mediated by the enzyme 2-aminoethanethiol dioxygenase. Furthermore, Hypotaurine can be biosynthesized from 3-sulfinoalanine; which is catalyzed by the enzyme cysteine sulfinic acid decarboxylase. Finally, Hypotaurine can be biosynthesized from 3-sulfinoalanine; which is mediated by the enzyme glutamate decarboxylase. In humans, hypotaurine is involved in the taurine and hypotaurine metabolism pathway.",
    "id" : null
  }, {
    "name" : "Hypotaurine ; HMDB00965",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000965",
    "description" : "Hypotaurine belongs to the class of organic compounds known as sulfinic acids. Sulfinic acids are compounds containing a sulfinic acid functional group, with the general structure RS(=O)OH (R = organyl, not H). Hypotaurine is soluble (in water) and an extremely strong acidic compound (based on its pKa). Hypotaurine has been found in human prostate tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, hypotaurine is primarily located in the cytoplasm. Hypotaurine exists in all eukaryotes, ranging from yeast to humans. Hypotaurine participates in a number of enzymatic reactions. In particular, Hypotaurine can be biosynthesized from cysteamine; which is mediated by the enzyme 2-aminoethanethiol dioxygenase. Furthermore, Hypotaurine can be biosynthesized from 3-sulfinoalanine; which is catalyzed by the enzyme cysteine sulfinic acid decarboxylase. Finally, Hypotaurine can be biosynthesized from 3-sulfinoalanine; which is mediated by the enzyme glutamate decarboxylase. In humans, hypotaurine is involved in the taurine and hypotaurine metabolism pathway.",
    "id" : null
  }, {
    "name" : "Hypoxanthine ; HMDB0000157",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000157",
    "description" : "Hypoxanthine, also known as purine-6-ol or Hyp, belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. Hypoxanthine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Hypoxanthine has been found throughout most human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, feces, and saliva. Within the cell, hypoxanthine is primarily located in the cytoplasm, lysosome and peroxisome. Hypoxanthine exists in all eukaryotes, ranging from yeast to humans. Hypoxanthine participates in a number of enzymatic reactions. In particular, Hypoxanthine and ribose 1-phosphate can be biosynthesized from inosine through its interaction with the enzyme purine nucleoside phosphorylase. In addition, Hypoxanthine and phosphoribosyl pyrophosphate can be biosynthesized from inosinic acid; which is mediated by the enzyme hypoxanthine-guanine phosphoribosyltransferase. In humans, hypoxanthine is involved in the azathioprine action pathway, the mercaptopurine action pathway, the thioguanine action pathway, and the purine metabolism pathway. Hypoxanthine is also involved in several metabolic disorders, some of which include adenylosuccinate lyase deficiency, myoadenylate deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and molybdenum cofactor deficiency. Hypoxanthine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Hypoxanthine ; HMDB00157",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000157",
    "description" : "Hypoxanthine, also known as purine-6-ol or Hyp, belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. Hypoxanthine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Hypoxanthine has been found throughout most human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, feces, and saliva. Within the cell, hypoxanthine is primarily located in the cytoplasm, lysosome and peroxisome. Hypoxanthine exists in all eukaryotes, ranging from yeast to humans. Hypoxanthine participates in a number of enzymatic reactions. In particular, Hypoxanthine and ribose 1-phosphate can be biosynthesized from inosine through its interaction with the enzyme purine nucleoside phosphorylase. In addition, Hypoxanthine and phosphoribosyl pyrophosphate can be biosynthesized from inosinic acid; which is mediated by the enzyme hypoxanthine-guanine phosphoribosyltransferase. In humans, hypoxanthine is involved in the azathioprine action pathway, the mercaptopurine action pathway, the thioguanine action pathway, and the purine metabolism pathway. Hypoxanthine is also involved in several metabolic disorders, some of which include adenylosuccinate lyase deficiency, myoadenylate deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and molybdenum cofactor deficiency. Hypoxanthine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Ibuprofen ; HMDB0001925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001925",
    "description" : "",
    "id" : null
  }, {
    "name" : "Ibuprofen ; HMDB01925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001925",
    "description" : "",
    "id" : null
  }, {
    "name" : "Imidazoleacetic acid ; HMDB0002024",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002024",
    "description" : "Imidazoleacetic acid, also known as 4(5)-imidazoleacetate or imac, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Imidazoleacetic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Imidazoleacetic acid has been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, imidazoleacetic acid is primarily located in the cytoplasm and mitochondria. Imidazoleacetic acid can be biosynthesized from imidazole-4-acetaldehyde through the action of the enzyme aldehyde dehydrogenase, mitochondrial. In humans, imidazoleacetic acid is involved in the histidine metabolism pathway. Imidazoleacetic acid is also involved in the metabolic disorder called the histidinemia pathway. Outside of the human body, imidazoleacetic acid can be found in a number of food items such as mulberry, herbs and spices, quince, and cloud ear fungus. This makes imidazoleacetic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Imidazoleacetic acid ; HMDB02024",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002024",
    "description" : "Imidazoleacetic acid, also known as 4(5)-imidazoleacetate or imac, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Imidazoleacetic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Imidazoleacetic acid has been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, imidazoleacetic acid is primarily located in the cytoplasm and mitochondria. Imidazoleacetic acid can be biosynthesized from imidazole-4-acetaldehyde through the action of the enzyme aldehyde dehydrogenase, mitochondrial. In humans, imidazoleacetic acid is involved in the histidine metabolism pathway. Imidazoleacetic acid is also involved in the metabolic disorder called the histidinemia pathway. Outside of the human body, imidazoleacetic acid can be found in a number of food items such as mulberry, herbs and spices, quince, and cloud ear fungus. This makes imidazoleacetic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Imidazolelactic acid ; HMDB0002320",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002320",
    "description" : "Imidazolelactic acid, also known as 1-imidazolelactate, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Imidazolelactic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Imidazolelactic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, imidazolelactic acid is primarily located in the cytoplasm. Imidazolelactic acid can be biosynthesized from rac-lactic acid.",
    "id" : null
  }, {
    "name" : "Imidazolelactic acid ; HMDB02320",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002320",
    "description" : "Imidazolelactic acid, also known as 1-imidazolelactate, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Imidazolelactic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Imidazolelactic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, imidazolelactic acid is primarily located in the cytoplasm. Imidazolelactic acid can be biosynthesized from rac-lactic acid.",
    "id" : null
  }, {
    "name" : "Imidazolepropionic acid ; HMDB0002271",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002271",
    "description" : "Imidazolepropionic acid, also known as deaminohistidine or 4-imidazolylpropionate, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Imidazolepropionic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Imidazolepropionic acid has been detected in multiple biofluids, such as feces and blood. Imidazolepropionic acid can be biosynthesized from propionic acid.",
    "id" : null
  }, {
    "name" : "Imidazolepropionic acid ; HMDB02271",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002271",
    "description" : "Imidazolepropionic acid, also known as deaminohistidine or 4-imidazolylpropionate, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Imidazolepropionic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Imidazolepropionic acid has been detected in multiple biofluids, such as feces and blood. Imidazolepropionic acid can be biosynthesized from propionic acid.",
    "id" : null
  }, {
    "name" : "Indole-3-carboxylic acid ; HMDB0003320",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003320",
    "description" : "Indole-3-carboxylic acid, also known as 3-indolecarboxylate or 3-indoleformate, belongs to the class of organic compounds known as indolecarboxylic acids and derivatives. Indolecarboxylic acids and derivatives are compounds containing a carboxylic acid group (or a derivative thereof) linked to an indole. Indole-3-carboxylic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Indole-3-carboxylic acid has been primarily detected in feces. Indole-3-carboxylic acid is also a parent compound for other transformation products, including but not limited to, 4-O-(1H-indol-3-ylcarbonyl)ascaroside, 3-indole carboxylic acid glucuronide, and tropisetron. Outside of the human body, indole-3-carboxylic acid can be found in a number of food items such as wakame, pomes, cucumber, and common beet. This makes indole-3-carboxylic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Indole-3-methyl acetate ; HMDB0029738",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029738",
    "description" : "Indole-3-methyl acetate, also known as methyl 3-indolylacetate or methyl b-indoleacetic acid, belongs to the class of organic compounds known as indole-3-acetic acid derivatives. Indole-3-acetic acid derivatives are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-methyl acetate exists as a solid, slightly soluble (in water), and an extremely weak acidic (essentially neutral) compound (based on its pKa). Indole-3-methyl acetate has been primarily detected in feces. Indole-3-methyl acetate can be biosynthesized from indole-3-acetic acid. Outside of the human body, indole-3-methyl acetate can be found in a number of food items such as pulses, green bean, sour cherry, and corn. This makes indole-3-methyl acetate a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Indole-3-propionic acid ; HMDB0002302",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002302",
    "description" : "Indole-3-propionic acid, also known as indolepropionate or b-(3-indolyl)propionic acid, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. Indole-3-propionic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Indole-3-propionic acid has been detected in multiple biofluids, such as feces, saliva, and blood. Within the cell, indole-3-propionic acid is primarily located in the membrane (predicted from logP). Indole-3-propionic acid can be biosynthesized from propionic acid. Outside of the human body, indole-3-propionic acid can be found in common pea. This makes indole-3-propionic acid a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Indole-3-propionic acid ; HMDB02302",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002302",
    "description" : "Indole-3-propionic acid, also known as indolepropionate or b-(3-indolyl)propionic acid, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. Indole-3-propionic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Indole-3-propionic acid has been detected in multiple biofluids, such as feces, saliva, and blood. Within the cell, indole-3-propionic acid is primarily located in the membrane (predicted from logP). Indole-3-propionic acid can be biosynthesized from propionic acid. Outside of the human body, indole-3-propionic acid can be found in common pea. This makes indole-3-propionic acid a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Indoleacetic acid ; HMDB0000197",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000197",
    "description" : "Indole-3-acetate, also known as indoleacetic acid or IAA, belongs to the class of organic compounds known as indole-3-acetic acid derivatives. Indole-3-acetic acid derivatives are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetate exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Indole-3-acetate has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, cerebrospinal fluid, urine, and feces. Within the cell, indole-3-acetate is primarily located in the cytoplasm and mitochondria. Indole-3-acetate exists in all eukaryotes, ranging from yeast to humans. In humans, indole-3-acetate is involved in the tryptophan metabolism pathway. Indole-3-acetate is a mild, odorless, and sour tasting compound that can be found in a number of food items such as yellow zucchini, cornmint, prickly pear, and lemon verbena. This makes indole-3-acetate a potential biomarker for the consumption of these food products. Indole-3-acetate is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Indoleacetic acid ; HMDB00197",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000197",
    "description" : "Indole-3-acetate, also known as indoleacetic acid or IAA, belongs to the class of organic compounds known as indole-3-acetic acid derivatives. Indole-3-acetic acid derivatives are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetate exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Indole-3-acetate has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, cerebrospinal fluid, urine, and feces. Within the cell, indole-3-acetate is primarily located in the cytoplasm and mitochondria. Indole-3-acetate exists in all eukaryotes, ranging from yeast to humans. In humans, indole-3-acetate is involved in the tryptophan metabolism pathway. Indole-3-acetate is a mild, odorless, and sour tasting compound that can be found in a number of food items such as yellow zucchini, cornmint, prickly pear, and lemon verbena. This makes indole-3-acetate a potential biomarker for the consumption of these food products. Indole-3-acetate is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Indolelactic acid ; HMDB0000671",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000671",
    "description" : "Indolelactic acid, also known as indole-3-lactate or 5-ihipa, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. Indolelactic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Indolelactic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. Indolelactic acid can be biosynthesized from rac-lactic acid.",
    "id" : null
  }, {
    "name" : "Indolelactic acid ; HMDB00671",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000671",
    "description" : "Indolelactic acid, also known as indole-3-lactate or 5-ihipa, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. Indolelactic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Indolelactic acid has been found in human prostate tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. Indolelactic acid can be biosynthesized from rac-lactic acid.",
    "id" : null
  }, {
    "name" : "Indoxyl sulfate ; HMDB0000682",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000682",
    "description" : "Indoxyl sulfate, also known as indican or sulfate, indoxyl, belongs to the class of organic compounds known as arylsulfates. These are organic compounds containing a sulfate group that carries an aryl group through an ether group. Indoxyl sulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. Indoxyl sulfate has been found in human prostate, kidney and muscle tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, indoxyl sulfate is primarily located in the cytoplasm. Indoxyl sulfate can be converted into indoxyl. Indoxyl sulfate is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Indoxyl sulfate ; HMDB00682",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000682",
    "description" : "Indoxyl sulfate, also known as indican or sulfate, indoxyl, belongs to the class of organic compounds known as arylsulfates. These are organic compounds containing a sulfate group that carries an aryl group through an ether group. Indoxyl sulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. Indoxyl sulfate has been found in human prostate, kidney and muscle tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, indoxyl sulfate is primarily located in the cytoplasm. Indoxyl sulfate can be converted into indoxyl. Indoxyl sulfate is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Inosine ; HMDB0000195",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000195",
    "description" : "Inosine, also known as hypoxanthosine or panholic-L, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Inosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Inosine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, urine, and saliva. Within the cell, inosine is primarily located in the cytoplasm, mitochondria and lysosome. Inosine exists in all eukaryotes, ranging from yeast to humans. Inosine participates in a number of enzymatic reactions. In particular, Inosine can be biosynthesized from inosinic acid through the action of the enzyme cytosolic purine 5'-nucleotidase. In addition, Inosine can be converted into hypoxanthine and ribose 1-phosphate through its interaction with the enzyme purine nucleoside phosphorylase. In humans, inosine is involved in the purine metabolism pathway, the azathioprine action pathway, the mercaptopurine action pathway, and the thioguanine action pathway. Inosine is also involved in several metabolic disorders, some of which include the AICA-ribosiduria pathway, purine nucleoside phosphorylase deficiency, adenylosuccinate lyase deficiency, and adenosine deaminase deficiency.",
    "id" : null
  }, {
    "name" : "Inosine ; HMDB00195",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000195",
    "description" : "Inosine, also known as hypoxanthosine or panholic-L, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Inosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Inosine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, urine, and saliva. Within the cell, inosine is primarily located in the cytoplasm, mitochondria and lysosome. Inosine exists in all eukaryotes, ranging from yeast to humans. Inosine participates in a number of enzymatic reactions. In particular, Inosine can be biosynthesized from inosinic acid through the action of the enzyme cytosolic purine 5'-nucleotidase. In addition, Inosine can be converted into hypoxanthine and ribose 1-phosphate through its interaction with the enzyme purine nucleoside phosphorylase. In humans, inosine is involved in the purine metabolism pathway, the azathioprine action pathway, the mercaptopurine action pathway, and the thioguanine action pathway. Inosine is also involved in several metabolic disorders, some of which include the AICA-ribosiduria pathway, purine nucleoside phosphorylase deficiency, adenylosuccinate lyase deficiency, and adenosine deaminase deficiency.",
    "id" : null
  }, {
    "name" : "Isobutyrylglycine ; HMDB0000730",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000730",
    "description" : "Isobutyrylglycine belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Isobutyrylglycine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Isobutyrylglycine has been detected in multiple biofluids, such as urine and blood. Within the cell, isobutyrylglycine is primarily located in the cytoplasm. Isobutyrylglycine has been found to be associated with the diseases known as isobutyryl-CoA dehydrogenase deficiency; isobutyrylglycine has also been linked to several inborn metabolic disorders including ethylmalonic encephalopathy, short chain acyl-CoA dehydrogenase deficiency, and propionic acidemia.",
    "id" : null
  }, {
    "name" : "Isoleucyl-Glycine ; HMDB0028907",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0028907",
    "description" : "Isoleucyl-glycine, also known as i-g dipeptide or ile-gly, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Isoleucyl-glycine is soluble (in water) and a weakly acidic compound (based on its pKa). Isoleucyl-glycine has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "Isoursodeoxycholic acid ; HMDB0000686",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000686",
    "description" : "Isoursodeoxycholic acid, also known as iso-ursodeoxycholate, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Isoursodeoxycholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Isoursodeoxycholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, isoursodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Isovaleric acid ; HMDB0000718",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000718",
    "description" : "Isovaleric acid, also known as isovalerate or 3-methylbutanoate, belongs to the class of organic compounds known as methyl-branched fatty acids. These are fatty acids with an acyl chain that has a methyl branch. Usually, they are saturated and contain only one or more methyl group. However, branches other than methyl may be present. Isovaleric acid exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Isovaleric acid has been detected in most biofluids, including blood, feces, cerebrospinal fluid, and saliva. Within the cell, isovaleric acid is primarily located in the cytoplasm and adiposome. Isovaleric acid exists in all eukaryotes, ranging from yeast to humans. Isovaleric acid is an animal, cheese, and feet tasting compound that can be found in a number of food items such as red raspberry, yellow bell pepper, burdock, and chinese cinnamon. This makes isovaleric acid a potential biomarker for the consumption of these food products. Isovaleric acid has been found to be associated with several diseases known as crohn's disease, irritable bowel syndrome, and ulcerative colitis; isovaleric acid has also been linked to several inborn metabolic disorders including isovaleric acidemia and celiac disease.",
    "id" : null
  }, {
    "name" : "Isovalerylcarnitine ; HMDB0000688",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000688",
    "description" : "Isovalerylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, isovalerylcarnitine is considered to be a fatty ester lipid molecule. Isovalerylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Isovalerylcarnitine has been detected in multiple biofluids, such as saliva, blood, and urine. Within the cell, isovalerylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Isovalerylcarnitine can be biosynthesized from isovaleric acid. Isovalerylcarnitine has been linked to several inborn metabolic disorders including very long chain acyl-CoA dehydrogenase deficiency, celiac disease, and isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Isovalerylcarnitine ; HMDB00688",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000688",
    "description" : "Isovalerylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, isovalerylcarnitine is considered to be a fatty ester lipid molecule. Isovalerylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Isovalerylcarnitine has been detected in multiple biofluids, such as saliva, blood, and urine. Within the cell, isovalerylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Isovalerylcarnitine can be biosynthesized from isovaleric acid. Isovalerylcarnitine has been linked to several inborn metabolic disorders including very long chain acyl-CoA dehydrogenase deficiency, celiac disease, and isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Isovalerylglycine ; HMDB0000678",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000678",
    "description" : "Isovalerylglycine, also known as isopentanoylglycine, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Isovalerylglycine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Isovalerylglycine has been detected in multiple biofluids, such as urine and blood. Isovalerylglycine has been found to be associated with several diseases known as anorexia nervosa and short/branched chain acyl-CoA dehydrogenase deficiency; isovalerylglycine has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Isoxanthopterin ; HMDB0000704",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000704",
    "description" : "Isoxanthopterin belongs to the class of organic compounds known as pterins and derivatives. These are polycyclic aromatic compounds containing a pterin moiety, which consist of a pteridine ring bearing a ketone and an amine group to form 2-aminopteridin-4(3H)-one. Isoxanthopterin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Isoxanthopterin has been primarily detected in urine. Within the cell, isoxanthopterin is primarily located in the cytoplasm. Outside of the human body, isoxanthopterin can be found in soy bean. This makes isoxanthopterin a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Isoxanthopterin ; HMDB00704",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000704",
    "description" : "Isoxanthopterin belongs to the class of organic compounds known as pterins and derivatives. These are polycyclic aromatic compounds containing a pterin moiety, which consist of a pteridine ring bearing a ketone and an amine group to form 2-aminopteridin-4(3H)-one. Isoxanthopterin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Isoxanthopterin has been primarily detected in urine. Within the cell, isoxanthopterin is primarily located in the cytoplasm. Outside of the human body, isoxanthopterin can be found in soy bean. This makes isoxanthopterin a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Ketoleucine ; HMDB0000695",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000695",
    "description" : "Ketoleucine, also known as 2-oxoisocaproate or a-oxoisohexanoate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. Ketoleucine exists as a liquid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Ketoleucine has been found in human prostate and muscle tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, feces, and urine. Within the cell, ketoleucine is primarily located in the cytoplasm and mitochondria. Ketoleucine exists in all eukaryotes, ranging from yeast to humans. Ketoleucine participates in a number of enzymatic reactions. In particular, Ketoleucine and L-glutamic acid can be biosynthesized from L-leucine and oxoglutaric acid; which is mediated by the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In addition, Ketoleucine and thiamine pyrophosphate can be converted into 3-methyl-1-hydroxybutyl-THPP; which is catalyzed by the enzyme 2-oxoisovalerate dehydrogenase. In humans, ketoleucine is involved in the valine, leucine and isoleucine degradation pathway. Ketoleucine is also involved in several metabolic disorders, some of which include isobutyryl-CoA dehydrogenase deficiency, 2-methyl-3-hydroxybutryl CoA dehydrogenase deficiency, the 3-methylglutaconic aciduria type IV pathway, and the methylmalonic aciduria pathway. Outside of the human body, ketoleucine can be found in a number of food items such as celery stalks, hyssop, elliott's blueberry, and horned melon. This makes ketoleucine a potential biomarker for the consumption of these food products. Ketoleucine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Ketoleucine ; HMDB00695",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000695",
    "description" : "Ketoleucine, also known as 2-oxoisocaproate or a-oxoisohexanoate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. Ketoleucine exists as a liquid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Ketoleucine has been found in human prostate and muscle tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, feces, and urine. Within the cell, ketoleucine is primarily located in the cytoplasm and mitochondria. Ketoleucine exists in all eukaryotes, ranging from yeast to humans. Ketoleucine participates in a number of enzymatic reactions. In particular, Ketoleucine and L-glutamic acid can be biosynthesized from L-leucine and oxoglutaric acid; which is mediated by the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In addition, Ketoleucine and thiamine pyrophosphate can be converted into 3-methyl-1-hydroxybutyl-THPP; which is catalyzed by the enzyme 2-oxoisovalerate dehydrogenase. In humans, ketoleucine is involved in the valine, leucine and isoleucine degradation pathway. Ketoleucine is also involved in several metabolic disorders, some of which include isobutyryl-CoA dehydrogenase deficiency, 2-methyl-3-hydroxybutryl CoA dehydrogenase deficiency, the 3-methylglutaconic aciduria type IV pathway, and the methylmalonic aciduria pathway. Outside of the human body, ketoleucine can be found in a number of food items such as celery stalks, hyssop, elliott's blueberry, and horned melon. This makes ketoleucine a potential biomarker for the consumption of these food products. Ketoleucine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Kynurenic acid ; HMDB0000715",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000715",
    "description" : "Kynurenic acid, also known as kynurenate or acid, kynurenic, belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. Kynurenic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Kynurenic acid has been found in human epidermis, brain and prostate tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, kynurenic acid is primarily located in the cytoplasm. Kynurenic acid exists in all eukaryotes, ranging from yeast to humans. In humans, kynurenic acid is involved in the tryptophan metabolism pathway. Kynurenic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Kynurenic acid ; HMDB00715",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000715",
    "description" : "Kynurenic acid, also known as kynurenate or acid, kynurenic, belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. Kynurenic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Kynurenic acid has been found in human epidermis, brain and prostate tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, kynurenic acid is primarily located in the cytoplasm. Kynurenic acid exists in all eukaryotes, ranging from yeast to humans. In humans, kynurenic acid is involved in the tryptophan metabolism pathway. Kynurenic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Acetylcarnitine ; HMDB0000201",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000201",
    "description" : "Acetyl-L-carnitine, also known as alcar or branigen, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, acetyl-L-carnitine is considered to be a fatty ester lipid molecule. Acetyl-L-carnitine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Acetyl-L-carnitine has been found throughout most human tissues, and has also been detected in most biofluids, including urine, saliva, cerebrospinal fluid, and breast milk. Acetyl-L-carnitine can be found anywhere throughout the human cell, such as in membrane (predicted from logP), endoplasmic reticulum, peroxisome, and cytoplasm. In humans, acetyl-L-carnitine is involved in the adrenoleukodystrophy, X-linked pathway, the Beta oxidation OF very long chain fatty acids pathway, and the oxidation OF branched chain fatty acids pathway. Acetyl-L-carnitine is also involved in the metabolic disorder called carnitine-acylcarnitine translocase deficiency.",
    "id" : null
  }, {
    "name" : "L-Acetylcarnitine ; HMDB00201",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000201",
    "description" : "Acetyl-L-carnitine, also known as alcar or branigen, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, acetyl-L-carnitine is considered to be a fatty ester lipid molecule. Acetyl-L-carnitine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Acetyl-L-carnitine has been found throughout most human tissues, and has also been detected in most biofluids, including urine, saliva, cerebrospinal fluid, and breast milk. Acetyl-L-carnitine can be found anywhere throughout the human cell, such as in membrane (predicted from logP), endoplasmic reticulum, peroxisome, and cytoplasm. In humans, acetyl-L-carnitine is involved in the adrenoleukodystrophy, X-linked pathway, the Beta oxidation OF very long chain fatty acids pathway, and the oxidation OF branched chain fatty acids pathway. Acetyl-L-carnitine is also involved in the metabolic disorder called carnitine-acylcarnitine translocase deficiency.",
    "id" : null
  }, {
    "name" : "L-Alanine ; HMDB0000161",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000161",
    "description" : "L-Alanine, also known as (S)-alanine or L-alpha-alanine, belongs to the class of organic compounds known as alanine and derivatives. Alanine and derivatives are compounds containing alanine or a derivative thereof resulting from reaction of alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Alanine is a drug which is used for protein synthesis. L-Alanine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Alanine has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, urine, cerebrospinal fluid, and blood. Within the cell, L-alanine is primarily located in the cytoplasm, mitochondria, lysosome and peroxisome. L-Alanine exists in all eukaryotes, ranging from yeast to humans. L-Alanine participates in a number of enzymatic reactions. In particular, L-Alanine and oxoglutaric acid can be converted into L-glutamic acid and pyruvic acid; which is mediated by the enzyme alanine aminotransferase 1. In addition, Hydroxypyruvic acid and L-alanine can be biosynthesized from pyruvic acid and L-serine through its interaction with the enzyme serine--pyruvate aminotransferase. In humans, L-alanine is involved in the transcription/translation pathway, the chloramphenicol action pathway, the clomocycline action pathway, and the selenoamino acid metabolism pathway. L-Alanine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, the hyperglycinemia, non-ketotic pathway, Gamma-glutamyl-transpeptidase deficiency, and the glutaminolysis and cancer pathway. Outside of the human body, L-alanine can be found in apple, blackcurrant, sour cherry, and tarragon. This makes L-alanine a potential biomarker for the consumption of these food products. L-Alanine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Alanine ; HMDB00161",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000161",
    "description" : "L-Alanine, also known as (S)-alanine or L-alpha-alanine, belongs to the class of organic compounds known as alanine and derivatives. Alanine and derivatives are compounds containing alanine or a derivative thereof resulting from reaction of alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Alanine is a drug which is used for protein synthesis. L-Alanine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Alanine has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, urine, cerebrospinal fluid, and blood. Within the cell, L-alanine is primarily located in the cytoplasm, mitochondria, lysosome and peroxisome. L-Alanine exists in all eukaryotes, ranging from yeast to humans. L-Alanine participates in a number of enzymatic reactions. In particular, L-Alanine and oxoglutaric acid can be converted into L-glutamic acid and pyruvic acid; which is mediated by the enzyme alanine aminotransferase 1. In addition, Hydroxypyruvic acid and L-alanine can be biosynthesized from pyruvic acid and L-serine through its interaction with the enzyme serine--pyruvate aminotransferase. In humans, L-alanine is involved in the transcription/translation pathway, the chloramphenicol action pathway, the clomocycline action pathway, and the selenoamino acid metabolism pathway. L-Alanine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, the hyperglycinemia, non-ketotic pathway, Gamma-glutamyl-transpeptidase deficiency, and the glutaminolysis and cancer pathway. Outside of the human body, L-alanine can be found in apple, blackcurrant, sour cherry, and tarragon. This makes L-alanine a potential biomarker for the consumption of these food products. L-Alanine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Allothreonine ; HMDB0004041",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004041",
    "description" : "L-Allothreonine belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Allothreonine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Allothreonine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces and urine. Within the cell, L-allothreonine is primarily located in the cytoplasm. L-Allothreonine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "L-alpha-Aminobutyric acid ; HMDB0000452",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000452",
    "description" : ", also known as L-butyrine or L-homoalanine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Thus, is considered to be a fatty acid lipid molecule. exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). has been found in human liver and kidney tissues, and has also been detected in most biofluids, including blood, feces, urine, and cerebrospinal fluid. Within the cell, is primarily located in the cytoplasm. exists in all eukaryotes, ranging from yeast to humans. can be converted into brivaracetam and L-2-amino-4-methoxy-cis-but-3-enoic acid.",
    "id" : null
  }, {
    "name" : "L-Arabinose ; HMDB0000646",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000646",
    "description" : "L-Arabinose, also known as L-arabinopyranose, belongs to the class of organic compounds known as pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms. L-Arabinose exists as a solid, very soluble (in water), and a very weakly acidic compound (based on its pKa). L-Arabinose has been found in human prostate tissue, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. L-Arabinose exists in all eukaryotes, ranging from yeast to humans. L-Arabinose has been linked to the inborn metabolic disorders including ribose-5-phosphate isomerase deficiency.",
    "id" : null
  }, {
    "name" : "L-Arginine ; HMDB0000517",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000517",
    "description" : "L-Arginine, also known as L-arg, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Arginine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. L-Arginine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Arginine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, urine, and saliva. Within the cell, L-arginine is primarily located in the cytoplasm, mitochondria and myelin sheath. L-Arginine exists in all eukaryotes, ranging from yeast to humans. L-Arginine participates in a number of enzymatic reactions. In particular, Glycine and L-arginine can be converted into guanidoacetic acid and orotidylic acid through its interaction with the enzyme glycine amidinotransferase, mitochondrial. Furthermore, Fumaric acid and L-arginine can be biosynthesized from argininosuccinic acid; which is mediated by the enzyme argininosuccinate lyase. Furthermore, L-Arginine can be converted into ornithine and urea through its interaction with the enzyme arginase-1. Finally, Fumaric acid and L-arginine can be biosynthesized from argininosuccinic acid; which is catalyzed by the enzyme argininosuccinate lyase. In humans, L-arginine is involved in the aspartate metabolism pathway, the arginine and proline metabolism pathway, the transcription/translation pathway, and the glycine and serine metabolism pathway. L-Arginine is also involved in several metabolic disorders, some of which include the hypoacetylaspartia pathway, dimethylglycine dehydrogenase deficiency, the hyperglycinemia, non-ketotic pathway, and the prolinemia type II pathway. Outside of the human body, L-arginine can be found in a number of food items such as avocado, black-eyed pea, squashberry, and chinese water chestnut. This makes L-arginine a potential biomarker for the consumption of these food products. L-Arginine is a potentially toxic compound. L-Arginine has been found to be associated with several diseases known as heart failure, myopathy, lactic acidosis, and sideroblastic anemia 1, and hyperlysinuria; l-arginine has also been linked to several inborn metabolic disorders including propionic acidemia and cystinuria.",
    "id" : null
  }, {
    "name" : "L-Arginine ; HMDB00517",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000517",
    "description" : "L-Arginine, also known as L-arg, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Arginine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. L-Arginine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Arginine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, urine, and saliva. Within the cell, L-arginine is primarily located in the cytoplasm, mitochondria and myelin sheath. L-Arginine exists in all eukaryotes, ranging from yeast to humans. L-Arginine participates in a number of enzymatic reactions. In particular, Glycine and L-arginine can be converted into guanidoacetic acid and orotidylic acid through its interaction with the enzyme glycine amidinotransferase, mitochondrial. Furthermore, Fumaric acid and L-arginine can be biosynthesized from argininosuccinic acid; which is mediated by the enzyme argininosuccinate lyase. Furthermore, L-Arginine can be converted into ornithine and urea through its interaction with the enzyme arginase-1. Finally, Fumaric acid and L-arginine can be biosynthesized from argininosuccinic acid; which is catalyzed by the enzyme argininosuccinate lyase. In humans, L-arginine is involved in the aspartate metabolism pathway, the arginine and proline metabolism pathway, the transcription/translation pathway, and the glycine and serine metabolism pathway. L-Arginine is also involved in several metabolic disorders, some of which include the hypoacetylaspartia pathway, dimethylglycine dehydrogenase deficiency, the hyperglycinemia, non-ketotic pathway, and the prolinemia type II pathway. Outside of the human body, L-arginine can be found in a number of food items such as avocado, black-eyed pea, squashberry, and chinese water chestnut. This makes L-arginine a potential biomarker for the consumption of these food products. L-Arginine is a potentially toxic compound. L-Arginine has been found to be associated with several diseases known as heart failure, myopathy, lactic acidosis, and sideroblastic anemia 1, and hyperlysinuria; l-arginine has also been linked to several inborn metabolic disorders including propionic acidemia and cystinuria.",
    "id" : null
  }, {
    "name" : "L-Asparagine ; HMDB0000168",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000168",
    "description" : "L-Asparagine, also known as Asn or aspartamic acid, belongs to the class of organic compounds known as asparagine and derivatives. Asparagine and derivatives are compounds containing asparagine or a derivative thereof resulting from reaction of asparagine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Asparagine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. L-Asparagine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Asparagine has been found throughout all human tissues, and has also been detected in most biofluids, including urine, sweat, cerebrospinal fluid, and breast milk. Within the cell, L-asparagine is primarily located in the cytoplasm and mitochondria. L-Asparagine exists in all eukaryotes, ranging from yeast to humans. L-Asparagine participates in a number of enzymatic reactions. In particular, L-Asparagine can be converted into L-aspartic acid through its interaction with the enzyme isoaspartyl peptidase/l-asparaginase. Furthermore, L-Asparagine and L-glutamic acid can be biosynthesized from L-aspartic acid and L-glutamine through its interaction with the enzyme asparagine synthetase [glutamine-hydrolyzing]. Furthermore, L-Asparagine and L-glutamic acid can be biosynthesized from L-aspartic acid and L-glutamine; which is catalyzed by the enzyme asparagine synthetase [glutamine-hydrolyzing]. Finally, L-Asparagine can be converted into L-aspartic acid through the action of the enzyme isoaspartyl peptidase/l-asparaginase. In humans, L-asparagine is involved in the clarithromycin action pathway, the doxycycline action pathway, the azithromycin action pathway, and the streptomycin action pathway. L-Asparagine is also involved in a few metabolic disorders, which include the hypoacetylaspartia pathway, the ammonia recycling pathway, and the canavan disease pathway. L-Asparagine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Asparagine ; HMDB00168",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000168",
    "description" : "L-Asparagine, also known as Asn or aspartamic acid, belongs to the class of organic compounds known as asparagine and derivatives. Asparagine and derivatives are compounds containing asparagine or a derivative thereof resulting from reaction of asparagine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Asparagine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. L-Asparagine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Asparagine has been found throughout all human tissues, and has also been detected in most biofluids, including urine, sweat, cerebrospinal fluid, and breast milk. Within the cell, L-asparagine is primarily located in the cytoplasm and mitochondria. L-Asparagine exists in all eukaryotes, ranging from yeast to humans. L-Asparagine participates in a number of enzymatic reactions. In particular, L-Asparagine can be converted into L-aspartic acid through its interaction with the enzyme isoaspartyl peptidase/l-asparaginase. Furthermore, L-Asparagine and L-glutamic acid can be biosynthesized from L-aspartic acid and L-glutamine through its interaction with the enzyme asparagine synthetase [glutamine-hydrolyzing]. Furthermore, L-Asparagine and L-glutamic acid can be biosynthesized from L-aspartic acid and L-glutamine; which is catalyzed by the enzyme asparagine synthetase [glutamine-hydrolyzing]. Finally, L-Asparagine can be converted into L-aspartic acid through the action of the enzyme isoaspartyl peptidase/l-asparaginase. In humans, L-asparagine is involved in the clarithromycin action pathway, the doxycycline action pathway, the azithromycin action pathway, and the streptomycin action pathway. L-Asparagine is also involved in a few metabolic disorders, which include the hypoacetylaspartia pathway, the ammonia recycling pathway, and the canavan disease pathway. L-Asparagine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Aspartic acid ; HMDB0000191",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000191",
    "description" : "L-Aspartic acid, also known as L-aspartate or 2-aminosuccinate, belongs to the class of organic compounds known as aspartic acid and derivatives. Aspartic acid and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Aspartic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Aspartic acid has been found throughout all human tissues, and has also been detected in most biofluids, including blood, breast milk, saliva, and sweat. Within the cell, L-aspartic acid is primarily located in the cytoplasm and mitochondria. L-Aspartic acid exists in all eukaryotes, ranging from yeast to humans. L-Aspartic acid participates in a number of enzymatic reactions. In particular, L-Aspartic acid and oxoglutaric acid can be converted into oxalacetic acid and L-glutamic acid through its interaction with the enzyme aspartate aminotransferase, mitochondrial. In addition, 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate and L-aspartic acid can be converted into saicar through its interaction with the enzyme multifunctional protein ADE2. In humans, L-aspartic acid is involved in the homocarnosinosis pathway, the aspartate metabolism pathway, the arginine and proline metabolism pathway, and the thioguanine action pathway. L-Aspartic acid is also involved in several metabolic disorders, some of which include the canavan disease pathway, 4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency, adenosine deaminase deficiency, and the hyperinsulinism-hyperammonemia syndrome pathway. Outside of the human body, L-aspartic acid can be found in a number of food items such as black elderberry, irish moss, black cabbage, and mammee apple. This makes L-aspartic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "L-Aspartic acid ; HMDB00191",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000191",
    "description" : "L-Aspartic acid, also known as L-aspartate or 2-aminosuccinate, belongs to the class of organic compounds known as aspartic acid and derivatives. Aspartic acid and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Aspartic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Aspartic acid has been found throughout all human tissues, and has also been detected in most biofluids, including blood, breast milk, saliva, and sweat. Within the cell, L-aspartic acid is primarily located in the cytoplasm and mitochondria. L-Aspartic acid exists in all eukaryotes, ranging from yeast to humans. L-Aspartic acid participates in a number of enzymatic reactions. In particular, L-Aspartic acid and oxoglutaric acid can be converted into oxalacetic acid and L-glutamic acid through its interaction with the enzyme aspartate aminotransferase, mitochondrial. In addition, 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate and L-aspartic acid can be converted into saicar through its interaction with the enzyme multifunctional protein ADE2. In humans, L-aspartic acid is involved in the homocarnosinosis pathway, the aspartate metabolism pathway, the arginine and proline metabolism pathway, and the thioguanine action pathway. L-Aspartic acid is also involved in several metabolic disorders, some of which include the canavan disease pathway, 4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency, adenosine deaminase deficiency, and the hyperinsulinism-hyperammonemia syndrome pathway. Outside of the human body, L-aspartic acid can be found in a number of food items such as black elderberry, irish moss, black cabbage, and mammee apple. This makes L-aspartic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "L-Carnitine ; HMDB0000062",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000062",
    "description" : "(R)-Carnitine, also known as carnitine or carnitor, belongs to the class of organic compounds known as carnitines. These are organic compounds containing the quaternary ammonium compound carnitine (R)-Carnitine is a drug which is used for treatment of primary systemic carnitine deficiency, a genetic impairment of normal biosynthesis or utilization of levocarnitine from dietary sources, or for the treatment of secondary carnitine deficiency resulting from an inborn error of metabolism such as glutaric aciduria ii, methyl malonic aciduria, propionic acidemia, and medium chain fatty acylcoa dehydrogenase deficiency. used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. parenteral levocarnitine is indicated for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease (R)-Carnitine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa) (R)-Carnitine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, urine, breast milk, and cerebrospinal fluid. Within the cell, (R)-carnitine is primarily located in the cytoplasm, mitochondria, endoplasmic reticulum and peroxisome (R)-Carnitine exists in all eukaryotes, ranging from yeast to humans. In humans, (R)-carnitine is involved in carnitine synthesis pathway, the Beta oxidation OF very long chain fatty acids pathway, the adrenoleukodystrophy, X-linked pathway, and the fatty acid metabolism pathway (R)-Carnitine is also involved in several metabolic disorders, some of which include the mitochondrial Beta-oxidation OF short chain saturated fatty acids pathway, medium chain acyl-CoA dehydrogenase deficiency (mcad), short chain acyl CoA dehydrogenase deficiency (scad deficiency), and very-long-chain acyl CoA dehydrogenase deficiency (vlcad) (R)-Carnitine is a potentially toxic compound (R)-Carnitine has been found to be associated with several diseases known as myopathic carnitine deficiency, carnitine transporter defect; primary systemic carnitine deficiency, and long-chain fatty acids, defect in transport of; (r)-carnitine has also been linked to several inborn metabolic disorders including propionic acidemia and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.",
    "id" : null
  }, {
    "name" : "L-Carnitine ; HMDB00062",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000062",
    "description" : "(R)-Carnitine, also known as carnitine or carnitor, belongs to the class of organic compounds known as carnitines. These are organic compounds containing the quaternary ammonium compound carnitine (R)-Carnitine is a drug which is used for treatment of primary systemic carnitine deficiency, a genetic impairment of normal biosynthesis or utilization of levocarnitine from dietary sources, or for the treatment of secondary carnitine deficiency resulting from an inborn error of metabolism such as glutaric aciduria ii, methyl malonic aciduria, propionic acidemia, and medium chain fatty acylcoa dehydrogenase deficiency. used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. parenteral levocarnitine is indicated for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease (R)-Carnitine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa) (R)-Carnitine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, urine, breast milk, and cerebrospinal fluid. Within the cell, (R)-carnitine is primarily located in the cytoplasm, mitochondria, endoplasmic reticulum and peroxisome (R)-Carnitine exists in all eukaryotes, ranging from yeast to humans. In humans, (R)-carnitine is involved in carnitine synthesis pathway, the Beta oxidation OF very long chain fatty acids pathway, the adrenoleukodystrophy, X-linked pathway, and the fatty acid metabolism pathway (R)-Carnitine is also involved in several metabolic disorders, some of which include the mitochondrial Beta-oxidation OF short chain saturated fatty acids pathway, medium chain acyl-CoA dehydrogenase deficiency (mcad), short chain acyl CoA dehydrogenase deficiency (scad deficiency), and very-long-chain acyl CoA dehydrogenase deficiency (vlcad) (R)-Carnitine is a potentially toxic compound (R)-Carnitine has been found to be associated with several diseases known as myopathic carnitine deficiency, carnitine transporter defect; primary systemic carnitine deficiency, and long-chain fatty acids, defect in transport of; (r)-carnitine has also been linked to several inborn metabolic disorders including propionic acidemia and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.",
    "id" : null
  }, {
    "name" : "L-Cystathionine ; HMDB0000099",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000099",
    "description" : "L-Cystathionine belongs to the class of organic compounds known as l-cysteine-s-conjugates. L-cysteine-S-conjugates are compounds containing L-cysteine where the thio-group is conjugated. L-Cystathionine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Cystathionine has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, L-cystathionine is primarily located in the cytoplasm. L-Cystathionine exists in all eukaryotes, ranging from yeast to humans. L-Cystathionine participates in a number of enzymatic reactions. In particular, L-Cystathionine can be biosynthesized from L-serine and homocysteine through its interaction with the enzyme cystathionine beta-synthase. Furthermore, L-Cystathionine can be converted into L-cysteine and 2-ketobutyric acid through its interaction with the enzyme cystathionine gamma-lyase. Furthermore, L-Cystathionine can be converted into L-cysteine and 2-ketobutyric acid; which is catalyzed by the enzyme cystathionine gamma-lyase. Finally, L-Cystathionine can be biosynthesized from L-homoserine and L-serine through the action of the enzyme cystathionine beta-synthase. In humans, L-cystathionine is involved in the homocysteine degradation pathway, the glycine and serine metabolism pathway, and the methionine metabolism pathway. L-Cystathionine is also involved in several metabolic disorders, some of which include the sarcosinemia pathway, dihydropyrimidine dehydrogenase deficiency (DHPD), the hyperglycinemia, non-ketotic pathway, and the NON ketotic hyperglycinemia pathway. L-Cystathionine has been found to be associated with several diseases known as autism and alzheimer's disease; l-cystathionine has also been linked to the inborn metabolic disorders including cystathioninuria.",
    "id" : null
  }, {
    "name" : "L-Cysteine ; HMDB0000574",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000574",
    "description" : "L-Cysteine, also known as C or E920, belongs to the class of organic compounds known as cysteine and derivatives. Cysteine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Cysteine is a drug which is used for the prevention of liver damage and kidney damage associated with overdoses of acetaminophen. L-Cysteine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Cysteine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, saliva, urine, and blood. Within the cell, L-cysteine is primarily located in the cytoplasm, mitochondria and myelin sheath. L-Cysteine exists in all eukaryotes, ranging from yeast to humans. L-Cysteine participates in a number of enzymatic reactions. In particular, L-Glutamic acid and L-cysteine can be converted into Gamma-glutamylcysteine; which is catalyzed by the enzyme glutamate--cysteine ligase. Furthermore, L-Cysteine and 2-ketobutyric acid can be biosynthesized from L-cystathionine; which is mediated by the enzyme cystathionine gamma-lyase. Furthermore, L-Cysteine and glycine can be biosynthesized from cysteinylglycine; which is catalyzed by the enzymes aminopeptidase N and caspase-7. Finally, L-Glutamic acid and L-cysteine can be converted into Gamma-glutamylcysteine through the action of the enzyme glutamate--cysteine ligase. In humans, L-cysteine is involved in the homocysteine degradation pathway, the glucose transporter defect (SGLT2) pathway, the cysteine metabolism pathway, and the metolazone action pathway. L-Cysteine is also involved in several metabolic disorders, some of which include the chlorothiazide action pathway, the triamterene action pathway, cystathionine Beta-synthase deficiency, and homocystinuria, cystathionine beta-synthase deficiency. L-Cysteine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Cysteine ; HMDB00574",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000574",
    "description" : "L-Cysteine, also known as C or E920, belongs to the class of organic compounds known as cysteine and derivatives. Cysteine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Cysteine is a drug which is used for the prevention of liver damage and kidney damage associated with overdoses of acetaminophen. L-Cysteine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Cysteine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, saliva, urine, and blood. Within the cell, L-cysteine is primarily located in the cytoplasm, mitochondria and myelin sheath. L-Cysteine exists in all eukaryotes, ranging from yeast to humans. L-Cysteine participates in a number of enzymatic reactions. In particular, L-Glutamic acid and L-cysteine can be converted into Gamma-glutamylcysteine; which is catalyzed by the enzyme glutamate--cysteine ligase. Furthermore, L-Cysteine and 2-ketobutyric acid can be biosynthesized from L-cystathionine; which is mediated by the enzyme cystathionine gamma-lyase. Furthermore, L-Cysteine and glycine can be biosynthesized from cysteinylglycine; which is catalyzed by the enzymes aminopeptidase N and caspase-7. Finally, L-Glutamic acid and L-cysteine can be converted into Gamma-glutamylcysteine through the action of the enzyme glutamate--cysteine ligase. In humans, L-cysteine is involved in the homocysteine degradation pathway, the glucose transporter defect (SGLT2) pathway, the cysteine metabolism pathway, and the metolazone action pathway. L-Cysteine is also involved in several metabolic disorders, some of which include the chlorothiazide action pathway, the triamterene action pathway, cystathionine Beta-synthase deficiency, and homocystinuria, cystathionine beta-synthase deficiency. L-Cysteine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Cystine ; HMDB0000192",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000192",
    "description" : "L-Cystine, also known as L-dicysteine or E921, belongs to the class of organic compounds known as l-cysteine-s-conjugates. L-cysteine-S-conjugates are compounds containing L-cysteine where the thio-group is conjugated. L-Cystine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Cystine has been found throughout all human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, L-cystine is primarily located in the cytoplasm. L-Cystine exists in all eukaryotes, ranging from yeast to humans. L-Cystine has been found to be associated with several diseases known as juvenile myoclonic epilepsy, schizophrenia, hyperlysinuria, and parkinson's disease; l-cystine has also been linked to the inborn metabolic disorders including cystinuria.",
    "id" : null
  }, {
    "name" : "L-Cystine ; HMDB00192",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000192",
    "description" : "L-Cystine, also known as L-dicysteine or E921, belongs to the class of organic compounds known as l-cysteine-s-conjugates. L-cysteine-S-conjugates are compounds containing L-cysteine where the thio-group is conjugated. L-Cystine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Cystine has been found throughout all human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, L-cystine is primarily located in the cytoplasm. L-Cystine exists in all eukaryotes, ranging from yeast to humans. L-Cystine has been found to be associated with several diseases known as juvenile myoclonic epilepsy, schizophrenia, hyperlysinuria, and parkinson's disease; l-cystine has also been linked to the inborn metabolic disorders including cystinuria.",
    "id" : null
  }, {
    "name" : "L-Fucose ; HMDB0000174",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000174",
    "description" : "Rhamnose, also known as L-rha or 6-deoxymannose, belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. Rhamnose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Rhamnose has been primarily detected in feces. Within the cell, rhamnose is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "L-Fucose ; HMDB00174",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000174",
    "description" : "Rhamnose, also known as L-rha or 6-deoxymannose, belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. Rhamnose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Rhamnose has been primarily detected in feces. Within the cell, rhamnose is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "L-Glutamic acid ; HMDB0000148",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000148",
    "description" : "L-Glutamic acid, also known as glutamate or acido glutamico, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Glutamic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Glutamic acid has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, cerebrospinal fluid, feces, and saliva. L-Glutamic acid can be found anywhere throughout the human cell, such as in myelin sheath, lysosome, endoplasmic reticulum, and cytoplasm. L-Glutamic acid exists in all eukaryotes, ranging from yeast to humans. L-Glutamic acid participates in a number of enzymatic reactions. In particular, Allysine and L-glutamic acid can be biosynthesized from saccharopine; which is mediated by the enzyme Alpha-aminoadipic semialdehyde synthase, mitochondrial. Furthermore, Oxoadipic acid and L-glutamic acid can be biosynthesized from aminoadipic acid and oxoglutaric acid through the action of the enzyme kynurenine/alpha-aminoadipate aminotransferase, mitochondrial. Furthermore, L-Glutamic acid can be converted into L-glutamine; which is catalyzed by the enzyme glutamine synthetase. Furthermore, L-Glutamic acid can be biosynthesized from L-glutamine; which is mediated by the enzyme glutaminase liver isoform, mitochondrial. Furthermore, Alpha-Ketoisovaleric acid and L-glutamic acid can be biosynthesized from L-valine and oxoglutaric acid; which is mediated by the enzyme branched-chain-amino-acid aminotransferase, cytosolic. Finally, Ketoleucine and L-glutamic acid can be biosynthesized from L-leucine and oxoglutaric acid through its interaction with the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In humans, L-glutamic acid is involved in the phenylalanine and tyrosine metabolism pathway, the aspartate metabolism pathway, the nicotinate and nicotinamide metabolism pathway, and the antrafenine action pathway. L-Glutamic acid is also involved in several metabolic disorders, some of which include the gout or kelley-seegmiller syndrome pathway, the glutaric aciduria type I pathway, dihydropyrimidine dehydrogenase deficiency (DHPD), and dopamine beta-hydroxylase deficiency. Outside of the human body, L-glutamic acid can be found in a number of food items such as common cabbage, bitter gourd, avocado, and italian oregano. This makes L-glutamic acid a potential biomarker for the consumption of these food products. L-Glutamic acid is a potentially toxic compound. L-Glutamic acid has been found to be associated with several diseases known as heart failure, anoxia, leukemia, and dicarboxylic aminoaciduria; l-glutamic acid has also been linked to the inborn metabolic disorders including n-acetylglutamate synthetase deficiency.",
    "id" : null
  }, {
    "name" : "L-Glutamic acid ; HMDB00148",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000148",
    "description" : "L-Glutamic acid, also known as glutamate or acido glutamico, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Glutamic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Glutamic acid has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, cerebrospinal fluid, feces, and saliva. L-Glutamic acid can be found anywhere throughout the human cell, such as in myelin sheath, lysosome, endoplasmic reticulum, and cytoplasm. L-Glutamic acid exists in all eukaryotes, ranging from yeast to humans. L-Glutamic acid participates in a number of enzymatic reactions. In particular, Allysine and L-glutamic acid can be biosynthesized from saccharopine; which is mediated by the enzyme Alpha-aminoadipic semialdehyde synthase, mitochondrial. Furthermore, Oxoadipic acid and L-glutamic acid can be biosynthesized from aminoadipic acid and oxoglutaric acid through the action of the enzyme kynurenine/alpha-aminoadipate aminotransferase, mitochondrial. Furthermore, L-Glutamic acid can be converted into L-glutamine; which is catalyzed by the enzyme glutamine synthetase. Furthermore, L-Glutamic acid can be biosynthesized from L-glutamine; which is mediated by the enzyme glutaminase liver isoform, mitochondrial. Furthermore, Alpha-Ketoisovaleric acid and L-glutamic acid can be biosynthesized from L-valine and oxoglutaric acid; which is mediated by the enzyme branched-chain-amino-acid aminotransferase, cytosolic. Finally, Ketoleucine and L-glutamic acid can be biosynthesized from L-leucine and oxoglutaric acid through its interaction with the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In humans, L-glutamic acid is involved in the phenylalanine and tyrosine metabolism pathway, the aspartate metabolism pathway, the nicotinate and nicotinamide metabolism pathway, and the antrafenine action pathway. L-Glutamic acid is also involved in several metabolic disorders, some of which include the gout or kelley-seegmiller syndrome pathway, the glutaric aciduria type I pathway, dihydropyrimidine dehydrogenase deficiency (DHPD), and dopamine beta-hydroxylase deficiency. Outside of the human body, L-glutamic acid can be found in a number of food items such as common cabbage, bitter gourd, avocado, and italian oregano. This makes L-glutamic acid a potential biomarker for the consumption of these food products. L-Glutamic acid is a potentially toxic compound. L-Glutamic acid has been found to be associated with several diseases known as heart failure, anoxia, leukemia, and dicarboxylic aminoaciduria; l-glutamic acid has also been linked to the inborn metabolic disorders including n-acetylglutamate synthetase deficiency.",
    "id" : null
  }, {
    "name" : "L-Glutamine ; HMDB0000641",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000641",
    "description" : "",
    "id" : null
  }, {
    "name" : "L-Glutamine ; HMDB00641",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000641",
    "description" : "",
    "id" : null
  }, {
    "name" : "L-Histidine ; HMDB0000177",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000177",
    "description" : "L-Histidine, also known as H, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Histidine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Histidine has been found throughout all human tissues, and has also been detected in most biofluids, including feces, urine, sweat, and blood. Within the cell, L-histidine is primarily located in the cytoplasm and mitochondria. L-Histidine exists in all eukaryotes, ranging from yeast to humans. L-Histidine can be converted into urocanic acid through its interaction with the enzyme histidine ammonia-lyase. In humans, L-histidine is involved in the kanamycin action pathway, the Beta-alanine metabolism pathway, the minocycline action pathway, and the amikacin action pathway. L-Histidine is also involved in several metabolic disorders, some of which include the carnosinuria, carnosinemia pathway, the histidinemia pathway, gaba-transaminase deficiency, and the ammonia recycling pathway. L-Histidine is a potentially toxic compound. L-Histidine has been found to be associated with several diseases known as pyridoxamine 5-prime-phosphate oxidase deficiency, alzheimer's disease, and dengue fever; l-histidine has also been linked to several inborn metabolic disorders including propionic acidemia and tyrosinemia I.",
    "id" : null
  }, {
    "name" : "L-Histidine ; HMDB00177",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000177",
    "description" : "L-Histidine, also known as H, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Histidine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Histidine has been found throughout all human tissues, and has also been detected in most biofluids, including feces, urine, sweat, and blood. Within the cell, L-histidine is primarily located in the cytoplasm and mitochondria. L-Histidine exists in all eukaryotes, ranging from yeast to humans. L-Histidine can be converted into urocanic acid through its interaction with the enzyme histidine ammonia-lyase. In humans, L-histidine is involved in the kanamycin action pathway, the Beta-alanine metabolism pathway, the minocycline action pathway, and the amikacin action pathway. L-Histidine is also involved in several metabolic disorders, some of which include the carnosinuria, carnosinemia pathway, the histidinemia pathway, gaba-transaminase deficiency, and the ammonia recycling pathway. L-Histidine is a potentially toxic compound. L-Histidine has been found to be associated with several diseases known as pyridoxamine 5-prime-phosphate oxidase deficiency, alzheimer's disease, and dengue fever; l-histidine has also been linked to several inborn metabolic disorders including propionic acidemia and tyrosinemia I.",
    "id" : null
  }, {
    "name" : "L-Isoleucine ; HMDB0000172",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000172",
    "description" : ", also known as I or 2S,3S-isoleucine, belongs to the class of organic compounds known as isoleucine and derivatives. Isoleucine and derivatives are compounds containing isoleucine or a derivative thereof resulting from reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Thus, is considered to be a fatty acid lipid molecule. exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). has been found throughout all human tissues, and has also been detected in most biofluids, including urine, sweat, breast milk, and saliva. Within the cell, is primarily located in the cytoplasm and mitochondria. exists in all eukaryotes, ranging from yeast to humans. In humans, is involved in the clarithromycin action pathway, the kanamycin action pathway, the doxycycline action pathway, and the azithromycin action pathway. is also involved in several metabolic disorders, some of which include Beta-ketothiolase deficiency, 3-methylcrotonyl CoA carboxylase deficiency type I, methylmalonate semialdehyde dehydrogenase deficiency, and the isovaleric aciduria pathway. is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Isoleucine ; HMDB00172",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000172",
    "description" : ", also known as I or 2S,3S-isoleucine, belongs to the class of organic compounds known as isoleucine and derivatives. Isoleucine and derivatives are compounds containing isoleucine or a derivative thereof resulting from reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Thus, is considered to be a fatty acid lipid molecule. exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). has been found throughout all human tissues, and has also been detected in most biofluids, including urine, sweat, breast milk, and saliva. Within the cell, is primarily located in the cytoplasm and mitochondria. exists in all eukaryotes, ranging from yeast to humans. In humans, is involved in the clarithromycin action pathway, the kanamycin action pathway, the doxycycline action pathway, and the azithromycin action pathway. is also involved in several metabolic disorders, some of which include Beta-ketothiolase deficiency, 3-methylcrotonyl CoA carboxylase deficiency type I, methylmalonate semialdehyde dehydrogenase deficiency, and the isovaleric aciduria pathway. is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Kynurenine ; HMDB0000684",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000684",
    "description" : "L-Kynurenine, also known as quinurenine, belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. L-Kynurenine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Kynurenine has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, L-kynurenine is primarily located in the cytoplasm and mitochondria. L-Kynurenine exists in all eukaryotes, ranging from yeast to humans. L-Kynurenine participates in a number of enzymatic reactions. In particular, L-Kynurenine and formic acid can be biosynthesized from n'-formylkynurenine; which is mediated by the enzyme kynurenine formamidase. Furthermore, L-Kynurenine can be converted into 2-aminobenzoic acid and L-alanine; which is mediated by the enzyme kynureninase. Furthermore, Formic acid and L-kynurenine can be biosynthesized from n'-formylkynurenine through its interaction with the enzyme kynurenine formamidase. Furthermore, L-Kynurenine can be converted into 3-hydroxy-L-kynurenine; which is catalyzed by the enzyme kynurenine 3-monooxygenase. Furthermore, L-Kynurenine can be converted into 3-hydroxy-L-kynurenine; which is catalyzed by the enzyme kynurenine 3-monooxygenase. Finally, Formic acid and L-kynurenine can be biosynthesized from n'-formylkynurenine; which is catalyzed by the enzyme kynurenine formamidase. In humans, L-kynurenine is involved in the tryptophan metabolism pathway.",
    "id" : null
  }, {
    "name" : "L-Kynurenine ; HMDB00684",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000684",
    "description" : "L-Kynurenine, also known as quinurenine, belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. L-Kynurenine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Kynurenine has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, L-kynurenine is primarily located in the cytoplasm and mitochondria. L-Kynurenine exists in all eukaryotes, ranging from yeast to humans. L-Kynurenine participates in a number of enzymatic reactions. In particular, L-Kynurenine and formic acid can be biosynthesized from n'-formylkynurenine; which is mediated by the enzyme kynurenine formamidase. Furthermore, L-Kynurenine can be converted into 2-aminobenzoic acid and L-alanine; which is mediated by the enzyme kynureninase. Furthermore, Formic acid and L-kynurenine can be biosynthesized from n'-formylkynurenine through its interaction with the enzyme kynurenine formamidase. Furthermore, L-Kynurenine can be converted into 3-hydroxy-L-kynurenine; which is catalyzed by the enzyme kynurenine 3-monooxygenase. Furthermore, L-Kynurenine can be converted into 3-hydroxy-L-kynurenine; which is catalyzed by the enzyme kynurenine 3-monooxygenase. Finally, Formic acid and L-kynurenine can be biosynthesized from n'-formylkynurenine; which is catalyzed by the enzyme kynurenine formamidase. In humans, L-kynurenine is involved in the tryptophan metabolism pathway.",
    "id" : null
  }, {
    "name" : "L-Lactic acid ; HMDB0000190",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000190",
    "description" : "D-Lactic acid, also known as lactate or D-milchsaeure, belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon. D-Lactic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). D-Lactic acid has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, D-lactic acid is primarily located in the mitochondria and cytoplasm. D-Lactic acid exists in all eukaryotes, ranging from yeast to humans. D-Lactic acid participates in a number of enzymatic reactions. In particular, D-Lactic acid can be converted into pyruvic acid; which is catalyzed by the enzyme probable D-lactate dehydrogenase, mitochondrial. Furthermore, Glutathione and D-lactic acid can be biosynthesized from S-lactoylglutathione; which is catalyzed by the enzyme hydroxyacylglutathione hydrolase, mitochondrial. Furthermore, D-Lactic acid can be converted into pyruvic acid; which is catalyzed by the enzyme probable D-lactate dehydrogenase, mitochondrial. Finally, Glutathione and D-lactic acid can be biosynthesized from S-lactoylglutathione; which is catalyzed by the enzyme hydroxyacylglutathione hydrolase, mitochondrial. In humans, D-lactic acid is involved in the pyruvate metabolism pathway and the pyruvaldehyde degradation pathway. D-Lactic acid is also involved in several metabolic disorders, some of which include pyruvate kinase deficiency, pyruvate dehydrogenase complex deficiency, pyruvate decarboxylase E1 component deficiency (pdhe1 deficiency), and the primary hyperoxaluria II, PH2 pathway. Outside of the human body, D-lactic acid can be found in a number of food items such as cucurbita (gourd), cereals and cereal products, capers, and cloud ear fungus. This makes D-lactic acid a potential biomarker for the consumption of these food products. D-Lactic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Lactic acid ; HMDB00190",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000190",
    "description" : "D-Lactic acid, also known as lactate or D-milchsaeure, belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon. D-Lactic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). D-Lactic acid has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, D-lactic acid is primarily located in the mitochondria and cytoplasm. D-Lactic acid exists in all eukaryotes, ranging from yeast to humans. D-Lactic acid participates in a number of enzymatic reactions. In particular, D-Lactic acid can be converted into pyruvic acid; which is catalyzed by the enzyme probable D-lactate dehydrogenase, mitochondrial. Furthermore, Glutathione and D-lactic acid can be biosynthesized from S-lactoylglutathione; which is catalyzed by the enzyme hydroxyacylglutathione hydrolase, mitochondrial. Furthermore, D-Lactic acid can be converted into pyruvic acid; which is catalyzed by the enzyme probable D-lactate dehydrogenase, mitochondrial. Finally, Glutathione and D-lactic acid can be biosynthesized from S-lactoylglutathione; which is catalyzed by the enzyme hydroxyacylglutathione hydrolase, mitochondrial. In humans, D-lactic acid is involved in the pyruvate metabolism pathway and the pyruvaldehyde degradation pathway. D-Lactic acid is also involved in several metabolic disorders, some of which include pyruvate kinase deficiency, pyruvate dehydrogenase complex deficiency, pyruvate decarboxylase E1 component deficiency (pdhe1 deficiency), and the primary hyperoxaluria II, PH2 pathway. Outside of the human body, D-lactic acid can be found in a number of food items such as cucurbita (gourd), cereals and cereal products, capers, and cloud ear fungus. This makes D-lactic acid a potential biomarker for the consumption of these food products. D-Lactic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Leucine ; HMDB0000687",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000687",
    "description" : "L-Leucine, also known as (S)-leucine or L-leucin, belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Leucine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Leucine has been found throughout most human tissues, and has also been detected in most biofluids, including breast milk, sweat, blood, and saliva. Within the cell, L-leucine is primarily located in the mitochondria and cytoplasm. L-Leucine exists in all eukaryotes, ranging from yeast to humans. L-Leucine and oxoglutaric acid can be converted into ketoleucine and L-glutamic acid through its interaction with the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In humans, L-leucine is involved in the methacycline action pathway, the telithromycin action pathway, the josamycin action pathway, and the neomycin action pathway. L-Leucine is also involved in several metabolic disorders, some of which include the 3-methylglutaconic aciduria type IV pathway, the 3-methylglutaconic aciduria type I pathway, 2-methyl-3-hydroxybutryl CoA dehydrogenase deficiency, and the isovaleric acidemia pathway. L-Leucine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Leucine ; HMDB00687",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000687",
    "description" : "L-Leucine, also known as (S)-leucine or L-leucin, belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Leucine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Leucine has been found throughout most human tissues, and has also been detected in most biofluids, including breast milk, sweat, blood, and saliva. Within the cell, L-leucine is primarily located in the mitochondria and cytoplasm. L-Leucine exists in all eukaryotes, ranging from yeast to humans. L-Leucine and oxoglutaric acid can be converted into ketoleucine and L-glutamic acid through its interaction with the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In humans, L-leucine is involved in the methacycline action pathway, the telithromycin action pathway, the josamycin action pathway, and the neomycin action pathway. L-Leucine is also involved in several metabolic disorders, some of which include the 3-methylglutaconic aciduria type IV pathway, the 3-methylglutaconic aciduria type I pathway, 2-methyl-3-hydroxybutryl CoA dehydrogenase deficiency, and the isovaleric acidemia pathway. L-Leucine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Lysine ; HMDB0000182",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000182",
    "description" : "L-Lysine, also known as (S)-lysine or L-lysin, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Lysine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Lysine has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, sweat, and cerebrospinal fluid. Within the cell, L-lysine is primarily located in the cytoplasm, mitochondria, nucleus and peroxisome. L-Lysine exists in all eukaryotes, ranging from yeast to humans. L-Lysine participates in a number of enzymatic reactions. In particular, L-Lysine and oxoglutaric acid can be converted into saccharopine; which is mediated by the enzyme Alpha-aminoadipic semialdehyde synthase, mitochondrial. Furthermore, L-Lysine can be converted into L-lysine through its interaction with the enzyme low affinity cationic amino acid transporter 2. Finally, L-Lysine and S-adenosylmethionine can be converted into N6,N6,N6-trimethyl-L-lysine and S-adenosylhomocysteine; which is mediated by the enzyme histone-lysine N-methyltransferase SETD7. In humans, L-lysine is involved in the biotin metabolism pathway, the lysine degradation pathway, carnitine synthesis pathway, and the pyridoxine dependency with seizures pathway. L-Lysine is also involved in several metabolic disorders, some of which include the hyperlysinemia II or saccharopinuria pathway, the saccharopinuria/hyperlysinemia II pathway, the glutaric aciduria type I pathway, and the hyperlysinemia I, familial pathway. L-Lysine has been found to be associated with several diseases known as pyruvate carboxylase deficiency, leukemia, schizophrenia, and lipoyltransferase 1 deficiency; l-lysine has also been linked to the inborn metabolic disorders including tyrosinemia I.",
    "id" : null
  }, {
    "name" : "L-Lysine ; HMDB00182",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000182",
    "description" : "L-Lysine, also known as (S)-lysine or L-lysin, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Lysine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Lysine has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, sweat, and cerebrospinal fluid. Within the cell, L-lysine is primarily located in the cytoplasm, mitochondria, nucleus and peroxisome. L-Lysine exists in all eukaryotes, ranging from yeast to humans. L-Lysine participates in a number of enzymatic reactions. In particular, L-Lysine and oxoglutaric acid can be converted into saccharopine; which is mediated by the enzyme Alpha-aminoadipic semialdehyde synthase, mitochondrial. Furthermore, L-Lysine can be converted into L-lysine through its interaction with the enzyme low affinity cationic amino acid transporter 2. Finally, L-Lysine and S-adenosylmethionine can be converted into N6,N6,N6-trimethyl-L-lysine and S-adenosylhomocysteine; which is mediated by the enzyme histone-lysine N-methyltransferase SETD7. In humans, L-lysine is involved in the biotin metabolism pathway, the lysine degradation pathway, carnitine synthesis pathway, and the pyridoxine dependency with seizures pathway. L-Lysine is also involved in several metabolic disorders, some of which include the hyperlysinemia II or saccharopinuria pathway, the saccharopinuria/hyperlysinemia II pathway, the glutaric aciduria type I pathway, and the hyperlysinemia I, familial pathway. L-Lysine has been found to be associated with several diseases known as pyruvate carboxylase deficiency, leukemia, schizophrenia, and lipoyltransferase 1 deficiency; l-lysine has also been linked to the inborn metabolic disorders including tyrosinemia I.",
    "id" : null
  }, {
    "name" : "L-Malic acid ; HMDB0000156",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000156",
    "description" : "(S)-Malic acid, also known as malate or L-apple acid, belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom (S)-Malic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa) (S)-Malic acid has been found in human prostate tissue, and has also been detected in most biofluids, including feces, urine, saliva, and blood. Within the cell, (S)-malic acid is primarily located in the cytoplasm and mitochondria (S)-Malic acid exists in all eukaryotes, ranging from yeast to humans. In humans, (S)-malic acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the oncogenic action OF fumarate pathway, the congenital lactic acidosis pathway, and the citric Acid cycle pathway (S)-Malic acid is also involved in several metabolic disorders, some of which include pyruvate dehydrogenase deficiency (e3), the transfer OF acetyl groups into mitochondria pathway, the primary hyperoxaluria II, PH2 pathway, and pyruvate decarboxylase E1 component deficiency (pdhe1 deficiency).",
    "id" : null
  }, {
    "name" : "L-Malic acid ; HMDB00156",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000156",
    "description" : "(S)-Malic acid, also known as malate or L-apple acid, belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom (S)-Malic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa) (S)-Malic acid has been found in human prostate tissue, and has also been detected in most biofluids, including feces, urine, saliva, and blood. Within the cell, (S)-malic acid is primarily located in the cytoplasm and mitochondria (S)-Malic acid exists in all eukaryotes, ranging from yeast to humans. In humans, (S)-malic acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the oncogenic action OF fumarate pathway, the congenital lactic acidosis pathway, and the citric Acid cycle pathway (S)-Malic acid is also involved in several metabolic disorders, some of which include pyruvate dehydrogenase deficiency (e3), the transfer OF acetyl groups into mitochondria pathway, the primary hyperoxaluria II, PH2 pathway, and pyruvate decarboxylase E1 component deficiency (pdhe1 deficiency).",
    "id" : null
  }, {
    "name" : "L-Methionine ; HMDB0000696",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000696",
    "description" : "L-Methionine, also known as liquimeth or pedameth, belongs to the class of organic compounds known as methionine and derivatives. Methionine and derivatives are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Methionine is a drug which is used for protein synthesis including the formation of same, l-homocysteine, l-cysteine, taurine, and sulfate. L-Methionine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Methionine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, saliva, and blood. Within the cell, L-methionine is primarily located in the mitochondria and cytoplasm. L-Methionine exists in all eukaryotes, ranging from yeast to humans. Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. In humans, L-methionine is involved in spermidine and spermine biosynthesis pathway, the arbekacin action pathway, the lincomycin action pathway, and the tobramycin action pathway. L-Methionine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, cystathionine Beta-synthase deficiency, the hypermethioninemia pathway, and the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway. L-Methionine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Methionine ; HMDB00696",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000696",
    "description" : "L-Methionine, also known as liquimeth or pedameth, belongs to the class of organic compounds known as methionine and derivatives. Methionine and derivatives are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Methionine is a drug which is used for protein synthesis including the formation of same, l-homocysteine, l-cysteine, taurine, and sulfate. L-Methionine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Methionine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, saliva, and blood. Within the cell, L-methionine is primarily located in the mitochondria and cytoplasm. L-Methionine exists in all eukaryotes, ranging from yeast to humans. Dimethylglycine and L-methionine can be biosynthesized from betaine and homocysteine; which is mediated by the enzyme betaine--homocysteine S-methyltransferase 1. In humans, L-methionine is involved in spermidine and spermine biosynthesis pathway, the arbekacin action pathway, the lincomycin action pathway, and the tobramycin action pathway. L-Methionine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, cystathionine Beta-synthase deficiency, the hypermethioninemia pathway, and the homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, CBLG complementation type pathway. L-Methionine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Octanoylcarnitine ; HMDB0000791",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000791",
    "description" : ", also known as octanoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, is considered to be a fatty ester lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and mitochondria. In humans, is involved in the metabolic disorder called the mitochondrial Beta-oxidation OF short chain saturated fatty acids pathway. has been linked to several inborn metabolic disorders including celiac disease and glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "L-Octanoylcarnitine ; HMDB00791",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000791",
    "description" : ", also known as octanoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, is considered to be a fatty ester lipid molecule. is considered to be a practically insoluble (in water) and relatively neutral molecule. has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, is primarily located in the membrane (predicted from logP), cytoplasm and mitochondria. In humans, is involved in the metabolic disorder called the mitochondrial Beta-oxidation OF short chain saturated fatty acids pathway. has been linked to several inborn metabolic disorders including celiac disease and glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "L-Palmitoylcarnitine ; HMDB0000222",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000222",
    "description" : "Palmitoylcarnitine, also known as hexadecanoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, palmitoylcarnitine is considered to be a fatty ester lipid molecule. Palmitoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Palmitoylcarnitine has been primarily detected in saliva, feces, urine, and blood. Within the cell, palmitoylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria. Palmitoylcarnitine exists in all eukaryotes, ranging from yeast to humans. In humans, palmitoylcarnitine is involved in the fatty acid metabolism pathway. Palmitoylcarnitine is also involved in several metabolic disorders, some of which include short chain acyl CoA dehydrogenase deficiency (scad deficiency), medium chain acyl-CoA dehydrogenase deficiency (mcad), trifunctional protein deficiency, and the ethylmalonic encephalopathy pathway. Palmitoylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "L-Palmitoylcarnitine ; HMDB00222",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000222",
    "description" : "Palmitoylcarnitine, also known as hexadecanoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, palmitoylcarnitine is considered to be a fatty ester lipid molecule. Palmitoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Palmitoylcarnitine has been primarily detected in saliva, feces, urine, and blood. Within the cell, palmitoylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria. Palmitoylcarnitine exists in all eukaryotes, ranging from yeast to humans. In humans, palmitoylcarnitine is involved in the fatty acid metabolism pathway. Palmitoylcarnitine is also involved in several metabolic disorders, some of which include short chain acyl CoA dehydrogenase deficiency (scad deficiency), medium chain acyl-CoA dehydrogenase deficiency (mcad), trifunctional protein deficiency, and the ethylmalonic encephalopathy pathway. Palmitoylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "L-Phenylalanine ; HMDB0000159",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000159",
    "description" : "L-Phenylalanine, also known as F or endorphenyl, belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Phenylalanine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Phenylalanine has been found throughout all human tissues, and has also been detected in most biofluids, including blood, cerebrospinal fluid, urine, and sweat. Within the cell, L-phenylalanine is primarily located in the cytoplasm and mitochondria. L-Phenylalanine exists in all eukaryotes, ranging from yeast to humans. L-Phenylalanine participates in a number of enzymatic reactions. In particular, L-Phenylalanine and oxoglutaric acid can be converted into phenylpyruvic acid and L-glutamic acid; which is mediated by the enzyme aspartate aminotransferase, cytoplasmic. In addition, L-Phenylalanine can be converted into phenylpyruvic acid; which is catalyzed by the enzyme L-amino-acid oxidase. In humans, L-phenylalanine is involved in the transcription/translation pathway and the phenylalanine and tyrosine metabolism pathway. L-Phenylalanine is also involved in a few metabolic disorders, which include the tyrosinemia type 3 (tyro3) pathway, the tyrosinemia type 2 (or richner-hanhart syndrome) pathway, and the phenylketonuria pathway. Outside of the human body, L-phenylalanine can be found in watermelon. This makes L-phenylalanine a potential biomarker for the consumption of this food product. L-Phenylalanine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Phenylalanine ; HMDB00159",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000159",
    "description" : "L-Phenylalanine, also known as F or endorphenyl, belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Phenylalanine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Phenylalanine has been found throughout all human tissues, and has also been detected in most biofluids, including blood, cerebrospinal fluid, urine, and sweat. Within the cell, L-phenylalanine is primarily located in the cytoplasm and mitochondria. L-Phenylalanine exists in all eukaryotes, ranging from yeast to humans. L-Phenylalanine participates in a number of enzymatic reactions. In particular, L-Phenylalanine and oxoglutaric acid can be converted into phenylpyruvic acid and L-glutamic acid; which is mediated by the enzyme aspartate aminotransferase, cytoplasmic. In addition, L-Phenylalanine can be converted into phenylpyruvic acid; which is catalyzed by the enzyme L-amino-acid oxidase. In humans, L-phenylalanine is involved in the transcription/translation pathway and the phenylalanine and tyrosine metabolism pathway. L-Phenylalanine is also involved in a few metabolic disorders, which include the tyrosinemia type 3 (tyro3) pathway, the tyrosinemia type 2 (or richner-hanhart syndrome) pathway, and the phenylketonuria pathway. Outside of the human body, L-phenylalanine can be found in watermelon. This makes L-phenylalanine a potential biomarker for the consumption of this food product. L-Phenylalanine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Pipecolic acid ; HMDB0000716",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000716",
    "description" : "L-Pipecolic acid, also known as (S)-pipecolate or L-homoproline, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Pipecolic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Pipecolic acid has been found in human liver tissue, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, L-pipecolic acid is primarily located in the peroxisome. L-Pipecolic acid can be converted into (S)-2,3,4,5-tetrahydropiperidine-2-carboxylate through the action of the enzyme peroxisomal sarcosine oxidase. In humans, L-pipecolic acid is involved in the lysine degradation pathway and the pyridoxine dependency with seizures pathway. L-Pipecolic acid is also involved in several metabolic disorders, some of which include the glutaric aciduria type I pathway, the hyperlysinemia I, familial pathway, the 2-aminoadipic 2-oxoadipic aciduria pathway, and the hyperlysinemia II or saccharopinuria pathway. Outside of the human body, L-pipecolic acid can be found in a number of food items such as natal plum, sacred lotus, redcurrant, and chinese cinnamon. This makes L-pipecolic acid a potential biomarker for the consumption of these food products. L-Pipecolic acid has been linked to several inborn metabolic disorders including peroxisomal biogenesis defect and adrenoleukodystrophy.",
    "id" : null
  }, {
    "name" : "L-Pipecolic acid ; HMDB00716",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000716",
    "description" : "L-Pipecolic acid, also known as (S)-pipecolate or L-homoproline, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Pipecolic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Pipecolic acid has been found in human liver tissue, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, L-pipecolic acid is primarily located in the peroxisome. L-Pipecolic acid can be converted into (S)-2,3,4,5-tetrahydropiperidine-2-carboxylate through the action of the enzyme peroxisomal sarcosine oxidase. In humans, L-pipecolic acid is involved in the lysine degradation pathway and the pyridoxine dependency with seizures pathway. L-Pipecolic acid is also involved in several metabolic disorders, some of which include the glutaric aciduria type I pathway, the hyperlysinemia I, familial pathway, the 2-aminoadipic 2-oxoadipic aciduria pathway, and the hyperlysinemia II or saccharopinuria pathway. Outside of the human body, L-pipecolic acid can be found in a number of food items such as natal plum, sacred lotus, redcurrant, and chinese cinnamon. This makes L-pipecolic acid a potential biomarker for the consumption of these food products. L-Pipecolic acid has been linked to several inborn metabolic disorders including peroxisomal biogenesis defect and adrenoleukodystrophy.",
    "id" : null
  }, {
    "name" : "L-Proline ; HMDB0000162",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000162",
    "description" : "L-Proline, also known as L-prolin, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Proline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Proline has been found throughout all human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, breast milk, and blood. Within the cell, L-proline is primarily located in the cytoplasm, mitochondria, lysosome and endoplasmic reticulum. L-Proline exists in all eukaryotes, ranging from yeast to humans. L-Proline participates in a number of enzymatic reactions. In particular, L-Proline can be biosynthesized from 1-pyrroline-5-carboxylic acid through the action of the enzyme proline dehydrogenase 1, mitochondrial. In addition, L-Proline can be converted into 1-pyrroline-5-carboxylic acid; which is mediated by the enzyme pyrroline-5-carboxylate reductase 2. In humans, L-proline is involved in the neomycin action pathway, the lymecycline action pathway, the netilmicin action pathway, and the clarithromycin action pathway. L-Proline is also involved in several metabolic disorders, some of which include creatine deficiency, guanidinoacetate methyltransferase deficiency, L-arginine:glycine amidinotransferase deficiency, arginine: glycine amidinotransferase deficiency (agat deficiency), and the hyperprolinemia type II pathway. L-Proline is a potentially toxic compound. L-Proline has been found to be associated with several diseases known as dicarboxylic aminoaciduria, alzheimer's disease, and hemodialysis; l-proline has also been linked to several inborn metabolic disorders including glutathione synthetase deficiency and iminoglycinuria.",
    "id" : null
  }, {
    "name" : "L-Proline ; HMDB00162",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000162",
    "description" : "L-Proline, also known as L-prolin, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Proline exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Proline has been found throughout all human tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, breast milk, and blood. Within the cell, L-proline is primarily located in the cytoplasm, mitochondria, lysosome and endoplasmic reticulum. L-Proline exists in all eukaryotes, ranging from yeast to humans. L-Proline participates in a number of enzymatic reactions. In particular, L-Proline can be biosynthesized from 1-pyrroline-5-carboxylic acid through the action of the enzyme proline dehydrogenase 1, mitochondrial. In addition, L-Proline can be converted into 1-pyrroline-5-carboxylic acid; which is mediated by the enzyme pyrroline-5-carboxylate reductase 2. In humans, L-proline is involved in the neomycin action pathway, the lymecycline action pathway, the netilmicin action pathway, and the clarithromycin action pathway. L-Proline is also involved in several metabolic disorders, some of which include creatine deficiency, guanidinoacetate methyltransferase deficiency, L-arginine:glycine amidinotransferase deficiency, arginine: glycine amidinotransferase deficiency (agat deficiency), and the hyperprolinemia type II pathway. L-Proline is a potentially toxic compound. L-Proline has been found to be associated with several diseases known as dicarboxylic aminoaciduria, alzheimer's disease, and hemodialysis; l-proline has also been linked to several inborn metabolic disorders including glutathione synthetase deficiency and iminoglycinuria.",
    "id" : null
  }, {
    "name" : "L-Serine ; HMDB0000187",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000187",
    "description" : "L-Serine, also known as (S)-serine or L-ser, belongs to the class of organic compounds known as serine and derivatives. Serine and derivatives are compounds containing serine or a derivative thereof resulting from reaction of serine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Serine is a drug which is used as a natural moisturizing agent in some cosmetics and skin care products. L-Serine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Serine has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, sweat, and saliva. Within the cell, L-serine is primarily located in the cytoplasm, mitochondria and peroxisome. L-Serine exists in all eukaryotes, ranging from yeast to humans. L-Serine participates in a number of enzymatic reactions. In particular, Tetrahydrofolic acid and L-serine can be biosynthesized from 5,10-methylene-THF and glycine through the action of the enzyme serine hydroxymethyltransferase, mitochondrial. Furthermore, Pyruvic acid and L-serine can be converted into hydroxypyruvic acid and L-alanine through its interaction with the enzyme serine--pyruvate aminotransferase. Furthermore, L-Serine can be converted into pyruvic acid through the action of the enzyme L-serine dehydratase/l-threonine deaminase. Finally, Tetrahydrofolic acid and L-serine can be converted into 5,10-methylene-THF, glycine, and water; which is catalyzed by the enzyme serine hydroxymethyltransferase, cytosolic. In humans, L-serine is involved in phosphatidylethanolamine biosynthesis pe(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)) pathway, phosphatidylethanolamine biosynthesis pe(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) pathway, phosphatidylethanolamine biosynthesis pe(14:0/24:0) pathway, and phosphatidylethanolamine biosynthesis pe(16:1(9Z)/18:0) pathway. L-Serine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, the gaucher disease pathway, the hypermethioninemia pathway, and Gamma-cystathionase deficiency (CTH). L-Serine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Serine ; HMDB00187",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000187",
    "description" : "L-Serine, also known as (S)-serine or L-ser, belongs to the class of organic compounds known as serine and derivatives. Serine and derivatives are compounds containing serine or a derivative thereof resulting from reaction of serine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Serine is a drug which is used as a natural moisturizing agent in some cosmetics and skin care products. L-Serine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Serine has been found throughout all human tissues, and has also been detected in most biofluids, including feces, blood, sweat, and saliva. Within the cell, L-serine is primarily located in the cytoplasm, mitochondria and peroxisome. L-Serine exists in all eukaryotes, ranging from yeast to humans. L-Serine participates in a number of enzymatic reactions. In particular, Tetrahydrofolic acid and L-serine can be biosynthesized from 5,10-methylene-THF and glycine through the action of the enzyme serine hydroxymethyltransferase, mitochondrial. Furthermore, Pyruvic acid and L-serine can be converted into hydroxypyruvic acid and L-alanine through its interaction with the enzyme serine--pyruvate aminotransferase. Furthermore, L-Serine can be converted into pyruvic acid through the action of the enzyme L-serine dehydratase/l-threonine deaminase. Finally, Tetrahydrofolic acid and L-serine can be converted into 5,10-methylene-THF, glycine, and water; which is catalyzed by the enzyme serine hydroxymethyltransferase, cytosolic. In humans, L-serine is involved in phosphatidylethanolamine biosynthesis pe(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)) pathway, phosphatidylethanolamine biosynthesis pe(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) pathway, phosphatidylethanolamine biosynthesis pe(14:0/24:0) pathway, and phosphatidylethanolamine biosynthesis pe(16:1(9Z)/18:0) pathway. L-Serine is also involved in several metabolic disorders, some of which include the NON ketotic hyperglycinemia pathway, the gaucher disease pathway, the hypermethioninemia pathway, and Gamma-cystathionase deficiency (CTH). L-Serine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Targinine ; HMDB0029416",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029416",
    "description" : "L-Targinine, also known as L-nmma or targinina, belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Targinine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). L-Targinine has been primarily detected in blood. Within the cell, L-targinine is primarily located in the cytoplasm. Outside of the human body, L-targinine can be found in pulses. This makes L-targinine a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "L-Targinine ; HMDB29416",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029416",
    "description" : "L-Targinine, also known as L-nmma or targinina, belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Targinine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). L-Targinine has been primarily detected in blood. Within the cell, L-targinine is primarily located in the cytoplasm. Outside of the human body, L-targinine can be found in pulses. This makes L-targinine a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "L-Theanine ; HMDB0034365",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0034365",
    "description" : "L-Theanine belongs to the class of organic compounds known as glutamine and derivatives. Glutamine and derivatives are compounds containing glutamine or a derivative thereof resulting from reaction of glutamine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Theanine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Theanine has been primarily detected in saliva. Within the cell, L-theanine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "L-Threonine ; HMDB0000167",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000167",
    "description" : "L-Threonine, also known as (2S)-threonine or L threonine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Threonine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Threonine has been found throughout all human tissues, and has also been detected in most biofluids, including sweat, feces, breast milk, and cerebrospinal fluid. Within the cell, L-threonine is primarily located in the cytoplasm and mitochondria. L-Threonine exists in all eukaryotes, ranging from yeast to humans. In humans, L-threonine is involved in the threonine and 2-oxobutanoate degradation pathway, the gentamicin action pathway, the clindamycin action pathway, and the erythromycin action pathway. L-Threonine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Threonine ; HMDB00167",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000167",
    "description" : "L-Threonine, also known as (2S)-threonine or L threonine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-Threonine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Threonine has been found throughout all human tissues, and has also been detected in most biofluids, including sweat, feces, breast milk, and cerebrospinal fluid. Within the cell, L-threonine is primarily located in the cytoplasm and mitochondria. L-Threonine exists in all eukaryotes, ranging from yeast to humans. In humans, L-threonine is involved in the threonine and 2-oxobutanoate degradation pathway, the gentamicin action pathway, the clindamycin action pathway, and the erythromycin action pathway. L-Threonine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Tryptophan ; HMDB0000929",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000929",
    "description" : "L-Tryptophan, also known as Trp or W, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. L-Tryptophan exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Tryptophan has been found in human prostate tissue, and has also been detected in most biofluids, including saliva, urine, feces, and blood. Within the cell, L-tryptophan is primarily located in the mitochondria and cytoplasm. L-Tryptophan exists in all eukaryotes, ranging from yeast to humans. L-Tryptophan participates in a number of enzymatic reactions. In particular, L-Tryptophan can be converted into n'-formylkynurenine; which is catalyzed by the enzyme tryptophan 2,3-dioxygenase. Furthermore, L-Tryptophan and tetrahydrobiopterin can be converted into 5-hydroxy-L-tryptophan and 4a-hydroxytetrahydrobiopterin; which is mediated by the enzyme tryptophan 5-hydroxylase 1. Furthermore, L-Tryptophan can be biosynthesized from L-serine and indole through the action of the enzyme tryptophan synthase. Finally, L-Tryptophan can be converted into n'-formylkynurenine through the action of the enzyme indoleamine 2,3-dioxygenase. In humans, L-tryptophan is involved in the tryptophan metabolism pathway and the transcription/translation pathway. L-Tryptophan is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Tryptophan ; HMDB00929",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000929",
    "description" : "L-Tryptophan, also known as Trp or W, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. L-Tryptophan exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Tryptophan has been found in human prostate tissue, and has also been detected in most biofluids, including saliva, urine, feces, and blood. Within the cell, L-tryptophan is primarily located in the mitochondria and cytoplasm. L-Tryptophan exists in all eukaryotes, ranging from yeast to humans. L-Tryptophan participates in a number of enzymatic reactions. In particular, L-Tryptophan can be converted into n'-formylkynurenine; which is catalyzed by the enzyme tryptophan 2,3-dioxygenase. Furthermore, L-Tryptophan and tetrahydrobiopterin can be converted into 5-hydroxy-L-tryptophan and 4a-hydroxytetrahydrobiopterin; which is mediated by the enzyme tryptophan 5-hydroxylase 1. Furthermore, L-Tryptophan can be biosynthesized from L-serine and indole through the action of the enzyme tryptophan synthase. Finally, L-Tryptophan can be converted into n'-formylkynurenine through the action of the enzyme indoleamine 2,3-dioxygenase. In humans, L-tryptophan is involved in the tryptophan metabolism pathway and the transcription/translation pathway. L-Tryptophan is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Tyrosine ; HMDB0000158",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000158",
    "description" : "L-Tyrosine, also known as (S)-tyrosine or para tyrosine, belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Tyrosine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Tyrosine has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, cerebrospinal fluid, feces, and blood. Within the cell, L-tyrosine is primarily located in the cytoplasm and mitochondria. L-Tyrosine exists in all eukaryotes, ranging from yeast to humans. L-Tyrosine participates in a number of enzymatic reactions. In particular, L-Tyrosine and oxoglutaric acid can be converted into 4-hydroxyphenylpyruvic acid and L-glutamic acid through the action of the enzyme tyrosine aminotransferase. Furthermore, L-Tyrosine can be converted into tyramine through the action of the enzyme aromatic-L-amino-acid decarboxylase. Finally, L-Tyrosine and sapropterin can be converted into L-dopa and dihydrobiopterin through the action of the enzyme tyrosine 3-monooxygenase. In humans, L-tyrosine is involved in thyroid hormone synthesis pathway, the tyrosine metabolism pathway, the phenylalanine and tyrosine metabolism pathway, and the disulfiram action pathway. L-Tyrosine is also involved in several metabolic disorders, some of which include the hawkinsinuria pathway, the tyrosinemia type I pathway, the tyrosinemia type 3 (tyro3) pathway, and aromatic L-aminoacid decarboxylase deficiency. L-Tyrosine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Tyrosine ; HMDB00158",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000158",
    "description" : "L-Tyrosine, also known as (S)-tyrosine or para tyrosine, belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Tyrosine exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). L-Tyrosine has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, cerebrospinal fluid, feces, and blood. Within the cell, L-tyrosine is primarily located in the cytoplasm and mitochondria. L-Tyrosine exists in all eukaryotes, ranging from yeast to humans. L-Tyrosine participates in a number of enzymatic reactions. In particular, L-Tyrosine and oxoglutaric acid can be converted into 4-hydroxyphenylpyruvic acid and L-glutamic acid through the action of the enzyme tyrosine aminotransferase. Furthermore, L-Tyrosine can be converted into tyramine through the action of the enzyme aromatic-L-amino-acid decarboxylase. Finally, L-Tyrosine and sapropterin can be converted into L-dopa and dihydrobiopterin through the action of the enzyme tyrosine 3-monooxygenase. In humans, L-tyrosine is involved in thyroid hormone synthesis pathway, the tyrosine metabolism pathway, the phenylalanine and tyrosine metabolism pathway, and the disulfiram action pathway. L-Tyrosine is also involved in several metabolic disorders, some of which include the hawkinsinuria pathway, the tyrosinemia type I pathway, the tyrosinemia type 3 (tyro3) pathway, and aromatic L-aminoacid decarboxylase deficiency. L-Tyrosine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "L-Urobilin ; HMDB0004159",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004159",
    "description" : "L-Urobilin, also known as L-stercobilin, belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. L-Urobilin exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. L-Urobilin has been detected in multiple biofluids, such as feces and urine. Within the cell, L-urobilin is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "L-Urobilin ; HMDB04159",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004159",
    "description" : "L-Urobilin, also known as L-stercobilin, belongs to the class of organic compounds known as bilirubins. These are organic compounds containing a dicarboxylic acyclic tetrapyrrole derivative. L-Urobilin exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. L-Urobilin has been detected in multiple biofluids, such as feces and urine. Within the cell, L-urobilin is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "L-Valine ; HMDB0000883",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000883",
    "description" : "L-Valine, also known as (S)-valine or L-valin, belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Valine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Valine has been found in human epidermis tissue, and has also been detected in most biofluids, including breast milk, sweat, urine, and saliva. Within the cell, L-valine is primarily located in the mitochondria and cytoplasm. L-Valine exists in all eukaryotes, ranging from yeast to humans. L-Valine and oxoglutaric acid can be converted into Alpha-ketoisovaleric acid and L-glutamic acid through the action of the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In humans, L-valine is involved in the doxycycline action pathway, the tobramycin action pathway, the clindamycin action pathway, and the minocycline action pathway. L-Valine is also involved in several metabolic disorders, some of which include the maple syrup urine disease pathway, 3-methylcrotonyl CoA carboxylase deficiency type I, Beta-ketothiolase deficiency, and the 3-methylglutaconic aciduria type I pathway. Outside of the human body, L-valine can be found in watermelon. This makes L-valine a potential biomarker for the consumption of this food product. L-Valine is a potentially toxic compound. L-Valine has been found to be associated with several diseases known as lipoyltransferase 1 deficiency, dihydrolipoamide dehydrogenase deficiency, paraquat poisoning, and lung cancer; l-valine has also been linked to the inborn metabolic disorders including hypervalinemia.",
    "id" : null
  }, {
    "name" : "L-Valine ; HMDB00883",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000883",
    "description" : "L-Valine, also known as (S)-valine or L-valin, belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Valine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Valine has been found in human epidermis tissue, and has also been detected in most biofluids, including breast milk, sweat, urine, and saliva. Within the cell, L-valine is primarily located in the mitochondria and cytoplasm. L-Valine exists in all eukaryotes, ranging from yeast to humans. L-Valine and oxoglutaric acid can be converted into Alpha-ketoisovaleric acid and L-glutamic acid through the action of the enzyme branched-chain-amino-acid aminotransferase, cytosolic. In humans, L-valine is involved in the doxycycline action pathway, the tobramycin action pathway, the clindamycin action pathway, and the minocycline action pathway. L-Valine is also involved in several metabolic disorders, some of which include the maple syrup urine disease pathway, 3-methylcrotonyl CoA carboxylase deficiency type I, Beta-ketothiolase deficiency, and the 3-methylglutaconic aciduria type I pathway. Outside of the human body, L-valine can be found in watermelon. This makes L-valine a potential biomarker for the consumption of this food product. L-Valine is a potentially toxic compound. L-Valine has been found to be associated with several diseases known as lipoyltransferase 1 deficiency, dihydrolipoamide dehydrogenase deficiency, paraquat poisoning, and lung cancer; l-valine has also been linked to the inborn metabolic disorders including hypervalinemia.",
    "id" : null
  }, {
    "name" : "Lenticin ; HMDB0061115",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061115",
    "description" : "Lenticin, also known as glyyunnanenine or L-hypaphorine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Lenticin is considered to be a practically insoluble (in water) and relatively neutral molecule. Lenticin has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "Leucyl-Alanine ; HMDB0028922",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0028922",
    "description" : "Leucyl-alanine, also known as L-a dipeptide or leu-ala, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Leucyl-alanine is soluble (in water) and a weakly acidic compound (based on its pKa). Leucyl-alanine has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "Levulinic acid ; HMDB0000720",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000720",
    "description" : "Levulinic acid, also known as laevulinsaeure or levulate, belongs to the class of organic compounds known as gamma-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the C4 carbon atom. Levulinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Levulinic acid has been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, levulinic acid is primarily located in the cytoplasm. Levulinic acid can be converted into 5-aminolevulinic acid. Levulinic acid is a sweet, acetoin, and acidic tasting compound that can be found in a number of food items such as alcoholic beverages, cereals and cereal products, fruits, and green vegetables. This makes levulinic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Levulinic acid ; HMDB00720",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000720",
    "description" : "Levulinic acid, also known as laevulinsaeure or levulate, belongs to the class of organic compounds known as gamma-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the C4 carbon atom. Levulinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Levulinic acid has been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, levulinic acid is primarily located in the cytoplasm. Levulinic acid can be converted into 5-aminolevulinic acid. Levulinic acid is a sweet, acetoin, and acidic tasting compound that can be found in a number of food items such as alcoholic beverages, cereals and cereal products, fruits, and green vegetables. This makes levulinic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Linoleic acid ; HMDB0000673",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000673",
    "description" : "Linoleic acid, also known as LA or linoleate, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Linoleic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Linoleic acid has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, cerebrospinal fluid, urine, and feces. Within the cell, linoleic acid is primarily located in the cytoplasm, membrane (predicted from logP) and myelin sheath. Linoleic acid can be converted into Gamma-linolenic acid through the action of the enzyme fatty acid desaturase 2. In humans, linoleic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Outside of the human body, linoleic acid can be found in a number of food items such as jujube, star fruit, winter savory, and black mulberry. This makes linoleic acid a potential biomarker for the consumption of these food products. Linoleic acid is a potentially toxic compound. Linoleic acid has been found to be associated with several diseases known as schizophrenia, thyroid cancer, cirrhosis, and hypertension; linoleic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Linoleic acid ; HMDB00673",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000673",
    "description" : "Linoleic acid, also known as LA or linoleate, belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. Linoleic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Linoleic acid has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, cerebrospinal fluid, urine, and feces. Within the cell, linoleic acid is primarily located in the cytoplasm, membrane (predicted from logP) and myelin sheath. Linoleic acid can be converted into Gamma-linolenic acid through the action of the enzyme fatty acid desaturase 2. In humans, linoleic acid is involved in the Alpha linolenic Acid and linoleic Acid metabolism pathway. Outside of the human body, linoleic acid can be found in a number of food items such as jujube, star fruit, winter savory, and black mulberry. This makes linoleic acid a potential biomarker for the consumption of these food products. Linoleic acid is a potentially toxic compound. Linoleic acid has been found to be associated with several diseases known as schizophrenia, thyroid cancer, cirrhosis, and hypertension; linoleic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Linoleoyl ethanolamide ; HMDB0012252",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012252",
    "description" : "Anandamide (18:2, N-6), also known as linoleamide mea or linoleoylethanolamide, belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, anandamide (18:2, N-6) is considered to be a fatty amide lipid molecule. Anandamide (18:2, N-6) is considered to be a practically insoluble (in water) and relatively neutral molecule. Anandamide (18:2, N-6) has been primarily detected in blood. Within the cell, anandamide (18:2, N-6) is primarily located in the membrane (predicted from logP). Anandamide (18:2, N-6) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "Linoleoyl ethanolamide ; HMDB12252",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012252",
    "description" : "Anandamide (18:2, N-6), also known as linoleamide mea or linoleoylethanolamide, belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, anandamide (18:2, N-6) is considered to be a fatty amide lipid molecule. Anandamide (18:2, N-6) is considered to be a practically insoluble (in water) and relatively neutral molecule. Anandamide (18:2, N-6) has been primarily detected in blood. Within the cell, anandamide (18:2, N-6) is primarily located in the membrane (predicted from logP). Anandamide (18:2, N-6) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "Linoleyl carnitine ; HMDB0006469",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006469",
    "description" : "9,12-Hexadecadienylcarnitine, also known as octadecadienyl-L-carnitine or alpha-linoleoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, 9,12-hexadecadienylcarnitine is considered to be a fatty ester lipid molecule. 9,12-Hexadecadienylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. 9,12-Hexadecadienylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, 9,12-hexadecadienylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria. 9,12-Hexadecadienylcarnitine can be biosynthesized from linoleic acid. 9,12-Hexadecadienylcarnitine has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Linoleyl carnitine ; HMDB06469",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006469",
    "description" : "9,12-Hexadecadienylcarnitine, also known as octadecadienyl-L-carnitine or alpha-linoleoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, 9,12-hexadecadienylcarnitine is considered to be a fatty ester lipid molecule. 9,12-Hexadecadienylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. 9,12-Hexadecadienylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, 9,12-hexadecadienylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria. 9,12-Hexadecadienylcarnitine can be biosynthesized from linoleic acid. 9,12-Hexadecadienylcarnitine has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Lithocholic acid ; HMDB0000761",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000761",
    "description" : "Lithocholic acid, also known as lithocholate or 5b-cholanate-3a-ol, belongs to the class of organic compounds known as monohydroxy bile acids, alcohols and derivatives. These are bile acids, alcohols or any of their derivatives bearing a hydroxyl group. Lithocholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Lithocholic acid has been found in human hepatic tissue, intestine and liver tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, lithocholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, lithocholic acid is involved in bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, congenital bile acid synthesis defect type III pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Lithocholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, the zellweger syndrome pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Lithocholic acid ; HMDB00761",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000761",
    "description" : "Lithocholic acid, also known as lithocholate or 5b-cholanate-3a-ol, belongs to the class of organic compounds known as monohydroxy bile acids, alcohols and derivatives. These are bile acids, alcohols or any of their derivatives bearing a hydroxyl group. Lithocholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Lithocholic acid has been found in human hepatic tissue, intestine and liver tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, lithocholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, lithocholic acid is involved in bile acid biosynthesis pathway, congenital bile acid synthesis defect type II pathway, congenital bile acid synthesis defect type III pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Lithocholic acid is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, the zellweger syndrome pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Lithocholic acid glycine conjugate ; HMDB0000698",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000698",
    "description" : "Lithocholic acid glycine conjugate, also known as glycolithocholic acid or lithocholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Lithocholic acid glycine conjugate is considered to be a practically insoluble (in water) and relatively neutral molecule. Lithocholic acid glycine conjugate has been found throughout all human tissues, and has also been primarily detected in bile, feces, blood, and urine. Within the cell, lithocholic acid glycine conjugate is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, lithocholic acid glycine conjugate is involved in bile acid biosynthesis pathway, the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type II pathway, and congenital bile acid synthesis defect type III pathway. Lithocholic acid glycine conjugate is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, the zellweger syndrome pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Lithocholic acid glycine conjugate ; HMDB00698",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000698",
    "description" : "Lithocholic acid glycine conjugate, also known as glycolithocholic acid or lithocholylglycine, belongs to the class of organic compounds known as glycinated bile acids and derivatives. Glycinated bile acids and derivatives are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. Lithocholic acid glycine conjugate is considered to be a practically insoluble (in water) and relatively neutral molecule. Lithocholic acid glycine conjugate has been found throughout all human tissues, and has also been primarily detected in bile, feces, blood, and urine. Within the cell, lithocholic acid glycine conjugate is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, lithocholic acid glycine conjugate is involved in bile acid biosynthesis pathway, the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type II pathway, and congenital bile acid synthesis defect type III pathway. Lithocholic acid glycine conjugate is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, the zellweger syndrome pathway, and 27-hydroxylase deficiency.",
    "id" : null
  }, {
    "name" : "Lithocholyltaurine ; HMDB0000722",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000722",
    "description" : "Lithocholyltaurine, also known as taurolithocholate, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Thus, lithocholyltaurine is considered to be a steroid conjugate lipid molecule. Lithocholyltaurine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Lithocholyltaurine has been found throughout all human tissues, and has also been primarily detected in bile, feces, blood, and urine. Within the cell, lithocholyltaurine is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, lithocholyltaurine is involved in the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, bile acid biosynthesis pathway, and congenital bile acid synthesis defect type II pathway. Lithocholyltaurine is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Lithocholyltaurine ; HMDB00722",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000722",
    "description" : "Lithocholyltaurine, also known as taurolithocholate, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Thus, lithocholyltaurine is considered to be a steroid conjugate lipid molecule. Lithocholyltaurine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Lithocholyltaurine has been found throughout all human tissues, and has also been primarily detected in bile, feces, blood, and urine. Within the cell, lithocholyltaurine is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, lithocholyltaurine is involved in the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, bile acid biosynthesis pathway, and congenital bile acid synthesis defect type II pathway. Lithocholyltaurine is also involved in a few metabolic disorders, which include the familial hypercholanemia (fhca) pathway, 27-hydroxylase deficiency, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "LysoPC(14:0/0:0) ; HMDB0010379",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010379",
    "description" : "PC(14:0/0:0), also known as LPC(14:0) or lysopc(14:0/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(14:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva and blood. Within the cell, PC(14:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/0:0) exists in all eukaryotes, ranging from yeast to humans. In humans, PC(14:0/0:0) is involved in the fenoprofen action pathway, the etoricoxib action pathway, the salicylate-sodium action pathway, and the celecoxib action pathway. PC(14:0/0:0) is also involved in a couple of metabolic disorders, which include the tiaprofenic Acid action pathway and leukotriene C4 synthesis deficiency.",
    "id" : null
  }, {
    "name" : "LysoPC(14:0/0:0) ; HMDB10379",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010379",
    "description" : "PC(14:0/0:0), also known as LPC(14:0) or lysopc(14:0/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(14:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva and blood. Within the cell, PC(14:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/0:0) exists in all eukaryotes, ranging from yeast to humans. In humans, PC(14:0/0:0) is involved in the fenoprofen action pathway, the etoricoxib action pathway, the salicylate-sodium action pathway, and the celecoxib action pathway. PC(14:0/0:0) is also involved in a couple of metabolic disorders, which include the tiaprofenic Acid action pathway and leukotriene C4 synthesis deficiency.",
    "id" : null
  }, {
    "name" : "LysoPC(16:0) ; HMDB0010382",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010382",
    "description" : "PC(16:0/0:0), also known as 16:0 lyso-PC or 1-palmitoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(16:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, PC(16:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/0:0) exists in all eukaryotes, ranging from yeast to humans. In humans, PC(16:0/0:0) is involved in phospholipid biosynthesis pathway.",
    "id" : null
  }, {
    "name" : "LysoPC(16:0) ; HMDB10382",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010382",
    "description" : "PC(16:0/0:0), also known as 16:0 lyso-PC or 1-palmitoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(16:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, PC(16:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/0:0) exists in all eukaryotes, ranging from yeast to humans. In humans, PC(16:0/0:0) is involved in phospholipid biosynthesis pathway.",
    "id" : null
  }, {
    "name" : "LysoPC(16:1(9Z)/0:0) ; HMDB0010383",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010383",
    "description" : "PC(16:1(9Z)/0:0), also known as LPC 16:1(9Z)/0:0 or 1-palmitoleoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(16:1(9Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(16:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:1(9Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(16:1(9Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:1(9Z)/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPC(16:1(9Z)/0:0) ; HMDB10383",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010383",
    "description" : "PC(16:1(9Z)/0:0), also known as LPC 16:1(9Z)/0:0 or 1-palmitoleoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(16:1(9Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(16:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:1(9Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(16:1(9Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:1(9Z)/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPC(18:0) ; HMDB0010384",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010384",
    "description" : "PC(18:0/0:0), also known as LPC 18:0/0:0 or 18:0 lyso-PC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/0:0) has been found throughout all human tissues, and has also been detected in most biofluids, including urine, blood, cerebrospinal fluid, and feces. Within the cell, PC(18:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPC(18:0) ; HMDB10384",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010384",
    "description" : "PC(18:0/0:0), also known as LPC 18:0/0:0 or 18:0 lyso-PC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/0:0) has been found throughout all human tissues, and has also been detected in most biofluids, including urine, blood, cerebrospinal fluid, and feces. Within the cell, PC(18:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPC(18:1(9Z)) ; HMDB0002815",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002815",
    "description" : "PC(18:1(9Z)/0:0), also known as lysopc 18:1(9Z)/0:0 or LPC(18:1W9/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:1(9Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:1(9Z)/0:0) has been detected in multiple biofluids, such as feces and blood. Within the cell, PC(18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:1(9Z)/0:0) exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, PC(18:1(9Z)/0:0) can be found in a number of food items such as cucumber, rice, common buckwheat, and common wheat. This makes PC(18:1(9Z)/0:0) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "LysoPC(18:1(9Z)) ; HMDB02815",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002815",
    "description" : "PC(18:1(9Z)/0:0), also known as lysopc 18:1(9Z)/0:0 or LPC(18:1W9/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:1(9Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:1(9Z)/0:0) has been detected in multiple biofluids, such as feces and blood. Within the cell, PC(18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:1(9Z)/0:0) exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, PC(18:1(9Z)/0:0) can be found in a number of food items such as cucumber, rice, common buckwheat, and common wheat. This makes PC(18:1(9Z)/0:0) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "LysoPC(18:2(9Z,12Z)) ; HMDB0010386",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010386",
    "description" : "PC(18:2(9Z,12Z)/0:0), also known as LPC 18:2(9Z,12Z)/0:0 or LPC(18:2n6/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:2(9Z,12Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:2(9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:2(9Z,12Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, PC(18:2(9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:2(9Z,12Z)/0:0) can be biosynthesized from linoleic acid. Outside of the human body, PC(18:2(9Z,12Z)/0:0) can be found in a number of food items such as acerola, deerberry, cowpea, and lemon thyme. This makes PC(18:2(9Z,12Z)/0:0) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "LysoPC(18:2(9Z,12Z)) ; HMDB10386",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010386",
    "description" : "PC(18:2(9Z,12Z)/0:0), also known as LPC 18:2(9Z,12Z)/0:0 or LPC(18:2n6/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:2(9Z,12Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:2(9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:2(9Z,12Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, PC(18:2(9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:2(9Z,12Z)/0:0) can be biosynthesized from linoleic acid. Outside of the human body, PC(18:2(9Z,12Z)/0:0) can be found in a number of food items such as acerola, deerberry, cowpea, and lemon thyme. This makes PC(18:2(9Z,12Z)/0:0) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "LysoPC(18:3(6Z,9Z,12Z)) ; HMDB0010387",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010387",
    "description" : "PC(18:3(6Z,9Z,12Z)/0:0), also known as LPC(18:3/0:0) or lysopc(18:3), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:3(6Z,9Z,12Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:3(6Z,9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:3(6Z,9Z,12Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(18:3(6Z,9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(18:3(6Z,9Z,12Z)) ; HMDB10387",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010387",
    "description" : "PC(18:3(6Z,9Z,12Z)/0:0), also known as LPC(18:3/0:0) or lysopc(18:3), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(18:3(6Z,9Z,12Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:3(6Z,9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:3(6Z,9Z,12Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(18:3(6Z,9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(20:1(11Z)) ; HMDB0010391",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010391",
    "description" : "PC(20:1(11Z)/0:0), also known as LPC(20:1n9/0:0) or lysopc(20:1(11Z)), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(20:1(11Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(20:1(11Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:1(11Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(20:1(11Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(20:1(11Z)) ; HMDB10391",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010391",
    "description" : "PC(20:1(11Z)/0:0), also known as LPC(20:1n9/0:0) or lysopc(20:1(11Z)), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(20:1(11Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(20:1(11Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:1(11Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(20:1(11Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(20:3(5Z,8Z,11Z)) ; HMDB0010393",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010393",
    "description" : "Lysopc(20:3(5Z,8Z,11Z)), also known as LPC 20:3(5Z,8Z,11Z)/0:0 or LPC(20:3/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, lysopc(20:3(5Z,8Z,11Z)) is considered to be a glycerophosphocholine lipid molecule. Lysopc(20:3(5Z,8Z,11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Lysopc(20:3(5Z,8Z,11Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, lysopc(20:3(5Z,8Z,11Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. Lysopc(20:3(5Z,8Z,11Z)) can be biosynthesized from (5Z,8Z,11Z)-icosatrienoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(20:3(5Z,8Z,11Z)) ; HMDB10393",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010393",
    "description" : "Lysopc(20:3(5Z,8Z,11Z)), also known as LPC 20:3(5Z,8Z,11Z)/0:0 or LPC(20:3/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, lysopc(20:3(5Z,8Z,11Z)) is considered to be a glycerophosphocholine lipid molecule. Lysopc(20:3(5Z,8Z,11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Lysopc(20:3(5Z,8Z,11Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, lysopc(20:3(5Z,8Z,11Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. Lysopc(20:3(5Z,8Z,11Z)) can be biosynthesized from (5Z,8Z,11Z)-icosatrienoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(20:4(5Z,8Z,11Z,14Z)) ; HMDB0010395",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010395",
    "description" : "PC(20:4(5Z,8Z,11Z,14Z)/0:0), also known as LPC 20:4(5Z,8Z,11Z,14Z)/0:0 or 1-arachidonoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:4(5Z,8Z,11Z,14Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, PC(20:4(5Z,8Z,11Z,14Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from arachidonic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(20:4(5Z,8Z,11Z,14Z)) ; HMDB10395",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010395",
    "description" : "PC(20:4(5Z,8Z,11Z,14Z)/0:0), also known as LPC 20:4(5Z,8Z,11Z,14Z)/0:0 or 1-arachidonoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:4(5Z,8Z,11Z,14Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, PC(20:4(5Z,8Z,11Z,14Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(20:4(5Z,8Z,11Z,14Z)/0:0) can be biosynthesized from arachidonic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) ; HMDB0010397",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010397",
    "description" : "PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0), also known as lysophosphatidylcholine(20:5/0:0) or LPC(20:5/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) ; HMDB10397",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010397",
    "description" : "PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0), also known as lysophosphatidylcholine(20:5/0:0) or LPC(20:5/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(22:4(7Z,10Z,13Z,16Z)) ; HMDB0010401",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010401",
    "description" : "PC(22:4(7Z,10Z,13Z,16Z)/0:0), also known as LPC(22:4/0:0) or 1-adrenoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(22:4(7Z,10Z,13Z,16Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(22:4(7Z,10Z,13Z,16Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(22:4(7Z,10Z,13Z,16Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(22:4(7Z,10Z,13Z,16Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(22:4(7Z,10Z,13Z,16Z)/0:0) can be biosynthesized from all-cis-docosa-7,10,13,16-tetraenoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(22:4(7Z,10Z,13Z,16Z)) ; HMDB10401",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010401",
    "description" : "PC(22:4(7Z,10Z,13Z,16Z)/0:0), also known as LPC(22:4/0:0) or 1-adrenoyl-GPC, belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(22:4(7Z,10Z,13Z,16Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(22:4(7Z,10Z,13Z,16Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(22:4(7Z,10Z,13Z,16Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(22:4(7Z,10Z,13Z,16Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(22:4(7Z,10Z,13Z,16Z)/0:0) can be biosynthesized from all-cis-docosa-7,10,13,16-tetraenoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)) ; HMDB0010403",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010403",
    "description" : "Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)), also known as lysophosphatidylcholine(22:5/0:0) or LPC(22:5/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphocholine lipid molecule. Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)) ; HMDB10403",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010403",
    "description" : "Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)), also known as lysophosphatidylcholine(22:5/0:0) or LPC(22:5/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphocholine lipid molecule. Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. Lysopc(22:5(7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0010404",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010404",
    "description" : "PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0), also known as LPC 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0 or lysophosphatidylcholine(22:6/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) can be biosynthesized from all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB10404",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010404",
    "description" : "PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0), also known as LPC 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0 or lysophosphatidylcholine(22:6/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) can be biosynthesized from all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(24:0) ; HMDB0010405",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010405",
    "description" : "PC(24:0/0:0), also known as GPC(24:0) or lysopc(24:0/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(24:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(24:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(24:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(24:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(24:0/0:0) can be biosynthesized from tetracosanoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(24:0) ; HMDB10405",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010405",
    "description" : "PC(24:0/0:0), also known as GPC(24:0) or lysopc(24:0/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphocholines. These are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, PC(24:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(24:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(24:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(24:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(24:0/0:0) can be biosynthesized from tetracosanoic acid.",
    "id" : null
  }, {
    "name" : "LysoPC(P-16:0) ; HMDB0010407",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010407",
    "description" : "PC(p-16:0/0:0), also known as LPC p-16:0/0:0 or lysoplasmalogens, belongs to the class of organic compounds known as 1-(1z-alkenyl)-glycero-3-phosphocholines. These are glycerophosphocholines that carry exactly one 1Z-alkenyl chain attached at the O1 position of a glycerol moiety through an ether linkage. Thus, PC(p-16:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-16:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(P-16:0) ; HMDB10407",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010407",
    "description" : "PC(p-16:0/0:0), also known as LPC p-16:0/0:0 or lysoplasmalogens, belongs to the class of organic compounds known as 1-(1z-alkenyl)-glycero-3-phosphocholines. These are glycerophosphocholines that carry exactly one 1Z-alkenyl chain attached at the O1 position of a glycerol moiety through an ether linkage. Thus, PC(p-16:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-16:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(P-18:0) ; HMDB0013122",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013122",
    "description" : "PC(p-18:0/0:0), also known as LPC(18:0/0:0) or GPC(p-18:0), belongs to the class of organic compounds known as 1-(1z-alkenyl)-glycero-3-phosphocholines. These are glycerophosphocholines that carry exactly one 1Z-alkenyl chain attached at the O1 position of a glycerol moiety through an ether linkage. Thus, PC(p-18:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/0:0) has been detected in multiple biofluids, such as blood and cerebrospinal fluid. Within the cell, PC(p-18:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPC(P-18:0) ; HMDB13122",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013122",
    "description" : "PC(p-18:0/0:0), also known as LPC(18:0/0:0) or GPC(p-18:0), belongs to the class of organic compounds known as 1-(1z-alkenyl)-glycero-3-phosphocholines. These are glycerophosphocholines that carry exactly one 1Z-alkenyl chain attached at the O1 position of a glycerol moiety through an ether linkage. Thus, PC(p-18:0/0:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/0:0) has been detected in multiple biofluids, such as blood and cerebrospinal fluid. Within the cell, PC(p-18:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPE(0:0/18:3(6Z,9Z,12Z)) ; HMDB0011478",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011478",
    "description" : "Lysope(0:0/18:3(6Z,9Z,12Z)), also known as lyso-pe(0:0/18:3) or lpe(18:3), belongs to the class of organic compounds known as 2-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-2 position, and linked at position 3 to a phosphoethanolamine. Thus, lysope(0:0/18:3(6Z,9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. Lysope(0:0/18:3(6Z,9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Lysope(0:0/18:3(6Z,9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, lysope(0:0/18:3(6Z,9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPE(0:0/18:3(6Z,9Z,12Z)) ; HMDB11478",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011478",
    "description" : "Lysope(0:0/18:3(6Z,9Z,12Z)), also known as lyso-pe(0:0/18:3) or lpe(18:3), belongs to the class of organic compounds known as 2-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-2 position, and linked at position 3 to a phosphoethanolamine. Thus, lysope(0:0/18:3(6Z,9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. Lysope(0:0/18:3(6Z,9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. Lysope(0:0/18:3(6Z,9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, lysope(0:0/18:3(6Z,9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPE(16:0/0:0) ; HMDB0011503",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011503",
    "description" : "PE(16:0/0:0), also known as 1-palmitoyl-gpe or gpe(16:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(16:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, PE(16:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/0:0) exists in all eukaryotes, ranging from yeast to humans. In humans, PE(16:0/0:0) is involved in phospholipid biosynthesis pathway.",
    "id" : null
  }, {
    "name" : "LysoPE(16:0/0:0) ; HMDB11503",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011503",
    "description" : "PE(16:0/0:0), also known as 1-palmitoyl-gpe or gpe(16:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(16:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, PE(16:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/0:0) exists in all eukaryotes, ranging from yeast to humans. In humans, PE(16:0/0:0) is involved in phospholipid biosynthesis pathway.",
    "id" : null
  }, {
    "name" : "LysoPE(18:0/0:0) ; HMDB0011130",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011130",
    "description" : "PE(18:0/0:0), also known as lyso-pe(18:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(18:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/0:0) has been detected in multiple biofluids, such as feces and blood. Within the cell, PE(18:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPE(18:0/0:0) ; HMDB11130",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011130",
    "description" : "PE(18:0/0:0), also known as lyso-pe(18:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(18:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/0:0) has been detected in multiple biofluids, such as feces and blood. Within the cell, PE(18:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPE(18:1(9Z)/0:0) ; HMDB0011506",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011506",
    "description" : "PE(18:1(9Z)/0:0), also known as 1-18:1-lysope or lyso-pe(18:1), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(18:1(9Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, PE(18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:1(9Z)/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPE(18:1(9Z)/0:0) ; HMDB11506",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011506",
    "description" : "PE(18:1(9Z)/0:0), also known as 1-18:1-lysope or lyso-pe(18:1), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(18:1(9Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:1(9Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, PE(18:1(9Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:1(9Z)/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPE(18:2(9Z,12Z)/0:0) ; HMDB0011507",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011507",
    "description" : "PE(18:2(9Z,12Z)/0:0), also known as lyso-pe(18:2n6/0:0) or lpe(18:2), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(18:2(9Z,12Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:2(9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:2(9Z,12Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, PE(18:2(9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:2(9Z,12Z)/0:0) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "LysoPE(18:2(9Z,12Z)/0:0) ; HMDB11507",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011507",
    "description" : "PE(18:2(9Z,12Z)/0:0), also known as lyso-pe(18:2n6/0:0) or lpe(18:2), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(18:2(9Z,12Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:2(9Z,12Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:2(9Z,12Z)/0:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, PE(18:2(9Z,12Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:2(9Z,12Z)/0:0) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "LysoPE(20:0/0:0) ; HMDB0011511",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011511",
    "description" : "PE(20:0/0:0), also known as lyso-pe(20:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(20:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(20:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(20:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(20:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(20:0/0:0) can be biosynthesized from arachidic acid.",
    "id" : null
  }, {
    "name" : "LysoPE(20:0/0:0) ; HMDB11511",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011511",
    "description" : "PE(20:0/0:0), also known as lyso-pe(20:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(20:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(20:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(20:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(20:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(20:0/0:0) can be biosynthesized from arachidic acid.",
    "id" : null
  }, {
    "name" : "LysoPE(20:1(11Z)/0:0) ; HMDB0011512",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011512",
    "description" : "PE(20:1(11Z)/0:0), also known as lyso-pe(20:1) or lpe(20:1/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(20:1(11Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(20:1(11Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(20:1(11Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(20:1(11Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPE(20:1(11Z)/0:0) ; HMDB11512",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011512",
    "description" : "PE(20:1(11Z)/0:0), also known as lyso-pe(20:1) or lpe(20:1/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(20:1(11Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(20:1(11Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(20:1(11Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(20:1(11Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0) ; HMDB0011517",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011517",
    "description" : "PE(20:4(5Z,8Z,11Z,14Z)/0:0), also known as lpe(20:4/0:0) or lysope(20:4), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(20:4(5Z,8Z,11Z,14Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(20:4(5Z,8Z,11Z,14Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(20:4(5Z,8Z,11Z,14Z)/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0) ; HMDB11517",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011517",
    "description" : "PE(20:4(5Z,8Z,11Z,14Z)/0:0), also known as lpe(20:4/0:0) or lysope(20:4), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(20:4(5Z,8Z,11Z,14Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(20:4(5Z,8Z,11Z,14Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(20:4(5Z,8Z,11Z,14Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(20:4(5Z,8Z,11Z,14Z)/0:0) exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "LysoPE(22:0/0:0) ; HMDB0011520",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011520",
    "description" : "PE(22:0/0:0), also known as lyso-pe(22:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(22:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(22:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(22:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(22:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPE(22:0/0:0) ; HMDB11520",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011520",
    "description" : "PE(22:0/0:0), also known as lyso-pe(22:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(22:0/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(22:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(22:0/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(22:0/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) ; HMDB0011526",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011526",
    "description" : "PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0), also known as lpe 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0 or lysophosphatidylethanolamine(22:6/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) can be biosynthesized from all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.",
    "id" : null
  }, {
    "name" : "LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) ; HMDB11526",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011526",
    "description" : "PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0), also known as lpe 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0 or lysophosphatidylethanolamine(22:6/0:0), belongs to the class of organic compounds known as 1-acyl-sn-glycero-3-phosphoethanolamines. These are glycerophoethanolamines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphoethanolamine. Thus, PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) can be biosynthesized from all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.",
    "id" : null
  }, {
    "name" : "Malondialdehyde ; HMDB0006112",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006112",
    "description" : "Malondialdehyde, also known as 1,3-propanedial or MDA, belongs to the class of organic compounds known as 1,3-dicarbonyl compounds. These are carbonyl compounds with the generic formula O=C(R)C(H)C(R')=O, where R and R' can be any group. Malondialdehyde exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Malondialdehyde has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Malondialdehyde is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Malondialdehyde ; HMDB06112",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006112",
    "description" : "Malondialdehyde, also known as 1,3-propanedial or MDA, belongs to the class of organic compounds known as 1,3-dicarbonyl compounds. These are carbonyl compounds with the generic formula O=C(R)C(H)C(R')=O, where R and R' can be any group. Malondialdehyde exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Malondialdehyde has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Malondialdehyde is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Malonic acid ; HMDB0000691",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000691",
    "description" : "Malonic acid, also known as malonate or H2MALO, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Malonic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Malonic acid has been found in human liver and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, malonic acid is primarily located in the cytoplasm. Malonic acid exists in all eukaryotes, ranging from yeast to humans. In humans, malonic acid is involved in the aspartate metabolism pathway and fatty acid biosynthesis pathway. Malonic acid has been found to be associated with the diseases known as combined malonic and methylmalonic aciduria; malonic acid has also been linked to the inborn metabolic disorders including malonyl-CoA decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "Malonic acid ; HMDB00691",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000691",
    "description" : "Malonic acid, also known as malonate or H2MALO, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Malonic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Malonic acid has been found in human liver and kidney tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, malonic acid is primarily located in the cytoplasm. Malonic acid exists in all eukaryotes, ranging from yeast to humans. In humans, malonic acid is involved in the aspartate metabolism pathway and fatty acid biosynthesis pathway. Malonic acid has been found to be associated with the diseases known as combined malonic and methylmalonic aciduria; malonic acid has also been linked to the inborn metabolic disorders including malonyl-CoA decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "Malonylcarnitine ; HMDB0002095",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002095",
    "description" : "Malonylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, malonylcarnitine is considered to be a fatty ester lipid molecule. Malonylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Malonylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, malonylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Malonylcarnitine can be biosynthesized from malonic acid.",
    "id" : null
  }, {
    "name" : "Malonylcarnitine ; HMDB02095",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002095",
    "description" : "Malonylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, malonylcarnitine is considered to be a fatty ester lipid molecule. Malonylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Malonylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, malonylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Malonylcarnitine can be biosynthesized from malonic acid.",
    "id" : null
  }, {
    "name" : "Maltotriose ; HMDB0001262",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001262",
    "description" : "Maltotriose belongs to the class of organic compounds known as oligosaccharides. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds. Maltotriose is soluble (in water) and a very weakly acidic compound (based on its pKa). Maltotriose has been found in human prostate, liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, maltotriose is primarily located in the cytoplasm and lysosome. In humans, maltotriose is involved in the galactose metabolism pathway.",
    "id" : null
  }, {
    "name" : "Mandelic acid ; HMDB0000703",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000703",
    "description" : "Mandelic acid, also known as L-mandelate or (S)-mandelsaeure, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Mandelic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Mandelic acid has been detected in multiple biofluids, such as feces and urine. Mandelic acid has been linked to the inborn metabolic disorders including phenylketonuria.",
    "id" : null
  }, {
    "name" : "Mandelic acid ; HMDB00703",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000703",
    "description" : "Mandelic acid, also known as L-mandelate or (S)-mandelsaeure, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Mandelic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Mandelic acid has been detected in multiple biofluids, such as feces and urine. Mandelic acid has been linked to the inborn metabolic disorders including phenylketonuria.",
    "id" : null
  }, {
    "name" : "Maslinic acid ; HMDB0002392",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002392",
    "description" : "Maslinic acid, also known as crategolic acid or crategolate, belongs to the class of organic compounds known as triterpenoids. These are terpene molecules containing six isoprene units. Maslinic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Within the cell, maslinic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Maslinic acid participates in a number of enzymatic reactions. In particular, maslinic acid can be biosynthesized from oleanane. Maslinic acid can also be converted into 2-O-caffeoyl maslinic acid and 3-O-[beta-D-glucopyranosyl]-28-O-[alpha-L-rhamnopyranosyl-(1-&gt;2)-beta-D-glucopyranosyl]maslinic acid.",
    "id" : null
  }, {
    "name" : "Maslinic acid ; HMDB02392",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002392",
    "description" : "Maslinic acid, also known as crategolic acid or crategolate, belongs to the class of organic compounds known as triterpenoids. These are terpene molecules containing six isoprene units. Maslinic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Within the cell, maslinic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Maslinic acid participates in a number of enzymatic reactions. In particular, maslinic acid can be biosynthesized from oleanane. Maslinic acid can also be converted into 2-O-caffeoyl maslinic acid and 3-O-[beta-D-glucopyranosyl]-28-O-[alpha-L-rhamnopyranosyl-(1-&gt;2)-beta-D-glucopyranosyl]maslinic acid.",
    "id" : null
  }, {
    "name" : "Mesaconic acid ; HMDB0000749",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000749",
    "description" : "Citraconic acid, also known as methylmaleic acid or 2-methylmaleate, belongs to the class of organic compounds known as methyl-branched fatty acids. These are fatty acids with an acyl chain that has a methyl branch. Usually, they are saturated and contain only one or more methyl group. However, branches other than methyl may be present. Citraconic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Citraconic acid has been detected in multiple biofluids, such as urine and blood. Within the cell, citraconic acid is primarily located in the cytoplasm and adiposome. Citraconic acid can be biosynthesized from maleic acid.",
    "id" : null
  }, {
    "name" : "Mesaconic acid ; HMDB00749",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000749",
    "description" : "Citraconic acid, also known as methylmaleic acid or 2-methylmaleate, belongs to the class of organic compounds known as methyl-branched fatty acids. These are fatty acids with an acyl chain that has a methyl branch. Usually, they are saturated and contain only one or more methyl group. However, branches other than methyl may be present. Citraconic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Citraconic acid has been detected in multiple biofluids, such as urine and blood. Within the cell, citraconic acid is primarily located in the cytoplasm and adiposome. Citraconic acid can be biosynthesized from maleic acid.",
    "id" : null
  }, {
    "name" : "Methionine sulfoxide ; HMDB0002005",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002005",
    "description" : "Methionine sulfoxide, also known as met-so or S-oxide-methionine, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Methionine sulfoxide exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Methionine sulfoxide has been found in human epidermis tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, methionine sulfoxide is primarily located in the cytoplasm and mitochondria. Methionine sulfoxide participates in a number of enzymatic reactions. In particular, Methionine sulfoxide can be biosynthesized from L-methionine through the action of the enzyme methionine-R-sulfoxide reductase B3. In addition, Methionine sulfoxide can be biosynthesized from L-methionine; which is catalyzed by the enzyme methionine-R-sulfoxide reductase b2, mitochondrial. In humans, methionine sulfoxide is involved in the methionine metabolism pathway. Methionine sulfoxide is also involved in several metabolic disorders, some of which include the hypermethioninemia pathway, glycine N-methyltransferase deficiency, methionine adenosyltransferase deficiency, and methylenetetrahydrofolate reductase deficiency (MTHFRD).",
    "id" : null
  }, {
    "name" : "Methionine sulfoxide ; HMDB02005",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002005",
    "description" : "Methionine sulfoxide, also known as met-so or S-oxide-methionine, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Methionine sulfoxide exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Methionine sulfoxide has been found in human epidermis tissue, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, methionine sulfoxide is primarily located in the cytoplasm and mitochondria. Methionine sulfoxide participates in a number of enzymatic reactions. In particular, Methionine sulfoxide can be biosynthesized from L-methionine through the action of the enzyme methionine-R-sulfoxide reductase B3. In addition, Methionine sulfoxide can be biosynthesized from L-methionine; which is catalyzed by the enzyme methionine-R-sulfoxide reductase b2, mitochondrial. In humans, methionine sulfoxide is involved in the methionine metabolism pathway. Methionine sulfoxide is also involved in several metabolic disorders, some of which include the hypermethioninemia pathway, glycine N-methyltransferase deficiency, methionine adenosyltransferase deficiency, and methylenetetrahydrofolate reductase deficiency (MTHFRD).",
    "id" : null
  }, {
    "name" : "Methylcysteine ; HMDB0002108",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002108",
    "description" : "Methylcysteine belongs to the class of organic compounds known as l-cysteine-s-conjugates. L-cysteine-S-conjugates are compounds containing L-cysteine where the thio-group is conjugated. Methylcysteine is soluble (in water) and a moderately acidic compound (based on its pKa). Methylcysteine has been detected in multiple biofluids, such as urine and blood. Outside of the human body, methylcysteine can be found in soft-necked garlic. This makes methylcysteine a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Methylcysteine ; HMDB02108",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002108",
    "description" : "Methylcysteine belongs to the class of organic compounds known as l-cysteine-s-conjugates. L-cysteine-S-conjugates are compounds containing L-cysteine where the thio-group is conjugated. Methylcysteine is soluble (in water) and a moderately acidic compound (based on its pKa). Methylcysteine has been detected in multiple biofluids, such as urine and blood. Outside of the human body, methylcysteine can be found in soft-necked garlic. This makes methylcysteine a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Methylimidazoleacetic acid ; HMDB0002820",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002820",
    "description" : "Methylimidazoleacetic acid, also known as 1-methylimidazole-4-acetate or miaa, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Methylimidazoleacetic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Methylimidazoleacetic acid has been found in human brain tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Methylimidazoleacetic acid can be biosynthesized from methylimidazole acetaldehyde through its interaction with the enzyme aldehyde dehydrogenase, dimeric nadp-preferring. In humans, methylimidazoleacetic acid is involved in the histidine metabolism pathway. Methylimidazoleacetic acid is also involved in the metabolic disorder called the histidinemia pathway.",
    "id" : null
  }, {
    "name" : "Methylimidazoleacetic acid ; HMDB02820",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002820",
    "description" : "Methylimidazoleacetic acid, also known as 1-methylimidazole-4-acetate or miaa, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Methylimidazoleacetic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Methylimidazoleacetic acid has been found in human brain tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Methylimidazoleacetic acid can be biosynthesized from methylimidazole acetaldehyde through its interaction with the enzyme aldehyde dehydrogenase, dimeric nadp-preferring. In humans, methylimidazoleacetic acid is involved in the histidine metabolism pathway. Methylimidazoleacetic acid is also involved in the metabolic disorder called the histidinemia pathway.",
    "id" : null
  }, {
    "name" : "Methylmalonic acid ; HMDB0000202",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000202",
    "description" : "Methylmalonic acid, also known as 2-methylmalonate or isosuccinic acid, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Methylmalonic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Methylmalonic acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, methylmalonic acid is primarily located in the cytoplasm. Methylmalonic acid exists in all eukaryotes, ranging from yeast to humans. In humans, methylmalonic acid is involved in the vitamin K metabolism pathway, the propanoate metabolism pathway, and the valine, leucine and isoleucine degradation pathway. Methylmalonic acid is also involved in several metabolic disorders, some of which include malonyl-CoA decarboxylase deficiency, the 3-methylglutaconic aciduria type III pathway, methylmalonate semialdehyde dehydrogenase deficiency, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Methylmalonic acid is a potentially toxic compound. Methylmalonic acid has been found to be associated with several diseases known as methylmalonic aciduria mitochondrial encephelopathy leigh-like, cobalamin f disease (cblf), and alzheimer's disease; methylmalonic acid has also been linked to several inborn metabolic disorders including transcobalamin II deficiency and cobalamin malabsorption.",
    "id" : null
  }, {
    "name" : "Methylmalonic acid ; HMDB00202",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000202",
    "description" : "Methylmalonic acid, also known as 2-methylmalonate or isosuccinic acid, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Methylmalonic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Methylmalonic acid has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, methylmalonic acid is primarily located in the cytoplasm. Methylmalonic acid exists in all eukaryotes, ranging from yeast to humans. In humans, methylmalonic acid is involved in the vitamin K metabolism pathway, the propanoate metabolism pathway, and the valine, leucine and isoleucine degradation pathway. Methylmalonic acid is also involved in several metabolic disorders, some of which include malonyl-CoA decarboxylase deficiency, the 3-methylglutaconic aciduria type III pathway, methylmalonate semialdehyde dehydrogenase deficiency, and 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Methylmalonic acid is a potentially toxic compound. Methylmalonic acid has been found to be associated with several diseases known as methylmalonic aciduria mitochondrial encephelopathy leigh-like, cobalamin f disease (cblf), and alzheimer's disease; methylmalonic acid has also been linked to several inborn metabolic disorders including transcobalamin II deficiency and cobalamin malabsorption.",
    "id" : null
  }, {
    "name" : "Methylmalonylcarnitine ; HMDB0013133",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013133",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Methylmalonylcarnitine ; HMDB13133",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013133",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Methylsuccinic acid ; HMDB0001844",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001844",
    "description" : "Methylsuccinic acid, also known as methylsuccinate or 2-methylbutanedioate, belongs to the class of organic compounds known as methyl-branched fatty acids. These are fatty acids with an acyl chain that has a methyl branch. Usually, they are saturated and contain only one or more methyl group. However, branches other than methyl may be present. Methylsuccinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Methylsuccinic acid has been primarily detected in saliva, feces, urine, and blood. Within the cell, methylsuccinic acid is primarily located in the cytoplasm and adiposome. Methylsuccinic acid has been linked to several inborn metabolic disorders including short chain acyl-CoA dehydrogenase deficiency, isovaleric acidemia, ethylmalonic encephalopathy, and medium chain acyl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Metoprolol ; HMDB0001932",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001932",
    "description" : "Metoprolol, also known as betaloc or (RS)-metoprolol, belongs to the class of organic compounds known as tyrosols and derivatives. Tyrosols and derivatives are compounds containing a hydroxyethyl group attached to the C4 carbon of a phenol group. Metoprolol is a drug which is used for the management of acute myocardial infarction, angina pectoris, heart failure and mild to moderate hypertension. may be used to treat supraventricular and tachyarrhythmias and as prophylaxis for migraine headaches. Metoprolol is considered to be a practically insoluble (in water) and relatively neutral molecule. Metoprolol has been found in human liver tissue, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, metoprolol is primarily located in the membrane (predicted from logP). In humans, metoprolol is involved in the metoprolol action pathway.",
    "id" : null
  }, {
    "name" : "Metoprolol ; HMDB01932",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001932",
    "description" : "Metoprolol, also known as betaloc or (RS)-metoprolol, belongs to the class of organic compounds known as tyrosols and derivatives. Tyrosols and derivatives are compounds containing a hydroxyethyl group attached to the C4 carbon of a phenol group. Metoprolol is a drug which is used for the management of acute myocardial infarction, angina pectoris, heart failure and mild to moderate hypertension. may be used to treat supraventricular and tachyarrhythmias and as prophylaxis for migraine headaches. Metoprolol is considered to be a practically insoluble (in water) and relatively neutral molecule. Metoprolol has been found in human liver tissue, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, metoprolol is primarily located in the membrane (predicted from logP). In humans, metoprolol is involved in the metoprolol action pathway.",
    "id" : null
  }, {
    "name" : "MG(14:1(9Z)/0:0/0:0) ; HMDB0011562",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011562",
    "description" : "MG(14:1(9Z)/0:0/0:0), also known as a-monoacylglycerol or mag(14:1/0:0), belongs to the class of organic compounds known as 1-monoacylglycerols. These are monoacylglycerols containing a glycerol acylated at the 1-position. MG(14:1(9Z)/0:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. MG(14:1(9Z)/0:0/0:0) has been found throughout all human tissues. Within the cell, MG(14:1(9Z)/0:0/0:0) is primarily located in the membrane (predicted from logP). MG(14:1(9Z)/0:0/0:0) exists in all eukaryotes, ranging from yeast to humans. MG(14:1(9Z)/0:0/0:0) participates in a number of enzymatic reactions. In particular, Palmitic acid and MG(14:1(9Z)/0:0/0:0) can be biosynthesized from DG(10:0/16:0/0:0) through the action of the enzyme diacylglycerol lipase. Furthermore, MG(14:1(9Z)/0:0/0:0) can be converted into palmitic acid and glycerol through its interaction with the enzyme monoglyceride lipase. Furthermore, Palmitic acid and MG(14:1(9Z)/0:0/0:0) can be biosynthesized from DG(10:0/16:1(9Z)/0:0) through its interaction with the enzyme diacylglycerol lipase. Furthermore, MG(14:1(9Z)/0:0/0:0) can be converted into palmitic acid and glycerol through the action of the enzyme monoglyceride lipase. Furthermore, Palmitic acid and MG(14:1(9Z)/0:0/0:0) can be biosynthesized from DG(10:0/18:0/0:0); which is catalyzed by the enzyme diacylglycerol lipase. Finally, MG(14:1(9Z)/0:0/0:0) can be converted into palmitic acid and glycerol; which is mediated by the enzyme monoglyceride lipase.",
    "id" : null
  }, {
    "name" : "MG(14:1(9Z)/0:0/0:0) ; HMDB11562",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011562",
    "description" : "MG(14:1(9Z)/0:0/0:0), also known as a-monoacylglycerol or mag(14:1/0:0), belongs to the class of organic compounds known as 1-monoacylglycerols. These are monoacylglycerols containing a glycerol acylated at the 1-position. MG(14:1(9Z)/0:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. MG(14:1(9Z)/0:0/0:0) has been found throughout all human tissues. Within the cell, MG(14:1(9Z)/0:0/0:0) is primarily located in the membrane (predicted from logP). MG(14:1(9Z)/0:0/0:0) exists in all eukaryotes, ranging from yeast to humans. MG(14:1(9Z)/0:0/0:0) participates in a number of enzymatic reactions. In particular, Palmitic acid and MG(14:1(9Z)/0:0/0:0) can be biosynthesized from DG(10:0/16:0/0:0) through the action of the enzyme diacylglycerol lipase. Furthermore, MG(14:1(9Z)/0:0/0:0) can be converted into palmitic acid and glycerol through its interaction with the enzyme monoglyceride lipase. Furthermore, Palmitic acid and MG(14:1(9Z)/0:0/0:0) can be biosynthesized from DG(10:0/16:1(9Z)/0:0) through its interaction with the enzyme diacylglycerol lipase. Furthermore, MG(14:1(9Z)/0:0/0:0) can be converted into palmitic acid and glycerol through the action of the enzyme monoglyceride lipase. Furthermore, Palmitic acid and MG(14:1(9Z)/0:0/0:0) can be biosynthesized from DG(10:0/18:0/0:0); which is catalyzed by the enzyme diacylglycerol lipase. Finally, MG(14:1(9Z)/0:0/0:0) can be converted into palmitic acid and glycerol; which is mediated by the enzyme monoglyceride lipase.",
    "id" : null
  }, {
    "name" : "MG(18:0/0:0/0:0) ; HMDB0011131",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011131",
    "description" : "MG(18:0/0:0/0:0), also known as (S)-1-monostearin or 1-stearoyl-glycerol, belongs to the class of organic compounds known as 1-monoacylglycerols. These are monoacylglycerols containing a glycerol acylated at the 1-position. MG(18:0/0:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. MG(18:0/0:0/0:0) has been detected in multiple biofluids, such as feces and sweat. Within the cell, MG(18:0/0:0/0:0) is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "MG(18:0/0:0/0:0) ; HMDB11131",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011131",
    "description" : "MG(18:0/0:0/0:0), also known as (S)-1-monostearin or 1-stearoyl-glycerol, belongs to the class of organic compounds known as 1-monoacylglycerols. These are monoacylglycerols containing a glycerol acylated at the 1-position. MG(18:0/0:0/0:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. MG(18:0/0:0/0:0) has been detected in multiple biofluids, such as feces and sweat. Within the cell, MG(18:0/0:0/0:0) is primarily located in the membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "myo-Inositol ; HMDB0000211",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000211",
    "description" : "Myoinositol, also known as bios i or cyclohexitol, belongs to the class of organic compounds known as cyclohexanols. Cyclohexanols are compounds containing an alcohol group attached to a cyclohexane ring. Myoinositol is soluble (in water) and a very weakly acidic compound (based on its pKa). Myoinositol has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, blood, saliva, and breast milk. Within the cell, myoinositol is primarily located in the myelin sheath. Myoinositol exists in all eukaryotes, ranging from yeast to humans. Myoinositol participates in a number of enzymatic reactions. In particular, D-Galactose and myoinositol can be converted into galactinol through the action of the enzyme Alpha-galactosidase a. Furthermore, Myoinositol can be biosynthesized from D-myo-inositol 4-phosphate through the action of the enzyme inositol monophosphatase 1. Furthermore, Myoinositol can be biosynthesized from D-myo-inositol 4-phosphate through the action of the enzyme inositol monophosphatase 1. Finally, Myoinositol can be biosynthesized from myo-inositol 1-phosphate; which is catalyzed by the enzyme inositol monophosphatase 1. In humans, myoinositol is involved in the galactose metabolism pathway, the inositol phosphate metabolism pathway, the inositol metabolism pathway, and the phosphatidylinositol phosphate metabolism pathway. Myoinositol is also involved in a couple of metabolic disorders, which include the galactosemia pathway and the joubert syndrome pathway.",
    "id" : null
  }, {
    "name" : "myo-Inositol ; HMDB00211",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000211",
    "description" : "Myoinositol, also known as bios i or cyclohexitol, belongs to the class of organic compounds known as cyclohexanols. Cyclohexanols are compounds containing an alcohol group attached to a cyclohexane ring. Myoinositol is soluble (in water) and a very weakly acidic compound (based on its pKa). Myoinositol has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, blood, saliva, and breast milk. Within the cell, myoinositol is primarily located in the myelin sheath. Myoinositol exists in all eukaryotes, ranging from yeast to humans. Myoinositol participates in a number of enzymatic reactions. In particular, D-Galactose and myoinositol can be converted into galactinol through the action of the enzyme Alpha-galactosidase a. Furthermore, Myoinositol can be biosynthesized from D-myo-inositol 4-phosphate through the action of the enzyme inositol monophosphatase 1. Furthermore, Myoinositol can be biosynthesized from D-myo-inositol 4-phosphate through the action of the enzyme inositol monophosphatase 1. Finally, Myoinositol can be biosynthesized from myo-inositol 1-phosphate; which is catalyzed by the enzyme inositol monophosphatase 1. In humans, myoinositol is involved in the galactose metabolism pathway, the inositol phosphate metabolism pathway, the inositol metabolism pathway, and the phosphatidylinositol phosphate metabolism pathway. Myoinositol is also involved in a couple of metabolic disorders, which include the galactosemia pathway and the joubert syndrome pathway.",
    "id" : null
  }, {
    "name" : "Myristic acid ; HMDB0000806",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000806",
    "description" : "Myristic acid, also known as 14 or tetradecanoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Myristic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Myristic acid has been found throughout most human tissues, and has also been detected in most biofluids, including feces, blood, urine, and cerebrospinal fluid. Within the cell, myristic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Myristic acid exists in all eukaryotes, ranging from yeast to humans. Myristic acid participates in a number of enzymatic reactions. In particular, Myristic acid can be biosynthesized from trans-tetra-dec-2-enoic acid through its interaction with the enzyme fatty acid synthase. enoyl reductase domain. Furthermore, Myristic acid and malonic acid can be converted into 3-oxohexadecanoic acid; which is catalyzed by the enzyme fatty acid synthase. Beta ketoacyl synthase domain. Furthermore, Myristic acid can be biosynthesized from trans-tetra-dec-2-enoic acid; which is mediated by the enzyme fatty acid synthase. enoyl reductase domain. Finally, Myristic acid and malonic acid can be converted into 3-oxohexadecanoic acid through its interaction with the enzyme fatty acid synthase. Beta ketoacyl synthase domain. In humans, myristic acid is involved in fatty acid biosynthesis pathway. Outside of the human body, myristic acid can be found in a number of food items such as lotus, buffalo currant, dill, and salmonberry. This makes myristic acid a potential biomarker for the consumption of these food products. Myristic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Myristic acid ; HMDB00806",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000806",
    "description" : "Myristic acid, also known as 14 or tetradecanoate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Myristic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Myristic acid has been found throughout most human tissues, and has also been detected in most biofluids, including feces, blood, urine, and cerebrospinal fluid. Within the cell, myristic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Myristic acid exists in all eukaryotes, ranging from yeast to humans. Myristic acid participates in a number of enzymatic reactions. In particular, Myristic acid can be biosynthesized from trans-tetra-dec-2-enoic acid through its interaction with the enzyme fatty acid synthase. enoyl reductase domain. Furthermore, Myristic acid and malonic acid can be converted into 3-oxohexadecanoic acid; which is catalyzed by the enzyme fatty acid synthase. Beta ketoacyl synthase domain. Furthermore, Myristic acid can be biosynthesized from trans-tetra-dec-2-enoic acid; which is mediated by the enzyme fatty acid synthase. enoyl reductase domain. Finally, Myristic acid and malonic acid can be converted into 3-oxohexadecanoic acid through its interaction with the enzyme fatty acid synthase. Beta ketoacyl synthase domain. In humans, myristic acid is involved in fatty acid biosynthesis pathway. Outside of the human body, myristic acid can be found in a number of food items such as lotus, buffalo currant, dill, and salmonberry. This makes myristic acid a potential biomarker for the consumption of these food products. Myristic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Myristoleic acid ; HMDB0002000",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002000",
    "description" : "Myristoleic acid, also known as 9-tetradecenoate or myristoleate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Myristoleic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Myristoleic acid has been found in human adipose tissue tissue, and has also been primarily detected in feces, saliva, blood, and urine. Within the cell, myristoleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Myristoleic acid exists in all eukaryotes, ranging from yeast to humans. Myristoleic acid is also a parent compound for other transformation products, including but not limited to, 1-[(9Z)-hexadecenoyl]-2-[(9Z)-tetradecenoyl]-sn-glycero-3-phosphocholine, O-[(9Z)-tetradecenoyl]-L-carnitine, and 1,2-dimyristoleoyl-sn-glycerol. Outside of the human body, myristoleic acid can be found in a number of food items such as lard, sorrel, walnut, and baby food. This makes myristoleic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Myristoleic acid ; HMDB02000",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002000",
    "description" : "Myristoleic acid, also known as 9-tetradecenoate or myristoleate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Myristoleic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Myristoleic acid has been found in human adipose tissue tissue, and has also been primarily detected in feces, saliva, blood, and urine. Within the cell, myristoleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Myristoleic acid exists in all eukaryotes, ranging from yeast to humans. Myristoleic acid is also a parent compound for other transformation products, including but not limited to, 1-[(9Z)-hexadecenoyl]-2-[(9Z)-tetradecenoyl]-sn-glycero-3-phosphocholine, O-[(9Z)-tetradecenoyl]-L-carnitine, and 1,2-dimyristoleoyl-sn-glycerol. Outside of the human body, myristoleic acid can be found in a number of food items such as lard, sorrel, walnut, and baby food. This makes myristoleic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "N-(3-acetamidopropyl)pyrrolidin-2-one ; HMDB0061384",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061384",
    "description" : "N-(3-Acetamidopropyl)pyrrolidin-2-one, also known as N-acetylisoputreanine-g-lactam or acisoga, belongs to the class of organic compounds known as n-alkylpyrrolidines. N-alkylpyrrolidines are compounds containing a pyrrolidine moiety that is substituted at the N1-position with an alkyl group. Pyrrolidine is a five-membered saturated aliphatic heterocycle with one nitrogen atom and four carbon atoms. N-(3-Acetamidopropyl)pyrrolidin-2-one is soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N-(3-Acetamidopropyl)pyrrolidin-2-one has been primarily detected in urine.",
    "id" : null
  }, {
    "name" : "N-a-Acetyl-L-arginine ; HMDB0004620",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004620",
    "description" : "N-a-Acetyl-L-arginine, also known as N-ac-L-arg-OH or N-alpha-acetylarginine, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-a-Acetyl-L-arginine is considered to be a practically insoluble (in water) and relatively neutral molecule. N-a-Acetyl-L-arginine has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Outside of the human body, N-a-acetyl-L-arginine can be found in apple and loquat. This makes N-a-acetyl-L-arginine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "N-a-Acetyl-L-arginine ; HMDB04620",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004620",
    "description" : "N-a-Acetyl-L-arginine, also known as N-ac-L-arg-OH or N-alpha-acetylarginine, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-a-Acetyl-L-arginine is considered to be a practically insoluble (in water) and relatively neutral molecule. N-a-Acetyl-L-arginine has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Outside of the human body, N-a-acetyl-L-arginine can be found in apple and loquat. This makes N-a-acetyl-L-arginine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "N-Acetyl-b-D-galactosamine ; HMDB0000853",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000853",
    "description" : "N-Acetyl-b-D-galactosamine, also known as beta-galnac or -galnac, belongs to the class of organic compounds known as n-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moiety in which the oxygen atom is replaced by an n-acyl group. N-Acetyl-b-D-galactosamine is soluble (in water) and a very weakly acidic compound (based on its pKa). N-Acetyl-b-D-galactosamine can be converted into 1beta-glutathionylseleno-N-acetyl-D-galactosamine. Outside of the human body, N-acetyl-b-D-galactosamine can be found in a number of food items such as opium poppy, spirulina, komatsuna, and orange bell pepper. This makes N-acetyl-b-D-galactosamine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "N-Acetyl-b-D-galactosamine ; HMDB00853",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000853",
    "description" : "N-Acetyl-b-D-galactosamine, also known as beta-galnac or -galnac, belongs to the class of organic compounds known as n-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moiety in which the oxygen atom is replaced by an n-acyl group. N-Acetyl-b-D-galactosamine is soluble (in water) and a very weakly acidic compound (based on its pKa). N-Acetyl-b-D-galactosamine can be converted into 1beta-glutathionylseleno-N-acetyl-D-galactosamine. Outside of the human body, N-acetyl-b-D-galactosamine can be found in a number of food items such as opium poppy, spirulina, komatsuna, and orange bell pepper. This makes N-acetyl-b-D-galactosamine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "N-Acetyl-beta-alanine ; HMDB0061880",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061880",
    "description" : "N-Acetyl-beta-alanine, also known as 3-(acetylamino)propanoate, belongs to the class of organic compounds known as carboxylic acids. Carboxylic acids are compounds containing a carboxylic acid group with the formula -C(=O)OH. N-Acetyl-beta-alanine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetyl-beta-alanine has been primarily detected in saliva.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-alanine ; HMDB0000766",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000766",
    "description" : "N-Acetyl-L-alanine, also known as ac-ala-OH or 2-acetamidopropionate, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetyl-L-alanine is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetyl-L-alanine has been detected in multiple biofluids, such as feces and urine. Within the cell, N-acetyl-L-alanine is primarily located in the cytoplasm. N-Acetyl-L-alanine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-alanine ; HMDB00766",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000766",
    "description" : "N-Acetyl-L-alanine, also known as ac-ala-OH or 2-acetamidopropionate, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetyl-L-alanine is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetyl-L-alanine has been detected in multiple biofluids, such as feces and urine. Within the cell, N-acetyl-L-alanine is primarily located in the cytoplasm. N-Acetyl-L-alanine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-aspartic acid ; HMDB0000812",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000812",
    "description" : "N-Acetyl-L-aspartic acid, also known as N-acetylaspartate or NAA, belongs to the class of organic compounds known as aspartic acid and derivatives. Aspartic acid and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-L-aspartic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetyl-L-aspartic acid has been found in human brain and prostate tissues, and has also been detected in most biofluids, including urine, feces, blood, and saliva. Within the cell, N-acetyl-L-aspartic acid is primarily located in the cytoplasm, mitochondria and myelin sheath. N-Acetyl-L-aspartic acid can be converted into acetic acid and L-aspartic acid through its interaction with the enzyme aspartoacylase. In humans, N-acetyl-L-aspartic acid is involved in the aspartate metabolism pathway. N-Acetyl-L-aspartic acid is also involved in a couple of metabolic disorders, which include the canavan disease pathway and the hypoacetylaspartia pathway. N-Acetyl-L-aspartic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-aspartic acid ; HMDB00812",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000812",
    "description" : "N-Acetyl-L-aspartic acid, also known as N-acetylaspartate or NAA, belongs to the class of organic compounds known as aspartic acid and derivatives. Aspartic acid and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-L-aspartic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetyl-L-aspartic acid has been found in human brain and prostate tissues, and has also been detected in most biofluids, including urine, feces, blood, and saliva. Within the cell, N-acetyl-L-aspartic acid is primarily located in the cytoplasm, mitochondria and myelin sheath. N-Acetyl-L-aspartic acid can be converted into acetic acid and L-aspartic acid through its interaction with the enzyme aspartoacylase. In humans, N-acetyl-L-aspartic acid is involved in the aspartate metabolism pathway. N-Acetyl-L-aspartic acid is also involved in a couple of metabolic disorders, which include the canavan disease pathway and the hypoacetylaspartia pathway. N-Acetyl-L-aspartic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-methionine ; HMDB0011745",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011745",
    "description" : "N-Acetyl-L-methionine, also known as N-ac-L-methionine or hepsan, belongs to the class of organic compounds known as methionine and derivatives. Methionine and derivatives are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-L-methionine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetyl-L-methionine has been detected in multiple biofluids, such as feces and saliva.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-methionine ; HMDB11745",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011745",
    "description" : "N-Acetyl-L-methionine, also known as N-ac-L-methionine or hepsan, belongs to the class of organic compounds known as methionine and derivatives. Methionine and derivatives are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-L-methionine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetyl-L-methionine has been detected in multiple biofluids, such as feces and saliva.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-phenylalanine ; HMDB0000512",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000512",
    "description" : "N-Acetyl-D-phenylalanine belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-D-phenylalanine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. N-Acetyl-D-phenylalanine has been detected in multiple biofluids, such as feces and saliva. Within the cell, N-acetyl-D-phenylalanine is primarily located in the cytoplasm. N-Acetyl-D-phenylalanine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Acetyl-L-tyrosine ; HMDB0000866",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000866",
    "description" : "N-Acetyl-L-tyrosine belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-L-tyrosine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetyl-L-tyrosine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, N-acetyl-L-tyrosine is primarily located in the cytoplasm. N-Acetyl-L-tyrosine has been found to be associated with the diseases known as preterm birth; n-acetyl-l-tyrosine has also been linked to several inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency and tyrosinemia I.",
    "id" : null
  }, {
    "name" : "N-Acetylasparagine ; HMDB0006028",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006028",
    "description" : "N-Acetylasparagine, also known as acasn, belongs to the class of organic compounds known as asparagine and derivatives. Asparagine and derivatives are compounds containing asparagine or a derivative thereof resulting from reaction of asparagine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetylasparagine is soluble (in water) and a weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "N-Acetylglutamic acid ; HMDB0001138",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001138",
    "description" : "N-Acetylglutamic acid, also known as N-acetylglutamate or ac-glu-OH, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetylglutamic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetylglutamic acid has been found in human liver tissue, and has also been detected in multiple biofluids, such as saliva, feces, and urine. Within the cell, N-acetylglutamic acid is primarily located in the mitochondria and cytoplasm.",
    "id" : null
  }, {
    "name" : "N-Acetylglutamic acid ; HMDB01138",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001138",
    "description" : "N-Acetylglutamic acid, also known as N-acetylglutamate or ac-glu-OH, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetylglutamic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetylglutamic acid has been found in human liver tissue, and has also been detected in multiple biofluids, such as saliva, feces, and urine. Within the cell, N-acetylglutamic acid is primarily located in the mitochondria and cytoplasm.",
    "id" : null
  }, {
    "name" : "N-Acetylglutamine ; HMDB0006029",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006029",
    "description" : "N-Acetyl-glutamine, also known as aceglutamide or glcnac, belongs to the class of organic compounds known as glutamine and derivatives. Glutamine and derivatives are compounds containing glutamine or a derivative thereof resulting from reaction of glutamine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-glutamine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetyl-glutamine has been primarily detected in urine. N-Acetyl-glutamine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Acetylglutamine ; HMDB06029",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006029",
    "description" : "N-Acetyl-glutamine, also known as aceglutamide or glcnac, belongs to the class of organic compounds known as glutamine and derivatives. Glutamine and derivatives are compounds containing glutamine or a derivative thereof resulting from reaction of glutamine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetyl-glutamine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetyl-glutamine has been primarily detected in urine. N-Acetyl-glutamine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Acetylhistamine ; HMDB0013253",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013253",
    "description" : "N-Acetylhistamine , also known as AHN, belongs to the class of organic compounds known as n-acetyl-2-arylethylamines. N-acetyl-2-arylethylamines are compounds containing an acetamide group that is N-linked to an arylethylamine. N-Acetylhistamine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-Acetylhistamine can be biosynthesized from histamine.",
    "id" : null
  }, {
    "name" : "N-Acetylhistamine ; HMDB13253",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013253",
    "description" : "N-Acetylhistamine , also known as AHN, belongs to the class of organic compounds known as n-acetyl-2-arylethylamines. N-acetyl-2-arylethylamines are compounds containing an acetamide group that is N-linked to an arylethylamine. N-Acetylhistamine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-Acetylhistamine can be biosynthesized from histamine.",
    "id" : null
  }, {
    "name" : "N-Acetylhistidine ; HMDB0032055",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0032055",
    "description" : "N-Acetylhistidine belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetylhistidine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Within the cell, N-acetylhistidine is primarily located in the cytoplasm. Outside of the human body, N-acetylhistidine can be found in fishes. This makes N-acetylhistidine a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "N-Acetylisoleucine ; HMDB0061684",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061684",
    "description" : "N-Acetylisoleucine belongs to the class of organic compounds known as isoleucine and derivatives. Isoleucine and derivatives are compounds containing isoleucine or a derivative thereof resulting from reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetylisoleucine is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetylisoleucine has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "N-Acetylleucine ; HMDB0011756",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011756",
    "description" : "N-Acetylleucine, also known as N-acetyl-leu or tanganil, belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetylleucine is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetylleucine has been detected in multiple biofluids, such as feces and saliva.",
    "id" : null
  }, {
    "name" : "N-Acetylneuraminic acid ; HMDB0000230",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000230",
    "description" : "N-Acetylneuraminic acid, also known as N-acetylneuraminate or beta-neu5ac, belongs to the class of organic compounds known as n-acylneuraminic acids. These are neuraminic acids carrying an N-acyl substituent. N-Acetylneuraminic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). N-Acetylneuraminic acid has been found throughout most human tissues, and has also been detected in most biofluids, including breast milk, feces, cerebrospinal fluid, and blood. Within the cell, N-acetylneuraminic acid is primarily located in the cytoplasm, nucleus, lysosome and myelin sheath. N-Acetylneuraminic acid participates in a number of enzymatic reactions. In particular, N-Acetylneuraminic acid can be biosynthesized from N-acetylmannosamine and phosphoenolpyruvic acid through its interaction with the enzyme sialic acid synthase. In addition, N-Acetylneuraminic acid can be converted into N-acetylmannosamine and pyruvic acid; which is mediated by the enzyme N-acetylneuraminate lyase. In humans, N-acetylneuraminic acid is involved in the amino sugar metabolism pathway. N-Acetylneuraminic acid is also involved in several metabolic disorders, some of which include the tay-sachs disease pathway, the salla disease/infantile sialic Acid storage disease pathway, the g(m2)-gangliosidosis: variant b, tay-sachs disease pathway, and the sialuria or french type sialuria pathway. N-Acetylneuraminic acid has been found to be associated with the diseases known as sialidosis, normosomatic type; n-acetylneuraminic acid has also been linked to the inborn metabolic disorders including salla disease.",
    "id" : null
  }, {
    "name" : "N-Acetylornithine ; HMDB0003357",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003357",
    "description" : "N-Acetylornithine, also known as AOR, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetylornithine is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetylornithine has been found in human prostate tissue, and has also been detected in multiple biofluids, such as saliva, urine, and blood. N-Acetylornithine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, N-acetylornithine can be found in a number of food items such as sago palm, prickly pear, deerberry, and poppy. This makes N-acetylornithine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "N-Acetylornithine ; HMDB03357",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003357",
    "description" : "N-Acetylornithine, also known as AOR, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetylornithine is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetylornithine has been found in human prostate tissue, and has also been detected in multiple biofluids, such as saliva, urine, and blood. N-Acetylornithine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, N-acetylornithine can be found in a number of food items such as sago palm, prickly pear, deerberry, and poppy. This makes N-acetylornithine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "N-Acetylproline ; HMDB0094701",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0094701",
    "description" : "N-Acetylproline belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Acetylproline is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetylproline has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "N-Acetylputrescine ; HMDB0002064",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002064",
    "description" : "N-Acetylputrescine belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). N-Acetylputrescine is soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N-Acetylputrescine has been primarily detected in saliva, feces, urine, and blood. Within the cell, N-acetylputrescine is primarily located in the cytoplasm. N-Acetylputrescine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Acetylputrescine ; HMDB02064",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002064",
    "description" : "N-Acetylputrescine belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). N-Acetylputrescine is soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N-Acetylputrescine has been primarily detected in saliva, feces, urine, and blood. Within the cell, N-acetylputrescine is primarily located in the cytoplasm. N-Acetylputrescine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Acetylserine ; HMDB0002931",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002931",
    "description" : "N-Acetylserine belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetylserine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetylserine has been detected in multiple biofluids, such as saliva and urine. Within the cell, N-acetylserine is primarily located in the cytoplasm. N-Acetylserine has been linked to the inborn metabolic disorders including aminoacylase I deficiency.",
    "id" : null
  }, {
    "name" : "N-Acetylserine ; HMDB02931",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002931",
    "description" : "N-Acetylserine belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetylserine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). N-Acetylserine has been detected in multiple biofluids, such as saliva and urine. Within the cell, N-acetylserine is primarily located in the cytoplasm. N-Acetylserine has been linked to the inborn metabolic disorders including aminoacylase I deficiency.",
    "id" : null
  }, {
    "name" : "N-Acetyltaurine ; HMDB0240253",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0240253",
    "description" : "N-Acetyltaurine, also known as atamg or nact, belongs to the class of organic compounds known as organosulfonic acids. Organosulfonic acids are compounds containing the sulfonic acid group, which has the general structure RS(=O)2OH (R is not a hydrogen atom). N-Acetyltaurine is soluble (in water) and an extremely strong acidic compound (based on its pKa). N-Acetyltaurine can be biosynthesized from taurine.",
    "id" : null
  }, {
    "name" : "N-Acetylthreonine ; HMDB0062557",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0062557",
    "description" : "N-Acetylthreonine belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetylthreonine has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "N-acetyltryptophan ; HMDB0013713",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013713",
    "description" : "N-Acetyltryptophan, also known as ac-try or acetyl-L-TRP, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetyltryptophan exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. N-Acetyltryptophan has been detected in multiple biofluids, such as feces and urine.",
    "id" : null
  }, {
    "name" : "N-acetyltryptophan ; HMDB13713",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013713",
    "description" : "N-Acetyltryptophan, also known as ac-try or acetyl-L-TRP, belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom. N-Acetyltryptophan exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. N-Acetyltryptophan has been detected in multiple biofluids, such as feces and urine.",
    "id" : null
  }, {
    "name" : "N-Acetylvaline ; HMDB0011757",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011757",
    "description" : "N-Acetylvaline, also known as acetyl-val, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-Acetylvaline is soluble (in water) and a weakly acidic compound (based on its pKa). N-Acetylvaline has been primarily detected in feces.",
    "id" : null
  }, {
    "name" : "N-Alpha-acetyllysine ; HMDB0000446",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000446",
    "description" : "Acetyllysine belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Acetyllysine exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Acetyllysine has been primarily detected in feces. Within the cell, acetyllysine is primarily located in the cytoplasm. Acetyllysine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N-Carboxyethyl-g-aminobutyric acid ; HMDB0002201",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002201",
    "description" : "N-Carboxyethyl-g-aminobutyric acid, also known as 4-(2-carboxy-ethylamino)-butyrate or carboxyethyl-gaba, belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. N-Carboxyethyl-g-aminobutyric acid is soluble (in water) and a weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "N-Formyl-L-methionine ; HMDB0001015",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001015",
    "description" : "N-Formyl-L-methionine, also known as fmet or for-met-OH, belongs to the class of organic compounds known as methionine and derivatives. Methionine and derivatives are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Formyl-L-methionine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). N-Formyl-L-methionine has been found in human intestine tissue, and has also been detected in multiple biofluids, such as feces and urine.",
    "id" : null
  }, {
    "name" : "N-Formyl-L-methionine ; HMDB01015",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001015",
    "description" : "N-Formyl-L-methionine, also known as fmet or for-met-OH, belongs to the class of organic compounds known as methionine and derivatives. Methionine and derivatives are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Formyl-L-methionine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). N-Formyl-L-methionine has been found in human intestine tissue, and has also been detected in multiple biofluids, such as feces and urine.",
    "id" : null
  }, {
    "name" : "N-Lauroylglycine ; HMDB0013272",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013272",
    "description" : "N-Lauroylglycine, also known as acylglycine c:12 or dodecanamidoacetate, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-Lauroylglycine is considered to be a practically insoluble (in water) and relatively neutral molecule. Within the cell, N-lauroylglycine is primarily located in the membrane (predicted from logP). N-Lauroylglycine can be biosynthesized from dodecanoic acid.",
    "id" : null
  }, {
    "name" : "N-Lauroylglycine ; HMDB13272",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013272",
    "description" : "N-Lauroylglycine, also known as acylglycine c:12 or dodecanamidoacetate, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-Lauroylglycine is considered to be a practically insoluble (in water) and relatively neutral molecule. Within the cell, N-lauroylglycine is primarily located in the membrane (predicted from logP). N-Lauroylglycine can be biosynthesized from dodecanoic acid.",
    "id" : null
  }, {
    "name" : "N-Methyl-L-proline ; HMDB0094696",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0094696",
    "description" : "N-Methyl-L-proline, also known as N-methyl-L-proline, (2S)-1-methylpyrrolidine-2-carboxylic acid, hydric acid, or monomethyl proline, is classified as a proline or a proline derivative. It is not naturally produced by humans and can only be obtained from the diet. In particular, it is a metabolically inert cell protectant found in many plants and is used by plants to protect against extremes in osmolarity and growth temperatures. N-Methyl-L-proline is found in the fruit juices of yellow orange, blood orange, lemon, mandarin, and bitter orange (PMID: 21838291).",
    "id" : null
  }, {
    "name" : "N-Methylhistamine ; HMDB0061685",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061685",
    "description" : "N-Methylhistamine belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. N-Methylhistamine is soluble (in water) and a very weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "N-Methylhistamine ; HMDB61685",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061685",
    "description" : "N-Methylhistamine belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. N-Methylhistamine is soluble (in water) and a very weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "N-Oleoylethanolamine ; HMDB0002088",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002088",
    "description" : "N-Oleoyl ethanolamine, also known as OEA or N-(hydroxyethyl)oleamide, belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, N-oleoyl ethanolamine is considered to be a fatty amide lipid molecule. N-Oleoyl ethanolamine is considered to be a practically insoluble (in water) and relatively neutral molecule. N-Oleoyl ethanolamine has been detected in multiple biofluids, such as feces and blood. Within the cell, N-oleoyl ethanolamine is primarily located in the membrane (predicted from logP). N-Oleoyl ethanolamine can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "N-Oleoylethanolamine ; HMDB02088",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002088",
    "description" : "N-Oleoyl ethanolamine, also known as OEA or N-(hydroxyethyl)oleamide, belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, N-oleoyl ethanolamine is considered to be a fatty amide lipid molecule. N-Oleoyl ethanolamine is considered to be a practically insoluble (in water) and relatively neutral molecule. N-Oleoyl ethanolamine has been detected in multiple biofluids, such as feces and blood. Within the cell, N-oleoyl ethanolamine is primarily located in the membrane (predicted from logP). N-Oleoyl ethanolamine can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "N1,N12-Diacetylspermine ; HMDB0002172",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002172",
    "description" : "N1,N12-Diacetylspermine, also known as daspm or n',n''-diacetylspermine, belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). N1,N12-Diacetylspermine is considered to be a practically insoluble (in water) and relatively neutral molecule. N1,N12-Diacetylspermine has been detected in multiple biofluids, such as urine and blood.",
    "id" : null
  }, {
    "name" : "N1-Acetylspermidine ; HMDB0001276",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001276",
    "description" : "N1-Acetylspermidine belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). N1-Acetylspermidine is slightly soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N1-Acetylspermidine has been detected in multiple biofluids, such as urine and blood. Within the cell, N1-acetylspermidine is primarily located in the cytoplasm. N1-Acetylspermidine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N1-Acetylspermidine ; HMDB01276",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001276",
    "description" : "N1-Acetylspermidine belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). N1-Acetylspermidine is slightly soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N1-Acetylspermidine has been detected in multiple biofluids, such as urine and blood. Within the cell, N1-acetylspermidine is primarily located in the cytoplasm. N1-Acetylspermidine exists in all eukaryotes, ranging from yeast to humans.",
    "id" : null
  }, {
    "name" : "N1-Methyl-2-pyridone-5-carboxamide ; HMDB0004193",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004193",
    "description" : "N1-Methyl-2-pyridone-5-carboxamide, also known as 1-methyl-5-carboxylamide-2-pyridone, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. N1-Methyl-2-pyridone-5-carboxamide is soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N1-Methyl-2-pyridone-5-carboxamide has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, N1-methyl-2-pyridone-5-carboxamide is primarily located in the cytoplasm. N1-Methyl-2-pyridone-5-carboxamide can be biosynthesized from 1-methylnicotinamide; which is mediated by the enzyme aldehyde oxidase. In humans, N1-methyl-2-pyridone-5-carboxamide is involved in the nicotinate and nicotinamide metabolism pathway. N1-Methyl-2-pyridone-5-carboxamide is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "N1-Methyl-2-pyridone-5-carboxamide ; HMDB04193",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004193",
    "description" : "N1-Methyl-2-pyridone-5-carboxamide, also known as 1-methyl-5-carboxylamide-2-pyridone, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. N1-Methyl-2-pyridone-5-carboxamide is soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N1-Methyl-2-pyridone-5-carboxamide has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, N1-methyl-2-pyridone-5-carboxamide is primarily located in the cytoplasm. N1-Methyl-2-pyridone-5-carboxamide can be biosynthesized from 1-methylnicotinamide; which is mediated by the enzyme aldehyde oxidase. In humans, N1-methyl-2-pyridone-5-carboxamide is involved in the nicotinate and nicotinamide metabolism pathway. N1-Methyl-2-pyridone-5-carboxamide is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "N1-Methyl-4-pyridone-3-carboxamide ; HMDB0004194",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004194",
    "description" : "N1-Methyl-4-pyridone-3-carboxamide, also known as 5-aminocarbonyl-1-methyl-4(1h)-pyridone, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. N1-Methyl-4-pyridone-3-carboxamide is soluble (in water) and an extremely weak acidic (essentially neutral) compound (based on its pKa). N1-Methyl-4-pyridone-3-carboxamide has been detected in multiple biofluids, such as urine and blood. Within the cell, N1-methyl-4-pyridone-3-carboxamide is primarily located in the cytoplasm. N1-Methyl-4-pyridone-3-carboxamide can be biosynthesized from 1-methylnicotinamide through the action of the enzyme aldehyde oxidase. In humans, N1-methyl-4-pyridone-3-carboxamide is involved in the nicotinate and nicotinamide metabolism pathway. N1-Methyl-4-pyridone-3-carboxamide is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "N2,N2-Dimethylguanosine ; HMDB0004824",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004824",
    "description" : "N2,N2-Dimethylguanosine, also known as M22G or m(2)(2)g, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. N2,N2-Dimethylguanosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). N2,N2-Dimethylguanosine has been detected in multiple biofluids, such as urine and blood.",
    "id" : null
  }, {
    "name" : "N2,N2-Dimethylguanosine ; HMDB04824",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004824",
    "description" : "N2,N2-Dimethylguanosine, also known as M22G or m(2)(2)g, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. N2,N2-Dimethylguanosine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). N2,N2-Dimethylguanosine has been detected in multiple biofluids, such as urine and blood.",
    "id" : null
  }, {
    "name" : "N2-gamma-Glutamylglutamine ; HMDB0011738",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011738",
    "description" : "N2-gamma-Glutamylglutamine, also known as gamma-L-glu-L-GLN or L-glutamyl-L-glutamine, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. N2-gamma-Glutamylglutamine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). N2-gamma-Glutamylglutamine has been found in human prostate tissue, and has also been detected in multiple biofluids, such as feces, blood, and cerebrospinal fluid. N2-gamma-Glutamylglutamine can be biosynthesized from L-glutamic acid and L-glutamine.",
    "id" : null
  }, {
    "name" : "N4-Acetylcytidine ; HMDB0005923",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005923",
    "description" : "N4-Acetylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. N4-Acetylcytidine is soluble (in water) and a very weakly acidic compound (based on its pKa). N4-Acetylcytidine has been primarily detected in urine.",
    "id" : null
  }, {
    "name" : "N4-Acetylcytidine ; HMDB05923",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005923",
    "description" : "N4-Acetylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. N4-Acetylcytidine is soluble (in water) and a very weakly acidic compound (based on its pKa). N4-Acetylcytidine has been primarily detected in urine.",
    "id" : null
  }, {
    "name" : "N6,N6,N6-Trimethyl-L-lysine ; HMDB0001325",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001325",
    "description" : "N6,N6,N6-Trimethyl-L-lysine, also known as epsilon-N-trimethyl-L-lysine or trimethyllysine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. N6,N6,N6-Trimethyl-L-lysine is considered to be a practically insoluble (in water) and relatively neutral molecule. N6,N6,N6-Trimethyl-L-lysine has been found in human testicle tissue, and has also been detected in multiple biofluids, such as feces, urine, and cerebrospinal fluid. Within the cell, N6,N6,N6-trimethyl-L-lysine is primarily located in the cytoplasm and endoplasmic reticulum. N6,N6,N6-Trimethyl-L-lysine participates in a number of enzymatic reactions. In particular, N6,N6,N6-Trimethyl-L-lysine and S-adenosylhomocysteine can be biosynthesized from L-lysine and S-adenosylmethionine; which is mediated by the enzyme histone-lysine N-methyltransferase SETD7. In addition, N6,N6,N6-Trimethyl-L-lysine and oxoglutaric acid can be converted into 3-hydroxy-N6,N6,N6-trimethyl-L-lysine and succinic acid through its interaction with the enzyme trimethyllysine dioxygenase, mitochondrial. In humans, N6,N6,N6-trimethyl-L-lysine is involved in carnitine synthesis pathway.",
    "id" : null
  }, {
    "name" : "N6,N6,N6-Trimethyl-L-lysine ; HMDB01325",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001325",
    "description" : "N6,N6,N6-Trimethyl-L-lysine, also known as epsilon-N-trimethyl-L-lysine or trimethyllysine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. N6,N6,N6-Trimethyl-L-lysine is considered to be a practically insoluble (in water) and relatively neutral molecule. N6,N6,N6-Trimethyl-L-lysine has been found in human testicle tissue, and has also been detected in multiple biofluids, such as feces, urine, and cerebrospinal fluid. Within the cell, N6,N6,N6-trimethyl-L-lysine is primarily located in the cytoplasm and endoplasmic reticulum. N6,N6,N6-Trimethyl-L-lysine participates in a number of enzymatic reactions. In particular, N6,N6,N6-Trimethyl-L-lysine and S-adenosylhomocysteine can be biosynthesized from L-lysine and S-adenosylmethionine; which is mediated by the enzyme histone-lysine N-methyltransferase SETD7. In addition, N6,N6,N6-Trimethyl-L-lysine and oxoglutaric acid can be converted into 3-hydroxy-N6,N6,N6-trimethyl-L-lysine and succinic acid through its interaction with the enzyme trimethyllysine dioxygenase, mitochondrial. In humans, N6,N6,N6-trimethyl-L-lysine is involved in carnitine synthesis pathway.",
    "id" : null
  }, {
    "name" : "N6-Acetyl-L-lysine ; HMDB0000206",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000206",
    "description" : "N6-Acetyl-L-lysine, also known as N(6)-acetyllysine or omega-acetyllsine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. N6-Acetyl-L-lysine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). N6-Acetyl-L-lysine has been primarily detected in saliva, feces, urine, and blood. Within the cell, N6-acetyl-L-lysine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "N6-Acetyl-L-lysine ; HMDB00206",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000206",
    "description" : "N6-Acetyl-L-lysine, also known as N(6)-acetyllysine or omega-acetyllsine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. N6-Acetyl-L-lysine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). N6-Acetyl-L-lysine has been primarily detected in saliva, feces, urine, and blood. Within the cell, N6-acetyl-L-lysine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "N6-Carbamoyl-L-threonyladenosine ; HMDB0041623",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0041623",
    "description" : "N6-Carbamoyl-L-threonyladenosine belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. N6-Carbamoyl-L-threonyladenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, N6-carbamoyl-L-threonyladenosine is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "N6-Methyladenosine ; HMDB0004044",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004044",
    "description" : "N6-Methyladenosine, also known as M6A or N(6)mado, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. N6-Methyladenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "Naproxen ; HMDB0001923",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001923",
    "description" : "Naproxen, also known as naprosyn or (S)-naproxen, belongs to the class of organic compounds known as naphthalenes. Naphthalenes are compounds containing a naphthalene moiety, which consists of two fused benzene rings. Naproxen is a drug which is used for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and acute gout. also for the relief of mild to moderate pain and the treatment of primary dysmenorrhea. Naproxen exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Naproxen has been found in human liver, kidney and skin tissues, and has also been primarily detected in blood. Within the cell, naproxen is primarily located in the membrane (predicted from logP). In humans, naproxen is involved in the naproxen action pathway.",
    "id" : null
  }, {
    "name" : "Naproxen ; HMDB01923",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001923",
    "description" : "Naproxen, also known as naprosyn or (S)-naproxen, belongs to the class of organic compounds known as naphthalenes. Naphthalenes are compounds containing a naphthalene moiety, which consists of two fused benzene rings. Naproxen is a drug which is used for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and acute gout. also for the relief of mild to moderate pain and the treatment of primary dysmenorrhea. Naproxen exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Naproxen has been found in human liver, kidney and skin tissues, and has also been primarily detected in blood. Within the cell, naproxen is primarily located in the membrane (predicted from logP). In humans, naproxen is involved in the naproxen action pathway.",
    "id" : null
  }, {
    "name" : "Ne,Ne dimethyllysine ; HMDB0013287",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013287",
    "description" : "Ne,ne dimethyllysine belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Ne,ne dimethyllysine is soluble (in water) and a moderately acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "Ne,Ne dimethyllysine ; HMDB13287",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013287",
    "description" : "Ne,ne dimethyllysine belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Ne,ne dimethyllysine is soluble (in water) and a moderately acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "Neopterin ; HMDB0000845",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000845",
    "description" : "Neopterin, also known as monapterin, belongs to the class of organic compounds known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. They are mainly synthesized in several parts of the body, including the pineal gland. Neopterin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Neopterin has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, neopterin is primarily located in the cytoplasm. In humans, neopterin is involved in pterine biosynthesis pathway. Neopterin is also involved in several metabolic disorders, some of which include sepiapterin reductase deficiency, the segawa syndrome pathway, the dopa-responsive dystonia pathway, and hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency. Neopterin is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Neopterin ; HMDB00845",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000845",
    "description" : "Neopterin, also known as monapterin, belongs to the class of organic compounds known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. They are mainly synthesized in several parts of the body, including the pineal gland. Neopterin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Neopterin has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, neopterin is primarily located in the cytoplasm. In humans, neopterin is involved in pterine biosynthesis pathway. Neopterin is also involved in several metabolic disorders, some of which include sepiapterin reductase deficiency, the segawa syndrome pathway, the dopa-responsive dystonia pathway, and hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency. Neopterin is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Nervonic acid ; HMDB0002368",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002368",
    "description" : "Nervonic acid, also known as selacholeate or nervonsaeure, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Nervonic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Nervonic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, nervonic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Nervonic acid is also a parent compound for other transformation products, including but not limited to, beta-D-glucosyl-N-[(15Z)-tetracosenoyl]sphingosine, beta-D-galactosyl-N-[(15Z)-tetracosenoyl]sphingosine, and beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(11)-N-[(15Z)-tetracosenoyl]sphingosine.",
    "id" : null
  }, {
    "name" : "Nervonic acid ; HMDB02368",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002368",
    "description" : "Nervonic acid, also known as selacholeate or nervonsaeure, belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Nervonic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Nervonic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, nervonic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Nervonic acid is also a parent compound for other transformation products, including but not limited to, beta-D-glucosyl-N-[(15Z)-tetracosenoyl]sphingosine, beta-D-galactosyl-N-[(15Z)-tetracosenoyl]sphingosine, and beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(11)-N-[(15Z)-tetracosenoyl]sphingosine.",
    "id" : null
  }, {
    "name" : "Niacinamide ; HMDB0001406",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001406",
    "description" : "Niacinamide, also known as vitamin B3 or b 3, vitamin, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. Niacinamide exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Niacinamide has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and breast milk. Niacinamide exists in all eukaryotes, ranging from yeast to humans. Niacinamide participates in a number of enzymatic reactions. In particular, S-Adenosylmethionine and niacinamide can be converted into S-adenosylhomocysteine and 1-methylnicotinamide through the action of the enzyme nicotinamide N-methyltransferase. Furthermore, Niacinamide and ribose-1-arsenate can be converted into nicotinamide riboside and phosphoric acid through the action of the enzyme purine nucleoside phosphorylase. Furthermore, Niacinamide can be converted into nicotinic acid and ammonium; which is mediated by the enzyme nicotinamidase. Finally, D-Ribose and niacinamide can be biosynthesized from nicotinamide riboside through the action of the enzyme uridine nucleosidase. In humans, niacinamide is involved in the nicotinate and nicotinamide metabolism pathway. Niacinamide is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Niacinamide ; HMDB01406",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001406",
    "description" : "Niacinamide, also known as vitamin B3 or b 3, vitamin, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. Niacinamide exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Niacinamide has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and breast milk. Niacinamide exists in all eukaryotes, ranging from yeast to humans. Niacinamide participates in a number of enzymatic reactions. In particular, S-Adenosylmethionine and niacinamide can be converted into S-adenosylhomocysteine and 1-methylnicotinamide through the action of the enzyme nicotinamide N-methyltransferase. Furthermore, Niacinamide and ribose-1-arsenate can be converted into nicotinamide riboside and phosphoric acid through the action of the enzyme purine nucleoside phosphorylase. Furthermore, Niacinamide can be converted into nicotinic acid and ammonium; which is mediated by the enzyme nicotinamidase. Finally, D-Ribose and niacinamide can be biosynthesized from nicotinamide riboside through the action of the enzyme uridine nucleosidase. In humans, niacinamide is involved in the nicotinate and nicotinamide metabolism pathway. Niacinamide is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Nicotinamide riboside ; HMDB0000855",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000855",
    "description" : "Nicotinamide riboside, also known as N-ribosylnicotinamide or SRT-647, belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Nicotinamide riboside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Nicotinamide riboside has been primarily detected in urine. Within the cell, nicotinamide riboside is primarily located in the cytoplasm. Nicotinamide riboside exists in all eukaryotes, ranging from yeast to humans. Nicotinamide riboside participates in a number of enzymatic reactions. In particular, Nicotinamide riboside and phosphoric acid can be biosynthesized from niacinamide and ribose-1-arsenate through the action of the enzyme purine nucleoside phosphorylase. Furthermore, Nicotinamide riboside can be converted into nicotinamide ribotide through the action of the enzyme cytosolic purine 5'-nucleotidase. Furthermore, Nicotinamide riboside can be converted into nicotinamide ribotide; which is mediated by the enzyme nicotinamide riboside kinase. Finally, Nicotinamide riboside can be converted into D-ribose and niacinamide through the action of the enzyme uridine nucleosidase. In humans, nicotinamide riboside is involved in the nicotinate and nicotinamide metabolism pathway. Outside of the human body, nicotinamide riboside can be found in a number of food items such as yautia, carob, hyssop, and citrus. This makes nicotinamide riboside a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Nonadecanoic acid ; HMDB0000772",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000772",
    "description" : "Nonadecylic acid, also known as N-nonadecanoate or nonadecylate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Nonadecylic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Nonadecylic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, nonadecylic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Nonadecylic acid is also a parent compound for other transformation products, including but not limited to, 2-hydroxynonadecanoic acid, (18R)-18-hydroxynonadecanoic acid, and methyl nonadecanoate. Outside of the human body, nonadecylic acid can be found in black elderberry, dandelion, garden onion, and peanut. This makes nonadecylic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Nonadecanoic acid ; HMDB00772",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000772",
    "description" : "Nonadecylic acid, also known as N-nonadecanoate or nonadecylate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Nonadecylic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Nonadecylic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, nonadecylic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Nonadecylic acid is also a parent compound for other transformation products, including but not limited to, 2-hydroxynonadecanoic acid, (18R)-18-hydroxynonadecanoic acid, and methyl nonadecanoate. Outside of the human body, nonadecylic acid can be found in black elderberry, dandelion, garden onion, and peanut. This makes nonadecylic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Nonanoylcarnitine ; HMDB0013288",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013288",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Nonanoylcarnitine ; HMDB13288",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013288",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "O-methoxycatechol-O-sulphate ; HMDB0060013",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060013",
    "description" : "O-Methoxycatechol-O-sulphate, also known as 2-methoxyphenyl sulfate or O-methylcatechol sulfuric acid, belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. O-Methoxycatechol-O-sulphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). O-Methoxycatechol-O-sulphate has been primarily detected in urine. O-Methoxycatechol-O-sulphate can be biosynthesized from catechol.",
    "id" : null
  }, {
    "name" : "O-Phosphoethanolamine ; HMDB0000224",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000224",
    "description" : "O-Phosphoethanolamine, also known as colamine phosphoric acid or ethanolamine phosphate, belongs to the class of organic compounds known as phosphoethanolamines. Phosphoethanolamines are compounds containing a phosphate linked to the second carbon of an ethanolamine. O-Phosphoethanolamine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). O-Phosphoethanolamine has been detected in most biofluids, including blood, urine, saliva, and cerebrospinal fluid. Within the cell, O-phosphoethanolamine is primarily located in the cytoplasm and endoplasmic reticulum. O-Phosphoethanolamine exists in all eukaryotes, ranging from yeast to humans. O-Phosphoethanolamine participates in a number of enzymatic reactions. In particular, O-Phosphoethanolamine and palmitaldehyde can be biosynthesized from sphinganine 1-phosphate through its interaction with the enzyme sphingosine-1-phosphate lyase 1. In addition, O-Phosphoethanolamine and palmitaldehyde can be biosynthesized from sphingosine 1-phosphate; which is mediated by the enzyme sphingosine-1-phosphate lyase 1. In humans, O-phosphoethanolamine is involved in phosphatidylethanolamine biosynthesis pe(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)) pathway, phosphatidylethanolamine biosynthesis pe(18:1(11Z)/22:1(13Z)) pathway, phosphatidylethanolamine biosynthesis pe(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) pathway, and phosphatidylethanolamine biosynthesis pe(24:0/22:5(7Z,10Z,13Z,16Z,19Z)) pathway. O-Phosphoethanolamine is also involved in a few metabolic disorders, which include the krabbe disease pathway, the fabry disease pathway, and the gaucher disease pathway. Outside of the human body, O-phosphoethanolamine can be found in a number of food items such as taro, mustard spinach, american butterfish, and chicory. This makes O-phosphoethanolamine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Octadecanedioic acid ; HMDB0000782",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000782",
    "description" : "Octadecanedioic acid, also known as 1,18-octadecanedioate or octadecane-1,18-dioate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Octadecanedioic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Octadecanedioic acid has been primarily detected in urine. Within the cell, octadecanedioic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "Oleic acid ; HMDB0000207",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000207",
    "description" : "Oleic acid, also known as oleate or 18:1 N-9, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Oleic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Oleic acid has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, feces, blood, and urine. Within the cell, oleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Oleic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, oleic acid can be found in a number of food items such as lemon thyme, mentha (mint), dandelion, and celery stalks. This makes oleic acid a potential biomarker for the consumption of these food products. Oleic acid is a potentially toxic compound. Oleic acid has been found to be associated with several diseases known as schizophrenia and gestational diabetes; oleic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Oleic acid ; HMDB00207",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000207",
    "description" : "Oleic acid, also known as oleate or 18:1 N-9, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Oleic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. Oleic acid has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, feces, blood, and urine. Within the cell, oleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Oleic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, oleic acid can be found in a number of food items such as lemon thyme, mentha (mint), dandelion, and celery stalks. This makes oleic acid a potential biomarker for the consumption of these food products. Oleic acid is a potentially toxic compound. Oleic acid has been found to be associated with several diseases known as schizophrenia and gestational diabetes; oleic acid has also been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Oleoyl glycine ; HMDB0013631",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013631",
    "description" : "N-Oleoyl glycine, also known as elmiric acid or ema-1, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Thus, N-oleoyl glycine is considered to be a fatty amide lipid molecule. N-Oleoyl glycine is considered to be a practically insoluble (in water) and relatively neutral molecule. N-Oleoyl glycine has been primarily detected in blood. Within the cell, N-oleoyl glycine is primarily located in the membrane (predicted from logP). N-Oleoyl glycine can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "Oleoyl glycine ; HMDB13631",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013631",
    "description" : "N-Oleoyl glycine, also known as elmiric acid or ema-1, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Thus, N-oleoyl glycine is considered to be a fatty amide lipid molecule. N-Oleoyl glycine is considered to be a practically insoluble (in water) and relatively neutral molecule. N-Oleoyl glycine has been primarily detected in blood. Within the cell, N-oleoyl glycine is primarily located in the membrane (predicted from logP). N-Oleoyl glycine can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "Oleoylcarnitine ; HMDB0005065",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005065",
    "description" : "Oleoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Oleoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Oleoylcarnitine has been detected in multiple biofluids, such as blood and urine. Within the cell, oleoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Oleoylcarnitine can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "Oleoylcarnitine ; HMDB05065",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005065",
    "description" : "Oleoylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Oleoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Oleoylcarnitine has been detected in multiple biofluids, such as blood and urine. Within the cell, oleoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Oleoylcarnitine can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "Omeprazole ; HMDB0001913",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001913",
    "description" : "Omeprazole, also known as prilosec or antra, belongs to the class of organic compounds known as sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety. Omeprazole exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Omeprazole has been primarily detected in blood. Within the cell, omeprazole is primarily located in the cytoplasm. In humans, omeprazole is involved in the omeprazole metabolism pathway and the omeprazole action pathway. Omeprazole is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Omeprazole ; HMDB01913",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001913",
    "description" : "Omeprazole, also known as prilosec or antra, belongs to the class of organic compounds known as sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety. Omeprazole exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Omeprazole has been primarily detected in blood. Within the cell, omeprazole is primarily located in the cytoplasm. In humans, omeprazole is involved in the omeprazole metabolism pathway and the omeprazole action pathway. Omeprazole is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Ornithine ; HMDB0000214",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000214",
    "description" : "Ornithine, also known as (S)-ornithine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Ornithine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. it has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing. Ornithine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Ornithine has been found in human skin, prostate and liver tissues, and has also been detected in most biofluids, including cerebrospinal fluid, sweat, feces, and blood. Within the cell, ornithine is primarily located in the mitochondria and cytoplasm. Ornithine exists in all eukaryotes, ranging from yeast to humans. Ornithine participates in a number of enzymatic reactions. In particular, Ornithine and oxoglutaric acid can be converted into L-glutamic gamma-semialdehyde and L-glutamic acid through the action of the enzyme ornithine aminotransferase, mitochondrial. Furthermore, Ornithine and guanidoacetic acid can be biosynthesized from L-arginine and glycine; which is catalyzed by the enzyme glycine amidinotransferase, mitochondrial. Furthermore, Carbamoyl phosphate and ornithine can be converted into citrulline; which is catalyzed by the enzyme ornithine carbamoyltransferase, mitochondrial. Finally, Ornithine and urea can be biosynthesized from L-arginine; which is mediated by the enzyme arginase-1. In humans, ornithine is involved in spermidine and spermine biosynthesis pathway, the arginine and proline metabolism pathway, the urea cycle pathway, and the glycine and serine metabolism pathway. Ornithine is also involved in several metabolic disorders, some of which include carbamoyl phosphate synthetase deficiency, the hyperprolinemia type II pathway, ornithine aminotransferase deficiency (oat deficiency), and the hyperornithinemia with gyrate atrophy (hoga) pathway. Outside of the human body, ornithine can be found in a number of food items such as broad bean, chestnut, hyacinth bean, and sunflower. This makes ornithine a potential biomarker for the consumption of these food products. Ornithine has been found to be associated with several diseases known as hyperlysinemia i, familial, hyperlysinuria, leukemia, and schizophrenia; ornithine has also been linked to the inborn metabolic disorders including cystinuria.",
    "id" : null
  }, {
    "name" : "Ornithine ; HMDB00214",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000214",
    "description" : "Ornithine, also known as (S)-ornithine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Ornithine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. it has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing. Ornithine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Ornithine has been found in human skin, prostate and liver tissues, and has also been detected in most biofluids, including cerebrospinal fluid, sweat, feces, and blood. Within the cell, ornithine is primarily located in the mitochondria and cytoplasm. Ornithine exists in all eukaryotes, ranging from yeast to humans. Ornithine participates in a number of enzymatic reactions. In particular, Ornithine and oxoglutaric acid can be converted into L-glutamic gamma-semialdehyde and L-glutamic acid through the action of the enzyme ornithine aminotransferase, mitochondrial. Furthermore, Ornithine and guanidoacetic acid can be biosynthesized from L-arginine and glycine; which is catalyzed by the enzyme glycine amidinotransferase, mitochondrial. Furthermore, Carbamoyl phosphate and ornithine can be converted into citrulline; which is catalyzed by the enzyme ornithine carbamoyltransferase, mitochondrial. Finally, Ornithine and urea can be biosynthesized from L-arginine; which is mediated by the enzyme arginase-1. In humans, ornithine is involved in spermidine and spermine biosynthesis pathway, the arginine and proline metabolism pathway, the urea cycle pathway, and the glycine and serine metabolism pathway. Ornithine is also involved in several metabolic disorders, some of which include carbamoyl phosphate synthetase deficiency, the hyperprolinemia type II pathway, ornithine aminotransferase deficiency (oat deficiency), and the hyperornithinemia with gyrate atrophy (hoga) pathway. Outside of the human body, ornithine can be found in a number of food items such as broad bean, chestnut, hyacinth bean, and sunflower. This makes ornithine a potential biomarker for the consumption of these food products. Ornithine has been found to be associated with several diseases known as hyperlysinemia i, familial, hyperlysinuria, leukemia, and schizophrenia; ornithine has also been linked to the inborn metabolic disorders including cystinuria.",
    "id" : null
  }, {
    "name" : "Orotic acid ; HMDB0000226",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000226",
    "description" : "Orotic acid, also known as orotate or orotsaeure, belongs to the class of organic compounds known as pyrimidinecarboxylic acids. These are pyrimidines with a structure containing a carboxyl group attached to the pyrimidine ring. Orotic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Orotic acid has been found in human liver and pancreas tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, orotic acid is primarily located in the cytoplasm and mitochondria. Orotic acid exists in all eukaryotes, ranging from yeast to humans. Orotic acid participates in a number of enzymatic reactions. In particular, Orotic acid can be biosynthesized from L-dihydroorotic acid and quinone; which is mediated by the enzyme dihydroorotate dehydrogenase (quinone), mitochondrial. In addition, Orotic acid and phosphoribosyl pyrophosphate can be converted into orotidylic acid through its interaction with the enzyme uridine monophosphate synthetase isoform a. In humans, orotic acid is involved in the pyrimidine metabolism pathway. Orotic acid is also involved in several metabolic disorders, some of which include the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, dihydropyrimidinase deficiency, UMP synthase deficiency (orotic aciduria), and Beta ureidopropionase deficiency. Outside of the human body, orotic acid can be found in a number of food items such as green vegetables, alaska blueberry, chickpea, and colorado pinyon. This makes orotic acid a potential biomarker for the consumption of these food products. Orotic acid is a potentially toxic compound. Orotic acid has been found to be associated with several diseases known as phosphoenolpyruvate carboxykinase deficiency 1, cytosolic and hyperornithinemia-hyperammonemia-homocitrullinuria; orotic acid has also been linked to several inborn metabolic disorders including n-acetylglutamate synthetase deficiency, lysinuric protein intolerance, and ornithine transcarbamylase deficiency.",
    "id" : null
  }, {
    "name" : "Orotic acid ; HMDB00226",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000226",
    "description" : "Orotic acid, also known as orotate or orotsaeure, belongs to the class of organic compounds known as pyrimidinecarboxylic acids. These are pyrimidines with a structure containing a carboxyl group attached to the pyrimidine ring. Orotic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Orotic acid has been found in human liver and pancreas tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, orotic acid is primarily located in the cytoplasm and mitochondria. Orotic acid exists in all eukaryotes, ranging from yeast to humans. Orotic acid participates in a number of enzymatic reactions. In particular, Orotic acid can be biosynthesized from L-dihydroorotic acid and quinone; which is mediated by the enzyme dihydroorotate dehydrogenase (quinone), mitochondrial. In addition, Orotic acid and phosphoribosyl pyrophosphate can be converted into orotidylic acid through its interaction with the enzyme uridine monophosphate synthetase isoform a. In humans, orotic acid is involved in the pyrimidine metabolism pathway. Orotic acid is also involved in several metabolic disorders, some of which include the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, dihydropyrimidinase deficiency, UMP synthase deficiency (orotic aciduria), and Beta ureidopropionase deficiency. Outside of the human body, orotic acid can be found in a number of food items such as green vegetables, alaska blueberry, chickpea, and colorado pinyon. This makes orotic acid a potential biomarker for the consumption of these food products. Orotic acid is a potentially toxic compound. Orotic acid has been found to be associated with several diseases known as phosphoenolpyruvate carboxykinase deficiency 1, cytosolic and hyperornithinemia-hyperammonemia-homocitrullinuria; orotic acid has also been linked to several inborn metabolic disorders including n-acetylglutamate synthetase deficiency, lysinuric protein intolerance, and ornithine transcarbamylase deficiency.",
    "id" : null
  }, {
    "name" : "Orotidine ; HMDB0000788",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000788",
    "description" : "Orotidine, also known as 6-carboxyuridine, belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. Orotidine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Orotidine has been detected in multiple biofluids, such as urine and blood. Within the cell, orotidine is primarily located in the cytoplasm. Orotidine has been linked to the inborn metabolic disorders including orotic aciduria I.",
    "id" : null
  }, {
    "name" : "Ortho-Hydroxyphenylacetic acid ; HMDB0000669",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000669",
    "description" : "Ortho-hydroxyphenylacetic acid, also known as (O-hydroxyphenyl)acetate or 2-hydroxybenzeneacetic acid, belongs to the class of organic compounds known as 2(hydroxyphenyl)acetic acids. These are phenylacetic acids that carry a hydroxyl group at the 2-position. Ortho-hydroxyphenylacetic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Ortho-hydroxyphenylacetic acid has been detected in multiple biofluids, such as feces, urine, and blood. Ortho-hydroxyphenylacetic acid can be biosynthesized from phenol and acetic acid. Outside of the human body, ortho-hydroxyphenylacetic acid can be found in a number of food items such as pigeon pea, jackfruit, rosemary, and purslane. This makes ortho-hydroxyphenylacetic acid a potential biomarker for the consumption of these food products. Ortho-hydroxyphenylacetic acid has been linked to the inborn metabolic disorders including phenylketonuria.",
    "id" : null
  }, {
    "name" : "Oxalic acid ; HMDB0002329",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002329",
    "description" : "Oxalic acid, also known as oxalate or ethanedioic acid, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Oxalic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Oxalic acid has been found throughout most human tissues, and has also been primarily detected in saliva, urine, blood, and sweat. Within the cell, oxalic acid is primarily located in the peroxisome. Oxalic acid is also a parent compound for other transformation products, including but not limited to, oxalyl-CoA, methyl oxalate, and oxamide. Outside of the human body, oxalic acid can be found in a number of food items such as lingonberry, winged bean, opium poppy, and jostaberry. This makes oxalic acid a potential biomarker for the consumption of these food products. Oxalic acid is a potentially toxic compound. Oxalic acid has been found to be associated with the diseases known as hemodialysis; oxalic acid has also been linked to several inborn metabolic disorders including fumarase deficiency, primary hyperoxaluria I, and glycolic aciduria.",
    "id" : null
  }, {
    "name" : "Oxalic acid ; HMDB02329",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002329",
    "description" : "Oxalic acid, also known as oxalate or ethanedioic acid, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Oxalic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Oxalic acid has been found throughout most human tissues, and has also been primarily detected in saliva, urine, blood, and sweat. Within the cell, oxalic acid is primarily located in the peroxisome. Oxalic acid is also a parent compound for other transformation products, including but not limited to, oxalyl-CoA, methyl oxalate, and oxamide. Outside of the human body, oxalic acid can be found in a number of food items such as lingonberry, winged bean, opium poppy, and jostaberry. This makes oxalic acid a potential biomarker for the consumption of these food products. Oxalic acid is a potentially toxic compound. Oxalic acid has been found to be associated with the diseases known as hemodialysis; oxalic acid has also been linked to several inborn metabolic disorders including fumarase deficiency, primary hyperoxaluria I, and glycolic aciduria.",
    "id" : null
  }, {
    "name" : "Oxoglutaric acid ; HMDB0000208",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000208",
    "description" : "Oxoglutaric acid, also known as alpha-ketoglutarate or 2-oxoglutarate, belongs to the class of organic compounds known as gamma-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the C4 carbon atom. Oxoglutaric acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Oxoglutaric acid has been detected in most biofluids, including saliva, urine, feces, and cerebrospinal fluid. Within the cell, oxoglutaric acid is primarily located in the mitochondria, endoplasmic reticulum, peroxisome and cytoplasm. Oxoglutaric acid exists in all eukaryotes, ranging from yeast to humans. Oxoglutaric acid participates in a number of enzymatic reactions. In particular, L-Lysine and oxoglutaric acid can be converted into saccharopine through its interaction with the enzyme Alpha-aminoadipic semialdehyde synthase, mitochondrial. Furthermore, Aminoadipic acid and oxoglutaric acid can be converted into oxoadipic acid and L-glutamic acid; which is mediated by the enzyme kynurenine/alpha-aminoadipate aminotransferase, mitochondrial. Furthermore, L-Alanine and oxoglutaric acid can be converted into L-glutamic acid and pyruvic acid through the action of the enzyme alanine aminotransferase 1. Furthermore, Oxoglutaric acid can be biosynthesized from L-glutamic acid through the action of the enzyme glutamate dehydrogenase 1, mitochondrial. Finally, Oxoglutaric acid can be biosynthesized from isocitric acid; which is mediated by the enzyme isocitrate dehydrogenase. In humans, oxoglutaric acid is involved in the glutamate metabolism pathway, the congenital lactic acidosis pathway, the tyrosine metabolism pathway, and the phenylalanine and tyrosine metabolism pathway. Oxoglutaric acid is also involved in several metabolic disorders, some of which include the sarcosinemia pathway, gaba-transaminase deficiency, fumarase deficiency, and the glutaminolysis and cancer pathway. Outside of the human body, oxoglutaric acid can be found in a number of food items such as sweet basil, mulberry, malus (crab apple), and mexican oregano. This makes oxoglutaric acid a potential biomarker for the consumption of these food products. Oxoglutaric acid has been found to be associated with several diseases known as deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome, schizophrenia, anoxia, and amish lethal microcephaly; oxoglutaric acid has also been linked to the inborn metabolic disorders including d-2-hydroxyglutaric aciduria.",
    "id" : null
  }, {
    "name" : "Oxoglutaric acid ; HMDB00208",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000208",
    "description" : "Oxoglutaric acid, also known as alpha-ketoglutarate or 2-oxoglutarate, belongs to the class of organic compounds known as gamma-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the C4 carbon atom. Oxoglutaric acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Oxoglutaric acid has been detected in most biofluids, including saliva, urine, feces, and cerebrospinal fluid. Within the cell, oxoglutaric acid is primarily located in the mitochondria, endoplasmic reticulum, peroxisome and cytoplasm. Oxoglutaric acid exists in all eukaryotes, ranging from yeast to humans. Oxoglutaric acid participates in a number of enzymatic reactions. In particular, L-Lysine and oxoglutaric acid can be converted into saccharopine through its interaction with the enzyme Alpha-aminoadipic semialdehyde synthase, mitochondrial. Furthermore, Aminoadipic acid and oxoglutaric acid can be converted into oxoadipic acid and L-glutamic acid; which is mediated by the enzyme kynurenine/alpha-aminoadipate aminotransferase, mitochondrial. Furthermore, L-Alanine and oxoglutaric acid can be converted into L-glutamic acid and pyruvic acid through the action of the enzyme alanine aminotransferase 1. Furthermore, Oxoglutaric acid can be biosynthesized from L-glutamic acid through the action of the enzyme glutamate dehydrogenase 1, mitochondrial. Finally, Oxoglutaric acid can be biosynthesized from isocitric acid; which is mediated by the enzyme isocitrate dehydrogenase. In humans, oxoglutaric acid is involved in the glutamate metabolism pathway, the congenital lactic acidosis pathway, the tyrosine metabolism pathway, and the phenylalanine and tyrosine metabolism pathway. Oxoglutaric acid is also involved in several metabolic disorders, some of which include the sarcosinemia pathway, gaba-transaminase deficiency, fumarase deficiency, and the glutaminolysis and cancer pathway. Outside of the human body, oxoglutaric acid can be found in a number of food items such as sweet basil, mulberry, malus (crab apple), and mexican oregano. This makes oxoglutaric acid a potential biomarker for the consumption of these food products. Oxoglutaric acid has been found to be associated with several diseases known as deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome, schizophrenia, anoxia, and amish lethal microcephaly; oxoglutaric acid has also been linked to the inborn metabolic disorders including d-2-hydroxyglutaric aciduria.",
    "id" : null
  }, {
    "name" : "Oxypurinol ; HMDB0000786",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000786",
    "description" : "Oxypurinol, also known as oxoallopurinol or alloxanthine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Oxypurinol exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Oxypurinol has been detected in multiple biofluids, such as urine and blood. Within the cell, oxypurinol is primarily located in the cytoplasm. Oxypurinol can be converted into 7-isobutyl-5-methyl-2-(1-naphthylmethyl)-3-(4-pyridyl)alloxanthine.",
    "id" : null
  }, {
    "name" : "Oxypurinol ; HMDB00786",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000786",
    "description" : "Oxypurinol, also known as oxoallopurinol or alloxanthine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Oxypurinol exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Oxypurinol has been detected in multiple biofluids, such as urine and blood. Within the cell, oxypurinol is primarily located in the cytoplasm. Oxypurinol can be converted into 7-isobutyl-5-methyl-2-(1-naphthylmethyl)-3-(4-pyridyl)alloxanthine.",
    "id" : null
  }, {
    "name" : "p-Cresol sulfate ; HMDB0011635",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011635",
    "description" : "p-Cresol sulfate, also known as P-cresyl-sulphate, belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. p-Cresol sulfate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). p-Cresol sulfate has been primarily detected in saliva, feces, urine, and blood. p-Cresol sulfate can be converted into p-cresol. p-Cresol sulfate is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "p-Hydroxymandelic acid ; HMDB0000822",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000822",
    "description" : "p-Hydroxymandelic acid, also known as 4-hydroxymandelate or 4-hydroxyphenylglycolate, belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that are unsubstituted at the 2-position. p-Hydroxymandelic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). p-Hydroxymandelic acid has been detected in multiple biofluids, such as urine, blood, and vitreous humor. p-Hydroxymandelic acid can be biosynthesized from mandelic acid.",
    "id" : null
  }, {
    "name" : "p-Hydroxymandelic acid ; HMDB00822",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000822",
    "description" : "p-Hydroxymandelic acid, also known as 4-hydroxymandelate or 4-hydroxyphenylglycolate, belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that are unsubstituted at the 2-position. p-Hydroxymandelic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). p-Hydroxymandelic acid has been detected in multiple biofluids, such as urine, blood, and vitreous humor. p-Hydroxymandelic acid can be biosynthesized from mandelic acid.",
    "id" : null
  }, {
    "name" : "p-Hydroxyphenylacetic acid ; HMDB0000020",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000020",
    "description" : "4-Hydroxyphenylacetic acid, also known as (p-hydroxyphenyl)acetate or 4-hydroxybenzeneacetate, belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that are unsubstituted at the 2-position. 4-Hydroxyphenylacetic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). 4-Hydroxyphenylacetic acid has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, feces, and urine. Within the cell, 4-hydroxyphenylacetic acid is primarily located in the cytoplasm. 4-Hydroxyphenylacetic acid exists in all eukaryotes, ranging from yeast to humans. In humans, 4-hydroxyphenylacetic acid is involved in the tyrosine metabolism pathway and the disulfiram action pathway. 4-Hydroxyphenylacetic acid is also involved in several metabolic disorders, some of which include the tyrosinemia type I pathway, the hawkinsinuria pathway, monoamine oxidase-a deficiency (mao-a), and tyrosinemia, transient, OF the newborn pathway. Outside of the human body, 4-hydroxyphenylacetic acid can be found in a number of food items such as evening primrose, corn, cocoa bean, and oat. This makes 4-hydroxyphenylacetic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "p-Hydroxyphenylacetic acid ; HMDB00020",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000020",
    "description" : "4-Hydroxyphenylacetic acid, also known as (p-hydroxyphenyl)acetate or 4-hydroxybenzeneacetate, belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that are unsubstituted at the 2-position. 4-Hydroxyphenylacetic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). 4-Hydroxyphenylacetic acid has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, feces, and urine. Within the cell, 4-hydroxyphenylacetic acid is primarily located in the cytoplasm. 4-Hydroxyphenylacetic acid exists in all eukaryotes, ranging from yeast to humans. In humans, 4-hydroxyphenylacetic acid is involved in the tyrosine metabolism pathway and the disulfiram action pathway. 4-Hydroxyphenylacetic acid is also involved in several metabolic disorders, some of which include the tyrosinemia type I pathway, the hawkinsinuria pathway, monoamine oxidase-a deficiency (mao-a), and tyrosinemia, transient, OF the newborn pathway. Outside of the human body, 4-hydroxyphenylacetic acid can be found in a number of food items such as evening primrose, corn, cocoa bean, and oat. This makes 4-hydroxyphenylacetic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Palmitic acid ; HMDB0000220",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000220",
    "description" : "Palmitic acid, also known as palmitate or C16, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Palmitic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Palmitic acid has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, feces, cerebrospinal fluid, and urine. Palmitic acid can be found anywhere throughout the human cell, such as in mitochondria, endoplasmic reticulum, peroxisome, and adiposome. Palmitic acid exists in all eukaryotes, ranging from yeast to humans. Cholesterol and palmitic acid can be biosynthesized from ce(22:2(13Z,16Z)); which is mediated by the enzyme lysosomal acid lipase/cholesteryl ester hydrolase. In humans, palmitic acid is involved in the zoledronate action pathway, the fatty acid metabolism pathway, steroid biosynthesis pathway, and the rosuvastatin action pathway. Palmitic acid is also involved in several metabolic disorders, some of which include short chain acyl CoA dehydrogenase deficiency (scad deficiency), medium chain acyl-CoA dehydrogenase deficiency (mcad), the hypercholesterolemia pathway, and the familial hypercholanemia (fhca) pathway. Outside of the human body, palmitic acid can be found in a number of food items such as lemon balm, tea, fireweed, and mentha (mint). This makes palmitic acid a potential biomarker for the consumption of these food products. Palmitic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Palmitic acid ; HMDB00220",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000220",
    "description" : "Palmitic acid, also known as palmitate or C16, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Palmitic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Palmitic acid has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, feces, cerebrospinal fluid, and urine. Palmitic acid can be found anywhere throughout the human cell, such as in mitochondria, endoplasmic reticulum, peroxisome, and adiposome. Palmitic acid exists in all eukaryotes, ranging from yeast to humans. Cholesterol and palmitic acid can be biosynthesized from ce(22:2(13Z,16Z)); which is mediated by the enzyme lysosomal acid lipase/cholesteryl ester hydrolase. In humans, palmitic acid is involved in the zoledronate action pathway, the fatty acid metabolism pathway, steroid biosynthesis pathway, and the rosuvastatin action pathway. Palmitic acid is also involved in several metabolic disorders, some of which include short chain acyl CoA dehydrogenase deficiency (scad deficiency), medium chain acyl-CoA dehydrogenase deficiency (mcad), the hypercholesterolemia pathway, and the familial hypercholanemia (fhca) pathway. Outside of the human body, palmitic acid can be found in a number of food items such as lemon balm, tea, fireweed, and mentha (mint). This makes palmitic acid a potential biomarker for the consumption of these food products. Palmitic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Palmitoleic acid ; HMDB0003229",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003229",
    "description" : "cis-9-Palmitoleic acid, also known as palmitoleate or (Z)-9-hexadecenoic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. cis-9-Palmitoleic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. cis-9-Palmitoleic acid has been found in human skeletal muscle, adipose tissue and prostate tissues, and has also been detected in most biofluids, including blood, feces, urine, and saliva. Within the cell, cis-9-palmitoleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. cis-9-Palmitoleic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, cis-9-palmitoleic acid can be found in a number of food items such as cashew nut, pineapple, safflower, and cloves. This makes cis-9-palmitoleic acid a potential biomarker for the consumption of these food products. cis-9-Palmitoleic acid has been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Palmitoleic acid ; HMDB03229",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003229",
    "description" : "cis-9-Palmitoleic acid, also known as palmitoleate or (Z)-9-hexadecenoic acid, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. cis-9-Palmitoleic acid exists as a liquid and is considered to be practically insoluble (in water) and relatively neutral. cis-9-Palmitoleic acid has been found in human skeletal muscle, adipose tissue and prostate tissues, and has also been detected in most biofluids, including blood, feces, urine, and saliva. Within the cell, cis-9-palmitoleic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. cis-9-Palmitoleic acid exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, cis-9-palmitoleic acid can be found in a number of food items such as cashew nut, pineapple, safflower, and cloves. This makes cis-9-palmitoleic acid a potential biomarker for the consumption of these food products. cis-9-Palmitoleic acid has been linked to the inborn metabolic disorders including isovaleric acidemia.",
    "id" : null
  }, {
    "name" : "Palmitoyl sphingomyelin ; HMDB0061712",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0061712",
    "description" : "SM(D18:1/16:0), also known as C16 sphingomyelin or N-PSPC, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/16:0) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/16:0) has been found in human brain tissue, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, SM(D18:1/16:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/16:0) can be biosynthesized from hexadecanoic acid.",
    "id" : null
  }, {
    "name" : "Palmitoylethanolamide ; HMDB0002100",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002100",
    "description" : "Palmitoyl-ea, also known as palmidrol or anandamide (16:0), belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). Thus, palmitoyl-ea is considered to be a fatty amide lipid molecule. Palmitoyl-ea exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Palmitoyl-ea has been detected in multiple biofluids, such as feces, blood, and cerebrospinal fluid. Within the cell, palmitoyl-ea is primarily located in the membrane (predicted from logP). Palmitoyl-ea can be biosynthesized from hexadecanoic acid. Outside of the human body, palmitoyl-ea can be found in eggs, nuts, and pulses. This makes palmitoyl-ea a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Palmitoylethanolamide ; HMDB02100",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002100",
    "description" : "Palmitoyl-ea, also known as palmidrol or anandamide (16:0), belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). Thus, palmitoyl-ea is considered to be a fatty amide lipid molecule. Palmitoyl-ea exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Palmitoyl-ea has been detected in multiple biofluids, such as feces, blood, and cerebrospinal fluid. Within the cell, palmitoyl-ea is primarily located in the membrane (predicted from logP). Palmitoyl-ea can be biosynthesized from hexadecanoic acid. Outside of the human body, palmitoyl-ea can be found in eggs, nuts, and pulses. This makes palmitoyl-ea a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Palmitoylglycine ; HMDB0013034",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013034",
    "description" : "N-Palmitoyl glycine, also known as hexadecanoylglycine or glycine stearamide, belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Thus, N-palmitoyl glycine is considered to be a fatty amide lipid molecule. N-Palmitoyl glycine is considered to be a practically insoluble (in water) and relatively neutral molecule. Within the cell, N-palmitoyl glycine is primarily located in the membrane (predicted from logP). N-Palmitoyl glycine can be biosynthesized from hexadecanoic acid.",
    "id" : null
  }, {
    "name" : "Pantoprazole ; HMDB0005017",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005017",
    "description" : "Pantoprazole, also known as protonix or SK and F 96022, belongs to the class of organic compounds known as sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety. Pantoprazole exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Pantoprazole has been primarily detected in blood. Within the cell, pantoprazole is primarily located in the membrane (predicted from logP). In humans, pantoprazole is involved in the pantoprazole metabolism pathway and the pantoprazole action pathway.",
    "id" : null
  }, {
    "name" : "Pantoprazole ; HMDB05017",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005017",
    "description" : "Pantoprazole, also known as protonix or SK and F 96022, belongs to the class of organic compounds known as sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety. Pantoprazole exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Pantoprazole has been primarily detected in blood. Within the cell, pantoprazole is primarily located in the membrane (predicted from logP). In humans, pantoprazole is involved in the pantoprazole metabolism pathway and the pantoprazole action pathway.",
    "id" : null
  }, {
    "name" : "Pantothenic acid ; HMDB0000210",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000210",
    "description" : "(R)-Pantothenic acid, also known as vitamin B5 or (R)-pantothenate, belongs to the class of organic compounds known as secondary alcohols. Secondary alcohols are compounds containing a secondary alcohol functional group, with the general structure HOC(R)(R') (R,R'=alkyl, aryl) (R)-Pantothenic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa) (R)-Pantothenic acid has been found in human prostate and liver tissues, and has also been detected in most biofluids, including blood, urine, breast milk, and feces. Within the cell, (R)-pantothenic acid is primarily located in the mitochondria and cytoplasm (R)-Pantothenic acid exists in all eukaryotes, ranging from yeast to humans. In humans, (R)-pantothenic acid is involved in pantothenate and CoA biosynthesis pathway and the Beta-alanine metabolism pathway (R)-Pantothenic acid is also involved in a few metabolic disorders, which include ureidopropionase deficiency, gaba-transaminase deficiency, and the carnosinuria, carnosinemia pathway. Outside of the human body, (R)-pantothenic acid can be found in a number of food items such as blackcurrant, oxheart cabbage, wakame, and opium poppy. This makes (R)-pantothenic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Pantothenic acid ; HMDB00210",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000210",
    "description" : "(R)-Pantothenic acid, also known as vitamin B5 or (R)-pantothenate, belongs to the class of organic compounds known as secondary alcohols. Secondary alcohols are compounds containing a secondary alcohol functional group, with the general structure HOC(R)(R') (R,R'=alkyl, aryl) (R)-Pantothenic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa) (R)-Pantothenic acid has been found in human prostate and liver tissues, and has also been detected in most biofluids, including blood, urine, breast milk, and feces. Within the cell, (R)-pantothenic acid is primarily located in the mitochondria and cytoplasm (R)-Pantothenic acid exists in all eukaryotes, ranging from yeast to humans. In humans, (R)-pantothenic acid is involved in pantothenate and CoA biosynthesis pathway and the Beta-alanine metabolism pathway (R)-Pantothenic acid is also involved in a few metabolic disorders, which include ureidopropionase deficiency, gaba-transaminase deficiency, and the carnosinuria, carnosinemia pathway. Outside of the human body, (R)-pantothenic acid can be found in a number of food items such as blackcurrant, oxheart cabbage, wakame, and opium poppy. This makes (R)-pantothenic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Pantothenol ; HMDB0004231",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004231",
    "description" : "Pantothenol, also known as DL-panthenol or bepanthen, belongs to the class of organic compounds known as n-acyl amines. N-acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Pantothenol exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Pantothenol has been found in human epidermis tissue, and has also been detected in multiple biofluids, such as saliva and urine. Within the cell, pantothenol is primarily located in the cytoplasm. In humans, pantothenol is involved in pantothenate and CoA biosynthesis pathway.",
    "id" : null
  }, {
    "name" : "Pantothenol ; HMDB04231",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004231",
    "description" : "Pantothenol, also known as DL-panthenol or bepanthen, belongs to the class of organic compounds known as n-acyl amines. N-acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Pantothenol exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Pantothenol has been found in human epidermis tissue, and has also been detected in multiple biofluids, such as saliva and urine. Within the cell, pantothenol is primarily located in the cytoplasm. In humans, pantothenol is involved in pantothenate and CoA biosynthesis pathway.",
    "id" : null
  }, {
    "name" : "Paracetamol sulfate ; HMDB0059911",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0059911",
    "description" : "Paracetamol sulfate, also known as acetaminophen sulphate, belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. Paracetamol sulfate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Paracetamol sulfate has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, paracetamol sulfate is primarily located in the cytoplasm. Paracetamol sulfate participates in a number of enzymatic reactions. In particular, Paracetamol sulfate and adenosine 3',5'-diphosphate can be biosynthesized from acetaminophen and phosphoadenosine phosphosulfate through the action of the enzymes sulfotransferase 1A1, estrogen sulfotransferase, bile salt sulfotransferase, and sulfotransferase 1a3/1a4. In addition, Paracetamol sulfate can be converted into paracetamol sulfate through the action of the enzyme ATP-binding cassette sub-family g member 2. In humans, paracetamol sulfate is involved in the acetaminophen metabolism pathway.",
    "id" : null
  }, {
    "name" : "Paraxanthine ; HMDB0001860",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001860",
    "description" : "Paraxanthine, also known as P-xanthine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Paraxanthine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Paraxanthine has been found in human prostate, liver and kidney tissues, and has also been detected in most biofluids, including saliva, cerebrospinal fluid, blood, and urine. Within the cell, paraxanthine is primarily located in the cytoplasm. Paraxanthine participates in a number of enzymatic reactions. In particular, Paraxanthine and formaldehyde can be biosynthesized from caffeine; which is mediated by the enzyme cytochrome P450 1A2. In addition, Paraxanthine and acetyl-CoA can be converted into 5-acetylamino-6-formylamino-3-methyluracil; which is mediated by the enzyme arylamine N-acetyltransferase 2. In humans, paraxanthine is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "PC(14:0/16:0) ; HMDB0007869",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007869",
    "description" : "PC(14:0/16:0), also known as MPPC or PC(30:0), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/16:0) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/16:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(14:0/16:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/16:0) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/16:0) can be biosynthesized from pe-nme2(14:0/16:0) and S-adenosylmethionine through its interaction with the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/16:0) ; HMDB07869",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007869",
    "description" : "PC(14:0/16:0), also known as MPPC or PC(30:0), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/16:0) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/16:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(14:0/16:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/16:0) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/16:0) can be biosynthesized from pe-nme2(14:0/16:0) and S-adenosylmethionine through its interaction with the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/16:1(9Z)) ; HMDB0007870",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007870",
    "description" : "PC(14:0/16:1(9Z)), also known as gpcho(14:0/16:1) or gpcho(30:1), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/16:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(14:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/16:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/16:1(9Z)) can be biosynthesized from pe-nme2(14:0/16:1(9Z)) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/16:1(9Z)) ; HMDB07870",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007870",
    "description" : "PC(14:0/16:1(9Z)), also known as gpcho(14:0/16:1) or gpcho(30:1), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/16:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(14:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/16:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/16:1(9Z)) can be biosynthesized from pe-nme2(14:0/16:1(9Z)) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/18:0) ; HMDB0007871",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007871",
    "description" : "PC(14:0/18:0), also known as 1m-2S-PC or gpcho(32:0), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/18:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(14:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/18:0) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/18:0) can be biosynthesized from pe-nme2(14:0/18:0) and S-adenosylmethionine through its interaction with the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/18:0) ; HMDB07871",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007871",
    "description" : "PC(14:0/18:0), also known as 1m-2S-PC or gpcho(32:0), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/18:0) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(14:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/18:0) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/18:0) can be biosynthesized from pe-nme2(14:0/18:0) and S-adenosylmethionine through its interaction with the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/18:1(9Z)) ; HMDB0007873",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007873",
    "description" : "PC(14:0/18:1(9Z)), also known as gpcho(14:0/18:1) or mopc CPD, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(14:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/18:1(9Z)) can be biosynthesized from pe-nme2(14:0/18:1(9Z)) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/18:1(9Z)) ; HMDB07873",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007873",
    "description" : "PC(14:0/18:1(9Z)), also known as gpcho(14:0/18:1) or mopc CPD, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(14:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(14:0/18:1(9Z)) can be biosynthesized from pe-nme2(14:0/18:1(9Z)) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(14:0/18:2(9Z,12Z)) ; HMDB0007874",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007874",
    "description" : "PC(14:0/18:2(9Z,12Z)), also known as gpcho(14:0/18:2) or PC(32:2), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(14:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(14:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(14:0/18:2(9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(14:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(14:0/18:2(9Z,12Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Finally, PC(14:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(14:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(14:0/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(14:0/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(14:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(14:0/18:2(9Z,12Z)) ; HMDB07874",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007874",
    "description" : "PC(14:0/18:2(9Z,12Z)), also known as gpcho(14:0/18:2) or PC(32:2), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(14:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(14:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(14:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(14:0/18:2(9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(14:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(14:0/18:2(9Z,12Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Finally, PC(14:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(14:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(14:0/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(14:0/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(14:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(14:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0007883",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007883",
    "description" : "PC(14:0/20:4(5Z,8Z,11Z,14Z)), also known as phosphatidylcholine(14:0/20:4) or gpcho(14:0/20:4), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(14:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. In humans, PC(14:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z)) pathway, the bromfenac action pathway, the rofecoxib action pathway, and the meloxicam action pathway. PC(14:0/20:4(5Z,8Z,11Z,14Z)) is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway.",
    "id" : null
  }, {
    "name" : "PC(14:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB07883",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007883",
    "description" : "PC(14:0/20:4(5Z,8Z,11Z,14Z)), also known as phosphatidylcholine(14:0/20:4) or gpcho(14:0/20:4), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(14:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(14:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(14:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(14:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. In humans, PC(14:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z)) pathway, the bromfenac action pathway, the rofecoxib action pathway, and the meloxicam action pathway. PC(14:0/20:4(5Z,8Z,11Z,14Z)) is also involved in a couple of metabolic disorders, which include leukotriene C4 synthesis deficiency and the tiaprofenic Acid action pathway.",
    "id" : null
  }, {
    "name" : "PC(16:0/18:0) ; HMDB0007970",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007970",
    "description" : "PC(16:0/18:0), also known as gpcho(34:0) or lecithin, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(16:0/18:0) can be biosynthesized from pe-nme2(16:0/18:0) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(16:0/18:0) ; HMDB07970",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007970",
    "description" : "PC(16:0/18:0), also known as gpcho(34:0) or lecithin, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(16:0/18:0) can be biosynthesized from pe-nme2(16:0/18:0) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(16:0/18:1(9Z)) ; HMDB0007972",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007972",
    "description" : "PC(16:0/18:1(9Z)), also known as 1-POPC or PC(16:0/18:1), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(16:0/18:1(9Z)) can be biosynthesized from pe-nme2(16:0/18:1(9Z)) and S-adenosylmethionine through its interaction with the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase. Outside of the human body, PC(16:0/18:1(9Z)) can be found in a number of food items such as babassu palm, tinda, common sage, and breadfruit. This makes PC(16:0/18:1(9Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(16:0/18:1(9Z)) ; HMDB07972",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007972",
    "description" : "PC(16:0/18:1(9Z)), also known as 1-POPC or PC(16:0/18:1), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(16:0/18:1(9Z)) can be biosynthesized from pe-nme2(16:0/18:1(9Z)) and S-adenosylmethionine through its interaction with the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase. Outside of the human body, PC(16:0/18:1(9Z)) can be found in a number of food items such as babassu palm, tinda, common sage, and breadfruit. This makes PC(16:0/18:1(9Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(16:0/18:2(9Z,12Z)) ; HMDB0007973",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007973",
    "description" : "PC(16:0/18:2(9Z,12Z)), also known as GPC(16:0/18:2) or gpcho 16:0/18:2(9Z,12Z), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:0/18:2(9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(16:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(16:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(16:0/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/18:2(9Z,12Z)) pathway. Outside of the human body, PC(16:0/18:2(9Z,12Z)) can be found in a number of food items such as jujube, common oregano, muskmelon, and beech nut. This makes PC(16:0/18:2(9Z,12Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(16:0/18:2(9Z,12Z)) ; HMDB07973",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007973",
    "description" : "PC(16:0/18:2(9Z,12Z)), also known as GPC(16:0/18:2) or gpcho 16:0/18:2(9Z,12Z), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:0/18:2(9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(16:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(16:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(16:0/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/18:2(9Z,12Z)) pathway. Outside of the human body, PC(16:0/18:2(9Z,12Z)) can be found in a number of food items such as jujube, common oregano, muskmelon, and beech nut. This makes PC(16:0/18:2(9Z,12Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(16:0/20:4(8Z,11Z,14Z,17Z)) ; HMDB0007983",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007983",
    "description" : "PC(16:0/20:4(8Z,11Z,14Z,17Z)), also known as phosphatidylcholine(16:0/20:4) or 1-palmitoyl-2-eicsoate, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/20:4(8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/20:4(8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/20:4(8Z,11Z,14Z,17Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:0/20:4(8Z,11Z,14Z,17Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:0/20:4(8Z,11Z,14Z,17Z)); which is catalyzed by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:0/20:4(8Z,11Z,14Z,17Z)) can be biosynthesized from CDP-choline and DG(16:0/20:4(8Z,11Z,14Z,17Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:0/20:4(8Z,11Z,14Z,17Z)) and L-serine can be converted into choline and PS(16:0/20:4(8Z,11Z,14Z,17Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(16:0/20:4(8Z,11Z,14Z,17Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/20:4(8Z,11Z,14Z,17Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/20:4(8Z,11Z,14Z,17Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(16:0/20:4(8Z,11Z,14Z,17Z)) ; HMDB07983",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007983",
    "description" : "PC(16:0/20:4(8Z,11Z,14Z,17Z)), also known as phosphatidylcholine(16:0/20:4) or 1-palmitoyl-2-eicsoate, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/20:4(8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/20:4(8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/20:4(8Z,11Z,14Z,17Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:0/20:4(8Z,11Z,14Z,17Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:0/20:4(8Z,11Z,14Z,17Z)); which is catalyzed by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:0/20:4(8Z,11Z,14Z,17Z)) can be biosynthesized from CDP-choline and DG(16:0/20:4(8Z,11Z,14Z,17Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:0/20:4(8Z,11Z,14Z,17Z)) and L-serine can be converted into choline and PS(16:0/20:4(8Z,11Z,14Z,17Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(16:0/20:4(8Z,11Z,14Z,17Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/20:4(8Z,11Z,14Z,17Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/20:4(8Z,11Z,14Z,17Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0007991",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007991",
    "description" : "PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as PC(16:0/22:6) or PC(38:6), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-choline and DG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and L-serine can be converted into choline and PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB07991",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0007991",
    "description" : "PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as PC(16:0/22:6) or PC(38:6), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-choline and DG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and L-serine can be converted into choline and PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(16:1(9Z)/18:2(9Z,12Z)) ; HMDB0008006",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008006",
    "description" : "PC(16:1(9Z)/18:2(9Z,12Z)), also known as gpcho(16:1/18:2) or lecithin, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:1(9Z)/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:1(9Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:1(9Z)/18:2(9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(16:1(9Z)/18:2(9Z,12Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:1(9Z)/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(16:1(9Z)/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylserine synthase. In humans, PC(16:1(9Z)/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(16:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(16:1(9Z)/18:2(9Z,12Z)) ; HMDB08006",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008006",
    "description" : "PC(16:1(9Z)/18:2(9Z,12Z)), also known as gpcho(16:1/18:2) or lecithin, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(16:1(9Z)/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(16:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(16:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(16:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(16:1(9Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(16:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(16:1(9Z)/18:2(9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(16:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(16:1(9Z)/18:2(9Z,12Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Finally, PC(16:1(9Z)/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(16:1(9Z)/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylserine synthase. In humans, PC(16:1(9Z)/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(16:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/18:0) ; HMDB0008036",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008036",
    "description" : "PC(18:0/18:0), also known as gpcho(36:0) or PC (18:0)2, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(18:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PC(18:0/18:0) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/18:0) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/18:0) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/18:0) can be biosynthesized from CDP-choline and DG(18:0/18:0/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/18:0) and L-serine can be converted into choline and PS(18:0/18:0); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(18:0/18:0) is involved in phosphatidylethanolamine biosynthesis pe(18:0/18:0) pathway and phosphatidylcholine biosynthesis PC(18:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/18:0) ; HMDB08036",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008036",
    "description" : "PC(18:0/18:0), also known as gpcho(36:0) or PC (18:0)2, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(18:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PC(18:0/18:0) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/18:0) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/18:0) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/18:0) can be biosynthesized from CDP-choline and DG(18:0/18:0/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/18:0) and L-serine can be converted into choline and PS(18:0/18:0); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(18:0/18:0) is involved in phosphatidylethanolamine biosynthesis pe(18:0/18:0) pathway and phosphatidylcholine biosynthesis PC(18:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/18:1(9Z)) ; HMDB0008038",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008038",
    "description" : "PC(18:0/18:1(9Z)), also known as sopc or 18:0-18:1-PC, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(18:0/18:1(9Z)) can be biosynthesized from pe-nme2(18:0/18:1(9Z)) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(18:0/18:1(9Z)) ; HMDB08038",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008038",
    "description" : "PC(18:0/18:1(9Z)), also known as sopc or 18:0-18:1-PC, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. S-Adenosylhomocysteine and PC(18:0/18:1(9Z)) can be biosynthesized from pe-nme2(18:0/18:1(9Z)) and S-adenosylmethionine; which is catalyzed by the enzyme phosphatidyl-N-methylethanolamine N-methyltransferase.",
    "id" : null
  }, {
    "name" : "PC(18:0/18:2(9Z,12Z)) ; HMDB0008039",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008039",
    "description" : "PC(18:0/18:2(9Z,12Z)), also known as PC(18:0/18:2) or 18:0-18:2-PC, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(18:0/18:2(9Z,12Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(18:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(18:0/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:0/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/18:2(9Z,12Z)) ; HMDB08039",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008039",
    "description" : "PC(18:0/18:2(9Z,12Z)), also known as PC(18:0/18:2) or 18:0-18:2-PC, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(18:0/18:2(9Z,12Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(18:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(18:0/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:0/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/20:3(8Z,11Z,14Z)) ; HMDB0008047",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008047",
    "description" : "PC(18:0/20:3(8Z,11Z,14Z)), also known as gpcho(18:0/20:3) or phosphatidylcholine(38:3), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/20:3(8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/20:3(8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/20:3(8Z,11Z,14Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/20:3(8Z,11Z,14Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/20:3(8Z,11Z,14Z)) can be biosynthesized from CDP-choline and DG(18:0/20:3(8Z,11Z,14Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/20:3(8Z,11Z,14Z)) and L-serine can be converted into choline and PS(18:0/20:3(8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(18:0/20:3(8Z,11Z,14Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:0/20:3(8Z,11Z,14Z)) pathway and phosphatidylcholine biosynthesis PC(18:0/20:3(8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/20:3(8Z,11Z,14Z)) ; HMDB08047",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008047",
    "description" : "PC(18:0/20:3(8Z,11Z,14Z)), also known as gpcho(18:0/20:3) or phosphatidylcholine(38:3), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/20:3(8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/20:3(8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/20:3(8Z,11Z,14Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/20:3(8Z,11Z,14Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/20:3(8Z,11Z,14Z)) can be biosynthesized from CDP-choline and DG(18:0/20:3(8Z,11Z,14Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/20:3(8Z,11Z,14Z)) and L-serine can be converted into choline and PS(18:0/20:3(8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(18:0/20:3(8Z,11Z,14Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:0/20:3(8Z,11Z,14Z)) pathway and phosphatidylcholine biosynthesis PC(18:0/20:3(8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0008048",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008048",
    "description" : "PC(18:0/20:4(5Z,8Z,11Z,14Z)), also known as phosphatidylcholine(18:0/20:4) or PC(18:0/20:4), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/20:4(5Z,8Z,11Z,14Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-choline and DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/20:4(5Z,8Z,11Z,14Z)) and L-serine can be converted into choline and PS(18:0/20:4(5Z,8Z,11Z,14Z)) through the action of the enzyme phosphatidylserine synthase. In humans, PC(18:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB08048",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008048",
    "description" : "PC(18:0/20:4(5Z,8Z,11Z,14Z)), also known as phosphatidylcholine(18:0/20:4) or PC(18:0/20:4), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/20:4(5Z,8Z,11Z,14Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-choline and DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/20:4(5Z,8Z,11Z,14Z)) and L-serine can be converted into choline and PS(18:0/20:4(5Z,8Z,11Z,14Z)) through the action of the enzyme phosphatidylserine synthase. In humans, PC(18:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0008057",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008057",
    "description" : "PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as phosphatidylcholine(18:0/22:6) or PC(18:0/22:6), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-choline and DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and L-serine can be converted into choline and PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through the action of the enzyme phosphatidylserine synthase. In humans, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB08057",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008057",
    "description" : "PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as phosphatidylcholine(18:0/22:6) or PC(18:0/22:6), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-choline and DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and L-serine can be converted into choline and PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through the action of the enzyme phosphatidylserine synthase. In humans, PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(18:1(9Z)/18:2(9Z,12Z)) ; HMDB0008105",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008105",
    "description" : "PC(18:1(9Z)/18:2(9Z,12Z)), also known as PC(18:1/18:2) or PC(18:1omega9/18:2omega6), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:1(9Z)/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:1(9Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:1(9Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(18:1(9Z)/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:1(9Z)/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(18:1(9Z)/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylserine synthase. In humans, PC(18:1(9Z)/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:2(9Z,12Z)) pathway. Outside of the human body, PC(18:1(9Z)/18:2(9Z,12Z)) can be found in a number of food items such as flaxseed, nance, orange bell pepper, and wild carrot. This makes PC(18:1(9Z)/18:2(9Z,12Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(18:1(9Z)/18:2(9Z,12Z)) ; HMDB08105",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008105",
    "description" : "PC(18:1(9Z)/18:2(9Z,12Z)), also known as PC(18:1/18:2) or PC(18:1omega9/18:2omega6), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:1(9Z)/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:1(9Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:1(9Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(18:1(9Z)/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:1(9Z)/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(18:1(9Z)/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylserine synthase. In humans, PC(18:1(9Z)/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:2(9Z,12Z)) pathway. Outside of the human body, PC(18:1(9Z)/18:2(9Z,12Z)) can be found in a number of food items such as flaxseed, nance, orange bell pepper, and wild carrot. This makes PC(18:1(9Z)/18:2(9Z,12Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(18:2(9Z,12Z)/18:2(9Z,12Z)) ; HMDB0008138",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008138",
    "description" : "PC(18:2(9Z,12Z)/18:2(9Z,12Z)), also known as dilinoleoylphosphatidylcholine or L-dilinoleoyllecithin, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:2(9Z,12Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:2(9Z,12Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:2(9Z,12Z)/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:2(9Z,12Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(18:2(9Z,12Z)/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylserine synthase. In humans, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway. Outside of the human body, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) can be found in a number of food items such as small-leaf linden, carob, italian oregano, and sago palm. This makes PC(18:2(9Z,12Z)/18:2(9Z,12Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(18:2(9Z,12Z)/18:2(9Z,12Z)) ; HMDB08138",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008138",
    "description" : "PC(18:2(9Z,12Z)/18:2(9Z,12Z)), also known as dilinoleoylphosphatidylcholine or L-dilinoleoyllecithin, belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(18:2(9Z,12Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(18:2(9Z,12Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(18:2(9Z,12Z)/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(18:2(9Z,12Z)/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(18:2(9Z,12Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(18:2(9Z,12Z)/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylserine synthase. In humans, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:2(9Z,12Z)/18:2(9Z,12Z)) pathway. Outside of the human body, PC(18:2(9Z,12Z)/18:2(9Z,12Z)) can be found in a number of food items such as small-leaf linden, carob, italian oregano, and sago palm. This makes PC(18:2(9Z,12Z)/18:2(9Z,12Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PC(20:0/18:2(9Z,12Z)) ; HMDB0008270",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008270",
    "description" : "PC(20:0/18:2(9Z,12Z)), also known as gpcho(20:0/18:2) or gpcho(38:2), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(20:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(20:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(20:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(20:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(20:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(20:0/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(20:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(20:0/18:2(9Z,12Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Finally, PC(20:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(20:0/18:2(9Z,12Z)) through the action of the enzyme phosphatidylserine synthase. In humans, PC(20:0/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(20:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(20:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(20:0/18:2(9Z,12Z)) ; HMDB08270",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008270",
    "description" : "PC(20:0/18:2(9Z,12Z)), also known as gpcho(20:0/18:2) or gpcho(38:2), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(20:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(20:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(20:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(20:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(20:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(20:0/18:2(9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(20:0/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(20:0/18:2(9Z,12Z)) can be biosynthesized from CDP-choline and DG(20:0/18:2(9Z,12Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Finally, PC(20:0/18:2(9Z,12Z)) and L-serine can be converted into choline and PS(20:0/18:2(9Z,12Z)) through the action of the enzyme phosphatidylserine synthase. In humans, PC(20:0/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(20:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(20:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) ; HMDB0008731",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008731",
    "description" : "PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)), also known as gpcho(22:6/18:3) or gpcho(40:9), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) can be biosynthesized from CDP-choline and DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Finally, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) and L-serine can be converted into choline and PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) ; HMDB08731",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008731",
    "description" : "PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)), also known as gpcho(22:6/18:3) or gpcho(40:9), belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) participates in a number of enzymatic reactions. In particular, S-Adenosylhomocysteine and PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) can be biosynthesized from S-adenosylmethionine and pe-nme2(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) through the action of the enzyme phosphatidylethanolamine N-methyltransferase. Furthermore, Cytidine monophosphate and PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) can be biosynthesized from CDP-choline and DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Finally, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) and L-serine can be converted into choline and PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/18:0) ; HMDB0011208",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011208",
    "description" : "PC(p-16:0/18:0), also known as gpcho(16:0/18:0) or gpcho(34:0), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/18:0) ; HMDB11208",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011208",
    "description" : "PC(p-16:0/18:0), also known as gpcho(16:0/18:0) or gpcho(34:0), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/18:1(9Z)) ; HMDB0011210",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011210",
    "description" : "PC(p-16:0/18:1(9Z)), also known as gpcho(16:0/18:1) or gpcho(34:1), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/18:1(9Z)) ; HMDB11210",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011210",
    "description" : "PC(p-16:0/18:1(9Z)), also known as gpcho(16:0/18:1) or gpcho(34:1), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/18:2(9Z,12Z)) ; HMDB0011211",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011211",
    "description" : "PC(p-16:0/18:2(9Z,12Z)), also known as PC(p-16:0/18:2) or gpcho(34:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-16:0/18:2(9Z,12Z)) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/18:2(9Z,12Z)) ; HMDB11211",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011211",
    "description" : "PC(p-16:0/18:2(9Z,12Z)), also known as PC(p-16:0/18:2) or gpcho(34:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-16:0/18:2(9Z,12Z)) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0011220",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011220",
    "description" : "PC(p-16:0/20:4(5Z,8Z,11Z,14Z)), also known as GPC(p-16:0/20:4) or PC(O-16:1(1Z)/20:4 (5Z,8Z,11Z,14Z)), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from arachidonic acid.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB11220",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011220",
    "description" : "PC(p-16:0/20:4(5Z,8Z,11Z,14Z)), also known as GPC(p-16:0/20:4) or PC(O-16:1(1Z)/20:4 (5Z,8Z,11Z,14Z)), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from arachidonic acid.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/20:4(8Z,11Z,14Z,17Z)) ; HMDB0011221",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011221",
    "description" : "PC(p-16:0/20:4(8Z,11Z,14Z,17Z)), also known as glycerophosphocholine or PC(20:4), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-16:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/20:4(8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/20:4(8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/20:4(8Z,11Z,14Z,17Z)) ; HMDB11221",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011221",
    "description" : "PC(p-16:0/20:4(8Z,11Z,14Z,17Z)), also known as glycerophosphocholine or PC(20:4), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-16:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/20:4(8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/20:4(8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0011229",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011229",
    "description" : "PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as phosphatidylcholine(16:0/22:6) or gpcho(16:0/22:6), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB11229",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011229",
    "description" : "PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as phosphatidylcholine(16:0/22:6) or gpcho(16:0/22:6), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/18:0) ; HMDB0011241",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011241",
    "description" : "PC(p-18:0/18:0), also known as gpcho(18:0/18:0) or gpcho(36:0), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-18:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/18:0) ; HMDB11241",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011241",
    "description" : "PC(p-18:0/18:0), also known as gpcho(18:0/18:0) or gpcho(36:0), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/18:0) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PC(p-18:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/18:1(9Z)) ; HMDB0011243",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011243",
    "description" : "PC(p-18:0/18:1(9Z)), also known as GPC(p-18:0/18:1) or gpcho(36:1), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-18:0/18:1(9Z)) can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/18:1(9Z)) ; HMDB11243",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011243",
    "description" : "PC(p-18:0/18:1(9Z)), also known as GPC(p-18:0/18:1) or gpcho(36:1), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/18:1(9Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/18:1(9Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-18:0/18:1(9Z)) can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/18:2(9Z,12Z)) ; HMDB0011244",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011244",
    "description" : "PC(p-18:0/18:2(9Z,12Z)), also known as PC(p-18:0/18:2) or gpcho(36:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-18:0/18:2(9Z,12Z)) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/18:2(9Z,12Z)) ; HMDB11244",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011244",
    "description" : "PC(p-18:0/18:2(9Z,12Z)), also known as PC(p-18:0/18:2) or gpcho(36:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/18:2(9Z,12Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PC(p-18:0/18:2(9Z,12Z)) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/20:3(8Z,11Z,14Z)) ; HMDB0011252",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011252",
    "description" : "PC(p-18:0/20:3(8Z,11Z,14Z)), also known as phosphatidylcholine(18:0/20:3) or gpcho(18:0/20:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/20:3(8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:0/20:3(8Z,11Z,14Z)) ; HMDB11252",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011252",
    "description" : "PC(p-18:0/20:3(8Z,11Z,14Z)), also known as phosphatidylcholine(18:0/20:3) or gpcho(18:0/20:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PC(p-18:0/20:3(8Z,11Z,14Z)) is considered to be a glycerophosphocholine lipid molecule. PC(p-18:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:1(9Z)/18:2(9Z,12Z)) ; HMDB0011310",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011310",
    "description" : "PC(p-18:1(9Z)/18:2(9Z,12Z)), also known as gpcho(18:1/18:2) or gpcho(36:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:1(9Z)/18:2(9Z,12Z)) ; HMDB11310",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011310",
    "description" : "PC(p-18:1(9Z)/18:2(9Z,12Z)), also known as gpcho(18:1/18:2) or gpcho(36:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0011319",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011319",
    "description" : "PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as gpcho(18:1/20:4) or gpcho(38:5), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PC(P-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB11319",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011319",
    "description" : "PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as gpcho(18:1/20:4) or gpcho(38:5), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acyl-glycerophosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, PC(p-18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(16:0/18:0) ; HMDB0008925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008925",
    "description" : "PE(16:0/18:0), also known as PE(34:0), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/18:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PE(16:0/18:0) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:0/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/18:0) can be biosynthesized from PS(16:0/18:0) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/18:0) can be biosynthesized from PS(16:0/18:0); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, Cytidine monophosphate and PE(16:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:0/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PE(16:0/18:0) and S-adenosylmethionine can be converted into pe-nme(16:0/18:0) and S-adenosylhomocysteine; which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. In humans, PE(16:0/18:0) is involved in phosphatidylethanolamine biosynthesis pe(16:0/18:0) pathway and phosphatidylcholine biosynthesis PC(16:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/18:0) ; HMDB08925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008925",
    "description" : "PE(16:0/18:0), also known as PE(34:0), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/18:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PE(16:0/18:0) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:0/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/18:0) can be biosynthesized from PS(16:0/18:0) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/18:0) can be biosynthesized from PS(16:0/18:0); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, Cytidine monophosphate and PE(16:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:0/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Finally, PE(16:0/18:0) and S-adenosylmethionine can be converted into pe-nme(16:0/18:0) and S-adenosylhomocysteine; which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. In humans, PE(16:0/18:0) is involved in phosphatidylethanolamine biosynthesis pe(16:0/18:0) pathway and phosphatidylcholine biosynthesis PC(16:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/18:2(9Z,12Z)) ; HMDB0008928",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008928",
    "description" : "PE(16:0/18:2(9Z,12Z)), also known as gpe(16:0/18:2) or GPEtn(34:2), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/18:2(9Z,12Z)) can be biosynthesized from PS(16:0/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/18:2(9Z,12Z)) can be biosynthesized from PS(16:0/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(16:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(16:0/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(16:0/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/18:2(9Z,12Z)) ; HMDB08928",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008928",
    "description" : "PE(16:0/18:2(9Z,12Z)), also known as gpe(16:0/18:2) or GPEtn(34:2), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/18:2(9Z,12Z)) can be biosynthesized from PS(16:0/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/18:2(9Z,12Z)) can be biosynthesized from PS(16:0/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(16:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(16:0/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(16:0/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0008937",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008937",
    "description" : "PE(16:0/20:4(5Z,8Z,11Z,14Z)), also known as gpe(16:0/20:4) or 1-palmitoyl-2-arachidonoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/20:4(5Z,8Z,11Z,14Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(16:0/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(16:0/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/20:4(5Z,8Z,11Z,14Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(16:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB08937",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008937",
    "description" : "PE(16:0/20:4(5Z,8Z,11Z,14Z)), also known as gpe(16:0/20:4) or 1-palmitoyl-2-arachidonoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/20:4(5Z,8Z,11Z,14Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(16:0/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(16:0/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(16:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/20:4(5Z,8Z,11Z,14Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(16:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/22:2(13Z,16Z)) ; HMDB0008942",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008942",
    "description" : "PE(16:0/22:2(13Z,16Z)), also known as PE(38:2) or GPEtn(16:0/22:2), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/22:2(13Z,16Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/22:2(13Z,16Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/22:2(13Z,16Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/22:2(13Z,16Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/22:2(13Z,16Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/22:2(13Z,16Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/22:2(13Z,16Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/22:2(13Z,16Z)) can be biosynthesized from PS(16:0/22:2(13Z,16Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/22:2(13Z,16Z)) can be biosynthesized from PS(16:0/22:2(13Z,16Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(16:0/22:2(13Z,16Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/22:2(13Z,16Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. In humans, PE(16:0/22:2(13Z,16Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/22:2(13Z,16Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/22:2(13Z,16Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/22:2(13Z,16Z)) ; HMDB08942",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008942",
    "description" : "PE(16:0/22:2(13Z,16Z)), also known as PE(38:2) or GPEtn(16:0/22:2), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(16:0/22:2(13Z,16Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(16:0/22:2(13Z,16Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/22:2(13Z,16Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/22:2(13Z,16Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(16:0/22:2(13Z,16Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(16:0/22:2(13Z,16Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/22:2(13Z,16Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(16:0/22:2(13Z,16Z)) can be biosynthesized from PS(16:0/22:2(13Z,16Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(16:0/22:2(13Z,16Z)) can be biosynthesized from PS(16:0/22:2(13Z,16Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(16:0/22:2(13Z,16Z)) can be biosynthesized from CDP-ethanolamine and DG(16:0/22:2(13Z,16Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. In humans, PE(16:0/22:2(13Z,16Z)) is involved in phosphatidylcholine biosynthesis PC(16:0/22:2(13Z,16Z)) pathway and phosphatidylethanolamine biosynthesis pe(16:0/22:2(13Z,16Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(16:0/P-18:1(9Z)) ; HMDB0008952",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008952",
    "description" : "PE(16:0/P-18:1(9Z)), also known as PE(16:1) or PE(16:0/P-18:1), belongs to the class of organic compounds known as glycerophosphoethanolamines. These are glycerolipids characterized by an ethanolamine ester of glycerophosphoric acid. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:0/P-18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/P-18:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/P-18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(16:0/P-18:1(9Z)) ; HMDB08952",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008952",
    "description" : "PE(16:0/P-18:1(9Z)), also known as PE(16:1) or PE(16:0/P-18:1), belongs to the class of organic compounds known as glycerophosphoethanolamines. These are glycerolipids characterized by an ethanolamine ester of glycerophosphoric acid. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:0/P-18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(16:0/P-18:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(16:0/P-18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(18:0/18:0) ; HMDB0008991",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008991",
    "description" : "PE(18:0/18:0), also known as DC18PE or dspe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/18:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PE(18:0/18:0) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:0/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:0) can be biosynthesized from PS(18:0/18:0) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/18:0) can be biosynthesized from PS(18:0/18:0) through the action of the enzyme phosphatidylserine decarboxylase. Furthermore, Cytidine monophosphate and PE(18:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:0/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:0) and S-adenosylmethionine can be converted into pe-nme(18:0/18:0) and S-adenosylhomocysteine; which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. Finally, PE(18:0/18:0) can be biosynthesized from lysope(18:0/0:0); which is catalyzed by the enzyme ALE1P acyltransferase. In humans, PE(18:0/18:0) is involved in phosphatidylcholine biosynthesis PC(18:0/18:0) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/18:0) ; HMDB08991",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008991",
    "description" : "PE(18:0/18:0), also known as DC18PE or dspe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/18:0) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PE(18:0/18:0) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:0/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:0) can be biosynthesized from PS(18:0/18:0) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/18:0) can be biosynthesized from PS(18:0/18:0) through the action of the enzyme phosphatidylserine decarboxylase. Furthermore, Cytidine monophosphate and PE(18:0/18:0) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:0/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:0) and S-adenosylmethionine can be converted into pe-nme(18:0/18:0) and S-adenosylhomocysteine; which is mediated by the enzyme phosphatidylethanolamine N-methyltransferase. Finally, PE(18:0/18:0) can be biosynthesized from lysope(18:0/0:0); which is catalyzed by the enzyme ALE1P acyltransferase. In humans, PE(18:0/18:0) is involved in phosphatidylcholine biosynthesis PC(18:0/18:0) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/18:1(9Z)) ; HMDB0008993",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008993",
    "description" : "PE(18:0/18:1(9Z)), also known as gpe(18:0/18:1) or PE(36:1), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/18:1(9Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/18:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. PE(18:0/18:1(9Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/18:1(9Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:1(9Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:1(9Z)) can be biosynthesized from PS(18:0/18:1(9Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/18:1(9Z)) can be biosynthesized from PS(18:0/18:1(9Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/18:1(9Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:1(9Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/18:1(9Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/18:1(9Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/18:1(9Z)) ; HMDB08993",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008993",
    "description" : "PE(18:0/18:1(9Z)), also known as gpe(18:0/18:1) or PE(36:1), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/18:1(9Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/18:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/18:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. PE(18:0/18:1(9Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/18:1(9Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:1(9Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:1(9Z)) can be biosynthesized from PS(18:0/18:1(9Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/18:1(9Z)) can be biosynthesized from PS(18:0/18:1(9Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/18:1(9Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:1(9Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/18:1(9Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/18:1(9Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/18:2(9Z,12Z)) ; HMDB0008994",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008994",
    "description" : "PE(18:0/18:2(9Z,12Z)), also known as PE(18:0/18:2) or GPEtn(36:2), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:2(9Z,12Z)) can be biosynthesized from PS(18:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/18:2(9Z,12Z)) can be biosynthesized from PS(18:0/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:2(9Z,12Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/18:2(9Z,12Z)) ; HMDB08994",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0008994",
    "description" : "PE(18:0/18:2(9Z,12Z)), also known as PE(18:0/18:2) or GPEtn(36:2), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:2(9Z,12Z)/0:0); which is mediated by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/18:2(9Z,12Z)) can be biosynthesized from PS(18:0/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/18:2(9Z,12Z)) can be biosynthesized from PS(18:0/18:2(9Z,12Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/18:2(9Z,12Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/18:2(9Z,12Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/18:2(9Z,12Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0009003",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009003",
    "description" : "PE(18:0/20:4(5Z,8Z,11Z,14Z)), also known as PE(18:0/20:4) or 1-stearoyl-2-arachidonoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:0/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:0/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB09003",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009003",
    "description" : "PE(18:0/20:4(5Z,8Z,11Z,14Z)), also known as PE(18:0/20:4) or 1-stearoyl-2-arachidonoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:0/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:0/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:0/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0009012",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009012",
    "description" : "PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as PE(18:0/22:6) or 1-stearoyl-2-docosahexaenoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway and phosphatidylcholine biosynthesis PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB09012",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009012",
    "description" : "PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as PE(18:0/22:6) or 1-stearoyl-2-docosahexaenoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) can be biosynthesized from CDP-ethanolamine and DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway and phosphatidylcholine biosynthesis PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:0/P-18:0) ; HMDB0009016",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009016",
    "description" : "PE(18:0/P-18:0), also known as PE(18:0), belongs to the class of organic compounds known as glycerophosphoethanolamines. These are glycerolipids characterized by an ethanolamine ester of glycerophosphoric acid. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:0/P-18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/P-18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/P-18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(18:0/P-18:0) ; HMDB09016",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009016",
    "description" : "PE(18:0/P-18:0), also known as PE(18:0), belongs to the class of organic compounds known as glycerophosphoethanolamines. These are glycerolipids characterized by an ethanolamine ester of glycerophosphoric acid. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:0/P-18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:0/P-18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:0/P-18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(18:1(9Z)/18:2(9Z,12Z)) ; HMDB0009060",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009060",
    "description" : "PE(18:1(9Z)/18:2(9Z,12Z)), also known as PE(18:1/18:2) or 1-oleoyl-2-linoleoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:1(9Z)/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:1(9Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/18:2(9Z,12Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from PS(18:1(9Z)/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from PS(18:1(9Z)/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/18:2(9Z,12Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:1(9Z)/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:1(9Z)/18:2(9Z,12Z)) ; HMDB09060",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009060",
    "description" : "PE(18:1(9Z)/18:2(9Z,12Z)), also known as PE(18:1/18:2) or 1-oleoyl-2-linoleoyl-gpe, belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:1(9Z)/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:1(9Z)/18:2(9Z,12Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/18:2(9Z,12Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from PS(18:1(9Z)/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from PS(18:1(9Z)/18:2(9Z,12Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:1(9Z)/18:2(9Z,12Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/18:2(9Z,12Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:1(9Z)/18:2(9Z,12Z)) is involved in phosphatidylethanolamine biosynthesis pe(18:1(9Z)/18:2(9Z,12Z)) pathway and phosphatidylcholine biosynthesis PC(18:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0009069",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009069",
    "description" : "PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as phophatidylethanolamine(38:5) or PE(18:1/20:4), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB09069",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009069",
    "description" : "PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as phophatidylethanolamine(38:5) or PE(18:1/20:4), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/0:0) through its interaction with the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) through its interaction with the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/0:0) through the action of the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:1(9Z)/P-18:0) ; HMDB0009082",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009082",
    "description" : "PE(18:1(9Z)/P-18:0), also known as PE(18:1) or PE(18:1/P-18:0), belongs to the class of organic compounds known as glycerophosphoethanolamines. These are glycerolipids characterized by an ethanolamine ester of glycerophosphoric acid. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:1(9Z)/P-18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/P-18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:1(9Z)/P-18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(18:1(9Z)/P-18:0) ; HMDB09082",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009082",
    "description" : "PE(18:1(9Z)/P-18:0), also known as PE(18:1) or PE(18:1/P-18:0), belongs to the class of organic compounds known as glycerophosphoethanolamines. These are glycerolipids characterized by an ethanolamine ester of glycerophosphoric acid. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:1(9Z)/P-18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:1(9Z)/P-18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:1(9Z)/P-18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0009102",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009102",
    "description" : "PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as GPEtn(38:6) or phophatidylethanolamine(18:2/20:4), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB09102",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0009102",
    "description" : "PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as GPEtn(38:6) or phophatidylethanolamine(18:2/20:4), belongs to the class of organic compounds known as phosphatidylethanolamines. These are glycerophosphoetahnolamines in which two fatty acids are bonded to the glycerol moiety through ester linkages. Thus, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) participates in a number of enzymatic reactions. In particular, Cytidine monophosphate and PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. Furthermore, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)); which is catalyzed by the enzyme phosphatidylserine decarboxylase. Furthermore, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from PS(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)); which is mediated by the enzyme phosphatidylserine decarboxylase. Finally, Cytidine monophosphate and PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from CDP-ethanolamine and DG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0); which is catalyzed by the enzyme choline/ethanolaminephosphotransferase. In humans, PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in phosphatidylcholine biosynthesis PC(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway and phosphatidylethanolamine biosynthesis pe(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "PE(P-16:0/18:2(9Z,12Z)) ; HMDB0011343",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011343",
    "description" : "PE(P-16:0/18:2(9Z,12Z)), also known as GPEtn(16:0/18:2) or GPEtn(34:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-16:0/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(P-16:0/18:2(9Z,12Z)) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "PE(P-16:0/18:2(9Z,12Z)) ; HMDB11343",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011343",
    "description" : "PE(P-16:0/18:2(9Z,12Z)), also known as GPEtn(16:0/18:2) or GPEtn(34:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-16:0/18:2(9Z,12Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-16:0/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(P-16:0/18:2(9Z,12Z)) can be biosynthesized from linoleic acid.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/20:3(8Z,11Z,14Z)) ; HMDB0011384",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011384",
    "description" : "PE(P-18:0/20:3(8Z,11Z,14Z)), also known as pe p-18:0/20:3 or GPEtn(18:0/20:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-18:0/20:3(8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-18:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(P-18:0/20:3(8Z,11Z,14Z)) can be biosynthesized from all-cis-icosa-8,11,14-trienoic acid.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/20:3(8Z,11Z,14Z)) ; HMDB11384",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011384",
    "description" : "PE(P-18:0/20:3(8Z,11Z,14Z)), also known as pe p-18:0/20:3 or GPEtn(18:0/20:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-18:0/20:3(8Z,11Z,14Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-18:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. PE(P-18:0/20:3(8Z,11Z,14Z)) can be biosynthesized from all-cis-icosa-8,11,14-trienoic acid.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) ; HMDB0011386",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011386",
    "description" : "PE(P-18:0/20:4(8Z,11Z,14Z,17Z)), also known as phophatidylethanolamine(18:0/20:4) or 1-(1-enyl-stearoyl)-2-eicsoate, belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) ; HMDB11386",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011386",
    "description" : "PE(P-18:0/20:4(8Z,11Z,14Z,17Z)), also known as phophatidylethanolamine(18:0/20:4) or 1-(1-enyl-stearoyl)-2-eicsoate, belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/20:4(8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) ; HMDB0011387",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011387",
    "description" : "PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)), also known as phophatidylethanolamine(18:0/20:5) or GPEtn(18:0/20:5), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) ; HMDB11387",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011387",
    "description" : "PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)), also known as phophatidylethanolamine(18:0/20:5) or GPEtn(18:0/20:5), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0011394",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011394",
    "description" : "PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as phophatidylethanolamine(18:0/22:6) or 1-(1-enyl-stearoyl)-2-docosahexaenoyl-gpe, belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB11394",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011394",
    "description" : "PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as phophatidylethanolamine(18:0/22:6) or 1-(1-enyl-stearoyl)-2-docosahexaenoyl-gpe, belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. Thus, PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a glycerophosphoethanolamine lipid molecule. PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) ; HMDB0011410",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011410",
    "description" : "PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)), also known as GPEtn(18:1/18:3) or GPEtn(36:4), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) ; HMDB11410",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011410",
    "description" : "PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)), also known as GPEtn(18:1/18:3) or GPEtn(36:4), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(11Z)/18:3(6Z,9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) ; HMDB0011420",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011420",
    "description" : "PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. Outside of the human body, PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) can be found in a number of food items such as common wheat, soy bean, sunflower, and sesame. This makes PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) ; HMDB11420",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011420",
    "description" : "PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane. Outside of the human body, PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) can be found in a number of food items such as common wheat, soy bean, sunflower, and sesame. This makes PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(9Z)/18:1(9Z)) ; HMDB0011441",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011441",
    "description" : "PE(P-18:1(9Z)/18:1(9Z)), also known as GPEtn(18:1/18:1) or GPEtn(36:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(9Z)/18:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(9Z)/18:1(9Z)) ; HMDB11441",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011441",
    "description" : "PE(P-18:1(9Z)/18:1(9Z)), also known as GPEtn(18:1/18:1) or GPEtn(36:2), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(9Z)/18:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(9Z)/18:2(9Z,12Z)) ; HMDB0011442",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011442",
    "description" : "PE(P-18:1(9Z)/18:2(9Z,12Z)), also known as GPEtn(18:1/18:2) or GPEtn(36:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "PE(P-18:1(9Z)/18:2(9Z,12Z)) ; HMDB11442",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011442",
    "description" : "PE(P-18:1(9Z)/18:2(9Z,12Z)), also known as GPEtn(18:1/18:2) or GPEtn(36:3), belongs to the class of organic compounds known as 1-(1z-alkenyl),2-acylglycerophosphoethanolamines. These are glycerophosphoethanolamines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one 1Z-alkenyl chain attached through an ether linkage at the O1-position. PE(P-18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. PE(P-18:1(9Z)/18:2(9Z,12Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PE(P-18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and intracellular membrane.",
    "id" : null
  }, {
    "name" : "Pentadecanoic acid ; HMDB0000826",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000826",
    "description" : "Pentadecylic acid, also known as C15 or pentadecylate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Pentadecylic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Pentadecylic acid has been found in human adipose tissue tissue, and has also been detected in most biofluids, including saliva, blood, feces, and urine. Within the cell, pentadecylic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Pentadecylic acid is also a parent compound for other transformation products, including but not limited to, (3S,4S)-3-hydroxytetradecane-1,3,4-tricarboxylic acid, 2-hydroxypentadecanoic acid, and cholesteryl pentadecanoate.",
    "id" : null
  }, {
    "name" : "Pentadecanoic acid ; HMDB00826",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000826",
    "description" : "Pentadecylic acid, also known as C15 or pentadecylate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Pentadecylic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Pentadecylic acid has been found in human adipose tissue tissue, and has also been detected in most biofluids, including saliva, blood, feces, and urine. Within the cell, pentadecylic acid is primarily located in the cytoplasm, membrane (predicted from logP) and adiposome. Pentadecylic acid is also a parent compound for other transformation products, including but not limited to, (3S,4S)-3-hydroxytetradecane-1,3,4-tricarboxylic acid, 2-hydroxypentadecanoic acid, and cholesteryl pentadecanoate.",
    "id" : null
  }, {
    "name" : "Phenol sulphate ; HMDB0060015",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0060015",
    "description" : "Phenol sulphate, also known as phenylsulfate or aryl sulphate, belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. Phenol sulphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Phenol sulphate has been detected in multiple biofluids, such as feces and urine. Within the cell, phenol sulphate is primarily located in the cytoplasm. Adenosine 3',5'-diphosphate and phenol sulphate can be biosynthesized from phosphoadenosine phosphosulfate and phenol through the action of the enzyme sulfotransferase 1A1. In humans, phenol sulphate is involved in the sulfate/sulfite metabolism pathway. Phenol sulphate is also involved in the metabolic disorder called sulfite oxidase deficiency.",
    "id" : null
  }, {
    "name" : "Phenylacetylglutamine ; HMDB0006344",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006344",
    "description" : "Alpha-N-Phenylacetyl-L-glutamine belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Alpha-N-Phenylacetyl-L-glutamine is considered to be a practically insoluble (in water) and relatively neutral molecule. Alpha-N-Phenylacetyl-L-glutamine has been detected in multiple biofluids, such as urine and blood. Within the cell, Alpha-N-phenylacetyl-L-glutamine is primarily located in the cytoplasm. Alpha-N-Phenylacetyl-L-glutamine can be biosynthesized from L-glutamine through the action of the enzyme glycine N-acyltransferase. In humans, Alpha-N-phenylacetyl-L-glutamine is involved in the phenylacetate metabolism pathway.",
    "id" : null
  }, {
    "name" : "Phenylacetylglutamine ; HMDB06344",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006344",
    "description" : "Alpha-N-Phenylacetyl-L-glutamine belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Alpha-N-Phenylacetyl-L-glutamine is considered to be a practically insoluble (in water) and relatively neutral molecule. Alpha-N-Phenylacetyl-L-glutamine has been detected in multiple biofluids, such as urine and blood. Within the cell, Alpha-N-phenylacetyl-L-glutamine is primarily located in the cytoplasm. Alpha-N-Phenylacetyl-L-glutamine can be biosynthesized from L-glutamine through the action of the enzyme glycine N-acyltransferase. In humans, Alpha-N-phenylacetyl-L-glutamine is involved in the phenylacetate metabolism pathway.",
    "id" : null
  }, {
    "name" : "Phenylalanyl-Glycine ; HMDB0028995",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0028995",
    "description" : "Phenylalanyl-glycine, also known as F-g dipeptide or phe-gly, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Phenylalanyl-glycine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Phenyllactic acid ; HMDB0000779",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000779",
    "description" : "Phenyllactic acid, also known as B-phenyllactate, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. Phenyllactic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Phenyllactic acid has been primarily detected in saliva, feces, urine, and blood. Phenyllactic acid can be biosynthesized from rac-lactic acid.",
    "id" : null
  }, {
    "name" : "Phenyllactic acid ; HMDB00779",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000779",
    "description" : "Phenyllactic acid, also known as B-phenyllactate, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. Phenyllactic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Phenyllactic acid has been primarily detected in saliva, feces, urine, and blood. Phenyllactic acid can be biosynthesized from rac-lactic acid.",
    "id" : null
  }, {
    "name" : "Phenylpyruvic acid ; HMDB0000205",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000205",
    "description" : "Keto-phenylpyruvic acid, also known as 3-phenyl-2-oxopropanoate or a-ketohydrocinnamate, belongs to the class of organic compounds known as phenylpyruvic acid derivatives. Phenylpyruvic acid derivatives are compounds containing a phenylpyruvic acid moiety, which consists of a phenyl group substituted at the second position by an pyruvic acid. Keto-phenylpyruvic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Keto-phenylpyruvic acid has been detected in multiple biofluids, such as urine and blood. Within the cell, keto-phenylpyruvic acid is primarily located in the cytoplasm and mitochondria. Keto-phenylpyruvic acid exists in all eukaryotes, ranging from yeast to humans. In humans, keto-phenylpyruvic acid is involved in the phenylalanine and tyrosine metabolism pathway. Keto-phenylpyruvic acid is also involved in a few metabolic disorders, which include the tyrosinemia type 2 (or richner-hanhart syndrome) pathway, the phenylketonuria pathway, and the tyrosinemia type 3 (tyro3) pathway.",
    "id" : null
  }, {
    "name" : "Phosphate ; HMDB0001429",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001429",
    "description" : "Phosphoric acid, also known as phosphate or [po(OH)3], belongs to the class of inorganic compounds known as non-metal phosphates. These are inorganic non-metallic compounds containing a phosphate as its largest oxoanion. Phosphoric acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, phosphoric acid is primarily located in the cytoplasm. Phosphoric acid exists in all eukaryotes, ranging from yeast to humans. In humans, phosphoric acid is involved in the glutamate metabolism pathway, the glutathione metabolism pathway, the glycerol phosphate shuttle pathway, and the purine metabolism pathway. Phosphoric acid is also involved in several metabolic disorders, some of which include the hypophosphatasia pathway, the leigh syndrome pathway, creatine deficiency, guanidinoacetate methyltransferase deficiency, and L-arginine:glycine amidinotransferase deficiency. Phosphoric acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Phosphorylcholine ; HMDB0001565",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001565",
    "description" : "Phosphorylcholine, also known as choline phosphate or CHOP, belongs to the class of organic compounds known as phosphocholines. Phosphocholines are compounds containing a [2-(trimethylazaniumyl)ethoxy]phosphonic acid or derivative. Phosphorylcholine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Phosphorylcholine has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, cerebrospinal fluid, and urine. Within the cell, phosphorylcholine is primarily located in the cytoplasm. Phosphorylcholine exists in all eukaryotes, ranging from yeast to humans. Ceramide (D18:1/18:0) and phosphorylcholine can be biosynthesized from SM(D18:1/18:0) and water; which is mediated by the enzyme ectonucleotide pyrophosphatase/phosphodiesterase family member 7. In humans, phosphorylcholine is involved in phosphatidylcholine biosynthesis PC(18:1(9Z)/14:1(9Z)) pathway, phosphatidylcholine biosynthesis PC(22:4(7Z,10Z,13Z,16Z)/14:0) pathway, phosphatidylcholine biosynthesis PC(22:0/16:0) pathway, and phosphatidylcholine biosynthesis PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) pathway. Phosphorylcholine is also involved in a few metabolic disorders, which include the fabry disease pathway, the gaucher disease pathway, and the krabbe disease pathway. Outside of the human body, phosphorylcholine can be found in a number of food items such as fireweed, swede, french plantain, and giant butterbur. This makes phosphorylcholine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Phosphorylcholine ; HMDB01565",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001565",
    "description" : "Phosphorylcholine, also known as choline phosphate or CHOP, belongs to the class of organic compounds known as phosphocholines. Phosphocholines are compounds containing a [2-(trimethylazaniumyl)ethoxy]phosphonic acid or derivative. Phosphorylcholine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Phosphorylcholine has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, cerebrospinal fluid, and urine. Within the cell, phosphorylcholine is primarily located in the cytoplasm. Phosphorylcholine exists in all eukaryotes, ranging from yeast to humans. Ceramide (D18:1/18:0) and phosphorylcholine can be biosynthesized from SM(D18:1/18:0) and water; which is mediated by the enzyme ectonucleotide pyrophosphatase/phosphodiesterase family member 7. In humans, phosphorylcholine is involved in phosphatidylcholine biosynthesis PC(18:1(9Z)/14:1(9Z)) pathway, phosphatidylcholine biosynthesis PC(22:4(7Z,10Z,13Z,16Z)/14:0) pathway, phosphatidylcholine biosynthesis PC(22:0/16:0) pathway, and phosphatidylcholine biosynthesis PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) pathway. Phosphorylcholine is also involved in a few metabolic disorders, which include the fabry disease pathway, the gaucher disease pathway, and the krabbe disease pathway. Outside of the human body, phosphorylcholine can be found in a number of food items such as fireweed, swede, french plantain, and giant butterbur. This makes phosphorylcholine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Phytanic acid ; HMDB0000801",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000801",
    "description" : "Phytanic acid, also known as phytanate or acid, phytanic, belongs to the class of organic compounds known as acyclic diterpenoids. These are diterpenoids (compounds made of four consecutive isoprene units) that do not contain a cycle. Phytanic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Phytanic acid has been found in human prostate and liver tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, phytanic acid is primarily located in the cytoplasm, membrane (predicted from logP), peroxisome and myelin sheath. In humans, phytanic acid is involved in the oxidation OF branched chain fatty acids pathway and the phytanic Acid peroxisomal oxidation pathway. Phytanic acid is also involved in the metabolic disorder called the refsum disease pathway. Phytanic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Phytanic acid ; HMDB00801",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000801",
    "description" : "Phytanic acid, also known as phytanate or acid, phytanic, belongs to the class of organic compounds known as acyclic diterpenoids. These are diterpenoids (compounds made of four consecutive isoprene units) that do not contain a cycle. Phytanic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Phytanic acid has been found in human prostate and liver tissues, and has also been detected in multiple biofluids, such as feces and blood. Within the cell, phytanic acid is primarily located in the cytoplasm, membrane (predicted from logP), peroxisome and myelin sheath. In humans, phytanic acid is involved in the oxidation OF branched chain fatty acids pathway and the phytanic Acid peroxisomal oxidation pathway. Phytanic acid is also involved in the metabolic disorder called the refsum disease pathway. Phytanic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Phytosphingosine ; HMDB0004610",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004610",
    "description" : "Phytosphingosine belongs to the class of organic compounds known as 1,3-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C3 atom. Thus, phytosphingosine is considered to be a sphingoid base lipid molecule. Phytosphingosine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Phytosphingosine has been found in human epidermis and endocrine gland tissues. Within the cell, phytosphingosine is primarily located in the membrane (predicted from logP). Phytosphingosine exists in all eukaryotes, ranging from yeast to humans. Phytosphingosine participates in a number of enzymatic reactions. In particular, Phytosphingosine and ferricytochrome c can be biosynthesized from sphinganine and ferrocytochrome through its interaction with the enzyme sphinganine C4-monooxygenase. Furthermore, Phytosphingosine can be biosynthesized from sphinganine; which is catalyzed by the enzyme dihydrosphingosine C-4 hydroxylase. Furthermore, Phytosphingosine can be biosynthesized from sphinganine; which is catalyzed by the enzyme dihydrosphingosine C-4 hydroxylase. Finally, Phytosphingosine and docosanoyl-CoA can be converted into N-docosanoyl-4-hydroxysphinganine; which is catalyzed by the enzyme ceramide synthase.",
    "id" : null
  }, {
    "name" : "Phytosphingosine ; HMDB04610",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004610",
    "description" : "Phytosphingosine belongs to the class of organic compounds known as 1,3-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C3 atom. Thus, phytosphingosine is considered to be a sphingoid base lipid molecule. Phytosphingosine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Phytosphingosine has been found in human epidermis and endocrine gland tissues. Within the cell, phytosphingosine is primarily located in the membrane (predicted from logP). Phytosphingosine exists in all eukaryotes, ranging from yeast to humans. Phytosphingosine participates in a number of enzymatic reactions. In particular, Phytosphingosine and ferricytochrome c can be biosynthesized from sphinganine and ferrocytochrome through its interaction with the enzyme sphinganine C4-monooxygenase. Furthermore, Phytosphingosine can be biosynthesized from sphinganine; which is catalyzed by the enzyme dihydrosphingosine C-4 hydroxylase. Furthermore, Phytosphingosine can be biosynthesized from sphinganine; which is catalyzed by the enzyme dihydrosphingosine C-4 hydroxylase. Finally, Phytosphingosine and docosanoyl-CoA can be converted into N-docosanoyl-4-hydroxysphinganine; which is catalyzed by the enzyme ceramide synthase.",
    "id" : null
  }, {
    "name" : "Picolinic acid ; HMDB0002243",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002243",
    "description" : "Picolinic acid, also known as a-picolinate or 2-carboxypyridine, belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. Picolinic acid exists as a solid, soluble (in water), and an extremely strong acidic compound (based on its pKa). Picolinic acid has been found in human prostate tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Picolinic acid is also a parent compound for other transformation products, including but not limited to, 5-(3-carboxy-3-oxopropenyl)-4,6-dihydroxypyridine-2-carboxylic acid, 5-(3'-carboxy-3'-oxopropenyl)-4,6-dihydroxypicolinic acid, and 5-(2'-formylethyl)-4,6-dihydroxypicolinic acid.",
    "id" : null
  }, {
    "name" : "Pipecolic acid ; HMDB0000070",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000070",
    "description" : "DL-Pipecolic acid, also known as pipecolinate or homoproline, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). DL-Pipecolic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). DL-Pipecolic acid has been found in human prostate and liver tissues, and has also been detected in most biofluids, including feces, saliva, cerebrospinal fluid, and blood. Within the cell, DL-pipecolic acid is primarily located in the cytoplasm. DL-Pipecolic acid exists in all eukaryotes, ranging from yeast to humans. DL-Pipecolic acid can be converted into 5-hydroxypipecolic acid. Outside of the human body, DL-pipecolic acid can be found in a number of food items such as ginger, french plantain, common pea, and carrot. This makes DL-pipecolic acid a potential biomarker for the consumption of these food products. DL-Pipecolic acid has been found to be associated with several diseases known as hyperpipecolatemia, malaria, and pseudoneonatal adrenoleukodystrophy; dl-pipecolic acid has also been linked to several inborn metabolic disorders including peroxisomal biogenesis defect and adrenoleukodystrophy.",
    "id" : null
  }, {
    "name" : "Piperine ; HMDB0029377",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029377",
    "description" : "Piperine, also known as fema 2909, belongs to the class of organic compounds known as alkaloids and derivatives. These are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic properties. Also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. Piperine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Piperine has been detected in multiple biofluids, such as feces and blood. Within the cell, piperine is primarily located in the membrane (predicted from logP). Piperine can be biosynthesized from (e,e)-piperic acid. Outside of the human body, piperine can be found in herbs and spices and pepper (spice). This makes piperine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Piperine ; HMDB29377",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029377",
    "description" : "Piperine, also known as fema 2909, belongs to the class of organic compounds known as alkaloids and derivatives. These are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic properties. Also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. Piperine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Piperine has been detected in multiple biofluids, such as feces and blood. Within the cell, piperine is primarily located in the membrane (predicted from logP). Piperine can be biosynthesized from (e,e)-piperic acid. Outside of the human body, piperine can be found in herbs and spices and pepper (spice). This makes piperine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Pregnanediol-3-glucuronide ; HMDB0010318",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010318",
    "description" : "Pregnanediol-3-glucuronide belongs to the class of organic compounds known as steroid glucuronide conjugates. These are sterol lipids containing a glucuronide moiety linked to the steroid skeleton. Pregnanediol-3-glucuronide is considered to be a practically insoluble (in water) and relatively neutral molecule. Pregnanediol-3-glucuronide has been found in human hepatic tissue, liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, pregnanediol-3-glucuronide is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Pregnenolone sulfate ; HMDB0000774",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000774",
    "description" : "Pregnenolone sulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. Pregnenolone sulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. Pregnenolone sulfate has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, pregnenolone sulfate is primarily located in the cytoplasm, membrane (predicted from logP) and endoplasmic reticulum.",
    "id" : null
  }, {
    "name" : "Proline betaine ; HMDB0004827",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004827",
    "description" : "Proline betaine, also known as stachydrine or dimethylproline, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Proline betaine is considered to be a practically insoluble (in water) and relatively neutral molecule. Proline betaine has been primarily detected in saliva, feces, urine, and blood. Proline betaine can be biosynthesized from L-prolinium. Outside of the human body, proline betaine can be found in a number of food items such as sweet orange, pummelo, alfalfa, and citrus. This makes proline betaine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Proline betaine ; HMDB04827",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004827",
    "description" : "Proline betaine, also known as stachydrine or dimethylproline, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Proline betaine is considered to be a practically insoluble (in water) and relatively neutral molecule. Proline betaine has been primarily detected in saliva, feces, urine, and blood. Proline betaine can be biosynthesized from L-prolinium. Outside of the human body, proline betaine can be found in a number of food items such as sweet orange, pummelo, alfalfa, and citrus. This makes proline betaine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Prolylglycine ; HMDB0011178",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011178",
    "description" : "Prolylglycine, also known as pro-gly, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Prolylglycine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Prolylglycine has been detected in multiple biofluids, such as urine and blood.",
    "id" : null
  }, {
    "name" : "Prolylhydroxyproline ; HMDB0006695",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0006695",
    "description" : "Prolylhydroxyproline, also known as L-pro-L-hyp, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Prolylhydroxyproline is soluble (in water) and a weakly acidic compound (based on its pKa). Prolylhydroxyproline has been detected in multiple biofluids, such as urine and cerebrospinal fluid. Prolylhydroxyproline can be biosynthesized from L-proline and trans-4-hydroxy-L-proline.",
    "id" : null
  }, {
    "name" : "Propionic acid ; HMDB0000237",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000237",
    "description" : "Propionic acid, also known as propionate or acide propanoique, belongs to the class of organic compounds known as carboxylic acids. Carboxylic acids are compounds containing a carboxylic acid group with the formula -C(=O)OH. Propionic acid exists as a liquid, soluble (in water), and a weakly acidic compound (based on its pKa). Propionic acid has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, feces, and urine. Within the cell, propionic acid is primarily located in the cytoplasm and mitochondria. Propionic acid exists in all eukaryotes, ranging from yeast to humans. Propionic acid participates in a number of enzymatic reactions. In particular, Propionic acid can be biosynthesized from propinol adenylate; which is mediated by the enzyme acyl-CoA synthetase short-chain family member 3, mitochondrial. In addition, Propionic acid can be biosynthesized from propinol adenylate through its interaction with the enzyme acetyl-coenzyme A synthetase 2-like, mitochondrial. In humans, propionic acid is involved in the propanoate metabolism pathway and the vitamin K metabolism pathway. Propionic acid is also involved in a few metabolic disorders, which include the malonic aciduria pathway, malonyl-CoA decarboxylase deficiency, and the methylmalonic aciduria due to cobalamin-related disorders pathway. Outside of the human body, propionic acid can be found in a number of food items such as winter squash, chicory, common buckwheat, and greenthread tea. This makes propionic acid a potential biomarker for the consumption of these food products. Propionic acid is a potentially toxic compound. Propionic acid has been found to be associated with several diseases known as irritable bowel syndrome, crohn's disease, and ulcerative colitis; propionic acid has also been linked to several inborn metabolic disorders including celiac disease and propionic acidemia.",
    "id" : null
  }, {
    "name" : "Propionic acid ; HMDB00237",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000237",
    "description" : "Propionic acid, also known as propionate or acide propanoique, belongs to the class of organic compounds known as carboxylic acids. Carboxylic acids are compounds containing a carboxylic acid group with the formula -C(=O)OH. Propionic acid exists as a liquid, soluble (in water), and a weakly acidic compound (based on its pKa). Propionic acid has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, feces, and urine. Within the cell, propionic acid is primarily located in the cytoplasm and mitochondria. Propionic acid exists in all eukaryotes, ranging from yeast to humans. Propionic acid participates in a number of enzymatic reactions. In particular, Propionic acid can be biosynthesized from propinol adenylate; which is mediated by the enzyme acyl-CoA synthetase short-chain family member 3, mitochondrial. In addition, Propionic acid can be biosynthesized from propinol adenylate through its interaction with the enzyme acetyl-coenzyme A synthetase 2-like, mitochondrial. In humans, propionic acid is involved in the propanoate metabolism pathway and the vitamin K metabolism pathway. Propionic acid is also involved in a few metabolic disorders, which include the malonic aciduria pathway, malonyl-CoA decarboxylase deficiency, and the methylmalonic aciduria due to cobalamin-related disorders pathway. Outside of the human body, propionic acid can be found in a number of food items such as winter squash, chicory, common buckwheat, and greenthread tea. This makes propionic acid a potential biomarker for the consumption of these food products. Propionic acid is a potentially toxic compound. Propionic acid has been found to be associated with several diseases known as irritable bowel syndrome, crohn's disease, and ulcerative colitis; propionic acid has also been linked to several inborn metabolic disorders including celiac disease and propionic acidemia.",
    "id" : null
  }, {
    "name" : "Propionylcarnitine ; HMDB0000824",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000824",
    "description" : "Propionylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, propionylcarnitine is considered to be a fatty ester lipid molecule. Propionylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Propionylcarnitine has been detected in most biofluids, including feces, urine, cerebrospinal fluid, and blood. Within the cell, propionylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP), mitochondria and peroxisome. Propionylcarnitine participates in a number of enzymatic reactions. In particular, Propionylcarnitine can be biosynthesized from propionyl-CoA and L-carnitine through its interaction with the enzyme carnitine O-acetyltransferase. In addition, Propionylcarnitine can be biosynthesized from propionyl-CoA and L-carnitine; which is mediated by the enzyme carnitine O-acetyltransferase. In humans, propionylcarnitine is involved in the oxidation OF branched chain fatty acids pathway. Propionylcarnitine has been linked to the inborn metabolic disorders including propionic acidemia.",
    "id" : null
  }, {
    "name" : "Propionylcarnitine ; HMDB00824",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000824",
    "description" : "Propionylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, propionylcarnitine is considered to be a fatty ester lipid molecule. Propionylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Propionylcarnitine has been detected in most biofluids, including feces, urine, cerebrospinal fluid, and blood. Within the cell, propionylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP), mitochondria and peroxisome. Propionylcarnitine participates in a number of enzymatic reactions. In particular, Propionylcarnitine can be biosynthesized from propionyl-CoA and L-carnitine through its interaction with the enzyme carnitine O-acetyltransferase. In addition, Propionylcarnitine can be biosynthesized from propionyl-CoA and L-carnitine; which is mediated by the enzyme carnitine O-acetyltransferase. In humans, propionylcarnitine is involved in the oxidation OF branched chain fatty acids pathway. Propionylcarnitine has been linked to the inborn metabolic disorders including propionic acidemia.",
    "id" : null
  }, {
    "name" : "PS(16:0/18:0) ; HMDB0012356",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012356",
    "description" : "PS(16:0/18:0), also known as pSer(34:0), belongs to the class of organic compounds known as phosphatidylserines. These are glycerophosphoserines in which two fatty acids are bonded to the glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. Thus, PS(16:0/18:0) is considered to be a glycerophosphoserine lipid molecule. PS(16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PS(16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PS(16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PS(16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PS(16:0/18:0) participates in a number of enzymatic reactions. In particular, PS(16:0/18:0) can be converted into PE(16:0/18:0); which is catalyzed by the enzyme phosphatidylserine decarboxylase. In addition, Choline and PS(16:0/18:0) can be biosynthesized from PC(16:0/18:0) and L-serine; which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PS(16:0/18:0) is involved in phosphatidylcholine biosynthesis PC(16:0/18:0) pathway and phosphatidylethanolamine biosynthesis pe(16:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "PS(16:0/18:0) ; HMDB12356",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012356",
    "description" : "PS(16:0/18:0), also known as pSer(34:0), belongs to the class of organic compounds known as phosphatidylserines. These are glycerophosphoserines in which two fatty acids are bonded to the glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. Thus, PS(16:0/18:0) is considered to be a glycerophosphoserine lipid molecule. PS(16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. PS(16:0/18:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, PS(16:0/18:0) is primarily located in the membrane (predicted from logP) and intracellular membrane. PS(16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. PS(16:0/18:0) participates in a number of enzymatic reactions. In particular, PS(16:0/18:0) can be converted into PE(16:0/18:0); which is catalyzed by the enzyme phosphatidylserine decarboxylase. In addition, Choline and PS(16:0/18:0) can be biosynthesized from PC(16:0/18:0) and L-serine; which is catalyzed by the enzyme phosphatidylserine synthase. In humans, PS(16:0/18:0) is involved in phosphatidylcholine biosynthesis PC(16:0/18:0) pathway and phosphatidylethanolamine biosynthesis pe(16:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "Pseudouridine ; HMDB0000767",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000767",
    "description" : "Beta-Pseudouridine, also known as p or 5-ribosyluracil, belongs to the class of organic compounds known as nucleoside and nucleotide analogues. These are analogues of nucleosides and nucleotides. These include phosphonated nucleosides, C-glycosylated nucleoside bases, analogues where the sugar unit is a pyranose, and carbocyclic nucleosides, among others. Beta-Pseudouridine is soluble (in water) and a very weakly acidic compound (based on its pKa). Beta-Pseudouridine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, Beta-pseudouridine is primarily located in the cytoplasm. Beta-Pseudouridine exists in all eukaryotes, ranging from yeast to humans. Beta-Pseudouridine is also a parent compound for other transformation products, including but not limited to, N(3)-methylpseudouridine 5'-monophosphate, N(1)-methylpseudouridine 5'-monophosphate, and pseudouridine 5'-phosphate. Outside of the human body, Beta-pseudouridine can be found in a number of food items such as lingonberry, lambsquarters, chicory leaves, and persian lime. This makes Beta-pseudouridine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Pseudouridine ; HMDB00767",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000767",
    "description" : "Beta-Pseudouridine, also known as p or 5-ribosyluracil, belongs to the class of organic compounds known as nucleoside and nucleotide analogues. These are analogues of nucleosides and nucleotides. These include phosphonated nucleosides, C-glycosylated nucleoside bases, analogues where the sugar unit is a pyranose, and carbocyclic nucleosides, among others. Beta-Pseudouridine is soluble (in water) and a very weakly acidic compound (based on its pKa). Beta-Pseudouridine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, Beta-pseudouridine is primarily located in the cytoplasm. Beta-Pseudouridine exists in all eukaryotes, ranging from yeast to humans. Beta-Pseudouridine is also a parent compound for other transformation products, including but not limited to, N(3)-methylpseudouridine 5'-monophosphate, N(1)-methylpseudouridine 5'-monophosphate, and pseudouridine 5'-phosphate. Outside of the human body, Beta-pseudouridine can be found in a number of food items such as lingonberry, lambsquarters, chicory leaves, and persian lime. This makes Beta-pseudouridine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Pterin ; HMDB0000802",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000802",
    "description" : "Pterin, also known as 4-oxopterin or pteridoxamine, belongs to the class of organic compounds known as pterins and derivatives. These are polycyclic aromatic compounds containing a pterin moiety, which consist of a pteridine ring bearing a ketone and an amine group to form 2-aminopteridin-4(3H)-one. Pterin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Pterin has been found in human epidermis and liver tissues, and has also been primarily detected in feces. Within the cell, pterin is primarily located in the cytoplasm. Pterin can be converted into 4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}benzoic acid. Outside of the human body, pterin can be found in soy bean. This makes pterin a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Pterin ; HMDB00802",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000802",
    "description" : "Pterin, also known as 4-oxopterin or pteridoxamine, belongs to the class of organic compounds known as pterins and derivatives. These are polycyclic aromatic compounds containing a pterin moiety, which consist of a pteridine ring bearing a ketone and an amine group to form 2-aminopteridin-4(3H)-one. Pterin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Pterin has been found in human epidermis and liver tissues, and has also been primarily detected in feces. Within the cell, pterin is primarily located in the cytoplasm. Pterin can be converted into 4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}benzoic acid. Outside of the human body, pterin can be found in soy bean. This makes pterin a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Putrescine ; HMDB0001414",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001414",
    "description" : "Putrescine, also known as 1,4-butanediamine or 1,4-diaminobutane, belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing an primary aliphatic amine group. Putrescine exists as a solid, soluble (in water), and a very strong basic compound (based on its pKa). Putrescine has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, saliva, blood, and urine. Within the cell, putrescine is primarily located in the mitochondria and cytoplasm. Putrescine exists in all eukaryotes, ranging from yeast to humans. S-Adenosylmethioninamine and putrescine can be converted into 5'-methylthioadenosine and spermidine through the action of the enzyme spermidine synthase. In humans, putrescine is involved in the methionine metabolism pathway and spermidine and spermine biosynthesis pathway. Putrescine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, methylenetetrahydrofolate reductase deficiency (MTHFRD), cystathionine Beta-synthase deficiency, and the hypermethioninemia pathway. Outside of the human body, putrescine can be found in french plantain. This makes putrescine a potential biomarker for the consumption of this food product. Putrescine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Putrescine ; HMDB01414",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001414",
    "description" : "Putrescine, also known as 1,4-butanediamine or 1,4-diaminobutane, belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing an primary aliphatic amine group. Putrescine exists as a solid, soluble (in water), and a very strong basic compound (based on its pKa). Putrescine has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, saliva, blood, and urine. Within the cell, putrescine is primarily located in the mitochondria and cytoplasm. Putrescine exists in all eukaryotes, ranging from yeast to humans. S-Adenosylmethioninamine and putrescine can be converted into 5'-methylthioadenosine and spermidine through the action of the enzyme spermidine synthase. In humans, putrescine is involved in the methionine metabolism pathway and spermidine and spermine biosynthesis pathway. Putrescine is also involved in several metabolic disorders, some of which include S-adenosylhomocysteine (sah) hydrolase deficiency, methylenetetrahydrofolate reductase deficiency (MTHFRD), cystathionine Beta-synthase deficiency, and the hypermethioninemia pathway. Outside of the human body, putrescine can be found in french plantain. This makes putrescine a potential biomarker for the consumption of this food product. Putrescine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Pyridoxal ; HMDB0001545",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001545",
    "description" : "Pyridoxal, also known as pyridoxaldehyde, belongs to the class of organic compounds known as pyridoxals and derivatives. Pyridoxals and derivatives are compounds containing a pyridoxal moiety, which consists of a pyridine ring substituted at positions 2,3,4, and 5 by a methyl group, a hydroxyl group, a carbaldehyde group, and a hydroxymethyl group, respectively. Pyridoxal exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Pyridoxal has been found in human kidney and placenta tissues, and has also been primarily detected in blood. Within the cell, pyridoxal is primarily located in the cytoplasm. Pyridoxal exists in all eukaryotes, ranging from yeast to humans. In humans, pyridoxal is involved in the vitamin B6 metabolism pathway and the valine, leucine and isoleucine degradation pathway. Pyridoxal is also involved in several metabolic disorders, some of which include methylmalonate semialdehyde dehydrogenase deficiency, the hypophosphatasia pathway, the isovaleric aciduria pathway, and isobutyryl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Pyridoxamine ; HMDB0001431",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001431",
    "description" : "Pyridoxamine, also known as PM, belongs to the class of organic compounds known as pyridoxamine 5'-phosphates. These are heterocyclic aromatic compounds containing a pyridoxamine that carries a phosphate group at the 5'-position. Pyridoxamine is soluble (in water) and a very weakly acidic compound (based on its pKa). Pyridoxamine has been found in human prostate tissue, and has also been primarily detected in blood. Pyridoxamine exists in all eukaryotes, ranging from yeast to humans. Pyridoxamine participates in a number of enzymatic reactions. In particular, Pyridoxamine can be converted into pyridoxal; which is mediated by the enzyme pyridoxine-5'-phosphate oxidase. Furthermore, Pyridoxamine can be converted into pyridoxamine 5'-phosphate through the action of the enzyme pyridoxal kinase. Finally, Pyridoxamine can be converted into pyridoxamine 5'-phosphate; which is mediated by the enzyme pyridoxal kinase. In humans, pyridoxamine is involved in the vitamin B6 metabolism pathway. Pyridoxamine is also involved in the metabolic disorder called the hypophosphatasia pathway. Outside of the human body, pyridoxamine can be found in a number of food items such as other bread, cloudberry, flaxseed, and jicama. This makes pyridoxamine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Pyridoxamine ; HMDB01431",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001431",
    "description" : "Pyridoxamine, also known as PM, belongs to the class of organic compounds known as pyridoxamine 5'-phosphates. These are heterocyclic aromatic compounds containing a pyridoxamine that carries a phosphate group at the 5'-position. Pyridoxamine is soluble (in water) and a very weakly acidic compound (based on its pKa). Pyridoxamine has been found in human prostate tissue, and has also been primarily detected in blood. Pyridoxamine exists in all eukaryotes, ranging from yeast to humans. Pyridoxamine participates in a number of enzymatic reactions. In particular, Pyridoxamine can be converted into pyridoxal; which is mediated by the enzyme pyridoxine-5'-phosphate oxidase. Furthermore, Pyridoxamine can be converted into pyridoxamine 5'-phosphate through the action of the enzyme pyridoxal kinase. Finally, Pyridoxamine can be converted into pyridoxamine 5'-phosphate; which is mediated by the enzyme pyridoxal kinase. In humans, pyridoxamine is involved in the vitamin B6 metabolism pathway. Pyridoxamine is also involved in the metabolic disorder called the hypophosphatasia pathway. Outside of the human body, pyridoxamine can be found in a number of food items such as other bread, cloudberry, flaxseed, and jicama. This makes pyridoxamine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Pyridoxine ; HMDB0000239",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000239",
    "description" : "Pyridoxine, also known as pyridoxol or vitamin B6, belongs to the class of organic compounds known as pyridoxines. These are pyridoxal derivatives in which the carbaldehyde group at position 2 of the pyridoxal moiety is replaced by a hydroxymethyl group. Pyridoxine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Pyridoxine has been found in human liver tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. Pyridoxine exists in all eukaryotes, ranging from yeast to humans. Pyridoxine participates in a number of enzymatic reactions. In particular, Pyridoxine can be converted into pyridoxal through the action of the enzyme pyridoxine-5'-phosphate oxidase. Furthermore, Pyridoxine can be converted into pyridoxine 5'-phosphate; which is catalyzed by the enzyme pyridoxal kinase. Finally, Pyridoxine can be converted into pyridoxine 5'-phosphate; which is mediated by the enzyme pyridoxal kinase. In humans, pyridoxine is involved in the vitamin B6 metabolism pathway. Pyridoxine is also involved in the metabolic disorder called the hypophosphatasia pathway. Pyridoxine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Pyridoxine ; HMDB00239",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000239",
    "description" : "Pyridoxine, also known as pyridoxol or vitamin B6, belongs to the class of organic compounds known as pyridoxines. These are pyridoxal derivatives in which the carbaldehyde group at position 2 of the pyridoxal moiety is replaced by a hydroxymethyl group. Pyridoxine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Pyridoxine has been found in human liver tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. Pyridoxine exists in all eukaryotes, ranging from yeast to humans. Pyridoxine participates in a number of enzymatic reactions. In particular, Pyridoxine can be converted into pyridoxal through the action of the enzyme pyridoxine-5'-phosphate oxidase. Furthermore, Pyridoxine can be converted into pyridoxine 5'-phosphate; which is catalyzed by the enzyme pyridoxal kinase. Finally, Pyridoxine can be converted into pyridoxine 5'-phosphate; which is mediated by the enzyme pyridoxal kinase. In humans, pyridoxine is involved in the vitamin B6 metabolism pathway. Pyridoxine is also involved in the metabolic disorder called the hypophosphatasia pathway. Pyridoxine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Pyrocatechol sulfate ; HMDB0059724",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0059724",
    "description" : "Catechol 1-O-sulphate, also known as catechol monosulfate or catechol sulfuric acid, belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. Catechol 1-O-sulphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Catechol 1-O-sulphate can be biosynthesized from catechol.",
    "id" : null
  }, {
    "name" : "Pyroglutamic acid ; HMDB0000267",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000267",
    "description" : "Pyroglutamic acid, also known as pyroglutamate or pidolic acid, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Pyroglutamic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Pyroglutamic acid has been found in human brain, prostate and skin tissues, and has also been detected in most biofluids, including cerebrospinal fluid, feces, saliva, and blood. Within the cell, pyroglutamic acid is primarily located in the cytoplasm. Pyroglutamic acid exists in all eukaryotes, ranging from yeast to humans. Pyroglutamic acid participates in a number of enzymatic reactions. In particular, Pyroglutamic acid can be converted into L-glutamic acid; which is catalyzed by the enzyme 5-oxoprolinase. In addition, L-Cysteine and pyroglutamic acid can be biosynthesized from Gamma-glutamylcysteine; which is mediated by the enzyme Gamma-glutamylcyclotransferase. In humans, pyroglutamic acid is involved in the glutathione metabolism pathway. Pyroglutamic acid is also involved in several metabolic disorders, some of which include glutathione synthetase deficiency, Gamma-glutamyltransferase deficiency, Gamma-glutamyl-transpeptidase deficiency, and 5-oxoprolinase deficiency. Outside of the human body, pyroglutamic acid can be found in a number of food items such as brussel sprouts, thistle, pear, and moth bean. This makes pyroglutamic acid a potential biomarker for the consumption of these food products. Pyroglutamic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Pyruvic acid ; HMDB0000243",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000243",
    "description" : "Pyruvic acid, also known as 2-oxopropanoate or pyroracemic acid, belongs to the class of organic compounds known as alpha-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the adjacent carbon. Pyruvic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Pyruvic acid exists as a liquid, soluble (in water), and a moderately acidic compound (based on its pKa). Pyruvic acid has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, blood, sweat, and breast milk. Within the cell, pyruvic acid is primarily located in the mitochondria, peroxisome and cytoplasm. Pyruvic acid exists in all eukaryotes, ranging from yeast to humans. Pyruvic acid participates in a number of enzymatic reactions. In particular, L-Glutamic acid and pyruvic acid can be biosynthesized from L-alanine and oxoglutaric acid through the action of the enzyme alanine aminotransferase 1. Furthermore, Pyruvic acid can be converted into oxalacetic acid; which is mediated by the enzyme pyruvate carboxylase, mitochondrial. Furthermore, Pyruvic acid can be biosynthesized from pyruvaldehyde through the action of the enzyme aldehyde dehydrogenase, mitochondrial. Finally, Pyruvic acid and L-serine can be converted into hydroxypyruvic acid and L-alanine; which is catalyzed by the enzyme serine--pyruvate aminotransferase. In humans, pyruvic acid is involved in the gluconeogenesis pathway, the pyruvate metabolism pathway, the alanine metabolism pathway, and the oncogenic action OF fumarate pathway. Pyruvic acid is also involved in several metabolic disorders, some of which include the lactic acidemia pathway, 4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency, the sialuria or french type sialuria pathway, and the glycogenosis, type vii. tarui disease pathway. Outside of the human body, pyruvic acid can be found in a number of food items such as calabash, squashberry, lambsquarters, and peach (var.). This makes pyruvic acid a potential biomarker for the consumption of these food products. Pyruvic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Pyruvic acid ; HMDB00243",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000243",
    "description" : "Pyruvic acid, also known as 2-oxopropanoate or pyroracemic acid, belongs to the class of organic compounds known as alpha-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the adjacent carbon. Pyruvic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Pyruvic acid exists as a liquid, soluble (in water), and a moderately acidic compound (based on its pKa). Pyruvic acid has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, blood, sweat, and breast milk. Within the cell, pyruvic acid is primarily located in the mitochondria, peroxisome and cytoplasm. Pyruvic acid exists in all eukaryotes, ranging from yeast to humans. Pyruvic acid participates in a number of enzymatic reactions. In particular, L-Glutamic acid and pyruvic acid can be biosynthesized from L-alanine and oxoglutaric acid through the action of the enzyme alanine aminotransferase 1. Furthermore, Pyruvic acid can be converted into oxalacetic acid; which is mediated by the enzyme pyruvate carboxylase, mitochondrial. Furthermore, Pyruvic acid can be biosynthesized from pyruvaldehyde through the action of the enzyme aldehyde dehydrogenase, mitochondrial. Finally, Pyruvic acid and L-serine can be converted into hydroxypyruvic acid and L-alanine; which is catalyzed by the enzyme serine--pyruvate aminotransferase. In humans, pyruvic acid is involved in the gluconeogenesis pathway, the pyruvate metabolism pathway, the alanine metabolism pathway, and the oncogenic action OF fumarate pathway. Pyruvic acid is also involved in several metabolic disorders, some of which include the lactic acidemia pathway, 4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency, the sialuria or french type sialuria pathway, and the glycogenosis, type vii. tarui disease pathway. Outside of the human body, pyruvic acid can be found in a number of food items such as calabash, squashberry, lambsquarters, and peach (var.). This makes pyruvic acid a potential biomarker for the consumption of these food products. Pyruvic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Quinaldine ; HMDB0042004",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042004",
    "description" : "Quinaldine or 2-methylquinoline is a simple derivative of a heterocyclic compound quinoline.",
    "id" : null
  }, {
    "name" : "Quinic acid ; HMDB0003072",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003072",
    "description" : "Quinic acid, also known as quinate or chinate, belongs to the class of organic compounds known as quinic acids and derivatives. Quinic acids and derivatives are compounds containing a quinic acid moiety (or a derivative thereof), which is a cyclitol made up of a cyclohexane ring that bears four hydroxyl groups at positions 1,3.4, and 5, as well as a carboxylic acid at position 1. Quinic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Quinic acid has been found in human spleen tissue, and has also been primarily detected in urine, feces, saliva, and blood. Within the cell, quinic acid is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Quinic acid ; HMDB03072",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003072",
    "description" : "Quinic acid, also known as quinate or chinate, belongs to the class of organic compounds known as quinic acids and derivatives. Quinic acids and derivatives are compounds containing a quinic acid moiety (or a derivative thereof), which is a cyclitol made up of a cyclohexane ring that bears four hydroxyl groups at positions 1,3.4, and 5, as well as a carboxylic acid at position 1. Quinic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Quinic acid has been found in human spleen tissue, and has also been primarily detected in urine, feces, saliva, and blood. Within the cell, quinic acid is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Quinine ; HMDB0014611",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0014611",
    "description" : "Quinine, also known as chinin or (8S,9R)-quinine, belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]octane moiety. Quinine is a drug which is used for the treatment of malaria and leg cramps. Quinine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Quinine has been detected in multiple biofluids, such as urine and blood. Within the cell, quinine is primarily located in the membrane (predicted from logP). Quinine participates in a number of enzymatic reactions. In particular, quinine can be biosynthesized from (8S)-cinchonan. Quinine can also be converted into 3-hydroxyquinine. Quinine has a bitter taste. Quinine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Quinine ; HMDB14611",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0014611",
    "description" : "Quinine, also known as chinin or (8S,9R)-quinine, belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]octane moiety. Quinine is a drug which is used for the treatment of malaria and leg cramps. Quinine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Quinine has been detected in multiple biofluids, such as urine and blood. Within the cell, quinine is primarily located in the membrane (predicted from logP). Quinine participates in a number of enzymatic reactions. In particular, quinine can be biosynthesized from (8S)-cinchonan. Quinine can also be converted into 3-hydroxyquinine. Quinine has a bitter taste. Quinine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Quinolinic acid ; HMDB0000232",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000232",
    "description" : "Quinolinic acid, also known as quinolinate, belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. Quinolinic acid exists as a solid, slightly soluble (in water), and an extremely strong acidic compound (based on its pKa). Quinolinic acid has been found in human brain, prostate and spleen tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, quinolinic acid is primarily located in the cytoplasm. Quinolinic acid exists in all eukaryotes, ranging from yeast to humans. Quinolinic acid and phosphoribosyl pyrophosphate can be biosynthesized from nicotinic acid mononucleotide through its interaction with the enzyme nicotinate-nucleotide pyrophosphorylase [carboxylating]. In humans, quinolinic acid is involved in the tryptophan metabolism pathway and the nicotinate and nicotinamide metabolism pathway. Outside of the human body, quinolinic acid can be found in a number of food items such as saffron, wild rice, angelica, and garden tomato. This makes quinolinic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Quinolinic acid ; HMDB00232",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000232",
    "description" : "Quinolinic acid, also known as quinolinate, belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. Quinolinic acid exists as a solid, slightly soluble (in water), and an extremely strong acidic compound (based on its pKa). Quinolinic acid has been found in human brain, prostate and spleen tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, quinolinic acid is primarily located in the cytoplasm. Quinolinic acid exists in all eukaryotes, ranging from yeast to humans. Quinolinic acid and phosphoribosyl pyrophosphate can be biosynthesized from nicotinic acid mononucleotide through its interaction with the enzyme nicotinate-nucleotide pyrophosphorylase [carboxylating]. In humans, quinolinic acid is involved in the tryptophan metabolism pathway and the nicotinate and nicotinamide metabolism pathway. Outside of the human body, quinolinic acid can be found in a number of food items such as saffron, wild rice, angelica, and garden tomato. This makes quinolinic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Ribitol ; HMDB0000508",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000508",
    "description" : "Ribitol, also known as adonitol or pentitol, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. Ribitol is soluble (in water) and a very weakly acidic compound (based on its pKa). Ribitol has been found in human prostate tissue, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, ribitol is primarily located in the cytoplasm. Ribitol is also a parent compound for other transformation products, including but not limited to, 5-amino-6-(D-ribitylamino)uracil, 1-deoxy-1-{[2,6-dihydroxy-5-(5-phosphonopentyl)pyrimidin-4-yl]amino}-D-ribitol, and 1-deoxy-1-{[2,6-dioxo-5-(5-phosphonopentyl)-1,2,3,6-tetrahydropyrimidin-4-yl]amino}-D-ribitol. Ribitol has been found to be associated with the diseases known as alzheimer's disease; ribitol has also been linked to the inborn metabolic disorders including ribose-5-phosphate isomerase deficiency.",
    "id" : null
  }, {
    "name" : "Ribitol ; HMDB00508",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000508",
    "description" : "Ribitol, also known as adonitol or pentitol, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. Ribitol is soluble (in water) and a very weakly acidic compound (based on its pKa). Ribitol has been found in human prostate tissue, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, ribitol is primarily located in the cytoplasm. Ribitol is also a parent compound for other transformation products, including but not limited to, 5-amino-6-(D-ribitylamino)uracil, 1-deoxy-1-{[2,6-dihydroxy-5-(5-phosphonopentyl)pyrimidin-4-yl]amino}-D-ribitol, and 1-deoxy-1-{[2,6-dioxo-5-(5-phosphonopentyl)-1,2,3,6-tetrahydropyrimidin-4-yl]amino}-D-ribitol. Ribitol has been found to be associated with the diseases known as alzheimer's disease; ribitol has also been linked to the inborn metabolic disorders including ribose-5-phosphate isomerase deficiency.",
    "id" : null
  }, {
    "name" : "Ribonic acid ; HMDB0000867",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000867",
    "description" : "Ribonic acid, also known as D-ribonate, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. Ribonic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Ribonic acid has been detected in multiple biofluids, such as feces and blood. Ribonic acid is also a parent compound for other transformation products, including but not limited to, 2-deoxy-D-ribono-1,4-lactone, 2-carboxy-D-arabinitol 1,5-bisphosphate, and 2-carboxy-D-arabinitol 1-phosphate.",
    "id" : null
  }, {
    "name" : "Ribonolactone ; HMDB0001900",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001900",
    "description" : "Ribonolactone belongs to the class of organic compounds known as pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms. Ribonolactone exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Ribonolactone has been primarily detected in urine. Within the cell, ribonolactone is primarily located in the cytoplasm. Ribonolactone can be biosynthesized from D-ribonic acid.",
    "id" : null
  }, {
    "name" : "Ribonolactone ; HMDB01900",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001900",
    "description" : "Ribonolactone belongs to the class of organic compounds known as pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms. Ribonolactone exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Ribonolactone has been primarily detected in urine. Within the cell, ribonolactone is primarily located in the cytoplasm. Ribonolactone can be biosynthesized from D-ribonic acid.",
    "id" : null
  }, {
    "name" : "Ribothymidine ; HMDB0000884",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000884",
    "description" : "Ribothymidine, also known as thymine riboside or 5-methyl-uridine, belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. Ribothymidine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Ribothymidine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, ribothymidine is primarily located in the cytoplasm. Ribothymidine can be converted into TMP and TDP.",
    "id" : null
  }, {
    "name" : "Ribothymidine ; HMDB00884",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000884",
    "description" : "Ribothymidine, also known as thymine riboside or 5-methyl-uridine, belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. Ribothymidine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Ribothymidine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, ribothymidine is primarily located in the cytoplasm. Ribothymidine can be converted into TMP and TDP.",
    "id" : null
  }, {
    "name" : "S-Allylcysteine ; HMDB0034323",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0034323",
    "description" : "S-Allylcysteine, also known as L-deoxyalliin, belongs to the class of organic compounds known as cysteine and derivatives. Cysteine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. S-Allylcysteine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Within the cell, S-allylcysteine is primarily located in the cytoplasm. S-Allylcysteine is a cooked and roasted tasting compound that can be found in garden onion, onion-family vegetables, and soft-necked garlic. This makes S-allylcysteine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Saccharin ; HMDB0029723",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029723",
    "description" : "Saccharin, also known as benzosulfimide or sweeta, belongs to the class of organic compounds known as benzothiazoles. These are organic compounds containing a benzene fused to a thiazole ring (a five-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). Saccharin exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Saccharin has been detected in multiple biofluids, such as feces and saliva. Within the cell, saccharin is primarily located in the cytoplasm. Saccharin can be converted into probenazole. Saccharin has a bitter and odorless taste.",
    "id" : null
  }, {
    "name" : "Saccharin ; HMDB29723",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029723",
    "description" : "Saccharin, also known as benzosulfimide or sweeta, belongs to the class of organic compounds known as benzothiazoles. These are organic compounds containing a benzene fused to a thiazole ring (a five-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). Saccharin exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Saccharin has been detected in multiple biofluids, such as feces and saliva. Within the cell, saccharin is primarily located in the cytoplasm. Saccharin can be converted into probenazole. Saccharin has a bitter and odorless taste.",
    "id" : null
  }, {
    "name" : "Salicylic acid ; HMDB0001895",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001895",
    "description" : "Salicylic acid, also known as ionil or salicylate, belongs to the class of organic compounds known as salicylic acids. These are ortho-hydroxylated benzoic acids. Salicylic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Salicylic acid has been found in human liver and skin tissues, and has also been primarily detected in saliva, feces, urine, and blood. Salicylic acid exists in all eukaryotes, ranging from yeast to humans. In humans, salicylic acid is involved in the salicylic Acid action pathway. Salicylic acid is a faint, nutty, and phenolic tasting compound that can be found in a number of food items such as cardamom, soursop, beer, and breakfast cereal. This makes salicylic acid a potential biomarker for the consumption of these food products. Salicylic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Salicylic acid ; HMDB01895",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001895",
    "description" : "Salicylic acid, also known as ionil or salicylate, belongs to the class of organic compounds known as salicylic acids. These are ortho-hydroxylated benzoic acids. Salicylic acid exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Salicylic acid has been found in human liver and skin tissues, and has also been primarily detected in saliva, feces, urine, and blood. Salicylic acid exists in all eukaryotes, ranging from yeast to humans. In humans, salicylic acid is involved in the salicylic Acid action pathway. Salicylic acid is a faint, nutty, and phenolic tasting compound that can be found in a number of food items such as cardamom, soursop, beer, and breakfast cereal. This makes salicylic acid a potential biomarker for the consumption of these food products. Salicylic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Salicyluric acid ; HMDB0000840",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000840",
    "description" : "Salicylurate, also known as salicyloylglycine or O-hydroxyhippate, belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. Salicylurate exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Salicylurate has been detected in multiple biofluids, such as urine and blood. Salicylurate exists in all eukaryotes, ranging from yeast to humans. Salicylurate participates in a number of enzymatic reactions. In particular, salicylurate can be biosynthesized from glycine. Salicylurate can also be converted into salicyluric beta-D-glucuronide and 5-aminosalicyluric acid.",
    "id" : null
  }, {
    "name" : "Salicyluric acid ; HMDB00840",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000840",
    "description" : "Salicylurate, also known as salicyloylglycine or O-hydroxyhippate, belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. Salicylurate exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Salicylurate has been detected in multiple biofluids, such as urine and blood. Salicylurate exists in all eukaryotes, ranging from yeast to humans. Salicylurate participates in a number of enzymatic reactions. In particular, salicylurate can be biosynthesized from glycine. Salicylurate can also be converted into salicyluric beta-D-glucuronide and 5-aminosalicyluric acid.",
    "id" : null
  }, {
    "name" : "Sarcosine ; HMDB0000271",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000271",
    "description" : "Sarcosine, also known as N-methylglycine or megly, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Sarcosine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Sarcosine has been found in human prostate, muscle and skeletal muscle tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, sarcosine is primarily located in the mitochondria, peroxisome and cytoplasm. Sarcosine participates in a number of enzymatic reactions. In particular, Formaldehyde and sarcosine can be biosynthesized from dimethylglycine through the action of the enzyme dimethylglycine dehydrogenase, mitochondrial. Furthermore, Sarcosine can be converted into formaldehyde and glycine through the action of the enzyme sarcosine dehydrogenase, mitochondrial. Finally, S-Adenosylhomocysteine and sarcosine can be biosynthesized from S-adenosylmethionine and glycine; which is catalyzed by the enzyme dna (cytosine-5)-methyltransferase 1. In humans, sarcosine is involved in the glycine and serine metabolism pathway, the methionine metabolism pathway, and the sarcosine oncometabolite pathway. Sarcosine is also involved in several metabolic disorders, some of which include the hypermethioninemia pathway, S-adenosylhomocysteine (sah) hydrolase deficiency, dihydropyrimidine dehydrogenase deficiency (DHPD), and 3-phosphoglycerate dehydrogenase deficiency. Outside of the human body, sarcosine can be found in peanut. This makes sarcosine a potential biomarker for the consumption of this food product. Sarcosine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Sarcosine ; HMDB00271",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000271",
    "description" : "Sarcosine, also known as N-methylglycine or megly, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Sarcosine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). Sarcosine has been found in human prostate, muscle and skeletal muscle tissues, and has also been primarily detected in saliva, feces, urine, and blood. Within the cell, sarcosine is primarily located in the mitochondria, peroxisome and cytoplasm. Sarcosine participates in a number of enzymatic reactions. In particular, Formaldehyde and sarcosine can be biosynthesized from dimethylglycine through the action of the enzyme dimethylglycine dehydrogenase, mitochondrial. Furthermore, Sarcosine can be converted into formaldehyde and glycine through the action of the enzyme sarcosine dehydrogenase, mitochondrial. Finally, S-Adenosylhomocysteine and sarcosine can be biosynthesized from S-adenosylmethionine and glycine; which is catalyzed by the enzyme dna (cytosine-5)-methyltransferase 1. In humans, sarcosine is involved in the glycine and serine metabolism pathway, the methionine metabolism pathway, and the sarcosine oncometabolite pathway. Sarcosine is also involved in several metabolic disorders, some of which include the hypermethioninemia pathway, S-adenosylhomocysteine (sah) hydrolase deficiency, dihydropyrimidine dehydrogenase deficiency (DHPD), and 3-phosphoglycerate dehydrogenase deficiency. Outside of the human body, sarcosine can be found in peanut. This makes sarcosine a potential biomarker for the consumption of this food product. Sarcosine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Sebacic acid ; HMDB0000792",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000792",
    "description" : "Sebacic acid, also known as 1,10-decanedioate or decanedioic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Sebacic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Sebacic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, sebacic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Sebacic acid participates in a number of enzymatic reactions. In particular, sebacic acid can be biosynthesized from decane. Sebacic acid can also be converted into 3-hydroxysebacic acid and decanedioyl-CoA. Sebacic acid is a potentially toxic compound. Sebacic acid has been found to be associated with several diseases known as 3-hydroxydicarboxylic aciduria and 3-hydroxy-3-methylglutaryl-CoA synthase deficiency; sebacic acid has also been linked to several inborn metabolic disorders including carnitine-acylcarnitine translocase deficiency and medium chain acyl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Sebacic acid ; HMDB00792",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000792",
    "description" : "Sebacic acid, also known as 1,10-decanedioate or decanedioic acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Sebacic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Sebacic acid has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, sebacic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Sebacic acid participates in a number of enzymatic reactions. In particular, sebacic acid can be biosynthesized from decane. Sebacic acid can also be converted into 3-hydroxysebacic acid and decanedioyl-CoA. Sebacic acid is a potentially toxic compound. Sebacic acid has been found to be associated with several diseases known as 3-hydroxydicarboxylic aciduria and 3-hydroxy-3-methylglutaryl-CoA synthase deficiency; sebacic acid has also been linked to several inborn metabolic disorders including carnitine-acylcarnitine translocase deficiency and medium chain acyl-CoA dehydrogenase deficiency.",
    "id" : null
  }, {
    "name" : "Sedoheptulose ; HMDB0003219",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003219",
    "description" : "Sedoheptulose, also known as altro-heptulose or volemulose, belongs to the class of organic compounds known as heptoses. These are monosaccharides in which the sugar unit is a seven-carbon containing moeity. Sedoheptulose is soluble (in water) and a very weakly acidic compound (based on its pKa). Within the cell, sedoheptulose is primarily located in the cytoplasm.",
    "id" : null
  }, {
    "name" : "Serotonin ; HMDB0000259",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000259",
    "description" : "Serotonin, also known as 5-HT or enteramine, belongs to the class of organic compounds known as serotonins. Serotonins are compounds containing a serotonin moiety, which consists of an indole that bears an aminoethyl a position 2 and a hydroxyl group at position 5. Serotonin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Serotonin has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, serotonin is primarily located in the cytoplasm. Serotonin can be converted into serotonin; which is catalyzed by the enzyme sodium-dependent serotonin transporter. In humans, serotonin is involved in the methadone action pathway, the ethylmorphine action pathway, the oxycodone action pathway, and the ropivacaine action pathway. Serotonin is also involved in the metabolic disorder called the dimethylthiambutene action pathway. Serotonin has been found to be associated with several diseases known as schizophrenia, brunner syndrome, hypothyroidism, and parkinson's disease; serotonin has also been linked to the inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "Serotonin ; HMDB00259",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000259",
    "description" : "Serotonin, also known as 5-HT or enteramine, belongs to the class of organic compounds known as serotonins. Serotonins are compounds containing a serotonin moiety, which consists of an indole that bears an aminoethyl a position 2 and a hydroxyl group at position 5. Serotonin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Serotonin has been found throughout most human tissues, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, serotonin is primarily located in the cytoplasm. Serotonin can be converted into serotonin; which is catalyzed by the enzyme sodium-dependent serotonin transporter. In humans, serotonin is involved in the methadone action pathway, the ethylmorphine action pathway, the oxycodone action pathway, and the ropivacaine action pathway. Serotonin is also involved in the metabolic disorder called the dimethylthiambutene action pathway. Serotonin has been found to be associated with several diseases known as schizophrenia, brunner syndrome, hypothyroidism, and parkinson's disease; serotonin has also been linked to the inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "SM(d18:1/14:0) ; HMDB0012097",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012097",
    "description" : "SM(D18:1/14:0), also known as C14 sphingomyelin or SM(32:1), belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/14:0) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/14:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/14:0) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/14:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/14:0) can be biosynthesized from tetradecanoic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/14:0) ; HMDB12097",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012097",
    "description" : "SM(D18:1/14:0), also known as C14 sphingomyelin or SM(32:1), belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/14:0) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/14:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/14:0) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/14:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/14:0) can be biosynthesized from tetradecanoic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/16:0) ; HMDB0010169",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010169",
    "description" : "SM(D18:1/16:0), also known as C16 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. SM(D18:1/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/16:0) has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/16:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon.",
    "id" : null
  }, {
    "name" : "SM(d18:1/16:0) ; HMDB10169",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010169",
    "description" : "SM(D18:1/16:0), also known as C16 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. SM(D18:1/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/16:0) has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/16:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon.",
    "id" : null
  }, {
    "name" : "SM(d18:1/18:0) ; HMDB0001348",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001348",
    "description" : "SM(D18:1/18:0), also known as sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. SM(D18:1/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/18:0) has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, urine, and breast milk. Within the cell, SM(D18:1/18:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/18:0) participates in a number of enzymatic reactions. In particular, SM(D18:1/18:0) and galactosylglycerol can be biosynthesized from ceramide (D18:1/18:0) and PC(15:0/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylcholine:ceramide cholinephosphotransferase 1. In addition, SM(D18:1/18:0) and water can be converted into ceramide (D18:1/18:0) and phosphorylcholine; which is catalyzed by the enzyme ectonucleotide pyrophosphatase/phosphodiesterase family member 7. In humans, SM(D18:1/18:0) is involved in the metachromatic leukodystrophy (MLD) pathway, the sphingolipid metabolism pathway, and the globoid cell leukodystrophy pathway. SM(D18:1/18:0) is also involved in a few metabolic disorders, which include the fabry disease pathway, the gaucher disease pathway, and the krabbe disease pathway.",
    "id" : null
  }, {
    "name" : "SM(d18:1/18:0) ; HMDB01348",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001348",
    "description" : "SM(D18:1/18:0), also known as sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. SM(D18:1/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/18:0) has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, urine, and breast milk. Within the cell, SM(D18:1/18:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/18:0) participates in a number of enzymatic reactions. In particular, SM(D18:1/18:0) and galactosylglycerol can be biosynthesized from ceramide (D18:1/18:0) and PC(15:0/18:2(9Z,12Z)) through its interaction with the enzyme phosphatidylcholine:ceramide cholinephosphotransferase 1. In addition, SM(D18:1/18:0) and water can be converted into ceramide (D18:1/18:0) and phosphorylcholine; which is catalyzed by the enzyme ectonucleotide pyrophosphatase/phosphodiesterase family member 7. In humans, SM(D18:1/18:0) is involved in the metachromatic leukodystrophy (MLD) pathway, the sphingolipid metabolism pathway, and the globoid cell leukodystrophy pathway. SM(D18:1/18:0) is also involved in a few metabolic disorders, which include the fabry disease pathway, the gaucher disease pathway, and the krabbe disease pathway.",
    "id" : null
  }, {
    "name" : "SM(d18:1/18:1(9Z)) ; HMDB0012101",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012101",
    "description" : "SM(D18:1/18:1(9Z)), also known as C18:1 sphingomyelin or N-oleoylsphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/18:1(9Z)) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/18:1(9Z)) has been found in human brain tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/18:1(9Z)) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/18:1(9Z)) can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/18:1(9Z)) ; HMDB12101",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012101",
    "description" : "SM(D18:1/18:1(9Z)), also known as C18:1 sphingomyelin or N-oleoylsphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/18:1(9Z)) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/18:1(9Z)) has been found in human brain tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/18:1(9Z)) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/18:1(9Z)) can be biosynthesized from oleic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/20:0) ; HMDB0012102",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012102",
    "description" : "SM(D18:1/20:0), also known as C20 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/20:0) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/20:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/20:0) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/20:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/20:0) can be biosynthesized from arachidic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/20:0) ; HMDB12102",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012102",
    "description" : "SM(D18:1/20:0), also known as C20 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/20:0) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/20:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/20:0) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/20:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/20:0) can be biosynthesized from arachidic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/22:0) ; HMDB0012103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012103",
    "description" : "SM(D18:1/22:0), also known as C22 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/22:0) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/22:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/22:0) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/22:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/22:0) can be biosynthesized from docosanoic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/22:0) ; HMDB12103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012103",
    "description" : "SM(D18:1/22:0), also known as C22 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/22:0) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/22:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/22:0) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/22:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/22:0) can be biosynthesized from docosanoic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/22:1(13Z)) ; HMDB0012104",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012104",
    "description" : "SM(D18:1/22:1), also known as sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/22:1) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/22:1) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/22:1) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/22:1) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/22:1) can be biosynthesized from erucic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/22:1(13Z)) ; HMDB12104",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012104",
    "description" : "SM(D18:1/22:1), also known as sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/22:1) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/22:1) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/22:1) has been found in human brain tissue, and has also been primarily detected in blood. Within the cell, SM(D18:1/22:1) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/22:1) can be biosynthesized from erucic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/24:0) ; HMDB0011697",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011697",
    "description" : "SM(D18:1/24:0) belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. SM(D18:1/24:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/24:0) has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/24:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon.",
    "id" : null
  }, {
    "name" : "SM(d18:1/24:0) ; HMDB11697",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011697",
    "description" : "SM(D18:1/24:0) belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. SM(D18:1/24:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/24:0) has been found throughout all human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/24:0) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon.",
    "id" : null
  }, {
    "name" : "SM(d18:1/24:1(15Z)) ; HMDB0012107",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012107",
    "description" : "SM(D18:1/24:1(15Z)), also known as C24:1 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/24:1(15Z)) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/24:1(15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/24:1(15Z)) has been found in human brain tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/24:1(15Z)) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/24:1(15Z)) can be biosynthesized from (15Z)-tetracosenoic acid.",
    "id" : null
  }, {
    "name" : "SM(d18:1/24:1(15Z)) ; HMDB12107",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0012107",
    "description" : "SM(D18:1/24:1(15Z)), also known as C24:1 sphingomyelin, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Thus, SM(D18:1/24:1(15Z)) is considered to be a phosphosphingolipid lipid molecule. SM(D18:1/24:1(15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. SM(D18:1/24:1(15Z)) has been found in human brain tissue, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, SM(D18:1/24:1(15Z)) is primarily located in the membrane (predicted from logP), endosome, myelin sheath and axon. SM(D18:1/24:1(15Z)) can be biosynthesized from (15Z)-tetracosenoic acid.",
    "id" : null
  }, {
    "name" : "Solanidine ; HMDB0003236",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003236",
    "description" : "Solanidine, also known as solatubin or solanid-5-en-3-ol, belongs to the class of organic compounds known as solanidines and derivatives. These are steroids with a structure based on the solanidane skeleton. Solanidane arises from the conversion of a cholestane side-chain into a bicyclic system. Thus, solanidine is considered to be a sterol lipid molecule. Solanidine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Solanidine has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, solanidine is primarily located in the membrane (predicted from logP) and cytoplasm. Solanidine can be converted into solanine.",
    "id" : null
  }, {
    "name" : "Solanidine ; HMDB03236",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003236",
    "description" : "Solanidine, also known as solatubin or solanid-5-en-3-ol, belongs to the class of organic compounds known as solanidines and derivatives. These are steroids with a structure based on the solanidane skeleton. Solanidane arises from the conversion of a cholestane side-chain into a bicyclic system. Thus, solanidine is considered to be a sterol lipid molecule. Solanidine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Solanidine has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, solanidine is primarily located in the membrane (predicted from logP) and cytoplasm. Solanidine can be converted into solanine.",
    "id" : null
  }, {
    "name" : "Sorbitol ; HMDB0000247",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000247",
    "description" : "D-Glucitol, also known as D-sorbitol or neosorb, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. D-Glucitol is a drug which is used as a non-stimulant laxative via an oral suspension or enema. D-Glucitol exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). D-Glucitol has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, saliva, feces, and urine. D-Glucitol exists in all eukaryotes, ranging from yeast to humans. In humans, D-glucitol is involved in the galactose metabolism pathway, the fructose and mannose degradation pathway, and the fructose intolerance, hereditary pathway. D-Glucitol is also involved in a couple of metabolic disorders, which include the fructosuria pathway and the galactosemia pathway. Outside of the human body, D-glucitol can be found in a number of food items such as purslane, soy bean, lemon balm, and rocket salad (ssp.). This makes D-glucitol a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Sorbitol ; HMDB00247",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000247",
    "description" : "D-Glucitol, also known as D-sorbitol or neosorb, belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. D-Glucitol is a drug which is used as a non-stimulant laxative via an oral suspension or enema. D-Glucitol exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). D-Glucitol has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, saliva, feces, and urine. D-Glucitol exists in all eukaryotes, ranging from yeast to humans. In humans, D-glucitol is involved in the galactose metabolism pathway, the fructose and mannose degradation pathway, and the fructose intolerance, hereditary pathway. D-Glucitol is also involved in a couple of metabolic disorders, which include the fructosuria pathway and the galactosemia pathway. Outside of the human body, D-glucitol can be found in a number of food items such as purslane, soy bean, lemon balm, and rocket salad (ssp.). This makes D-glucitol a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Spermidine ; HMDB0001257",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001257",
    "description" : "Spermidine, also known as SPD, belongs to the class of organic compounds known as dialkylamines. These are organic compounds containing a dialkylamine group, characterized by two alkyl groups bonded to the amino nitrogen. Spermidine exists as a solid, soluble (in water), and a very strong basic compound (based on its pKa). Spermidine has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, urine, blood, and saliva. Within the cell, spermidine is primarily located in the cytoplasm. Spermidine exists in all eukaryotes, ranging from yeast to humans. 5'-Methylthioadenosine and spermidine can be biosynthesized from S-adenosylmethioninamine and putrescine through the action of the enzyme spermidine synthase. In humans, spermidine is involved in the methionine metabolism pathway and spermidine and spermine biosynthesis pathway. Spermidine is also involved in several metabolic disorders, some of which include cystathionine Beta-synthase deficiency, S-adenosylhomocysteine (sah) hydrolase deficiency, methylenetetrahydrofolate reductase deficiency (MTHFRD), and methionine adenosyltransferase deficiency. Outside of the human body, spermidine can be found in radish. This makes spermidine a potential biomarker for the consumption of this food product. Spermidine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Sphinganine ; HMDB0000269",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000269",
    "description" : "Sphinganine, also known as safingol or D18:0, belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Thus, sphinganine is considered to be a sphingoid base lipid molecule. Sphinganine is considered to be a practically insoluble (in water) and relatively neutral molecule. Sphinganine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, sphinganine is primarily located in the cytoplasm, membrane (predicted from logP) and endoplasmic reticulum. Sphinganine exists in all eukaryotes, ranging from yeast to humans. Sphinganine participates in a number of enzymatic reactions. In particular, Sphinganine can be converted into 3-dehydrosphinganine through its interaction with the enzyme 3-ketodihydrosphingosine reductase. In addition, Sphinganine can be converted into sphinganine 1-phosphate; which is catalyzed by the enzyme sphingosine kinase 2. In humans, sphinganine is involved in the metachromatic leukodystrophy (MLD) pathway, the sphingolipid metabolism pathway, and the globoid cell leukodystrophy pathway. Sphinganine is also involved in a few metabolic disorders, which include the fabry disease pathway, the krabbe disease pathway, and the gaucher disease pathway. Outside of the human body, sphinganine can be found in a number of food items such as chinese cinnamon, spinach, grapefruit/pummelo hybrid, and pomes. This makes sphinganine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Sphinganine ; HMDB00269",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000269",
    "description" : "Sphinganine, also known as safingol or D18:0, belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Thus, sphinganine is considered to be a sphingoid base lipid molecule. Sphinganine is considered to be a practically insoluble (in water) and relatively neutral molecule. Sphinganine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, sphinganine is primarily located in the cytoplasm, membrane (predicted from logP) and endoplasmic reticulum. Sphinganine exists in all eukaryotes, ranging from yeast to humans. Sphinganine participates in a number of enzymatic reactions. In particular, Sphinganine can be converted into 3-dehydrosphinganine through its interaction with the enzyme 3-ketodihydrosphingosine reductase. In addition, Sphinganine can be converted into sphinganine 1-phosphate; which is catalyzed by the enzyme sphingosine kinase 2. In humans, sphinganine is involved in the metachromatic leukodystrophy (MLD) pathway, the sphingolipid metabolism pathway, and the globoid cell leukodystrophy pathway. Sphinganine is also involved in a few metabolic disorders, which include the fabry disease pathway, the krabbe disease pathway, and the gaucher disease pathway. Outside of the human body, sphinganine can be found in a number of food items such as chinese cinnamon, spinach, grapefruit/pummelo hybrid, and pomes. This makes sphinganine a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Sphingosine 1-phosphate ; HMDB0000277",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000277",
    "description" : "Sphingosine-1-phosphate, also known as S1P, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Sphingosine-1-phosphate is considered to be a practically insoluble (in water) and relatively neutral molecule. Sphingosine-1-phosphate has been primarily detected in blood. Within the cell, sphingosine-1-phosphate is primarily located in the cytoplasm, membrane (predicted from logP), endoplasmic reticulum and endosome. In humans, sphingosine-1-phosphate is involved in the metachromatic leukodystrophy (MLD) pathway, the sphingolipid metabolism pathway, and the globoid cell leukodystrophy pathway. Sphingosine-1-phosphate is also involved in a few metabolic disorders, which include the krabbe disease pathway, the fabry disease pathway, and the gaucher disease pathway.",
    "id" : null
  }, {
    "name" : "Sphingosine 1-phosphate ; HMDB00277",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000277",
    "description" : "Sphingosine-1-phosphate, also known as S1P, belongs to the class of organic compounds known as phosphosphingolipids. These are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Sphingosine-1-phosphate is considered to be a practically insoluble (in water) and relatively neutral molecule. Sphingosine-1-phosphate has been primarily detected in blood. Within the cell, sphingosine-1-phosphate is primarily located in the cytoplasm, membrane (predicted from logP), endoplasmic reticulum and endosome. In humans, sphingosine-1-phosphate is involved in the metachromatic leukodystrophy (MLD) pathway, the sphingolipid metabolism pathway, and the globoid cell leukodystrophy pathway. Sphingosine-1-phosphate is also involved in a few metabolic disorders, which include the krabbe disease pathway, the fabry disease pathway, and the gaucher disease pathway.",
    "id" : null
  }, {
    "name" : "Sphingosine ; HMDB0000252",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000252",
    "description" : "Sphingosine, also known as (4e)-sphingenine, belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Sphingosine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Sphingosine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Sphingosine can be found anywhere throughout the human cell, such as in endoplasmic reticulum, mitochondria, membrane (predicted from logP), and cytoplasm. Sphingosine exists in all eukaryotes, ranging from yeast to humans. Sphingosine participates in a number of enzymatic reactions. In particular, Sphingosine can be converted into sphingosine 1-phosphate through its interaction with the enzyme sphingosine kinase 2. In addition, Sphingosine can be biosynthesized from sphingosine 1-phosphate through its interaction with the enzyme sphingosine-1-phosphate phosphatase 2. In humans, sphingosine is involved in the sphingolipid metabolism pathway, the globoid cell leukodystrophy pathway, and the metachromatic leukodystrophy (MLD) pathway. Sphingosine is also involved in a few metabolic disorders, which include the gaucher disease pathway, the fabry disease pathway, and the krabbe disease pathway.",
    "id" : null
  }, {
    "name" : "Sphingosine ; HMDB00252",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000252",
    "description" : "Sphingosine, also known as (4e)-sphingenine, belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom. Sphingosine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Sphingosine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Sphingosine can be found anywhere throughout the human cell, such as in endoplasmic reticulum, mitochondria, membrane (predicted from logP), and cytoplasm. Sphingosine exists in all eukaryotes, ranging from yeast to humans. Sphingosine participates in a number of enzymatic reactions. In particular, Sphingosine can be converted into sphingosine 1-phosphate through its interaction with the enzyme sphingosine kinase 2. In addition, Sphingosine can be biosynthesized from sphingosine 1-phosphate through its interaction with the enzyme sphingosine-1-phosphate phosphatase 2. In humans, sphingosine is involved in the sphingolipid metabolism pathway, the globoid cell leukodystrophy pathway, and the metachromatic leukodystrophy (MLD) pathway. Sphingosine is also involved in a few metabolic disorders, which include the gaucher disease pathway, the fabry disease pathway, and the krabbe disease pathway.",
    "id" : null
  }, {
    "name" : "Stearic acid ; HMDB0000827",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000827",
    "description" : "Stearic acid, also known as stearate or 18:0, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Stearic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Stearic acid has been found throughout most human tissues, and has also been detected in most biofluids, including blood, urine, sweat, and saliva. Within the cell, stearic acid is primarily located in the cytoplasm, membrane (predicted from logP), myelin sheath and adiposome. Stearic acid exists in all eukaryotes, ranging from yeast to humans. Stearic acid participates in a number of enzymatic reactions. In particular, Dhap(18:0E) and stearic acid can be biosynthesized from dhap(18:0) and octadecanol; which is catalyzed by the enzyme dihydroxyacetone phosphate acyltransferase and alkyldihydroxyacetonephosphate synthase. In addition, Stearic acid can be biosynthesized from stearoyl-CoA through its interaction with the enzyme acyl-CoA thioesterase. In humans, stearic acid is involved in plasmalogen synthesis pathway. Stearic acid is also involved in the metabolic disorder called the mitochondrial Beta-oxidation OF long chain saturated fatty acids pathway. Outside of the human body, stearic acid can be found in a number of food items such as common cabbage, tamarind, breadnut tree seed, and pili nut. This makes stearic acid a potential biomarker for the consumption of these food products. Stearic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Stearic acid ; HMDB00827",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000827",
    "description" : "Stearic acid, also known as stearate or 18:0, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Stearic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Stearic acid has been found throughout most human tissues, and has also been detected in most biofluids, including blood, urine, sweat, and saliva. Within the cell, stearic acid is primarily located in the cytoplasm, membrane (predicted from logP), myelin sheath and adiposome. Stearic acid exists in all eukaryotes, ranging from yeast to humans. Stearic acid participates in a number of enzymatic reactions. In particular, Dhap(18:0E) and stearic acid can be biosynthesized from dhap(18:0) and octadecanol; which is catalyzed by the enzyme dihydroxyacetone phosphate acyltransferase and alkyldihydroxyacetonephosphate synthase. In addition, Stearic acid can be biosynthesized from stearoyl-CoA through its interaction with the enzyme acyl-CoA thioesterase. In humans, stearic acid is involved in plasmalogen synthesis pathway. Stearic acid is also involved in the metabolic disorder called the mitochondrial Beta-oxidation OF long chain saturated fatty acids pathway. Outside of the human body, stearic acid can be found in a number of food items such as common cabbage, tamarind, breadnut tree seed, and pili nut. This makes stearic acid a potential biomarker for the consumption of these food products. Stearic acid is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Stearoylcarnitine ; HMDB0000848",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000848",
    "description" : "Stearoylcarnitine, also known as acylcarnitine C18:0, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, stearoylcarnitine is considered to be a fatty ester lipid molecule. Stearoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Stearoylcarnitine has been detected in multiple biofluids, such as blood and urine. Within the cell, stearoylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria. In humans, stearoylcarnitine is involved in the metabolic disorder called the mitochondrial Beta-oxidation OF long chain saturated fatty acids pathway. Stearoylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "Stearoylcarnitine ; HMDB00848",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000848",
    "description" : "Stearoylcarnitine, also known as acylcarnitine C18:0, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, stearoylcarnitine is considered to be a fatty ester lipid molecule. Stearoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Stearoylcarnitine has been detected in multiple biofluids, such as blood and urine. Within the cell, stearoylcarnitine is primarily located in the cytoplasm, membrane (predicted from logP) and mitochondria. In humans, stearoylcarnitine is involved in the metabolic disorder called the mitochondrial Beta-oxidation OF long chain saturated fatty acids pathway. Stearoylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "Stearoylethanolamide ; HMDB0013078",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013078",
    "description" : "Stearoyl-ea, also known as stearamide mea, belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, stearoyl-ea is considered to be a fatty amide lipid molecule. Stearoyl-ea exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Stearoyl-ea has been primarily detected in blood. Within the cell, stearoyl-ea is primarily located in the membrane (predicted from logP). Stearoyl-ea can be biosynthesized from octadecanoic acid.",
    "id" : null
  }, {
    "name" : "Suberic acid ; HMDB0000893",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000893",
    "description" : "Suberic acid, also known as 1,8-octanedioate or cork acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Suberic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Suberic acid has been found in human prostate tissue, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, suberic acid is primarily located in the cytoplasm and adiposome. Suberic acid is also a parent compound for other transformation products, including but not limited to, 3-hydroxysuberic acid, 2-hydroxyoctanedioic acid, and 2-ethyloctanedioic acid. Outside of the human body, suberic acid can be found in green bean, pulses, and yellow wax bean. This makes suberic acid a potential biomarker for the consumption of these food products. Suberic acid has been found to be associated with several diseases known as schizophrenia and 3-hydroxy-3-methylglutaryl-CoA synthase deficiency; suberic acid has also been linked to several inborn metabolic disorders including medium chain acyl-CoA dehydrogenase deficiency, carnitine-acylcarnitine translocase deficiency, and malonyl-CoA decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "Suberic acid ; HMDB00893",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000893",
    "description" : "Suberic acid, also known as 1,8-octanedioate or cork acid, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Suberic acid exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Suberic acid has been found in human prostate tissue, and has also been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, suberic acid is primarily located in the cytoplasm and adiposome. Suberic acid is also a parent compound for other transformation products, including but not limited to, 3-hydroxysuberic acid, 2-hydroxyoctanedioic acid, and 2-ethyloctanedioic acid. Outside of the human body, suberic acid can be found in green bean, pulses, and yellow wax bean. This makes suberic acid a potential biomarker for the consumption of these food products. Suberic acid has been found to be associated with several diseases known as schizophrenia and 3-hydroxy-3-methylglutaryl-CoA synthase deficiency; suberic acid has also been linked to several inborn metabolic disorders including medium chain acyl-CoA dehydrogenase deficiency, carnitine-acylcarnitine translocase deficiency, and malonyl-CoA decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "Succinic acid ; HMDB0000254",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000254",
    "description" : "Succinic acid, also known as butanedionic acid or succinate, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Succinic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Succinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Succinic acid has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, breast milk, sweat, and blood. Within the cell, succinic acid is primarily located in the mitochondria, endoplasmic reticulum, peroxisome and cytoplasm. Succinic acid exists in all eukaryotes, ranging from yeast to humans. Succinic acid participates in a number of enzymatic reactions. In particular, Succinic acid can be biosynthesized from succinic acid semialdehyde; which is mediated by the enzyme succinate-semialdehyde dehydrogenase, mitochondrial. Furthermore, Succinic acid can be converted into fumaric acid; which is catalyzed by the enzyme succinate dehydrogenase. Finally, Succinic acid can be biosynthesized from acetoacetic acid and succinyl-CoA through the action of the enzyme succinyl-coa:3-ketoacid coenzyme A transferase 1, mitochondrial. In humans, succinic acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the citric Acid cycle pathway, the phytanic Acid peroxisomal oxidation pathway, and the ketone body metabolism pathway. Succinic acid is also involved in several metabolic disorders, some of which include the hyperornithinemia with gyrate atrophy (hoga) pathway, the isovaleric aciduria pathway, the 3-methylglutaconic aciduria type III pathway, and the hyperprolinemia type II pathway. Succinic acid is an odorless and sour tasting compound that can be found in a number of food items such as onion-family vegetables, dock, common walnut, and tarragon. This makes succinic acid a potential biomarker for the consumption of these food products. Succinic acid is a potentially toxic compound. Succinic acid has been found to be associated with several diseases known as lung cancer, lipoyltransferase 1 deficiency, canavan disease, and alzheimer's disease; succinic acid has also been linked to the inborn metabolic disorders including d-2-hydroxyglutaric aciduria.",
    "id" : null
  }, {
    "name" : "Succinic acid ; HMDB00254",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000254",
    "description" : "Succinic acid, also known as butanedionic acid or succinate, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Succinic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Succinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Succinic acid has been found throughout most human tissues, and has also been detected in most biofluids, including cerebrospinal fluid, breast milk, sweat, and blood. Within the cell, succinic acid is primarily located in the mitochondria, endoplasmic reticulum, peroxisome and cytoplasm. Succinic acid exists in all eukaryotes, ranging from yeast to humans. Succinic acid participates in a number of enzymatic reactions. In particular, Succinic acid can be biosynthesized from succinic acid semialdehyde; which is mediated by the enzyme succinate-semialdehyde dehydrogenase, mitochondrial. Furthermore, Succinic acid can be converted into fumaric acid; which is catalyzed by the enzyme succinate dehydrogenase. Finally, Succinic acid can be biosynthesized from acetoacetic acid and succinyl-CoA through the action of the enzyme succinyl-coa:3-ketoacid coenzyme A transferase 1, mitochondrial. In humans, succinic acid is involved in the oncogenic action OF 2-hydroxyglutarate pathway, the citric Acid cycle pathway, the phytanic Acid peroxisomal oxidation pathway, and the ketone body metabolism pathway. Succinic acid is also involved in several metabolic disorders, some of which include the hyperornithinemia with gyrate atrophy (hoga) pathway, the isovaleric aciduria pathway, the 3-methylglutaconic aciduria type III pathway, and the hyperprolinemia type II pathway. Succinic acid is an odorless and sour tasting compound that can be found in a number of food items such as onion-family vegetables, dock, common walnut, and tarragon. This makes succinic acid a potential biomarker for the consumption of these food products. Succinic acid is a potentially toxic compound. Succinic acid has been found to be associated with several diseases known as lung cancer, lipoyltransferase 1 deficiency, canavan disease, and alzheimer's disease; succinic acid has also been linked to the inborn metabolic disorders including d-2-hydroxyglutaric aciduria.",
    "id" : null
  }, {
    "name" : "Succinyladenosine ; HMDB0000912",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000912",
    "description" : "Succinyladenosine belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Succinyladenosine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Succinyladenosine has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, succinyladenosine is primarily located in the cytoplasm. Succinyladenosine can be biosynthesized from adenosine and succinic acid. Succinyladenosine has been found to be associated with the diseases known as autism; succinyladenosine has also been linked to several inborn metabolic disorders including adenylosuccinate lyase deficiency and fumarase deficiency.",
    "id" : null
  }, {
    "name" : "Succinyladenosine ; HMDB00912",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000912",
    "description" : "Succinyladenosine belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Succinyladenosine exists as a solid, slightly soluble (in water), and a weakly acidic compound (based on its pKa). Succinyladenosine has been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, succinyladenosine is primarily located in the cytoplasm. Succinyladenosine can be biosynthesized from adenosine and succinic acid. Succinyladenosine has been found to be associated with the diseases known as autism; succinyladenosine has also been linked to several inborn metabolic disorders including adenylosuccinate lyase deficiency and fumarase deficiency.",
    "id" : null
  }, {
    "name" : "Sucrose ; HMDB0000258",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000258",
    "description" : "Sucrose, also known as cane sugar or saccharose, belongs to the class of organic compounds known as o-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Sucrose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Sucrose has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, feces, and urine. Within the cell, sucrose is primarily located in the myelin sheath. Sucrose exists in all eukaryotes, ranging from yeast to humans. Sucrose participates in a number of enzymatic reactions. In particular, Sucrose and D-galactose can be biosynthesized from raffinose through the action of the enzyme Alpha-galactosidase a. Furthermore, Sucrose can be converted into D-galactose and D-fructose; which is mediated by the enzyme lysosomal alpha-glucosidase. Finally, Sucrose can be biosynthesized from Alpha-D-glucose and D-fructose through its interaction with the enzyme sucrase-isomaltase, intestinal. In humans, sucrose is involved in the galactose metabolism pathway and the starch and sucrose metabolism pathway. Sucrose is also involved in several metabolic disorders, some of which include the glycogenosis, type iii. cori disease, debrancher glycogenosis pathway, the glycogenosis, type vi. hers disease pathway, the galactosemia pathway, and the mucopolysaccharidosis vi. sly syndrome pathway. Outside of the human body, sucrose can be found in a number of food items such as horchata, eastern oyster, corn grits, and rye. This makes sucrose a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Sucrose ; HMDB00258",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000258",
    "description" : "Sucrose, also known as cane sugar or saccharose, belongs to the class of organic compounds known as o-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Sucrose exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Sucrose has been found throughout most human tissues, and has also been detected in most biofluids, including blood, saliva, feces, and urine. Within the cell, sucrose is primarily located in the myelin sheath. Sucrose exists in all eukaryotes, ranging from yeast to humans. Sucrose participates in a number of enzymatic reactions. In particular, Sucrose and D-galactose can be biosynthesized from raffinose through the action of the enzyme Alpha-galactosidase a. Furthermore, Sucrose can be converted into D-galactose and D-fructose; which is mediated by the enzyme lysosomal alpha-glucosidase. Finally, Sucrose can be biosynthesized from Alpha-D-glucose and D-fructose through its interaction with the enzyme sucrase-isomaltase, intestinal. In humans, sucrose is involved in the galactose metabolism pathway and the starch and sucrose metabolism pathway. Sucrose is also involved in several metabolic disorders, some of which include the glycogenosis, type iii. cori disease, debrancher glycogenosis pathway, the glycogenosis, type vi. hers disease pathway, the galactosemia pathway, and the mucopolysaccharidosis vi. sly syndrome pathway. Outside of the human body, sucrose can be found in a number of food items such as horchata, eastern oyster, corn grits, and rye. This makes sucrose a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Sulfamethoxazole ; HMDB0015150",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0015150",
    "description" : "Sulfamethoxazole, also known as gantanol or sinomin, belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. Sulfamethoxazole is a drug which is used for the treatment bacterial infections causing bronchitis, prostatitis and urinary tract infections. Sulfamethoxazole exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Sulfamethoxazole has been detected in multiple biofluids, such as urine and blood. Within the cell, sulfamethoxazole is primarily located in the cytoplasm and membrane (predicted from logP). Sulfamethoxazole participates in a number of enzymatic reactions. In particular, sulfamethoxazole can be biosynthesized from sulfanilamide. Sulfamethoxazole is also a parent compound for other transformation products, including but not limited to, sulfamethoxazole hydroxylamine, nitrososulfamethoxazole, and N-acetylsulfamethoxazole.",
    "id" : null
  }, {
    "name" : "Symmetric dimethylarginine ; HMDB0003334",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003334",
    "description" : "Symmetric dimethylarginine, also known as N,n'-dimethylarginine or sdma, belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Symmetric dimethylarginine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Symmetric dimethylarginine has been found in human kidney tissue, and has also been primarily detected in saliva, feces, urine, and blood. Outside of the human body, symmetric dimethylarginine can be found in pulses. This makes symmetric dimethylarginine a potential biomarker for the consumption of this food product. Symmetric dimethylarginine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Symmetric dimethylarginine ; HMDB03334",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0003334",
    "description" : "Symmetric dimethylarginine, also known as N,n'-dimethylarginine or sdma, belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Symmetric dimethylarginine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Symmetric dimethylarginine has been found in human kidney tissue, and has also been primarily detected in saliva, feces, urine, and blood. Outside of the human body, symmetric dimethylarginine can be found in pulses. This makes symmetric dimethylarginine a potential biomarker for the consumption of this food product. Symmetric dimethylarginine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Tartaric acid ; HMDB0000956",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000956",
    "description" : "",
    "id" : null
  }, {
    "name" : "Tartaric acid ; HMDB00956",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000956",
    "description" : "",
    "id" : null
  }, {
    "name" : "Taurine ; HMDB0000251",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000251",
    "description" : "Taurine, also known as taufon or 2-sulfoethylamine, belongs to the class of organic compounds known as organosulfonic acids. Organosulfonic acids are compounds containing the sulfonic acid group, which has the general structure RS(=O)2OH (R is not a hydrogen atom). Taurine exists as a solid, soluble (in water), and an extremely strong acidic compound (based on its pKa). Taurine has been found throughout most human tissues, and has also been detected in most biofluids, including breast milk, cerebrospinal fluid, blood, and feces. Within the cell, taurine is primarily located in the peroxisome. Taurine exists in all eukaryotes, ranging from yeast to humans. Taurine participates in a number of enzymatic reactions. In particular, Chenodeoxycholoyl-CoA and taurine can be converted into taurochenodesoxycholic acid through the action of the enzyme bile acid-coa:amino acid N-acyltransferase. In addition, Choloyl-CoA and taurine can be converted into taurocholic acid; which is mediated by the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, taurine is involved in the taurine and hypotaurine metabolism pathway, congenital bile acid synthesis defect type II pathway, congenital bile acid synthesis defect type III pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Taurine is also involved in a few metabolic disorders, which include 27-hydroxylase deficiency, the familial hypercholanemia (fhca) pathway, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Taurine ; HMDB00251",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000251",
    "description" : "Taurine, also known as taufon or 2-sulfoethylamine, belongs to the class of organic compounds known as organosulfonic acids. Organosulfonic acids are compounds containing the sulfonic acid group, which has the general structure RS(=O)2OH (R is not a hydrogen atom). Taurine exists as a solid, soluble (in water), and an extremely strong acidic compound (based on its pKa). Taurine has been found throughout most human tissues, and has also been detected in most biofluids, including breast milk, cerebrospinal fluid, blood, and feces. Within the cell, taurine is primarily located in the peroxisome. Taurine exists in all eukaryotes, ranging from yeast to humans. Taurine participates in a number of enzymatic reactions. In particular, Chenodeoxycholoyl-CoA and taurine can be converted into taurochenodesoxycholic acid through the action of the enzyme bile acid-coa:amino acid N-acyltransferase. In addition, Choloyl-CoA and taurine can be converted into taurocholic acid; which is mediated by the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, taurine is involved in the taurine and hypotaurine metabolism pathway, congenital bile acid synthesis defect type II pathway, congenital bile acid synthesis defect type III pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Taurine is also involved in a few metabolic disorders, which include 27-hydroxylase deficiency, the familial hypercholanemia (fhca) pathway, and the zellweger syndrome pathway.",
    "id" : null
  }, {
    "name" : "Tauro-b-muricholic acid ; HMDB0000932",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000932",
    "description" : "Tauro-b-muricholic acid, also known as tauro-beta-muricholate or T-alpha-MC, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Tauro-b-muricholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Tauro-b-muricholic acid has been found throughout all human tissues, and has also been primarily detected in urine. Within the cell, tauro-b-muricholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Tauro-b-muricholic acid ; HMDB00932",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000932",
    "description" : "Tauro-b-muricholic acid, also known as tauro-beta-muricholate or T-alpha-MC, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Tauro-b-muricholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Tauro-b-muricholic acid has been found throughout all human tissues, and has also been primarily detected in urine. Within the cell, tauro-b-muricholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Taurochenodeoxycholate-3-sulfate ; HMDB0002486",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002486",
    "description" : "Taurochenodeoxycholate-3-sulfate belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Taurochenodeoxycholate-3-sulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. Taurochenodeoxycholate-3-sulfate has been found in human hepatic tissue tissue, and has also been primarily detected in urine. Within the cell, taurochenodeoxycholate-3-sulfate is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Taurochenodesoxycholic acid ; HMDB0000951",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000951",
    "description" : "Taurochenodeoxycholic acid, also known as chenodeoxycholoyltaurine or taurine chenodeoxycholate, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Taurochenodeoxycholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Taurochenodeoxycholic acid has been found in human hepatic tissue tissue, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, taurochenodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, taurochenodeoxycholic acid is involved in bile acid biosynthesis pathway, congenital bile acid synthesis defect type III pathway, congenital bile acid synthesis defect type II pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Taurochenodeoxycholic acid is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "Taurochenodesoxycholic acid ; HMDB00951",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000951",
    "description" : "Taurochenodeoxycholic acid, also known as chenodeoxycholoyltaurine or taurine chenodeoxycholate, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Taurochenodeoxycholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Taurochenodeoxycholic acid has been found in human hepatic tissue tissue, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, taurochenodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, taurochenodeoxycholic acid is involved in bile acid biosynthesis pathway, congenital bile acid synthesis defect type III pathway, congenital bile acid synthesis defect type II pathway, and the cerebrotendinous xanthomatosis (CTX) pathway. Taurochenodeoxycholic acid is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "Taurocholic acid ; HMDB0000036",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000036",
    "description" : "Taurocholic acid, also known as N-choloyltaurine or taurocholate, belongs to the class of organic compounds known as trihydroxy bile acids, alcohols and derivatives. These are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Taurocholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Taurocholic acid has been found in human hepatic , intestine and liver tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, taurocholic acid is primarily located in the myelin sheath, membrane (predicted from logP) and cytoplasm. Taurocholic acid exists in all eukaryotes, ranging from yeast to humans. Taurocholic acid can be biosynthesized from choloyl-CoA and taurine; which is catalyzed by the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, taurocholic acid is involved in bile acid biosynthesis pathway, the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, and congenital bile acid synthesis defect type II pathway. Taurocholic acid is also involved in a few metabolic disorders, which include 27-hydroxylase deficiency, the zellweger syndrome pathway, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "Taurocholic acid ; HMDB00036",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000036",
    "description" : "Taurocholic acid, also known as N-choloyltaurine or taurocholate, belongs to the class of organic compounds known as trihydroxy bile acids, alcohols and derivatives. These are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Taurocholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Taurocholic acid has been found in human hepatic , intestine and liver tissues, and has also been primarily detected in bile, feces, urine, and blood. Within the cell, taurocholic acid is primarily located in the myelin sheath, membrane (predicted from logP) and cytoplasm. Taurocholic acid exists in all eukaryotes, ranging from yeast to humans. Taurocholic acid can be biosynthesized from choloyl-CoA and taurine; which is catalyzed by the enzyme bile acid-coa:amino acid N-acyltransferase. In humans, taurocholic acid is involved in bile acid biosynthesis pathway, the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, and congenital bile acid synthesis defect type II pathway. Taurocholic acid is also involved in a few metabolic disorders, which include 27-hydroxylase deficiency, the zellweger syndrome pathway, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "Taurodeoxycholic acid ; HMDB0000896",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000896",
    "description" : "Taurodeoxycholic acid, also known as taurodeoxycholate or deoxycholyltaurine, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Taurodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Taurodeoxycholic acid has been found in human hepatic tissue and intestine tissues, and has also been primarily detected in bile, feces, blood, and urine. Within the cell, taurodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, taurodeoxycholic acid is involved in the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, bile acid biosynthesis pathway, and congenital bile acid synthesis defect type II pathway. Taurodeoxycholic acid is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "Taurodeoxycholic acid ; HMDB00896",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000896",
    "description" : "Taurodeoxycholic acid, also known as taurodeoxycholate or deoxycholyltaurine, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Taurodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Taurodeoxycholic acid has been found in human hepatic tissue and intestine tissues, and has also been primarily detected in bile, feces, blood, and urine. Within the cell, taurodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. In humans, taurodeoxycholic acid is involved in the cerebrotendinous xanthomatosis (CTX) pathway, congenital bile acid synthesis defect type III pathway, bile acid biosynthesis pathway, and congenital bile acid synthesis defect type II pathway. Taurodeoxycholic acid is also involved in a few metabolic disorders, which include the zellweger syndrome pathway, 27-hydroxylase deficiency, and the familial hypercholanemia (fhca) pathway.",
    "id" : null
  }, {
    "name" : "Taurolithocholic acid 3-sulfate ; HMDB0002580",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002580",
    "description" : "Taurolithocholate sulfate, also known as SLCT-3-sulfate or TLC-S, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Taurolithocholate sulfate is considered to be a practically insoluble (in water) and relatively neutral molecule. Taurolithocholate sulfate has been found in human hepatic tissue tissue, and has also been detected in multiple biofluids, such as feces and urine. Within the cell, taurolithocholate sulfate is primarily located in the membrane (predicted from logP) and cytoplasm. Taurolithocholate sulfate can be converted into taurolithocholic acid.",
    "id" : null
  }, {
    "name" : "Tauroursodeoxycholic acid ; HMDB0000874",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000874",
    "description" : "Tauroursodeoxycholic acid, also known as tudca or ur 906, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Tauroursodeoxycholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Tauroursodeoxycholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, tauroursodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Tauroursodeoxycholic acid ; HMDB00874",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000874",
    "description" : "Tauroursodeoxycholic acid, also known as tudca or ur 906, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Tauroursodeoxycholic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Tauroursodeoxycholic acid has been found throughout all human tissues, and has also been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, tauroursodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm.",
    "id" : null
  }, {
    "name" : "Testosterone sulfate ; HMDB0002833",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002833",
    "description" : "Testosterone sulfate, also known as androgel or testolin, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. Testosterone sulfate exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Testosterone sulfate has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, testosterone sulfate is primarily located in the cytoplasm and membrane (predicted from logP).",
    "id" : null
  }, {
    "name" : "Tetradecanedioic acid ; HMDB0000872",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000872",
    "description" : "Tetradecanedioic acid, also known as 1,14-tetradecanedioate or NSC 9504, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Tetradecanedioic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Tetradecanedioic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, tetradecanedioic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Tetradecanedioic acid is also a parent compound for other transformation products, including but not limited to, tetradecane, tetradecanedioyl-CoA, and (3S)-hydroxytetradecanedioyl-CoA.",
    "id" : null
  }, {
    "name" : "Tetradecanedioic acid ; HMDB00872",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000872",
    "description" : "Tetradecanedioic acid, also known as 1,14-tetradecanedioate or NSC 9504, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Tetradecanedioic acid is considered to be a practically insoluble (in water) and relatively neutral molecule. Tetradecanedioic acid has been detected in multiple biofluids, such as feces, blood, and urine. Within the cell, tetradecanedioic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome. Tetradecanedioic acid is also a parent compound for other transformation products, including but not limited to, tetradecane, tetradecanedioyl-CoA, and (3S)-hydroxytetradecanedioyl-CoA.",
    "id" : null
  }, {
    "name" : "Tetradecanoylcarnitine ; HMDB0005066",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005066",
    "description" : "Tetradecanoylcarnitine, also known as (R)-myristoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, tetradecanoylcarnitine is considered to be a fatty ester lipid molecule. Tetradecanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Tetradecanoylcarnitine has been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, tetradecanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Tetradecanoylcarnitine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, tetradecanoylcarnitine can be found in cow milk. This makes tetradecanoylcarnitine a potential biomarker for the consumption of this food product. Tetradecanoylcarnitine has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "Tetradecanoylcarnitine ; HMDB05066",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005066",
    "description" : "Tetradecanoylcarnitine, also known as (R)-myristoylcarnitine, belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Thus, tetradecanoylcarnitine is considered to be a fatty ester lipid molecule. Tetradecanoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Tetradecanoylcarnitine has been detected in multiple biofluids, such as saliva, urine, and blood. Within the cell, tetradecanoylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Tetradecanoylcarnitine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, tetradecanoylcarnitine can be found in cow milk. This makes tetradecanoylcarnitine a potential biomarker for the consumption of this food product. Tetradecanoylcarnitine has been linked to the inborn metabolic disorders including glutaric aciduria II.",
    "id" : null
  }, {
    "name" : "TG(14:0/14:0/15:0) ; HMDB0042062",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042062",
    "description" : "TG(14:0/14:0/15:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/14:0/15:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/14:0/15:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/14:0/15:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/14:0/15:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/14:0/15:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/14:0/15:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/14:0/15:0) ; HMDB42062",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042062",
    "description" : "TG(14:0/14:0/15:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/14:0/15:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/14:0/15:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/14:0/15:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/14:0/15:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/14:0/15:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/14:0/15:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/14:0/16:0) ; HMDB0042063",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042063",
    "description" : "TG(14:0/14:0/16:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/14:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/14:0/16:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/14:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/14:0/16:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/14:0/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/14:0/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/14:0/16:0) ; HMDB42063",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042063",
    "description" : "TG(14:0/14:0/16:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/14:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/14:0/16:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/14:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/14:0/16:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/14:0/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/14:0/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/14:0/18:2(9Z,12Z)) ; HMDB0042076",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042076",
    "description" : "TG(14:0/14:0/18:2(9Z,12Z)), also known as tag(14:0/14:0/18:2) or tag(46:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/14:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/14:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/14:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/14:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/14:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/14:0/18:2(9Z,12Z)) ; HMDB42076",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042076",
    "description" : "TG(14:0/14:0/18:2(9Z,12Z)), also known as tag(14:0/14:0/18:2) or tag(46:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/14:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/14:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/14:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/14:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/14:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/14:1(9Z)) ; HMDB0042098",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042098",
    "description" : "TG(14:0/15:0/14:1(9Z)), also known as tag(43:1) or tracylglycerol(43:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/14:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/14:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/14:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/14:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/14:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/14:1(9Z)) ; HMDB42098",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042098",
    "description" : "TG(14:0/15:0/14:1(9Z)), also known as tag(43:1) or tracylglycerol(43:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/14:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/14:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/14:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/14:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/14:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/16:0) ; HMDB0042093",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042093",
    "description" : "TG(14:0/15:0/16:0), also known as TG(45:0) or triacylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/16:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/16:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/16:0) ; HMDB42093",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042093",
    "description" : "TG(14:0/15:0/16:0), also known as TG(45:0) or triacylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/16:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/16:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/16:1(9Z)) ; HMDB0042099",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042099",
    "description" : "TG(14:0/15:0/16:1(9Z)), also known as TG(45:1) or triacylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/16:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/16:1(9Z)) ; HMDB42099",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042099",
    "description" : "TG(14:0/15:0/16:1(9Z)), also known as TG(45:1) or triacylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/16:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/18:0) ; HMDB0042094",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042094",
    "description" : "TG(14:0/15:0/18:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/18:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/18:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/18:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/18:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/18:0) ; HMDB42094",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042094",
    "description" : "TG(14:0/15:0/18:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/18:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/18:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/18:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/18:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/18:1(11Z)) ; HMDB0042100",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042100",
    "description" : "TG(14:0/15:0/18:1(11Z)), also known as tag(47:1) or tracylglycerol(47:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/18:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/18:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/18:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/18:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/18:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/18:1(11Z)) ; HMDB42100",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042100",
    "description" : "TG(14:0/15:0/18:1(11Z)), also known as tag(47:1) or tracylglycerol(47:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/18:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/18:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/18:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/18:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/18:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/20:0) ; HMDB0042095",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042095",
    "description" : "TG(14:0/15:0/20:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/20:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/20:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/20:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/20:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/20:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/20:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/20:0) ; HMDB42095",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042095",
    "description" : "TG(14:0/15:0/20:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/20:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/20:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/20:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(14:0/15:0/20:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(14:0/15:0/20:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/20:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/20:3(5Z,8Z,11Z)) ; HMDB0042103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042103",
    "description" : "TG(14:0/15:0/20:3(5Z,8Z,11Z)), also known as tag(14:0/15:0/20:3) or tag(49:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/20:3(5Z,8Z,11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/20:3(5Z,8Z,11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/20:3(5Z,8Z,11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/20:3(5Z,8Z,11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/20:3(5Z,8Z,11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/20:3(5Z,8Z,11Z)) ; HMDB42103",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042103",
    "description" : "TG(14:0/15:0/20:3(5Z,8Z,11Z)), also known as tag(14:0/15:0/20:3) or tag(49:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/20:3(5Z,8Z,11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/20:3(5Z,8Z,11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/20:3(5Z,8Z,11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/20:3(5Z,8Z,11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/20:3(5Z,8Z,11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/22:1(13Z)) ; HMDB0042104",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042104",
    "description" : "TG(14:0/15:0/22:1(13Z)), also known as tag(51:1) or tracylglycerol(51:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/22:1(13Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/22:1(13Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/22:1(13Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/22:1(13Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/22:1(13Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/15:0/22:1(13Z)) ; HMDB42104",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042104",
    "description" : "TG(14:0/15:0/22:1(13Z)), also known as tag(51:1) or tracylglycerol(51:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/15:0/22:1(13Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/15:0/22:1(13Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/15:0/22:1(13Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/15:0/22:1(13Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/15:0/22:1(13Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/20:0/18:2(9Z,12Z)) ; HMDB0042196",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042196",
    "description" : "TG(14:0/20:0/18:2(9Z,12Z)), also known as tag(14:0/20:0/18:2) or tag(52:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/20:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/20:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/20:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/20:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/20:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/20:0/18:2(9Z,12Z)) ; HMDB42196",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042196",
    "description" : "TG(14:0/20:0/18:2(9Z,12Z)), also known as tag(14:0/20:0/18:2) or tag(52:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/20:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/20:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/20:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/20:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/20:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/22:0/18:2(9Z,12Z)) ; HMDB0042226",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042226",
    "description" : "TG(14:0/22:0/18:2(9Z,12Z)), also known as tag(14:0/22:0/18:2) or tag(54:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/22:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/22:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/22:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/22:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/22:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/22:0/18:2(9Z,12Z)) ; HMDB42226",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042226",
    "description" : "TG(14:0/22:0/18:2(9Z,12Z)), also known as tag(14:0/22:0/18:2) or tag(54:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/22:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/22:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/22:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/22:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/22:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/22:1(13Z)/18:2(9Z,12Z)) ; HMDB0042466",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042466",
    "description" : "TG(14:0/22:1(13Z)/18:2(9Z,12Z)), also known as tag(14:0/22:1/18:2) or tag(54:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/22:1(13Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/22:1(13Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/22:1(13Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/22:1(13Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/22:1(13Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(14:0/22:1(13Z)/18:2(9Z,12Z)) ; HMDB42466",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0042466",
    "description" : "TG(14:0/22:1(13Z)/18:2(9Z,12Z)), also known as tag(14:0/22:1/18:2) or tag(54:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(14:0/22:1(13Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:0/22:1(13Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:0/22:1(13Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:0/22:1(13Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(14:0/22:1(13Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/14:1(9Z)/14:1(9Z)) ; HMDB0043169",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0043169",
    "description" : "TG(14:1(9Z)/14:1(9Z)/15:0)[iso3], also known as tag(15:0/14:1/14:1) or tag(43:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is considered to be a triradylglycerol lipid molecule. TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/14:1(9Z)/14:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/14:1(9Z)/14:1(9Z)) ; HMDB43169",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0043169",
    "description" : "TG(14:1(9Z)/14:1(9Z)/15:0)[iso3], also known as tag(15:0/14:1/14:1) or tag(43:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is considered to be a triradylglycerol lipid molecule. TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(14:1(9Z)/14:1(9Z)/15:0)[iso3] is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/14:1(9Z)/14:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/14:1(9Z)/16:1(9Z)) ; HMDB0043170",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0043170",
    "description" : "TG(15:0/14:1(9Z)/16:1(9Z)), also known as tag(15:0/14:1/16:1) or tag(45:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/14:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/14:1(9Z)/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(15:0/14:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/14:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/14:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/14:1(9Z)/16:1(9Z)) ; HMDB43170",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0043170",
    "description" : "TG(15:0/14:1(9Z)/16:1(9Z)), also known as tag(15:0/14:1/16:1) or tag(45:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/14:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/14:1(9Z)/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(15:0/14:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/14:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/14:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/16:0/20:3(8Z,11Z,14Z)) ; HMDB0011701",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011701",
    "description" : "TG(15:0/16:0/20:3(8Z,11Z,14Z)), also known as tag(15:0/16:0/20:3n6) or tracylglycerol(15:0/16:0/20:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/16:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/16:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(15:0/16:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/16:0/20:3(8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/16:0/20:3(8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/16:0/20:3(8Z,11Z,14Z)) ; HMDB11701",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011701",
    "description" : "TG(15:0/16:0/20:3(8Z,11Z,14Z)), also known as tag(15:0/16:0/20:3n6) or tracylglycerol(15:0/16:0/20:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/16:0/20:3(8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/16:0/20:3(8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(15:0/16:0/20:3(8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/16:0/20:3(8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/16:0/20:3(8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/18:0/20:3(5Z,8Z,11Z)) ; HMDB0043058",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0043058",
    "description" : "TG(15:0/18:0/20:3(5Z,8Z,11Z)), also known as tag(15:0/18:0/20:3) or tag(53:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/18:0/20:3(5Z,8Z,11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/18:0/20:3(5Z,8Z,11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(15:0/18:0/20:3(5Z,8Z,11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/18:0/20:3(5Z,8Z,11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/18:0/20:3(5Z,8Z,11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/18:0/20:3(5Z,8Z,11Z)) ; HMDB43058",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0043058",
    "description" : "TG(15:0/18:0/20:3(5Z,8Z,11Z)), also known as tag(15:0/18:0/20:3) or tag(53:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/18:0/20:3(5Z,8Z,11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/18:0/20:3(5Z,8Z,11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(15:0/18:0/20:3(5Z,8Z,11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/18:0/20:3(5Z,8Z,11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/18:0/20:3(5Z,8Z,11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/18:1(9Z)/16:0) ; HMDB0011705",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011705",
    "description" : "TG(15:0/18:1(9Z)/16:0), also known as tag(49:1) or tracylglycerol(49:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/18:1(9Z)/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/18:1(9Z)/16:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(15:0/18:1(9Z)/16:0) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/18:1(9Z)/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/18:1(9Z)/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/18:1(9Z)/16:0) ; HMDB11705",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011705",
    "description" : "TG(15:0/18:1(9Z)/16:0), also known as tag(49:1) or tracylglycerol(49:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/18:1(9Z)/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/18:1(9Z)/16:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(15:0/18:1(9Z)/16:0) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/18:1(9Z)/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/18:1(9Z)/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/18:1(9Z)/16:1(9Z)) ; HMDB0011706",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011706",
    "description" : "TG(15:0/18:1(9Z)/16:1(9Z)), also known as tag(15:0/18:1/16:1) or tag(49:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/18:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/18:1(9Z)/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(15:0/18:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/18:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/18:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(15:0/18:1(9Z)/16:1(9Z)) ; HMDB11706",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0011706",
    "description" : "TG(15:0/18:1(9Z)/16:1(9Z)), also known as tag(15:0/18:1/16:1) or tag(49:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(15:0/18:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(15:0/18:1(9Z)/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(15:0/18:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(15:0/18:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(15:0/18:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/14:0/16:0) ; HMDB0010411",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010411",
    "description" : "TG(16:0/14:0/16:0), also known as tag(46:0) or tracylglycerol(46:0), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/14:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/14:0/16:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(16:0/14:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/14:0/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/14:0/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/14:0/16:0) ; HMDB10411",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010411",
    "description" : "TG(16:0/14:0/16:0), also known as tag(46:0) or tracylglycerol(46:0), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/14:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/14:0/16:0) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(16:0/14:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/14:0/16:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/14:0/16:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/14:0/16:1(9Z)) ; HMDB0010412",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010412",
    "description" : "TG(16:0/14:0/16:1(9Z)), also known as tag(16:0/14:0/16:1n7) or tag(46:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/14:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/14:0/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(16:0/14:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/14:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/14:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/14:0/16:1(9Z)) ; HMDB10412",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010412",
    "description" : "TG(16:0/14:0/16:1(9Z)), also known as tag(16:0/14:0/16:1n7) or tag(46:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/14:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/14:0/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(16:0/14:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/14:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/14:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/16:0) ; HMDB0005356",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005356",
    "description" : "TG(16:0/16:0/16:0), also known as tripalmitoylglycerol or glyceryl tripalmitate, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(16:0/16:0/16:0) is considered to be a triradylglycerol lipid molecule. TG(16:0/16:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/16:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:0/16:0/16:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(16:0/16:0/16:0) is involved in the glycerolipid metabolism pathway and the D-glyceric acidura pathway. TG(16:0/16:0/16:0) is also involved in a few metabolic disorders, which include de novo triacylglycerol biosynthesis TG(16:0/16:0/16:0) pathway, familial lipoprotein lipase deficiency, and glycerol kinase deficiency.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/16:0) ; HMDB05356",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005356",
    "description" : "TG(16:0/16:0/16:0), also known as tripalmitoylglycerol or glyceryl tripalmitate, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(16:0/16:0/16:0) is considered to be a triradylglycerol lipid molecule. TG(16:0/16:0/16:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/16:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/16:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:0/16:0/16:0) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(16:0/16:0/16:0) is involved in the glycerolipid metabolism pathway and the D-glyceric acidura pathway. TG(16:0/16:0/16:0) is also involved in a few metabolic disorders, which include de novo triacylglycerol biosynthesis TG(16:0/16:0/16:0) pathway, familial lipoprotein lipase deficiency, and glycerol kinase deficiency.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/16:1(9Z)) ; HMDB0005359",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005359",
    "description" : "TG(16:0/16:0/16:1(9Z)), also known as tag(16:0/16:0/16:1n7) or tag(48:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/16:1(9Z)) ; HMDB05359",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005359",
    "description" : "TG(16:0/16:0/16:1(9Z)), also known as tag(16:0/16:0/16:1n7) or tag(48:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/18:0) ; HMDB0005357",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005357",
    "description" : "TG(16:0/16:0/18:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/18:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/18:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:0/16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. TG(16:0/16:0/18:0) participates in a number of enzymatic reactions. In particular, TG(16:0/16:0/18:0) can be biosynthesized from DG(16:0/18:0/0:0) through its interaction with the enzyme diacylglycerol O-acyltransferase 1. In addition, TG(16:0/16:0/18:0) can be converted into DG(16:0/18:0/0:0) through the action of the enzyme triacylglycerol lipase complex. In humans, TG(16:0/16:0/18:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/18:0) ; HMDB05357",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005357",
    "description" : "TG(16:0/16:0/18:0), also known as triacylglycerol or triglyceride, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/18:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/18:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:0/16:0/18:0) exists in all eukaryotes, ranging from yeast to humans. TG(16:0/16:0/18:0) participates in a number of enzymatic reactions. In particular, TG(16:0/16:0/18:0) can be biosynthesized from DG(16:0/18:0/0:0) through its interaction with the enzyme diacylglycerol O-acyltransferase 1. In addition, TG(16:0/16:0/18:0) can be converted into DG(16:0/18:0/0:0) through the action of the enzyme triacylglycerol lipase complex. In humans, TG(16:0/16:0/18:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/18:1(9Z)) ; HMDB0005360",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005360",
    "description" : "TG(16:0/16:0/18:1(9Z)), also known as tag(50:1) or tracylglycerol(50:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/18:1(9Z)) ; HMDB05360",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005360",
    "description" : "TG(16:0/16:0/18:1(9Z)), also known as tag(50:1) or tracylglycerol(50:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/18:2(9Z,12Z)) ; HMDB0005362",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005362",
    "description" : "TG(16:0/16:0/18:2(9Z,12Z)), also known as tag(16:0/16:0/18:2n6) or tag(50:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/18:2(9Z,12Z)) ; HMDB05362",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005362",
    "description" : "TG(16:0/16:0/18:2(9Z,12Z)), also known as tag(16:0/16:0/18:2n6) or tag(50:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005363",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005363",
    "description" : "TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/16:0/20:4n6) or tracylglycerol(16:0/16:0/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB05363",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005363",
    "description" : "TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/16:0/20:4n6) or tracylglycerol(16:0/16:0/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:1(9Z)/16:1(9Z)) ; HMDB0005376",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005376",
    "description" : "TG(16:0/16:1(9Z)/16:1(9Z)), also known as tag(16:0/16:1/16:1) or tag(48:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:1(9Z)/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:1(9Z)/16:1(9Z)) ; HMDB05376",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005376",
    "description" : "TG(16:0/16:1(9Z)/16:1(9Z)), also known as tag(16:0/16:1/16:1) or tag(48:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:1(9Z)/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:1(9Z)/18:1(9Z)) ; HMDB0005377",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005377",
    "description" : "TG(16:0/16:1(9Z)/18:1(9Z)), also known as tag(16:0/16:1/18:1) or tag(50:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:1(9Z)/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:1(9Z)/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:1(9Z)/18:1(9Z)) ; HMDB05377",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005377",
    "description" : "TG(16:0/16:1(9Z)/18:1(9Z)), also known as tag(16:0/16:1/18:1) or tag(50:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:1(9Z)/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:1(9Z)/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005380",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005380",
    "description" : "TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/16:1/20:4) or tag(52:5), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05380",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005380",
    "description" : "TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/16:1/20:4) or tag(52:5), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/18:0) ; HMDB0005365",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005365",
    "description" : "TG(16:0/18:0/18:0), also known as triacylglycerol or tag(52:0), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/18:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/18:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:0/18:0/18:0) exists in all eukaryotes, ranging from yeast to humans. TG(16:0/18:0/18:0) participates in a number of enzymatic reactions. In particular, TG(16:0/18:0/18:0) can be biosynthesized from DG(16:0/18:0/0:0); which is catalyzed by the enzyme diacylglycerol O-acyltransferase 1. In addition, TG(16:0/18:0/18:0) can be converted into DG(16:0/18:0/0:0) through the action of the enzyme triacylglycerol lipase complex. In humans, TG(16:0/18:0/18:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/18:0) ; HMDB05365",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005365",
    "description" : "TG(16:0/18:0/18:0), also known as triacylglycerol or tag(52:0), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/18:0) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/18:0) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/18:0) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:0/18:0/18:0) exists in all eukaryotes, ranging from yeast to humans. TG(16:0/18:0/18:0) participates in a number of enzymatic reactions. In particular, TG(16:0/18:0/18:0) can be biosynthesized from DG(16:0/18:0/0:0); which is catalyzed by the enzyme diacylglycerol O-acyltransferase 1. In addition, TG(16:0/18:0/18:0) can be converted into DG(16:0/18:0/0:0) through the action of the enzyme triacylglycerol lipase complex. In humans, TG(16:0/18:0/18:0) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/18:0) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/18:1(9Z)) ; HMDB0005367",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005367",
    "description" : "TG(16:0/18:0/18:1(9Z)), also known as tag(52:1) or tracylglycerol(52:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:0/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/18:1(9Z)) ; HMDB05367",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005367",
    "description" : "TG(16:0/18:0/18:1(9Z)), also known as tag(52:1) or tracylglycerol(52:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:0/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/18:2(9Z,12Z)) ; HMDB0005369",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005369",
    "description" : "TG(16:0/18:0/18:2(9Z,12Z)), also known as tag(16:0/18:0/18:2n6) or tag(52:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/18:2(9Z,12Z)) ; HMDB05369",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005369",
    "description" : "TG(16:0/18:0/18:2(9Z,12Z)), also known as tag(16:0/18:0/18:2n6) or tag(52:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:0/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005370",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005370",
    "description" : "TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/18:0/20:4n6) or tracylglycerol(16:0/18:0/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB05370",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005370",
    "description" : "TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/18:0/20:4n6) or tracylglycerol(16:0/18:0/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:1(9Z)/18:2(9Z,12Z)) ; HMDB0005384",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005384",
    "description" : "TG(16:0/18:1(9Z)/18:2(9Z,12Z)), also known as tag(16:0/18:1/18:2) or tag(52:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:1(9Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:1(9Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:1(9Z)/18:2(9Z,12Z)) ; HMDB05384",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005384",
    "description" : "TG(16:0/18:1(9Z)/18:2(9Z,12Z)), also known as tag(16:0/18:1/18:2) or tag(52:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:1(9Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:1(9Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005385",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005385",
    "description" : "TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/18:1/20:4) or 1-palmitoyl-2-oleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05385",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005385",
    "description" : "TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/18:1/20:4) or 1-palmitoyl-2-oleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005391",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005391",
    "description" : "TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/18:2/20:4) or 1-palmitoyl-2-linoleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05391",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005391",
    "description" : "TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/18:2/20:4) or 1-palmitoyl-2-linoleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005392",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005392",
    "description" : "TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/20:4/20:4) or 1-palmitoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05392",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005392",
    "description" : "TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:0/20:4/20:4) or 1-palmitoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/14:0/16:1(9Z)) ; HMDB0010419",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010419",
    "description" : "TG(16:1(9Z)/14:0/16:1(9Z)), also known as tag(16:1/14:0/16:1) or tag(46:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/14:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/14:0/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/14:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/14:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/14:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/14:0/16:1(9Z)) ; HMDB10419",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010419",
    "description" : "TG(16:1(9Z)/14:0/16:1(9Z)), also known as tag(16:1/14:0/16:1) or tag(46:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/14:0/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/14:0/16:1(9Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/14:0/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/14:0/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/14:0/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) ; HMDB0005432",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005432",
    "description" : "TG(16:1(9Z)/16:1(9Z)/16:1(9Z)), also known as TG or 1,2,3-tri-(9Z)-hexadecenoylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is considered to be a triradylglycerol lipid molecule. TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) ; HMDB05432",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005432",
    "description" : "TG(16:1(9Z)/16:1(9Z)/16:1(9Z)), also known as TG or 1,2,3-tri-(9Z)-hexadecenoylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is considered to be a triradylglycerol lipid molecule. TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) exists in all eukaryotes, ranging from yeast to humans. In humans, TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/16:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) ; HMDB0005433",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005433",
    "description" : "TG(16:1(9Z)/16:1(9Z)/18:1(9Z)), also known as tag(16:1/16:1/18:1) or tag(50:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) ; HMDB05433",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005433",
    "description" : "TG(16:1(9Z)/16:1(9Z)/18:1(9Z)), also known as tag(16:1/16:1/18:1) or tag(50:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) ; HMDB0005435",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005435",
    "description" : "TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)), also known as tag(16:1/16:1/18:2) or tag(50:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) ; HMDB05435",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005435",
    "description" : "TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)), also known as tag(16:1/16:1/18:2) or tag(50:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005436",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005436",
    "description" : "TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:1/16:1/20:4) or tag(52:6), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05436",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005436",
    "description" : "TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:1/16:1/20:4) or tag(52:6), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005447",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005447",
    "description" : "TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:1/18:2/20:4) or 1-palmitoleoyl-2-linoleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05447",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005447",
    "description" : "TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:1/18:2/20:4) or 1-palmitoleoyl-2-linoleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005448",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005448",
    "description" : "TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:1/20:4/20:4) or 1-palmitoleoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05448",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005448",
    "description" : "TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(16:1/20:4/20:4) or 1-palmitoleoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:0/18:1(9Z)) ; HMDB0005395",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005395",
    "description" : "TG(18:0/18:0/18:1(9Z)), also known as tag(54:1) or tracylglycerol(54:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:0/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:0/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:0/18:1(9Z)) ; HMDB05395",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005395",
    "description" : "TG(18:0/18:0/18:1(9Z)), also known as tag(54:1) or tracylglycerol(54:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:0/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:0/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:0/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:0/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:0/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:0/20:1(11Z)) ; HMDB0005396",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005396",
    "description" : "TG(18:0/18:0/20:1(11Z)), also known as tag(18:0/18:0/20:1n9) or tag(56:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:0/20:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:0/20:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:0/20:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:0/20:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:0/20:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:0/20:1(11Z)) ; HMDB05396",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005396",
    "description" : "TG(18:0/18:0/20:1(11Z)), also known as tag(18:0/18:0/20:1n9) or tag(56:1), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:0/20:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:0/20:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:0/20:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:0/20:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:0/20:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005398",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005398",
    "description" : "TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:0/18:0/20:4n6) or tracylglycerol(18:0/18:0/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB05398",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005398",
    "description" : "TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:0/18:0/20:4n6) or tracylglycerol(18:0/18:0/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/18:1(9Z)) ; HMDB0005403",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005403",
    "description" : "TG(18:0/18:1(9Z)/18:1(9Z)), also known as tag(18:0/18:1/18:1) or tag(54:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/18:1(9Z)) ; HMDB05403",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005403",
    "description" : "TG(18:0/18:1(9Z)/18:1(9Z)), also known as tag(18:0/18:1/18:1) or tag(54:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/18:1(9Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/18:1(9Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/18:1(9Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/18:1(9Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/18:1(9Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/18:2(9Z,12Z)) ; HMDB0005405",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005405",
    "description" : "TG(18:0/18:1(9Z)/18:2(9Z,12Z)), also known as tag(18:0/18:1/18:2) or tag(54:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/18:2(9Z,12Z)) ; HMDB05405",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005405",
    "description" : "TG(18:0/18:1(9Z)/18:2(9Z,12Z)), also known as tag(18:0/18:1/18:2) or tag(54:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/18:2(9Z,12Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/18:2(9Z,12Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/18:2(9Z,12Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/18:2(9Z,12Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/18:2(9Z,12Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/20:1(11Z)) ; HMDB0005404",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005404",
    "description" : "TG(18:0/18:1(9Z)/20:1(11Z)), also known as tag(18:0/18:1/20:1) or tag(56:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/20:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/20:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/20:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/20:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/20:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/20:1(11Z)) ; HMDB05404",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005404",
    "description" : "TG(18:0/18:1(9Z)/20:1(11Z)), also known as tag(18:0/18:1/20:1) or tag(56:2), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/20:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/20:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/20:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/20:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/20:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005406",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005406",
    "description" : "TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:0/18:1/20:4) or 1-stearoyl-2-oleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05406",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005406",
    "description" : "TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:0/18:1/20:4) or 1-stearoyl-2-oleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:2(9Z,12Z)/20:1(11Z)) ; HMDB0005410",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005410",
    "description" : "TG(18:0/18:2(9Z,12Z)/20:1(11Z)), also known as tag(18:0/18:2/20:1) or tag(56:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:2(9Z,12Z)/20:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:2(9Z,12Z)/20:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:2(9Z,12Z)/20:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:2(9Z,12Z)/20:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:2(9Z,12Z)/20:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/18:2(9Z,12Z)/20:1(11Z)) ; HMDB05410",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005410",
    "description" : "TG(18:0/18:2(9Z,12Z)/20:1(11Z)), also known as tag(18:0/18:2/20:1) or tag(56:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/18:2(9Z,12Z)/20:1(11Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/18:2(9Z,12Z)/20:1(11Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/18:2(9Z,12Z)/20:1(11Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/18:2(9Z,12Z)/20:1(11Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/18:2(9Z,12Z)/20:1(11Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005413",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005413",
    "description" : "TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:0/20:4/20:4) or 1-stearoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05413",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005413",
    "description" : "TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:0/20:4/20:4) or 1-stearoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005456",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005456",
    "description" : "TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/18:1/20:4) or 1-oleoyl-2-oleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05456",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005456",
    "description" : "TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/18:1/20:4) or 1-oleoyl-2-oleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005462",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005462",
    "description" : "TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/18:2/20:4) or 1-oleoyl-2-linoleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05462",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005462",
    "description" : "TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/18:2/20:4) or 1-oleoyl-2-linoleoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005458",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005458",
    "description" : "TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/20:1/20:4) or 1-oleoyl-2-eicosenoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05458",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005458",
    "description" : "TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/20:1/20:4) or 1-oleoyl-2-eicosenoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005463",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005463",
    "description" : "TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/20:4/20:4) or 1-oleoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05463",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005463",
    "description" : "TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:1/20:4/20:4) or 1-oleoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) ; HMDB0010471",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010471",
    "description" : "TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)), also known as tag(18:2/14:0/18:3) or tag(50:5), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) ; HMDB10471",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010471",
    "description" : "TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)), also known as tag(18:2/14:0/18:3) or tag(50:5), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005471",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005471",
    "description" : "TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:2/20:1/20:4) or 1-linoleoyl-2-eicosenoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05471",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005471",
    "description" : "TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:2/20:1/20:4) or 1-linoleoyl-2-eicosenoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005476",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005476",
    "description" : "TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:2/20:4/20:4) or 1-linoleoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05476",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005476",
    "description" : "TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as tag(18:2/20:4/20:4) or 1-linoleoyl-2-arachidonoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) ; HMDB0010497",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010497",
    "description" : "TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)), also known as TG(18:3/14:0/18:3) or triacylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) ; HMDB10497",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010497",
    "description" : "TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)), also known as TG(18:3/14:0/18:3) or triacylglycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB0010498",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010498",
    "description" : "TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as 1-a-linolenoyl-2-myristoyl-3-docosahexaenoyl-glycerol or tag(18:3/14:0/22:6), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) ; HMDB10498",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010498",
    "description" : "TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)), also known as 1-a-linolenoyl-2-myristoyl-3-docosahexaenoyl-glycerol or tag(18:3/14:0/22:6), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) ; HMDB0010513",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010513",
    "description" : "TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)), also known as tag(18:3/20:4/18:3) or 1-a-linolenoyl-2-arachidonoyl-3-a-linolenoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) ; HMDB10513",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010513",
    "description" : "TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)), also known as tag(18:3/20:4/18:3) or 1-a-linolenoyl-2-arachidonoyl-3-a-linolenoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) ; HMDB0010517",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010517",
    "description" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)), also known as tag(20:4/14:0/18:3) or 1-arachidonoyl-2-myristoyl-3-a-linolenoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) ; HMDB10517",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010517",
    "description" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)), also known as tag(20:4/14:0/18:3) or 1-arachidonoyl-2-myristoyl-3-a-linolenoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB0010518",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010518",
    "description" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(20:4/14:0/20:4) or 1-arachidonoyl-2-myristoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) ; HMDB10518",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010518",
    "description" : "TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)), also known as tag(20:4/14:0/20:4) or 1-arachidonoyl-2-myristoyl-3-arachidonoyl-glycerol, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) ; HMDB0010531",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010531",
    "description" : "TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3], also known as 1-arachidonoyl-2-arachidonoyl-3-a-linolenoyl-glycerol or tag(20:4/20:4/18:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is considered to be a triradylglycerol lipid molecule. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) ; HMDB10531",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0010531",
    "description" : "TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3], also known as 1-arachidonoyl-2-arachidonoyl-3-a-linolenoyl-glycerol or tag(20:4/20:4/18:3), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is considered to be a triradylglycerol lipid molecule. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] has been found throughout all human tissues, and has also been primarily detected in blood. Within the cell, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is primarily located in the membrane (predicted from logP) and adiposome. In humans, TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3] is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB0005478",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005478",
    "description" : "TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as 1,2,3-tri-(5,8,11,14-eicosatetraenoyl)glycerol or TG(20:4/20:4/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a triradylglycerol lipid molecule. TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from DG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and arachidonyl-CoA; which is mediated by the enzyme diacylglycerol O-acyltransferase. In humans, TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) ; HMDB05478",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0005478",
    "description" : "TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), also known as 1,2,3-tri-(5,8,11,14-eicosatetraenoyl)glycerol or TG(20:4/20:4/20:4), belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a triradylglycerol lipid molecule. TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is considered to be a practically insoluble (in water) and relatively neutral molecule. TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) has been found in human adipose tissue tissue, and has also been primarily detected in blood. Within the cell, TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is primarily located in the membrane (predicted from logP) and adiposome. TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) can be biosynthesized from DG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0) and arachidonyl-CoA; which is mediated by the enzyme diacylglycerol O-acyltransferase. In humans, TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is involved in the metabolic disorder called de novo triacylglycerol biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) pathway.",
    "id" : null
  }, {
    "name" : "Theobromine ; HMDB0002825",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002825",
    "description" : "Theobromine, also known as diurobromine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Theobromine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Theobromine has been found in human liver and kidney tissues, and has also been detected in most biofluids, including urine, cerebrospinal fluid, blood, and feces. Within the cell, theobromine is primarily located in the cytoplasm. Theobromine participates in a number of enzymatic reactions. In particular, Theobromine and formaldehyde can be biosynthesized from caffeine through the action of the enzymes cytochrome P450 1A2 and cytochrome P450 2E1. In addition, Theobromine can be converted into 3,7-dimethyluric acid through the action of the enzyme xanthine dehydrogenase/oxidase. In humans, theobromine is involved in the caffeine metabolism pathway.",
    "id" : null
  }, {
    "name" : "Theophylline ; HMDB0001889",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001889",
    "description" : "Theophylline, also known as uniphyl or aerolate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Theophylline is a drug which is used for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis. Theophylline exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Theophylline has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, theophylline is primarily located in the cytoplasm. Theophylline participates in a number of enzymatic reactions. In particular, Theophylline and formaldehyde can be biosynthesized from caffeine through its interaction with the enzymes cytochrome P450 1A2, cytochrome P450 3A4, cytochrome P450 2C8, cytochrome P450 2C9, and cytochrome P450 2E1. In addition, Theophylline can be converted into 1-methylxanthine and formaldehyde; which is catalyzed by the enzyme cytochrome P450 1A2. In humans, theophylline is involved in the caffeine metabolism pathway. Theophylline is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Theophylline ; HMDB01889",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0001889",
    "description" : "Theophylline, also known as uniphyl or aerolate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Theophylline is a drug which is used for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis. Theophylline exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Theophylline has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine, blood, and cerebrospinal fluid. Within the cell, theophylline is primarily located in the cytoplasm. Theophylline participates in a number of enzymatic reactions. In particular, Theophylline and formaldehyde can be biosynthesized from caffeine through its interaction with the enzymes cytochrome P450 1A2, cytochrome P450 3A4, cytochrome P450 2C8, cytochrome P450 2C9, and cytochrome P450 2E1. In addition, Theophylline can be converted into 1-methylxanthine and formaldehyde; which is catalyzed by the enzyme cytochrome P450 1A2. In humans, theophylline is involved in the caffeine metabolism pathway. Theophylline is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Thiamine ; HMDB0000235",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000235",
    "description" : "Thiamine, also known as vitamin B1 or aneurin, belongs to the class of organic compounds known as thiamines. Thiamines are compounds containing a thiamine moiety, which is structurally characterized by a 3-[(4-Amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-5-yl backbone. Thiamine is a drug which is used for the treatment of thiamine and niacin deficiency states, korsakov's alcoholic psychosis, wernicke-korsakov syndrome, delirium, and peripheral neuritis. Thiamine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Thiamine has been found throughout most human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, thiamine is primarily located in the membrane (predicted from logP), mitochondria and myelin sheath. Thiamine exists in all eukaryotes, ranging from yeast to humans. Thiamine participates in a number of enzymatic reactions. In particular, Thiamine can be converted into thiamine pyrophosphate; which is catalyzed by the enzyme thiamin pyrophosphokinase. Furthermore, Thiamine can be converted into thiamine; which is mediated by the enzyme thiamine transporter 1. Furthermore, Thiamine can be biosynthesized from thiamine monophosphate; which is mediated by the enzyme acid phosphatases. Finally, Thiamine can be converted into thiamine pyrophosphate; which is catalyzed by the enzyme thiamin pyrophosphokinase. In humans, thiamine is involved in the metabolic disorder called the thiamine metabolism pathway. Thiamine is a bitter tasting compound that can be found in a number of food items such as coffee, cocktail, garden cress, and white sucker. This makes thiamine a potential biomarker for the consumption of these food products. Thiamine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Thiamine ; HMDB00235",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000235",
    "description" : "Thiamine, also known as vitamin B1 or aneurin, belongs to the class of organic compounds known as thiamines. Thiamines are compounds containing a thiamine moiety, which is structurally characterized by a 3-[(4-Amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-5-yl backbone. Thiamine is a drug which is used for the treatment of thiamine and niacin deficiency states, korsakov's alcoholic psychosis, wernicke-korsakov syndrome, delirium, and peripheral neuritis. Thiamine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Thiamine has been found throughout most human tissues, and has also been primarily detected in saliva, urine, blood, and cerebrospinal fluid. Within the cell, thiamine is primarily located in the membrane (predicted from logP), mitochondria and myelin sheath. Thiamine exists in all eukaryotes, ranging from yeast to humans. Thiamine participates in a number of enzymatic reactions. In particular, Thiamine can be converted into thiamine pyrophosphate; which is catalyzed by the enzyme thiamin pyrophosphokinase. Furthermore, Thiamine can be converted into thiamine; which is mediated by the enzyme thiamine transporter 1. Furthermore, Thiamine can be biosynthesized from thiamine monophosphate; which is mediated by the enzyme acid phosphatases. Finally, Thiamine can be converted into thiamine pyrophosphate; which is catalyzed by the enzyme thiamin pyrophosphokinase. In humans, thiamine is involved in the metabolic disorder called the thiamine metabolism pathway. Thiamine is a bitter tasting compound that can be found in a number of food items such as coffee, cocktail, garden cress, and white sucker. This makes thiamine a potential biomarker for the consumption of these food products. Thiamine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Threonic acid ; HMDB0000943",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000943",
    "description" : "Threonic acid, also known as threonate or MMFS-01, belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. Threonic acid is soluble (in water) and a weakly acidic compound (based on its pKa). Threonic acid has been detected in most biofluids, including sweat, feces, saliva, and blood. Within the cell, threonic acid is primarily located in the cytoplasm. Threonic acid can be converted into 4-phospho-D-threonic acid.",
    "id" : null
  }, {
    "name" : "Thymine ; HMDB0000262",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000262",
    "description" : "Thymine, also known as 5-methyluracil, belongs to the class of organic compounds known as hydroxypyrimidines. These are organic compounds containing a hydroxyl group attached to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Thymine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Thymine has been found in human prostate and skin tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, saliva, and urine. Thymine exists in all eukaryotes, ranging from yeast to humans. Thymine participates in a number of enzymatic reactions. In particular, Thymine and deoxyribose 1-phosphate can be biosynthesized from thymidine through the action of the enzyme thymidine phosphorylase. In addition, Thymine can be converted into dihydrothymine; which is catalyzed by the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. In humans, thymine is involved in the pyrimidine metabolism pathway. Thymine is also involved in several metabolic disorders, some of which include Beta ureidopropionase deficiency, dihydropyrimidinase deficiency, the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, and UMP synthase deficiency (orotic aciduria).",
    "id" : null
  }, {
    "name" : "Thymine ; HMDB00262",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000262",
    "description" : "Thymine, also known as 5-methyluracil, belongs to the class of organic compounds known as hydroxypyrimidines. These are organic compounds containing a hydroxyl group attached to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Thymine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Thymine has been found in human prostate and skin tissues, and has also been detected in most biofluids, including cerebrospinal fluid, blood, saliva, and urine. Thymine exists in all eukaryotes, ranging from yeast to humans. Thymine participates in a number of enzymatic reactions. In particular, Thymine and deoxyribose 1-phosphate can be biosynthesized from thymidine through the action of the enzyme thymidine phosphorylase. In addition, Thymine can be converted into dihydrothymine; which is catalyzed by the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. In humans, thymine is involved in the pyrimidine metabolism pathway. Thymine is also involved in several metabolic disorders, some of which include Beta ureidopropionase deficiency, dihydropyrimidinase deficiency, the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, and UMP synthase deficiency (orotic aciduria).",
    "id" : null
  }, {
    "name" : "Thymol Sulfate ; HMDB0062720",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0062720",
    "description" : "Thymol sulfate belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. Thymol sulfate can be converted into thymol.",
    "id" : null
  }, {
    "name" : "Thyroxine ; HMDB0000248",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000248",
    "description" : "Thyroxine, also known as levothyroxine or T4, belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Thyroxine is a drug which is used for use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor. Thyroxine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Thyroxine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine, saliva, and blood. Within the cell, thyroxine is primarily located in the cytoplasm, membrane (predicted from logP) and myelin sheath. In humans, thyroxine is involved in the tyrosine metabolism pathway and thyroid hormone synthesis pathway.",
    "id" : null
  }, {
    "name" : "Thyroxine ; HMDB00248",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000248",
    "description" : "Thyroxine, also known as levothyroxine or T4, belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Thyroxine is a drug which is used for use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor. Thyroxine exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Thyroxine has been found throughout most human tissues, and has also been detected in multiple biofluids, such as urine, saliva, and blood. Within the cell, thyroxine is primarily located in the cytoplasm, membrane (predicted from logP) and myelin sheath. In humans, thyroxine is involved in the tyrosine metabolism pathway and thyroid hormone synthesis pathway.",
    "id" : null
  }, {
    "name" : "Tiglylcarnitine ; HMDB0002366",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002366",
    "description" : "Tiglylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Tiglylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Tiglylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, tiglylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Tiglylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "Tiglylcarnitine ; HMDB02366",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0002366",
    "description" : "Tiglylcarnitine belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond. Tiglylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule. Tiglylcarnitine has been detected in multiple biofluids, such as urine and blood. Within the cell, tiglylcarnitine is primarily located in the membrane (predicted from logP) and cytoplasm. Tiglylcarnitine has been linked to the inborn metabolic disorders including celiac disease.",
    "id" : null
  }, {
    "name" : "trans-2-Dodecenoylcarnitine ; HMDB0013326",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013326",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "trans-2-Dodecenoylcarnitine ; HMDB13326",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0013326",
    "description" : "3-Hydroxy-9Z-octadecenoylcarnitine belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. 3-Hydroxy-9Z-octadecenoylcarnitine is considered to be a practically insoluble (in water) and relatively neutral molecule.",
    "id" : null
  }, {
    "name" : "Trans-urocanate ; HMDB0062562",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0062562",
    "description" : "Trans-urocanate is also known as (e)-3-(Imidazol-4-yl)propenoate or trans-Urocanic acid.  Trans-urocanate is considered to be soluble (in water) and acidic",
    "id" : null
  }, {
    "name" : "Trigonelline ; HMDB0000875",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000875",
    "description" : "Trigonelline, also known as caffearin or gynesine, belongs to the class of organic compounds known as alkaloids and derivatives. These are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic properties. Also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. Trigonelline is considered to be a practically insoluble (in water) and relatively neutral molecule. Trigonelline has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, trigonelline is primarily located in the cytoplasm. Trigonelline can be biosynthesized from nicotinate. Outside of the human body, trigonelline can be found in a number of food items such as yellow bell pepper, white lupine, soft-necked garlic, and common wheat. This makes trigonelline a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Trigonelline ; HMDB00875",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000875",
    "description" : "Trigonelline, also known as caffearin or gynesine, belongs to the class of organic compounds known as alkaloids and derivatives. These are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic properties. Also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. Trigonelline is considered to be a practically insoluble (in water) and relatively neutral molecule. Trigonelline has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, trigonelline is primarily located in the cytoplasm. Trigonelline can be biosynthesized from nicotinate. Outside of the human body, trigonelline can be found in a number of food items such as yellow bell pepper, white lupine, soft-necked garlic, and common wheat. This makes trigonelline a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Trimethylamine N-oxide ; HMDB0000925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000925",
    "description" : "Trimethylamine N-oxide, also known as (CH3)3no or tmao, belongs to the class of organic compounds known as trialkyl amine oxides. These are hydrocarbyl derivatives of the aminoxide anion, with the general formula R3N+[O-] or R3N=O, where R is an alkyl group. Trimethylamine N-oxide exists as a solid, soluble (in water), and a strong basic compound (based on its pKa). Trimethylamine N-oxide has been found in human epidermis, liver and kidney tissues, and has also been primarily detected in urine, feces, saliva, and blood. Within the cell, trimethylamine N-oxide is primarily located in the cytoplasm. Trimethylamine N-oxide can be converted into trimethylamine. Trimethylamine N-oxide has an odorless taste. Trimethylamine N-oxide is a potentially toxic compound. Trimethylamine N-oxide has been found to be associated with several diseases known as kidney disease, dimethylglycine dehydrogenase deficiency, rhabdomyolysis, and schizophrenia; trimethylamine n-oxide has also been linked to the inborn metabolic disorders including maple syrup urine disease.",
    "id" : null
  }, {
    "name" : "Trimethylamine N-oxide ; HMDB00925",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000925",
    "description" : "Trimethylamine N-oxide, also known as (CH3)3no or tmao, belongs to the class of organic compounds known as trialkyl amine oxides. These are hydrocarbyl derivatives of the aminoxide anion, with the general formula R3N+[O-] or R3N=O, where R is an alkyl group. Trimethylamine N-oxide exists as a solid, soluble (in water), and a strong basic compound (based on its pKa). Trimethylamine N-oxide has been found in human epidermis, liver and kidney tissues, and has also been primarily detected in urine, feces, saliva, and blood. Within the cell, trimethylamine N-oxide is primarily located in the cytoplasm. Trimethylamine N-oxide can be converted into trimethylamine. Trimethylamine N-oxide has an odorless taste. Trimethylamine N-oxide is a potentially toxic compound. Trimethylamine N-oxide has been found to be associated with several diseases known as kidney disease, dimethylglycine dehydrogenase deficiency, rhabdomyolysis, and schizophrenia; trimethylamine n-oxide has also been linked to the inborn metabolic disorders including maple syrup urine disease.",
    "id" : null
  }, {
    "name" : "Tryptophan 2-C-mannoside ; HMDB0240296",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0240296",
    "description" : "Tryptophan 2-C-mannoside, also known as 2-alpha-D-mannopyranosyl-L-tryptophan or C-mannosyltryptophan, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. It is an L-tryptophan derivative and a C-glycosyl compound in which the hydrogen at position 2 on the indole portion has been replaced by an alpha-mannosyl residue. Tryptophan 2-C-mannoside is a very strong basic compound (based on its pKa). Tryptophan 2-C-mannoside has been identified in blood and urine and is a marker of kidney function (PMID: 29234020).",
    "id" : null
  }, {
    "name" : "Undecanedioic acid ; HMDB0000888",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000888",
    "description" : "Undecanedioic acid, also known as 1,11-undecanedioate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Undecanedioic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Undecanedioic acid has been detected in multiple biofluids, such as feces, saliva, and urine. Within the cell, undecanedioic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "Undecanedioic acid ; HMDB00888",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000888",
    "description" : "Undecanedioic acid, also known as 1,11-undecanedioate, belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Undecanedioic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Undecanedioic acid has been detected in multiple biofluids, such as feces, saliva, and urine. Within the cell, undecanedioic acid is primarily located in the membrane (predicted from logP), cytoplasm and adiposome.",
    "id" : null
  }, {
    "name" : "Uracil ; HMDB0000300",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000300",
    "description" : "Uracil, also known as U or hybar X, belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Uracil exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Uracil has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, blood, feces, and cerebrospinal fluid. Uracil exists in all eukaryotes, ranging from yeast to humans. Uracil participates in a number of enzymatic reactions. In particular, Uracil and ribose 1-phosphate can be biosynthesized from uridine through its interaction with the enzyme uridine phosphorylase 2. Furthermore, Uracil can be converted into dihydrouracil through its interaction with the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. Finally, Uracil can be biosynthesized from dihydrouracil; which is catalyzed by the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. In humans, uracil is involved in the pyrimidine metabolism pathway and the Beta-alanine metabolism pathway. Uracil is also involved in several metabolic disorders, some of which include ureidopropionase deficiency, the carnosinuria, carnosinemia pathway, the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, and gaba-transaminase deficiency. Uracil has been found to be associated with several diseases known as canavan disease, molybdenium co-factor deficiency, and hypertension; uracil has also been linked to several inborn metabolic disorders including carbamoyl phosphate synthetase deficiency and argininemia.",
    "id" : null
  }, {
    "name" : "Uracil ; HMDB00300",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000300",
    "description" : "Uracil, also known as U or hybar X, belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Uracil exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Uracil has been found throughout all human tissues, and has also been detected in most biofluids, including saliva, blood, feces, and cerebrospinal fluid. Uracil exists in all eukaryotes, ranging from yeast to humans. Uracil participates in a number of enzymatic reactions. In particular, Uracil and ribose 1-phosphate can be biosynthesized from uridine through its interaction with the enzyme uridine phosphorylase 2. Furthermore, Uracil can be converted into dihydrouracil through its interaction with the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. Finally, Uracil can be biosynthesized from dihydrouracil; which is catalyzed by the enzyme dihydropyrimidine dehydrogenase [nadp(+)]. In humans, uracil is involved in the pyrimidine metabolism pathway and the Beta-alanine metabolism pathway. Uracil is also involved in several metabolic disorders, some of which include ureidopropionase deficiency, the carnosinuria, carnosinemia pathway, the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, and gaba-transaminase deficiency. Uracil has been found to be associated with several diseases known as canavan disease, molybdenium co-factor deficiency, and hypertension; uracil has also been linked to several inborn metabolic disorders including carbamoyl phosphate synthetase deficiency and argininemia.",
    "id" : null
  }, {
    "name" : "Urea ; HMDB0000294",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000294",
    "description" : "Urea, also known as ur or carbamide, belongs to the class of organic compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Urea exists as a solid, soluble (in water), and an extremely weak acidic (essentially neutral) compound (based on its pKa). Urea has been found throughout most human tissues, and has also been detected in most biofluids, including sweat, feces, urine, and blood. Within the cell, urea is primarily located in the mitochondria and cytoplasm. Urea exists in all eukaryotes, ranging from yeast to humans. Urea participates in a number of enzymatic reactions. In particular, Urea can be converted into urea; which is catalyzed by the enzyme urea transporter 2. Furthermore, Urea can be converted into urea; which is mediated by the enzyme urea transporter 2. Furthermore, Ornithine and urea can be biosynthesized from L-arginine; which is catalyzed by the enzyme arginase-1. Finally, Ornithine and urea can be biosynthesized from L-arginine through the action of the enzyme arginase-1. In humans, urea is involved in the ethacrynic Acid action pathway, the D-arginine and D-ornithine metabolism pathway, the glucose transporter defect (SGLT2) pathway, and the metolazone action pathway. Urea is also involved in several metabolic disorders, some of which include creatine deficiency, guanidinoacetate methyltransferase deficiency, the bendroflumethiazide action pathway, arginine: glycine amidinotransferase deficiency (agat deficiency), and the hyperprolinemia type I pathway. Urea has been found to be associated with several diseases known as bartter syndrome, type 4b, neonatal, with sensorineural deafness, meningitis, dimethylglycine dehydrogenase deficiency, and tuberculous meningitis; urea has also been linked to the inborn metabolic disorders including primary hypomagnesemia.",
    "id" : null
  }, {
    "name" : "Ureidopropionic acid ; HMDB0000026",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000026",
    "description" : "Ureidopropionic acid, also known as 3-ureidopropanoate or N-carbamoyl-b-alanine, belongs to the class of organic compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Ureidopropionic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Ureidopropionic acid has been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, ureidopropionic acid is primarily located in the cytoplasm. Ureidopropionic acid participates in a number of enzymatic reactions. In particular, Ureidopropionic acid can be biosynthesized from dihydrouracil; which is mediated by the enzyme dihydropyrimidinase. Furthermore, Ureidopropionic acid can be converted into Beta-alanine through the action of the enzyme Beta-ureidopropionase. Furthermore, Ureidopropionic acid can be converted into Beta-alanine through the action of the enzyme Beta-ureidopropionase. Finally, Ureidopropionic acid can be biosynthesized from dihydrouracil; which is catalyzed by the enzyme dihydropyrimidinase. In humans, ureidopropionic acid is involved in the Beta-alanine metabolism pathway and the pyrimidine metabolism pathway. Ureidopropionic acid is also involved in several metabolic disorders, some of which include UMP synthase deficiency (orotic aciduria), gaba-transaminase deficiency, the carnosinuria, carnosinemia pathway, and the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway. Outside of the human body, ureidopropionic acid can be found in a number of food items such as red bell pepper, garlic, yautia, and sparkleberry. This makes ureidopropionic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Ureidopropionic acid ; HMDB00026",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000026",
    "description" : "Ureidopropionic acid, also known as 3-ureidopropanoate or N-carbamoyl-b-alanine, belongs to the class of organic compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Ureidopropionic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Ureidopropionic acid has been primarily detected in feces, urine, blood, and cerebrospinal fluid. Within the cell, ureidopropionic acid is primarily located in the cytoplasm. Ureidopropionic acid participates in a number of enzymatic reactions. In particular, Ureidopropionic acid can be biosynthesized from dihydrouracil; which is mediated by the enzyme dihydropyrimidinase. Furthermore, Ureidopropionic acid can be converted into Beta-alanine through the action of the enzyme Beta-ureidopropionase. Furthermore, Ureidopropionic acid can be converted into Beta-alanine through the action of the enzyme Beta-ureidopropionase. Finally, Ureidopropionic acid can be biosynthesized from dihydrouracil; which is catalyzed by the enzyme dihydropyrimidinase. In humans, ureidopropionic acid is involved in the Beta-alanine metabolism pathway and the pyrimidine metabolism pathway. Ureidopropionic acid is also involved in several metabolic disorders, some of which include UMP synthase deficiency (orotic aciduria), gaba-transaminase deficiency, the carnosinuria, carnosinemia pathway, and the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway. Outside of the human body, ureidopropionic acid can be found in a number of food items such as red bell pepper, garlic, yautia, and sparkleberry. This makes ureidopropionic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Ureidosuccinic acid ; HMDB0000828",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000828",
    "description" : "Ureidosuccinic acid, also known as L-ureidosuccinate or carbamyl-L-aspartate, belongs to the class of organic compounds known as aspartic acid and derivatives. Aspartic acid and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Ureidosuccinic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Ureidosuccinic acid has been found in human prostate tissue, and has also been primarily detected in saliva. Within the cell, ureidosuccinic acid is primarily located in the cytoplasm. Ureidosuccinic acid exists in all eukaryotes, ranging from yeast to humans. Ureidosuccinic acid participates in a number of enzymatic reactions. In particular, Ureidosuccinic acid can be biosynthesized from carbamoyl phosphate and L-aspartic acid through its interaction with the enzyme cad protein. In addition, Ureidosuccinic acid can be biosynthesized from carbamoyl phosphate through the action of the enzyme cad protein. In humans, ureidosuccinic acid is involved in the pyrimidine metabolism pathway and the aspartate metabolism pathway. Ureidosuccinic acid is also involved in several metabolic disorders, some of which include the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, UMP synthase deficiency (orotic aciduria), the hypoacetylaspartia pathway, and the canavan disease pathway. Outside of the human body, ureidosuccinic acid can be found in a number of food items such as red beetroot, black crowberry, macadamia nut, and rowal. This makes ureidosuccinic acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Uric acid ; HMDB0000289",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000289",
    "description" : "Uric acid, also known as urate or acid, uric, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Uric acid exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Uric acid has been found throughout most human tissues, and has also been detected in most biofluids, including urine, saliva, cerebrospinal fluid, and feces. Within the cell, uric acid is primarily located in the peroxisome. Uric acid exists in all eukaryotes, ranging from yeast to humans. Uric acid can be biosynthesized from xanthine; which is mediated by the enzyme xanthine dehydrogenase/oxidase. In humans, uric acid is involved in the azathioprine action pathway, the mercaptopurine action pathway, the thioguanine action pathway, and the purine metabolism pathway. Uric acid is also involved in several metabolic disorders, some of which include the mitochondrial dna depletion syndrome pathway, molybdenum cofactor deficiency, adenylosuccinate lyase deficiency, and purine nucleoside phosphorylase deficiency. Outside of the human body, uric acid can be found in a number of food items such as butternut squash, breadnut tree seed, parsnip, and sesame. This makes uric acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Uric acid ; HMDB00289",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000289",
    "description" : "Uric acid, also known as urate or acid, uric, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Uric acid exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Uric acid has been found throughout most human tissues, and has also been detected in most biofluids, including urine, saliva, cerebrospinal fluid, and feces. Within the cell, uric acid is primarily located in the peroxisome. Uric acid exists in all eukaryotes, ranging from yeast to humans. Uric acid can be biosynthesized from xanthine; which is mediated by the enzyme xanthine dehydrogenase/oxidase. In humans, uric acid is involved in the azathioprine action pathway, the mercaptopurine action pathway, the thioguanine action pathway, and the purine metabolism pathway. Uric acid is also involved in several metabolic disorders, some of which include the mitochondrial dna depletion syndrome pathway, molybdenum cofactor deficiency, adenylosuccinate lyase deficiency, and purine nucleoside phosphorylase deficiency. Outside of the human body, uric acid can be found in a number of food items such as butternut squash, breadnut tree seed, parsnip, and sesame. This makes uric acid a potential biomarker for the consumption of these food products.",
    "id" : null
  }, {
    "name" : "Uridine ; HMDB0000296",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000296",
    "description" : "Uridine, also known as beta-uridine or allo uridine, belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. Uridine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Uridine has been detected in most biofluids, including feces, cerebrospinal fluid, urine, and blood. Within the cell, uridine is primarily located in the mitochondria, nucleus and lysosome. Uridine exists in all eukaryotes, ranging from yeast to humans. Uridine participates in a number of enzymatic reactions. In particular, Uridine can be biosynthesized from cytidine through the action of the enzyme guanine deaminase. In addition, Uridine can be biosynthesized from uridine 5'-monophosphate; which is mediated by the enzyme cytosolic purine 5'-nucleotidase. In humans, uridine is involved in the pyrimidine metabolism pathway. Uridine is also involved in several metabolic disorders, some of which include dihydropyrimidinase deficiency, the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, UMP synthase deficiency (orotic aciduria), and Beta ureidopropionase deficiency. Uridine has been found to be associated with several diseases known as degenerative disc disease and canavan disease; uridine has also been linked to the inborn metabolic disorders including lesch-nyhan syndrome.",
    "id" : null
  }, {
    "name" : "Uridine ; HMDB00296",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000296",
    "description" : "Uridine, also known as beta-uridine or allo uridine, belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. Uridine exists as a solid, soluble (in water), and a very weakly acidic compound (based on its pKa). Uridine has been detected in most biofluids, including feces, cerebrospinal fluid, urine, and blood. Within the cell, uridine is primarily located in the mitochondria, nucleus and lysosome. Uridine exists in all eukaryotes, ranging from yeast to humans. Uridine participates in a number of enzymatic reactions. In particular, Uridine can be biosynthesized from cytidine through the action of the enzyme guanine deaminase. In addition, Uridine can be biosynthesized from uridine 5'-monophosphate; which is mediated by the enzyme cytosolic purine 5'-nucleotidase. In humans, uridine is involved in the pyrimidine metabolism pathway. Uridine is also involved in several metabolic disorders, some of which include dihydropyrimidinase deficiency, the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, UMP synthase deficiency (orotic aciduria), and Beta ureidopropionase deficiency. Uridine has been found to be associated with several diseases known as degenerative disc disease and canavan disease; uridine has also been linked to the inborn metabolic disorders including lesch-nyhan syndrome.",
    "id" : null
  }, {
    "name" : "Urobilin ; HMDB0004160",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0004160",
    "description" : "Urobilin, also known as urochrome, is the tetrapyrrole chemical compound that is primarily responsible for the yellow color of urine. Urobilin is formed through the oxidation of its parent compound uroblinogen. Urobilin is actually generated through the degradation of heme, the red pigment in haemoglobin and red blood cells (RBCs). RBCs have a life span of about 120 days. When the RBCs have reached the end of their useful lifespan, the cells are engulfed by macrophages and their constituents recycled or disposed of.  Heme is broken down when the heme ring is opened by the enzyme known as heme oxygenase, which is found in the endoplasmic reticulum of the macrophages. The oxidation process produces the linear tetrapyrrole known as biliverdin along with ferric iron (Fe3+), and carbon monoxide (CO). In the next reaction, a second methylene group (located between rings III and IV of the porphyrin ring) is reduced by the enzyme known as biliverdin reductase, producing bilirubin. Bilirubin is significantly less extensively conjugated than biliverdin. This reduction causes a change in the color of the biliverdin molecule from blue-green (vert or verd for green) to yellow-red, which is the color of bilirubin (ruby or rubi for red). In plasma virtually all the bilirubin is tightly bound to plasma proteins, largely albumin, because it is only sparingly soluble in aqueous solutions at physiological pH. In the sinusoids unconjugated bilirubin dissociates from albumin, enters the liver cells across the cell membrane through non-ionic diffusion to the smooth endoplasmatic reticulum. In hepatocytes, bilirubin-UDP-glucuronyltransferase (bilirubin-UGT) adds 2 additional glucuronic acid molecules to bilirubin to produce the more water-soluble version of the molecule known as bilirubin diglucuronide. The bilirubin diglucuronide is transferred rapidly across the canalicular membrane into the bile canaliculi where it is then excreted as bile into the large intestine.  The bilirubin is further degraded (reduced) by microbes present in the large intestine to form a colorless product known as urobilinogen. Some of the urobilinogen produced by the gut bacteria is reabsorbed and re-enters the enterohepatic circulation. These urobilinogens are oxidized and converted to urobilin. The urobilin is processed through the kidneys and then excreted in the urine, which causes the yellowish color in urine. Many urine tests monitor the amount of urobilin in urine, as this provides some useful insight into urinary tract function. Normally, urine would appear as either light yellow or colorless. A lack of water intake, for example following sleep or dehydration, reduces the water content of urine, thereby concentrating urobilin and producing a darker color of urine. Obstructive jaundice reduces biliary bilirubin excretion, which is then excreted directly from the blood stream into the urine, giving a dark-colored urine. This dark colored urine has a paradoxically low urobilin concentration.",
    "id" : null
  }, {
    "name" : "Urocanic acid ; HMDB0000301",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000301",
    "description" : "Urocanic acid, also known as urocanate or acid, urocanic, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Urocanic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Urocanic acid has been found in human liver and skin tissues, and has also been detected in most biofluids, including sweat, saliva, blood, and urine. Within the cell, urocanic acid is primarily located in the cytoplasm. Urocanic acid participates in a number of enzymatic reactions. In particular, Urocanic acid can be biosynthesized from L-histidine; which is mediated by the enzyme histidine ammonia-lyase. In addition, Urocanic acid can be biosynthesized from L-histidine; which is mediated by the enzyme histidine ammonia-lyase. In humans, urocanic acid is involved in the histidine metabolism pathway. Urocanic acid is also involved in a couple of metabolic disorders, which include the histidinemia pathway and the ammonia recycling pathway. Outside of the human body, urocanic acid can be found in mung bean. This makes urocanic acid a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Urocanic acid ; HMDB00301",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000301",
    "description" : "Urocanic acid, also known as urocanate or acid, urocanic, belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. Urocanic acid exists as a solid, soluble (in water), and a weakly acidic compound (based on its pKa). Urocanic acid has been found in human liver and skin tissues, and has also been detected in most biofluids, including sweat, saliva, blood, and urine. Within the cell, urocanic acid is primarily located in the cytoplasm. Urocanic acid participates in a number of enzymatic reactions. In particular, Urocanic acid can be biosynthesized from L-histidine; which is mediated by the enzyme histidine ammonia-lyase. In addition, Urocanic acid can be biosynthesized from L-histidine; which is mediated by the enzyme histidine ammonia-lyase. In humans, urocanic acid is involved in the histidine metabolism pathway. Urocanic acid is also involved in a couple of metabolic disorders, which include the histidinemia pathway and the ammonia recycling pathway. Outside of the human body, urocanic acid can be found in mung bean. This makes urocanic acid a potential biomarker for the consumption of this food product.",
    "id" : null
  }, {
    "name" : "Ursodeoxycholic acid ; HMDB0000946",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000946",
    "description" : "Ursodeoxycholic acid, also known as ursodeoxycholate or actigall, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Ursodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Ursodeoxycholic acid has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, ursodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Ursodeoxycholic acid is also a parent compound for other transformation products, including but not limited to, glycoursodeoxycholic acid, 3alpha,7beta-dihydroxy-12-oxo-5beta-cholanic acid, and tauroursodeoxycholic acid.",
    "id" : null
  }, {
    "name" : "Ursodeoxycholic acid ; HMDB00946",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000946",
    "description" : "Ursodeoxycholic acid, also known as ursodeoxycholate or actigall, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Ursodeoxycholic acid exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. Ursodeoxycholic acid has been found throughout most human tissues, and has also been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, ursodeoxycholic acid is primarily located in the membrane (predicted from logP) and cytoplasm. Ursodeoxycholic acid is also a parent compound for other transformation products, including but not limited to, glycoursodeoxycholic acid, 3alpha,7beta-dihydroxy-12-oxo-5beta-cholanic acid, and tauroursodeoxycholic acid.",
    "id" : null
  }, {
    "name" : "Valsartan ; HMDB0014323",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0014323",
    "description" : "Valsartan is an angiotensin-receptor blocker (ARB) that may be used to treat a variety of cardiac conditions including hypertension, diabetic nephropathy and heart failure. Valsartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Valsartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease.",
    "id" : null
  }, {
    "name" : "Valyl-Glycine ; HMDB0029127",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0029127",
    "description" : "Valyl-glycine, also known as V-g dipeptide or val-gly, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Valyl-glycine is soluble (in water) and a weakly acidic compound (based on its pKa).",
    "id" : null
  }, {
    "name" : "Vanillactic acid ; HMDB0000913",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000913",
    "description" : "Vanillactic acid, also known as vanillactate or VLA, belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. Vanillactic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Vanillactic acid has been detected in multiple biofluids, such as urine and blood. Vanillactic acid has been linked to the inborn metabolic disorders including aromatic l-amino acid decarboxylase deficiency.",
    "id" : null
  }, {
    "name" : "Vitamin A ; HMDB0000305",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000305",
    "description" : "13-cis-Retinol, also known as neovitamin a, belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. Thus, 13-cis-retinol is considered to be an isoprenoid lipid molecule. 13-cis-Retinol is considered to be a practically insoluble (in water) and relatively neutral molecule. Within the cell, 13-cis-retinol is primarily located in the cytoplasm and membrane (predicted from logP). 13-cis-Retinol can be converted into 13-cis-retinyl hexadecanoate and 13-cis-retinyl tetradecanoate.",
    "id" : null
  }, {
    "name" : "Vitamin A ; HMDB00305",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000305",
    "description" : "13-cis-Retinol, also known as neovitamin a, belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. Thus, 13-cis-retinol is considered to be an isoprenoid lipid molecule. 13-cis-Retinol is considered to be a practically insoluble (in water) and relatively neutral molecule. Within the cell, 13-cis-retinol is primarily located in the cytoplasm and membrane (predicted from logP). 13-cis-Retinol can be converted into 13-cis-retinyl hexadecanoate and 13-cis-retinyl tetradecanoate.",
    "id" : null
  }, {
    "name" : "Xanthine ; HMDB0000292",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000292",
    "description" : "Xanthine, also known as Xan or 2,6-dioxopurine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Xanthine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Xanthine has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, sweat, blood, and cerebrospinal fluid. Within the cell, xanthine is primarily located in the cytoplasm and peroxisome. Xanthine exists in all eukaryotes, ranging from yeast to humans. Xanthine participates in a number of enzymatic reactions. In particular, Xanthine can be biosynthesized from guanine; which is catalyzed by the enzyme guanine deaminase. In addition, Xanthine and ribose 1-phosphate can be biosynthesized from xanthosine through the action of the enzyme purine nucleoside phosphorylase. In humans, xanthine is involved in the thioguanine action pathway, the mercaptopurine action pathway, the azathioprine action pathway, and the purine metabolism pathway. Xanthine is also involved in several metabolic disorders, some of which include the mitochondrial dna depletion syndrome pathway, the xanthinuria type I pathway, the lesch-nyhan syndrome (LNS) pathway, and adenylosuccinate lyase deficiency. Xanthine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Xanthine ; HMDB00292",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000292",
    "description" : "Xanthine, also known as Xan or 2,6-dioxopurine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Xanthine exists as a solid, slightly soluble (in water), and a very weakly acidic compound (based on its pKa). Xanthine has been found throughout most human tissues, and has also been detected in most biofluids, including saliva, sweat, blood, and cerebrospinal fluid. Within the cell, xanthine is primarily located in the cytoplasm and peroxisome. Xanthine exists in all eukaryotes, ranging from yeast to humans. Xanthine participates in a number of enzymatic reactions. In particular, Xanthine can be biosynthesized from guanine; which is catalyzed by the enzyme guanine deaminase. In addition, Xanthine and ribose 1-phosphate can be biosynthesized from xanthosine through the action of the enzyme purine nucleoside phosphorylase. In humans, xanthine is involved in the thioguanine action pathway, the mercaptopurine action pathway, the azathioprine action pathway, and the purine metabolism pathway. Xanthine is also involved in several metabolic disorders, some of which include the mitochondrial dna depletion syndrome pathway, the xanthinuria type I pathway, the lesch-nyhan syndrome (LNS) pathway, and adenylosuccinate lyase deficiency. Xanthine is a potentially toxic compound.",
    "id" : null
  }, {
    "name" : "Xanthosine ; HMDB0000299",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000299",
    "description" : "Xanthosine, also known as xanthine riboside, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Xanthosine is soluble (in water) and a very weakly acidic compound (based on its pKa). Xanthosine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, xanthosine is primarily located in the cytoplasm. Xanthosine exists in all eukaryotes, ranging from yeast to humans. Xanthosine participates in a number of enzymatic reactions. In particular, Xanthosine can be biosynthesized from xanthylic acid; which is catalyzed by the enzyme cytosolic purine 5'-nucleotidase. In addition, Xanthosine can be converted into xanthine and ribose 1-phosphate through the action of the enzyme purine nucleoside phosphorylase. In humans, xanthosine is involved in the mercaptopurine action pathway, the thioguanine action pathway, the azathioprine action pathway, and the purine metabolism pathway. Xanthosine is also involved in several metabolic disorders, some of which include the xanthinuria type II pathway, the lesch-nyhan syndrome (LNS) pathway, myoadenylate deaminase deficiency, and the mitochondrial dna depletion syndrome pathway.",
    "id" : null
  }, {
    "name" : "Xanthosine ; HMDB00299",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000299",
    "description" : "Xanthosine, also known as xanthine riboside, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Xanthosine is soluble (in water) and a very weakly acidic compound (based on its pKa). Xanthosine has been detected in multiple biofluids, such as feces, urine, and blood. Within the cell, xanthosine is primarily located in the cytoplasm. Xanthosine exists in all eukaryotes, ranging from yeast to humans. Xanthosine participates in a number of enzymatic reactions. In particular, Xanthosine can be biosynthesized from xanthylic acid; which is catalyzed by the enzyme cytosolic purine 5'-nucleotidase. In addition, Xanthosine can be converted into xanthine and ribose 1-phosphate through the action of the enzyme purine nucleoside phosphorylase. In humans, xanthosine is involved in the mercaptopurine action pathway, the thioguanine action pathway, the azathioprine action pathway, and the purine metabolism pathway. Xanthosine is also involved in several metabolic disorders, some of which include the xanthinuria type II pathway, the lesch-nyhan syndrome (LNS) pathway, myoadenylate deaminase deficiency, and the mitochondrial dna depletion syndrome pathway.",
    "id" : null
  }, {
    "name" : "Xanthurenic acid ; HMDB0000881",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000881",
    "description" : "Xanthurenic acid, also known as xanthurenate or 8-hydroxykynurenate, belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. Xanthurenic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Xanthurenic acid has been found in human epidermis tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. Xanthurenic acid exists in all eukaryotes, ranging from yeast to humans. In humans, xanthurenic acid is involved in the tryptophan metabolism pathway. Xanthurenic acid has been found to be associated with the diseases known as hemodialysis; xanthurenic acid has also been linked to the inborn metabolic disorders including kynureninase deficiency.",
    "id" : null
  }, {
    "name" : "Xanthurenic acid ; HMDB00881",
    "link" : "http://www.hmdb.ca/metabolites/HMDB0000881",
    "description" : "Xanthurenic acid, also known as xanthurenate or 8-hydroxykynurenate, belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. Xanthurenic acid exists as a solid, slightly soluble (in water), and a moderately acidic compound (based on its pKa). Xanthurenic acid has been found in human epidermis tissue, and has also been detected in multiple biofluids, such as feces, urine, and blood. Xanthurenic acid exists in all eukaryotes, ranging from yeast to humans. In humans, xanthurenic acid is involved in the tryptophan metabolism pathway. Xanthurenic acid has been found to be associated with the diseases known as hemodialysis; xanthurenic acid has also been linked to the inborn metabolic disorders including kynureninase deficiency.",
    "id" : null
  } ]
}, {
  "name" : "lk_human_sex",
  "rows" : [ {
    "name" : "Female",
    "link" : "",
    "description" : "Gender is Female.",
    "id" : ""
  }, {
    "name" : "Male",
    "link" : "",
    "description" : "Gender is Male.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "Gender is Other. Value may be used to differeniate as neither Male or Female.",
    "id" : ""
  }, {
    "name" : "Prefer Not to Answer",
    "link" : "",
    "description" : "A response indicating that an individual prefers or preferred not to answer.",
    "id" : ""
  }, {
    "name" : "Unknown",
    "link" : "",
    "description" : "Gender is Unknown. Value may be used to signify that gender is unknown at the time.",
    "id" : ""
  } ]
}, {
  "name" : "lk_lab_test_name",
  "rows" : [ {
    "name" : "name_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "25-Hydroxyvitamin D Measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92268",
    "description" : "A measurement of the total inactive Vitamin D in a biological specimen.",
    "id" : "VITDIT"
  }, {
    "name" : "A/G RATIO",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002402",
    "description" : "Blood Albumin Level to Blood Globulin Level Ratio",
    "id" : ""
  }, {
    "name" : "Acanthocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74699",
    "description" : "A measurement of the acanthocytes per unit of a biological specimen.",
    "id" : "ACANT"
  }, {
    "name" : "Acanthocytes/Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74633",
    "description" : "A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen.",
    "id" : "ACANTRBC"
  }, {
    "name" : "Activated Partial Thromboplastin Time",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000210",
    "description" : "A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.",
    "id" : "APTT"
  }, {
    "name" : "Alanine Aminotransferase",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000574",
    "description" : "A measurement of the alanine aminotransferase in a biological specimen.",
    "id" : "ALT"
  }, {
    "name" : "Albumin",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000549",
    "description" : "A measurement of the albumin protein in a biological specimen.",
    "id" : "ALB"
  }, {
    "name" : "Albumin/Creatinine",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74761",
    "description" : "A relative measurement (ratio or percentage) of the albumin to the creatinine in a urine sample.",
    "id" : "ALBCREAT"
  }, {
    "name" : "Alkaline Phosphatase",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000576",
    "description" : "A measurement of the alkaline phosphatase in a biological specimen.",
    "id" : "ALP"
  }, {
    "name" : "Amylase",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000280",
    "description" : "Urine Amylase Level",
    "id" : ""
  }, {
    "name" : "Anion Gap",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000067",
    "description" : "Anion Gap",
    "id" : ""
  }, {
    "name" : "Anisocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74797",
    "description" : "A measurement of the inequality in the size of the red blood cells in a whole blood specimen.",
    "id" : "ANISO"
  }, {
    "name" : "Anti-DNA Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81973",
    "description" : "A measurement of the anti-DNA antibodies in a biological specimen.",
    "id" : "DNAAB"
  }, {
    "name" : "Anti-Double Stranded DNA",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74913",
    "description" : "A measurement of the anti-double stranded DNA antibody in a biological specimen.",
    "id" : "ADSDNA"
  }, {
    "name" : "Anti-Ribonucleoprotein Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C121325",
    "description" : "An antinuclear antibody directed against U1 snRNP, that is strongly associated with mixed connective tissue disease and commonly detected in lupus.",
    "id" : ""
  }, {
    "name" : "Anti-Saccharomyces cerevisiae Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81976",
    "description" : "A measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen.",
    "id" : "ASCAB"
  }, {
    "name" : "Anti-Smith Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C121324",
    "description" : "An antinuclear antibody directed against small nuclear ribonucleoproteins (snRNPs), that is highly specific, but has poor sensitivity for systemic lupus erythematosus (SLE). Presence of anti-Sm antibodies are associated with central nervous system, kidney, lung and cardiac involvement in SLE, but are not indicative of disease activity.",
    "id" : ""
  }, {
    "name" : "Anti-SS-A antibody",
    "link" : "http://purl.bioontology.org/ontology/MEDDRA/10060213",
    "description" : "Anti-SS-A antibody",
    "id" : ""
  }, {
    "name" : "Anti-SS-B antibody",
    "link" : "http://purl.bioontology.org/ontology/MEDDRA/10060214",
    "description" : "Anti-SS-B antibody",
    "id" : ""
  }, {
    "name" : "Anticardiolipin IgG Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C70990",
    "description" : "An IgG autoantibody directed against cardiolipin. It is associated with thrombosis, spontaneous abortion, and complications during labor.",
    "id" : ""
  }, {
    "name" : "Anticardiolipin IgM Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C70619",
    "description" : "An IgM autoantibody directed against cardiolipin. It is associated with hemolytic anemia.",
    "id" : ""
  }, {
    "name" : "Antiglobulin Test, Direct",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81974",
    "description" : "A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.",
    "id" : "ANGLOBDR"
  }, {
    "name" : "Antimitochondrial Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81975",
    "description" : "A measurement of the antimitochondrial antibodies in a biological specimen.",
    "id" : "AMA"
  }, {
    "name" : "Antinuclear Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74916",
    "description" : "A measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen.",
    "id" : "ANA"
  }, {
    "name" : "Apolipoprotein A1",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000520",
    "description" : "Blood Apolipoprotein A1 Level",
    "id" : ""
  }, {
    "name" : "Apolipoprotein B",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000522",
    "description" : "Blood Apoliprotein B Level",
    "id" : ""
  }, {
    "name" : "Aspartate Aminotransferase",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000580",
    "description" : "A measurement of the aspartate aminotransferase in a biological specimen.",
    "id" : "AST"
  }, {
    "name" : "Aspartate Aminotransferase Antigen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81978",
    "description" : "A measurement of the aspartate aminotransferase antigen in a biological specimen.",
    "id" : "ASTAG"
  }, {
    "name" : "Auer Rods",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74657",
    "description" : "A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen.",
    "id" : "AUERRODS"
  }, {
    "name" : "Bacteria Count",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002656",
    "description" : "The quantitative determination of bacterial populations. The two most widely used methods for determining bacterial numbers are: 1) the standard, or viable, plate count method and 2) spectrophotometric (turbidimetric) analysis.",
    "id" : "BACT"
  }, {
    "name" : "Band",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002336",
    "description" : "Blood Band Neutrophil Count",
    "id" : ""
  }, {
    "name" : "Basophil % of WBC",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000368",
    "description" : "Blood Basophil Count to Total Leukocyte Count Ratio",
    "id" : ""
  }, {
    "name" : "Basophils",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000034",
    "description" : "A measurement of the basophils per unit of a biological specimen.",
    "id" : "BASO"
  }, {
    "name" : "Basophils/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000368",
    "description" : "A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen.",
    "id" : "BASOLE"
  }, {
    "name" : "BC_GLUC (GLUC)",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000046",
    "description" : "Blood Glucose Level",
    "id" : ""
  }, {
    "name" : "Beta-2 Glycoprotein Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81979",
    "description" : "A measurement of the beta-2 glycoprotein antibody in a biological specimen.",
    "id" : "B2GLYAB"
  }, {
    "name" : "Bicarbonate",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000498",
    "description" : "A measurement of the bicarbonate in a biological specimen",
    "id" : "BICARB"
  }, {
    "name" : "Bilirubin",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000123",
    "description" : "A measurement of the total bilirubin in a biological specimen.",
    "id" : "BILI"
  }, {
    "name" : "Bite Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74700",
    "description" : "A measurement of the bite cells (erthrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen .",
    "id" : "BITECE"
  }, {
    "name" : "Bite Cells/Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74634",
    "description" : "A relative measurement of the bite cells (erthrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen .",
    "id" : "BTECERBC"
  }, {
    "name" : "Blasts",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74605",
    "description" : "A measurement of the blast cells per unit of a biological specimen.",
    "id" : "BLAST"
  }, {
    "name" : "Blasts/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64487",
    "description" : "A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen.",
    "id" : "BLASTLE"
  }, {
    "name" : "blood alanine aminotransferase activity level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000574",
    "description" : "The amount of enzymatic activity of glutamic-pyruvate transaminase enzyme, commonly known as alanine transaminase or alanine aminotransferase (ALT), enzyme in a specified sample of blood. ALT catalyzes the reversible transamination between alanine and 2-oxoglutarate to generate pyruvate and glutamate. Blood ALT level is used as an enzymatic marker for  liver disease or damage.",
    "id" : ""
  }, {
    "name" : "blood alkaline phosphatase activity level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000576",
    "description" : "Quantitation of the catalytic effect exerted by alkaline phosphatase (AP) in a specified sample of blood. AP is an enzyme that catalyzes the cleavage of orthophosphate from orthophosphoric monoesters under alkaline conditions.",
    "id" : ""
  }, {
    "name" : "blood aspartate aminotransferase activity level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000580",
    "description" : "The amount of enzymatic activity of glutamic-oxaloacetic transaminase enzyme, commonly known as aspartate transaminase or aspartate aminotransferase (AST), in a specified sample of blood. AST catalyzes the reversible transfer of an amine group from l-glutamic acid to oxaloacetic acid, forming alpha-ketoglutaric acid and l-aspartic acid. Blood AST level is used as an enzymatic marker for liver disease or damage.",
    "id" : ""
  }, {
    "name" : "blood calcium level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000502",
    "description" : "The amount of calcium ions in a specified volume of blood.",
    "id" : ""
  }, {
    "name" : "blood carbon dioxide level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001322",
    "description" : "The concentration of carbon dioxide (the product of the combustion of carbon with an excess of oxygen) in the blood.",
    "id" : ""
  }, {
    "name" : "blood chloride level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000497",
    "description" : "The amount of chloride ions in a specified volume of blood.",
    "id" : ""
  }, {
    "name" : "blood creatine kinase activity level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002242",
    "description" : "The amount of enzymatic activity of creatine kinase (CK) enzyme in a specified sample of blood. CK catalyses the reversible transfer of phosphate between ATP and various phosphogens such as creatine phosphate. Blood CK level is used as an enzymatic marker for myocardial infarction, rhabdomyolysis and acute renal failure.",
    "id" : ""
  }, {
    "name" : "blood creatinine measurement",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000767",
    "description" : "blood creatinine measurement",
    "id" : ""
  }, {
    "name" : "blood eosinophil count",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000033",
    "description" : "The number of granulocytes categorized as eosinophils in a specified sample of blood. An eosinophil is a granular leukocyte having a nucleus with two lobes connected by a thread of chromatin, and cytoplasm containing coarse, round granules of uniform size that stain readily with eosin and other acid dyes.",
    "id" : ""
  }, {
    "name" : "blood fibrinogen level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000209",
    "description" : "Measurement of the amount of fibrinogen in blood, the fluid that circulates through the heart, arteries, capillaries and veins carrying nutrients and oxygen to the body tissues and metabolites away from them. Fibrinogen is a glycoprotein comprised of three pairs of nonidentical polypeptide chains; cleavage products of fibrinogen have a major role in blood clotting as well as roles in cell adhesion and spreading, display vasoconstrictor activity, and can function as chemotactic and mitogenic agents for several cell types.",
    "id" : ""
  }, {
    "name" : "blood high density lipoprotein cholesterol level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000052",
    "description" : "Measurement of the amount of cholesterol, a eukaryotic sterol that in higher animals is the precursor of bile acids and steroid hormones and a key constituent of cell membranes, carried in high-density lipoprotein (HDL) molecules in a specified volume of blood, the fluid that circulates through the heart, arteries, capillaries and veins carrying nutrients and oxygen to the body tissues and metabolites away from them. HDL is the smallest of the major lipoprotein particles, complex molecules that consist of a protein membrane surrounding a core of lipids. The HDL class of lipoproteins, specifically the subtypes of HDL2 and HDL3, have densities between 1.063 and 1.210 g/ml.",
    "id" : ""
  }, {
    "name" : "blood lactate dehydrogenase activity level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000666",
    "description" : "The amount of ezymatic activity of lactate dehydrogenase (LDH) in a specified volume of blood. LDH is the enzyme which catalyses the reaction S)-lactate + NAD(+) <=> pyruvate + NADH. Blood LDH level can be used as a marker for tissue damage.",
    "id" : ""
  }, {
    "name" : "blood low density lipoprotein cholesterol level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000053",
    "description" : "Measurement of the amount of cholesterol, a eukaryotic sterol that in higher animals is the precursor of bile acids and steroid hormones and a key constituent of cell membranes, carried in low-density lipoprotein (LDL) molecules in a specified volume of blood, the fluid that circulates through the heart, arteries, capillaries and veins carrying nutrients and oxygen to the body tissues and metabolites away from them. LDL constitute a class of relatively large, heterogeneous lipoprotein particles, complex molecules that consist of a protein membrane surrounding a core of lipids. The LDL class of lipoproteins has a density between 1.019 and 1.063 g/ml. In some animal species, such as canine and rodents, this may overlap with the HDL1 class and be designated LDL/HDL1.",
    "id" : ""
  }, {
    "name" : "blood magnesium level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000505",
    "description" : "blood magnesium level",
    "id" : ""
  }, {
    "name" : "blood phosphate level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000504",
    "description" : "The amount of phosphorus, measured as inorganic phosphate, in a specified sample of blood.",
    "id" : ""
  }, {
    "name" : "blood potassium level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000496",
    "description" : "The amount of potassium ions in a specified volume of blood.",
    "id" : ""
  }, {
    "name" : "blood sodium level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000499",
    "description" : "The amount of sodium ions in a specified volume of blood.",
    "id" : ""
  }, {
    "name" : "blood triglyceride level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000118",
    "description" : "The amount of triglycerides in a specific volume of blood, the fluid that circulates through the heart, arteries, capillaries and veins carrying nutrients and oxygen to the body tissues and metabolites away from them. Triglycerides are any of a group of lipids that are esters formed from one molecule of glycerol and three molecules of one or more fatty acids, are widespread in adipose tissue, and commonly circulate in the blood in the form of lipoproteins.",
    "id" : ""
  }, {
    "name" : "Blood Urea Nitrogen",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000049",
    "description" : "A measurement of the urea nitrogen in a blood specimen.",
    "id" : "BUN"
  }, {
    "name" : "blood urea nitrogen level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000049",
    "description" : "The level of urea in the blood in terms of nitrogen content; converted to urea concentration by multiplying by 60/28 or 2.14. Urea is the chief nitrogenous end product of protein metabolism in whole blood. Urea is formed in the liver from amino acids and from ammonia compounds and can be found in urine, blood, and lymph.",
    "id" : ""
  }, {
    "name" : "Brain-Derived Neurotrophic Factor Measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C82004",
    "description" : "A measurement of the brain-derived neurotrophic factor in a biological specimen.",
    "id" : "BDNF"
  }, {
    "name" : "BUN",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000049",
    "description" : "Blood Urea Nitrogen Level",
    "id" : ""
  }, {
    "name" : "Burr Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74701",
    "description" : "A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen.",
    "id" : "BURRCE"
  }, {
    "name" : "C Reactive Protein",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64548",
    "description" : "A measurement of the C reactive protein in a biological specimen.",
    "id" : "CRP"
  }, {
    "name" : "C-peptide",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74736",
    "description" : "The determination of the amount of C-peptide present in a sample.",
    "id" : "CPEPTIDE"
  }, {
    "name" : "Cabot Rings",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74702",
    "description" : "A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in  in an erythrocyte) in a biological specimen.",
    "id" : "CABOT"
  }, {
    "name" : "Calcium",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000502",
    "description" : "A measurement of the calcium in a biological specimen.",
    "id" : "CA"
  }, {
    "name" : "calculated urine creatinine level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002757",
    "description" : "Any measurement which has been normalized, adjusted or derived by a mathematical process or computation, of the amount of creatinine in a specified sample of urine.",
    "id" : ""
  }, {
    "name" : "Cancer Antigen 125",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C79089",
    "description" : "A measurement of the cancer antigen 125 in a biological specimen.",
    "id" : "CA125AG"
  }, {
    "name" : "Cancer Antigen 19-9",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81982",
    "description" : "A measurement of the cancer antigen 18-9 in a biological specimen.",
    "id" : "CA19_9AG"
  }, {
    "name" : "Carbon Dioxide",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001322",
    "description" : "A quantitative measurement of the gas carbon dioxide present in a sample.",
    "id" : "CO2"
  }, {
    "name" : "Carcinoembryonic Antigen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81983",
    "description" : "A measurement of the carcinoembryonic antigen in a biological specimen.",
    "id" : "CEA"
  }, {
    "name" : "CD19",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C103808",
    "description" : "A count of the CD19 B cells per unit of a biological specimen.",
    "id" : "CD19"
  }, {
    "name" : "CD19/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C103812",
    "description" : "A relative measurement (ratio or percentage) of CD19 B cells to all lymphocytes in a biological specimen.",
    "id" : "CD19LY"
  }, {
    "name" : "CD20 Expressing Cell Measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C103368",
    "description" : "A count of the CD20 expressing cells per unit of a biological specimen.",
    "id" : ""
  }, {
    "name" : "CD3",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C103809",
    "description" : "A count of the CD3 T cells per unit of a biological specimen.",
    "id" : "CD3"
  }, {
    "name" : "CD3 Positive",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C131386",
    "description" : "An indication that the CD3 complex has been detected in a sample.",
    "id" : ""
  }, {
    "name" : "CD3/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003221",
    "description" : "A relative measurement (ratio or percentage) of CD3 T cells to all lymphocytes in a biological specimen.",
    "id" : "CD3LY"
  }, {
    "name" : "CD4",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001087",
    "description" : "A count of the CD4 T cells per unit of a biological specimen.",
    "id" : "CD4"
  }, {
    "name" : "CD4 Positive",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C153220",
    "description" : "An indication that CD4 expression has been detected in a sample.",
    "id" : ""
  }, {
    "name" : "CD4/CD8",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000598",
    "description" : "A relative measure (ratio or percentage) of CD4 T cells to the CD8 T cells in a biological specimen.",
    "id" : "CD4CD8"
  }, {
    "name" : "CD4/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002354",
    "description" : "A relative measurement (ratio or percentage) of CD4 T cells to all lymphocytes in a biological specimen.",
    "id" : "CD4LY"
  }, {
    "name" : "CD40",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C82006",
    "description" : "A measurement of the CD40 in a biological specimen.",
    "id" : "CD40"
  }, {
    "name" : "CD40 Ligand",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C82007",
    "description" : "A measurement of the CD40 ligand in a biological specimen.",
    "id" : "CD40L"
  }, {
    "name" : "CD8",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000597",
    "description" : "A count of the CD8 T cells per unit of a biological specimen.",
    "id" : "CD8"
  }, {
    "name" : "CD8 Positive",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C139789",
    "description" : "Indicates that expression of the CD8 complex has been detected in a sample.",
    "id" : ""
  }, {
    "name" : "CD8/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002355",
    "description" : "A relative measurement (ratio or percentage) of CD8 T cells to all lymphocytes in a biological specimen.",
    "id" : "CD8LY"
  }, {
    "name" : "Chloride",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000497",
    "description" : "A measurement of the chloride in a biological specimen.",
    "id" : "CL"
  }, {
    "name" : "Cholesterol",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002280",
    "description" : "A measurement of the cholesterol in a biological specimen.",
    "id" : "CHOL"
  }, {
    "name" : "Cholesterol/HDL-Cholesterol",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80171",
    "description" : "A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen.",
    "id" : ""
  }, {
    "name" : "Complement Bb",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80172",
    "description" : "A measurement of the complement Bb in a biological specimen.",
    "id" : "CBB"
  }, {
    "name" : "Complement C1q Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80173",
    "description" : "A measurement of the complement C1q antibody in a biological specimen.",
    "id" : "C1QAB"
  }, {
    "name" : "Complement C3",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80174",
    "description" : "A measurement of the complement C3 in a biological specimen.",
    "id" : "C3"
  }, {
    "name" : "Complement C3a",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80175",
    "description" : "A measurement of the complement C3a in a biological specimen.",
    "id" : "C3A"
  }, {
    "name" : "Complement C3b",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80176",
    "description" : "A measurement of the complement C3b in a biological specimen.",
    "id" : "C3B"
  }, {
    "name" : "Complement C4",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80177",
    "description" : "A measurement of the complement C4 in a biological specimen.",
    "id" : "C4"
  }, {
    "name" : "Complement C4a",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80178",
    "description" : "A measurement of the complement C4a in a biological specimen.",
    "id" : "C4A"
  }, {
    "name" : "Complement C5a",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80179",
    "description" : "A measurement of the complement C5a in a biological specimen.",
    "id" : "C5A"
  }, {
    "name" : "Complement Total",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C80160",
    "description" : "A measurement of the total complement in a biological specimen.",
    "id" : "CTOT"
  }, {
    "name" : "Creatine Kinase",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002242",
    "description" : "A measurement of the total creatine kinase in a biological specimen.",
    "id" : "CK"
  }, {
    "name" : "Creatinine",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000538",
    "description" : "A measurement of the creatinine in a biological specimen.",
    "id" : "CREAT"
  }, {
    "name" : "Creatinine clearance",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000765",
    "description" : "The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.",
    "id" : "Creatinine Clearance"
  }, {
    "name" : "Crenated Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74703",
    "description" : "A measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen.",
    "id" : "CRENCE"
  }, {
    "name" : "Cytomegalovirus Viral Load Measurement",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003142",
    "description" : "The determination of the amount of cytomegalovirus viral load present in a sample.",
    "id" : "CMVVLD"
  }, {
    "name" : "Dacryocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64801",
    "description" : "A measurement of dacryocytes in unit of a biological specimen.",
    "id" : "TEARDCY"
  }, {
    "name" : "Differential Segment (percent)",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002337",
    "description" : "Blood Segmented Neutrophil Count to Total Leukocyte Count Ratio",
    "id" : ""
  }, {
    "name" : "Dohle Bodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74610",
    "description" : "A measurement of the Dohle bodie (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen.",
    "id" : "DOHLE"
  }, {
    "name" : "Elliptocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64549",
    "description" : "A measurement of the elliptically shaped erythrocytes in a biological specimen.",
    "id" : "ELLIPCY"
  }, {
    "name" : "Eosinophil",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000033",
    "description" : "Blood Eosinophil Count",
    "id" : ""
  }, {
    "name" : "Eosinophil % of WBC",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000369",
    "description" : "Blood Eosinophil Count to Total Leukocyte Count Ratio",
    "id" : ""
  }, {
    "name" : "Eosinophil Metamyelocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84819",
    "description" : "A measurement of the eosinphil metamyelocytes in a biological specimen.",
    "id" : "EOSMM"
  }, {
    "name" : "Eosinophil Myelocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84821",
    "description" : "A measurement of the eosinophil myelocytes in a biological specimen.",
    "id" : "EOSMYL"
  }, {
    "name" : "Eosinophils",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64550",
    "description" : "A measurement of the eosinophils per unit in a biological specimen.",
    "id" : "EOS"
  }, {
    "name" : "Eosinophils/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000369",
    "description" : "A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.",
    "id" : "EOSLE"
  }, {
    "name" : "Epithelial cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64605",
    "description" : "The determination of the number of epithelial cells in a sample.",
    "id" : "Epithelial Cells"
  }, {
    "name" : "Erythrocyte Sedimentation Rate",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74611",
    "description" : "The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour)",
    "id" : "ESR"
  }, {
    "name" : "Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000025",
    "description" : "A measurement of the total erythrocytes per unit of a biological specimen.",
    "id" : "RBC"
  }, {
    "name" : "Erythrocytes Distribution Width",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64800",
    "description" : "A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.",
    "id" : "RDW"
  }, {
    "name" : "Estimated GFR by Cockcroft-Gault",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000490",
    "description" : "Blood Glomerular Filtration Rate",
    "id" : ""
  }, {
    "name" : "Estimated GFR by MDRD",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000491",
    "description" : "Blood Glomerular Filtration Rate, Diet in Renal Disease Formula (MDRD)",
    "id" : ""
  }, {
    "name" : "Gamma Glutamyl Transpeptidase",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002239",
    "description" : "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
    "id" : "GGT"
  }, {
    "name" : "Giant Platelets",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74728",
    "description" : "A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen.",
    "id" : "PLATGNT"
  }, {
    "name" : "Globulin",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002398",
    "description" : "Blood Globulin Level",
    "id" : ""
  }, {
    "name" : "Glomerular Filtration Rate",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000490",
    "description" : "A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time.",
    "id" : "GFR"
  }, {
    "name" : "GLUC (GLUC)",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000046",
    "description" : "Blood Glucose Level",
    "id" : ""
  }, {
    "name" : "Glucose",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000046",
    "description" : "A measurement of the glucose in a biological specimen.",
    "id" : "GLUC"
  }, {
    "name" : "Glutamic Acid Decarboxylase 2 Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C82017",
    "description" : "A measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen.",
    "id" : "GAD2AB"
  }, {
    "name" : "Glutamic Acid Decarboxylase Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C96653",
    "description" : "The determination of the amount of glutamic acid decarboxylase antibody present in a sample.",
    "id" : "GADAB"
  }, {
    "name" : "Glycosylated Hemoglobin",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64849",
    "description" : "A quantitative measurement of the amount of glycosylated hemoglobin present in a sample of blood.",
    "id" : "HBA1C"
  }, {
    "name" : "Hairy Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74604",
    "description" : "A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen.",
    "id" : "HAIRYCE"
  }, {
    "name" : "Hairy Cells/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74640",
    "description" : "A measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen .",
    "id" : "HRYCELY"
  }, {
    "name" : "HDL Cholesterol",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C105587",
    "description" : "A measurement of the high density lipoprotein cholesterol in a biological specimen.",
    "id" : "HDL"
  }, {
    "name" : "Heinz Bodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74709",
    "description" : "A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen.",
    "id" : "HEINZ"
  }, {
    "name" : "Helmet Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74658",
    "description" : "A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen.",
    "id" : "HELMETCE"
  }, {
    "name" : "Hematocrit",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000037",
    "description" : "The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).",
    "id" : "HCT"
  }, {
    "name" : "Hemoglobin",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000508",
    "description" : "A measurement of the hemoglobin in a biological specimen.",
    "id" : "HGB"
  }, {
    "name" : "Hepatitis A Virus Surface Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74710",
    "description" : "A measurement of the surface antibody reaction of a biological specimen to the Hepatitis A virus.",
    "id" : "HASAB"
  }, {
    "name" : "Hepatitis B Virus Core Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C148282",
    "description" : "An indication that antibodies that recognize a hepatitis B virus core protein have been detected in a sample.",
    "id" : ""
  }, {
    "name" : "Hepatitis B Virus Surface Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74711",
    "description" : "A measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus.",
    "id" : "HBSAB"
  }, {
    "name" : "Hepatitis B Virus Surface Antigen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64850",
    "description" : "A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.",
    "id" : "HBSAG"
  }, {
    "name" : "Hepatitis C Virus Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C160411",
    "description" : "An indication that antibodies that recognize the hepatitis C virus have been detected in a sample.",
    "id" : ""
  }, {
    "name" : "Hepatitis C Virus Surface Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74712",
    "description" : "A measurement of the surface antibody reaction of a biological specimen to the Hepatitis C virus.",
    "id" : "HCSAB"
  }, {
    "name" : "Heterophile Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81984",
    "description" : "A measurement of the heterophile antibodies in a biological specimen.",
    "id" : "HTPHAB"
  }, {
    "name" : "HIV-1 Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74713",
    "description" : "A measurement of the antibody reaction of a biological specimen to the HIV-1 virus.",
    "id" : "HIV1AB"
  }, {
    "name" : "HIV-1/2 Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74714",
    "description" : "A measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus.",
    "id" : "HIV12AB"
  }, {
    "name" : "HIV-2 Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74715",
    "description" : "A measurement of the antibody reaction of a biological specimen to the HIV-2 virus.",
    "id" : "HIV2AB"
  }, {
    "name" : "Howell-Jolly Bodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74704",
    "description" : "A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen.",
    "id" : "HOWJOL"
  }, {
    "name" : "Hypersegmented Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74612",
    "description" : "A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen.",
    "id" : "HYPSEGCE"
  }, {
    "name" : "Hypochromia",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64802",
    "description" : "An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.",
    "id" : "HPOCROM"
  }, {
    "name" : "IgG1",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002115",
    "description" : "Serum Immunoglobulin G1 Level",
    "id" : ""
  }, {
    "name" : "IgG2",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002116",
    "description" : "Serum Immunoglobulin G2a Level",
    "id" : ""
  }, {
    "name" : "Immunoglobulin A",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002094",
    "description" : "A measurement of the Immunoglobulin A in a biological specimen.",
    "id" : "IGA"
  }, {
    "name" : "Immunoglobulin D",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002093",
    "description" : "Blood Immunoglobulin D Level",
    "id" : ""
  }, {
    "name" : "Immunoglobulin E",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002099",
    "description" : "A measurement of the Immunoglobulin E in a biological specimen.",
    "id" : "IGE"
  }, {
    "name" : "Immunoglobulin G",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002091",
    "description" : "A measurement of the Immunoglobulin G in a biological specimen.",
    "id" : "IGG"
  }, {
    "name" : "Immunoglobulin M",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002092",
    "description" : "A measurement of the Immunoglobulin M in a biological specimen.",
    "id" : "IGM"
  }, {
    "name" : "Indirect Antiglobulin Test",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C91372",
    "description" : "A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in serum.",
    "id" : "ANGLBIND"
  }, {
    "name" : "Insulin Autoantibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C119286",
    "description" : "The determination of the amount of insulin autoantibody in a biological specimen.",
    "id" : "INSAAB"
  }, {
    "name" : "Interferon Alpha",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81994",
    "description" : "A measurement of the interferon alpha in a biological specimen.",
    "id" : "IFNA"
  }, {
    "name" : "Interferon Beta",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81995",
    "description" : "A measurement of the interferon beta in a biological specimen.",
    "id" : "IFNB"
  }, {
    "name" : "Interferon Gamma",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81996",
    "description" : "A measurement of the interferon gamma in a biological specimen.",
    "id" : "IFNG"
  }, {
    "name" : "Interleukin 1",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74805",
    "description" : "A measurement of the interleukin 1 in a biological specimen.",
    "id" : "INTLK1"
  }, {
    "name" : "Interleukin 10",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74806",
    "description" : "A measurement of the interleukin 10 in a biological specimen.",
    "id" : "INTLK10"
  }, {
    "name" : "Interleukin 11",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74807",
    "description" : "A measurement of the interleukin 11 in a biological specimen.",
    "id" : "INTLK11"
  }, {
    "name" : "Interleukin 12",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74808",
    "description" : "A measurement of the interleukin 12 in a biological specimen.",
    "id" : "INTLK12"
  }, {
    "name" : "Interleukin 13",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74809",
    "description" : "A measurement of the interleukin 13 in a biological specimen.",
    "id" : "INTLK13"
  }, {
    "name" : "Interleukin 14",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74810",
    "description" : "A measurement of the interleukin 14 in a biological specimen.",
    "id" : "INTLK14"
  }, {
    "name" : "Interleukin 15",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74811",
    "description" : "A measurement of the interleukin 15 in a biological specimen.",
    "id" : "INTLK15"
  }, {
    "name" : "Interleukin 16",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74812",
    "description" : "A measurement of the interleukin 16 in a biological specimen.",
    "id" : "INTLK16"
  }, {
    "name" : "Interleukin 17",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74813",
    "description" : "A measurement of the interleukin 17 in a biological specimen.",
    "id" : "INTLK17"
  }, {
    "name" : "Interleukin 18",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74814",
    "description" : "A measurement of the interleukin 18 in a biological specimen.",
    "id" : "INTLK18"
  }, {
    "name" : "Interleukin 19",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74815",
    "description" : "A measurement of the interleukin 19 in a biological specimen.",
    "id" : "INTLK19"
  }, {
    "name" : "Interleukin 2",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74816",
    "description" : "A measurement of the interleukin 2 in a biological specimen.",
    "id" : "INTLK2"
  }, {
    "name" : "Interleukin 20",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74817",
    "description" : "A measurement of the interleukin 20 in a biological specimen.",
    "id" : "INTLK20"
  }, {
    "name" : "Interleukin 21",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74818",
    "description" : "A measurement of the interleukin 21 in a biological specimen.",
    "id" : "INTLK21"
  }, {
    "name" : "Interleukin 22",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74819",
    "description" : "A measurement of the interleukin 22 in a biological specimen.",
    "id" : "INTLK22"
  }, {
    "name" : "Interleukin 23",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74820",
    "description" : "A measurement of the interleukin 23 in a biological specimen.",
    "id" : "INTLK23"
  }, {
    "name" : "Interleukin 24",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74821",
    "description" : "A measurement of the interleukin 24 in a biological specimen.",
    "id" : "INTLK24"
  }, {
    "name" : "Interleukin 25",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74822",
    "description" : "A measurement of the interleukin 25 in a biological specimen.",
    "id" : "INTLK25"
  }, {
    "name" : "Interleukin 26",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74823",
    "description" : "A measurement of the interleukin 26 in a biological specimen.",
    "id" : "INTLK26"
  }, {
    "name" : "Interleukin 27",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74824",
    "description" : "A measurement of the interleukin 27 in a biological specimen.",
    "id" : "INTLK27"
  }, {
    "name" : "Interleukin 28",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74825",
    "description" : "A measurement of the interleukin 28 in a biological specimen.",
    "id" : "INTLK28"
  }, {
    "name" : "Interleukin 29",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74826",
    "description" : "A measurement of the interleukin 29 in a biological specimen.",
    "id" : "INTLK29"
  }, {
    "name" : "Interleukin 3",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74827",
    "description" : "A measurement of the interleukin 3 in a biological specimen.",
    "id" : "INTLK3"
  }, {
    "name" : "Interleukin 30",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74828",
    "description" : "A measurement of the interleukin 30 in a biological specimen.",
    "id" : "INTLK30"
  }, {
    "name" : "Interleukin 31",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74829",
    "description" : "A measurement of the interleukin 31 in a biological specimen.",
    "id" : "INTLK31"
  }, {
    "name" : "Interleukin 32",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74830",
    "description" : "A measurement of the interleukin 32 in a biological specimen.",
    "id" : "INTLK32"
  }, {
    "name" : "Interleukin 33",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74831",
    "description" : "A measurement of the interleukin 33 in a biological specimen.",
    "id" : "INTLK33"
  }, {
    "name" : "Interleukin 4",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003065",
    "description" : "A measurement of the interleukin 4 in a biological specimen.",
    "id" : "INTLK4"
  }, {
    "name" : "Interleukin 5",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74833",
    "description" : "A measurement of the interleukin 5 in a biological specimen.",
    "id" : "INTLK5"
  }, {
    "name" : "Interleukin 6",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001926",
    "description" : "A measurement of the interleukin 6 in a biological specimen.",
    "id" : "INTLK6"
  }, {
    "name" : "Interleukin 7",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74835",
    "description" : "A measurement of the interleukin 7 in a biological specimen.",
    "id" : "INTLK7"
  }, {
    "name" : "Interleukin 8",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74836",
    "description" : "A measurement of the interleukin 8 in a biological specimen.",
    "id" : "INTLK8"
  }, {
    "name" : "Interleukin 9",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003067",
    "description" : "A measurement of the interleukin 9 in a biological specimen.",
    "id" : "INTLK9"
  }, {
    "name" : "Islet Cell 512 Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81985",
    "description" : "A measurement of the islet cell 512 antibody in a biological specimen.",
    "id" : "IC512AB"
  }, {
    "name" : "Islet Cell 512 Antigen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81986",
    "description" : "A measurement of the islet cell 512 antigen in a biological specimen.",
    "id" : "IC512AG"
  }, {
    "name" : "Islet Neogenesis Associated Protein Antibody",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81987",
    "description" : "A measurement of the islet neogenesis associated protein antibody in a biological specimen.",
    "id" : "INGAPAB"
  }, {
    "name" : "Ketones",
    "link" : "https://medlineplus.gov/lab-tests/ketones-in-blood/ ; https://medlineplus.gov/lab-tests/ketones-in-urine/",
    "description" : "Organic compounds with a carbonyl group (C=O) bonded to two other carbon atoms as the skeleton structure. Acetone is the simplest ketone compound.",
    "id" : "KETONES"
  }, {
    "name" : "Lactate Dehydrogenase",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000666",
    "description" : "A quantitative measurement of the amount of lactate dehydrogenase present in a sample.",
    "id" : "LDH"
  }, {
    "name" : "Large Platelets",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74729",
    "description" : "A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen.",
    "id" : "PLATLRG"
  }, {
    "name" : "Large Unstained Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74659",
    "description" : "A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen.",
    "id" : "LGUNSCE"
  }, {
    "name" : "Large Unstained Cells/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C79467",
    "description" : "A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen.",
    "id" : "LGLUCLE"
  }, {
    "name" : "LDL Cholesterol",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000053",
    "description" : "A measurement of the low density lipoprotein cholesterol in a biological specimen.",
    "id" : "LDL"
  }, {
    "name" : "Leukemic Blasts",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74630",
    "description" : "A measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen.",
    "id" : "BLASTLM"
  }, {
    "name" : "Leukemic Blasts/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74641",
    "description" : "A relative measurement (ratio or percentage)  of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen.",
    "id" : "BLSTLMLY"
  }, {
    "name" : "Leukocyte esterase",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64856",
    "description" : "A quantitative measurement of the amount of leukocyte esterase present in a sample.",
    "id" : "LEUKASE"
  }, {
    "name" : "Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002341",
    "description" : "A measurement of the leukocytes per unit of a biological specimen.",
    "id" : "WBC"
  }, {
    "name" : "Lymphocyte",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000031",
    "description" : "A measurement of the lymphocytes per unit of a biological specimen.",
    "id" : "LYM"
  }, {
    "name" : "Lymphocyte % of WBC",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000371",
    "description" : "Blood Lymphocyte Count to Total Leukocyte Count Ratio",
    "id" : ""
  }, {
    "name" : "Lymphocyte count",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000031",
    "description" : "Blood Lymphocyte Count",
    "id" : ""
  }, {
    "name" : "Lymphocytes Atypical",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64818",
    "description" : "A measurement of the atypical lymphocytes per unit of a biological specimen.",
    "id" : "LYMAT"
  }, {
    "name" : "Lymphocytes Atypical/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64819",
    "description" : "A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.",
    "id" : "LYMATLE"
  }, {
    "name" : "Lymphocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000371",
    "description" : "A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.",
    "id" : "LYMLE"
  }, {
    "name" : "Lymphoma Cells",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001912",
    "description" : "A measurement of the malignant lymphocytes in a biological specimen.",
    "id" : "LYMMCE"
  }, {
    "name" : "Lymphoma Cells/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74910",
    "description" : "A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen.",
    "id" : "LYMMCELY"
  }, {
    "name" : "Macrocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64821",
    "description" : "A measurement of the macrocytes per unit of a biological specimen.",
    "id" : "MACROCY"
  }, {
    "name" : "Magnesium",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000505",
    "description" : "A quantitative measurement of the amount of magnesium present in a sample.",
    "id" : "MG"
  }, {
    "name" : "Malignant Cells, NOS",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74660",
    "description" : "A measurement of the malignant cells of all types in a biological specimen.",
    "id" : "MLIGCE"
  }, {
    "name" : "Malignant Cells, NOS/Blood Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74643",
    "description" : "A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen.",
    "id" : "MLIGCEBC"
  }, {
    "name" : "Mature Plasma Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74661",
    "description" : "A measurement of the mature plasma cells (plasmacytes) in a biological specimen.",
    "id" : "PLSMCE"
  }, {
    "name" : "Mature Plasma Cells/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74911",
    "description" : "A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.",
    "id" : "PLSMCELY"
  }, {
    "name" : "May-Hegglin Anomaly",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74614",
    "description" : "A measurement of the May-Hegglin Anomaly (which is characterized by large, misshapen platelets and the presence of Dohle bodies in the leukocytes) in a blood specimen.",
    "id" : "MAYHEG"
  }, {
    "name" : "Mean Corpuscular Hemoglobin",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000290",
    "description" : "A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.",
    "id" : "MCH"
  }, {
    "name" : "mean corpuscular hemoglobin concentration",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000291",
    "description" : "The amount of hemoglobin in a given volume of packed red blood cells and is often calculated by dividing the hemoglobin concentration by the hematocrit.",
    "id" : "MCHC"
  }, {
    "name" : "mean corpuscular hemoglobin level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000290",
    "description" : "The average amount of hemoglobin per red blood cell caculated by dividing the total mass of hemoglobin by the number of red blood cells in a volume of blood.",
    "id" : "MCH"
  }, {
    "name" : "Mean Corpuscular HGB Concentration",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000291",
    "description" : "A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.",
    "id" : "MCHC"
  }, {
    "name" : "Mean Corpuscular Volume",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000038",
    "description" : "A quantitative measurement of the mean volume of erythrocytes in a biological specimen.",
    "id" : "MCV"
  }, {
    "name" : "Mean Platelet Volume",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001348",
    "description" : "A measurement of the average size of the platelets found in a blood specimen.",
    "id" : "MPV"
  }, {
    "name" : "Metamyelocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74615",
    "description" : "A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen.",
    "id" : "METAMY"
  }, {
    "name" : "Metamyelocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74645",
    "description" : "A relative measurement (ratio or percentage )of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes  in a biological specimen.",
    "id" : "METAMYLE"
  }, {
    "name" : "Microcytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64822",
    "description" : "A measurement of the microcytes per unit of a biological specimen.",
    "id" : "MICROCY"
  }, {
    "name" : "Milk protein",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000789",
    "description" : "Milk Protein Measurement",
    "id" : ""
  }, {
    "name" : "Milk protein CAP-Klasse",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000789",
    "description" : "Milk Protein Measurement",
    "id" : ""
  }, {
    "name" : "Monoblasts",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74631",
    "description" : "A measurement of the monoblast cells per unit of a biological specimen.",
    "id" : "MONOBL"
  }, {
    "name" : "Monoblasts/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74646",
    "description" : "A relative measurement (ratio or percentage) of monoblast cells to all leukocytes in a biological specimen.",
    "id" : "MONOBLLE"
  }, {
    "name" : "Monocyte % of WBC",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000374",
    "description" : "Blood Monocyte Count to Total Leukocyte Count Ratio",
    "id" : ""
  }, {
    "name" : "Monocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000032",
    "description" : "A measurement of the monocytes per unit of a biological specimen.",
    "id" : "MONO"
  }, {
    "name" : "Monocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000374",
    "description" : "A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.",
    "id" : "MONOLE"
  }, {
    "name" : "Myeloblasts",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74632",
    "description" : "A measurement of the myeloblast cells per unit of a biological specimen.",
    "id" : "MYBLA"
  }, {
    "name" : "Myeloblasts/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64825",
    "description" : "A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.",
    "id" : "MYBLALE"
  }, {
    "name" : "Myelocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74662",
    "description" : "A measurement of the myelocytes per unit of a biological specimen.",
    "id" : "MYCY"
  }, {
    "name" : "Myelocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64826",
    "description" : "A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.",
    "id" : "MYCYLE"
  }, {
    "name" : "Myoglobin",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C79436",
    "description" : "A measurement of myoglobin in a biological specimen.",
    "id" : "MGB"
  }, {
    "name" : "Neutrophil",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000030",
    "description" : "A measurement of the neutrophils per unit of a biological specimen.",
    "id" : "NEUT"
  }, {
    "name" : "Neutrophil % of WBC",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000370",
    "description" : "Blood Neutrophil Count to Total Leukocyte Count Ratio",
    "id" : ""
  }, {
    "name" : "Neutrophilic Metamyelocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84822",
    "description" : "A measurement of the neutrophilic metamyelocytes in a biological specimen.",
    "id" : "NEUTMM"
  }, {
    "name" : "Neutrophilic Myelocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C84823",
    "description" : "A measurement of the neutrophilic myelocytes in a biological specimen.",
    "id" : "NEUTMY"
  }, {
    "name" : "Neutrophils Band Form",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002336",
    "description" : "A measurement of the banded neutrophils per unit of a biological specimen.",
    "id" : "NEUTB"
  }, {
    "name" : "Neutrophils Band Form/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64831",
    "description" : "A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.",
    "id" : "NEUTBLE"
  }, {
    "name" : "Neutrophils, Segmented",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002335",
    "description" : "A measurement of the segmented neutrophils in a biological specimen.",
    "id" : "NEUTSG"
  }, {
    "name" : "Neutrophils, Segmented/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002337",
    "description" : "A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen.",
    "id" : "NEUTSGLE"
  }, {
    "name" : "Neutrophils/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000370",
    "description" : "A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen.",
    "id" : "NEUTLE"
  }, {
    "name" : "Nitrite",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64810",
    "description" : "A quantitative measurement of the amount of nitrite present in a sample.",
    "id" : "NITRITE"
  }, {
    "name" : "Non-HDL Cholesterol, calc",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002283",
    "description" : "Plasma Non-HDL, Non-LDL Cholesterol Level",
    "id" : ""
  }, {
    "name" : "Nucleated Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74705",
    "description" : "A measurement of the nucleated red blood cells (large, immature nucleated erythrocytes) in a biological specimen.",
    "id" : "RBCNUC"
  }, {
    "name" : "Nucleated Erythrocytes/Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74647",
    "description" : "A relative measurement (ratio or percentage) of the nucleated red blood cells (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen.",
    "id" : "RBCNURBC"
  }, {
    "name" : "Nucleated Erythrocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C82046",
    "description" : "A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen.",
    "id" : "RBCNUCLE"
  }, {
    "name" : "Panel Reactive Antibody",
    "link" : "https://en.wikipedia.org/wiki/Panel-reactive_antibody",
    "description" : "An assessment of the reactivity between host immune cells and donor human leukocyte antigen. This test is most commonly carried out in subjects awaiting transplant. The recipient's blood or serum is mixed with either a panel of lymphocytes from random blood donations or a potential donor's purified human leukocyte antigens (HLA). Host reactivity is scored as a percent.",
    "id" : "PRA"
  }, {
    "name" : "Pappenheimer Bodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74616",
    "description" : "A measurement of the Pappenheimer Bodies (violet or blue staining, ferritin granules usually found along the periphery of the red blood cells) in a biological specimen.",
    "id" : "PAPPEN"
  }, {
    "name" : "Parathyroid Hormone, Intact",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74789",
    "description" : "A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen.",
    "id" : "PTHI"
  }, {
    "name" : "Partial thromboplastin time",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000210",
    "description" : "A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.",
    "id" : "APTT"
  }, {
    "name" : "Pelger Huet Anomaly",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74617",
    "description" : "A measurement of the Pelger Huet Anomaly (neutrophils and eosinophils nuclei appear rodlike, spherical or dumbbell shapped) in a biological specimen.",
    "id" : "PELGERH"
  }, {
    "name" : "Pemphigoid Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81988",
    "description" : "A measurement of the pemphigoid antibodies in a biological specimen.",
    "id" : "PEMAB"
  }, {
    "name" : "percent change in hematocrit",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002539",
    "description" : "A calculated measurement of the relative difference in hematocrit (the percentage of total blood volume that is made up of red blood cells) between a treated state and a control state or between two points in time, expressed as a percentage.",
    "id" : ""
  }, {
    "name" : "pH",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000379",
    "description" : "Quantity of dimension one used to express on a scale from 0 to 14 the amount-of-substance concentration of hydrogen ion of dilute aqueous solution, calculated as the logarithm of the reciprocal of hydrogen-ion concentration in gram atoms per liter.",
    "id" : "PH"
  }, {
    "name" : "Phosphate",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000504",
    "description" : "A measurement of the phosphate in a biological specimen.",
    "id" : "PHOS"
  }, {
    "name" : "Plasmacytoid Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74618",
    "description" : "A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen.",
    "id" : "LYMPL"
  }, {
    "name" : "Plasmacytoid Lymphocytes/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74648",
    "description" : "A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen.",
    "id" : "LYMPLLY"
  }, {
    "name" : "Plasminogen Activator Inhibitor-1 Antigen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81989",
    "description" : "A measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen.",
    "id" : "PAI1AG"
  }, {
    "name" : "Platelet",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000029",
    "description" : "A measurement of the platelets per unit of a biological specimen.",
    "id" : "PLAT"
  }, {
    "name" : "Platelet count",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000029",
    "description" : "Platelet Count",
    "id" : ""
  }, {
    "name" : "Platelet Distribution Width",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001350",
    "description" : "A mesurement of the range of platelet sizes in a blood specimen.",
    "id" : "PDW"
  }, {
    "name" : "Poikilocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C79602",
    "description" : "A measurement of the odd-shaped erythrocytes in a whole blood specimen.",
    "id" : "POIKILO"
  }, {
    "name" : "Poikilocytes/Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74649",
    "description" : "A relative measurement (ratio or percentage) of the poikilocytes irregularly shaped erythrocytes to all erythrocytes in a biological specimen.",
    "id" : "POIKRBC"
  }, {
    "name" : "Polychromasia",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64803",
    "description" : "A measurement of the blue-staining characteristic of newly generated erythrocytes.",
    "id" : "POLYCHR"
  }, {
    "name" : "Polymorphonuclear leukocyte count",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/116708001",
    "description" : "Polymorphonuclear leukocyte count",
    "id" : ""
  }, {
    "name" : "Potassium",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000496",
    "description" : "A measurement of the potassium in a biological specimen.",
    "id" : "K"
  }, {
    "name" : "Precursor Plasma Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74619",
    "description" : "A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen.",
    "id" : "PLSPCE"
  }, {
    "name" : "Precursor Plasma Cells/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74650",
    "description" : "A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen.",
    "id" : "PLSPCELY"
  }, {
    "name" : "Prolymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74620",
    "description" : "A measurement of the prolymphocytes in a biological specimen.",
    "id" : "PROLYM"
  }, {
    "name" : "Prolymphocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64829",
    "description" : "A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.",
    "id" : "PRLYMLE"
  }, {
    "name" : "Prolymphocytes/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74651",
    "description" : "A relative measurement (ratio or percentage) of prolymphocytes to all lymphocytes in a biological specimen.",
    "id" : "PROLYMLY"
  }, {
    "name" : "Promonocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74621",
    "description" : "A measurement of the promonocytes per unit of a biological specimen.",
    "id" : "PROMONO"
  }, {
    "name" : "Promonocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74652",
    "description" : "A relative measurement (ratio or percentage) of promonocytes to all leukocytes in a biological specimen.",
    "id" : "PROMONLE"
  }, {
    "name" : "Promyelocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74622",
    "description" : "A measurement of the promyelocytes (immature myelocytes) in a biological specimen.",
    "id" : "PROMY"
  }, {
    "name" : "Promyelocytes/Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74653",
    "description" : "A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes  in a biological specimen.",
    "id" : "PROMYLE"
  }, {
    "name" : "Prostate Specific Antigen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17634",
    "description" : "A measurement of the prostate specific antigen in a biological specimen.",
    "id" : "PSA"
  }, {
    "name" : "Protein",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000028",
    "description" : "A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.",
    "id" : "PROT"
  }, {
    "name" : "Protein/Creatinine",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C79463",
    "description" : "A relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen.",
    "id" : "PROTCRT"
  }, {
    "name" : "Prothrombin time",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000211",
    "description" : "A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.",
    "id" : ""
  }, {
    "name" : "Rapid Plasma Reagin",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74716",
    "description" : "A measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen.",
    "id" : "RPR"
  }, {
    "name" : "Reactive Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74629",
    "description" : "A measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen.",
    "id" : "LYMRCT"
  }, {
    "name" : "Reactive Lymphocytes/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74654",
    "description" : "A relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen.",
    "id" : "LYMRCTLY"
  }, {
    "name" : "Reticulocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003020",
    "description" : "A measurement of the reticulocytes per unit of a biological specimen.",
    "id" : "RETI"
  }, {
    "name" : "Reticulocytes/Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003021",
    "description" : "A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.",
    "id" : "RETIRBC"
  }, {
    "name" : "RF",
    "link" : "http://purl.obolibrary.org/obo/CMO_0002609",
    "description" : "Serum Immunoglobulin M-type Rheumatoid Factor Level",
    "id" : ""
  }, {
    "name" : "Rheumatoid Factor",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74717",
    "description" : "A measurement of the rheumatoid factor antibody in a biological specimen.",
    "id" : "RF"
  }, {
    "name" : "Rouleaux Formation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74624",
    "description" : "A measurement of the stacking of red blood cells within a biological specimen.",
    "id" : "ROULEAUX"
  }, {
    "name" : "SARS-CoV-2 PCR test",
    "link" : "https://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20Metathesaurus&code=CL1382066",
    "description" : "SARS-CoV-2 PCR test laboratory procedure",
    "id" : "CUI CL1382066"
  }, {
    "name" : "Schistocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74706",
    "description" : "A measurement of the schistocytes (fragmented red blood cells) in a biological specimen.",
    "id" : "SCHISTO"
  }, {
    "name" : "serum anti-coronavirus antibody",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003390",
    "description" : "The amount of immunoglobulin molecule with an amino acid sequence that binds to corona virus.",
    "id" : ""
  }, {
    "name" : "serum anti-cytomegalovirus (CMV) antibody level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003142",
    "description" : "The amount of immunoglobulin molecule with an amino acid sequence that binds to Cytomegalovirus.",
    "id" : ""
  }, {
    "name" : "serum anti-Epstein-Barr virus (EBV) antibody level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0003143",
    "description" : "The amount of immunoglobulin molecule with an amino acid sequence that binds to Epstein-Barr virus.",
    "id" : ""
  }, {
    "name" : "Sezary Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74625",
    "description" : "A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen.",
    "id" : "SEZCE"
  }, {
    "name" : "Sezary Cells/Lymphocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74655",
    "description" : "A relative measurement (ratio or percentage) of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen.",
    "id" : "SEZCELY"
  }, {
    "name" : "SGOT",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000580",
    "description" : "Blood Aspartate Aminotransferase Activity Level",
    "id" : ""
  }, {
    "name" : "SGPT",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000574",
    "description" : "Blood Alanine Aminotransferase Activity Level",
    "id" : ""
  }, {
    "name" : "Sickle Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74626",
    "description" : "A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen.",
    "id" : "SCKLCE"
  }, {
    "name" : "Sickle Cells/Erythrocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74656",
    "description" : "A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen.",
    "id" : "SCKCERBC"
  }, {
    "name" : "Smudge Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74627",
    "description" : "A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen.",
    "id" : "SMDGCE"
  }, {
    "name" : "Sodium",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000499",
    "description" : "A measurement of the sodium in a biological specimen.",
    "id" : "SODIUM"
  }, {
    "name" : "Specific Gravity",
    "link" : "https://en.wikipedia.org/wiki/Specific_gravity",
    "description" : "The density (mass per unit volume) of any material divided by that of water at a standard temperature.",
    "id" : "SPGRAV"
  }, {
    "name" : "Spherocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74707",
    "description" : "A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen.",
    "id" : "SPHERO"
  }, {
    "name" : "Stomatocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74708",
    "description" : "A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen.",
    "id" : "STOMCY"
  }, {
    "name" : "Thymic Stromal Lymphopoietin Measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C184511",
    "description" : "A measurement of the thymic stromal lymphopoietin in a biological specimen.",
    "id" : "TSLP"
  }, {
    "name" : "Thyroid Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81990",
    "description" : "A measurement of the thyroid antibodies in a biological specimen.",
    "id" : "THYAB"
  }, {
    "name" : "Thyroid Antimicrosomal Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81991",
    "description" : "A measurement of the thyroid antimicrosomal antibodies in a biological specimen.",
    "id" : "THYAMAB"
  }, {
    "name" : "Thyroid Antithyroglobulin Antibodies",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81992",
    "description" : "A measurement of the thyroid antithyroglobulin antibodies in a biological specimen.",
    "id" : "THYATAB"
  }, {
    "name" : "Thyrotropin",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64813",
    "description" : "A measurement of the thyrotropin in a biological specimen.",
    "id" : ""
  }, {
    "name" : "Thyroxine",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001288",
    "description" : "A hormone synthesized and secreted by the thyroid gland containing four iodine atoms and is converted to triiodothyronine (T3) in the body, influencing metabolism and organ function.",
    "id" : "T4"
  }, {
    "name" : "Tissue Plasminogen Activator Antigen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C81993",
    "description" : "A measurement of the tissue plasminogen activator antigen in a biological specimen.",
    "id" : "TPAAG"
  }, {
    "name" : "TNFA",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001435",
    "description" : "Inflammatory Exudate Tumor Necrosis Factor Level",
    "id" : ""
  }, {
    "name" : "Triglyceride",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000118",
    "description" : "A measurement of the triglycerides in a biological specimen..",
    "id" : "TRIG"
  }, {
    "name" : "Triiodothyronine",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001361",
    "description" : "A thyroid hormone containing 3 iodine atoms generally synthesized from levothyroxine, and has greater biological activity.",
    "id" : "T3"
  }, {
    "name" : "Urea Nitrogen, Serum/Plasma",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000049",
    "description" : "Blood Urea Nitrogen Level",
    "id" : ""
  }, {
    "name" : "Uric Acid",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000501",
    "description" : "Blood Uric Acid Level",
    "id" : ""
  }, {
    "name" : "Urobilinogen",
    "link" : "https://en.wikipedia.org/wiki/Urobilinogen",
    "description" : "A quantitative measurement of the amount of urobilinogen present in a sample.",
    "id" : "UROBIL"
  }, {
    "name" : "Vacuolated Neutrophils",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74628",
    "description" : "A measurement of the neutrophils containing small vacuoles in a biological specimen.",
    "id" : "NEUTVAC"
  }, {
    "name" : "Vitamin D3 Measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74905",
    "description" : "A measurement of the Vitamin D3 in a biological specimen.",
    "id" : "VITD3"
  }, {
    "name" : "White Blood Cell Count",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000027",
    "description" : "White Blood Cell Count",
    "id" : ""
  } ]
}, {
  "name" : "lk_lab_test_panel_name",
  "rows" : [ {
    "name" : "name_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "Autoimmune liver disease panel",
    "link" : "https://www.nlm.nih.gov/medlineplus/ency/article/003328.htm",
    "description" : "An autoimmune liver disease panel is a group of tests that is done to check for autoimmune liver disease.",
    "id" : null
  }, {
    "name" : "Blood Cell Count",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C28133 ; http://purl.bioontology.org/ontology/SNOMEDCT/252275004",
    "description" : "The determination of the number of red blood cells, white blood cells, and platelets in a blood sample.",
    "id" : null
  }, {
    "name" : "Blood Cell Count with Differential",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C98494",
    "description" : "A hematologic procedure to determine the number of red blood cells, white blood cells, and platelets, including the white cell differential count and red cell morphology, in a blood sample.",
    "id" : null
  }, {
    "name" : "Blood Flow Cytometry",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38062 ; http://purl.bioontology.org/ontology/SNOMEDCT/64444005",
    "description" : "Flow cytometry used to examine and quantitate the constituents of the blood.",
    "id" : null
  }, {
    "name" : "Blood Measurement",
    "link" : "http://purl.obolibrary.org/obo/CMO_0000035",
    "description" : "A measurement of the blood, it's contents, cells or other factors contained within the blood.",
    "id" : null
  }, {
    "name" : "Chemistry Test",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49237",
    "description" : "A laboratory test designed for the quantification of an organic or inorganic chemical within a biological specimen.",
    "id" : null
  }, {
    "name" : "Comprehensive Metabolic Panel",
    "link" : "http://purl.bioontology.org/ontology/CPT/80053",
    "description" : "Comprehensive Metabolic Panel",
    "id" : null
  }, {
    "name" : "Drug Test",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C78139 ; http://purl.bioontology.org/ontology/SNOMEDCT/394642008",
    "description" : "A laboratory test of biological material such as blood, urine, hair, saliva or sweat, used to detect the presence of a drug or its metabolites with in the body.",
    "id" : null
  }, {
    "name" : "Fasting Lipid Profile",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/252150008",
    "description" : "Fasting Lipid Profile",
    "id" : null
  }, {
    "name" : "Hormone measurement",
    "link" : "https://www.cdc.gov/labstandards/pdf/hs/HoSt_Brochure.pdf",
    "description" : "The determination of the amount of hormone present in a sample.",
    "id" : null
  }, {
    "name" : "Immunology Test",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C16723 ; http://purl.bioontology.org/ontology/SNOMEDCT/252318005",
    "description" : "Laboratory test involving interaction of antigens with specific antibodies",
    "id" : null
  }, {
    "name" : "Laboratory test related to hemostasis",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/127791007",
    "description" : "Laboratory test related to hemostasis",
    "id" : null
  }, {
    "name" : "Mixed-Meal Tolerance Test",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/15189492",
    "description" : "Mixed-Meal Tolerance Test",
    "id" : null
  }, {
    "name" : "Protein or Enzyme Type Measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64430 ; http://purl.bioontology.org/ontology/SNOMEDCT/122444009",
    "description" : "A term that refers to a chemistry test measuring a specific protein or enzyme in the peripheral blood or body fluid.",
    "id" : null
  }, {
    "name" : "Renal Function Test",
    "link" : "https://medlineplus.gov/kidneytests.html",
    "description" : "A laboratory procedure that evaluates the kidney function.",
    "id" : null
  }, {
    "name" : "serum antibody level",
    "link" : "http://purl.obolibrary.org/obo/CMO_0001277",
    "description" : "A measurement of the amount of an immunoglobulin molecule possessing a specific amino acid sequence that binds to a specific antigen, a substance introduced into an organism which initiates an immune response including the production of the very antibodies which bind to it in an effort to destroy it, in a specified sample of serum, the clear liquid that separates from blood after it has clotted completely, i.e. blood plasma from which fibrinogen has been removed. [ https://www.worldcat.org/search?q=bn%3A978-1416049982 Dorland:Dorlands_Illustrated_Medical_Dictionary--31st_Ed ]",
    "id" : null
  }, {
    "name" : "Serum protein electrophoresis",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/4903000",
    "description" : "Serum protein electrophoresis",
    "id" : null
  }, {
    "name" : "Thyroid Panel",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/35650009",
    "description" : "Thyroid Panel",
    "id" : null
  }, {
    "name" : "Total Protein Measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64858 ; http://purl.bioontology.org/ontology/SNOMEDCT/74040009",
    "description" : "A quantitative measurement of the amount of total protein present in a sample.",
    "id" : null
  }, {
    "name" : "Urinalysis",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17241",
    "description" : "Laboratory analysis of urine, commonly used to aid in the diagnosis of disease or to detect the presence of a specific substance. It involves examination of the urine by physical or chemical means as well as microscopic examination that helps to screen for urinary tract infections, renal disease, and diseases of other organs, that result in abnormal metabolites (break-down products) appearing in the urine.",
    "id" : null
  }, {
    "name" : "Vitamin measurement",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74803 ; http://purl.bioontology.org/ontology/SNOMEDCT/122446006",
    "description" : "Vitamin level",
    "id" : null
  } ]
}, {
  "name" : "lk_pcr_expression_unit",
  "rows" : [ {
    "name" : "expression_unit_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "Cq",
    "link" : "http://purl.obolibrary.org/obo/STATO_0000190",
    "description" : "Threshold cycle (or Ct or Cq) is a count which is defined as the fractional PCR cycle number at which the reporter fluorescence is greater than the threshold in the context of the RT-qPCR assay.",
    "id" : null
  }, {
    "name" : "Ct",
    "link" : "http://purl.obolibrary.org/obo/STATO_0000190",
    "description" : "Threshold cycle (or Ct or Cq) is a count which is defined as the fractional PCR cycle number at which the reporter fluorescence is greater than the threshold in the context of the RT-qPCR assay.",
    "id" : null
  }, {
    "name" : "Delta Ct",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/11846609",
    "description" : "Difference between the target gene and the reference gene.",
    "id" : null
  }, {
    "name" : "Delta Delta Ct",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/11846609",
    "description" : "Difference between the Delta Ct target gene of the treated sample and the Delta Ct of the target gene of the untreated sample.",
    "id" : null
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : null
  } ]
}, {
  "name" : "lk_personnel_role",
  "rows" : [ {
    "name" : "Bioinformatician",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5237444",
    "description" : "A person practiced in using computers, databases, and math to organize and analyze biological, medical, and health information. (NCI)",
    "id" : ""
  }, {
    "name" : "Biostatistician",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C4743697",
    "description" : "A person who is responsible for the statistical aspects of the clinical or pre-clinical study. (NCI)",
    "id" : ""
  }, {
    "name" : "Clinical Coordinator",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C4721857",
    "description" : "A person to whom a clinical investigator delegates a few of the routine administrative requirements of a protocol. The duties and responsibilities of a clinical research coordinator may vary across different infrastructures. Generally, the coordinator manages the subject's clinical trial participation and provides a vital linkage between the subject, the investigator, and the sponsor. (NCI)",
    "id" : ""
  }, {
    "name" : "Co-Principal Investigator",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C4708567",
    "description" : "A person who shares the primary responsibility for the preparation, conduct, and administration of a research grant, cooperative agreement, or other sponsored project in compliance with applicable laws and regulations and institutional policy governing the conduct of clinical research. (SNOMEDCT_US)",
    "id" : ""
  }, {
    "name" : "Consultant",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0009817",
    "description" : "An advisor participating in the service by performing evaluations and making recommendations,(HL7V3.0). Individuals referred to for expert or professional advice or services. (MSH)",
    "id" : ""
  }, {
    "name" : "Corresponding Author",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=22.04d&ns=ncit&code=C164481",
    "description" : "An indication that the specific author is considered the corresponding author.",
    "id" : ""
  }, {
    "name" : "Data Base Management",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0681314",
    "description" : "Database management involves the design and maintenance of electronic data storage systems to facilitate and optimize the categorization, selection, and retrieval of information. (NCI)",
    "id" : ""
  }, {
    "name" : "Group Coordinator",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C51827",
    "description" : "A person that is responsible for the integration and interaction of work or events from an assembly of different people with diverse interests and operations.",
    "id" : ""
  }, {
    "name" : "Investigator",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=22.04d&ns=ncit&code=C25936",
    "description" : "An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures. The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject). The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements.",
    "id" : ""
  }, {
    "name" : "Laboratory Personnel",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C3178774",
    "description" : "Professionals, technicians, and assistants staffing LABORATORIES. (MSH)",
    "id" : ""
  }, {
    "name" : "Manager",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0335141",
    "description" : "Someone (or something) that controls, directs, and organizes people, resources, or processes. (NCI)",
    "id" : ""
  }, {
    "name" : "Medical Monitor",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C51836",
    "description" : "Person employed by the sponsor or clinical research organization, who is responsible for determining that a clinical study is being conducted in accordance with the protocol. A monitor's duties may include, but are not limited to, helping to plan and initiate a trial, assessing the conduct of trial, assisting in data analysis, interpretation, and extrapolation. Monitor has medical authority for the checking data and documentation from the trial and for the evaluation of its safety aspects.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "A person having a Role that is some Other value not in CV Terms.",
    "id" : ""
  }, {
    "name" : "Principal Investigator",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000103",
    "description" : "A responsible party role played by a person responsible for the overall conduct of a study.",
    "id" : ""
  }, {
    "name" : "Program Director",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C1709698",
    "description" : "A professional who holds a leadership administrative, research, or academic position within a scientific program. A program director is responsible for the overall direction in the conduct of research; provision and coordination of training and education; operations, staffing, and maintenance of research facilities; development of new research activities; developing and maintaining relationships with other agencies, programs, scientific centers and departments, as well as with communities. [Definition Source: NCI]",
    "id" : ""
  }, {
    "name" : "Protocol Chair",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C1709745",
    "description" : "A person at the primary location of research that retains the responsibility for regulation compliance and ensures the proper administration of the objectives, study design, and methodology of study. (NCI)",
    "id" : ""
  }, {
    "name" : "responsible party role",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C1555579",
    "description" : "The person or organization that has primary responsibility for the act. The responsible party is not necessarily present in an action, but is accountable for the action through the power to delegate, and the duty to review actions with the performing actor after the fact. This responsibility may be ethical, legal, contractual, fiscal, or fiduciary in nature. Example:A person who is the head of a biochemical laboratory; a sponsor for a policy or government program. (HL7V3.0)",
    "id" : ""
  }, {
    "name" : "Site Manager",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C70652",
    "description" : "Someone (or something) that controls, directs, and organizes people, resources, or processes.",
    "id" : ""
  }, {
    "name" : "Sub-Investigator",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000224",
    "description" : "A worker role authorized to make study-related decisions and carry out tasks related to the study; this role occurs during the study timeline.",
    "id" : ""
  } ]
}, {
  "name" : "lk_plate_type",
  "rows" : [ {
    "name" : "Not Specified",
    "link" : "",
    "description" : "No plate type specified",
    "id" : ""
  } ]
}, {
  "name" : "lk_preferred_time_unit",
  "rows" : [ {
    "name" : "time_unit_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "d.p.c.",
    "link" : "https://en.wikipedia.org/wiki/Days_post_coitum",
    "description" : "Unit of Days Post Coitum (d.p.c.).",
    "id" : null
  }, {
    "name" : "Days",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25301",
    "description" : "Unit of Days.",
    "id" : null
  }, {
    "name" : "Hours",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25529",
    "description" : "Unit of Hours.",
    "id" : null
  }, {
    "name" : "Minutes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48154",
    "description" : "Unit of Minutes.",
    "id" : null
  }, {
    "name" : "Months",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29846",
    "description" : "Unit of Months.",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "",
    "description" : "Unit is not specified or not received. If no Unit value is received, then this is the system default value.",
    "id" : null
  }, {
    "name" : "Seconds",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25666",
    "description" : "Unit of Seconds.",
    "id" : null
  }, {
    "name" : "Weeks",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29844",
    "description" : "Unit of Weeks.",
    "id" : null
  }, {
    "name" : "Years",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29848",
    "description" : "Unit of Years.",
    "id" : null
  } ]
}, {
  "name" : "lk_protein_name",
  "rows" : [ {
    "name" : "uniprot_gene_name ;\nuniprot_id ;\nprotein_name_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "A1BG ; A1BG_HUMAN ; P04217",
    "link" : "https://www.uniprot.org/uniprot/P04217",
    "description" : "Alpha-1B-glycoprotein",
    "id" : null
  }, {
    "name" : "A2M ; A2MG_HUMAN ; P01023",
    "link" : "https://www.uniprot.org/uniprot/P01023",
    "description" : "Alpha-2-macroglobulin",
    "id" : null
  }, {
    "name" : "ABCA5 ; ABCA5_HUMAN ; Q8WWZ7",
    "link" : "https://www.uniprot.org/uniprot/Q8WWZ7",
    "description" : "ATP-binding cassette sub-family A member 5",
    "id" : null
  }, {
    "name" : "ABCB1 ; MDR1_HUMAN ; P08183",
    "link" : "https://www.uniprot.org/uniprot/P08183",
    "description" : "ATP-dependent translocase ABCB1",
    "id" : null
  }, {
    "name" : "ABCG2 ; ABCG2_HUMAN ; Q9UNQ0",
    "link" : "https://www.uniprot.org/uniprot/Q9UNQ0",
    "description" : "Broad substrate specificity ATP-binding cassette transporter ABCG2",
    "id" : null
  }, {
    "name" : "ACE ; ACE_HUMAN ; P12821",
    "link" : "https://www.uniprot.org/uniprot/P12821",
    "description" : "Angiotensin-converting enzyme",
    "id" : null
  }, {
    "name" : "ACKR1 ; ACKR1_HUMAN ; Q16570",
    "link" : "https://www.uniprot.org/uniprot/Q16570",
    "description" : "Atypical chemokine receptor 1",
    "id" : null
  }, {
    "name" : "ACKR3 ; ACKR3_HUMAN ; P25106",
    "link" : "https://www.uniprot.org/uniprot/P25106",
    "description" : "Atypical chemokine receptor 3",
    "id" : null
  }, {
    "name" : "ACOT4 ; ACOT4_HUMAN ; Q8N9L9",
    "link" : "https://www.uniprot.org/uniprot/Q8N9L9",
    "description" : "Peroxisomal succinyl-coenzyme A thioesterase",
    "id" : null
  }, {
    "name" : "ACP7 ; ACP7_HUMAN ; Q6ZNF0",
    "link" : "https://www.uniprot.org/uniprot/Q6ZNF0",
    "description" : "Acid phosphatase type 7",
    "id" : null
  }, {
    "name" : "ACTB ; ACTB_HUMAN ; P60709",
    "link" : "https://www.uniprot.org/uniprot/P60709",
    "description" : "Actin, cytoplasmic 1",
    "id" : null
  }, {
    "name" : "ADAM10 ; ADA10_HUMAN ; O14672",
    "link" : "https://www.uniprot.org/uniprot/O14672",
    "description" : "Disintegrin and metalloproteinase domain-containing protein 10",
    "id" : null
  }, {
    "name" : "ADAM17 ; ADA17_HUMAN ; P78536",
    "link" : "https://www.uniprot.org/uniprot/P78536",
    "description" : "Disintegrin and metalloproteinase domain-containing protein 17",
    "id" : null
  }, {
    "name" : "ADAM8 ; ADAM8_HUMAN ; P78325",
    "link" : "https://www.uniprot.org/uniprot/P78325",
    "description" : "Disintegrin and metalloproteinase domain-containing protein 8",
    "id" : null
  }, {
    "name" : "ADAMTS13 ; ATS13_HUMAN ; Q76LX8",
    "link" : "https://www.uniprot.org/uniprot/Q76LX8",
    "description" : "A disintegrin and metalloproteinase with thrombospondin motifs 13",
    "id" : null
  }, {
    "name" : "ADGRE2 ; AGRE2_HUMAN ; Q9UHX3",
    "link" : "https://www.uniprot.org/uniprot/Q9UHX3",
    "description" : "Adhesion G protein-coupled receptor E2",
    "id" : null
  }, {
    "name" : "AFM ; AFAM_HUMAN ; P43652",
    "link" : "https://www.uniprot.org/uniprot/P43652",
    "description" : "Afamin",
    "id" : null
  }, {
    "name" : "AFP ; FETA_HUMAN ; P02771",
    "link" : "https://www.uniprot.org/uniprot/P02771",
    "description" : "Alpha-fetoprotein",
    "id" : null
  }, {
    "name" : "AGT ; ANGT_HUMAN ; P01019",
    "link" : "https://www.uniprot.org/uniprot/P01019",
    "description" : "Angiotensinogen",
    "id" : null
  }, {
    "name" : "AHSG ; FETUA_HUMAN ; P02765",
    "link" : "https://www.uniprot.org/uniprot/P02765",
    "description" : "Alpha-2-HS-glycoprotein",
    "id" : null
  }, {
    "name" : "AKAP9 ; AKAP9_HUMAN ; Q99996",
    "link" : "https://www.uniprot.org/uniprot/Q99996",
    "description" : "A-kinase anchor protein 9",
    "id" : null
  }, {
    "name" : "ALB ; ALBU_HUMAN ; P02768",
    "link" : "https://www.uniprot.org/uniprot/P02768",
    "description" : "Albumin",
    "id" : null
  }, {
    "name" : "ALCAM ; CD166_HUMAN ; Q13740",
    "link" : "https://www.uniprot.org/uniprot/Q13740",
    "description" : "CD166 antigen",
    "id" : null
  }, {
    "name" : "ALK ; ALK_HUMAN ; Q9UM73",
    "link" : "https://www.uniprot.org/uniprot/Q9UM73",
    "description" : "ALK tyrosine kinase receptor",
    "id" : null
  }, {
    "name" : "AMBP ; AMBP_HUMAN ; P02760",
    "link" : "https://www.uniprot.org/uniprot/P02760",
    "description" : "Protein AMBP",
    "id" : null
  }, {
    "name" : "ANKRD26 ; ANR26_HUMAN ; Q9UPS8",
    "link" : "https://www.uniprot.org/uniprot/Q9UPS8",
    "description" : "Ankyrin repeat domain-containing protein 26",
    "id" : null
  }, {
    "name" : "ANPEP ; AMPN_HUMAN ; P15144",
    "link" : "https://www.uniprot.org/uniprot/P15144",
    "description" : "Aminopeptidase N",
    "id" : null
  }, {
    "name" : "ANXA5 ; ANXA5_HUMAN ; P08758",
    "link" : "https://www.uniprot.org/uniprot/P08758",
    "description" : "Annexin A5",
    "id" : null
  }, {
    "name" : "APCS ; SAMP_HUMAN ; P02743",
    "link" : "https://www.uniprot.org/uniprot/P02743",
    "description" : "Serum amyloid P-component",
    "id" : null
  }, {
    "name" : "APMAP ; APMAP_HUMAN ; Q9HDC9",
    "link" : "https://www.uniprot.org/uniprot/Q9HDC9",
    "description" : "Adipocyte plasma membrane-associated protein",
    "id" : null
  }, {
    "name" : "APOA1 ; APOA1_HUMAN ; P02647",
    "link" : "https://www.uniprot.org/uniprot/P02647",
    "description" : "Apolipoprotein A-I",
    "id" : null
  }, {
    "name" : "APOA2 ; APOA2_HUMAN ; P02652",
    "link" : "https://www.uniprot.org/uniprot/P02652",
    "description" : "Apolipoprotein A-II",
    "id" : null
  }, {
    "name" : "APOA4 ; APOA4_HUMAN ; P06727",
    "link" : "https://www.uniprot.org/uniprot/P06727",
    "description" : "Apolipoprotein A-IV",
    "id" : null
  }, {
    "name" : "APOB ; APOB_HUMAN ; P04114",
    "link" : "https://www.uniprot.org/uniprot/P04114",
    "description" : "Apolipoprotein B-100",
    "id" : null
  }, {
    "name" : "APOC2 ; APOC2_HUMAN ; P02655",
    "link" : "https://www.uniprot.org/uniprot/P02655",
    "description" : "Apolipoprotein C-II",
    "id" : null
  }, {
    "name" : "APOC3 ; APOC3_HUMAN ; P02656",
    "link" : "https://www.uniprot.org/uniprot/P02656",
    "description" : "Apolipoprotein C-III",
    "id" : null
  }, {
    "name" : "APOC4 ; APOC4_HUMAN ; P55056",
    "link" : "https://www.uniprot.org/uniprot/P55056",
    "description" : "Apolipoprotein C-IV",
    "id" : null
  }, {
    "name" : "APOD ; APOD_HUMAN ; P05090",
    "link" : "https://www.uniprot.org/uniprot/P05090",
    "description" : "Apolipoprotein D",
    "id" : null
  }, {
    "name" : "APOE ; APOE_HUMAN ; P02649",
    "link" : "https://www.uniprot.org/uniprot/P02649",
    "description" : "Apolipoprotein E",
    "id" : null
  }, {
    "name" : "APOH ; APOH_HUMAN ; P02749",
    "link" : "https://www.uniprot.org/uniprot/P02749",
    "description" : "Beta-2-glycoprotein 1",
    "id" : null
  }, {
    "name" : "APOL1 ; APOL1_HUMAN ; O14791",
    "link" : "https://www.uniprot.org/uniprot/O14791",
    "description" : "Apolipoprotein L1",
    "id" : null
  }, {
    "name" : "APOM ; APOM_HUMAN ; O95445",
    "link" : "https://www.uniprot.org/uniprot/O95445",
    "description" : "Apolipoprotein M",
    "id" : null
  }, {
    "name" : "ART1 ; NAR1_HUMAN ; P52961",
    "link" : "https://www.uniprot.org/uniprot/P52961",
    "description" : "GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1",
    "id" : null
  }, {
    "name" : "ART4 ; NAR4_HUMAN ; Q93070",
    "link" : "https://www.uniprot.org/uniprot/Q93070",
    "description" : "Ecto-ADP-ribosyltransferase 4",
    "id" : null
  }, {
    "name" : "ATP1B3 ; AT1B3_HUMAN ; P54709",
    "link" : "https://www.uniprot.org/uniprot/P54709",
    "description" : "Sodium/potassium-transporting ATPase subunit beta-3",
    "id" : null
  }, {
    "name" : "ATRN ; ATRN_HUMAN ; O75882",
    "link" : "https://www.uniprot.org/uniprot/O75882",
    "description" : "Attractin",
    "id" : null
  }, {
    "name" : "AZGP1 ; ZA2G_HUMAN ; P25311",
    "link" : "https://www.uniprot.org/uniprot/P25311",
    "description" : "Zinc-alpha-2-glycoprotein",
    "id" : null
  }, {
    "name" : "B2M ; B2MG_HUMAN ; P61769",
    "link" : "https://www.uniprot.org/uniprot/P61769",
    "description" : "Beta-2-microglobulin",
    "id" : null
  }, {
    "name" : "B3GAT1 ; B3GA1_HUMAN ; Q9P2W7",
    "link" : "https://www.uniprot.org/uniprot/Q9P2W7",
    "description" : "Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1",
    "id" : null
  }, {
    "name" : "BCAM ; BCAM_HUMAN ; P50895",
    "link" : "https://www.uniprot.org/uniprot/P50895",
    "description" : "Basal cell adhesion molecule",
    "id" : null
  }, {
    "name" : "BCL2 ; BCL2_HUMAN ; P10415",
    "link" : "https://www.uniprot.org/uniprot/P10415",
    "description" : "Apoptosis regulator Bcl-2",
    "id" : null
  }, {
    "name" : "BCL6 ; BCL6_HUMAN ; P41182",
    "link" : "https://www.uniprot.org/uniprot/P41182",
    "description" : "B-cell lymphoma 6 protein",
    "id" : null
  }, {
    "name" : "BMPR1A ; BMR1A_HUMAN ; P36894",
    "link" : "https://www.uniprot.org/uniprot/P36894",
    "description" : "Bone morphogenetic protein receptor type-1A",
    "id" : null
  }, {
    "name" : "BMPR1B ; BMR1B_HUMAN ; O00238",
    "link" : "https://www.uniprot.org/uniprot/O00238",
    "description" : "Bone morphogenetic protein receptor type-1B",
    "id" : null
  }, {
    "name" : "BSG ; BASI_HUMAN ; P35613",
    "link" : "https://www.uniprot.org/uniprot/P35613",
    "description" : "Basigin",
    "id" : null
  }, {
    "name" : "BST1 ; BST1_HUMAN ; Q10588",
    "link" : "https://www.uniprot.org/uniprot/Q10588",
    "description" : "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2",
    "id" : null
  }, {
    "name" : "BST2 ; BST2_HUMAN ; Q10589",
    "link" : "https://www.uniprot.org/uniprot/Q10589",
    "description" : "Bone marrow stromal antigen 2",
    "id" : null
  }, {
    "name" : "BTLA ; BTLA_HUMAN ; Q7Z6A9",
    "link" : "https://www.uniprot.org/uniprot/Q7Z6A9",
    "description" : "B- and T-lymphocyte attenuator",
    "id" : null
  }, {
    "name" : "BTN3A1 ; BT3A1_HUMAN ; O00481",
    "link" : "https://www.uniprot.org/uniprot/O00481",
    "description" : "Butyrophilin subfamily 3 member A1",
    "id" : null
  }, {
    "name" : "BUB3 ; BUB3_HUMAN ; O43684",
    "link" : "https://www.uniprot.org/uniprot/O43684",
    "description" : "Mitotic checkpoint protein BUB3",
    "id" : null
  }, {
    "name" : "C12orf42 ; CL042_HUMAN ; Q96LP6",
    "link" : "https://www.uniprot.org/uniprot/Q96LP6",
    "description" : "Uncharacterized protein C12orf42",
    "id" : null
  }, {
    "name" : "C1QB ; C1QB_HUMAN ; P02746",
    "link" : "https://www.uniprot.org/uniprot/P02746",
    "description" : "Complement C1q subcomponent subunit B",
    "id" : null
  }, {
    "name" : "C1QC ; C1QC_HUMAN ; P02747",
    "link" : "https://www.uniprot.org/uniprot/P02747",
    "description" : "Complement C1q subcomponent subunit C",
    "id" : null
  }, {
    "name" : "C1R ; C1R_HUMAN ; P00736",
    "link" : "https://www.uniprot.org/uniprot/P00736",
    "description" : "Complement C1r subcomponent",
    "id" : null
  }, {
    "name" : "C1RL ; C1RL_HUMAN ; Q9NZP8",
    "link" : "https://www.uniprot.org/uniprot/Q9NZP8",
    "description" : "Complement C1r subcomponent-like protein",
    "id" : null
  }, {
    "name" : "C1S ; C1S_HUMAN ; P09871",
    "link" : "https://www.uniprot.org/uniprot/P09871",
    "description" : "Complement C1s subcomponent",
    "id" : null
  }, {
    "name" : "C2 ; CO2_HUMAN ; P06681",
    "link" : "https://www.uniprot.org/uniprot/P06681",
    "description" : "Complement C2",
    "id" : null
  }, {
    "name" : "C3 ; CO3_HUMAN ; P01024",
    "link" : "https://www.uniprot.org/uniprot/P01024",
    "description" : "Complement C3",
    "id" : null
  }, {
    "name" : "C4A ; CO4A_HUMAN ; P0C0L4",
    "link" : "https://www.uniprot.org/uniprot/P0C0L4",
    "description" : "Complement C4-A",
    "id" : null
  }, {
    "name" : "C4B_2 ; CO4B_HUMAN ; P0C0L5",
    "link" : "https://www.uniprot.org/uniprot/P0C0L5",
    "description" : "Complement C4-B",
    "id" : null
  }, {
    "name" : "C4BPA ; C4BPA_HUMAN ; P04003",
    "link" : "https://www.uniprot.org/uniprot/P04003",
    "description" : "C4b-binding protein alpha chain",
    "id" : null
  }, {
    "name" : "C5 ; CO5_HUMAN ; P01031",
    "link" : "https://www.uniprot.org/uniprot/P01031",
    "description" : "Complement C5",
    "id" : null
  }, {
    "name" : "C5AR1 ; C5AR1_HUMAN ; P21730",
    "link" : "https://www.uniprot.org/uniprot/P21730",
    "description" : "C5a anaphylatoxin chemotactic receptor 1",
    "id" : null
  }, {
    "name" : "C6 ; CO6_HUMAN ; P13671",
    "link" : "https://www.uniprot.org/uniprot/P13671",
    "description" : "Complement component C6",
    "id" : null
  }, {
    "name" : "C7 ; CO7_HUMAN ; P10643",
    "link" : "https://www.uniprot.org/uniprot/P10643",
    "description" : "Complement component C7",
    "id" : null
  }, {
    "name" : "C8A ; CO8A_HUMAN ; P07357",
    "link" : "https://www.uniprot.org/uniprot/P07357",
    "description" : "Complement component C8 alpha chain",
    "id" : null
  }, {
    "name" : "C8B ; CO8B_HUMAN ; P07358",
    "link" : "https://www.uniprot.org/uniprot/P07358",
    "description" : "Complement component C8 beta chain",
    "id" : null
  }, {
    "name" : "C8G ; CO8G_HUMAN ; P07360",
    "link" : "https://www.uniprot.org/uniprot/P07360",
    "description" : "Complement component C8 gamma chain",
    "id" : null
  }, {
    "name" : "C9 ; CO9_HUMAN ; P02748",
    "link" : "https://www.uniprot.org/uniprot/P02748",
    "description" : "Complement component C9",
    "id" : null
  }, {
    "name" : "C9orf43 ; CI043_HUMAN ; Q8TAL5",
    "link" : "https://www.uniprot.org/uniprot/Q8TAL5",
    "description" : "Uncharacterized protein C9orf43",
    "id" : null
  }, {
    "name" : "CA1 ; CAH1_HUMAN ; P00915",
    "link" : "https://www.uniprot.org/uniprot/P00915",
    "description" : "Carbonic anhydrase 1",
    "id" : null
  }, {
    "name" : "CAPN10 ; CAN10_HUMAN ; Q9HC96",
    "link" : "https://www.uniprot.org/uniprot/Q9HC96",
    "description" : "Calpain-10",
    "id" : null
  }, {
    "name" : "CARD9 ; CARD9_HUMAN ; Q9H257",
    "link" : "https://www.uniprot.org/uniprot/Q9H257",
    "description" : "Caspase recruitment domain-containing protein 9",
    "id" : null
  }, {
    "name" : "CASP3 ; CASP3_HUMAN ; P42574",
    "link" : "https://www.uniprot.org/uniprot/P42574",
    "description" : "Caspase-3",
    "id" : null
  }, {
    "name" : "CCDC168 ; CC168_HUMAN ; Q8NDH2",
    "link" : "https://www.uniprot.org/uniprot/Q8NDH2",
    "description" : "Coiled-coil domain-containing protein 168",
    "id" : null
  }, {
    "name" : "CCDC18 ; CCD18_HUMAN ; Q5T9S5",
    "link" : "https://www.uniprot.org/uniprot/Q5T9S5",
    "description" : "Coiled-coil domain-containing protein 18",
    "id" : null
  }, {
    "name" : "CCL1 ; CCL1_HUMAN ; P22362",
    "link" : "https://www.uniprot.org/uniprot/P22362",
    "description" : "C-C motif chemokine 1",
    "id" : null
  }, {
    "name" : "CCL11 ; CCL11_HUMAN ; P51671",
    "link" : "https://www.uniprot.org/uniprot/P51671",
    "description" : "Eotaxin",
    "id" : null
  }, {
    "name" : "CCL13 ; CCL13_HUMAN ; Q99616",
    "link" : "https://www.uniprot.org/uniprot/Q99616",
    "description" : "C-C motif chemokine 13",
    "id" : null
  }, {
    "name" : "CCL14 ; CCL14_HUMAN ; Q16627",
    "link" : "https://www.uniprot.org/uniprot/Q16627",
    "description" : "C-C motif chemokine 14",
    "id" : null
  }, {
    "name" : "CCL15 ; CCL15_HUMAN ; Q16663",
    "link" : "https://www.uniprot.org/uniprot/Q16663",
    "description" : "C-C motif chemokine 15",
    "id" : null
  }, {
    "name" : "CCL16 ; CCL16_HUMAN ; O15467",
    "link" : "https://www.uniprot.org/uniprot/O15467",
    "description" : "C-C motif chemokine 16",
    "id" : null
  }, {
    "name" : "CCL17 ; CCL17_HUMAN ; Q92583",
    "link" : "https://www.uniprot.org/uniprot/Q92583",
    "description" : "C-C motif chemokine 17",
    "id" : null
  }, {
    "name" : "CCL18 ; CCL18_HUMAN ; P55774",
    "link" : "https://www.uniprot.org/uniprot/P55774",
    "description" : "C-C motif chemokine 18",
    "id" : null
  }, {
    "name" : "CCL19 ; CCL19_HUMAN ; Q99731",
    "link" : "https://www.uniprot.org/uniprot/Q99731",
    "description" : "C-C motif chemokine 19",
    "id" : null
  }, {
    "name" : "CCL2 ; CCL2_HUMAN ; P13500",
    "link" : "https://www.uniprot.org/uniprot/P13500",
    "description" : "C-C motif chemokine 2",
    "id" : null
  }, {
    "name" : "CCL20 ; CCL20_HUMAN ; P78556",
    "link" : "https://www.uniprot.org/uniprot/P78556",
    "description" : "C-C motif chemokine 20",
    "id" : null
  }, {
    "name" : "CCL21 ; CCL21_HUMAN ; O00585",
    "link" : "https://www.uniprot.org/uniprot/O00585",
    "description" : "C-C motif chemokine 21",
    "id" : null
  }, {
    "name" : "CCL22 ; CCL22_HUMAN ; O00626",
    "link" : "https://www.uniprot.org/uniprot/O00626",
    "description" : "C-C motif chemokine 22",
    "id" : null
  }, {
    "name" : "CCL23 ; CCL23_HUMAN ; P55773",
    "link" : "https://www.uniprot.org/uniprot/P55773",
    "description" : "C-C motif chemokine 23",
    "id" : null
  }, {
    "name" : "CCL24 ; CCL24_HUMAN ; O00175",
    "link" : "https://www.uniprot.org/uniprot/O00175",
    "description" : "C-C motif chemokine 24",
    "id" : null
  }, {
    "name" : "CCL25 ; CCL25_HUMAN ; O15444",
    "link" : "https://www.uniprot.org/uniprot/O15444",
    "description" : "C-C motif chemokine 25",
    "id" : null
  }, {
    "name" : "CCL26 ; CCL26_HUMAN ; Q9Y258",
    "link" : "https://www.uniprot.org/uniprot/Q9Y258",
    "description" : "C-C motif chemokine 26",
    "id" : null
  }, {
    "name" : "CCL27 ; CCL27_HUMAN ; Q9Y4X3",
    "link" : "https://www.uniprot.org/uniprot/Q9Y4X3",
    "description" : "C-C motif chemokine 27",
    "id" : null
  }, {
    "name" : "CCL3 ; CCL3_HUMAN ; P10147",
    "link" : "https://www.uniprot.org/uniprot/P10147",
    "description" : "C-C motif chemokine 3",
    "id" : null
  }, {
    "name" : "CCL3L3 ; CL3L1_HUMAN ; P16619",
    "link" : "https://www.uniprot.org/uniprot/P16619",
    "description" : "C-C motif chemokine 3-like 1",
    "id" : null
  }, {
    "name" : "CCL4 ; CCL4_HUMAN ; P13236",
    "link" : "https://www.uniprot.org/uniprot/P13236",
    "description" : "C-C motif chemokine 4",
    "id" : null
  }, {
    "name" : "CCL4L2 ; CC4L_HUMAN ; Q8NHW4",
    "link" : "https://www.uniprot.org/uniprot/Q8NHW4",
    "description" : "C-C motif chemokine 4-like",
    "id" : null
  }, {
    "name" : "CCL5 ; CCL5_HUMAN ; P13501",
    "link" : "https://www.uniprot.org/uniprot/P13501",
    "description" : "C-C motif chemokine 5",
    "id" : null
  }, {
    "name" : "CCL7 ; CCL7_HUMAN ; P80098",
    "link" : "https://www.uniprot.org/uniprot/P80098",
    "description" : "C-C motif chemokine 7",
    "id" : null
  }, {
    "name" : "CCL8 ; CCL8_HUMAN ; P80075",
    "link" : "https://www.uniprot.org/uniprot/P80075",
    "description" : "C-C motif chemokine 8",
    "id" : null
  }, {
    "name" : "CCR1 ; CCR1_HUMAN ; P32246",
    "link" : "https://www.uniprot.org/uniprot/P32246",
    "description" : "C-C chemokine receptor type 1",
    "id" : null
  }, {
    "name" : "CCR10 ; CCR10_HUMAN ; P46092",
    "link" : "https://www.uniprot.org/uniprot/P46092",
    "description" : "C-C chemokine receptor type 10",
    "id" : null
  }, {
    "name" : "CCR2 ; CCR2_HUMAN ; P41597",
    "link" : "https://www.uniprot.org/uniprot/P41597",
    "description" : "C-C chemokine receptor type 2",
    "id" : null
  }, {
    "name" : "CCR3 ; CCR3_HUMAN ; P51677",
    "link" : "https://www.uniprot.org/uniprot/P51677",
    "description" : "C-C chemokine receptor type 3",
    "id" : null
  }, {
    "name" : "CCR4 ; CCR4_HUMAN ; P51679",
    "link" : "https://www.uniprot.org/uniprot/P51679",
    "description" : "C-C chemokine receptor type 4",
    "id" : null
  }, {
    "name" : "CCR5 ; CCR5_HUMAN ; P51681",
    "link" : "https://www.uniprot.org/uniprot/P51681",
    "description" : "C-C chemokine receptor type 5",
    "id" : null
  }, {
    "name" : "CCR6 ; CCR6_HUMAN ; P51684",
    "link" : "https://www.uniprot.org/uniprot/P51684",
    "description" : "C-C chemokine receptor type 6",
    "id" : null
  }, {
    "name" : "CCR7 ; CCR7_HUMAN ; P32248",
    "link" : "https://www.uniprot.org/uniprot/P32248",
    "description" : "C-C chemokine receptor type 7",
    "id" : null
  }, {
    "name" : "CCR8 ; CCR8_HUMAN ; P51685",
    "link" : "https://www.uniprot.org/uniprot/P51685",
    "description" : "C-C chemokine receptor type 8",
    "id" : null
  }, {
    "name" : "CCR9 ; CCR9_HUMAN ; P51686",
    "link" : "https://www.uniprot.org/uniprot/P51686",
    "description" : "C-C chemokine receptor type 9",
    "id" : null
  }, {
    "name" : "CD101 ; IGSF2_HUMAN ; Q93033",
    "link" : "https://www.uniprot.org/uniprot/Q93033",
    "description" : "Immunoglobulin superfamily member 2",
    "id" : null
  }, {
    "name" : "CD109 ; CD109_HUMAN ; Q6YHK3",
    "link" : "https://www.uniprot.org/uniprot/Q6YHK3",
    "description" : "CD109 antigen",
    "id" : null
  }, {
    "name" : "CD14 ; CD14_HUMAN ; P08571",
    "link" : "https://www.uniprot.org/uniprot/P08571",
    "description" : "Monocyte differentiation antigen CD14",
    "id" : null
  }, {
    "name" : "CD151 ; CD151_HUMAN ; P48509",
    "link" : "https://www.uniprot.org/uniprot/P48509",
    "description" : "CD151 antigen",
    "id" : null
  }, {
    "name" : "CD160 ; BY55_HUMAN ; O95971",
    "link" : "https://www.uniprot.org/uniprot/O95971",
    "description" : "CD160 antigen",
    "id" : null
  }, {
    "name" : "CD163 ; C163A_HUMAN ; Q86VB7",
    "link" : "https://www.uniprot.org/uniprot/Q86VB7",
    "description" : "Scavenger receptor cysteine-rich type 1 protein M130",
    "id" : null
  }, {
    "name" : "CD164 ; MUC24_HUMAN ; Q04900",
    "link" : "https://www.uniprot.org/uniprot/Q04900",
    "description" : "Sialomucin core protein 24",
    "id" : null
  }, {
    "name" : "CD177 ; CD177_HUMAN ; Q8N6Q3",
    "link" : "https://www.uniprot.org/uniprot/Q8N6Q3",
    "description" : "CD177 antigen",
    "id" : null
  }, {
    "name" : "CD180 ; CD180_HUMAN ; Q99467",
    "link" : "https://www.uniprot.org/uniprot/Q99467",
    "description" : "CD180 antigen",
    "id" : null
  }, {
    "name" : "CD19 ; CD19_HUMAN ; P15391",
    "link" : "https://www.uniprot.org/uniprot/P15391",
    "description" : "B-lymphocyte antigen CD19",
    "id" : null
  }, {
    "name" : "CD1A ; CD1A_HUMAN ; P06126",
    "link" : "https://www.uniprot.org/uniprot/P06126",
    "description" : "T-cell surface glycoprotein CD1a",
    "id" : null
  }, {
    "name" : "CD1B ; CD1B_HUMAN ; P29016",
    "link" : "https://www.uniprot.org/uniprot/P29016",
    "description" : "T-cell surface glycoprotein CD1b",
    "id" : null
  }, {
    "name" : "CD1C ; CD1C_HUMAN ; P29017",
    "link" : "https://www.uniprot.org/uniprot/P29017",
    "description" : "T-cell surface glycoprotein CD1c",
    "id" : null
  }, {
    "name" : "CD1D ; CD1D_HUMAN ; P15813",
    "link" : "https://www.uniprot.org/uniprot/P15813",
    "description" : "Antigen-presenting glycoprotein CD1d",
    "id" : null
  }, {
    "name" : "CD1E ; CD1E_HUMAN ; P15812",
    "link" : "https://www.uniprot.org/uniprot/P15812",
    "description" : "T-cell surface glycoprotein CD1e, membrane-associated",
    "id" : null
  }, {
    "name" : "CD2 ; CD2_HUMAN ; P06729",
    "link" : "https://www.uniprot.org/uniprot/P06729",
    "description" : "T-cell surface antigen CD2",
    "id" : null
  }, {
    "name" : "CD200 ; OX2G_HUMAN ; P41217",
    "link" : "https://www.uniprot.org/uniprot/P41217",
    "description" : "OX-2 membrane glycoprotein",
    "id" : null
  }, {
    "name" : "CD207 ; CLC4K_HUMAN ; Q9UJ71",
    "link" : "https://www.uniprot.org/uniprot/Q9UJ71",
    "description" : "C-type lectin domain family 4 member K",
    "id" : null
  }, {
    "name" : "CD209 ; CD209_HUMAN ; Q9NNX6",
    "link" : "https://www.uniprot.org/uniprot/Q9NNX6",
    "description" : "CD209 antigen",
    "id" : null
  }, {
    "name" : "CD22 ; CD22_HUMAN ; P20273",
    "link" : "https://www.uniprot.org/uniprot/P20273",
    "description" : "B-cell receptor CD22",
    "id" : null
  }, {
    "name" : "CD226 ; CD226_HUMAN ; Q15762",
    "link" : "https://www.uniprot.org/uniprot/Q15762",
    "description" : "CD226 antigen",
    "id" : null
  }, {
    "name" : "CD24 ; CD24_HUMAN ; P25063",
    "link" : "https://www.uniprot.org/uniprot/P25063",
    "description" : "Signal transducer CD24",
    "id" : null
  }, {
    "name" : "CD244 ; CD244_HUMAN ; Q9BZW8",
    "link" : "https://www.uniprot.org/uniprot/Q9BZW8",
    "description" : "Natural killer cell receptor 2B4",
    "id" : null
  }, {
    "name" : "CD247 ; CD3Z_HUMAN ; P20963",
    "link" : "https://www.uniprot.org/uniprot/P20963",
    "description" : "T-cell surface glycoprotein CD3 zeta chain",
    "id" : null
  }, {
    "name" : "CD248 ; CD248_HUMAN ; Q9HCU0",
    "link" : "https://www.uniprot.org/uniprot/Q9HCU0",
    "description" : "Endosialin",
    "id" : null
  }, {
    "name" : "CD27 ; CD27_HUMAN ; P26842",
    "link" : "https://www.uniprot.org/uniprot/P26842",
    "description" : "CD27 antigen",
    "id" : null
  }, {
    "name" : "CD274 ; PD1L1_HUMAN ; Q9NZQ7",
    "link" : "https://www.uniprot.org/uniprot/Q9NZQ7",
    "description" : "Programmed cell death 1 ligand 1",
    "id" : null
  }, {
    "name" : "CD276 ; CD276_HUMAN ; Q5ZPR3",
    "link" : "https://www.uniprot.org/uniprot/Q5ZPR3",
    "description" : "CD276 antigen",
    "id" : null
  }, {
    "name" : "CD28 ; CD28_HUMAN ; P10747",
    "link" : "https://www.uniprot.org/uniprot/P10747",
    "description" : "T-cell-specific surface glycoprotein CD28",
    "id" : null
  }, {
    "name" : "CD300A ; CLM8_HUMAN ; Q9UGN4",
    "link" : "https://www.uniprot.org/uniprot/Q9UGN4",
    "description" : "CMRF35-like molecule 8",
    "id" : null
  }, {
    "name" : "CD300C ; CLM6_HUMAN ; Q08708",
    "link" : "https://www.uniprot.org/uniprot/Q08708",
    "description" : "CMRF35-like molecule 6",
    "id" : null
  }, {
    "name" : "CD300E ; CLM2_HUMAN ; Q496F6",
    "link" : "https://www.uniprot.org/uniprot/Q496F6",
    "description" : "CMRF35-like molecule 2",
    "id" : null
  }, {
    "name" : "CD302 ; CD302_HUMAN ; Q8IX05",
    "link" : "https://www.uniprot.org/uniprot/Q8IX05",
    "description" : "CD302 antigen",
    "id" : null
  }, {
    "name" : "CD320 ; CD320_HUMAN ; Q9NPF0",
    "link" : "https://www.uniprot.org/uniprot/Q9NPF0",
    "description" : "CD320 antigen",
    "id" : null
  }, {
    "name" : "CD33 ; CD33_HUMAN ; P20138",
    "link" : "https://www.uniprot.org/uniprot/P20138",
    "description" : "Myeloid cell surface antigen CD33",
    "id" : null
  }, {
    "name" : "CD34 ; CD34_HUMAN ; P28906",
    "link" : "https://www.uniprot.org/uniprot/P28906",
    "description" : "Hematopoietic progenitor cell antigen CD34",
    "id" : null
  }, {
    "name" : "CD36 ; CD36_HUMAN ; P16671",
    "link" : "https://www.uniprot.org/uniprot/P16671",
    "description" : "Platelet glycoprotein 4",
    "id" : null
  }, {
    "name" : "CD37 ; CD37_HUMAN ; P11049",
    "link" : "https://www.uniprot.org/uniprot/P11049",
    "description" : "Leukocyte antigen CD37",
    "id" : null
  }, {
    "name" : "CD38 ; CD38_HUMAN ; P28907",
    "link" : "https://www.uniprot.org/uniprot/P28907",
    "description" : "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1",
    "id" : null
  }, {
    "name" : "CD3D ; CD3D_HUMAN ; P04234",
    "link" : "https://www.uniprot.org/uniprot/P04234",
    "description" : "T-cell surface glycoprotein CD3 delta chain",
    "id" : null
  }, {
    "name" : "CD3E ; CD3E_HUMAN ; P07766",
    "link" : "https://www.uniprot.org/uniprot/P07766",
    "description" : "T-cell surface glycoprotein CD3 epsilon chain",
    "id" : null
  }, {
    "name" : "CD3G ; CD3G_HUMAN ; P09693",
    "link" : "https://www.uniprot.org/uniprot/P09693",
    "description" : "T-cell surface glycoprotein CD3 gamma chain",
    "id" : null
  }, {
    "name" : "CD4 ; CD4_HUMAN ; P01730",
    "link" : "https://www.uniprot.org/uniprot/P01730",
    "description" : "T-cell surface glycoprotein CD4",
    "id" : null
  }, {
    "name" : "CD40 ; TNR5_HUMAN ; P25942",
    "link" : "https://www.uniprot.org/uniprot/P25942",
    "description" : "Tumor necrosis factor receptor superfamily member 5",
    "id" : null
  }, {
    "name" : "CD40LG ; CD40L_HUMAN ; P29965",
    "link" : "https://www.uniprot.org/uniprot/P29965",
    "description" : "CD40 ligand",
    "id" : null
  }, {
    "name" : "CD44 ; CD44_HUMAN ; P16070",
    "link" : "https://www.uniprot.org/uniprot/P16070",
    "description" : "CD44 antigen",
    "id" : null
  }, {
    "name" : "CD46 ; MCP_HUMAN ; P15529",
    "link" : "https://www.uniprot.org/uniprot/P15529",
    "description" : "Membrane cofactor protein",
    "id" : null
  }, {
    "name" : "CD47 ; CD47_HUMAN ; Q08722",
    "link" : "https://www.uniprot.org/uniprot/Q08722",
    "description" : "Leukocyte surface antigen CD47",
    "id" : null
  }, {
    "name" : "CD48 ; CD48_HUMAN ; P09326",
    "link" : "https://www.uniprot.org/uniprot/P09326",
    "description" : "CD48 antigen",
    "id" : null
  }, {
    "name" : "CD5 ; CD5_HUMAN ; P06127",
    "link" : "https://www.uniprot.org/uniprot/P06127",
    "description" : "T-cell surface glycoprotein CD5",
    "id" : null
  }, {
    "name" : "CD52 ; CD52_HUMAN ; P31358",
    "link" : "https://www.uniprot.org/uniprot/P31358",
    "description" : "CAMPATH-1 antigen",
    "id" : null
  }, {
    "name" : "CD53 ; CD53_HUMAN ; P19397",
    "link" : "https://www.uniprot.org/uniprot/P19397",
    "description" : "Leukocyte surface antigen CD53",
    "id" : null
  }, {
    "name" : "CD55 ; DAF_HUMAN ; P08174",
    "link" : "https://www.uniprot.org/uniprot/P08174",
    "description" : "Complement decay-accelerating factor",
    "id" : null
  }, {
    "name" : "CD58 ; LFA3_HUMAN ; P19256",
    "link" : "https://www.uniprot.org/uniprot/P19256",
    "description" : "Lymphocyte function-associated antigen 3",
    "id" : null
  }, {
    "name" : "CD59 ; CD59_HUMAN ; P13987",
    "link" : "https://www.uniprot.org/uniprot/P13987",
    "description" : "CD59 glycoprotein",
    "id" : null
  }, {
    "name" : "CD5L ; CD5L_HUMAN ; O43866",
    "link" : "https://www.uniprot.org/uniprot/O43866",
    "description" : "CD5 antigen-like",
    "id" : null
  }, {
    "name" : "CD6 ; CD6_HUMAN ; P30203",
    "link" : "https://www.uniprot.org/uniprot/P30203",
    "description" : "T-cell differentiation antigen CD6",
    "id" : null
  }, {
    "name" : "CD63 ; CD63_HUMAN ; P08962",
    "link" : "https://www.uniprot.org/uniprot/P08962",
    "description" : "CD63 antigen",
    "id" : null
  }, {
    "name" : "CD68 ; CD68_HUMAN ; P34810",
    "link" : "https://www.uniprot.org/uniprot/P34810",
    "description" : "Macrosialin",
    "id" : null
  }, {
    "name" : "CD69 ; CD69_HUMAN ; Q07108",
    "link" : "https://www.uniprot.org/uniprot/Q07108",
    "description" : "Early activation antigen CD69",
    "id" : null
  }, {
    "name" : "CD7 ; CD7_HUMAN ; P09564",
    "link" : "https://www.uniprot.org/uniprot/P09564",
    "description" : "T-cell antigen CD7",
    "id" : null
  }, {
    "name" : "CD70 ; CD70_HUMAN ; P32970",
    "link" : "https://www.uniprot.org/uniprot/P32970",
    "description" : "CD70 antigen",
    "id" : null
  }, {
    "name" : "CD72 ; CD72_HUMAN ; P21854",
    "link" : "https://www.uniprot.org/uniprot/P21854",
    "description" : "B-cell differentiation antigen CD72",
    "id" : null
  }, {
    "name" : "CD74 ; HG2A_HUMAN ; P04233",
    "link" : "https://www.uniprot.org/uniprot/P04233",
    "description" : "HLA class II histocompatibility antigen gamma chain",
    "id" : null
  }, {
    "name" : "CD79A ; CD79A_HUMAN ; P11912",
    "link" : "https://www.uniprot.org/uniprot/P11912",
    "description" : "B-cell antigen receptor complex-associated protein alpha chain",
    "id" : null
  }, {
    "name" : "CD79B ; CD79B_HUMAN ; P40259",
    "link" : "https://www.uniprot.org/uniprot/P40259",
    "description" : "B-cell antigen receptor complex-associated protein beta chain",
    "id" : null
  }, {
    "name" : "CD80 ; CD80_HUMAN ; P33681",
    "link" : "https://www.uniprot.org/uniprot/P33681",
    "description" : "T-lymphocyte activation antigen CD80",
    "id" : null
  }, {
    "name" : "CD81 ; CD81_HUMAN ; P60033",
    "link" : "https://www.uniprot.org/uniprot/P60033",
    "description" : "CD81 antigen",
    "id" : null
  }, {
    "name" : "CD82 ; CD82_HUMAN ; P27701",
    "link" : "https://www.uniprot.org/uniprot/P27701",
    "description" : "CD82 antigen",
    "id" : null
  }, {
    "name" : "CD83 ; CD83_HUMAN ; Q01151",
    "link" : "https://www.uniprot.org/uniprot/Q01151",
    "description" : "CD83 antigen",
    "id" : null
  }, {
    "name" : "CD84 ; SLAF5_HUMAN ; Q9UIB8",
    "link" : "https://www.uniprot.org/uniprot/Q9UIB8",
    "description" : "SLAM family member 5",
    "id" : null
  }, {
    "name" : "CD86 ; CD86_HUMAN ; P42081",
    "link" : "https://www.uniprot.org/uniprot/P42081",
    "description" : "T-lymphocyte activation antigen CD86",
    "id" : null
  }, {
    "name" : "CD8A ; CD8A_HUMAN ; P01732",
    "link" : "https://www.uniprot.org/uniprot/P01732",
    "description" : "T-cell surface glycoprotein CD8 alpha chain",
    "id" : null
  }, {
    "name" : "CD8B ; CD8B_HUMAN ; P10966",
    "link" : "https://www.uniprot.org/uniprot/P10966",
    "description" : "T-cell surface glycoprotein CD8 beta chain",
    "id" : null
  }, {
    "name" : "CD9 ; CD9_HUMAN ; P21926",
    "link" : "https://www.uniprot.org/uniprot/P21926",
    "description" : "CD9 antigen",
    "id" : null
  }, {
    "name" : "CD93 ; C1QR1_HUMAN ; Q9NPY3",
    "link" : "https://www.uniprot.org/uniprot/Q9NPY3",
    "description" : "Complement component C1q receptor",
    "id" : null
  }, {
    "name" : "CD96 ; TACT_HUMAN ; P40200",
    "link" : "https://www.uniprot.org/uniprot/P40200",
    "description" : "T-cell surface protein tactile",
    "id" : null
  }, {
    "name" : "CD97 ; CD97_HUMAN ; P48960",
    "link" : "https://www.uniprot.org/uniprot/P48960",
    "description" : "CD97 antigen",
    "id" : null
  }, {
    "name" : "CD99 ; CD99_HUMAN ; P14209",
    "link" : "https://www.uniprot.org/uniprot/P14209",
    "description" : "CD99 antigen",
    "id" : null
  }, {
    "name" : "CDCP1 ; CDCP1_HUMAN ; Q9H5V8",
    "link" : "https://www.uniprot.org/uniprot/Q9H5V8",
    "description" : "CUB domain-containing protein 1",
    "id" : null
  }, {
    "name" : "CDH1 ; CADH1_HUMAN ; P12830",
    "link" : "https://www.uniprot.org/uniprot/P12830",
    "description" : "Cadherin-1",
    "id" : null
  }, {
    "name" : "CDH2 ; CADH2_HUMAN ; P19022",
    "link" : "https://www.uniprot.org/uniprot/P19022",
    "description" : "Cadherin-2",
    "id" : null
  }, {
    "name" : "CDH26 ; CAD26_HUMAN ; Q8IXH8",
    "link" : "https://www.uniprot.org/uniprot/Q8IXH8",
    "description" : "Cadherin-like protein 26",
    "id" : null
  }, {
    "name" : "CDH5 ; CADH5_HUMAN ; P33151",
    "link" : "https://www.uniprot.org/uniprot/P33151",
    "description" : "Cadherin-5",
    "id" : null
  }, {
    "name" : "CEACAM1 ; CEAM1_HUMAN ; P13688",
    "link" : "https://www.uniprot.org/uniprot/P13688",
    "description" : "Carcinoembryonic antigen-related cell adhesion molecule 1",
    "id" : null
  }, {
    "name" : "CEACAM3 ; CEAM3_HUMAN ; P40198",
    "link" : "https://www.uniprot.org/uniprot/P40198",
    "description" : "Carcinoembryonic antigen-related cell adhesion molecule 3",
    "id" : null
  }, {
    "name" : "CEACAM5 ; CEAM5_HUMAN ; P06731",
    "link" : "https://www.uniprot.org/uniprot/P06731",
    "description" : "Carcinoembryonic antigen-related cell adhesion molecule 5",
    "id" : null
  }, {
    "name" : "CEACAM6 ; CEAM6_HUMAN ; P40199",
    "link" : "https://www.uniprot.org/uniprot/P40199",
    "description" : "Carcinoembryonic antigen-related cell adhesion molecule 6",
    "id" : null
  }, {
    "name" : "CEACAM8 ; CEAM8_HUMAN ; P31997",
    "link" : "https://www.uniprot.org/uniprot/P31997",
    "description" : "Carcinoembryonic antigen-related cell adhesion molecule 8",
    "id" : null
  }, {
    "name" : "CENPB ; CENPB_HUMAN ; P07199",
    "link" : "https://www.uniprot.org/uniprot/P07199",
    "description" : "Major centromere autoantigen B",
    "id" : null
  }, {
    "name" : "CEP350 ; CE350_HUMAN ; Q5VT06",
    "link" : "https://www.uniprot.org/uniprot/Q5VT06",
    "description" : "Centrosome-associated protein 350",
    "id" : null
  }, {
    "name" : "CEP63 ; CEP63_HUMAN ; Q96MT8",
    "link" : "https://www.uniprot.org/uniprot/Q96MT8",
    "description" : "Centrosomal protein of 63 kDa",
    "id" : null
  }, {
    "name" : "CFB ; CFAB_HUMAN ; P00751",
    "link" : "https://www.uniprot.org/uniprot/P00751",
    "description" : "Complement factor B",
    "id" : null
  }, {
    "name" : "CFD ; CFAD_HUMAN ; P00746",
    "link" : "https://www.uniprot.org/uniprot/P00746",
    "description" : "Complement factor D",
    "id" : null
  }, {
    "name" : "CFH ; CFAH_HUMAN ; P08603",
    "link" : "https://www.uniprot.org/uniprot/P08603",
    "description" : "Complement factor H",
    "id" : null
  }, {
    "name" : "CFHR1 ; FHR1_HUMAN ; Q03591",
    "link" : "https://www.uniprot.org/uniprot/Q03591",
    "description" : "Complement factor H-related protein 1",
    "id" : null
  }, {
    "name" : "CFHR2 ; FHR2_HUMAN ; P36980",
    "link" : "https://www.uniprot.org/uniprot/P36980",
    "description" : "Complement factor H-related protein 2",
    "id" : null
  }, {
    "name" : "CFHR3 ; FHR3_HUMAN ; Q02985",
    "link" : "https://www.uniprot.org/uniprot/Q02985",
    "description" : "Complement factor H-related protein 3",
    "id" : null
  }, {
    "name" : "CFI ; CFAI_HUMAN ; P05156",
    "link" : "https://www.uniprot.org/uniprot/P05156",
    "description" : "Complement factor I",
    "id" : null
  }, {
    "name" : "CFP ; PROP_HUMAN ; P27918",
    "link" : "https://www.uniprot.org/uniprot/P27918",
    "description" : "Properdin",
    "id" : null
  }, {
    "name" : "CKLF ; CKLF_HUMAN ; Q9UBR5",
    "link" : "https://www.uniprot.org/uniprot/Q9UBR5",
    "description" : "Chemokine-like factor",
    "id" : null
  }, {
    "name" : "CLCF1 ; CLCF1_HUMAN ; Q9UBD9",
    "link" : "https://www.uniprot.org/uniprot/Q9UBD9",
    "description" : "Cardiotrophin-like cytokine factor 1",
    "id" : null
  }, {
    "name" : "CLEC10A ; CLC10_HUMAN ; Q8IUN9",
    "link" : "https://www.uniprot.org/uniprot/Q8IUN9",
    "description" : "C-type lectin domain family 10 member A",
    "id" : null
  }, {
    "name" : "CLEC3B ; TETN_HUMAN ; P05452",
    "link" : "https://www.uniprot.org/uniprot/P05452",
    "description" : "Tetranectin",
    "id" : null
  }, {
    "name" : "CLEC4C ; CLC4C_HUMAN ; Q8WTT0",
    "link" : "https://www.uniprot.org/uniprot/Q8WTT0",
    "description" : "C-type lectin domain family 4 member C",
    "id" : null
  }, {
    "name" : "CLEC4M ; CLC4M_HUMAN ; Q9H2X3",
    "link" : "https://www.uniprot.org/uniprot/Q9H2X3",
    "description" : "C-type lectin domain family 4 member M",
    "id" : null
  }, {
    "name" : "CLU ; CLUS_HUMAN ; P10909",
    "link" : "https://www.uniprot.org/uniprot/P10909",
    "description" : "Clusterin",
    "id" : null
  }, {
    "name" : "CMTM1 ; CKLF1_HUMAN ; Q8IZ96",
    "link" : "https://www.uniprot.org/uniprot/Q8IZ96",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 1",
    "id" : null
  }, {
    "name" : "CMTM6 ; CKLF6_HUMAN ; Q9NX76",
    "link" : "https://www.uniprot.org/uniprot/Q9NX76",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 6",
    "id" : null
  }, {
    "name" : "CMTM7 ; CKLF7_HUMAN ; Q96FZ5",
    "link" : "https://www.uniprot.org/uniprot/Q96FZ5",
    "description" : "CKLF-like MARVEL transmembrane domain-containing protein 7",
    "id" : null
  }, {
    "name" : "CNMD ; CNMD_HUMAN ; O75829",
    "link" : "https://www.uniprot.org/uniprot/O75829",
    "description" : "Leukocyte cell-derived chemotaxin 1",
    "id" : null
  }, {
    "name" : "CNTFR ; CNTFR_HUMAN ; P26992",
    "link" : "https://www.uniprot.org/uniprot/P26992",
    "description" : "Ciliary neurotrophic factor receptor subunit alpha",
    "id" : null
  }, {
    "name" : "CNTRL ; CNTRL_HUMAN ; Q7Z7A1",
    "link" : "https://www.uniprot.org/uniprot/Q7Z7A1",
    "description" : "Centriolin",
    "id" : null
  }, {
    "name" : "COMP ; COMP_HUMAN ; P49747",
    "link" : "https://www.uniprot.org/uniprot/P49747",
    "description" : "Cartilage oligomeric matrix protein",
    "id" : null
  }, {
    "name" : "CP ; CERU_HUMAN ; P00450",
    "link" : "https://www.uniprot.org/uniprot/P00450",
    "description" : "Ceruloplasmin",
    "id" : null
  }, {
    "name" : "CPB2 ; CBPB2_HUMAN ; Q96IY4",
    "link" : "https://www.uniprot.org/uniprot/Q96IY4",
    "description" : "Carboxypeptidase B2",
    "id" : null
  }, {
    "name" : "CPN1 ; CBPN_HUMAN ; P15169",
    "link" : "https://www.uniprot.org/uniprot/P15169",
    "description" : "Carboxypeptidase N catalytic chain",
    "id" : null
  }, {
    "name" : "CPN2 ; CPN2_HUMAN ; P22792",
    "link" : "https://www.uniprot.org/uniprot/P22792",
    "description" : "Carboxypeptidase N subunit 2",
    "id" : null
  }, {
    "name" : "CR1 ; CR1_HUMAN ; P17927",
    "link" : "https://www.uniprot.org/uniprot/P17927",
    "description" : "Complement receptor type 1",
    "id" : null
  }, {
    "name" : "CR2 ; CR2_HUMAN ; P20023",
    "link" : "https://www.uniprot.org/uniprot/P20023",
    "description" : "Complement receptor type 2",
    "id" : null
  }, {
    "name" : "CRISP3 ; CRIS3_HUMAN ; P54108",
    "link" : "https://www.uniprot.org/uniprot/P54108",
    "description" : "Cysteine-rich secretory protein 3",
    "id" : null
  }, {
    "name" : "CRP ; CRP_HUMAN ; P02741",
    "link" : "https://www.uniprot.org/uniprot/P02741",
    "description" : "C-reactive protein",
    "id" : null
  }, {
    "name" : "CSF1 ; CSF1_HUMAN ; P09603",
    "link" : "https://www.uniprot.org/uniprot/P09603",
    "description" : "Macrophage colony-stimulating factor 1",
    "id" : null
  }, {
    "name" : "CSF1R ; CSF1R_HUMAN ; P07333",
    "link" : "https://www.uniprot.org/uniprot/P07333",
    "description" : "Macrophage colony-stimulating factor 1 receptor",
    "id" : null
  }, {
    "name" : "CSF2 ; CSF2_HUMAN ; P04141",
    "link" : "https://www.uniprot.org/uniprot/P04141",
    "description" : "Granulocyte-macrophage colony-stimulating factor",
    "id" : null
  }, {
    "name" : "CSF2RA ; CSF2R_HUMAN ; P15509",
    "link" : "https://www.uniprot.org/uniprot/P15509",
    "description" : "Granulocyte-macrophage colony-stimulating factor receptor subunit alpha",
    "id" : null
  }, {
    "name" : "CSF2RB ; IL3RB_HUMAN ; P32927",
    "link" : "https://www.uniprot.org/uniprot/P32927",
    "description" : "Cytokine receptor common subunit beta",
    "id" : null
  }, {
    "name" : "CSF3 ; CSF3_HUMAN ; P09919",
    "link" : "https://www.uniprot.org/uniprot/P09919",
    "description" : "Granulocyte colony-stimulating factor",
    "id" : null
  }, {
    "name" : "CSF3R ; CSF3R_HUMAN ; Q99062",
    "link" : "https://www.uniprot.org/uniprot/Q99062",
    "description" : "Granulocyte colony-stimulating factor receptor",
    "id" : null
  }, {
    "name" : "CST3 ; CYTC_HUMAN ; P01034",
    "link" : "https://www.uniprot.org/uniprot/P01034",
    "description" : "Cystatin-C",
    "id" : null
  }, {
    "name" : "CTLA4 ; CTLA4_HUMAN ; P16410",
    "link" : "https://www.uniprot.org/uniprot/P16410",
    "description" : "Cytotoxic T-lymphocyte protein 4",
    "id" : null
  }, {
    "name" : "CX3CL1 ; X3CL1_HUMAN ; P78423",
    "link" : "https://www.uniprot.org/uniprot/P78423",
    "description" : "Fractalkine",
    "id" : null
  }, {
    "name" : "CX3CR1 ; CX3C1_HUMAN ; P49238",
    "link" : "https://www.uniprot.org/uniprot/P49238",
    "description" : "CX3C chemokine receptor 1",
    "id" : null
  }, {
    "name" : "CXCL1 ; GROA_HUMAN ; P09341",
    "link" : "https://www.uniprot.org/uniprot/P09341",
    "description" : "Growth-regulated alpha protein",
    "id" : null
  }, {
    "name" : "CXCL10 ; CXL10_HUMAN ; P02778",
    "link" : "https://www.uniprot.org/uniprot/P02778",
    "description" : "C-X-C motif chemokine 10",
    "id" : null
  }, {
    "name" : "CXCL11 ; CXL11_HUMAN ; O14625",
    "link" : "https://www.uniprot.org/uniprot/O14625",
    "description" : "C-X-C motif chemokine 11",
    "id" : null
  }, {
    "name" : "CXCL12 ; SDF1_HUMAN ; P48061",
    "link" : "https://www.uniprot.org/uniprot/P48061",
    "description" : "Stromal cell-derived factor 1",
    "id" : null
  }, {
    "name" : "CXCL13 ; CXL13_HUMAN ; O43927",
    "link" : "https://www.uniprot.org/uniprot/O43927",
    "description" : "C-X-C motif chemokine 13",
    "id" : null
  }, {
    "name" : "CXCL14 ; CXL14_HUMAN ; O95715",
    "link" : "https://www.uniprot.org/uniprot/O95715",
    "description" : "C-X-C motif chemokine 14",
    "id" : null
  }, {
    "name" : "CXCL16 ; CXL16_HUMAN ; Q9H2A7",
    "link" : "https://www.uniprot.org/uniprot/Q9H2A7",
    "description" : "C-X-C motif chemokine 16",
    "id" : null
  }, {
    "name" : "CXCL17 ; CXL17_HUMAN ; Q6UXB2",
    "link" : "https://www.uniprot.org/uniprot/Q6UXB2",
    "description" : "C-X-C motif chemokine 17",
    "id" : null
  }, {
    "name" : "CXCL2 ; CXCL2_HUMAN ; P19875",
    "link" : "https://www.uniprot.org/uniprot/P19875",
    "description" : "C-X-C motif chemokine 2",
    "id" : null
  }, {
    "name" : "CXCL3 ; CXCL3_HUMAN ; P19876",
    "link" : "https://www.uniprot.org/uniprot/P19876",
    "description" : "C-X-C motif chemokine 3",
    "id" : null
  }, {
    "name" : "CXCL5 ; CXCL5_HUMAN ; P42830",
    "link" : "https://www.uniprot.org/uniprot/P42830",
    "description" : "C-X-C motif chemokine 5",
    "id" : null
  }, {
    "name" : "CXCL6 ; CXCL6_HUMAN ; P80162",
    "link" : "https://www.uniprot.org/uniprot/P80162",
    "description" : "C-X-C motif chemokine 6",
    "id" : null
  }, {
    "name" : "CXCL8 ; IL8_HUMAN ; P10145",
    "link" : "https://www.uniprot.org/uniprot/P10145",
    "description" : "Interleukin-8",
    "id" : null
  }, {
    "name" : "CXCL9 ; CXCL9_HUMAN ; Q07325",
    "link" : "https://www.uniprot.org/uniprot/Q07325",
    "description" : "C-X-C motif chemokine 9",
    "id" : null
  }, {
    "name" : "CXCR1 ; CXCR1_HUMAN ; P25024",
    "link" : "https://www.uniprot.org/uniprot/P25024",
    "description" : "C-X-C chemokine receptor type 1",
    "id" : null
  }, {
    "name" : "CXCR2 ; CXCR2_HUMAN ; P25025",
    "link" : "https://www.uniprot.org/uniprot/P25025",
    "description" : "C-X-C chemokine receptor type 2",
    "id" : null
  }, {
    "name" : "CXCR3 ; CXCR3_HUMAN ; P49682",
    "link" : "https://www.uniprot.org/uniprot/P49682",
    "description" : "C-X-C chemokine receptor type 3",
    "id" : null
  }, {
    "name" : "CXCR4 ; CXCR4_HUMAN ; P61073",
    "link" : "https://www.uniprot.org/uniprot/P61073",
    "description" : "C-X-C chemokine receptor type 4",
    "id" : null
  }, {
    "name" : "CXCR5 ; CXCR5_HUMAN ; P32302",
    "link" : "https://www.uniprot.org/uniprot/P32302",
    "description" : "C-X-C chemokine receptor type 5",
    "id" : null
  }, {
    "name" : "CXCR6 ; CXCR6_HUMAN ; O00574",
    "link" : "https://www.uniprot.org/uniprot/O00574",
    "description" : "C-X-C chemokine receptor type 6",
    "id" : null
  }, {
    "name" : "DDR1 ; DDR1_HUMAN ; Q08345",
    "link" : "https://www.uniprot.org/uniprot/Q08345",
    "description" : "Epithelial discoidin domain-containing receptor 1",
    "id" : null
  }, {
    "name" : "DNAH5 ; DYH5_HUMAN ; Q8TE73",
    "link" : "https://www.uniprot.org/uniprot/Q8TE73",
    "description" : "Dynein heavy chain 5, axonemal",
    "id" : null
  }, {
    "name" : "DPP4 ; DPP4_HUMAN ; P27487",
    "link" : "https://www.uniprot.org/uniprot/P27487",
    "description" : "Dipeptidyl peptidase 4",
    "id" : null
  }, {
    "name" : "EBI3 ; IL27B_HUMAN ; Q14213",
    "link" : "https://www.uniprot.org/uniprot/Q14213",
    "description" : "Interleukin-27 subunit beta",
    "id" : null
  }, {
    "name" : "ECM1 ; ECM1_HUMAN ; Q16610",
    "link" : "https://www.uniprot.org/uniprot/Q16610",
    "description" : "Extracellular matrix protein 1",
    "id" : null
  }, {
    "name" : "EFEMP1 ; FBLN3_HUMAN ; Q12805",
    "link" : "https://www.uniprot.org/uniprot/Q12805",
    "description" : "EGF-containing fibulin-like extracellular matrix protein 1",
    "id" : null
  }, {
    "name" : "EGF ; EGF_HUMAN ; P01133",
    "link" : "https://www.uniprot.org/uniprot/P01133",
    "description" : "Pro-epidermal growth factor",
    "id" : null
  }, {
    "name" : "EGFR ; EGFR_HUMAN ; P00533",
    "link" : "https://www.uniprot.org/uniprot/P00533",
    "description" : "Epidermal growth factor receptor",
    "id" : null
  }, {
    "name" : "ENG ; EGLN_HUMAN ; P17813",
    "link" : "https://www.uniprot.org/uniprot/P17813",
    "description" : "Endoglin",
    "id" : null
  }, {
    "name" : "ENPEP ; AMPE_HUMAN ; Q07075",
    "link" : "https://www.uniprot.org/uniprot/Q07075",
    "description" : "Glutamyl aminopeptidase",
    "id" : null
  }, {
    "name" : "ENPP3 ; ENPP3_HUMAN ; O14638",
    "link" : "https://www.uniprot.org/uniprot/O14638",
    "description" : "Ectonucleotide pyrophosphatase/phosphodiesterase family member 3",
    "id" : null
  }, {
    "name" : "ENTPD1 ; ENTP1_HUMAN ; P49961",
    "link" : "https://www.uniprot.org/uniprot/P49961",
    "description" : "Ectonucleoside triphosphate diphosphohydrolase 1",
    "id" : null
  }, {
    "name" : "EPCAM ; EPCAM_HUMAN ; P16422",
    "link" : "https://www.uniprot.org/uniprot/P16422",
    "description" : "Epithelial cell adhesion molecule",
    "id" : null
  }, {
    "name" : "EPO ; EPO_HUMAN ; P01588",
    "link" : "https://www.uniprot.org/uniprot/P01588",
    "description" : "Erythropoietin",
    "id" : null
  }, {
    "name" : "EPOR ; EPOR_HUMAN ; P19235",
    "link" : "https://www.uniprot.org/uniprot/P19235",
    "description" : "Erythropoietin receptor",
    "id" : null
  }, {
    "name" : "ERBB2 ; ERBB2_HUMAN ; P04626",
    "link" : "https://www.uniprot.org/uniprot/P04626",
    "description" : "Receptor tyrosine-protein kinase erbB-2",
    "id" : null
  }, {
    "name" : "F11 ; FA11_HUMAN ; P03951",
    "link" : "https://www.uniprot.org/uniprot/P03951",
    "description" : "Coagulation factor XI",
    "id" : null
  }, {
    "name" : "F11R ; JAM1_HUMAN ; Q9Y624",
    "link" : "https://www.uniprot.org/uniprot/Q9Y624",
    "description" : "Junctional adhesion molecule A",
    "id" : null
  }, {
    "name" : "F12 ; FA12_HUMAN ; P00748",
    "link" : "https://www.uniprot.org/uniprot/P00748",
    "description" : "Coagulation factor XII",
    "id" : null
  }, {
    "name" : "F13B ; F13B_HUMAN ; P05160",
    "link" : "https://www.uniprot.org/uniprot/P05160",
    "description" : "Coagulation factor XIII B chain",
    "id" : null
  }, {
    "name" : "F2 ; THRB_HUMAN ; P00734",
    "link" : "https://www.uniprot.org/uniprot/P00734",
    "description" : "Prothrombin",
    "id" : null
  }, {
    "name" : "F3 ; TF_HUMAN ; P13726",
    "link" : "https://www.uniprot.org/uniprot/P13726",
    "description" : "Tissue factor",
    "id" : null
  }, {
    "name" : "F5 ; FA5_HUMAN ; P12259",
    "link" : "https://www.uniprot.org/uniprot/P12259",
    "description" : "Coagulation factor V",
    "id" : null
  }, {
    "name" : "F9 ; FA9_HUMAN ; P00740",
    "link" : "https://www.uniprot.org/uniprot/P00740",
    "description" : "Coagulation factor IX",
    "id" : null
  }, {
    "name" : "FAS ; TNR6_HUMAN ; P25445",
    "link" : "https://www.uniprot.org/uniprot/P25445",
    "description" : "Tumor necrosis factor receptor superfamily member 6",
    "id" : null
  }, {
    "name" : "FASLG ; TNFL6_HUMAN ; P48023",
    "link" : "https://www.uniprot.org/uniprot/P48023",
    "description" : "Tumor necrosis factor ligand superfamily member 6",
    "id" : null
  }, {
    "name" : "FBLN1 ; FBLN1_HUMAN ; P23142",
    "link" : "https://www.uniprot.org/uniprot/P23142",
    "description" : "Fibulin-1",
    "id" : null
  }, {
    "name" : "FCAR ; FCAR_HUMAN ; P24071",
    "link" : "https://www.uniprot.org/uniprot/P24071",
    "description" : "Immunoglobulin alpha Fc receptor",
    "id" : null
  }, {
    "name" : "FCER2 ; FCER2_HUMAN ; P06734",
    "link" : "https://www.uniprot.org/uniprot/P06734",
    "description" : "Low affinity immunoglobulin epsilon Fc receptor",
    "id" : null
  }, {
    "name" : "FCGBP ; FCGBP_HUMAN ; Q9Y6R7",
    "link" : "https://www.uniprot.org/uniprot/Q9Y6R7",
    "description" : "IgGFc-binding protein",
    "id" : null
  }, {
    "name" : "FCGR1A ; FCGR1_HUMAN ; P12314",
    "link" : "https://www.uniprot.org/uniprot/P12314",
    "description" : "High affinity immunoglobulin gamma Fc receptor I",
    "id" : null
  }, {
    "name" : "FCGR2A ; FCG2A_HUMAN ; P12318",
    "link" : "https://www.uniprot.org/uniprot/P12318",
    "description" : "Low affinity immunoglobulin gamma Fc region receptor II-a",
    "id" : null
  }, {
    "name" : "FCGR2B ; FCG2B_HUMAN ; P31994",
    "link" : "https://www.uniprot.org/uniprot/P31994",
    "description" : "Low affinity immunoglobulin gamma Fc region receptor II-b",
    "id" : null
  }, {
    "name" : "FCGR2C ; FCG2C_HUMAN ; P31995",
    "link" : "https://www.uniprot.org/uniprot/P31995",
    "description" : "Low affinity immunoglobulin gamma Fc region receptor II-c",
    "id" : null
  }, {
    "name" : "FCGR3A ; FCG3A_HUMAN ; P08637",
    "link" : "https://www.uniprot.org/uniprot/P08637",
    "description" : "Low affinity immunoglobulin gamma Fc region receptor III-A",
    "id" : null
  }, {
    "name" : "FCGR3B ; FCG3B_HUMAN ; O75015",
    "link" : "https://www.uniprot.org/uniprot/O75015",
    "description" : "Low affinity immunoglobulin gamma Fc region receptor III-B",
    "id" : null
  }, {
    "name" : "FCN3 ; FCN3_HUMAN ; O75636",
    "link" : "https://www.uniprot.org/uniprot/O75636",
    "description" : "Ficolin-3",
    "id" : null
  }, {
    "name" : "FETUB ; FETUB_HUMAN ; Q9UGM5",
    "link" : "https://www.uniprot.org/uniprot/Q9UGM5",
    "description" : "Fetuin-B",
    "id" : null
  }, {
    "name" : "FGA ; FIBA_HUMAN ; P02671",
    "link" : "https://www.uniprot.org/uniprot/P02671",
    "description" : "Fibrinogen alpha chain",
    "id" : null
  }, {
    "name" : "FGB ; FIBB_HUMAN ; P02675",
    "link" : "https://www.uniprot.org/uniprot/P02675",
    "description" : "Fibrinogen beta chain",
    "id" : null
  }, {
    "name" : "FGF1 ; FGF1_HUMAN ; P05230",
    "link" : "https://www.uniprot.org/uniprot/P05230",
    "description" : "Fibroblast growth factor 1",
    "id" : null
  }, {
    "name" : "FGF2 ; FGF2_HUMAN ; P09038",
    "link" : "https://www.uniprot.org/uniprot/P09038",
    "description" : "Fibroblast growth factor 2",
    "id" : null
  }, {
    "name" : "FGFR1 ; FGFR1_HUMAN ; P11362",
    "link" : "https://www.uniprot.org/uniprot/P11362",
    "description" : "Fibroblast growth factor receptor 1",
    "id" : null
  }, {
    "name" : "FGFR2 ; FGFR2_HUMAN ; P21802",
    "link" : "https://www.uniprot.org/uniprot/P21802",
    "description" : "Fibroblast growth factor receptor 2",
    "id" : null
  }, {
    "name" : "FGFR3 ; FGFR3_HUMAN ; P22607",
    "link" : "https://www.uniprot.org/uniprot/P22607",
    "description" : "Fibroblast growth factor receptor 3",
    "id" : null
  }, {
    "name" : "FGFR4 ; FGFR4_HUMAN ; P22455",
    "link" : "https://www.uniprot.org/uniprot/P22455",
    "description" : "Fibroblast growth factor receptor 4",
    "id" : null
  }, {
    "name" : "FGG ; FIBG_HUMAN ; P02679",
    "link" : "https://www.uniprot.org/uniprot/P02679",
    "description" : "Fibrinogen gamma chain",
    "id" : null
  }, {
    "name" : "FLT3 ; FLT3_HUMAN ; P36888",
    "link" : "https://www.uniprot.org/uniprot/P36888",
    "description" : "Receptor-type tyrosine-protein kinase FLT3",
    "id" : null
  }, {
    "name" : "FLT3LG ; FLT3L_HUMAN ; P49771",
    "link" : "https://www.uniprot.org/uniprot/P49771",
    "description" : "Fms-related tyrosine kinase 3 ligand",
    "id" : null
  }, {
    "name" : "FN1 ; FINC_HUMAN ; P02751",
    "link" : "https://www.uniprot.org/uniprot/P02751",
    "description" : "Fibronectin",
    "id" : null
  }, {
    "name" : "FOXP3 ; FOXP3_HUMAN ; Q9BZS1",
    "link" : "https://www.uniprot.org/uniprot/Q9BZS1",
    "description" : "Forkhead box protein P3",
    "id" : null
  }, {
    "name" : "FUT3 ; FUT3_HUMAN ; P21217",
    "link" : "https://www.uniprot.org/uniprot/P21217",
    "description" : "Galactoside 3(4)-L-fucosyltransferase",
    "id" : null
  }, {
    "name" : "FUT4 ; FUT4_HUMAN ; P22083",
    "link" : "https://www.uniprot.org/uniprot/P22083",
    "description" : "Alpha-(1,3)-fucosyltransferase 4",
    "id" : null
  }, {
    "name" : "FZD10 ; FZD10_HUMAN ; Q9ULW2",
    "link" : "https://www.uniprot.org/uniprot/Q9ULW2",
    "description" : "Frizzled-10",
    "id" : null
  }, {
    "name" : "FZD4 ; FZD4_HUMAN ; Q9ULV1",
    "link" : "https://www.uniprot.org/uniprot/Q9ULV1",
    "description" : "Frizzled-4",
    "id" : null
  }, {
    "name" : "FZD9 ; FZD9_HUMAN ; O00144",
    "link" : "https://www.uniprot.org/uniprot/O00144",
    "description" : "Frizzled-9",
    "id" : null
  }, {
    "name" : "GC ; VTDB_HUMAN ; P02774",
    "link" : "https://www.uniprot.org/uniprot/P02774",
    "description" : "Vitamin D-binding protein",
    "id" : null
  }, {
    "name" : "GDF15 ; GDF15_HUMAN ; Q99988",
    "link" : "https://www.uniprot.org/uniprot/Q99988",
    "description" : "Growth/differentiation factor 15",
    "id" : null
  }, {
    "name" : "GGT1 ; GGT1_HUMAN ; P19440",
    "link" : "https://www.uniprot.org/uniprot/P19440",
    "description" : "Glutathione hydrolase 1 proenzyme",
    "id" : null
  }, {
    "name" : "GOLGA6L2 ; GG6L2_HUMAN ; Q8N9W4",
    "link" : "https://www.uniprot.org/uniprot/Q8N9W4",
    "description" : "Golgin subfamily A member 6-like protein 2",
    "id" : null
  }, {
    "name" : "GOLGA8A ; GOG8A_HUMAN ; A7E2F4",
    "link" : "https://www.uniprot.org/uniprot/A7E2F4",
    "description" : "Golgin subfamily A member 8A",
    "id" : null
  }, {
    "name" : "GP1BA ; GP1BA_HUMAN ; P07359",
    "link" : "https://www.uniprot.org/uniprot/P07359",
    "description" : "Platelet glycoprotein Ib alpha chain",
    "id" : null
  }, {
    "name" : "GP1BB ; GP1BB_HUMAN ; P13224",
    "link" : "https://www.uniprot.org/uniprot/P13224",
    "description" : "Platelet glycoprotein Ib beta chain",
    "id" : null
  }, {
    "name" : "GP5 ; GPV_HUMAN ; P40197",
    "link" : "https://www.uniprot.org/uniprot/P40197",
    "description" : "Platelet glycoprotein V",
    "id" : null
  }, {
    "name" : "GP9 ; GPIX_HUMAN ; P14770",
    "link" : "https://www.uniprot.org/uniprot/P14770",
    "description" : "Platelet glycoprotein IX",
    "id" : null
  }, {
    "name" : "GPR15 ; GPR15_HUMAN ; P49685",
    "link" : "https://www.uniprot.org/uniprot/P49685",
    "description" : "G-protein coupled receptor 15",
    "id" : null
  }, {
    "name" : "GSN ; GELS_HUMAN ; P06396",
    "link" : "https://www.uniprot.org/uniprot/P06396",
    "description" : "Gelsolin",
    "id" : null
  }, {
    "name" : "GYPA ; GLPA_HUMAN ; P02724",
    "link" : "https://www.uniprot.org/uniprot/P02724",
    "description" : "Glycophorin-A",
    "id" : null
  }, {
    "name" : "GYPB ; GLPB_HUMAN ; P06028",
    "link" : "https://www.uniprot.org/uniprot/P06028",
    "description" : "Glycophorin-B",
    "id" : null
  }, {
    "name" : "GYPC ; GLPC_HUMAN ; P04921",
    "link" : "https://www.uniprot.org/uniprot/P04921",
    "description" : "Glycophorin-C",
    "id" : null
  }, {
    "name" : "GZMB ; GRAB_HUMAN ; P10144",
    "link" : "https://www.uniprot.org/uniprot/P10144",
    "description" : "Granzyme B",
    "id" : null
  }, {
    "name" : "HABP2 ; HABP2_HUMAN ; Q14520",
    "link" : "https://www.uniprot.org/uniprot/Q14520",
    "description" : "Hyaluronan-binding protein 2",
    "id" : null
  }, {
    "name" : "HBA2 ; HBA_HUMAN ; P69905",
    "link" : "https://www.uniprot.org/uniprot/P69905",
    "description" : "Hemoglobin subunit alpha",
    "id" : null
  }, {
    "name" : "HBB ; HBB_HUMAN ; P68871",
    "link" : "https://www.uniprot.org/uniprot/P68871",
    "description" : "Hemoglobin subunit beta",
    "id" : null
  }, {
    "name" : "HBD ; HBD_HUMAN ; P02042",
    "link" : "https://www.uniprot.org/uniprot/P02042",
    "description" : "Hemoglobin subunit delta",
    "id" : null
  }, {
    "name" : "HECTD4 ; HECD4_HUMAN ; Q9Y4D8",
    "link" : "https://www.uniprot.org/uniprot/Q9Y4D8",
    "description" : "Probable E3 ubiquitin-protein ligase HECTD4",
    "id" : null
  }, {
    "name" : "HELZ2 ; HELZ2_HUMAN ; Q9BYK8",
    "link" : "https://www.uniprot.org/uniprot/Q9BYK8",
    "description" : "Helicase with zinc finger domain 2",
    "id" : null
  }, {
    "name" : "HGF ; HGF_HUMAN ; P14210",
    "link" : "https://www.uniprot.org/uniprot/P14210",
    "description" : "Hepatocyte growth factor",
    "id" : null
  }, {
    "name" : "HGFAC ; HGFA_HUMAN ; Q04756",
    "link" : "https://www.uniprot.org/uniprot/Q04756",
    "description" : "Hepatocyte growth factor activator",
    "id" : null
  }, {
    "name" : "HLA-A ; HLAA_HUMAN ; P01892",
    "link" : "https://www.uniprot.org/uniprot/P04439",
    "description" : "HLA class I histocompatibility antigen, A alpha chain",
    "id" : null
  }, {
    "name" : "HLA-DRA ; DRA_HUMAN ; P01903",
    "link" : "https://www.uniprot.org/uniprot/P01903",
    "description" : "HLA class II histocompatibility antigen, DR alpha chain",
    "id" : null
  }, {
    "name" : "HLA-E ; HLAE_HUMAN ; P13747",
    "link" : "https://www.uniprot.org/uniprot/P13747",
    "description" : "HLA class I histocompatibility antigen, alpha chain E",
    "id" : null
  }, {
    "name" : "HLA-G ; HLAG_HUMAN ; P17693",
    "link" : "https://www.uniprot.org/uniprot/P17693",
    "description" : "HLA class I histocompatibility antigen, alpha chain G",
    "id" : null
  }, {
    "name" : "HMMR ; HMMR_HUMAN ; O75330",
    "link" : "https://www.uniprot.org/uniprot/O75330",
    "description" : "Hyaluronan mediated motility receptor",
    "id" : null
  }, {
    "name" : "HP ; HPT_HUMAN ; P00738",
    "link" : "https://www.uniprot.org/uniprot/P00738",
    "description" : "Haptoglobin",
    "id" : null
  }, {
    "name" : "HPR ; HPTR_HUMAN ; P00739",
    "link" : "https://www.uniprot.org/uniprot/P00739",
    "description" : "Haptoglobin-related protein",
    "id" : null
  }, {
    "name" : "HPX ; HEMO_HUMAN ; P02790",
    "link" : "https://www.uniprot.org/uniprot/P02790",
    "description" : "Hemopexin",
    "id" : null
  }, {
    "name" : "HRG ; HRG_HUMAN ; P04196",
    "link" : "https://www.uniprot.org/uniprot/P04196",
    "description" : "Histidine-rich glycoprotein",
    "id" : null
  }, {
    "name" : "HUWE1 ; HUWE1_HUMAN ; Q7Z6Z7",
    "link" : "https://www.uniprot.org/uniprot/Q7Z6Z7",
    "description" : "E3 ubiquitin-protein ligase HUWE1",
    "id" : null
  }, {
    "name" : "ICAM2 ; ICAM2_HUMAN ; P13598",
    "link" : "https://www.uniprot.org/uniprot/P13598",
    "description" : "Intercellular adhesion molecule 2",
    "id" : null
  }, {
    "name" : "ICAM3 ; ICAM3_HUMAN ; P32942",
    "link" : "https://www.uniprot.org/uniprot/P32942",
    "description" : "Intercellular adhesion molecule 3",
    "id" : null
  }, {
    "name" : "ICAM4 ; ICAM4_HUMAN ; Q14773",
    "link" : "https://www.uniprot.org/uniprot/Q14773",
    "description" : "Intercellular adhesion molecule 4",
    "id" : null
  }, {
    "name" : "ICOS ; ICOS_HUMAN ; Q9Y6W8",
    "link" : "https://www.uniprot.org/uniprot/Q9Y6W8",
    "description" : "Inducible T-cell costimulator",
    "id" : null
  }, {
    "name" : "ICOSLG ; ICOSL_HUMAN ; O75144",
    "link" : "https://www.uniprot.org/uniprot/O75144",
    "description" : "ICOS ligand",
    "id" : null
  }, {
    "name" : "IFITM1 ; IFM1_HUMAN ; P13164",
    "link" : "https://www.uniprot.org/uniprot/P13164",
    "description" : "Interferon-induced transmembrane protein 1",
    "id" : null
  }, {
    "name" : "IFNA10 ; IFN10_HUMAN ; P01566",
    "link" : "https://www.uniprot.org/uniprot/P01566",
    "description" : "Interferon alpha-10",
    "id" : null
  }, {
    "name" : "IFNA14 ; IFN14_HUMAN ; P01570",
    "link" : "https://www.uniprot.org/uniprot/P01570",
    "description" : "Interferon alpha-14",
    "id" : null
  }, {
    "name" : "IFNA16 ; IFN16_HUMAN ; P05015",
    "link" : "https://www.uniprot.org/uniprot/P05015",
    "description" : "Interferon alpha-16",
    "id" : null
  }, {
    "name" : "IFNA17 ; IFN17_HUMAN ; P01571",
    "link" : "https://www.uniprot.org/uniprot/P01571",
    "description" : "Interferon alpha-17",
    "id" : null
  }, {
    "name" : "IFNA2 ; IFNA2_HUMAN ; P01563",
    "link" : "https://www.uniprot.org/uniprot/P01563",
    "description" : "Interferon alpha-2",
    "id" : null
  }, {
    "name" : "IFNA21 ; IFN21_HUMAN ; P01568",
    "link" : "https://www.uniprot.org/uniprot/P01568",
    "description" : "Interferon alpha-21",
    "id" : null
  }, {
    "name" : "IFNA4 ; IFNA4_HUMAN ; P05014",
    "link" : "https://www.uniprot.org/uniprot/P05014",
    "description" : "Interferon alpha-4",
    "id" : null
  }, {
    "name" : "IFNA5 ; IFNA5_HUMAN ; P01569",
    "link" : "https://www.uniprot.org/uniprot/P01569",
    "description" : "Interferon alpha-5",
    "id" : null
  }, {
    "name" : "IFNA6 ; IFNA6_HUMAN ; P05013",
    "link" : "https://www.uniprot.org/uniprot/P05013",
    "description" : "Interferon alpha-6",
    "id" : null
  }, {
    "name" : "IFNA7 ; IFNA7_HUMAN ; P01567",
    "link" : "https://www.uniprot.org/uniprot/P01567",
    "description" : "Interferon alpha-7",
    "id" : null
  }, {
    "name" : "IFNA8 ; IFNA8_HUMAN ; P32881",
    "link" : "https://www.uniprot.org/uniprot/P32881",
    "description" : "Interferon alpha-8",
    "id" : null
  }, {
    "name" : "IFNAR1 ; INAR1_HUMAN ; P17181",
    "link" : "https://www.uniprot.org/uniprot/P17181",
    "description" : "Interferon alpha/beta receptor 1",
    "id" : null
  }, {
    "name" : "IFNAR2 ; INAR2_HUMAN ; P48551",
    "link" : "https://www.uniprot.org/uniprot/P48551",
    "description" : "Interferon alpha/beta receptor 2",
    "id" : null
  }, {
    "name" : "IFNB1 ; IFNB_HUMAN ; P01574",
    "link" : "https://www.uniprot.org/uniprot/P01574",
    "description" : "Interferon beta",
    "id" : null
  }, {
    "name" : "IFNE ; IFNE_HUMAN ; Q86WN2",
    "link" : "https://www.uniprot.org/uniprot/Q86WN2",
    "description" : "Interferon epsilon",
    "id" : null
  }, {
    "name" : "IFNG ; IFNG_HUMAN ; P01579",
    "link" : "https://www.uniprot.org/uniprot/P01579",
    "description" : "Interferon gamma",
    "id" : null
  }, {
    "name" : "IFNGR1 ; INGR1_HUMAN ; P15260",
    "link" : "https://www.uniprot.org/uniprot/P15260",
    "description" : "Interferon gamma receptor 1",
    "id" : null
  }, {
    "name" : "IFNGR2 ; INGR2_HUMAN ; P38484",
    "link" : "https://www.uniprot.org/uniprot/P38484",
    "description" : "Interferon gamma receptor 2",
    "id" : null
  }, {
    "name" : "IFNK ; IFNK_HUMAN ; Q9P0W0",
    "link" : "https://www.uniprot.org/uniprot/Q9P0W0",
    "description" : "Interferon kappa",
    "id" : null
  }, {
    "name" : "IFNL1 ; IFNL1_HUMAN ; Q8IU54",
    "link" : "https://www.uniprot.org/uniprot/Q8IU54",
    "description" : "Interferon lambda-1",
    "id" : null
  }, {
    "name" : "IFNL2 ; IFNL2_HUMAN ; Q8IZJ0",
    "link" : "https://www.uniprot.org/uniprot/Q8IZJ0",
    "description" : "Interferon lambda-2",
    "id" : null
  }, {
    "name" : "IFNL3 ; IFNL3_HUMAN ; Q8IZI9",
    "link" : "https://www.uniprot.org/uniprot/Q8IZI9",
    "description" : "Interferon lambda-3",
    "id" : null
  }, {
    "name" : "IFNLR1 ; INLR1_HUMAN ; Q8IU57",
    "link" : "https://www.uniprot.org/uniprot/Q8IU57",
    "description" : "Interferon lambda receptor 1",
    "id" : null
  }, {
    "name" : "IGF1R ; IGF1R_HUMAN ; P08069",
    "link" : "https://www.uniprot.org/uniprot/P08069",
    "description" : "Insulin-like growth factor 1 receptor",
    "id" : null
  }, {
    "name" : "IGF2 ; IGF2_HUMAN ; P01344",
    "link" : "https://www.uniprot.org/uniprot/P01344",
    "description" : "Insulin-like growth factor II",
    "id" : null
  }, {
    "name" : "IGF2R ; MPRI_HUMAN ; P11717",
    "link" : "https://www.uniprot.org/uniprot/P11717",
    "description" : "Cation-independent mannose-6-phosphate receptor",
    "id" : null
  }, {
    "name" : "IGFALS ; ALS_HUMAN ; P35858",
    "link" : "https://www.uniprot.org/uniprot/P35858",
    "description" : "Insulin-like growth factor-binding protein complex acid labile subunit",
    "id" : null
  }, {
    "name" : "IGFBP2 ; IBP2_HUMAN ; P18065",
    "link" : "https://www.uniprot.org/uniprot/P18065",
    "description" : "Insulin-like growth factor-binding protein 2",
    "id" : null
  }, {
    "name" : "IGFBP3 ; IBP3_HUMAN ; P17936",
    "link" : "https://www.uniprot.org/uniprot/P17936",
    "description" : "Insulin-like growth factor-binding protein 3",
    "id" : null
  }, {
    "name" : "IGHA1 ; IGHA1_HUMAN ; P01876",
    "link" : "https://www.uniprot.org/uniprot/P01876",
    "description" : "Immunoglobulin heavy constant alpha 1",
    "id" : null
  }, {
    "name" : "IGHA2 ; IGHA2_HUMAN ; P01877",
    "link" : "https://www.uniprot.org/uniprot/P01877",
    "description" : "Immunoglobulin heavy constant alpha 2",
    "id" : null
  }, {
    "name" : "IGHD ; IGHD_HUMAN ; P01880",
    "link" : "https://www.uniprot.org/uniprot/P01880",
    "description" : "Immunoglobulin heavy constant delta",
    "id" : null
  }, {
    "name" : "IGHG1 ; IGHG1_HUMAN ; P01857",
    "link" : "https://www.uniprot.org/uniprot/P01857",
    "description" : "Immunoglobulin heavy constant gamma 1",
    "id" : null
  }, {
    "name" : "IGHG2 ; IGHG2_HUMAN ; P01859",
    "link" : "https://www.uniprot.org/uniprot/P01859",
    "description" : "Immunoglobulin heavy constant gamma 2",
    "id" : null
  }, {
    "name" : "IGHG3 ; IGHG3_HUMAN ; P01860",
    "link" : "https://www.uniprot.org/uniprot/P01860",
    "description" : "Immunoglobulin heavy constant gamma 3",
    "id" : null
  }, {
    "name" : "IGHG4 ; IGHG4_HUMAN ; P01861",
    "link" : "https://www.uniprot.org/uniprot/P01861",
    "description" : "Immunoglobulin heavy constant gamma 4",
    "id" : null
  }, {
    "name" : "IGHM ; IGHM_HUMAN ; P01871",
    "link" : "https://www.uniprot.org/uniprot/P01871",
    "description" : "Immunoglobulin heavy constant mu",
    "id" : null
  }, {
    "name" : "IGHV1-18 ; HV118_HUMAN ; A0A0C4DH31",
    "link" : "https://www.uniprot.org/uniprot/A0A0C4DH31",
    "description" : "Immunoglobulin heavy variable 1-18",
    "id" : null
  }, {
    "name" : "IGHV1-2 ; HV102_HUMAN ; P23083",
    "link" : "https://www.uniprot.org/uniprot/P23083",
    "description" : "Immunoglobulin heavy variable 1-2",
    "id" : null
  }, {
    "name" : "IGHV1-69 ; HV169_HUMAN ; P01742",
    "link" : "https://www.uniprot.org/uniprot/P01742",
    "description" : "Immunoglobulin heavy variable 1-69",
    "id" : null
  }, {
    "name" : "IGHV2-26 ; HV226_HUMAN ; A0A0B4J1V2",
    "link" : "https://www.uniprot.org/uniprot/A0A0B4J1V2",
    "description" : "Immunoglobulin heavy variable 2-26",
    "id" : null
  }, {
    "name" : "IGHV2-70 ; HV270_HUMAN ; P01814",
    "link" : "https://www.uniprot.org/uniprot/P01814",
    "description" : "Immunoglobulin heavy variable 2-70",
    "id" : null
  }, {
    "name" : "IGHV3-11 ; HV311_HUMAN ; P01762",
    "link" : "https://www.uniprot.org/uniprot/P01762",
    "description" : "Immunoglobulin heavy variable 3-11",
    "id" : null
  }, {
    "name" : "IGHV3-13 ; HV313_HUMAN ; P01766",
    "link" : "https://www.uniprot.org/uniprot/P01766",
    "description" : "Immunoglobulin heavy variable 3-13",
    "id" : null
  }, {
    "name" : "IGHV3-15 ; HV315_HUMAN ; A0A0B4J1V0",
    "link" : "https://www.uniprot.org/uniprot/A0A0B4J1V0",
    "description" : "Immunoglobulin heavy variable 3-15",
    "id" : null
  }, {
    "name" : "IGHV3-23 ; HV323_HUMAN ; P01764",
    "link" : "https://www.uniprot.org/uniprot/P01764",
    "description" : "Immunoglobulin heavy variable 3-23",
    "id" : null
  }, {
    "name" : "IGHV3-49 ; HV349_HUMAN ; A0A0A0MS15",
    "link" : "https://www.uniprot.org/uniprot/A0A0A0MS15",
    "description" : "Immunoglobulin heavy variable 3-49",
    "id" : null
  }, {
    "name" : "IGHV3-7 ; HV307_HUMAN ; P01780",
    "link" : "https://www.uniprot.org/uniprot/P01780",
    "description" : "Immunoglobulin heavy variable 3-7",
    "id" : null
  }, {
    "name" : "IGHV3-72 ; HV372_HUMAN ; A0A0B4J1Y9",
    "link" : "https://www.uniprot.org/uniprot/A0A0B4J1Y9",
    "description" : "Immunoglobulin heavy variable 3-72",
    "id" : null
  }, {
    "name" : "IGHV3-74 ; HV374_HUMAN ; A0A0B4J1X5",
    "link" : "https://www.uniprot.org/uniprot/A0A0B4J1X5",
    "description" : "Immunoglobulin heavy variable 3-74",
    "id" : null
  }, {
    "name" : "IGHV5-10-1 ; HV5X1_HUMAN ; A0A0J9YXX1",
    "link" : "https://www.uniprot.org/uniprot/A0A0J9YXX1",
    "description" : "Immunoglobulin heavy variable 5-10-1",
    "id" : null
  }, {
    "name" : "IGHV5-51 ; HV551_HUMAN ; A0A0C4DH38",
    "link" : "https://www.uniprot.org/uniprot/A0A0C4DH38",
    "description" : "Immunoglobulin heavy variable 5-51",
    "id" : null
  }, {
    "name" : "IGKC ; IGKC_HUMAN ; P01834",
    "link" : "https://www.uniprot.org/uniprot/P01834",
    "description" : "Immunoglobulin kappa constant",
    "id" : null
  }, {
    "name" : "IGKV1-17 ; KV117_HUMAN ; P01599",
    "link" : "https://www.uniprot.org/uniprot/P01599",
    "description" : "Immunoglobulin kappa variable 1-17",
    "id" : null
  }, {
    "name" : "IGKV1-33 ; KV133_HUMAN ; P01594",
    "link" : "https://www.uniprot.org/uniprot/P01594",
    "description" : "Immunoglobulin kappa variable 1-33",
    "id" : null
  }, {
    "name" : "IGKV1-5 ; KV105_HUMAN ; P01602",
    "link" : "https://www.uniprot.org/uniprot/P01602",
    "description" : "Immunoglobulin kappa variable 1-5",
    "id" : null
  }, {
    "name" : "IGKV1-8 ; KV108_HUMAN ; A0A0C4DH67",
    "link" : "https://www.uniprot.org/uniprot/A0A0C4DH67",
    "description" : "Immunoglobulin kappa variable 1-8",
    "id" : null
  }, {
    "name" : "IGKV1D-12 ; KVD12_HUMAN ; P01611",
    "link" : "https://www.uniprot.org/uniprot/P01611",
    "description" : "Immunoglobulin kappa variable 1D-12",
    "id" : null
  }, {
    "name" : "IGKV1D-13 ; KVD13_HUMAN ; A0A0B4J2D9",
    "link" : "https://www.uniprot.org/uniprot/A0A0B4J2D9",
    "description" : "Immunoglobulin kappa variable 1D-13",
    "id" : null
  }, {
    "name" : "IGKV1D-33 ; KVD33_HUMAN ; P01593",
    "link" : "https://www.uniprot.org/uniprot/P01593",
    "description" : "Immunoglobulin kappa variable 1D-33",
    "id" : null
  }, {
    "name" : "IGKV2-30 ; KV230_HUMAN ; P06310",
    "link" : "https://www.uniprot.org/uniprot/P06310",
    "description" : "Immunoglobulin kappa variable 2-30",
    "id" : null
  }, {
    "name" : "IGKV2D-28 ; KVD28_HUMAN ; P01615",
    "link" : "https://www.uniprot.org/uniprot/P01615",
    "description" : "Immunoglobulin kappa variable 2D-28",
    "id" : null
  }, {
    "name" : "IGKV3-20 ; KV320_HUMAN ; P01619",
    "link" : "https://www.uniprot.org/uniprot/P01619",
    "description" : "Immunoglobulin kappa variable 3-20",
    "id" : null
  }, {
    "name" : "IGKV3-7 ; KV37_HUMAN ; A0A075B6H7",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6H7",
    "description" : "Probable non-functional immunoglobulin kappa variable 3-7",
    "id" : null
  }, {
    "name" : "IGKV3D-11 ; KVD11_HUMAN ; A0A0A0MRZ8",
    "link" : "https://www.uniprot.org/uniprot/A0A0A0MRZ8",
    "description" : "Immunoglobulin kappa variable 3D-11",
    "id" : null
  }, {
    "name" : "IGKV3D-15 ; KVD15_HUMAN ; A0A087WSY6",
    "link" : "https://www.uniprot.org/uniprot/A0A087WSY6",
    "description" : "Immunoglobulin kappa variable 3D-15",
    "id" : null
  }, {
    "name" : "IGKV3D-20 ; KVD20_HUMAN ; A0A0C4DH25",
    "link" : "https://www.uniprot.org/uniprot/A0A0C4DH25",
    "description" : "Immunoglobulin kappa variable 3D-20",
    "id" : null
  }, {
    "name" : "IGKV4-1 ; KV401_HUMAN ; P06312",
    "link" : "https://www.uniprot.org/uniprot/P06312",
    "description" : "Immunoglobulin kappa variable 4-1",
    "id" : null
  }, {
    "name" : "IGKV6D-21 ; KVD21_HUMAN ; A0A0A0MT36",
    "link" : "https://www.uniprot.org/uniprot/A0A0A0MT36",
    "description" : "Immunoglobulin kappa variable 6D-21",
    "id" : null
  }, {
    "name" : "IGLC2 ; IGLC2_HUMAN ; P0DOY2",
    "link" : "https://www.uniprot.org/uniprot/P0DOY2",
    "description" : "Immunoglobulin lambda constant 2",
    "id" : null
  }, {
    "name" : "IGLC3 ; IGLC3_HUMAN ; P0DOY3",
    "link" : "https://www.uniprot.org/uniprot/P0DOY3",
    "description" : "Immunoglobulin lambda constant 3",
    "id" : null
  }, {
    "name" : "IGLC6 ; IGLC6_HUMAN ; P0CF74",
    "link" : "https://www.uniprot.org/uniprot/P0CF74",
    "description" : "Immunoglobulin lambda constant 6",
    "id" : null
  }, {
    "name" : "IGLC7 ; IGLC7_HUMAN ; A0M8Q6",
    "link" : "https://www.uniprot.org/uniprot/A0M8Q6",
    "description" : "Immunoglobulin lambda constant 7",
    "id" : null
  }, {
    "name" : "IGLL1 ; IGLL1_HUMAN ; P15814",
    "link" : "https://www.uniprot.org/uniprot/P15814",
    "description" : "Immunoglobulin lambda-like polypeptide 1",
    "id" : null
  }, {
    "name" : "IGLL5 ; IGLL5_HUMAN ; B9A064",
    "link" : "https://www.uniprot.org/uniprot/B9A064",
    "description" : "Immunoglobulin lambda-like polypeptide 5",
    "id" : null
  }, {
    "name" : "IGLV1-40 ; LV140_HUMAN ; P01703",
    "link" : "https://www.uniprot.org/uniprot/P01703",
    "description" : "Immunoglobulin lambda variable 1-40",
    "id" : null
  }, {
    "name" : "IGLV1-44 ; LV144_HUMAN ; P01699",
    "link" : "https://www.uniprot.org/uniprot/P01699",
    "description" : "Immunoglobulin lambda variable 1-44",
    "id" : null
  }, {
    "name" : "IGLV1-47 ; LV147_HUMAN ; P01700",
    "link" : "https://www.uniprot.org/uniprot/P01700",
    "description" : "Immunoglobulin lambda variable 1-47",
    "id" : null
  }, {
    "name" : "IGLV1-51 ; LV151_HUMAN ; P01701",
    "link" : "https://www.uniprot.org/uniprot/P01701",
    "description" : "Immunoglobulin lambda variable 1-51",
    "id" : null
  }, {
    "name" : "IGLV10-54 ; LVX54_HUMAN ; A0A075B6I4",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6I4",
    "description" : "Immunoglobulin lambda variable 10-54",
    "id" : null
  }, {
    "name" : "IGLV2-11 ; LV211_HUMAN ; P01706",
    "link" : "https://www.uniprot.org/uniprot/P01706",
    "description" : "Immunoglobulin lambda variable 2-11",
    "id" : null
  }, {
    "name" : "IGLV2-14 ; LV214_HUMAN ; P01704",
    "link" : "https://www.uniprot.org/uniprot/P01704",
    "description" : "Immunoglobulin lambda variable 2-14",
    "id" : null
  }, {
    "name" : "IGLV2-18 ; LV218_HUMAN ; A0A075B6J9",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6J9",
    "description" : "Immunoglobulin lambda variable 2-18",
    "id" : null
  }, {
    "name" : "IGLV2-23 ; LV223_HUMAN ; P01705",
    "link" : "https://www.uniprot.org/uniprot/P01705",
    "description" : "Immunoglobulin lambda variable 2-23",
    "id" : null
  }, {
    "name" : "IGLV2-33 ; LV233_HUMAN ; A0A075B6J2",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6J2",
    "description" : "Probable non-functional immunoglobulin lambda variable 2-33",
    "id" : null
  }, {
    "name" : "IGLV2-8 ; LV208_HUMAN ; P01709",
    "link" : "https://www.uniprot.org/uniprot/P01709",
    "description" : "Immunoglobulin lambda variable 2-8",
    "id" : null
  }, {
    "name" : "IGLV3-10 ; LV310_HUMAN ; A0A075B6K4",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6K4",
    "description" : "Immunoglobulin lambda variable 3-10",
    "id" : null
  }, {
    "name" : "IGLV3-19 ; LV319_HUMAN ; P01714",
    "link" : "https://www.uniprot.org/uniprot/P01714",
    "description" : "Immunoglobulin lambda variable 3-19",
    "id" : null
  }, {
    "name" : "IGLV3-21 ; LV321_HUMAN ; P80748",
    "link" : "https://www.uniprot.org/uniprot/P80748",
    "description" : "Immunoglobulin lambda variable 3-21",
    "id" : null
  }, {
    "name" : "IGLV3-25 ; LV325_HUMAN ; P01717",
    "link" : "https://www.uniprot.org/uniprot/P01717",
    "description" : "Immunoglobulin lambda variable 3-25",
    "id" : null
  }, {
    "name" : "IGLV3-27 ; LV327_HUMAN ; P01718",
    "link" : "https://www.uniprot.org/uniprot/P01718",
    "description" : "Immunoglobulin lambda variable 3-27",
    "id" : null
  }, {
    "name" : "IGLV3-9 ; LV39_HUMAN ; A0A075B6K5",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6K5",
    "description" : "Immunoglobulin lambda variable 3-9",
    "id" : null
  }, {
    "name" : "IGLV4-69 ; LV469_HUMAN ; A0A075B6H9",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6H9",
    "description" : "Immunoglobulin lambda variable 4-69",
    "id" : null
  }, {
    "name" : "IGLV5-45 ; LV545_HUMAN ; A0A087WSX0",
    "link" : "https://www.uniprot.org/uniprot/A0A087WSX0",
    "description" : "Immunoglobulin lambda variable 5-45",
    "id" : null
  }, {
    "name" : "IGLV7-43 ; LV743_HUMAN ; P04211",
    "link" : "https://www.uniprot.org/uniprot/P04211",
    "description" : "Immunoglobulin lambda variable 7-43",
    "id" : null
  }, {
    "name" : "IGLV7-46 ; LV746_HUMAN ; A0A075B6I9",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6I9",
    "description" : "Immunoglobulin lambda variable 7-46",
    "id" : null
  }, {
    "name" : "IGLV8-61 ; LV861_HUMAN ; A0A075B6I0",
    "link" : "https://www.uniprot.org/uniprot/A0A075B6I0",
    "description" : "Immunoglobulin lambda variable 8-61",
    "id" : null
  }, {
    "name" : "IGSF8 ; IGSF8_HUMAN ; Q969P0",
    "link" : "https://www.uniprot.org/uniprot/Q969P0",
    "description" : "Immunoglobulin superfamily member 8",
    "id" : null
  }, {
    "name" : "IL10 ; IL10_HUMAN ; P22301",
    "link" : "https://www.uniprot.org/uniprot/P22301",
    "description" : "Interleukin-10",
    "id" : null
  }, {
    "name" : "IL10RA ; I10R1_HUMAN ; Q13651",
    "link" : "https://www.uniprot.org/uniprot/Q13651",
    "description" : "Interleukin-10 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL10RB ; I10R2_HUMAN ; Q08334",
    "link" : "https://www.uniprot.org/uniprot/Q08334",
    "description" : "Interleukin-10 receptor subunit beta",
    "id" : null
  }, {
    "name" : "IL11 ; IL11_HUMAN ; P20809",
    "link" : "https://www.uniprot.org/uniprot/P20809",
    "description" : "Interleukin-11",
    "id" : null
  }, {
    "name" : "IL11RA ; I11RA_HUMAN ; Q14626",
    "link" : "https://www.uniprot.org/uniprot/Q14626",
    "description" : "Interleukin-11 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL12A ; IL12A_HUMAN ; P29459",
    "link" : "https://www.uniprot.org/uniprot/P29459",
    "description" : "Interleukin-12 subunit alpha",
    "id" : null
  }, {
    "name" : "IL12B ; IL12B_HUMAN ; P29460",
    "link" : "https://www.uniprot.org/uniprot/P29460",
    "description" : "Interleukin-12 subunit beta",
    "id" : null
  }, {
    "name" : "IL12RB1 ; I12R1_HUMAN ; P42701",
    "link" : "https://www.uniprot.org/uniprot/P42701",
    "description" : "Interleukin-12 receptor subunit beta-1",
    "id" : null
  }, {
    "name" : "IL12RB2 ; I12R2_HUMAN ; Q99665",
    "link" : "https://www.uniprot.org/uniprot/Q99665",
    "description" : "Interleukin-12 receptor subunit beta-2",
    "id" : null
  }, {
    "name" : "IL13 ; IL13_HUMAN ; P35225",
    "link" : "https://www.uniprot.org/uniprot/P35225",
    "description" : "Interleukin-13",
    "id" : null
  }, {
    "name" : "IL13RA1 ; I13R1_HUMAN ; P78552",
    "link" : "https://www.uniprot.org/uniprot/P78552",
    "description" : "Interleukin-13 receptor subunit alpha-1",
    "id" : null
  }, {
    "name" : "IL13RA2 ; I13R2_HUMAN ; Q14627",
    "link" : "https://www.uniprot.org/uniprot/Q14627",
    "description" : "Interleukin-13 receptor subunit alpha-2",
    "id" : null
  }, {
    "name" : "IL15 ; IL15_HUMAN ; P40933",
    "link" : "https://www.uniprot.org/uniprot/P40933",
    "description" : "Interleukin-15",
    "id" : null
  }, {
    "name" : "IL15RA ; I15RA_HUMAN ; Q13261",
    "link" : "https://www.uniprot.org/uniprot/Q13261",
    "description" : "Interleukin-15 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL16 ; IL16_HUMAN ; Q14005",
    "link" : "https://www.uniprot.org/uniprot/Q14005",
    "description" : "Pro-interleukin-16",
    "id" : null
  }, {
    "name" : "IL17A ; IL17_HUMAN ; Q16552",
    "link" : "https://www.uniprot.org/uniprot/Q16552",
    "description" : "Interleukin-17A",
    "id" : null
  }, {
    "name" : "IL17B ; IL17B_HUMAN ; Q9UHF5",
    "link" : "https://www.uniprot.org/uniprot/Q9UHF5",
    "description" : "Interleukin-17B",
    "id" : null
  }, {
    "name" : "IL17C ; IL17C_HUMAN ; Q9P0M4",
    "link" : "https://www.uniprot.org/uniprot/Q9P0M4",
    "description" : "Interleukin-17C",
    "id" : null
  }, {
    "name" : "IL17D ; IL17D_HUMAN ; Q8TAD2",
    "link" : "https://www.uniprot.org/uniprot/Q8TAD2",
    "description" : "Interleukin-17D",
    "id" : null
  }, {
    "name" : "IL17F ; IL17F_HUMAN ; Q96PD4",
    "link" : "https://www.uniprot.org/uniprot/Q96PD4",
    "description" : "Interleukin-17F",
    "id" : null
  }, {
    "name" : "IL17RA ; I17RA_HUMAN ; Q96F46",
    "link" : "https://www.uniprot.org/uniprot/Q96F46",
    "description" : "Interleukin-17 receptor A",
    "id" : null
  }, {
    "name" : "IL18 ; IL18_HUMAN ; Q14116",
    "link" : "https://www.uniprot.org/uniprot/Q14116",
    "description" : "Interleukin-18",
    "id" : null
  }, {
    "name" : "IL18R1 ; IL18R_HUMAN ; Q13478",
    "link" : "https://www.uniprot.org/uniprot/Q13478",
    "description" : "Interleukin-18 receptor 1",
    "id" : null
  }, {
    "name" : "IL18RAP ; I18RA_HUMAN ; O95256",
    "link" : "https://www.uniprot.org/uniprot/O95256",
    "description" : "Interleukin-18 receptor accessory protein",
    "id" : null
  }, {
    "name" : "IL19 ; IL19_HUMAN ; Q9UHD0",
    "link" : "https://www.uniprot.org/uniprot/Q9UHD0",
    "description" : "Interleukin-19",
    "id" : null
  }, {
    "name" : "IL1A ; IL1A_HUMAN ; P01583",
    "link" : "https://www.uniprot.org/uniprot/P01583",
    "description" : "Interleukin-1 alpha",
    "id" : null
  }, {
    "name" : "IL1B ; IL1B_HUMAN ; P01584",
    "link" : "https://www.uniprot.org/uniprot/P01584",
    "description" : "Interleukin-1 beta",
    "id" : null
  }, {
    "name" : "IL1F10 ; IL1FA_HUMAN ; Q8WWZ1",
    "link" : "https://www.uniprot.org/uniprot/Q8WWZ1",
    "description" : "Interleukin-1 family member 10",
    "id" : null
  }, {
    "name" : "IL1R1 ; IL1R1_HUMAN ; P14778",
    "link" : "https://www.uniprot.org/uniprot/P14778",
    "description" : "Interleukin-1 receptor type 1",
    "id" : null
  }, {
    "name" : "IL1R2 ; IL1R2_HUMAN ; P27930",
    "link" : "https://www.uniprot.org/uniprot/P27930",
    "description" : "Interleukin-1 receptor type 2",
    "id" : null
  }, {
    "name" : "IL1RAP ; IL1AP_HUMAN ; Q9NPH3",
    "link" : "https://www.uniprot.org/uniprot/Q9NPH3",
    "description" : "Interleukin-1 receptor accessory protein",
    "id" : null
  }, {
    "name" : "IL1RN ; IL1RA_HUMAN ; P18510",
    "link" : "https://www.uniprot.org/uniprot/P18510",
    "description" : "Interleukin-1 receptor antagonist protein",
    "id" : null
  }, {
    "name" : "IL2 ; IL2_HUMAN ; P60568",
    "link" : "https://www.uniprot.org/uniprot/P60568",
    "description" : "Interleukin-2",
    "id" : null
  }, {
    "name" : "IL20 ; IL20_HUMAN ; Q9NYY1",
    "link" : "https://www.uniprot.org/uniprot/Q9NYY1",
    "description" : "Interleukin-20",
    "id" : null
  }, {
    "name" : "IL20RA ; I20RA_HUMAN ; Q9UHF4",
    "link" : "https://www.uniprot.org/uniprot/Q9UHF4",
    "description" : "Interleukin-20 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL20RB ; I20RB_HUMAN ; Q6UXL0",
    "link" : "https://www.uniprot.org/uniprot/Q6UXL0",
    "description" : "Interleukin-20 receptor subunit beta",
    "id" : null
  }, {
    "name" : "IL21 ; IL21_HUMAN ; Q9HBE4",
    "link" : "https://www.uniprot.org/uniprot/Q9HBE4",
    "description" : "Interleukin-21",
    "id" : null
  }, {
    "name" : "IL21R ; IL21R_HUMAN ; Q9HBE5",
    "link" : "https://www.uniprot.org/uniprot/Q9HBE5",
    "description" : "Interleukin-21 receptor",
    "id" : null
  }, {
    "name" : "IL22 ; IL22_HUMAN ; Q9GZX6",
    "link" : "https://www.uniprot.org/uniprot/Q9GZX6",
    "description" : "Interleukin-22",
    "id" : null
  }, {
    "name" : "IL22RA1 ; I22R1_HUMAN ; Q8N6P7",
    "link" : "https://www.uniprot.org/uniprot/Q8N6P7",
    "description" : "Interleukin-22 receptor subunit alpha-1",
    "id" : null
  }, {
    "name" : "IL22RA2 ; I22R2_HUMAN ; Q969J5",
    "link" : "https://www.uniprot.org/uniprot/Q969J5",
    "description" : "Interleukin-22 receptor subunit alpha-2",
    "id" : null
  }, {
    "name" : "IL23A ; IL23A_HUMAN ; Q9NPF7",
    "link" : "https://www.uniprot.org/uniprot/Q9NPF7",
    "description" : "Interleukin-23 subunit alpha",
    "id" : null
  }, {
    "name" : "IL23R ; IL23R_HUMAN ; Q5VWK5",
    "link" : "https://www.uniprot.org/uniprot/Q5VWK5",
    "description" : "Interleukin-23 receptor",
    "id" : null
  }, {
    "name" : "IL24 ; IL24_HUMAN ; Q13007",
    "link" : "https://www.uniprot.org/uniprot/Q13007",
    "description" : "Interleukin-24",
    "id" : null
  }, {
    "name" : "IL25 ; IL25_HUMAN ; Q9H293",
    "link" : "https://www.uniprot.org/uniprot/Q9H293",
    "description" : "Interleukin-25",
    "id" : null
  }, {
    "name" : "IL26 ; IL26_HUMAN ; Q9NPH9",
    "link" : "https://www.uniprot.org/uniprot/Q9NPH9",
    "description" : "Interleukin-26",
    "id" : null
  }, {
    "name" : "IL27 ; IL27A_HUMAN ; Q8NEV9",
    "link" : "https://www.uniprot.org/uniprot/Q8NEV9",
    "description" : "Interleukin-27 subunit alpha",
    "id" : null
  }, {
    "name" : "IL2RA ; IL2RA_HUMAN ; P01589",
    "link" : "https://www.uniprot.org/uniprot/P01589",
    "description" : "Interleukin-2 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL2RB ; IL2RB_HUMAN ; P14784",
    "link" : "https://www.uniprot.org/uniprot/P14784",
    "description" : "Interleukin-2 receptor subunit beta",
    "id" : null
  }, {
    "name" : "IL2RG ; IL2RG_HUMAN ; P31785",
    "link" : "https://www.uniprot.org/uniprot/P31785",
    "description" : "Cytokine receptor common subunit gamma",
    "id" : null
  }, {
    "name" : "IL3 ; IL3_HUMAN ; P08700",
    "link" : "https://www.uniprot.org/uniprot/P08700",
    "description" : "Interleukin-3",
    "id" : null
  }, {
    "name" : "IL31 ; IL31_HUMAN ; Q6EBC2",
    "link" : "https://www.uniprot.org/uniprot/Q6EBC2",
    "description" : "Interleukin-31",
    "id" : null
  }, {
    "name" : "IL32 ; IL32_HUMAN ; P24001",
    "link" : "https://www.uniprot.org/uniprot/P24001",
    "description" : "Interleukin-32",
    "id" : null
  }, {
    "name" : "IL33 ; IL33_HUMAN ; O95760",
    "link" : "https://www.uniprot.org/uniprot/O95760",
    "description" : "Interleukin-33",
    "id" : null
  }, {
    "name" : "IL34 ; IL34_HUMAN ; Q6ZMJ4",
    "link" : "https://www.uniprot.org/uniprot/Q6ZMJ4",
    "description" : "Interleukin-34",
    "id" : null
  }, {
    "name" : "IL36G ; IL36G_HUMAN ; Q9NZH8",
    "link" : "https://www.uniprot.org/uniprot/Q9NZH8",
    "description" : "Interleukin-36 gamma",
    "id" : null
  }, {
    "name" : "IL36RN ; I36RA_HUMAN ; Q9UBH0",
    "link" : "https://www.uniprot.org/uniprot/Q9UBH0",
    "description" : "Interleukin-36 receptor antagonist protein",
    "id" : null
  }, {
    "name" : "IL3RA ; IL3RA_HUMAN ; P26951",
    "link" : "https://www.uniprot.org/uniprot/P26951",
    "description" : "Interleukin-3 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL4 ; IL4_HUMAN ; P05112",
    "link" : "https://www.uniprot.org/uniprot/P05112",
    "description" : "Interleukin-4",
    "id" : null
  }, {
    "name" : "IL4R ; IL4RA_HUMAN ; P24394",
    "link" : "https://www.uniprot.org/uniprot/P24394",
    "description" : "Interleukin-4 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL5 ; IL5_HUMAN ; P05113",
    "link" : "https://www.uniprot.org/uniprot/P05113",
    "description" : "Interleukin-5",
    "id" : null
  }, {
    "name" : "IL5RA ; IL5RA_HUMAN ; Q01344",
    "link" : "https://www.uniprot.org/uniprot/Q01344",
    "description" : "Interleukin-5 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL6 ; IL6_HUMAN ; P05231",
    "link" : "https://www.uniprot.org/uniprot/P05231",
    "description" : "Interleukin-6",
    "id" : null
  }, {
    "name" : "IL6R ; IL6RA_HUMAN ; P08887",
    "link" : "https://www.uniprot.org/uniprot/P08887",
    "description" : "Interleukin-6 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL6ST ; IL6RB_HUMAN ; P40189",
    "link" : "https://www.uniprot.org/uniprot/P40189",
    "description" : "Interleukin-6 receptor subunit beta",
    "id" : null
  }, {
    "name" : "IL7 ; IL7_HUMAN ; P13232",
    "link" : "https://www.uniprot.org/uniprot/P13232",
    "description" : "Interleukin-7",
    "id" : null
  }, {
    "name" : "IL7R ; IL7RA_HUMAN ; P16871",
    "link" : "https://www.uniprot.org/uniprot/P16871",
    "description" : "Interleukin-7 receptor subunit alpha",
    "id" : null
  }, {
    "name" : "IL9 ; IL9_HUMAN ; P15248",
    "link" : "https://www.uniprot.org/uniprot/P15248",
    "description" : "Interleukin-9",
    "id" : null
  }, {
    "name" : "IL9R ; IL9R_HUMAN ; Q01113",
    "link" : "https://www.uniprot.org/uniprot/Q01113",
    "description" : "Interleukin-9 receptor",
    "id" : null
  }, {
    "name" : "INSM1 ; INSM1_HUMAN ; Q01101",
    "link" : "https://www.uniprot.org/uniprot/Q01101",
    "description" : "Insulinoma-associated protein 1",
    "id" : null
  }, {
    "name" : "INSR ; INSR_HUMAN ; P06213",
    "link" : "https://www.uniprot.org/uniprot/P06213",
    "description" : "Insulin receptor",
    "id" : null
  }, {
    "name" : "IQCG ; DRC9_HUMAN ; Q9H095",
    "link" : "https://www.uniprot.org/uniprot/Q9H095",
    "description" : "Dynein regulatory complex protein 9",
    "id" : null
  }, {
    "name" : "ITGA1 ; ITA1_HUMAN ; P56199",
    "link" : "https://www.uniprot.org/uniprot/P56199",
    "description" : "Integrin alpha-1",
    "id" : null
  }, {
    "name" : "ITGA2 ; ITA2_HUMAN ; P17301",
    "link" : "https://www.uniprot.org/uniprot/P17301",
    "description" : "Integrin alpha-2",
    "id" : null
  }, {
    "name" : "ITGA2B ; ITA2B_HUMAN ; P08514",
    "link" : "https://www.uniprot.org/uniprot/P08514",
    "description" : "Integrin alpha-IIb",
    "id" : null
  }, {
    "name" : "ITGA3 ; ITA3_HUMAN ; P26006",
    "link" : "https://www.uniprot.org/uniprot/P26006",
    "description" : "Integrin alpha-3",
    "id" : null
  }, {
    "name" : "ITGA4 ; ITA4_HUMAN ; P13612",
    "link" : "https://www.uniprot.org/uniprot/P13612",
    "description" : "Integrin alpha-4",
    "id" : null
  }, {
    "name" : "ITGA5 ; ITA5_HUMAN ; P08648",
    "link" : "https://www.uniprot.org/uniprot/P08648",
    "description" : "Integrin alpha-5",
    "id" : null
  }, {
    "name" : "ITGA6 ; ITA6_HUMAN ; P23229",
    "link" : "https://www.uniprot.org/uniprot/P23229",
    "description" : "Integrin alpha-6",
    "id" : null
  }, {
    "name" : "ITGAD ; ITAD_HUMAN ; Q13349",
    "link" : "https://www.uniprot.org/uniprot/Q13349",
    "description" : "Integrin alpha-D",
    "id" : null
  }, {
    "name" : "ITGAE ; ITAE_HUMAN ; P38570",
    "link" : "https://www.uniprot.org/uniprot/P38570",
    "description" : "Integrin alpha-E",
    "id" : null
  }, {
    "name" : "ITGAL ; ITAL_HUMAN ; P20701",
    "link" : "https://www.uniprot.org/uniprot/P20701",
    "description" : "Integrin alpha-L",
    "id" : null
  }, {
    "name" : "ITGAM ; ITAM_HUMAN ; P11215",
    "link" : "https://www.uniprot.org/uniprot/P11215",
    "description" : "Integrin alpha-M",
    "id" : null
  }, {
    "name" : "ITGAV ; ITAV_HUMAN ; P06756",
    "link" : "https://www.uniprot.org/uniprot/P06756",
    "description" : "Integrin alpha-V",
    "id" : null
  }, {
    "name" : "ITGAX ; ITAX_HUMAN ; P20702",
    "link" : "https://www.uniprot.org/uniprot/P20702",
    "description" : "Integrin alpha-X",
    "id" : null
  }, {
    "name" : "ITGB1 ; ITB1_HUMAN ; P05556",
    "link" : "https://www.uniprot.org/uniprot/P05556",
    "description" : "Integrin beta-1",
    "id" : null
  }, {
    "name" : "ITGB2 ; ITB2_HUMAN ; P05107",
    "link" : "https://www.uniprot.org/uniprot/P05107",
    "description" : "Integrin beta-2",
    "id" : null
  }, {
    "name" : "ITGB3 ; ITB3_HUMAN ; P05106",
    "link" : "https://www.uniprot.org/uniprot/P05106",
    "description" : "Integrin beta-3",
    "id" : null
  }, {
    "name" : "ITGB4 ; ITB4_HUMAN ; P16144",
    "link" : "https://www.uniprot.org/uniprot/P16144",
    "description" : "Integrin beta-4",
    "id" : null
  }, {
    "name" : "ITIH1 ; ITIH1_HUMAN ; P19827",
    "link" : "https://www.uniprot.org/uniprot/P19827",
    "description" : "Inter-alpha-trypsin inhibitor heavy chain H1",
    "id" : null
  }, {
    "name" : "ITIH2 ; ITIH2_HUMAN ; P19823",
    "link" : "https://www.uniprot.org/uniprot/P19823",
    "description" : "Inter-alpha-trypsin inhibitor heavy chain H2",
    "id" : null
  }, {
    "name" : "ITIH3 ; ITIH3_HUMAN ; Q06033",
    "link" : "https://www.uniprot.org/uniprot/Q06033",
    "description" : "Inter-alpha-trypsin inhibitor heavy chain H3",
    "id" : null
  }, {
    "name" : "ITIH4 ; ITIH4_HUMAN ; Q14624",
    "link" : "https://www.uniprot.org/uniprot/Q14624",
    "description" : "Inter-alpha-trypsin inhibitor heavy chain H4",
    "id" : null
  }, {
    "name" : "ITPRID2 ; ITPI2_HUMAN ; P28290",
    "link" : "https://www.uniprot.org/uniprot/P28290",
    "description" : "Protein ITPRID2",
    "id" : null
  }, {
    "name" : "JAG1 ; JAG1_HUMAN ; P78504",
    "link" : "https://www.uniprot.org/uniprot/P78504",
    "description" : "Protein jagged-1",
    "id" : null
  }, {
    "name" : "JAM2 ; JAM2_HUMAN ; P57087",
    "link" : "https://www.uniprot.org/uniprot/P57087",
    "description" : "Junctional adhesion molecule B",
    "id" : null
  }, {
    "name" : "JCHAIN ; IGJ_HUMAN ; P01591",
    "link" : "https://www.uniprot.org/uniprot/P01591",
    "description" : "Immunoglobulin J chain",
    "id" : null
  }, {
    "name" : "KDR ; VGFR2_HUMAN ; P35968",
    "link" : "https://www.uniprot.org/uniprot/P35968",
    "description" : "Vascular endothelial growth factor receptor 2",
    "id" : null
  }, {
    "name" : "KEL ; KELL_HUMAN ; P23276",
    "link" : "https://www.uniprot.org/uniprot/P23276",
    "description" : "Kell blood group glycoprotein",
    "id" : null
  }, {
    "name" : "KIR2DL1 ; KI2L1_HUMAN ; P43626",
    "link" : "https://www.uniprot.org/uniprot/P43626",
    "description" : "Killer cell immunoglobulin-like receptor 2DL1",
    "id" : null
  }, {
    "name" : "KIR2DL2 ; KI2L2_HUMAN ; P43627",
    "link" : "https://www.uniprot.org/uniprot/P43627",
    "description" : "Killer cell immunoglobulin-like receptor 2DL2",
    "id" : null
  }, {
    "name" : "KIR2DL3 ; KI2L3_HUMAN ; P43628",
    "link" : "https://www.uniprot.org/uniprot/P43628",
    "description" : "Killer cell immunoglobulin-like receptor 2DL3",
    "id" : null
  }, {
    "name" : "KIR2DL4 ; KI2L4_HUMAN ; Q99706",
    "link" : "https://www.uniprot.org/uniprot/Q99706",
    "description" : "Killer cell immunoglobulin-like receptor 2DL4",
    "id" : null
  }, {
    "name" : "KIR2DL5A ; KI2LA_HUMAN ; Q8N109",
    "link" : "https://www.uniprot.org/uniprot/Q8N109",
    "description" : "Killer cell immunoglobulin-like receptor 2DL5A",
    "id" : null
  }, {
    "name" : "KIR2DS1 ; KI2S1_HUMAN ; Q14954",
    "link" : "https://www.uniprot.org/uniprot/Q14954",
    "description" : "Killer cell immunoglobulin-like receptor 2DS1",
    "id" : null
  }, {
    "name" : "KIR2DS2 ; KI2S2_HUMAN ; P43631",
    "link" : "https://www.uniprot.org/uniprot/P43631",
    "description" : "Killer cell immunoglobulin-like receptor 2DS2",
    "id" : null
  }, {
    "name" : "KIR2DS4 ; KI2S4_HUMAN ; P43632",
    "link" : "https://www.uniprot.org/uniprot/P43632",
    "description" : "Killer cell immunoglobulin-like receptor 2DS4",
    "id" : null
  }, {
    "name" : "KIR2DS5 ; KI2S5_HUMAN ; Q14953",
    "link" : "https://www.uniprot.org/uniprot/Q14953",
    "description" : "Killer cell immunoglobulin-like receptor 2DS5",
    "id" : null
  }, {
    "name" : "KIR3DL1 ; KI3L1_HUMAN ; P43629",
    "link" : "https://www.uniprot.org/uniprot/P43629",
    "description" : "Killer cell immunoglobulin-like receptor 3DL1",
    "id" : null
  }, {
    "name" : "KIR3DL2 ; KI3L2_HUMAN ; P43630",
    "link" : "https://www.uniprot.org/uniprot/P43630",
    "description" : "Killer cell immunoglobulin-like receptor 3DL2",
    "id" : null
  }, {
    "name" : "KIR3DL3 ; KI3L3_HUMAN ; Q8N743",
    "link" : "https://www.uniprot.org/uniprot/Q8N743",
    "description" : "Killer cell immunoglobulin-like receptor 3DL3",
    "id" : null
  }, {
    "name" : "KIT ; KIT_HUMAN ; P10721",
    "link" : "https://www.uniprot.org/uniprot/P10721",
    "description" : "Mast/stem cell growth factor receptor Kit",
    "id" : null
  }, {
    "name" : "KITLG ; SCF_HUMAN ; P21583",
    "link" : "https://www.uniprot.org/uniprot/P21583",
    "description" : "Kit ligand",
    "id" : null
  }, {
    "name" : "KLKB1 ; KLKB1_HUMAN ; P03952",
    "link" : "https://www.uniprot.org/uniprot/P03952",
    "description" : "Plasma kallikrein",
    "id" : null
  }, {
    "name" : "KLRB1 ; KLRB1_HUMAN ; Q12918",
    "link" : "https://www.uniprot.org/uniprot/Q12918",
    "description" : "Killer cell lectin-like receptor subfamily B member 1",
    "id" : null
  }, {
    "name" : "KLRC1 ; NKG2A_HUMAN ; P26715",
    "link" : "https://www.uniprot.org/uniprot/P26715",
    "description" : "NKG2-A/NKG2-B type II integral membrane protein",
    "id" : null
  }, {
    "name" : "KLRC2 ; NKG2C_HUMAN ; P26717",
    "link" : "https://www.uniprot.org/uniprot/P26717",
    "description" : "NKG2-C type II integral membrane protein",
    "id" : null
  }, {
    "name" : "KLRD1 ; KLRD1_HUMAN ; Q13241",
    "link" : "https://www.uniprot.org/uniprot/Q13241",
    "description" : "Natural killer cells antigen CD94",
    "id" : null
  }, {
    "name" : "KLRK1 ; NKG2D_HUMAN ; P26718",
    "link" : "https://www.uniprot.org/uniprot/P26718",
    "description" : "NKG2-D type II integral membrane protein",
    "id" : null
  }, {
    "name" : "KMT2C ; KMT2C_HUMAN ; Q8NEZ4",
    "link" : "https://www.uniprot.org/uniprot/Q8NEZ4",
    "description" : "Histone-lysine N-methyltransferase 2C",
    "id" : null
  }, {
    "name" : "KNG1 ; KNG1_HUMAN ; P01042",
    "link" : "https://www.uniprot.org/uniprot/P01042",
    "description" : "Kininogen-1",
    "id" : null
  }, {
    "name" : "KPNA5 ; IMA6_HUMAN ; O15131",
    "link" : "https://www.uniprot.org/uniprot/O15131",
    "description" : "Importin subunit alpha-6",
    "id" : null
  }, {
    "name" : "KRT1 ; K2C1_HUMAN ; P04264",
    "link" : "https://www.uniprot.org/uniprot/P04264",
    "description" : "Keratin, type II cytoskeletal 1",
    "id" : null
  }, {
    "name" : "KRT10 ; K1C10_HUMAN ; P13645",
    "link" : "https://www.uniprot.org/uniprot/P13645",
    "description" : "Keratin, type I cytoskeletal 10",
    "id" : null
  }, {
    "name" : "KRT17 ; K1C17_HUMAN ; Q04695",
    "link" : "https://www.uniprot.org/uniprot/Q04695",
    "description" : "Keratin, type I cytoskeletal 17",
    "id" : null
  }, {
    "name" : "KRT2 ; K22E_HUMAN ; P35908",
    "link" : "https://www.uniprot.org/uniprot/P35908",
    "description" : "Keratin, type II cytoskeletal 2 epidermal",
    "id" : null
  }, {
    "name" : "KRT77 ; K2C1B_HUMAN ; Q7Z794",
    "link" : "https://www.uniprot.org/uniprot/Q7Z794",
    "description" : "Keratin, type II cytoskeletal 1b",
    "id" : null
  }, {
    "name" : "KRT81 ; KRT81_HUMAN ; Q14533",
    "link" : "https://www.uniprot.org/uniprot/Q14533",
    "description" : "Keratin, type II cuticular Hb1",
    "id" : null
  }, {
    "name" : "KRT9 ; K1C9_HUMAN ; P35527",
    "link" : "https://www.uniprot.org/uniprot/P35527",
    "description" : "Keratin, type I cytoskeletal 9",
    "id" : null
  }, {
    "name" : "KTN1 ; KTN1_HUMAN ; Q86UP2",
    "link" : "https://www.uniprot.org/uniprot/Q86UP2",
    "description" : "Kinectin",
    "id" : null
  }, {
    "name" : "L1CAM ; L1CAM_HUMAN ; P32004",
    "link" : "https://www.uniprot.org/uniprot/P32004",
    "description" : "Neural cell adhesion molecule L1",
    "id" : null
  }, {
    "name" : "LAG3 ; LAG3_HUMAN ; P18627",
    "link" : "https://www.uniprot.org/uniprot/P18627",
    "description" : "Lymphocyte activation gene 3 protein",
    "id" : null
  }, {
    "name" : "LAIR1 ; LAIR1_HUMAN ; Q6GTX8",
    "link" : "https://www.uniprot.org/uniprot/Q6GTX8",
    "description" : "Leukocyte-associated immunoglobulin-like receptor 1",
    "id" : null
  }, {
    "name" : "LAIR2 ; LAIR2_HUMAN ; Q6ISS4",
    "link" : "https://www.uniprot.org/uniprot/Q6ISS4",
    "description" : "Leukocyte-associated immunoglobulin-like receptor 2",
    "id" : null
  }, {
    "name" : "LAMP1 ; LAMP1_HUMAN ; P11279",
    "link" : "https://www.uniprot.org/uniprot/P11279",
    "description" : "Lysosome-associated membrane glycoprotein 1",
    "id" : null
  }, {
    "name" : "LAMP2 ; LAMP2_HUMAN ; P13473",
    "link" : "https://www.uniprot.org/uniprot/P13473",
    "description" : "Lysosome-associated membrane glycoprotein 2",
    "id" : null
  }, {
    "name" : "LAMP3 ; LAMP3_HUMAN ; Q9UQV4",
    "link" : "https://www.uniprot.org/uniprot/Q9UQV4",
    "description" : "Lysosome-associated membrane glycoprotein 3",
    "id" : null
  }, {
    "name" : "LBP ; LBP_HUMAN ; P18428",
    "link" : "https://www.uniprot.org/uniprot/P18428",
    "description" : "Lipopolysaccharide-binding protein",
    "id" : null
  }, {
    "name" : "LCAT ; LCAT_HUMAN ; P04180",
    "link" : "https://www.uniprot.org/uniprot/P04180",
    "description" : "Phosphatidylcholine-sterol acyltransferase",
    "id" : null
  }, {
    "name" : "LECT2 ; LECT2_HUMAN ; O14960",
    "link" : "https://www.uniprot.org/uniprot/O14960",
    "description" : "Leukocyte cell-derived chemotaxin-2",
    "id" : null
  }, {
    "name" : "LEPR ; LEPR_HUMAN ; P48357",
    "link" : "https://www.uniprot.org/uniprot/P48357",
    "description" : "Leptin receptor",
    "id" : null
  }, {
    "name" : "LGALS3BP ; LG3BP_HUMAN ; Q08380",
    "link" : "https://www.uniprot.org/uniprot/Q08380",
    "description" : "Galectin-3-binding protein",
    "id" : null
  }, {
    "name" : "LIF ; LIF_HUMAN ; P15018",
    "link" : "https://www.uniprot.org/uniprot/P15018",
    "description" : "Leukemia inhibitory factor",
    "id" : null
  }, {
    "name" : "LIFR ; LIFR_HUMAN ; P42702",
    "link" : "https://www.uniprot.org/uniprot/P42702",
    "description" : "Leukemia inhibitory factor receptor",
    "id" : null
  }, {
    "name" : "LILRA1 ; LIRA1_HUMAN ; O75019",
    "link" : "https://www.uniprot.org/uniprot/O75019",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily A member 1",
    "id" : null
  }, {
    "name" : "LILRA2 ; LIRA2_HUMAN ; Q8N149",
    "link" : "https://www.uniprot.org/uniprot/Q8N149",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily A member 2",
    "id" : null
  }, {
    "name" : "LILRA3 ; LIRA3_HUMAN ; Q8N6C8",
    "link" : "https://www.uniprot.org/uniprot/Q8N6C8",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily A member 3",
    "id" : null
  }, {
    "name" : "LILRA4 ; LIRA4_HUMAN ; P59901",
    "link" : "https://www.uniprot.org/uniprot/P59901",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily A member 4",
    "id" : null
  }, {
    "name" : "LILRA5 ; LIRA5_HUMAN ; A6NI73",
    "link" : "https://www.uniprot.org/uniprot/A6NI73",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily A member 5",
    "id" : null
  }, {
    "name" : "LILRA6 ; LIRA6_HUMAN ; Q6PI73",
    "link" : "https://www.uniprot.org/uniprot/Q6PI73",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily A member 6",
    "id" : null
  }, {
    "name" : "LILRB1 ; LIRB1_HUMAN ; Q8NHL6",
    "link" : "https://www.uniprot.org/uniprot/Q8NHL6",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily B member 1",
    "id" : null
  }, {
    "name" : "LILRB2 ; LIRB2_HUMAN ; Q8N423",
    "link" : "https://www.uniprot.org/uniprot/Q8N423",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily B member 2",
    "id" : null
  }, {
    "name" : "LILRB3 ; LIRB3_HUMAN ; O75022",
    "link" : "https://www.uniprot.org/uniprot/O75022",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily B member 3",
    "id" : null
  }, {
    "name" : "LILRB4 ; LIRB4_HUMAN ; Q8NHJ6",
    "link" : "https://www.uniprot.org/uniprot/Q8NHJ6",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily B member 4",
    "id" : null
  }, {
    "name" : "LILRB5 ; LIRB5_HUMAN ; O75023",
    "link" : "https://www.uniprot.org/uniprot/O75023",
    "description" : "Leukocyte immunoglobulin-like receptor subfamily B member 5",
    "id" : null
  }, {
    "name" : "LPA ; APOA_HUMAN ; P08519",
    "link" : "https://www.uniprot.org/uniprot/P08519",
    "description" : "Apolipoprotein(a)",
    "id" : null
  }, {
    "name" : "LRG1 ; A2GL_HUMAN ; P02750",
    "link" : "https://www.uniprot.org/uniprot/P02750",
    "description" : "Leucine-rich alpha-2-glycoprotein",
    "id" : null
  }, {
    "name" : "LRP1 ; LRP1_HUMAN ; Q07954",
    "link" : "https://www.uniprot.org/uniprot/Q07954",
    "description" : "Prolow-density lipoprotein receptor-related protein 1",
    "id" : null
  }, {
    "name" : "LTA ; TNFB_HUMAN ; P01374",
    "link" : "https://www.uniprot.org/uniprot/P01374",
    "description" : "Lymphotoxin-alpha",
    "id" : null
  }, {
    "name" : "LTB ; TNFC_HUMAN ; Q06643",
    "link" : "https://www.uniprot.org/uniprot/Q06643",
    "description" : "Lymphotoxin-beta",
    "id" : null
  }, {
    "name" : "LTBR ; TNR3_HUMAN ; P36941",
    "link" : "https://www.uniprot.org/uniprot/P36941",
    "description" : "Tumor necrosis factor receptor superfamily member 3",
    "id" : null
  }, {
    "name" : "LUM ; LUM_HUMAN ; P51884",
    "link" : "https://www.uniprot.org/uniprot/P51884",
    "description" : "Lumican",
    "id" : null
  }, {
    "name" : "LY75 ; LY75_HUMAN ; O60449",
    "link" : "https://www.uniprot.org/uniprot/O60449",
    "description" : "Lymphocyte antigen 75",
    "id" : null
  }, {
    "name" : "LY9 ; LY9_HUMAN ; Q9HBG7",
    "link" : "https://www.uniprot.org/uniprot/Q9HBG7",
    "description" : "T-lymphocyte surface antigen Ly-9",
    "id" : null
  }, {
    "name" : "LYVE1 ; LYVE1_HUMAN ; Q9Y5Y7",
    "link" : "https://www.uniprot.org/uniprot/Q9Y5Y7",
    "description" : "Lymphatic vessel endothelial hyaluronic acid receptor 1",
    "id" : null
  }, {
    "name" : "LYZ ; LYSC_HUMAN ; P61626",
    "link" : "https://www.uniprot.org/uniprot/P61626",
    "description" : "Lysozyme C",
    "id" : null
  }, {
    "name" : "MAP3K11 ; M3K11_HUMAN ; Q16584",
    "link" : "https://www.uniprot.org/uniprot/Q16584",
    "description" : "Mitogen-activated protein kinase kinase kinase 11",
    "id" : null
  }, {
    "name" : "MCAM ; MUC18_HUMAN ; P43121",
    "link" : "https://www.uniprot.org/uniprot/P43121",
    "description" : "Cell surface glycoprotein MUC18",
    "id" : null
  }, {
    "name" : "MELTF ; TRFM_HUMAN ; P08582",
    "link" : "https://www.uniprot.org/uniprot/P08582",
    "description" : "Melanotransferrin",
    "id" : null
  }, {
    "name" : "MET ; MET_HUMAN ; P08581",
    "link" : "https://www.uniprot.org/uniprot/P08581",
    "description" : "Hepatocyte growth factor receptor",
    "id" : null
  }, {
    "name" : "MIF ; MIF_HUMAN ; P14174",
    "link" : "https://www.uniprot.org/uniprot/P14174",
    "description" : "Macrophage migration inhibitory factor",
    "id" : null
  }, {
    "name" : "MKI67 ; KI67_HUMAN ; P46013",
    "link" : "https://www.uniprot.org/uniprot/P46013",
    "description" : "Proliferation marker protein Ki-67",
    "id" : null
  }, {
    "name" : "MME ; NEP_HUMAN ; P08473",
    "link" : "https://www.uniprot.org/uniprot/P08473",
    "description" : "Neprilysin",
    "id" : null
  }, {
    "name" : "MPL ; TPOR_HUMAN ; P40238",
    "link" : "https://www.uniprot.org/uniprot/P40238",
    "description" : "Thrombopoietin receptor",
    "id" : null
  }, {
    "name" : "MRC1 ; MRC1_HUMAN ; P22897",
    "link" : "https://www.uniprot.org/uniprot/P22897",
    "description" : "Macrophage mannose receptor 1",
    "id" : null
  }, {
    "name" : "MRC2 ; MRC2_HUMAN ; Q9UBG0",
    "link" : "https://www.uniprot.org/uniprot/Q9UBG0",
    "description" : "C-type mannose receptor 2",
    "id" : null
  }, {
    "name" : "MS4A1 ; CD20_HUMAN ; P11836",
    "link" : "https://www.uniprot.org/uniprot/P11836",
    "description" : "B-lymphocyte antigen CD20",
    "id" : null
  }, {
    "name" : "MSR1 ; MSRE_HUMAN ; P21757",
    "link" : "https://www.uniprot.org/uniprot/P21757",
    "description" : "Macrophage scavenger receptor types I and II",
    "id" : null
  }, {
    "name" : "MST1 ; HGFL_HUMAN ; P26927",
    "link" : "https://www.uniprot.org/uniprot/P26927",
    "description" : "Hepatocyte growth factor-like protein",
    "id" : null
  }, {
    "name" : "MST1R ; RON_HUMAN ; Q04912",
    "link" : "https://www.uniprot.org/uniprot/Q04912",
    "description" : "Macrophage-stimulating protein receptor",
    "id" : null
  }, {
    "name" : "MUC1 ; MUC1_HUMAN ; P15941",
    "link" : "https://www.uniprot.org/uniprot/P15941",
    "description" : "Mucin-1",
    "id" : null
  }, {
    "name" : "MYZAP ; MYZAP_HUMAN ; P0CAP1",
    "link" : "https://www.uniprot.org/uniprot/P0CAP1",
    "description" : "Myocardial zonula adherens protein",
    "id" : null
  }, {
    "name" : "N4BP3 ; N4BP3_HUMAN ; O15049",
    "link" : "https://www.uniprot.org/uniprot/O15049",
    "description" : "NEDD4-binding protein 3",
    "id" : null
  }, {
    "name" : "NCAM1 ; NCAM1_HUMAN ; P13591",
    "link" : "https://www.uniprot.org/uniprot/P13591",
    "description" : "Neural cell adhesion molecule 1",
    "id" : null
  }, {
    "name" : "NCR1 ; NCTR1_HUMAN ; O76036",
    "link" : "https://www.uniprot.org/uniprot/O76036",
    "description" : "Natural cytotoxicity triggering receptor 1",
    "id" : null
  }, {
    "name" : "NCR2 ; NCTR2_HUMAN ; O95944",
    "link" : "https://www.uniprot.org/uniprot/O95944",
    "description" : "Natural cytotoxicity triggering receptor 2",
    "id" : null
  }, {
    "name" : "NCR3 ; NCTR3_HUMAN ; O14931",
    "link" : "https://www.uniprot.org/uniprot/O14931",
    "description" : "Natural cytotoxicity triggering receptor 3",
    "id" : null
  }, {
    "name" : "NECTIN1 ; NECT1_HUMAN ; Q15223",
    "link" : "https://www.uniprot.org/uniprot/Q15223",
    "description" : "Nectin-1",
    "id" : null
  }, {
    "name" : "NECTIN2 ; NECT2_HUMAN ; Q92692",
    "link" : "https://www.uniprot.org/uniprot/Q92692",
    "description" : "Nectin-2",
    "id" : null
  }, {
    "name" : "NECTIN3 ; NECT3_HUMAN ; Q9NQS3",
    "link" : "https://www.uniprot.org/uniprot/Q9NQS3",
    "description" : "Nectin-3",
    "id" : null
  }, {
    "name" : "NGFR ; TNR16_HUMAN ; P08138",
    "link" : "https://www.uniprot.org/uniprot/P08138",
    "description" : "Tumor necrosis factor receptor superfamily member 16",
    "id" : null
  }, {
    "name" : "NRP1 ; NRP1_HUMAN ; O14786",
    "link" : "https://www.uniprot.org/uniprot/O14786",
    "description" : "Neuropilin-1",
    "id" : null
  }, {
    "name" : "NT5E ; 5NTD_HUMAN ; P21589",
    "link" : "https://www.uniprot.org/uniprot/P21589",
    "description" : "5'-nucleotidase",
    "id" : null
  }, {
    "name" : "NUCB1 ; NUCB1_HUMAN ; Q02818",
    "link" : "https://www.uniprot.org/uniprot/Q02818",
    "description" : "Nucleobindin-1",
    "id" : null
  }, {
    "name" : "ORM1 ; A1AG1_HUMAN ; P02763",
    "link" : "https://www.uniprot.org/uniprot/P02763",
    "description" : "Alpha-1-acid glycoprotein 1",
    "id" : null
  }, {
    "name" : "ORM2 ; A1AG2_HUMAN ; P19652",
    "link" : "https://www.uniprot.org/uniprot/P19652",
    "description" : "Alpha-1-acid glycoprotein 2",
    "id" : null
  }, {
    "name" : "OSM ; ONCM_HUMAN ; P13725",
    "link" : "https://www.uniprot.org/uniprot/P13725",
    "description" : "Oncostatin-M",
    "id" : null
  }, {
    "name" : "OSMR ; OSMR_HUMAN ; Q99650",
    "link" : "https://www.uniprot.org/uniprot/Q99650",
    "description" : "Oncostatin-M-specific receptor subunit beta",
    "id" : null
  }, {
    "name" : "PACRGL ; PACRL_HUMAN ; Q8N7B6",
    "link" : "https://www.uniprot.org/uniprot/Q8N7B6",
    "description" : "PACRG-like protein",
    "id" : null
  }, {
    "name" : "PARP14 ; PAR14_HUMAN ; Q460N5",
    "link" : "https://www.uniprot.org/uniprot/Q460N5",
    "description" : "Protein mono-ADP-ribosyltransferase PARP14",
    "id" : null
  }, {
    "name" : "PDCD1 ; PDCD1_HUMAN ; Q15116",
    "link" : "https://www.uniprot.org/uniprot/Q15116",
    "description" : "Programmed cell death protein 1",
    "id" : null
  }, {
    "name" : "PDCD1LG2 ; PD1L2_HUMAN ; Q9BQ51",
    "link" : "https://www.uniprot.org/uniprot/Q9BQ51",
    "description" : "Programmed cell death 1 ligand 2",
    "id" : null
  }, {
    "name" : "PDGFA ; PDGFA_HUMAN ; P04085",
    "link" : "https://www.uniprot.org/uniprot/P04085",
    "description" : "Platelet-derived growth factor subunit A",
    "id" : null
  }, {
    "name" : "PDGFB ; PDGFB_HUMAN ; P01127",
    "link" : "https://www.uniprot.org/uniprot/P01127",
    "description" : "Platelet-derived growth factor subunit B",
    "id" : null
  }, {
    "name" : "PDGFRA ; PGFRA_HUMAN ; P16234",
    "link" : "https://www.uniprot.org/uniprot/P16234",
    "description" : "Platelet-derived growth factor receptor alpha",
    "id" : null
  }, {
    "name" : "PDGFRB ; PGFRB_HUMAN ; P09619",
    "link" : "https://www.uniprot.org/uniprot/P09619",
    "description" : "Platelet-derived growth factor receptor beta",
    "id" : null
  }, {
    "name" : "PECAM1 ; PECA1_HUMAN ; P16284",
    "link" : "https://www.uniprot.org/uniprot/P16284",
    "description" : "Platelet endothelial cell adhesion molecule",
    "id" : null
  }, {
    "name" : "PER2 ; PER2_HUMAN ; O15055",
    "link" : "https://www.uniprot.org/uniprot/O15055",
    "description" : "Period circadian protein homolog 2",
    "id" : null
  }, {
    "name" : "PF4 ; PLF4_HUMAN ; P02776",
    "link" : "https://www.uniprot.org/uniprot/P02776",
    "description" : "Platelet factor 4",
    "id" : null
  }, {
    "name" : "PF4V1 ; PF4V_HUMAN ; P10720",
    "link" : "https://www.uniprot.org/uniprot/P10720",
    "description" : "Platelet factor 4 variant",
    "id" : null
  }, {
    "name" : "PFKP ; PFKAP_HUMAN ; Q01813",
    "link" : "https://www.uniprot.org/uniprot/Q01813",
    "description" : "ATP-dependent 6-phosphofructokinase, platelet type",
    "id" : null
  }, {
    "name" : "PGLYRP2 ; PGRP2_HUMAN ; Q96PD5",
    "link" : "https://www.uniprot.org/uniprot/Q96PD5",
    "description" : "N-acetylmuramoyl-L-alanine amidase",
    "id" : null
  }, {
    "name" : "PLAUR ; UPAR_HUMAN ; Q03405",
    "link" : "https://www.uniprot.org/uniprot/Q03405",
    "description" : "Urokinase plasminogen activator surface receptor",
    "id" : null
  }, {
    "name" : "PLG ; PLMN_HUMAN ; P00747",
    "link" : "https://www.uniprot.org/uniprot/P00747",
    "description" : "Plasminogen",
    "id" : null
  }, {
    "name" : "PLXNC1 ; PLXC1_HUMAN ; O60486",
    "link" : "https://www.uniprot.org/uniprot/O60486",
    "description" : "Plexin-C1",
    "id" : null
  }, {
    "name" : "PON1 ; PON1_HUMAN ; P27169",
    "link" : "https://www.uniprot.org/uniprot/P27169",
    "description" : "Serum paraoxonase/arylesterase 1",
    "id" : null
  }, {
    "name" : "PPBP ; CXCL7_HUMAN ; P02775",
    "link" : "https://www.uniprot.org/uniprot/P02775",
    "description" : "Platelet basic protein",
    "id" : null
  }, {
    "name" : "PRDX2 ; PRDX2_HUMAN ; P32119",
    "link" : "https://www.uniprot.org/uniprot/P32119",
    "description" : "Peroxiredoxin-2",
    "id" : null
  }, {
    "name" : "PRF1 ; PERF_HUMAN ; P14222",
    "link" : "https://www.uniprot.org/uniprot/P14222",
    "description" : "Perforin-1",
    "id" : null
  }, {
    "name" : "PRG4 ; PRG4_HUMAN ; Q92954",
    "link" : "https://www.uniprot.org/uniprot/Q92954",
    "description" : "Proteoglycan 4",
    "id" : null
  }, {
    "name" : "PRICKLE2 ; PRIC2_HUMAN ; Q7Z3G6",
    "link" : "https://www.uniprot.org/uniprot/Q7Z3G6",
    "description" : "Prickle-like protein 2",
    "id" : null
  }, {
    "name" : "PRNP ; APRIO_HUMAN ; F7VJQ1",
    "link" : "https://www.uniprot.org/uniprot/F7VJQ1",
    "description" : "Alternative prion protein",
    "id" : null
  }, {
    "name" : "PROC ; PROC_HUMAN ; P04070",
    "link" : "https://www.uniprot.org/uniprot/P04070",
    "description" : "Vitamin K-dependent protein C",
    "id" : null
  }, {
    "name" : "PROCR ; EPCR_HUMAN ; Q9UNN8",
    "link" : "https://www.uniprot.org/uniprot/Q9UNN8",
    "description" : "Endothelial protein C receptor",
    "id" : null
  }, {
    "name" : "PROM1 ; PROM1_HUMAN ; O43490",
    "link" : "https://www.uniprot.org/uniprot/O43490",
    "description" : "Prominin-1",
    "id" : null
  }, {
    "name" : "PROS1 ; PROS_HUMAN ; P07225",
    "link" : "https://www.uniprot.org/uniprot/P07225",
    "description" : "Vitamin K-dependent protein S",
    "id" : null
  }, {
    "name" : "PROZ ; PROZ_HUMAN ; P22891",
    "link" : "https://www.uniprot.org/uniprot/P22891",
    "description" : "Vitamin K-dependent protein Z",
    "id" : null
  }, {
    "name" : "PSG1 ; PSG1_HUMAN ; P11464",
    "link" : "https://www.uniprot.org/uniprot/P11464",
    "description" : "Pregnancy-specific beta-1-glycoprotein 1",
    "id" : null
  }, {
    "name" : "PTGDR2 ; PD2R2_HUMAN ; Q9Y5Y4",
    "link" : "https://www.uniprot.org/uniprot/Q9Y5Y4",
    "description" : "Prostaglandin D2 receptor 2",
    "id" : null
  }, {
    "name" : "PTGFRN ; FPRP_HUMAN ; Q9P2B2",
    "link" : "https://www.uniprot.org/uniprot/Q9P2B2",
    "description" : "Prostaglandin F2 receptor negative regulator",
    "id" : null
  }, {
    "name" : "PTPRC ; PTPRC_HUMAN ; P08575",
    "link" : "https://www.uniprot.org/uniprot/P08575",
    "description" : "Receptor-type tyrosine-protein phosphatase C",
    "id" : null
  }, {
    "name" : "PTPRJ ; PTPRJ_HUMAN ; Q12913",
    "link" : "https://www.uniprot.org/uniprot/Q12913",
    "description" : "Receptor-type tyrosine-protein phosphatase eta",
    "id" : null
  }, {
    "name" : "PVR ; PVR_HUMAN ; P15151",
    "link" : "https://www.uniprot.org/uniprot/P15151",
    "description" : "Poliovirus receptor",
    "id" : null
  }, {
    "name" : "PZP ; PZP_HUMAN ; P20742",
    "link" : "https://www.uniprot.org/uniprot/P20742",
    "description" : "Pregnancy zone protein",
    "id" : null
  }, {
    "name" : "RBP4 ; RET4_HUMAN ; P02753",
    "link" : "https://www.uniprot.org/uniprot/P02753",
    "description" : "Retinol-binding protein 4",
    "id" : null
  }, {
    "name" : "RETN ; RETN_HUMAN ; Q9HD89",
    "link" : "https://www.uniprot.org/uniprot/Q9HD89",
    "description" : "Resistin",
    "id" : null
  }, {
    "name" : "RHAG ; RHAG_HUMAN ; Q02094",
    "link" : "https://www.uniprot.org/uniprot/Q02094",
    "description" : "Ammonium transporter Rh type A",
    "id" : null
  }, {
    "name" : "RHCE ; RHCE_HUMAN ; P18577",
    "link" : "https://www.uniprot.org/uniprot/P18577",
    "description" : "Blood group Rh(CE) polypeptide",
    "id" : null
  }, {
    "name" : "RHD ; RHD_HUMAN ; Q02161",
    "link" : "https://www.uniprot.org/uniprot/Q02161",
    "description" : "Blood group Rh(D) polypeptide",
    "id" : null
  }, {
    "name" : "RNF180 ; RN180_HUMAN ; Q86T96",
    "link" : "https://www.uniprot.org/uniprot/Q86T96",
    "description" : "E3 ubiquitin-protein ligase RNF180",
    "id" : null
  }, {
    "name" : "ROCK2 ; ROCK2_HUMAN ; O75116",
    "link" : "https://www.uniprot.org/uniprot/O75116",
    "description" : "Rho-associated protein kinase 2",
    "id" : null
  }, {
    "name" : "RPAP3 ; RPAP3_HUMAN ; Q9H6T3",
    "link" : "https://www.uniprot.org/uniprot/Q9H6T3",
    "description" : "RNA polymerase II-associated protein 3",
    "id" : null
  }, {
    "name" : "RYR2 ; RYR2_HUMAN ; Q92736",
    "link" : "https://www.uniprot.org/uniprot/Q92736",
    "description" : "Ryanodine receptor 2",
    "id" : null
  }, {
    "name" : "SAA1 ; SAA1_HUMAN ; P0DJI8",
    "link" : "https://www.uniprot.org/uniprot/P0DJI8",
    "description" : "Serum amyloid A-1 protein",
    "id" : null
  }, {
    "name" : "SAA2 ; SAA2_HUMAN ; P0DJI9",
    "link" : "https://www.uniprot.org/uniprot/P0DJI9",
    "description" : "Serum amyloid A-2 proteincur",
    "id" : null
  }, {
    "name" : "SDC1 ; SDC1_HUMAN ; P18827",
    "link" : "https://www.uniprot.org/uniprot/P18827",
    "description" : "Syndecan-1",
    "id" : null
  }, {
    "name" : "SECISBP2L ; SBP2L_HUMAN ; Q93073",
    "link" : "https://www.uniprot.org/uniprot/Q93073",
    "description" : "Selenocysteine insertion sequence-binding protein 2-like",
    "id" : null
  }, {
    "name" : "SELE ; LYAM2_HUMAN ; P16581",
    "link" : "https://www.uniprot.org/uniprot/P16581",
    "description" : "E-selectin",
    "id" : null
  }, {
    "name" : "SELENOP ; SEPP1_HUMAN ; P49908",
    "link" : "https://www.uniprot.org/uniprot/P49908",
    "description" : "Selenoprotein P",
    "id" : null
  }, {
    "name" : "SELL ; LYAM1_HUMAN ; P14151",
    "link" : "https://www.uniprot.org/uniprot/P14151",
    "description" : "L-selectin",
    "id" : null
  }, {
    "name" : "SELP ; LYAM3_HUMAN ; P16109",
    "link" : "https://www.uniprot.org/uniprot/P16109",
    "description" : "P-selectin",
    "id" : null
  }, {
    "name" : "SELPLG ; SELPL_HUMAN ; Q14242",
    "link" : "https://www.uniprot.org/uniprot/Q14242",
    "description" : "P-selectin glycoprotein ligand 1",
    "id" : null
  }, {
    "name" : "SEMA4D ; SEM4D_HUMAN ; Q92854",
    "link" : "https://www.uniprot.org/uniprot/Q92854",
    "description" : "Semaphorin-4D",
    "id" : null
  }, {
    "name" : "SEMA7A ; SEM7A_HUMAN ; O75326",
    "link" : "https://www.uniprot.org/uniprot/O75326",
    "description" : "Semaphorin-7A",
    "id" : null
  }, {
    "name" : "SERPINA1 ; A1AT_HUMAN ; P01009",
    "link" : "https://www.uniprot.org/uniprot/P01009",
    "description" : "Alpha-1-antitrypsin",
    "id" : null
  }, {
    "name" : "SERPINA3 ; AACT_HUMAN ; P01011",
    "link" : "https://www.uniprot.org/uniprot/P01011",
    "description" : "Alpha-1-antichymotrypsin",
    "id" : null
  }, {
    "name" : "SERPINA6 ; CBG_HUMAN ; P08185",
    "link" : "https://www.uniprot.org/uniprot/P08185",
    "description" : "Corticosteroid-binding globulin",
    "id" : null
  }, {
    "name" : "SERPINA7 ; THBG_HUMAN ; P05543",
    "link" : "https://www.uniprot.org/uniprot/P05543",
    "description" : "Thyroxine-binding globulin",
    "id" : null
  }, {
    "name" : "SERPINC1 ; ANT3_HUMAN ; P01008",
    "link" : "https://www.uniprot.org/uniprot/P01008",
    "description" : "Antithrombin-III",
    "id" : null
  }, {
    "name" : "SERPIND1 ; HEP2_HUMAN ; P05546",
    "link" : "https://www.uniprot.org/uniprot/P05546",
    "description" : "Heparin cofactor 2",
    "id" : null
  }, {
    "name" : "SERPINF1 ; PEDF_HUMAN ; P36955",
    "link" : "https://www.uniprot.org/uniprot/P36955",
    "description" : "Pigment epithelium-derived factor",
    "id" : null
  }, {
    "name" : "SERPINF2 ; A2AP_HUMAN ; P08697",
    "link" : "https://www.uniprot.org/uniprot/P08697",
    "description" : "Alpha-2-antiplasmin",
    "id" : null
  }, {
    "name" : "SERPING1 ; IC1_HUMAN ; P05155",
    "link" : "https://www.uniprot.org/uniprot/P05155",
    "description" : "Plasma protease C1 inhibitor",
    "id" : null
  }, {
    "name" : "SETSIP ; SETLP_HUMAN ; P0DME0",
    "link" : "https://www.uniprot.org/uniprot/P0DME0",
    "description" : "Protein SETSIP",
    "id" : null
  }, {
    "name" : "SFI1 ; SFI1_HUMAN ; A8K8P3",
    "link" : "https://www.uniprot.org/uniprot/A8K8P3",
    "description" : "Protein SFI1 homolog",
    "id" : null
  }, {
    "name" : "SIGLEC1 ; SN_HUMAN ; Q9BZZ2",
    "link" : "https://www.uniprot.org/uniprot/Q9BZZ2",
    "description" : "Sialoadhesin",
    "id" : null
  }, {
    "name" : "SIGLEC5 ; SIGL5_HUMAN ; O15389",
    "link" : "https://www.uniprot.org/uniprot/O15389",
    "description" : "Sialic acid-binding Ig-like lectin 5",
    "id" : null
  }, {
    "name" : "SIGLEC6 ; SIGL6_HUMAN ; O43699",
    "link" : "https://www.uniprot.org/uniprot/O43699",
    "description" : "Sialic acid-binding Ig-like lectin 6",
    "id" : null
  }, {
    "name" : "SIGLEC7 ; SIGL7_HUMAN ; Q9Y286",
    "link" : "https://www.uniprot.org/uniprot/Q9Y286",
    "description" : "Sialic acid-binding Ig-like lectin 7",
    "id" : null
  }, {
    "name" : "SIGLEC9 ; SIGL9_HUMAN ; Q9Y336",
    "link" : "https://www.uniprot.org/uniprot/Q9Y336",
    "description" : "Sialic acid-binding Ig-like lectin 9",
    "id" : null
  }, {
    "name" : "SIRPA ; SHPS1_HUMAN ; P78324",
    "link" : "https://www.uniprot.org/uniprot/P78324",
    "description" : "Tyrosine-protein phosphatase non-receptor type substrate 1",
    "id" : null
  }, {
    "name" : "SIRPB1 ; SIRB1_HUMAN ; O00241",
    "link" : "https://www.uniprot.org/uniprot/O00241",
    "description" : "Signal-regulatory protein beta-1",
    "id" : null
  }, {
    "name" : "SIRPG ; SIRPG_HUMAN ; Q9P1W8",
    "link" : "https://www.uniprot.org/uniprot/Q9P1W8",
    "description" : "Signal-regulatory protein gamma",
    "id" : null
  }, {
    "name" : "SLAMF1 ; SLAF1_HUMAN ; Q13291",
    "link" : "https://www.uniprot.org/uniprot/Q13291",
    "description" : "Signaling lymphocytic activation molecule",
    "id" : null
  }, {
    "name" : "SLAMF7 ; SLAF7_HUMAN ; Q9NQ25",
    "link" : "https://www.uniprot.org/uniprot/Q9NQ25",
    "description" : "SLAM family member 7",
    "id" : null
  }, {
    "name" : "SLC44A1 ; CTL1_HUMAN ; Q8WWI5",
    "link" : "https://www.uniprot.org/uniprot/Q8WWI5",
    "description" : "Choline transporter-like protein 1",
    "id" : null
  }, {
    "name" : "SLC4A1 ; B3AT_HUMAN ; P02730",
    "link" : "https://www.uniprot.org/uniprot/P02730",
    "description" : "Band 3 anion transport protein",
    "id" : null
  }, {
    "name" : "SLC7A5 ; LAT1_HUMAN ; Q01650",
    "link" : "https://www.uniprot.org/uniprot/Q01650",
    "description" : "Large neutral amino acids transporter small subunit 1",
    "id" : null
  }, {
    "name" : "SMC3 ; SMC3_HUMAN ; Q9UQE7",
    "link" : "https://www.uniprot.org/uniprot/Q9UQE7",
    "description" : "Structural maintenance of chromosomes protein 3",
    "id" : null
  }, {
    "name" : "SOD1 ; SODC_HUMAN ; P00441",
    "link" : "https://www.uniprot.org/uniprot/P00441",
    "description" : "Superoxide dismutase [Cu-Zn]",
    "id" : null
  }, {
    "name" : "SPECC1L ; CYTSA_HUMAN ; Q69YQ0",
    "link" : "https://www.uniprot.org/uniprot/Q69YQ0",
    "description" : "Cytospin-A",
    "id" : null
  }, {
    "name" : "SPN ; LEUK_HUMAN ; P16150",
    "link" : "https://www.uniprot.org/uniprot/P16150",
    "description" : "Leukosialin",
    "id" : null
  }, {
    "name" : "SPP1 ; OSTP_HUMAN ; P10451",
    "link" : "https://www.uniprot.org/uniprot/P10451",
    "description" : "Osteopontin",
    "id" : null
  }, {
    "name" : "STAT1 ; STAT1_HUMAN ; P42224",
    "link" : "https://www.uniprot.org/uniprot/P42224",
    "description" : "Signal transducer and activator of transcription 1-alpha/beta",
    "id" : null
  }, {
    "name" : "STAT3 ; STAT3_HUMAN ; P40763",
    "link" : "https://www.uniprot.org/uniprot/P40763",
    "description" : "Signal transducer and activator of transcription 3",
    "id" : null
  }, {
    "name" : "STAT5A ; STA5A_HUMAN ; P42229",
    "link" : "https://www.uniprot.org/uniprot/P42229",
    "description" : "Signal transducer and activator of transcription 5A",
    "id" : null
  }, {
    "name" : "STIL ; STIL_HUMAN ; Q15468",
    "link" : "https://www.uniprot.org/uniprot/Q15468",
    "description" : "SCL-interrupting locus protein",
    "id" : null
  }, {
    "name" : "SYNE1 ; SYNE1_HUMAN ; Q8NF91",
    "link" : "https://www.uniprot.org/uniprot/Q8NF91",
    "description" : "Nesprin-1",
    "id" : null
  }, {
    "name" : "SYNE2 ; SYNE2_HUMAN ; Q8WXH0",
    "link" : "https://www.uniprot.org/uniprot/Q8WXH0",
    "description" : "Nesprin-2",
    "id" : null
  }, {
    "name" : "SYNGAP1 ; SYGP1_HUMAN ; Q96PV0",
    "link" : "https://www.uniprot.org/uniprot/Q96PV0",
    "description" : "Ras/Rap GTPase-activating protein SynGAP",
    "id" : null
  }, {
    "name" : "TCERG1 ; TCRG1_HUMAN ; O14776",
    "link" : "https://www.uniprot.org/uniprot/O14776",
    "description" : "Transcription elongation regulator 1",
    "id" : null
  }, {
    "name" : "TCP10L3 ; TCP10_HUMAN ; Q12799",
    "link" : "https://www.uniprot.org/uniprot/Q12799",
    "description" : "Putative T-complex protein 10A homolog",
    "id" : null
  }, {
    "name" : "TDGF1P3 ; TDGF3_HUMAN ; P51864",
    "link" : "https://www.uniprot.org/uniprot/P51864",
    "description" : "Putative teratocarcinoma-derived growth factor 3",
    "id" : null
  }, {
    "name" : "TDRD1 ; TDRD1_HUMAN ; Q9BXT4",
    "link" : "https://www.uniprot.org/uniprot/Q9BXT4",
    "description" : "Tudor domain-containing protein 1",
    "id" : null
  }, {
    "name" : "TDRD15 ; TDR15_HUMAN ; B5MCY1",
    "link" : "https://www.uniprot.org/uniprot/B5MCY1",
    "description" : "Tudor domain-containing protein 15",
    "id" : null
  }, {
    "name" : "TEK ; TIE2_HUMAN ; Q02763",
    "link" : "https://www.uniprot.org/uniprot/Q02763",
    "description" : "Angiopoietin-1 receptor",
    "id" : null
  }, {
    "name" : "TF ; TRFE_HUMAN ; P02787",
    "link" : "https://www.uniprot.org/uniprot/P02787",
    "description" : "Serotransferrin",
    "id" : null
  }, {
    "name" : "TFRC ; TFR1_HUMAN ; P02786",
    "link" : "https://www.uniprot.org/uniprot/P02786",
    "description" : "Transferrin receptor protein 1",
    "id" : null
  }, {
    "name" : "TGFB1 ; TGFB1_HUMAN ; P01137",
    "link" : "https://www.uniprot.org/uniprot/P01137",
    "description" : "Transforming growth factor beta-1 proprotein",
    "id" : null
  }, {
    "name" : "TGFB2 ; TGFB2_HUMAN ; P61812",
    "link" : "https://www.uniprot.org/uniprot/P61812",
    "description" : "Transforming growth factor beta-2 proprotein",
    "id" : null
  }, {
    "name" : "TGFB3 ; TGFB3_HUMAN ; P10600",
    "link" : "https://www.uniprot.org/uniprot/P10600",
    "description" : "Transforming growth factor beta-3 proprotein",
    "id" : null
  }, {
    "name" : "TGFBI ; BGH3_HUMAN ; Q15582",
    "link" : "https://www.uniprot.org/uniprot/Q15582",
    "description" : "Transforming growth factor-beta-induced protein ig-h3",
    "id" : null
  }, {
    "name" : "TGFBR1 ; TGFR1_HUMAN ; P36897",
    "link" : "https://www.uniprot.org/uniprot/P36897",
    "description" : "TGF-beta receptor type-1",
    "id" : null
  }, {
    "name" : "TGFBR2 ; TGFR2_HUMAN ; P37173",
    "link" : "https://www.uniprot.org/uniprot/P37173",
    "description" : "TGF-beta receptor type-2",
    "id" : null
  }, {
    "name" : "TGFBR3 ; TGBR3_HUMAN ; Q03167",
    "link" : "https://www.uniprot.org/uniprot/Q03167",
    "description" : "Transforming growth factor beta receptor type 3",
    "id" : null
  }, {
    "name" : "THBD ; TRBM_HUMAN ; P07204",
    "link" : "https://www.uniprot.org/uniprot/P07204",
    "description" : "Thrombomodulin",
    "id" : null
  }, {
    "name" : "THBS1 ; TSP1_HUMAN ; P07996",
    "link" : "https://www.uniprot.org/uniprot/P07996",
    "description" : "Thrombospondin-1",
    "id" : null
  }, {
    "name" : "THBS4 ; TSP4_HUMAN ; P35443",
    "link" : "https://www.uniprot.org/uniprot/P35443",
    "description" : "Thrombospondin-4",
    "id" : null
  }, {
    "name" : "THPO ; TPO_HUMAN ; P40225",
    "link" : "https://www.uniprot.org/uniprot/P40225",
    "description" : "Thrombopoietin",
    "id" : null
  }, {
    "name" : "THY1 ; THY1_HUMAN ; P04216",
    "link" : "https://www.uniprot.org/uniprot/P04216",
    "description" : "Thy-1 membrane glycoprotein",
    "id" : null
  }, {
    "name" : "TIAM2 ; TIAM2_HUMAN ; Q8IVF5",
    "link" : "https://www.uniprot.org/uniprot/Q8IVF5",
    "description" : "T-lymphoma invasion and metastasis-inducing protein 2",
    "id" : null
  }, {
    "name" : "TLR1 ; TLR1_HUMAN ; Q15399",
    "link" : "https://www.uniprot.org/uniprot/Q15399",
    "description" : "Toll-like receptor 1",
    "id" : null
  }, {
    "name" : "TLR10 ; TLR10_HUMAN ; Q9BXR5",
    "link" : "https://www.uniprot.org/uniprot/Q9BXR5",
    "description" : "Toll-like receptor 10",
    "id" : null
  }, {
    "name" : "TLR2 ; TLR2_HUMAN ; O60603",
    "link" : "https://www.uniprot.org/uniprot/O60603",
    "description" : "Toll-like receptor 2",
    "id" : null
  }, {
    "name" : "TLR3 ; TLR3_HUMAN ; O15455",
    "link" : "https://www.uniprot.org/uniprot/O15455",
    "description" : "Toll-like receptor 3",
    "id" : null
  }, {
    "name" : "TLR4 ; TLR4_HUMAN ; O00206",
    "link" : "https://www.uniprot.org/uniprot/O00206",
    "description" : "Toll-like receptor 4",
    "id" : null
  }, {
    "name" : "TLR5 ; TLR5_HUMAN ; O60602",
    "link" : "https://www.uniprot.org/uniprot/O60602",
    "description" : "Toll-like receptor 5",
    "id" : null
  }, {
    "name" : "TLR6 ; TLR6_HUMAN ; Q9Y2C9",
    "link" : "https://www.uniprot.org/uniprot/Q9Y2C9",
    "description" : "Toll-like receptor 6",
    "id" : null
  }, {
    "name" : "TLR7 ; TLR7_HUMAN ; Q9NYK1",
    "link" : "https://www.uniprot.org/uniprot/Q9NYK1",
    "description" : "Toll-like receptor 7",
    "id" : null
  }, {
    "name" : "TLR8 ; TLR8_HUMAN ; Q9NR97",
    "link" : "https://www.uniprot.org/uniprot/Q9NR97",
    "description" : "Toll-like receptor 8",
    "id" : null
  }, {
    "name" : "TLR9 ; TLR9_HUMAN ; Q9NR96",
    "link" : "https://www.uniprot.org/uniprot/Q9NR96",
    "description" : "Toll-like receptor 9",
    "id" : null
  }, {
    "name" : "TMEM198 ; TM198_HUMAN ; Q66K66",
    "link" : "https://www.uniprot.org/uniprot/Q66K66",
    "description" : "Transmembrane protein 198",
    "id" : null
  }, {
    "name" : "TNF ; TNFA_HUMAN ; P01375",
    "link" : "https://www.uniprot.org/uniprot/P01375",
    "description" : "Tumor necrosis factor",
    "id" : null
  }, {
    "name" : "TNFRSF10A ; TR10A_HUMAN ; O00220",
    "link" : "https://www.uniprot.org/uniprot/O00220",
    "description" : "Tumor necrosis factor receptor superfamily member 10A",
    "id" : null
  }, {
    "name" : "TNFRSF10B ; TR10B_HUMAN ; O14763",
    "link" : "https://www.uniprot.org/uniprot/O14763",
    "description" : "Tumor necrosis factor receptor superfamily member 10B",
    "id" : null
  }, {
    "name" : "TNFRSF10C ; TR10C_HUMAN ; O14798",
    "link" : "https://www.uniprot.org/uniprot/O14798",
    "description" : "Tumor necrosis factor receptor superfamily member 10C",
    "id" : null
  }, {
    "name" : "TNFRSF10D ; TR10D_HUMAN ; Q9UBN6",
    "link" : "https://www.uniprot.org/uniprot/Q9UBN6",
    "description" : "Tumor necrosis factor receptor superfamily member 10D",
    "id" : null
  }, {
    "name" : "TNFRSF11A ; TNR11_HUMAN ; Q9Y6Q6",
    "link" : "https://www.uniprot.org/uniprot/Q9Y6Q6",
    "description" : "Tumor necrosis factor receptor superfamily member 11A",
    "id" : null
  }, {
    "name" : "TNFRSF11B ; TR11B_HUMAN ; O00300",
    "link" : "https://www.uniprot.org/uniprot/O00300",
    "description" : "Tumor necrosis factor receptor superfamily member 11B",
    "id" : null
  }, {
    "name" : "TNFRSF12A ; TNR12_HUMAN ; Q9NP84",
    "link" : "https://www.uniprot.org/uniprot/Q9NP84",
    "description" : "Tumor necrosis factor receptor superfamily member 12A",
    "id" : null
  }, {
    "name" : "TNFRSF13B ; TR13B_HUMAN ; O14836",
    "link" : "https://www.uniprot.org/uniprot/O14836",
    "description" : "Tumor necrosis factor receptor superfamily member 13B",
    "id" : null
  }, {
    "name" : "TNFRSF13C ; TR13C_HUMAN ; Q96RJ3",
    "link" : "https://www.uniprot.org/uniprot/Q96RJ3",
    "description" : "Tumor necrosis factor receptor superfamily member 13C",
    "id" : null
  }, {
    "name" : "TNFRSF14 ; TNR14_HUMAN ; Q92956",
    "link" : "https://www.uniprot.org/uniprot/Q92956",
    "description" : "Tumor necrosis factor receptor superfamily member 14",
    "id" : null
  }, {
    "name" : "TNFRSF17 ; TNR17_HUMAN ; Q02223",
    "link" : "https://www.uniprot.org/uniprot/Q02223",
    "description" : "Tumor necrosis factor receptor superfamily member 17",
    "id" : null
  }, {
    "name" : "TNFRSF18 ; TNR18_HUMAN ; Q9Y5U5",
    "link" : "https://www.uniprot.org/uniprot/Q9Y5U5",
    "description" : "Tumor necrosis factor receptor superfamily member 18",
    "id" : null
  }, {
    "name" : "TNFRSF1A ; TNR1A_HUMAN ; P19438",
    "link" : "https://www.uniprot.org/uniprot/P19438",
    "description" : "Tumor necrosis factor receptor superfamily member 1A",
    "id" : null
  }, {
    "name" : "TNFRSF1B ; TNR1B_HUMAN ; P20333",
    "link" : "https://www.uniprot.org/uniprot/P20333",
    "description" : "Tumor necrosis factor receptor superfamily member 1B",
    "id" : null
  }, {
    "name" : "TNFRSF25 ; TNR25_HUMAN ; Q93038",
    "link" : "https://www.uniprot.org/uniprot/Q93038",
    "description" : "Tumor necrosis factor receptor superfamily member 25",
    "id" : null
  }, {
    "name" : "TNFRSF4 ; TNR4_HUMAN ; P43489",
    "link" : "https://www.uniprot.org/uniprot/P43489",
    "description" : "Tumor necrosis factor receptor superfamily member 4",
    "id" : null
  }, {
    "name" : "TNFRSF8 ; TNR8_HUMAN ; P28908",
    "link" : "https://www.uniprot.org/uniprot/P28908",
    "description" : "Tumor necrosis factor receptor superfamily member 8",
    "id" : null
  }, {
    "name" : "TNFRSF9 ; TNR9_HUMAN ; Q07011",
    "link" : "https://www.uniprot.org/uniprot/Q07011",
    "description" : "Tumor necrosis factor receptor superfamily member 9",
    "id" : null
  }, {
    "name" : "TNFSF10 ; TNF10_HUMAN ; P50591",
    "link" : "https://www.uniprot.org/uniprot/P50591",
    "description" : "Tumor necrosis factor ligand superfamily member 10",
    "id" : null
  }, {
    "name" : "TNFSF11 ; TNF11_HUMAN ; O14788",
    "link" : "https://www.uniprot.org/uniprot/O14788",
    "description" : "Tumor necrosis factor ligand superfamily member 11",
    "id" : null
  }, {
    "name" : "TNFSF12 ; TNF12_HUMAN ; O43508",
    "link" : "https://www.uniprot.org/uniprot/O43508",
    "description" : "Tumor necrosis factor ligand superfamily member 12",
    "id" : null
  }, {
    "name" : "TNFSF13 ; TNF13_HUMAN ; O75888",
    "link" : "https://www.uniprot.org/uniprot/O75888",
    "description" : "Tumor necrosis factor ligand superfamily member 13",
    "id" : null
  }, {
    "name" : "TNFSF13B ; TN13B_HUMAN ; Q9Y275",
    "link" : "https://www.uniprot.org/uniprot/Q9Y275",
    "description" : "Tumor necrosis factor ligand superfamily member 13B",
    "id" : null
  }, {
    "name" : "TNFSF14 ; TNF14_HUMAN ; O43557",
    "link" : "https://www.uniprot.org/uniprot/O43557",
    "description" : "Tumor necrosis factor ligand superfamily member 14",
    "id" : null
  }, {
    "name" : "TNFSF15 ; TNF15_HUMAN ; O95150",
    "link" : "https://www.uniprot.org/uniprot/O95150",
    "description" : "Tumor necrosis factor ligand superfamily member 15",
    "id" : null
  }, {
    "name" : "TNFSF18 ; TNF18_HUMAN ; Q9UNG2",
    "link" : "https://www.uniprot.org/uniprot/Q9UNG2",
    "description" : "Tumor necrosis factor ligand superfamily member 18",
    "id" : null
  }, {
    "name" : "TNFSF4 ; TNFL4_HUMAN ; P23510",
    "link" : "https://www.uniprot.org/uniprot/P23510",
    "description" : "Tumor necrosis factor ligand superfamily member 4",
    "id" : null
  }, {
    "name" : "TNFSF8 ; TNFL8_HUMAN ; P32971",
    "link" : "https://www.uniprot.org/uniprot/P32971",
    "description" : "Tumor necrosis factor ligand superfamily member 8",
    "id" : null
  }, {
    "name" : "TNFSF9 ; TNFL9_HUMAN ; P41273",
    "link" : "https://www.uniprot.org/uniprot/P41273",
    "description" : "Tumor necrosis factor ligand superfamily member 9",
    "id" : null
  }, {
    "name" : "TNNT3 ; TNNT3_HUMAN ; P45378",
    "link" : "https://www.uniprot.org/uniprot/P45378",
    "description" : "Troponin T, fast skeletal muscle",
    "id" : null
  }, {
    "name" : "TNS1 ; TENS1_HUMAN ; Q9HBL0",
    "link" : "https://www.uniprot.org/uniprot/Q9HBL0",
    "description" : "Tensin-1",
    "id" : null
  }, {
    "name" : "TOP3B ; TOP3B_HUMAN ; O95985",
    "link" : "https://www.uniprot.org/uniprot/O95985",
    "description" : "DNA topoisomerase 3-beta-1",
    "id" : null
  }, {
    "name" : "TRAF3IP3 ; T3JAM_HUMAN ; Q9Y228",
    "link" : "https://www.uniprot.org/uniprot/Q9Y228",
    "description" : "TRAF3-interacting JNK-activating modulator",
    "id" : null
  }, {
    "name" : "TRIM33 ; TRI33_HUMAN ; Q9UPN9",
    "link" : "https://www.uniprot.org/uniprot/Q9UPN9",
    "description" : "E3 ubiquitin-protein ligase TRIM33",
    "id" : null
  }, {
    "name" : "TRPC4AP ; TP4AP_HUMAN ; Q8TEL6",
    "link" : "https://www.uniprot.org/uniprot/Q8TEL6",
    "description" : "Short transient receptor potential channel 4-associated protein",
    "id" : null
  }, {
    "name" : "TSPAN7 ; TSN7_HUMAN ; P41732",
    "link" : "https://www.uniprot.org/uniprot/P41732",
    "description" : "Tetraspanin-7",
    "id" : null
  }, {
    "name" : "TTN ; TITIN_HUMAN ; Q8WZ42",
    "link" : "https://www.uniprot.org/uniprot/Q8WZ42",
    "description" : "Titin",
    "id" : null
  }, {
    "name" : "TTR ; TTHY_HUMAN ; P02766",
    "link" : "https://www.uniprot.org/uniprot/P02766",
    "description" : "Transthyretin",
    "id" : null
  }, {
    "name" : "TUSC2 ; TUSC2_HUMAN ; O75896",
    "link" : "https://www.uniprot.org/uniprot/O75896",
    "description" : "Tumor suppressor candidate 2",
    "id" : null
  }, {
    "name" : "TXLNB ; TXLNB_HUMAN ; Q8N3L3",
    "link" : "https://www.uniprot.org/uniprot/Q8N3L3",
    "description" : "Beta-taxilin",
    "id" : null
  }, {
    "name" : "UBQLN1 ; UBQL1_HUMAN ; Q9UMX0",
    "link" : "https://www.uniprot.org/uniprot/Q9UMX0",
    "description" : "Ubiquilin-1",
    "id" : null
  }, {
    "name" : "VEGFD ; VEGFD_HUMAN ; O43915",
    "link" : "https://www.uniprot.org/uniprot/O43915",
    "description" : "Vascular endothelial growth factor D",
    "id" : null
  }, {
    "name" : "VPREB1 ; VPREB_HUMAN ; P12018",
    "link" : "https://www.uniprot.org/uniprot/P12018",
    "description" : "Immunoglobulin iota chain",
    "id" : null
  }, {
    "name" : "VTN ; VTNC_HUMAN ; P04004",
    "link" : "https://www.uniprot.org/uniprot/P04004",
    "description" : "Vitronectin",
    "id" : null
  }, {
    "name" : "VWA8 ; VWA8_HUMAN ; A3KMH1",
    "link" : "https://www.uniprot.org/uniprot/A3KMH1",
    "description" : "von Willebrand factor A domain-containing protein 8",
    "id" : null
  }, {
    "name" : "VWF ; VWF_HUMAN ; P04275",
    "link" : "https://www.uniprot.org/uniprot/P04275",
    "description" : "von Willebrand factor",
    "id" : null
  }, {
    "name" : "WAPL ; WAPL_HUMAN ; Q7Z5K2",
    "link" : "https://www.uniprot.org/uniprot/Q7Z5K2",
    "description" : "Wings apart-like protein homolog",
    "id" : null
  }, {
    "name" : "XCL1 ; XCL1_HUMAN ; P47992",
    "link" : "https://www.uniprot.org/uniprot/P47992",
    "description" : "Lymphotactin",
    "id" : null
  }, {
    "name" : "XCL2 ; XCL2_HUMAN ; Q9UBD3",
    "link" : "https://www.uniprot.org/uniprot/Q9UBD3",
    "description" : "Cytokine SCM-1 beta",
    "id" : null
  }, {
    "name" : "XCR1 ; XCR1_HUMAN ; P46094",
    "link" : "https://www.uniprot.org/uniprot/P46094",
    "description" : "Chemokine XC receptor 1",
    "id" : null
  }, {
    "name" : "XRCC6 ; XRCC6_HUMAN ; P12956",
    "link" : "https://www.uniprot.org/uniprot/P12956",
    "description" : "X-ray repair cross-complementing protein 6",
    "id" : null
  } ]
}, {
  "name" : "lk_protocol_type",
  "rows" : [ {
    "name" : "Assay",
    "link" : "",
    "description" : "Protocol used to assay or measure an experiment sample",
    "id" : ""
  }, {
    "name" : "Bio Sample Preparation",
    "link" : "",
    "description" : "Biological Sample Preparation.",
    "id" : ""
  }, {
    "name" : "Bio Sample Treatment",
    "link" : "",
    "description" : "Protocol used to prepare Biological Sample.",
    "id" : ""
  }, {
    "name" : "Biomaterial Transformation",
    "link" : "",
    "description" : "Protocol used to prepare or modify a biological sample",
    "id" : ""
  }, {
    "name" : "Case Report Form",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C40988",
    "description" : "Case Report Form",
    "id" : ""
  }, {
    "name" : "Clinical",
    "link" : "",
    "description" : "Clinical",
    "id" : ""
  }, {
    "name" : "Clinical Study Protocol",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25320",
    "description" : "Clinical Study Protocol",
    "id" : ""
  }, {
    "name" : "Clinical Trial Monitoring Plan",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115753",
    "description" : "A proposed method to ensure the adequate monitoring of subjects during a clinical trial.",
    "id" : ""
  }, {
    "name" : "Clinical Trials Operational Procedure Manual",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115764",
    "description" : "Documentation describing clinical trial-related work processes.",
    "id" : ""
  }, {
    "name" : "Data Processing",
    "link" : "",
    "description" : "Data Processing",
    "id" : ""
  }, {
    "name" : "Data Transformation",
    "link" : "",
    "description" : "Protocol used to analyze or reformat data",
    "id" : ""
  }, {
    "name" : "Experiment",
    "link" : "",
    "description" : "Protocol used in the Experiment.",
    "id" : ""
  }, {
    "name" : "Experimental Sample",
    "link" : "",
    "description" : "Protocol used for Experimental Sample.",
    "id" : ""
  }, {
    "name" : "Institutional Review Board Independent Ethics Committee Informed Consent Document",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115697",
    "description" : "Records approved by the Institutional Review Board (IRB)/Independent Ethics Committee (IEC), explaining study information to assist study volunteers in understanding the expectations and requirements of trial participation.",
    "id" : ""
  }, {
    "name" : "Laboratory Sample Manual",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115541",
    "description" : "Documentation describing work processes and procedures for the collection, handling, and shipping of a sample.",
    "id" : ""
  }, {
    "name" : "Materials and Methods section",
    "link" : "http://semanticscience.org/resource/SIO_000197",
    "description" : "The materials and methods section is a document section containing a description of the materials and methods used in the study.",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "",
    "description" : "Protcol Type is not specified or not received. If no Protocol Type value is received, then this is the system default value.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "Other",
    "id" : ""
  }, {
    "name" : "Process Protocol",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C164368",
    "description" : "A standard operating procedure (SOP) that is a collection of activities and the rules that describe when each activity is performed to achieve a specific purpose or objective(s). [Definition Source: NCI]",
    "id" : ""
  }, {
    "name" : "Specimen Collection Protocol",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C164426",
    "description" : "The rule which guides how a specimen collection should be performed",
    "id" : ""
  }, {
    "name" : "Statistical Analysis Documentation",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115732",
    "description" : "Statistical Analysis Documentation",
    "id" : ""
  }, {
    "name" : "Study Protocol",
    "link" : "",
    "description" : "'Study_Protocol' Study design description.",
    "id" : ""
  }, {
    "name" : "Study Summary",
    "link" : "",
    "description" : "'Study_Summary' Study review after a study is closed.",
    "id" : ""
  }, {
    "name" : "Subject Organism Treatment",
    "link" : "",
    "description" : "Subject Organism Treatment",
    "id" : ""
  } ]
}, {
  "name" : "lk_public_repository",
  "rows" : [ {
    "name" : "ArrayExpress",
    "link" : "https://www.ebi.ac.uk/arrayexpress/",
    "description" : "ArrayExpress Archive of Functional Genomics Data stores data from high-throughput functional genomics experiments, and provides these data for reuse to the research community.",
    "id" : ""
  }, {
    "name" : "Broad Single Cell Portal",
    "link" : "https://singlecell.broadinstitute.org/single_cell",
    "description" : "The Single Cell Portal was developed to facilitate sharing scientific results, and disseminating data generated from single cell technologies.",
    "id" : ""
  }, {
    "name" : "dbGAP",
    "link" : "http://www.ncbi.nlm.nih.gov/gap",
    "description" : "The database of Genotypes and Phenotypes (dbGaP) was developed to archive and distribute the results of studies that have investigated the interaction of genotype and phenotype.",
    "id" : ""
  }, {
    "name" : "ENA",
    "link" : "http://www.ebi.ac.uk/ena",
    "description" : "The European Nucleotide Archive (ENA) provides a comprehensive record of the world's nucleotide sequencing information, covering raw sequencing data, sequence assembly information and functional annotation.",
    "id" : ""
  }, {
    "name" : "Ensembl",
    "link" : "",
    "description" : "Ensembl gene repository",
    "id" : ""
  }, {
    "name" : "FlowRepository",
    "link" : "http://flowrepository.org",
    "description" : "A database of flow cytometry experiments where you can query and download data collected and annotated according to the MIFlowCyt standard.",
    "id" : ""
  }, {
    "name" : "GenBank",
    "link" : "https://www.ncbi.nlm.nih.gov/genbank/",
    "description" : "GenBank is the NIH genetic sequence database, an annotated collection of all publicly available DNA sequences.",
    "id" : ""
  }, {
    "name" : "GEO",
    "link" : "http://www.ncbi.nlm.nih.gov/geo/",
    "description" : "GEO is a public functional genomics data repository supporting MIAME-compliant data submissions. Array- and sequence-based data are accepted. Tools are provided to help users query and download experiments and curated gene expression profiles.",
    "id" : ""
  }, {
    "name" : "GISAID",
    "link" : "https://www.gisaid.org/",
    "description" : "The GISAID Initiative promotes the rapid sharing of data from all influenza viruses and the coronavirus causing COVID-19. This includes genetic sequence and related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses, to help researchers understand how viruses evolve and spread during epidemics and pandemics.",
    "id" : ""
  }, {
    "name" : "IEDB",
    "link" : "https://www.iedb.org/",
    "description" : "The Immune Epitope Database (IEDB) is a freely available resource funded by NIAID. It catalogs experimental data on antibody and T cell epitopes studied in humans, non-human primates, and other animal species in the context of infectious disease, allergy, autoimmunity and transplantation. The IEDB also hosts tools to assist in the prediction and analysis of epitopes.",
    "id" : ""
  }, {
    "name" : "ImmPort",
    "link" : "http://www.immport.org/immport-open/public/home/home",
    "description" : "Immunology Database and Analysis Portal (ImmPort).",
    "id" : ""
  }, {
    "name" : "MassIVE",
    "link" : "https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp",
    "description" : "MassIVE is a community resource developed by the NIH-funded Center for Computational Mass Spectrometry to promote the global, free exchange of mass spectrometry data. MassIVE datasets can be assigned ProteomeXchange accessions to satisfy publication requirements.",
    "id" : ""
  }, {
    "name" : "MetaboLights",
    "link" : "https://www.ebi.ac.uk/metabolights/",
    "description" : "A database for Metabolomics experiments and derived information. The database is cross-species, cross-technique and covers metabolite structures and their reference spectra as well as their biological roles, locations and concentrations, and experimental data from metabolic experiments.",
    "id" : ""
  }, {
    "name" : "Metabolomics Workbench",
    "link" : "https://www.metabolomicsworkbench.org",
    "description" : "A National Metabolomics Data Repository (NMDR) which is a public repository for metabolomics metadata and experimental data",
    "id" : ""
  }, {
    "name" : "MGnify",
    "link" : "https://www.ebi.ac.uk/metagenomics/",
    "description" : "MGnify offers an automated pipeline for the analysis and archiving of microbiome data to help determine the taxonomic diversity and functional & metabolic potential of environmental samples. Users can submit their own data for analysis or freely browse all of the analysed public datasets held within the repository.",
    "id" : ""
  }, {
    "name" : "NCBI Gene",
    "link" : "",
    "description" : "NCBI gene repository",
    "id" : ""
  }, {
    "name" : "PRIDE",
    "link" : "https://www.ebi.ac.uk/pride/archive/",
    "description" : "The PRIDE PRoteomics IDEntifications (PRIDE) database is a centralized, standards compliant, public data repository for proteomics data, including protein and peptide identifications, post-translational modifications and supporting spectral evidence. PRIDE is a core member in the ProteomeXchange (PX) consortium, which provides a single point for submitting mass spectrometry based proteomics data to public-domain repositories. Datasets are submitted to PRIDE via ProteomeXchange and are handled by expert biocurators.",
    "id" : ""
  }, {
    "name" : "SRA",
    "link" : "http://www.ncbi.nlm.nih.gov/sra",
    "description" : "The Sequence Read Archive (SRA) stores raw sequencing data from the next generation of sequencing platforms including Roche 454 GS System, Illumina Genome Analyzer, Applied Biosystems SOLiD System, Helicos Heliscope, Complete Genomics, and Pacific Biosciences SMRT.",
    "id" : ""
  }, {
    "name" : "UniProt",
    "link" : "https://www.uniprot.org/",
    "description" : "The mission of UniProt is to provide the scientific community with a comprehensive, high-quality and freely accessible resource of protein sequence and functional information.",
    "id" : ""
  } ]
}, {
  "name" : "lk_race",
  "rows" : [ {
    "name" : "American Indian or Alaska Native",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment.",
    "id" : ""
  }, {
    "name" : "Asian",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent, including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam.",
    "id" : ""
  }, {
    "name" : "Black or African American",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "A person having origins in any of the black racial groups of Africa. Terms such as \"Haitian\" or \"Negro\" can be used in addition to \"Black or African American.\"",
    "id" : ""
  }, {
    "name" : "Multiracial",
    "link" : "https://ncit.nci.nih.gov/ncitbrowser/pages/concept_details.jsf?dictionary=NCI_Thesaurus&version=22.04d&code=C67109",
    "description" : "Having ancestors of several or various races.",
    "id" : ""
  }, {
    "name" : "Native Hawaiian or Other Pacific Islander",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands.",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "Race is not specified or not received. If no Race value is received, then this is the system default value.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "A person having a Race that is some Other value not in CV Terms.",
    "id" : ""
  }, {
    "name" : "Unknown",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "A person having a race that is Unknown.",
    "id" : ""
  }, {
    "name" : "White",
    "link" : "https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf",
    "description" : "A person having origins in any of the original peoples of Europe, the Middle East, or North Africa.",
    "id" : ""
  } ]
}, {
  "name" : "lk_reagent_type",
  "rows" : [ {
    "name" : "Array",
    "link" : "http://purl.obolibrary.org/obo/OBI_0400147 ; http://purl.obolibrary.org/obo/OBI_0001204 ; http://purl.obolibrary.org/obo/OBI_0001307 ; http://purl.obolibrary.org/obo/OBI_0400149",
    "description" : "Arrays (including microarrays) are a set of probes immobilized on a surface. The probes can be oligonucleotides, cDNAs, antibodies and other molecules that recognize a target. Microarrays can be constructed by several methods including (but not limited to in situ oligo synthesis (e.g. Affymetrix), cDNA spotting, bead arrays (e.g. Illumina) and antibody spotting. The position and identity of probes are provided by the manufacturer. The probe identifiers and their target are referred to as annotation or translation of probe identifiers to bioinformatic identifiers. Microarrays can be used for gene expression (mRNA transcript quantification), genotyping, cytokine quantification, etc. Microarrays for gene expression fall into two general classes- single channel and dual channel. The channel refers to the wavelength scanned for fluorescent signals. Affymetrix microarrays are obligatory single channel. Many commercial and non-commercial microarray manufacturers use two channel.",
    "id" : ""
  }, {
    "name" : "CyTOF",
    "link" : "http://en.wikipedia.org/wiki/Mass_cytometry",
    "description" : "Cytometry Time Of Flight CyTOF (DVS Sciences) or Mass cytometry, or , is a variation of flow cytometry in which antibodies are labeled with heavy metal ion tags rather than fluorochromes. Readout is by time-of-flight mass spectrometry.",
    "id" : ""
  }, {
    "name" : "Cytometric Bead Array",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000920",
    "description" : "An assay in which a series of beads coated with antibodies specific for different analytes and marked with discrete fluorescent labels are used to simultaneously capture and quantitate soluble analytes using flow cytometric analysis.",
    "id" : ""
  }, {
    "name" : "ELISA",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000661",
    "description" : "Enzyme-Linked ImmunoSorbant Assay. Quantification of a molecule (e.g cytokine) by an antibody immobilization strategy.",
    "id" : ""
  }, {
    "name" : "ELISPOT",
    "link" : "http://purl.obolibrary.org/obo/OBI_0600031",
    "description" : "Enzyme-linked ImmunoSPOT. A variant of ELISA with increased resolution that allows quantifying the number of cells in a population that release a molecule (e.g. cytokine).",
    "id" : ""
  }, {
    "name" : "Flow Cytometry",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000916",
    "description" : "Fluorescence Activated Cell Sorting.",
    "id" : ""
  }, {
    "name" : "Hemagglutination Inhibition",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000875",
    "description" : "Quantitate serum antibody to a specific antigen by blocking agglutination of cells.",
    "id" : ""
  }, {
    "name" : "HLA Typing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000435",
    "description" : "Human Leukocyte Antigen typing.",
    "id" : ""
  }, {
    "name" : "KIR Typing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000435",
    "description" : "Killer cell immunoglobulin-like receptors.",
    "id" : ""
  }, {
    "name" : "Luminex xMAP",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000920",
    "description" : "Microsphere based multiplexing system. Microspheres are color coded and linked to a detector or capture reagent (e.g. antibody, oligonucleotides, peptides, or receptors).",
    "id" : ""
  }, {
    "name" : "Neutralizing Antibody Titer",
    "link" : "http://purl.obolibrary.org/obo/VO_0000397",
    "description" : "Measurement of how much antibody an organism has produced that recognizes a particular epitope, expressed as the inverse of the greatest dilution that still gives a positive result.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "http://immport.org/immport-open/public/home/documentation",
    "description" : "Other reagent.",
    "id" : ""
  }, {
    "name" : "PCR",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000415",
    "description" : "Polymerase Chain Reaction is a technique to amplify a DNA template.",
    "id" : ""
  }, {
    "name" : "Sequencing",
    "link" : "http://purl.obolibrary.org/obo/OBI_0600047",
    "description" : "Sequencing is used to discover new sequence variants and to genotype a sample for known variants.",
    "id" : ""
  }, {
    "name" : "Virus Neutralization",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000872",
    "description" : "Block a viral function.",
    "id" : ""
  } ]
}, {
  "name" : "lk_release_status",
  "rows" : [ {
    "name" : "Initial",
    "link" : "",
    "description" : "The Initial Data Release for the study",
    "id" : ""
  }, {
    "name" : "Unknown",
    "link" : "",
    "description" : "The Data Release for the study is not known",
    "id" : ""
  }, {
    "name" : "Updated",
    "link" : "",
    "description" : "The Data Release for the study is an update",
    "id" : ""
  } ]
}, {
  "name" : "lk_research_focus",
  "rows" : [ {
    "name" : "Atopy/Allergy",
    "link" : "http://purl.obolibrary.org/obo/OBI_1110049",
    "description" : "Atopy or Allergy research focus.",
    "id" : ""
  }, {
    "name" : "Autoimmune",
    "link" : "http://purl.obolibrary.org/obo/OBI_1110054",
    "description" : "Autoimmune research focus.",
    "id" : ""
  }, {
    "name" : "Cardiovascular system disease",
    "link" : "http://purl.obolibrary.org/obo/DOID_1287",
    "description" : "A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis. [database_cross_reference: url:http://en.wikipedia.org/wiki/Circulatory_system][database_cross_reference: url:http://en.wikipedia.org/wiki/Circulatory_system][type: http://purl.obolibrary.org/obo/ECO_0007638][type: http://purl.obolibrary.org/obo/ECO_0007638]",
    "id" : ""
  }, {
    "name" : "Cell Biology",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17992",
    "description" : "The study of the internal workings of cells at the microscopic and molecular level.",
    "id" : ""
  }, {
    "name" : "Computational Modelling",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C5544479",
    "description" : "The development of mathematical or computational models to mimic or study a biological phenomenon.(NCI)",
    "id" : ""
  }, {
    "name" : "Development",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C18732",
    "description" : "Processes that involve and promote formation of more mature organs, organ systems, or organisms; general development.",
    "id" : ""
  }, {
    "name" : "Epidemiology",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0014507",
    "description" : "Field concerned with the determination of causes, incidence, and characteristic behavior of disease outbreaks affecting human populations. It includes the interrelationships of host, agent, and environment as related to the distribution and control of disease. (MSH)",
    "id" : ""
  }, {
    "name" : "Immune Response",
    "link" : "http://purl.obolibrary.org/obo/GO_0006955",
    "description" : "Immune Response research focus.",
    "id" : ""
  }, {
    "name" : "Infection Response",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C26726",
    "description" : "Infection Response research focus.",
    "id" : ""
  }, {
    "name" : "Method Development",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0178742",
    "description" : "An approach to develop novel, or enhance existing, scientific tools and methods for use in research. (NCI)",
    "id" : ""
  }, {
    "name" : "Molecular Biology",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C16872",
    "description" : "The study of biology at a molecular level. It chiefly concerns itself with understanding the interactions between the various systems of a cell, including the interrelationship of DNA, RNA and protein synthesis and learning how these interactions are regulated. The field overlaps with other areas of biology, particularly genetics and biochemistry.",
    "id" : ""
  }, {
    "name" : "No Research Focus Specified",
    "link" : "",
    "description" : "No Research Focus currently specified.",
    "id" : ""
  }, {
    "name" : "Oncology",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17837",
    "description" : "The study of tumors encompassing the physical, chemical, and biologic properties.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0205394",
    "description" : "Different than the one(s) previously specified or mentioned. (NCI)",
    "id" : ""
  }, {
    "name" : "Pregnancy",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25742",
    "description" : "The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.",
    "id" : ""
  }, {
    "name" : "Preterm Birth",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C92861",
    "description" : "Birth when a fetus is less than 37 weeks and 0 days gestational age.",
    "id" : ""
  }, {
    "name" : "Psychopathology",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17035",
    "description" : "The branch of pathology focusing on mental illness and abnormal behavior.",
    "id" : ""
  }, {
    "name" : "Radiation Biology",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17055",
    "description" : "The study of the mechanisms and biological effects of ionizing radiation, including repair processes.",
    "id" : ""
  }, {
    "name" : "Transplantation",
    "link" : "http://purl.obolibrary.org/obo/OBI_0000105",
    "description" : "Transplantation research focus.",
    "id" : ""
  }, {
    "name" : "Vaccine Response",
    "link" : "http://www.ebi.ac.uk/efo/EFO_0004645",
    "description" : "Vaccine Response research focus.",
    "id" : ""
  } ]
}, {
  "name" : "lk_rna_sequence_result_unit_type",
  "rows" : [ {
    "name" : "result_unit_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "FPKM",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/22872506",
    "description" : "Fragments Per Kilobase Million: Normalized expression value of a given gene as measured by paired-end RNA sequencing",
    "id" : null
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : null
  }, {
    "name" : "RPKM",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/22872506",
    "description" : "Reads Per Kilobase Million: Normalized expression value of a given gene as measured by single-end RNA sequencing",
    "id" : null
  }, {
    "name" : "TPM",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/22872506",
    "description" : "Transcripts per million reads- Measurement of mRNA abundance using RNA-seq data",
    "id" : null
  } ]
}, {
  "name" : "lk_sample_type",
  "rows" : [ {
    "name" : "Amniotic Fluid",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0000173",
    "description" : "Amniotic fluid is a bodily fluid consisting of watery liquid surrounding and cushioning a growing fetus within the amnion. It allows the fetus to move freely without the walls of the uterus being too tight against its body. Buoyancy is also provided. The composition of the fluid changes over the course of gestation. Initially, amniotic fluid is similar to maternal plasma, mainly water with electrolytes. As the fetus develops, proteins, carbohydrates, lipids, phospholipids originating from the lungs, fetal cells, and urea are deposited in the fluid. database_cross_reference: MP:MPdatabase_cross_reference: ENVO:02000021",
    "id" : ""
  }, {
    "name" : "Appendix",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12380",
    "description" : "Small tissue projection existing as a cecal diverticulum with a questionable history of vestigial versus specialized organ.",
    "id" : ""
  }, {
    "name" : "B cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000236",
    "description" : "CD3-, CD19+, CD20+",
    "id" : ""
  }, {
    "name" : "Basophils",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12531",
    "description" : "Granular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes. A type of immune cell that has granules (small particles) with enzymes that are released during allergic reactions and asthma. A basophil is a type of white blood cell and a type of granulocyte. (UMLS CUI: C0004827)",
    "id" : ""
  }, {
    "name" : "Bone",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001474",
    "description" : "Skeletal element that is composed of bone tissue.",
    "id" : ""
  }, {
    "name" : "Bone Marrow",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002371",
    "description" : "The soft tissue that fills the cavities of bones.",
    "id" : ""
  }, {
    "name" : "Brachial lymph node",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002525",
    "description" : "The lymph nodes located along the brachial vein that receive drainage from most of the free upper limb and send efferent vessels to the central axillary lymph nodes.",
    "id" : ""
  }, {
    "name" : "brain",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0000955",
    "description" : "The brain is the center of the nervous system in all vertebrate, and most invertebrate, animals. Some primitive animals such as jellyfish and starfish have a decentralized nervous system without a brain, while sponges lack any nervous system at all. In vertebrates, the brain is located in the head, protected by the skull and close to the primary sensory apparatus of vision, hearing, balance, taste, and smell[WP]. [database_cross_reference: http://en.wikipedia.org/wiki/Brain][database_cross_reference: https://github.com/obophenotype/uberon/issues/300]",
    "id" : ""
  }, {
    "name" : "Breast Milk",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C13257",
    "description" : "Milk produced by female mammals for the purpose of feeding their young. The off-white liquid secreted by the mammary glands of humans and other mammals. It contains proteins, sugar, lipids, vitamins, and minerals. (UMLS CUI: C0026131)",
    "id" : ""
  }, {
    "name" : "Bronchoalveolar Lavage Fluid",
    "link" : "https://en.wikipedia.org/wiki/Bronchoalveolar_lavage",
    "description" : "Bronchoalveolar lavage (BAL; informally, \"bronchoalveolar washing\") is a medical procedure in which a bronchoscope is passed through the mouth or nose into the lungs and fluid is squirted into a small part of the lung and then collected for examination.",
    "id" : ""
  }, {
    "name" : "Carbohydrate",
    "link" : "http://purl.obolibrary.org/obo/CHEBI_16646",
    "description" : "Any member of the class of organooxygen compounds that is a polyhydroxy-aldehyde or -ketone or a lactol resulting from their intramolecular condensation (monosaccharides); substances derived from these by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom; and polymeric products arising by intermolecular acetal formation between two or more such molecules (disaccharides, polysaccharides and oligosaccharides). Carbohydrates contain only carbon, hydrogen and oxygen atoms; prior to any oxidation or reduction, most have the empirical formula Cm(H2O)n. Compounds obtained from carbohydrates by substitution, etc., are known as carbohydrate derivatives and may contain other elements. Cyclitols are generally not regarded as carbohydrates.",
    "id" : ""
  }, {
    "name" : "Cell culture supernatant",
    "link" : "http://purl.obolibrary.org/obo/OBI_1000023",
    "description" : "Supernatant of a cell culture is a material entity which contains media, supplements, and secreted products of the cells and becomes the environment of cultivated cell.",
    "id" : ""
  }, {
    "name" : "cell line",
    "link" : "http://purl.obolibrary.org/obo/CLO_0000031",
    "description" : "A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).",
    "id" : ""
  }, {
    "name" : "Cerebrospinal Fluid",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12692",
    "description" : "A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES. The fluid that flows in and around the hollow spaces of the brain and spinal cord, and between two of the meninges (the thin layers of tissue that cover and protect the brain and spinal cord). CSF is made by tissue called the choroid plexus in the ventricles (hollow spaces) in the brain. (UMLS CUI: C0007806)",
    "id" : ""
  }, {
    "name" : "Cervical lymph nodes",
    "link" : "https://en.wikipedia.org/wiki/Cervical_lymph_nodes",
    "description" : "Lymph nodes found in the neck.",
    "id" : ""
  }, {
    "name" : "Colon",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001155",
    "description" : "Last portion of the large intestine before it becomes the rectum.",
    "id" : ""
  }, {
    "name" : "Colonic Lamina Propria",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0007177",
    "description" : "A lamina propria that is part of a colonic mucosa.",
    "id" : ""
  }, {
    "name" : "Convalescent Plasma",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C173750",
    "description" : "Plasma derived from patients who have recovered from an illness. (UMLS CUI: C5383282)",
    "id" : ""
  }, {
    "name" : "Cord blood",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0012168",
    "description" : "Blood that remains in the placenta and in the attached umbilical cord after childbirthWP. database_cross_reference: http://en.wikipedia.org/wiki/Cord_blood",
    "id" : ""
  }, {
    "name" : "Decidua",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0011106",
    "description" : "The hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow (decidua menstrualis) or at the termination of pregnancy. During pregnancy, the thickest part of the decidua forms the maternal portion of the PLACENTA, thus named decidua placentalis. The thin portion of the decidua covering the rest of the embryo is the decidua capsularis. (MSH). The epithelial tissue of the endometrium. (NCI)",
    "id" : ""
  }, {
    "name" : "Dendritic cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000451",
    "description" : "CD3-, CD19, CD20, CD14-, CD16-, CD56-, HLA-DR+",
    "id" : ""
  }, {
    "name" : "Dermis",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002067",
    "description" : "The dermis is a layer of skin between the epidermis (with which it makes up the skin) and subcutaneous tissues, and is composed of two layers, the papillary and reticular dermis.",
    "id" : ""
  }, {
    "name" : "DNA",
    "link" : "http://purl.obolibrary.org/obo/CHEBI_16991",
    "description" : "High molecular weight, linear polymers, composed of nucleotides containing deoxyribose and linked by phosphodiester bonds; DNA contain the genetic information of organisms.",
    "id" : ""
  }, {
    "name" : "Dried Blood Spot",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C113746",
    "description" : "Capillary blood collected on blotting paper, typically from heel or finger stick. (UMLS CUI: C3830395)",
    "id" : ""
  }, {
    "name" : "Endotracheal aspirate",
    "link" : "http://purl.bioontology.org/ontology/RCD/X7AAl",
    "description" : "A specimen that derives from a biofilm that forms on the inner surface of an endotracheal tube while the tube is in the trachea. The specimen is collected by suction without removing the tube.",
    "id" : ""
  }, {
    "name" : "Epithelium",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0000483",
    "description" : "Portion of tissue, that consists of one or more layers of epithelial cells connected to each other by cell junctions and which is underlain by a basal lamina. Examples: simple squamous epithelium, glandular cuboidal epithelium, transitional epithelium, myoepithelium[CARO].",
    "id" : ""
  }, {
    "name" : "Feces",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C13234",
    "description" : "The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.",
    "id" : ""
  }, {
    "name" : "Fibroblast",
    "link" : "http://purl.obolibrary.org/obo/CL_0000057",
    "description" : "A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.",
    "id" : ""
  }, {
    "name" : "Gastric lamina propria",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001199",
    "description" : "The closest term in Uberson is \"Mucosa of the stomach\" : The mucosal layer that lines the stomach. It consists of epithelium, lamina propria, and the muscularis mucosae.",
    "id" : ""
  }, {
    "name" : "Ileum",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002116",
    "description" : "The portion of the small intestine that extends from the jejunum to the colon.",
    "id" : ""
  }, {
    "name" : "Inguinal lymph node",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001542",
    "description" : "The lymph nodes located in the groin area.",
    "id" : ""
  }, {
    "name" : "Jejunum",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002115",
    "description" : "The portion of the small intestine that extends from the duodenum to the ileum.",
    "id" : ""
  }, {
    "name" : "Kidney",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002113",
    "description" : "A paired organ of the urinary tract which has the production of urine as its primary function.",
    "id" : ""
  }, {
    "name" : "Leukocytes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12529",
    "description" : "White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood cells that are devoid of hemoglobin, capable of ameboid motion and phagocytosis, and act as the principal components of the immune system. (UMLS CUI: C0023516)",
    "id" : ""
  }, {
    "name" : "Lipid",
    "link" : "http://purl.obolibrary.org/obo/CHEBI_18059",
    "description" : "'Lipids' is a loosely defined term for substances of biological origin that are soluble in nonpolar solvents. They consist of saponifiable lipids, such as glycerides (fats and oils) and phospholipids, as well as nonsaponifiable lipids, principally steroids.",
    "id" : ""
  }, {
    "name" : "Liver",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002107",
    "description" : "An exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes[GO].",
    "id" : ""
  }, {
    "name" : "Lung",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002048",
    "description" : "Respiration organ that develops as an oupocketing of the esophagus.",
    "id" : ""
  }, {
    "name" : "Lung lymph node",
    "link" : "http://purl.obolibrary.org/obo/FMA_68286",
    "description" : "Bronchopulmonary segment lymph node.",
    "id" : ""
  }, {
    "name" : "Lymph node",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0000029",
    "description" : "Any of the rounded masses of lymphoid tissue that are surrounded by a capsule of connective tissue, are distributed along the lymphatic vessels, and contain numerous lymphocytes which filter the flow of lymph.",
    "id" : ""
  }, {
    "name" : "Lymphocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000542",
    "description" : "A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin. [database_cross_reference: GOC:add][database_cross_reference: ISBN:0781735149][database_cross_reference: ISBN:0683073696]",
    "id" : ""
  }, {
    "name" : "Macrophage",
    "link" : "http://purl.obolibrary.org/obo/CL_0000235",
    "description" : "A mononuclear phagocyte present in variety of tissues, typically differentiated from monocytes, capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells. Morphology: Diameter 30_M-80 _M, abundant cytoplasm, low N/C ratio, eccentric nucleus. Irregular shape with pseudopods, highly adhesive. Contain vacuoles and phagosomes, may contain azurophilic granules; markers: Mouse and: CD68, in most cases CD11b. Mouse: in most cases F4/80+; role or process: immune, antigen presentation, and remodelling; lineage: hematopoietic, myeloid.",
    "id" : ""
  }, {
    "name" : "Mesenteric lymph node",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002509",
    "description" : "The lymph nodes located in the mesentery, of which there are 3 classes: ileocolic, juxtaintestinal mesenteric, and central superior group.",
    "id" : ""
  }, {
    "name" : "Monocyte",
    "link" : "http://purl.obolibrary.org/obo/CL_0000576;http://purl.obolibrary.org/obo/CL_0000860",
    "description" : "CD3-, CD19, CD20, CD56-, CD14+",
    "id" : ""
  }, {
    "name" : "Mouse Ear",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C22712",
    "description" : "Mouse Ear (UMLS CUI: C1512159)",
    "id" : ""
  }, {
    "name" : "Mucosa",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C13166",
    "description" : "The moist, inner lining of some organs and body cavities (such as the nose, mouth, lungs, and stomach). Glands in the mucosa make mucus (a thick, slippery fluid).",
    "id" : ""
  }, {
    "name" : "Multiple Epithelial Tissues Sample",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C189133",
    "description" : "A sample derived from multiple epithelial tissues.",
    "id" : ""
  }, {
    "name" : "Multiple Immune Cells Blood Sample",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C189134",
    "description" : "A sample derived from multiple immune cell types isolated from blood.",
    "id" : ""
  }, {
    "name" : "Multiple Immune Cells Tissue Sample",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C189135",
    "description" : "A sample derived from multiple immune cell types isolated from epithelial tissues.",
    "id" : ""
  }, {
    "name" : "Nasal lavage fluid",
    "link" : "http://purl.obolibrary.org/obo/BTO_0004977",
    "description" : "Fluid obtained by irrigation or washout of the nasal cavity and nasal mucosa. [database_cross_reference: Mondofacto_Dictionary:http://www.mondofacto.com/facts/dictionary?]",
    "id" : ""
  }, {
    "name" : "Nasal Swab",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C132119",
    "description" : "A biospecimen collected from the nasal passages by swabbing.",
    "id" : ""
  }, {
    "name" : "Nasal Swab or Nose Specimen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C155833",
    "description" : "A biospecimen collected from the nasal passages by swabbing.",
    "id" : ""
  }, {
    "name" : "Nasopharyngeal Swab Specimen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C155831",
    "description" : "A biospecimen collected from the back of the throat by swabbing.",
    "id" : ""
  }, {
    "name" : "Negative Control",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64357",
    "description" : "A control sample where a negative result is expected, to help correlate a positive result with the variable being tested. (UMLS CUI: C1947986)",
    "id" : ""
  }, {
    "name" : "Neutrophil",
    "link" : "http://purl.obolibrary.org/obo/CL_0000775",
    "description" : "has_broad_synonym: polynuclear neutrophilic leucocyte; poly; polymorphonuclear leucocyte; PMN; polymorphonuclear neutrophil; polymorphonuclear leukocyte; polynuclear neutrophilic leukocyte  Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. database_cross_reference: FMA:62860; BTO:0000130; CALOHA:TS-0688 [database_cross_reference: ISBN:0721601464]",
    "id" : ""
  }, {
    "name" : "NK cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000623",
    "description" : "A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.",
    "id" : ""
  }, {
    "name" : "Non-B-cell Non T-cell Sorted Blood Sample",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C189130",
    "description" : "A sample of non-B-cells and non-T-cells that were obtained from a blood specimen whose cellular components were sorted first.",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "",
    "description" : "Sample Type is not specified or not received. If no Sample Type value is received, then this is the system default value.",
    "id" : ""
  }, {
    "name" : "Optic Nerve",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12761",
    "description" : "The nerve that carries messages from the retina to the brain. (UMLS CUI: C0029130)",
    "id" : ""
  }, {
    "name" : "Organoids",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C172259",
    "description" : "An organization of cells into an organ-like structure. Organoids can be generated in culture. They are also found in certain neoplasms. An organization of cells into an organ-like structure. Organoids can be generated in culture. They are also found in certain neoplasms. (UMLS CUI: C0029250)",
    "id" : ""
  }, {
    "name" : "Oropharyngeal Swab Specimen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C155835",
    "description" : "A biospecimen collected from the oropharynx by swabbing.",
    "id" : ""
  }, {
    "name" : "Osteoblasts",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12568",
    "description" : "Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Cells which secrete an extracellular matrix into which hydroxyapaetite crystals are deposited to form bone. (UMLS CUI: C0029418)",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "",
    "description" : "A sample type that is not provided in the preferred values list.",
    "id" : ""
  }, {
    "name" : "Pancreas",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12393",
    "description" : "A digestive organ in the abdomen that has both endocrine and exocrine functions. An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known. (UMLS CUI: C0030274)",
    "id" : ""
  }, {
    "name" : "Pancreatic Stellate Cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C107531",
    "description" : "A Star-shaped, myofibroblast-like cells located in the periacinar, perivascular, and periductal regions of the EXOCRINE PANCREAS. They play a key role in the pathobiology of FIBROSIS; PANCREATITIS; and PANCREATIC CANCER. When pancreatic stellate cells are activated in response to an injury, they proliferate and synthesize large amounts of extracellular matrix. Pancreatic cancer cells can increase the activation of pancreatic stellate cells, which leads to fibrosis. (UMLS CUI: C2936598)",
    "id" : ""
  }, {
    "name" : "PBL",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12938",
    "description" : "Peripheral Blood Lymphocyte (UMLS CUI:C0599819)",
    "id" : ""
  }, {
    "name" : "PBMC",
    "link" : "http://purl.obolibrary.org/obo/CL_0000842",
    "description" : "Peripheral Blood Mononuclear Cell- A leukocyte with a single non-segmented nucleus in the mature form.",
    "id" : ""
  }, {
    "name" : "Placenta",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001987",
    "description" : "Organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin. The fetal portion of the placenta is known as the villous chorion. The maternal portion is known as the decidua basalis. The two portions are held together by anchoring villi that are anchored to the decidua basalis by the cytotrophoblastic shell. database_cross_reference: http://en.wikipedia.org/wiki/Placenta[database_cross_reference: http://www.med.umich.edu/lrc/coursepages/m1/embryology/embryo/06placenta.htm]",
    "id" : ""
  }, {
    "name" : "Plasma",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001969",
    "description" : "Body substance in liquid state contained in the lumen of arterial and venous trees, blood capillary and the cardiac chambers; constitutes the liquid phase of blood.",
    "id" : ""
  }, {
    "name" : "Pooled Sample",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C165587",
    "description" : "A sample containing a mixture of multiple individual specimens of interest that were collected in a study. (UMLS CUI: C1709595)",
    "id" : ""
  }, {
    "name" : "Popliteal lymph node",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001543",
    "description" : "The lymph nodes which drain the legs; contained in the popliteal fossa.",
    "id" : ""
  }, {
    "name" : "Positive Control",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64356",
    "description" : "A control sample that is known to produce a positive result if the test is working as expected. (UMLS CUI: C1883676)",
    "id" : ""
  }, {
    "name" : "Protein",
    "link" : "http://purl.obolibrary.org/obo/CHEBI_36080",
    "description" : "A biological macromolecule minimally consisting of one polypeptide chain synthesized at the ribosome.",
    "id" : ""
  }, {
    "name" : "Rectal Swab Specimen",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C173641",
    "description" : "A biospecimen collected from the rectum by swabbing.",
    "id" : ""
  }, {
    "name" : "Red Blood Cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000232",
    "description" : "A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen. database_cross_reference: MESH:A11.118.290database_cross_reference: GOC:tfm",
    "id" : ""
  }, {
    "name" : "Saliva",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001836",
    "description" : "A fluid produced in the oral cavity by salivary glands, typically used in predigestion, but also in other functions.",
    "id" : ""
  }, {
    "name" : "Salivary Glands",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C12426",
    "description" : "An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity. (UMLS CUI: C0036098)",
    "id" : ""
  }, {
    "name" : "Serum",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001977",
    "description" : "Body substance derived from plasma by the elimination of fibrinogen.",
    "id" : ""
  }, {
    "name" : "Skin of body",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002097",
    "description" : "Nonparenchymatous organ that consists of the dermis and epidermis. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external layer of the body.",
    "id" : ""
  }, {
    "name" : "Small intestine",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002108",
    "description" : "Subdivision of digestive tract that connects the stomach to the large intestine and is where much of the digestion and absorption of food takes place (with the exception of ruminants).",
    "id" : ""
  }, {
    "name" : "Sorted Tissue Sample",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C189132",
    "description" : "A sample derived from sorted tissues.",
    "id" : ""
  }, {
    "name" : "Spleen",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002106",
    "description" : "The organ that functions to filter blood and to store red corpuscles and platelets.",
    "id" : ""
  }, {
    "name" : "Sputum",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C13278",
    "description" : "Material containing mucus, cellular debris, microorganisms and sometimes blood or pus.  It is ejected through the mouth from the lungs, bronchi, and trachea. (UMLS CUI: C0038056)",
    "id" : ""
  }, {
    "name" : "Stomach",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0000945",
    "description" : "An expanded region of the vertebrate alimentary tract that serves as a food storage compartment and digestive organ. A stomach is lined, in whole or in part by a glandular epithelium.",
    "id" : ""
  }, {
    "name" : "Synovial fluid",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001090",
    "description" : "Transudate contained in the synovial cavity of joints, and in the cavity of tendon sheaths and bursae.",
    "id" : ""
  }, {
    "name" : "Synovial tissue",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0007616",
    "description" : "Thin, loose vascular connective tissue that makes up the membranes surrounding joints and the sheaths protecting tendons (particularly flexor tendons in the hands and feet) where they pass over bony prominences.",
    "id" : ""
  }, {
    "name" : "T cell",
    "link" : "http://purl.obolibrary.org/obo/CL_0000084",
    "description" : "CD3+",
    "id" : ""
  }, {
    "name" : "Thymus",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002370",
    "description" : "Anatomical structure of largely lymphoid tissue that functions in cell-mediated immunity by being the site where T cells develop.",
    "id" : ""
  }, {
    "name" : "Tonsil",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0002372",
    "description" : "Either of the two small almond-shaped masses of lymph tissue found on either side of the oropharynx.",
    "id" : ""
  }, {
    "name" : "Trachea",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0003126",
    "description" : "The trachea is the portion of the airway that attaches to the bronchi as it branches [GO:dph]. [database_cross_reference: GO:0060438][database_cross_reference: http://en.wikipedia.org/wiki/Vertebrate_trachea]",
    "id" : ""
  }, {
    "name" : "Tumor Tissue",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C18009",
    "description" : "A tumor sample, or entire tumor that is removed for microscopic examination.",
    "id" : ""
  }, {
    "name" : "Umbilical cord blood",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0012168",
    "description" : "Blood that remains in the placenta and in the attached umbilical cord after childbirth[WP]. [database_cross_reference: http://en.wikipedia.org/wiki/Cord_blood]",
    "id" : ""
  }, {
    "name" : "Unsorted Tissue Sample",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C189131",
    "description" : "A sample derived from multiple, unsorted tissues.",
    "id" : ""
  }, {
    "name" : "Urinary bladder",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001255",
    "description" : "Distensible musculomembranous organ situated in the anterior part of the pelvic cavity in which urine collects before excretion",
    "id" : ""
  }, {
    "name" : "Urine",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0001088",
    "description" : "Excretion that is the output of a kidney database_cross_reference: http://en.wikipedia.org/wiki/Urine[database_cross_reference: https://github.com/geneontology/go-ontology/issues/11025]",
    "id" : ""
  }, {
    "name" : "Vagina",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0000996",
    "description" : "A fibromuscular tubular tract leading from the uterus to the exterior of the body in female placental mammals and marsupials, or to the cloaca in female birds, monotremes, and some reptiles[WP]. [database_cross_reference: http://orcid.org/0000-0002-6601-2165] [database_cross_reference: http://en.wikipedia.org/wiki/Vagina]",
    "id" : ""
  }, {
    "name" : "Whole blood",
    "link" : "http://purl.obolibrary.org/obo/UBERON_0000178",
    "description" : "Circulating body substance which consists of blood plasma and hemoglobin-carrying red blood cells. Excludes blood analogues (see UBERON:0000179 haemolymphatic fluid).",
    "id" : ""
  } ]
}, {
  "name" : "lk_source_type",
  "rows" : [ {
    "name" : "CONTROL SAMPLE",
    "link" : "",
    "description" : "Sample used to perform quality control of assay results.",
    "id" : ""
  }, {
    "name" : "EXPSAMPLE",
    "link" : "",
    "description" : "Biological sample that is assayed or measured.",
    "id" : ""
  }, {
    "name" : "STANDARD CURVE",
    "link" : "",
    "description" : "An analysis product from analyzing the assay result from known quantities and used to interpret the assay result from a sample.",
    "id" : ""
  } ]
}, {
  "name" : "lk_species",
  "rows" : [ {
    "name" : "Anas platyrhynchos",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_8839",
    "description" : "Mallard duck",
    "id" : "8839"
  }, {
    "name" : "Aotus nancymaae",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_37293",
    "description" : "Ma's night monkey",
    "id" : "37293"
  }, {
    "name" : "Canis lupus familiaris",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9615",
    "description" : "dog",
    "id" : "9615"
  }, {
    "name" : "Cavia porcellus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10141",
    "description" : "guinea pig",
    "id" : "10141"
  }, {
    "name" : "Chlorocebus sabaeus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_60711",
    "description" : "Green monkey",
    "id" : "60711"
  }, {
    "name" : "Drosophila melanogaster",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_7227",
    "description" : "Fruit Fly",
    "id" : "7227"
  }, {
    "name" : "Gallus gallus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9031",
    "description" : "Chicken",
    "id" : "9031"
  }, {
    "name" : "Homo sapiens",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9606",
    "description" : "Human",
    "id" : "9606"
  }, {
    "name" : "Macaca fascicularis",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9541",
    "description" : "Macaca fascicularis",
    "id" : "9541"
  }, {
    "name" : "Macaca mulatta",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9544",
    "description" : "Rhesus macaque",
    "id" : "9544"
  }, {
    "name" : "Mesocricetus auratus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10036",
    "description" : "golden hamster",
    "id" : "10036"
  }, {
    "name" : "Mus musculus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10090",
    "description" : "Mouse",
    "id" : "10090"
  }, {
    "name" : "Mus musculus castaneus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10091",
    "description" : "Southeastern Asian house mouse",
    "id" : "10091"
  }, {
    "name" : "Mus spretus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10096",
    "description" : "Western wild mouse",
    "id" : "10096"
  }, {
    "name" : "Mustela putorius furo",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9669",
    "description" : "domestic ferret",
    "id" : "9669"
  }, {
    "name" : "Neogale vison",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_452646",
    "description" : "American mink",
    "id" : "452646"
  }, {
    "name" : "Not Specified",
    "link" : "Not Specified",
    "description" : "Not Specified",
    "id" : "Not Specif"
  }, {
    "name" : "Other",
    "link" : "Other",
    "description" : "Other",
    "id" : "Other"
  }, {
    "name" : "Pan troglodytes",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9598",
    "description" : "Chimpanzee",
    "id" : "9598"
  }, {
    "name" : "Rattus norvegicus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10116",
    "description" : "Rat",
    "id" : "10116"
  }, {
    "name" : "Rattus rattus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_10117",
    "description" : "Rat - Brown",
    "id" : "10117"
  }, {
    "name" : "Sigmodon hispidus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_42415",
    "description" : "Hispid Cotton Rat",
    "id" : "42415"
  }, {
    "name" : "Sus scrofa domesticus",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_9825",
    "description" : "domestic pig",
    "id" : "9825"
  } ]
}, {
  "name" : "lk_study_condition_pref_mappng",
  "rows" : [ {
    "name" : "condition_reported",
    "link" : null,
    "description" : "condition_preferred",
    "id" : null
  }, {
    "name" : "(H3N2) infection",
    "link" : null,
    "description" : "swine influenza",
    "id" : null
  }, {
    "name" : "2019 Novel Coronavirus (2019-nCoV)",
    "link" : null,
    "description" : "COVID-19",
    "id" : null
  }, {
    "name" : "2019-nCoV infection",
    "link" : null,
    "description" : "COVID-19",
    "id" : null
  }, {
    "name" : "A/Brisbane/59/07",
    "link" : null,
    "description" : "influenza",
    "id" : null
  }, {
    "name" : "acantholysis bullosa",
    "link" : null,
    "description" : "epidermolysis bullosa",
    "id" : null
  }, {
    "name" : "Acid reflux",
    "link" : null,
    "description" : "gastroesophageal reflux disease",
    "id" : null
  }, {
    "name" : "acquired Immune deficiency",
    "link" : null,
    "description" : "acquired immunodeficiency syndrome",
    "id" : null
  }, {
    "name" : "Acropustulosis",
    "link" : null,
    "description" : "pustulosis of palm and sole",
    "id" : null
  }, {
    "name" : "acute Bronchitis",
    "link" : null,
    "description" : "bronchitis",
    "id" : null
  }, {
    "name" : "acute disseminated encephalitis",
    "link" : null,
    "description" : "acute disseminated encephalomyelitis",
    "id" : null
  }, {
    "name" : "Acute Febrile Neutrophilic Dermatosis",
    "link" : null,
    "description" : "Sweet syndrome",
    "id" : null
  }, {
    "name" : "acute hepatitis",
    "link" : null,
    "description" : "hepatitis",
    "id" : null
  }, {
    "name" : "acute infective polyneuritis",
    "link" : null,
    "description" : "Guillain-Barre syndrome",
    "id" : null
  }, {
    "name" : "acute inflammatory demyelinating polyradiculopathy",
    "link" : null,
    "description" : "Guillain-Barre syndrome",
    "id" : null
  }, {
    "name" : "acute influenza infection",
    "link" : null,
    "description" : "influenza",
    "id" : null
  }, {
    "name" : "acute influenza invfection",
    "link" : null,
    "description" : "influenza",
    "id" : null
  }, {
    "name" : "acute juvenile rheumatoid arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "acute peptic ulcer with hemorrhage",
    "link" : null,
    "description" : "peptic ulcer disease",
    "id" : null
  }, {
    "name" : "acute peptic ulcer with hemorrhage and perforation",
    "link" : null,
    "description" : "peptic ulcer disease",
    "id" : null
  }, {
    "name" : "acute peptic ulcer without hemorrhage AND without perforation",
    "link" : null,
    "description" : "peptic ulcer disease",
    "id" : null
  }, {
    "name" : "acute pharyngitis",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "acute postinfectious polyneuropathy",
    "link" : null,
    "description" : "Guillain-Barre syndrome",
    "id" : null
  }, {
    "name" : "acute sore throat",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "Addison disease",
    "link" : null,
    "description" : "Addison's disease",
    "id" : null
  }, {
    "name" : "Addison disease, chronic adrenal insufficiency",
    "link" : null,
    "description" : "Addison's disease",
    "id" : null
  }, {
    "name" : "Addison's anaemia",
    "link" : null,
    "description" : "pernicious anemia",
    "id" : null
  }, {
    "name" : "ADEM",
    "link" : null,
    "description" : "acute disseminated encephalomyelitis",
    "id" : null
  }, {
    "name" : "ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE",
    "link" : null,
    "description" : "congenital adrenal insufficiency",
    "id" : null
  }, {
    "name" : "adult glioblastoma multiforme",
    "link" : null,
    "description" : "glioblastoma",
    "id" : null
  }, {
    "name" : "adults and neonates",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "adults of different ages",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Age-associated",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Age-dependent",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Age-related",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Age-specific",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Aging-specific",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "AIDS",
    "link" : null,
    "description" : "acquired immunodeficiency syndrome",
    "id" : null
  }, {
    "name" : "alcohol abuse",
    "link" : null,
    "description" : "alcohol use disorder",
    "id" : null
  }, {
    "name" : "alcoholic intoxication, chronic",
    "link" : null,
    "description" : "alcohol dependence",
    "id" : null
  }, {
    "name" : "alcoholism",
    "link" : null,
    "description" : "alcohol dependence",
    "id" : null
  }, {
    "name" : "allergic dermatitis",
    "link" : null,
    "description" : "atopic dermatitis",
    "id" : null
  }, {
    "name" : "allergic to peanuts",
    "link" : null,
    "description" : "peanut allergy",
    "id" : null
  }, {
    "name" : "Allergy to eggs",
    "link" : null,
    "description" : "egg allergy",
    "id" : null
  }, {
    "name" : "allergy to peanuts",
    "link" : null,
    "description" : "peanut allergy",
    "id" : null
  }, {
    "name" : "alzheimer's",
    "link" : null,
    "description" : "Alzheimer's disease",
    "id" : null
  }, {
    "name" : "anaemia",
    "link" : null,
    "description" : "anemia",
    "id" : null
  }, {
    "name" : "ANEMIA PERNICIOUS",
    "link" : null,
    "description" : "pernicious anemia",
    "id" : null
  }, {
    "name" : "Angiitis",
    "link" : null,
    "description" : "vasculitis",
    "id" : null
  }, {
    "name" : "angina pectoris",
    "link" : null,
    "description" : "Angina",
    "id" : null
  }, {
    "name" : "Anthrax",
    "link" : null,
    "description" : "anthrax disease",
    "id" : null
  }, {
    "name" : "anti-GBM disease",
    "link" : null,
    "description" : "Goodpasture syndrome",
    "id" : null
  }, {
    "name" : "anti-glomerular basement membrane disease",
    "link" : null,
    "description" : "Goodpasture syndrome",
    "id" : null
  }, {
    "name" : "antiphospholipid antibody syndrome",
    "link" : null,
    "description" : "antiphospholipid syndrome",
    "id" : null
  }, {
    "name" : "anxiety",
    "link" : null,
    "description" : "anxiety disorder",
    "id" : null
  }, {
    "name" : "anxiety state",
    "link" : null,
    "description" : "anxiety disorder",
    "id" : null
  }, {
    "name" : "arterial occlusive disease",
    "link" : null,
    "description" : "peripheral vascular disease",
    "id" : null
  }, {
    "name" : "Arthritis or polyarthritis, rheumatic",
    "link" : null,
    "description" : "rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "arthritis psoriatica",
    "link" : null,
    "description" : "psoriatic arthritis",
    "id" : null
  }, {
    "name" : "arthropathic psoriasis",
    "link" : null,
    "description" : "psoriatic arthritis",
    "id" : null
  }, {
    "name" : "as they age",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "atopic eczema",
    "link" : null,
    "description" : "atopic dermatitis",
    "id" : null
  }, {
    "name" : "Atopic neurodermatitis",
    "link" : null,
    "description" : "atopic dermatitis",
    "id" : null
  }, {
    "name" : "atopic rhinitis",
    "link" : null,
    "description" : "allergic rhinitis",
    "id" : null
  }, {
    "name" : "Atresia of bile duct",
    "link" : null,
    "description" : "biliary atresia",
    "id" : null
  }, {
    "name" : "atrophic Arthritis",
    "link" : null,
    "description" : "rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "autoimmune cholangiopathy",
    "link" : null,
    "description" : "autoimmune cholangitis",
    "id" : null
  }, {
    "name" : "Autoimmune chronic active hepatitis",
    "link" : null,
    "description" : "autoimmune hepatitis",
    "id" : null
  }, {
    "name" : "autoimmune condition",
    "link" : null,
    "description" : "autoimmune disease",
    "id" : null
  }, {
    "name" : "autoimmune diseases",
    "link" : null,
    "description" : "autoimmune disease",
    "id" : null
  }, {
    "name" : "Autoimmune haemolytic anaemia",
    "link" : null,
    "description" : "autoimmune hemolytic anemia",
    "id" : null
  }, {
    "name" : "Autoimmune hemolytic anaemia",
    "link" : null,
    "description" : "autoimmune hemolytic anemia",
    "id" : null
  }, {
    "name" : "autoimmune hepatitis with centrilobular necrosis",
    "link" : null,
    "description" : "autoimmune hepatitis",
    "id" : null
  }, {
    "name" : "autoimmune hypersensitivity disease",
    "link" : null,
    "description" : "autoimmune disease",
    "id" : null
  }, {
    "name" : "avian flu",
    "link" : null,
    "description" : "avian influenza",
    "id" : null
  }, {
    "name" : "avian influenza virus (AIV) infection",
    "link" : null,
    "description" : "avian influenza",
    "id" : null
  }, {
    "name" : "B/Florida/04/06",
    "link" : null,
    "description" : "influenza",
    "id" : null
  }, {
    "name" : "bacterial enteritis",
    "link" : null,
    "description" : "intestinal infectious disease",
    "id" : null
  }, {
    "name" : "Bannwarth syndrome",
    "link" : null,
    "description" : "Lyme disease",
    "id" : null
  }, {
    "name" : "Bannworth's syndrome",
    "link" : null,
    "description" : "Lyme disease",
    "id" : null
  }, {
    "name" : "Besnier's prurigo",
    "link" : null,
    "description" : "atopic dermatitis",
    "id" : null
  }, {
    "name" : "Biermer's anaemia",
    "link" : null,
    "description" : "pernicious anemia",
    "id" : null
  }, {
    "name" : "Biermer's anemia",
    "link" : null,
    "description" : "pernicious anemia",
    "id" : null
  }, {
    "name" : "bilateral pleural effusion",
    "link" : null,
    "description" : "Bilateral pleural effusion (disorder)",
    "id" : null
  }, {
    "name" : "biliary atresia, congenital",
    "link" : null,
    "description" : "biliary atresia",
    "id" : null
  }, {
    "name" : "biliary liver cirrhosis",
    "link" : null,
    "description" : "primary biliary cholangitis",
    "id" : null
  }, {
    "name" : "bird flu",
    "link" : null,
    "description" : "avian influenza",
    "id" : null
  }, {
    "name" : "blood cancer",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "Blood Component Transfusion",
    "link" : null,
    "description" : "Blood Transfusion",
    "id" : null
  }, {
    "name" : "Blood disease",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "blood disorder",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "Blood dyscrasia",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "Boeck sarcoid",
    "link" : null,
    "description" : "sarcoidosis",
    "id" : null
  }, {
    "name" : "bordetella infection",
    "link" : null,
    "description" : "pertussis",
    "id" : null
  }, {
    "name" : "BPD",
    "link" : null,
    "description" : "Bronchopulmonary Dysplasia",
    "id" : null
  }, {
    "name" : "brain Glioblastoma",
    "link" : null,
    "description" : "brain glioblastoma multiforme",
    "id" : null
  }, {
    "name" : "Brain tumor-Glioma",
    "link" : null,
    "description" : "brain glioma",
    "id" : null
  }, {
    "name" : "breakbone fever",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "breast carcinoma",
    "link" : null,
    "description" : "breast cancer",
    "id" : null
  }, {
    "name" : "breast tumor",
    "link" : null,
    "description" : "breast cancer",
    "id" : null
  }, {
    "name" : "bronchial hyperreactivity",
    "link" : null,
    "description" : "asthma",
    "id" : null
  }, {
    "name" : "bronchogenic lung adenocarcinoma",
    "link" : null,
    "description" : "lung adenocarcinoma",
    "id" : null
  }, {
    "name" : "C. difficile infection",
    "link" : null,
    "description" : "Clostridium difficile colitis",
    "id" : null
  }, {
    "name" : "C. difficile-infected",
    "link" : null,
    "description" : "Clostridium difficile colitis",
    "id" : null
  }, {
    "name" : "Cardiac Failure Congestive",
    "link" : null,
    "description" : "congestive heart failure",
    "id" : null
  }, {
    "name" : "CARDIAC TRANSPLANT",
    "link" : null,
    "description" : "Heart Transplantation",
    "id" : null
  }, {
    "name" : "Cardiac Transplantation",
    "link" : null,
    "description" : "Heart Transplantation",
    "id" : null
  }, {
    "name" : "Cardiometabolic Syndrome",
    "link" : null,
    "description" : "Metabolic Syndrome",
    "id" : null
  }, {
    "name" : "Cardiomyopathies",
    "link" : null,
    "description" : "cardiomyopathy",
    "id" : null
  }, {
    "name" : "cardiopulmonary arrest",
    "link" : null,
    "description" : "cardiac arrest",
    "id" : null
  }, {
    "name" : "celiac sprue",
    "link" : null,
    "description" : "celiac disease",
    "id" : null
  }, {
    "name" : "Cephalhematoma",
    "link" : null,
    "description" : "Cephalohematoma",
    "id" : null
  }, {
    "name" : "Cerebrovascular accident",
    "link" : null,
    "description" : "cerebrovascular disease",
    "id" : null
  }, {
    "name" : "cerebrovascular disorder",
    "link" : null,
    "description" : "cerebrovascular disease",
    "id" : null
  }, {
    "name" : "CF",
    "link" : null,
    "description" : "cystic fibrosis",
    "id" : null
  }, {
    "name" : "changes as a function of age",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "CHD",
    "link" : null,
    "description" : "coronary artery disease",
    "id" : null
  }, {
    "name" : "chest cold",
    "link" : null,
    "description" : "bronchitis",
    "id" : null
  }, {
    "name" : "Chest infection",
    "link" : null,
    "description" : "bronchitis",
    "id" : null
  }, {
    "name" : "CHF",
    "link" : null,
    "description" : "congestive heart failure",
    "id" : null
  }, {
    "name" : "Chikungunya fever",
    "link" : null,
    "description" : "chikungunya",
    "id" : null
  }, {
    "name" : "CHIKV infection",
    "link" : null,
    "description" : "chikungunya",
    "id" : null
  }, {
    "name" : "childhood Dermatomyositis",
    "link" : null,
    "description" : "childhood type dermatomyositis",
    "id" : null
  }, {
    "name" : "children (0-11 years) versus adolescents (12-21 years)",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Cholera - Vibrio cholerae",
    "link" : null,
    "description" : "cholera",
    "id" : null
  }, {
    "name" : "Cholera due to Vibrio cholerae",
    "link" : null,
    "description" : "cholera",
    "id" : null
  }, {
    "name" : "cholestatic cirrhosis",
    "link" : null,
    "description" : "primary biliary cholangitis",
    "id" : null
  }, {
    "name" : "Chondromalacia, systemic",
    "link" : null,
    "description" : "relapsing polychondritis",
    "id" : null
  }, {
    "name" : "chronic angina",
    "link" : null,
    "description" : "Angina",
    "id" : null
  }, {
    "name" : "chronic bilateral pleural effusions",
    "link" : null,
    "description" : "Bilateral pleural effusion (disorder)",
    "id" : null
  }, {
    "name" : "chronic bronchitis",
    "link" : null,
    "description" : "bronchitis",
    "id" : null
  }, {
    "name" : "chronic hepatitis B",
    "link" : null,
    "description" : "hepatitis B",
    "id" : null
  }, {
    "name" : "chronic hepatitis C",
    "link" : null,
    "description" : "hepatitis C",
    "id" : null
  }, {
    "name" : "chronic idiopathic urticaria",
    "link" : null,
    "description" : "chronic spontaneous urticaria",
    "id" : null
  }, {
    "name" : "chronic kidney diseases",
    "link" : null,
    "description" : "chronic kidney disease",
    "id" : null
  }, {
    "name" : "chronic nonsuppurative destructive cholangitis",
    "link" : null,
    "description" : "primary biliary cholangitis",
    "id" : null
  }, {
    "name" : "chronic obstructive airway disease",
    "link" : null,
    "description" : "chronic obstructive pulmonary disease",
    "id" : null
  }, {
    "name" : "chronic obstructive asthma",
    "link" : null,
    "description" : "asthma",
    "id" : null
  }, {
    "name" : "chronic obstructive asthma with acute exacerbation",
    "link" : null,
    "description" : "asthma",
    "id" : null
  }, {
    "name" : "chronic obstructive asthma with status asthmaticus",
    "link" : null,
    "description" : "asthma",
    "id" : null
  }, {
    "name" : "chronic obstructive lung disease",
    "link" : null,
    "description" : "chronic obstructive pulmonary disease",
    "id" : null
  }, {
    "name" : "chronic pharyn/nasopharyngitis",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "chronic pharyngitis",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "chronic pharyngitis and nasopharyngitis",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "chronic plaque type psoriasis",
    "link" : null,
    "description" : "chronic plaque psoriasis",
    "id" : null
  }, {
    "name" : "chronic pleural effusion",
    "link" : null,
    "description" : "Pleural effusions, chronic",
    "id" : null
  }, {
    "name" : "chronic sore throat",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "chronic tonsillitis",
    "link" : null,
    "description" : "tonsillitis",
    "id" : null
  }, {
    "name" : "CI - Chest infection",
    "link" : null,
    "description" : "bronchitis",
    "id" : null
  }, {
    "name" : "circulatory arrest",
    "link" : null,
    "description" : "cardiac arrest",
    "id" : null
  }, {
    "name" : "Circumscribed alopecia",
    "link" : null,
    "description" : "alopecia areata",
    "id" : null
  }, {
    "name" : "circumscribed scleroderma",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "classic dengue",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "clostridial tetanus",
    "link" : null,
    "description" : "tetanus",
    "id" : null
  }, {
    "name" : "clostridium difficile infection",
    "link" : null,
    "description" : "Clostridium difficile colitis",
    "id" : null
  }, {
    "name" : "CMV Infection",
    "link" : null,
    "description" : "Cytomegaloviral Infection",
    "id" : null
  }, {
    "name" : "CMV-seropositive",
    "link" : null,
    "description" : "Cytomegaloviral Infection",
    "id" : null
  }, {
    "name" : "CN-AML",
    "link" : null,
    "description" : "Cytogenetically Normal Acute Myeloid Leukemia",
    "id" : null
  }, {
    "name" : "coagulation protein disease",
    "link" : null,
    "description" : "blood coagulation disease",
    "id" : null
  }, {
    "name" : "coeliac disease",
    "link" : null,
    "description" : "celiac disease",
    "id" : null
  }, {
    "name" : "COLD",
    "link" : null,
    "description" : "chronic obstructive pulmonary disease",
    "id" : null
  }, {
    "name" : "Congenital anomaly of heart",
    "link" : null,
    "description" : "congenital heart disease",
    "id" : null
  }, {
    "name" : "Congenital atresia of esophagus",
    "link" : null,
    "description" : "esophageal atresia",
    "id" : null
  }, {
    "name" : "Congenital biliary atresia",
    "link" : null,
    "description" : "biliary atresia",
    "id" : null
  }, {
    "name" : "Congenital choledochal cyst",
    "link" : null,
    "description" : "choledochal cyst",
    "id" : null
  }, {
    "name" : "congenital disorder",
    "link" : null,
    "description" : "physical disorder",
    "id" : null
  }, {
    "name" : "congenital heart defect",
    "link" : null,
    "description" : "congenital heart disease",
    "id" : null
  }, {
    "name" : "Congenital Heart Defects",
    "link" : null,
    "description" : "congenital heart disease",
    "id" : null
  }, {
    "name" : "Congenital imperforate esophagus",
    "link" : null,
    "description" : "esophageal atresia",
    "id" : null
  }, {
    "name" : "congenital laryngomalacia",
    "link" : null,
    "description" : "laryngomalacia",
    "id" : null
  }, {
    "name" : "Congestive heart disease",
    "link" : null,
    "description" : "congestive heart failure",
    "id" : null
  }, {
    "name" : "connective and soft tissue neoplasm",
    "link" : null,
    "description" : "sarcoma",
    "id" : null
  }, {
    "name" : "Connective tissue disease overlap syndrome",
    "link" : null,
    "description" : "mixed connective tissue disease",
    "id" : null
  }, {
    "name" : "connective tissue disorder",
    "link" : null,
    "description" : "connective tissue disease",
    "id" : null
  }, {
    "name" : "controlled human malaria infection",
    "link" : null,
    "description" : "malaria",
    "id" : null
  }, {
    "name" : "COPD",
    "link" : null,
    "description" : "chronic obstructive pulmonary disease",
    "id" : null
  }, {
    "name" : "coronary arteriosclerosis",
    "link" : null,
    "description" : "coronary artery disease",
    "id" : null
  }, {
    "name" : "Coronary disease",
    "link" : null,
    "description" : "coronary artery disease",
    "id" : null
  }, {
    "name" : "coronary heart disease",
    "link" : null,
    "description" : "coronary artery disease",
    "id" : null
  }, {
    "name" : "corynebacterium infection",
    "link" : null,
    "description" : "diphtheria",
    "id" : null
  }, {
    "name" : "COVID19",
    "link" : null,
    "description" : "COVID-19",
    "id" : null
  }, {
    "name" : "Cranial nerve disorder",
    "link" : null,
    "description" : "cranial nerve disease",
    "id" : null
  }, {
    "name" : "Crohn disease",
    "link" : null,
    "description" : "Crohn's disease",
    "id" : null
  }, {
    "name" : "Crohn's disease of colon",
    "link" : null,
    "description" : "Crohn's disease",
    "id" : null
  }, {
    "name" : "Crohn's disease of large bowel",
    "link" : null,
    "description" : "Crohn's disease",
    "id" : null
  }, {
    "name" : "cryptogenic fibrosing alveolitis",
    "link" : null,
    "description" : "idiopathic pulmonary fibrosis",
    "id" : null
  }, {
    "name" : "CVA",
    "link" : null,
    "description" : "cerebrovascular disease",
    "id" : null
  }, {
    "name" : "cystine storage disease",
    "link" : null,
    "description" : "cystinosis",
    "id" : null
  }, {
    "name" : "cytogenically normal acute myeloid leukemia",
    "link" : null,
    "description" : "Cytogenetically Normal Acute Myeloid Leukemia",
    "id" : null
  }, {
    "name" : "Cytomegalovirus",
    "link" : null,
    "description" : "Cytomegaloviral Infection",
    "id" : null
  }, {
    "name" : "Cytomegalovirus (CMV)",
    "link" : null,
    "description" : "Cytomegaloviral Infection",
    "id" : null
  }, {
    "name" : "cytomegalovirus infection",
    "link" : null,
    "description" : "Cytomegaloviral Infection",
    "id" : null
  }, {
    "name" : "degenerative arthritis",
    "link" : null,
    "description" : "osteoarthritis",
    "id" : null
  }, {
    "name" : "degenerative joint disease",
    "link" : null,
    "description" : "osteoarthritis",
    "id" : null
  }, {
    "name" : "dengue endemic",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "Dengue Fever",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "dengue infection",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "dengue virus infection",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "dengue virus-infected",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "DENV infection",
    "link" : null,
    "description" : "dengue disease",
    "id" : null
  }, {
    "name" : "dermatopolymyositis",
    "link" : null,
    "description" : "dermatomyositis",
    "id" : null
  }, {
    "name" : "dermatosclerosis",
    "link" : null,
    "description" : "scleroderma",
    "id" : null
  }, {
    "name" : "Devic's disease",
    "link" : null,
    "description" : "neuromyelitis optica",
    "id" : null
  }, {
    "name" : "Devic's syndrome",
    "link" : null,
    "description" : "neuromyelitis optica",
    "id" : null
  }, {
    "name" : "DHF",
    "link" : null,
    "description" : "dengue hemorrhagic fever",
    "id" : null
  }, {
    "name" : "diabetes mellitus, insulin-dependent",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "diabetes mellitus, non-insulin-dependent",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "Diabetes Mellitus, Type 1",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "diabetes type i",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "diabetes type ii",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "different ages",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "disease of haematopoietic system",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "disease of hematopoietic system",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "disease of subdivision of hemolymphoid system",
    "link" : null,
    "description" : "cardiovascular system disease",
    "id" : null
  }, {
    "name" : "DISEASE OF THE BLOOD AND BLOOD-FORMING ORGANS",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "disorder of connective tissue",
    "link" : null,
    "description" : "connective tissue disease",
    "id" : null
  }, {
    "name" : "disorder of cranial nerve",
    "link" : null,
    "description" : "cranial nerve disease",
    "id" : null
  }, {
    "name" : "disorder of liver",
    "link" : null,
    "description" : "liver disease",
    "id" : null
  }, {
    "name" : "disseminated lupus erythematosus",
    "link" : null,
    "description" : "systemic lupus erythematosus",
    "id" : null
  }, {
    "name" : "donor of a kidney",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "E Coli Infection",
    "link" : null,
    "description" : "Escherichia Coli Infection",
    "id" : null
  }, {
    "name" : "EAEC infection",
    "link" : null,
    "description" : "Escherichia Coli Infection",
    "id" : null
  }, {
    "name" : "EAEC35 infected",
    "link" : null,
    "description" : "Escherichia Coli Infection",
    "id" : null
  }, {
    "name" : "Eaton-Lambert syndrome",
    "link" : null,
    "description" : "Lambert-Eaton myasthenic syndrome",
    "id" : null
  }, {
    "name" : "Ebola virus disease",
    "link" : null,
    "description" : "Ebola hemorrhagic fever",
    "id" : null
  }, {
    "name" : "egg-allergic",
    "link" : null,
    "description" : "egg allergy",
    "id" : null
  }, {
    "name" : "elderly",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "end stage renal disease on peritoneal dialysis",
    "link" : null,
    "description" : "Dependence on peritoneal dialysis due to end stage renal disease",
    "id" : null
  }, {
    "name" : "end stage renal failure",
    "link" : null,
    "description" : "end stage renal disease",
    "id" : null
  }, {
    "name" : "end-stage kidney disease",
    "link" : null,
    "description" : "end stage renal disease",
    "id" : null
  }, {
    "name" : "Enteroaggretive Escherichia coli (EAEC) infection",
    "link" : null,
    "description" : "Escherichia Coli Infection",
    "id" : null
  }, {
    "name" : "ENTEROCOLITIS NECROTIZING",
    "link" : null,
    "description" : "perinatal necrotizing enterocolitis",
    "id" : null
  }, {
    "name" : "Epidemiology, Family Medical History",
    "link" : null,
    "description" : "Family Medical History",
    "id" : null
  }, {
    "name" : "epilepsy syndrome",
    "link" : null,
    "description" : "epilepsy",
    "id" : null
  }, {
    "name" : "epileptic syndrome",
    "link" : null,
    "description" : "epilepsy",
    "id" : null
  }, {
    "name" : "Epstein-Barr virus infection",
    "link" : null,
    "description" : "EBV Infection",
    "id" : null
  }, {
    "name" : "esophageal atresia and/or tracheoesophageal fistula",
    "link" : null,
    "description" : "esophageal atresia/tracheoesophageal fistula",
    "id" : null
  }, {
    "name" : "Ethanol abuse",
    "link" : null,
    "description" : "alcohol use disorder",
    "id" : null
  }, {
    "name" : "Exercise induced asthma",
    "link" : null,
    "description" : "asthma",
    "id" : null
  }, {
    "name" : "exercise-induced asthma",
    "link" : null,
    "description" : "asthma",
    "id" : null
  }, {
    "name" : "exophthalmic goiter",
    "link" : null,
    "description" : "Graves' disease",
    "id" : null
  }, {
    "name" : "falciparum malaria",
    "link" : null,
    "description" : "Plasmodium falciparum malaria",
    "id" : null
  }, {
    "name" : "familial pemphigus vulgaris",
    "link" : null,
    "description" : "pemphigus vulgaris",
    "id" : null
  }, {
    "name" : "Family History",
    "link" : null,
    "description" : "Family Medical History",
    "id" : null
  }, {
    "name" : "Family History of",
    "link" : null,
    "description" : "Family Medical History",
    "id" : null
  }, {
    "name" : "FGS",
    "link" : null,
    "description" : "focal segmental glomerulosclerosis",
    "id" : null
  }, {
    "name" : "FIBROCYSTIC PULMONARY DYSPLASIA",
    "link" : null,
    "description" : "idiopathic pulmonary fibrosis",
    "id" : null
  }, {
    "name" : "flu",
    "link" : null,
    "description" : "influenza",
    "id" : null
  }, {
    "name" : "focal glomerular sclerosis",
    "link" : null,
    "description" : "focal segmental glomerulosclerosis",
    "id" : null
  }, {
    "name" : "focal glomerulosclerosis",
    "link" : null,
    "description" : "focal segmental glomerulosclerosis",
    "id" : null
  }, {
    "name" : "food hypersensitivity",
    "link" : null,
    "description" : "food allergy",
    "id" : null
  }, {
    "name" : "FORMER",
    "link" : null,
    "description" : "Previous",
    "id" : null
  }, {
    "name" : "FSGS",
    "link" : null,
    "description" : "focal segmental glomerulosclerosis",
    "id" : null
  }, {
    "name" : "Gastresophageal reflux",
    "link" : null,
    "description" : "gastroesophageal reflux disease",
    "id" : null
  }, {
    "name" : "Gastro-esophageal reflux",
    "link" : null,
    "description" : "gastroesophageal reflux disease",
    "id" : null
  }, {
    "name" : "Gastroesophageal reflux",
    "link" : null,
    "description" : "gastroesophageal reflux disease",
    "id" : null
  }, {
    "name" : "Gastrointestinal Bariatric Surgery",
    "link" : null,
    "description" : "Bariatric Surgery",
    "id" : null
  }, {
    "name" : "GBM",
    "link" : null,
    "description" : "glioblastoma",
    "id" : null
  }, {
    "name" : "Generalized multiple sclerosis",
    "link" : null,
    "description" : "multiple sclerosis",
    "id" : null
  }, {
    "name" : "GERD",
    "link" : null,
    "description" : "gastroesophageal reflux disease",
    "id" : null
  }, {
    "name" : "GERD - Gastro-esophageal reflux disease",
    "link" : null,
    "description" : "gastroesophageal reflux disease",
    "id" : null
  }, {
    "name" : "german measles",
    "link" : null,
    "description" : "rubella",
    "id" : null
  }, {
    "name" : "Gestation",
    "link" : null,
    "description" : "Pregnancy",
    "id" : null
  }, {
    "name" : "gestational hypertension",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "glioblastoma multiforme",
    "link" : null,
    "description" : "glioblastoma",
    "id" : null
  }, {
    "name" : "Glioblastoma multiforme of brain",
    "link" : null,
    "description" : "brain glioblastoma multiforme",
    "id" : null
  }, {
    "name" : "glioma of the optic nerve",
    "link" : null,
    "description" : "optic nerve glioma",
    "id" : null
  }, {
    "name" : "grade IV adult Astrocytic tumor",
    "link" : null,
    "description" : "glioblastoma",
    "id" : null
  }, {
    "name" : "Granulomatous Colitis",
    "link" : null,
    "description" : "Crohn's disease",
    "id" : null
  }, {
    "name" : "Grave's disease",
    "link" : null,
    "description" : "Graves' disease",
    "id" : null
  }, {
    "name" : "Graves disease",
    "link" : null,
    "description" : "Graves' disease",
    "id" : null
  }, {
    "name" : "H. influenza",
    "link" : null,
    "description" : "haemophilus meningitis",
    "id" : null
  }, {
    "name" : "H. pylori infection",
    "link" : null,
    "description" : "Helicobacter Pylori Infection",
    "id" : null
  }, {
    "name" : "H1N1 influenza",
    "link" : null,
    "description" : "swine influenza",
    "id" : null
  }, {
    "name" : "H5 influenza",
    "link" : null,
    "description" : "avian influenza",
    "id" : null
  }, {
    "name" : "haematopoietic system disease",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "haemolytic-uraemic syndrome",
    "link" : null,
    "description" : "hemolytic-uremic syndrome",
    "id" : null
  }, {
    "name" : "haemophilius meningitis",
    "link" : null,
    "description" : "haemophilus meningitis",
    "id" : null
  }, {
    "name" : "Hay Fever",
    "link" : null,
    "description" : "Seasonal Allergic Rhinitis",
    "id" : null
  }, {
    "name" : "HCMV Infection",
    "link" : null,
    "description" : "Cytomegaloviral Infection",
    "id" : null
  }, {
    "name" : "healthy adults",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "healthy adults- longitudinal follow-up",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "healthy appearing infants",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "healthy control",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "healthy controls",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "healthy, nonatopic subjects",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "heart attack",
    "link" : null,
    "description" : "myocardial infarction",
    "id" : null
  }, {
    "name" : "heart defect",
    "link" : null,
    "description" : "congenital heart disease",
    "id" : null
  }, {
    "name" : "Heart Grafting",
    "link" : null,
    "description" : "Heart Transplantation",
    "id" : null
  }, {
    "name" : "Heart Malformation",
    "link" : null,
    "description" : "congenital heart disease",
    "id" : null
  }, {
    "name" : "heart transplant",
    "link" : null,
    "description" : "Heart Transplantation",
    "id" : null
  }, {
    "name" : "Hematologic malignancy",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "Hematologic neoplasm",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "Hematological disease",
    "link" : null,
    "description" : "hematopoietic system disease",
    "id" : null
  }, {
    "name" : "Hematological tumors",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "hematopoietic and lymphoid system tumor",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "hematopoietic cancer",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "hematopoietic neoplasm",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "hematopoietic tumors",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "hemoglobinopathies",
    "link" : null,
    "description" : "hemoglobinopathy",
    "id" : null
  }, {
    "name" : "hemolytic uremic syndrome",
    "link" : null,
    "description" : "hemolytic-uremic syndrome",
    "id" : null
  }, {
    "name" : "hep B",
    "link" : null,
    "description" : "hepatitis B",
    "id" : null
  }, {
    "name" : "hepatic disorder",
    "link" : null,
    "description" : "liver disease",
    "id" : null
  }, {
    "name" : "Hepatic Transplantation",
    "link" : null,
    "description" : "Liver Transplantation",
    "id" : null
  }, {
    "name" : "hepatitis B infection",
    "link" : null,
    "description" : "hepatitis B",
    "id" : null
  }, {
    "name" : "hepatitis C infection",
    "link" : null,
    "description" : "hepatitis C",
    "id" : null
  }, {
    "name" : "hepatitis nonA nonB",
    "link" : null,
    "description" : "hepatitis C",
    "id" : null
  }, {
    "name" : "herpes simplex dermatitis",
    "link" : null,
    "description" : "eczema herpeticum",
    "id" : null
  }, {
    "name" : "Herpes simplex dermatitis of eyelid",
    "link" : null,
    "description" : "eczema herpeticum",
    "id" : null
  }, {
    "name" : "Herpes simplex eyelid dermatitis",
    "link" : null,
    "description" : "eczema herpeticum",
    "id" : null
  }, {
    "name" : "Herpes simplex virus dermatitis",
    "link" : null,
    "description" : "eczema herpeticum",
    "id" : null
  }, {
    "name" : "herpes simplex virus eyelid dermatitis",
    "link" : null,
    "description" : "eczema herpeticum",
    "id" : null
  }, {
    "name" : "herpes zona",
    "link" : null,
    "description" : "herpes zoster",
    "id" : null
  }, {
    "name" : "High blood pressure",
    "link" : null,
    "description" : "hypertension",
    "id" : null
  }, {
    "name" : "HIV",
    "link" : null,
    "description" : "human immunodeficiency virus infectious disease",
    "id" : null
  }, {
    "name" : "HIV infection",
    "link" : null,
    "description" : "human immunodeficiency virus infectious disease",
    "id" : null
  }, {
    "name" : "HTN",
    "link" : null,
    "description" : "hypertension",
    "id" : null
  }, {
    "name" : "hyperpiesia",
    "link" : null,
    "description" : "hypertension",
    "id" : null
  }, {
    "name" : "hypersensitivity",
    "link" : null,
    "description" : "allergic hypersensitivity disease",
    "id" : null
  }, {
    "name" : "hypersensitivity reaction type I disease",
    "link" : null,
    "description" : "allergic hypersensitivity disease",
    "id" : null
  }, {
    "name" : "hypersensitivity reaction type II disease",
    "link" : null,
    "description" : "autoimmune disease",
    "id" : null
  }, {
    "name" : "hypertension induced by pregnancy",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "hypertensive disease",
    "link" : null,
    "description" : "hypertension",
    "id" : null
  }, {
    "name" : "hypertrophic arthritis",
    "link" : null,
    "description" : "osteoarthritis",
    "id" : null
  }, {
    "name" : "HYPOADRENOCORTICISM, FAMILIAL",
    "link" : null,
    "description" : "Addison's disease",
    "id" : null
  }, {
    "name" : "Hypoglycaemia",
    "link" : null,
    "description" : "hypoglycemia",
    "id" : null
  }, {
    "name" : "hypoimmunity",
    "link" : null,
    "description" : "primary immunodeficiency disease",
    "id" : null
  }, {
    "name" : "ichthyoses",
    "link" : null,
    "description" : "ichthyosis",
    "id" : null
  }, {
    "name" : "IDDM",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL",
    "link" : null,
    "description" : "idiopathic pulmonary fibrosis",
    "id" : null
  }, {
    "name" : "idiopathic steatorrhea",
    "link" : null,
    "description" : "celiac disease",
    "id" : null
  }, {
    "name" : "idiopathic thrombocytopenic purpura",
    "link" : null,
    "description" : "autoimmune thrombocytopenic purpura",
    "id" : null
  }, {
    "name" : "immune deficiency disorder",
    "link" : null,
    "description" : "primary immunodeficiency disease",
    "id" : null
  }, {
    "name" : "immune deficiency/hiv/aids",
    "link" : null,
    "description" : "acquired immunodeficiency syndrome",
    "id" : null
  }, {
    "name" : "immune system tolerance",
    "link" : null,
    "description" : "Immunologic Tolerance",
    "id" : null
  }, {
    "name" : "Immune thrombocytopenic purpura",
    "link" : null,
    "description" : "autoimmune thrombocytopenic purpura",
    "id" : null
  }, {
    "name" : "Immune Tolerance",
    "link" : null,
    "description" : "Immunologic Tolerance",
    "id" : null
  }, {
    "name" : "immunocompromised condition",
    "link" : null,
    "description" : "Immunocompromised",
    "id" : null
  }, {
    "name" : "immunodeficiency syndrome",
    "link" : null,
    "description" : "primary immunodeficiency disease",
    "id" : null
  }, {
    "name" : "Immunological Tolerance",
    "link" : null,
    "description" : "Immunologic Tolerance",
    "id" : null
  }, {
    "name" : "Imperforate esophagus",
    "link" : null,
    "description" : "esophageal atresia",
    "id" : null
  }, {
    "name" : "induced malaria",
    "link" : null,
    "description" : "malaria",
    "id" : null
  }, {
    "name" : "infantile cerebral palsy",
    "link" : null,
    "description" : "cerebral palsy",
    "id" : null
  }, {
    "name" : "Infantile hemiplegia",
    "link" : null,
    "description" : "hemiplegia",
    "id" : null
  }, {
    "name" : "infection by CMV",
    "link" : null,
    "description" : "Cytomegaloviral Infection",
    "id" : null
  }, {
    "name" : "infection by EBV",
    "link" : null,
    "description" : "EBV Infection",
    "id" : null
  }, {
    "name" : "Infection due to Clostridium tetani",
    "link" : null,
    "description" : "tetanus",
    "id" : null
  }, {
    "name" : "infection with West Nile virus",
    "link" : null,
    "description" : "West Nile fever",
    "id" : null
  }, {
    "name" : "infections with Y. pestis",
    "link" : null,
    "description" : "plague",
    "id" : null
  }, {
    "name" : "infectious disease",
    "link" : null,
    "description" : "disease by infectious agent",
    "id" : null
  }, {
    "name" : "Infectious neuronitis",
    "link" : null,
    "description" : "Guillain-Barre syndrome",
    "id" : null
  }, {
    "name" : "Inflamed throat",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "Influenza A (H5N1)",
    "link" : null,
    "description" : "avian influenza",
    "id" : null
  }, {
    "name" : "influenza a virus, h5n1 subtype",
    "link" : null,
    "description" : "avian influenza",
    "id" : null
  }, {
    "name" : "influenza A(H1N1)",
    "link" : null,
    "description" : "swine influenza",
    "id" : null
  }, {
    "name" : "Influenza A/H1N1",
    "link" : null,
    "description" : "swine influenza",
    "id" : null
  }, {
    "name" : "influenza virus A subtype H1N1",
    "link" : null,
    "description" : "swine influenza",
    "id" : null
  }, {
    "name" : "Influenza with non-respiratory manifestation",
    "link" : null,
    "description" : "influenza",
    "id" : null
  }, {
    "name" : "Influenza with other manifestations",
    "link" : null,
    "description" : "influenza",
    "id" : null
  }, {
    "name" : "influenza-H1N1",
    "link" : null,
    "description" : "swine influenza",
    "id" : null
  }, {
    "name" : "insular sclerosis",
    "link" : null,
    "description" : "multiple sclerosis",
    "id" : null
  }, {
    "name" : "Insulin Dependent Diabetes Mellitus",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "insulin resistance",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "insulin-dependent diabetes mellitus",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "intra-amniotic infection",
    "link" : null,
    "description" : "chorioamnionitis",
    "id" : null
  }, {
    "name" : "invasive gastric cancer",
    "link" : null,
    "description" : "Malignant Gastric Neoplasm",
    "id" : null
  }, {
    "name" : "irritable bowel syndrome - diarrhea type",
    "link" : null,
    "description" : "Irritable bowel syndrome with diarrhea",
    "id" : null
  }, {
    "name" : "islet transplantation",
    "link" : null,
    "description" : "Pancreatic Islet Transplantation",
    "id" : null
  }, {
    "name" : "islets of Langerhans transplantation",
    "link" : null,
    "description" : "Pancreatic Islet Transplantation",
    "id" : null
  }, {
    "name" : "jia",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "jungle yellow fever",
    "link" : null,
    "description" : "yellow fever",
    "id" : null
  }, {
    "name" : "juvenile chronic polyarthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "Juvenile Dermatomyositis",
    "link" : null,
    "description" : "childhood type dermatomyositis",
    "id" : null
  }, {
    "name" : "Juvenile Idiopathic Arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "juvenile idiopathic arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "kidney failure, chronic",
    "link" : null,
    "description" : "kidney failure",
    "id" : null
  }, {
    "name" : "Kidney Grafting",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "kidney stones",
    "link" : null,
    "description" : "nephrolithiasis",
    "id" : null
  }, {
    "name" : "Kidney Transplanation",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "kidney transplant",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "KSHV",
    "link" : null,
    "description" : "viral tropism",
    "id" : null
  }, {
    "name" : "Lambert-Eaton syndrome",
    "link" : null,
    "description" : "Lambert-Eaton myasthenic syndrome",
    "id" : null
  }, {
    "name" : "large pulmonary nodules",
    "link" : null,
    "description" : "Multiple Pulmonary Nodules",
    "id" : null
  }, {
    "name" : "latent mycobacterium tuberculosis infection",
    "link" : null,
    "description" : "tuberculosis",
    "id" : null
  }, {
    "name" : "LCM",
    "link" : null,
    "description" : "lymphocytic choriomeningitis",
    "id" : null
  }, {
    "name" : "Left-sided ulcerative colitis",
    "link" : null,
    "description" : "ulcerative colitis",
    "id" : null
  }, {
    "name" : "LEMS",
    "link" : null,
    "description" : "Lambert-Eaton myasthenic syndrome",
    "id" : null
  }, {
    "name" : "lichen ruber planus",
    "link" : null,
    "description" : "lichen planus",
    "id" : null
  }, {
    "name" : "Lichen, ruber planus",
    "link" : null,
    "description" : "lichen planus",
    "id" : null
  }, {
    "name" : "liver cancer DOID:3571",
    "link" : null,
    "description" : "liver cancer",
    "id" : null
  }, {
    "name" : "Liver Grafting",
    "link" : null,
    "description" : "Liver Transplantation",
    "id" : null
  }, {
    "name" : "liver transplant",
    "link" : null,
    "description" : "Liver Transplantation",
    "id" : null
  }, {
    "name" : "localised morphea",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "localised morphoea",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "localised scleroderma",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "localized morphea",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "lower grade glioma",
    "link" : null,
    "description" : "brain glioma",
    "id" : null
  }, {
    "name" : "lung grafting",
    "link" : null,
    "description" : "Lung Transplantation",
    "id" : null
  }, {
    "name" : "lung transplant",
    "link" : null,
    "description" : "Lung Transplantation",
    "id" : null
  }, {
    "name" : "lupus",
    "link" : null,
    "description" : "lupus erythematosus",
    "id" : null
  }, {
    "name" : "Lupus Erythematosus, systemic",
    "link" : null,
    "description" : "systemic lupus erythematosus",
    "id" : null
  }, {
    "name" : "lyme",
    "link" : null,
    "description" : "Lyme disease",
    "id" : null
  }, {
    "name" : "Lyme borreliosis",
    "link" : null,
    "description" : "Lyme disease",
    "id" : null
  }, {
    "name" : "lyme neuroborreliosis",
    "link" : null,
    "description" : "Lyme disease",
    "id" : null
  }, {
    "name" : "lymphocytic choriomeningitis virus",
    "link" : null,
    "description" : "lymphocytic choriomeningitis",
    "id" : null
  }, {
    "name" : "Lymphocytic choriomeningitis virus encephalomyelitis",
    "link" : null,
    "description" : "lymphocytic choriomeningitis",
    "id" : null
  }, {
    "name" : "Lymphocytic meningitis",
    "link" : null,
    "description" : "lymphocytic choriomeningitis",
    "id" : null
  }, {
    "name" : "Lymphocytic meningoencephalitis",
    "link" : null,
    "description" : "lymphocytic choriomeningitis",
    "id" : null
  }, {
    "name" : "lymphogranulomatosis",
    "link" : null,
    "description" : "sarcoidosis",
    "id" : null
  }, {
    "name" : "lymphoid cancer",
    "link" : null,
    "description" : "lymphoma",
    "id" : null
  }, {
    "name" : "Malaria by Plasmodium vivax",
    "link" : null,
    "description" : "Plasmodium vivax malaria",
    "id" : null
  }, {
    "name" : "Malaria fever, subtertian",
    "link" : null,
    "description" : "Plasmodium falciparum malaria",
    "id" : null
  }, {
    "name" : "malaria infection",
    "link" : null,
    "description" : "malaria",
    "id" : null
  }, {
    "name" : "malignancy with pulmonary metastasis",
    "link" : null,
    "description" : "Malignant Lung Neoplasm",
    "id" : null
  }, {
    "name" : "malignant hematopoietic neoplasm",
    "link" : null,
    "description" : "hematologic cancer",
    "id" : null
  }, {
    "name" : "malignant neoplasm",
    "link" : null,
    "description" : "cancer",
    "id" : null
  }, {
    "name" : "malignant neoplasm of breast",
    "link" : null,
    "description" : "breast cancer",
    "id" : null
  }, {
    "name" : "malignant neoplasm of lung",
    "link" : null,
    "description" : "Malignant Lung Neoplasm",
    "id" : null
  }, {
    "name" : "malignant neoplasm of stomach",
    "link" : null,
    "description" : "Malignant Gastric Neoplasm",
    "id" : null
  }, {
    "name" : "malignant neoplasms",
    "link" : null,
    "description" : "cancer",
    "id" : null
  }, {
    "name" : "malignant tertian fever",
    "link" : null,
    "description" : "Plasmodium falciparum malaria",
    "id" : null
  }, {
    "name" : "malignant tumor",
    "link" : null,
    "description" : "cancer",
    "id" : null
  }, {
    "name" : "malignant tumor of the breast",
    "link" : null,
    "description" : "breast cancer",
    "id" : null
  }, {
    "name" : "mammary cancer",
    "link" : null,
    "description" : "breast cancer",
    "id" : null
  }, {
    "name" : "mammary tumor",
    "link" : null,
    "description" : "breast cancer",
    "id" : null
  }, {
    "name" : "meningococcus",
    "link" : null,
    "description" : "meningococcal meningitis",
    "id" : null
  }, {
    "name" : "mental or behavioural disorder",
    "link" : null,
    "description" : "psychotic disorder",
    "id" : null
  }, {
    "name" : "metabolic disease",
    "link" : null,
    "description" : "disease of metabolism",
    "id" : null
  }, {
    "name" : "Metabolic Syndrome X",
    "link" : null,
    "description" : "Metabolic Syndrome",
    "id" : null
  }, {
    "name" : "milk allergic reaction",
    "link" : null,
    "description" : "milk allergy",
    "id" : null
  }, {
    "name" : "mitral regurgitation",
    "link" : null,
    "description" : "mitral valve insufficiency",
    "id" : null
  }, {
    "name" : "mixed collagen vascular disease",
    "link" : null,
    "description" : "mixed connective tissue disease",
    "id" : null
  }, {
    "name" : "monarticular juvenile rheumatoid arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "morbilli",
    "link" : null,
    "description" : "measles",
    "id" : null
  }, {
    "name" : "Morphea",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "mtb infection",
    "link" : null,
    "description" : "tuberculosis",
    "id" : null
  }, {
    "name" : "mucoviscidosis",
    "link" : null,
    "description" : "cystic fibrosis",
    "id" : null
  }, {
    "name" : "Multiple Sclereosis",
    "link" : null,
    "description" : "multiple sclerosis",
    "id" : null
  }, {
    "name" : "Muscle-invasive bladder cancer",
    "link" : null,
    "description" : "muscle invasive bladder cancer",
    "id" : null
  }, {
    "name" : "Myocardial infarct",
    "link" : null,
    "description" : "myocardial infarction",
    "id" : null
  }, {
    "name" : "Myocardial inflammation",
    "link" : null,
    "description" : "myocarditis",
    "id" : null
  }, {
    "name" : "n/a",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "na",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "NANBH",
    "link" : null,
    "description" : "hepatitis C",
    "id" : null
  }, {
    "name" : "Narcolepsy, without cataplexy",
    "link" : null,
    "description" : "narcolepsy",
    "id" : null
  }, {
    "name" : "necrotizing enterocolitis",
    "link" : null,
    "description" : "perinatal necrotizing enterocolitis",
    "id" : null
  }, {
    "name" : "Necrotizing enterocolitis in fetus OR newborn",
    "link" : null,
    "description" : "perinatal necrotizing enterocolitis",
    "id" : null
  }, {
    "name" : "Necrotizing respiratory granulomatosis",
    "link" : null,
    "description" : "granulomatosis with polyangiitis",
    "id" : null
  }, {
    "name" : "neonatal and adult",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Neonatal Candida infection",
    "link" : null,
    "description" : "neonatal candidiasis",
    "id" : null
  }, {
    "name" : "Neonatal HIE",
    "link" : null,
    "description" : "Neonatal Hypoxic Ischemic Encephalopathy",
    "id" : null
  }, {
    "name" : "Neonatal monilia infection",
    "link" : null,
    "description" : "neonatal candidiasis",
    "id" : null
  }, {
    "name" : "neonatal moniliasis",
    "link" : null,
    "description" : "neonatal candidiasis",
    "id" : null
  }, {
    "name" : "nephrostomy tube",
    "link" : null,
    "description" : "Nephrostomy tube (physical object)",
    "id" : null
  }, {
    "name" : "nephrostomy tubes",
    "link" : null,
    "description" : "Nephrostomy tube (physical object)",
    "id" : null
  }, {
    "name" : "neuroborreliosis",
    "link" : null,
    "description" : "Lyme disease",
    "id" : null
  }, {
    "name" : "neurofibromatosis type 1 (nf1)",
    "link" : null,
    "description" : "neurofibromatosis 1",
    "id" : null
  }, {
    "name" : "neuroinvasive west nile virus (wnv)",
    "link" : null,
    "description" : "West Nile encephalitis",
    "id" : null
  }, {
    "name" : "Neurological Lyme disease",
    "link" : null,
    "description" : "Lyme disease",
    "id" : null
  }, {
    "name" : "neuromuscular condition",
    "link" : null,
    "description" : "neuromuscular disease",
    "id" : null
  }, {
    "name" : "neuromuscular diseases",
    "link" : null,
    "description" : "neuromuscular disease",
    "id" : null
  }, {
    "name" : "Newcastle's disease",
    "link" : null,
    "description" : "Newcastle disease",
    "id" : null
  }, {
    "name" : "NIDDM",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "no disease",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "non-insulin-dependent diabetes mellitus",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "Non-seasonal Allergic Rhinitis",
    "link" : null,
    "description" : "Perennial Allergic Rhinitis",
    "id" : null
  }, {
    "name" : "non-syndromic ichthyosis",
    "link" : null,
    "description" : "ichthyosis",
    "id" : null
  }, {
    "name" : "nonsmall cell adenocarcinoma",
    "link" : null,
    "description" : "lung adenocarcinoma",
    "id" : null
  }, {
    "name" : "normal donors",
    "link" : null,
    "description" : "healthy",
    "id" : null
  }, {
    "name" : "Normal Karyotype Acute Myeloid Leukemia",
    "link" : null,
    "description" : "Cytogenetically Normal Acute Myeloid Leukemia",
    "id" : null
  }, {
    "name" : "Not Applicable",
    "link" : null,
    "description" : "Not Applicable",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : null,
    "description" : "Not Specified",
    "id" : null
  }, {
    "name" : "Obstructive Uropathy",
    "link" : null,
    "description" : "urinary tract obstruction",
    "id" : null
  }, {
    "name" : "Oesophageal atresia",
    "link" : null,
    "description" : "esophageal atresia",
    "id" : null
  }, {
    "name" : "older people",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "older subjects",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "optic glioma",
    "link" : null,
    "description" : "optic nerve glioma",
    "id" : null
  }, {
    "name" : "Ordinary smallpox",
    "link" : null,
    "description" : "smallpox",
    "id" : null
  }, {
    "name" : "osteoarthrosis",
    "link" : null,
    "description" : "osteoarthritis",
    "id" : null
  }, {
    "name" : "Osteoarthrosis and allied disorder",
    "link" : null,
    "description" : "osteoarthritis",
    "id" : null
  }, {
    "name" : "P. coatneyi",
    "link" : null,
    "description" : "malaria",
    "id" : null
  }, {
    "name" : "P. cynomolgi",
    "link" : null,
    "description" : "malaria",
    "id" : null
  }, {
    "name" : "P450scc DEFICIENCY",
    "link" : null,
    "description" : "congenital adrenal insufficiency",
    "id" : null
  }, {
    "name" : "palmoplantar pustulosis",
    "link" : null,
    "description" : "pustulosis of palm and sole",
    "id" : null
  }, {
    "name" : "pancreas grafting",
    "link" : null,
    "description" : "Pancreas Transplantation",
    "id" : null
  }, {
    "name" : "pancreatic carcinoma",
    "link" : null,
    "description" : "pancreatic cancer",
    "id" : null
  }, {
    "name" : "paralysis agitans",
    "link" : null,
    "description" : "Parkinson's disease",
    "id" : null
  }, {
    "name" : "Paraplegia, lower",
    "link" : null,
    "description" : "paraplegia",
    "id" : null
  }, {
    "name" : "Parkinson disease",
    "link" : null,
    "description" : "Parkinson's disease",
    "id" : null
  }, {
    "name" : "paroxysmal sleep",
    "link" : null,
    "description" : "narcolepsy",
    "id" : null
  }, {
    "name" : "partial bowel resection with ostomy",
    "link" : null,
    "description" : "Partial Small Intestine Resection",
    "id" : null
  }, {
    "name" : "partial excision of small intestine",
    "link" : null,
    "description" : "Partial Small Intestine Resection",
    "id" : null
  }, {
    "name" : "pauciarticular juvenile arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "Pauciarticular onset juvenile chronic arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "peanut allergic reaction",
    "link" : null,
    "description" : "peanut allergy",
    "id" : null
  }, {
    "name" : "peanut-allergic",
    "link" : null,
    "description" : "peanut allergy",
    "id" : null
  }, {
    "name" : "Pediatric Crohn's disease",
    "link" : null,
    "description" : "Crohn's disease",
    "id" : null
  }, {
    "name" : "pediatric heart transplantation",
    "link" : null,
    "description" : "Heart Transplantation",
    "id" : null
  }, {
    "name" : "pediatric lung transplantation",
    "link" : null,
    "description" : "Lung Transplantation",
    "id" : null
  }, {
    "name" : "pediatric organ donors in the first two years of life, as compared to adult organ donors",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "pediatric renal transplantation",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "Perenial allergic rhinitis",
    "link" : null,
    "description" : "allergic rhinitis",
    "id" : null
  }, {
    "name" : "Perinatal necrotising enterocolitis",
    "link" : null,
    "description" : "perinatal necrotizing enterocolitis",
    "id" : null
  }, {
    "name" : "pernicious anaemia",
    "link" : null,
    "description" : "pernicious anemia",
    "id" : null
  }, {
    "name" : "Persistent sore throat",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "pervasive development disorder",
    "link" : null,
    "description" : "pervasive developmental disorder",
    "id" : null
  }, {
    "name" : "pH1N1",
    "link" : null,
    "description" : "swine influenza",
    "id" : null
  }, {
    "name" : "Pharyngeal disorder",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "Pharyngitis - acute",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "pituitary disease",
    "link" : null,
    "description" : "pituitary gland disease",
    "id" : null
  }, {
    "name" : "Plasmodium falciparum (Pf) malaria",
    "link" : null,
    "description" : "Plasmodium falciparum malaria",
    "id" : null
  }, {
    "name" : "pneumococcus",
    "link" : null,
    "description" : "Streptococcus pneumonia",
    "id" : null
  }, {
    "name" : "pollenosis",
    "link" : null,
    "description" : "allergic rhinitis",
    "id" : null
  }, {
    "name" : "Polymyositis with skin involvement",
    "link" : null,
    "description" : "dermatomyositis",
    "id" : null
  }, {
    "name" : "poorly controlled hypertension",
    "link" : null,
    "description" : "Hypertension not adequately controlled",
    "id" : null
  }, {
    "name" : "Post-infectious polyneuritis",
    "link" : null,
    "description" : "Guillain-Barre syndrome",
    "id" : null
  }, {
    "name" : "post-traumatic stress synmptoms (ptss)",
    "link" : null,
    "description" : "post-traumatic stress disorder",
    "id" : null
  }, {
    "name" : "Postinfectious polyneuritis",
    "link" : null,
    "description" : "Guillain-Barre syndrome",
    "id" : null
  }, {
    "name" : "Postinfective encephalitis",
    "link" : null,
    "description" : "postinfectious encephalitis",
    "id" : null
  }, {
    "name" : "Postnatal infantile hemiplegia",
    "link" : null,
    "description" : "hemiplegia",
    "id" : null
  }, {
    "name" : "postpartum coagulation defect",
    "link" : null,
    "description" : "blood coagulation disease",
    "id" : null
  }, {
    "name" : "postpartum coagulation defect with delivery",
    "link" : null,
    "description" : "blood coagulation disease",
    "id" : null
  }, {
    "name" : "pre-eclamptic toxaemia",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "Pre-Term",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "Pre-term birth",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "preeclampsia",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "preeclampsia/eclampsia",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "pregnancy associated hypertension",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "pregnancy toxemia",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "pregnant",
    "link" : null,
    "description" : "Pregnancy",
    "id" : null
  }, {
    "name" : "Premature delivery",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "Preterm",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "Preterm Delivery",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "preterm infant",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "preterm pregnancy",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "Previously",
    "link" : null,
    "description" : "Previous",
    "id" : null
  }, {
    "name" : "primary adrenocortical insufficiency",
    "link" : null,
    "description" : "Addison's disease",
    "id" : null
  }, {
    "name" : "primary biliary cirrhosis",
    "link" : null,
    "description" : "primary biliary cholangitis",
    "id" : null
  }, {
    "name" : "primary breast cancer",
    "link" : null,
    "description" : "breast cancer",
    "id" : null
  }, {
    "name" : "primary cancer",
    "link" : null,
    "description" : "cancer",
    "id" : null
  }, {
    "name" : "primary glioblastoma multiforme",
    "link" : null,
    "description" : "glioblastoma",
    "id" : null
  }, {
    "name" : "primary hypoadrenalism",
    "link" : null,
    "description" : "Addison's disease",
    "id" : null
  }, {
    "name" : "Primary Sjogren's syndrome",
    "link" : null,
    "description" : "Primary Sjogren Syndrome",
    "id" : null
  }, {
    "name" : "Primary Sjögren Syndrome",
    "link" : null,
    "description" : "Primary Sjogren Syndrome",
    "id" : null
  }, {
    "name" : "primary thrombocytopenic purpura",
    "link" : null,
    "description" : "autoimmune thrombocytopenic purpura",
    "id" : null
  }, {
    "name" : "progressive systemic sclerosis",
    "link" : null,
    "description" : "systemic scleroderma",
    "id" : null
  }, {
    "name" : "proteinuric hypertension of pregnancy",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "Pseudo-fowlpest",
    "link" : null,
    "description" : "Newcastle disease",
    "id" : null
  }, {
    "name" : "Pseudomembranous colitis",
    "link" : null,
    "description" : "Clostridium difficile colitis",
    "id" : null
  }, {
    "name" : "Pseudomembranous enterocolitis in newborn",
    "link" : null,
    "description" : "perinatal necrotizing enterocolitis",
    "id" : null
  }, {
    "name" : "Psoriais",
    "link" : null,
    "description" : "psoriasis",
    "id" : null
  }, {
    "name" : "psoriais, atopic dermatitis",
    "link" : null,
    "description" : "psoriasis",
    "id" : null
  }, {
    "name" : "psoriatic arthrits",
    "link" : null,
    "description" : "psoriatic arthritis",
    "id" : null
  }, {
    "name" : "psychological condition",
    "link" : null,
    "description" : "Psychiatric Disorder",
    "id" : null
  }, {
    "name" : "psychological/psychiatric condition",
    "link" : null,
    "description" : "Psychiatric Disorder",
    "id" : null
  }, {
    "name" : "Pustular psoriasis of the palms and/or soles",
    "link" : null,
    "description" : "pustulosis of palm and sole",
    "id" : null
  }, {
    "name" : "Raynaud's disease",
    "link" : null,
    "description" : "Raynaud disease",
    "id" : null
  }, {
    "name" : "Raynaud's syndrome",
    "link" : null,
    "description" : "Raynaud disease",
    "id" : null
  }, {
    "name" : "recurrent urinary tract infection",
    "link" : null,
    "description" : "Recurrent urinary tract infections",
    "id" : null
  }, {
    "name" : "recurrent uti",
    "link" : null,
    "description" : "Recurrent urinary tract infections",
    "id" : null
  }, {
    "name" : "recurrent wheezy bronchitis",
    "link" : null,
    "description" : "bronchitis",
    "id" : null
  }, {
    "name" : "renal (kidney) transplant",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "renal cortical necrosis",
    "link" : null,
    "description" : "kidney cortex necrosis",
    "id" : null
  }, {
    "name" : "renal Cyst",
    "link" : null,
    "description" : "cystic kidney disease",
    "id" : null
  }, {
    "name" : "renal failure",
    "link" : null,
    "description" : "kidney failure",
    "id" : null
  }, {
    "name" : "renal transplant",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "renal transplantation",
    "link" : null,
    "description" : "Kidney Transplantation",
    "id" : null
  }, {
    "name" : "renal tubulo-interstitial disease",
    "link" : null,
    "description" : "interstitial nephritis",
    "id" : null
  }, {
    "name" : "rheumatic carditis",
    "link" : null,
    "description" : "rheumatic heart disease",
    "id" : null
  }, {
    "name" : "rheumatiod arthitis",
    "link" : null,
    "description" : "rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "rheumatoid arthritis (ra)",
    "link" : null,
    "description" : "rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "rsv",
    "link" : null,
    "description" : "respiratory syncytial virus infectious disease",
    "id" : null
  }, {
    "name" : "S. pneumoniae",
    "link" : null,
    "description" : "Streptococcus pneumonia",
    "id" : null
  }, {
    "name" : "Salmonella infection",
    "link" : null,
    "description" : "salmonellosis",
    "id" : null
  }, {
    "name" : "SARS-CoV-2 infection",
    "link" : null,
    "description" : "COVID-19",
    "id" : null
  }, {
    "name" : "Scleroderma",
    "link" : null,
    "description" : "systemic scleroderma",
    "id" : null
  }, {
    "name" : "Scleroderma syndrome",
    "link" : null,
    "description" : "systemic scleroderma",
    "id" : null
  }, {
    "name" : "Scleroderma, circumscribed or localised",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "Scleroderma, circumscribed or localized",
    "link" : null,
    "description" : "localized scleroderma",
    "id" : null
  }, {
    "name" : "seasonal allergic rhinitis",
    "link" : null,
    "description" : "allergic rhinitis",
    "id" : null
  }, {
    "name" : "secondary encephalitis",
    "link" : null,
    "description" : "postinfectious encephalitis",
    "id" : null
  }, {
    "name" : "Self Tolerance",
    "link" : null,
    "description" : "Immunologic Tolerance",
    "id" : null
  }, {
    "name" : "Sexually Transmitted Disease",
    "link" : null,
    "description" : "Sexually Transmitted Disorder",
    "id" : null
  }, {
    "name" : "Sexually Transmitted Infection",
    "link" : null,
    "description" : "Sexually Transmitted Disorder",
    "id" : null
  }, {
    "name" : "Shingles",
    "link" : null,
    "description" : "herpes zoster",
    "id" : null
  }, {
    "name" : "shingles (herpes zoster)",
    "link" : null,
    "description" : "herpes zoster",
    "id" : null
  }, {
    "name" : "Sicca syndrome",
    "link" : null,
    "description" : "Sjogren's syndrome",
    "id" : null
  }, {
    "name" : "sjia",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "Sjogren syndrome",
    "link" : null,
    "description" : "Sjogren's syndrome",
    "id" : null
  }, {
    "name" : "SLE - Lupus Erythematosus, systemic",
    "link" : null,
    "description" : "systemic lupus erythematosus",
    "id" : null
  }, {
    "name" : "Solid Tumor",
    "link" : null,
    "description" : "Solid Neoplasm",
    "id" : null
  }, {
    "name" : "Solid tumor, NOS",
    "link" : null,
    "description" : "Solid Neoplasm",
    "id" : null
  }, {
    "name" : "Sore throat - chronic",
    "link" : null,
    "description" : "pharyngitis",
    "id" : null
  }, {
    "name" : "spongioblastoma multiforme",
    "link" : null,
    "description" : "glioblastoma",
    "id" : null
  }, {
    "name" : "spontaneous pre-term birth",
    "link" : null,
    "description" : "Preterm Birth",
    "id" : null
  }, {
    "name" : "Staphylococcus aureus",
    "link" : null,
    "description" : "Staphylococcus Aureus Infection",
    "id" : null
  }, {
    "name" : "STD",
    "link" : null,
    "description" : "Sexually Transmitted Disorder",
    "id" : null
  }, {
    "name" : "STI",
    "link" : null,
    "description" : "Sexually Transmitted Disorder",
    "id" : null
  }, {
    "name" : "Still's disease",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "Stone - kidney/ureter",
    "link" : null,
    "description" : "nephrolithiasis",
    "id" : null
  }, {
    "name" : "strep throat",
    "link" : null,
    "description" : "Streptococcal Pharyngitis",
    "id" : null
  }, {
    "name" : "stroke",
    "link" : null,
    "description" : "cerebrovascular disease",
    "id" : null
  }, {
    "name" : "substance use disorders",
    "link" : null,
    "description" : "substance-related disorder",
    "id" : null
  }, {
    "name" : "Sweet's syndrome",
    "link" : null,
    "description" : "Sweet syndrome",
    "id" : null
  }, {
    "name" : "Sylvatic yellow fever",
    "link" : null,
    "description" : "yellow fever",
    "id" : null
  }, {
    "name" : "systemic juvenile idiopathic arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "systemic juvenile rheumatoid arthritis",
    "link" : null,
    "description" : "juvenile rheumatoid arthritis",
    "id" : null
  }, {
    "name" : "Systemic Lupus",
    "link" : null,
    "description" : "systemic lupus erythematosus",
    "id" : null
  }, {
    "name" : "systemic lupus erythematosus (sle)",
    "link" : null,
    "description" : "systemic lupus erythematosus",
    "id" : null
  }, {
    "name" : "Systemic Sclerosis",
    "link" : null,
    "description" : "systemic scleroderma",
    "id" : null
  }, {
    "name" : "Systemic Sclerosis-Associated Pulmonary Arterial Hypertension",
    "link" : null,
    "description" : "hypertension",
    "id" : null
  }, {
    "name" : "T1DM",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "T2D",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "Throat infection - tonsillitis",
    "link" : null,
    "description" : "tonsillitis",
    "id" : null
  }, {
    "name" : "Thyroid deficiency",
    "link" : null,
    "description" : "hypothyroidism",
    "id" : null
  }, {
    "name" : "Thyroid insufficiency",
    "link" : null,
    "description" : "hypothyroidism",
    "id" : null
  }, {
    "name" : "Tolerance",
    "link" : null,
    "description" : "Immunologic Tolerance",
    "id" : null
  }, {
    "name" : "toxaemia of pregnancy",
    "link" : null,
    "description" : "pre-eclampsia",
    "id" : null
  }, {
    "name" : "tracheoesophageal fistula with or without esohageal atresia",
    "link" : null,
    "description" : "esophageal atresia/tracheoesophageal fistula",
    "id" : null
  }, {
    "name" : "Transfusion",
    "link" : null,
    "description" : "Blood Transfusion",
    "id" : null
  }, {
    "name" : "Transfusion of Blood Products",
    "link" : null,
    "description" : "Blood Transfusion",
    "id" : null
  }, {
    "name" : "Transplantation of Liver",
    "link" : null,
    "description" : "Liver Transplantation",
    "id" : null
  }, {
    "name" : "tumor of soft tissue and skeleton",
    "link" : null,
    "description" : "sarcoma",
    "id" : null
  }, {
    "name" : "Type 1 Diabetes",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "Type 1 Diabetic",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "type 2 diabetes",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "type I diabetes mellitus",
    "link" : null,
    "description" : "type 1 diabetes mellitus",
    "id" : null
  }, {
    "name" : "type II diabetes mellitus",
    "link" : null,
    "description" : "type 2 diabetes mellitus",
    "id" : null
  }, {
    "name" : "Typhoid",
    "link" : null,
    "description" : "typhoid fever",
    "id" : null
  }, {
    "name" : "urban yellow fever",
    "link" : null,
    "description" : "yellow fever",
    "id" : null
  }, {
    "name" : "urinary obstruction",
    "link" : null,
    "description" : "urinary tract obstruction",
    "id" : null
  }, {
    "name" : "vaccinia vaccine",
    "link" : null,
    "description" : "smallpox",
    "id" : null
  }, {
    "name" : "Varicella",
    "link" : null,
    "description" : "chickenpox",
    "id" : null
  }, {
    "name" : "varicella",
    "link" : null,
    "description" : "chickenpox",
    "id" : null
  }, {
    "name" : "varicella zoster",
    "link" : null,
    "description" : "chickenpox",
    "id" : null
  }, {
    "name" : "vascular hypertensive disorder",
    "link" : null,
    "description" : "hypertension",
    "id" : null
  }, {
    "name" : "VD",
    "link" : null,
    "description" : "Sexually Transmitted Disorder",
    "id" : null
  }, {
    "name" : "Venereal Disease",
    "link" : null,
    "description" : "Sexually Transmitted Disorder",
    "id" : null
  }, {
    "name" : "Vibrio cholerae",
    "link" : null,
    "description" : "cholera",
    "id" : null
  }, {
    "name" : "viral antigens (vaccinia",
    "link" : null,
    "description" : "smallpox",
    "id" : null
  }, {
    "name" : "Viral hepatitis C",
    "link" : null,
    "description" : "hepatitis C",
    "id" : null
  }, {
    "name" : "Viral hepatitis, type A",
    "link" : null,
    "description" : "hepatitis A",
    "id" : null
  }, {
    "name" : "Vivax Malaria",
    "link" : null,
    "description" : "Plasmodium vivax malaria",
    "id" : null
  }, {
    "name" : "WC - Whooping cough",
    "link" : null,
    "description" : "pertussis",
    "id" : null
  }, {
    "name" : "Weak heart",
    "link" : null,
    "description" : "congestive heart failure",
    "id" : null
  }, {
    "name" : "Wegener granulomatosis, formerly",
    "link" : null,
    "description" : "granulomatosis with polyangiitis",
    "id" : null
  }, {
    "name" : "Wegener's Granulomatosis",
    "link" : null,
    "description" : "granulomatosis with polyangiitis",
    "id" : null
  }, {
    "name" : "Weight Loss Surgery",
    "link" : null,
    "description" : "Bariatric Surgery",
    "id" : null
  }, {
    "name" : "West Nile encephalopathy",
    "link" : null,
    "description" : "West Nile encephalitis",
    "id" : null
  }, {
    "name" : "West Nile fever encephalitis",
    "link" : null,
    "description" : "West Nile encephalitis",
    "id" : null
  }, {
    "name" : "West Nile Fever with encephalitis",
    "link" : null,
    "description" : "West Nile encephalitis",
    "id" : null
  }, {
    "name" : "West Nile virus (WNv) infection",
    "link" : null,
    "description" : "West Nile fever",
    "id" : null
  }, {
    "name" : "West Nile virus (WNV)-infected",
    "link" : null,
    "description" : "West Nile fever",
    "id" : null
  }, {
    "name" : "West Nile Virus Infection",
    "link" : null,
    "description" : "West Nile fever",
    "id" : null
  }, {
    "name" : "whooping cough",
    "link" : null,
    "description" : "pertussis",
    "id" : null
  }, {
    "name" : "WNV disease",
    "link" : null,
    "description" : "West Nile fever",
    "id" : null
  }, {
    "name" : "WNv infection",
    "link" : null,
    "description" : "West Nile fever",
    "id" : null
  }, {
    "name" : "wnv infection",
    "link" : null,
    "description" : "West Nile fever",
    "id" : null
  }, {
    "name" : "Wuhan coronavirus infection",
    "link" : null,
    "description" : "COVID-19",
    "id" : null
  }, {
    "name" : "Wuhan seafood market pneumonia virus infection",
    "link" : null,
    "description" : "COVID-19",
    "id" : null
  }, {
    "name" : "xerodermosteosis",
    "link" : null,
    "description" : "Sjogren's syndrome",
    "id" : null
  }, {
    "name" : "Yellow fever, sylvan",
    "link" : null,
    "description" : "yellow fever",
    "id" : null
  }, {
    "name" : "YFEV",
    "link" : null,
    "description" : "yellow fever",
    "id" : null
  }, {
    "name" : "young and aged",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "young and elderly",
    "link" : null,
    "description" : "Aging",
    "id" : null
  }, {
    "name" : "Zika virus disease",
    "link" : null,
    "description" : "Zika fever",
    "id" : null
  }, {
    "name" : "Zika virus infection",
    "link" : null,
    "description" : "Zika fever",
    "id" : null
  }, {
    "name" : "Zika virus(ZIKV) infection",
    "link" : null,
    "description" : "Zika fever",
    "id" : null
  }, {
    "name" : "zoster",
    "link" : null,
    "description" : "herpes zoster",
    "id" : null
  } ]
}, {
  "name" : "lk_study_file_type",
  "rows" : [ {
    "name" : "Adverse Events",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C41331",
    "description" : "Study file type is Adverse Events.",
    "id" : ""
  }, {
    "name" : "Assessment Results",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25217",
    "description" : "Study file type is Assessment Results.",
    "id" : ""
  }, {
    "name" : "Case Report Form",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C40988",
    "description" : "Study file type is Case Report Form.",
    "id" : ""
  }, {
    "name" : "Case Report Form Data",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C4684580",
    "description" : "Information collected from a subject and presented on a case report form. (NCI)",
    "id" : ""
  }, {
    "name" : "Checksum",
    "link" : "http://purl.obolibrary.org/obo/MI_1212",
    "description" : "A fixed-size datum calculated (by using a hash function) for a molecular sequence or structure, typically for purposes of error detection or indexing",
    "id" : ""
  }, {
    "name" : "Clinical Data",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C15783",
    "description" : "Data obtained through patient examination or treatment.",
    "id" : ""
  }, {
    "name" : "Concomitant Medications",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49568",
    "description" : "Study file type is Concomitant Medications.",
    "id" : ""
  }, {
    "name" : "Data Dictionary",
    "link" : "http://purl.obolibrary.org/obo/T4FS_0000073",
    "description" : "A collection of descriptions of the data objects or items in a data model.",
    "id" : ""
  }, {
    "name" : "Database cross-mapping",
    "link" : "http://edamontology.org/data_0954",
    "description" : "The cross-mapping is typically a table where each row is an accession number and each column is a database being cross-referenced. The cells give the accession number or identifier of the corresponding entry in a database. If a cell in the table is not filled then no mapping could be found for the database. Additional information might be given on version, date etc. A mapping of the accession numbers (or other database identifier) of entries between (typically) two biological or biomedical databases.",
    "id" : ""
  }, {
    "name" : "Demographics",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C16495",
    "description" : "Study file type is Demographics.",
    "id" : ""
  }, {
    "name" : "Epidemiological Data",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0811339",
    "description" : "Identify post disaster needs (e.g., ongoing disaster-related health care needs, collection of epidemiological data, assessment of cause of disaster, steps for prevention of reoccurrence)",
    "id" : ""
  }, {
    "name" : "Family Member",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0086282",
    "description" : "Any of the individuals who are descended from a common progenitor, related by marriage or other legal tie, or by a feeling of closeness. (NCI)",
    "id" : ""
  }, {
    "name" : "Interventions",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25218",
    "description" : "Study file type is Interventions.",
    "id" : ""
  }, {
    "name" : "JSON Summary Description",
    "link" : "https://www.cancer.gov/research/key-initiatives/covid-19/coronavirus-research-initiatives/serological-sciences-network",
    "description" : "SeroNet JSON Summary Description",
    "id" : ""
  }, {
    "name" : "Lab Test Results",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C36292",
    "description" : "Study file type is Lab Test Results (e.g. CBC, chemistry, cytokine).",
    "id" : ""
  }, {
    "name" : "Medical History Data",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C18772",
    "description" : "Study file type is Medical History Data",
    "id" : ""
  }, {
    "name" : "Patient Reported Outcome",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C2987124",
    "description" : "Information collected directly from a patient that typically includes subjective feelings regarding symptoms, functions in daily life, physical, mental, emotional, spiritual, and social well being, and satisfaction with his/her health care. (NCI)",
    "id" : ""
  }, {
    "name" : "Protocol Deviation Data",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C50996",
    "description" : "Study file type is Protocol Deviation Data",
    "id" : ""
  }, {
    "name" : "Screening Data",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48262",
    "description" : "Study file type is Screening Data",
    "id" : ""
  }, {
    "name" : "Software Script",
    "link" : "http://semanticscience.org/resource/SIO_000103",
    "description" : "A software script is software whose instructions can be executed using a software interpreter.",
    "id" : ""
  }, {
    "name" : "Study Data",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64486",
    "description" : "Data associated with a study, but not arranged or included in any specific grouping. This is the default setting for data linked to a study.",
    "id" : ""
  }, {
    "name" : "Study Medication",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C459",
    "description" : "Study file type is Study Medication.",
    "id" : ""
  }, {
    "name" : "Study Summary Description",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C71141",
    "description" : "An abstract of a document detailed description which represents its most significant information",
    "id" : ""
  }, {
    "name" : "Substance Use",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49615",
    "description" : "Study file type is Substance Use.",
    "id" : ""
  } ]
}, {
  "name" : "lk_subject_location",
  "rows" : [ {
    "name" : "Afghanistan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006882",
    "description" : "A landlocked country that is located approximately in the center of Asia. It is bordered by Pakistan in the south and east Iran in the west, Turkmenistan, Uzbekistan and Tajikistan in the north, and China in the far northeast. Afghanistan is administratively divided into thirty-four (34) provinces (welayats). Each province is then divided into many provincial districts, and each district normally covers a city or several townships.",
    "id" : ""
  }, {
    "name" : "Albania",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002953",
    "description" : "A country in South Eastern Europe. Albania is bordered by Greece to the south-east, Montenegro to the north, Kosovo to the northeast, and the Republic of Macedonia to the east. It has a coast on the Adriatic Sea to the west, and on the Ionian Sea to the southwest. From the Strait of Otranto, Albania is less than 100 km from Italy. Albania is divided into 12 administrative divisions called (Albanian: official qark/qarku, but often prefekture/prefektura Counties), 36 districts (Rrethe) and 351 municipalities (Bashkia) and communes (Komuna).",
    "id" : ""
  }, {
    "name" : "Algeria",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000563",
    "description" : "A country in North Africa. It is bordered by Tunisia in the northeast, Libya in the east, Niger in the southeast, Mali and Mauritania in the southwest, a few km of the Western Sahara in the west, Morocco in the northwest, and the Mediterranean Sea in the north. It divided into 48 provinces (wilayas), 553 districts (dairas) and 1,541 municipalities (communes, baladiyahs).",
    "id" : ""
  }, {
    "name" : "American Samoa",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003957",
    "description" : "An unincorporated territory of the United States located in the South Pacific Ocean, southeast of the sovereign State of Samoa.",
    "id" : ""
  }, {
    "name" : "Andorra",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002948",
    "description" : "A small landlocked country in western Europe, located in the eastern Pyrenees mountains and bordered by Spain (Catalonia) and France. Andorra consists of seven communities known as parishes (Catalan: parroquies, singular - parroquia). Until relatively recently, it had only six parishes; the seventh, Escaldes-Engordany, was created in 1978. Some parishes have a further territorial subdivision. Ordino, La Massana and Sant Julia de Loria are subdivided into quarts (quarters), while Canillo is subdivided into veinats (neighborhoods). Those mostly coincide with villages, which are found in all parishes.",
    "id" : ""
  }, {
    "name" : "Angola",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001095",
    "description" : "A country in south-central Africa bordering Namibia to the south, Democratic Republic of the Congo to the north, and Zambia to the east, and with a west coast along the Atlantic Ocean. The exclave province Cabinda has a border with the Republic of the Congo and the Democratic Republic of the Congo.",
    "id" : ""
  }, {
    "name" : "Antigua and Barbuda",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006883",
    "description" : "An island nation located on the eastern boundary of the Caribbean Sea with the Atlantic Ocean.",
    "id" : ""
  }, {
    "name" : "Argentina",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002928",
    "description" : "A South American country, constituted as a federation of twenty-three provinces and an autonomous city. It is bordered by Paraguay and Bolivia in the north, Brazil and Uruguay in the northeast, and Chile in the west and south. The country claims the British controlled territories of the Falkland Islands and South Georgia and the South Sandwich Islands. Argentina also claims 969,464 km2 of Antarctica, known as Argentine Antarctica, overlapping other claims made by Chile and the United Kingdom. Argentina is subdivided into twenty-three provinces (Spanish: provincias, singular provincia) and one federal district (Capital de la Republica or Capital de la Nacion, informally the Capital Federal). The federal district and the provinces have their own constitutions, but exist under a federal system. Provinces are then divided into departments (Spanish: departamentos, singular departamento), except for Buenos Aires Province, which is divided into partidos.",
    "id" : ""
  }, {
    "name" : "Armenia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004094",
    "description" : "A landlocked mountainous country in Eurasia between the Black Sea and the Caspian Sea in the Southern Caucasus. It borders Turkey to the west, Georgia to the north, Azerbaijan to the east, and Iran and the Nakhchivan exclave of Azerbaijan to the south. A transcontinental country at the juncture of Eastern Europe and Western Asia. A former republic of the Soviet Union. Armenia is divided into ten marzes (provinces, singular marz), with the city (kaghak) of Yerevan having special administrative status as the country's capital.",
    "id" : ""
  }, {
    "name" : "Australia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000463",
    "description" : "A country in the southern hemisphere comprising the mainland of the world's smallest continent, the major island of Tasmania, and a number of other islands in the Indian and Pacific Oceans. The neighbouring countries are Indonesia, East Timor, and Papua New Guinea to the north, the Solomon Islands, Vanuatu, and New Caledonia to the north-east, and New Zealand to the south-east. Australia has six states, two major mainland territories, and other minor territories.",
    "id" : ""
  }, {
    "name" : "Austria",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002942",
    "description" : "A landlocked country in Central Europe. It borders both Germany and the Czech Republic to the north, Slovakia and Hungary to the east, Slovenia and Italy to the south, and Switzerland and Liechtenstein to the west. The capital is the city of Vienna on the Danube River. Austria is divided into nine states (Bundeslander). These states are then divided into districts (Bezirke) and cities (Statutarstadte). Districts are subdivided into municipalities (Gemeinden). Cities have the competencies otherwise granted to both districts and municipalities.",
    "id" : ""
  }, {
    "name" : "Azerbaijan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004941",
    "description" : "A country in the he South Caucasus region of Eurasia, it is bounded by the Caspian Sea to the east, Russia to the north, Georgia to the northwest, Armenia to the west, and Iran to the south. The Azerbaijani exclave of Nakhchivan is bordered by Armenia to the north and east, Iran to the south and west, and Turkey to the northwest. Nagorno-Karabakh, along with 7 other districts in Azerbaijan's southwest, have been controlled by Armenia since the end of the Nagorno-Karabakh War in 1994. Azerbaijan is divided into 59 rayons 11 city districts (saharlar), and one autonomous republic (muxtar respublika).",
    "id" : ""
  }, {
    "name" : "Bahamas",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002733",
    "description" : "A country consisting of two thousand cays and seven hundred islands that form an archipelago. It is located in the Atlantic Ocean, southeast of Florida and the United States, north of Cuba, the island of Hispanola and the Caribbean, and northwest of the British overseas territory of the Turks and Caicos Islands. It is divided into 32 districts, plus New Providence, whose affairs are handled directly by the central government.",
    "id" : ""
  }, {
    "name" : "Bahrain",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005281",
    "description" : "A borderless island country in the Persian Gulf. Saudi Arabia lies to the west and is connected to Bahrain by the King Fahd Causeway, and Qatar is to the south across the Gulf of Bahrain. Bahrain is split into five governorates.",
    "id" : ""
  }, {
    "name" : "Bangladesh",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003750",
    "description" : "A country in South Asia. It is bordered by India on all sides except for a small border with Myanmar to the far southeast and by the Bay of Bengal to the south. Bangladesh is divided into six administrative divisions. Divisions are subdivided into districts (zila). There are 64 districts in Bangladesh, each further subdivided into upazila (subdistricts) or thana (\"police stations\").",
    "id" : ""
  }, {
    "name" : "Barbados",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001251",
    "description" : "Barbados",
    "id" : ""
  }, {
    "name" : "Belarus",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006886",
    "description" : "A landlocked country in Eastern Europe, that borders Russia to the north and east, Ukraine to the south, Poland to the west, and Lithuania and Latvia to the north. Its capital is Minsk. Belarus is divided into six voblasts, or provinces. Voblasts are further subdivided into raions (commonly translated as districts or regions). As of 2002, there are six voblasts, 118 raions, 102 towns and 108 urbanized settlements. Minsk is given a special status, due to the city serving as the national capital.",
    "id" : ""
  }, {
    "name" : "Belgium",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002938",
    "description" : "A country in northwest Europe. Belgium shares borders with France (620 km), Germany (167 km), Luxembourg (148 km) and the Netherlands (450 km). The Flemish Region (Flanders) and the Walloon Region (Wallonia) each comprise five provinces; the third region, Brussels-Capital Region, is not a province, nor does it contain any Together, these comprise 589 municipalities, which in general consist of several sub-municipalities (which were independent municipalities before the municipal merger operation mainly in 1977).",
    "id" : ""
  }, {
    "name" : "Belize",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002934",
    "description" : "A country in Central America. It is the only officially English speaking country in the region. Belize was a British colony for more than a century and was known as British Honduras until 1973. It became an independent nation within The Commonwealth in 1981. Belize is divided into 6 districts, which are further divided into 31 constituencies.",
    "id" : ""
  }, {
    "name" : "Benin",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000904",
    "description" : "A country in Western Africa. It borders Togo to the west, Nigeria to the east and Burkina Faso and Niger to the north; its short coastline to the south leads to the Bight of Benin. Its capital is Porto Novo, but the seat of government is Cotonou. Benin is divided into 12 departments and subdivided into 77 communes.",
    "id" : ""
  }, {
    "name" : "Bermuda",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001264",
    "description" : "A British overseas territory in the North Atlantic Ocean. Located off the east coast of the United States, it is situated around 1770 km NE of Miami, Florida and 1350 km S of Halifax, Nova Scotia. Comprised of approximately 138 islands.",
    "id" : ""
  }, {
    "name" : "Bhutan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003920",
    "description" : "A landlocked nation in South Asia. It is located amidst the eastern end of the Himalaya Mountains and is bordered to the south, east and west by India and to the north by Tibet. Bhutan is separated from Nepal by the Indian State of Sikkim. Bhutan is divided into four dzongdey (administrative zones). Each dzongdey is further divided into dzongkhag (districts). There are twenty dzongkhag in Bhutan. Large dzongkhags are further divided into subdistricts known as dungkhag. At the basic level, groups of villages form a constituency called gewog.",
    "id" : ""
  }, {
    "name" : "Bolivia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002511",
    "description" : "A landlocked country in central South America. It is bordered by Brazil on the north and east, Paraguay and Argentina on the south, and Chile and Peru on the west. Bolivia is divided into 9 departments (Spanish: departamentos). Each of the departments is subdivided into provinces (provincias), which are further subdivided into municipalities (municipios).",
    "id" : ""
  }, {
    "name" : "Borneo",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00025355",
    "description" : "Borneo",
    "id" : ""
  }, {
    "name" : "Bosnia and Herzegovina",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006887",
    "description" : "A country on the Balkan peninsula of Southern Europe. Bordered by Croatia to the north, west and south, Serbia to the east, and Montenegro to the south, Bosnia and Herzegovina is mostly landlocked, except for 26 km of the Adriatic Sea coastline. Bosnia and Herzegovina is now divided into three political regions of which one, the Brcko District is part of the other two, the Federacija Bosne i Hercegovine and the Republika Srpska. All three have an equal constitutional status on the whole territory of Bosnia and Herzegovina.",
    "id" : ""
  }, {
    "name" : "Botswana",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001097",
    "description" : "A landlocked nation in Southern Africa. It is bordered by South Africa to the south and southeast, Namibia to the west, Zambia to the north, and Zimbabwe to the northeast. Botswana is divided into nine districts, which are subdivided into a total twenty-eight subdistricts.",
    "id" : ""
  }, {
    "name" : "Brazil",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002828",
    "description" : "A country in South America. Bordered by the Atlantic Ocean and by Venezuela, Suriname, Guyana and the department of French Guiana to the north, Colombia to the northwest, Bolivia and Peru to the west, Argentina and Paraguay to the southwest, and Uruguay to the south. Federation of twenty-six states (estados) and one federal district (Distrito Federal). The states are subdivided into municipalities. For statistical purposes, the States are grouped into five main regions: North, Northeast, Central-West, Southeast and South.",
    "id" : ""
  }, {
    "name" : "Brunei Darussalam",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003901",
    "description" : "A country located on the north coast of the island of Borneo, in Southeast Asia. Apart from its coastline with the South China Sea it is completely surrounded by the State of Sarawak, Malaysia, and in fact it is separated into two parts by Limbang, which is part of Sarawak. Brunei is divided into four districts (daerah), the districts are subdivided into thirty-eight mukims, which are then divided into kampong (villages).",
    "id" : ""
  }, {
    "name" : "Bulgaria",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002950",
    "description" : "A country in Southeastern Europe, borders five other countries; Romania to the north (mostly along the Danube), Serbia and the Republic of Macedonia to the west, and Greece and Turkey to the south. The Black Sea defines the extent of the country to the east. Since 1999, it has consisted of twenty-eight provinces. The provinces subdivide into 264 municipalities.",
    "id" : ""
  }, {
    "name" : "Burkina Faso",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000905",
    "description" : "A landlocked nation in West Africa. It is surrounded by six countries: Mali to the north, Niger to the east, Benin to the south east, Togo and Ghana to the south, and Cote d'Ivoire to the south west. Burkina Faso is divided into thirteen regions, forty-five provinces, and 301 departments (communes).",
    "id" : ""
  }, {
    "name" : "Burundi",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001090",
    "description" : "A small country in the Great Lakes region of Africa. It is bordered by Rwanda on the north, Tanzania on the south and east, and the Democratic Republic of the Congo on the west. Although the country is landlocked, much of its western border is adjacent to Lake Tanganyika. Burundi is divided into 17 provinces, 117 communes, and 2,638 collines.",
    "id" : ""
  }, {
    "name" : "Cambodia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006888",
    "description" : "A country in Southeast Asia. The country borders Thailand to its west and northwest, Laos to its northeast, and Vietnam to its east and southeast. In the south it faces the Gulf of Thailand.",
    "id" : ""
  }, {
    "name" : "Cameroon",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001093",
    "description" : "A country of central and western Africa. It borders Nigeria to the west; Chad to the northeast; the Central African Republic to the east; and Equatorial Guinea, Gabon, and the Republic of the Congo to the south. Cameroon's coastline lies on the Bight of Bonny, part of the Gulf of Guinea and the Atlantic Ocean. The Republic of Cameroon is divided into ten provinces and 58 divisions or departments. The divisions are further sub-divided into sub-divisions (arrondissements) and districts.",
    "id" : ""
  }, {
    "name" : "Canada",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002560",
    "description" : "A country occupying most of northern North America, extending from the Atlantic Ocean in the east to the Pacific Ocean in the west and northward into the Arctic Ocean. Canada is a federation composed of ten provinces and three territories; in turn, these may be grouped into regions. Western Canada consists of British Columbia and the three Prairie provinces (Alberta, Saskatchewan, and Manitoba). Central Canada consists of Quebec and Ontario. Atlantic Canada consists of the three Maritime provinces (New Brunswick, Prince Edward Island, and Nova Scotia), along with Newfoundland and Labrador. Eastern Canada refers to Central Canada and Atlantic Canada together. Three territories (Yukon, Northwest Territories, and Nunavut) make up Northern Canada.",
    "id" : ""
  }, {
    "name" : "Cape Verde",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001227",
    "description" : "A republic located on an archipelago in the Macaronesia ecoregion of the North Atlantic Ocean, off the western coast of Africa. Cape Verde is divided into 22 municipalities (concelhos), and subdivided into 32 parishes (freguesias).",
    "id" : ""
  }, {
    "name" : "Central African Republic",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001089",
    "description" : "A landlocked country in Central Africa. It borders Chad in the north, Sudan in the east, the Republic of the Congo and the Democratic Republic of the Congo in the south, and Cameroon in the west. The Central African Republic is divided into 14 administrative prefectures (prefectures), along with 2 economic prefectures (prefectures economiques) and one autonomous commune. The prefectures are further divided into 71 sub-prefectures (sous-prefectures).",
    "id" : ""
  }, {
    "name" : "Chad",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000586",
    "description" : "A landlocked country in central Africa. It is bordered by Libya to the north, Sudan to the east, the Central African Republic to the south, Cameroon and Nigeria to the southwest, and Niger to the west. Chad is divided into 18 regions. The departments are divided into 200 sub-prefectures, which are in turn composed of 446 cantons. This is due to change.",
    "id" : ""
  }, {
    "name" : "Chile",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002825",
    "description" : "A country in South America occupying a long and narrow coastal strip wedged between the Andes mountains and the Pacific Ocean. The Pacific forms the country's entire western border, with Peru to the north, Bolivia to the northeast, Argentina to the east, and the Drake Passage at the country's southernmost tip. Chile claims 1,250,000 km2 of territory in Antarctica. Chile is divided into 15 regions. Every region is further divided into provinces. Finally each province is divided into communes. Each region is designated by a name and a Roman numeral, assigned from north to south. The only exception is the region housing the nation's capital, which is designated RM, that stands for Region Metropolitana (Metropolitan Region). Two new regions were created in 2006: Arica-Parinacota in the north, and Los Rios in the south. Both became operative in 2007-10.",
    "id" : ""
  }, {
    "name" : "China",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002845",
    "description" : "A large country in Northeast Asia. China borders 14 nations (counted clockwise from south): Vietnam, Laos, Burma, India, Bhutan, Nepal, Pakistan, Afghanistan, Tajikistan, Kyrgyzstan, Kazakhstan, Russia, Mongolia and North Korea. Additionally the border between PRC and ROC is located in territorial waters. The People's Republic of China has administrative control over twenty-two provinces and considers Taiwan to be its twenty-third province. There are also five autonomous regions, each with a designated minority group; four municipalities; and two Special Administrative Regions that enjoy considerable autonomy. The People's Republic of China administers 33 province-level regions, 333 prefecture-level regions, 2,862 county-level regions, 41,636 township-level regions, and several village-level regions.",
    "id" : ""
  }, {
    "name" : "Colombia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002929",
    "description" : "A country located in the northwestern region of South America. Colombia is bordered to the east by Venezuela and Brazil; to the south by Ecuador and Peru; to the North by the Atlantic Ocean, through the Caribbean Sea; to the north-west by Panama; and to the west by the Pacific Ocean. Besides the countries in South America, the Republic of Colombia is recognized to share maritime borders with the Caribbean countries of Jamaica, Haiti, the Dominican Republic and the Central American countries of Honduras, Nicaragua, and Costa Rica. Colombia is divided into 32 departments and one capital district which is treated as a department. There are in total 10 districts assigned to cities in Colombia including Bogota, Barranquilla, Cartagena, Santa Marta, Tunja, Cucuta, Popayan, Buenaventura, Tumaco and Turbo. Colombia is also subdivided into some municipalities which form departments, each with a municipal seat capital city assigned. Colombia is also subdivided into corregimientos which form municipalities.",
    "id" : ""
  }, {
    "name" : "Comoros",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005820",
    "description" : "An island nation in the Indian Ocean, located off the eastern coast of Africa on the northern end of the Mozambique Channel between northern Madagascar and northeastern Mozambique.",
    "id" : ""
  }, {
    "name" : "Cook Islands",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00053798",
    "description" : "A self-governing parliamentary democracy in free association with New Zealand. The fifteen small islands in this South Pacific Ocean country have a total land area of 240 km2, but the Cook Islands Exclusive Economic Zone (EEZ) covers 1.8 million km2 of ocean.",
    "id" : ""
  }, {
    "name" : "Costa Rica",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002901",
    "description" : "A republic in Central America, bordered by Nicaragua to the north, Panama to the east-southeast, the Pacific Ocean to the west and south, and the Caribbean Sea to the east. Costa Rica is composed of seven provinces, which in turn are divided into 81 cantons.",
    "id" : ""
  }, {
    "name" : "Croatia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002719",
    "description" : "A country at the crossroads of the Mediterranean, Central Europe, and the Balkans. Its capital is Zagreb. Croatia borders with Slovenia and Hungary to the north, Serbia to the northeast, Bosnia and Herzegovina to the east, Montenegro to the far southeast, and the Adriatic Sea to the south. Croatia is divided into 21 counties (zupanija) and the capital Zagreb's city district.",
    "id" : ""
  }, {
    "name" : "Cuba",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003762",
    "description" : "A country that consists of the island of Cuba (the largest and second-most populous island of the Greater Antilles), Isla de la Juventud and several adjacent small islands. Fourteen provinces and one special municipality (the Isla de la Juventud) now compose Cuba.",
    "id" : ""
  }, {
    "name" : "Curacao",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00012582",
    "description" : "One of five island areas of the Netherlands Antilles.",
    "id" : ""
  }, {
    "name" : "Czech Republic",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002954",
    "description" : "A landlocked country in Central Europe. It has borders with Poland to the north, Germany to the northwest and southwest, Austria to the south, and Slovakia to the east. The capital and largest city is Prague. The country is composed of the historic regions of Bohemia and Moravia, as well as parts of Silesia. Since 2000, the Czech Republic is divided into thirteen regions (kraje, singular kraj) and the capital city of Prague. The older seventy-six districts (okresy, singular okres) including three 'statutory cities' (without Prague, which had special status) were disbanded in 1999 in an administrative reform; they remain as territorial division and seats of various branches of state administration. Since 2003-01-01, the regions have been divided into around 203 Municipalities with Extended Competence (unofficially named \"Little Districts\" (Czech: 'male okresy') which took over most of the administration of the former District Authorities. Some of these are further divided into Municipalities with Commissioned Local Authority. However, the old districts still exist as territorial units and remain as seats of some of the offices.",
    "id" : ""
  }, {
    "name" : "Democratic Republic of the Congo",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001086",
    "description" : "A country of central Africa. It borders the Central African Republic and Sudan on the north, Uganda, Rwanda, and Burundi on the east, Zambia and Angola on the south, the Republic of the Congo on the west, and is separated from Tanzania by Lake Tanganyika on the east. The country enjoys access to the ocean through a 40 km stretch of Atlantic coastline at Muanda and the roughly 9 km wide mouth of the Congo river which opens into the Gulf of Guinea. Congo Kinshasa is now divided into 11 Provinces, to be redistributed into 25 Provinces from 2.2009. Each Province is divided into Zones.",
    "id" : ""
  }, {
    "name" : "Denmark",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002635",
    "description" : "A nation situated in Scandinavia in northern Europe (Metropolitan Denmark) plus its two autonomous provinces, Greenland and The Faroe Islands. Denmark is divided into five regions and a total of 98 municipalities, plus two autonomous provinces.",
    "id" : ""
  }, {
    "name" : "Djibouti",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000582",
    "description" : "A country in eastern Africa. Djibouti is bordered by Eritrea in the north, Ethiopia in the west and south, and Somalia in the southeast. The remainder of the border is formed by the Red Sea and the Gulf of Aden. On the other side of the Red Sea, on the Arabian Peninsula, 20 km from the coast of Djibouti, is Yemen. The capital of Djibouti is the city of Djibouti. Djibouti is divided into 5 regions and one city. It is further subdivided into 11 districts.",
    "id" : ""
  }, {
    "name" : "Dominica",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006890",
    "description" : "An island nation in the Caribbean Sea. Dominica is divided into ten parishes.",
    "id" : ""
  }, {
    "name" : "Dominican Republic",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003952",
    "description" : "A country in the West Indies that occupies the E two-thirds of the Hispaniola island. The Dominican Republic's shores are washed by the Atlantic Ocean to the north and the Caribbean Sea to the south. The Mona Passage, a channel about 130 km wide, separates the country (and the Hispaniola) from Puerto Rico. The Dominican Republic is divided into 31 provinces. Additionally, the national capital, Santo Domingo, is contained within its own Distrito Nacional (National District). The provinces are divided into municipalities (municipios; singular municipio).",
    "id" : ""
  }, {
    "name" : "Ecuador",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002912",
    "description" : "A country in South America, bordered by Colombia on the north, by Peru on the east and south, and by the Pacific Ocean to the west. The country also includes the Galapagos Islands (Archipelago de Colon) in the Pacific, about 965 km west of the mainland. Ecuador is divided into 24 provinces, divided into 199 cantons and subdivided into parishes (or parroquias).",
    "id" : ""
  }, {
    "name" : "Egypt",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003934",
    "description" : "A country in North Africa that includes the Sinai Peninsula, a land bridge to Asia. Egypt borders Libya to the west, Sudan to the south, and the Gaza Strip and Israel to the east. The northern coast borders the Mediterranean Sea and the island of Cyprus; the eastern coast borders the Red Sea. Egypt is divided into 26 governorates (in Arabic, called muhafazat, singular muhafazah). The governorates are further divided into regions (markazes).",
    "id" : ""
  }, {
    "name" : "El Salvador",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002935",
    "description" : "A country in Central America, bordering the Pacific Ocean between Guatemala and Honduras. El Salvador is divided into 14 departments (departamentos), which, in turn, are subdivided into 267 municipalities (municipios).",
    "id" : ""
  }, {
    "name" : "England",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002641",
    "description" : "The largest and most populous constituent country of the United Kingdom of Great Britain and Northern Ireland. The subdivisions of England consists of as many as four levels of subnational division and at some levels there are a variety of types of administrative entity. They have been created for the purposes of local government in England.",
    "id" : ""
  }, {
    "name" : "Equatorial Guinea",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001091",
    "description" : "A country in Central Africa. It is one of the smallest countries in continental Africa, and comprises two regions: Rio Muni, continental region including several offshore islands; and Insular Region containing Annobon island in the South Atlantic Ocean, and Bioko island (formerly Fernando Po) that contains the capital, Malabo. Equatorial Guinea is divided into seven provinces which are divided into districts.",
    "id" : ""
  }, {
    "name" : "Eritrea",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000581",
    "description" : "A country situated in northern East Africa. It is bordered by Sudan in the west, Ethiopia in the south, and Djibouti in the southeast. The east and northeast of the country have an extensive coastline on the Red Sea, directly across from Saudi Arabia and Yemen. The Dahlak Archipelago and several of the Hanish Islands are part of Eritrea. Eritrea is divided into six regions (zobas) and subdivided into districts (\"sub-zobas\").",
    "id" : ""
  }, {
    "name" : "Estonia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002959",
    "description" : "A country in Northern Europe. Estonia has land borders to the south with Latvia and to the east with Russia. It is separated from Finland in the north by the Gulf of Finland and from Sweden in the west by the Baltic Sea. Estonia is divided into 15 counties. (maakonnad; sing. - maakond). Estonian counties are divided into rural (vallad, singular vald) and urban (linnad, singular linn; alevid, singular alev; alevikud, singular alevik) municipalities. The municipalities comprise populated places (asula or asustusuksus) - various settlements and territorial units that have no administrative function. A group of populated places form a rural municipality with local administration. Most towns constitute separate urban municipalities, while some have joined with surrounding rural municipalities.",
    "id" : ""
  }, {
    "name" : "Ethiopia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000567",
    "description" : "A country situated in the Horn of Africa that has been landlocked since the independence of its northern neighbor Eritrea in 1993. Apart from Eritrea to the north, Ethiopia is bordered by Sudan to the west, Kenya to the south, Djibouti to the northeast, and Somalia to the east. Since 1996 Ethiopia has had a tiered government system consisting of a federal government overseeing ethnically-based regional states, zones, districts (woredas), and neighborhoods (kebele). It is divided into nine ethnically-based administrative states (kililoch, singular kilil) and subdivided into sixty-eight zones and two chartered cities (astedader akababiwoch, singular astedader akababi): Addis Ababa and Dire Dawa. It is further subdivided into 550 woredas and six special woredas.",
    "id" : ""
  }, {
    "name" : "Fiji",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006891",
    "description" : "An island nation in the South Pacific Ocean east of Vanuatu, west of Tonga and south of Tuvalu. The country occupies an archipelago of about 322 islands, of which 106 are permanently inhabited, and 522 islets. The two major islands, Viti Levu and Vanua Levu, account for 87% of the population.",
    "id" : ""
  }, {
    "name" : "Finland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002937",
    "description" : "A Nordic country situated in the Fennoscandian region of Northern Europe. It has borders with Sweden to the west, Russia to the east, and Norway to the north, while Estonia lies to its south across the Gulf of Finland. The capital city is Helsinki. Finland is divided into six administrative provinces (laani, plural laanit). These are divided into 20 regions (maakunt), 77 subregions (seutukunta) and then into municipalities (kunta).",
    "id" : ""
  }, {
    "name" : "Gabon",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001092",
    "description" : "A country in west central Africa sharing borders with Equatorial Guinea, Cameroon, Republic of the Congo and the Gulf of Guinea. The capital and largest city is Libreville. Gabon is divided into 9 provinces and further divided into 37 departments.",
    "id" : ""
  }, {
    "name" : "Gambia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000907",
    "description" : "A country in Western Africa. It is the smallest country on the African continental mainland and is bordered to the north, east, and south by Senegal, and has a small coast on the Atlantic Ocean in the west. Flowing through the centre of the country and discharging to the Atlantic Ocean is the Gambia River. The Gambia is divided into five divisions and one city (Banjul). The divisions are further subdivided into 37 districts.",
    "id" : ""
  }, {
    "name" : "Georgia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004942",
    "description" : "A Eurasian country in the Caucasus located at the east coast of the Black Sea. In the north, Georgia has a 723 km common border with Russia, specifically with the Northern Caucasus federal district. The following Russian republics/subdivisions: from west to east: border Georgia: Krasnodar Krai, Karachay-Cherkessia, Kabardino-Balkaria, North Ossetia-Alania, Ingushetia, Chechnya, Dagestan. Georgia also shares borders with Azerbaijan (322 km) to the south-east, Armenia (164 km) to the south, and Turkey (252 km) to the south-west. It is a transcontinental country, located at the juncture of Eastern Europe and Western Asia. Georgia is divided into 9 regions, 2 autonomous republics (avtonomiuri respublika), and 1 city (k'alak'i). The regions are further subdivided into 69 districts (raioni).",
    "id" : ""
  }, {
    "name" : "Germany",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002646",
    "description" : "A country in Central Europe. It is bordered to the north by the North Sea, Denmark, and the Baltic Sea; to the east by Poland and the Czech Republic; to the south by Austria and Switzerland; and to the west by France, Luxembourg, Belgium, and the Netherlands. Germany comprises 16 states (Lander, Bundeslander), which are further subdivided into 439 districts (Kreise/Landkreise) and cities (kreisfreie Stadte).",
    "id" : ""
  }, {
    "name" : "Ghana",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000908",
    "description" : "A country in West Africa. It borders Cote d'Ivoire to the west, Burkina Faso to the north, Togo to the east, and the Gulf of Guinea to the south. Ghana is a divided into 10 regions, subdivided into a total of 138 districts.",
    "id" : ""
  }, {
    "name" : "Greece",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002945",
    "description" : "A country in southeastern Europe, situated on the southern end of the Balkan Peninsula. It has borders with Albania, the former Yugoslav Republic of Macedonia and Bulgaria to the north, and Turkey to the east. The Aegean Sea lies to the east and south of mainland Greece, while the Ionian Sea lies to the west. Both parts of the Eastern Mediterranean basin feature a vast number of islands. Greece consists of thirteen peripheries subdivided into a total of fifty-one prefectures (nomoi, singular nomos). There is also one autonomous area, Mount Athos, which borders the periphery of Central Macedonia.",
    "id" : ""
  }, {
    "name" : "Greenland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001507",
    "description" : "A self-governing Danish province located between the Arctic and Atlantic Oceans, east of the Canadian Arctic Archipelago.",
    "id" : ""
  }, {
    "name" : "Grenada",
    "link" : "http://purl.obolibrary.org/obo/GAZ_02000573",
    "description" : "Grenada",
    "id" : ""
  }, {
    "name" : "Guam",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006933",
    "description" : "An island which is the southernmost island in the Mariana island chain and is the largest island in Micronesia.",
    "id" : ""
  }, {
    "name" : "Guatemala",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002936",
    "description" : "A country in Central America bordered by Mexico to the northwest, the Pacific Ocean to the southwest, Belize and the Caribbean Sea to the northeast, and Honduras and El Salvador to the southeast. Guatemala is divided into 22 departments (departamentos) and sub-divided into about 332 municipalities (municipios).",
    "id" : ""
  }, {
    "name" : "Guinea",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000909",
    "description" : "A nation in West Africa, formerly known as French Guinea. Guinea's territory has a curved shape, with its base at the Atlantic Ocean, inland to the east, and turning south. The base borders Guinea-Bissau and Senegal to the north, and Mali to the north and north-east; the inland part borders Cote d'Ivoire to the south-east, Liberia to the south, and Sierra Leone to the west of the southern tip.",
    "id" : ""
  }, {
    "name" : "Guinea-Bissau",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000910",
    "description" : "A country in western Africa, and one of the smallest nations in continental Africa. It is bordered by Senegal to the north, and Guinea to the south and east, with the Atlantic Ocean to its west. Formerly the Portuguese colony of Portuguese Guinea, upon independence, the name of its capital, Bissau, was added to the country's name in order to prevent confusion between itself and the Republic of Guinea.",
    "id" : ""
  }, {
    "name" : "Guyana",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002522",
    "description" : "A country in the N of South America. Guyana lies north of the equator, in the tropics, and is located on the Atlantic Ocean. Guyana is bordered to the east by Suriname, to the south and southwest by Brazil and to the west by Venezuela. Guyana is divided into 10 regions. The regions of Guyana are divided into 27 neighborhood councils.",
    "id" : ""
  }, {
    "name" : "Haiti",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003953",
    "description" : "A country located in the Greater Antilles archipelago on the Caribbean island of Hispaniola, which it shares with the Dominican Republic. Haiti is divided into 10 departments. The departments are further divided into 41 arrondissements, and 133 communes which serve as second and third level administrative divisions.",
    "id" : ""
  }, {
    "name" : "Honduras",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002894",
    "description" : "A republic in Central America. The country is bordered to the west by Guatemala, to the southwest by El Salvador, to the southeast by Nicaragua, to the south by the Pacific Ocean at the Gulf of Fonseca, and to the north by the Gulf of Honduras, a large inlet of the Caribbean Sea. Honduras is divided into 18 departments. The capital city is Tegucigalpa Central District of the department of Francisco Morazan.",
    "id" : ""
  }, {
    "name" : "Hungary",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002952",
    "description" : "A landlocked country in the Carpathian Basin of Central Europe, bordered by Austria, Slovakia, Ukraine, Romania, Serbia, Croatia, and Slovenia. Its capital is Budapest. Hungary is divided into 19 counties (megyek, singular: megye). In addition, the capital city (fovaros), Budapest, is independent of any county government. The counties are further subdivided into 173 subregions (kistersegek), and Budapest is comprised of its own subregion. Since 1996, the counties and City of Budapest have been grouped into 7 regions for statistical and development purposes. These seven regions constitute NUTS second-level units of Hungary.",
    "id" : ""
  }, {
    "name" : "Iceland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000843",
    "description" : "A country in northern Europe, comprising the island of Iceland and its outlying islands in the North Atlantic Ocean between the rest of Europe and Greenland.",
    "id" : ""
  }, {
    "name" : "India",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002839",
    "description" : "A country in South Asia. Bounded by the Indian Ocean on the south, the Arabian Sea on the west, and the Bay of Bengal on the east, India has a coastline of 7,517 km. It borders Pakistan to the west; China, Nepal, and Bhutan to the north-east; and Bangladesh and Burma to the east. India is in the vicinity of Sri Lanka, the Maldives, and Indonesia in the Indian Ocean. India is a federal republic of twenty-eight states and seven Union Territories. Each state or union territory is divided into basic units of government and administration called districts. There are nearly 600 districts in India. The districts in turn are further divided into tehsils and eventually into villages.",
    "id" : ""
  }, {
    "name" : "Indonesia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003727",
    "description" : "An archipelagic state in Southeast Asia. The country shares land borders with Papua New Guinea, East Timor and Malaysia. Other neighboring countries include Singapore, the Philippines, Australia, and the Indian territory of the Andaman and Nicobar Islands. Indonesia consists of 33 provinces, five of which have special status. The provinces are subdivided into regencies (kabupaten, distrik in Papua and West Papua Provinces) and cities (kota), which are further subdivided into subdistricts (kecamatan), and again into village groupings (either desa or kelurahan).",
    "id" : ""
  }, {
    "name" : "Iran",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004474",
    "description" : "A country in Central Eurasia. Iran is bounded by the Gulf of Oman and the Persian Gulf to the south and the Caspian Sea to its north. It borders Armenia, Azerbaijan, Turkmenistan to the north, Afghanistan and Pakistan to the east, and Turkey and Iraq to the west. Iran is divided into 30 provinces (ostan). The provinces are divided into counties (shahrestan), and subdivided into districts (bakhsh) and sub-districts (dehestan).",
    "id" : ""
  }, {
    "name" : "Iraq",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004483",
    "description" : "A country in the Middle East spanning most of the northwestern end of the Zagros mountain range, the eastern part of the Syrian Desert and the northern part of the Arabian Desert. It shares borders with Kuwait and Saudi Arabia to the south, Jordan to the west, Syria to the northwest, Turkey to the north, and Iran to the east. It has a very narrow section of coastline at Umm Qasr on the Persian Gulf. There are two major flowing rivers: the Tigris and the Euphrates. Iraq is divided into 18 governorates (or provinces) (muhafazah). The governorates are divided into qadhas (or districts).",
    "id" : ""
  }, {
    "name" : "Israel",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002476",
    "description" : "A country in Western Asia located on the eastern edge of the Mediterranean Sea. It borders Lebanon in the north, Syria in the northeast, Jordan in the east, and Egypt on the southwest. The West Bank and Gaza Strip, which are partially administrated by the Palestinian National Authority, are also adjacent. The State of Israel is divided into six main administrative districts, known as mehozot (singular mahoz). Districts are further divided into fifteen sub-districts known as nafot (singular: nafa), which are themselves partitioned into fifty natural regions.",
    "id" : ""
  }, {
    "name" : "Italy",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002650",
    "description" : "A country located on the Italian Peninsula in Southern Europe, and on the two largest islands in the Mediterranean Sea, Sicily and Sardinia. Italy shares its northern Alpine boundary with France, Switzerland, Austria and Slovenia. The independent states of San Marino and the Vatican City are enclaves within the Italian Peninsula, while Campione d'Italia is an Italian exclave in Switzerland. Italy is subdivided into 20 regions (regioni, singular regione). Five of these regions have a special autonomous status that enables them to enact legislation on some of their local matters. It is further divided into 109 provinces (province) and 8,101 municipalities (comuni).",
    "id" : ""
  }, {
    "name" : "Ivory Coast",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000906",
    "description" : "A country in West Africa. It borders Liberia and Guinea to the west, Mali and Burkina Faso to the north, Ghana to the east, and the Gulf of Guinea to the south. Cote d'Ivoire is divided into nineteen regions (regions). The regions are further divided into 58 departments.",
    "id" : ""
  }, {
    "name" : "Jamaica",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003781",
    "description" : "A nation of the Greater Antilles. Jamaica is divided into 14 parishes, which are grouped into three historic counties that have no administrative relevance.",
    "id" : ""
  }, {
    "name" : "Japan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002747",
    "description" : "An island country in East Asia. Located in the Pacific Ocean, it lies to the east of China, Korea and Russia, stretching from the Sea of Okhotsk in the north to the East China Sea in the south.",
    "id" : ""
  }, {
    "name" : "Java",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00024383",
    "description" : "An island of Indonesia and the site of its capital city, Jakarta. It lies between Sumatra to the northwest and Bali to the east. Borneo lies to the north and Christmas Island to the south. Java is almost entirely of volcanic origin; it contains no fewer than thirty-eight mountains forming an east-west spine which have at one time or another been active volcanoes.",
    "id" : ""
  }, {
    "name" : "Jordan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002473",
    "description" : "A country in Southwest Asia, bordered by Syria to the north, Iraq to the north-east, Israel and the West Bank to the west, and Saudi Arabia to the east and south. It shares the coastlines of the Dead Sea, and the Gulf of Aqaba with Israel, Saudi Arabia, and Egypt. Jordan is divided into 12 provinces called governorates. The Governorates are subdivided into approximately fifty-two nahias.",
    "id" : ""
  }, {
    "name" : "Kazakhstan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004999",
    "description" : "A country in Central Asia and Europe. It is bordered by Russia, Kyrgyzstan, Turkmenistan, Uzbekistan and China. The country also borders on a significant part of the Caspian Sea. Kazakhstan is divided into 14 provinces and two municipal districts. The provinces of Kazakhstan are divided into raions.",
    "id" : ""
  }, {
    "name" : "Kenya",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001101",
    "description" : "A country in Eastern Africa. It is bordered by Ethiopia to the north, Somalia to the east, Tanzania to the south, Uganda to the west, and Sudan to the northwest, with the Indian Ocean running along the southeast border. Kenya comprises eight provinces each headed by a Provincial Commissioner (centrally appointed by the president). The provinces (mkoa singular mikoa plural in Swahili) are subdivided into districts (wilaya). There were 69 districts as of 1999 census. Districts are then subdivided into 497 divisions (taarafa). The divisions are then subdivided into 2,427 locations (kata) and then 6,612 sublocations (kata ndogo). The City of Nairobi enjoys the status of a full administrative province.",
    "id" : ""
  }, {
    "name" : "Kiribati",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006894",
    "description" : "An island nation located in the central tropical Pacific Ocean. It is composed of 32 atolls and one raised coral island dispersed over 3,500,000 km2 straddling the equator and bordering the International Date Line to the east. It is divided into three island groups which have no administrative function, including a group which unites the Line Islands and the Phoenix Islands (ministry at London, Christmas). Each inhabited island has its own council (three councils on Tarawa: Betio, South-Tarawa, North-Tarawa; two councils on Tabiteuea).",
    "id" : ""
  }, {
    "name" : "Kosovo",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00011337",
    "description" : "A country on the Balkan Peninsula. Kosovo borders Central Serbia to the north and east, Montenegro to the northwest, Albania to the west and the Republic of Macedonia to the south. Kosovo is divided into 7 districts (Rreth) and 30 municipalities. Serbia does not recognise the unilateral secession of Kosovo[8] and considers it a United Nations-governed entity within its sovereign territory, the Autonomous Province of Kosovo and Metohija.",
    "id" : ""
  }, {
    "name" : "Kurdistan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002468",
    "description" : "An extensive plateau and mountainous area in the Middle East, inhabited mainly by Kurds. It covers large parts of eastern Turkey, northern Iraq, northwestern Iran and smaller parts of northern Syria and Armenia. It roughly includes Zagros and eastern Taurus mountain ranges.",
    "id" : ""
  }, {
    "name" : "Kuwait",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005285",
    "description" : "A sovereign emirate on the coast of the Persian Gulf, enclosed by Saudi Arabia to the south and Iraq to the north and west. Kuwait is divided into six governorates (muhafazat, singular muhafadhah).",
    "id" : ""
  }, {
    "name" : "Kyrgyzstan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006893",
    "description" : "A country in Central Asia. Landlocked and mountainous, it is bordered by Kazakhstan to the north, Uzbekistan to the west, Tajikistan to the southwest and China to the east. Kyrgyzstan is divided into seven provinces (oblast. The capital, Bishkek, and the second large city Osh are administratively the independent cities (shaar) with a status equal to a province. Each province comprises a number of districts (raions).",
    "id" : ""
  }, {
    "name" : "Laos",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006889",
    "description" : "A landlocked country in southeast Asia, bordered by Burma (Myanmar) and China to the northwest, Vietnam to the east, Cambodia to the south, and Thailand to the west. Laos is divided into sixteen provinces (qwang) and Vientiane Capital (Na Kone Luang Vientiane). The provinces further divided into districts (muang).",
    "id" : ""
  }, {
    "name" : "Latvia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002958",
    "description" : "A country in Northern Europe. Latvia shares land borders with Estonia to the north and Lithuania to the south, and both Russia and Belarus to the east. It is separated from Sweden in the west by the Baltic Sea. The capital of Latvia is Riga. Latvia is divided into 26 districts (raioni). There are also seven cities (lielpilsetas) that have a separate status. Latvia is also historically, culturally and constitutionally divided in four or more distinct regions.",
    "id" : ""
  }, {
    "name" : "Lebanon",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002478",
    "description" : "A small, mostly mountainous country in Western Asia, on the eastern shore of the Mediterranean Sea. It is bordered by Syria to the north and east, and Israel to the south. Lebanon is divided into six governorates (mohaafazaat, which are further subdivided into twenty-five districts (aqdya, singular: qadaa).",
    "id" : ""
  }, {
    "name" : "Lesotho",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001098",
    "description" : "A land-locked country, entirely surrounded by the Republic of South Africa. Lesotho is divided into ten districts; these are further subdivided into 80 constituencies, which consists of 129 local community councils.",
    "id" : ""
  }, {
    "name" : "Liberia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000911",
    "description" : "A country on the west coast of Africa, bordered by Sierra Leone, Guinea, Cote d'Ivoire, and the Atlantic Ocean.",
    "id" : ""
  }, {
    "name" : "Libya",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000566",
    "description" : "A country in North Africa. Bordering the Mediterranean Sea to the north, Libya lies between Egypt to the east, Sudan to the southeast, Chad and Niger to the south, and Algeria and Tunisia to the west. There are thirty-four municipalities of Libya, known by the Arabic term sha'biyat (singular sha'biyah). These came recently (in the 1990s to replaced old Baladiyat systam. The Baladiyat system in turn was introduced to replace the system of muhafazah (governorates or provinces) that existed from the 1960s to the 1970s.",
    "id" : ""
  }, {
    "name" : "Liechtenstein",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003858",
    "description" : "A tiny, doubly landlocked alpine country in Western Europe, bordered by Switzerland to its west and by Austria to its east. The principality of Liechtenstein is divided into 11 municipalities called Gemeinden (singular Gemeinde). The Gemeinden mostly consist only of a single town. Five of them fall within the electoral district Unterland (the lower county), and the remainder within Oberland (the upper county).",
    "id" : ""
  }, {
    "name" : "Lithuania",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002960",
    "description" : "A country located along the south-eastern shore of the Baltic Sea, sharing borders with Latvia to the north, Belarus to the southeast, Poland, and the Russian exclave of the Kaliningrad Oblast to the southwest. Lithuania has a three-tier administrative division: the country is divided into 10 counties (singular apskritis, plural, apskritys) that are further subdivided into 60 municipalities (singular savivaldybe, plural savivaldybes) which consist of over 500 elderates (singular seniunija, plural seniunijos).",
    "id" : ""
  }, {
    "name" : "Luxembourg",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002947",
    "description" : "A small landlocked country in western Europe, bordered by Belgium, France, and Germany. Luxembourg is divided into 3 districts, which are further divided into 12 cantons and then 116 communes. Twelve of the communes have city status, of which the city of Luxembourg is the largest.",
    "id" : ""
  }, {
    "name" : "Macedonia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006895",
    "description" : "A landlocked country on the Balkan peninsula in southeastern Europe. It is bordered by Serbia and Kosovo to the north, Albania to the west, Greece to the south, and Bulgaria to the east. In 2004-08, the Republic of Macedonia was reorganised into 85 municipalities (opstini; singular opstina), 10 of which comprise Greater Skopje. This is reduced from the previous 123 municipalities established in 1996-09. Prior to this, local government was organised into 34 administrative districts.",
    "id" : ""
  }, {
    "name" : "Malawi",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001105",
    "description" : "A country in southeastern Africa. It is bordered by Zambia to the north-west, Tanzania to the north and Mozambique, which surrounds it on the east, south and west. Malawi is divided into three regions (the Northern, Central and Southern regions), which are further divided into twenty-seven districts, which in turn are further divided into 137 traditional authorities and 68 sub-chiefdoms.",
    "id" : ""
  }, {
    "name" : "Malaysia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003902",
    "description" : "A country that consists of thirteen states and three federal territories in Southeast Asia. The country is separated into two regions, Peninsular Malaysia and Malaysian Borneo, by the South China Sea. Malaysia borders Thailand, Indonesia, Singapore, Brunei and the Philippines. Malaysia consists of 13 states (Negeri) and 3 federal territories.",
    "id" : ""
  }, {
    "name" : "Mali",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000584",
    "description" : "A landlocked country in northern Africa. It borders Algeria on the north, Niger on the east, Burkina Faso and the Cote d'Ivoire on the south, Guinea on the south-west, and Senegal and Mauritania on the west. Mali is divided into 8 regions (regions) and 1 district, and subdivided into 49 cercles, totalling 288 arrondissements.",
    "id" : ""
  }, {
    "name" : "Mauritania",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000583",
    "description" : "A country in North-West Africa. It is bordered by the Atlantic Ocean on the west, by Senegal on the southwest, by Mali on the east and southeast, by Algeria on the northeast, and by Western Sahara on the northwest (most of which is occupied by Morocco). The capital and largest city is Nouakchott, located on the Atlantic coast. Mauritania is divided into 12 regions (regions) and one capital district, which in turn are subdivided into 44 departments (departements).",
    "id" : ""
  }, {
    "name" : "Metropolitan Denmark",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005852",
    "description" : "That part of the Kingdom of Denmark located in continental Europe. The mainland is bordered to the south by Germany; Denmark is located to the southwest of Sweden and the south of Norway. Denmark borders both the Baltic and the North Sea. The country consists of a large peninsula, Jutland (Jylland) and a large number of islands, most notably Zealand (Sjaelland), Funen (Fyn), Vendsyssel-Thy, Lolland, Falster and Bornholm as well as hundreds of minor islands often referred to as the Danish Archipelago.",
    "id" : ""
  }, {
    "name" : "Metropolitan France",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003940",
    "description" : "A part of the country of France that extends from the Mediterranean Sea to the English Channel and the North Sea, and from the Rhine to the Atlantic Ocean. Metropolitan France is bordered by Belgium, Luxembourg, Germany, Switzerland, Italy, Monaco, Andorra, and Spain. Due to its overseas departments.",
    "id" : ""
  }, {
    "name" : "Metropolitan Norway",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005851",
    "description" : "That part of the Kingdom of Norway that occupies the W part of the Scandinavian Peninusula and adjoining islands. Metropolitan Norway is divided into nineteen first-level administrative regions known as fylker (\"counties\", singular fylke) and 430[19] second-level kommuner (\"municipalities\", singular kommune).",
    "id" : ""
  }, {
    "name" : "Metropolitan Portugal",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004126",
    "description" : "That part of the Portugese Republic that occupies the W part of the Iberian Peninsula, and immediately adjacent islands.",
    "id" : ""
  }, {
    "name" : "Metropolitan Spain",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003936",
    "description" : "That part of the Kingdom of Spain that occupies the Iberian Peninsula plus the Balaeric Islands. The Spanish mainland is bordered to the south and east almost entirely by the Mediterranean Sea (except for a small land boundary with Gibraltar); to the north by France, Andorra, and the Bay of Biscay; and to the west by the Atlantic Ocean and Portugal.",
    "id" : ""
  }, {
    "name" : "Mexico",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002852",
    "description" : "A federal constitutional republic in North America. It is bounded on the north by the United States; on the south and west by the North Pacific Ocean; on the southeast by Guatemala, Belize, and the Caribbean Sea; and on the east by the Gulf of Mexico. The United Mexican States comprise a federation of thirty-one states and a federal district, the capital Mexico City.",
    "id" : ""
  }, {
    "name" : "Moldova",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003897",
    "description" : "A landlocked country in Eastern Europe, located between Romania to the west and Ukraine to the north, east and south. Moldova is divided into thirty-two districts (raioane, singular raion); three municipalities (Balti, Chisinau, Tighina); and two autonomous regions (Gagauzia and Transnistria). The cities of Comrat and Tiraspol also have municipality status, however not as first-tier subdivisions of Moldova, but as parts of the regions of Gagauzia and Transnistria, respectively. The status of Transnistria is however under dispute. Although it is de jure part of Moldova and is recognized as such by the international community, Transnistria is not de facto under the control of the central government of Moldova. It is administered by an unrecognized breakaway authority under the name Pridnestrovian Moldovan Republic.",
    "id" : ""
  }, {
    "name" : "Monaco",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003857",
    "description" : "A small country that is completely bordered by France to the north, west, and south; to the east it is bordered by the Mediterranean Sea. It consists of a single municipality (commune) currently divided into 4 quartiers and 10 wards.",
    "id" : ""
  }, {
    "name" : "Mongolia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00008744",
    "description" : "A country in East-Central Asia. The landlocked country borders Russia to the north and China to the south. The capital and largest city is Ulan Bator. Mongolia is divided into 21 aimags (provinces), which are in turn divided into 315 sums (districts). The capital Ulan Bator is administrated separately as a khot (municipality) with provincial status.",
    "id" : ""
  }, {
    "name" : "Montenegro",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006898",
    "description" : "A country located in Southeastern Europe. It has a coast on the Adriatic Sea to the south and borders Croatia to the west, Bosnia and Herzegovina to the northwest, Serbia and its partially recognized breakaway southern province of Kosovo to the northeast and Albania to the southeast. Its capital and largest city is Podgorica. Montenegro is divided into twenty-one municipalities (opstina), and two urban municipalities, subdivisions of Podgorica municipality.",
    "id" : ""
  }, {
    "name" : "Montserrat",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003988",
    "description" : "A British overseas territory located in the Leeward Islands. Montserrat is divided into three parishes.",
    "id" : ""
  }, {
    "name" : "Morocco",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000565",
    "description" : "A country in North Africa. It has a coast on the Atlantic Ocean that reaches past the Strait of Gibraltar into the Mediterranean Sea. Morocco has international borders with Algeria to the east, Spain to the north (a water border through the Strait and land borders with two small Spanish autonomous cities, Ceuta and Melilla), and Mauritania to the south. Morocco is divided into 16 regions, and subdivided into 62 prefectures and provinces. Because of the conflict over Western Sahara, the status of both regions of \"Saguia el-Hamra\" and \"Rio de Oro\" is disputed.",
    "id" : ""
  }, {
    "name" : "Mozambique",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001100",
    "description" : "A country in southeastern Africa bordered by the Indian Ocean to the east, Tanzania to the north, Malawi and Zambia to the northwest, Zimbabwe to the west and Swaziland and South Africa to the southwest. Mozambique is divided into ten provinces (provincias) and one capital city (cidade capital) with provincial status. The provinces are subdivided into 129 districts (distritos). Districts are further divided in \"Postos Administrativos\" (Administrative Posts) and these in Localidades (Localities) the lowest geographical level of central state administration.",
    "id" : ""
  }, {
    "name" : "Myanmar",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006899",
    "description" : "A country in SE Asia that is bordered by China on the north, Laos on the east, Thailand on the southeast, Bangladesh on the west, and India on the northwest, with the Bay of Bengal to the southwest. Myanmar is divided into seven states and seven divisions. The administrative divisions are further subdivided into districts, which are further subdivided into townships, wards, and villages.",
    "id" : ""
  }, {
    "name" : "Namibia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001096",
    "description" : "A country in southern Africa on the Atlantic coast. It shares borders with Angola and Zambia to the north, Botswana to the east, and South Africa to the south. Namibia is divided into 13 regions and subdivided into 102 constituencies.",
    "id" : ""
  }, {
    "name" : "Nauru",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006900",
    "description" : "An island nation in the Micronesian South Pacific. The nearest neighbour is Banaba Island in the Republic of Kiribati, 300 km due east. Nauru is divided into fourteen administrative districts which are grouped into eight electoral constituencies.",
    "id" : ""
  }, {
    "name" : "Nepal",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004399",
    "description" : "A landlocked nation in South Asia. It is bordered by the Tibet Autonomous Region of the People's Republic of China to the northeast and India to the south and west; it is separated from Bhutan by the Indian State of Sikkim and from Bangladesh by a small strip of the Indian State of West Bengal, known as the \"Chicken's Neck\". The Himalaya mountain range runs across Nepal's north and western parts, and eight of the world's ten highest mountains, including the highest, Mount Everest are situated within its territory. Nepal is divided into 14 zones and 75 districts, grouped into 5 development regions.",
    "id" : ""
  }, {
    "name" : "Netherlands",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002946",
    "description" : "The European part of the Kingdom of the Netherlands. It is bordered by the North Sea to the north and west, Belgium to the south, and Germany to the east. The Netherlands is divided into twelve administrative regions, called provinces. All provinces of the Netherlands are divided into municipalities (gemeenten), together 443 (2007).",
    "id" : ""
  }, {
    "name" : "New Zealand",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000469",
    "description" : "A nation in the south-western Pacific Ocean comprising two large islands (the North Island and the South Island) and numerous smaller islands, most notably Stewart Island/Rakiura and the Chatham Islands.",
    "id" : ""
  }, {
    "name" : "Nicaragua",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002978",
    "description" : "A republic in Central America. It is also the least densely populated with a demographic similar in size to its smaller neighbors. The country is bordered by Honduras to the north and by Costa Rica to the south. The Pacific Ocean lies to the west of the country, while the Caribbean Sea lies to the east. For administrative purposes it is divided into 15 departments (departamentos) and two self-governing regions (autonomous communities) based on the Spanish model. The departments are then subdivided into 153 municipios (municipalities). The two autonomous regions are Region Autonoma del Atlantico Norte and Region Autonoma del Atlantico Sur, often referred to as RAAN and RAAS, respectively. Until they were granted autonomy in 1985 they formed the single department of Zelaya.",
    "id" : ""
  }, {
    "name" : "Niger",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000585",
    "description" : "A landlocked country in Western Africa, named after the Niger River. It borders Nigeria and Benin to the south, Burkina Faso and Mali to the west, Algeria and Libya to the north and Chad to the east. The capital city is Niamey. Niger is divided into 7 departments and one capital district. The departments are subdivided into 36 arrondissements and further subdivided into 129 communes.",
    "id" : ""
  }, {
    "name" : "Nigeria",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000912",
    "description" : "A federal constitutional republic comprising thirty-six states and one Federal Capital Territory. The country is located in West Africa and shares land borders with the Republic of Benin in the west, Chad and Cameroon in the east, and Niger in the north. Its coast lies on the Gulf of Guinea, part of the Atlantic Ocean, in the south. The capital city is Abuja. Nigeria is divided into thirty-six states and one Federal Capital Territory, which are further sub-divided into 774 Local Government Areas (LGAs).",
    "id" : ""
  }, {
    "name" : "Niue Fekai",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006902",
    "description" : "An island nation located in the South Pacific Ocean. Although self-governing, Niue is in free association with New Zealand, meaning that the Sovereign in Right of New Zealand is also Niue's head of state.",
    "id" : ""
  }, {
    "name" : "North America",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000458",
    "description" : "North America",
    "id" : ""
  }, {
    "name" : "North Korea",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002801",
    "description" : "A state in East Asia in the northern half of the Korean Peninsula, with its capital in the city of Pyongyang. To the south and separated by the Korean Demilitarized Zone is South Korea, with which it formed one nation until division following World War II. At its northern Amnok River border are China and, separated by the Tumen River in the extreme north-east, Russia.",
    "id" : ""
  }, {
    "name" : "Northern Ireland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002638",
    "description" : "One of the four countries of the United Kingdom. Situated in the north-east of the island of Ireland, it shares a border with the Republic of Ireland to the south and west.",
    "id" : ""
  }, {
    "name" : "Northern Mariana Islands",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003958",
    "description" : "A group of 15 islands about three-quarters of the way from Hawaii to the Philippines.",
    "id" : ""
  }, {
    "name" : "Norway",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002699",
    "description" : "A country and constitutional monarchy in Northern Europe that occupies the western portion of the Scandinavian Peninsula. It is bordered by Sweden, Finland, and Russia. The Kingdom of Norway also includes the Arctic island territories of Svalbard and Jan Mayen. Norwegian sovereignty over Svalbard is based upon the Svalbard Treaty, but that treaty does not apply to Jan Mayen. Bouvet Island in the South Atlantic Ocean and Peter I Island and Queen Maud Land in Antarctica are external dependencies, but those three entities do not form part of the kingdom.",
    "id" : ""
  }, {
    "name" : "Oman",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005283",
    "description" : "A country in southwest Asia, on the southeast coast of the Arabian Peninsula. It borders the United Arab Emirates on the northwest, Saudi Arabia on the west, and Yemen on the southwest. The coast is formed by the Arabian Sea on the south and east, and the Gulf of Oman on the northeast. The country also contains Madha, an exclave enclosed by the United Arab Emirates, and Musandam, an exclave also separated by Emirati territory. Oman is divided into four governorates (muhafazah) and five regions (mintaqat). The regions are subdivided into provinces (wilayat).",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "Other",
    "description" : "Other",
    "id" : ""
  }, {
    "name" : "Pakistan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005246",
    "description" : "A country in Middle East which lies on the Iranian Plateau and some parts of South Asia. It is located in the region where South Asia converges with Central Asia and the Middle East. It has a 1,046 km coastline along the Arabian Sea in the south, and is bordered by Afghanistan and Iran in the west, India in the east and China in the far northeast. Pakistan is subdivided into four provinces and two territories. In addition, the portion of Kashmir that is administered by the Pakistani government is divided into two separate administrative units. The provinces are divided into a total of 105 zillas (districts). A zilla is further subdivided into tehsils (roughly equivalent to counties). Tehsils may contain villages or municipalities. There are over five thousand local governments in Pakistan.",
    "id" : ""
  }, {
    "name" : "Palau",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006905",
    "description" : "A nation that consists of eight principal islands and more than 250 smaller ones lying roughly 500 miles southeast of the Philippines.",
    "id" : ""
  }, {
    "name" : "Palestinian Territories",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002475",
    "description" : "The territory under the administration of the Palestine National Authority, as established by the Oslo Accords. The PNA divides the Palestinian territories into 16 governorates.",
    "id" : ""
  }, {
    "name" : "Panama",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002892",
    "description" : "The southernmost country of Central America. Situated on an isthmus, some categorize it as a transcontinental nation connecting the north and south part of America. It borders Costa Rica to the north-west, Colombia to the south-east, the Caribbean Sea to the north and the Pacific Ocean to the south. Panama's major divisions are nine provinces and five indigenous territories (comarcas indigenas). The provincial borders have not changed since they were determined at independence in 1903. The provinces are divided into districts, which in turn are subdivided into sections called corregimientos. Configurations of the corregimientos are changed periodically to accommodate population changes as revealed in the census reports.",
    "id" : ""
  }, {
    "name" : "Papua New Guinea",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003922",
    "description" : "Papua New Guinea",
    "id" : ""
  }, {
    "name" : "Paraguay",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002933",
    "description" : "A landlocked country in South America. It lies on both banks of the Paraguay River, bordering Argentina to the south and southwest, Brazil to the east and northeast, and Bolivia to the northwest, and is located in the very heart of South America. Paraguay consists of seventeen departments and one capital district (distrito capital). Each department is divided into districts.",
    "id" : ""
  }, {
    "name" : "Peru",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002932",
    "description" : "A country in western South America. It is bordered on the north by Ecuador and Colombia, on the east by Brazil, on the southeast by Bolivia, on the south by Chile, and on the west by the Pacific Ocean. Peru is divided into 25 regions and the province of Lima. These regions are subdivided into provinces, which are composed of districts (provincias and distritos). There are 195 provinces and 1833 districts in Peru. The Lima Province, located in the central coast of the country, is unique in that it doesn't belong to any of the twenty-five regions. The city of Lima, which is the nation's capital, is located in this province. Callao is its own region, even though it only contains one province, the Constitutional Province of Callao.",
    "id" : ""
  }, {
    "name" : "Philippines",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004525",
    "description" : "An archipelagic nation located in Southeast Asia. The Philippine archipelago comprises 7,107 islands in the western Pacific Ocean, bordering countries such as Indonesia, Malaysia, Palau and the Republic of China, although it is the only Southeast Asian country to share no land borders with its neighbors. The Philippines is divided into three island groups: Luzon, Visayas, and Mindanao. These are divided into 17 regions, 81 provinces, 136 cities, 1,494 municipalities and 41,995 barangays.",
    "id" : ""
  }, {
    "name" : "Poland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002939",
    "description" : "A country in Central Europe. Poland is bordered by Germany to the west; the Czech Republic and Slovakia to the south; Ukraine, Belarus and Lithuania to the east; and the Baltic Sea and Kaliningrad Oblast, a Russian exclave, to the north. The administrative division of Poland since 1999 has been based on three levels of subdivision. The territory of Poland is divided into voivodeships (provinces); these are further divided into powiats (counties), and these in turn are divided into gminas (communes or municipalities). Major cities normally have the status of both gmina and powiat. Poland currently has 16 voivodeships, 379 powiats (including 65 cities with powiat status), and 2,478 gminas.",
    "id" : ""
  }, {
    "name" : "Puerto Rico",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002822",
    "description" : "An island in the Caribbean Sea.",
    "id" : ""
  }, {
    "name" : "Qatar",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005286",
    "description" : "An Arab emirate in Southwest Asia, occupying the small Qatar Peninsula on the northeasterly coast of the larger Arabian Peninsula. It is bordered by Saudi Arabia to the south; otherwise the Persian Gulf surrounds the state. Qatar is divided into ten municipalities (Arabic: baladiyah), which are further divided into zones (districts).",
    "id" : ""
  }, {
    "name" : "Republic of Congo",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001088",
    "description" : "A country in Central Africa. It is bordered by Gabon, Cameroon, the Central African Republic, the Democratic Republic of the Congo, the Angolan exclave province of Cabinda, and the Gulf of Guinea. The Republic of the Congo is divided into 10 regions (regions) and one commune, the capital Brazzaville. The regions are subdivided into forty-six districts.",
    "id" : ""
  }, {
    "name" : "Republic of Ireland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002943",
    "description" : "A country in north-western Europe. The modern sovereign state occupies five-sixths of the island of Ireland, which was partitioned in 1921. It is bordered by Northern Ireland (part of the United Kingdom) to the north, by the Atlantic Ocean to the west and by the Irish Sea to the east. Administration follows the 34 \"county-level\" counties and cities of Ireland. Of these twenty-nine are counties, governed by county councils while the five cities of Dublin, Cork, Limerick, Galway and Waterford have city councils, (previously known as corporations), and are administered separately from the counties bearing those names. The City of Kilkenny is the only city in the republic which does not have a \"city council\"; it is still a borough but not a county borough and is administered as part of County Kilkenny. Ireland is split into eight regions for NUTS statistical purposes. These are not related to the four traditional provinces but are based on the administrative counties.",
    "id" : ""
  }, {
    "name" : "Romania",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002951",
    "description" : "A country in Southeastern Europe. It shares a border with Hungary and Serbia to the west, Ukraine and the Republic of Moldova to the northeast, and Bulgaria to the south. Romania has a stretch of sea coast along the Black Sea. It is located roughly in the lower basin of the Danube and almost all of the Danube Delta is located within its territory. Romania is divided into forty-one counties (judete), as well as the municipality of Bucharest (Bucuresti) - which is its own administrative unit. The country is further subdivided into 319 cities and 2686 communes (rural localities).",
    "id" : ""
  }, {
    "name" : "Russia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002721",
    "description" : "A transcontinental country extending over much of northern Eurasia. Russia shares land borders with the following countries (counter-clockwise from northwest to southeast): Norway, Finland, Estonia, Latvia, Lithuania (Kaliningrad Oblast), Poland (Kaliningrad Oblast), Belarus, Ukraine, Georgia, Azerbaijan, Kazakhstan, China, Mongolia and North Korea. The Russian Federation comprises 83 federal subjectsm 46 oblasts(provinces), 21 republics, 9 krais (territories), 4 autonomous okrugs (autonomous districts), one autonomous oblast, and two federal cities. The federal subjects are grouped into seven federal districts. These subjects are divided into districts (raions), cities/towns and urban-type settlements, and, at level 4, selsovets (rural councils), towns and urban-type settlements under the jurisdiction of the district and city districts.",
    "id" : ""
  }, {
    "name" : "Rwanda",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001087",
    "description" : "A small landlocked country in the Great Lakes region of east-central Africa, bordered by Uganda, Burundi, the Democratic Republic of the Congo and Tanzania. Rwanda is divided into five provinces (intara) and subdivided into thirty districts (akarere). The districts are divided into sectors (imirenge).",
    "id" : ""
  }, {
    "name" : "Saint Kitts-Nevis",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006906",
    "description" : "A federal two-island nation in the West Indies. Located in the Leeward Islands. Saint Kitts and Nevis are geographically part of the Leeward Islands. To the north-northwest lie the islands of Saint Eustatius, Saba, Saint Barthelemy, and Saint-Martin/Sint Maarten. To the east and northeast are Antigua and Barbuda, and to the southeast is the small uninhabited island of Redonda, and the island of Montserrat. The federation of Saint Kitts and Nevis is divided into fourteen parishes: nine divisions on Saint Kitts and five on Nevis.",
    "id" : ""
  }, {
    "name" : "Saint Lucia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006909",
    "description" : "An island nation in the eastern Caribbean Sea on the boundary with the Atlantic Ocean.",
    "id" : ""
  }, {
    "name" : "Saint Vincent and the Grenadines",
    "link" : "http://purl.obolibrary.org/obo/GAZ_02000565",
    "description" : "An island nation in the Lesser Antilles chain of the Caribbean Sea.",
    "id" : ""
  }, {
    "name" : "Samoa",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006910",
    "description" : "A country governing the western part of the Samoan Islands archipelago in the South Pacific Ocean. Samoa is made up of eleven itumalo (political districts).",
    "id" : ""
  }, {
    "name" : "San Marino",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003102",
    "description" : "A country in the Apennine Mountains. It is a landlocked enclave, completely surrounded by Italy. San Marino is an enclave in Italy, on the border between the regioni of Emilia Romagna and Marche. Its topography is dominated by the Apennines mountain range. San Marino is divided into nine municipalities, known locally as Castelli (singular castello).",
    "id" : ""
  }, {
    "name" : "Sao Tome and Principe",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006927",
    "description" : "An island nation in the Gulf of Guinea, off the western equatorial coast of Africa. It consists of two islands: Sao Tome and Principe, located about 140 km apart and about 250 and 225 km respectively, off of the northwestern coast of Gabon. Both islands are part of an extinct volcanic mountain range. Sao Tome and Principe is divided into 2 provinces: Principe, Sao Tome. The provinces are further divided into seven districts, six on Sao Tome and one on Principe (with Principe having self-government since 1995-04-29).",
    "id" : ""
  }, {
    "name" : "Saudi Arabia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005279",
    "description" : "A country on the Arabian Peninsula. It is bordered by Jordan on the northwest, Iraq on the north and northeast, Kuwait, Qatar, Bahrain, and the United Arab Emirates on the east, Oman on the southeast, and Yemen on the south. The Persian Gulf lies to the northeast and the Red Sea to its west. Saudi Arabia is divided into 13 provinces or regions (manatiq; singular mintaqah). Each is then divided into Governorates.",
    "id" : ""
  }, {
    "name" : "Scotland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002639",
    "description" : "A country that is part of the United Kingdom. Occupying the northern third of the island of Great Britain, it shares a border with England to the south and is bounded by the North Sea to the east, the Atlantic Ocean to the north and west, and the North Channel and Irish Sea to the southwest. In addition to the mainland, Scotland includes over 790 islands including the Northern Isles and the Hebrides.",
    "id" : ""
  }, {
    "name" : "Senegal",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000913",
    "description" : "A country south of the Senegal River in western Africa. Senegal is bounded by the Atlantic Ocean to the west, Mauritania to the north, Mali to the east, and Guinea and Guinea-Bissau to the south. The Gambia lies almost entirely within Senegal, surrounded on the north, east and south; from its western coast Gambia's territory follows the Gambia River more than 300 km inland. Dakar is the capital city of Senegal, located on the Cape Verde Peninsula on the country's Atlantic coast. Senegal is subdivided into 11 regions and further subdivided into 34 Departements, 103 Arrondissements (neither of which have administrative function) and by Collectivites Locales.",
    "id" : ""
  }, {
    "name" : "Serbia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002957",
    "description" : "A landlocked country in Central and Southeastern Europe, covering the southern part of the Pannonian Plain and the central part of the Balkan Peninsula. It is bordered by Hungary to the north; Romania and Bulgaria to the east; Republic of Macedonia, Montenegro to the south; Croatia and Bosnia and Herzegovina to the west. The capital is Belgrade. Serbia is divided into 29 districts plus the City of Belgrade. The districts and the city of Belgrade are further divided into municipalities. Serbia has two autonomous provinces: Kosovo and Metohija in the south (5 districts, 30 municipalities), and Vojvodina in the north (7 districts, 46 municipalities).",
    "id" : ""
  }, {
    "name" : "Sierra Leone",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000914",
    "description" : "A country in West Africa. It is bordered by Guinea in the north and east, Liberia in the southeast, and the Atlantic Ocean in the southwest and west. The Republic of Sierra Leone is composed of 3 provinces and one area called the Western Area; the provinces are further divided into 12 districts. The Western Area is also divided into 2 districts.",
    "id" : ""
  }, {
    "name" : "Singapore",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003923",
    "description" : "An island nation located at the southern tip of the Malay Peninsula. It lies 137 km north of the Equator, south of the Malaysian State of Johor and north of Indonesia's Riau Islands. Singapore consists of 63 islands, including mainland Singapore. There are two man-made connections to Johor, Malaysia, Johor-Singapore Causeway in the north, and Tuas Second Link in the west. Since 2001-11-24, Singapore has had an administrative subdivision into 5 districts. It is also divided into five Regions, urban planning subdivisions with no administrative role.",
    "id" : ""
  }, {
    "name" : "Slovak Republic",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002956",
    "description" : "A landlocked country in Central Europe. The Slovak Republic borders the Czech Republic and Austria to the west, Poland to the north, Ukraine to the east and Hungary to the south. The largest city is its capital, Bratislava. Slovakia is subdivided into 8 kraje (singular - kraj, usually translated as regions. The kraje are subdivided into many okresy (singular okres, usually translated as districts). Slovakia currently has 79 districts.",
    "id" : ""
  }, {
    "name" : "Slovenia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002955",
    "description" : "A country in southern Central Europe bordering Italy to the west, the Adriatic Sea to the southwest, Croatia to the south and east, Hungary to the northeast, and Austria to the north. The capital of Slovenia is Ljubljana. As of 2005-05 Slovenia is divided into 12 statistical regions for legal and statistical purposes. Slovenia is divided into 210 local municipalities, eleven of which have urban status.",
    "id" : ""
  }, {
    "name" : "Solomon Islands",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005275",
    "description" : "A nation in Melanesia, east of Papua New Guinea, consisting of nearly one thousand islands. Together they cover a land mass of 28,400 km2. The capital is Honiara, located on the island of Guadalcanal.",
    "id" : ""
  }, {
    "name" : "Somalia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001104",
    "description" : "A country located in the Horn of Africa. It is bordered by Djibouti to the northwest, Kenya on its southwest, the Gulf of Aden with Yemen on its north, the Indian Ocean at its east, and Ethiopia to the west. Prior to the civil war, Somalia was divided into eighteen regions (gobollada, singular gobol), which were in turn subdivided into districts. On a de facto basis, northern Somalia is now divided up among the quasi-independent states of Puntland, Somaliland, Galmudug and Maakhir.",
    "id" : ""
  }, {
    "name" : "South Africa",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001094",
    "description" : "A country located at the southern tip of Africa. It borders the Atlantic and Indian oceans and Namibia, Botswana, Zimbabwe, Mozambique, Swaziland, and Lesotho, an independent enclave surrounded by South African territory. It is divided into nine provinces which are further subdivided into 52 districts: 6 metropolitan and 46 district municipalities. The 46 district municipalities are further subdivided into 231 local municipalities. The district municipalities also contain 20 district management areas (mostly game parks) that are directly governed by the district municipalities. The six metropolitan municipalities perform the functions of both district and local municipalities.",
    "id" : ""
  }, {
    "name" : "South Korea",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002802",
    "description" : "A republic in East Asia, occupying the southern half of the Korean Peninsula. South Korea is divided into 8 provinces (do), 1 special autonomous province (teukbyeol jachido), 6 metropolitan cities (gwangyeoksi), and 1 special city (teukbyeolsi). These are further subdivided into a variety of smaller entities, including cities (si), counties (gun), districts (gu), towns (eup), townships (myeon), neighborhoods (dong) and villages (ri).",
    "id" : ""
  }, {
    "name" : "South Sudan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00233439",
    "description" : "A state located in Africa with Juba as its capital city. It's bordered by Ethiopia to the east, Kenya, Uganda, and the Democratic Republic of the Congo to the south, and the Central African Republic to the west and Sudan to the North. Southern Sudan includes the vast swamp region of the Sudd formed by the White Nile, locally called the Bahr el Jebel.",
    "id" : ""
  }, {
    "name" : "Sri Lanka",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003924",
    "description" : "An island nation in South Asia, located about 31 km off the southern coast of India. Sri Lanka is divided into 9 provinces and 25 districts. Districts are divided into Divisional Secretariats.",
    "id" : ""
  }, {
    "name" : "Sudan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000560",
    "description" : "A country in North Africa. It is bordered by Egypt to the north, the Red Sea to the northeast, Eritrea and Ethiopia to the east, Kenya and Uganda to the southeast, Democratic Republic of the Congo and the Central African Republic to the southwest, Chad to the west and Libya to the northwest. Sudan is divided into twenty-six states (wilayat, singular wilayah) which in turn are subdivided into 133 districts.",
    "id" : ""
  }, {
    "name" : "Sumatra",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00024432",
    "description" : "An Indonesian island that runs approximately 1,790 km northwest - southeast, crossing the equator near the center. At its widest point the island spans 435 km. The interior of the island is dominated by two geographical regions: the Barisan Mountains in the west and swampy plains in the east. To the southeast is Java, separated by the Sunda Strait. To the north is the Malay Peninsula, separated by the Straits of Malacca. To the east is Borneo, across the Karimata Strait. West of the island is the Indian Ocean. The backbone of the island is the Barisan mountains chain, with the active volcano Mount Kerinci's 3,805 m the highest point, located at about the midpoint of the range. The volcanic activity of this region endowed the region with fertile land and beautiful sceneries, for instance around the Lake Toba. It also contains deposits of coal and gold.",
    "id" : ""
  }, {
    "name" : "Suriname",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002525",
    "description" : "A country in northern South America. It is situated between French Guiana to the east and Guyana to the west. The southern border is shared with Brazil and the northern border is the Atlantic coast. The southernmost border with French Guiana is disputed along the Marowijne river. Suriname is divided into 10 districts, each of which is divided into Ressorten.",
    "id" : ""
  }, {
    "name" : "Swaziland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001099",
    "description" : "A small, landlocked country in Africa embedded between South Africa in the west, north and south and Mozambique in the east. Swaziland is divided into four districts, each of which is divided into Tinkhundla (singular, Inkhundla).",
    "id" : ""
  }, {
    "name" : "Sweden",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002729",
    "description" : "A Nordic country on the Scandinavian Peninsula in Northern Europe. It has borders with Norway (west and north) and Finland (northeast). Sweden is a unitary state, currently divided into twenty-one counties (lan). Each county further divides into a number of municipalities or kommuner, with a total of 290 municipalities in 2004.",
    "id" : ""
  }, {
    "name" : "Switzerland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002941",
    "description" : "A federal republic in Europe. Switzerland is bordered by Germany, France, Italy, Austria and Liechtenstein. The Swiss Confederation consists of 26 cantons. The Cantons comprise a total of 2,889 municipalities. Within Switzerland there are two enclaves: Busingen belongs to Germany, Campione d'Italia belongs to Italy.",
    "id" : ""
  }, {
    "name" : "Syria",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002474",
    "description" : "A country in Southwest Asia, bordering Lebanon, the Mediterranean Sea and the island of Cyprus to the west, Israel to the southwest, Jordan to the south, Iraq to the east, and Turkey to the north. Syria has fourteen governorates, or muhafazat (singular: muhafazah). The governorates are divided into sixty districts, or manatiq (singular: mintaqah), which are further divided into sub-districts, or nawahi (singular: nahia).",
    "id" : ""
  }, {
    "name" : "Tahiti",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005328",
    "description" : "The largest island in the Windward group of the French Polynesia, located in the archipelago of Society Islands in the southern Pacific Ocean. Tahiti is some 45 km long at the widest point and covers 1,045 km2, with the highest elevation being at 2,241 m) above sea level (Mount Orohena). The island consists of two roughly round portions centered on volcanic mountains, connected by a short isthmus named after the small town of Taravao, which sits there. The northwestern part is known as Tahiti Nui (\"big Tahiti\"), and the southeastern part, much smaller, is known as Tahiti Iti (\"small Tahiti\") or Taiarapu.",
    "id" : ""
  }, {
    "name" : "Tajikistan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006912",
    "description" : "A mountainous landlocked country in Central Asia. Afghanistan borders to the south, Uzbekistan to the west, Kyrgyzstan to the north, and People's Republic of China to the east. Tajikistan consists of 4 administrative divisions. These are the provinces (viloyat) of Sughd and Khatlon, the autonomous province of Gorno-Badakhshan (abbreviated as GBAO), and the Region of Republican Subordination (RRP, Raiony Respublikanskogo Podchineniya in Russian; formerly known as Karotegin Province). Each region is divided into several districts (nohiya or raion).",
    "id" : ""
  }, {
    "name" : "Tanzania",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001103",
    "description" : "A country in East Africa bordered by Kenya and Uganda on the north, Rwanda, Burundi and the Democratic Republic of the Congo on the west, and Zambia, Malawi and Mozambique on the south. To the east it borders the Indian Ocean. Tanzania is divided into 26 regions (mkoa), twenty-one on the mainland and five on Zanzibar (three on Unguja, two on Pemba). Ninety-eight districts (wilaya), each with at least one council, have been created to further increase local authority; the councils are also known as local government authorities. Currently there are 114 councils operating in 99 districts; 22 are urban and 92 are rural. The 22 urban units are further classified as city councils (Dar es Salaam and Mwanza), municipal councils (Arusha, Dodoma, Iringa, Kilimanjaro, Mbeya, Morogoro, Shinyanga, Tabora, and Tanga) or town councils (the remaining eleven communities).",
    "id" : ""
  }, {
    "name" : "Tawain",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005341",
    "description" : "A state in East Asia with de facto rule of the island of Tawain and adjacent territory. The Republic of China currently administers two historical provinces of China (one completely and a small part of another one) and centrally administers two direct-controlled municipalities.",
    "id" : ""
  }, {
    "name" : "Thailand",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003744",
    "description" : "A country in Southeast Asia. To its east lie Laos and Cambodia; to its south, the Gulf of Thailand and Malaysia; and to its west, the Andaman Sea and Burma. Its capital and largest city is Bangkok. Thailand is divided into 75 provinces (changwat), which are gathered into 5 groups of provinces by location. There are also 2 special governed districts: the capital Bangkok (Krung Thep Maha Nakhon) and Pattaya, of which Bangkok is at provincial level and thus often counted as a 76th province.",
    "id" : ""
  }, {
    "name" : "Timor-Leste",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006913",
    "description" : "A country in Southeast Asia. It comprises the eastern half of the island of Timor, the nearby islands of Atauro and Jaco, and Oecussi-Ambeno, an exclave on the northwestern side of the island, within Indonesian West Timor. The small country of 15,410 km2 is located about 640 km northwest of Darwin, Australia. East Timor is divided into thirteen administrative districts, are subdivided into 65 subdistricts, 443 sucos and 2,336 towns, villages and hamlets.",
    "id" : ""
  }, {
    "name" : "Togo",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000915",
    "description" : "A country in West Africa bordering Ghana in the west, Benin in the east and Burkina Faso in the north. In the south, it has a short Gulf of Guinea coast, on which the capital Lome is located.",
    "id" : ""
  }, {
    "name" : "Tonga",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006916",
    "description" : "An island nation in the Pacific Ocean.",
    "id" : ""
  }, {
    "name" : "Trinidad and Tobago",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003767",
    "description" : "An archipelagic state in the southern Caribbean, lying northeast of the South American nation of Venezuela and south of Grenada in the Lesser Antilles. It also shares maritime boundaries with Barbados to the northeast and Guyana to the southeast. The country covers an area of 5,128 km2and consists of two main islands, Trinidad and Tobago, and 21 smaller islands.",
    "id" : ""
  }, {
    "name" : "Tunisia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000562",
    "description" : "A country situated on the Mediterranean coast of North Africa. It is bordered by Algeria to the west and Libya to the southeast. Tunisia is subdivided into 24 governorates, divided into 262 \"delegations\" or \"districts\" (mutamadiyat), and further subdivided into municipalities (shaykhats).",
    "id" : ""
  }, {
    "name" : "Turkey",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000558",
    "description" : "A Eurasian country that stretches across the Anatolian peninsula in western Asia and Thrace (Rumelia) in the Balkan region of southeastern Europe. Turkey borders eight countries: Bulgaria to the northwest; Greece to the west, Georgia to the northeast; Armenia, Azerbaijan (the exclave of Nakhichevan), and Iran to the east; and Iraq and Syria to the southeast. The Mediterranean Sea and Cyprus are to the south; the Aegean Sea and Archipelago are to the west; and the Black Sea is to the north. Separating Anatolia and Thrace are the Sea of Marmara and the Turkish Straits (the Bosporus and the Dardanelles), which are commonly reckoned to delineate the border between Asia and Europe, thereby making Turkey transcontinental. The territory of Turkey is subdivided into 81 provinces for administrative purposes. The provinces are organized into 7 regions for census purposes; however, they do not represent an administrative structure. Each province is divided into districts, for a total of 923 districts.",
    "id" : ""
  }, {
    "name" : "Turkmenistan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005018",
    "description" : "A country in Central Asia. It is bordered by Afghanistan to the southeast, Iran to the southwest, Uzbekistan to the northeast, Kazakhstan to the northwest, and the Caspian Sea to the west. It was a constituent republic of the Soviet Union, the Turkmen Soviet Socialist Republic. Turkmenistan is divided into five provinces or welayatlar (singular - welayat) and one independent city.",
    "id" : ""
  }, {
    "name" : "Tuvalu",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00009715",
    "description" : "A Polynesian island nation located in the Pacific Ocean midway between Hawaii and Australia.",
    "id" : ""
  }, {
    "name" : "U.S. Virgin Islands",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003959",
    "description" : "A group of islands in the Caribbean that are an insular area of the United States.",
    "id" : ""
  }, {
    "name" : "Uganda",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001102",
    "description" : "A landlocked country in East Africa, bordered on the east by Kenya, the north by Sudan, on the west by the Democratic Republic of the Congo, on the southwest by Rwanda, and on the south by Tanzania. The southern part of the country includes a substantial portion of Lake Victoria, within which it shares borders with Kenya and Tanzania. Uganda is divided into 80 districts, spread across four administrative regions: Northern, Eastern, Central and Western. The districts are subdivided into counties.",
    "id" : ""
  }, {
    "name" : "Ukraine",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002724",
    "description" : "A country in Eastern Europe. It borders Russia to the east, Belarus to the north, Poland, Slovakia and Hungary to the west, Romania and Moldova to the southwest, and the Black Sea and Sea of Azov to the south. Ukraine is subdivided into twenty-four oblasts (provinces) and one autonomous republic (avtonomna respublika), Crimea. Additionally, the cities of Kiev, the capital, and Sevastopol, both have a special legal status. The 24 oblasts and Crimea are subdivided into 490 raions (districts), or second-level administrative units.",
    "id" : ""
  }, {
    "name" : "United Arab Emirates",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005282",
    "description" : "A Middle Eastern federation of seven states situated in the southeast of the Arabian Peninsula in Southwest Asia on the Persian Gulf, bordering Oman and Saudi Arabia. The seven states, termed emirates, are Abu Dhabi, Ajman, Dubai, Fujairah, Ras al-Khaimah, Sharjah, and Umm al-Quwain.",
    "id" : ""
  }, {
    "name" : "United States of America",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002459",
    "description" : "A federal constitutional republic comprising fifty states and a federal district. The country is situated mostly in central North America, where its forty-eight contiguous states and Washington, DC, the capital district, lie between the Pacific and Atlantic Oceans, bordered by Canada to the north and Mexico to the south. The State of Alaska is in the northwest of the continent, with Canada to its east and Russia to the west across the Bering Strait, and the State of Hawaii is in the mid-Pacific. The United States also possesses several territories, or insular areas, that are scattered around the Caribbean and Pacific. The states are divided into smaller administrative regions, called counties in most states, exceptions being Alaska (parts of the state are organized into subdivisions called boroughs; the rest of the state's territory that is not included in any borough is divided into \"census areas\"), and Louisiana (which is divided into county-equivalents that are called parishes). There are also independent cities which are within particular states but not part of any particular county or consolidated city-counties. Another type of organization is where the city and county are unified and function as an independent city. There are thirty-nine independent cities in Virginia and other independent cities or city-counties are San Francisco, California, Baltimore, Maryland, St. Louis, Missouri, Denver, Colorado and Carson City, Nevada. Counties can include a number of cities, towns, villages, or hamlets, or sometimes just a part of a city. Counties have varying degrees of political and legal significance, but they are always administrative divisions of the state. Counties in many states are further subdivided into townships, which, by definition, are administrative divisions of a county. In some states, such as Michigan, a township can file a charter with the state government, making itself into a \"charter township\", which is a type of mixed municipal and township status (giving the township some of the rights of a city without all of the responsibilities), much in the way a metropolitan municipality is a mixed municipality and county.",
    "id" : ""
  }, {
    "name" : "Unknown",
    "link" : "https://ontobee.org/ontology/NCIT?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FNCIT_C17998",
    "description" : "Unknown location",
    "id" : ""
  }, {
    "name" : "Uruguay",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002930",
    "description" : "A country located in the southeastern part of South America. It is bordered by Brazil to the north, by Argentina across the bank of both the Uruguay River to the west and the estuary of Rio de la Plata to the southwest, and the South Atlantic Ocean to the southeast. Uraguay consists of 19 departments (departamentos, singular - departamento).",
    "id" : ""
  }, {
    "name" : "US: Alabama",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006881",
    "description" : "A state located in the southern region of the United States of America. It is bordered by Tennessee to the north, Georgia to the east, Florida and the Gulf of Mexico to the south, and Mississippi to the west.",
    "id" : ""
  }, {
    "name" : "US: Alaska",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002521",
    "description" : "A state in the United States of America, in the extreme northwest portion of the North American continent. The state is bordered by Yukon Territory and British Columbia, Canada to the east, the Gulf of Alaska and the Pacific Ocean to the south, the Bering Sea, Bering Strait, and Chukchi Sea to the west, and the Beaufort Sea and the Arctic Ocean.",
    "id" : ""
  }, {
    "name" : "US: Arizona",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002518",
    "description" : "A state located in the southwestern region of the United States. It borders New Mexico, Utah, Nevada, California, touches Colorado, and has a 626 km international border with the States of Sonora and Baja California in Mexico.",
    "id" : ""
  }, {
    "name" : "US: Arkansas",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004441",
    "description" : "A state located in the southern region of the United States. Arkansas shares a border with six states, with its eastern border largely defined by the Mississippi River. Arkansas shares its southern border with Louisiana, its northern border with Missouri, its eastern border with Tennessee and Mississippi, and its western border with Texas and Oklahoma.",
    "id" : ""
  }, {
    "name" : "US: California",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002461",
    "description" : "A state on the West Coast of the United States, along the Pacific Ocean. It is bordered by Oregon to the north, Nevada to the east, Arizona to the southeast, and to the south the Mexican state of Baja California.",
    "id" : ""
  }, {
    "name" : "US: Colorado",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006254",
    "description" : "A state located in the Rocky Mountain region of the United States of America.",
    "id" : ""
  }, {
    "name" : "US: Connecticut",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002591",
    "description" : "A state located in the New England region of the northeastern United States of America. The state borders New York to the west and south (Long Island by sea), Massachusetts to the north, and Rhode Island to the east. Portions of southwestern Connecticut are considered part of the New York metropolitan area.",
    "id" : ""
  }, {
    "name" : "US: Delaware",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002878",
    "description" : "A state located on the Atlantic Coast in the Mid-Atlantic region of the United States. Delaware is located in the eastern section of the Delmarva Peninsula, between Delaware Bay and Chesapeake Bay. Delaware is bounded to the north by Pennsylvania; to the east by the Delaware River, Delaware Bay, New Jersey and the Atlantic Ocean; and to the west and south by Maryland.",
    "id" : ""
  }, {
    "name" : "US: District of Columbia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003175",
    "description" : "The area which constitutes of, and is coextensive with, the city of Washington, the Capital of the United States. The District of Columbia is not a state.",
    "id" : ""
  }, {
    "name" : "US: Florida",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002888",
    "description" : "A state located in the southeastern region of the United States, bordering Alabama to the northwest and Georgia to the northeast. Much of the land mass of the state is a large peninsula with the Gulf of Mexico to the west and south, and the Atlantic Ocean to the east.",
    "id" : ""
  }, {
    "name" : "US: Georgia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002611",
    "description" : "Georgia is bordered on the south by Florida; on the east by the Atlantic Ocean and South Carolina; on the west by Alabama and by Florida in the extreme southwest; and on the north by Tennessee and North Carolina. The northern part of the state is in the Blue Ridge Mountains, a mountain range in the vast mountain system of the Appalachians. The central piedmont extends from the foothills to the fall line, where the rivers cascade down in elevation to the continental coastal plain of the southern part of the state.",
    "id" : ""
  }, {
    "name" : "US: Hawaii",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003939",
    "description" : "A state in the United States, located on an archipelago in the central Pacific Ocean southwest of the continental United States, southeast of Japan, and northeast of Australia.",
    "id" : ""
  }, {
    "name" : "US: Idaho",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006291",
    "description" : "A state in the Pacific Northwest region of the United States of America. Idaho borders six states and one Canadian province, but does not border the Pacific Ocean at any point and is not, as such, a coastal state. The states of Washington and Oregon are to the west, Nevada and Utah are to the south, and Montana and Wyoming are to the east. The province of British Columbia, to the north, also shares a small (77 km) border with Idaho.",
    "id" : ""
  }, {
    "name" : "US: Illinois",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003142",
    "description" : "A midwestern state of the United States of America. The Northeastern border of Illinois is Lake Michigan. Its eastern border with Indiana is all of the land west of the Wabash River, and a north-south line above Post Vincennes, or 87deg31min30secW. Its northern border with Wisconsin is fixed at 42deg30minN. Its western border with Missouri and Iowa is the Mississippi River. Its southern border with Kentucky is the Ohio River. Illinois also borders Michigan, but only via a water boundary in Lake Michigan.",
    "id" : ""
  }, {
    "name" : "US: Indiana",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004439",
    "description" : "A midwestern state of the United States of America. Indiana is bounded on the north by Lake Michigan and the state of Michigan; on the east by Ohio; on the south by Kentucky, with which it shares the Ohio River as a border; and on the west by Illinois. Indiana is one of the Great Lakes states.",
    "id" : ""
  }, {
    "name" : "US: Iowa",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004438",
    "description" : "A state located in the Midwestern region of the United States of America. Iowa is bordered by the Mississippi River on the east; the Missouri River and the Big Sioux River on the west; the northern boundary is a line along 43 degrees, 30 minutes north latitude. The southern border is the Des Moines River and a line along approximately 40 degrees 35 minutes north.",
    "id" : ""
  }, {
    "name" : "US: Kansas",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004435",
    "description" : "A state in the central region of the United States of America. Kansas is bordered by Nebraska on the north; Missouri on the east; Oklahoma on the south; and Colorado on the west.",
    "id" : ""
  }, {
    "name" : "US: Kentucky",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004440",
    "description" : "A state located in the East Central United States of America. Kentucky borders on seven states, from both the Midwest and the Southeast. West Virginia lies to the east, Virginia to the southeast, Tennessee to the south, Missouri to the west, Illinois and Indiana to the northwest, and Ohio to the north and northeast.",
    "id" : ""
  }, {
    "name" : "US: Louisiana",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004432",
    "description" : "A state located in the southern region of the United States of America. Louisiana is bordered to the west by the State of Texas; to the north by Arkansas; to the east by the State of Mississippi; and to the south by the Gulf of Mexico.",
    "id" : ""
  }, {
    "name" : "US: Maine",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002602",
    "description" : "A state in the New England region of the northeastern United States of America, bordering the Atlantic Ocean to the southeast, New Hampshire to the southwest, the Canadian provinces of Quebec to the northwest and New Brunswick to the northeast.",
    "id" : ""
  }, {
    "name" : "US: Maryland",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002519",
    "description" : "A state located in the Mid Atlantic region of the United States, bordering Virginia, West Virginia and the District of Columbia to the south and west, Pennsylvania to the north, and Delaware to the east.",
    "id" : ""
  }, {
    "name" : "US: Massachusetts",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002537",
    "description" : "A state located in the New England region of the northeastern United States. It borders Rhode Island and Connecticut to the south, New York to the west, and Vermont and New Hampshire to the north. To the east, it borders the Atlantic Ocean.",
    "id" : ""
  }, {
    "name" : "US: Michigan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003152",
    "description" : "A Midwestern state of the United States of America. Michigan consists of two peninsulas that lie between 82deg30minW to about 90deg30minW longitude, and are separated by the Straits of Mackinac. With the exception of two small areas that are drained by the Mississippi River by way of the Wisconsin River in the Upper Peninsula and by way of the Kankakee-Illinois River in the Lower Peninsula, Michigan is drained by the Great Lakes-Saint Lawrence watershed. The Great Lakes that border Michigan from east to west are Lake Erie, Lake Huron, Lake Michigan and Lake Superior. The state is bounded on the south by the states of Ohio and Indiana, sharing land and water boundaries with both.",
    "id" : ""
  }, {
    "name" : "US: Midwest",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0026081",
    "description" : "The geographic area of the midwestern region of the United States in general or when the specific state or states are not indicated. The states usually included in this region are Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, Ohio, Oklahoma, North Dakota, South Dakota and Wisconsin.",
    "id" : ""
  }, {
    "name" : "US: Minnesota",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002539",
    "description" : "A state in the Midwestern region of the United States. The state shares a Lake Superior water border with Michigan and Wisconsin on the northeast; the remainder of the eastern border is with Wisconsin. Iowa is to the south, North Dakota and South Dakota to the west, and the Canadian provinces of Ontario and Manitoba to the north.",
    "id" : ""
  }, {
    "name" : "US: Mississippi",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004430",
    "description" : "A state located in the Deep South of the United States. Jackson is the state capital and largest city. Mississippi is bordered on the north by Tennessee, on the east by Alabama, on the south by Louisiana and a narrow coast on the Gulf of Mexico, and on the west, across the Mississippi River, by Louisiana and Arkansas.",
    "id" : ""
  }, {
    "name" : "US: Missouri",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004431",
    "description" : "A state in the Midwest region of the United States. Missouri is bounded on the north by Iowa; on the east, across the Mississippi River, by Illinois, Kentucky, and Tennessee; on the south by Arkansas; and on the west by Oklahoma, Kansas, and Nebraska (the last across the Missouri River).",
    "id" : ""
  }, {
    "name" : "US: Montana",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002606",
    "description" : "A state in the Western United States. To the north, Montana and Canada share a 877 km border. The state borders the Canadian provinces of British Columbia, Alberta, and Saskatchewan. To the east, the state borders North Dakota and South Dakota. To the south is Wyoming and to the west and southwest is Idaho.",
    "id" : ""
  }, {
    "name" : "US: Nebraska",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005070",
    "description" : "A state located on the Great Plains of the Midwestern United States and Western United States.",
    "id" : ""
  }, {
    "name" : "US: Nevada",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004444",
    "description" : "A state located in the western region of the United States of America. Nevada is almost entirely within the Basin and Range Province, and is broken up by many north-south mountain ranges. Most of these ranges have endorheic valleys between them, which belies the image portrayed by the term Great Basin. The southern third of the state, where the Las Vegas area is situated, is within the Mojave Desert.",
    "id" : ""
  }, {
    "name" : "US: New Hampshire",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004428",
    "description" : "A state in the New England region of the northeastern United States of America. It borders Massachusetts to the south, Vermont to the west, Maine to the east, and the Canadian province of Quebec to the north.",
    "id" : ""
  }, {
    "name" : "US: New Jersey",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002557",
    "description" : "A state in the Mid-Atlantic and Northeastern regions of the United States. It is bordered on the north by New York, on the east by the Atlantic Ocean, on the southwest by Delaware, and on the west by Pennsylvania. New Jersey lies within the sprawling metropolitan areas of New York and Philadelphia.",
    "id" : ""
  }, {
    "name" : "US: New Mexico",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004427",
    "description" : "A state located in the southwestern region of the United States.",
    "id" : ""
  }, {
    "name" : "US: New York",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002514",
    "description" : "US: New York",
    "id" : ""
  }, {
    "name" : "US: North Carolina",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002520",
    "description" : "A state located on the Atlantic Seaboard in the southeastern United States. The state borders South Carolina and Georgia to the south, Tennessee to the west and Virginia to the north.",
    "id" : ""
  }, {
    "name" : "US: North Dakota",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004442",
    "description" : "A state located in the Midwestern and Western regions of the United States of America.",
    "id" : ""
  }, {
    "name" : "US: Northeast",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C2698501",
    "description" : "A census region of the United States consisting of Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, and Pennsylvania.",
    "id" : ""
  }, {
    "name" : "US: Ohio",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004421",
    "description" : "A Midwestern state of the United States. Ohio's southern border is defined by the Ohio River (with the border being at the 1793 low-water mark on the north side of the river), and much of the northern border is defined by Lake Erie. Ohio's neighbors are Pennsylvania to the east, Michigan to the northwest, Ontario Canada, to the north, Indiana to the west, Kentucky on the south, and West Virginia on the southeast.",
    "id" : ""
  }, {
    "name" : "US: Oklahoma",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002546",
    "description" : "A state located in the South Central region and Southern Region of the United States of America. It is bounded on the east by Arkansas and Missouri, on the north by Kansas, on the northwest by Colorado, on the far west by New Mexico, and on the south and near-west by Texas.",
    "id" : ""
  }, {
    "name" : "US: Oregon",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002515",
    "description" : "A state in the Pacific Northwest region of the United States. Oregon is located on the Pacific coast between Washington to the north, California to the south, Nevada on the southeast and Idaho to the east. The Columbia and Snake rivers delineate much of Oregon's northern and eastern boundaries respectively.",
    "id" : ""
  }, {
    "name" : "US: Pennsylvania",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002542",
    "description" : "A state located in the Northeastern and Middle Atlantic regions of the United States. The state borders Delaware and Maryland to the south, West Virginia to the southwest, Ohio to the west, New York and Canada to the north, and New Jersey to the east.",
    "id" : ""
  }, {
    "name" : "US: Rhode Island",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002531",
    "description" : "A state in the New England region of the United States. By land Rhode Island borders Connecticut to the west and Massachusetts to the north and east. Rhode Island also shares a water border with New York to the southwest.",
    "id" : ""
  }, {
    "name" : "US: South",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C2699497",
    "description" : "A census region of the United States consisting of Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Washington, D.C., Delaware, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas.",
    "id" : ""
  }, {
    "name" : "US: South Carolina",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002524",
    "description" : "A state in the southern region (Deep South) of the United States. It borders Georgia to the south and North Carolina to the north.",
    "id" : ""
  }, {
    "name" : "US: South Dakota",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004443",
    "description" : "A state located in the Midwestern region of the United States of America.",
    "id" : ""
  }, {
    "name" : "US: Tennessee",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004411",
    "description" : "A state located in the Southern United States. The capital city is Nashville, and the largest city is Memphis. Tennessee borders eight other states: Kentucky and Virginia to the north; North Carolina to the east; Georgia, Alabama and Mississippi on the south; Arkansas and Missouri on the Mississippi River to the west.",
    "id" : ""
  }, {
    "name" : "US: Texas",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002580",
    "description" : "A state located in the South Central United States. The Rio Grande, Red River and Sabine River form natural state borders, Oklahoma on the north, Louisiana and Arkansas on the east, and the Mexican states of Chihuahua, Coahuila, Nuevo Leon, and Tamaulipas to the south.",
    "id" : ""
  }, {
    "name" : "US: Utah",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004413",
    "description" : "A western state of the United States. Utah has three distinct geological regions: the Rocky Mountains, the Great Basin, and the Colorado Plateau.",
    "id" : ""
  }, {
    "name" : "US: Vermont",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004429",
    "description" : "A state in the New England region of the northeastern United States of America. It is bordered by Massachusetts to the south, New Hampshire to the east, New York to the west, and the Canadian province of Quebec to the north.",
    "id" : ""
  }, {
    "name" : "US: Virginia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003171",
    "description" : "A state on the Atlantic Coast of the Southern United States. Virginia is bordered by Maryland and the District of Columbia to the north and east; the Atlantic Ocean to the east; by North Carolina and Tennessee to the south; by Kentucky to the west and by West Virginia to the north and west. Due to a peculiarity of Virginia's original charter, its boundary with Maryland does not extend past the low-water mark of the southern shore of the Potomac River, so Maryland and the District of Columbia contain the whole width of the river rather than splitting it between them and Virginia. The southern border is defined as the 36deg30min parallel north.",
    "id" : ""
  }, {
    "name" : "US: Washington",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002553",
    "description" : "The Northwestern-most state of the contiguous United States. Its northern border lies mostly along the 49th parallel, and then via marine boundaries through the Strait of Georgia, Haro Strait and Strait of Juan de Fuca, with the Canadian province of British Columbia to the north. Washington borders Oregon to the south, with the Columbia River forming most of the boundary and the 46th parallel forming the eastern part of the southern boundary. To the east Washington borders Idaho, bounded mostly by the meridian running north from the confluence of the Snake River and Clearwater River, except for the southernmost section where the border follows the Snake River. To the west of Washington lies the Pacific Ocean.",
    "id" : ""
  }, {
    "name" : "US: West",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C2700270",
    "description" : "A census region of the United States consisting of Alaska, California, Hawaii, Oregon, Washington, Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, and Wyoming.",
    "id" : ""
  }, {
    "name" : "US: West Virginia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004414",
    "description" : "A state in the Appalachian, Upland South, and Mid-Atlantic regions of the United States, bordered by Virginia on the southeast, Kentucky on the southwest, Ohio on the northwest, and Pennsylvania and Maryland on the northeast. The capital and largest city is Charleston.",
    "id" : ""
  }, {
    "name" : "US: Wisconsin",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002586",
    "description" : "A State located in the north-central part of the United States. Wisconsin is bordered by the Montreal River; Lake Superior and Michigan to the north; by Lake Michigan to the east; by Illinois to the south; and by Iowa and Minnesota to the west. The state's boundaries include the Mississippi River and Saint Croix River in the west, and the Menominee River in the northeast Wisconsin's capital is Madison, and its largest city is Milwaukee.",
    "id" : ""
  }, {
    "name" : "US: Wyoming",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002533",
    "description" : "A state in the northwestern region of the United States. Wyoming is bordered on the north by Montana, on the east by South Dakota and Nebraska, on the south by Colorado, on the southwest by Utah, and on the west by Idaho.",
    "id" : ""
  }, {
    "name" : "Uzbekistan",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00004979",
    "description" : "A doubly landlocked country in Central Asia, formerly part of the Soviet Union. It shares borders with Kazakhstan to the west and to the north, Kyrgyzstan and Tajikistan to the east, and Afghanistan and Turkmenistan to the south. Uzbekistan is divided into twelve provinces (viloyatlar) one autonomous republic (respublika and one independent city (shahar).",
    "id" : ""
  }, {
    "name" : "Vanuatu",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00006918",
    "description" : "An island nation located in the South Pacific Ocean.",
    "id" : ""
  }, {
    "name" : "Vatican City",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003103",
    "description" : "A landlocked sovereign city-state whose territory consists of a walled enclave within the City of Rome. It includes extraterritorial buildings and property in Rome and elsewhere it Italy.",
    "id" : ""
  }, {
    "name" : "Venezuela",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002931",
    "description" : "A country on the northern coast of South America. The country comprises a continental mainland and numerous islands located off the Venezuelan coastline in the Caribbean Sea. The Bolivarian Republic of Venezuela possesses borders with Guyana to the east, Brazil to the south, and Colombia to the west. Trinidad and Tobago, Grenada, St. Lucia, Barbados, Curacao, Bonaire, Aruba, Saint Vincent and the Grenadines and the Leeward Antilles lie just north, off the Venezuelan coast. Venezuela is divided into twenty-three states (Estados), a capital district (distrito capital) corresponding to the city of Caracas, the Federal Dependencies (Dependencias Federales, a special territory), and Guayana Esequiba (claimed in a border dispute with Guyana). Venezuela is further subdivided into 335 municipalities (municipios); these are subdivided into over one thousand parishes (parroquias).",
    "id" : ""
  }, {
    "name" : "Vietnam",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00003756",
    "description" : "The easternmost country on the Indochina Peninsula in Southeast Asia. It borders the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.",
    "id" : ""
  }, {
    "name" : "Wales",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00002640",
    "description" : "One of the four constituent countries of the United Kingdom of Great Britain and Northern Ireland. It is located in the south-west of the island of Great Britain and is bordered by England to the east, the Bristol Channel (Mor Hafren) to the south and the Irish Sea (Mor Iwerddon) to the west and north, and also by the estuary of the River Dee (Afon Dyfrdwy) in the north-east. Wales is divided into 22 unitary authorities. There are nine counties, three cities, and ten county boroughs, although all have equal powers. Collectively these are known as the principal areas of Wales. They came into being on 1996-04-01.",
    "id" : ""
  }, {
    "name" : "Western Sahara",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00000564",
    "description" : "A territory of northwestern Africa, bordered by Morocco to the north, Algeria in the northeast, Mauritania to the east and south, and the Atlantic Ocean on the west. Western Sahara is administratively divided into four regions.",
    "id" : ""
  }, {
    "name" : "Yemen",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00005284",
    "description" : "A country located on the Arabian Peninsula in Southwest Asia. Yemen is bordered by Saudi Arabia to the North, the Red Sea to the West, the Arabian Sea and Gulf of Aden to the South, and Oman to the east. Yemen's territory includes over 200 islands, the largest of which is Socotra, about 415 km to the south of Yemen, off the coast of Somalia. As of 2004-02, Yemen is divided into twenty governorates (muhafazah) and one municipality. The population of each governorate is listed in the table below. The governorates of Yemen are divided into 333 districts (muderiah). The districts are subdivided into 2,210 sub-districts, and then into 38,284 villages (as of 2001).",
    "id" : ""
  }, {
    "name" : "Yugoslavia (formerly)",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00052663",
    "description" : "A former state. The six countries that were once part of Yugoslavia are Bosnia-Herzegovina, Croatia, Macedonia, Montenegro, Serbia, and Slovenia.",
    "id" : ""
  }, {
    "name" : "Zambia",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001107",
    "description" : "A landlocked country in Southern Africa. The neighbouring countries are the Democratic Republic of the Congo to the north, Tanzania to the north-east, Malawi to the east, Mozambique, Zimbabwe, Botswana, and Namibia to the south, and Angola to the west. The capital city is Lusaka. Zambia is divided into nine provinces. Each province is subdivided into several districts with a total of 73 districts.",
    "id" : ""
  }, {
    "name" : "Zimbabwe",
    "link" : "http://purl.obolibrary.org/obo/GAZ_00001106",
    "description" : "A landlocked country in the southern part of the continent of Africa, between the Zambezi and Limpopo rivers. It is bordered by South Africa to the south, Botswana to the southwest, Zambia to the northwest, and Mozambique to the east. Zimbabwe is divided into eight provinces and two cities with provincial status. The provinces are subdivided into 59 districts and 1,200 municipalities.",
    "id" : ""
  } ]
}, {
  "name" : "lk_t0_event",
  "rows" : [ {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000165",
    "description" : "Time Zero Event (TZ0) is not specified or not received. If no Time Zero Event value is received, then this is the system default value.",
    "id" : ""
  }, {
    "name" : "Other",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000165",
    "description" : "Time Zero Event (TZ0) is the some Other time value not in CV Terms.",
    "id" : ""
  }, {
    "name" : "Time of enrollment",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000165",
    "description" : "Time Zero Event (TZ0) is the Time of enrollment.",
    "id" : ""
  }, {
    "name" : "Time of hospital admission",
    "link" : "https://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20Metathesaurus&code=C0488561",
    "description" : "Time Zero Event (TZ0) is the Time of hospital admission",
    "id" : ""
  }, {
    "name" : "Time of infection",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000165",
    "description" : "Time Zero Event (TZ0) is the Time of infection.",
    "id" : ""
  }, {
    "name" : "Time of initial treatment",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000165",
    "description" : "Time Zero Event (TZ0) is the Time of initial treatment.",
    "id" : ""
  }, {
    "name" : "Time of initial vaccine administration",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000165",
    "description" : "Time Zero Event (TZ0) is the Time of initial vaccine administration.",
    "id" : ""
  }, {
    "name" : "Time of transplantation",
    "link" : "http://purl.obolibrary.org/obo/PATO_0000165",
    "description" : "Time Zero Event (TZ0) is the Time of Transplantation.",
    "id" : ""
  } ]
}, {
  "name" : "lk_temperature_unit",
  "rows" : [ {
    "name" : "C",
    "link" : "http://purl.obolibrary.org/obo/UO_0000027",
    "description" : "Celsius",
    "id" : ""
  }, {
    "name" : "F",
    "link" : "http://purl.obolibrary.org/obo/UO_0000195",
    "description" : "Fahrenheit",
    "id" : ""
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : ""
  }, {
    "name" : "K",
    "link" : "http://purl.obolibrary.org/obo/UO_0000012",
    "description" : "Kelvin",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : ""
  } ]
}, {
  "name" : "lk_time_unit",
  "rows" : [ {
    "name" : "d.p.c.",
    "link" : "https://en.wikipedia.org/wiki/Days_post_coitum",
    "description" : "Unit of Days Post Coitum (d.p.c.).",
    "id" : ""
  }, {
    "name" : "Days",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25301",
    "description" : "Unit of Days.",
    "id" : ""
  }, {
    "name" : "Hours",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25529",
    "description" : "Unit of Hours.",
    "id" : ""
  }, {
    "name" : "Minutes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48154",
    "description" : "Unit of Minutes.",
    "id" : ""
  }, {
    "name" : "Months",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29846",
    "description" : "Unit of Months.",
    "id" : ""
  }, {
    "name" : "Not Specified",
    "link" : "",
    "description" : "Unit is not specified or not received. If no Unit value is received, then this is the system default value.",
    "id" : ""
  }, {
    "name" : "Seconds",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25666",
    "description" : "Unit of Seconds.",
    "id" : ""
  }, {
    "name" : "Weeks",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29844",
    "description" : "Unit of Weeks.",
    "id" : ""
  }, {
    "name" : "Years",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29848",
    "description" : "Unit of Years.",
    "id" : ""
  } ]
}, {
  "name" : "lk_titer_unit",
  "rows" : [ {
    "name" : "titer_unit_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "Antibody titer",
    "link" : "http://purl.obolibrary.org/obo/VO_0000150",
    "description" : "Antibody titer is a titer of antibody that shows how much antibody an organism has produced that recognizes a particular epitope, expressed as the greatest dilution ratio (or its reciprocal) that still gives a positive result. ELISA is a common means of determining antibody titers.",
    "id" : null
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : null
  }, {
    "name" : "titer",
    "link" : "http://purl.obolibrary.org/obo/VO_0000555",
    "description" : "A titer (or titre) is a measure of concentration. Titer testing employs serial dilution to obtain approximate quantitative information from an analytical procedure that inherently only evaluates as positive or negative. The titer corresponds to the highest dilution factor that still yields a positive reading; for example, positive readings in the first 8 serial twofold dilutions translate into a titer of 1:256.",
    "id" : null
  } ]
}, {
  "name" : "lk_transcript_type",
  "rows" : [ {
    "name" : "transcript_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "lincRNA",
    "link" : "https://en.wikipedia.org/wiki/Long_non-coding_RNA",
    "description" : "Long non-coding RNAs (long ncRNAs, lncRNA) are a type of RNA, defined as being transcripts with lengths exceeding 200 nucleotides that are not translated into protein. This somewhat arbitrary limit distinguishes long ncRNAs from small non-coding RNAs such as microRNAs (miRNAs), small interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), and other short RNAs. Long intervening/intergenic noncoding RNAs (lincRNAs) are sequences of lncRNA which do not overlap protein-coding genes.",
    "id" : null
  }, {
    "name" : "mRNA",
    "link" : "https://en.wikipedia.org/wiki/Messenger_RNA",
    "description" : "In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.",
    "id" : null
  }, {
    "name" : "snRNA",
    "link" : "",
    "description" : "Small nuclear RNA (snRNA) is a class of small RNA molecules that are found within the splicing speckles and Cajal bodies of the cell nucleus in eukaryotic cells. The length of an average snRNA is approximately 150 nucleotides. They are transcribed by either RNA polymerase II or RNA polymerase III. Their primary function is in the processing of pre-messenger RNA (hnRNA) in the nucleus. They have also been shown to aid in the regulation of transcription factors (7SK RNA) or RNA polymerase II (B2 RNA), and maintaining the telomeres. https://en.wikipedia.org/wiki/Small_nuclear_RNA",
    "id" : null
  } ]
}, {
  "name" : "lk_unit_of_measure",
  "rows" : [ {
    "name" : "unit_of_measure_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "AFU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C77534",
    "description" : "Arbitrary Fluorescence Units",
    "id" : null
  }, {
    "name" : "AI",
    "link" : "https://www.aacc.org/publications/cln/articles/2014/june/ana-testing",
    "description" : "Antibody Index",
    "id" : null
  }, {
    "name" : "Antibody titer",
    "link" : "http://purl.obolibrary.org/obo/VO_0000150",
    "description" : "Antibody titer is a titer of antibody that shows how much antibody an organism has produced that recognizes a particular epitope, expressed as the greatest dilution ratio (or its reciprocal) that still gives a positive result. ELISA is a common means of determining antibody titers.",
    "id" : null
  }, {
    "name" : "Arithmetic Mean Fluorescence Intensity Unit (aMFI)",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C163562",
    "description" : "Arithmetic Mean Fluorescence Intensity Unit",
    "id" : null
  }, {
    "name" : "AU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C70504",
    "description" : "Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.",
    "id" : null
  }, {
    "name" : "Base Pair Unit",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C132477",
    "description" : "The unit of measure for the number of paired nucleotides in a DNA or RNA sequence. UMLS CUI:C4318478, has exact synonym: Base Pair Unit; BASE PAIRS; BP; {BP}",
    "id" : null
  }, {
    "name" : "BCLC Stage",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C115134",
    "description" : "A stage for hepatocellular carcinoma defined according to the Barcelona Clinic Liver Cancer (BCLC) criteria.",
    "id" : null
  }, {
    "name" : "Beats per Minute",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49673",
    "description" : "The number of heartbeats measured per minute time.",
    "id" : null
  }, {
    "name" : "Body Mass Index Finding",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C138901",
    "description" : "The result of a body mass index measurement. [Definition Source: NCI]",
    "id" : null
  }, {
    "name" : "Boolean",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C45254",
    "description" : "The type of an expression with two possible values, \"true\" and \"false\".",
    "id" : null
  }, {
    "name" : "Breaths per Minute",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49674",
    "description" : "The number of breaths (inhalation and exhalation) taken per minute time.",
    "id" : null
  }, {
    "name" : "C",
    "link" : "http://purl.obolibrary.org/obo/UO_0000027",
    "description" : "Celsius",
    "id" : null
  }, {
    "name" : "Capsule Dosing Unit",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48480",
    "description" : "A dosing unit equal to the amount of active ingredient(s) contained in a capsule.",
    "id" : null
  }, {
    "name" : "categorical",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C142412",
    "description" : "Categorical data are types of data which may be divided into groups.",
    "id" : null
  }, {
    "name" : "cells",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48938",
    "description" : "cell count",
    "id" : null
  }, {
    "name" : "cells/kg body weight",
    "link" : "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138781/",
    "description" : "Cells per kg body weight",
    "id" : null
  }, {
    "name" : "cells/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C74919",
    "description" : "A unit of cell concentration expressed in cells per unit of volume equal to one milliliter.",
    "id" : null
  }, {
    "name" : "cells/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67242",
    "description" : "A unit of cell concentration expressed as a number of cells per unit volume equal to one microliter.",
    "id" : null
  }, {
    "name" : "CFU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C68902",
    "description" : "A derived unit of viable cell concentration defined as the number of colony forming units in one milliliter of substance",
    "id" : null
  }, {
    "name" : "cm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49668",
    "description" : "A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.",
    "id" : null
  }, {
    "name" : "Count",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25463",
    "description" : "Determining the number or amount of something.",
    "id" : null
  }, {
    "name" : "Cq",
    "link" : "http://purl.obolibrary.org/obo/STATO_0000190",
    "description" : "Threshold cycle (or Ct or Cq) is a count which is defined as the fractional PCR cycle number at which the reporter fluorescence is greater than the threshold in the context of the RT-qPCR assay.",
    "id" : null
  }, {
    "name" : "Ct",
    "link" : "http://purl.obolibrary.org/obo/STATO_0000190",
    "description" : "Threshold cycle (or Ct or Cq) is a count which is defined as the fractional PCR cycle number at which the reporter fluorescence is greater than the threshold in the context of the RT-qPCR assay.",
    "id" : null
  }, {
    "name" : "Day",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25301",
    "description" : "The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.",
    "id" : null
  }, {
    "name" : "Delta Ct",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/11846609",
    "description" : "Difference between the target gene and the reference gene.",
    "id" : null
  }, {
    "name" : "Delta Delta Ct",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/11846609",
    "description" : "Difference between the Delta Ct target gene of the treated sample and the Delta Ct of the target gene of the untreated sample.",
    "id" : null
  }, {
    "name" : "DK units/ml",
    "link" : "https://repository.niddk.nih.gov/studies/aab-calibrators/",
    "description" : "The NIDDK calibrators were tested together with dilutions of the WHO reference serum using harmonized assays on five occasions in the BDC, Bristol, and Munich laboratories and reported as WHO units/ml by calibration as previously described. For each of the NIDDK calibrators, the median value of the WHO units/ml obtained for the 15 measurements was assigned as its calibrator unit. The assigned units were termed digestive and kidney units (DK units)/ml.",
    "id" : null
  }, {
    "name" : "Donor Information",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C158611",
    "description" : "Information about the donor.",
    "id" : null
  }, {
    "name" : "Dose",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25488",
    "description" : "A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.",
    "id" : null
  }, {
    "name" : "F",
    "link" : "http://purl.obolibrary.org/obo/UO_0000195",
    "description" : "Fahrenheit",
    "id" : null
  }, {
    "name" : "FPKM",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/22872506",
    "description" : "Fragments Per Kilobase Million: Normalized expression value of a given gene as measured by paired-end RNA sequencing",
    "id" : null
  }, {
    "name" : "g/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64783",
    "description" : "A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.",
    "id" : null
  }, {
    "name" : "g/l",
    "link" : "http://purl.obolibrary.org/obo/UO_0000175",
    "description" : "grams per liter",
    "id" : null
  }, {
    "name" : "Gender",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C17357",
    "description" : "Characteristics of people that are socially constructed, including norms, behaviors, and roles based on sex. As a social construct, gender varies from society to society and can change over time. (Adapted from WHO.)",
    "id" : null
  }, {
    "name" : "Geometric Mean Fluorescence Intensity Unit (gMFI)",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C163563",
    "description" : "A unit of measure for the geometric mean fluorescence intensity.",
    "id" : null
  }, {
    "name" : "gm",
    "link" : "http://purl.obolibrary.org/obo/UO_0000021",
    "description" : "gram",
    "id" : null
  }, {
    "name" : "Grade",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48309",
    "description" : "A position on a scale of intensity or amount or quality.",
    "id" : null
  }, {
    "name" : "Gy",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C0556636",
    "description" : "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
    "id" : null
  }, {
    "name" : "HAU",
    "link" : "http://en.wikipedia.org/wiki/Virus_quantification",
    "description" : "hemagglutination units",
    "id" : null
  }, {
    "name" : "Hour",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25529",
    "description" : "A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day.",
    "id" : null
  }, {
    "name" : "in",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48500",
    "description" : "A traditional unit of length equal to 1/12 of a foot or 2.54 centimeters.",
    "id" : null
  }, {
    "name" : "IU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48579",
    "description" : "The unitage assigned by the WHO to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization (e.g. hormones, enzymes, and vaccines), to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.",
    "id" : null
  }, {
    "name" : "iu/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67376",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.",
    "id" : null
  }, {
    "name" : "IU/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67377",
    "description" : "A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.",
    "id" : null
  }, {
    "name" : "K",
    "link" : "http://purl.obolibrary.org/obo/UO_0000012",
    "description" : "Kelvin",
    "id" : null
  }, {
    "name" : "Kallikrein Inactivator Unit per Milliliter",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C73531",
    "description" : "An arbitrary unit of a kallikrein inactivator concentration equal to the concentration at which one milliliter of the mixture contains one unit of the kallikrein inactivator.",
    "id" : null
  }, {
    "name" : "kg",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C28252",
    "description" : "A basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds.",
    "id" : null
  }, {
    "name" : "kg/m2",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49671",
    "description" : "Kilogram per Square Meter, the SI derived unit of spread rate of a substance by mass, used also as a measure of area density and as a dose calculation unit.",
    "id" : null
  }, {
    "name" : "l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48505",
    "description" : "The non-SI unit of volume accepted for use with the SI. One liter is equal to cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.",
    "id" : null
  }, {
    "name" : "L/sec",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67390",
    "description" : "Liter per Second: A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one second.",
    "id" : null
  }, {
    "name" : "m",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C41139",
    "description" : "A unit of linear measure in the metric system, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). A meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards. [Definition Source: NCI]",
    "id" : null
  }, {
    "name" : "Mean Fluorescence Intensity Unit (MFI,FIU)",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C163046",
    "description" : "A unit of measure for the mean fluorescence intensity (when the mathematic calculation is unspecified or unknown).",
    "id" : null
  }, {
    "name" : "Median Fluorescence Intensity Unit (MdFI)",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C96687",
    "description" : "A unit of measure equal to the median fluorescence intensity of a log-normal distribution of fluorescence signals.",
    "id" : null
  }, {
    "name" : "MFI at 90th percentile",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C96687",
    "description" : "Mean Fluorescence Intensity at 90th Percentile.  MFI : A unit of measure equal to the geometric mean fluorescence intensity of a log-normal distribution of fluorescence signals.",
    "id" : null
  }, {
    "name" : "mg",
    "link" : "http://purl.obolibrary.org/obo/UO_0000022",
    "description" : "milligram",
    "id" : null
  }, {
    "name" : "mg/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67015",
    "description" : "A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.",
    "id" : null
  }, {
    "name" : "mg/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64572",
    "description" : "A metric unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one cubic meter. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of a substance which mass equal to one gram occupies the volume of one cubic meter.",
    "id" : null
  }, {
    "name" : "mg/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258798001",
    "description" : "microgram per milliliter",
    "id" : null
  }, {
    "name" : "Milligram per Kilogram",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67401",
    "description" : "A unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit. Has exact synonym: Attogram per Picogram; Milligram/Kilogram; Yoctogram per Attogram; milligram per kilogram; fg/ng; Femtogram per Nanogram; ng/mg; milligram(s)/kilogram; pg/mcg; ag/pg; Microgram per Gram; Nanogram per Milligram; Zeptogram per Femtogram; mcg/g; yg/ag; Picogram per Microgram; mg/kg; ug/g; zg/fg; Milligram per Kilogram; pg/ug; mg/kilo",
    "id" : null
  }, {
    "name" : "miu/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67376",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.",
    "id" : null
  }, {
    "name" : "ml",
    "link" : "http://purl.obolibrary.org/obo/UO_0000098",
    "description" : "milliliter",
    "id" : null
  }, {
    "name" : "mL/min",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C64777",
    "description" : "Milliliter per Minute: A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to one minute.",
    "id" : null
  }, {
    "name" : "mL/min/(173/100).m2",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67412",
    "description" : "Milliliter per Minute per 1.73 m2 of Body Surface Area: A unit used in the calculation of a rate of the substance removal from the body (such as creatinine clearance) for the measurement of renal excretory function, with the applied correction factor for body size. It is also used as a dose delivery rate calculation unit equal to the rate, at which one milliliter of medication is delivered during a period of time equal to one minute per 1.73 square meters of body surface area.",
    "id" : null
  }, {
    "name" : "mL/min/mmHg",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67417",
    "description" : "Milliliter per Minute per Millimeters of Mercury: A unit for measuring a pulmonary diffusing capacity expressed in units of gas flow rate (in milliliters per minute) per a unit of pressure (in torrs).",
    "id" : null
  }, {
    "name" : "mm",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C28251",
    "description" : "A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch. [Definition Source: NCI]",
    "id" : null
  }, {
    "name" : "mmHg",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C49670",
    "description" : "Millimeter of Mercury: A non-SI unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere. Use of this unit is generally deprecated by ISO and IUPAC.",
    "id" : null
  }, {
    "name" : "MOI",
    "link" : "http://en.wikipedia.org/wiki/Multiplicity_of_infection",
    "description" : "multiplicity of infection",
    "id" : null
  }, {
    "name" : "Month",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29846",
    "description" : "One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.",
    "id" : null
  }, {
    "name" : "Multidimensional Fatigue Inventory",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C54719",
    "description" : "A 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Motivation and Reduced Activity.",
    "id" : null
  }, {
    "name" : "ng",
    "link" : "http://purl.obolibrary.org/obo/UO_0000024",
    "description" : "nanogram",
    "id" : null
  }, {
    "name" : "ng/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67326",
    "description" : "A unit of mass concentration defined as the concentration of one nanogram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume of one deciliter.",
    "id" : null
  }, {
    "name" : "ng/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258806002",
    "description" : "nanogram per milliliter",
    "id" : null
  }, {
    "name" : "ng/nl",
    "link" : "",
    "description" : "nanogram per nanoliter",
    "id" : null
  }, {
    "name" : "ng/ul",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/272082007",
    "description" : "nanogram per microliter",
    "id" : null
  }, {
    "name" : "nl",
    "link" : "http://purl.obolibrary.org/obo/UO_0000102",
    "description" : "nanoliter",
    "id" : null
  }, {
    "name" : "nM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000065",
    "description" : "nanomolar",
    "id" : null
  }, {
    "name" : "Normalized Fluorescence Intensity Unit",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C154680",
    "description" : "A relative fluorescence intensity unit that is adjusted to a reference standard.",
    "id" : null
  }, {
    "name" : "Not Specified",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38046",
    "description" : "No value provided. Not stated explicitly or in detail.",
    "id" : null
  }, {
    "name" : "NPX",
    "link" : "https://www.olink.com/question/what-is-npx/",
    "description" : "NPX, Normalized Protein eXpression, is Olink's arbitrary unit which is in Log2 scale.  It is calculated from Ct values and data pre-processing (normalization) is performed to minimize both intra- and inter-assay variation. NPX data allows users to identify changes for individual protein levels across their sample set, and then use this data to establish protein signatures. The NPX scale is inverted compared to that of Ct. This means that a high NPX value equals a high protein concentration. Because NPX is in a log2 scale, a 1 NPX difference means a doubling of protein concentration. If needed NPX values can be converted into linear scale: 2^NPX= linear NPX.",
    "id" : null
  }, {
    "name" : "Number of Episodes",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C124281",
    "description" : "A measurement of the total number of events that have occurred.",
    "id" : null
  }, {
    "name" : "optical density",
    "link" : "http://purl.obolibrary.org/obo/CHMO_0002039",
    "description" : "The measurement of the light transmitted through a sample for a given wavelength. [database_cross_reference: ISBN:038733341X]",
    "id" : null
  }, {
    "name" : "percentage",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25613",
    "description" : "A fraction or ratio with 100 understood as the denominator. e.g. percentage of a cell population of interest within a parent population",
    "id" : null
  }, {
    "name" : "PFU",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67264",
    "description" : "Plaque-forming unit. A measure of viable infectious entities (e.g. viral particles or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope and/or to the naked eye as a plaque. A number of plaque forming units (PFU) per unit volume is a conventional way to refer the titer of an infective entity in a specimen or preparation.",
    "id" : null
  }, {
    "name" : "PFUe",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67264",
    "description" : "Plaque-forming unit equivalents",
    "id" : null
  }, {
    "name" : "pg",
    "link" : "http://purl.obolibrary.org/obo/UO_0000025",
    "description" : "picogram",
    "id" : null
  }, {
    "name" : "pg/mg creatinine",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C85780",
    "description" : "Protein/Creatinine [Ratio] in Urine",
    "id" : null
  }, {
    "name" : "pg/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67327",
    "description" : "picogram per milliliter",
    "id" : null
  }, {
    "name" : "pg/nl",
    "link" : "",
    "description" : "picogram per nanoliter",
    "id" : null
  }, {
    "name" : "pg/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67306",
    "description" : "picogram per microliter",
    "id" : null
  }, {
    "name" : "pl",
    "link" : "http://purl.obolibrary.org/obo/UO_0000103",
    "description" : "picoliter",
    "id" : null
  }, {
    "name" : "pM",
    "link" : "http://purl.obolibrary.org/obo/UO_0000066",
    "description" : "picomolar",
    "id" : null
  }, {
    "name" : "Point",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C113499",
    "description" : "A numeric unit used to quantify a score.",
    "id" : null
  }, {
    "name" : "Pound",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48531",
    "description" : "The traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds.",
    "id" : null
  }, {
    "name" : "Ratio",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C44256",
    "description" : "Quotient of quantities of the same kind for different components within the same system.",
    "id" : null
  }, {
    "name" : "Relative Fluorescence Intensity Unit",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C77535",
    "description" : "A unit of measurement that estimates the size or amount of material in a sample by normalizing its luminescence to that of a reference standard.",
    "id" : null
  }, {
    "name" : "RPKM",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/22872506",
    "description" : "Reads Per Kilobase Million: Normalized expression value of a given gene as measured by single-end RNA sequencing",
    "id" : null
  }, {
    "name" : "Scale",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25664",
    "description" : "An ordered reference standard used to measure incremental changes.",
    "id" : null
  }, {
    "name" : "Schirmer Test Wetting",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C75526",
    "description" : "A test used to determine the amount of tears collected on a filter paper strip in 5 minutes.",
    "id" : null
  }, {
    "name" : "Score",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C25338",
    "description" : "A number or range of numeric values measuring performance, function, quality, or ability.",
    "id" : null
  }, {
    "name" : "stim/unstim fold change",
    "link" : "https://en.wikipedia.org/wiki/Fold_change",
    "description" : "Fold change comparing stimulated vs unstimulated sample",
    "id" : null
  }, {
    "name" : "TCID50",
    "link" : "http://en.wikipedia.org/wiki/Virus_quantification",
    "description" : "mean tissue culture infective dose",
    "id" : null
  }, {
    "name" : "Thousand Cells per Microliter",
    "link" : "https://uts.nlm.nih.gov/uts/umls/concept/C1883312",
    "description" : "A unit of cell concentration expressed as a number of cells in thousands per unit volume equal to one microliter. Synonyms: 10E3 Cells/uL, Kcells/ul.",
    "id" : null
  }, {
    "name" : "titer",
    "link" : "http://purl.obolibrary.org/obo/VO_0000555",
    "description" : "A titer (or titre) is a measure of concentration. Titer testing employs serial dilution to obtain approximate quantitative information from an analytical procedure that inherently only evaluates as positive or negative. The titer corresponds to the highest dilution factor that still yields a positive reading; for example, positive readings in the first 8 serial twofold dilutions translate into a titer of 1:256.",
    "id" : null
  }, {
    "name" : "TPM",
    "link" : "http://www.ncbi.nlm.nih.gov/pubmed/22872506",
    "description" : "Transcripts per million reads- Measurement of mRNA abundance using RNA-seq data",
    "id" : null
  }, {
    "name" : "ug",
    "link" : "http://purl.obolibrary.org/obo/UO_0000023",
    "description" : "microgram",
    "id" : null
  }, {
    "name" : "ug/dl",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67305",
    "description" : "A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter.",
    "id" : null
  }, {
    "name" : "ug/kg",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67396",
    "description" : "Microgram per Kilogram: A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.",
    "id" : null
  }, {
    "name" : "ug/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67306",
    "description" : "A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumetric mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter.",
    "id" : null
  }, {
    "name" : "ug/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258801007",
    "description" : "microgram per milliliter",
    "id" : null
  }, {
    "name" : "ug/ul",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C42576",
    "description" : "microgram per microliter",
    "id" : null
  }, {
    "name" : "ugEq/g",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C166087",
    "description" : "Microgram Equivalents Per Gram: A concentration unit measured as a number of microgram equivalents per gram of substance.",
    "id" : null
  }, {
    "name" : "uiu/ml",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C67405",
    "description" : "Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one millionth of international unit per one milliliter of system volume.",
    "id" : null
  }, {
    "name" : "ul",
    "link" : "http://purl.obolibrary.org/obo/UO_0000101",
    "description" : "microliter",
    "id" : null
  }, {
    "name" : "uM",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/258814008",
    "description" : "micromolar",
    "id" : null
  }, {
    "name" : "umol/l",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C48508",
    "description" : "A unit of concentration (molarity unit) equal to one one-millionth of a mole (10E-6 mole) of solute per one liter of solution.",
    "id" : null
  }, {
    "name" : "Unit per Gram",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C77606",
    "description" : "An arbitrary unit of substance content expressed in unit(s) per gram.",
    "id" : null
  }, {
    "name" : "units/ml",
    "link" : "http://purl.bioontology.org/ontology/SNOMEDCT/259002007",
    "description" : "Enzyme Unit per Milliliter. Unit of catalytic activity concentration defined as activity equal to one enzyme unit per one milliliter of system volume.",
    "id" : null
  }, {
    "name" : "Week",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29844",
    "description" : "Any period of seven consecutive days.",
    "id" : null
  }, {
    "name" : "Year",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C29848",
    "description" : "A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.",
    "id" : null
  }, {
    "name" : "Yes, No, or Unknown Response",
    "link" : "http://purl.obolibrary.org/obo/NCIT_C38148",
    "description" : "A response or indicator that can have a value of yes, no, or unknown.",
    "id" : null
  } ]
}, {
  "name" : "lk_virus_strain",
  "rows" : [ {
    "name" : "virus_strain_preferred",
    "link" : "",
    "description" : "",
    "id" : ""
  }, {
    "name" : "A/Anhui/1/2005",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Anhui/1/2005(H5N1)&decorator=influenza",
    "description" : "A/Anhui/1/2005",
    "id" : "0"
  }, {
    "name" : "A/Brisbane/02/2018",
    "link" : "https://gsrs.ncats.nih.gov/app/substance/GV04CMM4LO",
    "description" : "A/Brisbane/02/2018",
    "id" : "0"
  }, {
    "name" : "A/Brisbane/10/2007",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'A/Brisbane/10/2007'. The virus name : 'H3N2', and season_list is: '2008-2009,2009-2010'.",
    "id" : "476294"
  }, {
    "name" : "A/Brisbane/59/2007",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'A/Brisbane/59/2007'. The virus name : 'H1N1', and season_list is: '2008-2009,2009-2010'.",
    "id" : "504904"
  }, {
    "name" : "A/California/04/2009",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/California/04/2009(H1N1)",
    "description" : "The virus strain name is: 'A/California/04/2009'. The virus name : 'H1N1', and season_list is: 'NA'.",
    "id" : "0"
  }, {
    "name" : "A/California/07/2004",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/California/07/2004(H3N2)&decorator=influenza",
    "description" : "A/California/07/2004",
    "id" : "479983"
  }, {
    "name" : "A/California/7/2009",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'A/California/7/2009'. The virus name : 'H1N1', and season_list is: '2010-2011,2011-2012,2012-2013'.",
    "id" : "1316510"
  }, {
    "name" : "A/Egypt/306",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Egypt/306(H1N1)&decorator=influenza",
    "description" : "A/Egypt/306",
    "id" : "0"
  }, {
    "name" : "A/Hong Kong/4801/2014",
    "link" : "https://www.sinobiological.com/research/virus/influenza-a-hong-kong-4801-2014",
    "description" : "A/Hong Kong/4801/2014",
    "id" : "0"
  }, {
    "name" : "A/Indonesia/5/2005",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Indonesia/5/2005&decorator=influenza",
    "description" : "A/Indonesia/5/2005(H5N1)",
    "id" : "400788"
  }, {
    "name" : "A/Kansas/14/2017",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Kansas/14/2017(H3N2)&decorator=influenza",
    "description" : "A/Kansas/14/2017",
    "id" : "11320"
  }, {
    "name" : "A/Michigan/45/2015",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Michigan/45/2015(H1N1)&decorator=influenza",
    "description" : "A/Michigan/45/2015",
    "id" : "1777792"
  }, {
    "name" : "A/New Caledonia/20/1999",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm ; https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/New Caledonia/20/1999&decorator=influenza",
    "description" : "The virus strain name is: 'A/New Caledonia/20/1999'. The virus name : 'H1N1', and season_list is: '2005-2006, 2006-2007'.",
    "id" : "381512"
  }, {
    "name" : "A/Perth/16/2009",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'A/Perth/16/2009'. The virus name : 'H3N2', and season_list is: '2010-2011,2011-2012'.",
    "id" : "654811"
  }, {
    "name" : "A/Perth/19/2009",
    "link" : "https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(16)30172-4/fulltext",
    "description" : "A/Perth/19/2009",
    "id" : "0"
  }, {
    "name" : "A/Puerto Rico/8/1934",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_183764",
    "description" : "A/Puerto Rico/8/1934(H1N1)",
    "id" : "211044"
  }, {
    "name" : "A/Solomon Islands/3/2006",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'A/Solomon Islands/3/2006'. The virus name : 'H1N1', and season_list is: '2007-2008'.",
    "id" : "464623"
  }, {
    "name" : "A/South Dakota/06/2007",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/South%20Dakota/06/2007(H1N1)&decorator=influenza&context=1620763142270",
    "description" : "The virus strain name is: 'A/South Dakota/06/2007'. The virus name : 'H1N1', and season_list is: '2009 Southern Hemisphere'.",
    "id" : "0"
  }, {
    "name" : "A/Switzerland/9715293/2013",
    "link" : "https://www.sinobiological.com/recombinant-proteins/h3n2-hemagglutinin-ha-40497-vnab",
    "description" : "A/Switzerland/9715293/2013",
    "id" : "0"
  }, {
    "name" : "A/Texas/50/2012",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Texas/50/2012(H3N2)&decorator=influenza",
    "description" : "The virus strain name is: 'A/Texas/50/2012'. The virus name : 'H3N2', and season_list is: '2013-2014, 2014-2015'.",
    "id" : "0"
  }, {
    "name" : "A/Turkey/15/2006",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Turkey/15/2006(H5N1)&decorator=influenza",
    "description" : "A/Turkey/15/2006",
    "id" : "0"
  }, {
    "name" : "A/Uruguay/716/2007",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm ; https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Uruguay/716/2007&decorator=influenza",
    "description" : "The virus strain name is: 'A/Uruguay/716/2007'. The virus name : 'H3N2', and season_list is: '2008-2009,2009-2010'.",
    "id" : "0"
  }, {
    "name" : "A/Victoria/3/1975",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A%2FVictoria%2F3%2F1975%28H3N2%29&decorator=influenza",
    "description" : "The virus strain name is: 'A/Victoria/3/1975'. The virus name : 'H3N2', and season_list is: 'NA'.",
    "id" : "392809"
  }, {
    "name" : "A/Victoria/361/2011",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'A/Victoria/361/2011'. The virus name : 'H3N2', and season_list is: '2012-2013'.",
    "id" : "1268360"
  }, {
    "name" : "A/Vietnam/1196/2004",
    "link" : "https://www.fludb.org/brc/fluSegmentDetails.spg?ncbiGenomicAccession=AY526747&decorator=influenza",
    "description" : "A/Vietnam/1196/2004",
    "id" : "0"
  }, {
    "name" : "A/Wisconsin/67/2005",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'A/Wisconsin/67/2005'. The virus name : 'H3N2', and season_list is: '2006-2007,2007-2008'.",
    "id" : "393902"
  }, {
    "name" : "A/X-31",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_132504",
    "description" : "A/X-31(H3N2)",
    "id" : "132504"
  }, {
    "name" : "B/Brisbane/03/2007",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_1600158",
    "description" : "B/Brisbane/03/2007",
    "id" : "1600158"
  }, {
    "name" : "B/Brisbane/3/2007",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=B/Brisbane/3/2007&decorator=influenza&context=1621535432290",
    "description" : "B/Brisbane/3/2007",
    "id" : "1600158"
  }, {
    "name" : "B/Brisbane/60/2008",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm ; https://www.viprbrc.org/brc/fluStrainDetails.spg?strainName=B/Brisbane/60/2008&decorator=influenza",
    "description" : "The virus strain name is: 'B/Brisbane/60/2008'. The virus name : 'B', and season_list is: '2009-2010'.",
    "id" : "604436"
  }, {
    "name" : "B/Colorado/06/2017",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=B/Colorado/06/2017&decorator=influenza",
    "description" : "B/Colorado/06/2017",
    "id" : "1987257"
  }, {
    "name" : "B/Florida/04/2006",
    "link" : "https://www.fludb.org/brc/fluSegmentDetails.spg?ncbiGenomicAccession=EU515992&decorator=influenza",
    "description" : "B/Florida/04/2006",
    "id" : "461739"
  }, {
    "name" : "B/Florida/4/2006",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'B/Florida/4/2006'. The virus name : 'B', and season_list is: '2008-2009'.",
    "id" : "461739"
  }, {
    "name" : "B/Lee/1940",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=B%2FLee%2F1940&decorator=influenza",
    "description" : "The virus strain name is: 'B/Lee/1940'. The virus name : 'B', and season_list is: 'NA'.",
    "id" : "0"
  }, {
    "name" : "B/Malaysia/2506/2004",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'B/Malaysia/2506/2004'. The virus name : 'B', and season_list is: '2006-2007,2007-2008'.",
    "id" : "464417"
  }, {
    "name" : "B/Massachusetts/02/2012",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'B/Massachusetts/02/2012'. The virus name : 'B', and season_list is: '2012-2013'.",
    "id" : "1321139"
  }, {
    "name" : "B/Massachusetts/2/2012",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=B/Massachusetts/02/2012&decorator=influenza",
    "description" : "B/Massachusetts/2/2012",
    "id" : "1321139"
  }, {
    "name" : "B/Phuket/3073/2013",
    "link" : "https://nibsc.org/documents/ifu/19-196.pdf",
    "description" : "B/Phuket/3073/2013",
    "id" : "0"
  }, {
    "name" : "B/Shanghai/361/2002",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'B/Shangai/361/2002'. The virus name : 'B', and season_list is: '2005-2006'.",
    "id" : "335812"
  }, {
    "name" : "B/Wisconsin/01/2010",
    "link" : "http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.htm",
    "description" : "The virus strain name is: 'B/Wisconsin/01/2010'. The virus name : 'B', and season_list is: '2012-2013'.",
    "id" : "1089607"
  }, {
    "name" : "B/Wisonsin/01/2010",
    "link" : "https://www.fludb.org/brc/fluStrainDetails.spg?strainName=B/Wisconsin/01/2010&decorator=influenza",
    "description" : "B/Wisonsin/01/2010",
    "id" : "1089607"
  }, {
    "name" : "SARS-CoV-2",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_2697049",
    "description" : "Severe acute respiratory syndrome coronavirus 2, equivalent: 2019-nCoV",
    "id" : "2697049"
  }, {
    "name" : "SARS-CoV-2 Alpha; B.1.1.7",
    "link" : "https://cov-lineages.org/lineage.html?lineage=B.1.1.7",
    "description" : "SARS-CoV-2 Alpha; B.1.1.7",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Beta; B.1.351",
    "link" : "https://cov-lineages.org/lineage.html?lineage=B.1.351",
    "description" : "SARS-CoV-2 Beta; B.1.351",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Delta; B.1.617.2",
    "link" : "https://cov-lineages.org/lineage.html?lineage=B.1.617.2",
    "description" : "SARS-CoV-2 Delta; B.1.617.2",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Gamma; P.1",
    "link" : "https://cov-lineages.org/lineage.html?lineage=P.1",
    "description" : "SARS-CoV-2 Gamma; P.1",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Lambda; C.37",
    "link" : "https://cov-lineages.org/lineage.html?lineage=C.37",
    "description" : "SARS-CoV-2 Lambda; C.37",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Mu; B.1.621",
    "link" : "https://cov-lineages.org/lineage.html?lineage=B.1.621",
    "description" : "SARS-CoV-2 Mu; B.1.621",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Omicron variant BA.2",
    "link" : "https://cov-lineages.org/lineage.html?lineage=BA.2",
    "description" : "SARS-CoV-2 Omicron variant BA.2",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Omicron variant BA.4",
    "link" : "https://cov-lineages.org/lineage.html?lineage=BA.3",
    "description" : "SARS-CoV-2 Omicron variant BA.4",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Omicron variant BA.5",
    "link" : "https://cov-lineages.org/lineage.html?lineage=BA.5",
    "description" : "SARS-CoV-2 Omicron variant BA.5",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Omicron varient BA.1",
    "link" : "https://cov-lineages.org/lineage.html?lineage=BA.1",
    "description" : "SARS-CoV-2 Omicron varient BA.1",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Omicron; B.1.1.529",
    "link" : "https://cov-lineages.org/lineage.html?lineage=B.1.1.529",
    "description" : "SARS-CoV-2 Omicron; B.1.1.529",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 WA1/2020 (D614G variant)",
    "link" : "https://www.ncbi.nlm.nih.gov/biosample/SAMN18527778",
    "description" : "SARS-CoV-2 WA1/2020 (D614G variant)",
    "id" : "0"
  }, {
    "name" : "SARS-COV-2 WUHAN-HU-1 in pseudovirus",
    "link" : "https://www.takarabio.com/products/covid-19-research/sars-cov-2-pseudovirus/wuhan-hu-1",
    "description" : "SARS-COV-2 WUHAN-HU-1 in pseudovirus",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Wuhan/2020",
    "link" : "https://www.ncbi.nlm.nih.gov/nuccore/MN908947",
    "description" : "SARS-CoV-2 Wuhan/2020",
    "id" : "0"
  }, {
    "name" : "SARS-CoV-2 Zeta; P.2",
    "link" : "https://cov-lineages.org/lineage.html?lineage=P.2",
    "description" : "SARS-CoV-2 Zeta; P.2",
    "id" : "0"
  }, {
    "name" : "SARS-like coronavirus WIV1",
    "link" : "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=1415852",
    "description" : "SARS-like coronavirus WIV1",
    "id" : "1415852"
  }, {
    "name" : "Yellow fever virus 17D",
    "link" : "http://purl.obolibrary.org/obo/NCBITaxon_11090",
    "description" : "Yellow fever virus 17D",
    "id" : "11090"
  } ]
}, {
  "name" : "lk_yes_no",
  "rows" : [ {
    "name" : "No",
    "link" : "",
    "description" : "No",
    "id" : ""
  }, {
    "name" : "Yes",
    "link" : "",
    "description" : "Yes",
    "id" : ""
  } ]
} ]